Citrus Sinensis ID: 041034

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-
Protein Sequence
SEIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEMFWLHESDNTQ
Secondary Structure (PSIPRED)
cHHHHHHHHcccccccccccccccccccccccccccccEEEEEccccccEEEcccccccccccccEEEccccEEEEcccHHHHcccccccEEccccEEEEcccHHcccccccccEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEccccEEEEccccccccccccccEEccccEEEEcccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccccccccEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccEEEHHHHHHHHHccccccccccHHHcccccccHHHHHccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHccccccccccccccccEEccccccEEEEEEccccccccccHHHHccccccEEEEEccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccccEEEcccccccEEEEccccEEEEEccHHHccccHHHHHHcccccccccccccHHEEEEHHHcccccccccccccccHHccHHHHHHHHHHcccccEEEccccEEEEEEEcccccEEEEEEcccccccccccccHHHHHHHHHHHHHHHHHHHHHEEcccccccEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEccccccHHHHHcHHEEEccccccEEEEEEccccccccHEEEEEEccccccHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHccccHHHccHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
SEIERQALLncgwwkdriphntsdhcnwvgitcdykgsitHIELVECSikgelgslnfscfpnlqylnlwnnnlsgsippqigslsnlkYLNLRWNNltgtipkeigsLRNLEVLYLSnnslhgttpieigslrNLEELYLRSNklsgvlpqeigNLKSLIWLSVMYntvggpipstlfrLTNLERLFLGcnqfngtipreignlknltHLSIITNKltgaipstlgHLTSLLYLDLSfnqlhsfipleignfsalaeldlsdnkirgiipdELSKlsnlqylnlssnllsgqipfaiGKLFNLVsldlsknklsgsfptgigncTELQHLALnhnsldgtippeIGKILLLQNldlshnnlsgtipmtlhpmfldmsfnnlegeiptylrdnppnsfvgnkglcgHVQVLAFTIFGFILLLKgksenlklvtggydgkiLYEDLINATEDFHIRYcigtggygsvykaelpdgkVVALKKLhqsetedsAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGslfyvlrdddeaiELNWTRRVNIVKSVAHALSYlhhdctpsivhrdissnnillnsNLEAFVADFGtarllhvdssnrtlragtygyiapdqrlsppvnqKIIQDIILVSTTALAclrskpksrptmQRISQelegktpmkkgLKEISISEMRNQEMFWLHESDNTQ
Flexible Loop (DISEMBL)
SEIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGyiapdqrlspPVNQKIIQDIILVSTTALAClrskpksrptmqrisqelegktpmkkgLKEISISEMRNQEMFWLHESDNTQ
Low Complexity Region (SEG)
SEIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPnlqylnlwnnnlSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDElsklsnlqylnlssnllsGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDissnnillnsnlEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEMFWLHESDNTQ
Disordered region (IsUnstruct)
******ALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLH*******AFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL**************************************************
Disordered Region (DISOPRED)
*EIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLK***************KILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE*****ESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEM**********
Disordered Region (DISEMBL)
SEIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR***********ISQELEGKTPMKKGLKEISISEMRNQEMFWLHESDNTQ
Disordered Region (DISPRO)
****RQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEMFWLHE*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SEIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEMFWLHESDNTQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	701	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.863	0.578	0.361	1e-124
Q9LP24	1120	Probable leucine-rich rep	no	no	0.887	0.555	0.350	1e-108
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.863	0.549	0.366	1e-102
Q9LHP4	1141	Receptor-like protein kin	no	no	0.861	0.529	0.350	2e-99
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.853	0.477	0.345	5e-98
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.821	0.461	0.345	6e-96
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.861	0.548	0.339	9e-96
Q42371	976	LRR receptor-like serine/	no	no	0.810	0.581	0.347	1e-95
C0LGV1	1135	LRR receptor-like serine/	no	no	0.857	0.529	0.340	2e-94
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.827	0.572	0.348	2e-94

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  447 bits (1150), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 285/789 (36%), Positives = 404/789 (51%), Gaps = 184/789 (23%)

Query: 57   NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
            +F    N+  LN++ N LSG IPP+IG+++ L  L+L  N LTG IP  +G+++ L VL+
Sbjct: 257  SFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLH 316

Query: 117  LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI-- 174
            L  N L+G+ P E+G + ++ +L +  NKL+G +P   G L +L WL +  N + GPI  
Sbjct: 317  LYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPP 376

Query: 175  ----------------------PSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLS 212
                                  P T+ R   LE L L  N F G +P+ + + K+L  + 
Sbjct: 377  GIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVR 436

Query: 213  IITNKLTGAIPSTLGHLTSLLYLDLSFNQLH------------------------SFIPL 248
               N  +G I    G   +L ++DLS N  H                          IP 
Sbjct: 437  FKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPP 496

Query: 249  EIGNFSALAELDLSDNKIRGIIPDELSK------------------------LSNLQYLN 284
            EI N + L++LDLS N+I G +P+ +S                         L+NL+YL+
Sbjct: 497  EIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLD 556

Query: 285  LSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP 344
            LSSN  S +IP  +  L  L  ++LS+N L  + P G+   ++LQ L L++N LDG I  
Sbjct: 557  LSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISS 616

Query: 345  EIGKILLLQNLDLSHNNLSGTIPMTLHPMF----LDMSFNNLEGEIP--TYLRDNPPNSF 398
            +   +  L+ LDLSHNNLSG IP +   M     +D+S NNL+G IP     R+ PP++F
Sbjct: 617  QFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAF 676

Query: 399  VGNKGLCGHVQV------------------------LAFTIFGFILLL------------ 422
             GNK LCG V                          +   I G I++L            
Sbjct: 677  EGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRK 736

Query: 423  --KGKSENLKLVTGG-------YDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPD 473
              K   E+    +GG       +DGK+ Y+++I AT +F  +Y IGTGG+G VYKA+LP+
Sbjct: 737  RTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN 796

Query: 474  GKVVALKKLHQSETEDSAFV-----ESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY 528
              ++A+KKL+  ET DS+       + F NE R L+ +RHRN+VKL+GFC H+R  F +Y
Sbjct: 797  A-IMAVKKLN--ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVY 853

Query: 529  EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 588
            EYMERGSL  VL +DDEA +L+W +R+N+VK VAHALSY+HHD +P+IVHRDISS NILL
Sbjct: 854  EYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILL 913

Query: 589  NSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP------------------------ 624
              + EA ++DFGTA+LL  DSSN +  AGTYGY+AP                        
Sbjct: 914  GEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEV 973

Query: 625  ----------------------------DQRLSPPVNQKIIQDIILVSTTALACLRSKPK 656
                                        D RL  P   +I ++++ +   AL CL S P+
Sbjct: 974  IKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPT-PEIKEEVLEILKVALLCLHSDPQ 1032

Query: 657  SRPTMQRIS 665
            +RPTM  IS
Sbjct: 1033 ARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  392 bits (1008), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 282/804 (35%), Positives = 401/804 (49%), Gaps = 182/804 (22%)

Query: 38   SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
            S+  +EL    + G + S +     NL  L L+ N L+G IPP++G++ ++  L L  N 
Sbjct: 319  SMIDLELSNNKLTGSIPS-SLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNK 377

Query: 98   LTGTIP------------------------KEIGSLRNLEVLYLSNNSLHGTTPIEIGSL 133
            LTG+IP                        +E+G++ ++  L LS N L G+ P   G+ 
Sbjct: 378  LTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNF 437

Query: 134  RNLEELYLRSNKLSGVLPQEIGN---LKSLIW---------------------LSVMYNT 169
              LE LYLR N LSG +P  + N   L +LI                      +S+ YN 
Sbjct: 438  TKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNH 497

Query: 170  VGGPIPSTLFRLTNLERL-FLGCNQFNGTIPREIG-----NLKNLTH------------- 210
            + GPIP +L    +L R  FLG N+F G I    G     N  + +H             
Sbjct: 498  LEGPIPKSLRDCKSLIRARFLG-NKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEK 556

Query: 211  ------LSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
                  L +  N +TGAIP+ + ++T L+ LDLS N L   +P  IGN + L+ L L+ N
Sbjct: 557  SPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGN 616

Query: 265  KIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGN 324
            ++ G +P  LS L+NL+ L+LSSN  S +IP        L  ++LS+NK  GS P  +  
Sbjct: 617  QLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSK 675

Query: 325  CTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMF----LDMSFN 380
             T+L  L L+HN LDG IP ++  +  L  LDLSHNNLSG IP T   M     +D+S N
Sbjct: 676  LTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNN 735

Query: 381  NLEGEIPTY--LRDNPPNSFVGNKGLCGHVQV---------------------LAFTIFG 417
             LEG +P     R    ++   N GLC ++                       +   I G
Sbjct: 736  KLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILG 795

Query: 418  FILLLK-----------------GKS------ENLKLVTGGYDGKILYEDLINATEDFHI 454
             +++L                  G++      EN+ + +   DGK  Y+D+I +T +F  
Sbjct: 796  VLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFS--VDGKFKYQDIIESTNEFDP 853

Query: 455  RYCIGTGGYGSVYKAELPDGKVVALKKLHQS---ETEDSAFVESFQNEARVLSTVRHRNI 511
             + IGTGGY  VY+A L D  ++A+K+LH +   E       + F NE + L+ +RHRN+
Sbjct: 854  THLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNV 912

Query: 512  VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
            VKL+GFC H+R  F IYEYME+GSL  +L +D+EA  L WT+R+N+VK VAHALSY+HHD
Sbjct: 913  VKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHD 972

Query: 572  CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
                IVHRDISS NILL+++  A ++DFGTA+LL  DSSN +  AGTYGY+AP+   +  
Sbjct: 973  RITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMK 1032

Query: 632  VNQK---------IIQDII------LVST------------------------------- 645
            V +K         I++ II      LVS+                               
Sbjct: 1033 VTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQNREKLL 1092

Query: 646  ----TALACLRSKPKSRPTMQRIS 665
                 AL CL++ P+SRPTM  IS
Sbjct: 1093 KMVEMALLCLQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  374 bits (961), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 248/677 (36%), Positives = 346/677 (51%), Gaps = 72/677 (10%)

Query: 37   GSITHIELVECSIKGELGSL--NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLR 94
            G +T +E ++ SI    G++       P L  L L++N L G IPP IG  SN   L++ 
Sbjct: 352  GELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMS 411

Query: 95   WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
             N+L+G IP      + L +L L +N L G  P ++ + ++L +L L  N+L+G LP E+
Sbjct: 412  ANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIEL 471

Query: 155  GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSII 214
             NL++L  L +  N + G I + L +L NLERL L  N F G IP EIGNL  +   +I 
Sbjct: 472  FNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNIS 531

Query: 215  TNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEL 274
            +N+LTG IP  LG   ++  LDLS N+   +I  E+G    L  L LSDN++ G IP   
Sbjct: 532  SNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSF 591

Query: 275  SKLSNLQYLNLSSNLLSGQIPFAIGKLFNL-VSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
              L+ L  L L  NLLS  IP  +GKL +L +SL++S N LSG+ P  +GN   L+ L L
Sbjct: 592  GDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYL 651

Query: 334  NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDN 393
            N N L G IP  IG ++ L   ++S+NNL GT+P T   +F  M  +N            
Sbjct: 652  NDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDT--AVFQRMDSSN------------ 697

Query: 394  PPNSFVGNKGLC----GHVQ--------------------------------VLAFTIFG 417
                F GN GLC     H Q                                V   T  G
Sbjct: 698  ----FAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLG 753

Query: 418  FILLLKGKSENLKLVTGGYDGKIL-----------YEDLINATEDFHIRYCIGTGGYGSV 466
                +K +      +       ++           Y+ L++AT +F     +G G  G+V
Sbjct: 754  LCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTV 813

Query: 467  YKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF 526
            YKAE+  G+V+A+KKL+ S  E ++   SF+ E   L  +RHRNIVKLYGFC H+     
Sbjct: 814  YKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLL 872

Query: 527  IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNI 586
            +YEYM +GSL   L+  ++   L+W  R  I    A  L YLHHDC P IVHRDI SNNI
Sbjct: 873  LYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNI 932

Query: 587  LLNSNLEAFVADFGTARLLHVD-SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVST 645
            LL+   +A V DFG A+L+ +  S + +  AG+YGYIAP+   +  V +K   DI     
Sbjct: 933  LLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKC--DIYSFGV 990

Query: 646  TALACLRSKPKSRPTMQ 662
              L  +  KP  +P  Q
Sbjct: 991  VLLELITGKPPVQPLEQ 1007

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  363 bits (933), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 253/722 (35%), Positives = 361/722 (50%), Gaps = 118/722 (16%)

Query: 48   SIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG 107
            SI  E+G L       L+ L LW N+L G IP +IG+ SNLK ++L  N L+G+IP  IG
Sbjct: 289  SIPREIGQLT-----KLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG 343

Query: 108  SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI----W- 162
             L  LE   +S+N   G+ P  I +  +L +L L  N++SG++P E+G L  L     W 
Sbjct: 344  RLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWS 403

Query: 163  -------------------LSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG 203
                               L +  N++ G IPS LF L NL +L L  N  +G IP+EIG
Sbjct: 404  NQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIG 463

Query: 204  NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
            N  +L  L +  N++TG IPS +G L  + +LD S N+LH  +P EIG+ S L  +DLS+
Sbjct: 464  NCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSN 523

Query: 264  NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIG 323
            N + G +P+ +S LS LQ L++S+N  SG+IP ++G+L +L  L LSKN  SGS PT +G
Sbjct: 524  NSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLG 583

Query: 324  NCTELQHLALNHNSLDGTIPPEIGKILLLQ-NLDLSHNNLSGTIPMTLHPM----FLDMS 378
             C+ LQ L L  N L G IP E+G I  L+  L+LS N L+G IP  +  +     LD+S
Sbjct: 584  MCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLS 643

Query: 379  FNNLEGEIPT-------------------YLRDNP------PNSFVGNKGLCGHVQVLAF 413
             N LEG++                     YL DN       P    GNK LC   Q   F
Sbjct: 644  HNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCF 703

Query: 414  -----------------------------------TIFGFILLLKGK----SENLKLVTG 434
                                                I G + +++ +    +E    +  
Sbjct: 704  LTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGE 763

Query: 435  GYDGKILYEDLINATEDFHIRY-----CIGTGGYGSVYKAELPDGKVVALKKL------- 482
             Y  +      +N + D  IR       IG G  G VY+A++ +G+V+A+KKL       
Sbjct: 764  TYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNG 823

Query: 483  -HQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR 541
             H  +T++    +SF  E + L T+RH+NIV+  G C ++     +Y+YM  GSL  +L 
Sbjct: 824  GHDEKTKN--VRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH 881

Query: 542  DDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT 601
             +     L+W  R  I+   A  L+YLHHDC P IVHRDI +NNIL+  + E ++ADFG 
Sbjct: 882  -ERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGL 940

Query: 602  ARLLHVDSSNRTLR--AGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRP 659
            A+L+      R     AG+YGYIAP+   S  + +K   D+       L  L  K    P
Sbjct: 941  AKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEK--SDVYSYGVVVLEVLTGKQPIDP 998

Query: 660  TM 661
            T+
Sbjct: 999  TV 1000

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  358 bits (920), Expect = 5e-98,   Method: Compositional matrix adjust.
 Identities = 246/711 (34%), Positives = 352/711 (49%), Gaps = 113/711 (15%)

Query: 35   YKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLR 94
            + G +  + L E    GE+     +C   LQ ++ + N LSG IP  IG L +L  L+LR
Sbjct: 431  FLGKLEIMYLYENRFSGEMPVEIGNC-TRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLR 489

Query: 95   WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
             N L G IP  +G+   + V+ L++N L G+ P   G L  LE   + +N L G LP  +
Sbjct: 490  ENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSL 549

Query: 155  GNLKSL-----------------------IWLSVMYNTVGGPIPSTLFRLTNLERLFLGC 191
             NLK+L                       +   V  N   G IP  L + TNL+RL LG 
Sbjct: 550  INLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGK 609

Query: 192  NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG 251
            NQF G IPR  G +  L+ L I  N L+G IP  LG    L ++DL+ N L   IP  +G
Sbjct: 610  NQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLG 669

Query: 252  NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK 311
                L EL LS NK  G +P E+  L+N+  L L  N L+G IP  IG L  L +L+L +
Sbjct: 670  KLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEE 729

Query: 312  NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQN-LDLSHNNLSGTIPMTL 370
            N+LSG  P+ IG  ++L  L L+ N+L G IP EIG++  LQ+ LDLS+NN +G IP T+
Sbjct: 730  NQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTI 789

Query: 371  HPM----------------------------FLDMSFNNLEGEIPTYLRDNPPNSFVGNK 402
              +                            +L++S+NNLEG++         ++FVGN 
Sbjct: 790  STLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNA 849

Query: 403  GLCG-----------------------------HVQVLAFTIFGFILLLKGKSENLKLV- 432
            GLCG                              +  +A  +   IL  K   +  K V 
Sbjct: 850  GLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVR 909

Query: 433  -------------------TGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPD 473
                                GG    I ++D++ AT   +  + IG+GG G VYKAEL +
Sbjct: 910  GGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKN 969

Query: 474  GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR--CMFFIYEYM 531
            G+ +A+KK+     +D    +SF  E + L T+RHR++VKL G+C  K       IYEYM
Sbjct: 970  GETIAVKKILWK--DDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYM 1027

Query: 532  ERGSLFYVLRDDDEAIE---LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 588
              GS++  L  ++   +   L W  R+ I   +A  + YLH+DC P IVHRDI S+N+LL
Sbjct: 1028 ANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLL 1087

Query: 589  NSNLEAFVADFGTARLL----HVDSSNRTLRAGTYGYIAPDQRLSPPVNQK 635
            +SN+EA + DFG A++L      ++ + T+ AG+YGYIAP+   S    +K
Sbjct: 1088 DSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEK 1138

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  352 bits (903), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 248/718 (34%), Positives = 350/718 (48%), Gaps = 142/718 (19%)

Query: 58   FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
             S    L+ L L+ N  SG IP +IG+ ++LK +++  N+  G IP  IG L+ L +L+L
Sbjct: 428  ISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHL 487

Query: 118  SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
              N L G  P  +G+   L  L L  N+LSG +P   G LK L  L +  N++ G +P +
Sbjct: 488  RQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDS 547

Query: 178  LFRLTNLERLFLGCNQFNGTI-----------------------PREIGNLKNLTHLSII 214
            L  L NL R+ L  N+ NGTI                       P E+GN +NL  L + 
Sbjct: 548  LISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLG 607

Query: 215  TNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEL 274
             N+LTG IP TLG +  L  LD+S N L   IPL++     L  +DL++N + G IP  L
Sbjct: 608  KNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWL 667

Query: 275  SKLSNLQYLNLSSNL------------------------LSGQIPFAIGKLFNLVSLDLS 310
             KLS L  L LSSN                         L+G IP  IG L  L  L+L 
Sbjct: 668  GKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLD 727

Query: 311  KNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQN---------------- 354
            KN+ SGS P  +G  ++L  L L+ NSL G IP EIG++  LQ+                
Sbjct: 728  KNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPST 787

Query: 355  ---------LDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTYLRDNPPNSFVGN 401
                     LDLSHN L+G +P ++  M    +L++SFNNL G++       P +SF+GN
Sbjct: 788  IGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGN 847

Query: 402  KGLCGH-------------------------VQVLAFTIFGFILLL-----KGKSENLKL 431
             GLCG                            + A T  G ++L+     K + +  K 
Sbjct: 848  TGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKK 907

Query: 432  V-----------------------TGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYK 468
            V                        G     I +ED++ AT +    + IG+GG G VYK
Sbjct: 908  VGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYK 967

Query: 469  AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR--CMFF 526
            AEL +G+ VA+KK+     +D    +SF  E + L  +RHR++VKL G+C  K       
Sbjct: 968  AELENGETVAVKKILWK--DDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLL 1025

Query: 527  IYEYMERGSLFYVLRDDDEAIE-----LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDI 581
            IYEYM+ GS++  L +D   +E     L+W  R+ I   +A  + YLHHDC P IVHRDI
Sbjct: 1026 IYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDI 1085

Query: 582  SSNNILLNSNLEAFVADFGTARLL----HVDSSNRTLRAGTYGYIAPDQRLSPPVNQK 635
             S+N+LL+SN+EA + DFG A++L      ++ + T  A +YGYIAP+   S    +K
Sbjct: 1086 KSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEK 1143

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  351 bits (901), Expect = 9e-96,   Method: Compositional matrix adjust.
 Identities = 252/743 (33%), Positives = 358/743 (48%), Gaps = 139/743 (18%)

Query: 49   IKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGS 108
            I  ELG L      +L++L L+ N L+G+IP +IG+LS    ++   N LTG IP E+G+
Sbjct: 281  IPKELGDLQ-----SLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGN 335

Query: 109  LRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL----------------YLR--------SN 144
            +  LE+LYL  N L GT P+E+ +L+NL +L                YLR         N
Sbjct: 336  IEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQN 395

Query: 145  KLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN 204
             LSG +P ++G    L  L +  N + G IPS L   +N+  L LG N  +G IP  I  
Sbjct: 396  SLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITT 455

Query: 205  LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
             K L  L +  N L G  PS L    ++  ++L  N+    IP E+GN SAL  L L+DN
Sbjct: 456  CKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADN 515

Query: 265  KIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI------------------------GK 300
               G +P E+  LS L  LN+SSN L+G++P  I                        G 
Sbjct: 516  GFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGS 575

Query: 301  LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQ-NLDLSH 359
            L+ L  L LS N LSG+ P  +GN + L  L +  N  +G+IP E+G +  LQ  L+LS+
Sbjct: 576  LYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSY 635

Query: 360  NNLSGTIPMTLHPMFL----------------------------DMSFNNLEGEIPTYLR 391
            N L+G IP  L  + +                            + S+N+L G IP  LR
Sbjct: 636  NKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP-LLR 694

Query: 392  DNPPNSFVGNKGLCGH----------------------------VQVLAFTIFGFILLLK 423
            +   +SF+GN+GLCG                             + + A  I G  L+L 
Sbjct: 695  NISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLI 754

Query: 424  G------KSENLKLVTGGYDGK---------------ILYEDLINATEDFHIRYCIGTGG 462
                   +     + +   DG+                 ++DL+ AT++F   + +G G 
Sbjct: 755  ALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGA 814

Query: 463  YGSVYKAELPDGKVVALKKLHQSET--EDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH 520
             G+VYKA LP G  +A+KKL  +     ++    SF+ E   L  +RHRNIVKL+GFC H
Sbjct: 815  CGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNH 874

Query: 521  KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRD 580
            +     +YEYM +GSL  +L   D +  L+W++R  I    A  L+YLHHDC P I HRD
Sbjct: 875  QGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRD 932

Query: 581  ISSNNILLNSNLEAFVADFGTARLLHVD-SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQD 639
            I SNNILL+   EA V DFG A+++ +  S + +  AG+YGYIAP+   +  V +K   D
Sbjct: 933  IKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEK--SD 990

Query: 640  IILVSTTALACLRSKPKSRPTMQ 662
            I       L  L  K   +P  Q
Sbjct: 991  IYSYGVVLLELLTGKAPVQPIDQ 1013

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  351 bits (900), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 224/644 (34%), Positives = 338/644 (52%), Gaps = 76/644 (11%)

Query: 64  LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH 123
           LQYL L  NNL G+I P +  L+ L Y ++R N+LTG+IP+ IG+    +VL LS N L 
Sbjct: 190 LQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLT 249

Query: 124 GTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTN 183
           G  P +IG L+ +  L L+ N+LSG +P  IG +++L  L +  N + G IP  L  LT 
Sbjct: 250 GEIPFDIGFLQ-VATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTF 308

Query: 184 LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
            E+L+L  N+  G+IP E+GN+  L +L +  N LTG IP  LG LT L  L+++ N L 
Sbjct: 309 TEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLE 368

Query: 244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN 303
             IP  + + + L  L++  NK  G IP    KL ++ YLNLSSN + G IP  + ++ N
Sbjct: 369 GPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGN 428

Query: 304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           L +LDLS NK++G  P+ +G+   L  + L+ N + G +P + G +  +  +DLS+N++S
Sbjct: 429 LDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDIS 488

Query: 364 GTIPMTLHPM---------------------------FLDMSFNNLEGEIP--TYLRDNP 394
           G IP  L+ +                            L++S NNL G+IP         
Sbjct: 489 GPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFS 548

Query: 395 PNSFVGNKGLCG-------------------HVQVLAFTIFGFILLLKGKSENLK----- 430
           P+SF+GN GLCG                      +L   I G ++LL       +     
Sbjct: 549 PDSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPP 608

Query: 431 -LVTGGYDGKI-----------------LYEDLINATEDFHIRYCIGTGGYGSVYKAELP 472
             + G  D  +                 +YED++  TE+   +Y IG G   +VYK  L 
Sbjct: 609 PFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLK 668

Query: 473 DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME 532
           + K VA+K+L+    +    ++ F+ E  +LS+++HRN+V L  + L        Y+Y+E
Sbjct: 669 NCKPVAIKRLYSHNPQS---MKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLE 725

Query: 533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL 592
            GSL+ +L    +   L+W  R+ I    A  L+YLHHDC+P I+HRD+ S+NILL+ +L
Sbjct: 726 NGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDL 785

Query: 593 EAFVADFGTARLLHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQK 635
           EA + DFG A+ L V  S+  T   GT GYI P+   +  + +K
Sbjct: 786 EARLTDFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEK 829

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  347 bits (889), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 244/717 (34%), Positives = 358/717 (49%), Gaps = 116/717 (16%)

Query: 52   ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRN 111
            ELG L      NL+ + LW NNL G IP +IG + +L  ++L  N  +GTIPK  G+L N
Sbjct: 294  ELGKLQ-----NLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSN 348

Query: 112  LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL----IW----- 162
            L+ L LS+N++ G+ P  + +   L +  + +N++SG++P EIG LK L     W     
Sbjct: 349  LQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLE 408

Query: 163  ---------------LSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKN 207
                           L +  N + G +P+ LF+L NL +L L  N  +G IP EIGN  +
Sbjct: 409  GNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTS 468

Query: 208  LTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIR 267
            L  L ++ N++TG IP  +G L +L +LDLS N L   +PLEI N   L  L+LS+N ++
Sbjct: 469  LVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQ 528

Query: 268  GIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTE 327
            G +P  LS L+ LQ L++SSN L+G+IP ++G L +L  L LSKN  +G  P+ +G+CT 
Sbjct: 529  GYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTN 588

Query: 328  LQHLALNHNSLDGTIPPEIGKILLLQ-NLDLSHNNLSGTIPMTL------------HPMF 374
            LQ L L+ N++ GTIP E+  I  L   L+LS N+L G IP  +            H M 
Sbjct: 589  LQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNML 648

Query: 375  ---------------LDMSFNNLEGEIP--TYLRDNPPNSFVGNKGLCGH---------- 407
                           L++S N   G +P     R        GN GLC            
Sbjct: 649  SGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNS 708

Query: 408  ---------------------VQVLA-FTIFGFILLLKGKSENLKLVTGGYDGKILYE-- 443
                                 + V A   + G + +++ K + ++       G+ L+   
Sbjct: 709  SQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAK-QMIRDDNDSETGENLWTWQ 767

Query: 444  ----DLINATEDFHIRYC------IGTGGYGSVYKAELPDGKVVALKKLH-------QSE 486
                  +N T + H+  C      IG G  G VYKAE+P+ +V+A+KKL          +
Sbjct: 768  FTPFQKLNFTVE-HVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEK 826

Query: 487  TEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEA 546
            T+ S   +SF  E + L ++RH+NIV+  G C +K     +Y+YM  GSL  +L +    
Sbjct: 827  TKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGV 886

Query: 547  IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
              L W  R  I+   A  L+YLHHDC P IVHRDI +NNIL+  + E ++ DFG A+L+ 
Sbjct: 887  CSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVD 946

Query: 607  VDSSNRTLR--AGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTM 661
                 R+    AG+YGYIAP+   S  + +K   D+       L  L  K    PT+
Sbjct: 947  DGDFARSSNTIAGSYGYIAPEYGYSMKITEK--SDVYSYGVVVLEVLTGKQPIDPTI 1001

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  347 bits (889), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 233/668 (34%), Positives = 349/668 (52%), Gaps = 88/668 (13%)

Query: 49  IKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGS 108
           I  E G++N     +L+YL+L    LSG IP ++G L +L+ L L  NN TGTIP+EIGS
Sbjct: 228 IPPEFGNIN-----SLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGS 282

Query: 109 LRNLEVLYLSNNSLHGTTPIEI------------------------GSLRNLEELYLRSN 144
           +  L+VL  S+N+L G  P+EI                         SL  L+ L L +N
Sbjct: 283 ITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNN 342

Query: 145 KLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN 204
            LSG LP ++G    L WL V  N+  G IPSTL    NL +L L  N F G IP  +  
Sbjct: 343 TLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLST 402

Query: 205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
            ++L  + +  N L G+IP   G L  L  L+L+ N+L   IP +I +  +L+ +D S N
Sbjct: 403 CQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRN 462

Query: 265 KIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGN 324
           +IR  +P  +  + NLQ   ++ N +SG++P       +L +LDLS N L+G+ P+ I +
Sbjct: 463 QIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIAS 522

Query: 325 CTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFN 380
           C +L  L L +N+L G IP +I  +  L  LDLS+N+L+G +P ++        L++S+N
Sbjct: 523 CEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYN 582

Query: 381 NLEGEIPT--YLRDNPPNSFVGNKGLCGHV--------------------QVLAFTIFGF 418
            L G +P   +L+   P+   GN GLCG V                    +++A  + G 
Sbjct: 583 KLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGI 642

Query: 419 -------ILLLKGKSENLKLVTGGYDGK-------------------ILYEDLINATEDF 452
                  IL +  ++   K  + G+ G                        D++   ++ 
Sbjct: 643 ASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKES 702

Query: 453 HIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVRHRN 510
           ++   IG G  G VYKAE+     V+A+KKL +S  + +      F  E  +L  +RHRN
Sbjct: 703 NM---IGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRN 759

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL--NWTRRVNIVKSVAHALSYL 568
           IV+L GF  + + M  +YE+M  G+L   +   + A  L  +W  R NI   VAH L+YL
Sbjct: 760 IVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYL 819

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
           HHDC P ++HRDI SNNILL++NL+A +ADFG AR++       ++ AG+YGYIAP+   
Sbjct: 820 HHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGY 879

Query: 629 SPPVNQKI 636
           +  V++KI
Sbjct: 880 TLKVDEKI 887

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	701
225465647	820	PREDICTED: probable LRR receptor-like se	0.972	0.831	0.447	1e-167
359484066	843	PREDICTED: probable LRR receptor-like se	0.972	0.809	0.438	1e-167
296085303	789	unnamed protein product [Vitis vinifera]	0.954	0.847	0.441	1e-166
224065665	847	predicted protein [Populus trichocarpa]	0.974	0.806	0.436	1e-163
225452751	878	PREDICTED: probable leucine-rich repeat	0.974	0.777	0.405	1e-162
296085307	874	unnamed protein product [Vitis vinifera]	0.980	0.786	0.416	1e-161
356506370	798	PREDICTED: probable LRR receptor-like se	0.975	0.857	0.442	1e-157
359484063	1003	PREDICTED: probable LRR receptor-like se	0.912	0.638	0.456	1e-156
357501751	799	Receptor kinase [Medicago truncatula] gi	0.978	0.858	0.423	1e-156
225452749	783	PREDICTED: probable LRR receptor-like se	0.930	0.832	0.422	1e-155

>gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  596 bits (1537), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 348/777 (44%), Positives = 467/777 (60%), Gaps = 95/777 (12%)

Query: 8   LLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKG-ELGSLNFSCFPNLQY 66
           L N  WW   + + TS HC W GITC+ +G +  I       K  EL  L FS FP+L +
Sbjct: 46  LRNSTWWW-YMENTTSHHCTWEGITCNTEGHVVRITYSYIDGKMVELSKLKFSSFPSLLH 104

Query: 67  LNLWNNNLSGSIPPQIGSLSNLKYL------------------------NLRWNNLTGTI 102
           L + ++++ G IP +IG L+ L YL                        +L +NNL+G I
Sbjct: 105 LYVSHSSIYGRIPDEIGMLTKLTYLRISECDVYGELPVSLGNLTLLEELDLAYNNLSGVI 164

Query: 103 PKEIGSLRNLEVLYLS-NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
           P  +G L+NL  L LS N  L G  P  +G L+NL+ L L  N+++G +P +IGNLK+L 
Sbjct: 165 PSSLGYLKNLIHLDLSFNYGLSGVIPPSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLT 224

Query: 162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
            L ++ N++ G IPS L  L+NLE LFL  N+ NG+IP EIGNLKNL  L +  N L GA
Sbjct: 225 HLYLVSNSLSGVIPSPLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCLSHNSLIGA 284

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
           IPS+LGHLT+L YL L  NQ+   IPL  G+ + L +L L  N+I G IP  +  L NL 
Sbjct: 285 IPSSLGHLTNLTYLHLFNNQIQGGIPLSFGHLTNLTDLYLCYNQINGSIPPIIWNLKNLI 344

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
           +L L  N L+G IP ++G L +L   ++S N++SG  P+ IGN   L  L L+ N + G 
Sbjct: 345 HLRLDHNNLTGVIPSSLGYLIHLHEFNISGNQISGQIPSSIGNLNNLTRLDLSDNLIHGK 404

Query: 342 IPPEIGKILLLQNLDLSHNNLSGTIPMTL-----HPMFLDMSFNNLEGEIPTYLRDN-PP 395
           IP ++  +  L  L+LSHN LSG+IP  L      P  LD+S+N+LEG IP  L+     
Sbjct: 405 IPSQVQNLKRLVYLNLSHNKLSGSIPTLLIYDHIRPS-LDLSYNDLEGHIPFELQSKFSQ 463

Query: 396 NSFVGNKGLCGHVQVLAFTIFGF----ILLLKGKSENLKLVTG------GYDGKILYEDL 445
            SF  NKGLCG ++ L      +    I+  K +++ +    G       YDGKI YED+
Sbjct: 464 GSFDNNKGLCGDIKGLPHCKEEYKTTRIITRKIQTKEIPTKNGDIFSVWNYDGKIAYEDI 523

Query: 446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           I ATEDF I+YCIGTGGYGSVYKA+LP G VVALKKLH  ET+++ +++SFQNE ++LS 
Sbjct: 524 IKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSK 583

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           +RHRNIVKL G+CLHKRCMF IY YM RGSL+ VL ++ EA+EL+W +RVN+VKS+ HA+
Sbjct: 584 IRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAV 643

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP- 624
            Y+HHDCTP I+HRDISSNNILL+S L+AF++DFGT+RLLH DSSN+TL +GTYGYIAP 
Sbjct: 644 CYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPE 703

Query: 625 --------------------------------------------------DQRLSPPVNQ 634
                                                             D RL  P +Q
Sbjct: 704 LAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQ 763

Query: 635 KIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEM 691
           ++ +D++LV   AL C+ S P+SRPTMQ IS +L  ++P       IS+ ++   E+
Sbjct: 764 QVARDVVLVVWLALKCIHSNPRSRPTMQHISSKLLTQSPFLGPFHGISLWQLNALEI 820

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  596 bits (1537), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 351/800 (43%), Positives = 469/800 (58%), Gaps = 118/800 (14%)

Query: 8   LLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKG-ELGSLNFSCFPNLQY 66
           L N  WW   + + TS HC W GITC+ +G +  I       K  EL  L FS FP+L +
Sbjct: 46  LRNSTWWW-YMENTTSHHCTWEGITCNTEGHVVRITYSYIDGKMVELSKLKFSSFPSLLH 104

Query: 67  LNLWNNNLSGSIPPQIGSLSNLKYL------------------------NLRWNNLTGTI 102
           LN+ ++++ G IP +IG L+ L YL                        +L +NNL+G I
Sbjct: 105 LNVSHSSIYGRIPDEIGMLTKLTYLRISECDVHGELPVSLGNLTLLEELDLAYNNLSGVI 164

Query: 103 PKEIGSLRNLEVLYLS-NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
           P  +G L+NL  L LS N  L G  P  +G L+NL+ L L  N+++G +P +IGNLK+L 
Sbjct: 165 PSSLGYLKNLIHLDLSFNYGLSGVIPSSLGYLKNLKYLDLSINEINGSIPYQIGNLKNLT 224

Query: 162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
            L ++ N++ G IPS+L  L+NLE LFL  N+ NG+IP EIGNLKNL  L    N L G 
Sbjct: 225 HLYLVSNSLSGVIPSSLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCFSHNSLIGT 284

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
           IP +LGHLT+L YL L  NQ+   IPL  G+ + L +L+L DN+I G IP  +  L NL 
Sbjct: 285 IPPSLGHLTNLTYLHLFNNQIQGGIPLSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLI 344

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
           +L L  N L+G IP ++G L +L   ++S N+++G  P+ IGN   L  L L+ N + G 
Sbjct: 345 HLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGK 404

Query: 342 IPPEIGKILLLQNLDLSHNNLSGTIPMTL-----HPMFLDMSFNNLEGEIPTYLRDN-PP 395
           IP ++  +  L  L+LSHN LSG+IP  L      P  LD+S N+LEG IP  L+     
Sbjct: 405 IPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPS-LDLSHNDLEGHIPFELQSKFSQ 463

Query: 396 NSFVGNKGLCGHVQ-----------------------VLAFTIFGFILL----LKGKSEN 428
            SF  NKGLCG ++                        L F + GF+LL     K +++ 
Sbjct: 464 GSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLLSRKTRKIQTKE 523

Query: 429 LKLVTG------GYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKL 482
           +    G       YDGKI YED+I ATEDF I+YCIGTGGYGSVYKA+LP G VVALKKL
Sbjct: 524 IPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKL 583

Query: 483 HQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD 542
           H  E +++ +++SFQNE ++LS +RHRNIVKL G+CLHKRCMF IY YM RGSL+ VL +
Sbjct: 584 HGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSN 643

Query: 543 DDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
           + EA+EL+W +RVN+VKS+ HA+ Y+HHDCTP I+HRDISSNNILL+S L+AF++DFGTA
Sbjct: 644 EVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTA 703

Query: 603 RLLHVDSSNRTLRAGTYGYIAP-------------------------------------- 624
           RLLH DSSN+TL AGTYGYIAP                                      
Sbjct: 704 RLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLS 763

Query: 625 -------------DQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGK 671
                        D RL  P +Q++ +D++LV   AL C+ S P+SRPTMQ I  +L  +
Sbjct: 764 SSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQHILSKLLTQ 823

Query: 672 TPMKKGLKEISISEMRNQEM 691
           +P       IS+ ++   E+
Sbjct: 824 SPFLGPFNWISLCQLTALEI 843

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  592 bits (1527), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 347/786 (44%), Positives = 463/786 (58%), Gaps = 117/786 (14%)

Query: 22  TSDHCNWVGITCDYKGSITHIELVECSIKG-ELGSLNFSCFPNLQYLNLWNNNLSGSIPP 80
           TS HC W GITC+ +G +  I       K  EL  L FS FP+L +LN+ ++++ G IP 
Sbjct: 5   TSHHCTWEGITCNTEGHVVRITYSYIDGKMVELSKLKFSSFPSLLHLNVSHSSIYGRIPD 64

Query: 81  QIGSLSNLKYL------------------------NLRWNNLTGTIPKEIGSLRNLEVLY 116
           +IG L+ L YL                        +L +NNL+G IP  +G L+NL  L 
Sbjct: 65  EIGMLTKLTYLRISECDVHGELPVSLGNLTLLEELDLAYNNLSGVIPSSLGYLKNLIHLD 124

Query: 117 LS-NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP 175
           LS N  L G  P  +G L+NL+ L L  N+++G +P +IGNLK+L  L ++ N++ G IP
Sbjct: 125 LSFNYGLSGVIPSSLGYLKNLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVIP 184

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
           S+L  L+NLE LFL  N+ NG+IP EIGNLKNL  L    N L G IP +LGHLT+L YL
Sbjct: 185 SSLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTYL 244

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP 295
            L  NQ+   IPL  G+ + L +L+L DN+I G IP  +  L NL +L L  N L+G IP
Sbjct: 245 HLFNNQIQGGIPLSFGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIP 304

Query: 296 FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNL 355
            ++G L +L   ++S N+++G  P+ IGN   L  L L+ N + G IP ++  +  L  L
Sbjct: 305 SSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYL 364

Query: 356 DLSHNNLSGTIPMTL-----HPMFLDMSFNNLEGEIPTYLRDN-PPNSFVGNKGLCGHVQ 409
           +LSHN LSG+IP  L      P  LD+S N+LEG IP  L+      SF  NKGLCG ++
Sbjct: 365 NLSHNKLSGSIPTLLIYDHIKPS-LDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIK 423

Query: 410 -----------------------VLAFTIFGFILL----LKGKSENLKLVTG------GY 436
                                   L F + GF+LL     K +++ +    G       Y
Sbjct: 424 GLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLLSRKTRKIQTKEIPTKNGDIFSVWNY 483

Query: 437 DGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESF 496
           DGKI YED+I ATEDF I+YCIGTGGYGSVYKA+LP G VVALKKLH  E +++ +++SF
Sbjct: 484 DGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSF 543

Query: 497 QNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN 556
           QNE ++LS +RHRNIVKL G+CLHKRCMF IY YM RGSL+ VL ++ EA+EL+W +RVN
Sbjct: 544 QNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVN 603

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA 616
           +VKS+ HA+ Y+HHDCTP I+HRDISSNNILL+S L+AF++DFGTARLLH DSSN+TL A
Sbjct: 604 VVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLA 663

Query: 617 GTYGYIAP---------------------------------------------------D 625
           GTYGYIAP                                                   D
Sbjct: 664 GTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILD 723

Query: 626 QRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISE 685
            RL  P +Q++ +D++LV   AL C+ S P+SRPTMQ I  +L  ++P       IS+ +
Sbjct: 724 SRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQHILSKLLTQSPFLGPFNWISLCQ 783

Query: 686 MRNQEM 691
           +   E+
Sbjct: 784 LTALEI 789

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224065665|ref|XP_002301910.1| predicted protein [Populus trichocarpa] gi|222843636|gb|EEE81183.1| predicted protein [Populus trichocarpa]

 Score =  582 bits (1499), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 349/799 (43%), Positives = 470/799 (58%), Gaps = 116/799 (14%)

Query: 4   ERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHI----ELVECSIKGELGSLNFS 59
           E +ALL  GWW D   + TS  C W GI CD  GSIT I    E ++  +  + G +NFS
Sbjct: 43  EGKALLESGWWSD-YRNLTSHRCKWTGIVCDRAGSITDISPPPEFLK--VGNKFGKMNFS 99

Query: 60  CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG------------------- 100
           CF NL  L+L N+ LSGSIPPQI  L  L+YLNL  NNL G                   
Sbjct: 100 CFSNLARLHLANHELSGSIPPQISILPQLRYLNLSSNNLAGELPSSLGNLSRLVELDFSS 159

Query: 101 -----TIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG 155
                +IP E+G+L+NLE+L  SNN L+G  P  +GSL  L  L L  N ++G +P EIG
Sbjct: 160 NNFINSIPPELGNLKNLEILDASNNRLNGPIPRTMGSLAKLRSLILSRNAINGFIPLEIG 219

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT 215
           NL +L  L ++ N + G IPST+  L++L  L L  N  NG+IP +IGNL NL HL + +
Sbjct: 220 NLTNLKDLQLISNILVGSIPSTIGFLSDLTNLDLSFNGINGSIPLQIGNLTNLEHLDLSS 279

Query: 216 NKLTGAIPST------------------------LGHLTSLLYLDLSFNQLHSFIPLEIG 251
           N L G+IPS                         +G+LT+L  L L  N++   IP+ +G
Sbjct: 280 NILAGSIPSIFSLLSNLILLHLFDNQINGSISSEIGNLTNLCRLFLRGNKITGSIPISLG 339

Query: 252 NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK 311
           N   L  LDLS+N+I G I  ++  L+NL+ L+LSSN +SG +P  +G L NL  LDL +
Sbjct: 340 NLRNLTFLDLSNNQIIGSIALKIRNLTNLEELHLSSNNISGSVPTILGSLLNLKKLDLCR 399

Query: 312 NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL- 370
           N+++GS P  I N T L+ L LN N+  G+IP  +G +  L+ LDLS N ++G+I  +L 
Sbjct: 400 NQINGSIPLEIQNLTNLEELCLNSNNFSGSIPFMLGSLTNLKKLDLSRNQINGSIASSLK 459

Query: 371 ---HPMFLDMSFNNLEGEIPTYLRDNPPNSFV--GNKGLCGHVQVL---AFTIFGFILLL 422
              +  +LD+S +NL G+IP+ L + P  S+V  G   L G V +     F +      L
Sbjct: 460 NCKYLTYLDLSHSNLSGQIPSQLYNLPSLSYVNFGYNNLSGSVPLQLPQPFDVSFTCDSL 519

Query: 423 KGKSENLKLV--TGGYDG-KILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVAL 479
            G+  N   +     ++G K L+ D  + TE+F +RYCIG+GGYGSVY+A+LP GK+VAL
Sbjct: 520 HGQRTNSPEIFQATAFEGNKDLHPDF-SPTENFDLRYCIGSGGYGSVYRAQLPSGKLVAL 578

Query: 480 KKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYV 539
           KKLH  E E+ AF +SF+NE  +L+ +RHR+IV+LYGFCLH+RCMF +YEYME+GSLF  
Sbjct: 579 KKLHHREAEEPAFDKSFKNEVELLTQIRHRSIVRLYGFCLHQRCMFLVYEYMEKGSLFCA 638

Query: 540 LRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 599
           LR+D  A+EL W +R +I+K +AHALSYLHH+C P IVHRDISS+N+LLNS  ++FVADF
Sbjct: 639 LRNDVGAVELKWMKRAHIIKDIAHALSYLHHECNPPIVHRDISSSNVLLNSVSKSFVADF 698

Query: 600 GTARLLHVDSSNRTLRAGTYGYIAP----------------------------------- 624
           G ARLL  DSSN T+ AGTYGYIAP                                   
Sbjct: 699 GVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGAVALETLMGRHPGDILS 758

Query: 625 ------------DQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKT 672
                       D RLSPP ++ +IQ+I +++T A +CL S PKSRP+M+ +SQE     
Sbjct: 759 SSARAITLKEVLDPRLSPPTDEIVIQNICIIATLAFSCLHSNPKSRPSMKFVSQEFLSPK 818

Query: 673 PMKKGLKEISISEMRNQEM 691
               GL EIS+ E+R   M
Sbjct: 819 RSLAGL-EISLLELRTLGM 836

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452751|ref|XP_002277606.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  578 bits (1490), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 342/844 (40%), Positives = 468/844 (55%), Gaps = 161/844 (19%)

Query: 4   ERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIK-GELGSLNFSCFP 62
           E +AL + GWW     ++TS HCNW G+ C+  G +T I   +   K GEL  L FS FP
Sbjct: 40  EAEALRSTGWW-----NSTSAHCNWDGVYCNNAGRVTQIAFFDSGKKLGELSKLEFSSFP 94

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
           +L  L L +  L+GSIP QIG+L+ L  L L  NNLTG +P  + +L  LE L L +N L
Sbjct: 95  SLVELFLSDCGLNGSIPHQIGTLTQLIILYLPLNNLTGELPLSLANLTQLEYLSLHSNRL 154

Query: 123 HGTTPIEIGSLRNL------------------------EELYLRSNKLSGVLPQEIGNLK 158
           HG+ P EIG ++NL                          LYL SN++SG +P +IG +K
Sbjct: 155 HGSIPPEIGKMKNLIYFILHDNNLTGVIPSSFGNLTNLTYLYLGSNQISGFIPPQIGKMK 214

Query: 159 SLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKL 218
           +L +LS+ YN + G IP  + +L NL  LFL  N     IP   GNL NLT+L + +N++
Sbjct: 215 NLEFLSLSYNGLHGSIPPEIGKLQNLNYLFLDYNNLTSVIPSSFGNLTNLTYLYLDSNQI 274

Query: 219 TGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLS 278
           +G IP  +G + +L  L+LS+N LH  IPLEIG    L  L+L  N + G+IP     L+
Sbjct: 275 SGFIPPQIGKIKNLELLELSYNGLHGPIPLEIGKLKNLKILNLGYNNLIGVIPSSFGNLT 334

Query: 279 NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL 338
           NL YL L  N +SG IP  IGK+ NL+  +L  N L+G  P+  GN T L  L L  N +
Sbjct: 335 NLTYLTLGGNQISGFIPPEIGKMKNLIFFNLGYNSLTGVIPSSFGNLTHLTSLILRGNQI 394

Query: 339 DGTIPPEIG---------------------KILLLQ---NLDLSHNNLSGTIPMTL---- 370
           +G+IPPEIG                     +IL L+   +LD+S+N +SG IP  L    
Sbjct: 395 NGSIPPEIGYLLDLLYLDLNTNQISGFIPEEILNLKKLGHLDISNNLISGKIPSELGNLK 454

Query: 371 HPMFLDMSFNNLEGEIPTYLRDN------------------PPNSFVGNKGLCGHVQ--- 409
             ++ ++S NN+ G IP  + +N                  P  +F  NKGLC  ++   
Sbjct: 455 EAIYFNLSRNNISGTIPLSISNNMWTLFDLSHNQLEGQSTAPLEAFDHNKGLCDGIKGLS 514

Query: 410 --------------------VLAFTIFGFIL----LLKGKSENLKLVTGG-------YDG 438
                               +L+  + GF+     + K +      V  G       YDG
Sbjct: 515 HCKKRHQIILIIAISLSATLLLSVAVLGFLFRKQKIRKNQLPKTTKVKNGDLFSIWDYDG 574

Query: 439 KILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQN 498
            I Y+D+I ATEDF I+YCIGTGGYGSVY+A+LP GKVVALKKLH  E +D  +++SF+N
Sbjct: 575 VIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERDDPTYLKSFEN 634

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIV 558
           E ++LS ++HRNIVKL+GFCLH +CMF +Y+YME+GSL+ +LRD+ E ++L+W +RVN+V
Sbjct: 635 EVQMLSRIQHRNIVKLHGFCLHNKCMFLVYKYMEKGSLYCMLRDEVEVVQLDWIKRVNVV 694

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
           K +A+ALSY+HHD T  I+HRDISSNNILL+S LEAFVADFGTARLL  DSSN+TL AGT
Sbjct: 695 KGIANALSYMHHDSTLPIIHRDISSNNILLDSKLEAFVADFGTARLLDPDSSNQTLLAGT 754

Query: 619 YGYIAP---------------------------------------------------DQR 627
           YGYIAP                                                   D R
Sbjct: 755 YGYIAPELAYTMVVTEKCDVYSFGMVALETIMGKHPGDLVTSLSASSTQNITLKDVLDSR 814

Query: 628 LSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMR 687
           LS P   ++  D+ LV + AL CL   P+ RP+MQ++S  L       + +  IS+ +++
Sbjct: 815 LSSPKGPQVANDVALVVSLALKCLHCNPRFRPSMQQVSWRLSASKSFPQPVGAISLLQLK 874

Query: 688 NQEM 691
           N+E+
Sbjct: 875 NEEI 878

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  573 bits (1478), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 349/837 (41%), Positives = 473/837 (56%), Gaps = 150/837 (17%)

Query: 2   EIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHI--------ELVECSIKGEL 53
           E E +AL N  WW   + + TS HC W GITC+ +G +  I         + +C + GEL
Sbjct: 41  EAEAEALRNSTWWW-YMENITSHHCTWDGITCNREGHVIQITYSHYNSPRISDCGLDGEL 99

Query: 54  GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWN----------------- 96
             ++      L YL+L  N ++GSIP +IG+L NL +L+L +N                 
Sbjct: 100 -PVSLGNLTLLVYLSLNFNRINGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSLGYLKNL 158

Query: 97  ---------NLTGTIPKEIGSLRNLEVLYLSNNS-LHGTTPIEIGSLRNLEELYLRSNKL 146
                    +L G IP  +G L+NL  L LS+NS L+G  P  +G+L NL  L L  N++
Sbjct: 159 IHLDLSHCYSLYGAIPSSLGYLKNLIHLDLSHNSDLYGVIPSSLGNLTNLVYLSLNFNRI 218

Query: 147 SGVLPQEIGNLKSLIWLSVMYN-------------------------TVGGPIPSTLFRL 181
           +G +P EIGNLK+LI L + YN                         ++   IPS+L  L
Sbjct: 219 NGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSSLGSL 278

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
           TNLE L+L  N+ NG+IP EIGNLKNL  LS+  N L G IPS+LG+L +L Y  L  NQ
Sbjct: 279 TNLEYLYLNFNRINGSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQ 338

Query: 242 LHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL 301
           +   IPL  GN + L  L L  N+I G IP  +  L NL +L L  N L+G IP ++G L
Sbjct: 339 IQGLIPLSFGNLTNLTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIP-SLGYL 397

Query: 302 FNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN 361
            +L   ++ +N++ G  P+ IGN   L  L L+ N +DG IP ++  +  L++L+LSHN 
Sbjct: 398 IHLNVFNIRRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNK 457

Query: 362 LSGTIP---MTLHP-MFLDMSFNNLEGEIPTYLR-DNPPNSFVGNKGLCGH--------- 407
           LSG IP   + +H    +D S N+ EG IP  L+   PP  F  NKGLCG          
Sbjct: 458 LSGHIPPLSIYIHKGSSIDFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKR 517

Query: 408 ------------VQVLAFTIFGFILLLKGKSENLKLVTG----------GYDGKILYEDL 445
                       +  L+F   G +LL +    N    T            YDGKI YED+
Sbjct: 518 GHKTILIISLSTILFLSFVALGILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDI 577

Query: 446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           I ATEDF I+YCIGTGGYGSVYKA+LP G VVALKKLH  E +++ +++SFQNE +VLS 
Sbjct: 578 IEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSK 637

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           ++HRNI+KL+G+CLHKRCMF IY+YMERGSL+ VL ++ EA+EL+W +RVN++KS+ HAL
Sbjct: 638 IQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHAL 697

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP- 624
            Y+HHD TP I+HRD+SSNNILL+  L+AF++DFGTARLLH DSSN+TL AGTYGYIAP 
Sbjct: 698 CYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPE 757

Query: 625 --------------------------------------------------DQRLSPPVNQ 634
                                                             D RL  P ++
Sbjct: 758 LAYTMAVTEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDR 817

Query: 635 KIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEM 691
           ++ +D++LV   AL C+ S P+SRPTMQ IS +L  ++P  +    IS+ ++  QE+
Sbjct: 818 QVARDVVLVVWLALKCIHSNPRSRPTMQHISSKLLIQSPFLEPFHGISLWQLNIQEI 874

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356506370|ref|XP_003521957.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  560 bits (1444), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 348/787 (44%), Positives = 463/787 (58%), Gaps = 103/787 (13%)

Query: 4   ERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHI---ELVECSIKGELGSLNFSC 60
           ERQALL  GWW D +  N SDHC W  ITC+  GS+  I   ++        L +LN + 
Sbjct: 13  ERQALLQSGWWNDYL--NISDHCAWDAITCNEAGSVIIILGWKIPPSEELRRLQNLNMTA 70

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
           FPNL+ L L+  +L GSIP +I +L+ L  L L  N+L G+IP E+GSL  L +L L NN
Sbjct: 71  FPNLEVLYLYGMSLRGSIPKEISTLTKLTDLYLSNNHLQGSIPVELGSLTQLVLLSLYNN 130

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
           SL G+ P  +  L NL  L L  N+L G +P E+GNL  LI   +  N++ G IPS+L +
Sbjct: 131 SLTGSIPSTLSQLVNLRYLLLSFNQLEGAIPAELGNLTQLIGFYLSNNSITGSIPSSLGQ 190

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L NL  L L  N+  G IP E GNLK+L  L +  N LT  IP TLG L +L +L L  N
Sbjct: 191 LQNLTILLLDSNRIQGPIPEEFGNLKSLHILYLSNNLLTSTIPPTLGRLENLTHLFLDSN 250

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK 300
           Q+   IPLE+ N S L  L LS NKI G+IP +L ++  +  L LSSNLLSG IP    K
Sbjct: 251 QIEGHIPLELANLSNLDTLHLSQNKISGLIPPKLFQMGKMHSLYLSSNLLSGSIPIENLK 310

Query: 301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHN 360
             ++ ++DLS N L+GS P+ IG C  + +L L+HN L G +P  +GK  +L  LDLS+N
Sbjct: 311 CPSIATVDLSYNLLNGSIPSQIG-C--VNNLDLSHNFLKGEVPSLLGKNSILDRLDLSYN 367

Query: 361 NLSGTIPMTLHPM-FLDMSFN--------NLEGEIPTYL---RD-----NPPN------- 396
           NL+G +   L  + ++++S+N        +L+  IP Y    RD     NPPN       
Sbjct: 368 NLTGKLYKELATLTYINLSYNSFDFSQDLDLKAHIPDYCSFPRDSLISHNPPNFTSCDPS 427

Query: 397 ---SFVGNKGLCGHVQVLAFT---------------IFGFILLLKGKSENLKLVT-GGYD 437
              +   +K     V VL                   F       G ++N  L +   YD
Sbjct: 428 PQTNSPTSKAKPITVIVLPIIGIILGVILLALYFARCFSKTKFEGGLAKNGDLFSVWNYD 487

Query: 438 GKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQ 497
           GK+ +ED+I ATEDFHI+YCIGTG YGSVY+ +LP GK+VA+KKLHQ E ++ +F +SF+
Sbjct: 488 GKVAFEDIIEATEDFHIKYCIGTGAYGSVYRVQLPTGKIVAVKKLHQMEAQNPSFDKSFR 547

Query: 498 NEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI 557
           NE ++L+ + HRNIVKL+GFCLH RCMF +Y+YME GSLFY L +D EA ELNW++RVNI
Sbjct: 548 NEVKMLTEICHRNIVKLHGFCLHNRCMFLVYQYMESGSLFYALNNDVEAQELNWSKRVNI 607

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           +K +A+ALSY+HHDCTP I+HRD++S+N+LLNS+L+AFV+DFGTARLL  DSSN+TL  G
Sbjct: 608 IKGMANALSYMHHDCTPPIIHRDVTSSNVLLNSHLQAFVSDFGTARLLDPDSSNQTLVVG 667

Query: 618 TYGYIAP---------------------------------------------------DQ 626
           TYGYIAP                                                   D 
Sbjct: 668 TYGYIAPELAYTLTVSEKCDVFSFGVVALETLMGRHPGEFISSLSNSSTQNILLKDLLDS 727

Query: 627 RLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQEL-EGKTPMKKGLKEISISE 685
           RL  PV  K  QDI+LV   ALACL  +PKSRP+MQ+++QEL   K P      +ISI++
Sbjct: 728 RLPLPVFPKDAQDIMLVVALALACLCFQPKSRPSMQQVAQELCASKLPPPLPFYKISIAQ 787

Query: 686 MRNQEMF 692
           +   ++ 
Sbjct: 788 LMTPDIL 794

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  559 bits (1441), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 337/739 (45%), Positives = 460/739 (62%), Gaps = 99/739 (13%)

Query: 45   VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
            + CSI  E+G+L      NL  LNL +N+LS  IP  +G+L+NL+YL+L +N++ G+IP 
Sbjct: 272  INCSIPFEIGNLK-----NLVALNLSSNSLSSVIPSFLGNLTNLEYLDLSFNSINGSIPF 326

Query: 105  EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLS 164
            EIG+LRN+  L LS+NSL    P  +G+L NLE L L  N ++G +P EIGNL++++ L+
Sbjct: 327  EIGNLRNVVALNLSSNSLSSVIPSSLGNLTNLEYLDLSFNSINGSIPFEIGNLRNVVALN 386

Query: 165  VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS 224
            + YN++   IPS+L  LTNLE L L  N  NG+IP EIGNL+N+  L++ +N L+  IPS
Sbjct: 387  LSYNSLSSVIPSSLGNLTNLEYLDLSFNSINGSIPFEIGNLRNVVALNLSSNSLSSVIPS 446

Query: 225  TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLN 284
             LG+LT+L YLDLSFN ++  IP EIGN   LA L+LS N +  +IP  L  L+NL  L+
Sbjct: 447  FLGNLTNLEYLDLSFNSINGSIPSEIGNLKNLAALNLSSNYLSSVIPSSLGNLTNLVTLS 506

Query: 285  LSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP 344
            L+ N L G IP ++G L NL   ++  N++ G  P  IGN   +  L L+ N ++  IP 
Sbjct: 507  LTLNSLVGAIPSSVGNLINLTEFNICGNQIRGCIPFEIGNLKNMASLDLSDNLINVKIPS 566

Query: 345  EIGKILLLQNLDLSHNNLSGTIPMTLHPMF----LDMSFNNLEGEIPTYLR-DNPPNSFV 399
            ++  +  L+NL+LSHN LSG IP    P +    +D+S+N+LEG IP  L+ ++ P  F 
Sbjct: 567  QLQNLESLENLNLSHNKLSGHIPTL--PKYGWLSIDLSYNDLEGHIPIELQLEHSPEVFS 624

Query: 400  GNKGLCGHVQ-----------------------VLAFTIFGFILL------------LKG 424
             NKGLCG ++                        L F +FGF+LL            LK 
Sbjct: 625  YNKGLCGEIKGWPHCKRGHKTMLITTIAISTILFLLFAVFGFLLLSRKMRQNQTKTPLKK 684

Query: 425  KSENLKLVT-GGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLH 483
              +N  + +   YDGKI YED+I ATEDF I+YCIGTGGYG+VYKA+LP G VVALKKLH
Sbjct: 685  NEKNGDIFSIWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGTVYKAQLPTGNVVALKKLH 744

Query: 484  QSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD 543
              E +++ + +SFQNE +VLS ++HRNI+KL+G+CLHKRCMF IY+YMERGSLF VL ++
Sbjct: 745  GWERDEATYFKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLFGVLSNE 804

Query: 544  DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             EA+EL+W +RVN+VKS+ HAL Y+HHD T  I+HRDISS+NILL+S L+AF++DFGTAR
Sbjct: 805  VEALELDWIKRVNVVKSIVHALCYMHHDYTLPIIHRDISSSNILLDSKLDAFLSDFGTAR 864

Query: 604  LLHVDSSNRTLRAGTYGYIAP--------------------------------------- 624
            LLH DSSN+T+ AGTYGYIAP                                       
Sbjct: 865  LLHHDSSNQTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPRELFTLLSS 924

Query: 625  ------------DQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKT 672
                        D RL  P +Q++ +D++LV   AL C+ S P+SRPTMQ IS  L  + 
Sbjct: 925  SSAQSIMLTDILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRSRPTMQLISSRLLTQL 984

Query: 673  PMKKGLKEISISEMRNQEM 691
            P  +    IS+  +  QE+
Sbjct: 985  PFLETFHGISLWLLNTQEI 1003

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357501751|ref|XP_003621164.1| Receptor kinase [Medicago truncatula] gi|355496179|gb|AES77382.1| Receptor kinase [Medicago truncatula]

 Score =  559 bits (1440), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 327/772 (42%), Positives = 463/772 (59%), Gaps = 86/772 (11%)

Query: 2   EIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELV-ECSIKGELGSLNFSC 60
           E E QAL+N GWW D   H  +  C W GITC+ +GSIT+I L  E  +  + G  +FS 
Sbjct: 29  EKEAQALVNSGWWNDFTNHAPT-RCQWPGITCNNEGSITNISLPPEIQLGDKFGKFHFSS 87

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
           F NL +LNL ++ + G+IP ++ +LS L +L++  N++ G IP  I SL+NL  L LS N
Sbjct: 88  FTNLVHLNLASHGIIGNIPFELATLSKLIFLDVSSNDIEGHIPSNIWSLKNLITLNLSRN 147

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            L+G+ P  IG L  L  L+L +N  SG +P EIG L++LI L + +N+  G IP  +  
Sbjct: 148 KLNGSIPSSIGQLTKLTFLHLDANMFSGSIPLEIGRLQNLIHLDLSHNSFFGLIPIEIGS 207

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L +L+ L L  N  +G+IP EIGNL NL +L +  N L G   S L +L +L+ L+LS N
Sbjct: 208 LKSLKYLSLSINNLSGSIPLEIGNLNNLLYLDLSDNNLGGESLSFLYNLINLIELNLSRN 267

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK 300
            + S +  E+  ++ L  + +SDNK  G+IP E+ KLS L  L+ S N+  G IP ++  
Sbjct: 268 NISSIMSHELVKWTQLEHMKISDNKFFGVIPSEIRKLSKLLVLDFSRNMFYGDIPTSLSN 327

Query: 301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHN 360
             NL  L+LS N ++GS P+ IG    L  + L+HN L G IP ++G +   + LDLSHN
Sbjct: 328 CSNLKVLNLSHNNITGSIPSHIGELVNLDLIDLSHNLLSGEIPYQLGNVKYTRVLDLSHN 387

Query: 361 NLSGTIPMTLHPMF-LDMSFNNLEGEIPTYLRDN-PPNSFVGNKGLCG------------ 406
           +L GTIP +L  +  +D+S+N+LEG+IP+ L+D   PN+F+GN+ LC             
Sbjct: 388 HLIGTIPSSLVLLRNIDLSYNSLEGKIPSSLQDTAAPNAFIGNEFLCNQFRYSTTCYSSP 447

Query: 407 ---------HVQV---------LAFTIFGFILLLKG-----KSENLK----LVTGGYDGK 439
                    H+++         L  +++ F+   K      +++  K         YDGK
Sbjct: 448 TKTNTRLKTHMKIFIPLISFLALLCSLYVFLCWCKACSFISRTQTTKNGDFFSIWNYDGK 507

Query: 440 ILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNE 499
           I YED+I ATE+F I+YCIG GGYGSVYKA LP G+VVALKKLH  E  +    + F+NE
Sbjct: 508 IAYEDIIEATENFDIKYCIGVGGYGSVYKANLPSGRVVALKKLHNLEANEPLIRKIFKNE 567

Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
            R+L+ +RHRNI+KLYGFCLH RCMF + EYME+GSL+ VLR+D EA+EL+W +RV IVK
Sbjct: 568 VRMLTKIRHRNILKLYGFCLHNRCMFLVLEYMEKGSLYCVLRNDVEAVELDWCKRVEIVK 627

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTY 619
            +A++LSYLH+DC P+I+HRD+++ N+LLNS +EA ++DFG ARL +  SSNRT+ AGTY
Sbjct: 628 GIANSLSYLHYDCEPAIIHRDVTTKNVLLNSEMEACLSDFGIARLRNSSSSNRTVLAGTY 687

Query: 620 GYIAP------------------------------------------DQRLSPPVNQKII 637
           GYIAP                                          D+RL   +NQ+  
Sbjct: 688 GYIAPEKCDVYSFGVVALEIIMGKHPGELVSSLRFSSTRNILLKDLIDKRLIATINQQSA 747

Query: 638 QDIILVSTTALACLRSKPKSRPTMQRISQEL-EGKTPMKKGLKEISISEMRN 688
           Q + L++T A  C+ S+P+ RPTMQ +  +L  GK  + K  +E+SI  M N
Sbjct: 748 QSLSLIATLAFECVHSQPRCRPTMQIVCDKLVTGKPSLTKPFEEVSIRMMLN 799

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452749|ref|XP_002277477.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  556 bits (1434), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 328/776 (42%), Positives = 448/776 (57%), Gaps = 124/776 (15%)

Query: 4   ERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIK-GELGSLNFSCFP 62
           E +AL + GWW     ++TS HC+W G+ C+  G +T I L     + GEL  L+FS FP
Sbjct: 40  EAEALRSTGWW-----NSTSAHCHWDGVFCNNAGRVTGIALYGSGKELGELSKLDFSSFP 94

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
           +L  L+L +  L+GSIP QIG+L+ L YL+L  NNLTG +P  + +L  LEVL   +N L
Sbjct: 95  SLVELSLSDCGLNGSIPHQIGTLTQLTYLSLGLNNLTGELPLSLANLTQLEVLSFYSNRL 154

Query: 123 HGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT 182
           HG+   EIG ++NL  L L +N L+GV                        IPS+   LT
Sbjct: 155 HGSILPEIGKMKNLTVLDLGNNNLTGV------------------------IPSSFGNLT 190

Query: 183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL 242
           NL  L+L  N+ +G IP +IG LKNL  L + +N L G IP  +G L +L  L L +N+L
Sbjct: 191 NLTFLYLDGNKISGFIPPQIGKLKNLRFLYLSSNGLHGPIPPEIGKLKNLEVLYLFYNKL 250

Query: 243 HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLF 302
           H  IP EIGN   L  L+L  N + G+IP     L+NL  L L  N +SG IP  IG L 
Sbjct: 251 HGLIPPEIGNMKKLIFLNLRSNNLTGVIPSSFGNLTNLNSLTLRGNQISGFIPPEIGYLL 310

Query: 303 NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNL 362
           NL  LDLS+N++SG  P  I N  +L HL +++N + G IP ++G +  ++  +LSHNNL
Sbjct: 311 NLSYLDLSENQISGFIPEEIVNLKKLGHLDMSNNLIRGKIPSQLGYLKEVEYFNLSHNNL 370

Query: 363 SGTIPMTLHPMFL----DMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQ--------- 409
           SGTIP ++   ++    D+S N LE +  T     P  +F  +KGLCG +          
Sbjct: 371 SGTIPHSISNNYMWTSIDLSHNQLESQSTT-----PHEAFGHDKGLCGGINGLSHCKKRH 425

Query: 410 --------------VLAFTIFGFI----------LLLKGKSENLKLVT-GGYDGKILYED 444
                         +L+ T  GF+          L    K++N  L +   YDG I Y+D
Sbjct: 426 QIVLIVVISLSATLLLSVTALGFLFHKQKIRKNQLSKTTKAKNGDLFSIWDYDGTIAYDD 485

Query: 445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           +I ATEDF I+YCIGTGGYGSVY+A+LP GKVVALKKLH  E ED  +++SF+NE ++LS
Sbjct: 486 IIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHSWEREDPTYLKSFENEVQMLS 545

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           T++HRNIVKL+GFCLH RCMF +Y+YME+GSL+ +LRD+ E +EL+W +RVN+VKS+A A
Sbjct: 546 TIQHRNIVKLHGFCLHNRCMFLVYKYMEKGSLYCMLRDEVEVVELDWIKRVNVVKSIASA 605

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LSY+HHD    I+HRDISSNNILL+S LEA V+DFGTARLL   SSN+TL  GTYGYIAP
Sbjct: 606 LSYMHHDYVMPIIHRDISSNNILLDSKLEACVSDFGTARLLDPYSSNQTLLVGTYGYIAP 665

Query: 625 ---------------------------------------------------DQRLSPPVN 633
                                                              D RLS P +
Sbjct: 666 ELAYTMVVTEKCDVYSFGMVALETMMGMHPGELVTSLSSSSTQNTTLKDVLDSRLSSPKS 725

Query: 634 QKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQ 689
            ++  ++ L+ + AL CL S P+ RP+MQ +S +L       + +  IS+ +++++
Sbjct: 726 TRVANNVALIVSLALKCLHSNPRFRPSMQEVSLKLVSTKSFPQPISAISLLQLKDE 781

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	701
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.539	0.361	0.364	4.3e-116
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.467	0.292	0.405	1.8e-112
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.492	0.313	0.382	1.1e-90
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.500	0.312	0.383	2.3e-89
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.445	0.283	0.376	1.2e-88
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.517	0.290	0.355	1e-86
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.514	0.288	0.352	5e-86
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.527	0.365	0.355	1e-83
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.450	0.278	0.412	2.2e-83
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.445	0.273	0.397	1.2e-82

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 578 (208.5 bits), Expect = 4.3e-116, Sum P(3) = 4.3e-116
 Identities = 140/384 (36%), Positives = 192/384 (50%)

Query:    21 NTSDHC-NWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPXXXXXXXXXXXXSGSIP 79
             NTS  C +W G+ C   GSI  + L    I+G      FS  P            SG+I 
Sbjct:    77 NTSSFCTSWYGVACSL-GSIIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTIS 135

Query:    80 PQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL 139
             P  G  S L+Y +L  N L G IP E+G L NL+ L+L  N L+G+ P EIG L  + E+
Sbjct:   136 PLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEI 195

Query:   140 YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIP 199
              +  N L+G +P   GNL  L+ L +  N++ G IPS +  L NL  L L  N   G IP
Sbjct:   196 AIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIP 255

Query:   200 REIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAEL 259
                GNLKN+T L++  N+L+G IP  +G++T+L  L L  N+L   IP  +GN   LA L
Sbjct:   256 SSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVL 315

Query:   260 DLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFP 319
              L  N++ G IP E                  G +P + GKL  L  L L  N+LSG  P
Sbjct:   316 HLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIP 375

Query:   320 TGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM--FLDM 377
              GI N TEL  L L+ N+  G +P  I +   L+NL L  N+  G +P +L      + +
Sbjct:   376 PGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRV 435

Query:   378 SF--NNLEGEIPTYLRDNPPNSFV 399
              F  N+  G+I       P  +F+
Sbjct:   436 RFKGNSFSGDISEAFGVYPTLNFI 459

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 592 (213.5 bits), Expect = 1.8e-112, Sum P(3) = 1.8e-112
 Identities = 136/335 (40%), Positives = 193/335 (57%)

Query:    75 SGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR 134
             +GSIP  +G+L NL  L L  N LTG IP E+G++ ++  L LS N L G+ P  +G+L+
Sbjct:   187 TGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLK 246

Query:   135 NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQF 194
             NL  LYL  N L+GV+P EIGN++S+  L++  N + G IPS+L  L NL  L L  N  
Sbjct:   247 NLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYL 306

Query:   195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFS 254
              G IP ++GN++++  L +  NKLTG+IPS+LG+L +L  L L  N L   IP E+GN  
Sbjct:   307 TGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNME 366

Query:   255 ALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKL 314
             ++ +L L++NK+ G IP                    G IP  +G + ++++LDLS+NKL
Sbjct:   367 SMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKL 426

Query:   315 SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP-- 372
             +GS P   GN T+L+ L L  N L G IPP +     L  L L  NN +G  P T+    
Sbjct:   427 TGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGR 486

Query:   373 --MFLDMSFNNLEGEIPTYLRDNPP---NSFVGNK 402
                 + + +N+LEG IP  LRD        F+GNK
Sbjct:   487 KLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNK 521

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 553 (199.7 bits), Expect = 1.1e-90, Sum P(2) = 1.1e-90
 Identities = 134/350 (38%), Positives = 184/350 (52%)

Query:    45 VECSIKGELGSLNFSCFPXXXXXXXXXXXXSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
             V C   G + S N+S  P            SG + P IG L +LK L+L +N L+G IPK
Sbjct:    57 VPCGWTGVMCS-NYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPK 115

Query:   105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLS 164
             EIG+  +LE+L L+NN   G  P+EIG L +LE L + +N++SG LP EIGNL SL  L 
Sbjct:   116 EIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLV 175

Query:   165 VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS 224
                N + G +P ++  L  L     G N  +G++P EIG  ++L  L +  N+L+G +P 
Sbjct:   176 TYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPK 235

Query:   225 TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXX 284
              +G L  L  + L  N+   FIP EI N ++L  L L  N++ G IP E           
Sbjct:   236 EIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLY 295

Query:   285 XXXXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP 344
                    G IP  IG L   + +D S+N L+G  P  +GN   L+ L L  N L GTIP 
Sbjct:   296 LYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPV 355

Query:   345 EIGKILLLQNLDLSHNNLSGTIPMT---LHPMFLDMSF-NNLEGEIPTYL 390
             E+  +  L  LDLS N L+G IP+    L  +F+   F N+L G IP  L
Sbjct:   356 ELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKL 405

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 553 (199.7 bits), Expect = 2.3e-89, Sum P(2) = 2.3e-89
 Identities = 141/368 (38%), Positives = 187/368 (50%)

Query:    27 NWVGIT---CDYKGSITHIELVECSIKGELGSLNFSCFPXXXXXXXXXXXXSGSIPPQIG 83
             NW GI    C++ G       V CS +G   S N                 SG + P IG
Sbjct:    57 NWNGIDETPCNWIG-------VNCSSQGSSSSSNSLVV---TSLDLSSMNLSGIVSPSIG 106

Query:    84 SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS 143
              L NL YLNL +N LTG IP+EIG+   LEV++L+NN   G+ P+EI  L  L    + +
Sbjct:   107 GLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICN 166

Query:   144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG 203
             NKLSG LP+EIG+L +L  L    N + GP+P +L  L  L     G N F+G IP EIG
Sbjct:   167 NKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIG 226

Query:   204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
                NL  L +  N ++G +P  +G L  L  + L  N+   FIP +IGN ++L  L L  
Sbjct:   227 KCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYG 286

Query:   264 NKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIG 323
             N + G IP E                  G IP  +GKL  ++ +D S+N LSG  P  + 
Sbjct:   287 NSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELS 346

Query:   324 NCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIP---MTLHPMF-LDMSF 379
               +EL+ L L  N L G IP E+ K+  L  LDLS N+L+G IP     L  M  L +  
Sbjct:   347 KISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFH 406

Query:   380 NNLEGEIP 387
             N+L G IP
Sbjct:   407 NSLSGVIP 414

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 1.2e-88, Sum P(2) = 1.2e-88
 Identities = 119/316 (37%), Positives = 167/316 (52%)

Query:    75 SGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR 134
             SG IPP +G++S L+ L L  N  TG+IP+EIG L  ++ LYL  N L G  P EIG+L 
Sbjct:   248 SGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLI 307

Query:   135 NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQF 194
             +  E+    N+L+G +P+E G++ +L  L +  N + GPIP  L  LT LE+L L  N+ 
Sbjct:   308 DAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRL 367

Query:   195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFS 254
             NGTIP+E+  L  L  L +  N+L G IP  +G  ++   LD+S N L   IP     F 
Sbjct:   368 NGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQ 427

Query:   255 ALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKL 314
              L  L L  NK+ G IP +                  G +P  +  L NL +L+L +N L
Sbjct:   428 TLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWL 487

Query:   315 SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMF 374
             SG+    +G    L+ L L +N+  G IPPEIG +  +   ++S N L+G IP  L    
Sbjct:   488 SGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCV 547

Query:   375 ----LDMSFNNLEGEI 386
                 LD+S N   G I
Sbjct:   548 TIQRLDLSGNKFSGYI 563

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 535 (193.4 bits), Expect = 1.0e-86, Sum P(3) = 1.0e-86
 Identities = 132/371 (35%), Positives = 195/371 (52%)

Query:    24 DHCNWVGITCDYKGSITHIELVECSIKGELGSLN--FSCFPXXXXXXXXXXXXSGSIPPQ 81
             ++C+W G+TCD  G    I L    + G  GS++  F  F              G IP  
Sbjct:    56 NYCSWTGVTCDNTGLFRVIALNLTGL-GLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTA 114

Query:    82 IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL 141
             + +L++L+ L L  N LTG IP ++GSL N+  L + +N L G  P  +G+L NL+ L L
Sbjct:   115 LSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLAL 174

Query:   142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPRE 201
              S +L+G +P ++G L  +  L +  N + GPIP+ L   ++L       N  NGTIP E
Sbjct:   175 ASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAE 234

Query:   202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
             +G L+NL  L++  N LTG IPS LG ++ L YL L  NQL   IP  + +   L  LDL
Sbjct:   235 LGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDL 294

Query:   262 SDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAI-GKLFNLVSLDLSKNKLSGSFPT 320
             S N + G IP+E                  G +P +I     NL  L LS  +LSG  P 
Sbjct:   295 SANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPV 354

Query:   321 GIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLD 376
              +  C  L+ L L++NSL G+IP  + +++ L +L L +N L GT+  ++  +    +L 
Sbjct:   355 ELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLV 414

Query:   377 MSFNNLEGEIP 387
             +  NNLEG++P
Sbjct:   415 LYHNNLEGKLP 425

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 523 (189.2 bits), Expect = 5.0e-86, Sum P(3) = 5.0e-86
 Identities = 130/369 (35%), Positives = 194/369 (52%)

Query:    25 HCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPXXXXXXXXXXXXSGSIPPQIGS 84
             +CNW G+TC  +  I  + L    + G + S +   F              G IP  + +
Sbjct:    60 YCNWTGVTCGGR-EIIGLNLSGLGLTGSI-SPSIGRFNNLIHIDLSSNRLVGPIPTTLSN 117

Query:    85 LSN-LKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS 143
             LS+ L+ L+L  N L+G IP ++GSL NL+ L L +N L+GT P   G+L NL+ L L S
Sbjct:   118 LSSSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALAS 177

Query:   144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG 203
              +L+G++P   G L  L  L +  N + GPIP+ +   T+L       N+ NG++P E+ 
Sbjct:   178 CRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELN 237

Query:   204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
              LKNL  L++  N  +G IPS LG L S+ YL+L  NQL   IP  +   + L  LDLS 
Sbjct:   238 RLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSS 297

Query:   264 NKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAI-GKLFNLVSLDLSKNKLSGSFPTGI 322
             N + G+I +E                  G +P  I     +L  L LS+ +LSG  P  I
Sbjct:   298 NNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEI 357

Query:   323 GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSF--- 379
              NC  L+ L L++N+L G IP  + +++ L NL L++N+L GT+  ++  +     F   
Sbjct:   358 SNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLY 417

Query:   380 -NNLEGEIP 387
              NNLEG++P
Sbjct:   418 HNNLEGKVP 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 544 (196.6 bits), Expect = 1.0e-83, Sum P(2) = 1.0e-83
 Identities = 134/377 (35%), Positives = 198/377 (52%)

Query:    38 SITHIELVECSIKGELGSLNFSCFPXXXXXXXXXXXXSGSIPPQIGSLSNLKYLNLRWNN 97
             S+ +++L    + GE+ S                   +G+IP +IGS++ LK L+   N 
Sbjct:   237 SLKYLDLAIGKLSGEIPS-ELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNA 295

Query:    98 LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNL 157
             LTG IP EI  L+NL++L L  N L G+ P  I SL  L+ L L +N LSG LP ++G  
Sbjct:   296 LTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKN 355

Query:   158 KSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK 217
               L WL V  N+  G IPSTL    NL +L L  N F G IP  +   ++L  + +  N 
Sbjct:   356 SPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNL 415

Query:   218 LTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXX 277
             L G+IP   G L  L  L+L+ N+L   IP +I +  +L+ +D S N+IR  +P      
Sbjct:   416 LNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSI 475

Query:   278 XXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNS 337
                           G++P       +L +LDLS N L+G+ P+ I +C +L  L L +N+
Sbjct:   476 HNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNN 535

Query:   338 LDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL--HPMF--LDMSFNNLEGEIPT--YLR 391
             L G IP +I  +  L  LDLS+N+L+G +P ++   P    L++S+N L G +P   +L+
Sbjct:   536 LTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLK 595

Query:   392 DNPPNSFVGNKGLCGHV 408
                P+   GN GLCG V
Sbjct:   596 TINPDDLRGNSGLCGGV 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 533 (192.7 bits), Expect = 2.2e-83, Sum P(2) = 2.2e-83
 Identities = 132/320 (41%), Positives = 177/320 (55%)

Query:    75 SGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR 134
             SG IP ++G+ S L  L L  N+L+GT+PKE+G L+NLE + L  N+LHG  P EIG ++
Sbjct:   264 SGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMK 323

Query:   135 NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQF 194
             +L  + L  N  SG +P+  GNL +L  L +  N + G IPS L   T L +  +  NQ 
Sbjct:   324 SLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQI 383

Query:   195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFS 254
             +G IP EIG LK L       NKL G IP  L    +L  LDLS N L   +P  +    
Sbjct:   384 SGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLR 443

Query:   255 ALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKL 314
              L +L L  N I G+IP E                  G+IP  IG L NL  LDLS+N L
Sbjct:   444 NLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNL 503

Query:   315 SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL-HPM 373
             SG  P  I NC +LQ L L++N+L G +P  +  +  LQ LD+S N+L+G IP +L H +
Sbjct:   504 SGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLI 563

Query:   374 FLD---MSFNNLEGEIPTYL 390
              L+   +S N+  GEIP+ L
Sbjct:   564 SLNRLILSKNSFNGEIPSSL 583

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 540 (195.1 bits), Expect = 1.2e-82, Sum P(2) = 1.2e-82
 Identities = 126/317 (39%), Positives = 177/317 (55%)

Query:    75 SGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR 134
             SGSIP  IG LS L+   +  N  +G+IP  I +  +L  L L  N + G  P E+G+L 
Sbjct:   335 SGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLT 394

Query:   135 NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQF 194
              L   +  SN+L G +P  + +   L  L +  N++ G IPS LF L NL +L L  N  
Sbjct:   395 KLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSL 454

Query:   195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFS 254
             +G IP+EIGN  +L  L +  N++TG IPS +G L  + +LD S N+LH  +P EIG+ S
Sbjct:   455 SGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCS 514

Query:   255 ALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKL 314
              L  +DLS+N + G +P+                   G+IP ++G+L +L  L LSKN  
Sbjct:   515 ELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLF 574

Query:   315 SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQ-NLDLSHNNLSGTIPMTLHPM 373
             SGS PT +G C+ LQ L L  N L G IP E+G I  L+  L+LS N L+G IP  +  +
Sbjct:   575 SGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASL 634

Query:   374 ----FLDMSFNNLEGEI 386
                  LD+S N LEG++
Sbjct:   635 NKLSILDLSHNMLEGDL 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_II000069 hypothetical protein (847 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	701
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-72
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-71
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-06
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	6e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
PLN03210	1153	PLN03210, PLN03210, Resistant to P	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	6e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.002
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.003
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  252 bits (645), Expect = 3e-72
 Identities = 158/376 (42%), Positives = 214/376 (56%), Gaps = 32/376 (8%)

Query: 22  TSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQ 81
           ++D C W GITC+    +  I+L   +I G++ S  F   P +Q +NL NN LSG IP  
Sbjct: 54  SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDD 112

Query: 82  IGSLS-NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELY 140
           I + S +L+YLNL  NN TG+IP+  GS+ NLE L LSNN L G  P +IGS  +L+ L 
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170

Query: 141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPR 200
           L  N L G +P  + NL SL +L++  N + G IP  L ++ +L+ ++LG N  +G IP 
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230

Query: 201 EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELD 260
           EIG L +L HL ++ N LTG IPS+LG+L +L YL L  N+L   IP  I +   L  LD
Sbjct: 231 EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290

Query: 261 LSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPT 320
           LSDN + G IP+ + +L NL+ L+L SN  +G+IP A+  L  L  L L  NK SG  P 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 321 GIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL----HPMFLD 376
            +G           HN+L  T+            LDLS NNL+G IP  L    +   L 
Sbjct: 351 NLGK----------HNNL--TV------------LDLSTNNLTGEIPEGLCSSGNLFKLI 386

Query: 377 MSFNNLEGEIPTYLRD 392
           +  N+LEGEIP  L  
Sbjct: 387 LFSNSLEGEIPKSLGA 402

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  249 bits (638), Expect = 3e-71
 Identities = 192/601 (31%), Positives = 288/601 (47%), Gaps = 55/601 (9%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
            L  L+L +N+LSG IP  +  L NL+ L+L  NN TG IP  + SL  L+VL L +N  
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344

Query: 123 HGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI---GNLKSLIWLSVMYNTVGGPIPSTLF 179
            G  P  +G   NL  L L +N L+G +P+ +   GNL  LI  S   N++ G IP +L 
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLG 401

Query: 180 RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSF 239
              +L R+ L  N F+G +P E   L  +  L I  N L G I S    + SL  L L+ 
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461

Query: 240 NQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIG 299
           N+    +P   G+   L  LDLS N+  G +P +L  LS L  L LS N LSG+IP  + 
Sbjct: 462 NKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS 520

Query: 300 KLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH 359
               LVSLDLS N+LSG  P        L  L L+ N L G IP  +G +  L  +++SH
Sbjct: 521 SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580

Query: 360 NNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDN----PPNSFVGNK--------GLCGH 407
           N+L G++P T    FL ++ + + G I     D     PP   V              G 
Sbjct: 581 NHLHGSLPST--GAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGA 638

Query: 408 VQVLAFTIFGFILLLKGKSENLKLV--------TGGYDGK----ILYEDLINATEDFHIR 455
             VLA   FGF+ +    +  LK V           +D K    I   D++++ ++ ++ 
Sbjct: 639 FLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENV- 697

Query: 456 YCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
             I  G  G+ YK +     +   +K+++   +  S+ +            ++H NIVKL
Sbjct: 698 --ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK-------LQHPNIVKL 748

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            G C  ++  + I+EY+E  +L  VLR+      L+W RR  I   +A AL +LH  C+P
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQ 634
           ++V  ++S   I+++   E  +       LL  D+      A    Y+AP+ R +  + +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITE 857

Query: 635 K 635
           K
Sbjct: 858 K 858

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  147 bits (374), Expect = 1e-40
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 22/220 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+G+VY A     GK VA+K + + ++     +E    E  +L  + H NIVKLYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
               +  ++ + EY E GSL  +L++++   +L+    + I+  +   L YLH +    I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 577 VHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ-RLSPPVNQ 634
           +HRD+   NILL+S N +  +ADFG ++LL  D S      GT  Y+AP+        ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 635 KIIQDI-----ILVSTTALA-----CLRSKPKSRPTMQRI 664
           K   DI     IL     L       L+  P+ RP+ + I
Sbjct: 174 KS--DIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEI 211

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (364), Expect = 8e-39
 Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 10/174 (5%)

Query: 452 FHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + I   +G G +G VY A +   GK+VA+K + + + +     E    E ++L  ++H N
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV+LY     +  ++ + EY E G LF +L+     +  +  R    ++ +  AL YLH 
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLHS 115

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
                IVHRD+   NILL+ +    +ADFG AR L       T   GT  Y+AP
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  139 bits (352), Expect = 4e-37
 Identities = 60/174 (34%), Positives = 88/174 (50%), Gaps = 8/174 (4%)

Query: 452 FHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + +   +G+G +G+VYKA     GK+VA+K L +   E S   ++ + E R+L  + H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV+L      K  ++ + EY E G LF  L        L+      I   +   L YLH 
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           +    I+HRD+   NILL+ N    +ADFG A+ L   SS+ T   GT  Y+AP
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (316), Expect = 3e-32
 Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 66/264 (25%)

Query: 458 IGTGGYGSVYKAEL--PDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G G +G VYK +L    GK    VA+K L +  +E    +E F  EAR++  + H N+V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           KL G C  +  ++ + EYME G L   LR +   +  + +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLESKN 122

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR--------------TLRAGT 618
               +HRD+++ N L+  NL   ++DFG +R L+ D   R              +L+ G 
Sbjct: 123 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 619 ------------------------YGYIAPDQ---------RLSPPVN-QKIIQDIILVS 644
                                   Y  ++ ++         RL  P N    + D++   
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLM--- 236

Query: 645 TTALACLRSKPKSRPTMQRISQEL 668
              L C    P+ RPT   + + L
Sbjct: 237 ---LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  125 bits (316), Expect = 3e-32
 Identities = 63/266 (23%), Positives = 100/266 (37%), Gaps = 69/266 (25%)

Query: 458 IGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G G +G VYK  L          VA+K L +  +E+    E F  EA ++  + H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH-HD 571
           +L G C     ++ + EYM  G L   LR   E + L     + +   +A  + YL   +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKN 122

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG-------------- 617
                VHRD+++ N L+  NL   ++DFG +R ++ D   R    G              
Sbjct: 123 F----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 618 --------------------TYG--------------YIAPDQRLSPPVN-QKIIQDIIL 642
                               T G               +    RL  P N    + +++ 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELM- 237

Query: 643 VSTTALACLRSKPKSRPTMQRISQEL 668
                L C    P+ RPT   + ++L
Sbjct: 238 -----LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (314), Expect = 5e-32
 Identities = 65/264 (24%), Positives = 106/264 (40%), Gaps = 65/264 (24%)

Query: 458 IGTGGYGSVYKAEL----PDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G G +G VYK  L       +V VA+K L +  +E    +E F  EAR++  + H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           KL G C  +  +  + EYM  G L   LR +    EL+ +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN 123

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR--------------TLRAGT 618
               +HRD+++ N L+  NL   ++DFG +R L+ D   +              +L+ G 
Sbjct: 124 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 619 ------------------------YGYIAPDQ---------RLSPPVN-QKIIQDIILVS 644
                                   Y  ++  +         RL  P N    +  ++   
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLM--- 237

Query: 645 TTALACLRSKPKSRPTMQRISQEL 668
              L C    P+ RPT   + + L
Sbjct: 238 ---LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 1e-30
 Identities = 64/271 (23%), Positives = 102/271 (37%), Gaps = 70/271 (25%)

Query: 458 IGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G +G VYK +L         VA+K L   E       + F  EARV+  + H N+V+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLK--EDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLR------DDDEAIELNWTRRVNIVKSVAHALSY 567
           L G C  +  ++ + EYME G L   LR         E   L+    ++    +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG---------- 617
           L        VHRD+++ N L+  +L   ++DFG +R ++ D   R    G          
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 618 ------------------------TYG--------------YIAPDQRLSPPVN-QKIIQ 638
                                   T G              Y+    RL  P      + 
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237

Query: 639 DIILVSTTALACLRSKPKSRPTMQRISQELE 669
           +++      L+C +  P+ RPT   + + LE
Sbjct: 238 ELM------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 1e-29
 Identities = 61/183 (33%), Positives = 88/183 (48%), Gaps = 22/183 (12%)

Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            F I   IG GG+G VYKA     GK VA+K +     E     E   NE ++L   +H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN------IVKSVAH 563
           NIVK YG  L K  ++ + E+   GSL  +L+        +  + +       + K +  
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK--------STNQTLTESQIAYVCKELLK 109

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
            L YLH   +  I+HRDI + NILL S+ E  + DFG +  L  D+  R    GT  ++A
Sbjct: 110 GLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMA 165

Query: 624 PDQ 626
           P+ 
Sbjct: 166 PEV 168

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  112 bits (283), Expect = 7e-28
 Identities = 55/175 (31%), Positives = 92/175 (52%), Gaps = 16/175 (9%)

Query: 457 CIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
            +G G +GSVY A   D G+++A+K + +   +    +E+ + E R+LS+++H NIV+ Y
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 516 GFCLHKRCMFF-IY-EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH-HDC 572
           G    +      I+ EY+  GSL  +L+     +     R+    + +   L+YLH +  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKY--TRQILEGLAYLHSNG- 121

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLH---VDSSNRTLRAGTYGYIAP 624
              IVHRDI   NIL++S+    +ADFG A+ L          ++R GT  ++AP
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR-GTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  112 bits (282), Expect = 1e-25
 Identities = 70/188 (37%), Positives = 109/188 (57%), Gaps = 2/188 (1%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           S+  + L + S  GEL S  F+  P + +L++ NNNL G I  +   + +L+ L+L  N 
Sbjct: 405 SLRRVRLQDNSFSGELPS-EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNL 157
             G +P   GS + LE L LS N   G  P ++GSL  L +L L  NKLSG +P E+ + 
Sbjct: 464 FFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522

Query: 158 KSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK 217
           K L+ L + +N + G IP++   +  L +L L  NQ +G IP+ +GN+++L  ++I  N 
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582

Query: 218 LTGAIPST 225
           L G++PST
Sbjct: 583 LHGSLPST 590

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 7e-25
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 15/223 (6%)

Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +G VYK   L  G  VA+K++   E      ++S   E  +L  ++H 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVK  G       ++ I EY E GSL  +++          +     V  V   L+YLH
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH 116

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS 629
                 ++HRDI + NIL   +    +ADFG A  L+  S +     GT  ++AP+    
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 630 PPVNQKIIQDIILVSTTALACLRSKP-----KSRPTMQRISQE 667
              +     DI  +  T +  L   P          + RI Q+
Sbjct: 174 SGASTA--SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD 214

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (265), Expect = 9e-25
 Identities = 64/184 (34%), Positives = 96/184 (52%), Gaps = 13/184 (7%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-R 509
            + I   +G G +G VY A   D K+VALK L +     S  VE F  E ++L+++ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKLY F   +  ++ + EY++ GSL  +L+       L+ +  + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFV-ADFGTARLLHVDSSNRTLRA------GTYGYI 622
              +  I+HRDI   NILL+ +       DFG A+LL    S  ++ A      GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 623 APDQ 626
           AP+ 
Sbjct: 176 APEV 179

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 1e-24
 Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 14/185 (7%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLH-QSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           IG G  G VYKA +   GK VA+KK+  + + ++        NE  ++   +H NIV  Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-----NEILIMKDCKHPNIVDYY 81

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
              L    ++ + EYM+ GSL  ++  +   + +N  +   + + V   L YLH   + +
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQN 136

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQK 635
           ++HRDI S+NILL+ +    +ADFG A  L  + S R    GT  ++AP+         K
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK 196

Query: 636 IIQDI 640
           +  DI
Sbjct: 197 V--DI 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (258), Expect = 2e-24
 Identities = 56/187 (29%), Positives = 82/187 (43%), Gaps = 19/187 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            D      +G G  G VYK    P GK+ ALKK+H     D  F +    E + L +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV--NIVKSVAHALS 566
             +VK YG    +  +  + EYM+ GSL      D           V   I + +   L 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLD 113

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA---GTYGYIA 623
           YLH      I+HRDI  +N+L+NS  E  +ADFG +++L    +         GT  Y++
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMS 168

Query: 624 PDQRLSP 630
           P +R+  
Sbjct: 169 P-ERIQG 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 49/154 (31%), Positives = 84/154 (54%), Gaps = 9/154 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   IG G +G V   +   G+ VA+K L     +DS   ++F  EA V++T+RH 
Sbjct: 6   KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLK----DDSTAAQAFLAEASVMTTLRHP 60

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G  L    ++ + EYM +GSL   LR    A+ +   +++     V   + YL 
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
                + VHRD+++ N+L++ +L A V+DFG A+
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 56/164 (34%), Positives = 85/164 (51%), Gaps = 11/164 (6%)

Query: 458 IGTGGYGSVYKA--ELPDGKV--VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           IG G +G V +   +LP  K   VA+K L    + D   ++ F  EA ++    H NI++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLD-FLTEASIMGQFDHPNIIR 69

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
           L G     R +  I EYME GSL   LR++D   +    + V +++ +A  + YL     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
              VHRD+++ NIL+NSNL   V+DFG +R L    +  T + G
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG 168

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 96.0 bits (240), Expect = 4e-22
 Identities = 55/188 (29%), Positives = 84/188 (44%), Gaps = 30/188 (15%)

Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLH-----QSETEDSAFVESFQNEARVLS 504
            + I   IG G +G VY      DGK+  LK++      + E ED+       NE ++L 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA------LNEVKILK 54

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE-------LNWTRRVNI 557
            + H NI+K Y     K  +  + EY + G L   ++   +  +       L+W   V +
Sbjct: 55  KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL 112

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL-HVDSSNRTLRA 616
                 AL YLH      I+HRDI   NI L SN    + DFG +++L       +T+  
Sbjct: 113 CL----ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-V 164

Query: 617 GTYGYIAP 624
           GT  Y++P
Sbjct: 165 GTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 60/175 (34%), Positives = 93/175 (53%), Gaps = 19/175 (10%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH---RNIVK 513
           IG G YG+VY+   +P G+VVALK ++    +D   V   Q E  +LS +R     NI K
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--VSDIQREVALLSQLRQSQPPNITK 66

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHALSYLHH 570
            YG  L    ++ I EY E GS+  +++     ++ I +       I++ V  AL Y+H 
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHK 119

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                ++HRDI + NIL+ +     + DFG A LL+ +SS R+   GT  ++AP+
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 17/174 (9%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G G +G V    +   GK+ A+K L + +      VE    E  +LS + H  IVKL Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALSYLH-HD 571
            F   ++ ++ + EY   G LF  L  +    E       R       +  AL YLH   
Sbjct: 61  AFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEE----RARF--YAAEIVLALEYLHSLG 113

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
               I++RD+   NILL+++    + DFG A+ L  + S      GT  Y+AP+
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 95.6 bits (238), Expect = 9e-22
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVL 503
           +   ++  +G G +G V+  E    +      +VA+K L ++ + D+   + F+ EA +L
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELL 62

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWT 552
           +  +H NIVK YG C        ++EYME G L   LR            D    EL  +
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           + + I   +A  + YL    +   VHRD+++ N L+  +L   + DFG +R
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLH---QSETEDSAFVESFQNEARVLSTV 506
           D+ +   IG G +G+V K     DGK++  K++     +E E    V    +E  +L  +
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILREL 56

Query: 507 RHRNIVKLYGFCLHK--RCMFFIYEYMERGSLFYVL---RDDDEAIELN--WTRRVNIVK 559
           +H NIV+ Y   + +  + ++ + EY E G L  ++   + + + IE    W     I+ 
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILT 112

Query: 560 SVAHALSYLHH--DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
            +  AL   H+  D   +++HRD+   NI L++N    + DFG A++L  DSS      G
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 618 TYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL 651
           T  Y++P+Q      ++K   DI      +L CL
Sbjct: 173 TPYYMSPEQLNHMSYDEK--SDI-----WSLGCL 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 62/179 (34%), Positives = 86/179 (48%), Gaps = 16/179 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E F +  CIG G +G VYKA +    +VVA+K +   E ED   +E  Q E + LS  R 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRS 58

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
             I K YG  L    ++ I EY   GS   +L+    D+  I         I++ V   L
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGL 111

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
            YLH +     +HRDI + NILL+   +  +ADFG +  L    S R    GT  ++AP
Sbjct: 112 EYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 2e-21
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
            +G G YG VYKA +   G++VALKK+     E+     + + E  +L  ++H NIVKL 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLL 64

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                +R ++ ++EY +   L   L      +  N  +   I+  +   L+Y H      
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR--- 118

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
           I+HRD+   NIL+N +    +ADFG AR   +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 9e-21
 Identities = 59/174 (33%), Positives = 87/174 (50%), Gaps = 17/174 (9%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYKA     G++VALKK+ + E E   F  +   E ++L  +RH NIV+L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 517 FCLHKRC--MFFIYEYME---RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
               K    ++ ++EYM+    G L      D   ++   ++    +K +   L YLH +
Sbjct: 66  IVTSKGKGSIYMVFEYMDHDLTGLL------DSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR-TLRAGTYGYIAP 624
               I+HRDI  +NIL+N++    +ADFG AR     +S   T R  T  Y  P
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 9/160 (5%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+         VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 121

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
                + +HRD+++ N L+  N    VADFG +RL+  D+
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 11/177 (6%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG V K      G++VA+KK  +SE +D    ++   E +VL  +RH NIV L  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH-HDCTPS 575
               K  ++ ++EY+ER +L  +L      +  +  R    +  +  A++Y H H+    
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCHSHN---- 120

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR-TLRAGTYGYIAPDQRLSPP 631
           I+HRDI   NIL++ +    + DFG AR L    ++  T    T  Y AP+  +   
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 56/155 (36%), Positives = 85/155 (54%), Gaps = 11/155 (7%)

Query: 458 IGTGGYGSVYKA--ELPDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           IG G +G V++   ++P  K   VA+K L    TE     + F +EA ++    H NI++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
           L G     +    I EYME G+L   LRD D   E +  + V +++ +A  + YL     
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSD--- 125

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
            + VHRD+++ NIL+NSNLE  V+DFG +R+L  D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 26/180 (14%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G VY A  L  G+++A+K++ + +  D   ++   +E +VL  ++H N+VK YG
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
             +H+  ++   EY   G+L  +L   R  DE +     R       +   L+YLH   +
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV----IRV--YTLQLLEGLAYLH---S 117

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYG--------YIAPD 625
             IVHRDI   NI L+ N    + DFG A  L     N T   G           Y+AP+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL----KNNTTTMGEEVQSLAGTPAYMAPE 173

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 10/176 (5%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G  G V K    P GK++A+K +      + A  +    E  +L       IV  YG
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
              +   +    EYM+ GSL  +L++    I      ++ +  +V   L+YLH      I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKH--KI 122

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPV 632
           +HRD+  +NIL+NS  +  + DFG +  L V+S  +T   GT  Y+AP +R+    
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF-VGTSSYMAP-ERIQGND 175

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 47/151 (31%), Positives = 80/151 (52%), Gaps = 8/151 (5%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF++    EA+++  +RH  +V+LY  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLVQLYAV 69

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +  ++ + EYM +GSL   L+   E  +L   + V++   +A  ++YL      + +
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           HRD+++ NIL+  NL   +ADFG ARL+  D
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 54/164 (32%), Positives = 87/164 (53%), Gaps = 25/164 (15%)

Query: 458 IGTGGYGSVYKAE-LPDG---KV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G   K+ VA+K L + ET   A  E   +EA V+++V H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKE-ILDEAYVMASVDHPHVV 72

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL  +    I + M  G L   +R+  + I     LNW  ++      A  +SYL
Sbjct: 73  RLLGICLSSQVQL-ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 569 --HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
                    +VHRD+++ N+L+ +     + DFG A+LL VD  
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.5 bits (222), Expect = 9e-20
 Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 11/173 (6%)

Query: 454 IRYCIGTGGYGSVYKAEL-PDGK---VVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           I   IG G +G V +  L   GK    VA+K L    TE       F +EA ++    H 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NI+ L G     R +  I E+ME G+L   LR +D   +    + V +++ +A  + YL 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLS 123

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
                + VHRD+++ NIL+NSNL   V+DFG +R L  D+S+ T  +   G I
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 67/210 (31%), Positives = 89/210 (42%), Gaps = 19/210 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E F I   +G G YGSVYKA     G+VVA+K +     ED    +    E  +L     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDS 57

Query: 509 RNIVKLYGFCLHKRCMFFI-YEYMERGSLFYVLRDDDEAIE--LNWTRRVNIVKSVAHAL 565
             IVK YG    K    +I  EY   GS+     D  +     L       I+      L
Sbjct: 58  PYIVKYYG-SYFKNTDLWIVMEYCGAGSV----SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            YLH +     +HRDI + NILLN   +A +ADFG +  L    + R    GT  ++AP+
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 626 QRLSPPVNQKIIQDIILVSTTALACLRSKP 655
                  N K   DI  +  TA+     KP
Sbjct: 170 VIQEIGYNNKA--DIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 57/180 (31%), Positives = 88/180 (48%), Gaps = 15/180 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED+ +   IG+G YG VYKA ++  G++VA+K +     +D    E  Q E  +L   RH
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQEISMLKECRH 59

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSL---FYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            NIV  +G  L +  ++ + EY   GSL   + V R       L+  +   + +     L
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGL 114

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +YLH       +HRDI   NILL  + +  +ADFG +  L    + R    GT  ++AP+
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 24/188 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +D+ +   IG G    VY A  LP+ + VA+K++   +      V+  + E + +S   H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD------DEAIELNWTRRVNIVKSVA 562
            N+VK Y   +    ++ +  Y+  GSL  +++        DEAI         ++K V 
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI------IATVLKEVL 112

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-----G 617
             L YLH +     +HRDI + NILL  +    +ADFG +  L  D  +RT +      G
Sbjct: 113 KGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA-DGGDRTRKVRKTFVG 168

Query: 618 TYGYIAPD 625
           T  ++AP+
Sbjct: 169 TPCWMAPE 176

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 7/156 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E+F +   +G+G +G V++    +   VA+K L     +D    + FQ E + L  +RH+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRLRHK 62

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           +++ L+  C     ++ I E ME+GSL   LR  +  + L     +++   VA  ++YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE 121

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
                + +HRD+++ NIL+  +L   VADFG ARL+
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 42/93 (45%), Positives = 59/93 (63%)

Query: 259 LDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF 318
           L L +  +RG IP+++SKL +LQ +NLS N + G IP ++G + +L  LDLS N  +GS 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 319 PTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
           P  +G  T L+ L LN NSL G +P  +G  LL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.4 bits (215), Expect = 1e-18
 Identities = 59/176 (33%), Positives = 81/176 (46%), Gaps = 10/176 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF     +GTG +G V        GK  ALK L +++      VE   NE R+L ++RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +V LYG       ++ + EY+  G LF  LR           R       V  AL YL
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFY--AAQVVLALEYL 117

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           H      IV+RD+   N+LL+S+    + DFG A+   V     TL  GT  Y+AP
Sbjct: 118 HSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK--RVKGRTYTL-CGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 18/180 (10%)

Query: 452 FHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           F +   IG G +G V   +  D  K+ A+K +++ +  +   V +  NE R+L  + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 511 IVKL-YGFCLHKRCMFFIYEYMERGSLFYVL----RDDDEAIELNWTRRVNIVKSVAHAL 565
           +V L Y F   +  M+ + + +  G L Y L    +  +E ++         +  +  AL
Sbjct: 62  LVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLAL 113

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            YLH   +  I+HRDI  +NILL+      + DF  A  +    +  T  +GT GY+AP+
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPE 169

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 9/146 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G+G +G V+  +      VA+K + +    +  F+E    EA+V+  + H N+V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F + EYM  G L   LR+    +   W   +++   V  A+ YL  +     +
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122

Query: 578 HRDISSNNILLNSNLEAFVADFGTAR 603
           HRD+++ N L+  +    V+DFG AR
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 8/164 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           +DF     IG G + +V  A E    K  A+K L + +      V+  + E  VL+ +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H  I+KLY     +  ++F+ EY   G L   +R    +++   TR       +  AL Y
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTR--FYAAEILLALEY 117

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
           LH   +  I+HRD+   NILL+ ++   + DFGTA++L  +SS 
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 58/192 (30%), Positives = 85/192 (44%), Gaps = 20/192 (10%)

Query: 445 LINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           L + T  F +   IG G YG VYKA     G++VA+K +   E E+    E  + E  +L
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNIL 56

Query: 504 STV-RHRNIVKLYGFCLHKRC------MFFIYEYMERGS---LFYVLRDDDEAIELNWTR 553
                H NI   YG  + K        ++ + E    GS   L   LR   + ++  W  
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI- 115

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT 613
              I++     L+YLH +    ++HRDI   NILL  N E  + DFG +  L      R 
Sbjct: 116 -AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 614 LRAGTYGYIAPD 625
              GT  ++AP+
Sbjct: 172 TFIGTPYWMAPE 183

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 12/189 (6%)

Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF I   IG G +G V+K     D +V A+K++  S+  +    E   +EARVL+ +   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSS 59

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKSVAHALS 566
            I++ Y   L K  +  + EY E G L  +L   R      +  W   + I+      L+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLA 115

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           +LH   +  I+HRDI S N+ L++     + D G A+LL  +++      GT  Y++P+ 
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 627 RLSPPVNQK 635
               P N+K
Sbjct: 173 CEDKPYNEK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 8/173 (4%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+G V   ++    +  ALK + +    ++   E   +E  +L    H  IVKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
               K+ ++ + EY   G L+ +LR  D  +   +T R   +  V  A  YLH+     I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARF-YIACVVLAFEYLHNR---GI 114

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS 629
           ++RD+   N+LL+SN    + DFG A+ L       T   GT  Y+AP+  L+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILN 166

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 9/169 (5%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+KA +   G+ VALKK+     E          E + L   +H  +VKL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
              H      + EYM    L  VLRD++  +     +    ++ +   ++Y+H +    I
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GI 120

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR-TLRAGTYGYIAP 624
           +HRD+   N+L++++    +ADFG ARL   +     + +  T  Y AP
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 23/170 (13%)

Query: 452 FHIRYCIGTGGYGSVYKA---ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + I  CIG G YG VYKA      DGK  A+KK    + + +   +S   E  +L  ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 509 RNIVKLYGFCLHK--RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV--NIVKS---- 560
            N+V L    L    + ++ +++Y E   L+ +++   +A        +  ++VKS    
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQ 116

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLH 606
           + + + YLH +    ++HRD+   NIL+           + D G ARL +
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 56/162 (34%), Positives = 81/162 (50%), Gaps = 17/162 (10%)

Query: 454 IRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           I   IG G +G V   + +LP  +   VA+K L    TE       F +EA ++    H 
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD---EAIELNWTRRVNIVKSVAHALS 566
           NI+ L G     + +  + EYME GSL   LR  D     I+L     V +++ +A  + 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMK 120

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           YL        VHRD+++ NIL+NSNL   V+DFG +R+L  D
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 40/148 (27%), Positives = 76/148 (51%), Gaps = 8/148 (5%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V++    +   VA+K L       +   + F  EA+++  +RH  +++LY  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +  ++ + E M+ GSL   L+       L   + +++   VA  ++YL      + +
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLL 605
           HRD+++ N+L+  N    VADFG AR++
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 34/173 (19%)

Query: 458 IGTGGYGSVYKAEL--PDGK-------VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +G G +G VYK EL  P+ +       +  LK+  + + +       F+ EA ++S ++H
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-----FRQEAELMSDLQH 67

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSL--FYVLR-----------DDDEAIELNWTRRV 555
            NIV L G C  ++    ++EY+  G L  F V             D+     L+ +  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 556 NIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           +I   +A  + YL  HH      VHRD+++ N L+   L   ++DFG +R ++
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 32/177 (18%)

Query: 454 IRYC--IGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           I Y   IG G +G V++A  P         +VA+K L +  + D      FQ EA +++ 
Sbjct: 7   IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAE 64

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD-------------------DDEA 546
             H NIVKL G C   + M  ++EYM  G L   LR                        
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 547 IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           + L+ T ++ I K VA  ++YL        VHRD+++ N L+  N+   +ADFG +R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 12/178 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +D      +GTG +G V+   +       ALK +   E       +   NE RVL  V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             I++L+     +R ++ + EY+  G LF  LR+   +   + +  +     +  AL YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYL 117

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGYIAPD 625
           H   +  IV+RD+   NILL+      + DFG A+ L     +RT    GT  Y+AP+
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLAPE 168

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 8/169 (4%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYKA +   G++VA+KK+      +     + + E ++L  + H NI+KL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
              HK  ++ ++E+M+   L+ +++D      L  +   + +  +   L++ H      I
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD+   N+L+N+     +ADFG AR         T    T  Y AP+
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPE 168

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 14/173 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VY+A +   G++VALKK+      D   + S + E  +L  +RH NIV+L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73

Query: 517 FCLHKR--CMFFIYEYMER--GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
             + K    +F + EY E+   SL      D+     + ++   ++  +   L YLH + 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              I+HRD+  +N+LL       +ADFG AR   + +   T +  T  Y AP+
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 16/206 (7%)

Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLH--QSETEDSAFVESFQNEARVLSTVRHRNIVK 513
            +G G +G VY   ++  G+ +A+K++       E    V + + E ++L  ++H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 514 LYGFCLHKRCMFFIY-EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
            YG CL       I+ EYM  GS+   L+    A+    TR+    + +   + YLH   
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYT--RQILEGVEYLH--- 121

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTA-RLLHVDSSNRTLRA--GTYGYIAPDQRLS 629
           +  IVHRDI   NIL +S     + DFG + RL  + SS   +++  GT  +++P+    
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 630 PPVNQKIIQDIILVSTTALACLRSKP 655
               +K   D+  V  T +  L  KP
Sbjct: 182 EGYGRK--ADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 7/146 (4%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G +G VYK  L     VA+K    +   D      F  EA +L    H NIVKL G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C+ K+ ++ + E +  GSL   LR     + +   + + +    A  + YL        +
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKNC---I 115

Query: 578 HRDISSNNILLNSNLEAFVADFGTAR 603
           HRD+++ N L+  N    ++DFG +R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.4 bits (195), Expect = 3e-16
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E ED   +E  Q E  VLS      + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KK 122

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRDI + N+LL+ + E  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK- 181

Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   + +P
Sbjct: 182 -ADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 34/185 (18%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--------- 507
           IG G YG+VYKA +L  G+ VALKK+    +E+             LST+R         
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----------PLSTLREIALLKQLE 56

Query: 508 ---HRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
              H NIV+L   C   R      +  ++E++++    Y+ +     +     +  ++++
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK--DLMR 114

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTY 619
            +   + +LH   +  IVHRD+   NIL+ S+ +  +ADFG AR+   + +  T    T 
Sbjct: 115 QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTL 170

Query: 620 GYIAP 624
            Y AP
Sbjct: 171 WYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 24/193 (12%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY- 515
           IG G YG VYKA   D G++VALKK+ + + E   F  +   E ++L  + HRNIV L  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 516 ---------GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
                     F   K   + ++EYM+   L  +L  +   +  +     + +K +   L+
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN-RTLRAGTYGYIAP- 624
           Y H     + +HRDI  +NILLN+  +  +ADFG ARL + + S   T +  T  Y  P 
Sbjct: 131 YCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187

Query: 625 ----DQRLSPPVN 633
               ++R  P ++
Sbjct: 188 LLLGEERYGPAID 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 53/172 (30%), Positives = 86/172 (50%), Gaps = 24/172 (13%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE----LPDGK--VVALKKLHQSETEDSAFVESFQNEARVL 503
            D  +++ +G G +G V+ AE    LP+    +VA+K L   E  +SA  + FQ EA +L
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELL 61

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD--DEAI----------ELNW 551
           + ++H++IV+ YG C   R +  ++EYM  G L   LR    D  I          +L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 552 TRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            + + I   +A  + YL    +   VHRD+++ N L+   L   + DFG +R
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 41/146 (28%), Positives = 76/146 (52%), Gaps = 9/146 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R ++ + EYM  G L   LR+  +  +   ++ + + K V   ++YL    +   +
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 578 HRDISSNNILLNSNLEAFVADFGTAR 603
           HRD+++ N L++      V+DFG +R
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 31/184 (16%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           I  G YG V+ A+    G + A+K + +++      V+    E  +LS  +   +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
               K+ ++ + EY+  G L  +L      D+D A           +  +  AL YLH +
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA--------RIYIAEIVLALEYLHSN 112

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-----------GTYG 620
               I+HRD+  +NIL++SN    + DFG   L  V    R +             GT  
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFG---LSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 621 YIAP 624
           YIAP
Sbjct: 167 YIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 21/180 (11%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQ---SETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +GTG + S Y+A ++  G ++A+K++     + +E    VE+ + E R+++ + H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALSYLHH 570
           + G            E+M  GS+ ++L       EA+ +N+T +      +   LSYLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121

Query: 571 DCTPSIVHRDISSNNILLNSNLEAF-VADFGTARLLHVDSSNRTL----RAGTYGYIAPD 625
           +    I+HRD+   N+L++S  +   +ADFG A  L    +          GT  ++AP+
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 27/190 (14%)

Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G V+ AE        D  +VA+K L   +  D+A  + F  EA +L+ ++H +I
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNA-RKDFHREAELLTNLQHEHI 69

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR----------DDDEAIELNWTRRVNIVKSV 561
           VK YG C+    +  ++EYM+ G L   LR          + +   EL  ++ ++I + +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGY 621
           A  + YL    +   VHRD+++ N L+  NL   + DFG +R ++   S    R G  G+
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY---STDYYRVG--GH 181

Query: 622 IAPDQRLSPP 631
                R  PP
Sbjct: 182 TMLPIRWMPP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 11/160 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+   E I+L   + +++   +A  ++++      + +
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           HRD+ + NIL++  L   +ADFG ARL  ++ +  T R G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREG 162

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 11/160 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        +F+E    EA+++  +RH  +V+LY  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLYA- 68

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ + EYM +GSL   L+D +    L     V++   VA  ++Y+      + +
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           HRD+ S NIL+   L   +ADFG ARL  ++ +  T R G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQG 162

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 43/158 (27%), Positives = 83/158 (52%), Gaps = 10/158 (6%)

Query: 446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           IN +E   ++  +G+G +G V+  +      VA+K +++    +  F+E    EA+V+  
Sbjct: 1   INPSELTFMKE-LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMK 55

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + H  +V+LYG C  ++ ++ + E+ME G L   LR     +  +    +++ + V   +
Sbjct: 56  LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGM 113

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            YL  +   S +HRD+++ N L++S     V+DFG  R
Sbjct: 114 EYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 23/162 (14%)

Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQ-----NEARVLSTV-RHR 509
            +G G +GSVY A     G++VA+KK+ +          S++      E + L  +  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHP 58

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYL 568
           NIVKL         ++F++EYME G+L+ +++D        +  R  +I+  +   L+++
Sbjct: 59  NIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR--SIIYQILQGLAHI 115

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
           H        HRD+   N+L++      +ADFG AR   + S 
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSR 152

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 458 IGTGGYGSVYKA--ELPDGKV--VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G +GSV K    +  GK   VA+K L Q E   +   E F  EA V++ + H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAGKKE-FLREASVMAQLDHPCIVR 60

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
           L G C  +  M  + E    G L   L+   E    +      +   VA  ++YL    +
Sbjct: 61  LIGVCKGEPLML-VMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLE---S 113

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
              VHRD+++ N+LL +  +A ++DFG +R L   S 
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 53/181 (29%), Positives = 92/181 (50%), Gaps = 20/181 (11%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG+G  G+VYK    P G++ ALK ++ +   +         E  +L  V H N+VK + 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV-NIVKSVAHALSYLHHDCTPS 575
              H   +  + E+M+ GSL        E   +   + + ++ + +   ++YLH      
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL--------EGTHIADEQFLADVARQILSGIAYLHRR---H 188

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLH--VDSSNRTLRAGTYGYIAPDQRLSPPVN 633
           IVHRDI  +N+L+NS     +ADFG +R+L   +D  N ++  GT  Y++P +R++  +N
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSP-ERINTDLN 245

Query: 634 Q 634
            
Sbjct: 246 H 246

Length = 353

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 14/182 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 119

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD+ + NIL+  NL   VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174

Query: 627 RL 628
            L
Sbjct: 175 AL 176

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 39/164 (23%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKL---HQSETED----SAFVESFQNEARVLSTVRHR 509
           +G G Y  VYKA     G++VA+KK+    + E +D    +A       E ++L  ++H 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-----REIKLLQELKHP 62

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH------ 563
           NI+ L     HK  +  ++E+ME   L  V++D             +IV + A       
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKD------------KSIVLTPADIKSYML 109

Query: 564 ----ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
                L YLH +    I+HRD+  NN+L+ S+    +ADFG AR
Sbjct: 110 MTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 11/152 (7%)

Query: 458 IGTGGYGSVYKAEL--PDGKV--VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G +G V + E     GKV  VA+K L     + S  ++ F  EA ++ ++ H N+++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
           LYG  L    M  + E    GSL   LR D        +   +    +A+ + YL    +
Sbjct: 61  LYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLE---S 115

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
              +HRD+++ NILL S+ +  + DFG  R L
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 44/160 (27%), Positives = 85/160 (53%), Gaps = 10/160 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+     +   VA+K L       +  V++F  EA ++ T++H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              +  ++ I EYM +GSL   L+  DE  ++   + ++    +A  ++Y+      + +
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           HRD+ + N+L++ +L   +ADFG AR+  ++ +  T R G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREG 163

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 62/265 (23%)

Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKK-----LHQSETEDSAFVESFQNEARVLS 504
           DF +   +G G YGSVYK + L D +  ALK+     + Q E ED+       NE R+L+
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV------NEIRILA 54

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV-NIVKSVAH 563
           +V H NI+      L    +  + EY   G L   +    +  +L   + +  I   +  
Sbjct: 55  SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA--GTYGY 621
            L  LH      I+HRD+ S NILL +N    + D G +++L         +   GT  Y
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHY 167

Query: 622 IAPD-----------------------QRLSPPVNQKIIQDIIL---------------- 642
           +AP+                          +PP   + +QD+                  
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227

Query: 643 -VSTTALACLRSKPKSRPTMQRISQ 666
            +     + L+ KPK RP   +I  
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 19/176 (10%)

Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEI 58

Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  + EY+  GSL   L+   E ++    R++ +  S
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLYAS 115

Query: 561 -VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR 615
            +   + YL    +   VHRD+++ NIL+ S     + DFG  ++L  D     +R
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 14/159 (8%)

Query: 458 IGTGGYGSVYKA--ELPDGK---VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G G +G V     +         VA+K L+ S  E       F+ E  +L T+ H NIV
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHENIV 69

Query: 513 KLYGFC--LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           K  G C     R +  I EY+  GSL   L+   +  ++N  R +     +   + YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG- 126

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
             +   +HRD+++ NIL+ S     ++DFG A++L  D 
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 7e-15
 Identities = 34/82 (41%), Positives = 52/82 (63%)

Query: 218 LTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL 277
           L G IP+ +  L  L  ++LS N +   IP  +G+ ++L  LDLS N   G IP+ L +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 278 SNLQYLNLSSNLLSGQIPFAIG 299
           ++L+ LNL+ N LSG++P A+G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 17/178 (9%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKK--LHQSETEDSAF-VESFQNEARVLSTVRHRNIVKL 514
           +G G YG+VY      G+++A+K+  L  S    +    E  Q E  +L +++H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            G CL    +    E++  GS+  +L       E  + +     K +   ++YLH++C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLL-----HVDSSN--RTLRAGTYGYIAPD 625
            +VHRDI  NN++L  N    + DFG AR L     H   SN  +++  GT  ++AP+
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 9/148 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     + + VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYGV 67

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +  +  ++E+ME G L   LR   +  + +    + +   V   ++YL       ++
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLL 605
           HRD+++ N L+  N    V+DFG  R +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 30/200 (15%)

Query: 451 DFHIRYCIGTGGYGSVYKAE------LPDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           D  ++  +G G +G V+ AE        D  +VA+K L   +    A  + FQ EA +L+
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 62

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR--DDDEAI-----------ELNW 551
            ++H +IVK YG C     +  ++EYM+ G L   LR    D  I           EL  
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 552 TRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
           ++ ++I   +A  + YL    +   VHRD+++ N L+ +NL   + DFG +R ++   S 
Sbjct: 123 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY---ST 176

Query: 612 RTLRAGTYGYIAPDQRLSPP 631
              R G  G+     R  PP
Sbjct: 177 DYYRVG--GHTMLPIRWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 16/177 (9%)

Query: 455 RYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           R  +G G YG VY A     +V +A+K++      DS +V+    E  + S ++HRNIV+
Sbjct: 13  RVVLGKGTYGIVYAARDLSTQVRIAIKEI---PERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 514 LYGFCLHKRCMFFIYEYMER---GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
             G         F   +ME+   GSL  +LR     ++ N    +   K +   L YLH 
Sbjct: 70  YLGSDSENG---FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 571 DCTPSIVHRDISSNNILLNSNLEAF-VADFGTA-RLLHVDSSNRTLRAGTYGYIAPD 625
           +    IVHRDI  +N+L+N+      ++DFGT+ RL  ++    T   GT  Y+AP+
Sbjct: 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPE 179

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    +VVA+K +   E ED   +E  Q E  VLS      + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +LR    A   +  +   ++K +   L YLH +     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 122

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRDI + N+LL+   +  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK- 181

Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   + +P
Sbjct: 182 -ADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 10/181 (5%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLH-QSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G G +G V+      D K+V +K++  +  T+D     + QNE +VL  + H NI++ Y
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEYY 65

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
              L  + +  + EY   G+L   ++    ++    T    I+      L  LHH  T  
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----ILHFFVQILLALHHVHTKL 121

Query: 576 IVHRDISSNNILLNSNLEAF-VADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQ 634
           I+HRD+ + NILL+ +     + DFG +++L   S   T+  GT  YI+P+     P NQ
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPELCEGKPYNQ 180

Query: 635 K 635
           K
Sbjct: 181 K 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 49/155 (31%), Positives = 86/155 (55%), Gaps = 13/155 (8%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G +G+V + E   G+ VA+K +    T      ++F  E  V++ + H+N+V+L G 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            LH   ++ + E M +G+L   LR    A+ ++  + +     VA  + YL    +  +V
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 578 HRDISSNNILLNSNLEAFVADFGTARL--LHVDSS 610
           HRD+++ NIL++ +  A V+DFG AR+  + VD+S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 13/138 (9%)

Query: 477 VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL 536
           VA+K L    ++++   E F  E ++LS +   NI +L G C     +  I EYME G L
Sbjct: 49  VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 537 -----FYVLRDDDEAIELNWTRR---VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 588
                 +V      A           + +   +A  + YL    + + VHRD+++ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 589 NSNLEAFVADFGTARLLH 606
             N    +ADFG +R L+
Sbjct: 164 GKNYTIKIADFGMSRNLY 181

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 14/182 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+++  +RH 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLRHD 61

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V LY   + +  ++ + E+M +GSL   L++ D    L   + V++   +A  ++Y+ 
Sbjct: 62  KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE 119

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + +HRD+ + NIL+  NL   +ADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174

Query: 627 RL 628
            L
Sbjct: 175 AL 176

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 11/155 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K +     ++ A  ++F  EA V++ +RH 
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHS 59

Query: 510 NIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           N+V+L G  +  K  ++ + EYM +GSL   LR    ++ L     +     V  A+ YL
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 118

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             +   + VHRD+++ N+L++ +  A V+DFG  +
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 10/169 (5%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G VYK  +    +VVA+K +   E ED   +E  Q E  VLS      I + YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +L+       L  T    I++ +   L YLH +     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RK 122

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRDI + N+LL+   +  +ADFG A  L      R    GT  ++AP+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 22/173 (12%)

Query: 446 INATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
            +   D+ I   +G G +G VYKA ++  G+VVALKK+     +D   + + + E ++L 
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62

Query: 505 TVRHRNIVKLY-------GFCLHKR-CMFFIYEYMER---GSLFYVLRDDDEAIELNWTR 553
            ++H N+V L             KR  ++ +  YM+    G L      ++ +++L  ++
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL------ENPSVKLTESQ 116

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
               +  +   ++YLH +    I+HRDI + NIL+++     +ADFG AR   
Sbjct: 117 IKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 16/174 (9%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALK--KLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G+G +GSVY+   L DG   A+K   L          V+  + E  +LS ++H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDD---EAIELNWTRRVNIVKSVAHALSYLHHD 571
            G    +  ++   E +  GSL  +L+      E +   +TR++         L YLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              + VHRDI   NIL+++N    +ADFG A+ +   S  ++ +   Y ++AP+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPE 171

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 9/169 (5%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G VYKA+  +  + A  K+   + E    +E F  E  +LS  +H NIV LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKI--IQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
             ++  ++ + E+ + G+L  ++ + +  +     R V   + +  AL++LH      ++
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV--CRQMLEALNFLHSH---KVI 125

Query: 578 HRDISSNNILLNSNLEAFVADFG-TARLLHVDSSNRTLRAGTYGYIAPD 625
           HRD+ + NILL  + +  +ADFG +A+         T   GT  ++AP+
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 15/183 (8%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG V+K    + G++VA+KK  +SE +D    +    E R+L  ++H N+V L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH-HDCTPS 575
               KR +  ++EY +  ++   L  +   +  +  ++  I+     A+++ H H+C   
Sbjct: 68  VFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK--IIWQTLQAVNFCHKHNC--- 121

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP-----DQRLSP 630
            +HRD+   NIL+    +  + DFG AR+L     + T    T  Y AP     D +  P
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 631 PVN 633
           PV+
Sbjct: 181 PVD 183

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 7/146 (4%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+K  L D   VA+K   +   ++      F +EAR+L    H NIVKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  ++ ++ + E +  G     LR   +  EL   + V      A  ++YL    + + +
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 578 HRDISSNNILLNSNLEAFVADFGTAR 603
           HRD+++ N L+  N    ++DFG +R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 8e-14
 Identities = 39/89 (43%), Positives = 53/89 (59%)

Query: 67  LNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTT 126
           L L N  L G IP  I  L +L+ +NL  N++ G IP  +GS+ +LEVL LS NS +G+ 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 127 PIEIGSLRNLEELYLRSNKLSGVLPQEIG 155
           P  +G L +L  L L  N LSG +P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 10/180 (5%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           N  EDF +   IG+G YG VYKA  +  G++ A+K +     ED A V   Q E  ++  
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV---QQEIIMMKD 62

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            +H NIV  +G  L +  ++   E+   GSL  +        E    +   + +     L
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGL 119

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            YLH   +   +HRDI   NILL  N    +ADFG +  +    + R    GT  ++AP+
Sbjct: 120 YYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 12/171 (7%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG V K +  + G++VA+KK  +SE +D    +    E R+L  +RH N+V L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESE-DDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE--LNWTRRVNIVKSVAHALSYLHHDCTP 574
               K+ ++ ++E+++   L     DD E     L+ +R    +  +   + + H     
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +I+HRDI   NIL++ +    + DFG AR L       T    T  Y AP+
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 10/180 (5%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           N   D+ +   +G+G YG VYKA  L  G++ A+K +     +D + +   Q E  ++  
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI---QQEIFMVKE 62

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            +H NIV  +G  L +  ++   EY   GSL  +        EL   +   + +     L
Sbjct: 63  CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGL 119

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +YLH   +   +HRDI   NILL  N +  +ADFG A  +    + R    GT  ++AP+
Sbjct: 120 AYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 72.7 bits (178), Expect = 1e-13
 Identities = 81/237 (34%), Positives = 116/237 (48%), Gaps = 8/237 (3%)

Query: 71  NNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEI 130
           +   S      + +L  L  L+L  N L   I  E+  L NL  L L NN++    P+  
Sbjct: 78  SGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIPPLIG 136

Query: 131 GSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLG 190
               NL+EL L  NK+   LP  + NL +L  L + +N +   +P  L  L+NL  L L 
Sbjct: 137 LLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLS 194

Query: 191 CNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI 250
            N+ +  +P EI  L  L  L +  N +   + S+L +L +L  L+LS N+L   +P  I
Sbjct: 195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESI 251

Query: 251 GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSL 307
           GN S L  LDLS+N+I       L  L+NL+ L+LS N LS  +P     L  L  L
Sbjct: 252 GNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL 306

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 2e-13
 Identities = 35/111 (31%), Positives = 63/111 (56%), Gaps = 6/111 (5%)

Query: 28  WVGITCDYKGSITH-----IELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI 82
           W G  C +  +        + L    ++G + + + S   +LQ +NL  N++ G+IPP +
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 83  GSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSL 133
           GS+++L+ L+L +N+  G+IP+ +G L +L +L L+ NSL G  P  +G  
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 55/172 (31%), Positives = 85/172 (49%), Gaps = 11/172 (6%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YGSVYK    P G  +A+K++ + E ++S F +    E  +L       IV  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIM-ELDILHKAVSPYIVDFYG 66

Query: 517 FCLHKRCMFFIYEYMERGSL--FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
               +  ++   EYM+ GSL   Y      E I  +  RR  I  +V   L +L  +   
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE--H 122

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           +I+HRD+   N+L+N N +  + DFG +  L V S  +T   G   Y+AP++
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKT-NIGCQSYMAPER 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 27/201 (13%)

Query: 429 LKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSET 487
           L+LV    D +     L N  +       IG G  G V  A +   G+ VA+KK+   + 
Sbjct: 8   LQLVVDPGDPR---SYLDNFVK-------IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ 57

Query: 488 EDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVL---RDDD 544
           +     E   NE  ++   +H NIV++Y   L    ++ + E++E G+L  ++   R ++
Sbjct: 58  QRR---ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 114

Query: 545 EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL 604
           E I         +  +V  ALS+LH      ++HRDI S++ILL S+    ++DFG    
Sbjct: 115 EQI-------ATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164

Query: 605 LHVDSSNRTLRAGTYGYIAPD 625
           +  +   R    GT  ++AP+
Sbjct: 165 VSKEVPRRKSLVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEA--RVLSTVRHRNIVKL 514
           IG G YG+VYKA  P  G  VALK +     ED   + + +  A  + L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 515 YGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
              C   R      +  ++E++++    Y+ +     +     +  ++++     L +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFLH 125

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL 604
            +C   IVHRD+   NIL+ S  +  +ADFG AR+
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 7/169 (4%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H NIVKL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
               +  ++ ++E++ +    ++       I L   +  + +  +   L++ H   +  +
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCH---SHRV 121

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD+   N+L+N+     +ADFG AR   V     T    T  Y AP+
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 18/159 (11%)

Query: 458 IGTGGYGSVYKAE---LPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+          V   VA+K L +S +E       F  EA ++S   H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLMEALIMSKFNHQNI 71

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD----DEAIELNWTRRVNIVKSVAHALSY 567
           V+L G    +   F + E M  G L   LR++    +    L     +   + VA    Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 568 LHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTAR 603
           L        +HRDI++ N LL        A +ADFG AR
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 8/147 (5%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+   L  D   VA+K     ET        F  EAR+L    H NIV+L G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
            C  K+ ++ + E ++ G     LR   E   L     + +V++ A  + YL        
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 577 VHRDISSNNILLNSNLEAFVADFGTAR 603
           +HRD+++ N L+       ++DFG +R
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 45/160 (28%), Positives = 84/160 (52%), Gaps = 11/160 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+ A       VA+K +        AF+     EA V+ T++H  +VKL+  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLHA- 68

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + K  ++ I E+M +GSL   L+ D E  +    + ++    +A  ++++      + +
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           HRD+ + NIL++++L   +ADFG AR+  ++ +  T R G
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREG 162

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 6e-13
 Identities = 36/89 (40%), Positives = 52/89 (58%)

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
           L L    L  FIP +I     L  ++LS N IRG IP  L  +++L+ L+LS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPTGIG 323
           P ++G+L +L  L+L+ N LSG  P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 31/181 (17%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYKA +   G++VALKK+ + ETED     +   E  +L  + H NIV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 517 FCLHKRCMFFIYE--------YMERGSLFYVLRDDDEAIELNWTRRVNIVKS----VAHA 564
               +  ++ ++E        YM+   L  +                 ++KS    +   
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP--------------LIKSYLYQLLQG 111

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           ++Y H   +  ++HRD+   N+L++      +ADFG AR   V     T    T  Y AP
Sbjct: 112 IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAP 168

Query: 625 D 625
           +
Sbjct: 169 E 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 7e-13
 Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 8/108 (7%)

Query: 307 LDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTI 366
           L L    L G  P  I     LQ + L+ NS+ G IPP +G I  L+ LDLS+N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 367 PMTLHPM----FLDMSFNNLEGEIPTYLRDNPPN----SFVGNKGLCG 406
           P +L  +     L+++ N+L G +P  L     +    +F  N GLCG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530

Length = 623

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 17/158 (10%)

Query: 458 IGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G V+ A+           +V +K L   +T+D      F+ E  +   + H+N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE------LNWTRRVNIVKSVAHAL 565
           V+L G C      + I EY + G L   LR      E      L+  ++V +   +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            +L        VHRD+++ N L++S  E  V+    ++
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 16/173 (9%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG+V+KA      ++VALK++ + + +D     S   E  +L  ++H+NIV+LY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS----VAHALSYLHHDC 572
                + +  ++EY ++    Y    D      N      IVKS    +   L++ H   
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYF---DS----CNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             +++HRD+   N+L+N N E  +ADFG AR   +     +    T  Y  PD
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 17/185 (9%)

Query: 446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           +N  E + I   +G G +G VYKA+  +  V+A  K+  +++E+   +E +  E  +L++
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILAS 58

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H NIVKL     ++  ++ + E+   G++  V+ + +  +     R V   K    AL
Sbjct: 59  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEAL 116

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-----AGTYG 620
           +YLH +    I+HRD+ + NIL   + +  +ADFG +       + RT++      GT  
Sbjct: 117 NYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPY 168

Query: 621 YIAPD 625
           ++AP+
Sbjct: 169 WMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.3 bits (168), Expect = 2e-12
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 40/165 (24%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQN---------EARVLSTVR 507
           IG+G YG V  A     G+ VA+KK+             F +         E ++L  +R
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKIS----------NVFDDLIDAKRILREIKLLRHLR 57

Query: 508 HRNIVKLYGFCLHKRCMFF--IY---EYMERGSLFYVLRD----DDEAIELNWTRRVNIV 558
           H NI+ L           F  +Y   E ME   L  V++      D+ I+         +
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQY-------FL 109

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             +   L YLH   + +++HRD+  +NIL+NSN +  + DFG AR
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 21/198 (10%)

Query: 429 LKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSET 487
           L++V    D + L E+ I           IG G  G V  A E   G+ VA+K +   + 
Sbjct: 10  LRMVVDQGDPRSLLENYIK----------IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ 59

Query: 488 EDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAI 547
           +     E   NE  ++   +H+N+V++Y   L    ++ + E+++ G+L  ++       
Sbjct: 60  QRR---ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----T 112

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
            LN  +   + +SV  AL YLH   +  ++HRDI S++ILL  +    ++DFG    +  
Sbjct: 113 RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169

Query: 608 DSSNRTLRAGTYGYIAPD 625
           D   R    GT  ++AP+
Sbjct: 170 DVPKRKSLVGTPYWMAPE 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 45/168 (26%), Positives = 85/168 (50%), Gaps = 7/168 (4%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G VYKA+  +   +A  K+ ++++E+   +E +  E  +L+T  H  IVKL G 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLLGA 77

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
                 ++ + E+   G++  ++ + D  +     +   I + +  AL YLH   +  I+
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLH---SMKII 132

Query: 578 HRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           HRD+ + N+LL  + +  +ADFG +         R    GT  ++AP+
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.0 bits (167), Expect = 3e-12
 Identities = 58/196 (29%), Positives = 86/196 (43%), Gaps = 54/196 (27%)

Query: 452 FHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--- 507
           + I   +G G YG V+KA +    +VVALKK+  +          F+N      T R   
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA----------FRNATDAQRTFREIM 58

Query: 508 -------HRNIVKLYGFCLHK----RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN 556
                  H NIVKL    + K    + ++ ++EYME               +L+   R N
Sbjct: 59  FLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYME--------------TDLHAVIRAN 102

Query: 557 IVKSVAH---------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
           I++ V           AL Y+H   + +++HRD+  +NILLNS+    +ADFG AR L  
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 608 DSSNRTLRAGTYGYIA 623
              N      T  Y+A
Sbjct: 160 LEENPENPVLTD-YVA 174

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 25/169 (14%)

Query: 458 IGTGGYGSVYKAEL-----PDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V KAE      P+    VA+K L    TE    +    +E  ++  + +H+N
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKN 77

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--VNI 557
           I+ L G C  +  ++ + EY   G+L   LR           DD    E   T++  V+ 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
              VA  + +L    +   +HRD+++ N+L+  +    +ADFG AR +H
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A E   GK VA+KK+   + +     E   NE  ++    H N+V +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L     D      +N  +   +  SV  ALSYLH      +
Sbjct: 87  SYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGV 139

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRDI S++ILL S+    ++DFG    +  +   R    GT  ++AP+     P   ++
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 637 IQDIILVSTTALACLRSKPK--SRPTMQRISQELEGKTPMKKGLKEIS 682
             DI  +    +  +  +P   + P +Q + +  +   P  K   ++S
Sbjct: 200 --DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVS 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 37/169 (21%), Positives = 72/169 (42%), Gaps = 18/169 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYK---AELPDGKV---VALKKLHQSETEDSAFVESFQNEARVL 503
           E   +   +G G +G VY+     +  G+    VA+K ++++ +        F NEA V+
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVM 63

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR----DDDEA---IELNWTRRVN 556
                 ++V+L G     +    + E M +G L   LR    + +           + + 
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
           +   +A  ++YL        VHRD+++ N ++  +L   + DFG  R +
Sbjct: 124 MAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 55/181 (30%), Positives = 79/181 (43%), Gaps = 27/181 (14%)

Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G  GSV K  L +   + ALK +  +   +    +    E  +  + +   IVK YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 517 -FCLHKRCMFFI-YEYMERGSLFYVLRDDDEAIELNWTRRVN---------IVKSVAHAL 565
            F         I  EY E GSL        ++I     +R           I +SV   L
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           SYLH   +  I+HRDI  +NILL    +  + DFG +  L V+S   T   GT  Y+AP+
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTF-TGTSFYMAPE 173

Query: 626 Q 626
           +
Sbjct: 174 R 174

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 21/187 (11%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYKA +    + +ALKK+ + E ED     +   E  +L  ++H NIV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS----VAHALSYLHHDC 572
               ++ ++ ++EY++      + +  D + +     R  ++K+    +   ++Y H   
Sbjct: 69  VVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPR--LIKTYLYQILRGIAYCH--- 119

Query: 573 TPSIVHRDISSNNILLNSNLEAF-VADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL--- 628
           +  ++HRD+   N+L++    A  +ADFG AR   +     T    T  Y AP+  L   
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 629 --SPPVN 633
             S PV+
Sbjct: 180 HYSTPVD 186

Length = 294

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 21/169 (12%)

Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K L+++ T   A VE F +EA +++++ H ++V
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVE-FMDEALIMASMDHPHLV 72

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDD---EAIELNWTRRVNIVKSVAHALSYL 568
           +L G CL       + + M  G L  YV    D     + LNW  ++      A  + YL
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD+++ N+L+ S     + DFG ARLL  D        G
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 17/172 (9%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+K+++  +       E   NE  V+   +H NIV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
             L    ++ + EY+  GSL  V+ +   D+  I         + +    AL +LH +  
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLHSN-- 134

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             ++HRDI S+NILL  +    + DFG    +  + S R+   GT  ++AP+
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLH------QSETEDSAFVESFQNEARVLSTVRHRN 510
           IG+G +GSVY       G+++A+K++        S+    + +++   E  +L  ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV+  G  L    +    EY+  GS+  +L ++  A E    R  N V+ +   L+YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLH- 123

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA------GTYGYIAP 624
                I+HRDI   NIL+++     ++DFG ++ L  +S +           G+  ++AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 625 D 625
           +
Sbjct: 182 E 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 8e-12
 Identities = 34/88 (38%), Positives = 52/88 (59%)

Query: 91  LNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVL 150
           L L    L G IP +I  LR+L+ + LS NS+ G  P  +GS+ +LE L L  N  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 151 PQEIGNLKSLIWLSVMYNTVGGPIPSTL 178
           P+ +G L SL  L++  N++ G +P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 21/187 (11%)

Query: 449 TEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
             +F I   IG G +  VYKA  L DG+VVALKK+   E  D+   +    E  +L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVL---RDDDEAIELN--WTRRVNIVKSVA 562
           H N++K     +    +  + E  + G L  ++   +     I     W   V +     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA----GT 618
            AL ++H   +  I+HRDI   N+ + +     + D G  R      S++T  A    GT
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169

Query: 619 YGYIAPD 625
             Y++P+
Sbjct: 170 PYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)

Query: 458 IGTGGYGSVYKAELPDG--KVVALKKLH-------QSETEDSAFVESFQNEARVL-STVR 507
           +G+G +G VYK    +    ++ALK+++       + + E    +    +E  ++   +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSL---FYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           H NIV+ Y   L    ++ + + +E   L   F  L++  +       R  NI   +  A
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--RIWNIFVQMVLA 125

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L YLH +    IVHRD++ NNI+L  + +  + DFG A+      S  T   GT  Y  P
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILYSCP 182

Query: 625 DQRLSPPVNQK 635
           +   + P  +K
Sbjct: 183 EIVKNEPYGEK 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 458 IGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G +GSV +A+L       + VA+K L +++   S+ +E F  EA  +    H N++K
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 514 LYGFCLHKRCM------FFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKSVAHA 564
           L G  L  R          I  +M+ G L   L   R  +E   L     V  +  +A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           + YL    + + +HRD+++ N +LN N+   VADFG ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 54/175 (30%), Positives = 85/175 (48%), Gaps = 23/175 (13%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN---EARVLSTVRHRNIVK 513
           IG G +G+VY A ++   +VVA+KK+  S  +     E +Q+   E R L  +RH N ++
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS---NEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 514 LYGFCLHKRCMFFIYEYMERGS---LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
             G  L +   + + EY   GS   +  V +   + +E+       I       L+YLH 
Sbjct: 80  YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEI-----AAICHGALQGLAYLHS 133

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 +HRDI + NILL       +ADFG+A L  V  +N  +  GT  ++AP+
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL--VSPANSFV--GTPYWMAPE 181

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 44/156 (28%), Positives = 82/156 (52%), Gaps = 14/156 (8%)

Query: 458 IGTGGYGSVYKA-ELPDG-KVVALKKLHQSETEDSAFVESFQNEA--RVLSTVRHRNIVK 513
           IG G YG V+KA +L +G + VALK++     E+   + + +  A  R L T  H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 514 LYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           L+  C   R      +  ++E++++    Y+ +  +  +     +  +++  +   L +L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL 604
           H   +  +VHRD+   NIL+ S+ +  +ADFG AR+
Sbjct: 127 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 18/183 (9%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHR 509
           F +   +G G YG VYK   +  G++ A+K +  +E E+    E  + E  +L     HR
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73

Query: 510 NIVKLYGFCL------HKRCMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVA 562
           NI   YG  +      H   ++ + E+   GS+  ++++    A++ +W     I + + 
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREIL 131

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             L++LH      ++HRDI   N+LL  N E  + DFG +  L      R    GT  ++
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 623 APD 625
           AP+
Sbjct: 189 APE 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 13/156 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+     VA+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 72

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           +L G CL       I + M  G L   +R+  + I   +   +N    +A  ++YL    
Sbjct: 73  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEER- 128

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
              +VHRD+++ N+L+ +     + DFG A+LL  D
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 451 DFHIRYCIGTGGYGSVYKAEL-PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTV- 506
           D   +  IG G +G V KA +  DG  +  A+K++ +  ++D      F  E  VL  + 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65

Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD-------------DDEAIELNWTR 553
            H NI+ L G C H+  ++   EY   G+L   LR              +  A  L+  +
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            ++    VA  + YL        +HRD+++ NIL+  N  A +ADFG +R
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 52/162 (32%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 458 IGTGGYGSVYKAELPD------GKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           +G+G +G VY+    D      G + VA+K L +  T D    E F  EA ++S   H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKE-FLKEAHLMSNFNHPN 60

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALS 566
           IVKL G CL     + I E ME G L   LRD          L     ++I   VA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAF-----VADFGTAR 603
           YL        +HRD+++ N L++           + DFG AR
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 31/198 (15%)

Query: 452 FHIRYCIGTGGYGSVYKAELPDG------KVVALKKLHQSETEDSAFVESFQNEARVLST 505
           + I   IG G +G +Y A+          K + L K+   E E S      + E  +L+ 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS------KKEVILLAK 55

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFY-------VLRDDDEAIELNWTRRVNIV 558
           ++H NIV  +        +F + EY + G L         VL  +D+   L+W  ++++ 
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSWFVQISL- 112

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTARLLHVDSSNRTLRAG 617
                 L ++H      I+HRDI S NI L+ N + A + DFG AR L+          G
Sbjct: 113 -----GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164

Query: 618 TYGYIAPDQRLSPPVNQK 635
           T  Y++P+   + P N K
Sbjct: 165 TPYYLSPEICQNRPYNNK 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 9/169 (5%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G Y +VYK +   +GK+VALK +   E E + F      EA +L  ++H NIV L+ 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
               K  +  ++EY+      Y+   D     L+       +  +   LSY+H      I
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQR---YI 124

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD+   N+L++   E  +ADFG AR   V S   +    T  Y  PD
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 18/183 (9%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHR 509
           F +   +G G YG VYK   +  G++ A+K +  +  E+    E  + E  +L     HR
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 510 NIVKLYGFCLHKRC------MFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVA 562
           NI   YG  + K        ++ + E+   GS+  ++++     ++  W     I + + 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             LS+LH      ++HRDI   N+LL  N E  + DFG +  L      R    GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 623 APD 625
           AP+
Sbjct: 179 APE 181

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 29/196 (14%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKK-LHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           IG G +G V+KA      ++VALKK L ++E E   F  +   E ++L  ++H N+V L 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLI 77

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLR--DDDEA-------IELNWTRRVNIVKSVAHALS 566
             C  K   +  Y    +GS + V    + D A       ++   +    ++K + + L 
Sbjct: 78  EICRTKATPYNRY----KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV---DSSNR-TLRAGTYGYI 622
           Y+H      I+HRD+ + NIL+  +    +ADFG AR   +      NR T R  T  Y 
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190

Query: 623 AP-----DQRLSPPVN 633
            P     ++   PP++
Sbjct: 191 PPELLLGERDYGPPID 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKL--HQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G G +G VY     D G+ +A+K++       E S  V + + E ++L  +RH  IV+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 515 YGFCL----HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           YG CL     K+   F+ EYM  GS+   L+      E N TRR    + +   +SYLH 
Sbjct: 70  YG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVSYLHS 124

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTA-RLLHVDSSNRTLRA--GTYGYIAPDQR 627
           +    IVHRDI   NIL +S     + DFG + R+  +  S   +++  GT  +++P+  
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 628 LSPPVNQKIIQDIILVSTTALACLRSKP 655
                 +K   D+  V+ T +  L  KP
Sbjct: 182 SGEGYGRK--ADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 10/163 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKA--ELPDGKVVALK-KLHQSETEDSAFVESFQNEARVLSTV 506
           ED  +  CIG G +G VY+     P+ + +A+  K  ++ T  S   E F  EA ++   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-REKFLQEAYIMRQF 64

Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H +IVKL G       ++ + E    G L   L+ +  +++L     +     ++ AL+
Sbjct: 65  DHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALA 121

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
           YL    +   VHRDI++ N+L++S     + DFG +R L  +S
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 38/195 (19%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVL-------STVRHR 509
           +G G YG V K   +P G ++A+K++  +       V S Q + R+L        +V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT-------VNS-QEQKRLLMDLDISMRSVDCP 60

Query: 510 NIVKLYGFCLHKR-----CMFFIYEYMERGSL--FY--VLRDDDEAIELNWTRRVNIVKS 560
             V  YG  L +      CM    E M+  SL  FY  V  D    I  +   +  I  S
Sbjct: 61  YTVTFYG-ALFREGDVWICM----EVMDT-SLDKFYKKVY-DKGLTIPEDILGK--IAVS 111

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYG 620
           +  AL YLH     S++HRD+  +N+L+N N +  + DFG +  L VDS  +T+ AG   
Sbjct: 112 IVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKP 168

Query: 621 YIAPDQRLSPPVNQK 635
           Y+AP +R++P +NQK
Sbjct: 169 YMAP-ERINPELNQK 182

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 21/162 (12%)

Query: 458 IGTGGYGSVYKA-ELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +PDG+     VA+K L ++ +  +   +   +EA V++ V    + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVC 72

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       + + M  G L   +R++ + I     LNW  ++      A  +SYL
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
                  +VHRD+++ N+L+ S     + DFG ARLL +D +
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 45/201 (22%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR- 507
            D      IG+G  G VYK      G V+A+K++ ++  ++           R+L  +  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--------ENKRILMDLDV 66

Query: 508 ----HR--NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN----- 556
               H    IVK YG+ +    +F   E M   +    L            +R+      
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLL-----------KRIQGPIPE 113

Query: 557 -----IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA-RLLHVDSS 610
                +  ++  AL YL       ++HRD+  +NILL+++    + DFG + RL  VDS 
Sbjct: 114 DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSK 169

Query: 611 NRTLRAGTYGYIAPDQRLSPP 631
            +T  AG   Y+AP +R+ PP
Sbjct: 170 AKTRSAGCAAYMAP-ERIDPP 189

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 20/181 (11%)

Query: 451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF +   +GTG +G V  A+    G+  A+K L + E      V+    E  +L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH-----A 564
            IV +      +  ++F+ E++  G LF  LR           R  N V    H     A
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--------RFPNDVAKFYHAELVLA 130

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
             YL H     I++RD+   N+LL++     V DFG A+   V     TL  GT  Y+AP
Sbjct: 131 FEYL-HSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTL-CGTPEYLAP 184

Query: 625 D 625
           +
Sbjct: 185 E 185

Length = 329

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 19/186 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYK      G++VA+KK+ + E+E+     +   E  +L  ++H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDC 572
             + +  ++ I+E+     L   L+   +++         +VKS  +     + + H   
Sbjct: 67  VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD-----QR 627
           +  ++HRD+   N+L+++     +ADFG AR   +     T    T  Y AP+      R
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 628 LSPPVN 633
            S PV+
Sbjct: 179 YSTPVD 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.4 bits (155), Expect = 7e-11
 Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 18/189 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +++     I  G YG VY+A +   G++VALKKL + E E   F  +   E  +L  ++H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQH 63

Query: 509 RNIVKL----YGFCLHKRCMFFIYEYMERG--SLFYVLRDDDEAIELNWTRRVNIVKSVA 562
            NIV +     G  L K  ++ + EY+E    SL   ++      E+       ++  + 
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVK-----CLMLQLL 116

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             +++LH +    I+HRD+ ++N+LLN+     + DFG AR         T    T  Y 
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 623 APDQRLSPP 631
           AP+  L   
Sbjct: 174 APELLLGAK 182

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 9/179 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF ++  +G G +G V    E   G + A+K + +S       V  F+ E  +LS    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 509 RNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
             I +L Y F   K  ++ + EY   G L  +L   ++  + +  +    +  +  A+  
Sbjct: 61  PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAIHS 117

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS-NRTLRAGTYGYIAPD 625
           +H       VHRDI   N+L++      +ADFG+A  L  +   N  L  GT  YIAP+
Sbjct: 118 VH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 1e-10
 Identities = 33/89 (37%), Positives = 50/89 (56%)

Query: 115 LYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           L L N  L G  P +I  LR+L+ + L  N + G +P  +G++ SL  L + YN+  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIPREIG 203
           P +L +LT+L  L L  N  +G +P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 11/170 (6%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G Y +V+K        +VALK++ + E E+ A   + + E  +L  ++H NIV L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK-SVAHALSYLHHDCTPS 575
               +RC+  ++EY++     Y+    D    L     V I    +   LSY H      
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I+HRD+   N+L+N   E  +ADFG AR   V +   +    T  Y  PD
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 10/180 (5%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
            AT   ++   +G G Y +VYK     +G++VALK +     E   F      EA +L  
Sbjct: 3   AATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI--REASLLKG 59

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           ++H NIV L+     K  + F++EYM      Y+++        N       +  +   L
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL---FMFQLLRGL 116

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +Y+H      I+HRD+   N+L++   E  +ADFG AR   + S   +    T  Y  PD
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 52/187 (27%), Positives = 92/187 (49%), Gaps = 9/187 (4%)

Query: 452 FHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           F +   +G G YG V K    + K +VA+KK   SE E+    E+   E ++L T++  N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQEN 61

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV+L      +  ++ ++EY+E+ ++  +L +    +     R  + +  +  A+ + H 
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR--SYIYQLIKAIHWCHK 118

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTAR-LLHVDSSNRTLRAGTYGYIAPDQRLS 629
           +    IVHRDI   N+L++ N    + DFG AR L    ++N T    T  Y +P+  L 
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175

Query: 630 PPVNQKI 636
            P  + +
Sbjct: 176 APYGKAV 182

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 58/171 (33%), Positives = 86/171 (50%), Gaps = 5/171 (2%)

Query: 192 NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG 251
           +     +P  +  L +L  LS           + L +L  L  LDL+ N+L S I  E+ 
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNI-SELL 113

Query: 252 NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK 311
             + L  LDL +N I  I P      SNL+ L+LS N +   +P  +  L NL +LDLS 
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172

Query: 312 NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNL 362
           N LS   P  + N + L +L L+ N +   +PPEI  +  L+ LDLS+N++
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 16/153 (10%)

Query: 458 IGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           IG G +G VY   L   DG+ +  A+K L  +   D   VE F  E  ++    H N++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 514 LYGFCLHKRCM-FFIYEYMERGSLFYVLRDDDEAIELNWTRR--VNIVKSVAHALSYLHH 570
           L G CL        +  YM+ G L   +R +      N T +  +     VA  + YL  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL-- 114

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             +   VHRD+++ N +L+ +    VADFG AR
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 17/227 (7%)

Query: 456 YC----IGTGGYGSVYKAE-LPDGKVVALKKL---HQSETEDSAFVESFQNEARVLSTVR 507
           YC    +G G YG V       DGK   +KKL   + S  E  A     + EA++LS ++
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA----EQEAQLLSQLK 57

Query: 508 HRNIVKLYGFCLHKRCMFFI-YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           H NIV        +  + +I   + E G L++ L++    + L   + V     +A AL 
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQ 116

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           YLH      I+HRD+ + N+ L       V D G AR+L       +   GT  Y++P+ 
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 627 RLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTP 673
             + P N K     +      +A L+    ++     + + +EGK P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 9/170 (5%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G Y +VYK      G++VALK++H    E +    +   E  ++  ++H NIV+L+ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHD 65

Query: 517 FCLHKRCMFFIYEYMERGSLFYV-LRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
               +  +  ++EYM++    Y+       A++ N  +  +    +   +++ H +    
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN---R 120

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           ++HRD+   N+L+N   E  +ADFG AR   +  +  +    T  Y APD
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD 170

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 11/169 (6%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L     D      +N  +   +  +V  ALS LH      +
Sbjct: 85  SYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGV 137

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRDI S++ILL  +    ++DFG    +  +   R    GT  ++AP+
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 22/180 (12%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLH--QSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G G +G VY   ++  G+ +A K++       E S  V + + E ++L  ++H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 515 YGFCLH---KRCMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALSYL 568
           YG CL    ++ +    EYM  GS+   L+      E++   +TR++         +SYL
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYL 122

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA-RLLHVDSSNRTLRA--GTYGYIAPD 625
           H +    IVHRDI   NIL +S     + DFG + RL  +  S   +R+  GT  +++P+
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 19/159 (11%)

Query: 458 IGTGGYGSVYKA-ELPDGKV----VALKKLHQSETEDSAFVESFQ---NEARVLSTVRHR 509
           +G+G +G+V+K   +P+G      VA+K +     +D +  ++FQ   +    + ++ H 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            IV+L G C     +  + +    GSL   +R   ++  L+  R +N    +A  + YL 
Sbjct: 70  YIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLE 126

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                 +VHR++++ NILL S+    +ADFG A LL+ D
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 61.7 bits (149), Expect = 3e-10
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 15/171 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+V+ A ++  G+ VA+K+++  +       E   NE  V+  +++ NIV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELKNPNIVNFLD 83

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    +F + EY+  GSL  V+ +   DEA      +   + +    AL +LH +   
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQALEFLHAN--- 134

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRDI S+N+LL  +    + DFG    +  + S R+   GT  ++AP+
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 58/184 (31%), Positives = 87/184 (47%), Gaps = 17/184 (9%)

Query: 451 DFHIRYCIGTGGYGSVY---KAELPD-GKVVALKKLHQSE-TEDSAFVESFQNEARVLST 505
           +F +   +GTG YG V+   K    D GK+ A+K L ++   + +   E  + E +VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 506 VRHRN-IVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVA 562
           +R    +V L Y F    + +  I +Y+  G LF  L   +   E    + V I    + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGY 621
            AL +LH      I++RDI   NILL+SN    + DFG ++  H D   R     GT  Y
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 622 IAPD 625
           +APD
Sbjct: 173 MAPD 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 15/171 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++   +VVA+KK+  S  + +   +    E + L  ++H N ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 517 FCLHKRCMFFIYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L +   + + EY       L  V +   + +E+       I       L+YLH   + 
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLH---SH 144

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +++HRDI + NILL    +  +ADFG+A +    +S      GT  ++AP+
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPE 191

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 18/187 (9%)

Query: 444 DLINATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARV 502
           DL N  ED      +G G  GSV K + +P G V+A K +H      S+  +    E ++
Sbjct: 1   DLRN--EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQI 56

Query: 503 LSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           +   R   IV  YG  L++  +    E+M+ GSL  + +   +   +       I  +V 
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVV 113

Query: 563 HALSYL---HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTY 619
             L+YL   H      I+HRDI  +NIL+NS  +  + DFG +  L ++S   T   GT 
Sbjct: 114 EGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTF-VGTS 166

Query: 620 GYIAPDQ 626
            Y++P++
Sbjct: 167 TYMSPER 173

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 19/184 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   IG G +G V   ++ + G+V A+K L++ E    A    F+ E  VL     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 509 RNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR-----RVNIVKSVA 562
           R I  L Y F   +  ++ + +Y   G L  +L   ++ +  +  R      V  + SV 
Sbjct: 61  RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV- 118

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GTYGY 621
           H L Y         VHRDI  +N+LL+ N    +ADFG+   L  D + ++  A GT  Y
Sbjct: 119 HQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169

Query: 622 IAPD 625
           I+P+
Sbjct: 170 ISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLH--QSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G G +G VY     D G+ +A+K++       E S  V + + E ++L  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 515 YGFCLH---KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
           YG CL    +R +    E+M  GS+   L+      E N TR+    + +   +SYLH  
Sbjct: 70  YG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLH-- 123

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH---VDSSNRTLRAGTYGYIAPDQRL 628
            +  IVHRDI   NIL +S     + DFG ++ L    +  +      GT  +++P+   
Sbjct: 124 -SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 629 SPPVNQKIIQDIILVSTTALACLRSKP 655
                +K   DI  V  T +  L  KP
Sbjct: 183 GEGYGRK--ADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 8/181 (4%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           +G G +G V+ AEL    +  A+K L +        VE    E RVLS    H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                K  +FF+ EY+  G L + ++      + +  R       +   L +LH   +  
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLH---SKG 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQK 635
           IV+RD+  +NILL+++    +ADFG  +   +  +      GT  YIAP+  L    N  
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 636 I 636
           +
Sbjct: 177 V 177

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 22/171 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTV 506
           ED      IG G +G V +A +  DG  +  A+K L +  +E+      F  E  VL  +
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKL 59

Query: 507 -RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWT 552
             H NI+ L G C ++  ++   EY   G+L   LR             +   A  L   
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           + +     VA  + YL        +HRD+++ N+L+  NL + +ADFG +R
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 15/182 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   IG G +G V   +L +  KV A+K L++ E    A    F+ E  VL    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR----RVNIVKSVAHA 564
           + I  L+     +  ++ + +Y   G L  +L   ++ +  +  R     + I     H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA-RLLHVDSSNRTLRAGTYGYIA 623
           L Y         VHRDI  +NIL++ N    +ADFG+  +L+   +   ++  GT  YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 624 PD 625
           P+
Sbjct: 172 PE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           +G G +G V  AEL    ++ A+K L +        VE    E RVL+   +H  + +L+
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                K  +FF+ EY+  G L + ++      E    R       +   L +LH      
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHER---G 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I++RD+  +N+LL+S     +ADFG  +   +     +   GT  YIAP+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 29/198 (14%)

Query: 443 EDLINATEDFHIRYCIGTGGYGSVYK-AELPDGKVVALKKLHQSETEDSAFVESFQNEAR 501
           E L + T+ + I   IG G YG VYK     DG + A+K L      D    E  + E  
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYN 70

Query: 502 VLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIE--LNWTR 553
           +L ++  H N+VK YG       MF+  + +  G L+ VL         E ++  L   +
Sbjct: 71  ILQSLPNHPNVVKFYG-------MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 554 RVN------IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
           R++      I+      L +LH++    I+HRD+  NNILL +     + DFG +  L  
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 608 DSSNRTLRAGTYGYIAPD 625
               R    GT  ++AP+
Sbjct: 181 TRLRRNTSVGTPFWMAPE 198

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 15/171 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G+VY A      +VVA+KK+  S  + +   +    E + L  ++H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 517 FCLHKRCMFFIYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L +   + + EY       L  V +   + +E+       I       L+YLH     
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSHN-- 141

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRDI + NILL    +  +ADFG+A      SS      GT  ++AP+
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMAPE 187

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 15/187 (8%)

Query: 444 DLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSET---EDSAFVESFQNE 499
           DL    ED+ +   IG G +G V         KV A+K L + E     DSAF   F  E
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEE 93

Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
             +++      +V+L+      R ++ + EYM  G L  ++ + D  +   W R      
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYT--A 149

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GT 618
            V  AL  +H   +   +HRD+  +N+LL+ +    +ADFGT   ++ +   R   A GT
Sbjct: 150 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206

Query: 619 YGYIAPD 625
             YI+P+
Sbjct: 207 PDYISPE 213

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 15/171 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++ + +VVA+KK+  S  + +   +    E R L  +RH N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 517 FCLHKRCMFFIYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L +   + + EY       L  V +   + +E+       +       L+YLH     
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLHSH--- 134

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +++HRD+ + NILL+      + DFG+A ++   +       GT  ++AP+
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPE 181

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 28/167 (16%)

Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G   +G VYK  L         + VA+K L   +  +    E F++EA + S ++H NI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSL--FYVLR---------DDDEAIE--LNWTRRVNIV 558
           V L G    ++ +  I+ Y     L  F V+R         DDD+ ++  L     V+IV
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 559 KSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             +A  + +L  HH     +VH+D+++ N+L+   L   ++D G  R
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.5 bits (146), Expect = 7e-10
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 15/171 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+K+++  +       E   NE  V+   ++ NIV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDFLHSN--- 134

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRDI S+NILL  +    + DFG    +  + S R+   GT  ++AP+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.1 bits (148), Expect = 8e-10
 Identities = 72/231 (31%), Positives = 101/231 (43%), Gaps = 36/231 (15%)

Query: 62  PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS 121
           PNL+ L+L  N+LS  +P  + +LSNL  L+L   N    +P EI  L  LE L LSNNS
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS-GNKISDLPPEIELLSALEELDLSNNS 220

Query: 122 LHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL 181
           +       + +L+NL  L L +NKL                           +P ++  L
Sbjct: 221 II-ELLSSLSNLKNLSGLELSNNKLE-------------------------DLPESIGNL 254

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPST-LGHLTSLLYLDLSFN 240
           +NLE L L  NQ   +    +G+L NL  L +  N L+ A+P   L  L   L L+L   
Sbjct: 255 SNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
                  LE+   S L   ++  N      P+ LS L +L  L    N L 
Sbjct: 313 L----KALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 8e-10
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 31/198 (15%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           +    +     IG G YG V  A   P G  VA+KK+  S  E   F +    E ++L  
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRR 59

Query: 506 VRHRNIVKLY------GFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRR 554
            +H NI+ +        F      ++ + E ME   L+ +++     +D     L    R
Sbjct: 60  FKHENIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR 117

Query: 555 VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL---LHVDSSN 611
                     L Y+H   + +++HRD+  +N+LLN+N +  + DFG AR+    H  +  
Sbjct: 118 ---------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 612 RTLRAGTYGYIAPDQRLS 629
            T    T  Y AP+  L+
Sbjct: 166 LTEYVATRWYRAPEIMLN 183

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 10/171 (5%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++   GK+ A KKL +   +     +   NE ++L  V  R IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F   K  +  +   M  G L Y + +  E       R +     +   L +LH      
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---R 115

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHV-DSSNRTLRAGTYGYIAPD 625
           IV+RD+   N+LL+ +    ++D G A  + +        RAGT GY+AP+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 11/154 (7%)

Query: 458 IGTGGYGSVYKA---ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G+G +G+V K         K VA+K L +++  D A  +    EA V+  + +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            G C  +  M  + E  E G L   L+ +    E N T    +V  V+  + YL      
Sbjct: 62  IGICEAESWML-VMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEET--- 114

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           + VHRD+++ N+LL +   A ++DFG ++ L  D
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSE-----TEDSAFVES------FQNEARVLST 505
           +G G YG V KA     GK+VA+KK+   E     T+D   V           E ++++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           ++H NI+ L    +    +  + + M    L  V+   D  I L  ++   I+  + + L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNGL 132

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           + LH       +HRD+S  NI +NS     +ADFG AR
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 28/179 (15%)

Query: 458 IGTGGYGSVYKAEL-------PDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V +AE        PD  V VA+K L  + T+    +    +E  ++  + +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--LADLISEMELMKLIGKH 77

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIE--LNWTRRV 555
           +NI+ L G C  +  ++ I EY  +G+L   LR           D  +  E  L++   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH-VDSSNRT 613
           +    VA  + YL    +   +HRD+++ N+L+  +    +ADFG AR +H +D   +T
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 37/128 (28%), Positives = 65/128 (50%), Gaps = 14/128 (10%)

Query: 461 GGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH 520
           G YG ++K E      V LK L +S      + ESF   A ++S + H+++V  YG C+ 
Sbjct: 20  GDYGELHKTE------VLLKVLDKSHRN---YSESFFEAASMMSQLSHKHLVLNYGVCVC 70

Query: 521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRD 580
                 + EY++ GSL   L+ +   I ++W  ++ + K +A AL +L       + H +
Sbjct: 71  GDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGN 125

Query: 581 ISSNNILL 588
           + + N+LL
Sbjct: 126 VCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 48/182 (26%), Positives = 95/182 (52%), Gaps = 24/182 (13%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLH----QSETEDSA---FVESFQNEARVLSTVRHR 509
           IG G YG VY A  +  G+++A+K++      +   DS     V++ ++E   L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALS 566
           NIV+  GF   +  +    EY+  GS+   LR     +E +   +T +V         L+
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGLA 122

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL---LHVDSSNRTLRAGTYGYIA 623
           YLH   +  I+HRD+ ++N+L++++    ++DFG ++    ++ +  N +++ G+  ++A
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMA 178

Query: 624 PD 625
           P+
Sbjct: 179 PE 180

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 34/89 (38%), Positives = 54/89 (60%)

Query: 139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTI 198
           L L +  L G +P +I  L+ L  +++  N++ G IP +L  +T+LE L L  N FNG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 199 PREIGNLKNLTHLSIITNKLTGAIPSTLG 227
           P  +G L +L  L++  N L+G +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 9/169 (5%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G Y +VYK      G++VALK++     E + F      EA +L  ++H NIV L+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI--REASLLKDLKHANIVTLHD 70

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
               K+ +  ++EY++   L   + D    + ++  R    +  +   L+Y H      +
Sbjct: 71  IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL--FLFQLLRGLAYCHQR---RV 124

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD+   N+L++   E  +ADFG AR   V S   +    T  Y  PD
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 41/142 (28%), Positives = 70/142 (49%), Gaps = 18/142 (12%)

Query: 476 VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS 535
           +VA+K L    T+ +     F  E +++S +++ NI++L G C+    +  I EYME G 
Sbjct: 46  LVAVKMLRADVTKTAR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 536 LFYVLRDDDEAIELNWTRRVNI-----------VKSVAHALSYLHHDCTPSIVHRDISSN 584
           L   L   +  IE  +T   NI              +A  + YL    + + VHRD+++ 
Sbjct: 104 LNQFLSQRE--IESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158

Query: 585 NILLNSNLEAFVADFGTARLLH 606
           N L+ ++    +ADFG +R L+
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY 180

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 91/290 (31%)

Query: 458 IGTGGYGSVYKAE------LPDGKVVALKKLHQ--SETEDSAFVESFQNEARVLSTVRHR 509
           +G G +G V KA             VA+K L +  S +E    +  F     +L  V H 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LLKQVNHP 63

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---------------------DDDEAIE 548
           +++KLYG C     +  I EY + GSL   LR                     D+ +   
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           L     ++    ++  + YL       +VHRD+++ N+L+    +  ++DFG +R ++ +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 609 ------SSNR---------------------------------TLRAGTYGYIAPDQ--- 626
                 S  R                                 TL    Y  IAP++   
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Query: 627 ------RLSPPVN-QKIIQDIILVSTTALACLRSKPKSRPTMQRISQELE 669
                 R+  P N  + + +++      L C + +P  RPT   IS+ELE
Sbjct: 241 LLKTGYRMERPENCSEEMYNLM------LTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 10/182 (5%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVL-STVRHRNIVKL- 514
           IG G +G V  A+   DGK  A+K L +    +    +    E  VL   V+H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
           Y F   ++ ++F+ +++  G LF+ L+ +    E    R       +A AL YLH   + 
Sbjct: 63  YSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SI 115

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQ 634
           +IV+RD+   NILL+S     + DFG  +     S   T   GT  Y+AP+     P + 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 635 KI 636
            +
Sbjct: 176 TV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 26/166 (15%)

Query: 458 IGTGGYGSVYKAEL-PDGKV--VALKKLH-----QSETEDSAFVESFQNEARVLSTVRHR 509
           +G G +GSV + +L  D  +  VA+K +      +SE ED      F +EA  +    H 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED------FLSEAVCMKEFDHP 60

Query: 510 NIVKLYGFCLHKR------CMFFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKS 560
           N+++L G CL             I  +M+ G L   L   R  D    L     V  +  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           +A  + YL    + S +HRD+++ N +LN N+   VADFG ++ ++
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVL-STVRHRNIVKLY 515
           IG G +G V  A+   DGK  A+K L +         +    E  VL   V+H  +V L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                   ++F+ +Y+  G LF+ L+ +    E    R       +A AL YLH   + +
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SLN 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I++RD+   NILL+S     + DFG  +     S   +   GT  Y+AP+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 21/178 (11%)

Query: 458 IGTGGYGSVYKAELPDG----KVVALKKLHQS----ETEDSAFVESFQNEARVLSTVRHR 509
           +G GGYG V++     G    K+ A+K L ++      +D+A  ++ +N   +L  V+H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVKHP 60

Query: 510 NIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            IV L Y F    + ++ I EY+  G LF  L  + E I +  T    + + ++ AL +L
Sbjct: 61  FIVDLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE-ISLALEHL 116

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR-LLHVDSSNRTLRAGTYGYIAPD 625
           H      I++RD+   NILL++     + DFG  +  +H  +   T   GT  Y+AP+
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.6 bits (141), Expect = 3e-09
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 15/171 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +       E   NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRDI S+NILL  +    + DFG    +  + S R+   GT  ++AP+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 45/190 (23%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQN---------EARVLSTVR 507
           IG G +G V+    P DGK VALKK+             FQN         E ++L   +
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM----------PNVFQNLVSCKRVFRELKMLCFFK 57

Query: 508 HRNIVKLYGF-------CLHKRCMFFIYEYMERGSLFYVL----RDDDEAIELNWTRRVN 556
           H N++               +  ++ + E M+   L  ++        + +++       
Sbjct: 58  HDNVLSALDILQPPHIDPFEE--IYVVTELMQ-SDLHKIIVSPQPLSSDHVKV------- 107

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS-NRTLR 615
            +  +   L YLH   +  I+HRDI   N+L+NSN    + DFG AR+   D S + T  
Sbjct: 108 FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 616 AGTYGYIAPD 625
             T  Y AP+
Sbjct: 165 VVTQYYRAPE 174

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 58/189 (30%), Positives = 87/189 (46%), Gaps = 26/189 (13%)

Query: 458 IGTGGYGSVYKAEL----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           IG G +G   KA L     DGK   +K+++ S+       ES + E  VLS ++H NIV+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFY-------VLRDDDEAIELNWTRRVNIVKSVAHALS 566
                     ++ + +Y E G L+        VL  +D+   L+W   V I  ++ H   
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWF--VQICLALKHV-- 117

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
              HD    I+HRDI S NI L  +    + DFG AR+L+          GT  Y++P+ 
Sbjct: 118 ---HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 627 RLSPPVNQK 635
             + P N K
Sbjct: 173 CENRPYNNK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 15/181 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSET---EDSAFVESFQNEARVLST 505
           EDF +   IG G +G V         +V A+K L + E     DSAF   F  E  +++ 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF---FWEERDIMAH 99

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
                IV+L+      + ++ + EYM  G L  ++ + D  I   W R       V  AL
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFY--TAEVVLAL 155

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GTYGYIAP 624
             +H   +   +HRD+  +N+LL+ +    +ADFGT   +  +   R   A GT  YI+P
Sbjct: 156 DAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212

Query: 625 D 625
           +
Sbjct: 213 E 213

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 11/170 (6%)

Query: 458 IGTGGYGSVYK--AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G G Y +VYK  ++L D  +VALK++ + E E+ A   + + E  +L  ++H NIV L+
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                ++ +  ++EY+++    Y+   DD    +N       +  +   L+Y H      
Sbjct: 71  DIIHTEKSLTLVFEYLDKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRR---K 124

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           ++HRD+   N+L+N   E  +ADFG AR   + +   +    T  Y  PD
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 35/139 (25%), Positives = 70/139 (50%), Gaps = 13/139 (9%)

Query: 476 VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS 535
           +VA+K L +   +++     F  E +++S ++  NI++L   C+    +  I EYME G 
Sbjct: 48  LVAVKMLREDANKNAR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 536 LFYVLR--------DDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL 587
           L   L         +  + + ++++  + +   +A  + YL    + + VHRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162

Query: 588 LNSNLEAFVADFGTARLLH 606
           +  N    +ADFG +R L+
Sbjct: 163 VGKNYTIKIADFGMSRNLY 181

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 23/175 (13%)

Query: 458 IGTGGYGSVYKAEL--PDGKV--VALKKLH---QSETEDSAFVESFQNEARVLSTVRHRN 510
           +G G +GSV + +L   DG    VA+K +     + +E    +E F +EA  +    H N
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE----IEEFLSEAACMKDFDHPN 62

Query: 511 IVKLYGFCLHKRCM------FFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKSV 561
           ++KL G C     +        I  +M+ G L   L   R      +L     +  +  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA 616
           A  + YL      + +HRD+++ N +L  ++   VADFG ++ ++     R  R 
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 32/181 (17%)

Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 80

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSL---------------FYVLRDDDEAIELNWTR 553
           +NI+ L G C     ++ I EY  +G+L               + + R  DE  ++ +  
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE--QMTFKD 138

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH-VDSSNR 612
            V+    VA  + YL    +   +HRD+++ N+L+  N    +ADFG AR ++ +D   +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 613 T 613
           T
Sbjct: 196 T 196

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 7/171 (4%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++   GK+ A KKL++   +     E    E R+L+ V  R IV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 516 GFCLHKRCMFFIYEYMERGSL-FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            F   K  +  +   M  G L +++   D+E       R       +   L +LH     
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            I++RD+   N+LL+++    ++D G A  L    S     AGT G++AP+
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE 167

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 57/184 (30%), Positives = 84/184 (45%), Gaps = 17/184 (9%)

Query: 451 DFHIRYCIGTGGYGSVY---KAELPD-GKVVALKKLHQSE-TEDSAFVESFQNEARVLST 505
           +F +   +GTG YG V+   K    D GK+ A+K L ++   + +  VE  + E  VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 506 VRHRN-IVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVA 562
           VR    +V L Y F    + +  I +Y+  G +F  L   D   E      V      + 
Sbjct: 61  VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEII 115

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGY 621
            AL +LH      IV+RDI   NILL+S     + DFG ++    +   RT    GT  Y
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 622 IAPD 625
           +AP+
Sbjct: 173 MAPE 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.7 bits (142), Expect = 7e-09
 Identities = 29/80 (36%), Positives = 46/80 (57%)

Query: 172 GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
           G IP+ + +L +L+ + L  N   G IP  +G++ +L  L +  N   G+IP +LG LTS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 232 LLYLDLSFNQLHSFIPLEIG 251
           L  L+L+ N L   +P  +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 19/192 (9%)

Query: 451 DFHIRYCIGTGGYGS--VYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            +++   +G G +G   + +    D K  A+K++   ++  S+ VE  + EA +L+ ++H
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKY-AMKEIRLPKS--SSAVEDSRKEAVLLAKMKH 57

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-----EAIELNWTRRVNIVKSVAH 563
            NIV           ++ + EY + G L   ++        E   L W   V +   V H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLGVQH 115

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
                 H+    ++HRDI S NI L  N +  + DFG+ARLL    +      GT  Y+ 
Sbjct: 116 I-----HE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168

Query: 624 PDQRLSPPVNQK 635
           P+   + P N K
Sbjct: 169 PEIWENMPYNNK 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 21/183 (11%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKV--VALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           EDF+    +GTG +G V  A   +     VA+K+  +S+      V+   +E ++L+ + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA--- 564
           H   V LYG    +  ++ + E++  G  F  LR +         R  N V     A   
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--------KRFPNDVGCFYAAQIV 141

Query: 565 --LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
               YL    + +IV+RD+   N+LL+ +    + DFG A++  VD+   TL  GT  YI
Sbjct: 142 LIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYTL-CGTPEYI 195

Query: 623 APD 625
           AP+
Sbjct: 196 APE 198

Length = 340

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 15/161 (9%)

Query: 458 IGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHR 509
           +G G +G V +A            KV A+K L    T  S+  E+  +E +++S +  H 
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKV-AVKML--KPTAHSSEREALMSELKIMSHLGNHE 99

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIV L G C     +  I EY   G L   LR   E+  L     ++    VA  +++L 
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL- 157

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
              + + +HRD+++ N+LL       + DFG AR +  DS+
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.4 bits (139), Expect = 7e-09
 Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 30/199 (15%)

Query: 442 YEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
            EDL +  E       IG G +G+V K    P G ++A+K++    T D    +    + 
Sbjct: 3   AEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDL 53

Query: 501 RVLSTVRHRN---IVKLYGFCLHKR----CMFFIYEYMERGSL--FYVLRDDDEAIELNW 551
            V   +R  +   IVK YG    +     CM    E M+  SL  FY    +     +  
Sbjct: 54  DV--VMRSSDCPYIVKFYGALFREGDCWICM----ELMDI-SLDKFYKYVYEVLKSVIPE 106

Query: 552 TRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
                I  +   AL+YL  +    I+HRD+  +NILL+ N    + DFG +  L VDS  
Sbjct: 107 EILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIA 163

Query: 612 RTLRAGTYGYIAPDQRLSP 630
           +T  AG   Y+AP +R+ P
Sbjct: 164 KTRDAGCRPYMAP-ERIDP 181

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 17/164 (10%)

Query: 451 DFHIRY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           D   RY     IG+G YG V  A +   GK VA+KK+  +    +    + + E ++L  
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60

Query: 506 VRHRNIVKLYGFCLHK----RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
            +H NI+ +           + ++ + + ME   L +++  D + +     R    +  +
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRY--FLYQL 116

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
              L Y+H      ++HRD+  +N+L+N + E  + DFG AR L
Sbjct: 117 LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 18/175 (10%)

Query: 458 IGTGGYGS--VYKAELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G   +Y+    D  VV     L +L + E  D+       NE  +LS ++H NI
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA------LNEIVILSLLQHPNI 61

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           +  Y   +    +    EY   G+L+  ++R   +  E      +  +  +  A+SY+H 
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV--LWYLFQIVSAVSYIHK 119

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                I+HRDI + NI L       + DFG +++L  + S      GT  Y++P+
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 22/163 (13%)

Query: 458 IGTGGYGSVYKAELP-DGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVK 513
           IG G +G V KA +  DG  +  A+K++ +  ++D      F  E  VL  +  H NI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRVNIVKS 560
           L G C H+  ++   EY   G+L   LR              +  A  L+  + ++    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           VA  + YL        +HRD+++ NIL+  N  A +ADFG +R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 42/168 (25%), Positives = 82/168 (48%), Gaps = 24/168 (14%)

Query: 458 IGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G   +G +YK  L        ++VA+K L   +  +      FQ EA +++ + H NIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 513 KLYGFCLHKRCMFFIYEYMERGSL--FYVLR----------DDDEAIE--LNWTRRVNIV 558
            L G    ++ +  ++EY+ +G L  F ++R          D+D  ++  L+    ++I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
             +A  + YL    +   VH+D+++ NIL+   L   ++D G +R ++
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 9/170 (5%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G G +G V    E   GK  A+K L +        V     E+RVL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F    R + F+ EY+  G LF+ L   +     + TR       +  AL YLH   +  
Sbjct: 63  SFQTKDR-LCFVMEYVNGGELFFHL-SRERVFSEDRTRFYG--AEIVSALDYLH---SGK 115

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           IV+RD+   N++L+ +    + DFG  +    D++      GT  Y+AP+
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 3/177 (1%)

Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +F I   IG G +  VY+A  L DG  VALKK+   +  D+        E  +L  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N++K Y   +    +  + E  + G L  +++   +   L   + V   K      S L 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSALE 120

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           H  +  ++HRDI   N+ + +     + D G  R     ++      GT  Y++P++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 1e-08
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 28/204 (13%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG GG G VY A  P   + VALKK+ +  +E+    + F  EA++ + + H  IV +Y 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC---- 572
            C     +++   Y+E  +L  +L+   +   L  ++ +    SV   LS  H  C    
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIE 127

Query: 573 ---TPSIVHRDISSNNILLNSNLEAFVADFGTAR--------LLHVD-------SSNRTL 614
              +  ++HRD+  +NILL    E  + D+G A         LL +D        S+ T+
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 615 RA---GTYGYIAPDQRLSPPVNQK 635
                GT  Y+AP++ L  P ++ 
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASES 211

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 10/182 (5%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVL-STVRHRNIVKL- 514
           IG G +G V  A+   DG   A+K L +              E  VL   ++H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
           Y F   ++ ++F+ +Y+  G LF+ L+ +   +E    R       VA A+ YLH   + 
Sbjct: 63  YSFQTAEK-LYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAEVASAIGYLH---SL 115

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQ 634
           +I++RD+   NILL+S     + DFG  +         +   GT  Y+AP+     P ++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 635 KI 636
            +
Sbjct: 176 TV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 21/147 (14%)

Query: 476 VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS 535
           +VA+K L     +++     F  E ++LS ++  NI++L G C+ +  +  I EYME G 
Sbjct: 48  LVAVKILRPDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 536 LFYVLR----DDDEA------------IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHR 579
           L   L     DD E               ++++  +++   +A  + YL    + + VHR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162

Query: 580 DISSNNILLNSNLEAFVADFGTARLLH 606
           D+++ N L+  NL   +ADFG +R L+
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLY 189

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 21/164 (12%)

Query: 452 FHIRYC-----IGTGGYGSV----YKAELPD-GKVVALKKLHQSETEDSAFVESFQNEAR 501
           FH RY      +G G +G V    Y       G++VA+K L +   + +     ++ E  
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEIN 58

Query: 502 VLSTVRHRNIVKLYGFCLHK--RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
           +L T+ H NIVK  G C  +  + +  I EY+  GS    LRD     +LN  + +   +
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS----LRDYLPKHKLNLAQLLLFAQ 114

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            +   ++YLH   +   +HRD+++ N+LL+++    + DFG A+
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 14/173 (8%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY 515
           +G G +G V  AEL    +V A+K L +        V+    E R+L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
                K  +FF+ EY+  G L + +   R  DE       R       V  AL +LH   
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLALMFLHRH- 115

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              +++RD+  +NILL++     +ADFG  +   ++    T   GT  YIAP+
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 13/171 (7%)

Query: 458 IGTGGYGSVYK--AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G G Y +V+K  ++L +  +VALK++ + E E+ A   + + E  +L  ++H NIV L+
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVAHALSYLHHDCTP 574
                 + +  ++EY+++    Y+    D+   +     V I +  +   L+Y H     
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQYM----DDCGNIMSMHNVKIFLYQILRGLAYCHRR--- 123

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRD+   N+L+N   E  +ADFG AR   V +   +    T  Y  PD
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 31/189 (16%)

Query: 450 EDFHIRYCIGTGGYGSV----YKAELPDGKVVALKKLHQSET---EDSAFVESFQNEARV 502
           ED+ +   IG G +G V    +K+     KV A+K L + E     DSAF   F  E  +
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSS---QKVYAMKLLSKFEMIKRSDSAF---FWEERDI 96

Query: 503 LSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           ++      +V+L+      + ++ + EYM  G L  ++ + D  +   W +       V 
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVV 152

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR------LLHVDSSNRTLRA 616
            AL  +H   +  ++HRD+  +N+LL+ +    +ADFGT        ++  D++      
Sbjct: 153 LALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-----V 204

Query: 617 GTYGYIAPD 625
           GT  YI+P+
Sbjct: 205 GTPDYISPE 213

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 16/174 (9%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY 515
           +G G +G V  A L   G++ A+K L +        VE    E R+LS  R H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 516 GFCLHK-RCMFFIYEYMERGSLFYVL---RDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
             C      +FF+ E++  G L + +   R  DEA      R       +  AL +LH  
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEITSALMFLH-- 113

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
               I++RD+  +N+LL+      +ADFG  +    +    +   GT  YIAP+
Sbjct: 114 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 10/182 (5%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVL-STVRHRNIVKL- 514
           IG G +G V  A    + K  A+K L +         +   +E  VL   V+H  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
           + F    + ++F+ +Y+  G LFY L+ +   +E    R       +A AL YLH   + 
Sbjct: 63  FSFQTADK-LYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASALGYLH---SL 115

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQ 634
           +IV+RD+   NILL+S     + DFG  +     +   +   GT  Y+AP+     P ++
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 635 KI 636
            +
Sbjct: 176 TV 177

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 12/172 (6%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A KKL +   +         NE ++L  V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 517 FCLHKRCMFFIYEYMERGSL-FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
               K  +  +   M  G L F++    +   E    R V     +   L  LH +    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE--EGRAVFYAAEICCGLEDLHQE---R 122

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL--RAGTYGYIAPD 625
           IV+RD+   NILL+ +    ++D G A  +HV    +T+  R GT GY+AP+
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHV-PEGQTIKGRVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 18/182 (9%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR-NIVKLY 515
           I  G +GSVY A+    G   A+K L +S+      V + + E  ++        + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 516 GFCLHKRCMFFIYEYMERG---SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
                K  ++ + EY+  G   SL   L    E    +W +    +  V   +  LH   
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE----DWAK--QYIAEVVLGVEDLHQR- 116

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPV 632
              I+HRDI   N+L++      + DFG +R       N+    GT  Y+AP+  L    
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF-VGTPDYLAPETILGVGD 170

Query: 633 NQ 634
           ++
Sbjct: 171 DK 172

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 9/170 (5%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G G +G V    E   G+  A+K L +        V     E+RVL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F  H R + F+ EY   G LF+ L  +    E    R       +  AL YLH   +  
Sbjct: 63  AFQTHDR-LCFVMEYANGGELFFHLSRERVFTE---ERARFYGAEIVSALEYLH---SRD 115

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +V+RDI   N++L+ +    + DFG  +    D +      GT  Y+AP+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 59/184 (32%), Positives = 84/184 (45%), Gaps = 19/184 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF     +G G  G V K    P G ++A K +H  E +  A       E +VL     
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIK-PAIRNQIIRELKVLHECNS 58

Query: 509 RNIVKLYGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
             IV  YG          CM    E+M+ GSL  VL+      E N   +++I  +V   
Sbjct: 59  PYIVGFYGAFYSDGEISICM----EHMDGGSLDQVLKKAGRIPE-NILGKISI--AVLRG 111

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L+YL       I+HRD+  +NIL+NS  E  + DFG +  L  DS   +   GT  Y++P
Sbjct: 112 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF-VGTRSYMSP 167

Query: 625 DQRL 628
            +RL
Sbjct: 168 -ERL 170

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 11/147 (7%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVK 513
           +G G +G V  AE    G++ A+K L + +      VES   E R+  T    RH  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
           L+     +  + F+ EY   G L   +  D      +  R V     V   L YLH +  
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN-- 120

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFG 600
             IV+RD+  +N+LL++     +ADFG
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFG 146

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 3/177 (1%)

Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +F I   IG G +  VY+A  L D K VALKK+   E  D+   +    E  +L  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N++K     +    +  + E  + G L  +++   +   L   R   + K      S + 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER--TVWKYFVQLCSAVE 120

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           H  +  ++HRDI   N+ + +     + D G  R     ++      GT  Y++P++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 25/162 (15%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF I   +G GGYG V+ A+  D G++VALK++ +S       V     E  +L+T +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEA----IELNWTRRVNIVKS 560
            +VKL         ++   EY+  G    +L       +D A     E+        V +
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM-----FEAVDA 116

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
           + H L Y+H D  P          N L++++    + DFG +
Sbjct: 117 L-HELGYIHRDLKPE---------NFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 40/208 (19%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF +   IG G +G V+   +   G+V A+K L +S+      +   + E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR--RVNIVKSVAHALS 566
             IVKLY     +  ++ + EYM  G L  +L   D   E    R     +V ++  ++ 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFYIAELVLAL-DSVH 118

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA------------------------ 602
            L        +HRDI  +NIL++++    +ADFG                          
Sbjct: 119 KLGF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 603 -RLLHVDSSNRTLRA----GTYGYIAPD 625
             +   D   R +RA    GT  YIAP+
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPE 200

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 9/179 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   IG G +G V   ++    ++ A+K L++ E    A    F+ E  VL     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR-RVNIVKSVAHALSY 567
           + I  L+     +  ++ + +Y   G L  +L   ++ +  +  R  +  +    H++  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS-NRTLRAGTYGYIAPD 625
           LH+      VHRDI  +N+LL+ N    +ADFG+   ++ D +   ++  GT  YI+P+
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 20/178 (11%)

Query: 458 IGTGGYGSVYKAELPDGKVVA------LKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G+VY  +  D K VA      LK++   E   +  V++ Q EA++LS + H  I
Sbjct: 8   LGKGSFGTVYLVK--DKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAI 64

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV----NIVKSVAHALSY 567
           VK +   L +     I EY E   L      D +  EL  T +      + +     L  
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +H+     I+HRD+ + NI L +NL   + DFG +RLL       T   GT  Y++P+
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 7e-08
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 13/159 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F I   I  G +G VY   +  + K+ A+K + +++  +   V   Q E   L+  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERG---SLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             IV LY        ++ + EY+  G   SL ++    DE + + +      +  VA AL
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALAL 117

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL 604
            YLH      I+HRD+  +N+L+++     + DFG +++
Sbjct: 118 DYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 29/184 (15%)

Query: 458 IGTGGYGSV-YKAELPDGKVVALKKLH---QSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G+G YG+V    +   G  VA+KKL+   QSE     F +    E R+L  ++H N++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMKHENVIG 78

Query: 514 LYGF-----CLHKRCMFF-IYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           L         L +   F+ +  +M  + G L    +  ++ I+        +V  +   L
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGL 131

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            Y+H      I+HRD+   N+ +N + E  + DFG AR    DS   T    T  Y AP+
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSE-MTGYVVTRWYRAPE 185

Query: 626 QRLS 629
             L+
Sbjct: 186 VILN 189

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G G +G V    E   G+  A+K L +        V     E RVL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F  H R + F+ EY   G LF+ L  +    E    R       +  AL YLH +   +
Sbjct: 63  SFQTHDR-LCFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSALDYLHSE--KN 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +V+RD+   N++L+ +    + DFG  +    D +      GT  Y+AP+
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.7 bits (117), Expect = 1e-07
 Identities = 26/59 (44%), Positives = 33/59 (55%)

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKL 314
           L  LDLS+N++  I       L NL+ L+LS N L+   P A   L +L SLDLS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 8/177 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +DF     +G G  G V K +     ++  +KL   E +  A       E +VL      
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 63

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            IV  YG       +    E+M+ GSL  VL++     E     +V+I  +V   L+YL 
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI--AVLRGLAYLR 120

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
                 I+HRD+  +NIL+NS  E  + DFG +  L +DS   +   GT  Y++P++
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPER 173

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 23/159 (14%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            F     +G G  G V+   L   GK+ ALK L + E      V+    E  +L+T+ H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS--------- 560
            +  LY     +  +  + +Y   G LF +L+           +    +           
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQ----------RQPGKCLSEEVARFYAAE 111

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 599
           V  AL YLH      IV+RD+   NILL+ +    ++DF
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 17/179 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +D   +  +G G  G+VYKA  L   +++A+K +    T +    +   +E  +L     
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58

Query: 509 RNIVKLYG-FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
             I+  YG F +  R +    E+M+ GSL     D    I  +   R+ +  +V   L+Y
Sbjct: 59  PYIIGFYGAFFVENR-ISICTEFMDGGSL-----DVYRKIPEHVLGRIAV--AVVKGLTY 110

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           L    +  I+HRD+  +N+L+N+  +  + DFG +  L V+S  +T   GT  Y+AP++
Sbjct: 111 L---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTY-VGTNAYMAPER 164

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 14/173 (8%)

Query: 458 IGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIV 512
           +G G +G V  AEL        + ALKK    E +D   VE    E RVL+    H  + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VECTMVERRVLALAWEHPFLT 59

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
            L+     K  +FF+ EY+  G L + ++    +   +  R       +   L +LH   
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH--- 113

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              I++RD+  +N+LL+ +    +ADFG  +         +   GT  YIAP+
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 17/195 (8%)

Query: 440 ILYEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN 498
           I+++   + ++ + I   IG G YG V+K     +G   A+K L      D   +E+  N
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE-IEAEYN 66

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTR 553
             + LS   H N+VK YG    K       ++ + E    GS+  +++       L    
Sbjct: 67  ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG-----FLKRGE 119

Query: 554 RVN--IVKSVAH-ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
           R+   I+  + H AL  L H      +HRD+  NNILL +     + DFG +  L     
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 611 NRTLRAGTYGYIAPD 625
            R    GT  ++AP+
Sbjct: 180 RRNTSVGTPFWMAPE 194

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 28/179 (15%)

Query: 458 IGTGGYGSVYKAEL-------PDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE        P+    VA+K L    TE    +    +E  ++  + +H
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 83

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   LR                   +L++   V
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD+++ N+L+  +    +ADFG AR + H+D   +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 17/183 (9%)

Query: 452 FHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + I+  IG G YG V  A +   G+ VA+KK++    E  +       E ++L  +RH +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPD 60

Query: 511 IVKLYGFCLHK-----RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           IV++    L       + ++ ++E ME   L  V++ +D+   L        +  +  AL
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRAL 116

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            Y+H   T ++ HRD+   NIL N++ +  + DFG AR+   D+           T  Y 
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 623 APD 625
           AP+
Sbjct: 174 APE 176

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 10/113 (8%)

Query: 477 VALKKLHQSETEDS-AFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS 535
           V LK L  S  + S AF E+    A ++  V H++IV LYG C+       + E++E G 
Sbjct: 35  VILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90

Query: 536 LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 588
           L   +    + +   W  +  + K +A ALSYL       +VH ++ + NILL
Sbjct: 91  LDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.9 bits (115), Expect = 2e-07
 Identities = 27/61 (44%), Positives = 34/61 (55%), Gaps = 2/61 (3%)

Query: 63  NLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS 121
           NL+ L+L NN L+  IP      L NLK L+L  NNLT   P+    L +L  L LS N+
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 122 L 122
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 28/183 (15%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLH---QSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G+G YGSV  A +   G+ VA+KKL    QSE     F +    E  +L  ++H N++ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIG 78

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYV----LRDDDEAI---ELNWTRRVNIVKSVAHALS 566
           L    L         +  +    FY+    ++ D + I    L+  +   +V  +   L 
Sbjct: 79  L----LDVFTSAVSGDEFQD---FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           Y+H   +  I+HRD+   N+ +N + E  + DFG AR  H D+   T    T  Y AP+ 
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAE-MTGYVVTRWYRAPEV 185

Query: 627 RLS 629
            L+
Sbjct: 186 ILN 188

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 29/180 (16%)

Query: 431 LVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS 490
           L  G + GKI    L  +TE+   R  + +   G   K E    +++A  K  ++ +  +
Sbjct: 156 LPAGAF-GKIFICALRASTEEAEARRGVNSTNQG-KPKCE----RLIA--KRVKAGSRAA 207

Query: 491 AFVESFQNEARVLSTVRHRNIVKL--------YGFCLHKRCMFFIYEYMERGSLFYVLRD 542
             +E   NE   L  + H NI+K+          + + ++  F +Y +M   +      D
Sbjct: 208 IQLE---NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----D 259

Query: 543 DDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
             +   L  TR   I+K +  A+ Y+H      ++HRDI   NI LN + +  + DFGTA
Sbjct: 260 WKDRPLLKQTRA--IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Length = 501

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 10/171 (5%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++ + GK+ A KKL +   +  +  +    E  +L  V    IV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 516 GFCLHKRCMFFIYEYMERGSL-FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            F   K  +  +   M  G L +++    +  +E+   R ++    +   + +LH   + 
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME--RVIHYSAQITCGILHLH---SM 114

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            IV+RD+   N+LL+      ++D G A  L  D    T RAGT GY+AP+
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRAGTNGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 19/155 (12%)

Query: 454 IRYCIGTGGYGSV--------YKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           I   +GTG +G +         K ELP    VA+  L    ++       F  EA  L  
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELP----VAIHTLRAGCSDKQR--RGFLAEALTLGQ 62

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H NIV+L G       M  + EYM  G+L   LR  +   +L   + + ++  +A  +
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGM 120

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 600
            YL        VH+ ++++ +L+NS+L   ++ F 
Sbjct: 121 KYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A K+L +   +         NE ++L  V  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 517 FCLHKRCMFFIYEYMERGSL-FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
               K  +  +   M  G L F++    +   E    R +     +   L  LH +   +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--RALFYAAEILCGLEDLHRE---N 122

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            V+RD+   NILL+      ++D G A  +    S R  R GT GY+AP+
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG-RVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           +G G +G V  AEL   G+  A+K L +        VE    E RVL+    +  +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                K  +FF+ E++  G L + ++D       +  R       +   L +LH   +  
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLH---SKG 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I++RD+  +N++L+ +    +ADFG  +      +  +   GT  YIAP+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.1 bits (130), Expect = 3e-07
 Identities = 54/197 (27%), Positives = 78/197 (39%), Gaps = 27/197 (13%)

Query: 474 GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY--GFCLHKRCMFFIYEYM 531
           G  VA+K L     E+      F+ E  + + + H NIV L   G       +F ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61

Query: 532 ERGSLFYVLRDDD--EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN 589
              +L  VL  D    A E        ++  V  AL+  H+     IVHRD+   NI+++
Sbjct: 62  PGRTLREVLAADGALPAGE-----TGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113

Query: 590 -SNLE--AFVADFGTARLL---HVDSSNRTLRA----GTYGYIAPDQ-RLSPPVNQKIIQ 638
            + +   A V DFG   LL            R     GT  Y AP+Q R  P        
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN---S 170

Query: 639 DIILVSTTALACLRSKP 655
           D+       L CL  + 
Sbjct: 171 DLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 8/177 (4%)

Query: 451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF+    +G G +G V  AE     ++ A+K L +        VE    E RVL+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 510 NIVKLYGFCLHK-RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +     C      ++F+ EY+  G L Y ++   +  E    + V     ++  L +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFFL 117

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H      I++RD+  +N++L+S     +ADFG  +   VD        GT  YIAP+
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE 171

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 21/142 (14%)

Query: 458 IGTGGYGSVYKAEL---PDGKV--------VALKKLHQSETEDSAFVESFQNEARVLSTV 506
           +G G + ++YK  L    D  +        V LK L     +  AF E+    A ++S +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET----ASLMSQL 58

Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H+++VKLYG C+    +  + EY++ G L   L  +   + L+W  ++++ K +A AL 
Sbjct: 59  SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 567 YLHHDCTPSIVHRDISSNNILL 588
           YL       +VH ++   NIL+
Sbjct: 116 YLEDK---KLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 52/198 (26%), Positives = 79/198 (39%), Gaps = 36/198 (18%)

Query: 446 INAT-EDFHIRY----CIGTGGYGSVYKAELPDGKV-VALKKLH---QSETEDSAFVESF 496
           +N T  +   RY     +G+G YG V  A        VA+KKL    QS        +  
Sbjct: 6   LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRT 61

Query: 497 QNEARVLSTVRHRNIVKLYG-FCLHKRCMFF--IY---EYMERGSLFYVLRDD---DEAI 547
             E R+L  + H N++ L   F        F  +Y     M    L  +++     D+ I
Sbjct: 62  YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHI 120

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
           +        +V  +   L Y+H   +  I+HRD+  +NI +N + E  + DFG AR    
Sbjct: 121 QF-------LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-- 168

Query: 608 DSSNRTLRAGTYGYIAPD 625
                T    T  Y AP+
Sbjct: 169 -DDEMTGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 30/196 (15%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLY 515
           IG G YG VYKA +   GK+VALKK  + E ++     +   E  +L  +     IV+L 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66

Query: 516 GFCLH-------KRCMFFIYEYMERGSLFYVL---RDDDEAIELNWTRRV--NIVKSVAH 563
              +        K  ++ ++EY++     ++    R     +     +     ++K VAH
Sbjct: 67  -LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTARLLHVDSSNRTLRAGTYGYI 622
              +        ++HRD+   N+L++       +AD G  R   +   + T    T  Y 
Sbjct: 126 CHKH-------GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178

Query: 623 APDQRL-----SPPVN 633
           AP+  L     S PV+
Sbjct: 179 APEVLLGSTHYSTPVD 194

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 56/188 (29%), Positives = 83/188 (44%), Gaps = 25/188 (13%)

Query: 451 DFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETEDSA-FVESFQNEARVLST 505
           +F +   +GTG YG V+          GK+ A+K L ++     A   E  + E +VL  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 506 VRHRN-IVKL-YGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIV 558
           VR    +V L Y F    + +  I +Y+  G LF  L       + E        RV I 
Sbjct: 61  VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEV-------RVYIA 112

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AG 617
           + V  AL +LH      I++RDI   NILL+S     + DFG ++    +   R     G
Sbjct: 113 EIVL-ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 618 TYGYIAPD 625
           T  Y+AP+
Sbjct: 169 TIEYMAPE 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 10/178 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYK-AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF     +G G  G V+K +  P G ++A K +H       A       E +VL     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             IV  YG       +    E+M+ GSL  VL+      E     +V+I  +V   L+YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYL 119

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
                  I+HRD+  +NIL+NS  E  + DFG +  L +DS   +   GT  Y++P++
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPER 173

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 12/173 (6%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G VY+    D  ++ A+K L + E      V     E  +L          + G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 517 FCLHKRC---MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH-HDC 572
                +    ++ + +YM  G LF+ L+ +    E    R    +  +  AL +LH +D 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE---DRAKFYIAELVLALEHLHKYD- 116

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              IV+RD+   NILL++     + DFG ++    D+       GT  Y+AP+
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 458 IGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           +G G +G VY+        + P+ +V A+K ++++ +        F NEA V+      +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEASVMKEFNCHH 70

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTRRVNIVKSVAH 563
           +V+L G     +    I E M RG L   LR     +E N         + + +   +A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            ++YL+ +     VHRD+++ N ++  +    + DFG  R
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 1e-06
 Identities = 24/60 (40%), Positives = 29/60 (48%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL 146
           NLK L+L  N LT         L NL+VL LS N+L   +P     L +L  L L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 9/170 (5%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G G +G V    E   GK  A+K L +        V     E+RVL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F  H R + F+ EY   G LF+ L  +    E +  R       +  AL YLH   +  
Sbjct: 63  SFQTHDR-LCFVMEYANGGELFFHLSRERVFSE-DRARFYG--AEIVSALGYLH---SCD 115

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +V+RD+   N++L+ +    + DFG  +    D +      GT  Y+AP+
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 17/163 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF     IG G +G V   +  D G + A+KKL +SE  +   V   + E  +L+   +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR-----RVNIVKSVAH 563
             +VKLY     +  ++ I EY+  G +  +L   D   E   TR      +  + S+ H
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE-EETRFYIAETILAIDSI-H 118

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
            L Y         +HRDI  +N+LL++     ++DFG    L 
Sbjct: 119 KLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 27/171 (15%)

Query: 458 IGTGGYGSVYKAEL-------PDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE        P+  V VA+K L    T+    +    +E  ++  + +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKH 77

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD-----DEAIE--------LNWTRRV 555
           +NI+ L G C     ++ + EY  +G+L   LR       D + +        L +   V
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           +    VA  + YL    +   +HRD+++ N+L+  +    +ADFG AR +H
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 11/163 (6%)

Query: 458 IGTGGYGSVYKA--ELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G+G +G V K   ++   ++ VA+K L      + +  +    EA ++  + +  IV++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            G C  +  M  + E    G L   L    + I +  +  V ++  V+  + YL      
Sbjct: 61  IGVCEAEALML-VMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEGK--- 114

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           + VHRD+++ N+LL +   A ++DFG ++ L  D S    R+ 
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 2e-06
 Identities = 23/60 (38%), Positives = 30/60 (50%)

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
           +L  LDLS N+L             L  LDLS N +  I P+  S L +L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 9/175 (5%)

Query: 453 HIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           H R  +G GG+G V   ++   GK+ A KKL +   +         NE R+L  V  R +
Sbjct: 4   HYR-VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV 62

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSL-FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           V L      K  +  +   M  G L F++    +   +    R +     +   L  L  
Sbjct: 63  VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ--RAIFYAAELCCGLEDLQR 120

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +    IV+RD+   NILL+      ++D G A  +    + R  R GT GY+AP+
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG-RVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF     IG G +G V   +  D G + A+K L +++  +   V   + E  +L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD----EAIELNWTRRVNIVKSVAHA 564
             +VK++     KR ++ I E++  G +  +L   D    EA +      V  + ++ H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 600
           L +         +HRDI  +N+LL++     ++DFG
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 7/169 (4%)

Query: 458 IGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V +    D  ++ ALK + ++     + V     E  VL+ V    IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
                  ++ +  ++  G LF+ L+ +      + +R       +  AL  LH     ++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLH---KFNV 114

Query: 577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           ++RD+   NILL+      + DFG  +L   D        GT  Y+AP+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE 163

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 28/182 (15%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY 515
           IG G +  V KA     GK  A+K + +   +    V +   E + L  +  H NI++L 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNL-REIQALRRLSPHPNILRLI 64

Query: 516 GFCLHKR---CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
              L  R    +  ++E M+  +L+ +++       L   R  + +  +  +L ++H + 
Sbjct: 65  E-VLFDRKTGRLALVFELMD-MNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMHRN- 119

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS------SNRTLRA-------GTY 619
              I HRDI   NIL+  ++   +ADFG+ R ++         S R  RA       G Y
Sbjct: 120 --GIFHRDIKPENILIKDDILK-LADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 620 GY 621
           G 
Sbjct: 177 GP 178

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 33/113 (29%), Positives = 59/113 (52%), Gaps = 10/113 (8%)

Query: 477 VALKKLHQSETEDS-AFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS 535
           V LK L  S  + + AF E+    A ++S V H ++  ++G C+       + E++E G 
Sbjct: 47  VVLKVLDPSHRDIALAFFET----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGP 102

Query: 536 LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 588
           L   LR +   + + W  ++ + + +A ALSYL      ++VH ++ + NILL
Sbjct: 103 LDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     IG G +G V   +  D G V A+K L +++  +   V   + E  +L     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD----EAIELNWTRRVNIVKSVAHA 564
             +VK++     K  ++ I E++  G +  +L   D    E  +      V  + S+ H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 600
           L +         +HRDI  +N+LL+S     ++DFG
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 16/166 (9%)

Query: 458 IGTGGYGSV----YKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G G +G V    Y  E  + G+ VA+K L      +   +   + E  +L  + H NIV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 69

Query: 513 KLYGFCLHK--RCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           K  G C       +  I E++  GSL  Y+ R+ ++   +N  +++     +   + YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR 615
              +   VHRD+++ N+L+ S  +  + DFG  + +  D    T++
Sbjct: 127 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 4e-06
 Identities = 22/60 (36%), Positives = 27/60 (45%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKI 266
           NL  L +  N+LT         L +L  LDLS N L S  P       +L  LDLS N +
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.7 bits (117), Expect = 4e-06
 Identities = 29/119 (24%), Positives = 56/119 (47%), Gaps = 13/119 (10%)

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           + N +KLY      +    I +Y++ G LF +L+ +   +     +   I++ +  AL+ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVK--KIIRQLVEALND 124

Query: 568 LH-HDCTPSIVHRDISSNNILLNSNLE-AFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LH H    +I+H DI   N+L +   +  ++ D+G  +++   S       GT  Y +P
Sbjct: 125 LHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSP 175

Length = 267

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 499 EARVLSTVRHRNIVKLYG-FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI 557
           EA +L  + H +I++L G F  +K     +  Y  +  L+  L        +     + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRN---IAICDILAI 187

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
            +SV  A+ YLH +    I+HRDI + NI +N   +  + DFG A
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 12/190 (6%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           DF+    +G G +G V  AE     ++ A+K L +        VE    E RVL+   + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 509 RNIVKLYG-FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
             + +L+  F    R ++F+ EY+  G L Y ++   +  E      V     +A  L +
Sbjct: 61  PFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFF 116

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAPDQ 626
           LH   +  I++RD+  +N++L++     +ADFG  +  +    + RT   GT  YIAP+ 
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF-CGTPDYIAPEI 172

Query: 627 RLSPPVNQKI 636
               P  + +
Sbjct: 173 IAYQPYGKSV 182

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           IG G Y  V    L    ++ A+K + +    D   ++  Q E  V      H  +V L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                +  +FF+ EY+  G L + ++   +  E +  R  +    ++ AL+YLH      
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYS--AEISLALNYLHER---G 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I++RD+  +N+LL+S     + D+G  +         +   GT  YIAP+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 23/178 (12%)

Query: 458 IGTGGYGSVY---KAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G +G V+   K   PD G++ A+K L ++  +    V + + E  +L+ V H  IVK
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62

Query: 514 L-YGFCLHKRCMFFIYEYMERGSLFYVLRDD----DEAIELNWTRRVNIVKSVAHALSYL 568
           L Y F    + ++ I +++  G LF  L  +    +E ++         +  +A AL +L
Sbjct: 63  LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALALDHL 114

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGYIAPD 625
           H   +  I++RD+   NILL+      + DFG ++   +D   +     GT  Y+AP+
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 168

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 10/150 (6%)

Query: 458 IGTGGYGSVYKAELPDGKVVA---LKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           IG G +G V   E   G   A   +K+L  S T D      F  E +    + H N+++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV--NIVKSVAHALSYLHHDC 572
            G C+       + E+   G L   LR +   +     + V   +   VA  L +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTA 602
               +H D++  N  L ++L   + D+G A
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 49/216 (22%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLS-FNQLHSFIPLEIGNFSALAELDLSDNK 265
           N+  L   +N+LT +IP+TL      + L ++   +L   +P      SAL  LDL  NK
Sbjct: 221 NIKTLYANSNQLT-SIPATLPDTIQEMELSINRITELPERLP------SALQSLDLFHNK 273

Query: 266 IRGIIPDELSKLSNLQYLNLSSN---LLSGQIPFAIGKLF---------------NLVSL 307
           I   +P+ L +   L+YL++  N    L   +P  I  L                 L +L
Sbjct: 274 ISC-LPENLPE--ELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTALPETLPPGLKTL 330

Query: 308 DLSKNKLSGSFPTGIGNCTELQHLALNHNS---LDGTIPPEIGKILLLQNLDLSHN---N 361
           +  +N L+ S P  +    ELQ L ++ N    L  T+PP I        LD+S N   N
Sbjct: 331 EAGENALT-SLPASLP--PELQVLDVSKNQITVLPETLPPTI------TTLDVSRNALTN 381

Query: 362 LSGTIPMTLHPMFLDMSFNN---LEGEIPTYLRDNP 394
           L   +P  L    +  S NN   L   +P +  + P
Sbjct: 382 LPENLPAALQ--IMQASRNNLVRLPESLPHFRGEGP 415

Length = 754

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 8/177 (4%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF+    +G G +G V  AE     ++ A+K L +        VE    E RVL+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 510 NIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +     C      ++F+ EY+  G L Y ++      E      V     +A  L +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIGLFFL 117

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  I++RD+  +N++L+S     +ADFG  +    D        GT  YIAP+
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 34/183 (18%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++   GK+ A KKL +   +         NE ++L  V  R +V L Y
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 516 GF------CLHKRCM------FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
            +      CL    M      F IY     G         DE       R V     +  
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGF--------DEE------RAVFYAAEITC 113

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL-RAGTYGYI 622
            L  LH +    IV+RD+   NILL+      ++D G A  + +        R GT GY+
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYM 168

Query: 623 APD 625
           AP+
Sbjct: 169 APE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 35/137 (25%), Positives = 55/137 (40%), Gaps = 27/137 (19%)

Query: 499 EARVLSTVRHRNIVKL-----YG--FCL---HKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
           EA +L  V H +++++      G   C+   H     + Y       L       D+A+ 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPL-----PIDQAL- 160

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                   I K +   L YLH      I+HRD+ + NI +N   +  + D G A+   V 
Sbjct: 161 -------IIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210

Query: 609 SSNRTLRAGTYGYIAPD 625
            +   L AGT    AP+
Sbjct: 211 PAFLGL-AGTVETNAPE 226

Length = 357

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 23/60 (38%), Positives = 31/60 (51%)

Query: 279 NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL 338
           NL+ L+LS+N L+     A   L NL  LDLS N L+   P        L+ L L+ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 2e-05
 Identities = 21/58 (36%), Positives = 27/58 (46%)

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           NL+ L LSNN L          L NL+ L L  N L+ + P+    L SL  L +  N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 94/376 (25%), Positives = 141/376 (37%), Gaps = 109/376 (28%)

Query: 84  SLSNLKYLNLRWN-NLTGTIPKEIGSLR---NLEVLYLSNNSLHGTTPIEIGSLRNLEEL 139
           SL+ L+ ++LR + NL     KEI  L    NLE L LS+ S     P  I  L  LE+L
Sbjct: 632 SLTGLRNIDLRGSKNL-----KEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686

Query: 140 YLRSNKLSGVLPQEIGNLKSLIWLSVM--------------------YNTVGGPIPSTLF 179
            +   +   +LP  I NLKSL  L++                       T     PS L 
Sbjct: 687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNL- 744

Query: 180 RLTNL-------------------------------ERLFLGCNQFNGTIPREIGNLKNL 208
           RL NL                                RLFL        +P  I NL  L
Sbjct: 745 RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL 804

Query: 209 THLSIITNKLTGAIPSTLGHLTSLLYLDLS-FNQLHSFIPLEIGNFSALAELDLSDNKIR 267
            HL I        +P+ + +L SL  LDLS  ++L +F  +     + +++L+LS   I 
Sbjct: 805 EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDIS----TNISDLNLSRTGIE 859

Query: 268 GIIPDELSKLSNLQYLNLS--SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC 325
             +P  + K SNL +L+++  +NL   ++   I KL +L ++D S             +C
Sbjct: 860 E-VPWWIEKFSNLSFLDMNGCNNLQ--RVSLNISKLKHLETVDFS-------------DC 903

Query: 326 TELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT------------LHPM 373
             L   + N        P E+         D  H+ L  T+ +             L   
Sbjct: 904 GALTEASWN------GSPSEVAM-----ATDNIHSKLPSTVCINFINCFNLDQEALLQQQ 952

Query: 374 FLDMSFNNLEGEIPTY 389
            +         E+P+Y
Sbjct: 953 SIFKQLILSGEEVPSY 968

syringae 6; Provisional. Length = 1153

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 27/114 (23%)

Query: 499 EARVLSTVRHRNIVKL-YGF------CL---HKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
           E  +L T+ HR I+ L + +      C+     +C  F Y             D    + 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTY------------VDRSGPLP 183

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
           L   + + I + +  AL+YLH      I+HRD+ + NI L+    A + DFG A
Sbjct: 184 LE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 49/195 (25%), Positives = 77/195 (39%), Gaps = 46/195 (23%)

Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN---------EARVLSTV 506
            IG G YG V  A      + VA+KK+  +          F N         E ++L  +
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKVAIKKIANA----------FDNRIDAKRTLREIKLLRHL 61

Query: 507 RHRNIVKLYGFCL--HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH- 563
            H N++ +       H+     +Y       + Y L D D    L+   R +   S  H 
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVY-------IVYELMDTD----LHQIIRSSQTLSDDHC 110

Query: 564 ---------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL 614
                     L Y+H   + +++HRD+  +N+LLN+N +  + DFG AR         T 
Sbjct: 111 QYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167

Query: 615 RAGTYGYIAPDQRLS 629
              T  Y AP+  L+
Sbjct: 168 YVVTRWYRAPELLLN 182

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 18/161 (11%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG- 516
           +G G YG VYKA+  DGK    K+    + E +    S   E  +L  ++H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 517 FCLHK-RCMFFIYEYMERGSLFYVL------RDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           F  H  R ++ +++Y E   L++++      + + + ++L  +   +++  +   + YLH
Sbjct: 67  FLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 570 HDCTPSIVHRDISSNNILL----NSNLEAFVADFGTARLLH 606
            +    ++HRD+   NIL+           +AD G ARL +
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 26/149 (17%), Positives = 51/149 (34%), Gaps = 18/149 (12%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV--KLY 515
           +  G    VY     D   V LK     E          + E  +L  +  + +   K+ 
Sbjct: 6   LKGGLTNRVYLLGTKDEDYV-LKINPSREKG-----ADREREVAILQLLARKGLPVPKVL 59

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                    + + E++E           +   E++   + +I + +A  L+ LH      
Sbjct: 60  ASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARL 604
           + H D+   NIL++      + D+  A  
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 55/182 (30%), Positives = 78/182 (42%), Gaps = 32/182 (17%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALK-------KLHQSETEDSAFVESFQNEARVLSTVRHR 509
           IG GG+G VY     D GK+ A+K       K+ Q ET          NE  +LS V   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIMLSLVSTG 54

Query: 510 N---IVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           +   IV + Y F    + + FI + M  G L Y L       E        +    A  +
Sbjct: 55  DCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSE------AEMRFYAAEII 107

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA--GTYGYIA 623
             L H     +V+RD+   NILL+ +    ++D G A     D S +   A  GT+GY+A
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMA 163

Query: 624 PD 625
           P+
Sbjct: 164 PE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V  A +   G+ VA+KK+ +  +       +++ E ++L  +RH NI+ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76

Query: 517 FCLHKRC-MFFIYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
             +     ++F+ E +  +   L      + + I+         +  +   L Y+H   +
Sbjct: 77  IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-------FLYQILRGLKYVH---S 126

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS 629
             +VHRD+  +NIL+N N +  + DFG AR   +     T    T  Y AP+  L+
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIMLT 179

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 40/202 (19%)

Query: 455 RYC----IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           RY     +G G  G V+ A   D  K VA+KK+  +   D   V+    E +++  + H 
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT---DPQSVKHALREIKIIRRLDHD 62

Query: 510 NIVKLY--------------GFCLHKRCMFFIYEYMERGSLFYVLRDD---DEAIELNWT 552
           NIVK+Y              G       ++ + EYME   L  VL      +E   L   
Sbjct: 63  NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARL--- 118

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSN 611
                +  +   L Y+H   + +++HRD+   N+ +N+ +L   + DFG AR++    S+
Sbjct: 119 ----FMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Query: 612 R---TLRAGTYGYIAPDQRLSP 630
           +   +    T  Y +P   LSP
Sbjct: 172 KGYLSEGLVTKWYRSPRLLLSP 193

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 6e-05
 Identities = 22/60 (36%), Positives = 25/60 (41%)

Query: 183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL 242
           NL+ L L  N+           L NL  L +  N LT   P     L SL  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 40.6 bits (96), Expect = 6e-05
 Identities = 15/38 (39%), Positives = 25/38 (65%), Gaps = 2/38 (5%)

Query: 62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLT 99
           NL+ L+L NN ++  +PP + +L NL+ L+L  N +T
Sbjct: 1  TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 29/147 (19%), Positives = 60/147 (40%), Gaps = 6/147 (4%)

Query: 457 CIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           C        + K + P   +VA+KK++  ++     ++  Q E      ++H NI+    
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINL-DSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             +    ++ +   M  GS    L        L       I+K V +AL Y+H       
Sbjct: 67  SFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GF 122

Query: 577 VHRDISSNNILLNSNLEAFVADFGTAR 603
           +HR + +++ILL+ + +  ++    + 
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSV 149

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 24/164 (14%)

Query: 458 IGTGGYGSVYKAELPDG---KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G G YG VYKA+  DG   +  ALK++     E +    S   E  +L  ++H N++ L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVISL 63

Query: 515 YG-FCLH-KRCMFFIYEYMERGSLFYVL------RDDDEAIELNWTRRVNIVKSVAHALS 566
              F  H  R ++ +++Y E   L++++      + + + ++L      +++  +   + 
Sbjct: 64  QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 567 YLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGTARLLH 606
           YLH +    ++HRD+   NIL+           +AD G ARL +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 18/175 (10%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN----IV 512
           IG GG+G VY     D GK+ A+K L +   +         NE  +LS V   +    + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
             Y F    + + FI + M  G L Y L       E            +   L ++H+  
Sbjct: 62  MTYAFHTPDK-LCFILDLMNGGDLHYHLSQHGVFSEKEMRF---YATEIILGLEHMHNRF 117

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPD 625
              +V+RD+   NILL+ +    ++D G A     D S +   A  GT+GY+AP+
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 18/193 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDFH    IG G +G V   +    GK+ A+K L +SE      +   + E  VL+    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR--RVNIVKSVA--HA 564
             +V LY      + ++ I E++  G L  +L   D   E + TR      V ++   H 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-DVTRFYMAECVLAIEAVHK 119

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH-VDSSN--RTLRAGTYGY 621
           L +         +HRDI  +NIL++      ++DFG +   H    S   + L  G    
Sbjct: 120 LGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170

Query: 622 IAPDQRLSPPVNQ 634
              D R S  V+ 
Sbjct: 171 NRIDNRNSVAVDS 183

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 24/180 (13%)

Query: 458 IGTGGYGSVYKAELPDG---KVVALKKLHQSET--EDSAFVESFQNEARVLSTVRHRNIV 512
           IG G +G V   E+  G     V +K+L  S +  E   F+E    EA+   +++H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV--NIVKSVAHALSYLHH 570
           +  G C        + E+   G L   LR   +A  +         +   +A  L +LH 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP 630
           +   + +H D++  N LL ++L   + D+G +   + +            Y+ PDQ   P
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY----------YVTPDQLWVP 165

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 33/127 (25%), Positives = 43/127 (33%), Gaps = 18/127 (14%)

Query: 256 LAELDLSDNKIRGI----IPDELSKLSNLQYLNLSSNLLSGQIPF------AIGKLFNLV 305
           L  L L  N +       +   L    +L+ L LS N               + K   L 
Sbjct: 25  LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84

Query: 306 SLDLSKNKLSGSFPTGIGNCT---ELQHLALNHNSLDGTIPPEIGKILL-----LQNLDL 357
            LDLS N L       + +      LQ L LN+N L       + K L      L+ L L
Sbjct: 85  ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144

Query: 358 SHNNLSG 364
             N L G
Sbjct: 145 GRNRLEG 151

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 9/174 (5%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL +   +     +    E R+L  ++H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 517 -FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F   +    F   Y+    +   L +  +  +L       ++  +   L Y+H   +  
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 140

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS 629
           I+HRD+  +N+ +N + E  + DFG AR  H D    T    T  Y AP+  L+
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLN 191

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 22/161 (13%)

Query: 458 IGTGGYGSVY--------KAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +G G +G VY        K E  + +V A+K +++S +        F NEA V+      
Sbjct: 14  LGQGSFGMVYEGNARDIIKGE-AETRV-AVKTVNESASLRERI--EFLNEASVMKGFTCH 69

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR-------RVNIVKSVA 562
           ++V+L G     +    + E M  G L   LR      E N  R        + +   +A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             ++YL+       VHRD+++ N ++  +    + DFG  R
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 22/192 (11%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     I  G YG+VY     + +   A+KK+++        ++    E  +L+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +V ++     KR +  + EY+E G    +L++   A+ ++   R+   ++V  AL YL
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVD-MARMYFAETVL-ALEYL 117

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFG---------TARLL--HVDSSNRTLR-- 615
           H      IVHRD+  +N+L+ S     + DFG         T  L   H++   R     
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 616 --AGTYGYIAPD 625
              GT  YIAP+
Sbjct: 175 QVCGTPEYIAPE 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 14/173 (8%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           IG G Y  V   EL    ++ A+K + +    D   ++  Q E  V  T   H  +V L+
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN---WTRRVNIVKSVAHALSYLHHDC 572
                +  +FF+ E++  G L + ++   +  E +   ++  +++      AL++LH   
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLHER- 115

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              I++RD+  +N+LL++     + D+G  +         +   GT  YIAP+
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 5e-04
 Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 21/155 (13%)

Query: 458 IGTGGYGSV---YKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           IG+G  G V   Y A L   + VA+KKL +     +    +++ E  ++  V H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 515 YGFCLHKRCM------FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
                 ++ +      + + E M+  +L  V++     +EL+  R   ++  +   + +L
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHL 135

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           H   +  I+HRD+  +NI++ S+    + DFG AR
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG+G  G V  A +   G  VA+KKL +     +    +++ E  +L  V H+NI+ L  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 517 FCLHKRCM------FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
               ++ +      + + E M+  +L  V+      +EL+  R   ++  +   + +LH 
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 140

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             +  I+HRD+  +NI++ S+    + DFG AR
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 27/175 (15%)

Query: 461 GGYGSVYKAELPDGKV-----VALKKL--HQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           G +G ++   L D K      V +K +  H SE +    V     E+ +L  + H+NI+ 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ----VTLLLQESCLLYGLSHQNILP 72

Query: 514 LYGFCLHKRCM-FFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAHALSY 567
           +   C+      F +Y YM  G+L   L+     + +    L+  + V++   +A  +SY
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL-----HV--DSSNRTLR 615
           LH      ++H+DI++ N +++  L+  + D   +R L     H   D+ NR ++
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.4 bits (100), Expect = 6e-04
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 33/161 (20%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN---------EARVLSTVR 507
           IG+G  G V  A +   G+ VA+KKL +           FQN         E  ++  V 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRP----------FQNVTHAKRAYRELVLMKLVN 73

Query: 508 HRNIVKLYG-FCLHKRCMFF--IYEYME--RGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           H+NI+ L   F   K    F  +Y  ME    +L  V++     ++L+  R   ++  + 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQML 128

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             + +LH   +  I+HRD+  +NI++ S+    + DFG AR
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.5 bits (100), Expect = 7e-04
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV---DSSNRTLRAGTYGYIAP 624
           +HH  +  ++HRDI S NILL SN    + DFG +++      D   RT   GT  Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAP 214

Query: 625 D 625
           +
Sbjct: 215 E 215

Length = 496

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 25/61 (40%), Positives = 34/61 (55%), Gaps = 2/61 (3%)

Query: 303 NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPE-IGKILLLQNLDLSHNN 361
           NL SLDLS N+L+            L+ L L+ N+L  +I PE    +  L++LDLS NN
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 362 L 362
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 16/43 (37%), Positives = 25/43 (58%), Gaps = 2/43 (4%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE 129
           NL+ L+L  N +T  +P  + +L NLE L LS N +   +P+ 
Sbjct: 2   NLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKITDLSPLS 42

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 17/149 (11%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V      D   + A+K L +++          + E  +L+   +  +VKLY 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 517 FCLHKRCMFFIYEYMERGSLFYVL-----RDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
               K  ++F+ +Y+  G +  +L      ++D A       R  I + +  A+  +H  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYIAE-LTCAIESVHK- 119

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFG 600
                +HRDI  +NIL++ +    + DFG
Sbjct: 120 --MGFIHRDIKPDNILIDRDGHIKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 52/206 (25%)

Query: 454 IRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST-------- 505
           I   IG GG+G VY+              H    +  A +E+ +NE  V+ T        
Sbjct: 16  IDKLIGCGGFGCVYE--------TQCASDHCINNQAVAKIENLENETIVMETLVYNNIYD 67

Query: 506 ------------VRHRNIVKLYGFCLHKRC-MFFIYEYMER-----GSLF-YVLRDDDEA 546
                       + H  I K YG    KRC M++ +  +E+       +F  +   + + 
Sbjct: 68  IDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL 127

Query: 547 IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL- 605
           I+       NI+K +   L Y+H      I H DI   NI+++ N   ++ D+G A    
Sbjct: 128 IK-------NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177

Query: 606 ----HVDSS--NRTLRAGTYGYIAPD 625
               H++ S   + L  GT  Y   D
Sbjct: 178 IHGKHIEYSKEQKDLHRGTLYYAGLD 203

Length = 294

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 21/155 (13%)

Query: 458 IGTGGYGSV---YKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           IG+G  G V   Y A L   + VA+KKL +     +    +++ E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 515 YGFCLHKRCM------FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
                 ++ +      + + E M+  +L  V++     +EL+  R   ++  +   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHL 142

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           H   +  I+HRD+  +NI++ S+    + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 51/224 (22%), Positives = 79/224 (35%), Gaps = 53/224 (23%)

Query: 206 KNLTHLSIITNKL------TGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSA---- 255
            +L  L +  N+         ++   L     L  LDLS N   +  P   G   +    
Sbjct: 51  PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDN---ALGPDGCGVLESLLRS 107

Query: 256 --LAELDLSDNKIRGIIPDELSK-----LSNLQYLNLSSNLLSGQIPFAIGKLF----NL 304
             L EL L++N +       L+K        L+ L L  N L G    A+ K      +L
Sbjct: 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDL 167

Query: 305 VSLDLSKNKLSGS-----FPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL-------- 351
             L+L+ N +  +           NC  L+ L LN+N L      + G   L        
Sbjct: 168 KELNLANNGIGDAGIRALAEGLKANC-NLEVLDLNNNGLT-----DEGASALAETLASLK 221

Query: 352 -LQNLDLSHNNLSGTIPMTLHPMF---------LDMSFNNLEGE 385
            L+ L+L  NNL+      L             L +S N++  +
Sbjct: 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDD 265

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 9/97 (9%)

Query: 458 IGTGGYGSVYKA------ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A      +  +   VA+K L  S   D    E+  +E ++LS + +H+N
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE--REALMSELKILSHLGQHKN 103

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAI 547
           IV L G C H   +  I EY   G L   LR   E  
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 23/154 (14%)

Query: 458 IGTGGYGSVYKAEL---PDGKVVALKKLHQSET--EDSAFVESFQNEARVLSTVRHRNIV 512
           IG G +G V  +E+        V +K+L  + +  E + F++   +  R+L   +H NI+
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQ-GDPYRIL---QHPNIL 58

Query: 513 KLYGFCLHKRCMFFIYEYMERGSL-FYV-----LRDDDEAIELNWTRRVNIVKSVAHALS 566
           +  G C+       ++EY E G L  Y+      R + + + L       +   +A  ++
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG 600
           ++H     + +H D++  N  L S+L   V D+G
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG 144

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 32/161 (19%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +    + VA+KKL +   +          E R+L  ++H N++ L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK--------------SVA 562
                  +F     +E  +  Y++ +   A +LN     NIVK               + 
Sbjct: 82  -------VFTPATSIENFNEVYLVTNLMGA-DLN-----NIVKCQKLSDEHVQFLIYQLL 128

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
             L Y+H   +  I+HRD+  +N+ +N + E  + DFG AR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 8/170 (4%)

Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLY 515
           IG G Y  V    L  + ++ A+K + +    D   ++  Q E  V         +V L+
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                   +F + EY+  G L + ++   +  E            +  AL++LH      
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE---EHARFYAAEICIALNFLHER---G 116

Query: 576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I++RD+  +N+LL+++    + D+G  +         +   GT  YIAP+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	701
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.98
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.98
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.98
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.98
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.98
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.98
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.98
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.98
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.98
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.98
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.93
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.9
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.89
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
PLN00181	793	protein SPA1-RELATED; Provisional	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.82
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
smart00090	237	RIO RIO-like kinase.	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.69
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.69
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.57
PLN03150	623	hypothetical protein; Provisional	99.53
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.4
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
PLN03150	623	hypothetical protein; Provisional	99.29
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.25
KOG1243	690	consensus Protein kinase [General function predict	99.25
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.23
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.22
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.04
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.04
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.93
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.74
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.71
PRK09902	216	hypothetical protein; Provisional	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.68
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.65
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.55

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5e-83  Score=767.79  Aligned_cols=624  Identities=35%  Similarity=0.561  Sum_probs=383.2

Q ss_pred             HHHHHHHhcC-------CCCcCCCCCCCCCCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcc
Q 041034            2 EIERQALLNC-------GWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNL   74 (701)
Q Consensus         2 ~~~~~~l~~~-------~~~~~~~~~~~~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l   74 (701)
                      +.||+||++.       ..+...|. .+.|||.|.||+|+..++|+.|+|+++.++|.++. .|..+++|+.|+|++|++
T Consensus        28 ~~~~~~l~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~  105 (968)
T PLN00113         28 AEELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQL  105 (968)
T ss_pred             HHHHHHHHHHHHhCCCCcccCCCCC-CCCCCCcCcceecCCCCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCcc
Confidence            6799999871       11222342 25689999999999888999999999888876543 456666666666666666


Q ss_pred             eeeCCcccC-CCCCCCEEECc----------------------CCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccC
Q 041034           75 SGSIPPQIG-SLSNLKYLNLR----------------------WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG  131 (701)
Q Consensus        75 ~~~~~~~~~-~l~~L~~L~L~----------------------~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  131 (701)
                      ++.+|..+. .+++|++|+|+                      +|.+++.+|..++++++|++|+|++|.+.+..|..+.
T Consensus       106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  185 (968)
T PLN00113        106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT  185 (968)
T ss_pred             CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence            555554332 33333333333                      3333344445555555555555555555555555555


Q ss_pred             CccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCC-----------
Q 041034          132 SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPR-----------  200 (701)
Q Consensus       132 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----------  200 (701)
                      ++++|++|+|++|.+++.+|..++++++|+.|+|++|.+.+.+|..+.++++|++|+|++|++++.+|.           
T Consensus       186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  265 (968)
T PLN00113        186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL  265 (968)
T ss_pred             hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEE
Confidence            555555555555555555555555555555555555555555554444445555555554444444444           


Q ss_pred             -------------CCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCc
Q 041034          201 -------------EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIR  267 (701)
Q Consensus       201 -------------~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~  267 (701)
                                   .+.++++|++|++++|.+++.+|..+.++++|++|++++|.+.+.+|..+..+++|+.|+|++|+++
T Consensus       266 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~  345 (968)
T PLN00113        266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS  345 (968)
T ss_pred             ECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCc
Confidence                         4444444555555555555555555555556666666666666656666666666666666666665


Q ss_pred             cccCcccCCCCCCcEEEccCccCCCCC-----------------------------------------------------
Q 041034          268 GIIPDELSKLSNLQYLNLSSNLLSGQI-----------------------------------------------------  294 (701)
Q Consensus       268 ~~~p~~l~~l~~L~~L~L~~N~l~~~~-----------------------------------------------------  294 (701)
                      +.+|..++.+++|+.|++++|.+++.+                                                     
T Consensus       346 ~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~  425 (968)
T PLN00113        346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT  425 (968)
T ss_pred             CcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHh
Confidence            555544443333333333333332211                                                     


Q ss_pred             ------------------------------------------------------------------cccccCccceeeec
Q 041034          295 ------------------------------------------------------------------PFAIGKLFNLVSLD  308 (701)
Q Consensus       295 ------------------------------------------------------------------~~~~~~l~~L~~L~  308 (701)
                                                                                        |..+.++++|+.|+
T Consensus       426 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~  505 (968)
T PLN00113        426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLK  505 (968)
T ss_pred             cCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEE
Confidence                                                                              11122222333333


Q ss_pred             CCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccCCCCC
Q 041034          309 LSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNNLEG  384 (701)
Q Consensus       309 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~l~g  384 (701)
                      |++|++++.+|..+.++++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..    ..+++++|+++|
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            3333333344444444455555555555555555555555555555555555555555554432    356777777777


Q ss_pred             cCCCcCC--CCCCCCcCCCccccccee-----------------eeeeee---------eeeee-eeeccc-ccccccc-
Q 041034          385 EIPTYLR--DNPPNSFVGNKGLCGHVQ-----------------VLAFTI---------FGFIL-LLKGKS-ENLKLVT-  433 (701)
Q Consensus       385 ~~p~~~~--~~~~~~~~~~~~~~~~~~-----------------v~~~~~---------~~~~~-~~~~~~-~~~~~~~-  433 (701)
                      .+|....  .....++.||+.+||...                 +++.++         +++.+ +.++++ .+.+.+. 
T Consensus       586 ~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  665 (968)
T PLN00113        586 SLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN  665 (968)
T ss_pred             eCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence            7775422  334567889998887421                 011000         11111 112221 1111110 


Q ss_pred             ----cC---CC----CcccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHH
Q 041034          434 ----GG---YD----GKILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEAR  501 (701)
Q Consensus       434 ----~~---~~----~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~  501 (701)
                          +.   +.    ..+.+++   ..+.|...+.||+|+||.||+|.. .+++.||||++......       ...|++
T Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~  735 (968)
T PLN00113        666 EDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIA  735 (968)
T ss_pred             ccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHH
Confidence                00   00    1123333   345678889999999999999965 57899999998754321       134688


Q ss_pred             HHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 041034          502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDI  581 (701)
Q Consensus       502 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dl  581 (701)
                      ++++++||||+++++++.+.+..|+||||+++|+|.++++.      ++|..+.+++.|+|+||+|||+.+.++|+||||
T Consensus       736 ~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl  809 (968)
T PLN00113        736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL  809 (968)
T ss_pred             HHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence            89999999999999999999999999999999999999953      789999999999999999999766679999999


Q ss_pred             CCCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          582 SSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       582 kp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ||+||+++.++.+++. ||.+.....+    ....+|+.|+|||+..+..++.+.  ||||+|+++||+
T Consensus       810 kp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~s--Dv~S~Gvvl~el  871 (968)
T PLN00113        810 SPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKS--DIYGFGLILIEL  871 (968)
T ss_pred             CHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCccc--chhhHHHHHHHH
Confidence            9999999999888875 6665443211    223688999999999888887776  999999998753

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=347.22  Aligned_cols=216  Identities=28%  Similarity=0.461  Sum_probs=192.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...+|...+.||+|+||+||+|++. ++..||||.+.+... .....+.+..|+.+++.++|||||+++++++.++..|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            4568899999999999999999665 589999999987653 34456788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC------CCeEEEeec
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN------LEAFVADFG  600 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~------~~~kL~DFG  600 (701)
                      |||||.||+|.+|++..+   .+++..++.++.|+|.||++||++   +||||||||.|||++..      -.+||+|||
T Consensus        87 VMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            999999999999999876   599999999999999999999999   99999999999999764      468999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhhcCCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELEGKTP  673 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~~~~~  673 (701)
                      +|+.+.. .......+|++.|||||++....|+.++  |+||+|+|+|+|+.+.| .++.|..|+....+....
T Consensus       161 fAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKA--DLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~  231 (429)
T KOG0595|consen  161 FARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKA--DLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE  231 (429)
T ss_pred             hhhhCCc-hhHHHHhhCCccccCHHHHHhccccchh--hHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc
Confidence            9999863 3445567899999999999999999997  99999999999999984 566899999998876554

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-42  Score=358.98  Aligned_cols=212  Identities=37%  Similarity=0.669  Sum_probs=185.8

Q ss_pred             CCcccHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeee
Q 041034          437 DGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       437 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      ...|+++++..+|++|.....||+|+||.||+|...+|+.||||++.......   .++|.+|+.++.+++|||+|+++|
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence            45689999999999999999999999999999999999999999887755432   256999999999999999999999


Q ss_pred             eeeeCc-EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 041034          517 FCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF  595 (701)
Q Consensus       517 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~k  595 (701)
                      ||.+.+ ..++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.+.||||||||+|||+|+++++|
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            999988 599999999999999999886654 789999999999999999999999888999999999999999999999


Q ss_pred             EEeecCccccccCCCCceee-cccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          596 VADFGTARLLHVDSSNRTLR-AGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       596 L~DFGla~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      |+|||+|+............ .||.+|+|||.......+.+.  ||||+|++++|++++.
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~Ks--DVySFGVvllElitgr  275 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKS--DVYSFGVVLLELITGR  275 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCccc--ccccchHHHHHHHhCC
Confidence            99999997654312222222 799999999999887777776  9999999998744444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-42  Score=356.53  Aligned_cols=197  Identities=27%  Similarity=0.453  Sum_probs=182.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .+|+..+.||+|||+.||+++. ..|+.||+|++.+.........+.+.+||++.++++|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999966 789999999999877777777899999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |+|+.++|..++++.+   ++++.+++.++.||+.||.|||+.   +|+|||||..|+|++++.+|||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998654   699999999999999999999999   9999999999999999999999999999999888


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .+.....+|||.|+|||++........+  ||||+|||+|.+|.+.
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEv--DiWSlGcvmYtLL~G~  215 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEV--DIWSLGCVMYTLLVGR  215 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCch--hhhhhhhHHHhhhhCC
Confidence            8888889999999999999988777776  9999999999544333

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-42  Score=338.02  Aligned_cols=201  Identities=29%  Similarity=0.438  Sum_probs=170.9

Q ss_pred             hhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChH----HHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSA----FVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ..+.|.+.+.+|+|+||.|-+| ..++|+.||||++++.......    ......+|+++|++++|||||+++++|+.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567889999999999999999 5568999999999886544311    2234679999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEEee
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADF  599 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~---~~~kL~DF  599 (701)
                      ..||||||++||+|.+.+-..+   .+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999987765   477778889999999999999999   99999999999999755   78999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhh-HHHHHHHHHHHHHcccCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI-IQDIILVSTTALACLRSKP  655 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~Di~slg~i~~~cl~~~P  655 (701)
                      |+|+..+ ........+|||.|.|||++.+..+.... .-|+||+||++|-|+.+.|
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p  379 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP  379 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence            9999876 45556678999999999999877654332 3499999999985555443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=326.37  Aligned_cols=198  Identities=27%  Similarity=0.377  Sum_probs=173.8

Q ss_pred             hhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeee-eeeeCcE-E
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG-FCLHKRC-M  524 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~  524 (701)
                      ...+|++.++||+|.||+||+| ...+|..||.|.+.-.. -+....+....|+.+|++++|||||++++ .+.++.. .
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            3467899999999999999999 56789999999998544 34556788999999999999999999998 4444444 8


Q ss_pred             EEEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          525 FFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g--ivH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      +||||||++|+|.+.++..+ ....+++..+++++.|++.||..+|.+ .+.  |+||||||.||+++.+|.|||+|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchh
Confidence            99999999999999987643 244699999999999999999999985 234  89999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ++.+..........+|||.||+||.+.+.+|+.++  ||||+||++||
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kS--DiWslGCllyE  220 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKS--DIWSLGCLLYE  220 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcch--hHHHHHHHHHH
Confidence            99998776667778999999999999999999997  99999999996

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.6e-41  Score=404.40  Aligned_cols=326  Identities=42%  Similarity=0.585  Sum_probs=281.7

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccC-CCCCCCEEECCCCCCCCCCccccCCccccceee
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG-SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELY  140 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  140 (701)
                      .+++.|+|++|++++.+|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            4688999999999999999999999999999999999988887655 899999999999999887774  5688899999


Q ss_pred             cccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccC
Q 041034          141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG  220 (701)
Q Consensus       141 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  220 (701)
                      |++|.+++.+|..++++++|++|+|++|.+.+.+|..+.++++|++|+|++|++++.+|..++++++|++|+|++|++++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            99999988888889999999999999999888888888889999999999999888888888888899999999999888


Q ss_pred             CccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccC
Q 041034          221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK  300 (701)
Q Consensus       221 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  300 (701)
                      .+|..++++++|++|++++|++++.+|..++++++|+.|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+.+
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  306 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ  306 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence            88888888889999999999888888888888888888999888888888888888888888888888888888888888


Q ss_pred             ccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccc
Q 041034          301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLD  376 (701)
Q Consensus       301 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~  376 (701)
                      +++|+.|++++|.+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|++++|+++|.+|..+..    ..++
T Consensus       307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~  386 (968)
T PLN00113        307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI  386 (968)
T ss_pred             CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence            888888888888888888888888888888888888888888888888888888888888888877765532    3456


Q ss_pred             cccCCCCCcCCCc
Q 041034          377 MSFNNLEGEIPTY  389 (701)
Q Consensus       377 ls~N~l~g~~p~~  389 (701)
                      +++|++++.+|..
T Consensus       387 l~~n~l~~~~p~~  399 (968)
T PLN00113        387 LFSNSLEGEIPKS  399 (968)
T ss_pred             CcCCEecccCCHH
Confidence            6666666555543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=326.52  Aligned_cols=217  Identities=25%  Similarity=0.420  Sum_probs=192.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.++||+|+||+||.++.. +++.+|+|++++...-.....+....|..++.+++||+||+++-.|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3678999999999999999999554 589999999998876665557788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |+||+.||.|...+++.+   .+++..+.-++..|+.||.|||++   |||||||||+|||+|.+|+++|+|||+++..-
T Consensus       103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999998766   699999999999999999999999   99999999999999999999999999999766


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhhcCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELEGKT  672 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~~~~  672 (701)
                      ..+......+||+.|||||++.+.+++..+  |+||+|+++|+|+.+-|. .-++..++.+.+....
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~v--DWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k  241 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAV--DWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK  241 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCccc--chHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence            565666668999999999999999999887  999999999999999854 3455555555554433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=328.03  Aligned_cols=187  Identities=30%  Similarity=0.427  Sum_probs=168.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-EEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-CMFFIY  528 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  528 (701)
                      +.+....||+|..|+||+|+++ +++.+|+|++....  +....+++.+|+++++.++|||||++||.|..+. ...|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            4456789999999999999664 78999999995443  4566789999999999999999999999999998 599999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||++|+|++++...+   ++++....+|+.++++||.|||+ +   +||||||||+|||++..|+|||||||.++.+..
T Consensus       158 EYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999999998764   69999999999999999999996 5   999999999999999999999999999998753


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .  .....+||..|||||.+.+..|+.+.  ||||||..++|
T Consensus       232 S--~a~tfvGT~~YMsPERi~g~~Ys~~s--DIWSLGLsllE  269 (364)
T KOG0581|consen  232 S--IANTFVGTSAYMSPERISGESYSVKS--DIWSLGLSLLE  269 (364)
T ss_pred             h--hcccccccccccChhhhcCCcCCccc--ceecccHHHHH
Confidence            3  45667899999999999999999886  99999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=339.37  Aligned_cols=215  Identities=32%  Similarity=0.568  Sum_probs=188.5

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-EEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-CMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  528 (701)
                      ++..+.+.+|+|+||+||+|.+.....||||++......... .+.|.+|+.+|.+++|||||+++|++.++. ..++||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            344556669999999999999965455999999887655444 789999999999999999999999999887 799999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCcEEEcCCC-CeEEEeecCccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS-IVHRDISSNNILLNSNL-EAFVADFGTARLLH  606 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g-ivH~Dlkp~NIll~~~~-~~kL~DFGla~~~~  606 (701)
                      ||+++|+|.++++.. ....+++..+++++.|||+|++|||++   + ||||||||+|||++.++ ++||+|||+++...
T Consensus       120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            999999999999874 223699999999999999999999999   7 99999999999999997 99999999998765


Q ss_pred             cCCCCceeecccccccCCCCCC--CCcCChhhHHHHHHHHHHHHH-----------------------------------
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRL--SPPVNQKIIQDIILVSTTALA-----------------------------------  649 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~~Di~slg~i~~~-----------------------------------  649 (701)
                      ......+...||+.|||||++.  ...++.+.  ||||+|+++|+                                   
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~--DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKS--DVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccc--hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            4333444468999999999999  56888887  99999999995                                   


Q ss_pred             --------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 --------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 --------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                              ||..+|..||++.+++..++..
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                    9999999999999999998854

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.4e-40  Score=311.20  Aligned_cols=214  Identities=25%  Similarity=0.372  Sum_probs=186.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +.|+...++|+|+||+||+++.+ +|+.||||++..... ++...+-..+|++++++++|+|+|.++++|.....+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            56888899999999999999776 599999999987653 4555677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |||+. ++.+-++....  .++...+.++++|++.|+.|+|++   ++|||||||+|||++.+|.+||||||+|+.+..+
T Consensus        81 E~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99988 65555655544  488899999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHHhhcCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK--SRPTMQRISQELEGKT  672 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~--~Rpt~~~i~~~l~~~~  672 (701)
                      +...+..+.|.+|.|||.+.+ .+|...+  |||++||++.|++++.|-  -|...+|+........
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pV--DiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPV--DIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcc--cchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            777888899999999999988 5566666  999999999999999984  4667777766554433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=331.27  Aligned_cols=193  Identities=25%  Similarity=0.383  Sum_probs=167.8

Q ss_pred             hhhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCc-E
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKR-C  523 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~  523 (701)
                      ...++|.++++||.|.||.||+| ...++..||||+++.....-++.  .-.||+..++++. ||||+++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            34578999999999999999999 44579999999998866543322  2268999999998 999999999999988 9


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .|+|||||+. +|+++++++.  ..+++..++.|++||++||+|+|++   |+.|||+||+|||+.....+||+|||+|+
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence            9999999976 9999998873  4799999999999999999999999   99999999999999988899999999999


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .+.. ....+..+.|++|+|||++....+..... |+|++|||++|
T Consensus       159 ev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pv-D~wA~GcI~aE  202 (538)
T KOG0661|consen  159 EVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPV-DMWAVGCIMAE  202 (538)
T ss_pred             cccc-CCCcchhhhcccccchHHhhhccccCCch-HHHHHHHHHHH
Confidence            8754 34456678999999999988776655543 99999999985

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=325.44  Aligned_cols=206  Identities=27%  Similarity=0.439  Sum_probs=182.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      ...++|..++.||+|+|++|++|+. ..+++||||++.+...-.+...+.+.+|-.+|.+| .||.|++++-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            4568899999999999999999944 57999999999876554444456778899999999 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+|+||+++|+|.+++++.+   .+++...+.++.+|+.||+|||+.   |||||||||+|||+|.||++||.|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999876   699999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCC-----------C--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 041034          605 LHVDSS-----------N--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPT  660 (701)
Q Consensus       605 ~~~~~~-----------~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~Rpt  660 (701)
                      +.+...           .  ...++||..|.+||.+.....+...  |+|+||||+|+|+++.|..|-.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~s--DiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSS--DLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCccc--chHHHHHHHHHHhcCCCCCccc
Confidence            753211           1  1447899999999999999998887  9999999999999999888753

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=296.27  Aligned_cols=217  Identities=29%  Similarity=0.400  Sum_probs=188.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||.|+||.|..++.+ +|..+|+|++.+...-+....+...+|..+++.+.||+++++++.+.+.+..|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            457899999999999999999664 6889999999987766666677788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||++||-|..++++.+   ++++..++-++.||+.||+|||+.   +|++||+||+|||+|.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999998866   699999999999999999999999   999999999999999999999999999998642


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHH-hhcCCCccc
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRP-TMQRISQE-LEGKTPMKK  676 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~Rp-t~~~i~~~-l~~~~~~~~  676 (701)
                         ..-..+|||.|+|||++...+++..+  |.|+||+++|||+.+.|...- +..++.+. +++...++.
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkav--DWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~  262 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAV--DWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS  262 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcch--hHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc
Confidence               24456899999999999999999887  999999999999999986542 22344433 344444443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.3e-38  Score=293.24  Aligned_cols=214  Identities=27%  Similarity=0.402  Sum_probs=186.7

Q ss_pred             cCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .+|...+++|+|.||.||+| +..+|+.||||+++.....+ .......+|++.++.++|+||+.++++|.+.+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            46888999999999999999 45679999999999875543 23456789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++. +|+..++...  ..++..++..++.++++||+|||.+   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99987 9999998754  3689999999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhhcCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELEGKT  672 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~~~~  672 (701)
                      ....+..+-|.+|.|||.+.+.. |+...  ||||+|||+.|++-+.|..  +-..+|+...+....
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~V--DmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG  219 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGV--DMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG  219 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcc--hhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence            77777778999999999887654 55555  9999999999999998854  456777777666554

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=318.33  Aligned_cols=214  Identities=27%  Similarity=0.421  Sum_probs=190.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+....+ ...+.+.+|+++++.++||||+.++++|+...++|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            67999999999999999999554 68899999998866543 34677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+.| +|..++....   .+++..+..+++|++.||.|||+.   +|.|||+||.|||++..|.+|+||||+|+.....
T Consensus        81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99987 9999998765   599999999999999999999999   9999999999999999999999999999998776


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhcCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSR-PTMQRISQELEGKTP  673 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~R-pt~~~i~~~l~~~~~  673 (701)
                      ....+...|||.|||||...+.+|+..+  |+||+||++|||..+.|..- -++.++++.+.....
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~s--DlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v  217 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTS--DLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV  217 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchh--hHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC
Confidence            6667777899999999999999999887  99999999999999997543 356677776655443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.7e-37  Score=315.86  Aligned_cols=215  Identities=27%  Similarity=0.368  Sum_probs=185.6

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|+++..||+|+||+||.|+.+ +|..+|+|++++.........+.++.|-.+|...++|+||+++-.|++.++.|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35689999999999999999999554 69999999999987766666788899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |||||++||++..+|...+   .+++..+..++.+++-|++.+|+.   |+|||||||+|+|||..|++||+|||++.-+
T Consensus       218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999998766   699999999999999999999999   9999999999999999999999999998543


Q ss_pred             cc-----------------------CCCC----c--------------------eeecccccccCCCCCCCCcCChhhHH
Q 041034          606 HV-----------------------DSSN----R--------------------TLRAGTYGYIAPDQRLSPPVNQKIIQ  638 (701)
Q Consensus       606 ~~-----------------------~~~~----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~~  638 (701)
                      ..                       +...    .                    ...+|||.|+|||++.+..|+...  
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c--  369 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC--  369 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc--
Confidence            21                       0000    0                    024699999999999999998887  


Q ss_pred             HHHHHHHHHHHcccCCCCC-CCCHHHHHHHhh
Q 041034          639 DIILVSTTALACLRSKPKS-RPTMQRISQELE  669 (701)
Q Consensus       639 Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~l~  669 (701)
                      |+||||||+||||.+-|.. --+..+..+.+.
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~  401 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIV  401 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999988654 234555555543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-37  Score=315.63  Aligned_cols=215  Identities=29%  Similarity=0.440  Sum_probs=183.2

Q ss_pred             hcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  525 (701)
                      .+.|+.+++||+|.||.||+| +..+|+.||+|++...... ..+..-+.+||.+|++++||||+++.+...+.  ..+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            456788899999999999999 4567999999999876533 44567788999999999999999999998876  6899


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +|+|||+. +|.-++....  ..+++.++..+++|++.||+|+|.+   ||+|||||.+|||||.+|.+||+|||+|+++
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            99999988 9988886533  4699999999999999999999999   9999999999999999999999999999988


Q ss_pred             ccCCC-CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhhcCC
Q 041034          606 HVDSS-NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELEGKT  672 (701)
Q Consensus       606 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~~~~  672 (701)
                      ..... ..+..+-|.+|.|||.+.+.. |+..+  |+||+|||+.|++.+.|-.  |--++|+-..++-..
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aV--DlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG  337 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAV--DLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG  337 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccce--eehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence            75543 367788999999999998865 44444  9999999999999999965  345666655555443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-37  Score=305.67  Aligned_cols=213  Identities=26%  Similarity=0.449  Sum_probs=185.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      -.++|++.+.||.|..++||+|+. +.+..||||++........  .+.+++|+..|+.++||||++++..|..+...|+
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            357899999999999999999954 5789999999988766544  6889999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||.||.+|++.++++..-+. .+++..+..|.+++++||.|||++   |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999999876433 499999999999999999999999   99999999999999999999999999887665


Q ss_pred             cCCCCc----eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------------
Q 041034          607 VDSSNR----TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------------  649 (701)
Q Consensus       607 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------------  649 (701)
                      ..+...    ...+||+.|||||++...-......+||||||+.+.|                                 
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~  257 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL  257 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence            444433    3348999999999965544444444599999999885                                 


Q ss_pred             ------------------cccCCCCCCCCHHHHHH
Q 041034          650 ------------------CLRSKPKSRPTMQRISQ  666 (701)
Q Consensus       650 ------------------cl~~~P~~Rpt~~~i~~  666 (701)
                                        |+..||.+|||++++++
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                              99999999999988876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=318.02  Aligned_cols=190  Identities=29%  Similarity=0.438  Sum_probs=174.2

Q ss_pred             hhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ....|...++||+|+.|.||.| +..+++.||||++.......   .+-+.+|+.+|+..+|+|||.+++.|...+..|+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            3567888899999999999999 55678999999998766443   3667899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||++||+|.+.+...    .+++.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|||++..+.
T Consensus       348 VMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            99999999999998765    489999999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .........+|||.|||||+.....|+.+.  ||||||++++|
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtrk~YG~KV--DIWSLGIMaIE  461 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTRKPYGPKV--DIWSLGIMAIE  461 (550)
T ss_pred             cccCccccccCCCCccchhhhhhcccCccc--cchhhhhHHHH
Confidence            777777888999999999999999999998  99999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=319.58  Aligned_cols=217  Identities=27%  Similarity=0.487  Sum_probs=186.3

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      +...+.++..+.||+|-||+||.|.+.....||+|.++.....    .+.|.+|+.+|++++|++||+++++|..++.+|
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            3445556778999999999999999987779999999886544    267889999999999999999999999988999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||||+.|+|.++++... ...+...+.+.++.|||+|++||+++   ++|||||.++||||+++..+||+|||+|+..
T Consensus       278 IVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEEEecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence            9999999999999998732 33688999999999999999999999   9999999999999999999999999999965


Q ss_pred             ccCCCCce-eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------------------------
Q 041034          606 HVDSSNRT-LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------------------------  649 (701)
Q Consensus       606 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------------------------  649 (701)
                      .++..... ...-...|.|||.+....++.++  ||||||++++|                                   
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kS--DVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~  431 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKS--DVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPD  431 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCccccc--ceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCH
Confidence            43322211 11234569999999999888887  99999999985                                   


Q ss_pred             --------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 --------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 --------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                              ||..+|++|||++.+...++...
T Consensus       432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  432 EVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                    99999999999998888877643

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=324.58  Aligned_cols=344  Identities=26%  Similarity=0.277  Sum_probs=271.3

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEEC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL  117 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  117 (701)
                      .+..|++++|.+.. +....|.++++|+.+++.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+.+..++.|+.|||
T Consensus        79 ~t~~LdlsnNkl~~-id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL  156 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSH-IDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL  156 (873)
T ss_pred             ceeeeecccccccc-CcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence            45678888888763 44445778899999999999888 77877777778999999999998888888888999999999


Q ss_pred             CCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCC
Q 041034          118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT  197 (701)
Q Consensus       118 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  197 (701)
                      |.|.|+.+.-.+|..-.++++|+|++|.|+......|.++.+|..|.|+.|+++...+..|.+++.|+.|+|..|+|.-.
T Consensus       157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv  236 (873)
T KOG4194|consen  157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV  236 (873)
T ss_pred             hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence            99999877777888888899999999999988888899999999999999999888888888899999999999988744


Q ss_pred             CCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCC
Q 041034          198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL  277 (701)
Q Consensus       198 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l  277 (701)
                      ---.|.++++|+.|.|..|.|+..-...|..|.++++|+|..|++...-..++.++++|++|+||+|.|..+.++++.-.
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft  316 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT  316 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence            45567888888888888888887777778888888888888888887777778888888888888888887777888778


Q ss_pred             CCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCc---cccccccCCe
Q 041034          278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP---EIGKILLLQN  354 (701)
Q Consensus       278 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~  354 (701)
                      ++|++|+|++|+|+...+.+|..+..|++|.|++|.++..-...|..+++|+.|||++|.|++.|.+   .|..+++|+.
T Consensus       317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk  396 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK  396 (873)
T ss_pred             ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence            8888888888888877777777777777777777777755555667777777777777777765553   3556777777


Q ss_pred             EEcccccCcccCCCC-c---c-ccccccccCCCCC
Q 041034          355 LDLSHNNLSGTIPMT-L---H-PMFLDMSFNNLEG  384 (701)
Q Consensus       355 l~ls~N~l~g~~p~~-~---~-~~~l~ls~N~l~g  384 (701)
                      |.|.+|++. .||.- +   . ...|||.+|.+..
T Consensus       397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaS  430 (873)
T KOG4194|consen  397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIAS  430 (873)
T ss_pred             eeecCceee-ecchhhhccCcccceecCCCCccee
Confidence            777777776 33331 1   1 2356776666643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-37  Score=302.91  Aligned_cols=214  Identities=22%  Similarity=0.386  Sum_probs=186.4

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      +..-+|++.+.||+|.||.|-+|.. ..|+.||||.+++....++...-.+++|++||+.++||||+++|++|+..+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            3356789999999999999999954 679999999999998888877788999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |||||..+|.|++|+.+.+   .+++..+.+++.||+.|+.|+|++   +++|||||.+|||+|+++++||+|||++..+
T Consensus       130 ivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            9999999999999998876   699999999999999999999999   9999999999999999999999999999887


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHh
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQEL  668 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l  668 (701)
                      .. ......++|+|-|.+||+..+.+|..... |.||+|+++|.+..+. |.+--....+++++
T Consensus       204 ~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEV-DsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI  265 (668)
T KOG0611|consen  204 AD-KKFLQTFCGSPLYASPEIVNGTPYKGPEV-DSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI  265 (668)
T ss_pred             cc-ccHHHHhcCCcccCCccccCCCCCCCCcc-chhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence            53 34456679999999999999999977653 9999999999655443 44433444444443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=327.87  Aligned_cols=332  Identities=26%  Similarity=0.281  Sum_probs=271.9

Q ss_pred             CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEE
Q 041034           36 KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL  115 (701)
Q Consensus        36 ~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  115 (701)
                      .|++++|+|.+|.|+ ++....++.++.|++|||+.|.|+.+.-+.|..-.++++|+|++|+|+...-..|.++.+|.+|
T Consensus       124 sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl  202 (873)
T KOG4194|consen  124 SGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL  202 (873)
T ss_pred             ccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence            467888888888776 3445567778888888888888886655677777888888888888887777888888888888


Q ss_pred             ECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC
Q 041034          116 YLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       116 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      .|++|+++...+..|.+|++|+.|+|..|++.-..--.|.+|++|+.|.|..|.+...-...|..+.++++|+|+.|+++
T Consensus       203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~  282 (873)
T KOG4194|consen  203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ  282 (873)
T ss_pred             ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence            88888888777788888888888888888887665667888888888888888888888888888888888888888888


Q ss_pred             CCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccC
Q 041034          196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                      ..-..++.++..|+.|+||.|.|...-+++...+++|+.|+|++|+|+...+.+|..+..|++|+|++|+|...-..+|.
T Consensus       283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~  362 (873)
T KOG4194|consen  283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV  362 (873)
T ss_pred             hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence            77777888888888888888888888888888888888888888888888888888888888888888888877777788


Q ss_pred             CCCCCcEEEccCccCCCCCc---ccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccC
Q 041034          276 KLSNLQYLNLSSNLLSGQIP---FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLL  352 (701)
Q Consensus       276 ~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  352 (701)
                      .+++|+.|||++|.+++.+-   ..|.++++|+.|+|.+|+|....-.+|..+..|++|||.+|.|..+-|.+|..+ .|
T Consensus       363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~L  441 (873)
T KOG4194|consen  363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-EL  441 (873)
T ss_pred             HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hh
Confidence            88888888888888876553   356778888888888888885555678888888888888888888888888888 88


Q ss_pred             CeEEcccccCcccCCCC
Q 041034          353 QNLDLSHNNLSGTIPMT  369 (701)
Q Consensus       353 ~~l~ls~N~l~g~~p~~  369 (701)
                      +.|.+..-.|-+.+...
T Consensus       442 k~Lv~nSssflCDCql~  458 (873)
T KOG4194|consen  442 KELVMNSSSFLCDCQLK  458 (873)
T ss_pred             hhhhhcccceEEeccHH
Confidence            88888777776665443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-37  Score=296.58  Aligned_cols=216  Identities=25%  Similarity=0.323  Sum_probs=185.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCM  524 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  524 (701)
                      ..++|+.++.|++|+||.||+|+. ++++.||+|+++..... ..+.-...+||.++.+++|||||.+-++...  -+.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            457789999999999999999965 47899999999987633 3344566899999999999999999888764  4579


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+|||||+. +|..++..-.  .++...++..++.|+++|++|||.+   .|+||||||+|+|+...|.+||+|||+|+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence            999999988 9999998755  3689999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhhcC
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELEGK  671 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~~~  671 (701)
                      +..+....+..+-|.+|.|||.+.+.+....+. |+||+|||+.+++...|-.  +--+.|+-..+.-.
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~i-DMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll  294 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAV-DMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL  294 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcch-hhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence            988777788889999999999999877655543 9999999999999999854  34566666655443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=310.24  Aligned_cols=214  Identities=22%  Similarity=0.370  Sum_probs=181.3

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc-C-hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCc
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE-D-SAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKR  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  522 (701)
                      ....+|.+.+.||+|+||.|+.|.. .+++.||+|++...... . ....+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999944 57899999977764222 1 123466779999999999 999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEeecC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGT  601 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DFGl  601 (701)
                      .+|+||||+.||+|.+++...+   ++.+..+..++.|++.|++|+|++   ||+||||||+||+++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999998844   588899999999999999999999   99999999999999999 9999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      +.............+||+.|+|||++.+.. |+... .||||+|+++|-|+.+. |...+....+...
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~-aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k  234 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKA-ADVWSLGVILYVLLCGRLPFDDSNVPNLYRK  234 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCch-hhhhhhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            998743444556679999999999999988 77554 59999999999888776 6555554444444

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-36  Score=300.04  Aligned_cols=192  Identities=30%  Similarity=0.439  Sum_probs=160.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc--EEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR--CMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  525 (701)
                      ..+|...+.||+|+||.||++... +|+.+|||.+.......   .+.+.+|+.+|++++|||||+++|......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            456788999999999999999654 48999999987763221   577899999999999999999999855444  689


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEeecCccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARL  604 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DFGla~~  604 (701)
                      +.|||+++|+|.+++...+.  .+++..++.++.||++||+|||++   |||||||||+|||++. ++.+||+|||+|+.
T Consensus        93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            99999999999999988654  599999999999999999999999   9999999999999999 79999999999987


Q ss_pred             ccc---CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          605 LHV---DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       605 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ...   .........||+.|||||++....... ..+||||+||++.+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~-~~sDiWSlGCtVvE  214 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVAR-RESDIWSLGCTVVE  214 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCC-ccchhhhcCCEEEe
Confidence            653   112233467999999999998632222 23499999998765

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=303.81  Aligned_cols=210  Identities=33%  Similarity=0.479  Sum_probs=189.4

Q ss_pred             hhcCCccceEEeeccceEEEEEE-cCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +...|+..+.||+|+||.||+|. ...++.||+|++......+.  .+++++|+.++.+++++||.++|+.+..+..+++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            45568888999999999999994 45789999999988765543  5788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      +||||.||++.+.++...   .+++..+.-++++++.|+.|+|.+   +.+|||||+.||++..+|.||++|||.+..+.
T Consensus        89 iMey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence            999999999999997654   347778888999999999999999   99999999999999999999999999998887


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------------
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------------  649 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------------  649 (701)
                      .........+|||.|||||++.+..|+.++  ||||||+++++                                     
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KA--DIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKA--DIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             chhhccccccccccccchhhhccccccchh--hhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHH
Confidence            666666778999999999999988899887  99999999995                                     


Q ss_pred             -----cccCCCCCCCCHHHHHHH
Q 041034          650 -----CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -----cl~~~P~~Rpt~~~i~~~  667 (701)
                           |+..+|+.||++.++++.
T Consensus       241 EFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhh
Confidence                 999999999999999875

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-36  Score=309.40  Aligned_cols=212  Identities=25%  Similarity=0.417  Sum_probs=191.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE-EEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC-MFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~l  526 (701)
                      -++|..++.+|+|+||.++.++.+ +++.||+|++......+.. ++...+|+.++++++|||||.+.+.|.+++. .+|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            367999999999999999999654 6889999999876654433 4578899999999999999999999999888 999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||+||+||++.+.+.+.+ +..+++..+.+++.|++.|+.|||++   .|+|||||+.|||++.+..|||+|||+|+.+.
T Consensus        82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            999999999999998765 44799999999999999999999988   99999999999999999999999999999998


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------------
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------------  649 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------------  649 (701)
                      .+.......+||+.|+.||.+.+.+|+.+.  ||||+||++|+                                     
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KS--DiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~  235 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKS--DIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELR  235 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccC--cchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHH
Confidence            776666778999999999999999999998  99999999996                                     


Q ss_pred             -----cccCCCCCCCCHHHHHHH
Q 041034          650 -----CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -----cl~~~P~~Rpt~~~i~~~  667 (701)
                           |+..+|..||++.+++.+
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhC
Confidence                 788888888888888776

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=308.83  Aligned_cols=231  Identities=25%  Similarity=0.448  Sum_probs=197.3

Q ss_pred             cccHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeee
Q 041034          439 KILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFC  518 (701)
Q Consensus       439 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  518 (701)
                      +...++++...+...+.+.||+|.||+||+|++.  ..||||++......++ ..+.|+.|+.++++-+|.||+-+.||+
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhh
Confidence            3345677888888999999999999999999885  3699999988765544 678999999999999999999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                      ..+.. .||+.+|+|.+|+.+++-...  +++..+.++|+.|||+|+.|||.+   +|||||||..|||+.++++|||+|
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence            98887 999999999999999987653  688999999999999999999999   999999999999999999999999


Q ss_pred             ecCcccccc--CCCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHH------------------------
Q 041034          599 FGTARLLHV--DSSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALA------------------------  649 (701)
Q Consensus       599 FGla~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~------------------------  649 (701)
                      ||+|..-..  .........|..-|||||++...   ++...  +|||++|+++||                        
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~q--SDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~  609 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQ--SDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY  609 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcc--cchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc
Confidence            999975431  22233345688899999987643   44444  499999999996                        


Q ss_pred             ----------------------cccCCCCCCCCHHHHHHHhhcCCCccchhhh
Q 041034          650 ----------------------CLRSKPKSRPTMQRISQELEGKTPMKKGLKE  680 (701)
Q Consensus       650 ----------------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~  680 (701)
                                            ||..+|++||.+.+|+.+|+...+..+.+.+
T Consensus       610 l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R  662 (678)
T KOG0193|consen  610 LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR  662 (678)
T ss_pred             cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence                                  9999999999999999999988875544443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=306.18  Aligned_cols=218  Identities=22%  Similarity=0.349  Sum_probs=189.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|.+.++||+|+||.|++|..+ +++.+|||++++...-..+..+..+.|.+|+.... ||.++.++..|+..++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999664 68899999999987665556788899999988885 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+.||++..+.+..    .+++..+.-++..|+.||+|||++   |||+||||.+|||+|.+|++||+|||+++.-
T Consensus       446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999954444332    599999999999999999999999   9999999999999999999999999999976


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhcCCCc
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSR-PTMQRISQELEGKTPM  674 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~R-pt~~~i~~~l~~~~~~  674 (701)
                      -..+...+..+|||.|||||++.+..|+..+  |+|+||+++|+|+.+.+... -+-+|+.+.+....+.
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aV--DWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~  586 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAV--DWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR  586 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchh--hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC
Confidence            5556677788999999999999999999988  99999999999999986554 5666666666555543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-35  Score=290.97  Aligned_cols=204  Identities=26%  Similarity=0.369  Sum_probs=175.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCc----
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLYGFCLHKR----  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----  522 (701)
                      ...|..+++||+|+||+||+|+. .+|+.||+|++...... +.......+|+.+++.++|+| |+.+++++....    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            45577788899999999999954 57899999999876543 223456689999999999999 999999998877    


Q ss_pred             --EEEEEEEccCCCCHHHHHhcCCCc-cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          523 --CMFFIYEYMERGSLFYVLRDDDEA-IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       523 --~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                        ..++|+||++. +|.+++...... ..++...++.+++||+.||+|||++   +|+||||||.||+|+++|.+||+||
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence              78999999976 999999876532 3477789999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKSRP  659 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~Rp  659 (701)
                      |+|+.+.-+....+..++|.+|.|||++.+. .|....  ||||+|||+.+|....|-.+-
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~v--DiWs~GcIfaEm~~~~~LFpG  223 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSV--DIWSLGCIFAEMFTRRPLFPG  223 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCc--chHhHHHHHHHHHhCCCCCCC
Confidence            9999887666666777899999999999887 455555  999999999999998776654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-34  Score=307.26  Aligned_cols=198  Identities=23%  Similarity=0.368  Sum_probs=161.3

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCL  519 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (701)
                      .+.++|++.+.||+|+||.||+|..      .+++.||||+++....  ....+.+.+|+.+++.+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            3457899999999999999999953      2356899999875432  22346788999999999 8999999999887


Q ss_pred             eC-cEEEEEEEccCCCCHHHHHhcCCC-----------------------------------------------------
Q 041034          520 HK-RCMFFIYEYMERGSLFYVLRDDDE-----------------------------------------------------  545 (701)
Q Consensus       520 ~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  545 (701)
                      .. ...++||||+++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 458999999999999999875321                                                     


Q ss_pred             ------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC--Cceeecc
Q 041034          546 ------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAG  617 (701)
Q Consensus       546 ------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~g  617 (701)
                            ...+++..+..++.||++||+|||++   ||+||||||+||+++.++.+||+|||+++.......  ......+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  12477889999999999999999998   999999999999999999999999999986533221  1122345


Q ss_pred             cccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          618 TYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       618 t~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ++.|+|||++.+..++.++  ||||+|+++|+|+
T Consensus       239 ~~~y~aPE~~~~~~~~~~s--DiwslG~il~el~  270 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQS--DVWSFGVLLWEIF  270 (338)
T ss_pred             CccccCcHHhhcCCCCccc--CHHHHHHHHHHHH
Confidence            6789999999888777776  9999999998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=294.58  Aligned_cols=199  Identities=26%  Similarity=0.388  Sum_probs=160.4

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccCh-----------HHHHHHHHHHHHHhcCCCCceeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDS-----------AFVESFQNEARVLSTVRHRNIVKL  514 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l  514 (701)
                      ...+.|++.+.||+|.||.|-+|+. .+++.||||++.+......           .-.+...+||.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3467899999999999999999965 4799999999976532211           113578999999999999999999


Q ss_pred             eeeeeeC--cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 041034          515 YGFCLHK--RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL  592 (701)
Q Consensus       515 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~  592 (701)
                      +++..++  +.+|||+|||..|.+...-.   ....+++.++++|+.+++.||+|||.+   |||||||||+|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            9998764  57999999999887754321   122389999999999999999999999   999999999999999999


Q ss_pred             CeEEEeecCccccccC-----CCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHHccc
Q 041034          593 EAFVADFGTARLLHVD-----SSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +|||+|||.+..+...     .......+|||.|+|||...+.   .+... +.|||++|+.+|.++-
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~-a~DiWalGVTLYCllf  314 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGF-ALDIWALGVTLYCLLF  314 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccch-hhhhhhhhhhHHHhhh
Confidence            9999999999866221     1112235799999999998873   33333 3599999999996443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-35  Score=271.73  Aligned_cols=217  Identities=28%  Similarity=0.443  Sum_probs=191.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +.++|++.+.||+|.||.||.|+. +++-.||+|++.+..........++.+|+++-+.++||||.++|++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            457899999999999999999965 4688999999988776666667889999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ++||...|.+...++.... .++++.....+++|+|.|+.|+|..   +|+||||||+|+|++..+..||+|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999986443 3689999999999999999999988   99999999999999999999999999986543


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhhcCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELEGKT  672 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~~~~  672 (701)
                        .......+||..|.|||+..+...+..+  |+|++|++.|+.+.+.|. +--+..+..+++.+..
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~V--d~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~  238 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFV--DLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD  238 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchh--hHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence              4456677999999999999999999988  999999999999999864 4456777777776655

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-34  Score=303.32  Aligned_cols=197  Identities=23%  Similarity=0.384  Sum_probs=174.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..-|++++.||.|+.|.|-.|++ .+|+.+|||++.+...........+.+|+-+|+-+.||||+++|+++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45688999999999999999955 57999999999887433334456789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      .||+++|-|.+++-.++   ++++.++.+++.||+.|+.|+|+.   +|+|||+||+|+|+|..+.+||+|||.|..-. 
T Consensus        91 lEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-  163 (786)
T ss_pred             EEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence            99999999999998776   588999999999999999999998   99999999999999999999999999997643 


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ++.-....+|+|.|+|||++.+.+|+... +||||+|+|+|.+|++
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~-sDVWSCGVILfALLtG  208 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRP-SDVWSCGVILFALLTG  208 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCc-cccchhHHHHHHHHhC
Confidence            34445567999999999999999999886 5999999999964433

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=285.05  Aligned_cols=197  Identities=27%  Similarity=0.400  Sum_probs=164.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-----C
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-----K  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  521 (701)
                      ....|...+.||+|+||.|+.|.. .+|+.||||++.... ......++..+|+++++.++|+||+.+.+++..     -
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            455677789999999999999944 579999999997433 234456788999999999999999999998865     3


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...|+|+|+|+. +|.+.++...   .++...+.-+++|++.||.|+|+.   +|+|||+||+|++++.+...||+|||+
T Consensus        99 ~DvYiV~elMet-DL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELMET-DLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHHhh-HHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            468999999955 9999998765   489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccC--CCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC
Q 041034          602 ARLLHVD--SSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       602 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      |+.....  ....+..+.|.+|.|||.+.... |+...  ||||+|||+.||+.+.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~ai--DiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAI--DIWSVGCILAEMLTGK  225 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchh--hhhhhhHHHHHHHcCC
Confidence            9987542  23345667899999999886554 44444  9999999999644433

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-34  Score=301.10  Aligned_cols=191  Identities=24%  Similarity=0.316  Sum_probs=165.1

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG  534 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (701)
                      +.||+|+||.||+|.. .+|+.||+|+++............+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999955 478999999998654333334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCcee
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL  614 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  614 (701)
                      +|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9999987654   588999999999999999999999   9999999999999999999999999999764333333445


Q ss_pred             ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          615 RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..||+.|+|||++.+..++.+.  ||||+|+++++|+.+.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~elltg~  192 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGR  192 (323)
T ss_pred             eecCccccChhhhcCCCCCccc--cCcccchhhhhhhcCC
Confidence            6799999999999888777765  9999999999877765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=300.36  Aligned_cols=208  Identities=29%  Similarity=0.524  Sum_probs=185.4

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      +...+.....+-||.|+.|.||.|+.+ ++.||||+++..+          ..+|+-|++++||||+.+.|+|.....++
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            344444556788999999999999884 6889999986432          45788899999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||||+.|-|.++++...   .++......+..+||.|+.|||.+   .|||||||.-||||..+..|||+|||.++..
T Consensus       189 IiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             EeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence            9999999999999998765   588889999999999999999999   9999999999999999999999999999887


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                      ... ...-.++||..|||||++...+..+++  ||||||+|+|+                                    
T Consensus       263 ~~~-STkMSFaGTVaWMAPEvIrnePcsEKV--DIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  263 SDK-STKMSFAGTVAWMAPEVIRNEPCSEKV--DIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             hhh-hhhhhhhhhHhhhCHHHhhcCCccccc--ceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence            644 444557899999999999999999998  99999999995                                    


Q ss_pred             -------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 -------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 -------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                             ||...|..||++.+|+..++-..|
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence                   999999999999999999886654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-33  Score=294.85  Aligned_cols=197  Identities=24%  Similarity=0.376  Sum_probs=162.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-----------------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCce
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-----------------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (701)
                      .++|.+.+.||+|+||.||+|.+.+                 +..||+|.+.....  .....++.+|+.++++++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence            4678999999999999999996432                 34699999876432  3345678999999999999999


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCC----------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD----------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPS  575 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g  575 (701)
                      +++++++.+.+..++||||+++|+|.+++....                ....+++..+.+++.||+.||+|||+.   +
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            999999999999999999999999999986532                112467889999999999999999998   9


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       576 ivH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |+||||||+||+++.++.+||+|||+++........  .....++..|+|||.+....++.+.  ||||+|+++++++.
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~~l~el~~  235 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS--DVWAFGVTLWEILM  235 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchh--hhHHHHHHHHHHHH
Confidence            999999999999999999999999999865332211  1123457889999998877777665  99999999998653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-33  Score=301.90  Aligned_cols=211  Identities=24%  Similarity=0.332  Sum_probs=176.7

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++.............+.+|+.++.+++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            5799999999999999999955 468999999997644333344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999997654   589999999999999999999999   9999999999999999999999999999754321


Q ss_pred             CC-----------------------------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          609 SS-----------------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       609 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ..                                   .....+||+.|+|||++.+..++.++  |+||+|+++|+|+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~--DvwSlGvil~ell~G  232 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCch--hhhhhHHHHHHHHhC
Confidence            10                                   01234699999999999888777765  999999999999998


Q ss_pred             CCCC-CCCHHHHHHHh
Q 041034          654 KPKS-RPTMQRISQEL  668 (701)
Q Consensus       654 ~P~~-Rpt~~~i~~~l  668 (701)
                      .+.. ..+..+..+.+
T Consensus       233 ~~Pf~~~~~~~~~~~i  248 (363)
T cd05628         233 YPPFCSETPQETYKKV  248 (363)
T ss_pred             CCCCCCCCHHHHHHHH
Confidence            7543 34445554444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=310.44  Aligned_cols=224  Identities=22%  Similarity=0.366  Sum_probs=185.3

Q ss_pred             cCCccceEEeeccceEEEEEEcCCC-cEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeee-eee------
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGF-CLH------  520 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------  520 (701)
                      -++++.+.|.+|||+.||.|....+ ..||+|++...   ++...+.+++||++|+.|+ |+|||.+++. ...      
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3567889999999999999976654 99999998764   4566789999999999997 9999999993 221      


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      .-+++|.||||.||.|-+++..+... .+++.++++|++|+++|+++||.. .++|||||||-+|||++.++..||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            13678999999999999999876444 499999999999999999999987 7789999999999999999999999999


Q ss_pred             CccccccCCCCc---------eeecccccccCCCCC---CCCcCChhhHHHHHHHHHHHHH-------------------
Q 041034          601 TARLLHVDSSNR---------TLRAGTYGYIAPDQR---LSPPVNQKIIQDIILVSTTALA-------------------  649 (701)
Q Consensus       601 la~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~~~Di~slg~i~~~-------------------  649 (701)
                      .|.-........         -...-|+.|+|||++   .+.+.++++  |||+|||++|.                   
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKs--DIWALGclLYkLCy~t~PFe~sg~laIlng  269 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKS--DIWALGCLLYKLCYFTTPFEESGKLAILNG  269 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchh--HHHHHHHHHHHHHHhCCCcCcCcceeEEec
Confidence            997543222111         123479999999975   466778876  99999999993                   


Q ss_pred             --------------------cccCCCCCCCCHHHHHHHhhcCCCccchhhh
Q 041034          650 --------------------CLRSKPKSRPTMQRISQELEGKTPMKKGLKE  680 (701)
Q Consensus       650 --------------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~  680 (701)
                                          ||+.+|.+||++.||++.+.+....+....+
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~  320 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD  320 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence                                9999999999999999988776654444433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=291.70  Aligned_cols=196  Identities=28%  Similarity=0.380  Sum_probs=170.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999654 68999999997644333334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999997654   588999999999999999999999   9999999999999999999999999999876422


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                         .....||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+.
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~~l~~g~~p  197 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAV--DWWALGILIYEMLVGYPP  197 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchh--hHHHHHHHHHHHHhCCCC
Confidence               2234699999999999887777665  999999999999987643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=302.59  Aligned_cols=227  Identities=26%  Similarity=0.431  Sum_probs=190.4

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEcC--CC--cE-EEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeee
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAELP--DG--KV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF  517 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  517 (701)
                      +.++..-++-...+.||+|+||+||+|.+.  ++  .. ||||..+...........+|.+|+++|++++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            334445566667799999999999999654  22  23 89999986444445667899999999999999999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                      +.....+++|||+|.||+|.+++++.+.  .++..++..++.+.|.||+|||++   +++||||-++|+|++.++.+||+
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence            9999999999999999999999998764  589999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------------
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------------  649 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------------  649 (701)
                      |||+++.-...........-...|+|||.+....++...  |||++|+++||                            
T Consensus       305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kT--DV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~  382 (474)
T KOG0194|consen  305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKT--DVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM  382 (474)
T ss_pred             ccccccCCcceeeccccccCcceecChhhhccCcccccc--chhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence            999987543111111122245689999999998887876  99999999884                            


Q ss_pred             ----------------cccCCCCCCCCHHHHHHHhhcCCCccc
Q 041034          650 ----------------CLRSKPKSRPTMQRISQELEGKTPMKK  676 (701)
Q Consensus       650 ----------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~  676 (701)
                                      ||..+|++||+|.++.+.++.......
T Consensus       383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                            999999999999999999987665544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-33  Score=290.67  Aligned_cols=199  Identities=23%  Similarity=0.311  Sum_probs=169.4

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.............+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999965 5799999999876543333334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++...... 
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            9999999988764332 2588999999999999999999999   9999999999999999999999999999875422 


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .......||+.|+|||++.+..++.+.  ||||+|+++++++.+.+.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~--DvwslGvil~el~~g~~p  200 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSP--DWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCccc--CchhHHHHHHHHHhCCCC
Confidence            222345689999999999888887765  999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=274.28  Aligned_cols=213  Identities=22%  Similarity=0.373  Sum_probs=180.6

Q ss_pred             hhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|++.+.||+|+|+.||++ ..++|+.+|+|.+........ ..+++.+|++|.+.++||||+++.+.+.+....|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3577899999999999999999 556899999998876554332 35788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~~~kL~DFGla~  603 (701)
                      |+|+|+|++|..-+-.+   ..+++..+.+++.||++||.|+|.+   +|||||+||+|+++.   ....+||+|||+|.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999996443322   2588899999999999999999999   999999999999994   34579999999999


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhc
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRP-TMQRISQELEG  670 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~Rp-t~~~i~~~l~~  670 (701)
                      .+. ++.....++|||+|||||++...++...+  |||+.|+|+|-++.+-|..-- +-..+.+.+..
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpv--DiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~  226 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPV--DIWACGVILYILLVGYPPFWDEDQHRLYEQIKA  226 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHhhcCCCCCcc--hhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence            887 55666678899999999999999999887  999999999998888765433 55666655543

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-34  Score=282.65  Aligned_cols=208  Identities=25%  Similarity=0.387  Sum_probs=168.9

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----EE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----CM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  524 (701)
                      .|...+.+|.|+||.||+|... +++.||||++..+....       .+|+.+|+.++|||||++.-+|....     +.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            4677899999999999999554 57999999997765322       46999999999999999998886432     34


Q ss_pred             EEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEeecCc
Q 041034          525 FFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTA  602 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DFGla  602 (701)
                      .+|||||+. +|.++++.. .....++...++-+++||.+||+|||+.   ||+||||||.|+|+|.+ |.+||||||.|
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            689999987 999999853 1123577788899999999999999998   99999999999999976 99999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhhcCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELEGKT  672 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~~~~  672 (701)
                      +.+...... ....-|+.|+|||.+.+.. |+.+.  ||||.|||+.|++.+.|-.  +-+..|+.+.++-..
T Consensus       174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~I--DiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSI--DIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             eeeccCCCc-eeEEEeccccCHHHHcCccccCcee--EEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence            998655544 3446789999999988765 44455  9999999999999999854  456666666655444

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-33  Score=286.85  Aligned_cols=184  Identities=19%  Similarity=0.285  Sum_probs=157.4

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CcEEEEEEEcc
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KRCMFFIYEYM  531 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  531 (701)
                      ..||+|+++.||+|.. +|+.||||+++..........+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999987 689999999987655555556788999999999999999999999876    35789999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN  611 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~  611 (701)
                      ++|+|.+++....   .+++.....++.|++.||.|||+..  +++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999997654   5889999999999999999999732  78899999999999999999999999998654321  


Q ss_pred             ceeecccccccCCCCCCC--CcCChhhHHHHHHHHHHHHHc
Q 041034          612 RTLRAGTYGYIAPDQRLS--PPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       612 ~~~~~gt~~y~aPE~~~~--~~~~~~~~~Di~slg~i~~~c  650 (701)
                       ....++..|+|||.+.+  ..++.+.  ||||+|+++|++
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~--Di~SlGvil~el  215 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKD--DIYSLGVVLWEI  215 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchh--hhhHHHHHHHHH
Confidence             23468899999999876  4455554  999999999963

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-33  Score=300.38  Aligned_cols=198  Identities=26%  Similarity=0.350  Sum_probs=163.2

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCL  519 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (701)
                      ...++|++.+.||+|+||.||+|..      .++..||||+++.....  ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            3456899999999999999999953      23568999999754432  2346788999999999 8999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCC------------------------------------------------------
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDE------------------------------------------------------  545 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  545 (701)
                      +.+..++||||+++|+|.++++....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999999864321                                                      


Q ss_pred             ------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          546 ------------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       546 ------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                                        ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              12478889999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          608 DSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       608 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ....  .....++..|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s--Di~slG~~l~ell  310 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFES--DVWSYGILLWEIF  310 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCC--CHHHHHHHHHHHH
Confidence            2221  1122345679999999888877776  9999999998744

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-33  Score=293.89  Aligned_cols=197  Identities=25%  Similarity=0.355  Sum_probs=172.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            467999999999999999999664 6899999999765433333456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999997654   578899999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .   .....||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+.
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~elltg~~p  214 (329)
T PTZ00263        171 R---TFTLCGTPEYLAPEVIQSKGHGKAV--DWWTMGVLLYEFIAGYPP  214 (329)
T ss_pred             C---cceecCChhhcCHHHHcCCCCCCcc--eeechHHHHHHHHcCCCC
Confidence            2   2235799999999999888777665  999999999999988643

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5e-33  Score=293.86  Aligned_cols=209  Identities=24%  Similarity=0.339  Sum_probs=175.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-C-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-D-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|... + +..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3567999999999999999999643 2 4689999987644333334567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||+++..
T Consensus       108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            9999999999999997654   588999999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHH
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQE  667 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~  667 (701)
                      ...   .....||+.|+|||++.+..++...  |+||+|+++|+++.+.+ ....+...+.+.
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  239 (340)
T PTZ00426        182 DTR---TYTLCGTPEYIAPEILLNVGHGKAA--DWWTLGIFIYEILVGCPPFYANEPLLIYQK  239 (340)
T ss_pred             CCC---cceecCChhhcCHHHHhCCCCCccc--cccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence            422   2345799999999999877776665  99999999999998874 444444443333

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-33  Score=298.74  Aligned_cols=205  Identities=23%  Similarity=0.309  Sum_probs=172.2

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      .|++++.||+|+||+||+|.. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588999999999999999955 4688999999976544344445778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999997654   588899999999999999999998   99999999999999999999999999986432100


Q ss_pred             C-----------------------------------------------CceeecccccccCCCCCCCCcCChhhHHHHHH
Q 041034          610 S-----------------------------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIIL  642 (701)
Q Consensus       610 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~s  642 (701)
                      .                                               .....+||+.|+|||++.+..++.+.  ||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~--DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC--DWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc--ceee
Confidence            0                                               01124699999999999887777665  9999


Q ss_pred             HHHHHHHcccCCCC-CCCCHHH
Q 041034          643 VSTTALACLRSKPK-SRPTMQR  663 (701)
Q Consensus       643 lg~i~~~cl~~~P~-~Rpt~~~  663 (701)
                      +|+++|+++.+.+. ..++..+
T Consensus       234 lG~il~elltG~~Pf~~~~~~~  255 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTE  255 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHH
Confidence            99999999998743 3344333

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-32  Score=289.05  Aligned_cols=204  Identities=23%  Similarity=0.312  Sum_probs=171.1

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG  534 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (701)
                      +.||+|+||.||+|.. .+|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999965 468999999998654333334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCcee
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL  614 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  614 (701)
                      +|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9998887654   588999999999999999999999   9999999999999999999999999998764333333334


Q ss_pred             ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          615 RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      ..||+.|+|||++.+..++.+.  ||||+|+++|+++.+. |....+..++.+.
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvil~ell~g~~Pf~~~~~~~~~~~  206 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHERLFEL  206 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchh--chhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            5699999999999887777665  9999999999999876 5444554444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=290.78  Aligned_cols=202  Identities=25%  Similarity=0.389  Sum_probs=180.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (701)
                      ..+.|++.+.||+|.||.||++..+ +|+.+|+|.+.+.........+.+.+|+.+|+++. ||||++++++|++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567999999999999999999665 59999999998877655445678999999999998 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----CCCeEEEeecC
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS----NLEAFVADFGT  601 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~----~~~~kL~DFGl  601 (701)
                      +|||++.||.|.+.+...    .+++..+..++.|++.|+.|||+.   ||+|||+||+|+|+..    ++.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999875    289999999999999999999998   9999999999999953    35899999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRP  659 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~Rp  659 (701)
                      |..... .......+||+.|+|||+....++....  ||||+|+++|.++.+.|+.+.
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~--DiWS~Gvi~yiLL~G~~PF~~  240 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEV--DVWSIGVILYILLSGVPPFWG  240 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCCCCCccc--chhHHHHHHHHHhhCCCCCcC
Confidence            998876 5567778999999999999988888887  999999999999988866553

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=299.64  Aligned_cols=199  Identities=27%  Similarity=0.379  Sum_probs=169.7

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|.. .+++.||||++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4799999999999999999954 478999999987644333344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+|+.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999997644   588899999999999999999999   9999999999999999999999999999643210


Q ss_pred             CC-----------------------------------------------CceeecccccccCCCCCCCCcCChhhHHHHH
Q 041034          609 SS-----------------------------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDII  641 (701)
Q Consensus       609 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~  641 (701)
                      ..                                               .....+||+.|+|||++.+..++.+.  |||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Diw  232 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC--DWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce--eeE
Confidence            00                                               00123699999999999888777766  999


Q ss_pred             HHHHHHHHcccCCCC
Q 041034          642 LVSTTALACLRSKPK  656 (701)
Q Consensus       642 slg~i~~~cl~~~P~  656 (701)
                      |+||++|+|+.+.|.
T Consensus       233 SlGvil~elltG~~P  247 (377)
T cd05629         233 SLGAIMFECLIGWPP  247 (377)
T ss_pred             ecchhhhhhhcCCCC
Confidence            999999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-33  Score=297.70  Aligned_cols=199  Identities=26%  Similarity=0.378  Sum_probs=170.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||||++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999654 68999999997643333344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999997654   589999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CC--------------------------------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          609 SS--------------------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       609 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ..                                      .....+||+.|+|||++....++.+.  ||||+||++|+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~el  232 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCee--eeecchhHHHHh
Confidence            10                                      00123599999999999888777766  999999999999


Q ss_pred             ccCCCC
Q 041034          651 LRSKPK  656 (701)
Q Consensus       651 l~~~P~  656 (701)
                      +.+.|.
T Consensus       233 ~~G~~P  238 (364)
T cd05599         233 LVGYPP  238 (364)
T ss_pred             hcCCCC
Confidence            988743

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-32  Score=287.68  Aligned_cols=211  Identities=23%  Similarity=0.345  Sum_probs=175.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCcEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  528 (701)
                      +|++.+.||+|+||.||+|... +++.||+|++...........+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999654 578999999986543333335677889999999976 56889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999987654   588999999999999999999998   9999999999999999999999999998754333


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                      ........||+.|+|||++.+.+++.+.  |+||+|+++++++.+. |....+..++.+.+.
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCccc--chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3334456799999999999888877665  9999999999999987 444455555554443

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.6e-34  Score=307.18  Aligned_cols=221  Identities=26%  Similarity=0.454  Sum_probs=187.1

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL  519 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  519 (701)
                      +....+.+..+.||+|+||+||+|+..      +...||||.++....  .....+|++|++.++.++|||||+++|+|.
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            334556677889999999999999653      345799999987653  345789999999999999999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCC-------C----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDD-------E----AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL  588 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll  588 (701)
                      +++.+++|+|||..|||.++|....       .    ..+++..+.+.||.|||.|++||-++   .+|||||-.+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence            9999999999999999999997532       1    22388999999999999999999998   89999999999999


Q ss_pred             cCCCCeEEEeecCccccccCCC-Cce-eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------
Q 041034          589 NSNLEAFVADFGTARLLHVDSS-NRT-LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------  649 (701)
Q Consensus       589 ~~~~~~kL~DFGla~~~~~~~~-~~~-~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------  649 (701)
                      .++..|||+|||+++..-..+. +.. ...-...|||||.+....++..+  ||||+|+++||                 
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS--DVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES--DVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh--hhhhhhhhhhhhhccccCcccccchHHH
Confidence            9999999999999986532211 111 12345689999999999898886  99999999995                 


Q ss_pred             --------------------------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 --------------------------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 --------------------------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                                                ||+..|.+||+++||...|+....
T Consensus       715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                                      999999999999999999987553

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1e-32  Score=281.97  Aligned_cols=212  Identities=21%  Similarity=0.307  Sum_probs=169.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++....  ....+.+.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            457899999999999999999542    356899999986533  23346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||++   +++||||||+||+++.++.++++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999999876432  588999999999999999999999   999999999999999999999999998765


Q ss_pred             cccCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhh
Q 041034          605 LHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELE  669 (701)
Q Consensus       605 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~  669 (701)
                      ....... .....++..|+|||.+.+..++.+.  ||||+|+++++++. +. |..--+..++++.++
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS--DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE  222 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchh--HHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            4222111 1122356789999998887777665  99999999997442 33 333233344444443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-33  Score=292.30  Aligned_cols=196  Identities=23%  Similarity=0.343  Sum_probs=171.5

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|+++..........+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46999999999999999999665 58999999998654333334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997654   588999999999999999999999   999999999999999999999999999986543 


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                        ......||+.|+|||.+.+..++.+.  ||||+|+++|+++.+.+.
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~--DvwslG~il~ell~g~~p  197 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTV--DYWSLGCMLYEFLCGFPP  197 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCcc--ceecchHHHhhhhhCCCC
Confidence              23345799999999999888777665  999999999999987643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-32  Score=280.50  Aligned_cols=200  Identities=22%  Similarity=0.298  Sum_probs=169.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+......+......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999965 478999999887654444555677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||+++++|.+++.... ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998886432 123578899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .........+++.|+|||...+...+.+.  |+||+|+++++++++.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~--Di~slG~~l~el~~g~  203 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEMAALQ  203 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchh--hHHHHHHHHHHHhcCC
Confidence            33333345688899999998777666554  9999999999766544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-33  Score=297.86  Aligned_cols=200  Identities=26%  Similarity=0.382  Sum_probs=163.7

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ....++|++.+.||+|+||.||+|..      .+++.||+|+++.....  ...+.+.+|+.+++.+ +||||+++++++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            34456899999999999999999853      13457999999765432  2356788999999999 899999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-----------------------------------------------------
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-----------------------------------------------------  545 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  545 (701)
                      .+.+..++||||+++|+|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999998864211                                                     


Q ss_pred             --------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC
Q 041034          546 --------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN  611 (701)
Q Consensus       546 --------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~  611 (701)
                                    ..++++..+.+++.||+.||+|||++   ||+||||||+||++++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                          12478889999999999999999998   9999999999999999999999999999865432211


Q ss_pred             --ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          612 --RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       612 --~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                        .....++..|+|||++.+..++.+.  ||||+|+++++|++
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwSlGvil~ellt  309 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFS  309 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccc--cHHHHHHHHHHHHh
Confidence              1112345679999999887777765  99999999997653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-32  Score=289.10  Aligned_cols=205  Identities=23%  Similarity=0.325  Sum_probs=172.2

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG  534 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (701)
                      +.||+|+||.||+|.. .+++.||+|++.............+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999965 468999999998654333344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCcee
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL  614 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  614 (701)
                      +|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9998887644   588999999999999999999999   9999999999999999999999999999764333333344


Q ss_pred             ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHh
Q 041034          615 RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQEL  668 (701)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l  668 (701)
                      ..||+.|+|||++.+..++.+.  ||||+|+++|+++.+. |....+..++.+.+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~--DiwslGvil~elltG~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccC--CccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence            5799999999999887777766  9999999999999887 44444544444433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-32  Score=288.43  Aligned_cols=208  Identities=25%  Similarity=0.362  Sum_probs=171.5

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHH---hcCCCCceeeeeeeeeeCcEEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVL---STVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      |++.+.||+|+||.||+|.. .+++.||||+++..........+.+.+|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999965 46899999999865332233345666676654   566899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|..+++..    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999999888643    489999999999999999999999   999999999999999999999999999876443


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHh
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQEL  668 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l  668 (701)
                      .........|++.|+|||.+.+..++.+.  |+||+|+++|+++.+. |....+..++.+.+
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~G~~pf~~~~~~~~~~~i  213 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAV--DWWGLGVLIYEMLVGESPFPGDDEEEVFDSI  213 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCccc--chhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            33334456799999999999887777665  9999999999999887 44445555554444

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-33  Score=265.69  Aligned_cols=195  Identities=25%  Similarity=0.359  Sum_probs=166.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTV-RHRNIVKLYGFCLH  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  520 (701)
                      .-+.|.-.+.+|+|..++|-++.. ++|+.+|+|++......     .....+.-.+|+.+++++ .||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            456788899999999999999844 57899999998753321     234456678899999999 59999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +..+++|+|.|+.|.|.|++.+.-   .+++....+|+.|+.+|++|||..   +||||||||+|||+|++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            999999999999999999998765   689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCC----hhhHHHHHHHHHHHHH
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVN----QKIIQDIILVSTTALA  649 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~Di~slg~i~~~  649 (701)
                      +|+.+. .+......+|||+|.|||.+....+.    ....-|+|++|+|+|.
T Consensus       169 Fa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyT  220 (411)
T KOG0599|consen  169 FACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYT  220 (411)
T ss_pred             eeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHH
Confidence            999875 45566678999999999987654322    1223499999999994

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.9e-33  Score=298.47  Aligned_cols=208  Identities=22%  Similarity=0.278  Sum_probs=171.9

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++.............+.+|++++++++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3699999999999999999965 468999999987543322233466889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999997654   578899999999999999999999   9999999999999999999999999998533100


Q ss_pred             C-------------------------------------------CCceeecccccccCCCCCCCCcCChhhHHHHHHHHH
Q 041034          609 S-------------------------------------------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVST  645 (701)
Q Consensus       609 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~  645 (701)
                      .                                           .......||+.|+|||++.+..++.+.  ||||+||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGv  232 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce--eeeeccc
Confidence            0                                           001124699999999999888887765  9999999


Q ss_pred             HHHHcccCCC-CCCCCHHHHH
Q 041034          646 TALACLRSKP-KSRPTMQRIS  665 (701)
Q Consensus       646 i~~~cl~~~P-~~Rpt~~~i~  665 (701)
                      ++|+|+.+.+ ....+..+..
T Consensus       233 ilyell~G~~Pf~~~~~~~~~  253 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQ  253 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHH
Confidence            9999998874 3334444433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=287.99  Aligned_cols=201  Identities=22%  Similarity=0.330  Sum_probs=169.3

Q ss_pred             EeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|+||.||+|... +++.||+|++.............+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999654 5889999999764333333456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeec
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA  616 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  616 (701)
                      .+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99997654   588999999999999999999998   999999999999999999999999999986543333344557


Q ss_pred             ccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHH
Q 041034          617 GTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQ  666 (701)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~  666 (701)
                      ||+.|+|||++.+..++.+.  ||||+|+++++++.+.+. ...+..++.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~--DvwslGvil~el~tg~~pf~~~~~~~~~~  203 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAV--DWWTLGVLLYEMLTGLPPFYDENVNEMYR  203 (312)
T ss_pred             CCcccCCHHHHcCCCCCCcc--ceechhHHHHHHHhCCCCcCCCCHHHHHH
Confidence            99999999999888777765  999999999999988754 3333444333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.5e-33  Score=296.30  Aligned_cols=204  Identities=23%  Similarity=0.319  Sum_probs=171.3

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ++....++|++.+.||+|+||.||+|... +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34445688999999999999999999664 68899999987543322333456788999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..|+||||+++|+|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999999654    378899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCC-CceeecccccccCCCCCCCCc----CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSS-NRTLRAGTYGYIAPDQRLSPP----VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +....... ......||+.|+|||++.+..    ++.+  .|+||+|+++|+|+.+.+.
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~--~DiwSlG~ilyell~G~~P  246 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE--CDWWSVGVFLFEMLVGDTP  246 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcc--cCEEeehHHHHHHHhCCCC
Confidence            87643222 223457999999999986643    3344  4999999999999988743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-32  Score=287.68  Aligned_cols=195  Identities=26%  Similarity=0.329  Sum_probs=168.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... ++..||+|.+....  .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999654 68899999987643  233457789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999997654   5889999999999999999999752  699999999999999999999999999976532


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .  ......|++.|+|||++.+..++.+.  ||||+|+++|+++.+.
T Consensus       157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~--DiwslG~il~el~tg~  199 (331)
T cd06649         157 S--MANSFVGTRSYMSPERLQGTHYSVQS--DIWSMGLSLVELAIGR  199 (331)
T ss_pred             c--ccccCCCCcCcCCHhHhcCCCCCchH--hHHHHHHHHHHHHhCC
Confidence            2  22334689999999999887777665  9999999999877664

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-32  Score=273.19  Aligned_cols=238  Identities=21%  Similarity=0.287  Sum_probs=195.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+.|++.+.||+|.-|+||+|+..+ +..+|+|++.+..........+.+.|-+||+.++||.++.+|+.++.++..++|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3457788999999999999997764 689999999987766566677889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||+||+|..+.+++... .+++..++-++..++-||+|||-.   |||.|||||+||||.++|++-|+||.++.....
T Consensus       156 meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            9999999999998876543 699999999999999999999998   999999999999999999999999998743210


Q ss_pred             ---------------------------------C-C----------------------CCceeecccccccCCCCCCCCc
Q 041034          608 ---------------------------------D-S----------------------SNRTLRAGTYGYIAPDQRLSPP  631 (701)
Q Consensus       608 ---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~  631 (701)
                                                       . .                      ......+||-.|.|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                      0011246999999999999999


Q ss_pred             CChhhHHHHHHHHHHHHHcccCC-CCCCC------------------------CHHHHHHHhhcCCCccchhhhhhHHHH
Q 041034          632 VNQKIIQDIILVSTTALACLRSK-PKSRP------------------------TMQRISQELEGKTPMKKGLKEISISEM  686 (701)
Q Consensus       632 ~~~~~~~Di~slg~i~~~cl~~~-P~~Rp------------------------t~~~i~~~l~~~~~~~~~~~~~~~~~~  686 (701)
                      .+..+  |+|+||+++|||+.+. |.+-.                        ++.++++.|--+.|.++--...-..++
T Consensus       312 HgsAV--DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  312 HGSAV--DWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CCchh--hHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            88887  9999999999988764 43322                        345666666666666655555556777


Q ss_pred             hcccce
Q 041034          687 RNQEMF  692 (701)
Q Consensus       687 ~~~~~~  692 (701)
                      +.+++|
T Consensus       390 K~HpFF  395 (459)
T KOG0610|consen  390 KRHPFF  395 (459)
T ss_pred             hcCccc
Confidence            777766

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-32  Score=290.02  Aligned_cols=192  Identities=27%  Similarity=0.403  Sum_probs=160.8

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEAR-VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||+||+|... +++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999654 68999999997643322222344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999987644   588999999999999999999999   999999999999999999999999999976433333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DvwslG~il~ell~g~~  194 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTV--DWWCLGAVLYEMLYGLP  194 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccc--cccccchhhhhhhcCCC
Confidence            45799999999999888877765  99999999999887764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.9e-32  Score=286.75  Aligned_cols=211  Identities=24%  Similarity=0.354  Sum_probs=175.7

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +|++.+.||+|+||.||+|... +++.||+|++.+.........+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999654 5789999999865433333345667788888777 5899999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999987654   588999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                      ........||+.|+|||++.+.+++.+.  |+||+|+++|+++.+. |....+..++.+.+.
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~  214 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  214 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCcc--chhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3334455799999999999888887776  9999999999999987 444445555555443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-32  Score=296.53  Aligned_cols=198  Identities=22%  Similarity=0.299  Sum_probs=169.1

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++++.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588999999999999999955 4688999999976543333445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999987653   578899999999999999999999   99999999999999999999999999985431100


Q ss_pred             -----------------------------------------------CCceeecccccccCCCCCCCCcCChhhHHHHHH
Q 041034          610 -----------------------------------------------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIIL  642 (701)
Q Consensus       610 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~s  642 (701)
                                                                     ......+||+.|+|||++.+..++..+  ||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~--DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee--eEEe
Confidence                                                           001123689999999999888887765  9999


Q ss_pred             HHHHHHHcccCCCC
Q 041034          643 VSTTALACLRSKPK  656 (701)
Q Consensus       643 lg~i~~~cl~~~P~  656 (701)
                      +||++|+|+.+.|.
T Consensus       234 lGvil~elltG~~P  247 (382)
T cd05625         234 VGVILYEMLVGQPP  247 (382)
T ss_pred             chHHHHHHHhCCCC
Confidence            99999999988754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=275.90  Aligned_cols=189  Identities=30%  Similarity=0.437  Sum_probs=169.8

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+-|.++++||+|+||.||+|.+ ..|+.||||++.....     .+++.+|+.+|++++.|+||++||.|......|+|
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            34578899999999999999954 5799999999976432     57889999999999999999999999888899999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||-.|+..++++.+.+  ++++..+..+....++||+|||..   .-||||||+.|||++.+|.+||+|||.|..+.+
T Consensus       107 MEYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             hhhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            999999999999987654  699999999999999999999988   889999999999999999999999999988876


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .-.......|||.|||||++....|+..+  ||||+|+.+.+
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~A--DIWSLGITaIE  221 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKA--DIWSLGITAIE  221 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhh--hHhhhcchhhh
Confidence            55566778899999999999988888876  99999999875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.9e-33  Score=281.55  Aligned_cols=197  Identities=27%  Similarity=0.458  Sum_probs=168.6

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      .+.++|++.+.||+|+||.||+|...+++.+|+|.+.....   .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            45678999999999999999999887799999999876543   224678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++..... ..+++..+..++.|++.||+|||+.   |++|+||||+||++++++.+||+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            9999999999999976432 3589999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..........++..|+|||......+..+.  |+|++|++++++++
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~--DiwslG~~l~~l~~  199 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKS--DVWSFGILLYEMFT  199 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchh--hHHHHHHHHHHHHc
Confidence            433333333467789999998777666654  99999999987554

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-32  Score=293.95  Aligned_cols=218  Identities=22%  Similarity=0.299  Sum_probs=178.2

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      +.++....++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455666789999999999999999999664 688999999875433233334567889999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +...++||||+++|+|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999998654    378888999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCC-CceeecccccccCCCCCCCCc----CChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHh
Q 041034          601 TARLLHVDSS-NRTLRAGTYGYIAPDQRLSPP----VNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQEL  668 (701)
Q Consensus       601 la~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l  668 (701)
                      +|+....... ......||+.|+|||++....    ++.+  .||||+|+++|+|+.+.+ ....+..+..+.+
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~--~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  259 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE--CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  259 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCc--cceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9987643322 223457999999999986543    3344  499999999999998874 4444444444443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-32  Score=309.81  Aligned_cols=200  Identities=27%  Similarity=0.433  Sum_probs=168.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|++...........+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999654 68999999998765555555678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCC--------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          529 EYMERGSLFYVLRDDD--------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      ||++||+|.+++....        .....++..++.++.||++||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421        112456778899999999999999999   99999999999999999999999999


Q ss_pred             CccccccCC------------------CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDS------------------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +|+......                  ......+||+.|+|||++.+..++.+.  ||||+|+++++|+++.
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS--DIWSLGVILyELLTG~  228 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST--DIYALGVILYQMLTLS  228 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh--HHHHHHHHHHHHHHCC
Confidence            998662110                  011124699999999999888777665  9999999999766554

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-32  Score=277.29  Aligned_cols=209  Identities=22%  Similarity=0.395  Sum_probs=169.9

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      ++|++.+.||+|+||.||+|...++..+|+|.+......    .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            568889999999999999998888889999988754322    3568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++|+|.++++....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999999875432  488999999999999999999998   99999999999999999999999999997653222


Q ss_pred             CC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhh
Q 041034          610 SN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELE  669 (701)
Q Consensus       610 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~  669 (701)
                      .. .....++..|+|||...+..++.+.  |+||+|+++++++. +. |....+-.++.+.+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~  215 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKS--DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS  215 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhh--hhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            11 1122345689999998877666654  99999999998776 44 333333344444443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.9e-32  Score=276.39  Aligned_cols=199  Identities=24%  Similarity=0.321  Sum_probs=169.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|.++.....+....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999665 79999999987654444444678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||+++++|.+++.... ....+++.++..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||.+..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 233588999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      .........+++.|+|||.+.+..++.+.  |+|++|+++++++.+
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~--Di~slG~il~~l~~g  202 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEMAAL  202 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchh--cHHHHHHHHHHHHHC
Confidence            33333445688999999998877766655  999999999865444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-32  Score=292.16  Aligned_cols=193  Identities=26%  Similarity=0.403  Sum_probs=159.8

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|+..+.||+|+||.||+|.. .+++.||||++....  .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            4567789999999999999965 468999999986543  2344577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+..       ..++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986432       356678889999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCceeecccccccCCCCCCCCcCC---hhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVN---QKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ........||..|+|||++......   .....||||||+++|+++.+.
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~  270 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR  270 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence            3333445799999999987542211   112359999999999887765

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=293.14  Aligned_cols=198  Identities=26%  Similarity=0.394  Sum_probs=172.4

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|+++............+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999654 68999999998654333334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999998753   588999999999999999999998   9999999999999999999999999999876533


Q ss_pred             C-----------------------------CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 S-----------------------------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .                             .......||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~ell~g~~  228 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC--DWWSLGVILYEMLYGFP  228 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCce--eeEecchhhhhhccCCC
Confidence            2                             122345699999999999888777766  99999999999988764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-32  Score=294.25  Aligned_cols=198  Identities=22%  Similarity=0.333  Sum_probs=162.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCL  519 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  519 (701)
                      ...++|.+.+.||+|+||.||+|...      .+..||||+++....  ....+.+.+|+++++++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            34678999999999999999999642      134699999976432  233467899999999996 999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCC------------------------------------------------------
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDE------------------------------------------------------  545 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  545 (701)
                      +.+..|+||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            99999999999999999998864310                                                      


Q ss_pred             ---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 041034          546 ---------------------------------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNI  586 (701)
Q Consensus       546 ---------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NI  586 (701)
                                                             ...+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence                                                   12477888899999999999999998   999999999999


Q ss_pred             EEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          587 LLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       587 ll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +++.++.+||+|||+++.......  ......+++.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwSlGvil~ell  333 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS--DVWSYGILLWEIF  333 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchh--hHHHHHHHHHHHH
Confidence            999999999999999986543222  11223467889999999887777665  9999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.2e-32  Score=285.36  Aligned_cols=206  Identities=24%  Similarity=0.371  Sum_probs=168.2

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|+++..........+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999654 5889999999865432223345556677777654 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99999987654   588999999999999999999998   999999999999999999999999999986543333444


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++++|+.+. |....+..++...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~  209 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESV--DWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL  209 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcc--cchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            56799999999999888777665  9999999999999886 433344444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-32  Score=286.26  Aligned_cols=207  Identities=23%  Similarity=0.365  Sum_probs=172.1

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|++.+.........+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999654 6889999999764332223346677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999887654   588999999999999999999999   999999999999999999999999999876433333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhhc
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~~  670 (701)
                      ...||+.|+|||++.+..++.+.  |+||+|+++|+++.+. |....+..++.+.+..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~  210 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN  210 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCcc--chhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence            55799999999999887777765  9999999999999887 4455566666555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-32  Score=278.34  Aligned_cols=200  Identities=22%  Similarity=0.318  Sum_probs=169.5

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|.. .+++.||||.+......+.....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5788999999999999999964 578999999887654444445578889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||+++++|.+++.... ....+++..+..++.|+++||+|||++   |++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 223589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .........++..|+|||...+...+...  |+||+|+++++++.+.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~--Dv~slG~il~~l~~g~  203 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEMAALQ  203 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchh--hHHHHHHHHHHHHhCC
Confidence            43333345688999999998777766654  9999999998644443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-32  Score=287.94  Aligned_cols=204  Identities=22%  Similarity=0.307  Sum_probs=170.2

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG  534 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (701)
                      +.||+|+||.||+|.. .+++.||+|+++............+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999955 478999999998654333334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      +|.+++....   .+++..+..++.||+.||+|||+ .   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            9999887644   58999999999999999999996 6   999999999999999999999999999876433333334


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++|+++.+. |....+..++.+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~tG~~Pf~~~~~~~~~~~  207 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  207 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCcc--ccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence            45799999999999888777765  9999999999999887 4434444444333

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-32  Score=300.10  Aligned_cols=192  Identities=20%  Similarity=0.225  Sum_probs=161.9

Q ss_pred             cCCccceEEeeccceEEEEEEc-CC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..|.+.+.||+|++|.||+|.. .+ ++.||+|.+....   ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            3489999999999999999954 34 6788888775432   23345678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          528 YEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||+++|+|.+++... .....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999999988643 2233588999999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          607 VDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       607 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ....  ......||+.|+|||++.+..++.+.  ||||+|+++++
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Dv~slG~~l~e  263 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKA--DMWSLGVILYE  263 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHH--hHHHHHHHHHH
Confidence            3221  12345699999999999887777665  99999999985

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-32  Score=293.43  Aligned_cols=211  Identities=23%  Similarity=0.341  Sum_probs=175.7

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|++.............+.+|+.++.+++||+|+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46899999999999999999654 68999999997543333334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999997654   588999999999999999999999   9999999999999999999999999998754311


Q ss_pred             CC-----------------------------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          609 SS-----------------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       609 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ..                                   .....+||+.|+|||++.+..++..+  |+||+|+++|+|+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~--DiwSlGvilyel~tG  232 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcc--eeccccceeeecccC
Confidence            00                                   01124699999999999888887765  999999999999998


Q ss_pred             CC-CCCCCHHHHHHHh
Q 041034          654 KP-KSRPTMQRISQEL  668 (701)
Q Consensus       654 ~P-~~Rpt~~~i~~~l  668 (701)
                      .| ....+..+..+.+
T Consensus       233 ~~Pf~~~~~~~~~~~i  248 (360)
T cd05627         233 YPPFCSETPQETYRKV  248 (360)
T ss_pred             CCCCCCCCHHHHHHHH
Confidence            74 3444444444443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.6e-32  Score=286.98  Aligned_cols=193  Identities=25%  Similarity=0.376  Sum_probs=161.3

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEAR-VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|++.............+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999664 68899999987644332233345555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      ++|.+.+....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99998886543   578889999999999999999998   999999999999999999999999999876433333334


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~p  195 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTV--DWWCLGAVLYEMLYGLPP  195 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcC--cccccchhhhhhhcCCCC
Confidence            45799999999999888777765  999999999999887754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.4e-32  Score=278.41  Aligned_cols=195  Identities=24%  Similarity=0.424  Sum_probs=165.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.+.||+|++|.||+|...+++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            3567999999999999999999887888999999875432    246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.++++.... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999999999976432 2588899999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          608 DSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       608 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .... .....++..|+|||......++.+.  |+||+|+++|++++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~l~t  199 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKS--DVWSFGILLYEIVT  199 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhh--hhhhhHHHHHHHHc
Confidence            2211 1222356789999998877766654  99999999998664

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.6e-32  Score=281.25  Aligned_cols=198  Identities=27%  Similarity=0.401  Sum_probs=167.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            47999999999999999999665 6889999999765332 233467789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++++.+..+.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9999877765543322   588999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .. ......|++.|+|||++.+..++.+.  |+||+|+++|+++.+.|.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwslGvil~el~~g~~p  200 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAV--DMWSVGCILGELSDGQPL  200 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCch--hHHhHHHHHHHHHhCCCC
Confidence            22 22335689999999999887776655  999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.6e-32  Score=281.08  Aligned_cols=198  Identities=27%  Similarity=0.369  Sum_probs=165.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++........  ...+.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            478999999999999999999664 689999999875433221  24567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||++ ++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 588888765432  478899999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .........+|+.|+|||++.+.. ++..  +||||+|+++++++.+.+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTC--LDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcH--HHHHHHHHHHHHHHhCCCC
Confidence            333334456899999999876543 4444  4999999999999988744

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-32  Score=292.37  Aligned_cols=188  Identities=23%  Similarity=0.309  Sum_probs=162.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+...         +.+.+|++++++++||||+++++++......++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            46799999999999999999955 5689999996532         3467899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||++. ++|.+++....   .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus       162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99995 58988886543   588999999999999999999999   999999999999999999999999999975432


Q ss_pred             C-CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 D-SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      . ........||+.|+|||++.+..++.+.  ||||+|+++|+++.+.
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvil~elltg~  280 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAV--DIWSAGIVLFEMATCH  280 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHH--HHHHHHHHHHHHHHCC
Confidence            2 1222345799999999999888777665  9999999999998875

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-32  Score=280.03  Aligned_cols=198  Identities=20%  Similarity=0.313  Sum_probs=163.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||.||+|...      .++.||+|++.....  .....++.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            5678999999999999999998542      356799999865332  22346688999999999999999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCC-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDE-------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA  594 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~  594 (701)
                      ...++||||+++++|.+++.....       ....++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            999999999999999999875321       12367889999999999999999998   99999999999999999999


Q ss_pred             EEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          595 FVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       595 kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +|+|||+++........  .....+++.|+|||.+.+..++...  |+||+|+++++++.
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~  216 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS--DVWSFGVVLWEIAT  216 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchh--HHHHHHHHHHHHHc
Confidence            99999998765322211  1122457789999998877776665  99999999998665

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-32  Score=275.73  Aligned_cols=195  Identities=24%  Similarity=0.414  Sum_probs=165.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.+.||+|++|.||+|...+++.||+|.++.....    .+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            45679999999999999999998777888999998764322    36688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999997644 23589999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCCce-eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          608 DSSNRT-LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       608 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ...... ....+..|+|||...+...+.+.  |+||+|++++++++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~t  199 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKS--DVWSFGILLTEIVT  199 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchh--hHHHHHHHHHHHHh
Confidence            221111 11234579999998877776665  99999999997664

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.2e-32  Score=279.44  Aligned_cols=197  Identities=24%  Similarity=0.428  Sum_probs=163.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .++|++.+.||+|+||.||+|....      .+.||+|.+....  .......+.+|+.++++++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            3578999999999999999996532      2579999987543  2334567899999999999999999999999989


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      ..+++|||+++++|.+++.....             ...+++..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence            99999999999999999975421             13578899999999999999999999   999999999999999


Q ss_pred             CCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          590 SNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +++.+||+|||+++.......  ......+++.|+|||.+.+..++.+.  |+||+|++++++++
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s--Dv~slG~il~el~~  221 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES--DIWSFGVVLWEIFS  221 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhh--hHHHHHHHHHHHHc
Confidence            999999999999976532221  12233567889999998877777665  99999999997553

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-33  Score=256.61  Aligned_cols=218  Identities=23%  Similarity=0.346  Sum_probs=180.5

Q ss_pred             hhcCCccceEEeeccceEEEEEE-cCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      -.++|.+.+.+|+|||+-||.+. ..+++.+|+|++.-...   +..+..++|++..++++||||++++++...+     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            35789999999999999999994 56789999999986652   3357889999999999999999999887543     


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      ...|++++|+..|+|.+.+.... ++..+++.++++|+.++++||++||+. .+++.||||||.||++.+++.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            34899999999999999987643 344699999999999999999999998 3459999999999999999999999999


Q ss_pred             CccccccCCCC---------ceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHH-------------------
Q 041034          601 TARLLHVDSSN---------RTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALA-------------------  649 (701)
Q Consensus       601 la~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~-------------------  649 (701)
                      .++...-.-..         ......|..|.|||.+.-.   ..+++.  |||||||++|.                   
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ert--DIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERT--DIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccccc--chhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            99765321110         1112368899999987543   344554  99999999983                   


Q ss_pred             --------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 --------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 --------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                |++.||.+||+..+++..++..
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                                      9999999999999999988754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6e-32  Score=285.31  Aligned_cols=195  Identities=26%  Similarity=0.336  Sum_probs=166.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+.....  ......+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            478999999999999999999654 688999998876432  23356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+..  +++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999997644   5788999999999999999999742  799999999999999999999999999976532


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .  ......|+..|+|||++.+..++.+.  |+||+|+++|+++.+.
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~il~~l~~g~  199 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQGTHYSVQS--DIWSMGLSLVEMAIGR  199 (333)
T ss_pred             h--ccccCCCCccccCHHHhcCCCCCcHH--HHHHHHHHHHHHHHCC
Confidence            2  12334689999999999877666654  9999999998876653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.8e-32  Score=287.43  Aligned_cols=192  Identities=22%  Similarity=0.355  Sum_probs=165.7

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|+++..........+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999654 6889999999875444444456788999999998 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99999886543   589999999999999999999999   999999999999999999999999999975332333334


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...||+.|+|||++.+..++.+.  |+||+|+++|+++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~~l~el~~g~~  194 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRS  194 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCcc--ceechHHHHHHHHHCCC
Confidence            45799999999999888777765  99999999999988764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-32  Score=288.39  Aligned_cols=192  Identities=28%  Similarity=0.402  Sum_probs=161.4

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEAR-VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||+||+|.. .+|+.||+|++.............+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999955 468999999997653332233345556655 46778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99998887544   588999999999999999999998   999999999999999999999999999975433333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++++++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DvwslG~il~el~~G~~  194 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTV--DWWCLGAVLYEMLYGLP  194 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcC--ccccccceehhhhcCCC
Confidence            55799999999999888887765  99999999999887764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.2e-32  Score=275.80  Aligned_cols=208  Identities=24%  Similarity=0.412  Sum_probs=169.6

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      ++|++.+.||+|+||.||.|+..++..||+|.+......    .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            568899999999999999998777778999998754322    3568899999999999999999999998889999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++|+|.+++.....  .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999976433  589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHh
Q 041034          610 SN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQEL  668 (701)
Q Consensus       610 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l  668 (701)
                      .. .....++..|+|||...+..++.+.  |+||+|+++++++. +. |.......++.+.+
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~--Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKS--DVWAFGVLMWEVYSLGKMPYERFNNSETVEKV  214 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchh--HHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            11 1112355679999999877766654  99999999998775 44 43333333444433

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.1e-32  Score=284.12  Aligned_cols=211  Identities=24%  Similarity=0.360  Sum_probs=174.3

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +|+..+.||+|+||.||+|.. .+++.||+|++...........+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999965 468999999997643322333466778889988886 578889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++....   .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999987654   589999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhh
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELE  669 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~  669 (701)
                      ........||+.|+|||++.+..++.+.  |+||+|+++++|+.+.+. ...+..++.+.+.
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSV--DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCcc--chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3333445699999999999887777665  999999999999998743 4445555555443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-32  Score=280.26  Aligned_cols=199  Identities=24%  Similarity=0.314  Sum_probs=168.9

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||+|.. .+++.||+|++.............+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            488899999999999999965 4689999999976543333334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++|+|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999988865432 2589999999999999999999998   99999999999999999999999999998754222


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                       ......|++.|+|||.+.+..++...  |+||+|+++|+++.+.+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~--Diws~G~~l~el~~g~~p  200 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSP--DWWGLGCLIYEMIEGKSP  200 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccc--cchhHHHHHHHHHHCCCC
Confidence             22334689999999999877776665  999999999999887753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=6.9e-32  Score=277.96  Aligned_cols=193  Identities=26%  Similarity=0.359  Sum_probs=164.2

Q ss_pred             EeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|+||+||+|.. .+++.||+|++...........+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            68999999999955 46899999998765433333346678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceee
Q 041034          537 FYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR  615 (701)
Q Consensus       537 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  615 (701)
                      .+++.... ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.+..+..........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            98875422 233589999999999999999999999   99999999999999999999999999998765433333445


Q ss_pred             cccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          616 AGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       616 ~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .||+.|+|||.+.+..++.+.  |+||+|+++|+++.+.+
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~--DvwslG~il~el~~g~~  195 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSV--DYFALGVTLYEMIAARG  195 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccc--cHHHHHHHHHHHHhCCC
Confidence            789999999999888777665  99999999999988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.98  E-value=9.7e-32  Score=278.09  Aligned_cols=210  Identities=25%  Similarity=0.345  Sum_probs=171.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++......  ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            36799999999999999999955 468999999987543221  135677899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++ +|.+++.....  .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            999975 99998865432  478899999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC-CCCHHHHHHHh
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS-RPTMQRISQEL  668 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~l  668 (701)
                      .........+++.|+|||.+.+. .++.+  .||||+|+++++++.+.|.. ..+..+.+..+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~  216 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTP--IDMWGVGCILYEMATGRPMFPGSTVKEELHLI  216 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcH--HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            33333445689999999988653 44544  49999999999999988543 33444444433

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=9.6e-32  Score=281.60  Aligned_cols=208  Identities=26%  Similarity=0.394  Sum_probs=170.3

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|+++..........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999664 5789999999765322122235566778888764 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999997643   588899999999999999999999   999999999999999999999999999975433333334


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhhcC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELEGK  671 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~~~  671 (701)
                      ...||+.|+|||++.+..++.+.  |+||+|+++|+|+.+. |....+..++.+.+...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~  211 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSV--DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD  211 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchh--hhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            45799999999999887777665  9999999999999887 44445566666555443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=2.8e-32  Score=291.76  Aligned_cols=202  Identities=23%  Similarity=0.309  Sum_probs=169.2

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ....++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345678999999999999999999654 6889999999754322223345578899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+++|+|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999998654    378888999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCC-CceeecccccccCCCCCCCCc----CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVDSS-NRTLRAGTYGYIAPDQRLSPP----VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...... ......||+.|+|||.+.+..    ++.+.  |+||+|+++|+++.+.+.
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~--DiwSlGvilyelltG~~P  246 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC--DWWSVGVFLYEMLVGDTP  246 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCce--eeeehhHHHHHHHhCCCC
Confidence            643322 223457999999999886543    34444  999999999999988743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=4e-32  Score=286.14  Aligned_cols=193  Identities=22%  Similarity=0.353  Sum_probs=166.0

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|++++.........+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 6889999999876544444456788899988877 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99998886644   589999999999999999999999   999999999999999999999999999976433333334


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...||+.|+|||++.+..++.+.  |+||+|+++|+++.+.+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~P  195 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCcc--ceecccHHHHHHhhCCCC
Confidence            45799999999999888777765  999999999999988643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=9e-32  Score=275.00  Aligned_cols=194  Identities=28%  Similarity=0.416  Sum_probs=163.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|.+.    +...||+|.++....  ......+.+|+.++++++||||+++++++.+.+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            467999999999999999999664    245799998875432  33356788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||+++.
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            999999999999999976443  589999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCCc--eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          605 LHVDSSNR--TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       605 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ........  ....++..|+|||...+..++.+.  |+|++|+++++++
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~--Dv~slG~~l~~l~  202 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSAS--DVWSFGIVMWEVM  202 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCcccc--chHHHHHHHHHHH
Confidence            75222111  112345789999998877776665  9999999998644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=5.5e-32  Score=286.80  Aligned_cols=195  Identities=28%  Similarity=0.415  Sum_probs=160.5

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----cEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----RCM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  524 (701)
                      +|++.+.||+|+||.||+|.. .+++.||||++...... .....++.+|+.+++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            588999999999999999965 46899999998754322 22235688999999999999999999987543     358


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+. ++|.+++....   .+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999995 58999887654   589999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCC---CceeecccccccCCCCCCC--CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          605 LHVDSS---NRTLRAGTYGYIAPDQRLS--PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       605 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ......   ......||+.|+|||++.+  ..++.+  .||||+|+++++++++.|
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPA--IDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCch--hHHHHHHHHHHHHHcCCC
Confidence            532221   1133468999999998765  344444  499999999999888764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=3.5e-35  Score=303.14  Aligned_cols=317  Identities=31%  Similarity=0.446  Sum_probs=275.5

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCccee-eCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSG-SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+.||.+++|++...-+.  ++.+|.|+.++++.|++.. -+|+.+..+..|+.||||+|++. ..|..+...+++-+|+
T Consensus        56 kLEHLs~~HN~L~~vhGE--Ls~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLN  132 (1255)
T KOG0444|consen   56 KLEHLSMAHNQLISVHGE--LSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLN  132 (1255)
T ss_pred             hhhhhhhhhhhhHhhhhh--hccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEE
Confidence            566777777776643332  4678899999999998863 36777888999999999999998 7888899999999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC-
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN-  195 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-  195 (701)
                      ||+|+|..+....|.+|+.|-.||||+|++. .+|..+..|..|++|.|++|.+.-..-..+..+++|++|++++.+-+ 
T Consensus       133 LS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl  211 (1255)
T KOG0444|consen  133 LSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL  211 (1255)
T ss_pred             cccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh
Confidence            9999999777777889999999999999998 56667888999999999999886555566677888999999887643 


Q ss_pred             CCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccC
Q 041034          196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                      ..+|.++..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+. +....+.+.+|+.|+||.|+++ .+|++++
T Consensus       212 ~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avc  288 (1255)
T KOG0444|consen  212 DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVC  288 (1255)
T ss_pred             hcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHh
Confidence            468899999999999999999999 889999999999999999999987 4445667889999999999999 8899999


Q ss_pred             CCCCCcEEEccCccCCC-CCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCe
Q 041034          276 KLSNLQYLNLSSNLLSG-QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQN  354 (701)
Q Consensus       276 ~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  354 (701)
                      .++.|+.|++.+|+++- -+|..++.+.+|+++..++|.+. .+|++++.|..|+.|.|++|++. ++|.++.-++.|+.
T Consensus       289 KL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~v  366 (1255)
T KOG0444|consen  289 KLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKV  366 (1255)
T ss_pred             hhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcce
Confidence            99999999999999873 57999999999999999999997 89999999999999999999998 89999999999999


Q ss_pred             EEcccccCc
Q 041034          355 LDLSHNNLS  363 (701)
Q Consensus       355 l~ls~N~l~  363 (701)
                      ||+..|+=-
T Consensus       367 LDlreNpnL  375 (1255)
T KOG0444|consen  367 LDLRENPNL  375 (1255)
T ss_pred             eeccCCcCc
Confidence            999999754

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.98  E-value=5.7e-32  Score=284.28  Aligned_cols=205  Identities=24%  Similarity=0.369  Sum_probs=169.7

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|+++..........+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999654 5889999999765433333346677888888866 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99999887654   588999999999999999999999   999999999999999999999999999976543333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHh
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQEL  668 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l  668 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+ ....+..++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DvwslG~il~el~tg~~Pf~~~~~~~~~~~i  208 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSV--DWWALGVLMYEMMAGQPPFEADNEDDLFESI  208 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCcc--ceechhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            45799999999999887777765  99999999999998874 3444444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-33  Score=287.96  Aligned_cols=206  Identities=29%  Similarity=0.434  Sum_probs=178.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +-|.-.+.||.|+||.||.|+. .+.+.||||++.-........-.++..|++++++++|||++.+.|+|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3466678899999999999955 468899999998776665555678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |||-| +-.|++.-..+  ++.+..+..|+.+.++||+|||+.   +.||||||+.|||+++.|.|||+|||.|....+ 
T Consensus       106 EYClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHHhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            99955 88888765544  588899999999999999999999   999999999999999999999999999987543 


Q ss_pred             CCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          609 SSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                         ...++|||.|||||++.   .+.|+.++  ||||+|+...+                                    
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkv--DvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~  253 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKV--DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY  253 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCcc--ceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence               34578999999999876   35677777  99999998763                                    


Q ss_pred             -------cccCCCCCCCCHHHHHHH
Q 041034          650 -------CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -------cl~~~P~~Rpt~~~i~~~  667 (701)
                             |+..-|.+|||.++++..
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhc
Confidence                   999999999999988774

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.98  E-value=9.7e-32  Score=282.67  Aligned_cols=194  Identities=24%  Similarity=0.378  Sum_probs=164.4

Q ss_pred             ceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          455 RYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      ++.||+|+||.||+|+.    .+++.||+|+++..... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36799999999999964    35789999998764321 12234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++....   .+.+..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999987654   478888999999999999999999   99999999999999999999999999997543333


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .......||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+.
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~G~~p  199 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAV--DWWSLGALMYDMLTGAPP  199 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcc--eecccHHHHHHHhcCCCC
Confidence            333445799999999999887776665  999999999999988754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.98  E-value=5.8e-32  Score=284.76  Aligned_cols=193  Identities=20%  Similarity=0.330  Sum_probs=166.3

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|.. .+++.||+|+++.....+....+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 46889999999876544444456788999999888 599999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99999887544   589999999999999999999999   999999999999999999999999999975433333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...||+.|+|||.+.+..++.+.  |+||+|+++|+++.+.+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslGvil~ell~g~~p  195 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSV--DWWALGVLMFEMMAGRSP  195 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchh--eeehhHHHHHHHHhCCCC
Confidence            56799999999999888777665  999999999999988753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.98  E-value=9.5e-32  Score=281.72  Aligned_cols=206  Identities=23%  Similarity=0.365  Sum_probs=168.7

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|.++..........+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999664 6889999999764322122235567788887754 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99999987643   588899999999999999999999   999999999999999999999999999875433333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++++++.+. |....+..++.+.+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~  209 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSV--DWWSFGVLLYEMLIGQSPFHGDDEDELFESIR  209 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCccc--chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            56799999999999888777665  9999999999999886 444445555554443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=8.1e-32  Score=297.52  Aligned_cols=198  Identities=23%  Similarity=0.279  Sum_probs=165.0

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc--
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR--  522 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  522 (701)
                      ....++|.+.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++..++|+||+++++.+...+  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            34567999999999999999999954 57999999999765432 333567889999999999999999988765432  


Q ss_pred             ------EEEEEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 041034          523 ------CMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF  595 (701)
Q Consensus       523 ------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~k  595 (701)
                            .+++||||+++|+|.++++... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence                  3689999999999999987542 233689999999999999999999998   999999999999999999999


Q ss_pred             EEeecCccccccCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          596 VADFGTARLLHVDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       596 L~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      |+|||+++.+....  .......||+.|+|||++.+..++.+.  ||||+|+++|+
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~--DVwSlGvilye  237 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA--DMFSLGVLLYE  237 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHH--HHHHHHHHHHH
Confidence            99999998764321  122345699999999999888777665  99999999985

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.98  E-value=7.3e-32  Score=282.94  Aligned_cols=214  Identities=24%  Similarity=0.429  Sum_probs=176.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..+|++.+.||+|+||.||+|.+. +++    .||+|+++...  .....+++.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            357999999999999999999653 333    48999987533  233457788999999999999999999998765 5


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++|+||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            6799999999999999986542  478899999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCce--eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          604 LLHVDSSNRT--LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       604 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      ..........  ...++..|+|||.+.+..++.+.  ||||+|+++|+                                
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~--Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS--DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI  235 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchh--hhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence            7653322211  12346689999999887777665  99999999885                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                 ||..+|.+||++.+++..+....
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                       66678888888888888876544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.98  E-value=7.3e-32  Score=277.85  Aligned_cols=197  Identities=25%  Similarity=0.440  Sum_probs=164.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .++|.+.+.||+|+||.||+|...      +++.||+|.++....  ....+.+.+|+++++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            456889999999999999999653      347899999876433  223578899999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCC-----------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDE-----------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      ..++||||+++++|.+++.....           ...+++..+..++.|++.|++|||++   +++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            99999999999999999975421           23478899999999999999999999   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          592 LEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +.+||+|||.++.......  ......+++.|+|||.+.+..++.+.  ||||+|+++++|+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~e~~~  219 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTES--DVWSFGVVLWEIFT  219 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhh--hHHHHHHHHHHHHh
Confidence            9999999999976532221  11223457889999999888777765  99999999998664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=5.1e-32  Score=285.96  Aligned_cols=217  Identities=22%  Similarity=0.365  Sum_probs=183.4

Q ss_pred             CCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-C-----CceeeeeeeeeeCcE
Q 041034          451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-H-----RNIVKLYGFCLHKRC  523 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~  523 (701)
                      +|.+.+.||+|+||+|.+| +..+++.||||+++...    .+.++...|+.+|..++ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            8999999999999999999 55679999999998754    45677888999999997 4     489999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--CCeEEEeecC
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN--LEAFVADFGT  601 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~--~~~kL~DFGl  601 (701)
                      .|||+|.++. +|.++++...-. .++...++.++.||+.||.+||+.   +|||+||||+|||+.+.  ..+||+|||.
T Consensus       263 lciVfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999966 999999876533 589999999999999999999998   99999999999999643  4899999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCC--CCHHHHHHHhhcCCCccchhh
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSR--PTMQRISQELEGKTPMKKGLK  679 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~R--pt~~~i~~~l~~~~~~~~~~~  679 (701)
                      |+......   ...+-++.|+|||++.+.+|+...  ||||||||+.|+..+.|-.-  --++|+..+++-....++.+-
T Consensus       338 Sc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~I--DmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  338 SCFESQRV---YTYIQSRFYRAPEVILGLPYDTAI--DMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccccCCcc---eeeeeccccccchhhccCCCCCcc--ceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98764322   245688999999999999999998  99999999999999998553  235666666665555555444


Q ss_pred             hh
Q 041034          680 EI  681 (701)
Q Consensus       680 ~~  681 (701)
                      +.
T Consensus       413 ~~  414 (586)
T KOG0667|consen  413 DT  414 (586)
T ss_pred             Hh
Confidence            43

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=277.03  Aligned_cols=197  Identities=23%  Similarity=0.362  Sum_probs=172.8

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .=|.+.+.||+|.|++|-.|++ -+|..||||++.+.+.++ .....+.+|++.|+-++|||||++|++......+|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4477788899999999999955 479999999999877654 33466789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~DFGla~~~~~  607 (701)
                      |.-++|+|.+|+.+..++  +.+....+++.||+.|+.|+|+-   .+|||||||+||.+- .-|-|||.|||++..+. 
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-  170 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-  170 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence            999999999999887664  88999999999999999999998   899999999998874 56899999999998875 


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ++...+..+|+..|.|||++.+..|+..+. ||||+|+|+|.+.-+.
T Consensus       171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAV-DiWSLGVILyMLVCGq  216 (864)
T KOG4717|consen  171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAV-DIWSLGVILYMLVCGQ  216 (864)
T ss_pred             CcchhhcccchhhccCchhhhcCccCCcch-hhhHHHHHHHHHHhCC
Confidence            345566779999999999999999998874 9999999999644443

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=4.8e-32  Score=285.31  Aligned_cols=192  Identities=27%  Similarity=0.378  Sum_probs=159.4

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHH-HHHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEA-RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|++.............+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999654 6788999999764322222223444444 456788999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999987644   477888999999999999999999   999999999999999999999999999976433333344


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...||+.|+|||++.+..++.+.  ||||+|+++|+++.+.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~  194 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLP  194 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCcc--ccccccHHHHHHhcCCC
Confidence            55799999999999888777765  99999999999887764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=8.9e-32  Score=274.58  Aligned_cols=194  Identities=27%  Similarity=0.430  Sum_probs=162.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..+|.+.+.||+|++|.||+|... .++.||+|.+.....    ..+.+.+|++++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            356888999999999999999654 588999999875422    246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++..... ..+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            999999999999876432 2588999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCCc-eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          608 DSSNR-TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       608 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..... ....++..|+|||...+..++.+.  ||||+|++++++++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~t  200 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKS--DVWAFGVLLWEIAT  200 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchh--HHHHHHHHHHHHHc
Confidence            22111 112245679999998877776664  99999999997554

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.98  E-value=1.6e-31  Score=275.88  Aligned_cols=213  Identities=21%  Similarity=0.342  Sum_probs=169.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++|++.+.||+|+||.||+|..     .+++.||+|.+.....  ......+.+|+.++++++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            5688999999999999999963     2467899999975432  33346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCC--------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          525 FFIYEYMERGSLFYVLRDDDE--------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      ++||||+++++|.+++.....              ...+++.++..++.|++.||+|||++   +++||||||+||++++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            999999999999999853221              12478899999999999999999999   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHH
Q 041034          591 NLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQ  666 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~  666 (701)
                      ++.+||+|||+++.......  ......++..|+|||...+..++.+.  |+||+|++++++++ +. |....+..++.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS--DIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchh--hhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999986543221  12223456789999998877766654  99999999998775 44 322223344444


Q ss_pred             Hhh
Q 041034          667 ELE  669 (701)
Q Consensus       667 ~l~  669 (701)
                      .+.
T Consensus       238 ~~~  240 (283)
T cd05090         238 MVR  240 (283)
T ss_pred             HHH
Confidence            443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.98  E-value=2.2e-32  Score=278.18  Aligned_cols=189  Identities=34%  Similarity=0.542  Sum_probs=154.4

Q ss_pred             ccceEEeeccceEEEEEEcC-----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          453 HIRYCIGTGGYGSVYKAELP-----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++.+.||.|+||.||+|.+.     .+..|+||.++...  .....+.+.+|++.+++++||||++++|++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence            35688999999999999665     35679999996533  233368899999999999999999999999988889999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++..... ..+++..+..|+.||++||+|||++   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EE--TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            999999999999988622 2589999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          608 DSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ....  .........|+|||.+....++.+.  ||||||+++++
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ks--DVysfG~~l~e  197 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKS--DVYSFGMLLYE  197 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHH--HHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccc--ccccccccccc
Confidence            2111  1223467789999998777766665  99999999996

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=283.45  Aligned_cols=199  Identities=26%  Similarity=0.359  Sum_probs=167.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|++.+.........+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999654 68999999997533323333466889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++.+...  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999975332  588999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CC-CceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SS-NRTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .. ......||+.|+|||++..     ..++.+  .||||+|+++|+|+.+.+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~--~DiwslG~~l~el~~g~~  206 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPE--CDWWSLGVCMYEMLYGET  206 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCc--ceeehhhhHHHHHhhCCC
Confidence            22 2233469999999999863     223344  499999999999998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.98  E-value=1.3e-31  Score=273.94  Aligned_cols=196  Identities=30%  Similarity=0.433  Sum_probs=165.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......   ...+.+|+.++++++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            46799999999999999999965 568899999987543222   35678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.++++...   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999987543   588999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCCceeecccccccCCCCCCC---CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLS---PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........+++.|+|||.+..   ..++.+  .|+||+|+++++++.+.+
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~--~Dvws~G~il~el~~g~~  207 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL--CDIWAVGITAIELAELQP  207 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcch--hhHHHHHHHHHHHHhCCC
Confidence            3333334568899999998743   223333  499999999999877654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.98  E-value=1e-31  Score=272.89  Aligned_cols=210  Identities=24%  Similarity=0.405  Sum_probs=171.1

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      .+|++.+.||+|+||.||+|...+++.+|+|.+......    .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            458889999999999999998777778999998754332    2567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999976433  589999999999999999999999   99999999999999999999999999997654221


Q ss_pred             CCc-eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhhc
Q 041034          610 SNR-TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       610 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~~  670 (701)
                      ... ....++..|+|||...+..++.+.  |+||+|+++++++. +. |....+..++.+.+..
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~--Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  216 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKS--DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA  216 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchh--hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc
Confidence            111 111234579999998877776654  99999999999876 44 4444445555555543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.98  E-value=1.7e-31  Score=270.55  Aligned_cols=188  Identities=23%  Similarity=0.406  Sum_probs=156.2

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG  534 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (701)
                      +.||+|+||.||+|... +++.||+|.+....  .......+.+|++++++++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46899999999999664 68999999886543  2334577899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC--c
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN--R  612 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~  612 (701)
                      +|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+.........  .
T Consensus        79 ~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            99999875432  588999999999999999999998   9999999999999999999999999998765322111  1


Q ss_pred             eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          613 TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .....+..|+|||.+.+..++.+.  |+||+|+++++++.
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~e~~~  191 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSES--DVWSFGILLWEAFS  191 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHH--HHHHHHHHHHHHHh
Confidence            111234579999998877776664  99999999997553

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.98  E-value=1e-31  Score=276.26  Aligned_cols=192  Identities=26%  Similarity=0.357  Sum_probs=161.1

Q ss_pred             EeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|+||.||++... +|+.||+|++.............+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            689999999999654 6899999998754332222234556799999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeec
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA  616 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  616 (701)
                      .+++..... ..+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++...... .......
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA  155 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence            988865432 2488999999999999999999998   9999999999999999999999999999876432 2223346


Q ss_pred             ccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          617 GTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |++.|+|||++.+..++.+.  |+||+|+++|+++.+.+.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~--DvwslGv~l~el~~g~~p  193 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPV--DWFAMGCSIYEMVAGRTP  193 (277)
T ss_pred             CCCCccCHHHHccCCCCCch--hHHHHHHHHHHHHhCCCC
Confidence            89999999999888777665  999999999998876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=7e-35  Score=300.96  Aligned_cols=335  Identities=30%  Similarity=0.420  Sum_probs=252.0

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcc-cCCcccCCCCCCCEEE
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG-TIPKEIGSLRNLEVLY  116 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~  116 (701)
                      +++-|.|...++.- +| ..++.+..|++|.+++|++. .+...+..|+.|+.+++++|++.. -+|..+..+..|++||
T Consensus        33 ~~~WLkLnrt~L~~-vP-eEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD  109 (1255)
T KOG0444|consen   33 QMTWLKLNRTKLEQ-VP-EELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD  109 (1255)
T ss_pred             heeEEEechhhhhh-Ch-HHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence            44444444443331 11 13455666777777777766 344556667777777777776642 2455666777777777


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCC
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG  196 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (701)
                      ||+|++. ..|..+..-.++-+|+||+|+|..+....|-+|..|-.|||++|++. .+|+.+..+..|++|+|++|.+..
T Consensus       110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h  187 (1255)
T KOG0444|consen  110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNH  187 (1255)
T ss_pred             cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhH
Confidence            7777777 66777777777777777777777666666777777777777777774 445566777777777777777664


Q ss_pred             CCCCCCCCccccCcccccccccc-CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccC
Q 041034          197 TIPREIGNLKNLTHLSIITNKLT-GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                      .--..+..|.+|+.|.+++.+-+ ..+|.++..+.+|..+|+|.|.+.- +|..+.++++|+.|+||+|+|+ .+.-..+
T Consensus       188 fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~it-eL~~~~~  265 (1255)
T KOG0444|consen  188 FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNKIT-ELNMTEG  265 (1255)
T ss_pred             HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCcee-eeeccHH
Confidence            43344555666777777776543 3678889999999999999999986 7888889999999999999998 4555566


Q ss_pred             CCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCC-CCCCcccCCCCCCeeeccCCccCCCCCccccccccCCe
Q 041034          276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG-SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQN  354 (701)
Q Consensus       276 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  354 (701)
                      ...+|++|+||.|+++ .+|.++..++.|+.|++.+|+++- -+|.+++.+..|+.+..++|.+. .+|..+..+.+|+.
T Consensus       266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k  343 (1255)
T KOG0444|consen  266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK  343 (1255)
T ss_pred             HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence            7788999999999998 889999999999999999999863 48999999999999999999998 89999999999999


Q ss_pred             EEcccccCcccCCCCccc----cccccccCCC
Q 041034          355 LDLSHNNLSGTIPMTLHP----MFLDMSFNNL  382 (701)
Q Consensus       355 l~ls~N~l~g~~p~~~~~----~~l~ls~N~l  382 (701)
                      |.|+.|+|. ++|..++.    ..||+..|.=
T Consensus       344 L~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  344 LKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             hccccccee-echhhhhhcCCcceeeccCCcC
Confidence            999999997 67877653    3688887753

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=2.5e-31  Score=269.92  Aligned_cols=210  Identities=28%  Similarity=0.398  Sum_probs=176.2

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|.. .+++.|++|.+...... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            578899999999999999965 46899999998754332 3345778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||.++.+....
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999997642 23688999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      .......+++.|+|||...+...+.+.  |+||+|+++++++.+. |....+..++...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~p~~~~~~~~~~~~  212 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKS--DVWALGVVLYECCTGKHPFDANNQGALILK  212 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCcc--chHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            334445688999999999887776665  9999999999988876 4444444444333

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=291.21  Aligned_cols=201  Identities=27%  Similarity=0.402  Sum_probs=173.7

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc------EE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR------CM  524 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  524 (701)
                      |...+.||+|+||.||+++. ..|+.||||.+.......  ..+...+|+++|++++|||||+++++-++..      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            45678899999999999974 579999999998755332  3577899999999999999999999865433      56


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCC--CeEEEeec
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNL--EAFVADFG  600 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~--~~~--~~kL~DFG  600 (701)
                      .+|||||.+|||+..+++......+++...+.+..+++.||.|||++   |||||||||.||++-  .+|  ..||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            89999999999999999887777899999999999999999999999   999999999999983  333  46899999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPKSRPT  660 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~~Rpt  660 (701)
                      .|+.+.++. .....+||..|.+||.... ..++...  |.||+|+++|+|.++.-+.||.
T Consensus       170 ~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tV--DLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  170 AARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATV--DLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccccCCCCC-eeeeecCchhhcChHHHhhccCcCcee--ehhhhhhHHHHHhccCCCCCcC
Confidence            999886544 6667799999999999984 7777777  9999999999999999767764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=1.8e-31  Score=281.97  Aligned_cols=198  Identities=26%  Similarity=0.346  Sum_probs=166.1

Q ss_pred             CCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  524 (701)
                      +|++.+.||+|+||.||+|+.    .+++.||+|++.+.... .....+.+.+|+.+++.++ ||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588999999999999999854    35789999998754321 2233466788999999995 99999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999987654   588999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCC-CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVDSS-NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +..... ......||+.|+|||++.+.. ++...  ||||+|+++++++++.+.
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--DiwslG~il~elltg~~p  206 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAV--DWWSLGILIFELLTGASP  206 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCcc--ccccchhhhhhhhcCCCC
Confidence            543222 223457999999999987643 44444  999999999999988743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=1.6e-31  Score=276.57  Aligned_cols=198  Identities=20%  Similarity=0.292  Sum_probs=161.2

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+.....  ......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            35678999999999999999998542      245799998865432  2234567889999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCC-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDE-------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE  593 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~  593 (701)
                      ....++||||+++|+|.+++.....       ....++..+..++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence            9999999999999999999975321       12456788899999999999999998   9999999999999999999


Q ss_pred             eEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          594 AFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       594 ~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ++|+|||+++........  .....++..|+|||...+..++.+.  |+||+|+++++++
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~--DvwslG~~l~el~  215 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS--DMWSFGVVLWEIT  215 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHh--HHHHHHHHHHHHH
Confidence            999999999865322211  1122356789999998877776665  9999999998643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=6.8e-32  Score=284.99  Aligned_cols=199  Identities=24%  Similarity=0.347  Sum_probs=169.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|.. .+++.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4799999999999999999955 468999999998654433344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999976532  589999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCC-ceeecccccccCCCCCCC------CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLS------PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~------~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ... .....||+.|+|||++..      ..++.+  .||||+|+++|+++.+.+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~--~DiwslG~il~el~~g~~  207 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE--CDWWSLGVIAYEMIYGRS  207 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCc--ceeecccceeeeeccCCC
Confidence            322 223468999999998863      334444  499999999999998773

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=2.1e-31  Score=279.47  Aligned_cols=206  Identities=25%  Similarity=0.373  Sum_probs=171.2

Q ss_pred             eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|... +++.||+|+++..........+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999664 5889999999865433333346677888998888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99999887654   589999999999999999999998   999999999999999999999999999875433333334


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                      ...|++.|+|||++.+..++.+.  |+||+|+++++++.+. |....+..++.+.+.
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~--DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~  209 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAV--DWWALGVLLYEMLAGQSPFEGDDEDELFQSIL  209 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcch--hhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            45699999999999888877765  9999999999999876 444445555555443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=2e-31  Score=271.75  Aligned_cols=209  Identities=26%  Similarity=0.419  Sum_probs=168.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .++|++.+.||+|+||.||+|...+...||+|+++.....    .+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            4679999999999999999997776678999999764332    2568899999999999999999998754 5579999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++..... ..+++..+..++.|+++||+|+|+.   +++||||||+||++++++.+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          80 EYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99999999999976432 2578999999999999999999998   9999999999999999999999999999866433


Q ss_pred             CCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHh
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQEL  668 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l  668 (701)
                      ... .....++..|+|||...+..++...  |+||+|++++++++ +. |....+..++.+.+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~  216 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQV  216 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchh--hHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence            221 1123456789999998777776665  99999999998776 44 33333344444443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=1e-31  Score=283.78  Aligned_cols=199  Identities=24%  Similarity=0.359  Sum_probs=162.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCL  519 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (701)
                      .+.++|++.+.||+|+||.||+|...      +++.||+|+++....  ....+.+.+|+.++.++ +|+||+++++++.
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            34568999999999999999999532      357899999875432  22346678899999999 7999999999886


Q ss_pred             eC-cEEEEEEEccCCCCHHHHHhcCCC-----------------------------------------------------
Q 041034          520 HK-RCMFFIYEYMERGSLFYVLRDDDE-----------------------------------------------------  545 (701)
Q Consensus       520 ~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  545 (701)
                      .. ...+++|||+++++|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            54 568899999999999999864321                                                     


Q ss_pred             -----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC--ceeeccc
Q 041034          546 -----AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGT  618 (701)
Q Consensus       546 -----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt  618 (701)
                           ...+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+++.+......  .....++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 12578999999999999999999998   9999999999999999999999999999876432221  1223456


Q ss_pred             ccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          619 YGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       619 ~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..|+|||++.+..++.+.  ||||+|+++++|+.
T Consensus       239 ~~y~aPE~~~~~~~~~~~--Di~SlGv~l~el~t  270 (337)
T cd05054         239 LKWMAPESIFDKVYTTQS--DVWSFGVLLWEIFS  270 (337)
T ss_pred             ccccCcHHhcCCCCCccc--cHHHHHHHHHHHHH
Confidence            789999999888887776  99999999997553

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-31  Score=269.27  Aligned_cols=199  Identities=26%  Similarity=0.392  Sum_probs=169.1

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETED--SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ++|++.+.||+|++|.||.|.. .++++||+|.+.......  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999965 468999999987543221  2234678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999987654   478899999999999999999999   99999999999999999999999999997654


Q ss_pred             cCCCCc---eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          607 VDSSNR---TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       607 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ......   ....++..|+|||...+...+.+.  |+||+|+++++++.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~~p  206 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA--DVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchh--hhHHHHHHHHHHHhCCCC
Confidence            321111   234578899999999887766665  999999999999988643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.1e-31  Score=278.41  Aligned_cols=197  Identities=23%  Similarity=0.376  Sum_probs=162.6

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ....++|++.+.||+|+||.||+|...      ....||+|.+.....  .....++.+|+.+++++ +|+||+++++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345678999999999999999999653      236799999876432  22346688999999999 799999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcC-------------CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDD-------------DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      ...+..+++|||+++|+|.++++..             .....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            9999999999999999999998643             1233688999999999999999999998   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      |++++++.+||+|||.++........  .....++..|+|||...+..++.+.  ||||+|+++|+
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~e  226 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLLWE  226 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccc--ceeehhhHHHH
Confidence            99999999999999999876432211  1112345679999998777777665  99999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=2.4e-31  Score=270.06  Aligned_cols=210  Identities=22%  Similarity=0.346  Sum_probs=173.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||++... +++.||+|.++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            5889999999999999999654 689999999865432  2335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.++++|||.++......
T Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999999886532 22578999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHh
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQEL  668 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l  668 (701)
                      .......+++.|+|||+..+...+.+.  |+||+|+++++++.+. |....+..+....+
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~--Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~  212 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKS--DIWSLGCILYELCTLKHPFQANSWKNLILKV  212 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchh--hhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence            333445689999999998877666655  9999999999877765 33333444444333

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=2.4e-31  Score=270.91  Aligned_cols=212  Identities=25%  Similarity=0.406  Sum_probs=172.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.++||+|+||.||+|...+++.||+|.+......    .+.+.+|+.++++++|+||+++++++. .+..+++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            45789999999999999999998888899999998765432    357889999999999999999999874 4568999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++..... ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            999999999999876432 3689999999999999999999998   999999999999999999999999999987652


Q ss_pred             CCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CCC-CCCCCHHHHHHHhhc
Q 041034          608 DSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SKP-KSRPTMQRISQELEG  670 (701)
Q Consensus       608 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~P-~~Rpt~~~i~~~l~~  670 (701)
                      ... ......++..|+|||.+....++.+.  |+||+|+++++++. +.+ ....+..++.+.+..
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~--Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  218 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKS--DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER  218 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCccc--chHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Confidence            221 12223456789999998777766655  99999999999886 553 333444555555443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=8.1e-32  Score=274.13  Aligned_cols=194  Identities=32%  Similarity=0.497  Sum_probs=165.4

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |++.+.||+|+||.||+|... +++.||+|++......... .....+|+.++++++||||+++++++.+....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            678999999999999999665 5778999999887543322 23345699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +++++|.+++....   .+++..+..++.|+++||++||+.   +++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999998333   589999999999999999999999   999999999999999999999999999976433333


Q ss_pred             CceeecccccccCCCCCC-CCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          611 NRTLRAGTYGYIAPDQRL-SPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~-~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ......++..|+|||... +...+.+.  |+||+|+++++++.+.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~--Di~slG~il~~l~~~~  196 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKS--DIWSLGIILYELLTGK  196 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHH--HHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccccccccccccccc--cccccccccccccccc
Confidence            444567899999999987 55565555  9999999999877764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.4e-31  Score=282.33  Aligned_cols=199  Identities=24%  Similarity=0.340  Sum_probs=167.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.............+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999654 68899999987543222333456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999976432  588899999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCC-ceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ... .....||+.|+|||++.+     ..++.+.  |+||+|+++|+++.+.+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~--DiwSlGvil~ell~g~~  206 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC--DWWSLGVCMYEMLYGET  206 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcc--cEEeeehhhhhhhhCCC
Confidence            322 223469999999998765     2344444  99999999999998864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=2.3e-31  Score=271.00  Aligned_cols=196  Identities=27%  Similarity=0.453  Sum_probs=163.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.+.||+|+||.||+|...++..||+|.+......    .+.+.+|+.++++++|++++++++++. ....+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            34679999999999999999998878888999999765432    256889999999999999999999875 4567899


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.++++.... ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.+..+..
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            999999999999976432 2589999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC
Q 041034          608 DSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK  654 (701)
Q Consensus       608 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~  654 (701)
                      .... .....++..|+|||...+...+.+.  |+||+|+++++++. +.
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~l~~~g~  201 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELVTKGR  201 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchh--hhHHHHHHHHHHHhcCC
Confidence            2211 1122355679999998776666555  99999999998775 44

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-33  Score=286.81  Aligned_cols=211  Identities=26%  Similarity=0.419  Sum_probs=180.6

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCc-EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ++.+-|.++..||.|+||.||+|..++.. ..|.|++.-..   ..-.+++.-|+.||+.++||+||++++.|...+..|
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            44567888999999999999999665544 45666664432   344688999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |+.|||.||-...++-.-+.  .+++.++.-+++|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+...
T Consensus       106 iliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             EEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence            99999999999888876544  589999999999999999999999   9999999999999999999999999998766


Q ss_pred             ccCCCCceeecccccccCCCCCC-----CCcCChhhHHHHHHHHHHHHH-------------------------------
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRL-----SPPVNQKIIQDIILVSTTALA-------------------------------  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~~Di~slg~i~~~-------------------------------  649 (701)
                      .........+.|||+|||||+..     ..+|+..+  ||||||+.+.+                               
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyka--DiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKA--DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP  258 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhh--hHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence            55555666789999999999765     45677776  99999999874                               


Q ss_pred             -------------cccCCCCCCCCHHHHHHH
Q 041034          650 -------------CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~~  667 (701)
                                   |+..+|..||+++++++.
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                         899999999999888764

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.6e-31  Score=273.21  Aligned_cols=196  Identities=30%  Similarity=0.429  Sum_probs=167.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.++.....   ....+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            46789999999999999999955 46899999998765322   235678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++.++..++.|++.|++|||+.   |++|+||||+||+++.++.+||+|||.+.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999987654   588999999999999999999999   999999999999999999999999999976643


Q ss_pred             CCCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........|++.|+|||.+.   ...++.+  .|+||+|+++++++.+.+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~--~DvwSlG~il~~l~~~~~  207 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL--CDIWAVGITAIELAELQP  207 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCch--hhhHHHHHHHHHHhcCCC
Confidence            333334457899999999874   3334444  499999999999988764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=2e-31  Score=281.42  Aligned_cols=211  Identities=25%  Similarity=0.327  Sum_probs=171.4

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||++... +++.||+|++.+...........+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999665 57889999986533222333456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++.+...  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999976432  588999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCC-ceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      ... .....||+.|+|||++..     ..++.+.  |+||+|+++|+++.+. |....+..+....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~--DvwSlGvil~ell~g~~Pf~~~~~~~~~~~  219 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPEC--DWWSLGVCMYEMLYGETPFYAESLVETYGK  219 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcC--CEEeeHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            222 223569999999998763     2344444  9999999999999887 4333344443333

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=3.5e-31  Score=274.00  Aligned_cols=195  Identities=25%  Similarity=0.467  Sum_probs=161.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ..+|.+.+.||+|+||.||+|..      .++..+|+|.+....   ....+.+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            35789999999999999999963      234568999886542   233567899999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCC----------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDD----------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL  592 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~  592 (701)
                      ..++||||+++++|.+++....          ....+++..+..++.|++.||+|||++   |++||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            9999999999999999987542          122489999999999999999999998   999999999999999999


Q ss_pred             CeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          593 EAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      .+||+|||.++.......  ......++..|+|||++.+..++.+.  |+||+|+++++++
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s--DiwslG~il~~l~  216 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES--DVWSLGVVLWEIF  216 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchh--hHHHHHHHHHHHH
Confidence            999999999986532221  11223357789999998877666655  9999999999644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=2.2e-31  Score=286.09  Aligned_cols=200  Identities=23%  Similarity=0.357  Sum_probs=164.0

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFC  518 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  518 (701)
                      ....++|.+.+.||+|+||.||+|.+.      .++.||+|+++.....  ...+.+.+|+.++.++. ||||+++++++
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            445567889999999999999999743      3468999999764332  22457889999999997 99999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-----------------------------------------------------
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-----------------------------------------------------  545 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  545 (701)
                      ...+..++||||+++|+|.+++++...                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999865321                                                     


Q ss_pred             ------------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          546 ------------------------------------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       546 ------------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                                                                ...+++..+..++.|++.||+|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                      12367788899999999999999988   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +||++++++.+||+|||+++.......  ......+++.|+|||.+.+..+..+.  |+||+|+++++++.
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslGvil~e~l~  336 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS--DVWSFGILLWEIFT  336 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh--HHHHHHHHHHHHHH
Confidence            999999999999999999986532221  11223567889999999877766654  99999999998665

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=2.8e-31  Score=275.05  Aligned_cols=200  Identities=28%  Similarity=0.420  Sum_probs=162.8

Q ss_pred             cCCccceEEeeccceEEEEEEc-C-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC---CCCceeeeeeeee-----
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-P-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVKLYGFCL-----  519 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  519 (701)
                      ++|++.+.||+|+||.||+|.. . +++.||+|+++....... ....+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            4799999999999999999965 3 468899999876443221 224456677776665   6999999999885     


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      .....++||||++ ++|.+++...... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            2456899999997 5999998764322 488999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSR  658 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~R  658 (701)
                      |+++..... .......||+.|+|||.+.+..++.+.  ||||+|+++|+++.+.|..+
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~~f~  210 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRKPLFR  210 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCCCCCcc--chHHHHHHHHHHHcCCCCcC
Confidence            999876433 223345689999999999877777665  99999999999999887543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=3.8e-31  Score=270.55  Aligned_cols=212  Identities=27%  Similarity=0.398  Sum_probs=169.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-C---CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-D---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|... +   +..+|+|.++....  ....+.+.+|+.++++++||||+++++++.+++..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            357899999999999999999653 2   34799999875432  23356889999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++.....  .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.+..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            999999999999999976532  578999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCCce---eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhh
Q 041034          605 LHVDSSNRT---LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELE  669 (701)
Q Consensus       605 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~  669 (701)
                      .........   ...++..|+|||...+..++.+.  |+|++|+++++++. +. |...-+..++...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~--Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  223 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS--DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE  223 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchh--hhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh
Confidence            653322111   11235679999999877766665  99999999998664 44 333333344444443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=4.2e-31  Score=272.84  Aligned_cols=194  Identities=26%  Similarity=0.437  Sum_probs=159.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--C
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--K  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  521 (701)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++....   ....+.+.+|++++++++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            35789999999999999999963     357899999987543   2335678999999999999999999998754  3


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   |++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence            468999999999999999975432  488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCc---eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDSSNR---TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ++.........   ....++..|+|||+..+..++.+.  |+||+|+++++++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~  206 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVAS--DVWSFGVVLYELFT  206 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHH--HHHHHHHHHHHHhh
Confidence            98764332211   111234469999998777666654  99999999886554

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.1e-31  Score=275.37  Aligned_cols=211  Identities=22%  Similarity=0.350  Sum_probs=167.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC---------------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD---------------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK  513 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  513 (701)
                      ..+|++.+.||+|+||.||+|...+               ...||+|+++....  ....+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence            4689999999999999999986532               23589999876432  233567899999999999999999


Q ss_pred             eeeeeeeCcEEEEEEEccCCCCHHHHHhcCCC---------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 041034          514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE---------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSN  584 (701)
Q Consensus       514 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~  584 (701)
                      +++++...+..++||||+++++|.+++.....         ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999999865321         12368899999999999999999998   9999999999


Q ss_pred             cEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc--C-CCCCCC
Q 041034          585 NILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR--S-KPKSRP  659 (701)
Q Consensus       585 NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~--~-~P~~Rp  659 (701)
                      ||++++++.+||+|||+++........  .....++..|+|||......++.+.  |+||+|+++++++.  + .|....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS--DVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh--hHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999999765322111  1122356789999998877776665  99999999998764  2 244444


Q ss_pred             CHHHHHH
Q 041034          660 TMQRISQ  666 (701)
Q Consensus       660 t~~~i~~  666 (701)
                      +..++.+
T Consensus       237 ~~~~~~~  243 (295)
T cd05097         237 SDEQVIE  243 (295)
T ss_pred             ChHHHHH
Confidence            4444443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=3.7e-31  Score=276.03  Aligned_cols=197  Identities=23%  Similarity=0.383  Sum_probs=162.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc--------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ..++|.+.+.||+|+||.||+|+.        .++..||+|.+.....  ....+.+.+|+.+++.+ +||||+++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            456789999999999999999953        1345799998875432  23346788999999999 799999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      ......++||||+++|+|.+++.....             ...+++.++..++.||++||+|||++   |++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            999999999999999999999976421             13578899999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      |++++++.+||+|||+++........  .....+++.|+|||+..+..++.+.  ||||+|+++++++
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~  233 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLMWEIF  233 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchh--hHHHHHHHHHHHH
Confidence            99999999999999999876432221  1223456789999999877776664  9999999998644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=8e-31  Score=266.38  Aligned_cols=190  Identities=27%  Similarity=0.461  Sum_probs=163.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .++|++.+.||+|+||.||+|... ++.||+|.+.....    ..+++.+|+.+++.++|+||+++++++.+....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            467899999999999999999764 78999999976543    3577899999999999999999999999889999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...... .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            999999999999765432 589999999999999999999999   9999999999999999999999999999876322


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..   ....+..|+|||......++.+.  |+||+|+++++++.
T Consensus       156 ~~---~~~~~~~~~ape~~~~~~~~~~~--Di~slG~il~~l~~  194 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREKKFSTKS--DVWSFGILLWEIYS  194 (256)
T ss_pred             cc---cCCCcccccCchhhcCCcCCcHH--HHHHHHHHHHHHHh
Confidence            11   23356679999998777666554  99999999987653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=3.7e-31  Score=274.96  Aligned_cols=213  Identities=25%  Similarity=0.364  Sum_probs=170.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-----------------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCce
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-----------------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (701)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+......  ...+.+.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            4689999999999999999986532                 245899998765432  345788999999999999999


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCC--------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE--------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      +++++++..++..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence            9999999999999999999999999999876431        12588999999999999999999998   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc---CCCCCC
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR---SKPKSR  658 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~---~~P~~R  658 (701)
                      +||+++.++.++|+|||+++.......  ......+++.|+|||...+..++.+.  ||||+|+++|+++.   ..|...
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS--DVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccc--hhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999976532221  11223467789999998776666665  99999999998664   224444


Q ss_pred             CCHHHHHHHh
Q 041034          659 PTMQRISQEL  668 (701)
Q Consensus       659 pt~~~i~~~l  668 (701)
                      .+..++.+.+
T Consensus       237 ~~~~~~~~~~  246 (296)
T cd05051         237 LTDQQVIENA  246 (296)
T ss_pred             cChHHHHHHH
Confidence            4444444433

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=5e-31  Score=272.39  Aligned_cols=200  Identities=25%  Similarity=0.361  Sum_probs=166.7

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|... +++.||+|+++..... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            5888999999999999999654 6899999998754322 2224667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |++ ++|.+++........+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 58988887654434689999999999999999999998   99999999999999999999999999997664333


Q ss_pred             CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .......+++.|+|||.+.+.. ++.+  .|+||+|+++++++.+.|..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~il~~l~tg~~~~  202 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTP--VDIWSIGTIFAEMATKKPLF  202 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcH--HHHHHHHHHHHHHHHCCCCC
Confidence            3333345788999999876543 3444  49999999999999887543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=2e-31  Score=277.87  Aligned_cols=194  Identities=27%  Similarity=0.429  Sum_probs=157.4

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCc--EEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGK--VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|... ++.  .+|+|.++...  .....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            467899999999999999999654 454  45777765432  233356788999999999 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          525 FFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      |+||||+++++|.++++....             ...+++.+++.++.|++.|++|||++   |++||||||+||+++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999975421             12578999999999999999999998   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      +.+||+|||+++...... ......++..|+|||...+..++.+.  ||||+|++++++
T Consensus       161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el  216 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNS--DVWSYGVLLWEI  216 (303)
T ss_pred             CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccc--cchhhhhHHHHH
Confidence            999999999986432111 11112346679999998777666654  999999998853

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=4.2e-31  Score=272.06  Aligned_cols=211  Identities=24%  Similarity=0.389  Sum_probs=170.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++|++.+.||+|+||+||+|.+. +++    .|++|.+....  ......++..|+.++++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            57888999999999999999653 444    47777775432  22334677888889999999999999998764 457


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++++||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            889999999999999976432  589999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------------
Q 041034          605 LHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------------  649 (701)
Q Consensus       605 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------------  649 (701)
                      ......  ......++..|+|||...+..++.+.  |+||+|+++|+                                 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~--Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQS--DVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC  236 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchh--hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCC
Confidence            643222  12234467789999999877776665  99999999985                                 


Q ss_pred             ----------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 ----------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 ----------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                |+..+|.+||++.|+++.+..
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                      666677777777777776655

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=3.4e-31  Score=272.74  Aligned_cols=191  Identities=26%  Similarity=0.450  Sum_probs=158.3

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|++.+.||+|+||+||+|.+ .+++    .||+|+++....  ....+.+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            46789999999999999999964 3444    489999875432  33456788999999999999999999998754 4


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .+++|||+++|+|.+++.....  .+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            7799999999999999976432  588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          604 LLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       604 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ........  .....+++.|+|||...+..++.+.  ||||+|+++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~~l~e  203 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQS--DVWSYGVTVWE  203 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchh--HHHHHHHHHHH
Confidence            76432221  1112346789999999887777665  99999999986

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=2.4e-31  Score=274.50  Aligned_cols=196  Identities=22%  Similarity=0.326  Sum_probs=160.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .+|++.+.||+|+||.||+|...      +++.||+|+++....  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            35788899999999999999642      357899999975432  3345678899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          524 MFFIYEYMERGSLFYVLRDDD-------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      .++++||+++++|.+++....             ....+++..+..++.|++.||+|+|++   |++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999999985321             112478889999999999999999998   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          591 NLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ++.+||+|||+++........  .....+++.|+|||+..+..++.+.  ||||+|+++++++.
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~~l~el~~  221 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS--DIWSYGVVLWEVFS  221 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch--hHHHHHHHHHHHHc
Confidence            999999999998865322211  1223457789999998777766665  99999999997543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.8e-31  Score=280.17  Aligned_cols=203  Identities=22%  Similarity=0.268  Sum_probs=169.1

Q ss_pred             eEEeeccceEEEEEEc----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          456 YCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      +.||+|+||.||+++.    .+|+.||+|++...... ......+.+|++++++++||||+++++++.+++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            6799999999999854    35889999999764322 122355678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN  611 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~  611 (701)
                      ++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            9999999986543   589999999999999999999999   9999999999999999999999999999866443333


Q ss_pred             ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          612 RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       612 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      .....||+.|+|||.+.+..++.+.  ||||+|+++|+++.+. |....+..++...
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~--DiwslG~il~el~tg~~p~~~~~~~~~~~~  209 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGSLPFQGKDRKETMTM  209 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCcc--ceeccceEeeeeccCCCCCCCCCHHHHHHH
Confidence            3445799999999999887776665  9999999999999886 4444444444443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=3.7e-31  Score=271.35  Aligned_cols=200  Identities=27%  Similarity=0.443  Sum_probs=165.7

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC--
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHK--  521 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--  521 (701)
                      +.+.+.|++.+.||+|+||.||+|... +++.||+|++......    ...+.+|+.+++++ +||||+++++++...  
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            346778999999999999999999654 6889999998754322    25678899999998 699999999998753  


Q ss_pred             ----cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          522 ----RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       522 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                          ...++||||+++++|.+++..... ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence                468999999999999999876432 2588999999999999999999998   99999999999999999999999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCC-----cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-----PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |||++..............|++.|+|||.+.+.     .++..  .|+||+|+++++++++.+
T Consensus       154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~--~Dv~slGv~l~el~~g~~  214 (272)
T cd06637         154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK--SDLWSLGITAIEMAEGAP  214 (272)
T ss_pred             cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCch--hhHHHHHHHHHHHHhCCC
Confidence            999998664333333445789999999987632     33334  599999999999888764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=5.4e-31  Score=273.58  Aligned_cols=196  Identities=26%  Similarity=0.411  Sum_probs=168.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...+|++.+.||+|++|.||+|.. .+++.||+|.+.......   .+.+.+|+.+++.++||||+++++.+......++
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            356899999999999999999964 468999999987654332   3668899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++...    .+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||.+....
T Consensus        95 v~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            99999999999998653    478899999999999999999999   99999999999999999999999999988654


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..........+++.|+|||...+...+.+.  |+|++|+++++++.+.+
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~s~Gvil~~l~~g~~  214 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV--DIWSLGIMAIEMIEGEP  214 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCCCCCccc--hHHHHHHHHHHHHhCCC
Confidence            433333445689999999998877666655  99999999998776653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=3.5e-31  Score=280.82  Aligned_cols=197  Identities=23%  Similarity=0.353  Sum_probs=159.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLH  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  520 (701)
                      ..++|++.+.||+|+||.||+|..      .+++.||||+++.....  .....+.+|+.++.++ +||||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            457899999999999999999953      35788999999764322  2346788999999999 68999999998865


Q ss_pred             C-cEEEEEEEccCCCCHHHHHhcCCC------------------------------------------------------
Q 041034          521 K-RCMFFIYEYMERGSLFYVLRDDDE------------------------------------------------------  545 (701)
Q Consensus       521 ~-~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  545 (701)
                      . ...++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 467899999999999999864310                                                      


Q ss_pred             ----------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC--ce
Q 041034          546 ----------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN--RT  613 (701)
Q Consensus       546 ----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~  613 (701)
                                ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++........  ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      12367888999999999999999998   9999999999999999999999999999865322211  11


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ...+++.|+|||...+..++.+.  |+|++|+++++++
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~  275 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEIF  275 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchh--hHHHHHHHHHHHH
Confidence            22356779999998877776665  9999999998755

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.8e-31  Score=278.71  Aligned_cols=212  Identities=25%  Similarity=0.388  Sum_probs=186.2

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      .....|.+...||+|.|+.|..|++. ++..||+|.+.+....... ...+.+|+++|..++|||||+++.+.......|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            34678999999999999999999654 6999999999887765443 455899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+.+|.+++++...+   ++.+..+..++.|+.+|++|||++   .|||||||++||+++.+..+||+|||++..+
T Consensus       132 lV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            9999999999999998877   455688899999999999999999   9999999999999999999999999999988


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                      .. .......+|++.|+|||.+.+..++... .|+|++|+++|.                                    
T Consensus       206 ~~-~~~lqt~cgsppyAaPEl~~g~~y~gpe-~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce  283 (596)
T KOG0586|consen  206 DY-GLMLQTFCGSPPYAAPELFNGKKYDGPE-VDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCE  283 (596)
T ss_pred             cc-cccccccCCCCCccChHhhcCcccCCcc-eehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhH
Confidence            73 4445567899999999999999877654 499999999983                                    


Q ss_pred             -----cccCCCCCCCCHHHHHHH
Q 041034          650 -----CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -----cl~~~P~~Rpt~~~i~~~  667 (701)
                           ++..+|.+|++++++++.
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhhh
Confidence                 566888889988888764

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=5.5e-31  Score=273.69  Aligned_cols=196  Identities=27%  Similarity=0.410  Sum_probs=169.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...+|++.+.||+|++|.||+|.. .+++.||+|.+.......   .+.+.+|+.+++.++||||+++++++..++..++
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            457899999999999999999965 579999999987644322   3667899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++.+.    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.+....
T Consensus        94 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          94 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             eecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            99999999999998653    478899999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..........+++.|+|||...+...+.+.  |+||+|+++++++.+.+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slGvil~~l~tg~~  213 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV--DIWSLGIMAIEMVEGEP  213 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcCCCCCcHH--HHHHHHHHHHHHHhCCC
Confidence            443333445688999999998877766654  99999999998766553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.3e-31  Score=268.45  Aligned_cols=197  Identities=26%  Similarity=0.475  Sum_probs=167.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.+.||+|+||.||+|...+++.||||.+......    .+++.+|+.++++++|+||+++++++......++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            45789999999999999999998777889999998764432    36788999999999999999999999988899999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.... ...+++..+..++.|++.|++|||++   +++|+||||+||++++++.+||+|||.++....
T Consensus        80 ~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          80 TEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999997643 23589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC
Q 041034          608 DSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK  654 (701)
Q Consensus       608 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~  654 (701)
                      .... .....++..|+|||...+...+.+.  |+||+|++++++++ +.
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~il~~l~t~g~  202 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKS--DVWSFGILLTEIVTYGR  202 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchh--HHHHHHHHHHHHHhCCC
Confidence            2111 1122345689999998877666654  99999999998775 44

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=3.9e-31  Score=274.06  Aligned_cols=216  Identities=26%  Similarity=0.457  Sum_probs=176.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ..+|.+.+.||+|+||.||+|..      .++..+++|.+....   ....+.+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            35688899999999999999953      235568999886543   233467889999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      ..++||||+++++|.+++.....             ...+++..++.++.|++.||+|||++   +++||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence            99999999999999999975321             12488999999999999999999999   999999999999999


Q ss_pred             CCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------
Q 041034          590 SNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------  649 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------  649 (701)
                      .++.++|+|||+++.......  ......++..|+|||.+.+..++.+.  ||||+|+++++                  
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES--DVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999976543221  11223467889999998877776665  99999999985                  


Q ss_pred             -------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                               |+..+|.+||++.++++.++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         236 ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                                     66777777777777777776553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.4e-31  Score=272.38  Aligned_cols=198  Identities=20%  Similarity=0.307  Sum_probs=164.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||.||+|...      .++.||+|.+.....  ......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            3568999999999999999999653      246899999865432  23346788999999999999999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCC-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDE-------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA  594 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~  594 (701)
                      ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            999999999999999999875322       12478899999999999999999998   99999999999999999999


Q ss_pred             EEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          595 FVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       595 kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||+|||+++.......  ......++..|+|||...+...+.+.  |+||+|++++++++
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~t  216 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKS--DVWSFGVVLWEMAT  216 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCccc--chHHHHHHHHHhhc
Confidence            9999999976543221  12233467889999998777666665  99999999998664

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=5.5e-31  Score=273.67  Aligned_cols=210  Identities=22%  Similarity=0.370  Sum_probs=166.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-----------------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCce
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-----------------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (701)
                      .++|++.+.||+|+||.||+|...                 ++..||+|++.....  ....+.+.+|+.+++.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence            467999999999999999998532                 234689999875432  3345788999999999999999


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCC--------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE--------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      +++++++...+..++||||+++++|.+++.....        ...+++.++..++.|++.||+|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence            9999999999999999999999999999876421        12477889999999999999999999   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc---CCCCCC
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR---SKPKSR  658 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~---~~P~~R  658 (701)
                      +||+++.++.++|+|||+++.+.....  ......++..|+|||...+..++.+.  |+||+|+++|+++.   ..|...
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~--DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS--DVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchh--hhhHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999999986533221  11122346789999987777766655  99999999998764   234444


Q ss_pred             CCHHHHH
Q 041034          659 PTMQRIS  665 (701)
Q Consensus       659 pt~~~i~  665 (701)
                      .+..++.
T Consensus       237 ~~~~~~~  243 (296)
T cd05095         237 LSDEQVI  243 (296)
T ss_pred             cChHHHH
Confidence            4444433

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=9.2e-31  Score=265.87  Aligned_cols=198  Identities=23%  Similarity=0.318  Sum_probs=170.0

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|+..+.||+|+||.||.++. .+++.|++|.+....... ...+++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            588999999999999999954 468999999987554322 335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999997653 23589999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......+++.|+|||...+...+.+.  |+||+|+++++++.+.+
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~--Dv~slG~i~~~l~~g~~  199 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKS--DIWALGCVLYELLTLKR  199 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcc--hhHHHHHHHHHHHHCCC
Confidence            333445689999999998877666554  99999999999887754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=5.3e-31  Score=272.06  Aligned_cols=200  Identities=24%  Similarity=0.315  Sum_probs=169.7

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+...........+.+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377889999999999999955 4689999999876544444444567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999998865432 2588999999999999999999998   99999999999999999999999999997654222


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                       ......|+..|+|||.+.+..++.+.  |+||+|+++++++.+.+..
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~--DiwslG~~l~~l~~g~~Pf  201 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSP--DWWALGCLLYEMIAGQSPF  201 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCcc--ccHHHHHHHHHHHhCCCCC
Confidence             22334689999999999887777665  9999999999999887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1e-30  Score=267.56  Aligned_cols=205  Identities=27%  Similarity=0.377  Sum_probs=167.0

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ++.+++++.....||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++..++.
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            345667777778999999999999964 4678899998875432   234678899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEeecCc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTA  602 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DFGla  602 (701)
                      .++||||+++++|.+++.........++..+..++.|++.||+|||++   +|+||||||+||+++. ++.++|+|||.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999999997643221237888999999999999999998   9999999999999976 679999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..............+++.|+|||.+...........|+||+|+++++++.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~  209 (268)
T cd06624         157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP  209 (268)
T ss_pred             eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCC
Confidence            76643333333345889999999986654323334599999999999887653

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=8.8e-31  Score=266.75  Aligned_cols=193  Identities=26%  Similarity=0.448  Sum_probs=160.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .++|.+.+.||+|++|.||+|...++..||+|.+.....    ..+.+.+|+.++++++|||++++++++. .+..++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            467899999999999999999877777899998875432    2366888999999999999999999875 45688999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.++++.... ..+++..+..++.|++.||+|||+.   |++|+||||+||++++++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          80 EFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999999999976432 2578999999999999999999998   9999999999999999999999999999866432


Q ss_pred             CCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ... .....++..|+|||...+...+.+.  |+||+|+++++++.
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~--Di~slG~~l~el~t  198 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELVT  198 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHH--HHHHHHHHHHHHHh
Confidence            211 1123456789999988776666554  99999999998775

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=8.3e-31  Score=265.21  Aligned_cols=188  Identities=25%  Similarity=0.406  Sum_probs=157.5

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCC
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS  535 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  535 (701)
                      +.||+|+||.||+|...+++.||+|.+.....  ......+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999877889999999876542  2334568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC-cee
Q 041034          536 LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN-RTL  614 (701)
Q Consensus       536 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~  614 (701)
                      |.+++.....  .+++..+..++.|++.||.|+|++   |++||||||+||+++.++.+||+|||++......... ...
T Consensus        79 L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          79 FLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            9999875432  478999999999999999999998   9999999999999999999999999999754322111 112


Q ss_pred             ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          615 RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..++..|+|||...+..+..+.  |+||+|+++++++.
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~--Di~slG~ll~~~~~  189 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSES--DVWSYGILLWETFS  189 (250)
T ss_pred             CCCcccccCHHHhccCCCCchh--HHHHHHHHHHHHhc
Confidence            2346779999998777666554  99999999997654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=4.7e-31  Score=272.71  Aligned_cols=207  Identities=24%  Similarity=0.391  Sum_probs=169.3

Q ss_pred             ccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          440 ILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       440 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      +.++.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|++......    ...+.+|+.+++.+ +||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            45666777899999999999999999999955 46889999987653221    25677899999999 69999999998


Q ss_pred             ee-----eCcEEEEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          518 CL-----HKRCMFFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       518 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      +.     .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.   +++||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence            74     345789999999999999987642 1223588999999999999999999998   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCCC-----cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-----PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.+||+|||+++.............|++.|+|||.+...     .++.+  .|+||+|+++++++.+.+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Dv~slGvi~~el~~g~~  227 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR--CDVWSLGITAIELGDGDP  227 (286)
T ss_pred             CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccch--hhhhhHHHHHHHHhcCCC
Confidence            999999999998765433333445689999999987532     23334  499999999999887764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=5.8e-31  Score=274.95  Aligned_cols=198  Identities=24%  Similarity=0.366  Sum_probs=161.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC--------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP--------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ..++|.+.+.||+|+||.||+|...        +...||+|.++....  ......+.+|+.+++.+ +||||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3467999999999999999999642        235699999976432  22246788899999999 799999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      ...+..|+||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   |++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999976431             12488999999999999999999998   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |++++++.+||+|||.++........  .....+++.|+|||+..+..++.+.  |+||+|+++|+++.
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~~l~el~~  237 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS--DVWSFGVLLWEIFT  237 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHH--HHHHHHHHHHHHHc
Confidence            99999999999999999765422111  1112345689999998877666554  99999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=301.27  Aligned_cols=218  Identities=27%  Similarity=0.448  Sum_probs=184.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC--CCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP--DGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .++.+....||+|+||.||.|...  ++.    .||||.+++...  .....+|.+|..+|+.++||||++++|++.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            456677889999999999999654  343    489998887543  344688999999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCC----CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          523 CMFFIYEYMERGSLFYVLRDDD----EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                      ..+|++|||++|+|..++++..    ....++..+.+.++.|||+|+.||+++   ++|||||.++|+|++....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999998752    133588999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccc-cCCCCceee-cccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------
Q 041034          599 FGTARLLH-VDSSNRTLR-AGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------  649 (701)
Q Consensus       599 FGla~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------  649 (701)
                      ||+|+.+. .+....... .-...|||||.+....++.+.  ||||||+++||                           
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskS--DvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKS--DVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhccccccc--chhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            99999443 222222222 223579999999998888886  99999999995                           


Q ss_pred             ----------------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 ----------------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 ----------------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                                      ||+.+|++||++..+++++.....
T Consensus       924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                            999999999999999998776553

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.1e-31  Score=280.92  Aligned_cols=187  Identities=24%  Similarity=0.314  Sum_probs=159.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...+|++.+.||+|+||.||+|... +++.||+|+....         ....|+.++++++||||+++++++.+....++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999664 5788999975432         23468999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+. ++|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999995 588888865432  589999999999999999999999   99999999999999999999999999997543


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .. .......||+.|+|||++.+..++.+.  ||||+|+++|+++.
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvvl~ell~  251 (357)
T PHA03209        209 VA-PAFLGLAGTVETNAPEVLARDKYNSKA--DIWSAGIVLFEMLA  251 (357)
T ss_pred             cC-cccccccccccccCCeecCCCCCCchh--hHHHHHHHHHHHHH
Confidence            22 222335699999999999888877765  99999999999875

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.4e-30  Score=268.09  Aligned_cols=189  Identities=23%  Similarity=0.325  Sum_probs=162.7

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            4688999999999999999954 5789999999875432  233467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|..+.       .+++..+..++.|++.||+|||+.   ||+|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999996542       367888999999999999999999   9999999999999999999999999999765422


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                        ......++..|+|||.+.+..++.+.  |+||+|+++++++.+.
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~~l~~l~~g~  190 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHS--DVWSLGISFMELALGR  190 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcc--hHHHHHHHHHHHHhCC
Confidence              22335789999999999887776665  9999999999887765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=8.1e-31  Score=270.74  Aligned_cols=198  Identities=22%  Similarity=0.298  Sum_probs=168.3

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.............+.+|+++++.++|+||+++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67789999999999999955 46899999998765443333345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            999999988865432 2589999999999999999999998   99999999999999999999999999997653222 


Q ss_pred             CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          611 NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ......|+..|+|||.+.+..++.+.  |+||+|+++++++.+.+.
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~--Di~slG~~l~~l~~g~~P  200 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSP--DYWGLGCLIYEMIEGQSP  200 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCccc--chHHHHHHHHHHHhCCCC
Confidence            22334689999999999887777665  999999999998887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=6.4e-31  Score=271.44  Aligned_cols=194  Identities=22%  Similarity=0.377  Sum_probs=161.5

Q ss_pred             cCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--c
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--R  522 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  522 (701)
                      .-|++.+.||+|+||.||.|..     .+++.||+|.++....  ....+.+.+|+.+++.++||||+++++++.+.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3478899999999999999963     3578899999875432  33456789999999999999999999998775  5


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++++|.+++.+...  .+++..+..++.|++.||+|||+.   |++||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            68999999999999999865432  489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          603 RLLHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       603 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +.+......   .....++..|+|||...+..++.+.  ||||+|+++++++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~--Di~slG~il~ellt  207 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS--DVWSFGVTLYELLT  207 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccc--cchhhhhhhhhhhc
Confidence            876433221   1223466789999998777666665  99999999887654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=9.7e-31  Score=265.90  Aligned_cols=204  Identities=22%  Similarity=0.358  Sum_probs=161.6

Q ss_pred             EEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          457 CIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      .||+|+||.||+|.+.   ++..||+|++.....  ....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            3899999999999553   355799999876532  344577899999999999999999999875 4568999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      ++|.+++.....  .+++..+.+++.|++.||+|||++   |++||||||+||+++.++.+||+|||+++..........
T Consensus        79 ~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          79 GPLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            999999875432  589999999999999999999998   999999999999999999999999999986543322211


Q ss_pred             ---eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhhc
Q 041034          614 ---LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       614 ---~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~~  670 (701)
                         ...++..|+|||......++.+.  |+||+|+++++++. +. |....+..++...+..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  213 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRS--DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ  213 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchh--hHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence               11235689999998777766665  99999999998664 33 4444444555554443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=7.4e-31  Score=271.86  Aligned_cols=194  Identities=23%  Similarity=0.382  Sum_probs=158.9

Q ss_pred             CCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.....  ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4788999999999999999542      235788888875432  23346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC---------------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          525 FFIYEYMERGSLFYVLRDDD---------------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      ++||||+++++|.+++....                     ....+++..+..++.|++.||+|||+.   +++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            99999999999999986421                     113578999999999999999999998   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +||++++++.+||+|||+++.......  ......++..|+|||...+..++.+.  ||||+|+++++++
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~--Di~slG~~l~el~  223 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS--DVWSFGVLLWEIV  223 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHh--HHHHHHHHHHHHH
Confidence            999999999999999999986533221  11223456789999998777666655  9999999988644

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=276.41  Aligned_cols=195  Identities=26%  Similarity=0.379  Sum_probs=168.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      .+.+...++++||+|-||+|..+....+..||||+++.....  ..+++|.+|+++|.+++||||++++|+|..++.+++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            456677889999999999999998877899999999987654  346899999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |+|||++|+|.+++.+..... .......+|+.|||.|++||.+.   ++||||+.+.|+|+|.++++||+|||.++.+-
T Consensus       613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999998874332 45566677999999999999988   99999999999999999999999999998654


Q ss_pred             cCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          607 VDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       607 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .....  ....+-...|||||.+....++..+  |+|++|+.+||
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaS--DvWafgvTlwE  731 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTAS--DVWAFGVTLWE  731 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchh--hhhhhHHHHHH
Confidence            33222  1223456789999999888888776  99999999995

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=6.5e-31  Score=282.07  Aligned_cols=194  Identities=27%  Similarity=0.353  Sum_probs=160.9

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----EE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----CM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  524 (701)
                      +|++.+.||+|+||.||+|.. .+++.||+|++..... +....+++.+|+.+++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            478899999999999999965 4789999999865432 2233567889999999999999999999998776     78


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+. ++|.+++....   .+++..+..++.||+.||+|||++   +++||||||+||+++.++.+||+|||+|+.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999997 48888876543   589999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCC-CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC
Q 041034          605 LHVDSS-NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ...... ......+++.|+|||.+.+.. ++.+  .||||+|+++++++.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~il~el~~g~  202 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA--VDIWSVGCIFAELLGRR  202 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcH--HHHHhHHHHHHHHHcCC
Confidence            543221 223346789999999987644 4444  49999999999877654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-31  Score=282.31  Aligned_cols=203  Identities=24%  Similarity=0.346  Sum_probs=162.4

Q ss_pred             EeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC---CCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       458 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      ||+|+||+||+|.. .+++.||+|++.............+..|..++...   +||||+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999965 46899999998754332222234455677777655   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99999887644   588999999999999999999999   999999999999999999999999999976433333334


Q ss_pred             eecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHh
Q 041034          614 LRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQEL  668 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l  668 (701)
                      ...||+.|+|||++.+.. ++...  ||||+|+++|+|+.+. |....+..++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~--DvwslGvil~elltG~~Pf~~~~~~~~~~~i  209 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHV--DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI  209 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCcc--ceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence            457999999999986543 45554  9999999999988775 44444444444433

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=1.1e-30  Score=267.75  Aligned_cols=195  Identities=25%  Similarity=0.378  Sum_probs=156.0

Q ss_pred             CccceEEeeccceEEEEEEcCC-Cc--EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------c
Q 041034          452 FHIRYCIGTGGYGSVYKAELPD-GK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------R  522 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  522 (701)
                      |.+.+.||+|+||.||+|...+ ++  .||+|.++.... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3567899999999999997643 33  689998876532 233357788999999999999999999987432      2


Q ss_pred             EEEEEEEccCCCCHHHHHhcC---CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          523 CMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      ..+++|||+++|+|.+++...   .....+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            468999999999999887432   1223588999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          600 GTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       600 Gla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |+++........  .....+++.|+|||...+..++.+.  |+||+|+++++++.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~--Di~slG~il~el~~  209 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKS--DVWSFGVTMWEIAT  209 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHH--HHHHHHHHHHHHHc
Confidence            999876432211  1223466789999999877776665  99999999997554

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=1.7e-30  Score=264.07  Aligned_cols=210  Identities=25%  Similarity=0.363  Sum_probs=171.9

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CcEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-KRCMFFIY  528 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  528 (701)
                      +|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+.++++++|+|++++++.+.. +...++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5889999999999999999554 5789999998754332 2334678899999999999999999998764 44689999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++..... ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999999876432 2589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHH
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQE  667 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~  667 (701)
                      ........+++.|+|||...+..++.+.  |+||+|+++++++.+.+. ...+..++...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  213 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKS--DVWALGCCVYEMATLKHAFNAKDMNSLVYR  213 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchh--hhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            3333445689999999999887776665  999999999998887643 33344444433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1e-30  Score=269.80  Aligned_cols=192  Identities=24%  Similarity=0.356  Sum_probs=158.7

Q ss_pred             CccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCM  524 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (701)
                      |++.+.||+|+||+||.+..     .+++.||+|.++....  ......+.+|+++++.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            38899999999999987632     3578899999876432  22346788999999999999999999987653  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++...    .+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999999754    489999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          605 LHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .......   .....++..|+|||.......+.+.  ||||+|+++++++++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~--Di~slG~~l~el~tg~  207 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS--DVWSFGVTLYELLTHC  207 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCccc--ccHHHHHHHHHHHhCC
Confidence            6432211   1122356679999998777766665  9999999999877653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.1e-31  Score=297.91  Aligned_cols=210  Identities=27%  Similarity=0.453  Sum_probs=172.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH------  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  520 (701)
                      -..+|+..+.||+||||.||+|+.+ ||+.||||++....  .......+.+|+.++++++|||||+++..+.+      
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            3567888999999999999999766 89999999998876  23345678899999999999999999854210      


Q ss_pred             -------------------------------------------------C------------------------------
Q 041034          521 -------------------------------------------------K------------------------------  521 (701)
Q Consensus       521 -------------------------------------------------~------------------------------  521 (701)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             ----------------------------------cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHH
Q 041034          522 ----------------------------------RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY  567 (701)
Q Consensus       522 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~  567 (701)
                                                        ..+||-||||+.-++.+++++..-.  -.....++++.+|++||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHH
Confidence                                              1257889999997778887765421  1356788999999999999


Q ss_pred             HhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc------------------cCCCCceeecccccccCCCCCCC
Q 041034          568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH------------------VDSSNRTLRAGTYGYIAPDQRLS  629 (701)
Q Consensus       568 LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~  629 (701)
                      +|++   |||||||||.|||+|++..|||+|||+|+...                  .+....+..+||.-|+|||.+.+
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9999   99999999999999999999999999998721                  01123456789999999999887


Q ss_pred             Cc---CChhhHHHHHHHHHHHHH-------------------------------------------cccCCCCCCCCHHH
Q 041034          630 PP---VNQKIIQDIILVSTTALA-------------------------------------------CLRSKPKSRPTMQR  663 (701)
Q Consensus       630 ~~---~~~~~~~Di~slg~i~~~-------------------------------------------cl~~~P~~Rpt~~~  663 (701)
                      ..   |+.++  |+||+|+|++|                                           |+..||.+|||+.|
T Consensus       790 ~~~~~Yn~Ki--DmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  790 TSSNKYNSKI--DMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             cccccccchh--hhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            65   77776  99999999996                                           67789999999999


Q ss_pred             HHH
Q 041034          664 ISQ  666 (701)
Q Consensus       664 i~~  666 (701)
                      ++.
T Consensus       868 LL~  870 (1351)
T KOG1035|consen  868 LLN  870 (1351)
T ss_pred             Hhh
Confidence            876

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-31  Score=275.03  Aligned_cols=210  Identities=24%  Similarity=0.434  Sum_probs=177.3

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ..|++.+.||+||.+.||++...+.+.||+|++..... +.....-|.+|+..|.+++ |.+|+++++|-..++.+||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            45899999999999999999988889999998877554 3456788999999999995 999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||-+. +|.+++++.... ...| .++.+.+||+.|+.++|++   ||||.||||+|+|+ -.|.+||+|||+|..+..+
T Consensus       440 E~Gd~-DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecccc-cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            98755 999999876543 2334 7888999999999999999   99999999999999 5679999999999988765


Q ss_pred             CCC--ceeecccccccCCCCCCCCcCC---------hhhHHHHHHHHHHHHH----------------------------
Q 041034          609 SSN--RTLRAGTYGYIAPDQRLSPPVN---------QKIIQDIILVSTTALA----------------------------  649 (701)
Q Consensus       609 ~~~--~~~~~gt~~y~aPE~~~~~~~~---------~~~~~Di~slg~i~~~----------------------------  649 (701)
                      ...  ....+||+.||+||.+.....+         -...+||||+|||+|+                            
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            443  2345899999999987654443         1123599999999994                            


Q ss_pred             -----------------cccCCCCCCCCHHHHHHH
Q 041034          650 -----------------CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -----------------cl~~~P~~Rpt~~~i~~~  667 (701)
                                       ||..||.+||+..++++.
T Consensus       593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                             888999999998888774

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=1.3e-30  Score=270.68  Aligned_cols=195  Identities=26%  Similarity=0.418  Sum_probs=169.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..+|++.+.||.|++|.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            45799999999999999999954 57899999998754332   246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++...    .+++.++..++.|++.||+|||+.   |++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999999999988653    488999999999999999999999   999999999999999999999999999887654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........++..|+|||.+.+...+.+.  |+||+|+++++++.+.+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slGvil~~lltg~~  213 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKV--DIWSLGIMAIEMVEGEP  213 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            43333345688999999998877666654  99999999999887764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.1e-30  Score=265.37  Aligned_cols=207  Identities=25%  Similarity=0.410  Sum_probs=169.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL-HKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... ++.||+|.++...     ..+.+.+|+.++++++|+|++++++++. .....++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            357899999999999999999764 7889999886432     1367889999999999999999999764 45678999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.++++.... ..+++..+..++.|++.||+|||++   |++||||||+||++++++.+||+|||+++....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999999976543 2488999999999999999999998   999999999999999999999999999876532


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhhc
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~~  670 (701)
                      ..   ....++..|+|||......++.+.  |+||+|+++|+++. +. |....+..++...+..
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~  214 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALREKKFSTKS--DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK  214 (256)
T ss_pred             cC---CCCccceeecCHHHHccCCCCchh--hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            21   223356689999998877776654  99999999998875 44 4455566666665544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=8.1e-31  Score=274.75  Aligned_cols=219  Identities=24%  Similarity=0.405  Sum_probs=177.8

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC--------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP--------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYG  516 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  516 (701)
                      ....++|.+.+.||+|+||.||+|...        ....||+|.++....  ......+.+|+.+++++ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            344578999999999999999999531        245799998875432  23356788999999999 6999999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      ++.+.+..++||||+++|+|.+++.....             ...+++.++..++.|++.||+|||++   |++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            99999999999999999999999975321             23588999999999999999999998   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------  649 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------  649 (701)
                      +||+++.++.+||+|||.++........  .....++..|+|||.+.+..++.+.  ||||+|+++++            
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS--DVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccc--hhhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999865432111  1112244679999998877776665  99999999874            


Q ss_pred             -------------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -------------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -------------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                     |+..+|.+||++.++++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                                           6677888888888888877754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=1.2e-30  Score=265.16  Aligned_cols=204  Identities=24%  Similarity=0.381  Sum_probs=163.6

Q ss_pred             EEeeccceEEEEEEc---CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          457 CIGTGGYGSVYKAEL---PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      .||+|+||.||+|.+   .+++.||+|+++... .+....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999954   357889999987543 23445678899999999999999999999875 4567899999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc-
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR-  612 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~-  612 (701)
                      ++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||++++++.+||+|||.++......... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999997543   588999999999999999999998   99999999999999999999999999998764332211 


Q ss_pred             --eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhhc
Q 041034          613 --TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       613 --~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~~  670 (701)
                        ....++..|+|||.......+.+.  |+||+|+++++++. +. |...-+..++.+.++.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~  213 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKS--DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES  213 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchh--HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence              112345789999998766666554  99999999998775 44 4444445555555554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=7.9e-31  Score=270.15  Aligned_cols=196  Identities=26%  Similarity=0.464  Sum_probs=162.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ..+|...+.||+|+||.||+|..      .++..+|+|.+....   ....+.+.+|+++++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            35678899999999999999953      235679999886543   233567899999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCC------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDE------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      ..++||||+++++|.+++.....            ...+++..+..++.|++.|++|||+.   +++||||||+||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence            99999999999999999875431            12478999999999999999999998   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          591 NLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ++.+||+|||+++.......  ......+++.|+|||...+..++.+.  |+||+|+++++++.
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~  219 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES--DIWSFGVVLWEIFT  219 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchh--hHHHHHHHHHHHHc
Confidence            99999999999976532211  11122356789999998887776665  99999999998665

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=1.2e-30  Score=271.86  Aligned_cols=196  Identities=24%  Similarity=0.353  Sum_probs=163.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHK  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  521 (701)
                      .++|.+.+.||+|+||.||+|..      ..+..||+|+++....  ....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            46799999999999999999953      1345799999876432  23356789999999999 799999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      +..++||||+++|+|.++++.... ..+++.++..++.|++.||+|||++   +++|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999975432 2389999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ++........  .....++..|+|||.+.+..++.+.  ||||+|++++++++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwslGvil~el~t  238 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFES--DVWSYGILLWEIFS  238 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHh--HHHHHHHHHHHHHh
Confidence            9866432211  1122356789999998877776665  99999999998664

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=7e-31  Score=280.15  Aligned_cols=195  Identities=25%  Similarity=0.315  Sum_probs=161.5

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC----
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK----  521 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  521 (701)
                      ...++|++.+.||+|+||.||+|.. ..++.||||++...... ......+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            3467899999999999999999955 46889999998764332 23346778899999999999999999988643    


Q ss_pred             --cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          522 --RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       522 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                        ...++||||+++ ++.+.+..     .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence              357999999976 67776643     478889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      |+++..... .......||+.|+|||++.+..++.+.  ||||+|+++++++.+.
T Consensus       164 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~  215 (355)
T cd07874         164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK  215 (355)
T ss_pred             cccccCCCc-cccCCccccCCccCHHHHcCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            999865432 222335689999999999887777765  9999999998766544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=8.8e-31  Score=269.37  Aligned_cols=215  Identities=25%  Similarity=0.335  Sum_probs=168.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|++|.||+|...      .+..||+|.+.....  ......+.+|+.++++++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3577999999999999999999664      356789998865432  22346688999999999999999999999998


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCC----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---Ce
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDE----AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EA  594 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~---~~  594 (701)
                      +..++||||+++++|.+++.....    ...+++..+..++.||+.||+|||++   +++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence            899999999999999999876432    22589999999999999999999999   999999999999998654   59


Q ss_pred             EEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhh
Q 041034          595 FVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELE  669 (701)
Q Consensus       595 kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~  669 (701)
                      ||+|||+++........  ......+..|+|||++.+..++.+.  ||||+|+++++++. +. |....+..++.+.+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKT--DVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchh--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999866322111  1112235679999999877777665  99999999998664 33 333334444444443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=5.8e-31  Score=299.07  Aligned_cols=204  Identities=20%  Similarity=0.316  Sum_probs=162.4

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--C
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--K  521 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  521 (701)
                      .....++|.+.+.||+|+||.||+|... +++.||+|.+...... ......+..|+.++++++||||++++++|.+  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3445678999999999999999999654 5788999988765432 3345778999999999999999999998854  4


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEecCCCCCcEEEcC------
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCT----PSIVHRDISSNNILLNS------  590 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~givH~Dlkp~NIll~~------  590 (701)
                      ..+|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+||||||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            57899999999999999987532 12358999999999999999999998521    25999999999999964      


Q ss_pred             -----------CCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCc--CChhhHHHHHHHHHHHHHccc
Q 041034          591 -----------NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP--VNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       591 -----------~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Di~slg~i~~~cl~  652 (701)
                                 .+.+||+|||++..+.... ......||+.|+|||++.+..  ++.+  .|||||||++|+|+.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~K--SDVWSLG~ILYELLT  238 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDK--SDMWALGCIIYELCS  238 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCch--hHHHHHHHHHHHHHH
Confidence                       2358999999998764322 223457999999999986543  4444  499999999996433

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=6.6e-31  Score=271.95  Aligned_cols=215  Identities=26%  Similarity=0.419  Sum_probs=170.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||.||+|...      +++.||+|++.....  ....+.+.+|+.++++++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            3567999999999999999999642      467899999875432  33356788999999999999999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCC-------------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDD-------------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDIS  582 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlk  582 (701)
                      +..++||||+++|+|.+++....                   ....+++..++.++.|++.||+|||++   +++|||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence            99999999999999999997431                   112478889999999999999999998   99999999


Q ss_pred             CCcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-C-CCCCC
Q 041034          583 SNNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-S-KPKSR  658 (701)
Q Consensus       583 p~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~-~P~~R  658 (701)
                      |+||++++++.++|+|||.++.......  .......+..|+|||...+..++.+.  |+||+|++++++++ + .|..-
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES--DVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchh--HHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999876532221  11122346679999998777776665  99999999998664 2 23333


Q ss_pred             CCHHHHHHHhh
Q 041034          659 PTMQRISQELE  669 (701)
Q Consensus       659 pt~~~i~~~l~  669 (701)
                      .+..++.+.+.
T Consensus       236 ~~~~~~~~~~~  246 (288)
T cd05050         236 MAHEEVIYYVR  246 (288)
T ss_pred             CCHHHHHHHHh
Confidence            33444444443

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.4e-30  Score=272.06  Aligned_cols=194  Identities=26%  Similarity=0.320  Sum_probs=166.2

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....  .....++.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            46899999999999999999654 688899998875432  334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.++++...   .+++..+..++.|+++||+|||+.+  +++||||||+||+++.++.+||+|||++......
T Consensus        79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999997653   5889999999999999999999732  8999999999999999999999999998765322


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                        ......+++.|+|||...+..++.+.  |+||+|+++++++.+.
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~--DiwslG~~l~~l~~g~  195 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQS--DIWSLGLSLVEMAIGR  195 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccc--hHHHHHHHHHHHHhCC
Confidence              22334689999999998777666654  9999999999988875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.1e-30  Score=266.14  Aligned_cols=182  Identities=25%  Similarity=0.321  Sum_probs=148.6

Q ss_pred             eEEeeccceEEEEEEcCC-------------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          456 YCIGTGGYGSVYKAELPD-------------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      +.||+|+||.||+|...+             ...||+|.+....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999996432             2258888876543   233467888999999999999999999999988


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-------eE
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-------AF  595 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~-------~k  595 (701)
                      ..++||||+++++|..++.....  .+++..+..++.||++||+|||++   +|+||||||+||+++.++.       ++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            99999999999999988865432  588999999999999999999998   9999999999999987654       89


Q ss_pred             EEeecCccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcc
Q 041034          596 VADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       596 L~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ++|||++......    ....++..|+|||.+.. ..++.+  .||||+|+++|+++
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~~l~el~  203 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIA--ADKWSFGTTLWEIC  203 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcCCCCCCch--hHHHHHHHHHHHHH
Confidence            9999998755322    23457889999998763 344444  49999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.5e-32  Score=258.83  Aligned_cols=204  Identities=25%  Similarity=0.364  Sum_probs=170.2

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC---C--CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP---D--GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-  520 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  520 (701)
                      .....|+.+..||+|.||.||+|...   +  .+.+|+|+++.....+ .......+|+..++.++||||+.+..++.. 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34567999999999999999999332   2  2379999998775433 334667899999999999999999999887 


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcC--CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC----CCe
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN----LEA  594 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~----~~~  594 (701)
                      +...++++||.+. +|.++++-.  .+...++...+..|++||+.|+.|||++   -|+||||||+|||+..+    |.|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            7889999999988 999888643  2334688999999999999999999999   89999999999999876    999


Q ss_pred             EEEeecCccccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          595 FVADFGTARLLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       595 kL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ||+|||+|+.+...-.   .....+-|.+|.|||.+.+.....++. |+|++|||+.|+++..|-
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~Ai-DvWAiGCIfaElLtl~Pl  239 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAI-DVWAIGCIFAELLTLEPL  239 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchh-hhHHHHHHHHHHHccCcc
Confidence            9999999999865432   233467899999999999887655553 999999999999988774

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=2.4e-30  Score=268.30  Aligned_cols=199  Identities=27%  Similarity=0.398  Sum_probs=167.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..+...++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            3577999999999999999999664 58899999987542   3345778899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|..++.+...  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+....
T Consensus        87 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999888765432  588999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCCCceeecccccccCCCCCCCC-----cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSP-----PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ..........+++.|+|||.+.+.     .++.+  .|+||+|+++|+++.+.|.
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Dv~slG~il~el~~g~~p  214 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK--ADIWSLGITLIEMAQIEPP  214 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCch--hhhHhHHHHHHHHhcCCCC
Confidence            333333455688999999987532     23333  5999999999998877754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1.5e-30  Score=264.23  Aligned_cols=210  Identities=22%  Similarity=0.407  Sum_probs=171.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ..+|++.+.||+|+||.||+|...+++.+|+|.+......    ...+.+|++++++++||+++++++++......++||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3578889999999999999997767889999998754432    256888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++.....  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.....
T Consensus        79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          79 EFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            99999999999876432  478999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhh
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELE  669 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~  669 (701)
                      ... .....++..|+|||...+..+..+.  |+||+|+++++++. +. |.......++.+.+.
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~--Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  215 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKS--DVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN  215 (256)
T ss_pred             cccccCCCccchhhcCHhHhccCCcChHH--HHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence            111 1122356789999998877666554  99999999998775 43 443444455555544

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=1.2e-30  Score=269.90  Aligned_cols=198  Identities=30%  Similarity=0.423  Sum_probs=160.8

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC---CCCceeeeeeeeee-----C
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVKLYGFCLH-----K  521 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  521 (701)
                      +|++.+.||+|+||+||+|... +++.||+|.++.....+. ....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5889999999999999999654 689999999876432221 123455677766655   79999999998864     3


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||+++ +|.+++..... ..+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            458999999975 89888876432 2489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      ++...... ......+|..|+|||++.+..++.+.  ||||+|+++++++.+.|..
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~--DiwslG~~l~~l~~g~~~f  207 (288)
T cd07863         155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPV--DMWSVGCIFAEMFRRKPLF  207 (288)
T ss_pred             cccccCcc-cCCCccccccccCchHhhCCCCCCcc--hhhhHHHHHHHHHhCCcCc
Confidence            98764322 22334689999999999887777765  9999999999999887643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=1.9e-30  Score=265.02  Aligned_cols=197  Identities=27%  Similarity=0.421  Sum_probs=168.1

Q ss_pred             CCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE---DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      +|++.+.||+|+||.||+|...+++.+|+|.+......   .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47889999999999999998778999999998754322   223346688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.+..   .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997654   478899999999999999999998   999999999999999999999999999876532


Q ss_pred             CC------CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DS------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..      .......++..|+|||...+..++...  |+|++|+++++++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~--Dv~slG~~~~~l~~g~~  206 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKS--DIWSIGCTVFEMATGKP  206 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchh--hHHHHHHHHHHHHhCCC
Confidence            11      111234588999999999877766664  99999999999998874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.5e-30  Score=266.40  Aligned_cols=210  Identities=28%  Similarity=0.427  Sum_probs=167.4

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CC---cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DG---KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.++...  ......++..|+.+++.++||||+++++++.++...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            45889999999999999999654 33   369999987543  2334578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++++|.+++.....  .+++.++..++.|++.||+|||++   |++|+||||+||+++.++.+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            99999999999999876432  588999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCCc--ee-ec--ccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHh
Q 041034          606 HVDSSNR--TL-RA--GTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQEL  668 (701)
Q Consensus       606 ~~~~~~~--~~-~~--gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l  668 (701)
                      .......  .. ..  .+..|+|||......++.+.  |+||+|+++++++. +. |...-+..++.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSAS--DVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchh--hhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            4322111  11 11  23579999999877776665  99999999998553 33 43333344444444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=9.8e-31  Score=265.58  Aligned_cols=195  Identities=32%  Similarity=0.461  Sum_probs=170.4

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|...+ ++.||+|.+.....     .+++.+|++++++++||||+++++++.+....+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            4689999999999999999997654 88999999865422     57889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      +||+++++|.+++.....  .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          77 MEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999875432  589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........++..|+|||++.+..++.+.  |+|++|+++++++.+.+
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~s~G~il~~l~~g~~  197 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKA--DIWSLGITAIEMAEGKP  197 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            43333445688999999998887776665  99999999999988764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-30  Score=265.05  Aligned_cols=208  Identities=26%  Similarity=0.434  Sum_probs=172.3

Q ss_pred             eEEeeccceEEEEEEcCC----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          456 YCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      +.||+|+||.||+|....    +..||+|.+.......  ..+.+.+|+++++.++|+||+++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            468999999999996643    7889999998765432  3578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCC------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          532 ERGSLFYVLRDDDE------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       532 ~~gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ++++|.+++.....      ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987521      23689999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhhc
Q 041034          606 HVDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS--KPKSRPTMQRISQELEG  670 (701)
Q Consensus       606 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~--~P~~Rpt~~~i~~~l~~  670 (701)
                      ....  .......++..|+|||......++.+.  |+||+|+++++++..  .|....+..++.+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  222 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS--DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK  222 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhh--ccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            5432  222334578899999998877666555  999999999998763  35555566666666653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.3e-30  Score=264.65  Aligned_cols=197  Identities=26%  Similarity=0.436  Sum_probs=166.6

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccC------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETED------SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      +|.+...||+|++|.||+|.. .+++.||+|.+.......      ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            478889999999999999965 468899999887643321      2234678899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997654   578899999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCC------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          604 LLHVDSS------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       604 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......      ......|+..|+|||...+..++...  |+|++|+++++++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~--Dv~slG~il~~l~~g~~  210 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKA--DIWSLGCLVVEMLTGKH  210 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchh--hhHHHHHHHHHHhhCCC
Confidence            7653211      11223578899999998877666554  99999999999888763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=1.4e-30  Score=268.30  Aligned_cols=197  Identities=19%  Similarity=0.316  Sum_probs=162.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-Cc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-KR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  522 (701)
                      .++|++.+.||+|+||.||+|...+     +..||+|++....  .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            5789999999999999999997654     6889999887543  23345778899999999999999999998766 46


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCc-----cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEA-----IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                      ..++++||+++++|.+++......     ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998764322     3589999999999999999999998   99999999999999999999999


Q ss_pred             eecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          598 DFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       598 DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |||+++.+......  .....++..|+|||.+.+..++.+.  ||||+|++++++++
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~--Di~slG~~l~el~~  214 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSAS--DVWSFGVLLWELMT  214 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchh--hHHHhHHHHHHHhc
Confidence            99999865432211  1123456789999998877776665  99999999987543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=3.3e-30  Score=275.29  Aligned_cols=195  Identities=25%  Similarity=0.309  Sum_probs=162.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  522 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.+++.++||||+++++++....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            457899999999999999999955 46899999999764322 233467789999999999999999999986543    


Q ss_pred             --EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          523 --CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       523 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                        ..|+||||+++ ++.+.+..     .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence              57999999976 67666643     378889999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +++..... .......||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+
T Consensus       169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~--DiwSlG~il~el~tg~~  220 (359)
T cd07876         169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGELVKGSV  220 (359)
T ss_pred             CccccccC-ccCCCCcccCCCCCchhccCCCCCcch--hhHHHHHHHHHHHhCCC
Confidence            99765322 222334689999999999888877765  99999999999887764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=279.27  Aligned_cols=206  Identities=29%  Similarity=0.425  Sum_probs=179.5

Q ss_pred             eEEeeccceEEEEEEcCC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCC
Q 041034          456 YCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG  534 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (701)
                      -++|+|.||+||.|++.+ ...+|||.+.....   .+.+-+..|+...++++|.|||+++|.+.+++.+-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            479999999999997654 56799999876543   33567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEEeecCccccccCCCCce
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      +|.++++..-...+-.+.++-.+.+||++||.|||++   .|||||||-+||||+ -.|.+||+|||.++.+..-.....
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            9999998765544458889999999999999999999   999999999999996 568999999999988765555566


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHH--------------------------------------------H
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTAL--------------------------------------------A  649 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~--------------------------------------------~  649 (701)
                      .+.||..|||||++-..+......+|||||||.+.                                            .
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            67899999999999988887777789999999865                                            3


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 041034          650 CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 cl~~~P~~Rpt~~~i~~~  667 (701)
                      |+.++|..||+++++++.
T Consensus       815 cFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HcCCCcccCccHHHhccC
Confidence            899999999999998874

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.3e-30  Score=268.84  Aligned_cols=197  Identities=26%  Similarity=0.398  Sum_probs=164.5

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +-|++.+.||+|+||.||+|... ++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            34788899999999999999664 57888999886543   233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|..++.....  .+++..+..++.|++.||+|||+.   |++||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          82 EFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            99999999988765322  589999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCCceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ........+++.|+|||.+..     ..++..  .|+||+|+++++++.+.|.
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Dv~slGvil~el~~g~~p  207 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK--ADVWSLGITLIEMAQIEPP  207 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCcc--chhhhHHHHHHHHccCCCC
Confidence            333344568999999998742     223334  4999999999998877643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.5e-31  Score=269.58  Aligned_cols=199  Identities=26%  Similarity=0.410  Sum_probs=169.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|++|.||+|... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++..+...++
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            4678999999999999999999664 68899999986542   3335678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++.....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            9999999999999876432  589999999999999999999999   99999999999999999999999999987664


Q ss_pred             cCCCCceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ..........+++.|+|||.+..     .+++.+  +|+||+|+++|+|+.+.|.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~--sDi~slG~il~~l~~g~~p  207 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK--ADIWSLGITLIELAQMEPP  207 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCcc--ccHHHHHHHHHHHHhCCCC
Confidence            44434445578999999998753     233334  4999999999998887753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-30  Score=263.76  Aligned_cols=198  Identities=30%  Similarity=0.449  Sum_probs=170.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+......   ..+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            468999999999999999999654 5788999999765432   357789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+.....
T Consensus        79 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EeCCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999876422  588999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .........++..|+|||.....   ..+..  +|+||+|+++++++++.|.
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~--~Di~slG~~l~~~~tg~~p  203 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGK--CDIWALGITAIELAELQPP  203 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCch--hhhHHHHHHHHHHHhCCCC
Confidence            33333445688899999998765   55554  4999999999999988754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-30  Score=265.71  Aligned_cols=195  Identities=23%  Similarity=0.371  Sum_probs=158.5

Q ss_pred             CccceEEeeccceEEEEEEcC-C---CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE----
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-D---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC----  523 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  523 (701)
                      |++.+.||+|+||.||+|... +   +..||+|+++..... ....+.+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            577899999999999999653 2   367999998764332 3335678999999999999999999998866543    


Q ss_pred             --EEEEEEccCCCCHHHHHhcCC---CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          524 --MFFIYEYMERGSLFYVLRDDD---EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       524 --~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                        .++||||+++|+|.+++....   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence              799999999999999885432   223589999999999999999999998   999999999999999999999999


Q ss_pred             ecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          599 FGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       599 FGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||+++........  .....++..|+|||...+..++.+.  ||||+|+++++++.
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~--Dv~SlG~il~el~~  210 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS--DVWAFGVTMWEIAT  210 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCccc--chHHHHHHHHHHHh
Confidence            9999866432211  1122356789999998777777665  99999999997543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=2.4e-30  Score=264.80  Aligned_cols=195  Identities=30%  Similarity=0.449  Sum_probs=160.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CC---cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DG---KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|++.....  ....+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            457888999999999999999654 33   3799998875432  23356788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++.....  .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999999976432  588999999999999999999998   999999999999999999999999999976


Q ss_pred             cccCCCCce---eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          605 LHVDSSNRT---LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       605 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .........   ....+..|+|||.+....++.+.  |+||+|+++|+++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Dv~slG~il~ell~  205 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS--DVWSFGIVMWEVMS  205 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHh--HHHHHHHHHHHHHh
Confidence            643222111   11234579999998776666554  99999999997543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=2.1e-30  Score=269.46  Aligned_cols=192  Identities=27%  Similarity=0.426  Sum_probs=156.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCc--EEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGK--VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++...  .....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            57999999999999999999654 333  47888876432  223356788999999999 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 041034          526 FIYEYMERGSLFYVLRDDD-------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL  592 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~  592 (701)
                      +||||+++++|.+++....             ....+++..+..++.|++.||+|||++   |++||||||+||++++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence            9999999999999996532             112488899999999999999999998   999999999999999999


Q ss_pred             CeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          593 EAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .+||+|||++........ ......+..|+|||...+..++.+.  ||||+|+++++
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~--DvwSlG~il~e  210 (297)
T cd05089         157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKS--DVWSFGVLLWE  210 (297)
T ss_pred             eEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchh--hHHHHHHHHHH
Confidence            999999999864321111 1112235579999998877776665  99999999985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.5e-30  Score=278.45  Aligned_cols=194  Identities=24%  Similarity=0.301  Sum_probs=162.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|.. ..++.||||++...... ......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            457899999999999999999955 46889999999764322 23346678899999999999999999987543     


Q ss_pred             -cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 -RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                       ...|+||||+++ ++.+.+..     .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999976 77777743     378889999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +++...... ......+|+.|+|||++.+..++.+.  ||||+|+++|+++.+.
T Consensus       172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~--DiwSlG~il~ell~g~  222 (364)
T cd07875         172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIKGG  222 (364)
T ss_pred             CccccCCCC-cccCCcccCCcCCHHHHhCCCCCchh--hHHhHHHHHHHHHhCC
Confidence            998654322 22335689999999999888777765  9999999999988775

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=1.5e-30  Score=264.94  Aligned_cols=213  Identities=23%  Similarity=0.402  Sum_probs=172.4

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...++|++.+.||+|+||.||+|...++..+|+|.+....    ...+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            3457899999999999999999987777889999887542    224678899999999999999999999887 77899


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      +|||+++++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            999999999999997643 23578899999999999999999998   99999999999999999999999999997664


Q ss_pred             cCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhhc
Q 041034          607 VDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       607 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~~  670 (701)
                      ..... .....++..|+|||.+.....+...  |+||+|+++++++. +. |....+..++.+.+..
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~  218 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKS--DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER  218 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccc--cchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence            32211 1222356779999998777666655  99999999998776 55 3333444455554443

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.6e-31  Score=279.43  Aligned_cols=192  Identities=26%  Similarity=0.418  Sum_probs=161.1

Q ss_pred             ccceEEeeccceEEEEEEc-CCCcEEEEEEecCCC-ccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE--EEEEE
Q 041034          453 HIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSE-TEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC--MFFIY  528 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  528 (701)
                      +..++||+|+|-+||+|.+ .+|-.||=-.++... .......++|..|+.+|+.|+||||+++|.++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3467899999999999944 457777754443222 2334456899999999999999999999999987654  88999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DFGla~~~~~  607 (701)
                      |.+..|+|..|.++.+   +++...++.|++||++||.|||++ .|+|||||||-+||||+. .|.|||+|.|+|+....
T Consensus       123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999999876   588899999999999999999999 789999999999999975 48999999999998753


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      .  .....+|||.|||||+.. ..|++.+  ||||||+.++||.+.
T Consensus       199 s--~aksvIGTPEFMAPEmYE-E~YnE~V--DVYaFGMCmLEMvT~  239 (632)
T KOG0584|consen  199 S--HAKSVIGTPEFMAPEMYE-ENYNELV--DVYAFGMCMLEMVTS  239 (632)
T ss_pred             c--ccceeccCccccChHHHh-hhcchhh--hhhhhhHHHHHHHhc
Confidence            3  333478999999999986 7788887  999999999974443

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=2.1e-30  Score=263.22  Aligned_cols=198  Identities=25%  Similarity=0.355  Sum_probs=168.5

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||++.. .+++.||+|.+...... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            588999999999999999954 46899999998754322 2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++..... ..+++.++..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999999875432 2478999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......|++.|+|||...+...+.+.  |+|++|+++++++.+.+
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~--Dv~slG~i~~~l~~g~~  199 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKS--DIWALGCVLYEMCTLKH  199 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCcc--chhHHHHHHHHHHcCCC
Confidence            333344688899999998877766655  99999999999877764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.9e-30  Score=261.41  Aligned_cols=188  Identities=26%  Similarity=0.393  Sum_probs=158.7

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCC
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGS  535 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  535 (701)
                      +.||+|++|.||+|...+++.||+|.+......  ...+.+.+|++++++++||||+++++++.+....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            468999999999997766999999998765433  345778999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc--e
Q 041034          536 LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR--T  613 (701)
Q Consensus       536 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--~  613 (701)
                      |.+++.....  .+++..+..++.+++.||+|||++   +++||||||+||+++.++.+||+|||.++.........  .
T Consensus        79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9999876432  578899999999999999999999   99999999999999999999999999997654211111  1


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ....+..|+|||.+.+..++.+.  |+||+|++++++++
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~i~~~l~t  190 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSES--DVWSYGILLWETFS  190 (251)
T ss_pred             cCcceeccCChHhhccCCCCcch--hHHHHHHHHHHHHh
Confidence            12335679999998877776665  99999999998775

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=286.78  Aligned_cols=221  Identities=29%  Similarity=0.447  Sum_probs=192.0

Q ss_pred             CCccceEEeeccceEEEEEEcCC----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++.++||.|.||+||+|+++-    ...||||.++....  +..+.+|..|+.||.+++||||+++.|+.......+|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            45678999999999999997642    34699999987654  4456899999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |+|||++|+|+.+|+.++.  .+++.+...+.++||.|+.||-+.   ++|||||.++|||++.+...|++|||+++.+.
T Consensus       708 iTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999998764  489999999999999999999998   99999999999999999999999999999886


Q ss_pred             cCCCC-ceeecc--cccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------------------
Q 041034          607 VDSSN-RTLRAG--TYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------------------  649 (701)
Q Consensus       607 ~~~~~-~~~~~g--t~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------------------  649 (701)
                      ++... .+...|  ...|.|||.+....++..+  |+||+|++|||                                  
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsAS--DVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP  860 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSAS--DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCP  860 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchh--hccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCc
Confidence            65533 222222  3579999999988887765  99999999884                                  


Q ss_pred             ---------cccCCCCCCCCHHHHHHHhhcCCCccchhhh
Q 041034          650 ---------CLRSKPKSRPTMQRISQELEGKTPMKKGLKE  680 (701)
Q Consensus       650 ---------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~  680 (701)
                               ||+.|-.+||.+.||+..|++...-+..++.
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence                     9999999999999999999987766665554

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=1.7e-30  Score=274.78  Aligned_cols=218  Identities=24%  Similarity=0.406  Sum_probs=179.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC--------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP--------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ...+|++.+.||+|+||.||+|...        .+..||+|.++....  ....+.+.+|+.+++++ +||||+++++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3457999999999999999999542        123689998875432  23357789999999999 799999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCC-------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDD-------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      .+.+..+++|||+++|+|.+++....             ....+++.++..++.|++.||+|||++   |++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            99999999999999999999987532             123578899999999999999999998   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------  649 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------  649 (701)
                      |++++++.+||+|||+++........  .....++..|+|||...+..++.+.  ||||+|+++++              
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchh--hhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999865432211  1122345679999999887776664  99999999884              


Q ss_pred             -----------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -----------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -----------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                                   |+..+|.+||++.++++.|+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                                         77888999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=4e-30  Score=262.80  Aligned_cols=199  Identities=26%  Similarity=0.392  Sum_probs=165.6

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE--DSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  524 (701)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++......  .....+.+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4789999999999999999965 46899999988754322  22345678899999999999999999998875  3678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      +++|||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            99999999999999997644   478899999999999999999998   999999999999999999999999999976


Q ss_pred             cccCC---CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVDS---SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .....   .......++..|+|||.+.+...+...  |+||+|+++++++.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~i~~el~~g~~p  208 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKA--DVWSLGCTVVEMLTEKPP  208 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchh--hhHHHHHHHHHHHHCCCC
Confidence            53211   112234588899999998877666554  999999999999887643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.5e-30  Score=261.81  Aligned_cols=186  Identities=27%  Similarity=0.379  Sum_probs=154.2

Q ss_pred             eEEeeccceEEEEEEcC--C--CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          456 YCIGTGGYGSVYKAELP--D--GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      +.||+|+||.||+|.+.  +  +..||+|.+......  ...+++.+|+.+++.+.||||+++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46899999999999543  2  268999998865543  33567889999999999999999999876 45679999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN  611 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~  611 (701)
                      ++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999997654   588999999999999999999998   9999999999999999999999999999876433322


Q ss_pred             cee---ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          612 RTL---RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       612 ~~~---~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ...   ..++..|+|||...+..++.+.  |+||+|+++++++.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~~~~  193 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKS--DVWSYGVTLWEAFS  193 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccc--hHHHHHHHHHHHHc
Confidence            111   1234679999998877777665  99999999997654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-30  Score=266.13  Aligned_cols=194  Identities=26%  Similarity=0.438  Sum_probs=160.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..+|++.+.||+|+||.||+|... +++    .||+|.......  ......+.+|+.++++++||||+++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            467899999999999999999653 233    589998876543  3345678899999999999999999999887 77


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            8999999999999999976533  488999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCce--eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          604 LLHVDSSNRT--LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       604 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..........  ...++..|+|||......++.+.  |+||+|++++++++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~~l~el~~  206 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKS--DVWSYGVTVWELMT  206 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchh--hHHHHHHHHHHHhc
Confidence            7653222111  12235679999998776666655  99999999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.7e-30  Score=275.95  Aligned_cols=195  Identities=26%  Similarity=0.342  Sum_probs=161.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC----
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK----  521 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  521 (701)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.++++++||||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3468899999999999999999954 56889999998754322 22345677899999999999999999987543    


Q ss_pred             --cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          522 --RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       522 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                        ...+++||++ +++|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence              3578999998 67998887643    489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |+++.....   .....||+.|+|||.+.+. .++.+.  ||||+|+++++++.+.+
T Consensus       163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~el~~g~~  214 (343)
T cd07878         163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLKGKA  214 (343)
T ss_pred             ccceecCCC---cCCccccccccCchHhcCCccCCchh--hhHhHHHHHHHHHHCCC
Confidence            999875432   2334689999999998763 444444  99999999999887764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=3.3e-30  Score=268.15  Aligned_cols=198  Identities=28%  Similarity=0.373  Sum_probs=166.7

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE--DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      +|++.+.||+|++|.||+|.. .+++.||+|++......  .......+..|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999965 46899999999865433  122345677899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+ +++|.+++....  ..+++..+..++.||++||+|||++   |++|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999997643  2589999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .........+++.|+|||.+.+. .++..  .|+|++|+++++++.+.|.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~il~e~~~g~~~  202 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVG--VDMWSVGCIFAELLLRVPF  202 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcH--HHHHHHHHHHHHHHcCCcc
Confidence            43333444578889999987543 33333  4999999999999887763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=1.1e-30  Score=268.55  Aligned_cols=192  Identities=31%  Similarity=0.432  Sum_probs=163.0

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+.....  ....+.+.+|+.++++++||||+++++++..+...++||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            3467788899999999999955 4688999998875432  233567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          82 EYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            999999999988643    488999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ........++..|+|||+..+..++.+.  |+||+|+++++++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~t  196 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKA--DIWSLGITAIELAK  196 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhh--hHHHHHHHHHHHHh
Confidence            3333344688899999999877666554  99999999986443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=2.5e-30  Score=262.83  Aligned_cols=205  Identities=23%  Similarity=0.416  Sum_probs=167.7

Q ss_pred             eEEeeccceEEEEEEcCC--C--cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          456 YCIGTGGYGSVYKAELPD--G--KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......  ...+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999996532  3  36999999876543  456789999999999999999999999988 8899999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN  611 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~  611 (701)
                      ++++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.+......
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999977543 3589999999999999999999998   9999999999999999999999999999876542221


Q ss_pred             ---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhh
Q 041034          612 ---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELE  669 (701)
Q Consensus       612 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~  669 (701)
                         .....++..|+|||.+.+..++.+.  |+||+|++++++++ +. |...-+..++.+.+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~--Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  214 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHAS--DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID  214 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchh--hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence               1123467889999998877776665  99999999999875 44 444445555555444

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=3e-30  Score=265.11  Aligned_cols=196  Identities=20%  Similarity=0.345  Sum_probs=162.7

Q ss_pred             cCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ++|++.+.||+|+||.||+|+..      +.+.||+|.+.....  ....+.+.+|++++++++||||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            67899999999999999999653      346799998865432  2345778999999999999999999999999899


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCc------cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEA------IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                      .++||||+++|+|.+++......      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999999765422      1589999999999999999999998   99999999999999999999999


Q ss_pred             eecCccccccC-CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          598 DFGTARLLHVD-SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       598 DFGla~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |||++...... ........++..|+|||.+.+.......  ||||+|+++++++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~~l~~l~~  213 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKS--DVWSFGVLMWEVFT  213 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchh--hHHHHHHHHHHHHh
Confidence            99998754321 1112233467789999998777666554  99999999997664

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=236.96  Aligned_cols=195  Identities=23%  Similarity=0.364  Sum_probs=170.1

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|...++||+|.||+||+|+. .+++.||+|+++....++ .......+|+-+++.++|.|||+++++...+...-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            466678899999999999955 468999999998765443 334667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      ||+. +|.++......  .++.+.+..++.|+++||.|+|++   ++.|||+||.|.+|+.+|+.|++|||+|+.++-+.
T Consensus        82 ~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9976 89988876543  588899999999999999999999   99999999999999999999999999999987666


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ...+..+-|.+|.+|+++.+......+. |+||.|||+.++-..
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsi-dmwsagcifaelana  198 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANA  198 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccch-HhhhcchHHHHHhhc
Confidence            6667778899999999998877655553 999999999997653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=261.93  Aligned_cols=191  Identities=27%  Similarity=0.412  Sum_probs=159.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC--CCCceeeeeeeeeeCc---
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV--RHRNIVKLYGFCLHKR---  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~---  522 (701)
                      ......+.+.||+|.||+||+|++ .|+.||||++....      .+.+.+|.++.+.+  +|+||..+++.-..+.   
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            345678899999999999999999 48899999997543      25677888888775  9999999998865443   


Q ss_pred             -EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          523 -CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       523 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                       ++|+|++|.+.|||.||+.+.    .++....++++..+|.||++||..     ..|.|.|||||..|||+..++...|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             689999999999999999874    488999999999999999999954     4678999999999999999999999


Q ss_pred             EeecCccccccCCC----CceeecccccccCCCCCCCC----cCChhhHHHHHHHHHHHHH
Q 041034          597 ADFGTARLLHVDSS----NRTLRAGTYGYIAPDQRLSP----PVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       597 ~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~~~~~----~~~~~~~~Di~slg~i~~~  649 (701)
                      +|+|+|.....+..    ....++||..|||||++...    .++....+||||||.|+||
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWE  418 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWE  418 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHH
Confidence            99999987654422    24557899999999987543    2344456799999999995

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=4.3e-30  Score=268.66  Aligned_cols=210  Identities=23%  Similarity=0.337  Sum_probs=171.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++......  ....+.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            367999999999999999999654 68889999987554322  134567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++ +|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        83 ~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            999976 88888765432  478899999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC-CCCHHHHHHHh
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS-RPTMQRISQEL  668 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~l  668 (701)
                      .........+++.|+|||.+.+. .++.+  .||||+|+++++++++.|.. ..+..+....+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  217 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQ--IDMWGVGCIFFEMASGRPLFPGSTVEDELHLI  217 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcH--HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            33333345689999999987653 34444  49999999999999988543 34444444443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=2.1e-30  Score=267.89  Aligned_cols=198  Identities=26%  Similarity=0.396  Sum_probs=167.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47899999999999999999765 58999999987654332 34567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++++++.++.....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999998888765433   489999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ........++..|+|||...+.. .+.+  +|+||+|+++++++.+.|.
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRA--VDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCch--HhHHHHHHHHHHHHcCCCC
Confidence            33333446889999999886543 3333  5999999999999988753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=2.1e-30  Score=265.94  Aligned_cols=181  Identities=24%  Similarity=0.335  Sum_probs=146.8

Q ss_pred             EEeeccceEEEEEEcC-------------------------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCce
Q 041034          457 CIGTGGYGSVYKAELP-------------------------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (701)
                      .||+|+||.||+|...                         ....||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            5899999999998531                         11358899886542   2334678889999999999999


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      +++++++.+....++||||+++|+|..++.....  .+++..+..++.|+++||+|||++   +|+||||||+||+++..
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            9999999999999999999999999999865332  578899999999999999999998   99999999999999764


Q ss_pred             C-------CeEEEeecCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcc
Q 041034          592 L-------EAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       592 ~-------~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +       .+|++|||.+......    ....++..|+|||.+.+. .++.+  .|+||+|+++++++
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~--~Dv~slG~~l~el~  215 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTA--ADKWSFGTTLLEIC  215 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcH--HHHHHHHHHHHHHH
Confidence            3       4799999988654221    223578889999988653 34444  49999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=2.8e-30  Score=267.68  Aligned_cols=208  Identities=27%  Similarity=0.393  Sum_probs=169.9

Q ss_pred             ccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          440 ILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       440 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      +.++++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+.....    ....+.+|+.+++++ +|||+++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            34456667789999999999999999999965 4688999999865422    135677899999999 79999999999


Q ss_pred             eeeC-----cEEEEEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          518 CLHK-----RCMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       518 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      +...     ...++||||+++++|.++++... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence            8754     35899999999999999886421 223588999999999999999999998   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCc-----CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-----VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.+||+|||++..............++..|+|||.+....     .+.+  .|+||+|+++++++.+.|.
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Di~slGvi~~el~~g~~p  232 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDAR--CDVWSLGITAIELGDGDPP  232 (291)
T ss_pred             CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCc--cchHHHHHHHHHHhhCCCC
Confidence            9999999999987654333333456889999999875433     2334  4999999999999988743

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=5.9e-30  Score=261.42  Aligned_cols=198  Identities=27%  Similarity=0.398  Sum_probs=165.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCc--cChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSET--EDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (701)
                      ++|++.+.||+|+||.||.|.. .+++.||+|.+.....  ......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5799999999999999999965 4689999998864322  2233456788999999999999999999988763  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999987654   478888999999999999999999   999999999999999999999999999976


Q ss_pred             cccCC---CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          605 LHVDS---SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       605 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .....   .......++..|+|||...+...+...  |+||+|+++++++.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~~g~~  207 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKA--DIWSVGCTVVEMLTEKP  207 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcch--hHHHHHHHHHHHhhCCC
Confidence            53211   112234588999999998877666554  99999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=3.1e-30  Score=270.78  Aligned_cols=192  Identities=26%  Similarity=0.416  Sum_probs=155.1

Q ss_pred             ceEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEEEEEEE
Q 041034          455 RYCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCMFFIYE  529 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  529 (701)
                      .++||+|+||+||+|...   +++.||+|.+.....     ...+.+|+.++++++||||+++++++..  +...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            467999999999999653   467899999875432     2456789999999999999999998854  456899999


Q ss_pred             ccCCCCHHHHHhcCC------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCCCeEEEee
Q 041034          530 YMERGSLFYVLRDDD------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADF  599 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll----~~~~~~kL~DF  599 (701)
                      |+.+ +|.+++....      ....+++..+..++.||+.||+|||++   ||+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9965 8888775321      123588999999999999999999999   99999999999999    45679999999


Q ss_pred             cCccccccCCC---CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          600 GTARLLHVDSS---NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       600 Gla~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |+|+.+.....   ......+|+.|+|||++.+.. ++.+.  ||||+|+++++++.+.|..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~el~~g~~~f  216 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchh--hHHHHHHHHHHHHhCCCCc
Confidence            99987643221   123456899999999987643 45544  9999999999999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=4e-30  Score=264.50  Aligned_cols=194  Identities=30%  Similarity=0.431  Sum_probs=165.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +.|+..+.||+|+||.||+|... +++.||+|.+.....  ......+.+|+.++++++||||+++++++.++...++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46788899999999999999654 688999999875432  233577889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...    .+++.++..++.|++.||+|+|+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999998653    478899999999999999999998   9999999999999999999999999999776543


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ........++..|+|||.+.+...+.+.  |+||+|+++++++.+.
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~--Dv~slG~il~el~tg~  198 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKA--DIWSLGITAIELAKGE  198 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHH--HHHHHHHHHHHHHHCC
Confidence            3333445688899999998777666554  9999999998755444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=3e-30  Score=262.54  Aligned_cols=181  Identities=25%  Similarity=0.387  Sum_probs=150.6

Q ss_pred             eEEeeccceEEEEEEcCC-C----------cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          456 YCIGTGGYGSVYKAELPD-G----------KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      +.||+|+||.||+|...+ +          ..|++|.+......    ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            468999999999996653 3          25777876544321    4778899999999999999999999988 778


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-------CeEEE
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-------EAFVA  597 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-------~~kL~  597 (701)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+||+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999999976543  588999999999999999999998   999999999999999887       79999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCC--cCChhhHHHHHHHHHHHHHccc
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP--PVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |||++.....    .....++..|+|||++...  .++.+  .|+||+|+++++++.
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~--~Di~slG~~~~~l~~  201 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIA--ADKWSFGTTLLEICS  201 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhhhcCCCCCcchh--hHHHHHHHHHHHHHh
Confidence            9999986543    2234577889999998776  44444  499999999998665

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.9e-30  Score=266.32  Aligned_cols=206  Identities=26%  Similarity=0.423  Sum_probs=169.4

Q ss_pred             ccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          440 ILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       440 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      .++.++..+.+.|++.+.||+|+||.||+|.. .+++.||+|.+....    .....+..|+.+++++ +||||++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            45566667889999999999999999999965 468899999886542    1235678899999998 69999999999


Q ss_pred             eee------CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          518 CLH------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       518 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      +..      ....+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++++
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            853      4578999999999999999876432 2578888999999999999999998   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.++|+|||++..............|++.|+|||.+..     ..++.+  .|+||+|+++++++.+.+
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~--~DvwslG~~l~el~~g~~  224 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR--SDIWSLGITAIEMAEGAP  224 (282)
T ss_pred             CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcc--cchhHHHHHHHHHHhCCC
Confidence            99999999998765433333344568999999998753     234444  499999999999888774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-30  Score=264.16  Aligned_cols=196  Identities=34%  Similarity=0.484  Sum_probs=170.1

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||.|++|.||+|... +++.||+|.+.....  ......+.+|+.+++.++|+||+++++++.++...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            46888999999999999999654 689999999876432  223466889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||++   +++||||+|+||++++++.++|+|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999998764    589999999999999999999998   9999999999999999999999999999887644


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ........+++.|+|||...+...+.+.  |+|++|+++++++++.|.
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~s--Dv~slG~il~~l~tg~~p  197 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKA--DIWSLGITAIELAKGEPP  197 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchh--hHHHHHHHHHHHHhCCCC
Confidence            3334445788999999999887766665  999999999998887643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=3.6e-30  Score=281.10  Aligned_cols=196  Identities=21%  Similarity=0.327  Sum_probs=158.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....       ....+|+.+++.++||||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            356899999999999999999965 468899999886432       2235799999999999999999886432     


Q ss_pred             ---cEEEEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEE
Q 041034          522 ---RCMFFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFV  596 (701)
Q Consensus       522 ---~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL  596 (701)
                         ...++||||+++ ++.+++... .....+++..+..++.||+.||+|||++   +|+||||||+||+++.++ .+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence               246799999975 777776532 1223688999999999999999999999   999999999999998664 7999


Q ss_pred             EeecCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          597 ADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       597 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      +|||+|+.+.... ......||+.|+|||++.+. .++.+.  ||||+|+++|+++.+.|..
T Consensus       213 ~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwSlGvil~elltG~~pf  271 (440)
T PTZ00036        213 CDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHI--DLWSLGCIIAEMILGYPIF  271 (440)
T ss_pred             eccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHH--HHHHHHHHHHHHHhCCCCC
Confidence            9999998764332 22335689999999987654 455554  9999999999999988654

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=7.1e-30  Score=260.47  Aligned_cols=213  Identities=24%  Similarity=0.394  Sum_probs=172.2

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  527 (701)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+...... ....+++..|+.+++.++||||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            588899999999999999954 56889999998764432 3335678899999999999999999998754  4568999


Q ss_pred             EEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          528 YEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLH-----HDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      |||+++++|.+++.... ....+++..++.++.|++.||+|||     +.   +++|+||||+||+++.++.+||+|||.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence            99999999999987532 2236899999999999999999999     66   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhh
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELE  669 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~  669 (701)
                      +..............+++.|+|||.+.+...+.+.  |+|++|+++++++.+.+ .......++.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~--Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  223 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKS--DIWSLGCLIYELCALSPPFTARNQLQLASKIK  223 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCCCCCchh--HHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh
Confidence            98876544323445689999999998877766554  99999999998887663 33333444444433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1.5e-30  Score=269.63  Aligned_cols=194  Identities=28%  Similarity=0.421  Sum_probs=164.9

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +.|.....||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            4455567799999999999965 468899999986533   223467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...    .+++..+..++.||+.||+|||++   +++||||||+||++++++.++|+|||++......
T Consensus        99 e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          99 EFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             eCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999999988543    478899999999999999999999   9999999999999999999999999999765443


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ........++..|+|||...+..++.+.  |+||+|+++++++.+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slGvil~el~~g~~  216 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEV--DIWSLGIMVIEMIDGEP  216 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            3333445689999999998777666654  99999999999887763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=1e-29  Score=263.29  Aligned_cols=196  Identities=31%  Similarity=0.434  Sum_probs=171.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47899999999999999999654 68999999987654444444677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999997654   588999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                         .....+++.|+|||.+.+...+.+.  |+|++|+++++++.+.+.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~p  197 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAV--DWWALGILIYEMLAGYPP  197 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccc--cHHHHHHHHHHHHhCCCC
Confidence               2334689999999998777666555  999999999999988743

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=4.3e-30  Score=261.95  Aligned_cols=188  Identities=26%  Similarity=0.394  Sum_probs=151.4

Q ss_pred             eEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCcEEEEEEEc
Q 041034          456 YCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL-HKRCMFFIYEY  530 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  530 (701)
                      +.||+|+||.||+|...    +...||+|++....  .....+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            36899999999999642    24579999886432  2333567889999999999999999999775 45568999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +.+|+|.+++.....  ..++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          79 MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999999976432  367788899999999999999998   999999999999999999999999999976532211


Q ss_pred             ----CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          611 ----NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       611 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                          ......++..|+|||......++.+.  ||||+|+++++++.
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~  197 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKS--DVWSFGVLLWELMT  197 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHH--HHHHHHHHHHHHHc
Confidence                11123456789999998777666654  99999999997554

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4.8e-30  Score=265.21  Aligned_cols=200  Identities=24%  Similarity=0.356  Sum_probs=165.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|.++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            46889999999999999999665 68999999887542  2223467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++........+++..+..++.|++.||.|||+++  +++||||||+||+++.++.+||+|||.+..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999876432335899999999999999999999632  8999999999999999999999999999765322


Q ss_pred             CCCceeecccccccCCCCCCCCcC----ChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPV----NQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                        ......+++.|+|||.+.+...    ......|+||+|+++++++.+.+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~  205 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY  205 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence              2223468889999998865433    11223599999999999887663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=5.7e-30  Score=267.20  Aligned_cols=197  Identities=24%  Similarity=0.327  Sum_probs=165.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47899999999999999999654 58899999987654333344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997654   588999999999999999999998   9999999999999999999999999998642110


Q ss_pred             CC---------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SS---------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..               ......++..|+|||.+....++.+.  |+||+|+++++++.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~vl~el~~g~  213 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV--DWWAMGIILYEFLVGC  213 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            00               01123578899999998877776665  9999999999877765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=266.08  Aligned_cols=204  Identities=23%  Similarity=0.308  Sum_probs=178.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|..-++||+|+||+||.++.+ +|+.+|.|++.+..............|-.++..+..+.||.+--.|+..+..++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3467888899999999999999554 699999998877655444444566889999999999999999989999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |+..|.||+|.-++...+. ..+++..++-++.+|+.||++||+.   +||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999988876554 3699999999999999999999999   99999999999999999999999999999885


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSR  658 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~R  658 (701)
                      . +.....++||.+|||||++....|+.+.  |+|++||++|+|+++....|
T Consensus       339 ~-g~~~~~rvGT~GYMAPEvl~ne~Y~~s~--Dwf~lGCllYemi~G~sPFr  387 (591)
T KOG0986|consen  339 E-GKPIRGRVGTVGYMAPEVLQNEVYDFSP--DWFSLGCLLYEMIAGHSPFR  387 (591)
T ss_pred             C-CCccccccCcccccCHHHHcCCcccCCc--cHHHHHhHHHHHHcccCchh
Confidence            4 3444556899999999999999998887  99999999999999875444

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=5.8e-30  Score=264.15  Aligned_cols=196  Identities=26%  Similarity=0.405  Sum_probs=163.7

Q ss_pred             cCCccceEEeeccceEEEEEEcC-----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--Cc
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KR  522 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  522 (701)
                      +.|++.+.||+|+||.||+|...     +++.||||++......  ...+.+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            56788899999999999999643     3678999999865432  345789999999999999999999999877  55


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            78999999999999999976543  489999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCc---eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          603 RLLHVDSSNR---TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       603 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..........   ....++..|+|||...+..+....  |+||+|+++++++++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~--Di~slG~~l~el~tg~  209 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS--DVWSFGVTLYELFTYG  209 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCccc--chHHHhhhhheeeccC
Confidence            8765322211   112345679999998777666665  9999999998877654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=294.41  Aligned_cols=205  Identities=27%  Similarity=0.350  Sum_probs=176.4

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ..++....++|.++++||+|+||.|..++.+ ++++||+|++.+...-......-|..|-.+|..-..+-|++++-.|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3456667899999999999999999999664 689999999987332222223568889999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +.+.|+|||||+||+|..++.+..   ++++.-+..++..|+-||.-+|+.   |+|||||||+|||+|..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999998776   588899999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCC-ceeecccccccCCCCCCCC-----cCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSN-RTLRAGTYGYIAPDQRLSP-----PVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .+-.+..++.. ....+|||.|++||++...     .|+...  |+||+|+++|+|+.+.
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ec--DwWSlGV~~YEMlyG~  278 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGREC--DWWSLGVFMYEMLYGE  278 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCcc--chhhhHHHHHHHHcCC
Confidence            99888755543 4556899999999987643     345555  9999999999998876

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=251.85  Aligned_cols=208  Identities=24%  Similarity=0.393  Sum_probs=169.3

Q ss_pred             cccCCCCcccHHHHHhhhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CC
Q 041034          432 VTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HR  509 (701)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~  509 (701)
                      .+.+..++  |+|+-..+     .+.||+|+|+.|-.+ ...+|.+||||++.+..   ...+.++.+|++++.+++ |+
T Consensus        67 ~~ss~~g~--F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~  136 (463)
T KOG0607|consen   67 ATSSLSGK--FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHK  136 (463)
T ss_pred             ccccccch--HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCc
Confidence            44444444  45555544     367999999999998 56789999999998764   344688899999999995 99


Q ss_pred             ceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       510 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      ||+++++||+++..+|+|||-|.||+|...++++.   .+++.++.++.++|+.||.|||.+   ||.|||+||+|||..
T Consensus       137 nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~  210 (463)
T KOG0607|consen  137 NILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCE  210 (463)
T ss_pred             cHHHHHHHhcccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeec
Confidence            99999999999999999999999999999998765   699999999999999999999999   999999999999996


Q ss_pred             CC---CCeEEEeecCccccccCCC-------CceeecccccccCCCCCC---CC--cCChhhHHHHHHHHHHHHHcccCC
Q 041034          590 SN---LEAFVADFGTARLLHVDSS-------NRTLRAGTYGYIAPDQRL---SP--PVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       590 ~~---~~~kL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~--~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..   ..+|||||.++.-+.....       .....+|+..|||||+..   +.  .|+.+.  |.||||+|+|-|+.+-
T Consensus       211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC--DlwSLGvIlYImLsGY  288 (463)
T KOG0607|consen  211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC--DLWSLGVILYIMLSGY  288 (463)
T ss_pred             CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccc--cHHHHHHHHHHHHhCC
Confidence            54   4689999998865432211       123457999999999653   22  344454  9999999999999987


Q ss_pred             CCC
Q 041034          655 PKS  657 (701)
Q Consensus       655 P~~  657 (701)
                      |..
T Consensus       289 pPF  291 (463)
T KOG0607|consen  289 PPF  291 (463)
T ss_pred             CCc
Confidence            643

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.1e-30  Score=268.43  Aligned_cols=199  Identities=26%  Similarity=0.343  Sum_probs=168.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...........+.+..|+++++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46899999999999999999665 58999999998765544345677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987543 23689999999999999999999998   9999999999999999999999999998755322


Q ss_pred             CC-----------------------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SS-----------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..                             ......|+..|+|||...+...+.+.  ||||+|+++|+++.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~--Di~slG~ll~~l~~g~  229 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGT  229 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchH--HHHHHHHHHHHHhhCC
Confidence            11                             01123578899999999877766654  9999999999876655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.1e-29  Score=261.21  Aligned_cols=194  Identities=31%  Similarity=0.442  Sum_probs=164.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +-|++.+.||+|+||.||+|.. .+++.||+|.+.....  ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            3478889999999999999955 4688999998865432  233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          82 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            999999999998643    488999999999999999999998   9999999999999999999999999999776543


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ........++..|+|||...+...+.+.  |+||+|+++++++.+.
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Dv~slG~~l~~l~~g~  198 (277)
T cd06641         155 QIKRNTFVGTPFWMAPEVIKQSAYDSKA--DIWSLGITAIELAKGE  198 (277)
T ss_pred             hhhhccccCCccccChhhhccCCCCchh--hHHHHHHHHHHHHcCC
Confidence            3333345688899999998776666554  9999999999754444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=2.3e-30  Score=267.35  Aligned_cols=195  Identities=23%  Similarity=0.370  Sum_probs=162.8

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||+|... +|+.||+|+++..... ......+.+|+.++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            5888999999999999999654 6899999998754322 2223567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++ +|.+++.....  .+++..+..++.||++||.|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCDQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            9975 88887765332  589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .......+++.|+|||.+.+.. ++.+  .||||+|+++++++++.
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~il~~l~tg~  197 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTS--IDMWSAGCIFAELANAG  197 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcH--HHHHHHHHHHHHHHhcC
Confidence            3333456789999999876643 3444  49999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=4.2e-30  Score=260.79  Aligned_cols=205  Identities=24%  Similarity=0.423  Sum_probs=166.3

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      ++|++.+.||+|+||.||++.. .++.||+|.++...     ..+.+.+|+.++++++|||++++++++... ..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            5689999999999999999965 67889999986532     136788999999999999999999998764 4799999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.   |++||||||+||+++.++.+||+|||.+...... 
T Consensus        79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999976532 2588999999999999999999998   9999999999999999999999999998764321 


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CCC-CCCCCHHHHHHHhhc
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SKP-KSRPTMQRISQELEG  670 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~P-~~Rpt~~~i~~~l~~  670 (701)
                        ......+..|+|||...+..++.+.  |+||+|+++++++. +.+ ....+..++.+.+..
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~--Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  212 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKS--DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK  212 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchh--hHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC
Confidence              1122345679999998777766654  99999999999875 443 333445555555443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=9.1e-30  Score=260.63  Aligned_cols=198  Identities=25%  Similarity=0.419  Sum_probs=162.0

Q ss_pred             CCccceEEeeccceEEEEEEcCC--CcEEEEEEecCCCc-------cChHHHHHHHHHHHHHhc-CCCCceeeeeeeeee
Q 041034          451 DFHIRYCIGTGGYGSVYKAELPD--GKVVALKKLHQSET-------EDSAFVESFQNEARVLST-VRHRNIVKLYGFCLH  520 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  520 (701)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+.....       .......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999997654  78899998864321       123334567788888865 799999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999987542 122358899999999999999999996 5   899999999999999999999999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ||.+....... ......++..|+|||...+..++.+.  |+||+|+++|+++.+.
T Consensus       158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~--Dv~slG~ll~~l~~g~  210 (269)
T cd08528         158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKA--DVWAFGCILYQMCTLQ  210 (269)
T ss_pred             ccceeeccccc-ccccccCcccCcChhhhcCCCCchHH--HHHHHHHHHHHHHhCC
Confidence            99998764332 33445689999999999877666554  9999999998644443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.4e-30  Score=278.03  Aligned_cols=189  Identities=23%  Similarity=0.329  Sum_probs=161.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+...        +...+|++++++++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999542   3678999988653        23467999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +|||++. ++|.+++....   .+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999996 58888885433   589999999999999999999999   9999999999999999999999999999766


Q ss_pred             ccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          606 HVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       606 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ......  .....||+.|+|||++....++.+.  ||||+|+++|+++.+.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DvwslGvil~el~~g~  284 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKT--DIWSAGLVLFEMSVKN  284 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchh--hHHHHHHHHHHHHHCC
Confidence            432221  2235699999999999888777665  9999999999998765

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=4.8e-30  Score=267.46  Aligned_cols=213  Identities=24%  Similarity=0.435  Sum_probs=172.9

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|+..+.||+|+||.||+|.. .+++    .||+|.+.....  .....++.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            46788899999999999999965 3444    578888865432  23345688999999999999999999998754 4


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++++||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            6799999999999999876432  478899999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          604 LLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       604 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      ........  .....++..|+|||...+..++.+.  ||||+|+++|+                                
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS--DVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI  235 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHH--HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence            76432221  1123356789999998877777665  99999999885                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                 ||..+|.+||+++++++.++..
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                       6666788888888887777654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=6.3e-30  Score=261.85  Aligned_cols=202  Identities=20%  Similarity=0.268  Sum_probs=158.1

Q ss_pred             eEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          456 YCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      +.||+|+||.||+|...   .+..+|+|.++.....  .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            35899999999999653   3457999988765432  223578889999999999999999999999899999999999


Q ss_pred             CCCHHHHHhcCCC--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          533 RGSLFYVLRDDDE--AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       533 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +|+|.+++.....  ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999975432  22467788889999999999999998   999999999999999999999999999975432221


Q ss_pred             C--ceeecccccccCCCCCCCCc-------CChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHH
Q 041034          611 N--RTLRAGTYGYIAPDQRLSPP-------VNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRI  664 (701)
Q Consensus       611 ~--~~~~~gt~~y~aPE~~~~~~-------~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i  664 (701)
                      .  .....++..|+|||...+..       ++.+  .|+||+|+++++++. +. |..-.+..+.
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~--~DiwslG~~l~el~~~g~~p~~~~~~~~~  218 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE--SNVWSLGVTIWELFELGSQPYRHLSDEQV  218 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCcc--chhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence            1  12235678899999875432       2333  499999999999875 55 4433333333

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=8.2e-30  Score=260.46  Aligned_cols=199  Identities=27%  Similarity=0.417  Sum_probs=169.5

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||.|++|+||+|.. .++..+|+|++.......  ..+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            4799999999999999999965 468899999987644332  3577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++........+++..+..++.|++.||+|||++   |++||||||+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999997653323589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCC----ceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSN----RTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...    .....++..|+|||++... ..+.+.  |+|++|+++++++.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~--Dv~slG~i~~~l~~g~~  205 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA--DIWSFGITAIELATGAA  205 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCccc--chHhHhHHHHHHHhCCC
Confidence            222    1334688999999988766 444444  99999999999998864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.1e-30  Score=278.16  Aligned_cols=207  Identities=22%  Similarity=0.303  Sum_probs=174.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..+|.+.+.||+|+||.||+|... .++.||||....         ..+.+|++++++++|+||+++++++...+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            457999999999999999999664 588999996422         3456899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||++. ++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+++....
T Consensus       239 ~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99995 688888865432  589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC---------CCCCCCCHHHHHHHhhcCC
Q 041034          608 DSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS---------KPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       608 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~---------~P~~Rpt~~~i~~~l~~~~  672 (701)
                      ....  .....||+.|+|||++.+..++.+.  ||||+|+++|+++.+         .|..+|...++.+.++...
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~s--DvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~  386 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV--DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ  386 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchH--HHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence            2211  2234699999999999888877665  999999999998643         3567888888888877644

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=8e-30  Score=261.20  Aligned_cols=193  Identities=25%  Similarity=0.375  Sum_probs=158.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|.+.+.||+|+||.||+|...+    ...||+|.......  ....+.+.+|+.++++++||||+++++++.+ ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            4568899999999999999996532    34689998865432  3345788999999999999999999999875 457


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            899999999999999976432  489999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          605 LHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       605 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ....... .....++..|+|||......++...  |+||+|+++++++
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~  202 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSAS--DVWMFGVCMWEIL  202 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchh--hhHHHHHHHHHHH
Confidence            6433211 1122345679999998777666554  9999999998744

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=268.72  Aligned_cols=191  Identities=26%  Similarity=0.395  Sum_probs=164.7

Q ss_pred             ceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          455 RYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      .+.||+|-||+||-|.+ ++|+.||||++.+....... ..++++|+.|++.+.||.||.+-..|+..+..|.|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            57899999999999955 57999999999887655433 37889999999999999999999999999999999999965


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEeecCccccccCCC
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~DFGla~~~~~~~~  610 (701)
                       +..+.+-...++ ++++.....++.||+.||.|||.+   +|+|+||||+|||+..   -.++||||||+|+++.... 
T Consensus       648 -DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  648 -DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             -hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence             666666544433 688888899999999999999999   9999999999999953   3589999999999986443 


Q ss_pred             CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          611 NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .....+|||.|.|||++....|+...  |+||+|+|+|--+.+.
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSL--DMWSVGVIiYVsLSGT  763 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSL--DMWSVGVIIYVSLSGT  763 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccc--cceeeeEEEEEEeccc
Confidence            34456899999999999999999887  9999999999766654

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=6.9e-30  Score=263.96  Aligned_cols=197  Identities=25%  Similarity=0.391  Sum_probs=166.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+.++++++|||++++++++......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            47899999999999999999665 6899999998754322 122356789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++++++..+.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988888765433   589999999999999999999998   9999999999999999999999999999877544


Q ss_pred             CCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ........++..|+|||.+.+. .++.+  +|+||+|+++++++.+.|
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~--~Di~slG~i~~~l~~g~~  199 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPP--VDVWAIGCVFAELLTGQP  199 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCch--hhhHHHHHHHHHHHhCCC
Confidence            3333344678899999987653 34444  499999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.6e-30  Score=264.50  Aligned_cols=184  Identities=22%  Similarity=0.383  Sum_probs=150.6

Q ss_pred             eEEeeccceEEEEEEcCC--------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          456 YCIGTGGYGSVYKAELPD--------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      +.||+|+||.||+|....        ...||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            468999999999995432        2348888775432   23456788899999999999999999999998999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--------eEEEee
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--------AFVADF  599 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~--------~kL~DF  599 (701)
                      |||+++|+|.++++....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999999976543  588999999999999999999999   9999999999999987765        699999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      |.+.....    .....++..|+|||.+.+.. ++..  .|+||+|+++|+++.+
T Consensus       153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~~l~~l~~g  201 (258)
T cd05078         153 GISITVLP----KEILLERIPWVPPECIENPQNLSLA--ADKWSFGTTLWEIFSG  201 (258)
T ss_pred             ccccccCC----chhccccCCccCchhccCCCCCCch--hhHHHHHHHHHHHHcC
Confidence            99865432    22346888999999987643 4444  4999999999975554

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=5.5e-30  Score=262.26  Aligned_cols=204  Identities=21%  Similarity=0.275  Sum_probs=156.3

Q ss_pred             EEeeccceEEEEEEcCC---CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          457 CIGTGGYGSVYKAELPD---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      .||+|+||.||+|...+   ...+|+|.+....  .......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999995432   4568888776433  233346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCC--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC-
Q 041034          534 GSLFYVLRDDDE--AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS-  610 (701)
Q Consensus       534 gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~-  610 (701)
                      |+|.+++.....  ....++.....++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999976532  12356788899999999999999999   999999999999999999999999999875432211 


Q ss_pred             -CceeecccccccCCCCCCCCc-----CChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHH
Q 041034          611 -NRTLRAGTYGYIAPDQRLSPP-----VNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRIS  665 (701)
Q Consensus       611 -~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~  665 (701)
                       ......+++.|+|||......     .......||||+|+++++++. +. |....+-.++.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~  219 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL  219 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence             112234567899999864321     112223599999999999887 43 43344433333

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.1e-29  Score=257.73  Aligned_cols=196  Identities=26%  Similarity=0.385  Sum_probs=165.4

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|.. .+++.+|+|.+....... ...+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            588999999999999999955 468899999987654332 335778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEeecCccccccC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTARLLHVD  608 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DFGla~~~~~~  608 (701)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||++   +++|+||||+||+++++ +.+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999997643 22588999999999999999999998   99999999999999865 46899999999876433


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      . ......++..|+|||...+...+.+.  |+||+|+++++++.+.
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~~l~~l~~~~  198 (256)
T cd08220         156 S-KAYTVVGTPCYISPELCEGKPYNQKS--DIWALGCVLYELASLK  198 (256)
T ss_pred             c-cccccccCCcccCchhccCCCCCccc--chHHHHHHHHHHHhCC
Confidence            2 22234688999999999877666554  9999999999877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=269.22  Aligned_cols=240  Identities=26%  Similarity=0.408  Sum_probs=192.8

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCC---Cc--EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPD---GK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      +...+.....++||.|-||.||+|.+.+   |+  .||||.-+.+...+.  .+.|..|..+|+.++||||++++|+|.+
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            3445556677889999999999995532   33  488998877554433  6889999999999999999999999975


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      . .+|||||.++.|-|..|++..+.  .++......+++||+.||+|||+.   .+|||||-.+|||+....-|||+|||
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence            4 58999999999999999987654  588899999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCcee-ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------
Q 041034          601 TARLLHVDSSNRTL-RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       601 la~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      +++.+..+...... ..-...|||||.+.-..++..+  |+|.||+.+||                              
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtAS--DVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P  614 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTAS--DVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP  614 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhcccchh--hHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC
Confidence            99988655433222 2234579999998776666654  99999999995                              


Q ss_pred             -------------cccCCCCCCCCHHHHHHHhhcCCCccchhhhhhH-HHHhcccceeec
Q 041034          650 -------------CLRSKPKSRPTMQRISQELEGKTPMKKGLKEISI-SEMRNQEMFWLH  695 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~~~~-~~~~~~~~~w~~  695 (701)
                                   ||..+|.+||.+.++...|.....+......-+. ..-+...+.|..
T Consensus       615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R~~a~~~~~~  674 (974)
T KOG4257|consen  615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQRKVASMIWQN  674 (974)
T ss_pred             CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhhcccceeecc
Confidence                         9999999999999999999877654443333222 233445567763

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=3.7e-30  Score=267.39  Aligned_cols=193  Identities=26%  Similarity=0.417  Sum_probs=164.3

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      .|.....||+|+||.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            344556799999999999955 46899999998654322   24668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..+....
T Consensus        99 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          99 FLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             cCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            99999999987542    488999999999999999999999   99999999999999999999999999997665444


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......++..|+|||.+.+..++.+.  |+||+|+++++++.+.+
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~~g~~  215 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEV--DIWSLGIMVIEMVDGEP  215 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            334445789999999998877766554  99999999998777664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=9.5e-30  Score=263.70  Aligned_cols=198  Identities=26%  Similarity=0.378  Sum_probs=164.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|++|.||+|... +++.||+|.+........  ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            478999999999999999999654 689999999876432211  24467899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++ +|.+++.....  .+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            999985 99998876543  588999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .........++..|+|||...+. .++.+  .|+||+|+++++++.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~--~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTS--LDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcH--HHHHHHHHHHHHHHhCCCC
Confidence            22222333568899999987653 34444  4999999999999988743

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=8.8e-30  Score=260.92  Aligned_cols=205  Identities=26%  Similarity=0.419  Sum_probs=158.8

Q ss_pred             eEEeeccceEEEEEEcC-CCc--EEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          456 YCIGTGGYGSVYKAELP-DGK--VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      +.||+|+||.||+|... ++.  .+|+|.++...  .....+.+.+|+.+++++ +||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            35899999999999664 344  46888887432  223346788999999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          532 ERGSLFYVLRDDD-------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       532 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                      ++|+|.+++....             ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence            9999999987532             112478999999999999999999998   999999999999999999999999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHh
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQEL  668 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l  668 (701)
                      ||++....... .......+..|+|||......++.+.  |+||+|++++++++ +. |..+-+..++.+.+
T Consensus       156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~--Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  224 (270)
T cd05047         156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNS--DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  224 (270)
T ss_pred             CCCccccchhh-hccCCCCccccCChHHHccCCCCchh--hHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence            99986432111 11112245679999998777666665  99999999998764 33 33333444444433

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=8.6e-30  Score=260.60  Aligned_cols=197  Identities=24%  Similarity=0.424  Sum_probs=167.1

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE---DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +|+..+.||+|++|.||+|.. .+++.||+|++......   .....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999954 57899999998754322   12345788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla~~~  605 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   |++|+||||+||+++.++ .+||+|||.+..+
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999997644   588999999999999999999999   999999999999998776 5999999999876


Q ss_pred             ccCCC----CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          606 HVDSS----NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       606 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .....    ......++..|+|||.+.+..++.+.  |+|++|+++++++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~--Dv~slG~~l~~l~~g~~  206 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSC--DVWSVGCVIIEMATAKP  206 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCccc--chHHHHHHHHHHHhCCC
Confidence            53321    11234578899999998777666655  99999999999988874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-31  Score=270.16  Aligned_cols=219  Identities=29%  Similarity=0.488  Sum_probs=191.1

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcCC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      +++++....+.....+||-|-||.||.|.|+. .-.||||.++.+...    .++|..|+.+|+.++|||+|+++|+|..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            35666667778889999999999999998864 567999999876533    6889999999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +..+|||+|||..|+|.+|+++..+. .++....+.++.||+.|++||..+   ++|||||-+.|.|+.++..||++|||
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999999987543 577778889999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecc---cccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------------
Q 041034          601 TARLLHVDSSNRTLRAG---TYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------------  649 (701)
Q Consensus       601 la~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------------  649 (701)
                      +++.+..+.  .+...|   ...|.|||.+.-..+..+.  |||+||+++|+                            
T Consensus       411 LsRlMtgDT--YTAHAGAKFPIKWTAPEsLAyNtFSiKS--DVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  411 LSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNTFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD  486 (1157)
T ss_pred             hhhhhcCCc--eecccCccCcccccCcccccccccccch--hhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence            999987543  333344   4569999999888777776  99999999995                            


Q ss_pred             ---------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ---------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ---------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                     ||...|.+||+++|+-+.++...
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                           99999999999999988877543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=8e-30  Score=260.91  Aligned_cols=191  Identities=19%  Similarity=0.291  Sum_probs=150.3

Q ss_pred             EEeeccceEEEEEEcCCC---cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          457 CIGTGGYGSVYKAELPDG---KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      .||+|+||.||+|...++   ..+++|.+.....  ....+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999964433   3466776654432  23357889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC--C
Q 041034          534 GSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS--S  610 (701)
Q Consensus       534 gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~--~  610 (701)
                      |+|.+++.+... ....++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++.......  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999976432 22466778889999999999999998   99999999999999999999999999986432111  1


Q ss_pred             CceeecccccccCCCCCCCCc-----CChhhHHHHHHHHHHHHHccc
Q 041034          611 NRTLRAGTYGYIAPDQRLSPP-----VNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ......++..|+|||......     .......||||+|+++++++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  203 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE  203 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence            122346788999999875321     111223499999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=1.2e-29  Score=257.75  Aligned_cols=197  Identities=26%  Similarity=0.363  Sum_probs=167.7

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETE--DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      +|+..+.||+|++|.||+|... +++.||+|.+......  .....+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999665 7899999998754321  233457789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997653   488999999999999999999998   999999999999999999999999999887543


Q ss_pred             CCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .. ......++..|+|||...... .+.+  .|+|++|+++++++.+.+.
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~--~D~~slG~~l~~l~~g~~p  201 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLA--ADIWSLGCTVLEMATGKPP  201 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCch--hhhHHHHHHHHHHHhCCCC
Confidence            32 223456889999999886655 4444  4999999999999987754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1.1e-29  Score=258.00  Aligned_cols=211  Identities=27%  Similarity=0.452  Sum_probs=170.6

Q ss_pred             CccceEEeeccceEEEEEEcCC-----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAELPD-----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +++.+.||+|+||.||+|...+     +..||+|++......  ...+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            4577899999999999996643     388999999765432  235788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      +|||+++++|.+++...... .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.++...
T Consensus        79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999999764421 289999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCCce-eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-CC-CCCCCCHHHHHHHhhc
Q 041034          607 VDSSNRT-LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-SK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       607 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~~-P~~Rpt~~~i~~~l~~  670 (701)
                      ....... ...+++.|+|||...+...+.+.  |+|++|+++++++. +. |....+..++.+.+..
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~--Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~  219 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKS--DVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK  219 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcch--hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            4322111 22367899999998666666655  99999999998875 33 4344455555555443

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.7e-29  Score=257.64  Aligned_cols=197  Identities=28%  Similarity=0.427  Sum_probs=168.8

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            588999999999999999965 46899999998866543 3456889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++....   .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999997643   478899999999999999999998   99999999999999999999999999998765433


Q ss_pred             CCce----eecccccccCCCCCCCCc---CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRT----LRAGTYGYIAPDQRLSPP---VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~----~~~gt~~y~aPE~~~~~~---~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ....    ...+++.|+|||.+.+..   ...+  .|+|++|+++++++.+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~--~Dv~s~G~il~~l~~g~~p  205 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA--ADIWSLGCVVLEMATGKRP  205 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcc--cchHHHHHHHHHHHhCCCC
Confidence            2211    245788999999987665   4444  4999999999999887644

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1e-29  Score=260.72  Aligned_cols=198  Identities=25%  Similarity=0.366  Sum_probs=164.6

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc-------ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE-------DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      +|.+.+.||+|++|.||+|.. .+++.||+|.++.....       .....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999954 46899999988643211       1123456788999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999997653   588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCC--CceeecccccccCCCCCCCCc--CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSS--NRTLRAGTYGYIAPDQRLSPP--VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.......  ......++..|+|||......  ++.+  .|+||+|+++++++.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~--~Dv~slG~~l~~l~~g~~p  211 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAK--VDIWSLGCVVLEMFAGRRP  211 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCcc--chhHHHHHHHHHHHhCCCC
Confidence            76542211  122345888999999887654  3444  4999999999998888743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-30  Score=263.09  Aligned_cols=202  Identities=29%  Similarity=0.443  Sum_probs=167.7

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCc--
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKR--  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--  522 (701)
                      .+.++|++.+.||+|++|.||+|... +++.|++|++.....    ..+.+.+|+.+++++ .|+||+++++++....  
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            46789999999999999999999664 678999999876432    236788999999999 6999999999997644  


Q ss_pred             ----EEEEEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          523 ----CMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       523 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                          ..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence                4899999999999999886532 123689999999999999999999998   99999999999999999999999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCCc-----CChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-----VNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |||.+..............++..|+|||.+....     ++.+  +|+|++|+++++++.+.+..
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Dv~slG~il~~l~~g~~p~  218 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR--SDVWSLGITAIELADGKPPL  218 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCcccc--ccHHHhHHHHHHHHhCCCCc
Confidence            9999987654333344456899999999875432     3333  49999999999998877543

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=2.7e-29  Score=256.14  Aligned_cols=196  Identities=30%  Similarity=0.463  Sum_probs=171.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|++......  ...+.+.+|+.++++++|+|++++++++......++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            46889999999999999999665 5999999998765432  34578899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||+++++|.+++....   .+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999997653   58999999999999999999999 8   999999999999999999999999999987754


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........++..|+|||.......+.+.  |+|++|+++++++.+.+
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~--Dv~slG~il~~l~tg~~  198 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGESYSYAA--DIWSLGLTLLECALGKF  198 (264)
T ss_pred             CCCcccceeecccccCHhhhCCCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            44443345688999999998877666554  99999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1e-29  Score=258.32  Aligned_cols=198  Identities=25%  Similarity=0.374  Sum_probs=167.0

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+.+++.++|+||+++++.+.+....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5888999999999999999664 58899999987643221 224677899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCccccccC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTARLLHVD  608 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla~~~~~~  608 (701)
                      |+++++|.+++..... ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++ .+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999999876432 2579999999999999999999998   999999999999998885 4699999999876544


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ........|++.|+|||...+...+.+.  |+||+|+++++++.+.+
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~--Dv~slG~il~~l~~g~~  200 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKT--DIWSLGCVLYELCTLKH  200 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            3333345689999999998777666554  99999999999887753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=1.6e-29  Score=262.08  Aligned_cols=195  Identities=27%  Similarity=0.414  Sum_probs=167.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            46899999999999999999954 4688999999864322   2246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      +||+++++|.+++.+.    .+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999998753    378899999999999999999999   999999999999999999999999999876654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........+++.|+|||.......+...  |+|++|+++++++.+.+
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Dv~slG~ll~~ll~g~~  213 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKV--DIWSLGIMAIEMVEGEP  213 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            43333445688999999998776665554  99999999999887764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=261.52  Aligned_cols=192  Identities=29%  Similarity=0.474  Sum_probs=158.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhc--CCCCceeeeeeeeeeCc----
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST--VRHRNIVKLYGFCLHKR----  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----  522 (701)
                      ....+..+.||+|.||.||+|.+. ++.||||++....      .+.|..|-+|.+.  ++|+||++++++-+...    
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            345567889999999999999884 5999999997543      3667777777665  47999999999876554    


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecCCCCCcEEEcCCCCeEE
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC------TPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                      .++||+||.+.|+|.++++.+    .++|....+|+..|++||+|||+..      .++|+|||||..|||+..|+...|
T Consensus       282 eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            799999999999999999876    4999999999999999999999763      467999999999999999999999


Q ss_pred             EeecCccccccCCCC--ceeecccccccCCCCCCCCcC----ChhhHHHHHHHHHHHHHcc
Q 041034          597 ADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPV----NQKIIQDIILVSTTALACL  651 (701)
Q Consensus       597 ~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~~~~~Di~slg~i~~~cl  651 (701)
                      +|||+|..+......  ....+||..|||||++.+.-.    +.....||||+|.|+||+.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~  418 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA  418 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999988643322  223579999999999876432    2223469999999999844

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=1.2e-29  Score=263.15  Aligned_cols=199  Identities=26%  Similarity=0.351  Sum_probs=166.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  525 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|.++..... ......+.+|+.++++++||||+++++++...  ...|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            357999999999999999999665 6889999999765433 22335667899999999999999999998877  8899


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++ +|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++..
T Consensus        83 lv~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99999975 99998876443  589999999999999999999999   9999999999999999999999999999877


Q ss_pred             ccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...........+++.|+|||.+.+.. .+.+  .|+||+|+++++++.+.|.
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~--~Di~slG~~l~~l~~g~~~  206 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTA--IDMWSVGCIFAELLTKKPL  206 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccch--hhHHHHHHHHHHHHhCCCC
Confidence            54433334456788999999886543 3333  4999999999999998753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=1.6e-29  Score=260.96  Aligned_cols=197  Identities=25%  Similarity=0.367  Sum_probs=164.5

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|... +++.||||++....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            5889999999999999999654 68999999987543222 223568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+. ++|.+++..... ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 589888865432 2589999999999999999999998   99999999999999999999999999998664433


Q ss_pred             CCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHHcccCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......+++.|+|||...+... +..  .|+|++|+++++++++.+
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~il~~l~tg~~  199 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTA--VDIWSLGCIFAEMVTRRA  199 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcH--HHHHHHHHHHHHHHHCCC
Confidence            33334457889999998765443 333  599999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=251.14  Aligned_cols=198  Identities=25%  Similarity=0.339  Sum_probs=177.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|...++||+|.||.|..++. ..++.+|+|++++...-.......-..|-++++..+||.+..+.-.|+..+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999955 47999999999987765555455667899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||..||.|.-++.+..   .+++....-+...|+.||.|||++   +||.||+|.+|.++|.+|++||.|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999998887644   588899999999999999999999   999999999999999999999999999987555


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .+......+|||.|.|||++....|+...  |+|.+|+++|+|+-+.
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraV--DWWG~GVVMYEMmCGR  365 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAV--DWWGVGVVMYEMMCGR  365 (516)
T ss_pred             ccceeccccCChhhcCchhhcccccccee--ehhhhhHHHHHHHhcc
Confidence            66677788999999999999999999888  9999999999976654

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=5.8e-29  Score=257.79  Aligned_cols=199  Identities=27%  Similarity=0.356  Sum_probs=164.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ++++|.+.+.||+|+||.||+|.. .+++.||+|++.......  ....+.+|+.+++.++|+||+++++++.+++..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            467899999999999999999955 468999999987654322  12456789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+. +++.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999996 577777654332  477888999999999999999998   99999999999999999999999999997654


Q ss_pred             cCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ..........+++.|+|||.+.+.. ++.+  .|+||+|+++++++++.+.
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSA--LDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcH--HHHHHHHHHHHHHHhCCCC
Confidence            3333334446789999999886532 3444  4999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-29  Score=258.93  Aligned_cols=193  Identities=32%  Similarity=0.479  Sum_probs=162.9

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCcEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR---HRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  526 (701)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+......  ...+++.+|+.++++++   |||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            478889999999999999965 57899999998754322  23467888999999996   9999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.++++..    .+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||.+..+.
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999998653    588999999999999999999998   99999999999999999999999999998775


Q ss_pred             cCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..........|+..|+|||...+.. ++..  .|+|++|+++++++.+.
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~~l~~ll~g~  199 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTK--ADIWSLGITIYEMATGN  199 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccc--hhHHHHHHHHHHHHhCC
Confidence            4443344456899999999876533 3444  49999999999755544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=1.8e-29  Score=266.02  Aligned_cols=195  Identities=19%  Similarity=0.281  Sum_probs=158.7

Q ss_pred             cceEEeec--cceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          454 IRYCIGTG--GYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       454 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      +.++||+|  +|++||++.. .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            46789999  7889999955 57899999999765432 23356778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +++|+|.+++...... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+........
T Consensus        81 ~~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999998654322 488999999999999999999998   999999999999999999999999986544321111


Q ss_pred             -------CceeecccccccCCCCCCCC--cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          611 -------NRTLRAGTYGYIAPDQRLSP--PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       611 -------~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                             ......++..|+|||++.+.  .++.+  .||||+|+++++++.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~--~DiwslG~il~el~~g~~  208 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK--SDIYSVGITACELANGHV  208 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCch--hhHHHHHHHHHHHHHCCC
Confidence                   11223467789999998763  34444  499999999998887664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1e-29  Score=262.41  Aligned_cols=195  Identities=27%  Similarity=0.364  Sum_probs=166.1

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++.....  ....+.+.+|+++++.++||||+++++++......++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            5788999999999999999965 4688999998875432  334578899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++++|.+++...+   .+++..+..++.+++.||.|||+..  +++||||||+||++++++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999987643   5889999999999999999999632  8999999999999999999999999998754322


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                        ......|+..|+|||++.+...+.+.  |+||+|+++++++.+.+
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~--Di~slG~~l~~l~tg~~  200 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKS--DVWSLGISIIELALGKF  200 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccc--hHHHHHHHHHHHHhCCC
Confidence              12234689999999998777666665  99999999998876553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=1.1e-29  Score=259.41  Aligned_cols=194  Identities=27%  Similarity=0.368  Sum_probs=167.8

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|+..+.||+|++|.||+|... +++.||+|.+......  ...+++.+|+.++++++||||+++++++......++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            46888899999999999999664 6899999998765432  33567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||+ .   +++|+||||+||++++++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999997653  268899999999999999999998 7   999999999999999999999999999876643


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ....  ...++..|+|||...+..++.+.  |+||+|+++++++.+.
T Consensus       154 ~~~~--~~~~~~~y~~PE~~~~~~~~~~~--Dv~slG~~l~~l~~g~  196 (265)
T cd06605         154 SLAK--TFVGTSSYMAPERIQGNDYSVKS--DIWSLGLSLIELATGR  196 (265)
T ss_pred             HHhh--cccCChhccCHHHHcCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            2221  25688999999998887766665  9999999999999866

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=3.3e-29  Score=260.92  Aligned_cols=209  Identities=24%  Similarity=0.340  Sum_probs=170.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.......  ....+.+|+.+++.++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            367999999999999999999654 68899999987543322  234567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||++ ++|.+++.....  .+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        83 ~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             Eeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99997 499988876432  478899999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQE  667 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~  667 (701)
                      .........+++.|+|||++.+.. ++.+  .||||+|+++++|+++.|. ...+..+..+.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~  216 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQ--IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF  216 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccH--HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            333333446789999999876543 3333  4999999999999999854 34455444433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=2.6e-29  Score=259.97  Aligned_cols=197  Identities=27%  Similarity=0.410  Sum_probs=166.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|+++..... ....+.+.+|+++++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            46899999999999999999665 5889999988764332 233577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++++.+..+.....   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||.+......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9999877766554432   488999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CC-CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SS-NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .. ......++..|+|||.+.+. ..+.+  .|+||+|+++++++.+.|
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~--~Dv~slG~~l~~l~~g~~  200 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKP--VDVWAIGCIMAELLDGEP  200 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCch--hhHHHHHHHHHHHHhCCC
Confidence            32 23345678999999998776 45554  499999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-31  Score=297.53  Aligned_cols=196  Identities=29%  Similarity=0.420  Sum_probs=165.2

Q ss_pred             hhhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ..+-+++....||.|.||.||.| ...+|...|+|-++..... ....+...+|+.++..++|||+|+++|+-.+.+..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34557888899999999999999 4557999999988876544 444577889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |.||||++|+|.+.++...   ..++.....+..|++.|++|||++   |||||||||+||+++.+|.+|++|||.|..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999997654   356677777999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCC----ceeecccccccCCCCCCCCcCCh-hhHHHHHHHHHHHHH
Q 041034          606 HVDSSN----RTLRAGTYGYIAPDQRLSPPVNQ-KIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~-~~~~Di~slg~i~~~  649 (701)
                      ....+.    .....||+.|||||++.+..... .-++||||+|||.+|
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence            654322    12356999999999998765322 223599999999774

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=4.6e-29  Score=260.60  Aligned_cols=195  Identities=28%  Similarity=0.383  Sum_probs=161.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            4567999999999999999999654 689999999875544444445678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++ ++.+++.....  .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~g-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCLG-SASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhCC-CHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9999974 77777754332  589999999999999999999998   99999999999999999999999999987653


Q ss_pred             cCCCCceeecccccccCCCCCCC---CcCChhhHHHHHHHHHHHHHcccCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLS---PPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..    ....+++.|+|||.+.+   ..++.+  +|||++|+++++++++.
T Consensus       167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~--sDv~s~G~il~el~tg~  211 (307)
T cd06607         167 PA----NSFVGTPYWMAPEVILAMDEGQYDGK--VDVWSLGITCIELAERK  211 (307)
T ss_pred             CC----CCccCCccccCceeeeccCCCCCCcc--cchHHHHHHHHHHHcCC
Confidence            22    23468889999998742   334444  49999999998755544

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.1e-29  Score=281.50  Aligned_cols=201  Identities=20%  Similarity=0.272  Sum_probs=156.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC--CCcEEEEEE--------------ecCCCccChHHHHHHHHHHHHHhcCCCCce
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP--DGKVVALKK--------------LHQSETEDSAFVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (701)
                      ..++|++.+.||+|+||+||+|..+  .+..+++|.              +.+...........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998543  222222221              111111122345678899999999999999


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCC--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE--AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      +++++++.+.+..|+|+|++.+ ++.+++.....  ........+..++.|++.||+|||++   |||||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999964 77777654321  11234567788999999999999998   999999999999999


Q ss_pred             CCCCeEEEeecCccccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          590 SNLEAFVADFGTARLLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .++.+||+|||+++.+..... ......||+.|+|||++.+..++...  ||||+|+++|+++.+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvil~ell~~~  365 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT--DIWSCGLILLDMLSHD  365 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHH--HHHHHHHHHHHHHHCC
Confidence            999999999999987654322 22235799999999999888777665  9999999999988764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=2.7e-29  Score=259.16  Aligned_cols=198  Identities=24%  Similarity=0.383  Sum_probs=159.0

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHH-HhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARV-LSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.......  ..++..|+.+ ++..+||||+++++++..++..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47899999999999999999654 699999999876543222  2345556654 6667899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          528 YEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||++ |+|.+++... .....+++..+..++.|++.||+|||+++  +++||||||+||+++.++.+||+|||.+..+.
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99997 5888887643 22246899999999999999999999753  89999999999999999999999999998664


Q ss_pred             cCCCCceeecccccccCCCCCCCC----cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSP----PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .. .......++..|+|||.+.+.    .++.+  .|+|++|+++++++.+.+
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~--~Di~slG~~l~~l~~g~~  205 (283)
T cd06617         156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVK--SDVWSLGITMIELATGRF  205 (283)
T ss_pred             cc-cccccccCCccccChhhcCCcccccccCcc--ccchhhHHHHHHHHhCCC
Confidence            22 222334688999999987652    23444  499999999999888763

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=2e-29  Score=264.48  Aligned_cols=200  Identities=26%  Similarity=0.438  Sum_probs=162.5

Q ss_pred             CCccceEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMF  525 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  525 (701)
                      +|++.+.||+|++|.||+|...   +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4888999999999999999653   4789999999875422233346678899999999999999999999988  8899


Q ss_pred             EEEEccCCCCHHHHHhcCCC--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----CCCeEEEee
Q 041034          526 FIYEYMERGSLFYVLRDDDE--AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS----NLEAFVADF  599 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~----~~~~kL~DF  599 (701)
                      +||||+++ ++.+++.....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 77776653321  22588999999999999999999998   9999999999999999    899999999


Q ss_pred             cCccccccCCC---CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          600 GTARLLHVDSS---NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       600 Gla~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |+++.......   ......+++.|+|||.+.+. .++.+  +|+||+|+++++++.+.|.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~~l~~l~~~~~~  215 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKA--IDIWAIGCIFAELLTLEPI  215 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcH--HHHHHHHHHHHHHHhcCCC
Confidence            99987643322   12234678899999987654 34444  4999999999998877643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=3.4e-29  Score=256.94  Aligned_cols=195  Identities=26%  Similarity=0.395  Sum_probs=156.5

Q ss_pred             CccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----
Q 041034          452 FHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----  522 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (701)
                      |++.+.||+|+||.||+|...    .++.||||++...... ....+++.+|+.++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            677889999999999999542    3688999999765433 233567889999999999999999999886532     


Q ss_pred             -EEEEEEEccCCCCHHHHHhcC---CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          523 -CMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       523 -~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                       ..++++||+++|+|.+++...   .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence             347899999999999887532   1223478899999999999999999998   999999999999999999999999


Q ss_pred             ecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          599 FGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       599 FGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||.++.......  ......+++.|++||......++.+.  ||||+|+++++++.
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~s--Di~slG~il~el~~  210 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHS--DVWAFGVTMWEIMT  210 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhh--hhHHHHHHHHHHhh
Confidence            999986543221  11223456789999998777766654  99999999997554

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=1.8e-29  Score=258.43  Aligned_cols=189  Identities=29%  Similarity=0.421  Sum_probs=154.5

Q ss_pred             EEeeccceEEEEEEcCC-------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          457 CIGTGGYGSVYKAELPD-------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      .||+|+||.||+|...+       ++.||+|.+.....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            58999999999996532       25799998865432  1224678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC----CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-----CeEEEeec
Q 041034          530 YMERGSLFYVLRDDD----EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-----EAFVADFG  600 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-----~~kL~DFG  600 (701)
                      |+++++|.+++....    ....+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999997532    122478899999999999999999998   999999999999999877     89999999


Q ss_pred             CccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          601 TARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       601 la~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +++.......  ......++..|+|||.+.+...+.+.  ||||+|++++++++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~ellt  208 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQS--DVWSFGVLMWEILT  208 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccch--hHHHHHHHHHHHHH
Confidence            9976532211  11223456789999998877776665  99999999998664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.2e-29  Score=251.41  Aligned_cols=197  Identities=28%  Similarity=0.423  Sum_probs=170.4

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++|||++++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            5888999999999999999554 6889999999876432 2345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999987653   589999999999999999999998   99999999999999999999999999998775444


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .......++..|+|||...+...+.+  .|+|++|+++++++.+.+.
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~--~Dv~~lG~~l~~l~~g~~p  198 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTA--SDIWSLGCTVIELLTGNPP  198 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcc--hhHHHHHHHHHHHHhCCCC
Confidence            33344568899999999877665554  4999999999998887643

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=3e-29  Score=277.01  Aligned_cols=197  Identities=18%  Similarity=0.233  Sum_probs=159.7

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC------Cceeeeeee
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH------RNIVKLYGF  517 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~  517 (701)
                      +....++|++.+.||+|+||.||+|.. ..++.||||+++...    ...+.+..|+.+++.++|      .++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            344568899999999999999999965 468899999996432    123445667777776654      468889998


Q ss_pred             eeeC-cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCC---
Q 041034          518 CLHK-RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNL---  592 (701)
Q Consensus       518 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~---  592 (701)
                      +... ..+++|||++ +++|.+++.+..   .+++..+..|+.||+.||+|||+ .   |||||||||+|||++.++   
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence            8764 5789999998 678998887654   58999999999999999999996 5   999999999999998665   


Q ss_pred             -------------CeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          593 -------------EAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       593 -------------~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                                   .+||+|||.+....   ......+||+.|+|||++.+..++.+.  ||||+||++|+|+.+.|..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~--DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHH--HHHHHHHHHHHHHhCCCCC
Confidence                         49999999886432   223446799999999999988887765  9999999999999988654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=3.9e-29  Score=258.41  Aligned_cols=197  Identities=30%  Similarity=0.442  Sum_probs=170.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...+.|++.+.||+|++|.||+|... +++.||+|++.....    ..+.+.+|+++++.++|+|++++++++......+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            45678999999999999999999665 688999999976543    3467889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +|+||+++++|.+++....  ..+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||.+...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            9999999999999998754  2589999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ...........++..|+|||...+..++.+.  |+|++|+++++++.+.
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--Dv~slGvil~~l~~g~  213 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV--DIWSLGIMCIEMAEGE  213 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCcc--ccHHHHHHHHHHHhCC
Confidence            4333333344578899999998877777665  9999999999988765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=4.8e-29  Score=257.28  Aligned_cols=197  Identities=24%  Similarity=0.370  Sum_probs=164.2

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |++.+.||.|++|.||+|.. .+|+.||+|++...... ....+.+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67889999999999999965 47999999998765322 22235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      ++ ++|.+++..... ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||.++.......
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            95 589999876542 2589999999999999999999998   999999999999999999999999999976543333


Q ss_pred             CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          611 NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ......++..|+|||.+.+.. ++.+  .|+||+|+++++++++.|.
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~--~Di~slG~~l~~l~~g~~p  199 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTP--VDIWSIGCIFAEMVNRRPL  199 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcH--HHHHHHHHHHHHHHhCCCC
Confidence            333345788999999876543 3444  4999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=5.1e-29  Score=257.31  Aligned_cols=193  Identities=27%  Similarity=0.405  Sum_probs=165.3

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|...+.||+|++|.||+|.. .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            455668999999999999964 4788999998864322   224568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++...    .+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999998762    488899999999999999999999   99999999999999999999999999987654433


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......|++.|+|||...+..++.+.  |+||+|+++++++.+.+
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slGv~l~ell~g~~  213 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEV--DIWSLGIMVIEMVDGEP  213 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcc--cHHHHHHHHHHHHhCCC
Confidence            333345689999999998877776665  99999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=1.5e-28  Score=257.88  Aligned_cols=188  Identities=27%  Similarity=0.399  Sum_probs=157.7

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +.|+..+.||+|+||.||+|.. .+++.||+|++.............+.+|+++++.++|||++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4478889999999999999965 468899999987654444445567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++ ++.+.+.....  .+++.++..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 78777754332  589999999999999999999998   999999999999999999999999999875432 


Q ss_pred             CCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHH
Q 041034          609 SSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~  649 (701)
                         .....+++.|+|||.+.   ...++.+.  |+||+|+++++
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~--Dv~slGvil~e  216 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKV--DVWSLGITCIE  216 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccc--cHHHHHHHHHH
Confidence               22346889999999874   23344444  99999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=2.7e-29  Score=258.55  Aligned_cols=210  Identities=28%  Similarity=0.414  Sum_probs=174.9

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999654 79999999987654433344577889999999998 99999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.+..   .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999997654   589999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCC--------------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHH
Q 041034          608 DSS--------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQ  666 (701)
Q Consensus       608 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~  666 (701)
                      ...                    ......++..|+|||...........  |+|++|+++++++.+.+ ...++..+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~--Di~slG~~l~~l~~g~~p~~~~~~~~~~~  232 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS--DLWALGCIIYQMLTGKPPFRGSNEYLTFQ  232 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhh--hHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            221                    12234578899999998776655554  99999999999988774 34455444433


Q ss_pred             H
Q 041034          667 E  667 (701)
Q Consensus       667 ~  667 (701)
                      .
T Consensus       233 ~  233 (280)
T cd05581         233 K  233 (280)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.1e-28  Score=255.22  Aligned_cols=196  Identities=28%  Similarity=0.363  Sum_probs=163.9

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMFF  526 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  526 (701)
                      ++|...+.||.|++|.||+|... +++.||+|.+.....  .....++.+|++++++++||||+++++++.+.  ...++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            46888999999999999999664 688999999875433  23457789999999999999999999988653  46899


Q ss_pred             EEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999998875421 223588899999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ....  .....++..|+|||...+..++.+.  |+|++|+++|+++.+.
T Consensus       156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~--Dv~slG~il~~l~~g~  200 (287)
T cd06621         156 VNSL--AGTFTGTSFYMAPERIQGKPYSITS--DVWSLGLTLLEVAQNR  200 (287)
T ss_pred             cccc--cccccCCccccCHHHhcCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            3222  1234578899999998877776665  9999999999988775

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=6.2e-29  Score=255.79  Aligned_cols=190  Identities=24%  Similarity=0.302  Sum_probs=152.8

Q ss_pred             EEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHH---HhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          457 CIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARV---LSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      .||+|+||.||+|.. .+++.||+|.+.............+.+|..+   +...+||+|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            379999999999965 4689999999876543322222333444433   334479999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR  612 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  612 (701)
                      +++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++......  ..
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence            999999987654   589999999999999999999998   9999999999999999999999999999765322  22


Q ss_pred             eeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          613 TLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       613 ~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ....|+..|+|||.... ..++.+.  |+||+|+++++++.+.+.
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~--Di~slG~~l~~l~~g~~p  195 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSA--DWFSLGCMLFKLLRGHSP  195 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchh--hhHHHHHHHHHHHhCCCC
Confidence            23468999999998764 3445554  999999999998887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.8e-30  Score=251.83  Aligned_cols=217  Identities=24%  Similarity=0.348  Sum_probs=186.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ...+|..+.+||+|+||.|-+|..+ +.+.+|||++++...-.....+--+.|-++|+-. +-|.+++++..|+.-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3467899999999999999999554 4678999999987544333334446677777766 4789999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+.||+|.-.+++.+   ++.+..+.-+|..||-||-+||++   |||.||||.+||++|.+|++||+|||.++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999999998776   577888999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhhcCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELEGKT  672 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~~~~  672 (701)
                      -.+.......+|||.|+|||++..++|...+  |+|++|+++|+|+.+.| .+--.-.++.+.+.+..
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksv--DWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn  566 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN  566 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccch--hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence            5566667778999999999999999999887  99999999999999985 45567778877776655

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.1e-28  Score=250.60  Aligned_cols=214  Identities=27%  Similarity=0.392  Sum_probs=178.6

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+++++.++|||++++++.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            5888999999999999999654 6899999999765432 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          530 YMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||+.   |++|+||+|+||++++++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999997642 123689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhhc
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~~  670 (701)
                      ........+++.|+|||...+...+.+.  |+|++|+++++++.+. |.......++.+.+..
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~--Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  217 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKS--DIWSLGCVLYELCTLKHPFEGENLLELALKILK  217 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccc--cHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence            3333445688999999998777766665  9999999999988776 4344455555555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=6.3e-29  Score=252.71  Aligned_cols=196  Identities=28%  Similarity=0.435  Sum_probs=171.4

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.++...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999664 689999999987654444456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++....   .+++..+..++.|+++||.|||+.   +++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            999999999997653   588999999999999999999998   99999999999999999999999999998764332


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                       ......|+..|+|||.......+.+.  |+|++|+++++++.+.+
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~--Di~slG~~l~~l~~g~~  197 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAV--DWWSLGVTAYECLRGKR  197 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcc--cchhhHHHHHHHHhCCC
Confidence             23345688899999998877766665  99999999999998873

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=8.5e-29  Score=254.62  Aligned_cols=191  Identities=26%  Similarity=0.356  Sum_probs=161.1

Q ss_pred             EeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|+||+||+|.. .+++.||+|.+.............+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999954 46899999998764433233345667899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeec
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA  616 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  616 (701)
                      .+++..... ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+..... ........
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence            999876543 2589999999999999999999998   999999999999999999999999999976543 22223346


Q ss_pred             ccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          617 GTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ++..|+|||...+..++.+.  |+|++|+++++++.+.+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~--Di~slG~il~~l~~g~~  192 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSV--DWFALGCTLYEMIAGRS  192 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchh--hhHHHHHHHHHHhhCCC
Confidence            78899999998777665554  99999999999988764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1.6e-28  Score=248.22  Aligned_cols=195  Identities=35%  Similarity=0.511  Sum_probs=169.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|...+.||+|++|.||+|... +++.|++|++.....   ...+.+.+|+.+++.++|++++++++++..+...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4788899999999999999664 688999999976543   235788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||++   +++||||+|+||++++++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999987653  2589999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      . .....++..|+|||...+...+.+.  |+|++|+++++++.+.+.
T Consensus       153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~--Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVINGKPYDYKA--DIWSLGITAIELAEGKPP  196 (253)
T ss_pred             c-ccceecCCcccCHHHHcCCCCCccc--cHHHHHHHHHHHHhCCCC
Confidence            2 3345688999999998776655554  999999999998887643

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=261.61  Aligned_cols=201  Identities=24%  Similarity=0.350  Sum_probs=180.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCC-cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++++++..||-|+||.|-.+..+.. ..+|+|.+++...-+....+.+..|-++|..++.|.||++|..|.++.+.|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            45677888999999999999976543 34899999887766666678888999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||-|-||.+...+++++   .++..+..-++..+++|++|||.+   |||.|||||+|.++|.+|-+||.|||+|+.+..
T Consensus       499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999998876   588899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSR  658 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~R  658 (701)
                      .. ..-.++|||.|.|||++.....+..+  |.|+||+++|+++.+.|..+
T Consensus       573 g~-KTwTFcGTpEYVAPEIILnKGHD~av--DyWaLGIli~ELL~G~pPFs  620 (732)
T KOG0614|consen  573 GR-KTWTFCGTPEYVAPEIILNKGHDRAV--DYWALGILIYELLTGSPPFS  620 (732)
T ss_pred             CC-ceeeecCCcccccchhhhccCcchhh--HHHHHHHHHHHHHcCCCCCC
Confidence            43 34457999999999999999999887  99999999999999998775

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=1.3e-28  Score=254.25  Aligned_cols=198  Identities=25%  Similarity=0.394  Sum_probs=166.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|... +++.||+|+++......  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            5889999999999999999664 68999999997654322  23566789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++ +|.+++........+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.++......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 8988887654334689999999999999999999998   99999999999999999999999999997654333


Q ss_pred             CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .......++..|+|||.+.+.. ++.+  +|+|++|+++++++.+.|.
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~--~Dv~slG~~l~~l~~g~~~  200 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTS--IDIWSVGCIMAEMITGRPL  200 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcH--HHHHHHHHHHHHHHhCCCC
Confidence            3333446788999999876543 3333  5999999999999998753

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=4.6e-29  Score=254.44  Aligned_cols=190  Identities=27%  Similarity=0.431  Sum_probs=162.9

Q ss_pred             EeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            588999999999765 5999999999765544445567889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC------
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS------  610 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~------  610 (701)
                      .+++.+..   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997654   589999999999999999999998   999999999999999999999999999876543311      


Q ss_pred             --CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          611 --NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       611 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                        ......++..|+|||.......+.+.  |+|++|+++++++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~--Dv~slG~~~~~l~~g~~  199 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTV--DWWSLGCILYEFLVGIP  199 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcch--hhHHHHHHHHHHHhCCC
Confidence              22334578899999998776655554  99999999999988764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-30  Score=255.87  Aligned_cols=222  Identities=27%  Similarity=0.441  Sum_probs=179.5

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccC----hHHHHHHHHHHHHHhcCCCCceeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETED----SAFVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      |.|-....++|-....||+|||++||+| +....+.||||+-...+.+.    ..+.+...+|.+|.+.++||-||++|+
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            3444455678999999999999999999 66678889999876555443    345566789999999999999999999


Q ss_pred             eee-eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCC
Q 041034          517 FCL-HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNL  592 (701)
Q Consensus       517 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~  592 (701)
                      |+. +.+.++-|+|||+|.+|.-|++...   .+++..+..|+.||+.||.||.+. .++|||-||||.|||+.   ..|
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            996 4567899999999999999998766   589999999999999999999988 77899999999999994   458


Q ss_pred             CeEEEeecCccccccCCCC-------ceeecccccccCCCCCCCC--cCChhhHHHHHHHHHHHHHcccCC-CCC-CCCH
Q 041034          593 EAFVADFGTARLLHVDSSN-------RTLRAGTYGYIAPDQRLSP--PVNQKIIQDIILVSTTALACLRSK-PKS-RPTM  661 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~~~Di~slg~i~~~cl~~~-P~~-Rpt~  661 (701)
                      .+||.|||+++++..+...       .+...||.+|.+||.+.-.  +.......||||+|+|+|.|+.+. |.- -.+-
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            9999999999998754332       3456799999999987644  222222339999999999999987 432 2456


Q ss_pred             HHHHHH
Q 041034          662 QRISQE  667 (701)
Q Consensus       662 ~~i~~~  667 (701)
                      ++|++.
T Consensus       691 QdILqe  696 (775)
T KOG1151|consen  691 QDILQE  696 (775)
T ss_pred             HHHHhh
Confidence            666664

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=2.6e-28  Score=247.85  Aligned_cols=196  Identities=30%  Similarity=0.426  Sum_probs=170.0

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  527 (701)
                      +|++.+.||+|++|.||+|... +++.|++|++...... ....+.+.+|+.++++++||||+++++.+.+.  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4788899999999999999665 6899999998765432 34467889999999999999999999999988  889999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999997654   689999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...  ......++..|+|||.......+.+.  |+|++|+++++++.+.+
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~--Dv~slG~il~~l~~g~~  201 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAA--DIWSLGCTVIEMATGKP  201 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            432  13345688999999998877666655  99999999999888653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=8.8e-29  Score=251.15  Aligned_cols=211  Identities=27%  Similarity=0.371  Sum_probs=174.6

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|.. .+++.+|+|.+....... ....++.+|+.+++.++|+||+++++++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            588899999999999999954 478899999987654322 234677889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          530 YMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |+++++|.+++..... ...+++..+..++.|++.||+|||+.   |++|+||+|+||++++++.+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999999866321 23588999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                        ......+++.|+|||...+..++.+.  |+|++|+++++++.+. |....+..++.....
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~--D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  214 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKS--DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ  214 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence              22234688999999999887776655  9999999999988776 444455555444433

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=239.32  Aligned_cols=192  Identities=22%  Similarity=0.342  Sum_probs=156.2

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++.+.+..||.|+.|+|++++.. .|...|||.+......  ...+++...++++.... +|+||+.+|||..+...++.
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            44556788999999999999665 5899999999876543  33467777777776654 89999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||.|.- ..+.+++....  ++++..+-++...+++||.||.+++  +|+|||+||+|||+|+.|.+|+||||++..+.+
T Consensus       170 MelMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  170 MELMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence            999854 77777766543  5888889999999999999999876  999999999999999999999999999987643


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~  649 (701)
                      . ...+..+|.+.|||||.+.-. ......++|+||||+.+++
T Consensus       245 S-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlve  286 (391)
T KOG0983|consen  245 S-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVE  286 (391)
T ss_pred             c-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhh
Confidence            2 333445799999999987543 2223345599999999986

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=261.23  Aligned_cols=195  Identities=27%  Similarity=0.439  Sum_probs=160.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----c
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----R  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  522 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++++++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            57899999999999999999954 578999999986432  223356678899999999999999999987654     3


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++ ++.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            57999999975 888877543    489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCC---ceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDSSN---RTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........   .....|++.|+|||.+.+ ..++.+  +|+||+|+++++++.+.|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DvwslGvil~el~~G~~  208 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKA--IDIWSVGCILAEMLSNRP  208 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcH--HHHHHHHHHHHHHHhCCC
Confidence            765432211   123468899999998654 334444  499999999999888764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=3.1e-32  Score=268.91  Aligned_cols=239  Identities=34%  Similarity=0.491  Sum_probs=155.6

Q ss_pred             EEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECC
Q 041034           39 ITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS  118 (701)
Q Consensus        39 v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  118 (701)
                      ++.+++.++.+.. +++ .+..+..++.|+.++|+++ .+|+.++++.+|..|+.++|.+. .+|+.++.+..|+.|+..
T Consensus        70 l~vl~~~~n~l~~-lp~-aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~  145 (565)
T KOG0472|consen   70 LTVLNVHDNKLSQ-LPA-AIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT  145 (565)
T ss_pred             eeEEEeccchhhh-CCH-HHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence            3444445554442 111 2344455555556666555 55556666666666666666665 445556666666666666


Q ss_pred             CCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCC
Q 041034          119 NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTI  198 (701)
Q Consensus       119 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  198 (701)
                      +|+++ ..|..+.++.+|..|++.+|++....|..+. |+.|+.||...|-+ +.+|+.++.+.+|+.|+|..|++. ..
T Consensus       146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~l  221 (565)
T KOG0472|consen  146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FL  221 (565)
T ss_pred             ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cC
Confidence            66665 4555666666666666666666654444443 77777777777766 456666777777777777777776 44


Q ss_pred             CCCCCCccccCccccccccccCCccccc-cCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCC
Q 041034          199 PREIGNLKNLTHLSIITNKLTGAIPSTL-GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL  277 (701)
Q Consensus       199 ~~~~~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l  277 (701)
                      | +|.+++.|++|+++.|+|. .+|... .++++|.+|||..|+++. .|..+.-+.+|+.||+|+|.|+ .+|..++++
T Consensus       222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl  297 (565)
T KOG0472|consen  222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL  297 (565)
T ss_pred             C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecccccccc-CchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence            5 6777777777777777777 444444 377888888888888876 6777777888888888888888 456677777


Q ss_pred             CCCcEEEccCccC
Q 041034          278 SNLQYLNLSSNLL  290 (701)
Q Consensus       278 ~~L~~L~L~~N~l  290 (701)
                       .|+.|-+-+|.+
T Consensus       298 -hL~~L~leGNPl  309 (565)
T KOG0472|consen  298 -HLKFLALEGNPL  309 (565)
T ss_pred             -eeeehhhcCCch
Confidence             777777777765

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=3.6e-28  Score=251.07  Aligned_cols=198  Identities=27%  Similarity=0.391  Sum_probs=168.1

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|++.+.||+|++|.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            588999999999999999965 46899999998765432 2335678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+ +++|.+++....  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999987544  2589999999999999999999998   99999999999999999999999999998765432


Q ss_pred             C-CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          610 S-NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       610 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      . ......++..|+|||.+.+.. .+.+  .|||++|+++++++.+.|..
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Di~slG~~l~~l~tg~~~~  201 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPG--VDLWAVGCIFAELLNGSPLF  201 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCch--hHHHHHHHHHHHHHcCCcCc
Confidence            1 123346899999999886543 3344  49999999999999987644

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=1.9e-28  Score=257.23  Aligned_cols=193  Identities=26%  Similarity=0.410  Sum_probs=155.0

Q ss_pred             ceEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEEEEEEE
Q 041034          455 RYCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCMFFIYE  529 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  529 (701)
                      ..+||+|+||.||+|...   +++.||+|.+.....     ...+.+|+.++++++||||+++++++..  +...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            467999999999999754   457899999875432     2456789999999999999999998853  567899999


Q ss_pred             ccCCCCHHHHHhcC------CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCCCeEEEee
Q 041034          530 YMERGSLFYVLRDD------DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADF  599 (701)
Q Consensus       530 ~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll----~~~~~~kL~DF  599 (701)
                      |+++ +|.+++...      .....+++..+..++.|++.||+|||++   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9975 787776532      1223588999999999999999999998   99999999999999    56679999999


Q ss_pred             cCccccccCCC---CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCCC
Q 041034          600 GTARLLHVDSS---NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKSR  658 (701)
Q Consensus       600 Gla~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~R  658 (701)
                      |+|+.......   ......+|+.|+|||++.+.. ++.+  .||||+|+++++++++.|...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA--IDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcH--HHHHhHHHHHHHHHhCCCCcc
Confidence            99987643221   123346899999999987643 4444  499999999999999987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.4e-29  Score=266.99  Aligned_cols=201  Identities=26%  Similarity=0.435  Sum_probs=174.5

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      .++.+...++-|++.+.||+|.+|.||+++. ++++.+|+|+.......+    +++..|.++++.. .|||++.++|+|
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEE
Confidence            4555667788999999999999999999954 578999999988766544    6677889999888 599999999998


Q ss_pred             ee-----CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC
Q 041034          519 LH-----KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE  593 (701)
Q Consensus       519 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~  593 (701)
                      ..     ++.+|+|||||.+||..|+++... +.++.|..+.-|.+.++.|+.+||+.   .++|||||-.|||++.++.
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            64     568999999999999999998766 56799999999999999999999999   8999999999999999999


Q ss_pred             eEEEeecCccccccCCCCceeecccccccCCCCCCCCc---CChhhHHHHHHHHHHHHH
Q 041034          594 AFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP---VNQKIIQDIILVSTTALA  649 (701)
Q Consensus       594 ~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Di~slg~i~~~  649 (701)
                      ||++|||++..++.........+|||.|||||++...+   .+..++.|+||||+++.+
T Consensus       162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE  220 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE  220 (953)
T ss_pred             EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence            99999999998877666677789999999999887543   344456699999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.2e-28  Score=255.38  Aligned_cols=191  Identities=27%  Similarity=0.412  Sum_probs=162.6

Q ss_pred             cceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          454 IRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      ....||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            346789999999999965 478999999886432   2234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR  612 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  612 (701)
                      +++|.+++...    .+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||.+..........
T Consensus       101 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657         101 GGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            99999987543    478899999999999999999998   99999999999999999999999999987664433333


Q ss_pred             eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          613 TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ....+++.|+|||...+...+.+.  |+|++|+++++++.+.+.
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~--Dv~slGvil~el~tg~~p  215 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEV--DIWSLGIMVIEMVDGEPP  215 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchh--hHHHHHHHHHHHHhCCCC
Confidence            445688999999998776666554  999999999998887653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=2.6e-28  Score=253.12  Aligned_cols=199  Identities=22%  Similarity=0.320  Sum_probs=149.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC----CcEEEEEEecCCCccC--hH------HHHHHHHHHHHHhcCCCCceeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETED--SA------FVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~~------~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      .++|++.+.||+|+||.||+|...+    +..+|+|+........  ..      .......+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999996643    4456666543322110  00      0011223445566778999999998


Q ss_pred             eeeeCc----EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 041034          517 FCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL  592 (701)
Q Consensus       517 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~  592 (701)
                      .+....    ..++++|++.. ++.+.+....   ..++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            765543    45788888754 6776665432   356788899999999999999998   999999999999999999


Q ss_pred             CeEEEeecCccccccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          593 EAFVADFGTARLLHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .++|+|||+|+.+.....       ......||+.|+|||+..+..++.+.  ||||+|+++++++.+.+.
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~--DiwSlG~~l~el~~g~~P  232 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRG--DLESLGYCMLKWAGIKLP  232 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            999999999987643221       12234699999999999888877765  999999999999888754

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-28  Score=250.03  Aligned_cols=200  Identities=23%  Similarity=0.308  Sum_probs=159.8

Q ss_pred             eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHH-HhcCCCCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARV-LSTVRHRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      +.||+|+||.||+|.. .+++.||+|.+.............+..|..+ ....+|+|++++++++...+..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999965 4689999999876433222223344555544 4455899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      ++|.+++....   .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999997654   578899999999999999999998   999999999999999999999999999876432    22


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHH
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQE  667 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~  667 (701)
                      ...+++.|+|||...+..++.+.  |+|++|+++++++.+.+ ....+..++.+.
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~--Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  204 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMS--DWWSLGCVIFEFLFGYPPFHAETPDAVFDN  204 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchh--hhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            34688999999998877655554  99999999999988764 333344444333

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=2.6e-28  Score=248.75  Aligned_cols=190  Identities=27%  Similarity=0.421  Sum_probs=164.7

Q ss_pred             EeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||.|++|.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999664 5899999999876554445567899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeec
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA  616 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  616 (701)
                      .+++.+..   .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.++...... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99997654   488999999999999999999998   99999999999999999999999999998765332 223346


Q ss_pred             ccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          617 GTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +++.|+|||......++.+.  |+|++|+++|+++.+.+.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~--Di~slG~il~~l~~g~~p  191 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSV--DYWSLGILLYELLTGRPP  191 (262)
T ss_pred             CCcCccChhHhcCCCCCChh--hhhhhHHHHHHHHhCCCC
Confidence            88999999998776666654  999999999999888754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=2.3e-28  Score=253.77  Aligned_cols=200  Identities=24%  Similarity=0.327  Sum_probs=162.9

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcE----
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRC----  523 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----  523 (701)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.+++.++ ||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            4789999999999999999965 46899999988764322 122356788999999995 6999999999887665    


Q ss_pred             -EEEEEEccCCCCHHHHHhcCCC--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEee
Q 041034          524 -MFFIYEYMERGSLFYVLRDDDE--AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADF  599 (701)
Q Consensus       524 -~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DF  599 (701)
                       .|+||||+++ ++.+++.....  ...+++..+..++.||+.||+|||++   +++||||||+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999986 89888765422  23589999999999999999999998   9999999999999998 899999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |.++.+...........+++.|+|||.+.+. .++.+  .|+|++|+++++++.+.|.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~--~Di~slG~~l~~l~~g~~~  211 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTP--VDIWSVGCIFAEMSRKQPL  211 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCch--HHHHHHHHHHHHHHcCCCC
Confidence            9998764433333334578899999987653 33444  4999999999999988753

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=2e-28  Score=256.10  Aligned_cols=199  Identities=25%  Similarity=0.435  Sum_probs=160.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  522 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||.+....... .....+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3567999999999999999999654 68999999886543221 22345678999999999999999999887543    


Q ss_pred             ----EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          523 ----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       523 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                          ..++||||+.+ ++.+++....  ..+++.++..++.|++.||+|||++   +++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence                45999999965 8888876543  2589999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccccCCC----CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCC
Q 041034          599 FGTARLLHVDSS----NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       599 FGla~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ||.+........    ......++..|+|||.+.+.. .+.+  .|+||+|+++++++.+.|
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Di~slG~~l~el~t~~~  222 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPP--IDMWGAGCIMAEMWTRSP  222 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCch--hhhHHHHHHHHHHHhCCC
Confidence            999986643221    112345788999999876543 3443  499999999999988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.6e-28  Score=261.58  Aligned_cols=194  Identities=25%  Similarity=0.322  Sum_probs=162.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            457899999999999999999955 47899999998654322 23345677899999999999999999988643     


Q ss_pred             -cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 -RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                       ...|+||||+.+ +|.+.+..     .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence             357999999965 88887754     278889999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .++...... ......+++.|+|||.+.+..++.+.  |+||+|+++++|+.+.
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~~l~~l~~g~  214 (353)
T cd07850         164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIRGT  214 (353)
T ss_pred             cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCch--hhHhHHHHHHHHHHCC
Confidence            998764322 22334688999999999888777665  9999999999998775

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.9e-29  Score=259.08  Aligned_cols=201  Identities=21%  Similarity=0.288  Sum_probs=170.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..-|..++.||-|+||+|.+++.. +...||.|.+.+...-........+.|..||+..+.+-||++|-.|.+.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            345778889999999999999544 4667999998876544444456678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||++||++..+|-+.+   .+++..++.++..+..|+++.|+.   |+|||||||+|||||.+|++||.|||+++-+..
T Consensus       708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            99999999999987655   588899999999999999999999   999999999999999999999999999864321


Q ss_pred             ---------CCC---------------------------------CceeecccccccCCCCCCCCcCChhhHHHHHHHHH
Q 041034          608 ---------DSS---------------------------------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVST  645 (701)
Q Consensus       608 ---------~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~  645 (701)
                               ..+                                 .....+||+.|+|||++....++...  |+|++|+
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c--dwws~gv  859 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC--DWWSVGV  859 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc--hhhHhhH
Confidence                     000                                 00124699999999999999999887  9999999


Q ss_pred             HHHHcccCCCCC
Q 041034          646 TALACLRSKPKS  657 (701)
Q Consensus       646 i~~~cl~~~P~~  657 (701)
                      |+|+|+.+.|..
T Consensus       860 il~em~~g~~pf  871 (1034)
T KOG0608|consen  860 ILYEMLVGQPPF  871 (1034)
T ss_pred             HHHHHhhCCCCc
Confidence            999999887643

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.3e-28  Score=246.27  Aligned_cols=199  Identities=27%  Similarity=0.407  Sum_probs=166.0

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCc--cChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSET--EDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (701)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.....  ........+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999965 4689999998754321  1233456789999999999999999999998764  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999987643   478899999999999999999999   999999999999999999999999999986


Q ss_pred             cccC---CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVD---SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ....   ........++..|+|||...+...+.+.  |+||+|+++++++.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~p  208 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKA--DVWSVACTVVEMLTEKPP  208 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccc--cHHHHHHHHHHHHhCCCC
Confidence            5321   1112234588999999998876666555  999999999999988643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=3.9e-28  Score=250.30  Aligned_cols=193  Identities=25%  Similarity=0.333  Sum_probs=157.1

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeC--cEEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHK--RCMFFI  527 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  527 (701)
                      |++.+.||+|+||.||+|.. .+++.||+|+++.......  .....+|+.+++++. |+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            67889999999999999965 4689999999876533222  123457888898885 99999999999987  889999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++ ++.+.+.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++. +.+||+|||.++....
T Consensus        79 ~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMDM-NLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCCc-cHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            999975 88888765432  589999999999999999999999   9999999999999999 9999999999987643


Q ss_pred             CCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ... .....++..|+|||...... .+..  .|+||+|+++++++.+.|.
T Consensus       152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~--~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         152 KPP-YTEYISTRWYRAPECLLTDGYYGPK--MDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             CCC-cCCCCCCcccCChhHhhcCCCCCcc--hhHHHHHHHHHHHHcCCcC
Confidence            322 22345789999999765433 3444  4999999999999987643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=7e-28  Score=252.28  Aligned_cols=191  Identities=28%  Similarity=0.390  Sum_probs=158.7

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |...+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            67778899999999999965 46889999998765544444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +. |++.+++.....  .+++.++..++.|++.|++|||+.   |++|+||||+||+++.++.+||+|||.+....    
T Consensus       103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 478777765332  588999999999999999999998   99999999999999999999999999986432    


Q ss_pred             CceeecccccccCCCCCCC---CcCChhhHHHHHHHHHHHHHcccCC
Q 041034          611 NRTLRAGTYGYIAPDQRLS---PPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ......|+..|+|||.+..   ..++..  .|+||+|+++++++.+.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~--sDv~slGvil~el~~g~  217 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGK--VDVWSLGITCIELAERK  217 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCch--hhHHHHHHHHHHHHhCC
Confidence            1223468899999999743   334444  49999999999755544

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=4.7e-28  Score=253.26  Aligned_cols=200  Identities=30%  Similarity=0.415  Sum_probs=164.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCM  524 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (701)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|+++...... .....+.+|+.++++++|+||+++++++.+.  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            457899999999999999999965 468999999987543322 1223456799999999999999999998765  568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++ +|.+++....  ..+++..+..++.|++.||+|||+.   |++||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            999999975 8888887543  2589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ............+++.|+|||.+.+. .++.+  .|+||+|+++++++.+.|.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DvwslG~il~el~~g~~~  208 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA--IDMWAVGCILAELLAHKPL  208 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCch--HHHHHHHHHHHHHHhCCCC
Confidence            65433333334568889999988653 34444  4999999999999988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=4.1e-28  Score=253.48  Aligned_cols=192  Identities=27%  Similarity=0.400  Sum_probs=158.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +.+.|+..+.||+|++|.||+|... +++.||+|.+...........+++.+|+.+++.++|+|++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3455888899999999999999654 688999999875433333445678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+. |++.+++.....  .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        93 v~e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            999996 588877754332  478999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCCCceeecccccccCCCCCCC---CcCChhhHHHHHHHHHHHHHcc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLS---PPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ..    ....+++.|+|||.+.+   ...+.+  .||||+|+++++++
T Consensus       167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~--~Di~slG~il~el~  208 (308)
T cd06634         167 PA----NXFVGTPYWMAPEVILAMDEGQYDGK--VDVWSLGITCIELA  208 (308)
T ss_pred             Cc----ccccCCccccCHHHHhhcccCCCCcc--cchHHHHHHHHHHH
Confidence            22    23468889999998743   234444  49999999998633

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=3.4e-28  Score=250.20  Aligned_cols=189  Identities=24%  Similarity=0.301  Sum_probs=153.3

Q ss_pred             EEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHH---HHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          457 CIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEA---RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       457 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      .||+|+||.||+|.. .+++.||+|.+.............+..|.   ..++...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            379999999999965 45889999998765433222122233333   34555679999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR  612 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  612 (701)
                      +++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..+....  .
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            999999886543   589999999999999999999998   99999999999999999999999999997654322  2


Q ss_pred             eeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          613 TLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ....|+..|+|||.+.+. .++.+.  |+||+|+++++++.+.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~--Di~s~G~~l~~l~~g~~  194 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHS  194 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCccc--chHhHHHHHHHHHhCCC
Confidence            234689999999998754 455554  99999999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=7.2e-28  Score=249.48  Aligned_cols=200  Identities=26%  Similarity=0.344  Sum_probs=164.9

Q ss_pred             CCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      +|++.+.||+|+||.||.|..    .+|+.||+|++...... .....+.+.+|+.+++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            488899999999999999965    36889999998754321 222346678899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999987643   578899999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...... ......|+..|+|||.............|+|++|+++++++.+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p  207 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP  207 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence            643221 1223458899999999875432222224999999999999998743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=7.1e-28  Score=250.03  Aligned_cols=200  Identities=24%  Similarity=0.371  Sum_probs=163.5

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            57999999999999999999654 6899999998654322 223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DFGla~~~~~  607 (701)
                      ||+++ ++.+++..... ..+++..+..++.||+.||+|||++   +++||||||+||+++. ++.+||+|||++.....
T Consensus        81 e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ecccc-cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            99964 88888765432 2467888899999999999999998   9999999999999985 56799999999976543


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .........+++.|+|||.+.+. .++.+  .|+||+|+++++++++.|..
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--~Dv~slG~i~~~l~tg~~pf  204 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTP--VDIWSVGCIFAEMVNQKPLF  204 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcH--HHHHHHHHHHHHHHhCCCCC
Confidence            33333334678899999987653 33444  49999999999999987643

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=2.5e-28  Score=252.59  Aligned_cols=199  Identities=25%  Similarity=0.348  Sum_probs=163.3

Q ss_pred             CCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      +|++.+.||+|++|.||+|..    .+++.||||.++..... .....+.+.+|+.++.++ +||+|+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999853    35788999998754321 223346788999999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++....   .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999987543   588899999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          605 LHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       605 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +...... .....++..|+|||...+.........|+|++|+++++++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~  206 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS  206 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence            5433221 22345889999999987654222233599999999999887663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=2e-28  Score=253.45  Aligned_cols=199  Identities=25%  Similarity=0.309  Sum_probs=159.5

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+......  .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            4566778999999999999955 46899999998764332  33567889999999996 99999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC--CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |||+.. ++.++....  .....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            999865 665543211  11235899999999999999999999632  8999999999999999999999999999765


Q ss_pred             ccCCCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .... ......|++.|+|||.+.+.   .++..  +|+||+|+++++++.+.+.
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~--~Di~slG~il~el~~g~~p  209 (288)
T cd06616         159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVR--SDVWSLGITLYEVATGKFP  209 (288)
T ss_pred             ccCC-ccccccCccCccCHHHhccccccCCcch--hhhhHHHHHHHHHHhCCCC
Confidence            4322 22234688999999998765   34444  4999999999999887754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-28  Score=249.40  Aligned_cols=195  Identities=32%  Similarity=0.476  Sum_probs=163.0

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMFFIY  528 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  528 (701)
                      |++.+.||+|++|.||+|... +++.||+|++.... ......+.+.+|+.+++.++|||++++++++.+.  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            678899999999999999665 58899999998764 2233346788999999999999999999999988  8899999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++ +|.+++....  ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||.+......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99975 8988886643  2589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CC-CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SS-NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .. ......++..|+|||.+.+. .++.+  .|+|++|+++++++.+.+
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--~Dv~slG~~l~el~t~~~  200 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPE--VDMWSVGCILAELFLGKP  200 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChH--HHHHHHHHHHHHHHhCCC
Confidence            21 12334578889999977543 33444  499999999999988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=3e-28  Score=257.84  Aligned_cols=197  Identities=24%  Similarity=0.349  Sum_probs=161.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----c
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----R  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  522 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||.+...... ......+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45799999999999999999955 46899999998764322 22245677899999999999999999988654     3


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+. ++|.+++....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999996 58988887543   589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.............++..|+|||.+.. ..++.+  .|+|++|+++++++.+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwslG~il~~l~~g~~  207 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA--IDVWSVGCIFAELLGRKP  207 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCc--ccHHHHHHHHHHHHcCCC
Confidence            876443333334468889999998764 334444  499999999988877664

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=2.7e-28  Score=248.40  Aligned_cols=199  Identities=24%  Similarity=0.299  Sum_probs=160.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETE--DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      +|.+.+.||+|+||.||+|... .+..+++|.++.....  ......++.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5889999999999999999654 3455666665542221  112234567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          528 YEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||+.   |++|+||||+||+++. +.++|+|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 2233689999999999999999999998   9999999999999975 579999999998765


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..........+++.|+|||...+...+.+.  |+|++|+++++++.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~--Dv~slG~~~~~l~~~~~  203 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKS--DIWSLGCILYEMCCLAH  203 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            443333445688999999998776666554  99999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=7.8e-28  Score=248.67  Aligned_cols=196  Identities=29%  Similarity=0.430  Sum_probs=162.1

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC---CCCceeeeeeeeeeCcE----
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVKLYGFCLHKRC----  523 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----  523 (701)
                      |++.+.||+|+||.||+|... +++.||+|+++.....+ .....+.+|+.+++++   +|||++++++++.+.+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            678899999999999999765 58999999997654322 2234566787777666   59999999999988776    


Q ss_pred             -EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          524 -MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       524 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                       .+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence             9999999975 89888876432 2589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ..+..... .....++..|+|||.+.+...+.+.  |+||+|+++++++.+.|.
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~--Di~s~G~~l~~l~~~~~~  205 (287)
T cd07838         155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPV--DMWSVGCIFAELFRRRPL  205 (287)
T ss_pred             eeccCCcc-cccccccccccChHHhccCCCCCcc--hhhhHHHHHHHHHhCCCc
Confidence            87643322 2233578899999999887776665  999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=1.6e-31  Score=263.93  Aligned_cols=154  Identities=32%  Similarity=0.475  Sum_probs=105.0

Q ss_pred             cCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccc
Q 041034           58 FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLE  137 (701)
Q Consensus        58 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  137 (701)
                      +..+..|..|++.+|.+....|..+. ++.|++||..+|.++ .+|+.++.+.+|+-|||..|++. ..| +|.++..|+
T Consensus       156 ~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~  231 (565)
T KOG0472|consen  156 MVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLK  231 (565)
T ss_pred             HHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHH
Confidence            34445566666666666633333333 666777777777665 56666777777777777777776 444 677777777


Q ss_pred             eeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccc
Q 041034          138 ELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK  217 (701)
Q Consensus       138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  217 (701)
                      +|+++.|+++....+...++.+|..|||.+|+++ ..|..++-+++|++||+|+|.++ ..|.+++++ .|+.|.+.+|.
T Consensus       232 Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  232 ELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             HHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCc
Confidence            7777777777443334447778888888888874 56677777778888888888887 456677777 77777777776


Q ss_pred             c
Q 041034          218 L  218 (701)
Q Consensus       218 l  218 (701)
                      +
T Consensus       309 l  309 (565)
T KOG0472|consen  309 L  309 (565)
T ss_pred             h
Confidence            5

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=3.2e-28  Score=257.39  Aligned_cols=197  Identities=26%  Similarity=0.388  Sum_probs=161.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  523 (701)
                      .++|++.+.||+|++|.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            37899999999999999999955 46999999998764322 2234667789999999999999999998763    356


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+. ++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999996 58999886543   489999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCC----ceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          604 LLHVDSSN----RTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       604 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ........    .....++..|+|||.+.+ ..++.+.  |+|++|+++++++.+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~--Di~slG~~l~el~~g~~  210 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI--DMWSVGCIFAEMLGRRQ  210 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCccccccc--chHHHHHHHHHHHcCCC
Confidence            65432211    123468899999998765 3344454  99999999988776554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.5e-28  Score=255.28  Aligned_cols=195  Identities=27%  Similarity=0.379  Sum_probs=161.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEE-cCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc---
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR---  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  522 (701)
                      ...++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+.+|+.++++++||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            346789999999999999999995 4578999999986543 22334567889999999999999999999887543   


Q ss_pred             ---EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          523 ---CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       523 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                         .+++||||+ +++|.+++...    .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence               468999999 67998888643    488999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |++......   .....+++.|+|||.+.+. ..+.+  .|+||+|+++++++.+.+
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~--~Di~slG~ll~~l~~g~~  214 (343)
T cd07880         163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQT--VDIWSVGCIMAEMLTGKP  214 (343)
T ss_pred             ccccccccC---ccccccCCcccCHHHHhCCCCCCcH--HHHHHHHHHHHHHHhCCC
Confidence            999865322   2234578899999988653 33344  499999999998777664

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=7e-28  Score=251.08  Aligned_cols=201  Identities=30%  Similarity=0.467  Sum_probs=163.6

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc---
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR---  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  522 (701)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++...... .....+.+|+.++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            45678999999999999999999664 68899999987643221 22356778999999999999999999987654   


Q ss_pred             -------EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 041034          523 -------CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF  595 (701)
Q Consensus       523 -------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~k  595 (701)
                             ..++||||+++ ++.+.+....  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                   78999999986 7777776542  2589999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccccCCC-CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          596 VADFGTARLLHVDSS-NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       596 L~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |+|||.+........ ......++..|+|||.+.+.. .+..  .|||++|+++++++.+.|.
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~--~Di~slG~~~~el~~g~~~  217 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPA--IDVWSCGCILGELFTKKPI  217 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCch--hHHHHHHHHHHHHHhCCCC
Confidence            999999987654332 222335678899999876433 3333  5999999999999887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=5.9e-28  Score=255.52  Aligned_cols=198  Identities=26%  Similarity=0.332  Sum_probs=160.4

Q ss_pred             hcCCcc-ceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChH-----------HHHHHHHHHHHHhcCCCCceeeee
Q 041034          449 TEDFHI-RYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSA-----------FVESFQNEARVLSTVRHRNIVKLY  515 (701)
Q Consensus       449 ~~~y~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~  515 (701)
                      .++|.. .+.||+|+||+||+|.. .+++.||+|+++........           ....+.+|+.++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456654 57799999999999965 46899999998754322100           112467899999999999999999


Q ss_pred             eeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 041034          516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF  595 (701)
Q Consensus       516 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~k  595 (701)
                      +++...+..++||||++ |+|.+++....   .+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            99999999999999997 59999887543   588999999999999999999998   999999999999999999999


Q ss_pred             EEeecCccccccC--------------CCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCC
Q 041034          596 VADFGTARLLHVD--------------SSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       596 L~DFGla~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |+|||.++.....              ........+++.|+|||.+.+.. ++.+  .|+||+|+++++++.+.|
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA--VDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcH--HHHHHHHHHHHHHHhCCC
Confidence            9999999766411              11122234688899999886543 3333  599999999999988765

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=5.2e-28  Score=253.54  Aligned_cols=196  Identities=19%  Similarity=0.213  Sum_probs=156.8

Q ss_pred             ccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          453 HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      .+.+.+|.|+++.||++.. +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            3445556666666666654 689999999976532 23345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC--
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS--  610 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~--  610 (701)
                      +++|.+++...... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+........  
T Consensus        83 ~~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          83 YGSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            99999999764322 588899999999999999999999   999999999999999999999999998875532211  


Q ss_pred             -----CceeecccccccCCCCCCCC--cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          611 -----NRTLRAGTYGYIAPDQRLSP--PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       611 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                           ......++..|+|||.+...  .++.+  .|+||+|+++++++.+.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~--~Diws~G~il~el~~g~~p  209 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK--SDIYSVGITACELANGHVP  209 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcc--hhHHHHHHHHHHHHhCCCC
Confidence                 11233577889999998664  24444  4999999999988776543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=6.5e-29  Score=260.31  Aligned_cols=211  Identities=27%  Similarity=0.466  Sum_probs=179.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC--CCc--EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP--DGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .+.....+.||+|.||+|++|.|.  .|+  .||||.++......  ...+|.+|+.+|.+++|||++++||+..+ ..+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            344566789999999999999664  454  58999998765443  46899999999999999999999999887 678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      .+|||.++.|+|.+.+++.. ...+-......++.|||.|+.||..+   ++|||||-..|+++...-.|||+|||+.+.
T Consensus       186 mMV~ELaplGSLldrLrka~-~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAK-KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hHHhhhcccchHHHHHhhcc-ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence            89999999999999998833 33577888899999999999999999   999999999999999888999999999998


Q ss_pred             cccCCCCce---eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          605 LHVDSSNRT---LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       605 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      +........   ...-...|+|||.+....+...+  |+|++|+.+||                                
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaS--DvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~  339 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHAS--DVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKY  339 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccc--hhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCC
Confidence            875544332   12345679999999988887776  99999999995                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHh
Q 041034          650 -----------CLRSKPKSRPTMQRISQEL  668 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l  668 (701)
                                 ||..+|.+|||+..|.+.+
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                       9999999999999997554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=7.8e-29  Score=224.34  Aligned_cols=222  Identities=23%  Similarity=0.320  Sum_probs=174.7

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      ...++...++.||+|++|.|-+.++ .+|+..|+|++......  ...++..+|+.+..+. .+|++|.+||.+......
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3445556678899999999998855 57999999999876543  3346778888876665 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          525 FFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      |+.||.|+- ||..+.++. ..+..+++...-+|+..+++||.|||++.  .++|||+||+|||++.+|++|+||||++-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999965 887665432 23346899999999999999999999885  89999999999999999999999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCc--CChhhHHHHHHHHHHHHHcccCC---CCCCCCHHHHHHHhhcCCCc
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPP--VNQKIIQDIILVSTTALACLRSK---PKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Di~slg~i~~~cl~~~---P~~Rpt~~~i~~~l~~~~~~  674 (701)
                      .+.+ .-..+...|...|||||.+...-  ......+||||||+.+.|+-...   +..+-.++++-+..++-.|.
T Consensus       198 ~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  198 YLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             eehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence            7743 23334457899999999875331  12334459999999999987665   44566678887777765543

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=7.2e-28  Score=248.41  Aligned_cols=195  Identities=28%  Similarity=0.410  Sum_probs=165.2

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |++.+.||+|++|.||+|... +++.+|+|++...... ......+.+|+.++++++|+||+++++++.++...++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            677899999999999999664 6889999998765433 23356788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +++ ++.+++....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            976 8888887643  2589999999999999999999999   999999999999999999999999999987754432


Q ss_pred             CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          611 NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ......++..|+|||.+.+. ..+.+  .|+|++|+++++++++.+
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~--~Di~slG~~l~~l~tg~~  197 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTP--VDIWSVGCIFAELLSRRP  197 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCch--hHHHHHHHHHHHHHhCCC
Confidence            33334688899999998765 44444  499999999999998864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4.4e-28  Score=256.03  Aligned_cols=195  Identities=30%  Similarity=0.394  Sum_probs=163.9

Q ss_pred             CCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----EE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----CM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  524 (701)
                      +|++.+.||+|++|.||+|... +++.||+|++..... +....+.+.+|+.+++.++||||+++++++...+     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5889999999999999999765 589999999876432 2233567889999999999999999999998775     78


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+++ +|.+++....   .+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||.+..
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            999999975 8988887644   689999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCC---CCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          605 LHVDS---SNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       605 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .....   .......+++.|+|||.+.+. ..+.+  +|+||+|+++++++.+.|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--sDi~slG~il~~l~~g~~  205 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKA--IDIWSVGCIFAELLTRKP  205 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcc--hhHHHHHHHHHHHHcCCC
Confidence            65432   123344688899999998876 45444  499999999988776654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=6.2e-29  Score=255.79  Aligned_cols=195  Identities=26%  Similarity=0.332  Sum_probs=167.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHH-----HHHHHHHHHhcCC---CCceeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVE-----SFQNEARVLSTVR---HRNIVKLYGFCL  519 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~niv~l~~~~~  519 (701)
                      ..+|...+.+|+|+||.|+.|.++ +...|+||.+.+.+.-...+.+     .+--|+.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            457999999999999999999664 5778999999876543222222     2346999999997   999999999999


Q ss_pred             eCcEEEEEEEcc-CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          520 HKRCMFFIYEYM-ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       520 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                      +++++||+||-- ++.+|.+++..+.   .+++..+..|++|++.|+++||++   ||||||||-+|+.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            999999999975 4568999998765   589999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||.|....  .......+||.+|.|||.+.+.+|..+. +|||++|+++|...-
T Consensus       714 fgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~-qdiwalgillytivy  764 (772)
T KOG1152|consen  714 FGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKP-QDIWALGILLYTIVY  764 (772)
T ss_pred             ccchhhhc--CCCcceeeeeccccchhhhCCCccCCCc-chhhhhhheeeEEEe
Confidence            99997764  3345567899999999999999998876 599999999997654

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=8.5e-28  Score=249.71  Aligned_cols=198  Identities=23%  Similarity=0.357  Sum_probs=160.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|++|.||+|... +++.||||.++.....  .....+.+|+.++.+.. ||||+++++++.+....+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            3577899999999999999999775 4899999999765332  22355666777666664 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      +||||+.+ ++.+++.....  .+++..+..++.|++.|++|||+ .   +++||||+|+||++++++.+||+|||.+..
T Consensus        91 ~v~e~~~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EEeeccCc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            99999854 78777765332  58999999999999999999996 5   899999999999999999999999999976


Q ss_pred             cccCCCCceeecccccccCCCCCCCCc----CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPP----VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.... ......++..|+|||.+.+..    ++.+  .|+||+|+++++++.+.+.
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~--~Di~slG~il~el~~g~~p  217 (296)
T cd06618         165 LVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIR--ADVWSLGISLVELATGQFP  217 (296)
T ss_pred             ccCCC-cccCCCCCccccCHhhcCCCCCccccccc--hhHHHHHHHHHHHHhCCCC
Confidence            64322 223345788999999987553    4444  4999999999998877643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=6.8e-28  Score=255.26  Aligned_cols=197  Identities=31%  Similarity=0.414  Sum_probs=159.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC--cE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHK--RC  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~  523 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4678999999999999999999654 68899999886543222 2235677899999999 999999999988653  46


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++ +|.+++...    .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||.++
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            8999999975 999888654    478899999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCC-----CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          604 LLHVDSS-----NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       604 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .......     ......|++.|+|||.+.+. ..+..  +|+||+|+++++++++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--sDi~slG~~l~el~tg~~  211 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKG--VDMWSVGCILGEMLLGKP  211 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeecccccccc--chHHHHHHHHHHHHhCCC
Confidence            6643321     12234588999999987553 34444  499999999987766653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=9.5e-28  Score=253.06  Aligned_cols=196  Identities=20%  Similarity=0.280  Sum_probs=156.8

Q ss_pred             eEEeec--cceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          456 YCIGTG--GYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       456 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      +.||+|  +||+||+|.. .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  9999999965 47999999998765433 2345788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR  612 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  612 (701)
                      ++++.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999999876532 2488999999999999999999998   99999999999999999999999998654332211111


Q ss_pred             -------eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          613 -------TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       613 -------~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                             ....++..|+|||++.+.........||||+|+++++++.+.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  209 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP  209 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                   11234567999999876533323335999999999998877643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=2.9e-27  Score=241.74  Aligned_cols=194  Identities=22%  Similarity=0.370  Sum_probs=160.1

Q ss_pred             HHHHHhhhcCCccceEE--eeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          442 YEDLINATEDFHIRYCI--GTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      ..+.....++|++.+.+  |+|+||.||++.. .+++.+|+|.+.......        .|+.....+ +||||++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEE
Confidence            44555666788888877  9999999999955 468899999987543221        122222222 69999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEE
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFV  596 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL  596 (701)
                      +...+..++||||+++++|.+++....   .+++..+..++.|+++||+|||+.   +++||||||+||+++.++ .++|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence            999999999999999999999997654   589999999999999999999999   999999999999999988 9999


Q ss_pred             EeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          597 ADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       597 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +|||.++.....    ....++..|+|||.+.+..++.+.  |+||+|+++++++.+.+
T Consensus       152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~il~~l~~g~~  204 (267)
T PHA03390        152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSF--DWWAVGVLTYELLTGKH  204 (267)
T ss_pred             ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchh--hHHHHHHHHHHHHHCCC
Confidence            999998765422    223588999999999887776654  99999999999998873

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-30  Score=239.85  Aligned_cols=199  Identities=25%  Similarity=0.338  Sum_probs=158.9

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++.+-...||.|+||+|++-.+ +.|+..|||++.....  ....+++..|.++..+- +.||||++||.+..++..||.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3444567799999999999955 5799999999987654  23357788888765554 689999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC--CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||.|+- ++..+.+..  .....+++...-+|+...+.||.||.+..  .|||||+||+|||++..|.+||||||++..+
T Consensus       142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence            999965 776554321  11236889999999999999999998764  8999999999999999999999999999766


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .. .-..+..+|...|||||.+.........++|+||||+.++|..+++
T Consensus       219 v~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~  266 (361)
T KOG1006|consen  219 VD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN  266 (361)
T ss_pred             HH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence            42 2334556799999999998765555556679999999999755555

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-29  Score=238.25  Aligned_cols=195  Identities=25%  Similarity=0.357  Sum_probs=163.7

Q ss_pred             hhcCCccc-eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee----
Q 041034          448 ATEDFHIR-YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLH----  520 (701)
Q Consensus       448 ~~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  520 (701)
                      .+++|++. ++||-|-.|.|-.+.. .+++++|+|++...        ...++|++..-.. .|||||.++++|+.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            46777764 5789999999999944 47899999998653        4457788876666 59999999999864    


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEE
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVA  597 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~~~kL~  597 (701)
                      .....+|||.|+||.|...+++++. ..+++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .+..+||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            4578899999999999999988654 3699999999999999999999999   999999999999996   45689999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |||+|+.-.. .......+-||.|.|||++....++...  |+||+|+++|-++-+-|..
T Consensus       207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydksc--dmwSlgVimYIlLCGyPPF  263 (400)
T KOG0604|consen  207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYILLCGYPPF  263 (400)
T ss_pred             ccccccccCC-CccccCCcccccccCHHHhCchhcCCCC--CccchhHHHHHhhcCCCcc
Confidence            9999987543 2333456789999999999988888887  9999999999888777644

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.5e-29  Score=263.35  Aligned_cols=221  Identities=24%  Similarity=0.428  Sum_probs=187.9

Q ss_pred             CccceEEeeccceEEEEEEc-CCCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      .+..++||+|+||+||+|.+ ++|+    +||+|++.......  ..+++.+|+-+|.+++|||++++++++..+. +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            45578999999999999944 4444    68999887665432  3478999999999999999999999998776 889


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |++|++.|+|.++++..+.  .+.....+.|.+|||+|+.|||++   ++|||||-++|||+.....+||.|||+|+...
T Consensus       775 vtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            9999999999999988654  477789999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeecc--cccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------------------------
Q 041034          607 VDSSNRTLRAG--TYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------------------------  649 (701)
Q Consensus       607 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------------------------  649 (701)
                      .+........|  .+.|||=|.+....++..+  |||++|+.+||                                   
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqS--DVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQS--DVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchh--hhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccH
Confidence            66655444333  4568999998888888776  99999999995                                   


Q ss_pred             --------cccCCCCCCCCHHHHHHHhhcCCCccchhhhhh
Q 041034          650 --------CLRSKPKSRPTMQRISQELEGKTPMKKGLKEIS  682 (701)
Q Consensus       650 --------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~~~  682 (701)
                              ||..|+..||+++++.+++.+....+..+..++
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence                    899999999999999999888776666555554

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=9e-28  Score=247.54  Aligned_cols=196  Identities=29%  Similarity=0.409  Sum_probs=165.4

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |+..+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|+.+++.++|+|++++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            567788999999999999665 589999999987542 223346778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      +++ +|.+++....  ..+++..+..++.|++.||+|||++   +++||||+|+||++++++.++|+|||.++.......
T Consensus        80 ~~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CDM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            984 9999998653  2589999999999999999999999   999999999999999999999999999987654433


Q ss_pred             CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          611 NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ......++..|+|||.+.+. ..+.+.  |+|++|+++++++.+.|.
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~--Dv~slG~~l~~l~~~~~~  198 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAV--DIWSVGCIFAEMITGKPL  198 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccc--cHHHHHHHHHHHHhCCCC
Confidence            33344567889999988665 444444  999999999999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.6e-27  Score=252.75  Aligned_cols=191  Identities=28%  Similarity=0.382  Sum_probs=156.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (701)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            47899999999999999999965 46899999998764322 22345678999999999999999999998754      


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ..+++|+||+.. ++.++...     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            346999999965 77766531     478899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ++.....   .....++..|+|||.+.+. .++.+  +|+||+|+++++++.+.
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slGvil~el~~g~  212 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQT--VDIWSVGCIMAEMLTGK  212 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCch--HHHHHHHHHHHHHHhCC
Confidence            9765321   2234578899999987653 34444  49999999999887765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.1e-27  Score=250.74  Aligned_cols=201  Identities=25%  Similarity=0.329  Sum_probs=164.8

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ..++....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            455667789999999999999999999954 57899999998764322 2234667889999999999999999998764


Q ss_pred             C------cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCe
Q 041034          521 K------RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA  594 (701)
Q Consensus       521 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~  594 (701)
                      .      ...+++++++ +++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence            3      3468888887 77998887643    488999999999999999999999   99999999999999999999


Q ss_pred             EEEeecCccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          595 FVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       595 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ||+|||+++....   ......++..|+|||...+ ..++.+  .|+||+|+++++++.+.|.
T Consensus       160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~--~DvwslG~il~el~~g~~p  217 (345)
T cd07877         160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQT--VDIWSVGCIMAELLTGRTL  217 (345)
T ss_pred             EEecccccccccc---cccccccCCCccCHHHHhCccCCCch--hhHHHHHHHHHHHHhCCCC
Confidence            9999999976432   2233468899999998765 334444  4999999999999988653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=236.03  Aligned_cols=198  Identities=21%  Similarity=0.349  Sum_probs=180.4

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|.+..+||+|+|+.|..++.. +.+.+|+|++++....+.+..+..+.|-.+..+. +||.+|-++..|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            568999999999999999999764 5789999999998777766678888898888777 59999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |.||++||+|.-.++++.   .++++.+.-+...|.-||.|||++   |||.||||.+|+|+|..|++||.|+|.++.--
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999988777665   589999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .++...+..+|||.|+|||++.+..|....  |+|++|+++++|+++.
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsv--dwwalgvlmfemmagr  448 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSV--DWWALGVLMFEMMAGR  448 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCcee--hHHHHHHHHHHHHcCC
Confidence            666777888999999999999999999998  9999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=5.6e-30  Score=238.21  Aligned_cols=201  Identities=25%  Similarity=0.420  Sum_probs=164.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-------  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  520 (701)
                      ...|+...+||+|.||+||+|+.. +|+.||+|++-.... ...+.....+|++++..++|+|++.+++.|..       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            456777889999999999999664 588899987654321 22344667899999999999999999998864       


Q ss_pred             -CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          521 -KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       521 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                       ...+|+||++|+. +|.-++....  .+++..++.+++.++..||.|+|..   .|+|||+||+|+||+.+|.+||+||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence             2358999999988 8988886543  3688999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccC----CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          600 GTARLLHVD----SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       600 Gla~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |+|+.+...    ....+.++.|.+|.+||.+.+........ |||+.|||+.+||++.|-.
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~i-DiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPI-DIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcc-hhHhHHHHHHHHHccCccc
Confidence            999876432    22345667899999999988875544443 9999999999988877643

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-27  Score=243.78  Aligned_cols=195  Identities=26%  Similarity=0.389  Sum_probs=161.3

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      |++.+.||+|++|.||+|... +++.||+|++........  .....+|+..+++++ |||++++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            678899999999999999765 578999999876543211  233457899999999 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+ +|+|.+++.... ...+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.++......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 779998887654 23589999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                       ......++..|+|||++.... .+.+  .|+||+|+++++++++.|.
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~--~Di~s~G~~l~el~~g~~~  198 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSP--VDIWALGCIMAELYTLRPL  198 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCc--cchhhHHHHHHHHHhCCCc
Confidence             223346888999999875433 3444  4999999999999887753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.6e-27  Score=237.06  Aligned_cols=204  Identities=27%  Similarity=0.371  Sum_probs=170.9

Q ss_pred             EeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|+||.||++... +++.||+|.+...........+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999654 5899999999876554444567889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeec
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA  616 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  616 (701)
                      .+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99997654   588999999999999999999998   999999999999999999999999999987654333344456


Q ss_pred             ccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhh
Q 041034          617 GTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELE  669 (701)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~  669 (701)
                      ++..|+|||...+...+..  .|+|++|+++++++.+. |.......++.+.+.
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~--~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  206 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKA--VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL  206 (250)
T ss_pred             CCccccChHHhCCCCCCch--hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            8899999999877665555  49999999999999877 444444444444443

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=4.1e-27  Score=248.69  Aligned_cols=196  Identities=26%  Similarity=0.379  Sum_probs=157.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-C--CcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee----Cc
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-D--GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLH----KR  522 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~  522 (701)
                      +|++.+.||+|+||.||+|... +  ++.||+|++...... ....+.+.+|+.+++++ +||||+++++++..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            5888999999999999999654 4  788999998753322 22346678899999999 59999999987543    24


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++++||+. ++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||.+
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5789999986 58998886543   588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCC----CceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSS----NRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.+.....    ......|++.|+|||...+ ..++.+  .|+||+|+++++++.+.|.
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~--~Di~slGv~l~~l~~g~~p  209 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKA--IDVWSVGCILAELLGRKPV  209 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcH--HHHHHHHHHHHHHHhCCcC
Confidence            86543211    1223468999999998755 344544  4999999999988877653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2e-27  Score=252.20  Aligned_cols=194  Identities=26%  Similarity=0.355  Sum_probs=161.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE---
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC---  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  523 (701)
                      ..++|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+.+++.++|||++++++++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4678999999999999999999664 6889999998754322 2334667789999999999999999998876554   


Q ss_pred             ---EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          524 ---MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       524 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                         .++|+||+ +++|.+++...    .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999999 56999988753    589999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .+......   .....++..|+|||...+. ..+.+  .|+||+|+++++++++.+
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~--~DvwslGv~l~elltg~~  214 (343)
T cd07851         164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQT--VDIWSVGCIMAELLTGKT  214 (343)
T ss_pred             cccccccc---ccCCcccccccCHHHHhCCCCCCch--HhHHHHHHHHHHHHhCCC
Confidence            99865432   2334678899999987543 33444  499999999998887764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=6.1e-27  Score=245.03  Aligned_cols=200  Identities=28%  Similarity=0.421  Sum_probs=160.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (701)
                      .++|++.+.||+|++|.||+|.. .+++.||+|++......+. ....+.+|+++++.++||||+++++++.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            57899999999999999999965 4689999999875433221 124567899999999999999999987543      


Q ss_pred             --cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          522 --RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       522 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                        ..+++||||+.+ ++.+.+....  ..+++..+..++.|+++||+|||++   |++|+||||+||++++++.++|+||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              347999999975 7777765432  2589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCC-----------ceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          600 GTARLLHVDSSN-----------RTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       600 Gla~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |+++........           .+...+++.|+|||...+. .++.+  .|+||+|+++++++.+.|..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA--VDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch--hHhHHHHHHHHHHHhCCCCC
Confidence            999865432211           1223568889999987653 34444  49999999999999987643

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=3.1e-27  Score=250.50  Aligned_cols=194  Identities=26%  Similarity=0.366  Sum_probs=156.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (701)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            36899999999999999999955 4689999999876543   2246688899999999999999999876543      


Q ss_pred             --------cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CC
Q 041034          522 --------RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NL  592 (701)
Q Consensus       522 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~  592 (701)
                              ...++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.   |++||||||+||+++. ++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                    35799999997 4898888643    488999999999999999999998   9999999999999974 56


Q ss_pred             CeEEEeecCccccccCCC---CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          593 EAFVADFGTARLLHVDSS---NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .+|++|||.++.......   ......++..|+|||.+.+. .++.+  +||||+|+++++++.+.+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~DiwSlGvil~el~~g~~  217 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA--IDMWAAGCIFAEMLTGKP  217 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch--hhHHHHHHHHHHHHhCCC
Confidence            789999999976532211   11223578899999986543 34444  499999999998877663

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=1.3e-26  Score=244.13  Aligned_cols=198  Identities=26%  Similarity=0.374  Sum_probs=162.2

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-Cc
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-KR  522 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  522 (701)
                      +....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            345678999999999999999999954 47999999988654322 2234667889999999999999999999865 55


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+ +++|.++++..    .+++..+..++.|+++||+|||+.   +++||||||+||++++++.++|+|||.+
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            789999998 56898888643    477888889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ......   .....++..|+|||.+.+ ..++.+  .|+|++|+++++++.+.|.
T Consensus       156 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~--~Dv~slG~il~el~tg~~~  205 (328)
T cd07856         156 RIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVE--VDIWSAGCIFAEMLEGKPL  205 (328)
T ss_pred             cccCCC---cCCCcccccccCceeeeccCCcCcH--HHHHHHHHHHHHHHhCCCC
Confidence            764322   223357889999998755 334444  4999999999998887643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=251.33  Aligned_cols=203  Identities=24%  Similarity=0.324  Sum_probs=166.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      .++.|.....+|.|+|+.|-.+.. .+++..+||++.+...       +..+|+.++... +||||+++++.+.+..+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            467888999999999999999944 5789999999987632       234577666666 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE-cCCCCeEEEeecCccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL-NSNLEAFVADFGTARL  604 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll-~~~~~~kL~DFGla~~  604 (701)
                      +|||.+.|+-+.+.+.....   .. ..+..|+.+|+.|+.|||++   |||||||||+|||+ +..++++|+|||.++.
T Consensus       393 ~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            99999999988887766542   22 67778999999999999999   99999999999999 5889999999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhh
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELE  669 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~  669 (701)
                      ...+   ....+-|..|.|||+.....+++..  ||||+|+++|+||.+.+..  .|.-.++..++.
T Consensus       466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~ac--D~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~  527 (612)
T KOG0603|consen  466 LERS---CDTPALTLQYVAPEVLAIQEYTEAC--DWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ  527 (612)
T ss_pred             Cchh---hcccchhhcccChhhhccCCCCcch--hhHHHHHHHHHHHhCCCccccCCchHHHHHhhc
Confidence            6544   2334678899999999988888887  9999999999888776432  344444444443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=1.5e-26  Score=231.94  Aligned_cols=176  Identities=20%  Similarity=0.183  Sum_probs=147.6

Q ss_pred             ccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCHHHH
Q 041034          461 GGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYV  539 (701)
Q Consensus       461 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  539 (701)
                      |.+|.||+|.. .+++.||+|++....        .+.+|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            89999999955 478999999997642        223445555566799999999999999999999999999999999


Q ss_pred             HhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeecccc
Q 041034          540 LRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTY  619 (701)
Q Consensus       540 l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~  619 (701)
                      +....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+......   .....++.
T Consensus        76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~  146 (237)
T cd05576          76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN  146 (237)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence            87654   488999999999999999999998   9999999999999999999999999988665322   22234677


Q ss_pred             cccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          620 GYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       620 ~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .|+|||.......+.+.  |+||+|+++++++.+.+
T Consensus       147 ~y~aPE~~~~~~~~~~~--DvwslG~il~el~~g~~  180 (237)
T cd05576         147 MYCAPEVGGISEETEAC--DWWSLGAILFELLTGKT  180 (237)
T ss_pred             cccCCcccCCCCCCchh--hHHHHHHHHHHHHHCcc
Confidence            89999998777666654  99999999999988753

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-28  Score=237.29  Aligned_cols=207  Identities=21%  Similarity=0.296  Sum_probs=171.6

Q ss_pred             CCCCcccHHHHHhhhcCCccceEEeeccceEEEEEE-cCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC--C--
Q 041034          435 GYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH--R--  509 (701)
Q Consensus       435 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~--  509 (701)
                      ..+|.+.|+.--...++|.++..+|+|.||.|-.+. ...+..||||+++.-    ..+.+..+-|+++++++.+  |  
T Consensus        74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g  149 (415)
T KOG0671|consen   74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNG  149 (415)
T ss_pred             CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCC
Confidence            334555554444458899999999999999999994 445789999999754    3456777889999999942  2  


Q ss_pred             --ceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 041034          510 --NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL  587 (701)
Q Consensus       510 --niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIl  587 (701)
                        -++++.+||.-.++.+||+|.+ |-|+.+++....- .+++...+..+++|++++++|||+.   +++|-||||+||+
T Consensus       150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENIL  224 (415)
T KOG0671|consen  150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENIL  224 (415)
T ss_pred             ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEE
Confidence              4888999999999999999998 5699999987543 3688999999999999999999999   9999999999999


Q ss_pred             EcC--------------------CCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHH
Q 041034          588 LNS--------------------NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTA  647 (701)
Q Consensus       588 l~~--------------------~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~  647 (701)
                      +..                    +..+|++|||.|+.-.   +..+..+.|..|.|||++.+-++....  ||||+|||+
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pC--DvWSiGCIL  299 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPC--DVWSIGCIL  299 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCcc--CceeeeeEE
Confidence            832                    3468999999998743   333667899999999999999999998  999999999


Q ss_pred             HHcccCCC
Q 041034          648 LACLRSKP  655 (701)
Q Consensus       648 ~~cl~~~P  655 (701)
                      .|+..+.-
T Consensus       300 ~ElytG~~  307 (415)
T KOG0671|consen  300 VELYTGET  307 (415)
T ss_pred             EEeeccce
Confidence            98777653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=8.2e-27  Score=259.87  Aligned_cols=195  Identities=22%  Similarity=0.246  Sum_probs=135.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-C----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeee-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-D----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF-----  517 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-----  517 (701)
                      ..++|++.+.||+|+||.||+|... +    ++.||+|++......     +....|  .++...+.++..++..     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            5678999999999999999999664 4    689999988643211     111111  1112222222222211     


Q ss_pred             -eeeCcEEEEEEEccCCCCHHHHHhcCCCc-----------------cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041034          518 -CLHKRCMFFIYEYMERGSLFYVLRDDDEA-----------------IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHR  579 (701)
Q Consensus       518 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~  579 (701)
                       .......++||||+++++|.+++......                 .......+..++.|++.||+|||++   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             23566799999999999999998754211                 0112344668999999999999998   99999


Q ss_pred             CCCCCcEEEcC-CCCeEEEeecCccccccCC-CCceeecccccccCCCCCCCCcCCh--------------------hhH
Q 041034          580 DISSNNILLNS-NLEAFVADFGTARLLHVDS-SNRTLRAGTYGYIAPDQRLSPPVNQ--------------------KII  637 (701)
Q Consensus       580 Dlkp~NIll~~-~~~~kL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~--------------------~~~  637 (701)
                      ||||+|||++. ++.+||+|||+|+.+.... .......+++.|+|||++.......                    ...
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999985 5799999999998654322 2233457899999999654322111                    112


Q ss_pred             HHHHHHHHHHHHccc
Q 041034          638 QDIILVSTTALACLR  652 (701)
Q Consensus       638 ~Di~slg~i~~~cl~  652 (701)
                      .||||+||++|+++.
T Consensus       360 ~DVwSlGviL~el~~  374 (566)
T PLN03225        360 FDIYSAGLIFLQMAF  374 (566)
T ss_pred             cccHHHHHHHHHHHh
Confidence            399999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-28  Score=255.92  Aligned_cols=209  Identities=31%  Similarity=0.481  Sum_probs=183.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      +..++|...+++|.|.||.||+|+. ..++..|+|+++....++   ..-.++|+-+++.++||||+.++|.+...+..|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            5678999999999999999999955 468999999998876554   356688999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +.||||.+|+|++..+-..   ++++.++..+.+..++|++|||++   |-+|||||-.||++++.|.+|+.|||.+..+
T Consensus        89 icMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence            9999999999999887655   689999999999999999999999   9999999999999999999999999999877


Q ss_pred             ccCCCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHH---------------------------------
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALA---------------------------------  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~---------------------------------  649 (701)
                      ...-.+...+.||+.|||||+..   ...|.+..  |+|++|+.+.+                                 
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlc--diwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC--DIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK  240 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccc--cccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence            65555566778999999999754   34455665  99999988764                                 


Q ss_pred             -------------cccCCCCCCCCHHHHHH
Q 041034          650 -------------CLRSKPKSRPTMQRISQ  666 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~  666 (701)
                                   +++.+|++||+++.++.
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                         88999999999876654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.2e-26  Score=247.59  Aligned_cols=204  Identities=18%  Similarity=0.267  Sum_probs=150.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-----------------CCCcEEEEEEecCCCccCh-H----------HHHHHHHH
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-----------------PDGKVVALKKLHQSETEDS-A----------FVESFQNE  499 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~-~----------~~~~~~~E  499 (701)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........ .          ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999843                 2356799999865322110 0          01223457


Q ss_pred             HHHHhcCCCCce-----eeeeeeeee--------CcEEEEEEEccCCCCHHHHHhcCCC---------------------
Q 041034          500 ARVLSTVRHRNI-----VKLYGFCLH--------KRCMFFIYEYMERGSLFYVLRDDDE---------------------  545 (701)
Q Consensus       500 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  545 (701)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766544     677777753        3568999999999999999874211                     


Q ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC-ceeecccccccCC
Q 041034          546 AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN-RTLRAGTYGYIAP  624 (701)
Q Consensus       546 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~gt~~y~aP  624 (701)
                      ...+++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||+++........ .....+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11346778899999999999999998   9999999999999999999999999999765332211 1122358899999


Q ss_pred             CCCCCCcC--------------------ChhhHHHHHHHHHHHHHcccCC
Q 041034          625 DQRLSPPV--------------------NQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       625 E~~~~~~~--------------------~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      |++.....                    ......|+||+|+++++|+.+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~  429 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE  429 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCC
Confidence            98764321                    1111249999999999998764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-26  Score=259.85  Aligned_cols=220  Identities=27%  Similarity=0.411  Sum_probs=184.4

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcC----C----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeee
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELP----D----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY  515 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  515 (701)
                      ++...++.++.+.+|+|+||.|++|...    .    ...||||.++.....  ...+.+..|+++|+.+. |+||+.++
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            3445566677789999999999999532    1    457999999876654  34688999999999995 99999999


Q ss_pred             eeeeeCcEEEEEEEccCCCCHHHHHhcCC-------C----c--cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 041034          516 GFCLHKRCMFFIYEYMERGSLFYVLRDDD-------E----A--IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDIS  582 (701)
Q Consensus       516 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlk  582 (701)
                      |++..++..++|+||++.|+|.++++...       .    .  ..++..+.+.+++|||.|++||++.   ++|||||-
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence            99999999999999999999999998765       0    0  1388899999999999999999999   99999999


Q ss_pred             CCcEEEcCCCCeEEEeecCccccccCCCCc-eeecc--cccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------
Q 041034          583 SNNILLNSNLEAFVADFGTARLLHVDSSNR-TLRAG--TYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------  649 (701)
Q Consensus       583 p~NIll~~~~~~kL~DFGla~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------  649 (701)
                      ++|||+.++..+||+|||+|+......... ....+  ...|||||.+....++.++  ||||+|+++||          
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kS--DVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKS--DVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccc--hhhHHHHHHHHHhhCCCCCCC
Confidence            999999999999999999998654333222 11122  2349999999998888876  99999999985          


Q ss_pred             ----------------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ----------------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ----------------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                        ||+.+|.+||++.++.+.++..
T Consensus       524 ~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  524 GIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                                              9999999999999999999873

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=3.3e-27  Score=216.85  Aligned_cols=200  Identities=19%  Similarity=0.364  Sum_probs=165.0

Q ss_pred             hcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeC--cEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHK--RCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~  524 (701)
                      .++|++.+++|+|.+++||.| ...+.++++||++++-+      .+.+.+|+.++..++ ||||++++++..++  ..+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            578999999999999999999 45578899999998754      367899999999997 99999999998875  457


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEeecCcc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTAR  603 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DFGla~  603 (701)
                      .+|+||+.+.+...+..      .++...+..++.++++||.|+|+.   ||+|||+||.|++||.. -..+|+|+|+|.
T Consensus       111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            89999999988776653      367788899999999999999999   99999999999999854 579999999999


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHHcc-cCCCCCCC--CHHHHHH
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALACL-RSKPKSRP--TMQRISQ  666 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~cl-~~~P~~Rp--t~~~i~~  666 (701)
                      ++.+. .....++.+..|.-||.+..-+. +.+.  |+||+||++..|. ..+|..+-  ...|+++
T Consensus       182 FYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSL--D~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  182 FYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             hcCCC-ceeeeeeehhhcCCchheeechhccccH--HHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence            88644 44556778899999999877554 4444  9999999999865 44576542  3444443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-28  Score=228.62  Aligned_cols=195  Identities=29%  Similarity=0.360  Sum_probs=159.4

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----EE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----CM  524 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  524 (701)
                      +.+-.+.||-|+||+||.+.+ ++|+.||+|++..-. ..-...+++.+|++++..++|.|+...++...-..     ++
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            455678899999999999965 479999999986533 22334578899999999999999999888765442     46


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |.++|.|.. +|.+++-...   .++...+.-+.+||++||.|||+.   +|.||||||.|.|++.+...||||||+|+.
T Consensus       133 YV~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            788998865 8888876543   578888888999999999999999   999999999999999999999999999997


Q ss_pred             cccCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          605 LHVDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       605 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      -..+. ...+..+-|..|.|||.+.+....... -||||+|||+.|++...
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~A-vDiWSVGCIFaELLgRr  255 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGA-VDIWSVGCIFAELLQRK  255 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCc-cceehhhHHHHHHHhhh
Confidence            65433 234556789999999999887654444 39999999999987653

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-28  Score=265.30  Aligned_cols=332  Identities=34%  Similarity=0.446  Sum_probs=218.7

Q ss_pred             EEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECC
Q 041034           39 ITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS  118 (701)
Q Consensus        39 v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  118 (701)
                      +.+|+++.+.+.. . +..+..+.+|+.|+++.|.|. .+|.+.+++.+|++|.|.+|.+. ..|..+..+++|++|++|
T Consensus        47 L~~l~lsnn~~~~-f-p~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   47 LKSLDLSNNQISS-F-PIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eEEeecccccccc-C-CchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence            6778888877653 2 223556677888888888887 56777778888888888888887 677788888888888888


Q ss_pred             CCCCCCCCccccCCcccc-------------------ceeecccccCCCCCcccccCCCC--------------------
Q 041034          119 NNSLHGTTPIEIGSLRNL-------------------EELYLRSNKLSGVLPQEIGNLKS--------------------  159 (701)
Q Consensus       119 ~N~l~~~~~~~~~~l~~L-------------------~~L~L~~n~l~~~~~~~~~~l~~--------------------  159 (701)
                      +|++. ..|..+..++.+                   +.++|..|.+.+.++..+.++..                    
T Consensus       123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l  201 (1081)
T KOG0618|consen  123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANL  201 (1081)
T ss_pred             hhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccch
Confidence            88876 333333222222                   22222222222222222222222                    


Q ss_pred             -----------------------------------------CcEEEceecccCCCcCcccccccccceeEeeecccCCCC
Q 041034          160 -----------------------------------------LIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTI  198 (701)
Q Consensus       160 -----------------------------------------L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  198 (701)
                                                               |+++++++|++++. |++++.+.+|+.|...+|+|+ .+
T Consensus       202 ~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~l  279 (1081)
T KOG0618|consen  202 EVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-AL  279 (1081)
T ss_pred             hhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hh
Confidence                                                     23333333333222 133333444444444444442 33


Q ss_pred             CCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccC-------------------------CC
Q 041034          199 PREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG-------------------------NF  253 (701)
Q Consensus       199 ~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-------------------------~~  253 (701)
                      |..+..+.+|+.|++..|.+. -+|.....+++|++|+|..|+|....+..+.                         .+
T Consensus       280 p~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~  358 (1081)
T KOG0618|consen  280 PLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNH  358 (1081)
T ss_pred             HHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhh
Confidence            333333444444444444444 4566667778888888888888764322211                         13


Q ss_pred             CcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeec
Q 041034          254 SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL  333 (701)
Q Consensus       254 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  333 (701)
                      +.|+.|.+.+|.++...-..+-++.+|+.|+|++|++.......+.++..|+.|+||+|+++ .+|..+.++..|+.|..
T Consensus       359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            45777778888887766566778889999999999998666667889999999999999998 78899999999999999


Q ss_pred             cCCccCCCCCccccccccCCeEEcccccCc-ccCCCCcc---ccccccccCC
Q 041034          334 NHNSLDGTIPPEIGKILLLQNLDLSHNNLS-GTIPMTLH---PMFLDMSFNN  381 (701)
Q Consensus       334 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~-g~~p~~~~---~~~l~ls~N~  381 (701)
                      .+|++. ..| .+..++.|+.+|+|.|+|+ +.+|....   ..+|||++|.
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            999998 677 8899999999999999997 45554433   3589999996

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=4.8e-27  Score=252.30  Aligned_cols=226  Identities=23%  Similarity=0.363  Sum_probs=172.3

Q ss_pred             ccceEEeeccce-EEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEEEc
Q 041034          453 HIRYCIGTGGYG-SVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       453 ~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      .-.+.+|.|+.| .||+|.+ +|+.||||++-...      .+...+|+..++.- +|||||++++.-.+++..||..|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            334567888886 6899988 58899999986543      35678999999988 499999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---C--CCeEEEeecCccc
Q 041034          531 MERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---N--LEAFVADFGTARL  604 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~--~~~kL~DFGla~~  604 (701)
                      |.. +|.+++..... .........+.+..|+++||++||+-   +||||||||.||||+.   +  .+++|+|||+++.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            976 99999987411 11111144577899999999999997   9999999999999975   3  5789999999998


Q ss_pred             cccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC------CCCCC---------------C-
Q 041034          605 LHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS------KPKSR---------------P-  659 (701)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~------~P~~R---------------p-  659 (701)
                      +..+...   .....||-+|+|||++........+  |||++||++|+++++      |+.+|               | 
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~av--DiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~  738 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAV--DIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPL  738 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCccc--chhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccC
Confidence            8654432   3345699999999999888777765  999999999976665      22223               1 


Q ss_pred             ---CHHHHHHHhhcCCCccchhhhhhHHHHhcccceeec
Q 041034          660 ---TMQRISQELEGKTPMKKGLKEISISEMRNQEMFWLH  695 (701)
Q Consensus       660 ---t~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~w~~  695 (701)
                         -+.++++.+-.    +....+.++.+...+++||..
T Consensus       739 ~d~eA~dLI~~ml~----~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  739 PDCEAKDLISRMLN----PDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             chHHHHHHHHHhcC----CCcccCCCHHHHhCCCccCCh
Confidence               23333333332    334556777888888899873

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=4.1e-25  Score=216.37  Aligned_cols=201  Identities=34%  Similarity=0.577  Sum_probs=170.6

Q ss_pred             EeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCH
Q 041034          458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      ||+|++|.||++... +++.+++|++.......  ..+.+.+|+..++.++|++++++++++......+++|||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            589999999999765 48999999998764322  346789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEeecCccccccCCCCceee
Q 041034          537 FYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSNRTLR  615 (701)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~  615 (701)
                      .+++....  ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99987652  2488999999999999999999999   9999999999999999 8999999999998765432223345


Q ss_pred             cccccccCCCCCCCC-cCChhhHHHHHHHHHHHH----------HcccCCCCCCCCHHHHHHH
Q 041034          616 AGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTAL----------ACLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       616 ~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~----------~cl~~~P~~Rpt~~~i~~~  667 (701)
                      .+...|++||..... ..+..  .|+|++|++++          .|+..+|.+||++.++++.
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~--~D~~~lg~~~~~l~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEK--SDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             cCCCCccChhHhcccCCCCch--hhhHHHHHHHHHHHHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            688899999998775 44444  49999998875          4888999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=1.6e-25  Score=255.98  Aligned_cols=190  Identities=24%  Similarity=0.338  Sum_probs=161.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|... +++.||||+++............+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999664 6899999999876555555667889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..++.++.||+.||+|||.+   +||||||||+|||++.++.+||+|||+++....
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            99999999999997644   478899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVST  645 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~  645 (701)
                      .........+|+.|+|||......... ...++|++|.
T Consensus       157 ~~~~~~~~~~t~~~~~pe~~~~~~~~~-~~s~~~s~g~  193 (669)
T cd05610         157 RELNMMDILTTPSMAKPKNDYSRTPGQ-VLSLISSLGF  193 (669)
T ss_pred             CcccccccccCccccCccccccCCCCc-eeeeeeecCc
Confidence            444445567999999999765433322 2346677663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-25  Score=224.50  Aligned_cols=132  Identities=25%  Similarity=0.507  Sum_probs=113.6

Q ss_pred             hcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-----C---Cceeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-----H---RNIVKLYGFCL  519 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~  519 (701)
                      ..+|.+.++||.|.|++||+| +....+.||+|+++..    ..+.+....||++|++++     |   .+||++++.|.
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            368999999999999999999 5557889999999864    456678899999999984     2   47999999997


Q ss_pred             e----CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 041034          520 H----KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL  588 (701)
Q Consensus       520 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll  588 (701)
                      .    +.+.+||+|++ |-+|..+|.... -..++...+.+|++||+.||.|||.+|  ||||.||||+|||+
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            5    45899999999 668888887643 225888999999999999999999998  99999999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=6.9e-25  Score=220.09  Aligned_cols=200  Identities=28%  Similarity=0.461  Sum_probs=166.2

Q ss_pred             cceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCHHHHH
Q 041034          462 GYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVL  540 (701)
Q Consensus       462 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  540 (701)
                      +||.||+|... +++.||+|++........  .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999765 589999999986554322  478899999999999999999999999999999999999999999998


Q ss_pred             hcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeeccccc
Q 041034          541 RDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYG  620 (701)
Q Consensus       541 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~  620 (701)
                      ....   .+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus        79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             Hhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            7654   278899999999999999999998   99999999999999999999999999998765432 2334568889


Q ss_pred             ccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC-C-CCHHHHHHHhhcCC
Q 041034          621 YIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS-R-PTMQRISQELEGKT  672 (701)
Q Consensus       621 y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~-R-pt~~~i~~~l~~~~  672 (701)
                      |+|||.......+.+.  |+|++|+++++++.+.+.. - .....+.+.+....
T Consensus       152 ~~~pE~~~~~~~~~~~--Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~  203 (244)
T smart00220      152 YMAPEVLLGKGYGKAV--DVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK  203 (244)
T ss_pred             CCCHHHHccCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence            9999998877776654  9999999999988876432 2 45555555555433

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=8.3e-24  Score=209.86  Aligned_cols=212  Identities=31%  Similarity=0.425  Sum_probs=173.2

Q ss_pred             CccceEEeeccceEEEEEEcCC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |.+.+.||+|++|.||+|...+ ++.+|+|.+......  ...+.+.+|++.++.++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5678999999999999997764 889999999865433  2357889999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC-
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS-  609 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~-  609 (701)
                      +++++|.+++.....  .+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999999976542  178899999999999999999998   99999999999999999999999999998775432 


Q ss_pred             CCceeecccccccCCCCC-CCCcCChhhHHHHHHHHHHHHHcccCCCCC---CCCHHHHHHHhhcCC
Q 041034          610 SNRTLRAGTYGYIAPDQR-LSPPVNQKIIQDIILVSTTALACLRSKPKS---RPTMQRISQELEGKT  672 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~Di~slg~i~~~cl~~~P~~---Rpt~~~i~~~l~~~~  672 (701)
                      .......++..|++||.. ........  .|+|++|+++++++.+.+..   +-...++.+.+....
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~--~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEA--VDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCch--hhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            122334678899999998 44444443  59999999999999887543   223345555555444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=2.4e-24  Score=241.59  Aligned_cols=265  Identities=28%  Similarity=0.323  Sum_probs=210.4

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ..-..|+|+.|+++ .+|+.+.  ++|+.|++++|+|+. +|..   +++|++|+|++|+|+.. |.   ..++|+.|+|
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsL-P~---lp~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSL-PV---LPPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcc-cC---cccccceeec
Confidence            34678999999998 6788775  489999999999994 5542   58999999999999954 43   2468999999


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA  221 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  221 (701)
                      ++|.++. +|..+   .+|+.|++++|+++.. |..   .++|+.|+|++|+|++ +|...   .+|+.|++++|+|++ 
T Consensus       270 s~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~L-P~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-  336 (788)
T PRK15387        270 FSNPLTH-LPALP---SGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-  336 (788)
T ss_pred             cCCchhh-hhhch---hhcCEEECcCCccccc-ccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-
Confidence            9999985 34333   5688999999999754 432   4689999999999985 45432   468889999999985 


Q ss_pred             ccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCc
Q 041034          222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL  301 (701)
Q Consensus       222 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  301 (701)
                      +|..   ..+|++|+|++|+|++ +|..   .++|+.|++++|+|++ +|..   ..+|+.|+|++|.|++ +|..   .
T Consensus       337 LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~  401 (788)
T PRK15387        337 LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---P  401 (788)
T ss_pred             cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---c
Confidence            5542   2579999999999997 4543   3578889999999995 6653   3579999999999985 5543   3


Q ss_pred             cceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCc
Q 041034          302 FNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL  370 (701)
Q Consensus       302 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~  370 (701)
                      ++|+.|++++|+|++ +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|+|.+|..+
T Consensus       402 s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        402 SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            679999999999984 7754   356889999999998 789999999999999999999998877654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=3.3e-25  Score=214.04  Aligned_cols=192  Identities=26%  Similarity=0.321  Sum_probs=160.5

Q ss_pred             hcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (701)
                      ..+|.-...+|.|+- .|..| +.-.+++||+|++...... ....++..+|...+..+.|+||++++.+|.-.      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            456777788899988 56666 3346899999988765333 33346778999999999999999999998643      


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...|+|||+|.. +|.+.+..     .++..++..+.+|++.|++|||+.   ||+||||||+||++..++.+||.|||+
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            357999999966 99888873     578899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      |+.-..+ -..+..+.|..|.|||++.+..+.+.+  ||||+||++.+++.+.
T Consensus       165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~v--diwSvGci~gEli~~~  214 (369)
T KOG0665|consen  165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGELILGT  214 (369)
T ss_pred             hcccCcc-cccCchhheeeccCchheeccCCcccc--hhhhhhhHHHHHhhce
Confidence            9865433 345666899999999999998877776  9999999999987654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.6e-25  Score=206.79  Aligned_cols=227  Identities=21%  Similarity=0.305  Sum_probs=170.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeee-eeeeCcE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYG-FCLHKRC  523 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~~~  523 (701)
                      ...+.|.+.+.+|+|.||.+-+|+++ ..+.+|+|.+......    .++|.+|...--.+. |.||+.-|+ .|+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            34577999999999999999999765 5788999998875543    477888887766664 899998775 4677888


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCeEEEeecC
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGT  601 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~--~~~~~kL~DFGl  601 (701)
                      +++++||++.|+|.+-+...    .+.+....+++.|++.|+.|||++   ++||||||.+||||-  +..++||||||.
T Consensus        97 YvF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             EEEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence            99999999999999877654    377888999999999999999999   999999999999993  345999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHHcccCCCC-C-----CCCHHHHHHHhhcCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALACLRSKPK-S-----RPTMQRISQELEGKT  672 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~cl~~~P~-~-----Rpt~~~i~~~l~~~~  672 (701)
                      .+..+.   .......+..|.|||.....   .+......|+|.+|++++.|+++.|. +     -|.-.+-++.+.++.
T Consensus       170 t~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  170 TRKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             ccccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence            876432   22223456779999865433   22112234999999999999999853 3     234455666666655


Q ss_pred             C-ccchhhhhhHHHHh
Q 041034          673 P-MKKGLKEISISEMR  687 (701)
Q Consensus       673 ~-~~~~~~~~~~~~~~  687 (701)
                      + .++.|+..+-..++
T Consensus       247 ~~~P~~F~~fs~~a~r  262 (378)
T KOG1345|consen  247 PALPKKFNPFSEKALR  262 (378)
T ss_pred             ccCchhhcccCHHHHH
Confidence            3 34445544444444

>PLN03210 Resistant to P

Probab=99.91  E-value=5.3e-23  Score=248.35  Aligned_cols=282  Identities=25%  Similarity=0.264  Sum_probs=159.7

Q ss_pred             CCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecc
Q 041034           63 NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLR  142 (701)
Q Consensus        63 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  142 (701)
                      .|+.|++.++.+. .+|..| ...+|+.|+|++|++. .+|..+..+++|+.|+|++|.....+| .++.+++|++|+|+
T Consensus       590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~  665 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLS  665 (1153)
T ss_pred             ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEec
Confidence            4777777776665 555555 3567777777777766 455666667777777777665444444 36666777777777


Q ss_pred             cccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCc
Q 041034          143 SNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAI  222 (701)
Q Consensus       143 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  222 (701)
                      +|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|+|++|...+.+|..   ..+|++|++++|.+. .+
T Consensus       666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~l  740 (1153)
T PLN03210        666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EF  740 (1153)
T ss_pred             CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cc
Confidence            766555667777777777777777765545555544 5667777777766544444432   245666677777665 34


Q ss_pred             cccccCCCcccEEEeccCCCC-------CCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCc
Q 041034          223 PSTLGHLTSLLYLDLSFNQLH-------SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP  295 (701)
Q Consensus       223 p~~l~~l~~L~~L~L~~N~l~-------~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  295 (701)
                      |..+ .+++|++|++.++...       ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|
T Consensus       741 P~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP  819 (1153)
T PLN03210        741 PSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP  819 (1153)
T ss_pred             cccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence            4433 3455555555543211       1111112223455555555555555555555555555555555554333444


Q ss_pred             ccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEccc
Q 041034          296 FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH  359 (701)
Q Consensus       296 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~  359 (701)
                      ..+ ++++|+.|+|++|.....+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++
T Consensus       820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~  878 (1153)
T PLN03210        820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG  878 (1153)
T ss_pred             CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence            443 4555555555555443344432   234555555555555 4555555555555555555

syringae 6; Provisional

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.7e-23  Score=217.94  Aligned_cols=167  Identities=20%  Similarity=0.186  Sum_probs=130.2

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcC--CCcEEEEEEecCCCc--cChHHHHHHHHHHHHHhcCCCCceee-eeeeee
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELP--DGKVVALKKLHQSET--EDSAFVESFQNEARVLSTVRHRNIVK-LYGFCL  519 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~  519 (701)
                      .....++|.+.+.||+|+||+||+|...  +++.||||++.....  ......+.+.+|++++++++|+|+++ ++++  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3455678999999999999999999653  577889998764321  12334567999999999999999985 5442  


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCcEEEcCCCCeEEEe
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDI-SSNNILLNSNLEAFVAD  598 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dl-kp~NIll~~~~~~kL~D  598 (701)
                        +..|+||||++|++|... ..      ..   ...++.|+++||+|||++   ||+|||| ||+||+++.++.+||+|
T Consensus        91 --~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             --CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence              457999999999999632 11      11   146789999999999999   9999999 99999999999999999


Q ss_pred             ecCccccccCCCCc--------eeecccccccCCCCCC
Q 041034          599 FGTARLLHVDSSNR--------TLRAGTYGYIAPDQRL  628 (701)
Q Consensus       599 FGla~~~~~~~~~~--------~~~~gt~~y~aPE~~~  628 (701)
                      ||+|+.+.......        ....+++.|+|||.+.
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999775432211        2346788899999764

>PLN03210 Resistant to P

Probab=99.90  E-value=4.7e-23  Score=248.79  Aligned_cols=313  Identities=25%  Similarity=0.308  Sum_probs=183.4

Q ss_pred             cccCCCCCCcEEECCCCc------ceeeCCcccCCCC-CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCcc
Q 041034           56 LNFSCFPNLQYLNLWNNN------LSGSIPPQIGSLS-NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPI  128 (701)
Q Consensus        56 ~~~~~~~~L~~L~L~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  128 (701)
                      ..|..+++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|++|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            345666677776665442      3334555555553 4677777766665 455555 3566777777777665 3455


Q ss_pred             ccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCcccc
Q 041034          129 EIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNL  208 (701)
Q Consensus       129 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  208 (701)
                      .+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+.++++|+.|++++|..-..+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            556667777777766654444443 5666677777777666556666666667777777776654334555544 56667


Q ss_pred             CccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCc-------cccCcccCCCCCCc
Q 041034          209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIR-------GIIPDELSKLSNLQ  281 (701)
Q Consensus       209 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~-------~~~p~~l~~l~~L~  281 (701)
                      +.|++++|.....+|..   .++|++|++++|.+.. +|..+ .+++|+.|++.++...       ...|......++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            77777766554444432   3456667777776654 44433 4566666666653321       11111222345667


Q ss_pred             EEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEccccc
Q 041034          282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN  361 (701)
Q Consensus       282 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~  361 (701)
                      .|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|..   ..+|+.|+|++|.
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~  857 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG  857 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence            77777766666666666677777777777665444566554 5666777777766544444443   2456667777776


Q ss_pred             CcccCCCCccc----ccccccc-CCCC
Q 041034          362 LSGTIPMTLHP----MFLDMSF-NNLE  383 (701)
Q Consensus       362 l~g~~p~~~~~----~~l~ls~-N~l~  383 (701)
                      ++ .+|.++..    .+|++++ |+++
T Consensus       858 i~-~iP~si~~l~~L~~L~L~~C~~L~  883 (1153)
T PLN03210        858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ  883 (1153)
T ss_pred             Cc-cChHHHhcCCCCCEEECCCCCCcC
Confidence            65 45544321    3566665 3444

syringae 6; Provisional

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=1.4e-24  Score=220.99  Aligned_cols=218  Identities=21%  Similarity=0.237  Sum_probs=178.4

Q ss_pred             CcccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC------CCc
Q 041034          438 GKILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR------HRN  510 (701)
Q Consensus       438 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~n  510 (701)
                      |.|.+.--+....+|.+....|+|-|++|..|.. ..|+.||||++......    .+.=.+|+++|+++.      --|
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhH
Confidence            3344333344567899999999999999999955 45889999999876432    345578999999995      348


Q ss_pred             eeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       511 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      +++++..|...+++|||+|-+.- +|.+++++.+....+....+..++.|+.-||..|...   ||+|.||||+|||+++
T Consensus       496 clrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE  571 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence            99999999999999999999854 9999999988877888999999999999999999988   9999999999999986


Q ss_pred             C-CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC-CCCHHHHHHH
Q 041034          591 N-LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS-RPTMQRISQE  667 (701)
Q Consensus       591 ~-~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~  667 (701)
                      . ..+||||||.|.....+  ..+....+..|.|||++.+.+|+...  |+||+||.+|++.++.--. --|-.+++..
T Consensus       572 ~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~i--D~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPI--DTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             CcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCc--cceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            5 57899999999876432  23334567789999999999999998  9999999999999987322 2344555543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.7e-23  Score=234.86  Aligned_cols=266  Identities=26%  Similarity=0.327  Sum_probs=211.9

Q ss_pred             EEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECC
Q 041034           39 ITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS  118 (701)
Q Consensus        39 v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  118 (701)
                      -..|+++.++++ .+|.. +  .++|+.|++.+|+|+. +|.   .+++|++|+|++|+|+. +|..   .++|+.|+|+
T Consensus       203 ~~~LdLs~~~Lt-sLP~~-l--~~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls  270 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDC-L--PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIF  270 (788)
T ss_pred             CcEEEcCCCCCC-cCCcc-h--hcCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence            346788999888 45542 2  2589999999999984 564   25899999999999994 4543   4789999999


Q ss_pred             CCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCC
Q 041034          119 NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTI  198 (701)
Q Consensus       119 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  198 (701)
                      +|.++. +|..   +++|+.|+|++|+++.. |.   ..++|+.|+|++|++++. |...   .+|+.|++++|++++ +
T Consensus       271 ~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-L  337 (788)
T PRK15387        271 SNPLTH-LPAL---PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-L  337 (788)
T ss_pred             CCchhh-hhhc---hhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCCc---ccccccccccCcccc-c
Confidence            999984 3432   36789999999999854 43   247899999999999864 4322   468899999999985 5


Q ss_pred             CCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCC
Q 041034          199 PREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLS  278 (701)
Q Consensus       199 ~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~  278 (701)
                      |..   ..+|++|+|++|+|++ +|..   .++|+.|++++|+|++ +|..   ..+|+.|+|++|+|++ +|..   .+
T Consensus       338 P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s  402 (788)
T PRK15387        338 PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PS  402 (788)
T ss_pred             ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---cc
Confidence            542   2579999999999995 5543   3578999999999997 5643   3579999999999995 5543   36


Q ss_pred             CCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCcccccc
Q 041034          279 NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKI  349 (701)
Q Consensus       279 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  349 (701)
                      +|+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..+..+
T Consensus       403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            89999999999995 6653   357889999999998 799999999999999999999999888877544

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-25  Score=222.32  Aligned_cols=297  Identities=23%  Similarity=0.239  Sum_probs=220.8

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCC-CCCCCCCccccCCccccceee
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN-NSLHGTTPIEIGSLRNLEELY  140 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~  140 (701)
                      +....++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.++++|..|-+.+ |+|+......|++|..|+.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            5678899999999988888899999999999999999999999999999888877766 899988888899999999999


Q ss_pred             cccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccC
Q 041034          141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG  220 (701)
Q Consensus       141 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  220 (701)
                      +.-|++..+..++|..|++|..|.+.+|.+....-.+|..+.+++.+++..|.+-     ...+++-+..- +.      
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~-~a------  214 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADD-LA------  214 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhhH-Hh------
Confidence            9999999888899999999999999999887665568888888888888888743     12233322211 11      


Q ss_pred             CccccccCCCcccEEEeccCCCCCCCCcccCCC-CcccEEEcCCCCCccccC-cccCCCCCCcEEEccCccCCCCCcccc
Q 041034          221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF-SALAELDLSDNKIRGIIP-DELSKLSNLQYLNLSSNLLSGQIPFAI  298 (701)
Q Consensus       221 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~  298 (701)
                      ..|..++...-..-..+.++++...-+..|... ..+..=-.+.+...++.| ..|..+++|+.|+|++|+++++-+.+|
T Consensus       215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF  294 (498)
T KOG4237|consen  215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF  294 (498)
T ss_pred             hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence            122233333444444555555555444444321 122111122222333333 457888888888888888888888888


Q ss_pred             cCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCc
Q 041034          299 GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL  370 (701)
Q Consensus       299 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~  370 (701)
                      .+...+++|+|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+.+|..|+|-.|++.+.....|
T Consensus       295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w  366 (498)
T KOG4237|consen  295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW  366 (498)
T ss_pred             cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence            888888888888888876556667888888889999999988888888888899999999999887765544

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-25  Score=221.37  Aligned_cols=289  Identities=22%  Similarity=0.197  Sum_probs=185.0

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcC-CcCcccCCcccCCCCCCCEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRW-NNLTGTIPKEIGSLRNLEVL  115 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L  115 (701)
                      ...+.++|..|+|+ .+|+..|+.+++|+.|||++|+|+-+-|++|..+++|.+|-+-+ |+|+....+.|.+|..|+.|
T Consensus        67 ~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL  145 (498)
T KOG4237|consen   67 PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL  145 (498)
T ss_pred             CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence            46789999999998 68888999999999999999999999999999999998887777 99998888899999999999


Q ss_pred             ECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC
Q 041034          116 YLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       116 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      .+.-|++..+....|..+++|..|.|.+|.+..+-..+|..+..++.+.+..|.+..     .++++.+.... .     
T Consensus       146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~~~-a-----  214 (498)
T KOG4237|consen  146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLADDL-A-----  214 (498)
T ss_pred             hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhhHH-h-----
Confidence            999999999999999999999999999999997766799999999999999998532     22222222111 1     


Q ss_pred             CCCCCCCCCccccCccccccccccCCccccccCC-CcccEEEeccCCCCCCCCc-ccCCCCcccEEEcCCCCCccccCcc
Q 041034          196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHL-TSLLYLDLSFNQLHSFIPL-EIGNFSALAELDLSDNKIRGIIPDE  273 (701)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~  273 (701)
                       ..|-.++...-.....+.++++...-+..|... .++..--.+.+...+..|. .|..+++|+.|+|++|+|+++-+.+
T Consensus       215 -~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~a  293 (498)
T KOG4237|consen  215 -MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGA  293 (498)
T ss_pred             -hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhh
Confidence             112223333333333344444332222222111 1111111111111122221 3444555555555555555544555


Q ss_pred             cCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCcc
Q 041034          274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL  338 (701)
Q Consensus       274 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  338 (701)
                      |.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+
T Consensus       294 Fe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  294 FEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             hcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            55555555555555555443344444455555555555555544455555555555555554444

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.89  E-value=7.7e-24  Score=208.93  Aligned_cols=223  Identities=18%  Similarity=0.288  Sum_probs=183.9

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY  515 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  515 (701)
                      .+++.....+++....+-+|.||.||.|.+.      +.+.|.+|.++....  +-....+..|.-.+..+.|||+.++.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCcccee
Confidence            4566666778888889999999999999443      345688888876543  33457788999999999999999999


Q ss_pred             eeeeeC-cEEEEEEEccCCCCHHHHHh-----cCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          516 GFCLHK-RCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       516 ~~~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      +++.++ ..++.++.++.-|+|..++.     +....+.++..+...++.|++.|++|||++   +|||.||.++|.+||
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            988654 56788999999999999998     333445678888999999999999999999   999999999999999


Q ss_pred             CCCCeEEEeecCccccccCCCCc--eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------
Q 041034          590 SNLEAFVADFGTARLLHVDSSNR--TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------  649 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------  649 (701)
                      +..++||+|=.+++.+-+.+...  ...-....||+||.+....+...+  |+||||+++||                  
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssas--DvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSAS--DVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchh--hhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            99999999999998764332211  111245679999999999888776  99999999995                  


Q ss_pred             -------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                               ||...|++||+++|+..-|.+.
T Consensus       509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                                     9999999999999999887653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=9.2e-24  Score=211.82  Aligned_cols=203  Identities=28%  Similarity=0.405  Sum_probs=165.4

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEc-C---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeee
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAEL-P---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGF  517 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  517 (701)
                      +++....+.|..+++||+|.|++||+|.. .   ..+.||+|.+......     .++..|+++|..+. +.||+++.+.
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhh
Confidence            34455678899999999999999999943 2   4678999999775543     66889999999995 8999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEE
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFV  596 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL  596 (701)
                      +...+...+|+||++.....++...      ++...+..+++.+..||+++|++   |||||||||+|++.+. .++-.|
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceE
Confidence            9999999999999999998888764      66788999999999999999999   9999999999999985 467889


Q ss_pred             EeecCccccccC-------C-------C------------------------------CceeecccccccCCCCCCCCcC
Q 041034          597 ADFGTARLLHVD-------S-------S------------------------------NRTLRAGTYGYIAPDQRLSPPV  632 (701)
Q Consensus       597 ~DFGla~~~~~~-------~-------~------------------------------~~~~~~gt~~y~aPE~~~~~~~  632 (701)
                      +|||+|......       .       .                              ....++||++|.|||++...+.
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            999999722100       0       0                              0012469999999999877665


Q ss_pred             ChhhHHHHHHHHHHHHHcccCC-CCCCCC
Q 041034          633 NQKIIQDIILVSTTALACLRSK-PKSRPT  660 (701)
Q Consensus       633 ~~~~~~Di~slg~i~~~cl~~~-P~~Rpt  660 (701)
                      ...+ .||||.|+|++..+... |..+++
T Consensus       255 Qtta-iDiws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  255 QTTA-IDIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             cCCc-cceeeccceeehhhccccccccCc
Confidence            4444 39999999999877765 666654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.88  E-value=6.9e-25  Score=237.95  Aligned_cols=269  Identities=32%  Similarity=0.346  Sum_probs=183.1

Q ss_pred             CCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEc
Q 041034           86 SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV  165 (701)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  165 (701)
                      ++|+.|+.++|.++...+ . ..-.+|+++++++|++++ +|.+++.+.+|+.|+..+|+|+ .+|..+..+.+|+.|++
T Consensus       219 ~~l~~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~  294 (1081)
T KOG0618|consen  219 PSLTALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA  294 (1081)
T ss_pred             cchheeeeccCcceeecc-c-cccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence            344555555555542211 1 122456666666666663 3366666666666666666663 45556666666666666


Q ss_pred             eecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccc-cCccccccccccCCccccccCCCcccEEEeccCCCCC
Q 041034          166 MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKN-LTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHS  244 (701)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  244 (701)
                      ..|.+. -+|.....+++|++|+|..|+|....+..+.-+.. |..|..+.|.+.......=..++.|+.|++.+|.++.
T Consensus       295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd  373 (1081)
T KOG0618|consen  295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD  373 (1081)
T ss_pred             hhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence            666664 34445555666666666666666333333333322 5666666666653221111235668889999999988


Q ss_pred             CCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccC
Q 041034          245 FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGN  324 (701)
Q Consensus       245 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  324 (701)
                      ..-..+.++.+|+.|+|++|+|.......+.+++.|+.|+||+|+++ .+|..+.++..|++|...+|++. .+| .+..
T Consensus       374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~  450 (1081)
T KOG0618|consen  374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ  450 (1081)
T ss_pred             cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence            77677888899999999999998665567888999999999999998 78888999999999999999998 788 6888


Q ss_pred             CCCCCeeeccCCccCCCCCccccccccCCeEEcccccC
Q 041034          325 CTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNL  362 (701)
Q Consensus       325 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l  362 (701)
                      ++.|+.+|++.|+|+...-.....-++|++|||+||.-
T Consensus       451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             cCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            99999999999999854333333337899999999974

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=1.5e-22  Score=228.93  Aligned_cols=201  Identities=29%  Similarity=0.466  Sum_probs=91.0

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  143 (701)
                      .+.|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+. +|..+.  ++|+.|+|++
T Consensus       180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~  250 (754)
T PRK15370        180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSI  250 (754)
T ss_pred             ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcC
Confidence            455566555555 3444332  34556666666655 3333332  355666666665552 333222  2455555555


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      |++. .+|..+.  ++|+.|++++|+++. +|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. +|
T Consensus       251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP  320 (754)
T PRK15370        251 NRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LP  320 (754)
T ss_pred             CccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CC
Confidence            5555 2333332  245555555555542 333332  245555555555542 232221  244555555555542 23


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCC
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      ..+.  ++|++|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|.|+
T Consensus       321 ~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        321 ETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             cccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence            2221  344455555554444 333221  34444444444444 2333221  34444444444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=3.9e-22  Score=185.10  Aligned_cols=200  Identities=18%  Similarity=0.284  Sum_probs=162.0

Q ss_pred             hcCCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  526 (701)
                      ..+|.++++||.|+||.+|.| ...+|..||||+-......     .++..|.++.+.+++ ..|+.+..|+.+..+-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            468999999999999999999 5568999999987655433     456778999999975 788888889899999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~DFGla~  603 (701)
                      |||.+ |.+|++++.-..+  .++..+++-++-|++.-++|+|.+   ++|||||||+|+|..-   ...+.++|||+|+
T Consensus        89 VMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            99998 7799999875543  588899999999999999999999   9999999999999863   3578899999999


Q ss_pred             ccccCCCC-------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCH
Q 041034          604 LLHVDSSN-------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTM  661 (701)
Q Consensus       604 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~  661 (701)
                      .+.+....       .....||..|++-....+.....+  +|+.|+|.++.....+. |++--.+
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR--DDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR--DDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhh--hhhhhhcceeeeeecCCCcccccch
Confidence            87543221       233469999988776655544444  59999999998877766 7765443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=6.5e-22  Score=223.69  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=196.6

Q ss_pred             CCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEc
Q 041034           86 SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV  165 (701)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  165 (701)
                      .+.+.|++++++++ .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|++|+|++|+|+. +|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence            46789999999999 5666553  589999999999995 454443  589999999999985 465543  47999999


Q ss_pred             eecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCC
Q 041034          166 MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF  245 (701)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  245 (701)
                      ++|.+. .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|+.|++++|+|++ +|..+.  ++|+.|++++|+++. 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-  318 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-  318 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence            999997 5666654  58999999999998 5676664  589999999999985 565443  579999999999997 


Q ss_pred             CCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCC
Q 041034          246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC  325 (701)
Q Consensus       246 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  325 (701)
                      +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  
T Consensus       319 LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--  387 (754)
T PRK15370        319 LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--  387 (754)
T ss_pred             CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--
Confidence            45443  3689999999999985 676664  68999999999998 5666553  68999999999998 5676654  


Q ss_pred             CCCCeeeccCCccCCCCCccc----cccccCCeEEcccccCc
Q 041034          326 TELQHLALNHNSLDGTIPPEI----GKILLLQNLDLSHNNLS  363 (701)
Q Consensus       326 ~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~l~ls~N~l~  363 (701)
                      ..|+.|++++|+|+ .+|..+    +.++.+..|+|.+|+++
T Consensus       388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            46999999999998 566554    34578899999999987

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=9.2e-22  Score=188.58  Aligned_cols=142  Identities=20%  Similarity=0.216  Sum_probs=109.5

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChH-----------------------HHHHHHHHHHHHhcCCCCce
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSA-----------------------FVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni  511 (701)
                      .+.||+|++|.||+|...+|+.||||+++........                       ......+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998778999999999865321100                       01223459999999988776


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCcEEEcC
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL-HHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~givH~Dlkp~NIll~~  590 (701)
                      .....+...  ..++||||++++++........   .++...+..++.|++.+|.|+ |+.   ||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            544333222  2389999999887765432222   588899999999999999999 677   999999999999998 


Q ss_pred             CCCeEEEeecCcccc
Q 041034          591 NLEAFVADFGTARLL  605 (701)
Q Consensus       591 ~~~~kL~DFGla~~~  605 (701)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.6e-21  Score=187.68  Aligned_cols=207  Identities=18%  Similarity=0.300  Sum_probs=167.6

Q ss_pred             CCccceEEeeccceEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .|++.++||+|.||+++.| ..-+++.||||.-.....     ..++..|.+..+.+. .+.|+.++-|..++.+-.+|+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            6899999999999999999 445799999996544322     256778888888885 699999999988888899999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-----CCeEEEeecCcc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-----LEAFVADFGTAR  603 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-----~~~kL~DFGla~  603 (701)
                      |.+ |.+|+|+..-.++  .++..++..+|.|++.-++|+|++   .+|.|||||+|+||...     ..+.++|||+|+
T Consensus       104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            998 7799999987654  699999999999999999999999   99999999999999754     357899999999


Q ss_pred             ccccCCCCc-------eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhhc
Q 041034          604 LLHVDSSNR-------TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELEG  670 (701)
Q Consensus       604 ~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~~  670 (701)
                      .+.++....       ....||..||+--...+.....+  +|+.++|-+++..|.+. |++--.+...-+.-++
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR--DDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR--DDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhh--hhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            886543322       23469999999888777766665  49999999999999887 7765433333333333

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.4e-20  Score=181.35  Aligned_cols=142  Identities=23%  Similarity=0.278  Sum_probs=111.7

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-----------------------HHHHHHHHHHHHHhcCCCCce
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-----------------------AFVESFQNEARVLSTVRHRNI  511 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~ni  511 (701)
                      ...||+|++|.||+|...+|+.||||+++.......                       .....+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            578999999999999777899999999987532100                       012234678999999999987


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHHH-HhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEc
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFYV-LRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~  589 (701)
                      .....+....  .++||||++++++... +.. .   .++......++.|++.++.++|+ .   ||+||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~---~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-V---PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh-c---cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            5544443332  4899999998855433 332 2   46788899999999999999999 8   999999999999998


Q ss_pred             CCCCeEEEeecCccccc
Q 041034          590 SNLEAFVADFGTARLLH  606 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~  606 (701)
                       ++.++|+|||+|+...
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-20  Score=195.96  Aligned_cols=200  Identities=22%  Similarity=0.283  Sum_probs=159.8

Q ss_pred             CCccceEEeeccceEEEEEEcCC--CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC----Cceeeeeeee-eeCcE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELPD--GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH----RNIVKLYGFC-LHKRC  523 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~  523 (701)
                      +|++.+.||+|+||.||.|....  .+.+|+|..........   ..+..|+.++..+..    +++.++++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            89999999999999999996544  35788887766432221   256778888888863    6899999998 47788


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-----CCeEEEe
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-----LEAFVAD  598 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-----~~~kL~D  598 (701)
                      .|+||+.+ |.+|.++..... ...++..++..|+.|++.+|+++|+.   |++||||||+|+.+...     ..++|.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99999988 779999886655 44799999999999999999999999   99999999999999754     3689999


Q ss_pred             ecCcc--ccccCC-C------C-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC-CCCCCCC
Q 041034          599 FGTAR--LLHVDS-S------N-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS-KPKSRPT  660 (701)
Q Consensus       599 FGla~--~~~~~~-~------~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~-~P~~Rpt  660 (701)
                      ||+|+  .+.... .      . .....||..|+++....+.......  |+||++.++.++..+ -|.+-.+
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~D--Dles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRD--DLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCch--hhhhHHHHHHHHhcCCCCCcccc
Confidence            99998  321111 1      1 2234599999999988888777765  999999999999988 4654333

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.84  E-value=2.4e-21  Score=227.26  Aligned_cols=137  Identities=15%  Similarity=0.194  Sum_probs=103.3

Q ss_pred             cCCC-Cceeeeeeee-------eeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 041034          505 TVRH-RNIVKLYGFC-------LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI  576 (701)
Q Consensus       505 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~gi  576 (701)
                      .++| +||.++++++       .+.+.++.+|||+ +++|.+++....  ..+++.+++.++.||++||+|||++   ||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3445 5777788877       2334577888988 559999997543  2589999999999999999999998   99


Q ss_pred             EecCCCCCcEEEcCC-------------------CCeEEEeecCccccccCC----------------CCceeecccccc
Q 041034          577 VHRDISSNNILLNSN-------------------LEAFVADFGTARLLHVDS----------------SNRTLRAGTYGY  621 (701)
Q Consensus       577 vH~Dlkp~NIll~~~-------------------~~~kL~DFGla~~~~~~~----------------~~~~~~~gt~~y  621 (701)
                      +||||||+|||++..                   +.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   455666666665321100                001123578899


Q ss_pred             cCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          622 IAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       622 ~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +|||++.+..++.+.  ||||+||++|+
T Consensus       182 ~APE~~~~~~~~~~s--DVwSlGviL~E  207 (793)
T PLN00181        182 TSPEEDNGSSSNCAS--DVYRLGVLLFE  207 (793)
T ss_pred             EChhhhccCCCCchh--hhhhHHHHHHH
Confidence            999999888887765  99999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=4.7e-21  Score=185.31  Aligned_cols=180  Identities=16%  Similarity=0.180  Sum_probs=137.1

Q ss_pred             ccHHHHHh--hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHH------HHHHHHHHhcCCCCce
Q 041034          440 ILYEDLIN--ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVES------FQNEARVLSTVRHRNI  511 (701)
Q Consensus       440 ~~~~~~~~--~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~ni  511 (701)
                      ..|.++..  ..++|++.+.+|.|+||.||.+.. +++.+|+|.+.+.....+.....      +.+|+..+.++.||+|
T Consensus        19 ~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI   97 (232)
T PRK10359         19 NKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL   97 (232)
T ss_pred             ccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence            33445432  468999999999999999999866 57789999998776555554444      5899999999999999


Q ss_pred             eeeeeeeeeC--------cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          512 VKLYGFCLHK--------RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       512 v~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      ..+.+++...        ...++||||++|.+|.++..       ++.    ....+++.++..+|+.   |++|||+||
T Consensus        98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp  163 (232)
T PRK10359         98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHK  163 (232)
T ss_pred             CcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCCh
Confidence            9999886643        35789999999999988731       222    2466999999999999   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +||++++++ ++|+|||.......+... ..           ......++..  .|+|++|+.+..
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~-d~-----------~vler~y~~~--~di~~lg~~~~~  214 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAK-DR-----------IDLERHYGIK--NEIKDLGYYLLI  214 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhH-HH-----------HHHHhHhccc--ccccceeEeehH
Confidence            999999988 999999988655321111 00           2223334433  499999998764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.5e-20  Score=173.75  Aligned_cols=184  Identities=12%  Similarity=0.080  Sum_probs=136.8

Q ss_pred             ccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-HHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEEEc
Q 041034          453 HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-AFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      .+...|++|+||+||.+.. .+.+++.+.+........ .....+.+|+++|+++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4578899999999998866 678888887776544221 11235789999999995 5889999886    346899999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDI-SSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dl-kp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      ++|.+|.+....          ....++.|++.+|.++|++   ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654321          1134788999999999999   9999999 7999999999999999999998654332


Q ss_pred             CC-------------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          610 SN-------------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       610 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..             ......++.|++|+...--........+.++.|+.+|.+++..
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~  204 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR  204 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence            10             0112367788888765433233333457888999999887654

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.82  E-value=1.4e-22  Score=212.86  Aligned_cols=277  Identities=22%  Similarity=0.230  Sum_probs=149.6

Q ss_pred             EEECCCCcce-eeCCcccCCCCCCCEEECcCCcCccc----CCcccCCCCCCCEEECCCCCCCC------CCccccCCcc
Q 041034           66 YLNLWNNNLS-GSIPPQIGSLSNLKYLNLRWNNLTGT----IPKEIGSLRNLEVLYLSNNSLHG------TTPIEIGSLR  134 (701)
Q Consensus        66 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~  134 (701)
                      .|+|..+.++ ......+..+.+|+.|+++++.++..    ++..+...++|+.|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4667777776 33445566667788888888777432    44556666777777777777652      1223344555


Q ss_pred             ccceeecccccCCCCCcccccCCCC---CcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCc-cccCc
Q 041034          135 NLEELYLRSNKLSGVLPQEIGNLKS---LIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL-KNLTH  210 (701)
Q Consensus       135 ~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~  210 (701)
                      +|+.|+|++|.+.+..+..+..+.+   |++|++++|++++...                    ..+...+..+ ++|+.
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~  141 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK  141 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence            6666666666665444444433333   4444444444432100                    0111222333 45555


Q ss_pred             cccccccccCC----ccccccCCCcccEEEeccCCCCCC----CCcccCCCCcccEEEcCCCCCccc----cCcccCCCC
Q 041034          211 LSIITNKLTGA----IPSTLGHLTSLLYLDLSFNQLHSF----IPLEIGNFSALAELDLSDNKIRGI----IPDELSKLS  278 (701)
Q Consensus       211 L~l~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~  278 (701)
                      |++++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++.    ++..+..++
T Consensus       142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~  221 (319)
T cd00116         142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK  221 (319)
T ss_pred             EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence            55555555521    223344555666666666666531    222334445666666666666533    233445566


Q ss_pred             CCcEEEccCccCCCCCcccccC-----ccceeeecCCCCcCCC----CCCCcccCCCCCCeeeccCCccCCC----CCcc
Q 041034          279 NLQYLNLSSNLLSGQIPFAIGK-----LFNLVSLDLSKNKLSG----SFPTGIGNCTELQHLALNHNSLDGT----IPPE  345 (701)
Q Consensus       279 ~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~  345 (701)
                      +|+.|++++|.+++.....+..     .+.|+.|++++|.++.    .+...+..+++|+++++++|.++..    +...
T Consensus       222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~  301 (319)
T cd00116         222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES  301 (319)
T ss_pred             CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence            6777777777766432222221     2567777777777652    2333445556777777777777643    2233


Q ss_pred             cccc-ccCCeEEcccccC
Q 041034          346 IGKI-LLLQNLDLSHNNL  362 (701)
Q Consensus       346 ~~~l-~~L~~l~ls~N~l  362 (701)
                      +... +.|+++++.+|++
T Consensus       302 ~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         302 LLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HhhcCCchhhcccCCCCC
Confidence            3333 4566677666653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=2e-22  Score=211.79  Aligned_cols=204  Identities=26%  Similarity=0.269  Sum_probs=135.6

Q ss_pred             EEEecccccccccCCcccCCCCCCcEEECCCCccee----eCCcccCCCCCCCEEECcCCcCcc------cCCcccCCCC
Q 041034           41 HIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSG----SIPPQIGSLSNLKYLNLRWNNLTG------TIPKEIGSLR  110 (701)
Q Consensus        41 ~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~  110 (701)
                      .|+|..+.+++.--...|..+..|+.|+++++.++.    .++..+...+.|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            356666666644333445667789999999999854    356667788899999999998872      3445678899


Q ss_pred             CCCEEECCCCCCCCCCccccCCccc---cceeecccccCCC----CCcccccCC-CCCcEEEceecccCCC----cCccc
Q 041034          111 NLEVLYLSNNSLHGTTPIEIGSLRN---LEELYLRSNKLSG----VLPQEIGNL-KSLIWLSVMYNTVGGP----IPSTL  178 (701)
Q Consensus       111 ~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~  178 (701)
                      +|+.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            9999999999998777767766665   9999999999984    233445566 7788888888887743    22334


Q ss_pred             ccccccceeEeeecccCCC----CCCCCCCccccCccccccccccCC----ccccccCCCcccEEEeccCCCCC
Q 041034          179 FRLTNLERLFLGCNQFNGT----IPREIGNLKNLTHLSIITNKLTGA----IPSTLGHLTSLLYLDLSFNQLHS  244 (701)
Q Consensus       179 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~  244 (701)
                      ..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            4556677777777766632    122233334555666665555432    12233344455555555555543

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=1.2e-18  Score=183.30  Aligned_cols=214  Identities=32%  Similarity=0.451  Sum_probs=173.5

Q ss_pred             CccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCC-ceeeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR-NIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  530 (701)
                      |.+.+.||.|+||.||++...  ..+++|.+.............+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            678899999999999999765  78999999887655444568899999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCccccccCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTARLLHVDS  609 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla~~~~~~~  609 (701)
                      +.++++.+++........+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776543112478899999999999999999999   999999999999999888 79999999998654333


Q ss_pred             C------CceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHHcccCC-CCCCCC----HHHHHHHhhcCC
Q 041034          610 S------NRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALACLRSK-PKSRPT----MQRISQELEGKT  672 (701)
Q Consensus       610 ~------~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt----~~~i~~~l~~~~  672 (701)
                      .      ......|+..|+|||...+.   .....  .|+|++|+++++.+.+. |.....    ..+..+.+....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~--~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS--SDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCch--HhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            2      23556799999999999874   44444  49999999999877776 544443    356655554444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=9.4e-20  Score=202.51  Aligned_cols=189  Identities=21%  Similarity=0.303  Sum_probs=151.0

Q ss_pred             ccceEEeeccceEEEEE-EcCCCcEEEEEEecC---CCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          453 HIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQ---SETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ...+.+|.|++|.|+.+ +....+.++.|....   .......+...+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988877 333455555554431   12222333344777888888999999999888887777776679


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |||++ +|..++....   .++..++..++.|++.|++|+|..   |+.|||+||+|+++..+|.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999998753   477788889999999999999999   9999999999999999999999999999877544


Q ss_pred             CC----CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          609 SS----NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       609 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ..    .....+|+..|+|||.+....+++... |||+.|++++.
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~v-DiwS~~ii~~~  517 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAV-DVWSCGIIYIC  517 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchh-hhhhccceEEE
Confidence            33    344567999999999999999999875 99999988764

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.5e-18  Score=167.73  Aligned_cols=136  Identities=17%  Similarity=0.183  Sum_probs=105.6

Q ss_pred             ccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-----CCCceeeeeeeeeeCc---E-
Q 041034          453 HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-----RHRNIVKLYGFCLHKR---C-  523 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-  523 (701)
                      .-.+.||+|+||.||. .-.++.. +||++......   ..+.+.+|+.+++.+     .||||++++|+++++.   . 
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            3457899999999996 3234444 79988764322   246789999999999     5799999999998864   4 


Q ss_pred             EEEEEEc--cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCcEEEcC----CCCeEE
Q 041034          524 MFFIYEY--MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL-SYLHHDCTPSIVHRDISSNNILLNS----NLEAFV  596 (701)
Q Consensus       524 ~~lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~givH~Dlkp~NIll~~----~~~~kL  596 (701)
                      +.+||||  +++|+|.+++.+.    .+++.  ..++.|++.++ +|||++   +|+||||||+||+++.    ++.++|
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            3378999  5679999999653    25554  35678888887 999999   9999999999999974    348999


Q ss_pred             EeecCc
Q 041034          597 ADFGTA  602 (701)
Q Consensus       597 ~DFGla  602 (701)
                      +||+.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995444

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1.6e-20  Score=165.55  Aligned_cols=155  Identities=32%  Similarity=0.532  Sum_probs=96.0

Q ss_pred             CccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEE
Q 041034          204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYL  283 (701)
Q Consensus       204 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  283 (701)
                      +++.++.|.|++|+++ .+|..++.+.+|+.|++++|+|+. .|..+..+++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            3444555555555555 444455555556666666665554 4555556666666666666655 556666666666666


Q ss_pred             EccCccCCC-CCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccC
Q 041034          284 NLSSNLLSG-QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNL  362 (701)
Q Consensus       284 ~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l  362 (701)
                      ||++|++++ .+|..|..+..|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- .+|.+++.+++|++|++.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            666666653 34556666666666666666665 56666666667777777766666 6666677777777777777766


Q ss_pred             c
Q 041034          363 S  363 (701)
Q Consensus       363 ~  363 (701)
                      +
T Consensus       186 ~  186 (264)
T KOG0617|consen  186 T  186 (264)
T ss_pred             e
Confidence            6

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=2.3e-18  Score=170.83  Aligned_cols=144  Identities=22%  Similarity=0.222  Sum_probs=112.4

Q ss_pred             CCccceEEeeccceEEEEEE--cCCCcEEEEEEecCCCccC---------------------hHHHHHHHHHHHHHhcCC
Q 041034          451 DFHIRYCIGTGGYGSVYKAE--LPDGKVVALKKLHQSETED---------------------SAFVESFQNEARVLSTVR  507 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  507 (701)
                      -|.+.+.||+|++|.||+|.  ..+|+.||+|+++......                     ......+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            38899999999999999997  5689999999987643210                     001234678999999997


Q ss_pred             CC--ceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCC
Q 041034          508 HR--NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS-IVHRDISSN  584 (701)
Q Consensus       508 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g-ivH~Dlkp~  584 (701)
                      +.  .+++++++    ...++||||++++++........   .........++.|++.++++||++   | ++||||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            53  34455543    23589999999988876543222   355667788999999999999999   9 999999999


Q ss_pred             cEEEcCCCCeEEEeecCcccc
Q 041034          585 NILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       585 NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||+++ ++.++|+|||.|...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=2.1e-20  Score=164.83  Aligned_cols=168  Identities=34%  Similarity=0.595  Sum_probs=149.9

Q ss_pred             ccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcc
Q 041034          177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL  256 (701)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L  256 (701)
                      .+.+++.++.|.||+|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++.- .|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhc-CccccCCCchh
Confidence            3556788889999999998 66778899999999999999998 678889999999999999999975 78899999999


Q ss_pred             cEEEcCCCCCcc-ccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccC
Q 041034          257 AELDLSDNKIRG-IIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH  335 (701)
Q Consensus       257 ~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  335 (701)
                      +.|||++|+++. .+|..|..|..|+.|+|++|.|. .+|..++++++|+.|.+.+|.+- .+|..++.+++|+.|.+.+
T Consensus       105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence            999999999864 47889999999999999999998 78889999999999999999998 7999999999999999999


Q ss_pred             CccCCCCCccccccc
Q 041034          336 NSLDGTIPPEIGKIL  350 (701)
Q Consensus       336 N~l~~~~p~~~~~l~  350 (701)
                      |+++ .+|++++++.
T Consensus       183 nrl~-vlppel~~l~  196 (264)
T KOG0617|consen  183 NRLT-VLPPELANLD  196 (264)
T ss_pred             ceee-ecChhhhhhh
Confidence            9998 8888887643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=2.5e-18  Score=194.34  Aligned_cols=196  Identities=22%  Similarity=0.262  Sum_probs=156.3

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      +.--+.|.|.+.||+|+||.||+|...+|+.||+|+-++...++--...+++..++ . + --+-|..+...+...+.-+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~-~-~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-P-Q-MLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-h-h-hhcchHHHHHHHccCCcce
Confidence            34456789999999999999999988789999999998877665333333322222 0 0 1244555555556677788


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-------CCCCeEEEe
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-------SNLEAFVAD  598 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-------~~~~~kL~D  598 (701)
                      +|+||.+.|+|.+++...+   .++|..++.++.||+..+++||..   +|||+||||+|.++.       +...++|+|
T Consensus       771 lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999998433   699999999999999999999999   999999999999994       234689999


Q ss_pred             ecCccccc--cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          599 FGTARLLH--VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       599 FGla~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||.+-.+.  .+........+|-.+-.+|++.+.+++...  |.|.++.+++-||-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~--DyfGlAa~~h~mLF  898 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQI--DYFGLAATVHVMLF  898 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhh--hhHHHHHHHHHHHH
Confidence            99986553  345566777899999999999999999998  99999999886543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.74  E-value=7.2e-19  Score=166.02  Aligned_cols=211  Identities=20%  Similarity=0.364  Sum_probs=165.0

Q ss_pred             CccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          452 FHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      .....+|.+...|+.|+|+++ |..+++|++...... ....++|..|.-.++-+.||||..+++.|..+....++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            344567888999999999996 455666776654332 333477899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN  611 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~  611 (701)
                      +.|+|+..+++... ..++..++.+++.+||+|++|||+- .+-|.---+....++||++.+++|.= +-+++.    .+
T Consensus       270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs----fq  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS----FQ  342 (448)
T ss_pred             cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee----ee
Confidence            99999999998643 3578899999999999999999987 33344456889999999998888631 112211    11


Q ss_pred             ceeecccccccCCCCCCCCcCChh-hHHHHHHHHHHHHH-----------------------------------------
Q 041034          612 RTLRAGTYGYIAPDQRLSPPVNQK-IIQDIILVSTTALA-----------------------------------------  649 (701)
Q Consensus       612 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~Di~slg~i~~~-----------------------------------------  649 (701)
                      ...+...|.||+||.++..+.+.. ...|+|||++++++                                         
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm  422 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM  422 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence            122456789999999987776543 23599999999996                                         


Q ss_pred             --cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 --CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 --cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                        |+..||.+||.+..|+-.|++.
T Consensus       423 ~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  423 NICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHhcCCCCcCCCcceehhhHHHh
Confidence              8889999999998888887764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.5e-17  Score=163.53  Aligned_cols=138  Identities=19%  Similarity=0.339  Sum_probs=115.8

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-----AFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      +.||+|++|.||+|.. .+..|++|+.........     ....++.+|+.++..+.|++++....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999977 677899998765433221     1234678899999999999988877777777788999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ++|++|.+++....      . .+..++.+++.+|.++|+.   +++|||++|+||+++ ++.++++|||.+...
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999986432      1 7888999999999999999   999999999999999 789999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.73  E-value=1.4e-17  Score=158.73  Aligned_cols=103  Identities=21%  Similarity=0.152  Sum_probs=88.7

Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCce
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT  613 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  613 (701)
                      |+|.++++....  .+++..+..++.|++.||+|||++   +      ||+||+++.++.+|+  ||.++......    
T Consensus         1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            689999976432  599999999999999999999988   5      999999999999999  99998764322    


Q ss_pred             eecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          614 LRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                       ..||+.|+|||++.+..++.++  ||||+|+++|+|+++.+.
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~--DiwSlG~il~elltg~~p  103 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKA--DIYSLGITLYEALDYELP  103 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchh--hHHHHHHHHHHHHhCCCC
Confidence             2589999999999988887765  999999999999988753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.1e-17  Score=160.54  Aligned_cols=146  Identities=21%  Similarity=0.233  Sum_probs=112.0

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-------------------HHHHHHHHHHHHHhc
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-------------------AFVESFQNEARVLST  505 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~  505 (701)
                      +...-.-|.+.+.||+|+||.||+|...+|+.||||++........                   .....+.+|..++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3333334888999999999999999887899999998765331100                   011236778889988


Q ss_pred             CCCC--ceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          506 VRHR--NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       506 l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      +.|+  .+++.++.    ...++||||+++++|.+....         .....++.+++.++.++|+.   |++||||||
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence            8777  44444442    345899999999998765421         23456889999999999998   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccc
Q 041034          584 NNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      +||++++++.++|+|||.+....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.9e-17  Score=158.27  Aligned_cols=133  Identities=22%  Similarity=0.365  Sum_probs=108.1

Q ss_pred             EeeccceEEEEEEcCCCcEEEEEEecCCCccC-----hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          458 IGTGGYGSVYKAELPDGKVVALKKLHQSETED-----SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       458 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      ||+|++|.||+|.. +++.|++|+........     .....++.+|++++..++|+++.....++......++||||++
T Consensus         2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            79999999999985 57889999866533221     1123567889999999998876655555556667789999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |++|.+++....    .      .++.+++.+|.++|+.   |++|+|++|+||+++ ++.++++|||.++..
T Consensus        81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998875422    0      7899999999999999   999999999999999 889999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=5.5e-17  Score=181.52  Aligned_cols=142  Identities=21%  Similarity=0.292  Sum_probs=114.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ....|...+.||+|+||.||+|.+.+.. +++|+.......     .....+++.+|+++++.++|++++....++.+..
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455677899999999999999775443 444433222111     1123456889999999999999998887777777


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++++|.+++.           ....++.|++++|.|||+.   +++|||+||+||++ .++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            7899999999999998875           3466899999999999999   99999999999999 6789999999999


Q ss_pred             ccc
Q 041034          603 RLL  605 (701)
Q Consensus       603 ~~~  605 (701)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.69  E-value=4.8e-18  Score=179.59  Aligned_cols=187  Identities=23%  Similarity=0.265  Sum_probs=154.3

Q ss_pred             EeeccceEEEEEEc----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEEEccC
Q 041034          458 IGTGGYGSVYKAEL----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       458 lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      +|+|+||.|+.++.    ..+..+|+|+.++......... ....|..++..++ ||.+++++-.++.+...+++++|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            68999999998733    2367789998877544322212 4567888888887 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCc
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR  612 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  612 (701)
                      +|.+...+....   .+++.....+...++-|++++|+.   +++|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999988876554   577888888999999999999998   999999999999999999999999999987642221  


Q ss_pred             eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 041034          613 TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRP  659 (701)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~Rp  659 (701)
                        .+||..|||||+..  ......  |.|++|+++++++++.-..++
T Consensus       153 --~cgt~eymApEI~~--gh~~a~--D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAA--DWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcc--cchhhhhhHHHHhhCCCCCch
Confidence              28999999999987  334444  999999999999998866666

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.69  E-value=1.3e-17  Score=184.60  Aligned_cols=212  Identities=19%  Similarity=0.247  Sum_probs=158.1

Q ss_pred             CCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      +|...+.+|++.|=.|.+|+++.|. |+||++.+.... .-....+...|++ ...++|||++++.-+-..+...|||=+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778899999999999999887777 889988765422 1111233334455 566789999999888777777888889


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc--cc
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL--HV  607 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~--~~  607 (701)
                      |... +|+|.+..+.   -+...+.+.|+.|++.||..+|+.   ||+|||||.+||||+.-.-+.|+||..-+..  ..
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9876 9999887654   577788899999999999999999   9999999999999999999999999765432  11


Q ss_pred             -CCCCceeec----ccccccCCCCCCCCc--------CC-hhhHHHHHHHHHHHHH------------------------
Q 041034          608 -DSSNRTLRA----GTYGYIAPDQRLSPP--------VN-QKIIQDIILVSTTALA------------------------  649 (701)
Q Consensus       608 -~~~~~~~~~----gt~~y~aPE~~~~~~--------~~-~~~~~Di~slg~i~~~------------------------  649 (701)
                       +....+...    .-..|.|||.+....        .. -+...||||+||++.|                        
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence             122222222    234599999765421        00 1233599999999986                        


Q ss_pred             -------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                         |++.||.+|-++++.++.-.+.
T Consensus       255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence                               6777888888888777765443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.67  E-value=1.5e-16  Score=158.65  Aligned_cols=221  Identities=14%  Similarity=0.192  Sum_probs=137.1

Q ss_pred             CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC----------Cceeeeeeeee-
Q 041034          452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH----------RNIVKLYGFCL-  519 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-  519 (701)
                      +...+.||.|+++.||.+.+. +++++|+|++...........+++++|.-....+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456789999999999999664 699999998876554334446777777766655432          12222222211 


Q ss_pred             --------eC---c-----EEEEEEEccCCCCHHHHHhc---CC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041034          520 --------HK---R-----CMFFIYEYMERGSLFYVLRD---DD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHR  579 (701)
Q Consensus       520 --------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~  579 (701)
                              ..   .     ..+++|+-+.+ +|.+++..   .. .........++.+..|+++.+++||+.   |+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     23678888854 88887642   11 112344566778889999999999999   99999


Q ss_pred             CCCCCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCC------cCChhhHHHHHHHHHHHHHcccC
Q 041034          580 DISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP------PVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       580 Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ||||+|++++++|.++|+||+.....+..   ......+..|.+||.....      ........|.|++|+++|.+|-.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999999987654321   1213455778899865332      12222345999999999998887


Q ss_pred             C-CCCCCCHHHHHH-HhhcCCCccchhh
Q 041034          654 K-PKSRPTMQRISQ-ELEGKTPMKKGLK  679 (701)
Q Consensus       654 ~-P~~Rpt~~~i~~-~l~~~~~~~~~~~  679 (701)
                      + |...++.....+ .++....+++.++
T Consensus       247 ~lPf~~~~~~~~~~~~f~~C~~~Pe~v~  274 (288)
T PF14531_consen  247 RLPFGLSSPEADPEWDFSRCRDMPEPVQ  274 (288)
T ss_dssp             S-STCCCGGGSTSGGGGTTSS---HHHH
T ss_pred             cCCCCCCCccccccccchhcCCcCHHHH
Confidence            7 776665333322 3444444444433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=2.1e-16  Score=157.20  Aligned_cols=193  Identities=24%  Similarity=0.371  Sum_probs=132.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-Cc-----------------------------------EEEEEEecCCCcc--Ch
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-GK-----------------------------------VVALKKLHQSETE--DS  490 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~-----------------------------------~vavK~~~~~~~~--~~  490 (701)
                      .++|++.+.||+|....||.|+.++ |.                                   +.|+|.+-.-..+  +.
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~  235 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA  235 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence            4668999999999999999986532 11                                   1455654432221  22


Q ss_pred             HHHHHHHHHHH--------------HHhc--------CCCCceeeeeeeeee---------------------------C
Q 041034          491 AFVESFQNEAR--------------VLST--------VRHRNIVKLYGFCLH---------------------------K  521 (701)
Q Consensus       491 ~~~~~~~~E~~--------------~l~~--------l~h~niv~l~~~~~~---------------------------~  521 (701)
                      ...+.+-+|.-              ..+.        -+|||||++.++|.+                           +
T Consensus       236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~  315 (598)
T KOG4158|consen  236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP  315 (598)
T ss_pred             HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence            22333333321              0111        259999999988753                           2


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE--cCCC--CeEEE
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL--NSNL--EAFVA  597 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll--~~~~--~~kL~  597 (701)
                      ..+|+||..++. +|.+++..+.    .+.....-+..|+++|+.|||++   ||.|||+|.+|||+  |+|+  ...|+
T Consensus       316 ~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVva  387 (598)
T KOG4158|consen  316 KTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVA  387 (598)
T ss_pred             ceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEc
Confidence            357999999977 9999998764    45566777899999999999999   99999999999999  3444  45789


Q ss_pred             eecCcccccc------CCCCceeecccccccCCCCCCCCcCCh----hhHHHHHHHHHHHHH
Q 041034          598 DFGTARLLHV------DSSNRTLRAGTYGYIAPDQRLSPPVNQ----KIIQDIILVSTTALA  649 (701)
Q Consensus       598 DFGla~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~~~Di~slg~i~~~  649 (701)
                      |||++---+.      -........|...-||||+....+-..    ...+|.|+.|.++||
T Consensus       388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYE  449 (598)
T KOG4158|consen  388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYE  449 (598)
T ss_pred             ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHH
Confidence            9998742211      011222345777889999876544221    123599999999996

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=4.6e-16  Score=149.80  Aligned_cols=139  Identities=22%  Similarity=0.243  Sum_probs=98.8

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHH---------------------HHHHHHHHhcCCCC--ce
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVES---------------------FQNEARVLSTVRHR--NI  511 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--ni  511 (701)
                      .+.||+|+||.||+|...+++.||||++.............                     ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            56799999999999988789999999987643221111111                     13455556555433  24


Q ss_pred             eeeeeeeeeCcEEEEEEEccCCCCHHH-HHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEc
Q 041034          512 VKLYGFCLHKRCMFFIYEYMERGSLFY-VLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~  589 (701)
                      ++.++.    ...++||||++++++.. .+....    .. .....++.+++.++.++|. .   +|+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444443    23589999999954321 111111    11 5577899999999999998 7   999999999999999


Q ss_pred             CCCCeEEEeecCccccc
Q 041034          590 SNLEAFVADFGTARLLH  606 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~  606 (701)
                       ++.++++|||.|....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.1e-15  Score=139.55  Aligned_cols=135  Identities=19%  Similarity=0.176  Sum_probs=113.9

Q ss_pred             cceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCcEEEEEEEcc
Q 041034          454 IRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH--RNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      +++.||+|.++.||++...+ +.+++|.......     ...+.+|+.+++.++|  .++++++++....+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            46789999999999998744 7899999866432     3568889999999976  58999999888888899999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      +++.+..+          +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98766543          4466677899999999999986445799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=3.8e-15  Score=148.16  Aligned_cols=138  Identities=17%  Similarity=0.276  Sum_probs=106.0

Q ss_pred             ceEEe-eccceEEEEEEcCCCcEEEEEEecCCCc----------cChHHHHHHHHHHHHHhcCCCCce--eeeeeeeeeC
Q 041034          455 RYCIG-TGGYGSVYKAELPDGKVVALKKLHQSET----------EDSAFVESFQNEARVLSTVRHRNI--VKLYGFCLHK  521 (701)
Q Consensus       455 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  521 (701)
                      ...|| .|+.|+||.+... +..+|||.+.....          .......++.+|+.++..++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999999774 77899998854211          111223567899999999998775  6777764432


Q ss_pred             c----EEEEEEEccCC-CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          522 R----CMFFIYEYMER-GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       522 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                      .    ..++||||++| .+|.+++...    .++..    .+.+++.+|.+||++   ||+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6999888653    24433    367899999999999   9999999999999999899999


Q ss_pred             EeecCccc
Q 041034          597 ADFGTARL  604 (701)
Q Consensus       597 ~DFGla~~  604 (701)
                      +|||.++.
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.57  E-value=4.9e-16  Score=161.40  Aligned_cols=123  Identities=24%  Similarity=0.371  Sum_probs=108.6

Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      .++||.|++|+..+|.+++.+.......++...+.++.|++.|++|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            3589999999999999999877666678889999999999999999   5   899999999999999999999999999


Q ss_pred             ccccccCC------CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDS------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ........      ...+..+||..||+||++.+..|..++  |||+||.++++++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kv--dIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKV--DIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhc--chhhHHHHHHHHHH
Confidence            98765443      134556799999999999999999998  99999999998655

>PLN03150 hypothetical protein; Provisional

Probab=99.53  E-value=1.3e-14  Score=164.06  Aligned_cols=106  Identities=38%  Similarity=0.555  Sum_probs=83.0

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  143 (701)
                      ++.|+|++|.+.|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            45677888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccCCCCCcccccCC-CCCcEEEceecc
Q 041034          144 NKLSGVLPQEIGNL-KSLIWLSVMYNT  169 (701)
Q Consensus       144 n~l~~~~~~~~~~l-~~L~~L~L~~N~  169 (701)
                      |+++|.+|..++.+ .++..+++.+|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~  526 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNA  526 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCc
Confidence            88888877776653 344455555554

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.53  E-value=1.6e-14  Score=153.39  Aligned_cols=167  Identities=25%  Similarity=0.408  Sum_probs=134.8

Q ss_pred             HhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCC
Q 041034          503 LSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI-VHRDI  581 (701)
Q Consensus       503 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~gi-vH~Dl  581 (701)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+...  ...+++.-...++++|++||+|+|+-   .| +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            46788999999999999999999999999999999999873  34689999999999999999999977   44 99999


Q ss_pred             CCCcEEEcCCCCeEEEeecCcccccc--CCCCceeecccccccCCCCCCCCcCC-----hhhHHHHHHHHHHHHH-----
Q 041034          582 SSNNILLNSNLEAFVADFGTARLLHV--DSSNRTLRAGTYGYIAPDQRLSPPVN-----QKIIQDIILVSTTALA-----  649 (701)
Q Consensus       582 kp~NIll~~~~~~kL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~Di~slg~i~~~-----  649 (701)
                      ++.|.++|....+||.|||+......  ............-|.|||.+......     .....|+||+|+++++     
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999877642  11112222345669999988764221     2334599999999985     


Q ss_pred             -----------------------------------------------cccCCCCCCCCHHHHHHHhhcCCCc
Q 041034          650 -----------------------------------------------CLRSKPKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       650 -----------------------------------------------cl~~~P~~Rpt~~~i~~~l~~~~~~  674 (701)
                                                                     ||..+|.+||++++|...++.....
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence                                                           8888888888888887777766553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.51  E-value=1.6e-14  Score=160.50  Aligned_cols=158  Identities=25%  Similarity=0.371  Sum_probs=113.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...+|..++.|..|+||.||.++++ ..+++|+| +.++..        +.+-  ++.....|.+|              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--cccccCCccee--------------
Confidence            3578999999999999999999776 47788984 433211        1110  33333445444              


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                             |+=.+.++..+   .++        .+++.+++|+|+.   ||+|||+||+|.+|+.-|++|+.|||+.+...
T Consensus       136 -------gDc~tllk~~g---~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 -------GDCATLLKNIG---PLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             -------chhhhhcccCC---CCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                   33333443322   122        1238899999998   99999999999999999999999999987532


Q ss_pred             cC-------------CC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          607 VD-------------SS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       607 ~~-------------~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ..             .+  .....+||+.|+|||++....|...+  |+|++|+|+|+.+.+
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpv--dwwamGiIlyeFLVg  254 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPV--DWWAMGIILYEFLVG  254 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCc--cHHHHHHHHHHHhee
Confidence            10             00  12245799999999999999998888  999999999985443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.2e-13  Score=149.45  Aligned_cols=142  Identities=22%  Similarity=0.286  Sum_probs=100.4

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-------------------------------HHHH------HHH
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-------------------------------AFVE------SFQ  497 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~~~~------~~~  497 (701)
                      .+.||.|++|+||+|+..+|+.||||+.++.....-                               .+.+      ++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999876531110                               0000      244


Q ss_pred             HHHHHHhcCC-----CCce--eeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHH-HHHHHh
Q 041034          498 NEARVLSTVR-----HRNI--VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH-ALSYLH  569 (701)
Q Consensus       498 ~E~~~l~~l~-----h~ni--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH  569 (701)
                      +|++.+.+++     ++++  ++++.  ......++||||++|+++.++......  ..   ....++.+++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH
Confidence            4555555542     3332  22322  223456899999999999887653221  12   23456666666 478889


Q ss_pred             cCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       570 ~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ..   |++|+|+||.||++++++.++++|||++..+.
T Consensus       275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            88   99999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=2.7e-15  Score=155.93  Aligned_cols=190  Identities=34%  Similarity=0.494  Sum_probs=131.9

Q ss_pred             EEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCC
Q 041034          162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ  241 (701)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~  241 (701)
                      ..||+.|++. .+|..++.+-.|+.+.|..|.+. .+|..++++..|++|+|+.|+++ .+|..+..|+ |+.|.+++|+
T Consensus        79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk  154 (722)
T KOG0532|consen   79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK  154 (722)
T ss_pred             hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence            3444555542 45566666677777777777776 67777777777777777777777 5666666665 7777777777


Q ss_pred             CCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCc
Q 041034          242 LHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG  321 (701)
Q Consensus       242 l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  321 (701)
                      ++. +|..++...+|..||.+.|.|. .+|..++.+.+|+.|++..|++. .+|..+..| .|..||+|.|+++ .+|..
T Consensus       155 l~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~  229 (722)
T KOG0532|consen  155 LTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVD  229 (722)
T ss_pred             ccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchh
Confidence            776 6677777777777788877777 55666777777888888777777 556666643 5777788888877 67777


Q ss_pred             ccCCCCCCeeeccCCccCCCCCccccccc---cCCeEEccccc
Q 041034          322 IGNCTELQHLALNHNSLDGTIPPEIGKIL---LLQNLDLSHNN  361 (701)
Q Consensus       322 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~l~ls~N~  361 (701)
                      |..|+.|++|-|.+|.|. ..|..+....   -.++|+..-++
T Consensus       230 fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  230 FRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             hhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            888888888888888776 4455543322   23566665554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=2.3e-15  Score=156.34  Aligned_cols=182  Identities=30%  Similarity=0.468  Sum_probs=163.7

Q ss_pred             cccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEE
Q 041034          180 RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAEL  259 (701)
Q Consensus       180 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L  259 (701)
                      .++--...||+.|++. .+|..+..+..|+.+.|..|.|. .+|..+.++..|++|||+.|+++. .|..++.++ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeE
Confidence            4556678899999998 88999999999999999999999 889999999999999999999997 677777665 8999


Q ss_pred             EcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccC
Q 041034          260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       260 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      -+++|+++ .+|+.++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..++.++ |..||+|.|+++
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis  224 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS  224 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee
Confidence            99999998 78888999999999999999998 78889999999999999999998 6888888655 999999999999


Q ss_pred             CCCCccccccccCCeEEcccccCcccCCCCcc
Q 041034          340 GTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH  371 (701)
Q Consensus       340 ~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~  371 (701)
                       .+|-.|.+|..|++|-|.+|+|+ .-|..++
T Consensus       225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             -ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence             99999999999999999999998 3455443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2e-13  Score=147.66  Aligned_cols=261  Identities=34%  Similarity=0.425  Sum_probs=159.6

Q ss_pred             EEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcc-ccceeecccccCCCCCcccccCCCCCcEEEceec
Q 041034           90 YLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR-NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN  168 (701)
Q Consensus        90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  168 (701)
                      .|+++.|.+... +..+..++.++.|++.+|+++ .++.....++ +|++|++++|++. .+|..+..++.|+.|++++|
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            566666666422 223444566777777777776 3444445553 6777777777776 33455667777777777777


Q ss_pred             ccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCc
Q 041034          169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPL  248 (701)
Q Consensus       169 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  248 (701)
                      .+... |...+.+++|+.|++++|+++ .+|........|++|.+++|.+. ..+..+..+.++..+.+.+|++.. .+.
T Consensus       174 ~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         174 DLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            77533 333336677888888888887 55555555566888888888544 455667788888888888888876 356


Q ss_pred             ccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCC
Q 041034          249 EIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTEL  328 (701)
Q Consensus       249 ~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  328 (701)
                      .++.++.++.|++++|.++... . ++.+.+|+.|++++|.+....|........... ... +.++ ..+........+
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~-~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~-~~~-~~~~-~~~~~~~~~~~~  324 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSIS-S-LGSLTNLRELDLSGNSLSNALPLIALLLLLLEL-LLN-LLLT-LKALELKLNSIL  324 (394)
T ss_pred             hhccccccceeccccccccccc-c-ccccCccCEEeccCccccccchhhhccchhHHh-hhh-hhhh-cccccccccccc
Confidence            6777888888888888888443 3 778888888888888888666654433222211 111 2222 222222333334


Q ss_pred             CeeeccCCccCCCCCccccccccCCeEEcccccCc
Q 041034          329 QHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS  363 (701)
Q Consensus       329 ~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  363 (701)
                      ...++..+... ..+..+.....+..++...+...
T Consensus       325 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         325 LNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             ccccccccccc-ccchhhcccccccCceecccccc
Confidence            44444444444 44444444445555555544443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=3.3e-13  Score=146.06  Aligned_cols=200  Identities=37%  Similarity=0.523  Sum_probs=125.2

Q ss_pred             CEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCC-CCcEEEceecccCCCcCcccccccccceeEeee
Q 041034          113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLK-SLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGC  191 (701)
Q Consensus       113 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (701)
                      ..|+++.|.+.. ....+..++.++.|++.+|.++. ++.....++ +|+.|++++|.+.. +|..+..+++|+.|++++
T Consensus        96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             ceeecccccccc-CchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchhh-hhhhhhccccccccccCC
Confidence            356777776642 22234455667777777777763 344444553 67777777777743 334566677777777777


Q ss_pred             cccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccC
Q 041034          192 NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIP  271 (701)
Q Consensus       192 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p  271 (701)
                      |+++ .+|...+.++.|+.|++++|+++ .+|........|++|++++|.+.. .+..+.++.++..|.+.+|++.. ++
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~-~~~~~~~~~~l~~l~l~~n~~~~-~~  248 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLED-LP  248 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCccee-cchhhhhcccccccccCCceeee-cc
Confidence            7776 44444446667777777777777 455544455557777777775333 34556666777777777777663 35


Q ss_pred             cccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCc
Q 041034          272 DELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG  321 (701)
Q Consensus       272 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  321 (701)
                      ..+..+++|+.|++++|.++...+  ++.+.+|+.|++++|.++...|..
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence            566667777777777777763332  666777777777777777555543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=2.2e-13  Score=148.67  Aligned_cols=148  Identities=20%  Similarity=0.228  Sum_probs=93.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-CcEEEEEEecCCCccC-------------------------------hHHHHHH
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETED-------------------------------SAFVESF  496 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------------------------------~~~~~~~  496 (701)
                      ..+|.. +.||+|++|+||+|+.++ |+.||||+.++.....                               .++.+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            455776 789999999999998877 9999999998653110                               0112223


Q ss_pred             H------HHHHHHhcCC----CCceeeeeeeeee-CcEEEEEEEccCCCCHHHHH--hcCC-CccCCCHHHHHHHHHHHH
Q 041034          497 Q------NEARVLSTVR----HRNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVL--RDDD-EAIELNWTRRVNIVKSVA  562 (701)
Q Consensus       497 ~------~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qi~  562 (701)
                      .      +|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-  ...+ ....+....+..++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence            3      3333333332    2222222222222 33467999999999998742  2221 0011222223333333  


Q ss_pred             HHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEEeecCcccccc
Q 041034          563 HALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFGTARLLHV  607 (701)
Q Consensus       563 ~~L~~LH~~~~~givH~Dlkp~NIll~~~~----~~kL~DFGla~~~~~  607 (701)
                           ++..   |++|+|+||.||+++.++    +++++|||++..++.
T Consensus       276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3445   999999999999999888    999999999987643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=3.7e-14  Score=158.02  Aligned_cols=208  Identities=22%  Similarity=0.315  Sum_probs=164.4

Q ss_pred             hcCCccceEEeeccceEEEEEEcC--CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP--DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (701)
                      ...|.+.+.||+|+|+.|-.+...  ....+|+|.+.... ...........|..+-..+. |+|++++++...+.+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            456788888999999999888543  34556777666543 23334566667888888887 999999999999999999


Q ss_pred             EEEEccCCCCHHHHH-hcCCCccCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCc
Q 041034          526 FIYEYMERGSLFYVL-RDDDEAIELNWTRRVNIVKSVAHALSYLH-HDCTPSIVHRDISSNNILLNSNL-EAFVADFGTA  602 (701)
Q Consensus       526 lv~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla  602 (701)
                      ++++|.+++++.+.+ +....  ..+......++.|+..++.|+| +.   ++.|||+||+|.+++..+ ..+++|||+|
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             cccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence            999999999998888 33221  3555667779999999999999 77   999999999999999999 9999999999


Q ss_pred             ccccc-CCCC--ceeecc-cccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHH
Q 041034          603 RLLHV-DSSN--RTLRAG-TYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQR  663 (701)
Q Consensus       603 ~~~~~-~~~~--~~~~~g-t~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~  663 (701)
                      ..+.. .+..  ....+| ++.|+|||...+..+.... .|+|+.|+++..++.++ |...|..++
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~-~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPS-VDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCC-cccccccccccccccCCCCcccccccc
Confidence            88765 3222  234568 9999999999886554443 39999999999888876 777776554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=3.6e-12  Score=120.52  Aligned_cols=131  Identities=21%  Similarity=0.209  Sum_probs=96.2

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCcEEEEEEEccCC
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      ++.++.|.++.||+++.. ++.|++|........    ...+.+|+.+++.+.+.+ +++++.+..  ...++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence            467889999999999864 778999987654321    134578888888886544 345555533  335799999999


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC--TPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      .++.+.    .       .....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++|||.|..
T Consensus        76 ~~l~~~----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTE----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Cccccc----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            877543    0       011235788999999999882  12359999999999998 67899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=2.1e-11  Score=115.70  Aligned_cols=139  Identities=19%  Similarity=0.188  Sum_probs=100.0

Q ss_pred             ceEEeeccceEEEEEEcCC-------CcEEEEEEecCCCcc----------C---------hHHHHH----HHHHHHHHh
Q 041034          455 RYCIGTGGYGSVYKAELPD-------GKVVALKKLHQSETE----------D---------SAFVES----FQNEARVLS  504 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~---------~~~~~~----~~~E~~~l~  504 (701)
                      ...||.|.-+.||.|...+       +..+|||+.+.....          +         ....+.    ..+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999996543       478999987632110          0         011222    348999999


Q ss_pred             cCC--CCceeeeeeeeeeCcEEEEEEEccCCCCHH-HHHhcCCCccCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecC
Q 041034          505 TVR--HRNIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYL-HHDCTPSIVHRD  580 (701)
Q Consensus       505 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~givH~D  580 (701)
                      ++.  .-++++++++    ...++||||+.+..+. ..++..    .++..+...+..+++.++..+ |+.   |+||+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            985  3567777765    4568999999764332 122221    244556677889999999999 777   999999


Q ss_pred             CCCCcEEEcCCCCeEEEeecCcccc
Q 041034          581 ISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       581 lkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ++|.||+++ ++.++++|||.|...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999996 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.29  E-value=4e-12  Score=143.97  Aligned_cols=108  Identities=36%  Similarity=0.547  Sum_probs=73.4

Q ss_pred             CcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEccc
Q 041034          280 LQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH  359 (701)
Q Consensus       280 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~  359 (701)
                      ++.|+|++|.++|.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            56677777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             ccCcccCCCCccc-----cccccccCCCCCcCC
Q 041034          360 NNLSGTIPMTLHP-----MFLDMSFNNLEGEIP  387 (701)
Q Consensus       360 N~l~g~~p~~~~~-----~~l~ls~N~l~g~~p  387 (701)
                      |+++|.+|..+..     ..+++++|...+..|
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC
Confidence            7777777765432     245666665444344

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.27  E-value=5.6e-13  Score=134.91  Aligned_cols=228  Identities=26%  Similarity=0.267  Sum_probs=158.8

Q ss_pred             cEEECCCCcceeeCCccc----CCCCCCCEEECcCCcCcccCC-cccCCCCCCCEEECCCCCCCCCCc--cccCCccccc
Q 041034           65 QYLNLWNNNLSGSIPPQI----GSLSNLKYLNLRWNNLTGTIP-KEIGSLRNLEVLYLSNNSLHGTTP--IEIGSLRNLE  137 (701)
Q Consensus        65 ~~L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~  137 (701)
                      ..+.+++-.++++.-+.+    .++.+|+...|.+..+..... .....+++++.||||.|-+....+  .-...|++|+
T Consensus        96 ~~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le  175 (505)
T KOG3207|consen   96 SVLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLE  175 (505)
T ss_pred             hHhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccch
Confidence            345556666665443333    357788888888887763221 355678888888888887775544  2345788888


Q ss_pred             eeecccccCCCCCccc-ccCCCCCcEEEceecccCCC-cCcccccccccceeEeeecccCCCCCCCCCCccccCcccccc
Q 041034          138 ELYLRSNKLSGVLPQE-IGNLKSLIWLSVMYNTVGGP-IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT  215 (701)
Q Consensus       138 ~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  215 (701)
                      .|+|+.|++....... -..+++|+.|.|+.|.++.. +-..+..+|+|+.|+|..|...+.......-+..|++|+|++
T Consensus       176 ~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~  255 (505)
T KOG3207|consen  176 NLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSN  255 (505)
T ss_pred             hcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccC
Confidence            8888888886432222 22567888888888888632 223355678999999999964334444556678899999999


Q ss_pred             ccccCCcc--ccccCCCcccEEEeccCCCCCCC-Ccc-----cCCCCcccEEEcCCCCCccc-cCcccCCCCCCcEEEcc
Q 041034          216 NKLTGAIP--STLGHLTSLLYLDLSFNQLHSFI-PLE-----IGNFSALAELDLSDNKIRGI-IPDELSKLSNLQYLNLS  286 (701)
Q Consensus       216 N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~-~~~-----~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~  286 (701)
                      |++.. .+  ...+.++.|+.|+++.+.+..+- |..     ...+++|++|+++.|+|... --..+..+++|+.|.+.
T Consensus       256 N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~  334 (505)
T KOG3207|consen  256 NNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT  334 (505)
T ss_pred             Ccccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence            98873 33  45678899999999999988742 222     35689999999999999632 11345567888999999


Q ss_pred             CccCCCC
Q 041034          287 SNLLSGQ  293 (701)
Q Consensus       287 ~N~l~~~  293 (701)
                      .|.++.+
T Consensus       335 ~n~ln~e  341 (505)
T KOG3207|consen  335 LNYLNKE  341 (505)
T ss_pred             ccccccc
Confidence            9999754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=5.8e-11  Score=108.31  Aligned_cols=134  Identities=22%  Similarity=0.364  Sum_probs=101.7

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccChH-----HHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSA-----FVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      ..+++|+-+.||.+.+. |..+++|.-.++....+.     ..++..+|++++.+++--.|...+=+..+++...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 444667754444333222     234567899999998765555555555677778899999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++|..|.+.+...          ...++..+-.-+.-||..   ||||+||.++||++..+ .+.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            9999998888764          134677777888999999   99999999999999765 499999999975

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.25  E-value=8.5e-13  Score=133.64  Aligned_cols=228  Identities=24%  Similarity=0.253  Sum_probs=159.7

Q ss_pred             EEECcCCcCcccCCccc----CCCCCCCEEECCCCCCCCCCc-cccCCccccceeecccccCCCC--CcccccCCCCCcE
Q 041034           90 YLNLRWNNLTGTIPKEI----GSLRNLEVLYLSNNSLHGTTP-IEIGSLRNLEELYLRSNKLSGV--LPQEIGNLKSLIW  162 (701)
Q Consensus        90 ~L~L~~n~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~  162 (701)
                      .+.+++-++.++--+.+    +++.+|+...|.+..+..... .....+++++.|||+.|-|...  +-.....|++|+.
T Consensus        97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~  176 (505)
T KOG3207|consen   97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN  176 (505)
T ss_pred             HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence            34455555553322222    467889999999888763332 3567889999999999988743  3344567899999


Q ss_pred             EEceecccCCCcCccc-ccccccceeEeeecccCCC-CCCCCCCccccCccccccccccCCccccccCCCcccEEEeccC
Q 041034          163 LSVMYNTVGGPIPSTL-FRLTNLERLFLGCNQFNGT-IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN  240 (701)
Q Consensus       163 L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N  240 (701)
                      |+|+.|++.....+.. ..++.|+.|.|+.+.|+.. +-..+..+|+|+.|+|..|.....-......+..|+.|||++|
T Consensus       177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N  256 (505)
T KOG3207|consen  177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN  256 (505)
T ss_pred             cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC
Confidence            9999998865443322 2567899999999988832 1222456788999999999643343444555778999999999


Q ss_pred             CCCCCCC-cccCCCCcccEEEcCCCCCccc-cCcc-----cCCCCCCcEEEccCccCCCC-CcccccCccceeeecCCCC
Q 041034          241 QLHSFIP-LEIGNFSALAELDLSDNKIRGI-IPDE-----LSKLSNLQYLNLSSNLLSGQ-IPFAIGKLFNLVSLDLSKN  312 (701)
Q Consensus       241 ~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~-~p~~-----l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N  312 (701)
                      ++..... ...+.++.|+.|+++.|.|..+ .|+.     ...+++|++|+++.|++..- .-..+..+.+|+.|....|
T Consensus       257 ~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n  336 (505)
T KOG3207|consen  257 NLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLN  336 (505)
T ss_pred             cccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccc
Confidence            9887432 3567899999999999998754 3433     35678999999999998631 1224555677888888888


Q ss_pred             cCCCC
Q 041034          313 KLSGS  317 (701)
Q Consensus       313 ~l~~~  317 (701)
                      .|+.+
T Consensus       337 ~ln~e  341 (505)
T KOG3207|consen  337 YLNKE  341 (505)
T ss_pred             ccccc
Confidence            88743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.25  E-value=1.5e-10  Score=124.42  Aligned_cols=167  Identities=16%  Similarity=0.165  Sum_probs=127.3

Q ss_pred             EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCC
Q 041034          470 ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL  549 (701)
Q Consensus       470 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l  549 (701)
                      +..++.+|.|...+....   .......+.++.++.++||||+++++.++.++..|+|+|.+.  .|..++++..     
T Consensus        33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----  102 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----  102 (690)
T ss_pred             eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence            445788899888876554   334566788999999999999999999999999999999985  6777776533     


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCC
Q 041034          550 NWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS  629 (701)
Q Consensus       550 ~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~  629 (701)
                       ...+..-+.||+.||.|||+.|  +++|++|.-+-|+++..|+.||++|-++..............--..|..|+....
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence             4556667899999999999776  8999999999999999999999999988654322211111122234566665433


Q ss_pred             CcCChhhHHHHHHHHHHHHHcccC
Q 041034          630 PPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       630 ~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ..  -.  -|.|.||+++++.+.+
T Consensus       180 s~--~s--~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WS--IDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cc--hhhhhHHHHHHHHhCc
Confidence            22  22  2999999999998887

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.23  E-value=1.4e-12  Score=141.40  Aligned_cols=249  Identities=31%  Similarity=0.333  Sum_probs=140.1

Q ss_pred             CCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEE
Q 041034           84 SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL  163 (701)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  163 (701)
                      .+..++.++++.|.+.. +-..+..+++|+.|++.+|+|..+.. .+..+++|++|+|++|+|+.+  ..+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccc--cchhhccchhhh
Confidence            34444455555555542 22334455555555555555553222 244555555555555555543  223444445555


Q ss_pred             EceecccCCCcCcccccccccceeEeeecccCCCCC-CCCCCccccCccccccccccCCccccccCCCcccEEEeccCCC
Q 041034          164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIP-REIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL  242 (701)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  242 (701)
                      ++++|.++..  ..+..+++|+.+++++|++...-+ . ...+.+++.+.+.+|.+...  ..+..+..+..+++..|.+
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccc
Confidence            5555555432  234445666666666666664333 1 45566677777777776532  3344445555557777777


Q ss_pred             CCCCCcccCCCC--cccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCC---
Q 041034          243 HSFIPLEIGNFS--ALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS---  317 (701)
Q Consensus       243 ~~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---  317 (701)
                      +..-+.  ..+.  .|+.+++++|.+. ..+..+..+.++..|++.+|++...-  .+.....+..+.+..|.+...   
T Consensus       221 ~~~~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  295 (414)
T KOG0531|consen  221 SKLEGL--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAI  295 (414)
T ss_pred             eeccCc--ccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhh
Confidence            653322  2222  3777788888776 33345666777888888888776432  244456667777777776522   


Q ss_pred             CCCc-ccCCCCCCeeeccCCccCCCCCccc
Q 041034          318 FPTG-IGNCTELQHLALNHNSLDGTIPPEI  346 (701)
Q Consensus       318 ~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~  346 (701)
                      .... ....+.++.+.+..|.+....+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
T KOG0531|consen  296 SQEYITSAAPTLVTLTLELNPIRKISSLDL  325 (414)
T ss_pred             hccccccccccccccccccCcccccccccH
Confidence            1111 4556778888888888876655443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.22  E-value=1.6e-13  Score=135.30  Aligned_cols=249  Identities=24%  Similarity=0.291  Sum_probs=126.3

Q ss_pred             CCCCCCcEEECCCCccee----eCCcccCCCCCCCEEECcCC---cCcccCCcc-------cCCCCCCCEEECCCCCCCC
Q 041034           59 SCFPNLQYLNLWNNNLSG----SIPPQIGSLSNLKYLNLRWN---NLTGTIPKE-------IGSLRNLEVLYLSNNSLHG  124 (701)
Q Consensus        59 ~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~N~l~~  124 (701)
                      ..+..++.|+|++|.+..    .+...+.+.++|+..++|+=   ++...+|+.       +...++|++||||+|.|.-
T Consensus        27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~  106 (382)
T KOG1909|consen   27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP  106 (382)
T ss_pred             cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence            345678888888888853    34455677788888888762   333344433       3445688888888888764


Q ss_pred             CCccc----cCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCC--
Q 041034          125 TTPIE----IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTI--  198 (701)
Q Consensus       125 ~~~~~----~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--  198 (701)
                      ..+..    +.+.+.|++|.|.+|.+.-.....++.  .|..|.  .|.       -...-+.|+++..++|++....  
T Consensus       107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~  175 (382)
T KOG1909|consen  107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGAT  175 (382)
T ss_pred             cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHH
Confidence            44433    345677888888887775322222111  011111  111       1122245666666666654221  


Q ss_pred             --CCCCCCccccCccccccccccC----CccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCc
Q 041034          199 --PREIGNLKNLTHLSIITNKLTG----AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD  272 (701)
Q Consensus       199 --~~~~~~l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~  272 (701)
                        ...|...+.|+.+.++.|.|..    .+...|..+++|+.|||..|.|+.....                    .+..
T Consensus       176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~--------------------~Lak  235 (382)
T KOG1909|consen  176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV--------------------ALAK  235 (382)
T ss_pred             HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH--------------------HHHH
Confidence              1123333445555555554431    1122334444444444444444331111                    1223


Q ss_pred             ccCCCCCCcEEEccCccCCCCCcccc-----cCccceeeecCCCCcCCC----CCCCcccCCCCCCeeeccCCcc
Q 041034          273 ELSKLSNLQYLNLSSNLLSGQIPFAI-----GKLFNLVSLDLSKNKLSG----SFPTGIGNCTELQHLALNHNSL  338 (701)
Q Consensus       273 ~l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l  338 (701)
                      .++.+++|+.|++++|.+...-..++     ...++|++|.|.+|.++-    .+-.++...+.|+.|+|++|++
T Consensus       236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            34445555555555555543222222     124566666666666642    1223344566677777777777

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=1.2e-10  Score=105.60  Aligned_cols=146  Identities=18%  Similarity=0.241  Sum_probs=109.3

Q ss_pred             cceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          454 IRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ....+.+|+-+.|+++.+ .|+.++||.-......     ..-...+..+|++.+.+++--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            578899999999999988 5787777754443332     2233566789999999987555544444555666678999


Q ss_pred             EccCC-CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEEEeecCccc
Q 041034          529 EYMER-GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFVADFGTARL  604 (701)
Q Consensus       529 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~---~~kL~DFGla~~  604 (701)
                      ||++| .++.+++....... .........+.+|-+.+.-||..   ++||+||..+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 47888887654432 22233367889999999999999   999999999999997654   457999999864

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.22  E-value=1.4e-12  Score=141.35  Aligned_cols=268  Identities=28%  Similarity=0.297  Sum_probs=177.3

Q ss_pred             CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEce
Q 041034           87 NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM  166 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  166 (701)
                      .++.++..++.+.+..-. ...+..++.+.+..|.+.. .-..+..+++|+.|++.+|++..+.. .+..+++|++|+++
T Consensus        50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls  126 (414)
T KOG0531|consen   50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLS  126 (414)
T ss_pred             hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheecc
Confidence            445555555544422111 1456677777788888763 33346778888888888888875422 26678888888888


Q ss_pred             ecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc-ccccCCCcccEEEeccCCCCCC
Q 041034          167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP-STLGHLTSLLYLDLSFNQLHSF  245 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~  245 (701)
                      +|.|+...  .+..++.|+.|++++|.++..  ..+..+..|+.+++++|++...-+ . +..+.+++.+++++|.+...
T Consensus       127 ~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i  201 (414)
T KOG0531|consen  127 FNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI  201 (414)
T ss_pred             cccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc
Confidence            88887653  355666688888888888743  345567888888888888875544 2 46677888888888888753


Q ss_pred             CCcccCCCCcccEEEcCCCCCccccCcccCCCCC--CcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCccc
Q 041034          246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSN--LQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIG  323 (701)
Q Consensus       246 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  323 (701)
                        ..+..+..+..+++..|.++-.-+  +..+..  |+.+++++|++. ..+..+..+..+..|++.+|++...-  .+.
T Consensus       202 --~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~  274 (414)
T KOG0531|consen  202 --EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLE  274 (414)
T ss_pred             --cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--ccc
Confidence              334445566666888888774322  223333  788888888887 33355666778888888888886432  244


Q ss_pred             CCCCCCeeeccCCccCCC---CCcc-ccccccCCeEEcccccCcccCCCC
Q 041034          324 NCTELQHLALNHNSLDGT---IPPE-IGKILLLQNLDLSHNNLSGTIPMT  369 (701)
Q Consensus       324 ~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~l~ls~N~l~g~~p~~  369 (701)
                      ....+..+.++.|.+...   .... ......++.+.+.+|+.....+..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
T KOG0531|consen  275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLD  324 (414)
T ss_pred             ccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccccc
Confidence            556677777777776522   1121 456677888888888877665543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=2.1e-11  Score=119.28  Aligned_cols=163  Identities=25%  Similarity=0.391  Sum_probs=123.3

Q ss_pred             HHHhcCCCCceeeeeeeeeeCc-----EEEEEEEccCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 041034          501 RVLSTVRHRNIVKLYGFCLHKR-----CMFFIYEYMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTP  574 (701)
Q Consensus       501 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  574 (701)
                      .-+-++.|.|+++++.|+.+..     ...+++|||+.|++.+++++.+. ...+......+++-||..||.|||+. .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3345567999999999987643     46889999999999999986532 23577778889999999999999986 88


Q ss_pred             CeEecCCCCCcEEEcCCCCeEEEeecCcccccc-----CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHV-----DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       575 givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .|+|+++..+-|++..+|-+|++--. ......     .........+-++|.|||.-.........  |||++|+.+++
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~--dIy~fgmcAle  274 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGAS--DIYKFGMCALE  274 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccch--hhhhhhHHHHH
Confidence            99999999999999999988874321 111110     00111223467899999976655555554  99999988774


Q ss_pred             ---------------------------------------cccCCCCCCCCHHHHHHH
Q 041034          650 ---------------------------------------CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 ---------------------------------------cl~~~P~~Rpt~~~i~~~  667 (701)
                                                             |+.+.|..||+|.+++..
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence                                                   999999999999887654

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=2.9e-12  Score=123.47  Aligned_cols=133  Identities=33%  Similarity=0.395  Sum_probs=94.0

Q ss_pred             cCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceee
Q 041034          227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVS  306 (701)
Q Consensus       227 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  306 (701)
                      .....|+++|||+|.|+. +..++.-.|+++.|++|+|.|..+  +.+..+++|+.||||+|.++ .+..+-..+.+.+.
T Consensus       281 dTWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             chHhhhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            334567788888888776 556667778888888888888744  33777788888888888877 33344456777788


Q ss_pred             ecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCC-CCccccccccCCeEEcccccCccc
Q 041034          307 LDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT-IPPEIGKILLLQNLDLSHNNLSGT  365 (701)
Q Consensus       307 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~g~  365 (701)
                      |.|++|.|..  -.++..+-+|..||+++|+|... -...+++++.|+.+.|.+|++.+.
T Consensus       357 L~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  357 LKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             eehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            8888887752  23566777788888888887632 235677888888888888887753

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=3.1e-12  Score=123.28  Aligned_cols=141  Identities=30%  Similarity=0.362  Sum_probs=112.8

Q ss_pred             CCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccC
Q 041034          196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                      |..-........|++|||++|.|+ .+.+++.-.|.++.|++|+|.|..+  ..+..+++|+.||||+|.++ .+..+-.
T Consensus       274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~  349 (490)
T KOG1259|consen  274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHL  349 (490)
T ss_pred             CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHh
Confidence            333344455577999999999998 6777888889999999999999874  34788999999999999988 4445556


Q ss_pred             CCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCC-CCCcccCCCCCCeeeccCCccCCCC
Q 041034          276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS-FPTGIGNCTELQHLALNHNSLDGTI  342 (701)
Q Consensus       276 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~  342 (701)
                      .+-+++.|.|+.|.+..  -..+..+.+|..||+++|+|... --..+++++-|+.|.|.+|.+.+..
T Consensus       350 KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  350 KLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            67889999999999863  24577889999999999999632 2356899999999999999998543

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.20  E-value=9.1e-13  Score=130.06  Aligned_cols=244  Identities=22%  Similarity=0.213  Sum_probs=133.5

Q ss_pred             CCCEEEEEeccccccccc---CCcccCCCCCCcEEECCCCcc---eeeCC-------cccCCCCCCCEEECcCCcCcccC
Q 041034           36 KGSITHIELVECSIKGEL---GSLNFSCFPNLQYLNLWNNNL---SGSIP-------PQIGSLSNLKYLNLRWNNLTGTI  102 (701)
Q Consensus        36 ~~~v~~l~l~~~~~~~~~---~~~~~~~~~~L~~L~L~~n~l---~~~~~-------~~~~~l~~L~~L~L~~n~l~~~~  102 (701)
                      ...++.++|+++.+...-   -...+.+.++|+..++++--.   ...+|       +.+...++|++||||+|-|.-.-
T Consensus        29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g  108 (382)
T KOG1909|consen   29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG  108 (382)
T ss_pred             cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence            457999999999875321   112355667888888865422   22333       34556789999999999887444


Q ss_pred             Ccc----cCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCC----c
Q 041034          103 PKE----IGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP----I  174 (701)
Q Consensus       103 p~~----~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~  174 (701)
                      +..    +..+..|++|+|.+|.+.-.-...++.  .|..|.  .|+..       ..-++|+.+...+|++..-    +
T Consensus       109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk~-------~~~~~Lrv~i~~rNrlen~ga~~~  177 (382)
T KOG1909|consen  109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKKA-------ASKPKLRVFICGRNRLENGGATAL  177 (382)
T ss_pred             hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhcc-------CCCcceEEEEeeccccccccHHHH
Confidence            433    456899999999999886222111111  111111  11111       1112344444444444322    1


Q ss_pred             CcccccccccceeEeeecccCCC----CCCCCCCccccCccccccccccCC----ccccccCCCcccEEEeccCCCCCCC
Q 041034          175 PSTLFRLTNLERLFLGCNQFNGT----IPREIGNLKNLTHLSIITNKLTGA----IPSTLGHLTSLLYLDLSFNQLHSFI  246 (701)
Q Consensus       175 ~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~  246 (701)
                      ...|...+.|+.+.+..|.|...    +...|..+++|+.|||..|-++..    +...+..+++|+.|++++|.+....
T Consensus       178 A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~G  257 (382)
T KOG1909|consen  178 AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEG  257 (382)
T ss_pred             HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccccc
Confidence            22344445566666666655421    123455566677777777666532    2334555566667777766666543


Q ss_pred             Cccc-----CCCCcccEEEcCCCCCccc----cCcccCCCCCCcEEEccCccC
Q 041034          247 PLEI-----GNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNLSSNLL  290 (701)
Q Consensus       247 ~~~~-----~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l  290 (701)
                      ..+|     ...++|+.|.|.+|.|+-.    +..++...+.|..|+|++|++
T Consensus       258 a~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  258 AIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            3332     1245666666666666422    222233455566666666655

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=1.5e-10  Score=114.66  Aligned_cols=144  Identities=22%  Similarity=0.268  Sum_probs=110.6

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCc---EEEEEEE
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH--RNIVKLYGFCLHKR---CMFFIYE  529 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e  529 (701)
                      .+.++.|..+.||++...+|+.+++|........  .....+.+|+++++.+++  ..+++++.+.....   ..++|||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            3678999999999998766789999987654321  123567899999999975  44677787776542   5689999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC-------------------------------------  572 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------  572 (701)
                      |++|.++.+.+..    ..++..+...++.+++++|.+||+..                                     
T Consensus        81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9999888765432    13677778888889999999888531                                     


Q ss_pred             ----------------CCCeEecCCCCCcEEEcC--CCCeEEEeecCccc
Q 041034          573 ----------------TPSIVHRDISSNNILLNS--NLEAFVADFGTARL  604 (701)
Q Consensus       573 ----------------~~givH~Dlkp~NIll~~--~~~~kL~DFGla~~  604 (701)
                                      ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            245799999999999998  56689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=5.1e-11  Score=126.86  Aligned_cols=191  Identities=22%  Similarity=0.185  Sum_probs=145.3

Q ss_pred             hcCCccceEEee--ccceEEEEEEc---CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGT--GGYGSVYKAEL---PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  522 (701)
                      ...|.+.+.+|.  |.+|.||.+..   .++..+|+|+-+....... ...+=.+|+...+.++ |++.++.+..++..+
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-DSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-ccccccchhhcccccCccccccccCcccccCC
Confidence            345677888999  99999999965   4688899998544332111 1122245666666664 999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEE
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVA  597 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~  597 (701)
                      ..|+-+|++. .++.++.+....  .++....+.+..+...    ||.++|..   +++|-|+||+||+...+ ...+++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            9999999995 588888766443  3666777778888888    99999998   99999999999999988 889999


Q ss_pred             eecCccccccCCCCceee-----cccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          598 DFGTARLLHVDSSNRTLR-----AGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      |||+...+....-.....     .|...|++||...+-...   .+|++++|.++++
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~---~~di~sl~ev~l~  319 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF---ASDIFSLGEVILE  319 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccch---HhhhcchhhhhHh
Confidence            999998886544222222     577789999988664332   2499999998874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=4.1e-11  Score=111.50  Aligned_cols=108  Identities=33%  Similarity=0.377  Sum_probs=32.8

Q ss_pred             CCCCCcEEECCCCcceeeCCcccC-CCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccce
Q 041034           60 CFPNLQYLNLWNNNLSGSIPPQIG-SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEE  138 (701)
Q Consensus        60 ~~~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  138 (701)
                      +...++.|+|.+|.|+.+  +.++ .+.+|+.|||++|.|+..  +.+..+++|++|++++|+|+...+.....+++|++
T Consensus        17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            334567788888887743  2454 467788888888888744  24777788888888888887543322235777888


Q ss_pred             eecccccCCCCC-cccccCCCCCcEEEceecccC
Q 041034          139 LYLRSNKLSGVL-PQEIGNLKSLIWLSVMYNTVG  171 (701)
Q Consensus       139 L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~  171 (701)
                      |+|++|++.... -..+..+++|+.|+|.+|.+.
T Consensus        93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            888888776431 133445555555555555554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=2.9e-11  Score=112.48  Aligned_cols=100  Identities=34%  Similarity=0.363  Sum_probs=27.8

Q ss_pred             CCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCccc-CCCCCCcEEEccCccCCCCC-cccccCccceee
Q 041034          229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEL-SKLSNLQYLNLSSNLLSGQI-PFAIGKLFNLVS  306 (701)
Q Consensus       229 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~  306 (701)
                      +.+|+.|+|++|.|+..  ..+..+++|+.|++++|+|+.. ++.+ ..+++|+.|+|++|+|...- -..+..+++|+.
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            34444444444444442  1233444555555555555432 1122 23445555555555544211 123344555555


Q ss_pred             ecCCCCcCCCCCCC----cccCCCCCCeee
Q 041034          307 LDLSKNKLSGSFPT----GIGNCTELQHLA  332 (701)
Q Consensus       307 L~Ls~N~l~~~~p~----~~~~l~~L~~L~  332 (701)
                      |+|.+|.++.. +.    .+..+|+|+.||
T Consensus       118 L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen  118 LSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             EE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             eeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            55555555422 11    133455565555

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=8.7e-10  Score=104.40  Aligned_cols=128  Identities=27%  Similarity=0.351  Sum_probs=84.3

Q ss_pred             EEEEEEcCCCcEEEEEEecCCCc-----------------------cChHHHHHHHHHHHHHhcCCCC--ceeeeeeeee
Q 041034          465 SVYKAELPDGKVVALKKLHQSET-----------------------EDSAFVESFQNEARVLSTVRHR--NIVKLYGFCL  519 (701)
Q Consensus       465 ~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  519 (701)
                      .||.|...+|..+|||..+....                       ..........+|.+.|.++...  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888999999998764211                       1112234568899999999755  577777653 


Q ss_pred             eCcEEEEEEEccC--CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          520 HKRCMFFIYEYME--RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY-LHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       520 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                         ..++||||++  |..+..+....     ++......++.+++..+.. +|..   |++|+|+.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               2469999998  54554433221     1123445678888886666 4677   99999999999999887 9999


Q ss_pred             EeecCcccc
Q 041034          597 ADFGTARLL  605 (701)
Q Consensus       597 ~DFGla~~~  605 (701)
                      +|||.|...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.04  E-value=1e-10  Score=135.36  Aligned_cols=128  Identities=33%  Similarity=0.376  Sum_probs=76.7

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCc--CcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccccee
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN--LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  139 (701)
                      ...+...+-+|.+. .++... ..++|++|-+..|.  +....++.|..++.|++|||++|.=-+.+|..++.|-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            44555556566554 222222 22356666666664  443333445666667777776665555666666666667777


Q ss_pred             ecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeec
Q 041034          140 YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCN  192 (701)
Q Consensus       140 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  192 (701)
                      +|++..++ .+|..+++|++|.+|++..+.-...+|.....+++|++|.+..-
T Consensus       601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            77666666 56666666667777776666555555555666667776666544

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.04  E-value=2e-10  Score=132.90  Aligned_cols=253  Identities=25%  Similarity=0.225  Sum_probs=160.7

Q ss_pred             CCCCCcEEECCCCc--ceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccc
Q 041034           60 CFPNLQYLNLWNNN--LSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLE  137 (701)
Q Consensus        60 ~~~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  137 (701)
                      ..+.|++|-+..|.  +....++.|..++.|++|||++|.=-+.+|+.++.|-+|++|+|++..+. .+|..+.+|..|.
T Consensus       543 ~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~  621 (889)
T KOG4658|consen  543 ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI  621 (889)
T ss_pred             CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence            34579999999996  55455566888999999999998777799999999999999999999998 8899999999999


Q ss_pred             eeecccccCCCCCcccccCCCCCcEEEceecc--cCCCcCcccccccccceeEeeecccCCCCCCCCCCccccC----cc
Q 041034          138 ELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT--VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT----HL  211 (701)
Q Consensus       138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L  211 (701)
                      +|++..+.-...+|..+..|.+|++|.+..-.  .+...-..+..+..|+.+.......  .+-..+..+..|.    .+
T Consensus       622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l  699 (889)
T KOG4658|consen  622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSL  699 (889)
T ss_pred             eeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhh
Confidence            99999998776778888889999999987654  2222333445555666555533322  1111222233322    33


Q ss_pred             ccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCC------CCcccEEEcCCCCCccccCcccCCCCCCcEEEc
Q 041034          212 SIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN------FSALAELDLSDNKIRGIIPDELSKLSNLQYLNL  285 (701)
Q Consensus       212 ~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~------~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  285 (701)
                      .+..+... ..+..+..+.+|+.|.+.++.+..........      ++++..+...++..- ..+.+.--.++|+.|.+
T Consensus       700 ~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l  777 (889)
T KOG4658|consen  700 SIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSL  777 (889)
T ss_pred             hhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEE
Confidence            33333322 34556677788888888888776432222111      122222222222111 11122223467777777


Q ss_pred             cCccCCCCCcccccCccceeeecCCCCcCCCC
Q 041034          286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS  317 (701)
Q Consensus       286 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  317 (701)
                      ..+.....+......+..+..+-+..+.+.+.
T Consensus       778 ~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  778 VSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             ecccccccCCCHHHHhhhcccEEecccccccc
Confidence            77666555544455555555555555555543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.96  E-value=1e-08  Score=103.23  Aligned_cols=144  Identities=22%  Similarity=0.139  Sum_probs=101.1

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccC--h------HHHHHHHHHHHHHhcCCCCc--eeeeeeeeee-----
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETED--S------AFVESFQNEARVLSTVRHRN--IVKLYGFCLH-----  520 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----  520 (701)
                      +.+-.-....|+++.. +|+.|.||+........  .      .....+.+|...+..+...+  +++++++++.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444445777765 57889999775432110  0      00114678988888885333  3344555543     


Q ss_pred             CcEEEEEEEccCCC-CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-------CC
Q 041034          521 KRCMFFIYEYMERG-SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-------NL  592 (701)
Q Consensus       521 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-------~~  592 (701)
                      ...-++|||++++. +|.+++..... ...+...+..++.+++..+.-||..   ||+|+|++++|||++.       ++
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999886 79998864221 1355677788999999999999999   9999999999999975       46


Q ss_pred             CeEEEeecCccc
Q 041034          593 EAFVADFGTARL  604 (701)
Q Consensus       593 ~~kL~DFGla~~  604 (701)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            889999998864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=5.6e-09  Score=101.19  Aligned_cols=138  Identities=24%  Similarity=0.234  Sum_probs=101.1

Q ss_pred             CccceEEeeccceEEEEEEcCCCcEEEEEEecCCCc-------------------cChHHHHHHHHHHHHHhcCCCC--c
Q 041034          452 FHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSET-------------------EDSAFVESFQNEARVLSTVRHR--N  510 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~h~--n  510 (701)
                      +.+...||.|.-+.||.|..+.|.++|||.=+....                   +-...+....+|.++|..+...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456789999999999999999999999995432211                   0011234568899999999644  7


Q ss_pred             eeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       511 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      |++.+++    +...+||||++|--|...-        ++....-.++..|+.-+.-.-..   |+||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            8888776    4568999999996664332        12233344555666666555556   9999999999999999


Q ss_pred             CCCeEEEeecCccc
Q 041034          591 NLEAFVADFGTARL  604 (701)
Q Consensus       591 ~~~~kL~DFGla~~  604 (701)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.93  E-value=7.5e-10  Score=118.10  Aligned_cols=197  Identities=21%  Similarity=0.184  Sum_probs=144.5

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc--CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL--PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  523 (701)
                      ....+|..+..||.|.|+.|+.+..  .++..|++|.+.......... ..-..|+.+...+ .|.+++.++..+...+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            4466789999999999999999843  468899999887765443221 2224566666666 48999998887777777


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEeecCc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTA  602 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DFGla  602 (701)
                      .|+--|||++++......-   ...+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +.-+++|||.+
T Consensus       341 ~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            8899999999988766522   22577788899999999999999988   99999999999999876 78889999998


Q ss_pred             cccccCCCCceeecccccc-cCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          603 RLLHVDSSNRTLRAGTYGY-IAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +.+..  ........+..| .+|+.....+...+.  |+++++.-+.+.....
T Consensus       415 t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~--~~~sl~~~~~e~~~~~  463 (524)
T KOG0601|consen  415 TRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKA--DIFSLGLSVDEAITGS  463 (524)
T ss_pred             cccce--ecccccccccccccchhhcccccccccc--ccccccccccccccCc
Confidence            75321  111112233344 355555555555555  9999997777654443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=1.4e-09  Score=83.26  Aligned_cols=60  Identities=45%  Similarity=0.569  Sum_probs=33.9

Q ss_pred             CCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCC
Q 041034           63 NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL  122 (701)
Q Consensus        63 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  122 (701)
                      +|++|++++|+|+...+..|..+++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555544445555555555555555555555555555555555555555543

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.8e-09  Score=82.52  Aligned_cols=60  Identities=47%  Similarity=0.654  Sum_probs=36.1

Q ss_pred             cccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccC
Q 041034          231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL  290 (701)
Q Consensus       231 ~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  290 (701)
                      +|++|++++|+|+...+..|.++++|+.|++++|+|+...|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455666666666655455556666666666666666655555666666666666666653

...

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.74  E-value=1.2e-10  Score=124.64  Aligned_cols=127  Identities=29%  Similarity=0.331  Sum_probs=81.5

Q ss_pred             ccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcC
Q 041034          183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS  262 (701)
Q Consensus       183 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~  262 (701)
                      .|...++++|.+. ....++.-++.|+.|+|++|+++.+  +.+..++.|++|||++|++....-.....+. |+.|.|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4666677777776 4555666667777777777777754  3667777777777777777763322333333 7777777


Q ss_pred             CCCCccccCcccCCCCCCcEEEccCccCCCCC-cccccCccceeeecCCCCcCC
Q 041034          263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI-PFAIGKLFNLVSLDLSKNKLS  315 (701)
Q Consensus       263 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  315 (701)
                      +|-++..  ..+.+|.+|+.||+++|-|.+.- -..+..+..|+.|+|.+|.+.
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            7776633  24666777777777777766421 123445666777777777664

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.71  E-value=3.6e-07  Score=95.67  Aligned_cols=139  Identities=17%  Similarity=0.308  Sum_probs=108.2

Q ss_pred             eEEEEE-EcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CcEEEEEEEccCC-CCHH
Q 041034          464 GSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KRCMFFIYEYMER-GSLF  537 (701)
Q Consensus       464 g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~  537 (701)
                      .+.|++ ...||..|++|+++..+....   ..-..-+++++++.|+|||++.+++..    +...++||+|+++ ++|.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            578898 445899999999955443322   112334778999999999999998873    4568999999987 4677


Q ss_pred             HHHhcCC------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          538 YVLRDDD------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       538 ~~l~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ++.....            .+...++...+.++.|+..||.++|+.   |..-+-|.|.+|+++.+.+++|+..|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            6653221            223577899999999999999999999   9999999999999999999999888877665


Q ss_pred             ccC
Q 041034          606 HVD  608 (701)
Q Consensus       606 ~~~  608 (701)
                      ..+
T Consensus       444 ~~d  446 (655)
T KOG3741|consen  444 QED  446 (655)
T ss_pred             cCC
Confidence            443

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=2.9e-07  Score=87.58  Aligned_cols=140  Identities=17%  Similarity=0.119  Sum_probs=103.3

Q ss_pred             eeccceEEEEEEcCCCcEEEEEEecCCCccC---hHHHHHHHHHHHHHhcCCC--Cceeeeeeeee-e----CcEEEEEE
Q 041034          459 GTGGYGSVYKAELPDGKVVALKKLHQSETED---SAFVESFQNEARVLSTVRH--RNIVKLYGFCL-H----KRCMFFIY  528 (701)
Q Consensus       459 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~----~~~~~lv~  528 (701)
                      |+||.+-|+..... |+.+-+|+-.......   +.....|.+|...+.++..  -.++++. ++. .    .-.-+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            67999999998774 4578889775211111   1234678999999998853  3355555 332 1    12468999


Q ss_pred             EccCC-CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--eEEEeecCccc
Q 041034          529 EYMER-GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--AFVADFGTARL  604 (701)
Q Consensus       529 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~--~kL~DFGla~~  604 (701)
                      |-+++ .+|.+++...... +.+...+..+..+++.++.-||+.   |+.|+|+-+.||+++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98764 4898888654322 467788889999999999999999   9999999999999986666  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=1.5e-07  Score=91.67  Aligned_cols=106  Identities=20%  Similarity=0.318  Sum_probs=83.5

Q ss_pred             HHHHHHHHHHhcCCC--CceeeeeeeeeeC----cEEEEEEEccCCC-CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHH
Q 041034          494 ESFQNEARVLSTVRH--RNIVKLYGFCLHK----RCMFFIYEYMERG-SLFYVLRDDDEAIELNWTRRVNIVKSVAHALS  566 (701)
Q Consensus       494 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~  566 (701)
                      .+..+|...+..+..  =.+++.+++.+..    ...++|+|++++. +|.+++.....   .+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            456788888777753  3355566666542    2458999999884 79999876432   455677889999999999


Q ss_pred             HHhcCCCCCeEecCCCCCcEEEcCCC---CeEEEeecCcccc
Q 041034          567 YLHHDCTPSIVHRDISSNNILLNSNL---EAFVADFGTARLL  605 (701)
Q Consensus       567 ~LH~~~~~givH~Dlkp~NIll~~~~---~~kL~DFGla~~~  605 (701)
                      -||++   ||+|+|++|.|||++.+.   .+.++||+.++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999998876   8999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.65  E-value=5e-09  Score=101.44  Aligned_cols=187  Identities=25%  Similarity=0.234  Sum_probs=89.8

Q ss_pred             CCCCCEEECcCCcCcc--cCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCC-CcccccCCCCCc
Q 041034           85 LSNLKYLNLRWNNLTG--TIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLI  161 (701)
Q Consensus        85 l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~  161 (701)
                      .+.++.|||.+|.|+.  .+-..+.+++.|++|+|+.|++...+-..-..+.+|++|.|.+..+.-. ....+..++.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            4556666666666652  2223345666666666666666543322113455666666666665422 222334444445


Q ss_pred             EEEceecccCCCcCcccccccccceeEeeecccCCCCCC--CCCCccccCccccccccccCCccccccCCCcccEEEecc
Q 041034          162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPR--EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSF  239 (701)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~  239 (701)
                      .|+++.|.+              +.+++..|.+...-|.  .+..++.+..+.++-|++...       ++++..+.+..
T Consensus       150 elHmS~N~~--------------rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e  208 (418)
T KOG2982|consen  150 ELHMSDNSL--------------RQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCE  208 (418)
T ss_pred             hhhhccchh--------------hhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeec
Confidence            555544422              2223333332211110  112223344444444444422       24555566666


Q ss_pred             CCCCCCCC-cccCCCCcccEEEcCCCCCccc-cCcccCCCCCCcEEEccCccCCC
Q 041034          240 NQLHSFIP-LEIGNFSALAELDLSDNKIRGI-IPDELSKLSNLQYLNLSSNLLSG  292 (701)
Q Consensus       240 N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~  292 (701)
                      |.+..... ..+-.++.+..|+|+.|+|... --+++.++++|..|.+++|.+..
T Consensus       209 ~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  209 GPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             CcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            65554221 1233455555666666666432 12345566666666666666653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1e-07  Score=103.89  Aligned_cols=144  Identities=19%  Similarity=0.223  Sum_probs=93.0

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-------------------------------HHHH------HHHH
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-------------------------------AFVE------SFQN  498 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~~~~------~~~~  498 (701)
                      +.|+.++-|+||+|+.++|+.||||+.++.....-                               .+.+      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            77899999999999999999999999876532110                               0011      1234


Q ss_pred             HHHHHhcCC-----CCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHH-HHHHhcCC
Q 041034          499 EARVLSTVR-----HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA-LSYLHHDC  572 (701)
Q Consensus       499 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~-L~~LH~~~  572 (701)
                      |..-+.+++     .+.+.-..=|++-.....++|||++|-.+.+...-...  ..+.   ..++..++++ +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~---k~ia~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDR---KELAELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCH---HHHHHHHHHHHHHHHHhc-
Confidence            444444442     23322211122224556899999999888877422221  2442   2344444443 3333334 


Q ss_pred             CCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       573 ~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                        |++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              999999999999999999999999999877653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.65  E-value=3.5e-10  Score=121.27  Aligned_cols=126  Identities=33%  Similarity=0.345  Sum_probs=65.7

Q ss_pred             ccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCc-ccCCCCCCcEEEc
Q 041034          207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD-ELSKLSNLQYLNL  285 (701)
Q Consensus       207 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L  285 (701)
                      .|.+.+.+.|.+. ....++.-++.|+.|+|++|+++..  ..+..+++|+.|||+.|.++- +|. ...++ .|..|.|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhh-hheeeee
Confidence            3555566666665 4445555556666666666666653  245556666666666666652 222 11222 2666666


Q ss_pred             cCccCCCCCcccccCccceeeecCCCCcCCCCC-CCcccCCCCCCeeeccCCccC
Q 041034          286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF-PTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       286 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      ++|.++..  ..+.++.+|+.||+++|-|.+-- -..++.+..|+.|+|.+|.+-
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            66665521  23445555666666666554311 112344455555555555553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.62  E-value=1e-08  Score=115.12  Aligned_cols=218  Identities=19%  Similarity=0.221  Sum_probs=151.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...+.+.+.+-+.+|+++.++.+.-. .|...+.|.......-.....+....+-.++-..++|.++...-.+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            44567778888889999999988443 34334444333221111111233334444444455677776655555566789


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +|++|+.+++|...++...   ..+..-.......+..+.+|||..   .+.|+|++|.|+++..++..++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999999888654   244444555677788999999987   7999999999999999999999999844322


Q ss_pred             ccC---------------------C----------CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          606 HVD---------------------S----------SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       606 ~~~---------------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..-                     .          .......+|+.|.|||...+......+  |+|++|+++++-+.+.
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a--d~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA--DWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc--hhhhhhhhhhhhhcCC
Confidence            100                     0          012234689999999999988777776  9999999999998887


Q ss_pred             C-CCCCCHHHHHHHhhcCC
Q 041034          655 P-KSRPTMQRISQELEGKT  672 (701)
Q Consensus       655 P-~~Rpt~~~i~~~l~~~~  672 (701)
                      | .+-++-+++.+.+-...
T Consensus      1033 pp~na~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRD 1051 (1205)
T ss_pred             CCCCCcchhhhhhccccCC
Confidence            5 45678888877665444

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=6.1e-07  Score=86.47  Aligned_cols=157  Identities=24%  Similarity=0.273  Sum_probs=105.2

Q ss_pred             cccHHHHHhhhcCCccceEEe---eccceEEEEEEcCCCcEEEEEEecCCCccChH---------------------HHH
Q 041034          439 KILYEDLINATEDFHIRYCIG---TGGYGSVYKAELPDGKVVALKKLHQSETEDSA---------------------FVE  494 (701)
Q Consensus       439 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~  494 (701)
                      +.+++.+....++..+.+..|   .|.-+.||+|...++..||||+++.....-..                     ...
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            445666777777777766555   56667999998778999999998754322111                     011


Q ss_pred             HHHHHHHHHhcCC--CCceeeeeeeeeeCcEEEEEEEccCCCC-HHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcC
Q 041034          495 SFQNEARVLSTVR--HRNIVKLYGFCLHKRCMFFIYEYMERGS-LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD  571 (701)
Q Consensus       495 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  571 (701)
                      ...+|..-|.++.  +-.+++.+++.    .-.+||||+.... -.-.|+..    .+.......+..++++.+.-|-..
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHh
Confidence            2345666666663  44455555543    2469999995531 11111111    223335677888889998888773


Q ss_pred             CCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       572 ~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      +  ++||+||+.-|||+. ++.+.|+|||-|....
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            2  999999999999998 8899999999887553

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=7.7e-07  Score=87.77  Aligned_cols=138  Identities=16%  Similarity=0.185  Sum_probs=86.0

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCC--ceeeeeeeeeeCcEEEEEEEccCC
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR--NIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      ..||+|..+.||+.   .+..+++|.......     .....+|.++++.+..-  .+++.+++....+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            67899999999984   255688898865332     24568899999888643  357788888777888899999999


Q ss_pred             CC-HHHHH---------------------hcCCCccCCCHHHHH-HHHH----------HHHH-HHHHHhcC-CCCCeEe
Q 041034          534 GS-LFYVL---------------------RDDDEAIELNWTRRV-NIVK----------SVAH-ALSYLHHD-CTPSIVH  578 (701)
Q Consensus       534 gs-L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------qi~~-~L~~LH~~-~~~givH  578 (701)
                      .+ +...+                     +..... ........ .+..          .+.. ...+|... ..+.++|
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            63 21111                     111000 11111100 0000          0111 11222211 1335789


Q ss_pred             cCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          579 RDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       579 ~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999887 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.55  E-value=1.1e-08  Score=99.10  Aligned_cols=191  Identities=26%  Similarity=0.324  Sum_probs=132.0

Q ss_pred             CCCCCCcEEECCCCccee--eCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCc-cccCCccc
Q 041034           59 SCFPNLQYLNLWNNNLSG--SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTP-IEIGSLRN  135 (701)
Q Consensus        59 ~~~~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~  135 (701)
                      +...+++.|||.+|.|+.  .+-..+.++|+|++|+|+.|++...+...-..+.+|++|-|.+..+.-... ..+..+|.
T Consensus        68 ~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~  147 (418)
T KOG2982|consen   68 SSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPK  147 (418)
T ss_pred             HHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchh
Confidence            345789999999999984  455567899999999999999985543222567899999999998864433 45678999


Q ss_pred             cceeecccccCCCCCcccccCCCCCcEEEceecccCCCcC--cccccccccceeEeeecccCCCCCCCCCCccccCcccc
Q 041034          136 LEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP--STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSI  213 (701)
Q Consensus       136 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (701)
                      +++|.++.|.+.              .+.+..|.+...-|  ..+..++.+..++++-|++...+       +++..+.+
T Consensus       148 vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~F-------pnv~sv~v  206 (418)
T KOG2982|consen  148 VTELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIF-------PNVNSVFV  206 (418)
T ss_pred             hhhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhc-------ccchheee
Confidence            999999999654              22333343332221  12334556677777777776543       35566667


Q ss_pred             ccccccCCc-cccccCCCcccEEEeccCCCCCCC-CcccCCCCcccEEEcCCCCCcccc
Q 041034          214 ITNKLTGAI-PSTLGHLTSLLYLDLSFNQLHSFI-PLEIGNFSALAELDLSDNKIRGII  270 (701)
Q Consensus       214 ~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~~~~L~~L~L~~N~l~~~~  270 (701)
                      ..|.+...- ...+..++.+..|+|+.|+|...- -..+..+++|..|.+++|.+...+
T Consensus       207 ~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l  265 (418)
T KOG2982|consen  207 CEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPL  265 (418)
T ss_pred             ecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccc
Confidence            777665322 234455677778888888887632 235778899999999999887544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	701
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-30
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-30
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-27
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-27
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-17
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-11
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-11
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		7e-11
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		2e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-11
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		8e-11
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		4e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-10
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		3e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-09
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		2e-09
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		2e-09
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		3e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-08
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		9e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-06
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		1e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-06
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		4e-06
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		4e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-06
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		5e-06
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		1e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
2ft3_A	332	Crystal Structure Of The Biglycan Dimer Core Protei		3e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-05
4fho_A	231	Crystal Structure Of An Internalin C2 (Inlc2) From		7e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-04
4aw4_A	311	Engineered Variant Of Listeria Monocytogenes Inlb I		1e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		3e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		8e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		3e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-04
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		4e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-04
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		4e-04
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		4e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-04
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		7e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 125/401 (31%), Positives = 173/401 (43%), Gaps = 81/401 (20%)
Query: 75  SGSIPPQIGSLS-NLKYLNLRWNNLTGTI-PKEIGSLRN-LEVLYLSNNSLHGTTPIEIG 131
           SG +P  + +LS +L  L+L  NN +G I P    + +N L+ LYL NN   G  P  + 
Sbjct: 353 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 412
Query: 132 SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGC 191
           +   L  L+L  N LSG +P  +G+L  L  L +  N + G IP  L  +  LE L L  
Sbjct: 413 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 472
Query: 192 NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG 251
           N   G IP  + N  NL  +S+  N+LTG IP  +G L +L  L LS N     IP E+G
Sbjct: 473 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 532
Query: 252 NFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIP--FAIGKLFNLVSLDL 309
           +  +L  LDL+ N   G IP                    G+I   F  GK +  +  D 
Sbjct: 533 DCRSLIWLDLNTNLFNGTIP-------------AAMFKQSGKIAANFIAGKRYVYIKNDG 579
Query: 310 SK--------------------NKLSGSFPTGI-------------GNCTELQHLALNHN 336
            K                    N+LS   P  I              N   +  L +++N
Sbjct: 580 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 639
Query: 337 SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTY--- 389
            L G IP EIG +  L  L+L HN++SG+IP  +  +     LD+S N L+G IP     
Sbjct: 640 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 699
Query: 390 --------LRDN---------------PPNSFVGNKGLCGH 407
                   L +N               PP  F+ N GLCG+
Sbjct: 700 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 740

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 125/401 (31%), Positives = 173/401 (43%), Gaps = 81/401 (20%)
Query: 75  SGSIPPQIGSLS-NLKYLNLRWNNLTGTI-PKEIGSLRN-LEVLYLSNNSLHGTTPIEIG 131
           SG +P  + +LS +L  L+L  NN +G I P    + +N L+ LYL NN   G  P  + 
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 132 SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGC 191
           +   L  L+L  N LSG +P  +G+L  L  L +  N + G IP  L  +  LE L L  
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 192 NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG 251
           N   G IP  + N  NL  +S+  N+LTG IP  +G L +L  L LS N     IP E+G
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 252 NFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIP--FAIGKLFNLVSLDL 309
           +  +L  LDL+ N   G IP                    G+I   F  GK +  +  D 
Sbjct: 536 DCRSLIWLDLNTNLFNGTIP-------------AAMFKQSGKIAANFIAGKRYVYIKNDG 582
Query: 310 SK--------------------NKLSGSFPTGI-------------GNCTELQHLALNHN 336
            K                    N+LS   P  I              N   +  L +++N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 337 SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTY--- 389
            L G IP EIG +  L  L+L HN++SG+IP  +  +     LD+S N L+G IP     
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
Query: 390 --------LRDN---------------PPNSFVGNKGLCGH 407
                   L +N               PP  F+ N GLCG+
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/188 (36%), Positives = 99/188 (52%), Gaps = 12/188 (6%)
Query: 444 DLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           +L  A+++F  +  +G GG+G VYK  L DG +VA+K+L +  T+       FQ E  ++
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL--QFQTEVEMI 81
Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE-LNWTRRVNIVKSVA 562
           S   HRN+++L GFC+       +Y YM  GS+   LR+  E+   L+W +R  I    A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLL-----HVDSSNRTLRAG 617
             L+YLH  C P I+HRD            EA V DFG A+L+     HV  + R    G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR----G 197
Query: 618 TYGYIAPD 625
             G+IAP+
Sbjct: 198 XIGHIAPE 205

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/188 (36%), Positives = 99/188 (52%), Gaps = 12/188 (6%)
Query: 444 DLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           +L  A+++F  +  +G GG+G VYK  L DG +VA+K+L +   +       FQ E  ++
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMI 89
Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE-LNWTRRVNIVKSVA 562
           S   HRN+++L GFC+       +Y YM  GS+   LR+  E+   L+W +R  I    A
Sbjct: 90  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLL-----HVDSSNRTLRAG 617
             L+YLH  C P I+HRD            EA V DFG A+L+     HV  + R    G
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR----G 205
Query: 618 TYGYIAPD 625
           T G+IAP+
Sbjct: 206 TIGHIAPE 213

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 117/245 (47%), Gaps = 16/245 (6%)
Query: 173 PIPSTLFRLTNLERLFLG-CNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
           PIPS+L  L  L  L++G  N   G IP  I  L  L +L I    ++GAIP  L  + +
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEX-XXXXXXXXXXXXXXXX 290
           L+ LD S+N L   +P  I +   L  +    N+I G IPD                   
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 291 XGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL 350
            G+IP     L NL  +DLS+N L G      G+    Q + L  NSL      ++GK+ 
Sbjct: 187 TGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF----DLGKVG 241
Query: 351 LLQN---LDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPT--YLRDNPPNSFVGN 401
           L +N   LDL +N + GT+P  L  +     L++SFNNL GEIP    L+    +++  N
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 402 KGLCG 406
           K LCG
Sbjct: 302 KCLCG 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 8/210 (3%)
Query: 426 SENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQS 485
           +ENL    G  DG    +D+     D +I+  IG G +G+V++AE   G  VA+K L + 
Sbjct: 18  TENLYF-QGAMDG----DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQ 71
Query: 486 ETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE 545
           +   +  V  F  E  ++  +RH NIV   G       +  + EY+ RGSL+ +L     
Sbjct: 72  DFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 546 AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLL 605
             +L+  RR+++   VA  ++YLH+   P IVHRD               V DFG +RL 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQK 635
                     AGT  ++AP+     P N+K
Sbjct: 190 ASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 444 DLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           DL  AT +F  ++ IG G +G VYK  L DG  VALK+      E S  +E F+ E   L
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEEFETEIETL 89
Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVA 562
           S  RH ++V L GFC  +  M  IY+YME G+L   L   D   + ++W +R+ I    A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL-LHVDSSN-RTLRAGTYG 620
             L YLH   T +I+HRD               + DFG ++    +D ++   +  GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 621 YIAPDQRLSPPVNQK 635
           YI P+  +   + +K
Sbjct: 207 YIDPEYFIKGRLTEK 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 8/210 (3%)
Query: 426 SENLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQS 485
           +ENL    G  DG    +D+     D +I+  IG G +G+V++AE   G  VA+K L + 
Sbjct: 18  TENLYF-QGAMDG----DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQ 71
Query: 486 ETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE 545
           +   +  V  F  E  ++  +RH NIV   G       +  + EY+ RGSL+ +L     
Sbjct: 72  DFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 546 AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLL 605
             +L+  RR+++   VA  ++YLH+   P IVHR+               V DFG +RL 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQK 635
                +    AGT  ++AP+     P N+K
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY  RG ++  L+   +  + +  R    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 181

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 148
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 202

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 444 DLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           DL  AT +F  ++ IG G +G VYK  L DG  VALK+      E S  +E F+ E   L
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEEFETEIETL 89
Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVA 562
           S  RH ++V L GFC  +  M  IY+YME G+L   L   D   + ++W +R+ I    A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL-LHVDSSN-RTLRAGTYG 620
             L YLH   T +I+HRD               + DFG ++    +  ++   +  GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 621 YIAPDQRLSPPVNQK 635
           YI P+  +   + +K
Sbjct: 207 YIDPEYFIKGRLTEK 221

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 139
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 193

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 176

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPE 176

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 126
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 180

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 181

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 179

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 121
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 175

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +   H  SS RT  +GT  Y+ P+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPE 177

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 179

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 181

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPE 176

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY  RG ++  L+   +  + +  R    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPE 181

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPE 176

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPE 177

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 119
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 173

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPE 181

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPE 176

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPE 176

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPE 179

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +A+FG +  +H  SS RT   GT  Y+ P+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPE 179

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 124
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPE 178

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPE 176

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPE 176

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 124
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +A+FG +  +H  SS RT   GT  Y+ P+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPE 178

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPE 177

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPE 179

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 148
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPE 202

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           RH NI++LYG+      ++ I EY   G+++   R+  +  + +  R    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPE 179

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 9/177 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++LYG+      ++ I EY   G+++   R+  +    +  R    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSRFDEQRTATYITELANALSYC 128
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD            E  +ADFG +  +H  SS RT   GT  Y+ P+
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPE 180

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 9/177 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   +G G +G+VY A     K ++ALK L +++ E +      + E  + S +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++LYG+      ++ I EY   G+++   R+  +    +  R    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSRFDEQRTATYITELANALSYC 128
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD            E  +ADFG +  +H  SS R    GT  Y+ P+
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPE 180

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 9/177 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +G G +G+VY A E     +VALK L +S+ E        + E  + + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++LY +   +R ++ I EY  RG L+  L+   ++   +  R   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQ---KSCTFDEQRTATIMEELADALMYC 139
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H      ++HRD            E  +ADFG +  +H  S  R    GT  Y+ P+
Sbjct: 140 H---GKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPE 191

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG GG+G VY+A     +V      H  + + S  +E+ + EA++ + ++H NI+ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 518 CLHKRCMFFIYEYMERGSLFYVL--RDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           CL +  +  + E+   G L  VL  +     I +NW  +      +A  ++YLH +    
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIVP 128
Query: 576 IVHRDXXXXXXXXXXXXE--------AFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I+HRD            E          + DFG AR  H   + +   AG Y ++AP+
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPE 184

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 9/177 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +G G +G+VY A     K ++ALK L +S+ E        + E  + S +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI+++Y +   ++ ++ + E+  RG L+  L+      E    R    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 131
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H      ++HRD            E  +ADFG +  +H  S  R    GT  Y+ P+
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPE 183

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 9/177 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +G G +G+VY A     K ++ALK L +S+ E        + E  + S +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI+++Y +   ++ ++ + E+  RG L+  L+      E    R    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 130
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H      ++HRD            E  +ADFG +  +H  S  R    GT  Y+ P+
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPE 182

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   +G G +G V KA+    K VA+K++ +SE+E  AF+     E R LS V H 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFI----VELRQLSRVNHP 62
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKLYG CL+  C+  + EY E GSL+ VL   +          ++     +  ++YLH
Sbjct: 63  NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAF-VADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                +++HRD                + DFGTA  +    +N     G+  ++AP+
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPE 174

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   +G G +G V KA+    K VA+K++ +SE+E  AF+     E R LS V H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFI----VELRQLSRVNHP 61
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKLYG CL+  C+  + EY E GSL+ VL   +          ++     +  ++YLH
Sbjct: 62  NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAF-VADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                +++HRD                + DFGTA  +    +N     G+  ++AP+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPE 173

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 91/178 (51%), Gaps = 18/178 (10%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKL----HQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           IG GG+G V+K  L  D  VVA+K L     + ETE     + FQ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           KLYG   +   M  + E++  G L++ L   D+A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 573 TPSIVHRDXXXXXXXXXXXXE-----AFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            P IVHRD            E     A VADFGT++   V S +  L  G + ++AP+
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-QSVHSVSGLL--GNFQWMAPE 196

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 11/192 (5%)
Query: 442 YEDLINATEDFHIRYC------IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVES 495
           + +L N T +F  R        +G GG+G VYK  + +  V   K     +       + 
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 76
Query: 496 FQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           F  E +V++  +H N+V+L GF      +  +Y YM  GSL   L   D    L+W  R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH--VDSSNRT 613
            I +  A+ +++LH +     +HRD             A ++DFG AR       +   +
Sbjct: 137 KIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 614 LRAGTYGYIAPD 625
              GT  Y+AP+
Sbjct: 194 RIVGTTAYMAPE 205

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 90/178 (50%), Gaps = 18/178 (10%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKL----HQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           IG GG+G V+K  L  D  VVA+K L     + ETE     + FQ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           KLYG   +   M  + E++  G L++ L   D+A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 573 TPSIVHRDXXXXXXXXXXXXE-----AFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            P IVHRD            E     A VADFG ++   V S +  L  G + ++AP+
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLL--GNFQWMAPE 196

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 11/192 (5%)
Query: 442 YEDLINATEDFHIRYC------IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVES 495
           + +L N T +F  R        +G GG+G VYK  + +  V   K     +       + 
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 76
Query: 496 FQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           F  E +V++  +H N+V+L GF      +  +Y YM  GSL   L   D    L+W  R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH--VDSSNRT 613
            I +  A+ +++LH +     +HRD             A ++DFG AR       +    
Sbjct: 137 KIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 614 LRAGTYGYIAPD 625
              GT  Y+AP+
Sbjct: 194 RIVGTTAYMAPE 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 12/171 (7%)
Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G   K    + G+V+ +K+L + + E      +F  E +V+  + H N++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIG 74
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
                + + FI EY++ G+L  +++  D   +  W++RV+  K +A  ++YLH   + +I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
           +HRD               VADFG ARL+ VD   +T   G      PD++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLM-VDE--KTQPEGLRSLKKPDRK 177

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 11/192 (5%)
Query: 442 YEDLINATEDFHIRYC------IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVES 495
           + +L N T +F  R        +G GG+G VYK  + +  V   K     +       + 
Sbjct: 11  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 70
Query: 496 FQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           F  E +V++  +H N+V+L GF      +  +Y YM  GSL   L   D    L+W  R 
Sbjct: 71  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 130
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
            I +  A+ +++LH +     +HRD             A ++DFG AR     +      
Sbjct: 131 KIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 616 --AGTYGYIAPD 625
              GT  Y+AP+
Sbjct: 188 RIVGTTAYMAPE 199

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G YG VYKA+   G++VALK++ + + ED     +   E  +L  + H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR--RVNIVKSVAHALSYLHHDCTPS 575
              +RC+  ++E+ME+  L  VL ++   ++ +  +     +++ VAH   +        
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------R 139
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I+HRD               +ADFG AR   +   + T    T  Y APD
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G YG VYKA+   G++VALK++ + + ED     +   E  +L  + H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR--RVNIVKSVAHALSYLHHDCTPS 575
              +RC+  ++E+ME+  L  VL ++   ++ +  +     +++ VAH   +        
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------R 139
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           I+HRD               +ADFG AR   +   + T    T  Y APD
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 18/178 (10%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKL----HQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           IG GG+G V+K  L  D  VVA+K L     + ETE     + FQ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           KLYG   +   M  + E++  G L++ L   D+A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 573 TPSIVHRDXXXXXXXXXXXXE-----AFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            P IVHRD            E     A VADF  ++   V S +  L  G + ++AP+
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-QSVHSVSGLL--GNFQWMAPE 196

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 131/282 (46%), Gaps = 44/282 (15%)
Query: 82  IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL 141
           + +L+NL  L L  N +T   P  + +L NL  L LS+N++   +   +  L +L++L  
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSF 158
Query: 142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPRE 201
            SN+++ + P  + NL +L  L +  N V     S L +LTNLE L    NQ +   P  
Sbjct: 159 SSNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 212
Query: 202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           +G L NL  LS+  N+L      TL  LT+L  LDL+ NQ+ +  PL     + L EL L
Sbjct: 213 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKL 268
Query: 262 SDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG 321
             N+I  I P                          +  L  L +L+L++N+L    P  
Sbjct: 269 GANQISNISP--------------------------LAGLTALTNLELNENQLEDISP-- 300
Query: 322 IGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           I N   L +L L  N++    P  +  +  LQ L  S+N +S
Sbjct: 301 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKVS 340

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 70
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 129
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
                + +HRD               VADFG +RL+  D+   T  AG 
Sbjct: 130 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGA 173

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
                + +HRD               VADFG +RL+  D+   T  AG 
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGA 177

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 70
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 129
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 130 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 9/177 (5%)
Query: 434 GGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAF 492
           G  D    Y+       D  +++ +G G YG VY+       + VA+K L     ED+  
Sbjct: 1   GAMDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTME 56
Query: 493 VESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWT 552
           VE F  EA V+  ++H N+V+L G C  +   + I E+M  G+L   LR+ +   E+N  
Sbjct: 57  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAV 115
Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
             + +   ++ A+ YL      + +HRD               VADFG +RL+  D+
Sbjct: 116 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 71
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 82
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 141
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 142 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 178

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 71
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 71
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 11/178 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+ + E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERG--SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           NIVKLY     K+ +  ++E++++    L  V     E++        + +  + + ++Y
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAY 115
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            H      ++HRD            E  +ADFG AR   +     T    T  Y APD
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 11/178 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+ + E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERG--SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           NIVKLY     K+ +  ++E++++    L  V     E++        + +  + + ++Y
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAY 115
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            H      ++HRD            E  +ADFG AR   +     T    T  Y APD
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLH---QSETEDSAFVESFQNEARVLS 504
            ED+ + Y IGTG YG   K     DGK++  K+L     +E E    V    +E  +L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV----SEVNLLR 60
Query: 505 TVRHRNIVKLYGFCLHKR--CMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVK 559
            ++H NIV+ Y   + +    ++ + EY E G L  V+     + + ++  +  RV    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTY 619
           ++A    +   D   +++HRD               + DFG AR+L+ D+S      GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 620 GYIAPDQRLSPPVNQK 635
            Y++P+Q      N+K
Sbjct: 181 YYMSPEQMNRMSYNEK 196

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLH---QSETEDSAFVESFQNEARVLS 504
            ED+ + Y IGTG YG   K     DGK++  K+L     +E E    V    +E  +L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV----SEVNLLR 60
Query: 505 TVRHRNIVKLYGFCLHKR--CMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVK 559
            ++H NIV+ Y   + +    ++ + EY E G L  V+     + + ++  +  RV    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTY 619
           ++A    +   D   +++HRD               + DFG AR+L+ D+S      GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 180
Query: 620 GYIAPDQRLSPPVNQK 635
            Y++P+Q      N+K
Sbjct: 181 YYMSPEQMNRMSYNEK 196

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 11/178 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+ + E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERG--SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           NIVKLY     K+ +  ++E++++    L  V     E++        + +  + + ++Y
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAY 115
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            H      ++HRD            E  +ADFG AR   +     T    T  Y APD
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 98/190 (51%), Gaps = 14/190 (7%)
Query: 82  IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL 141
           + +L+NL  L L  N +T   P  + +L NL  L LS+N++   +   +  L +L++L  
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSF 158
Query: 142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPRE 201
            SN+++ + P  + NL +L  L +  N V     S L +LTNLE L    NQ +   P  
Sbjct: 159 SSNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 212
Query: 202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           +G L NL  LS+  N+L      TL  LT+L  LDL+ NQ+ +  PL     + L EL L
Sbjct: 213 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKL 268
Query: 262 SDNKIRGIIP 271
             N+I  I P
Sbjct: 269 GANQISNISP 278

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 22/281 (7%)
Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           L NL  +  SNN L   TP++  +L  L ++ + +N+++ + P  + NL +L  L++  N
Sbjct: 62  LNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGH 228
            +    P  L  LTNL RL L  N  +      +  L +L  LS  +N++T   P  L +
Sbjct: 118 QITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP--LAN 171
Query: 229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXX 288
           LT+L  LD+S N++     L     + L  L  ++N+I  I P                 
Sbjct: 172 LTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQL 229
Query: 289 XXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGK 348
              G     +  L NL  LDL+ N++S   P  +   T+L  L L  N +    P  +  
Sbjct: 230 KDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 281
Query: 349 ILLLQNLDLSHNNLSGTIPMT--LHPMFLDMSFNNLEGEIP 387
           +  L NL+L+ N L    P++   +  +L + FNN+    P
Sbjct: 282 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 322

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R +  D    ++     G   P  R SPP
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-----GSKFP-VRWSPP 190

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 315
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E+N    + +   ++ A+ YL 
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 374
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HR+               VADFG +RL+  D+
Sbjct: 375 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 411

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 126
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
                + +HRD               VADFG +RL+  D+   T  AG 
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGA 170

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 5/169 (2%)
Query: 459 GTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFC 518
           G GG+G VYK  + +  V   K     +       + F  E +V +  +H N+V+L GF 
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFS 90
Query: 519 LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVH 578
                +  +Y Y   GSL   L   D    L+W  R  I +  A+ +++LH +     +H
Sbjct: 91  SDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN---HHIH 147
Query: 579 RDXXXXXXXXXXXXEAFVADFGTARLLH--VDSSNRTLRAGTYGYIAPD 625
           RD             A ++DFG AR           +   GT  Y AP+
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE 196

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 98/190 (51%), Gaps = 14/190 (7%)
Query: 82  IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL 141
           + +L+NL  L L  N +T   P  + +L NL  L LS+N++   +   +  L +L++L  
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLNF 158
Query: 142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPRE 201
            SN+++ + P  + NL +L  L +  N V     S L +LTNLE L    NQ +   P  
Sbjct: 159 SSNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 212
Query: 202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           +G L NL  LS+  N+L      TL  LT+L  LDL+ NQ+ +  PL     + L EL L
Sbjct: 213 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKL 268
Query: 262 SDNKIRGIIP 271
             N+I  I P
Sbjct: 269 GANQISNISP 278

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 22/281 (7%)
Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           L NL  +  SNN L   TP++  +L  L ++ + +N+++ + P  + NL +L  L++  N
Sbjct: 62  LNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGH 228
            +    P  L  LTNL RL L  N  +      +  L +L  L+  +N++T   P  L +
Sbjct: 118 QITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LAN 171
Query: 229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXX 288
           LT+L  LD+S N++     L     + L  L  ++N+I  I P                 
Sbjct: 172 LTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQL 229
Query: 289 XXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGK 348
              G     +  L NL  LDL+ N++S   P  +   T+L  L L  N +    P  +  
Sbjct: 230 KDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 281
Query: 349 ILLLQNLDLSHNNLSGTIPMT--LHPMFLDMSFNNLEGEIP 387
           +  L NL+L+ N L    P++   +  +L + FNN+    P
Sbjct: 282 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 322

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R + +D    + R   +       R SPP
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPV-----RWSPP 175

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 6/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF +   +G G +  VY+AE +  G  VA+K + +     +  V+  QNE ++   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            +I++LY +      ++ + E    G +   L++  +    N  R  + +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYL 128
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  I+HRD               +ADFG A  L +         GT  YI+P+
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 126
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R +  D    ++     G   P  R SPP
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFP-VRWSPP 190

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R +  D    ++     G   P  R SPP
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFP-VRWSPP 175

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 457 CIGTGGYGSVYKAELP--DGKV---VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
            IG G +G VYK  L    GK    VA+K L    TE       F  EA ++    H NI
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNI 108
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
           ++L G     + M  I EYME G+L   LR+ D   E +  + V +++ +A  + YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL--- 163
Query: 572 CTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
              + VHRD               V+DFG +R+L  D
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 78
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 133
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R +  D    ++     G   P  R SPP
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFP-VRWSPP 181

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 71
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 126
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R +  D    ++     G   P  R SPP
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFP-VRWSPP 174

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K + +    +  F+E    EA+V+  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           C  +R +F I EYM  G L   LR+     +    + + + K V  A+ YL    +   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 122
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
           HRD               V+DFG +R +  D    ++     G   P  R SPP
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFP-VRWSPP 170

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 76/179 (42%), Gaps = 10/179 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED  +   IG G +G V+   L  D  +VA+K   ++   D      F  EAR+L    H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIV+L G C  K+ ++ + E ++ G     LR   E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR--LLHVDSSNRTLRAGTYGYIAPD 625
              C    +HRD               ++DFG +R     V +++  LR     + AP+
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE 285

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G +G VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 126
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
                + +HRD               VADFG +RL+  D+   T  AG 
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGA 170

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL 
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 335
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HR+               VADFG +RL+  D+
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 9/160 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           D  +++ +G G YG VY        + VA+K L     ED+  VE F  EA V+  ++H 
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 88
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V+L G C  +   + + EYM  G+L   LR+ +   E+     + +   ++ A+ YL 
Sbjct: 89  NLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAMEYLE 147
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS 609
                + +HRD               VADFG +RL+  D+
Sbjct: 148 KK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 77/141 (54%), Gaps = 15/141 (10%)
Query: 100 GTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKS 159
            ++P  I +  N ++LYL +N +    P    SL NL+ELYL SN+L G LP  +G   S
Sbjct: 32  ASVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALP--VGVFDS 86
Query: 160 LIWLSVM-----YNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSI 213
           L  L+V+       TV   +PS +F RL +L+ LF+ CN+    +PR I  L +LTHL++
Sbjct: 87  LTQLTVLDLGTNQLTV---LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 214 ITNKLTGAIPSTLGHLTSLLY 234
             N+L          L+SL +
Sbjct: 143 DQNQLKSIPHGAFDRLSSLTH 163

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 8/155 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED  +   IG G +G V+   L  D  +VA+K   ++   D      F  EAR+L    H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIV+L G C  K+ ++ + E ++ G     LR   E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
              C    +HRD               ++DFG +R
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLH---QSETEDSAFVESFQNEARVLS 504
            ED+ + Y IGTG YG   K     DGK++  K+L     +E E    V    +E  +L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV----SEVNLLR 60
Query: 505 TVRHRNIVKLYGFCLHKR--CMFFIYEYMERGSLFYVL-RDDDEAIELNWTRRVNIVKSV 561
            ++H NIV+ Y   + +    ++ + EY E G L  V+ +   E   L+    + ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 562 AHALSYLHH--DCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTY 619
             AL   H   D   +++HRD               + DFG AR+L+ D        GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTP 180
Query: 620 GYIAPDQRLSPPVNQK 635
            Y++P+Q      N+K
Sbjct: 181 YYMSPEQMNRMSYNEK 196

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G V+ AE        D  +VA+K L   +  D+A  + F  EA +L+ ++H +I
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNA-RKDFHREAELLTNLQHEHI 77
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR----------DDDEAIELNWTRRVNIVKSV 561
           VK YG C+    +  ++EYM+ G L   LR          + +   EL  ++ ++I + +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGY 621
           A  + YL    +   VHRD               + DFG +R ++   S    R G  G+
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY---STDYYRVG--GH 189
Query: 622 IAPDQRLSPP 631
                R  PP
Sbjct: 190 TMLPIRWMPP 199

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+     +   VA+K L        AF+E    EA ++ T++H  +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLVRLYAV 76
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              +  ++ I EYM +GSL   L+  DE  ++   + ++    +A  ++Y+      + +
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG AR+  ++ +  T R G 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGA 171

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 451 DFHIRYCIGTGGYGSVYKAE----LP--DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           D  +++ +G G +G V+ AE    LP  D  +VA+K L   E  +SA  + FQ EA +L+
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELLT 98
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR------------DDDEAIELNWT 552
            ++H++IV+ +G C   R +  ++EYM  G L   LR            +D     L   
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           + + +   VA  + YL        VHRD               + DFG +R
Sbjct: 159 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+     +   VA+K L        AF+E    EA ++ T++H  +V+LY  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLVRLYAV 75
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              +  ++ I E+M +GSL   L+  DE  ++   + ++    +A  ++Y+      + +
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG AR+  ++ +  T R G 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGA 170

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 451 DFHIRYCIGTGGYGSVYKAE----LP--DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           D  +++ +G G +G V+ AE    LP  D  +VA+K L   E  +SA  + FQ EA +L+
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELLT 69
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR------------DDDEAIELNWT 552
            ++H++IV+ +G C   R +  ++EYM  G L   LR            +D     L   
Sbjct: 70  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           + + +   VA  + YL        VHRD               + DFG +R
Sbjct: 130 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 451 DFHIRYCIGTGGYGSVYKAE----LP--DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           D  +++ +G G +G V+ AE    LP  D  +VA+K L   E  +SA  + FQ EA +L+
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELLT 75
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR------------DDDEAIELNWT 552
            ++H++IV+ +G C   R +  ++EYM  G L   LR            +D     L   
Sbjct: 76  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           + + +   VA  + YL        VHRD               + DFG +R
Sbjct: 136 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 27/283 (9%)
Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           L NL  +  SNN L   TP++  +L  L ++ + +N+++ + P  + NL +L  L++  N
Sbjct: 67  LNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122
Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT--NKLTGAIPSTL 226
            +    P  L  LTNL RL L  N        +I  L  LT L  ++  N++T   P  L
Sbjct: 123 QITDIDP--LKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKP--L 173
Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXX 286
            +LT+L  LD+S N++     L     + L  L  ++N+I  I P               
Sbjct: 174 ANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231
Query: 287 XXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
                G     +  L NL  LDL+ N++S   P  +   T+L  L L  N +    P  +
Sbjct: 232 QLKDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 283
Query: 347 GKILLLQNLDLSHNNLSGTIPMT--LHPMFLDMSFNNLEGEIP 387
             +  L NL+L+ N L    P++   +  +L + FNN+    P
Sbjct: 284 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 326

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 11/173 (6%)
Query: 454 IRYCIGTGGYGSVYKA--ELPDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           I   IG G +G V     +LP  +   VA+K L    TE       F +EA ++    H 
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 94
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N++ L G       +  I E+ME GSL   LR +D    +   + V +++ +A  + YL 
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 151
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
                + VHRD               V+DFG +R L  D+S+ T  +   G I
Sbjct: 152 --ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 202

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 27/283 (9%)
Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           L NL  +  SNN L   TP++  +L  L ++ + +N+++ + P  + NL +L  L++  N
Sbjct: 66  LNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 121
Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT--NKLTGAIPSTL 226
            +    P  L  LTNL RL L  N        +I  L  LT L  ++  N++T   P  L
Sbjct: 122 QITDIDP--LKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKP--L 172
Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXX 286
            +LT+L  LD+S N++     L     + L  L  ++N+I  I P               
Sbjct: 173 ANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 230
Query: 287 XXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
                G     +  L NL  LDL+ N++S   P  +   T+L  L L  N +    P  +
Sbjct: 231 QLKDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 282
Query: 347 GKILLLQNLDLSHNNLSGTIPMT--LHPMFLDMSFNNLEGEIP 387
             +  L NL+L+ N L    P++   +  +L + FNN+    P
Sbjct: 283 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 325

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 45/282 (15%)
Query: 82  IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL 141
           + +L+NL  L L  N +T   P  + +L NL  L LS+N++   +   +  L +L++L  
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLNF 158
Query: 142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPRE 201
             N+++ + P  + NL +L  L +  N V     S L +LTNLE L    NQ +   P  
Sbjct: 159 -GNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 211
Query: 202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           +G L NL  LS+  N+L      TL  LT+L  LDL+ NQ+ +  PL     + L EL L
Sbjct: 212 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKL 267
Query: 262 SDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG 321
             N+I  I P                          +  L  L +L+L++N+L    P  
Sbjct: 268 GANQISNISP--------------------------LAGLTALTNLELNENQLEDISP-- 299
Query: 322 IGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           I N   L +L L  N++    P  +  +  LQ L  S+N +S
Sbjct: 300 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKVS 339

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 126/283 (44%), Gaps = 27/283 (9%)
Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           L NL  +  SNN L   TP++  +L  L ++ + +N+++ + P  + NL +L  L++  N
Sbjct: 62  LNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT--NKLTGAIPSTL 226
            +    P  L  LTNL RL L  N        +I  L  LT L  +   N++T   P  L
Sbjct: 118 QITDIDP--LKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLNFGNQVTDLKP--L 168
Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXX 286
            +LT+L  LD+S N++     L     + L  L  ++N+I  I P               
Sbjct: 169 ANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 226
Query: 287 XXXXXGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
                G     +  L NL  LDL+ N++S   P  +   T+L  L L  N +    P  +
Sbjct: 227 QLKDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 278
Query: 347 GKILLLQNLDLSHNNLSGTIPMT--LHPMFLDMSFNNLEGEIP 387
             +  L NL+L+ N L    P++   +  +L + FNN+    P
Sbjct: 279 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 321

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 84
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 85  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 140
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 179

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 83
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 84  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 139
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 178

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 14/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        +F+E    EA+++  ++H  +V+LY  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQLYA- 71
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ + EYM +GSL   L+ D E   L     V++   VA  ++Y+      + +
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 127
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQRL 628
           HRD               +ADFG ARL  ++ +  T R G      + AP+  L
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARL--IEDNEXTARQGAKFPIKWTAPEAAL 179

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 81
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 176

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+ A       VA+K +       S  VE+F  EA V+ T++H 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHD 70
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +VKL+   + K  ++ I E+M +GSL   L+  DE  +    + ++    +A  ++++ 
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
                + +HRD               +ADFG AR+  ++ +  T R G 
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGA 172

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG V+K    D G++VA+KK  +SE +D    +    E R+L  ++H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA----HALSYLH-HD 571
               KR +  ++EY +   L  + R      E       ++VKS+      A+++ H H+
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE-------HLVKSITWQTLQAVNFCHKHN 122
Query: 572 CTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP-----DQ 626
           C    +HRD               + DFG ARLL   S        T  Y +P     D 
Sbjct: 123 C----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 627 RLSPPVN 633
           +  PPV+
Sbjct: 179 QYGPPVD 185

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            I   IG G +G V +  L  P  K   VA+K L    TE       F +EA ++    H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEH 74
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++L G   +   +  + E+ME G+L   LR +D    +   + V +++ +A  + YL
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL 132
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
                 S VHRD               V+DFG +R L  +SS+ T  +   G I
Sbjct: 133 AE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 170

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG AR+L  D  +  T R G
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 77
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 78  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 133
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 172

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 85
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 86  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 141
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGA 180

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 81
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGA 176

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 170

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 80
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 81  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 136
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGA 175

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 66
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 67  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 124
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 125 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 179
Query: 627 RL 628
            L
Sbjct: 180 AL 181

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 76
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 77  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 132
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGA 171

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 11/173 (6%)
Query: 454 IRYCIGTGGYGSVYKAEL--PDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           I   IG G +G V +  L  P  K   VA+K L    TE       F +EA ++    H 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHP 77
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NI++L G   +   +  + E+ME G+L   LR +D   +    + V +++ +A  + YL 
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYL- 134
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
                S VHRD               V+DFG +R L  +SS+ T  +   G I
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 85/193 (44%), Gaps = 20/193 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +GTG +G V+      +G+  A+K L +        VE   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS-----VAH 563
             I++++G     + +F I +Y+E G LF +LR           R  N V       V  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCL 117
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
           AL YLH   +  I++RD               + DFG A+  +V      L  GT  YIA
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYXL-CGTPDYIA 171
Query: 624 PDQRLSPPVNQKI 636
           P+   + P N+ I
Sbjct: 172 PEVVSTKPYNKSI 184

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKIRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGA 170

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 90/216 (41%), Gaps = 12/216 (5%)
Query: 441 LYEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNE 499
           LY   ++  E F     IG G +G V+K  +    KVVA+K +   E      +E  Q E
Sbjct: 18  LYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQE 75
Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
             VLS      + K YG  L    ++ I EY+  GS   +L    E   L+ T+   I++
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILR 131
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTY 619
            +   L YLH +     +HRD            E  +ADFG A  L      R    GT 
Sbjct: 132 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 188
Query: 620 GYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP 655
            ++AP+       + K   DI  +  TA+   R +P
Sbjct: 189 FWMAPEVIKQSAYDSK--ADIWSLGITAIELARGEP 222

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 70
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 71  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 126
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGA 165

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+ A       VA+K +       S  VE+F  EA V+ T++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHD 243
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +VKL+   + K  ++ I E+M +GSL   L+  DE  +    + ++    +A  ++++ 
Sbjct: 244 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
                + +HRD               +ADFG AR+  ++ +  T R G 
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGA 345

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 49/278 (17%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVL-------STVRHR 509
           +G G YG V K   +P G+++A+K++        A V S Q + R+L        TV   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIR-------ATVNS-QEQKRLLMDLDISMRTVDCP 110
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERG--SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
             V  YG    +  ++   E M+      +  + D  + I  +   ++ +  S+  AL +
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEH 168
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
           LH     S++HRD            +  + DFG +  L VDS  +T+ AG   Y+AP +R
Sbjct: 169 LHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAP-ER 224
Query: 628 LSPPVNQK---IIQDI--ILVSTTALACLRSKPKSRPT-MQRISQELEGKTP-------- 673
           ++P +NQK   +  DI  + ++   LA LR    S  T  Q++ Q +E  +P        
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 284
Query: 674 ----------MKKGLKE-ISISEMRNQEMFWLHESDNT 700
                     +KK  KE  +  E+     F LHES  T
Sbjct: 285 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 322

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 82
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 157 ASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEWTARQGAKFPIKWTAPEA 183
Query: 627 RL 628
            L
Sbjct: 184 AL 185

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 30  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 86
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 144
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 145 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 322
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 323 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 380
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTY---GYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 435
Query: 627 RL 628
            L
Sbjct: 436 AL 437

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 21/190 (11%)
Query: 442 YEDLINATEDF---------HIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F  EA ++    H NI++L G     + +  + EYME GSL   LR  D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           +   + V +++ +A  + YL        VHRD               V+DFG +R+L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 609 -SSNRTLRAG 617
             +  T R G
Sbjct: 201 PEAAYTTRGG 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 82
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 192

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 18/188 (9%)
Query: 438 GKILYEDLINAT-EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETED 489
           G + +ED      E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E 
Sbjct: 1   GAMAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE- 59
Query: 490 SAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAI 547
              +  F+ E  +L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I
Sbjct: 60  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHV 607
             +  + +     +   + YL    T   +HRD               + DFG  ++L  
Sbjct: 118 --DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 608 DSSNRTLR 615
           D     ++
Sbjct: 173 DKEXXKVK 180

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 30/201 (14%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
            D  ++  +G G +G V+ AE        D  +VA+K L        A  + FQ EA +L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELL 71
Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD--DEAI-----------ELN 550
           + ++H +IVK YG C     +  ++EYM+ G L   LR    D  I           EL 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            ++ ++I   +A  + YL    +   VHRD               + DFG +R ++   S
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY---S 185
Query: 611 NRTLRAGTYGYIAPDQRLSPP 631
               R G  G+     R  PP
Sbjct: 186 TDYYRVG--GHTMLPIRWMPP 204

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 64
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 21/190 (11%)
Query: 442 YEDLINATEDF---------HIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F  EA ++    H NI++L G     + +  + EYME GSL   LR  D    
Sbjct: 86  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           +   + V +++ +A  + YL        VHRD               V+DFG +R+L  D
Sbjct: 144 V--IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198
Query: 609 -SSNRTLRAG 617
             +  T R G
Sbjct: 199 PEAAYTTRGG 208

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 352
Query: 627 RL 628
            L
Sbjct: 353 AL 354

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 95
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 153
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 154 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 205

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 21/190 (11%)
Query: 442 YEDLINATEDF---------HIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F  EA ++    H NI++L G     + +  + EYME GSL   LR  D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           +   + V +++ +A  + YL        VHRD               V+DFG +R+L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 609 -SSNRTLRAG 617
             +  T R G
Sbjct: 201 PEAAYTTRGG 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 183
Query: 627 RL 628
            L
Sbjct: 184 AL 185

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 62
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 63  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 120
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 121 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 175
Query: 627 RL 628
            L
Sbjct: 176 AL 177

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 6   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 62
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 120
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 121 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 172

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 69
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 127
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 352
Query: 627 RL 628
            L
Sbjct: 353 AL 354

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 64
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 67
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 125
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 64
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 122
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 123 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 177
Query: 627 RL 628
            L
Sbjct: 178 AL 179

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 7   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 63
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 121
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 122 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 173

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 13  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 69
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 127
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 128 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 179

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 15  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 71
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 129
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 130 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 181

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G  G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HRD               +ADFG ARL  ++ +  T R G 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDAEXTAREGA 170

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 12  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 68
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 126
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 127 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 178

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 63
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  +  + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 64  KLVQLYAV-VSEEPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 121
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 122 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEA 176
Query: 627 RL 628
            L
Sbjct: 177 AL 178

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 352
Query: 627 RL 628
            L
Sbjct: 353 AL 354

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + EYME GSL   LR  D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG  R+L  D  +  T R G
Sbjct: 157 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 17/170 (10%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 64
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
           +   + YL    T   +HRD               + DFG  ++L  D  
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 95/258 (36%), Gaps = 61/258 (23%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H  +V+LYG 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 73
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           CL +  +  ++E+ME G L   LR             + +   V   ++YL   C   ++
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 128
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPV----- 632
           HRD               V+DFG  R +  D         + G   P +  SP V     
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-----SSTGTKFPVKWASPEVFSFSR 183
Query: 633 -----------------------------NQKIIQDII---------LVSTTALA----C 650
                                        N ++++DI          L ST        C
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 243
Query: 651 LRSKPKSRPTMQRISQEL 668
            R +P+ RP   R+ ++L
Sbjct: 244 WRERPEDRPAFSRLLRQL 261

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 457 CIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           C+G G YG V++     G+ VA+ K+  S  E S F E+   E      +RH NI+    
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAV-KIFSSRDEKSWFRET---ELYNTVMLRHENILGFIA 98
Query: 517 FCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
             +  R     ++ I  Y E GSL+  L    +   L+    + IV S+A  L++LH + 
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 573 -----TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNR-----TLRAGTYGYI 622
                 P+I HRD            +  +AD G A ++H  S+N+       R GT  Y+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 623 APD 625
           AP+
Sbjct: 214 APE 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 85/192 (44%), Gaps = 24/192 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
              D  +  C+G G YG V++     G+ VA+ K+  S  E S F E+   E      +R
Sbjct: 6   VARDITLLECVGKGRYGEVWRGSW-QGENVAV-KIFSSRDEKSWFRET---ELYNTVMLR 60
Query: 508 HRNIVKLYGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           H NI+      +  R     ++ I  Y E GSL+  L    +   L+    + IV S+A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIAS 116
Query: 564 ALSYLHHDC-----TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNR-----T 613
            L++LH +       P+I HRD            +  +AD G A ++H  S+N+      
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNN 175
Query: 614 LRAGTYGYIAPD 625
            R GT  Y+AP+
Sbjct: 176 PRVGTKRYMAPE 187

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H  +V+LYG 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGV 90
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           CL +  +  ++E+ME G L   LR             + +   V   ++YL   C   ++
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 145
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           HRD               V+DFG  R +  D
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 176

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L Q      AF+     EA ++  ++H+ +V+LY  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 71
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++      + +
Sbjct: 72  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 127
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
           HR+               +ADFG ARL  ++ +  T R G 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGA 166

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 11/173 (6%)
Query: 454 IRYCIGTGGYGSVYKA--ELPDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           I   IG G +G V     +LP  +   VA+K L    TE       F +EA ++    H 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 68
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N++ L G       +  I E+ME GSL   LR +D    +   + V +++ +A  + YL 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 125
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
                + VHR                V+DFG +R L  D+S+ T  +   G I
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 457 CIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           C+G G YG V++     G+ VA+ K+  S  E S F E+   E      +RH NI+    
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAV-KIFSSRDEKSWFRET---ELYNTVMLRHENILGFIA 69
Query: 517 FCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
             +  R     ++ I  Y E GSL+  L    +   L+    + IV S+A  L++LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 573 -----TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNR-----TLRAGTYGYI 622
                 P+I HRD            +  +AD G A ++H  S+N+       R GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 623 APD 625
           AP+
Sbjct: 185 APE 187

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 67
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQ 125
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +G L   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           CL +  +  ++E+ME G L   LR             + +   V   ++YL   C   ++
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 125
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           HRD               V+DFG  R +  D
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 156

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 84/199 (42%), Gaps = 12/199 (6%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E      +E  Q E  VLS      + K YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 140
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRD            E  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK- 199
Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   R +P
Sbjct: 200 -ADIWSLGITAIELARGEP 217

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H  +V+LYG 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 68
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           CL +  +  ++E+ME G L   LR             + +   V   ++YL   C   ++
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 123
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           HRD               V+DFG  R +  D
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+ A       VA+K +       S  VE+F  EA V+ T++H 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHD 237
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +VKL+   + K  ++ I E+M +GSL   L+  DE  +    + ++    +A  ++++ 
Sbjct: 238 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
                + +HRD               +ADFG AR+
Sbjct: 296 QR---NYIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 84/199 (42%), Gaps = 12/199 (6%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E      +E  Q E  VLS      + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRD            E  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK- 184
Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   R +P
Sbjct: 185 -ADIWSLGITAIELARGEP 202

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 11  EERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 67
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I E++  GSL   L+   E I  +  + +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQ 125
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    T   +HRD               + DFG  ++L  D     ++
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 77  ST-KPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLH---AKSII 130
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 84/199 (42%), Gaps = 12/199 (6%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E      +E  Q E  VLS      + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRD            E  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK- 184
Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   R +P
Sbjct: 185 -ADIWSLGITAIELARGEP 202

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 13/207 (6%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E F +   +G G YGSVYKA     G++VA+K++          ++    E  ++     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDS 83
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            ++VK YG       ++ + EY   GS+  ++R  ++   L       I++S    L YL
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYL 141
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
           H       +HRD             A +ADFG A  L    + R    GT  ++AP+  +
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE--V 196
Query: 629 SPPVNQKIIQDIILVSTTALACLRSKP 655
              +    + DI  +  TA+     KP
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKP 223

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +G L   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG ARL  ++ +  T R G      + AP+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 186
Query: 627 RL 628
            L
Sbjct: 187 AL 188

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 78/190 (41%), Gaps = 21/190 (11%)
Query: 442 YEDLINATEDF---------HIRYCIGTGGYGSVYKAELP-DGK---VVALKKLHQSETE 488
           +ED   A  +F          I   IG G +G V    L   GK    VA+K L    T+
Sbjct: 12  FEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F +EA ++    H NI+ L G     + +  I EYME GSL   LR +D    
Sbjct: 72  KQR--RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           +   + V +++ +   + YL      S VHRD               V+DFG +R+L  D
Sbjct: 130 V--IQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 609 -SSNRTLRAG 617
             +  T R G
Sbjct: 185 PEAAYTTRGG 194

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA+V+  +RH 
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ----EAQVMKKLRHE 240
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY   + +  ++ + EYM +GSL   L+  +    L   + V++   +A  ++Y+ 
Sbjct: 241 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPDQ 626
                + VHRD               VADFG  RL  ++ +  T R G      + AP+ 
Sbjct: 299 R---MNYVHRDLRAANILVGENLVCKVADFGLGRL--IEDNEYTARQGAKFPIKWTAPEA 353
Query: 627 RL 628
            L
Sbjct: 354 AL 355

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 89  ST-KPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLH---AKSII 142
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTA 602
           HRD               + DFG A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K L+++ T   A VE F +EA +++++ H ++V
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVE-FMDEALIMASMDHPHLV 103
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL    +  + + M  G L   + +  + I     LNW  +      +A  + YL
Sbjct: 104 RLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 156
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG ARLL  D        G
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEA--RVLS 504
           AT  +     IG G YG+VYKA  P  G  VALK +     E+   + + +  A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 505 TVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
              H N+V+L   C   R      +  ++E++++    Y+ +     +     +  ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLMR 119
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
                L +LH +C   IVHRD               +ADFG AR+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 72/171 (42%), Gaps = 12/171 (7%)
Query: 452 FHIRYCIGTGGYGSVYKAELP-DGK---VVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
             I   IG G +G V    L   GK    VA+K L    T+       F +EA ++    
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFD 67
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H NI+ L G     + +  I EYME GSL   LR +D    +   + V +++ +   + Y
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 125
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           L      S VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 126 LSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGG 173

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 23/286 (8%)
Query: 85  LSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN 144
           L+NL+YLNL  N +T   P  + +L  L  LY+  N +   + ++  +L NL ELYL  +
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ--NLTNLRELYLNED 120
Query: 145 KLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN 204
            +S + P  + NL     L++  N     + S L   T L  L +  ++     P  I N
Sbjct: 121 NISDISP--LANLTKXYSLNLGANHNLSDL-SPLSNXTGLNYLTVTESKVKDVTP--IAN 175
Query: 205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
           L +L  LS+  N++    P  L  LTSL Y     NQ+    P  + N + L  L + +N
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANXTRLNSLKIGNN 231
Query: 265 KIRGIIPDEXXXXXXXXXXXXXXXXXXGQIP--FAIGKLFNLVSLDLSKNKLSGSFPTGI 322
           KI  + P                     QI    A+  L  L  L++  N++S    + +
Sbjct: 232 KITDLSP------LANLSQLTWLEIGTNQISDINAVKDLTKLKXLNVGSNQISD--ISVL 283
Query: 323 GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPM 368
            N ++L  L LN+N L       IG +  L  L LS N+++   P+
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRPL 329

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 452 FHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSE------TEDSAFVESFQ----NEA 500
           F +R  +G+G YG V   +  +G    A+K + +S+      ++D+  +E F     NE 
Sbjct: 39  FKVRK-LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
            +L ++ H NI+KL+     K+  + + E+ E G LF  + +  +  E +     NI+K 
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD---AANIMKQ 154
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTLRAG 617
           +   + YLH     +IVHRD                  + DFG +     D   R  R G
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD-RLG 210
Query: 618 TYGYIAPDQRLSPPVNQK 635
           T  YIAP + L    N+K
Sbjct: 211 TAYYIAP-EVLKKKYNEK 227

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEA--RVLS 504
           AT  +     IG G YG+VYKA  P  G  VALK +     E+   + + +  A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 505 TVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
              H N+V+L   C   R      +  ++E++++    Y+ +     +     +  ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLMR 119
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
                L +LH +C   IVHRD               +ADFG AR+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEA--RVLS 504
           AT  +     IG G YG+VYKA  P  G  VALK +     E+   + + +  A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 505 TVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
              H N+V+L   C   R      +  ++E++++    Y+ +     +     +  ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--DLMR 119
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
                L +LH +C   IVHRD               +ADFG AR+
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 72/171 (42%), Gaps = 12/171 (7%)
Query: 452 FHIRYCIGTGGYGSVYKAELP-DGK---VVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
             I   IG G +G V    L   GK    VA+K L    T+       F +EA ++    
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFD 73
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H NI+ L G     + +  I EYME GSL   LR +D    +   + V +++ +   + Y
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 131
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           L      S VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 132 LSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGG 179

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 450 EDF-HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF  I   +G G +G VYKA+  +  V+A  K+  +++E+   +E +  E  +L++  H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL     ++  ++ + E+   G++  V+ + +    L  ++   + K    AL+YL
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 151
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H +    I+HRD            +  +ADFG +         R    GT  ++AP+
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 73  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 126
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 78  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 78  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 131
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 75  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 128
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 17/170 (10%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H+++   +G G +GSV       L D  G+VVA+KKL  S  E    +  F+ E  +
Sbjct: 9   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 65
Query: 503 LSTVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L +++H NIVK  G C    +R +  I EY+  GSL   L+   E I  +  + +     
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 123
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
           +   + YL    T   +HR+               + DFG  ++L  D  
Sbjct: 124 ICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 94/258 (36%), Gaps = 61/258 (23%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H  +V+LYG 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 71
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           CL +  +  + E+ME G L   LR             + +   V   ++YL   C   ++
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 126
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPV----- 632
           HRD               V+DFG  R +  D         + G   P +  SP V     
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-----SSTGTKFPVKWASPEVFSFSR 181
Query: 633 -----------------------------NQKIIQDII---------LVSTTALA----C 650
                                        N ++++DI          L ST        C
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 241
Query: 651 LRSKPKSRPTMQRISQEL 668
            R +P+ RP   R+ ++L
Sbjct: 242 WRERPEDRPAFSRLLRQL 259

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           HI   IG+G  G V    L  P  +   VA+K L    TE       F +EA ++    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++L G     R    + EYME GSL   LR  D    +   + V +++ V   + YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL 167
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
                   VHRD               V+DFG +R+L  D
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
           CL +  +  ++E+ME G L   LR             + +   V   ++YL      S++
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEE---ASVI 125
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           HRD               V+DFG  R +  D
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD 156

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           HI   IG+G  G V    L  P  +   VA+K L    TE       F +EA ++    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++L G     R    + EYME GSL   LR  D    +   + V +++ V   + YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL 167
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
                   VHRD               V+DFG +R+L  D
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 77/190 (40%), Gaps = 21/190 (11%)
Query: 442 YEDLINATEDF---------HIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F  EA ++    H NI++L G     + +  + E ME GSL   LR  D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           +   + V +++ +A  + YL        VHRD               V+DFG +R+L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 609 -SSNRTLRAG 617
             +  T R G
Sbjct: 201 PEAAYTTRGG 210

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 42  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + E ME GSL   LR  D    +   + V +++ +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 156
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 157 ASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 78/194 (40%), Gaps = 29/194 (14%)
Query: 442 YEDLINATEDFH---------IRYCIGTGGYGSVY--------KAELPDGKVVALKKLHQ 484
           YED   A  +F          I   IG G +G V         K ELP    VA+K L  
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELP----VAIKTLKV 60
Query: 485 SETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD 544
             TE       F  EA ++    H NI+ L G     + +  + EYME GSL   L+ +D
Sbjct: 61  GYTEKQR--RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKND 118
Query: 545 EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
              +    + V +++ ++  + YL        VHRD               V+DFG +R+
Sbjct: 119 G--QFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 605 LHVD-SSNRTLRAG 617
           L  D  +  T R G
Sbjct: 174 LEDDPEAAYTTRGG 187

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 450 EDF-HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF  I   +G G +G VYKA+  +  V+A  K+  +++E+   +E +  E  +L++  H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL     ++  ++ + E+   G++  V+ + +    L  ++   + K    AL+YL
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 151
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H +    I+HRD            +  +ADFG +         R    GT  ++AP+
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K L+++ T   A VE F +EA +++++ H ++V
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVE-FMDEALIMASMDHPHLV 80
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL    +  + + M  G L   + +  + I     LNW  +      +A  + YL
Sbjct: 81  RLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 133
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG ARLL  D        G
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 450 EDF-HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF  I   +G G +G VYKA+  +  V+A  K+  +++E+   +E +  E  +L++  H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL     ++  ++ + E+   G++  V+ + +    L  ++   + K    AL+YL
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 151
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H +    I+HRD            +  +ADFG +         R    GT  ++AP+
Sbjct: 152 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 13/177 (7%)
Query: 446 INATEDFHIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETEDSAFVESFQNEAR 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE       F  EA 
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 69
Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++    H NI++L G     + +  + E ME GSL   LR  D    +   + V +++ +
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 127
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD-SSNRTLRAG 617
           A  + YL        VHRD               V+DFG +R+L  D  +  T R G
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
               + +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 89  STAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLH---AKSII 142
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTA 602
           HRD               + DFG A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 101 ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 154
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 204

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 73  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 126
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTA 602
           HRD               + DFG A
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 12/171 (7%)
Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG V K    D G++VA+KK  +S+ +D    +    E ++L  +RH N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE--LNWTRRVNIVKSVAHALSYLHHDCTP 574
            C  K+  + ++E+++     + + DD E     L++      +  + + + + H   + 
Sbjct: 92  VCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SH 143
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +I+HRD               + DFG AR L            T  Y AP+
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 100 ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 153
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 8/189 (4%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           EDF +   +G G +G V+ AE     +  A+K L +        VE    E RVLS    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H  +  ++     K  +FF+ EY+  G L Y ++      + + +R       +   L +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 134
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
           LH   +  IV+RD               +ADFG  +   +  +      GT  YIAP+  
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 628 LSPPVNQKI 636
           L    N  +
Sbjct: 192 LGQKYNHSV 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 30/182 (16%)
Query: 461 GGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST--VRHRNIVKLYGFC 518
           G +G V+KA+L + + VA+K     + +      S+QNE  V S   ++H NI++  G  
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQ------SWQNEYEVYSLPGMKHENILQFIG-- 85
Query: 519 LHKRC------MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
             KR       ++ I  + E+GSL   L+    A  ++W    +I +++A  L+YLH D 
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 573 -------TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS--NRTLRAGTYGYIA 623
                   P+I HRD             A +ADFG A       S  +   + GT  Y+A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 624 PD 625
           P+
Sbjct: 202 PE 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
               + +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 73  STAPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 126
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S +      +G+  ++AP+
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 93  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 146
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTA 602
           HRD               + DFG A
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 83/195 (42%), Gaps = 30/195 (15%)
Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEI-GSLRN 135
           +IP  I +  + K L+L+ N L+    K    L  L +LYL++N L  T P  I   L+N
Sbjct: 30  AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 136 LEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQF 194
           LE L++  NKL                           +P  +F +L NL  L L  NQ 
Sbjct: 87  LETLWVTDNKLQA-------------------------LPIGVFDQLVNLAELRLDRNQL 121
Query: 195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFS 254
               PR   +L  LT+LS+  N+L          LTSL  L L  NQL           +
Sbjct: 122 KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 255 ALAELDLSDNKIRGI 269
            L  L L +N+++ +
Sbjct: 182 ELKTLKLDNNQLKRV 196

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 87/181 (48%), Gaps = 9/181 (4%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           ++  E + I   +G G +G VYKA+  +   +A  K+ ++++E+   +E +  E  +L+T
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILAT 64
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIV-KSVAHA 564
             H  IVKL G   H   ++ + E+   G++  ++ + D  +      ++ +V + +  A
Sbjct: 65  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEA 121
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L++LH   +  I+HRD            +  +ADFG +         R    GT  ++AP
Sbjct: 122 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 178
Query: 625 D 625
           +
Sbjct: 179 E 179

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 27/172 (15%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF     +G G +G V KA    D +  A+KK+  +E + S  +    +E  +L+++ H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQ 62
Query: 510 NIVKLYGFCLHKR-------------CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV- 555
            +V+ Y   L +R              +F   EY E G+L+ ++  ++    LN  R   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEY 118
Query: 556 -NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
             + + +  ALSY+H   +  I+HRD               + DFG A+ +H
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
              K  +  + ++ E  SL++ L   +   E+   + ++I +  A  + YLH     SI+
Sbjct: 101 ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 154
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTA 602
           HRD               + DFG A
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 8/189 (4%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           EDF +   +G G +G V+ AE     +  A+K L +        VE    E RVLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H  +  ++     K  +FF+ EY+  G L Y ++      + + +R       +   L +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 133
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
           LH   +  IV+RD               +ADFG  +   +  +      GT  YIAP+  
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 628 LSPPVNQKI 636
           L    N  +
Sbjct: 191 LGQKYNHSV 199

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L   +     F ++F+NE  VL   RH NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQF-QAFRNEVAVLRKTRHVNILLFMGY 100
Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIV 577
            + K  +  + ++ E  SL+  L   +   ++   + ++I +  A  + YLH     +I+
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLH---AKNII 154
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           HRD               + DFG A +    S ++ +    G+  ++AP+
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 87/181 (48%), Gaps = 9/181 (4%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           ++  E + I   +G G +G VYKA+  +   +A  K+ ++++E+   +E +  E  +L+T
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILAT 72
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIV-KSVAHA 564
             H  IVKL G   H   ++ + E+   G++  ++ + D  +      ++ +V + +  A
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEA 129
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L++LH   +  I+HRD            +  +ADFG +         R    GT  ++AP
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 625 D 625
           +
Sbjct: 187 E 187

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 68/173 (39%), Gaps = 32/173 (18%)
Query: 458 IGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           IG G +G V++A  P         +VA+K L +  + D      FQ EA +++   + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNI 112
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR---------------------DDDEAIELN 550
           VKL G C   + M  ++EYM  G L   LR                            L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
              ++ I + VA  ++YL        VHRD               +ADFG +R
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 106/259 (40%), Gaps = 25/259 (9%)
Query: 375 LDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTG 434
           L MSF     ++   LRD  P S V +  L   +  L + +  F  L K K  N+     
Sbjct: 3   LHMSFETRFEKMDNLLRD--PKSEVNSDCLLDGLDALVYDL-DFPALRKNK--NIDNFLS 57
Query: 435 GYDGKI-LYEDLINATEDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSET---ED 489
            Y   I    DL    ED+ +   IG G +G V         KV A+K L + E     D
Sbjct: 58  RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 117
Query: 490 SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD--EAI 547
           SAF   F  E  +++      +V+L+      R ++ + EYM  G L  ++ + D  E  
Sbjct: 118 SAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 174
Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHV 607
              +T  V +     H++ ++H D  P  +  D               +ADFGT   ++ 
Sbjct: 175 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK---------LADFGTCMKMNK 225
Query: 608 DSSNRTLRA-GTYGYIAPD 625
           +   R   A GT  YI+P+
Sbjct: 226 EGMVRCDTAVGTPDYISPE 244

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 15/228 (6%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A E   GK VA+KK+   + +     E   NE  ++    H N+V +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHDNVVDMYS 109
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  SV  ALSYLH+     +
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ---GV 162
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRD               ++DFG    +  +   R    GT  ++AP+     P   ++
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 637 IQDIILVSTTALACLRSKPK--SRPTMQRISQELEGKTPMKKGLKEIS 682
             DI  +    +  +  +P   + P +Q + +  +   P  K L ++S
Sbjct: 223 --DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVS 268

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 12/199 (6%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    +VVA+K +   E      +E  Q E  VLS      + K YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +LR    A   +  +   ++K +   L YLH +     
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKK--- 141
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRD            +  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK- 200
Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   + +P
Sbjct: 201 -ADIWSLGITAIELAKGEP 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 457 CIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV--RHRNIVKL 514
           C+G G YG V++  L  G+ VA+ K+  S  E S F      E  + +TV  RH NI+  
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAV-KIFSSRDEQSWF-----RETEIYNTVLLRHDNILGF 67
Query: 515 YGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
               +  R     ++ I  Y E GSL+  L+   + +E +   R+ +  S A  L++LH 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQ--RQTLEPHLALRLAV--SAACGLAHLHV 123
Query: 571 DC-----TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSN-----RTLRAGTYG 620
           +       P+I HRD            +  +AD G A ++H   S+        R GT  
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKR 182
Query: 621 YIAPD 625
           Y+AP+
Sbjct: 183 YMAPE 187

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 24/178 (13%)
Query: 458 IGTGGYGSVY----KAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G+G YG V     K    +  +  ++K   S + +S  +E    E  VL  + H NI+K
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE----EVAVLKLLDHPNIMK 100
Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAI---ELNWTRRVNIVKSVAHALSYLHH 570
           LY F   KR  + + E  + G LF      DE I   + N      I+K V   ++YLH 
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELF------DEIIHRMKFNEVDAAVIIKQVLSGVTYLH- 153
Query: 571 DCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
               +IVHRD            +     + DFG + +   +      R GT  YIAP+
Sbjct: 154 --KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAPE 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 21/198 (10%)
Query: 429 LKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSET 487
           L++V    D ++L +  +           IG G  G V  A E   G+ VA+K +   + 
Sbjct: 34  LRMVVDQGDPRLLLDSYVK----------IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ 83
Query: 488 EDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAI 547
           +     E   NE  ++   +H N+V++Y   L    ++ + E+++ G+L  ++      +
Sbjct: 84  QRR---ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQV 136
Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHV 607
            LN  +   + ++V  AL+YLH      ++HRD               ++DFG    +  
Sbjct: 137 RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 608 DSSNRTLRAGTYGYIAPD 625
           D   R    GT  ++AP+
Sbjct: 194 DVPKRKXLVGTPYWMAPE 211

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K +     ++ A  ++F  EA V++ +RH N+V+L G 
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 518 CLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
            + ++  ++ + EYM +GSL   LR    ++ L     +     V  A+ YL  +   + 
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTAR 603
           VHRD             A V+DFG  +
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF     +G G +G V KA    D +  A+KK+  +E + S  +    +E  +L+++ H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQ 62
Query: 510 NIVKLYGFCLHKR-------------CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV- 555
            +V+ Y   L +R              +F   EY E  +L+ ++  ++    LN  R   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN----LNQQRDEY 118
Query: 556 -NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
             + + +  ALSY+H   +  I+HRD               + DFG A+ +H
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   IG G +  V   ++   G+V A+K +++ +      V  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR--RVNIVKSV--AHA 564
           R I +L+     +  ++ + EY   G L  +L    E I     R     IV ++   H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA-GTYGYIA 623
           L Y+H D  P  +  D               +ADFG+   L  D + R+L A GT  Y++
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIR---------LADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 624 PD 625
           P+
Sbjct: 232 PE 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   LS+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 15/179 (8%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K + +++   S+  + F+ E R++  + H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI---VKSVAHALS 566
           NIVKL+     ++ ++ + EY   G +F      D  +   W +        + +  A+ 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVF------DYLVAHGWMKEKEARAKFRQIVSAVQ 120
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           Y H      IVHRD               +ADFG +      +   T   G+  Y AP+
Sbjct: 121 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPE 175

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K +     ++ A  ++F  EA V++ +RH N+V+L G 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 518 CLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
            + ++  ++ + EYM +GSL   LR    ++ L     +     V  A+ YL  +   + 
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTAR 603
           VHRD             A V+DFG  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 70/169 (41%), Gaps = 26/169 (15%)
Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
           S L  LTNL  L L  NQ           L NL  L ++ N+L          LT+L YL
Sbjct: 79  SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIP 295
           +L+ NQL S         + L ELDLS N+++  +P+                       
Sbjct: 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEG---------------------- 175
Query: 296 FAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIP 343
               KL  L  L L +N+L  S P G+    T LQ++ L+ N  D T P
Sbjct: 176 -VFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 222

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 20/180 (11%)
Query: 442 YEDLINATEDF---------HIRYCIGTGGYGSVY--KAELPDGK--VVALKKLHQSETE 488
           YED   A   F          I   IG G +G V   + +LP  +   VA+K L    TE
Sbjct: 26  YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F  EA ++    H N+V L G     + +  + E+ME G+L   LR  D   +
Sbjct: 86  KQR--RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG--Q 141
Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
               + V +++ +A  + YL        VHRD               V+DFG +R++  D
Sbjct: 142 FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K +     ++ A  ++F  EA V++ +RH N+V+L G 
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 518 CLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
            + ++  ++ + EYM +GSL   LR    ++ L     +     V  A+ YL  +   + 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTAR 603
           VHRD             A V+DFG  +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K +     ++ A  ++F  EA V++ +RH N+V+L G 
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 518 CLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
            + ++  ++ + EYM +GSL   LR    ++ L     +     V  A+ YL  +   + 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTAR 603
           VHRD             A V+DFG  +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 15/176 (8%)
Query: 443 EDLINATEDFHIRYCIGTGGYGSVYKAELP--DGKVVALK-KLHQSETEDSAFVESFQNE 499
           ED++   + F +   +G G +GSV +A+L   DG  V +  K+ +++   S+ +E F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCM------FFIYEYMERGSLFYVL---RDDDEAIELN 550
           A  +    H ++ KL G  L  R          I  +M+ G L   L   R  +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
               V  +  +A  + YL    + + +HRD               VADFG +R ++
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 30/197 (15%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE----------DSAFVES----F 496
           D+ I   +  G +  +   E  D K  ALKK  +S  E          D   ++S    F
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 497 QNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDE--AIELNWTRR 554
           +NE ++++ +++   +   G   +   ++ IYEYME  S   +L+ D+    ++ N+T  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNYTCF 147
Query: 555 V------NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVD 608
           +       I+KSV ++ SY+H++   +I HRD               ++DFG +  + VD
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VD 204
Query: 609 SSNRTLRAGTYGYIAPD 625
              +  R GTY ++ P+
Sbjct: 205 KKIKGSR-GTYEFMPPE 220

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 25/256 (9%)
Query: 378 SFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYD 437
           SF     ++   LRD  P S V +  L   +  L + +  F  L K K  N+      Y 
Sbjct: 1   SFETRFEKMDNLLRD--PKSEVNSDCLLDGLDALVYDL-DFPALRKNK--NIDNFLSRYK 55
Query: 438 GKI-LYEDLINATEDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSET---EDSAF 492
             I    DL    ED+ +   IG G +G V         KV A+K L + E     DSAF
Sbjct: 56  DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115
Query: 493 VESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD--EAIELN 550
              F  E  +++      +V+L+      R ++ + EYM  G L  ++ + D  E     
Sbjct: 116 ---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 172
Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
           +T  V +     H++ ++H D  P  +  D               +ADFGT   ++ +  
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK---------LADFGTCMKMNKEGM 223
Query: 611 NRTLRA-GTYGYIAPD 625
            R   A GT  YI+P+
Sbjct: 224 VRCDTAVGTPDYISPE 239

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 77/176 (43%), Gaps = 19/176 (10%)
Query: 458 IGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G YG V   K +L  G   A+K + +S    ++   +  +E  VL  + H NI+KLY
Sbjct: 12  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN---IVKSVAHALSYLHHDC 572
            F   KR  + + E    G LF      DE I       V+   I+K V    +YLH   
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELF------DEIILRQKFSEVDAAVIMKQVLSGTTYLH--- 121
Query: 573 TPSIVHRDXX-XXXXXXXXXXEAF--VADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             +IVHRD             +A   + DFG +    V    +  R GT  YIAP+
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE-RLGTAYYIAPE 176

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 445 LINATEDFHIRYCIGTGGYGSVYKA-ELPD-GKVVALKKLHQSETEDSAFVESFQNEA-- 500
           L  A + +     IG G YG V+KA +L + G+ VALK++     E+   + + +  A  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 501 RVLSTVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           R L T  H N+V+L+  C   R      +  ++E++++    Y+ +  +  +     +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
           +++  +   L +LH   +  +VHRD            +  +ADFG AR+
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 12/190 (6%)
Query: 451 DFHIRYCIGTGGYGSV----YKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           DFH    IG G +G V    +KAE     V  L+K    + ++   + S +N   +L  V
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNV 96
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           +H  +V L+        ++F+ +Y+  G LFY L+ +   +E    R       +A AL 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASALG 153
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           YLH   + +IV+RD               + DFG  +     +S  +   GT  Y+AP+ 
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 627 RLSPPVNQKI 636
               P ++ +
Sbjct: 211 LHKQPYDRTV 220

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 455 RYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           R  +G G YG VY   +L +   +A+K++ +    DS + +    E  +   ++H+NIV+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
             G       +    E +  GSL  +LR     ++ N        K +   L YLH +  
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 574 PSIVHRDXXXXXXXXXXXXEAF-VADFGTA-RLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
             IVHRD                ++DFGT+ RL  ++    T   GT  Y+AP+     P
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGP 185
Query: 632 VNQKIIQDIILVSTTALACLRSKP 655
                  DI  +  T +     KP
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKP 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 65
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 25/256 (9%)
Query: 378 SFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYD 437
           SF     ++   LRD  P S V +  L   +  L + +  F  L K K  N+      Y 
Sbjct: 6   SFETRFEKMDNLLRD--PKSEVNSDCLLDGLDALVYDL-DFPALRKNK--NIDNFLSRYK 60
Query: 438 GKI-LYEDLINATEDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSET---EDSAF 492
             I    DL    ED+ +   IG G +G V         KV A+K L + E     DSAF
Sbjct: 61  DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 120
Query: 493 VESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD--EAIELN 550
              F  E  +++      +V+L+      R ++ + EYM  G L  ++ + D  E     
Sbjct: 121 ---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 177
Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
           +T  V +     H++ ++H D  P  +  D               +ADFGT   ++ +  
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK---------LADFGTCMKMNKEGM 228
Query: 611 NRTLRA-GTYGYIAPD 625
            R   A GT  YI+P+
Sbjct: 229 VRCDTAVGTPDYISPE 244

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 8/169 (4%)
Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V   E    G  VA+K L++ +      V   + E + L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
                   F + EY+  G LF  +       E+   R   + + +  A+ Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCHRHM---V 132
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           VHRD             A +ADFG + ++      RT   G+  Y AP+
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE 180

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 455 RYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           R  +G G YG VY   +L +   +A+K++ +    DS + +    E  +   ++H+NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
             G       +    E +  GSL  +LR     ++ N        K +   L YLH +  
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 574 PSIVHRDXXXXXXXXXXXXEAF-VADFGTA-RLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
             IVHRD                ++DFGT+ RL  ++    T   GT  Y+AP+     P
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGP 199
Query: 632 VNQKIIQDIILVSTTALACLRSKP 655
                  DI  +  T +     KP
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 143
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIA 623
            YLH      I+HRD               + DFGTA++L  +S      A  GT  Y++
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 624 PD 625
           P+
Sbjct: 201 PE 202

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 77
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 78  VDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 130
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 77/176 (43%), Gaps = 19/176 (10%)
Query: 458 IGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G YG V   K +L  G   A+K + +S    ++   +  +E  VL  + H NI+KLY
Sbjct: 29  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN---IVKSVAHALSYLHHDC 572
            F   KR  + + E    G LF      DE I       V+   I+K V    +YLH   
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELF------DEIILRQKFSEVDAAVIMKQVLSGTTYLHKH- 140
Query: 573 TPSIVHRDXX-XXXXXXXXXXEAF--VADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             +IVHRD             +A   + DFG +    V    +  R GT  YIAP+
Sbjct: 141 --NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE-RLGTAYYIAPE 193

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 16/192 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   I   IG G +G VY      G+V    +L   E ++   +++F+ E       RH 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEVAI--RLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V   G C+    +  I    +  +L+ V+RD    +++N TR+  I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ--IAQEIVKGMGYLH 147
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNR-----TLRAGTYGYIAP 624
                 I+H+D            +  + DFG   +  V  + R      ++ G   ++AP
Sbjct: 148 ---AKGILHKD-LKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 625 D--QRLSPPVNQ 634
           +  ++LSP   +
Sbjct: 204 EIIRQLSPDTEE 215

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 77  VDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 129
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 82
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 83  RLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 17/183 (9%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 509 RNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHA 564
              VKLY FC      ++F   Y + G L   +R     DE     +T        +  A
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSA 149
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYI 622
           L YLH      I+HRD               + DFGTA++L  +S         GT  Y+
Sbjct: 150 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 623 APD 625
           +P+
Sbjct: 207 SPE 209

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 76  VDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 128
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 12/171 (7%)
Query: 458 IGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V   E    G  VA+K L++ +      V   + E + L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
                   F + EY+  G LF  +       E+   R   + + +  A+ Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCHRHM---V 132
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           VHRD             A +ADFG + ++   S    LR   G+  Y AP+
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRDSCGSPNYAAPE 180

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 74
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 75  VDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------ 127
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 82
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           +L G CL       I + M  G L   +R+  + I   +   +N    +A  ++YL    
Sbjct: 83  RLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEDR- 138
Query: 573 TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
              +VHRD               + DFG A+LL  +        G
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +GT G   V K EL  G  VA+K L++ +      V   + E + L   RH +I+KLY  
Sbjct: 26  VGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 518 CLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
                 +F + EY+  G LF Y+ ++    ++   +RR  + + +   + Y H      +
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRR--LFQQILSGVDYCHRHM---V 137
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           VHRD             A +ADFG + ++   S    LR   G+  Y AP+
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRXSCGSPNYAAPE 185

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 15/185 (8%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 60
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS---- 560
            + H NIVKL      +  ++ ++E++        L+D  +A  L     + ++KS    
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDFMDASALTGI-PLPLIKSYLFQ 114
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
           +   L++ H   +  ++HRD               +ADFG AR   V          T  
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 171
Query: 621 YIAPD 625
           Y AP+
Sbjct: 172 YRAPE 176

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 84
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           +L G CL       I + M  G L   +R+  + I   +   +N    +A  ++YL    
Sbjct: 85  RLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEDR- 140
Query: 573 TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
              +VHRD               + DFG A+LL  +        G
Sbjct: 141 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 81
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 82  RLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 445 LINATEDFHIRYCIGTGGYGSVYKA-ELPD-GKVVALKKLHQSETEDSAFVESFQNEA-- 500
           L  A + +     IG G YG V+KA +L + G+ VALK++     E+   + + +  A  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 501 RVLSTVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           R L T  H N+V+L+  C   R      +  ++E++++    Y+ +  +  +     +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
           +++  +   L +LH   +  +VHRD            +  +ADFG AR+
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 80
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 81  RLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 445 LINATEDFHIRYCIGTGGYGSVYKA-ELPD-GKVVALKKLHQSETEDSAFVESFQNEA-- 500
           L  A + +     IG G YG V+KA +L + G+ VALK++     E+   + + +  A  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 501 RVLSTVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           R L T  H N+V+L+  C   R      +  ++E++++    Y+ +  +  +     +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
           +++  +   L +LH   +  +VHRD            +  +ADFG AR+
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 77  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 129
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 81  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 133
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 77  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 129
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 41/205 (20%)
Query: 451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF     +G G +G V KA    D +  A+KK+  +E + S  +    +E  +L+++ H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVXLLASLNHQ 62
Query: 510 NIVKLYGFCLHKR-------------CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV- 555
            +V+ Y   L +R              +F   EY E  +L+ ++  ++    LN  R   
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN----LNQQRDEY 118
Query: 556 -NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHV------- 607
             + + +  ALSY+H   +  I+HR+               + DFG A+ +H        
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 608 -------DSSNRTLRAGTYGYIAPD 625
                   S N T   GT  Y+A +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATE 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 15/185 (8%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 59
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS---- 560
            + H NIVKL      +  ++ ++E++        L+D  +A  L     + ++KS    
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDFMDASALTGI-PLPLIKSYLFQ 113
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
           +   L++ H   +  ++HRD               +ADFG AR   V          T  
Sbjct: 114 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 170
Query: 621 YIAPD 625
           Y AP+
Sbjct: 171 YRAPE 175

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 13/172 (7%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           V + ++ +L G CL       I + M  G L   +R+  + I   +   +N    +A  +
Sbjct: 81  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGM 137
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           +YL       +VHRD               + DFG A+LL  +        G
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 76  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 128
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 74  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 126
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 15/183 (8%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS----VA 562
            H NIVKL      +  ++ ++E++ +      L+D  +A  L     + ++KS    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-----LKDFMDASALTGI-PLPLIKSYLFQLL 113
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             L++ H   +  ++HRD               +ADFG AR   V          T  Y 
Sbjct: 114 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 623 APD 625
           AP+
Sbjct: 171 APE 173

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  G+ VA+K + +++   ++  + F+ E R++  + H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 71
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ I EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCH 128
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG +    V     T   G+  Y AP+
Sbjct: 129 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGSPPYAAPE 180

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 82
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           +L G CL       I + M  G L   +R+  + I   +   +N    +A  ++YL    
Sbjct: 83  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEDR- 138
Query: 573 TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
              +VHRD               + DFG A+LL  +        G
Sbjct: 139 --RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 80
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 81  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 445 LINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNE 499
           ++  TE   I+  +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +E
Sbjct: 36  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 92
Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRV 555
           A V+++V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
                 A  ++YL       +VHRD               + DFG A+LL  +       
Sbjct: 152 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 616 AG 617
            G
Sbjct: 203 GG 204

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 16/168 (9%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAF---VESFQNEA--R 501
           AT  +     IG G YG+VYKA  P  G  VALK +             + + +  A  R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 502 VLSTVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN 556
            L    H N+V+L   C   R      +  ++E++++    Y+ +     +     +  +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--D 124
Query: 557 IVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARL 604
           +++     L +LH +C   IVHRD               +ADFG AR+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 74  VDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------ 126
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 13/172 (7%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           V + ++ +L G CL       I + M  G L   +R+  + I   +   +N    +A  +
Sbjct: 77  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGM 133
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           +YL       +VHRD               + DFG A+LL  +        G
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 86
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 87  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 139
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 80
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 81  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 7/181 (3%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 61
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
            + H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQG 119
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L++ H   +  ++HRD               +ADFG AR   V          T  Y AP
Sbjct: 120 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 176
Query: 625 D 625
           +
Sbjct: 177 E 177

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 77
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 78  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGMNYL 130
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +PDG+     VA+K L ++ +  +   +   +EA V++ V    + 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVS 82
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       + + M  G L   +R++   +     LNW  ++      A  +SYL
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYL 135
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSN 611
                  +VHRD               + DFG ARLL +D + 
Sbjct: 136 ED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 88/201 (43%), Gaps = 30/201 (14%)
Query: 91  LNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVL 150
           L+L+ N +T     +  +L+NL  L L NN +   +P     L  LE LYL  N+L   L
Sbjct: 57  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-L 115
Query: 151 PQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCN----------QFNG---- 196
           P+++   K+L  L V  N +     S    L  +  + LG N           F G    
Sbjct: 116 PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 197 -----------TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF 245
                      TIP+  G   +LT L +  NK+T    ++L  L +L  L LSFN + + 
Sbjct: 174 SYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 246 IPLEIGNFSALAELDLSDNKI 266
               + N   L EL L++NK+
Sbjct: 232 DNGSLANTPHLRELHLNNNKL 252

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 88/201 (43%), Gaps = 30/201 (14%)
Query: 91  LNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVL 150
           L+L+ N +T     +  +L+NL  L L NN +   +P     L  LE LYL  N+L   L
Sbjct: 57  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-L 115
Query: 151 PQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCN----------QFNG---- 196
           P+++   K+L  L V  N +     S    L  +  + LG N           F G    
Sbjct: 116 PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 197 -----------TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF 245
                      TIP+  G   +LT L +  NK+T    ++L  L +L  L LSFN + + 
Sbjct: 174 SYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 246 IPLEIGNFSALAELDLSDNKI 266
               + N   L EL L++NK+
Sbjct: 232 DNGSLANTPHLRELHLNNNKL 252

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 7/181 (3%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 60
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
            + H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L++ H   +  ++HRD               +ADFG AR   V          T  Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 625 D 625
           +
Sbjct: 176 E 176

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 90
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           +L G CL       I + M  G L   +R+  + I   +   +N    +A  ++YL    
Sbjct: 91  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEDR- 146
Query: 573 TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
              +VHRD               + DFG A+LL  +        G
Sbjct: 147 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E ++L  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 517 FCLHK-----RC---MFFIYEYMER---GSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            C  K     RC   ++ ++++ E    G L  VL      ++   +    +++ + + L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGL 138
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            Y+H +    I+HRD               +ADFG AR
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 146
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIA 623
            YLH      I+HRD               + DFGTA++L  +S      +  GT  Y++
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 624 PD 625
           P+
Sbjct: 204 PE 205

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 95
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 148
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD               ++DFG    +  +   R    GT  ++AP+
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 197

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 5/144 (3%)
Query: 130 IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLF 188
           I  L N+  L L  NKL  +    +  L +L +L +  N +   +P+ +F +LTNL+ L 
Sbjct: 59  IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELV 115
Query: 189 LGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPL 248
           L  NQ           L NLT+L +  N+L          LT+L  LDL  NQL S    
Sbjct: 116 LVENQLQSLPDGVFDKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQSLPEG 175
Query: 249 EIGNFSALAELDLSDNKIRGIIPD 272
                + L +L L+DN+++  +PD
Sbjct: 176 VFDKLTQLKQLSLNDNQLKS-VPD 198

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 65/139 (46%), Gaps = 6/139 (4%)
Query: 202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           I  L N+ +L++  NKL     S L  LT+L YL L+ NQL S         + L EL L
Sbjct: 59  IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116
Query: 262 SDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAI-GKLFNLVSLDLSKNKLSGSFPT 320
            +N+++ + PD                     +P  +  KL NL  LDL  N+L  S P 
Sbjct: 117 VENQLQSL-PDGVFDKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQ-SLPE 174
Query: 321 GI-GNCTELQHLALNHNSL 338
           G+    T+L+ L+LN N L
Sbjct: 175 GVFDKLTQLKQLSLNDNQL 193

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 88
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGV 141
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD               ++DFG    +  +   R    GT  ++AP+
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 190

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E ++L  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 517 FCLHK-----RC---MFFIYEYMER---GSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            C  K     RC   ++ ++++ E    G L  VL      ++   +    +++ + + L
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGL 138
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            Y+H +    I+HRD               +ADFG AR
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 137
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD               ++DFG    +  +   R    GT  ++AP+
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 186

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 123
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 124 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 178
Query: 622 IAPD 625
           ++P+
Sbjct: 179 VSPE 182

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E ++L  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 517 FCLHK-----RC---MFFIYEYMER---GSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            C  K     RC   ++ ++++ E    G L  VL      ++   +    +++ + + L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGL 138
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            Y+H +    I+HRD               +ADFG AR
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K + +++   S+  + F+ E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG +      +   T   G+  Y AP+
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPE 182

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYT------AEIVSAL 145
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIA 623
            YLH      I+HRD               + DFGTA++L  +S      +  GT  Y++
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 624 PD 625
           P+
Sbjct: 203 PE 204

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K + +++   S+  + F+ E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG +      +   T   G+  Y AP+
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPE 182

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 447 NATEDFHIRYCIGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVES-FQNEARVL 503
           N  + F     +G+G +  V+  K  L  GK+ ALK + +S     AF +S  +NE  VL
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKS----PAFRDSSLENEIAVL 60
Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
             ++H NIV L          + + + +  G LF  + +     E + +    +++ V  
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLS 117
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXE---AFVADFGTARLLHVDSSNRTLRAGTYG 620
           A+ YLH +    IVHRD            E     + DFG +++    +   +   GT G
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTACGTPG 172
Query: 621 YIAPDQRLSPPVNQKIIQDIILVSTTALAC 650
           Y+AP+     P ++ +    I V T  L C
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLC 202

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 145
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPD 625
           ++P+
Sbjct: 201 VSPE 204

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 93
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 146
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD               ++DFG    +  +   R    GT  ++AP+
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 195

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 78  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 623 APD 625
           AP+
Sbjct: 192 APE 194

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 148
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 149 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 203
Query: 622 IAPD 625
           ++P+
Sbjct: 204 VSPE 207

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 78/184 (42%), Gaps = 18/184 (9%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E + I   +G GG  +VY AE     + VA+K +     E    ++ F+ E    S + H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD-----DEAIELNWTRRVNIVKSVAH 563
           +NIV +        C + + EY+E  +L   +        D AI  N+T +  I+  + H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQ--ILDGIKH 126
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA-GTYGYI 622
           A     HD    IVHRD               + DFG A+ L   S  +T    GT  Y 
Sbjct: 127 A-----HDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 623 APDQ 626
           +P+Q
Sbjct: 180 SPEQ 183

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 22/170 (12%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTV- 506
           D   +  IG G +G V KA +    +    A+K++ +  ++D      F  E  VL  + 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 83
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD-------------DDEAIELNWTR 553
            H NI+ L G C H+  ++   EY   G+L   LR              +  A  L+  +
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            ++    VA  + YL        +HRD             A +ADFG +R
Sbjct: 144 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 623 APD 625
           AP+
Sbjct: 182 APE 184

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 138
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 191
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD               ++DFG    +  +   R    GT  ++AP+
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 240

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E ++L  ++H N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 517 FCLHK-----RC---MFFIYEYMER---GSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            C  K     RC   ++ ++++ E    G L  VL      ++   +    +++ + + L
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGL 137
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            Y+H +    I+HRD               +ADFG AR
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 146
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 201
Query: 622 IAPD 625
           ++P+
Sbjct: 202 VSPE 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 74
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 75  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 127
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++ + +VVA+KK+  S  + +   +    E R L  +RH N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 517 FCLHKRCMFFIYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L +   + + EY       L  V +   + +E+       +       L+YLH   + 
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 173
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +++HRD               + DFG+A ++    +      GT  ++AP+
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPE 220

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 122
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 123 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 177
Query: 622 IAPD 625
           ++P+
Sbjct: 178 VSPE 181

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 22/170 (12%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTV- 506
           D   +  IG G +G V KA +    +    A+K++ +  ++D      F  E  VL  + 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 73
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD-------------DDEAIELNWTR 553
            H NI+ L G C H+  ++   EY   G+L   LR              +  A  L+  +
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            ++    VA  + YL        +HRD             A +ADFG +R
Sbjct: 134 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 145
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPD 625
           ++P+
Sbjct: 201 VSPE 204

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ ++  IG G +  V  A  +  G+ VA+K + +++   ++  + F+ E R++  + H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCH 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG +    V +   T   G+  Y AP+
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTF-CGSPPYAAPE 183

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 120
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 121 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 175
Query: 622 IAPD 625
           ++P+
Sbjct: 176 VSPE 179

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 145
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPD 625
           ++P+
Sbjct: 201 VSPE 204

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 31/183 (16%)
Query: 461 GGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST--VRHRNIVKLYGFC 518
           G +G V+KA+L +   VA+K     + +      S+Q+E  + ST  ++H N+++     
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQ------SWQSEREIFSTPGMKHENLLQF--IA 76
Query: 519 LHKRC------MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
             KR       ++ I  + ++GSL   L+ +     + W    ++ ++++  LSYLH D 
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDV 132
Query: 573 --------TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS--SNRTLRAGTYGYI 622
                    PSI HRD             A +ADFG A          +   + GT  Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 623 APD 625
           AP+
Sbjct: 193 APE 195

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  + + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINAMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 76/183 (41%), Gaps = 17/183 (9%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   IG G +G V   +L +  KV A+K L++ E    A    F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVL-----RDDDEAIELNWTRRVNIVKSVAH 563
           + I  L+        ++ + +Y   G L  +L     R  +E         V  + SV H
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV-H 192
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTA-RLLHVDSSNRTLRAGTYGYI 622
            L Y+H D  P  +  D               +ADFG+  +L+   +   ++  GT  YI
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIR---------LADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 623 APD 625
           +P+
Sbjct: 244 SPE 246

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 145
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPD 625
           ++P+
Sbjct: 201 VSPE 204

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S + H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKLNHQNI 110
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 31/204 (15%)
Query: 451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF     IG+GG+G V+KA+   DGK   +K++  +        E  + E + L+ + H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 510 NIVKLYGFCL-----------------HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWT 552
           NIV  Y  C                    +C+F   E+ ++G+L   + +     +L+  
Sbjct: 65  NIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKV 122
Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNR 612
             + + + +   + Y+H   +  +++RD            +  + DFG    L  D   R
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKR 178
Query: 613 TLRAGTYGYIAPDQRLSPPVNQKI 636
               GT  Y++P+Q  S    +++
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEV 202

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 18/183 (9%)
Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHR 509
           F +   +G G YG VYK   +  G++ A+K +  +  E+    E  + E  +L     HR
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 510 NIVKLYGFCLHKR------CMFFIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVA 562
           NI   YG  + K        ++ + E+   GS+  ++++     ++  W     I + + 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 139
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             LS+LH      ++HRD            E  + DFG +  L      R    GT  ++
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 623 APD 625
           AP+
Sbjct: 197 APE 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 143
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 198
Query: 622 IAPD 625
           ++P+
Sbjct: 199 VSPE 202

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 145
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPD 625
           ++P+
Sbjct: 201 VSPE 204

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 121
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 122 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 176
Query: 622 IAPD 625
           ++P+
Sbjct: 177 VSPE 180

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 447 NATEDFHIRY----CIGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           ++T  F  RY     +G G +G V   K ++  G+  A+K + + + +     ES   E 
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREV 77
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           ++L  + H NI+KLY F   K   + + E    G LF  +       E++  R   I++ 
Sbjct: 78  QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQ 134
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTL-RA 616
           V   ++Y+H +    IVHRD            +     + DFG +   H ++S +   + 
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI 189
Query: 617 GTYGYIAPD 625
           GT  YIAP+
Sbjct: 190 GTAYYIAPE 198

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K + +++   S+  + F+ E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFG 600
                 IVHRD               +ADFG
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 143
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 198
Query: 622 IAPD 625
           ++P+
Sbjct: 199 VSPE 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 19/192 (9%)
Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           F  +  +GTG +  V  AE    GK+ A+K + +   +      S +NE  VL  ++H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE--SSIENEIAVLRKIKHEN 81
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN---IVKSVAHALSY 567
           IV L         ++ + + +  G LF      D  +E  +    +   +++ V  A+ Y
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELF------DRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEA---FVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LH      IVHRD            E     ++DFG +++        T   GT GY+AP
Sbjct: 136 LHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA-CGTPGYVAP 191
Query: 625 DQRLSPPVNQKI 636
           +     P ++ +
Sbjct: 192 EVLAQKPYSKAV 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 447 NATEDFHIRY----CIGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           ++T  F  RY     +G G +G V   K ++  G+  A+K + + + +     ES   E 
Sbjct: 42  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREV 100
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           ++L  + H NI+KLY F   K   + + E    G LF  +       E++  R   I++ 
Sbjct: 101 QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQ 157
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTL-RA 616
           V   ++Y+H +    IVHRD            +     + DFG +   H ++S +   + 
Sbjct: 158 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI 212
Query: 617 GTYGYIAPD 625
           GT  YIAP+
Sbjct: 213 GTAYYIAPE 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 142
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIA 623
            YLH      I+HRD               + DFGTA++L  +S      +  GT  Y++
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 624 PD 625
           P+
Sbjct: 200 PE 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 447 NATEDFHIRY----CIGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           ++T  F  RY     +G G +G V   K ++  G+  A+K + + + +     ES   E 
Sbjct: 25  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREV 83
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           ++L  + H NI+KLY F   K   + + E    G LF  +       E++  R   I++ 
Sbjct: 84  QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQ 140
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTL-RA 616
           V   ++Y+H +    IVHRD            +     + DFG +   H ++S +   + 
Sbjct: 141 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI 195
Query: 617 GTYGYIAPD 625
           GT  YIAP+
Sbjct: 196 GTAYYIAPE 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 447 NATEDFHIRY----CIGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           ++T  F  RY     +G G +G V   K ++  G+  A+K + + + +     ES   E 
Sbjct: 43  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREV 101
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           ++L  + H NI+KLY F   K   + + E    G LF  +       E++  R   I++ 
Sbjct: 102 QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQ 158
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTL-RA 616
           V   ++Y+H +    IVHRD            +     + DFG +   H ++S +   + 
Sbjct: 159 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI 213
Query: 617 GTYGYIAPD 625
           GT  YIAP+
Sbjct: 214 GTAYYIAPE 222

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++++    ++       I L   +  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +     E   NE  ++   +H N+V++Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 215
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ + E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 268
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD               ++DFG    +  +   R    GT  ++AP+
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 317

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++ + +VVA+KK+  S  + +   +    E R L  +RH N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 517 FCLHKRCMFFIYEYM--ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L +   + + EY       L  V +   + +E+       +       L+YLH   + 
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 134
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +++HRD               + DFG+A ++    +      GT  ++AP+
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPE 181

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 120 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 78  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 623 APD 625
           AP+
Sbjct: 192 APE 194

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S + H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKLNHQNI 96
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 72  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 623 APD 625
           AP+
Sbjct: 186 APE 188

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL--DFLMEALIISKFNHQNI 110
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 7/181 (3%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 60
Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
            + H NIVKL      +  ++ ++E++      ++       I L   +  + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L++ H   +  ++HRD               +ADFG AR   V          T  Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 625 D 625
           +
Sbjct: 176 E 176

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 110
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 120
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 19/185 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKAE----LPDGKVVALKKLHQS----ETEDSAFVESFQNEAR 501
           E F +   +G GGYG V++         GK+ A+K L ++      +D+A  ++ +N   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 502 VLSTVRHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           +L  V+H  IV L Y F    + ++ I EY+  G LF  L  + E I +  T    + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE- 129
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
           ++ AL +LH      I++RD               + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 621 YIAPD 625
           Y+AP+
Sbjct: 187 YMAPE 191

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVAL K+ + +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVAL K+ + +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  ++HRD               +ADFG AR   V     T    T  Y AP+
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 623 APD 625
           AP+
Sbjct: 182 APE 184

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK +++     S      + E   L  +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           +I+KLY     K  +  + EY       Y+++ D    +++        + +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG + ++  D +      G+  Y AP+
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPE 182

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 142
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDS--SNRTLRAGTYGYIA 623
            YLH      I+HRD               + DFGTA++L  +S  +      GT  Y++
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 624 PD 625
           P+
Sbjct: 200 PE 201

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 87
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 148 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK +++     S      + E   L  +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           +I+KLY     K  +  + EY       Y+++ D    +++        + +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 120
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG + ++  D +      G+  Y AP+
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPE 172

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK +++     S      + E   L  +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           +I+KLY     K  +  + EY       Y+++ D    +++        + +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 124
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG + ++  D +      G+  Y AP+
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPE 176

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 95
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 26/175 (14%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 136
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNRTLRAGTY 619
           L  +     +HRD               VA   DFG AR ++        RAG Y
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--------RAGYY 240

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 71/182 (39%), Gaps = 15/182 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 127
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIA 623
            YLH      I+HRD               + DFGTA++L  +S         GT  Y++
Sbjct: 128 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 624 PD 625
           P+
Sbjct: 185 PE 186

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 19/185 (10%)
Query: 450 EDFHIRYCIGTGGYGSVYKAE----LPDGKVVALKKLHQS----ETEDSAFVESFQNEAR 501
           E F +   +G GGYG V++         GK+ A+K L ++      +D+A  ++ +N   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 502 VLSTVRHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           +L  V+H  IV L Y F    + ++ I EY+  G LF  L  + E I +  T    + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE- 129
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
           ++ AL +LH      I++RD               + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 621 YIAPD 625
           Y+AP+
Sbjct: 187 YMAPE 191

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 72  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 623 APD 625
           AP+
Sbjct: 186 APE 188

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          ++ F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R  +   VA  +
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL---RAGTYGYI 622
            YL    +   +HRD               + DFG  R L  +  +  +   R   + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 623 APD 625
           AP+
Sbjct: 182 APE 184

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 76/190 (40%), Gaps = 4/190 (2%)
Query: 439 KILYEDL-INATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESF 496
           K L  D+  N   +F I   IG G +  VY+A  L DG  VALKK+   +  D+      
Sbjct: 20  KALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79
Query: 497 QNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN 556
             E  +L  + H N++K Y   +    +  + E  + G L  +++   +   L   R   
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER--T 137
Query: 557 IVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA 616
           + K      S L H  +  ++HRD               + D G  R     ++      
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 617 GTYGYIAPDQ 626
           GT  Y++P++
Sbjct: 198 GTPYYMSPER 207

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 95
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 446 INATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALK--KLHQSETEDSAFVESFQNEARV 502
           ++++  F     +G G Y +VYK      G  VALK  KL   E   S  +     E  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISL 56
Query: 503 LSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYV----LRDDDEAIELNWTRRVNIV 558
           +  ++H NIV+LY     +  +  ++E+M+     Y+    + +    +ELN  +     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW- 115
Query: 559 KSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT 618
             +   L++ H +    I+HRD            +  + DFG AR   +  +  +    T
Sbjct: 116 -QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 619 YGYIAPD 625
             Y APD
Sbjct: 172 LWYRAPD 178

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK +++     S      + E   L  +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           +I+KLY     K  +  + EY       Y+++ D    +++        + +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH 129
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG + ++  D +      G+  Y AP+
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPE 181

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 118
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 112
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 173 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 26/175 (14%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 113
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNRTLRAGTY 619
           L  +     +HRD               VA   DFG AR ++        RAG Y
Sbjct: 174 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--------RAGYY 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA++ + +++   S+  + F+ E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG +      +   T   G+  Y AP+
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPE 182

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           +  R  +GTG +  V  AE     K+VA+K + +   E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV L         ++ I + +  G LF  + +     E + +R   ++  V  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 571 DCTPSIVHRDXXXXXXXXXXXXEA---FVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
                IVHRD            E     ++DFG +++    S   T   GT GY+AP+  
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVL 190
Query: 628 LSPPVNQKI 636
              P ++ +
Sbjct: 191 AQKPYSKAV 199

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 7/179 (3%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+ + +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
            H NIVKL      +  ++ ++E++      ++       I L   +  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + H   +  ++HRD               +ADFG AR   V          T  Y AP+
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 102
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 163 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 12/199 (6%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G VYK  +    +VVA+K +   E      +E  Q E  VLS      I + +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
             L    ++ I EY+  GS   +L+       L  T    I++ +   L YLH +     
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERK--- 137
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKI 636
           +HRD            +  +ADFG A  L      R    GT  ++AP+       + K 
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK- 196
Query: 637 IQDIILVSTTALACLRSKP 655
             DI  +  TA+   + +P
Sbjct: 197 -ADIWSLGITAIELAKGEP 214

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 108
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 166
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 202

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 96
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 458 IGTGGYGSVYKA-ELPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A     GK      VA+K L  +   D    E+  +E +++S + +H N
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 103
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------DDDEAIELNWTRRVNIVKSVAH 563
           IV L G C H   +  I EY   G L   LR       D ++   L     ++    VA 
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            +++L    + + +HRD             A + DFG AR +  DS+
Sbjct: 164 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           +  R  +GTG +  V  AE     K+VA+K + +   E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV L         ++ I + +  G LF  + +     E + +R   ++  V  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 571 DCTPSIVHRDXXXXXXXXXXXXEA---FVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
                IVHRD            E     ++DFG +++    S   T   GT GY+AP+  
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL 190
Query: 628 LSPPVNQKI 636
              P ++ +
Sbjct: 191 AQKPYSKAV 199

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 458 IGTGGYGSVYK--AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G G Y +VYK  ++L D  +VALK++ + E E+ A   + + E  +L  ++H NIV L+
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                ++ +  ++EY+++    Y+   DD    +N       +  +   L+Y H      
Sbjct: 67  DIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQ---K 120
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           ++HRD            E  +ADFG AR   + +        T  Y  PD
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA++ + +++   S+  + F+ E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFG 600
                 IVHRD               +ADFG
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 109
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 167
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 203

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     + +G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 81  VDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 133
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 9/176 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  G+ VA+K + +++   ++  + F+ E R++  + H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ I EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCH 131
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
                 IVHRD               +ADFG +    V         G   Y AP+
Sbjct: 132 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPE 183

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 89
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 147
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 183

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 8/171 (4%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG VYKA +    + VA+K++ + E E+     +   E  +L  ++HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV--AHALSYLHHDCTP 574
              H   +  I+EY E     Y+ ++ D ++ +  +    ++  V   H+   LH D  P
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
               ++               + DFG AR   +     T    T  Y  P+
Sbjct: 161 ----QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 85
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 136
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRD               + DFG    +  + S R+   GT  ++AP+
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE 187

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 73/184 (39%), Gaps = 19/184 (10%)
Query: 450 EDFHIRYCIGTGGYGS-VYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + + V   EL   +  A+K L +        V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNIVKSVAHAL 565
              VKLY        ++F   Y + G L   +R     DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------AEIVSAL 143
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA----GTYGY 621
            YLH      I+HRD               + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 198
Query: 622 IAPD 625
           ++P+
Sbjct: 199 VSPE 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 44/207 (21%)
Query: 451 DFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           DF     IG+GG+G V+KA+   DGK   ++++  +        E  + E + L+ + H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAEREVKALAKLDHV 65
Query: 510 NIVKLYGFCL------------------------------HKRCMFFIYEYMERGSLFYV 539
           NIV  Y  C                                 +C+F   E+ ++G+L   
Sbjct: 66  NIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 540 LRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADF 599
           + +     +L+    + + + +   + Y+H   +  ++HRD            +  + DF
Sbjct: 125 I-EKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 600 GTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           G    L  D   RT   GT  Y++P+Q
Sbjct: 181 GLVTSLKND-GKRTRSKGTLRYMSPEQ 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRD               + DFG    +  + S R+   GT  ++AP+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE 186

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 21/176 (11%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     + +G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSV 561
           V + ++ +L G CL       I + M  G L   +R+  + I     LNW  ++      
Sbjct: 81  VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 133
Query: 562 AHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           A  ++YL       +VHRD               + DFG A+LL  +        G
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 122
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG AR ++  S  R
Sbjct: 183 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 7/169 (4%)
Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+   ++    D K V A K + +S        E    E  +  ++ H+++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
           F      +F + E   R SL   L    +A+     R    ++ +     YLH +    +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 162
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD            E  + DFG A  +  D   + +  GT  YIAP+
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           +  R  +GTG +  V  AE     K+VA+K + +   E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV L         ++ I + +  G LF  + +     E + +R   ++  V  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 571 DCTPSIVHRDXXXXXXXXXXXXEA---FVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
                IVHRD            E     ++DFG +++    S   T   GT GY+AP+  
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL 190
Query: 628 LSPPVNQKI 636
              P ++ +
Sbjct: 191 AQKPYSKAV 199

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 16/173 (9%)
Query: 458 IGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG+V+KA+  +  ++VALK++ + + +D     S   E  +L  ++H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS----VAHALSYLHHDC 572
                + +  ++E+ ++    Y           N      IVKS    +   L + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYF-------DSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 573 TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + +++HRD            E  +ADFG AR   +     +    T  Y  PD
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 171

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRD               + DFG    +  + S R+   GT  ++AP+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 452 FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           +  R  +GTG +  V  AE     K+VA+K + +   E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV L         ++ I + +  G LF  + +     E + +R   ++  V  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 571 DCTPSIVHRDXXXXXXXXXXXXE---AFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
                IVHRD            E     ++DFG +++    S   T   GT GY+AP+  
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL 190
Query: 628 LSPPVNQKI 636
              P ++ +
Sbjct: 191 AQKPYSKAV 199

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 7/169 (4%)
Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+   ++    D K V A K + +S        E    E  +  ++ H+++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
           F      +F + E   R SL   L    +A+     R    ++ +     YLH +    +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 160
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD            E  + DFG A  +  D   + +  GT  YIAP+
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 209

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 148
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 184

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 77/172 (44%), Gaps = 13/172 (7%)
Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLST 505
           +F     +G+G +G+VYK   +P+G+ V    A+ +L ++ +  +   +   +EA V+++
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKAN--KEILDEAYVMAS 107
Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           V + ++ +L G CL       I + M  G L   +R+  + I   +   +N    +A  +
Sbjct: 108 VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGM 164
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
           +YL       +VHRD               + DFG A+LL  +        G
Sbjct: 165 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 22/170 (12%)
Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTV- 506
           D   +  IG G +G V KA +    +    A+K++ +  ++D      F  E  VL  + 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 80
Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD-------------DDEAIELNWTR 553
            H NI+ L G C H+  ++   EY   G+L   LR              +  A  L+  +
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            ++    VA  + YL        +HR+             A +ADFG +R
Sbjct: 141 LLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 82
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 140
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 176

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 458 IGTGGYGSVYKA-ELPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A     GK      VA+K L  +   D    E+  +E +++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------DDDEAIELNWTRRVNIVKSVAH 563
           IV L G C H   +  I EY   G L   LR       D ++   L     ++    VA 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            +++L    + + +HRD             A + DFG AR +  DS+
Sbjct: 172 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGKVV----ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
           + +G +G+VYK   +P+G+ V    A+K+L ++ +  +   +   +EA V+++V + ++ 
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 80
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G CL       I + M  G L   +R+  + I     LNW  ++      A  ++YL
Sbjct: 81  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAG 617
                  +VHRD               + DFG A+LL  +        G
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 24/188 (12%)
Query: 458 IGTGGYG-SVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +G ++      DG+   +K+++ S        ES + E  VL+ ++H NIV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRE 90
Query: 517 FCLHKRCMFFIYEYMERGSLFY-------VLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
                  ++ + +Y E G LF        VL  +D+   L+W  ++ +      AL ++H
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQICL------ALKHVH 142
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAPDQR 627
                 I+HRD               + DFG AR+L  +S+    RA  GT  Y++P+  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEIC 197
Query: 628 LSPPVNQK 635
            + P N K
Sbjct: 198 ENKPYNNK 205

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 89
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 147
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 183

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 88
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 146
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 182

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 62/156 (39%), Gaps = 12/156 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 148
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           L    +   VHRD               VADFG AR
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 451 DFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K + +++   S+  + F+ E R+   + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKL+     ++ ++ + EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAK---FRQIVSAVQYCH 130
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFG 600
                 IVHRD               +ADFG
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFG 158

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 20/188 (10%)
Query: 452 FHIRYCIGTGGYGSVYK-AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + I   +GTG +G V++  E   G   A K +      D    E+ + E + +S +RH  
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHPT 215
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD------DDEAIELNWTRRVNIVKSVAHA 564
           +V L+        M  IYE+M  G LF  + D      +DEA+E  + R+V       H 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE--YMRQVCKGLCHMHE 273
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
            +Y+H D  P  +               E  + DFG    L    S + +  GT  + AP
Sbjct: 274 NNYVHLDLKPENI-------MFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAP 325
Query: 625 DQRLSPPV 632
           +     PV
Sbjct: 326 EVAEGKPV 333

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 87
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 145
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 57/154 (37%), Gaps = 8/154 (5%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           H    IG G +G VY   L   DGK +       +   D   V  F  E  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 511 IVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           ++ L G CL        +  YM+ G L   +R++     +     +     VA  + YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL- 144
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
              +   VHRD               VADFG AR
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 7/169 (4%)
Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+   ++    D K V A K + +S        E    E  +  ++ H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
           F      +F + E   R SL   L    +A+     R    ++ +     YLH +    +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--LRQIVLGCQYLHRN---RV 138
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD            E  + DFG A  +  D   +    GT  YIAP+
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE 187

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HRD               + DFG    +  + S R+   GT  ++AP+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE 186

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 7/169 (4%)
Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+   ++    D K V A K + +S        E    E  +  ++ H+++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
           F      +F + E   R SL   L    +A+     R    ++ +     YLH +    +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 136
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD            E  + DFG A  +  D   + +  GT  YIAP+
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 20/188 (10%)
Query: 452 FHIRYCIGTGGYGSVYK-AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + I   +GTG +G V++  E   G   A K +      D    E+ + E + +S +RH  
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHPT 109
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD------DDEAIELNWTRRVNIVKSVAHA 564
           +V L+        M  IYE+M  G LF  + D      +DEA+E  + R+V       H 
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE--YMRQVCKGLCHMHE 167
Query: 565 LSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
            +Y+H D  P  +               E  + DFG    L    S + +  GT  + AP
Sbjct: 168 NNYVHLDLKPENI-------MFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAP 219
Query: 625 DQRLSPPV 632
           +     PV
Sbjct: 220 EVAEGKPV 227

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 7/169 (4%)
Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+   ++    D K V A K + +S        E    E  +  ++ H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
           F      +F + E   R SL   L    +A+     R    ++ +     YLH +    +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 138
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD            E  + DFG A  +  D   +    GT  YIAP+
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE 187

>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 117/266 (43%), Gaps = 40/266 (15%)
Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNL 136
           ++P +I   + L  L+L+ N+++     +   L++L  L L NN +          LR L
Sbjct: 47  AVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 137 EELYLRSNKLSGVLPQEIGNL-KSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQF 194
           ++LY+  N L  + P    NL  SL+ L +  N +   +P  +F  L N+  + +G N  
Sbjct: 105 QKLYISKNHLVEIPP----NLPSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPL 159
Query: 195 --NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN 252
             +G  P     LK L +L I   KLTG IP  L    + L+LD   N++ +    ++  
Sbjct: 160 ENSGFEPGAFDGLK-LNYLRISEAKLTG-IPKDLPETLNELHLD--HNKIQAIELEDLLR 215
Query: 253 FSALAELDLSDNKIRGIIPDEXXXXXXXXXXXXXXXXXXGQIPFAIGKLFNLVSLDLSKN 312
           +S L  L L  N+IR I                      G + F    L  L  L L  N
Sbjct: 216 YSKLYRLGLGHNQIRMI--------------------ENGSLSF----LPTLRELHLDNN 251
Query: 313 KLSGSFPTGIGNCTELQHLALNHNSL 338
           KLS   P G+ +   LQ + L+ N++
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNI 276

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 66/161 (40%), Gaps = 16/161 (9%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 149
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRR--VNIVKSVAHAL 565
            N++ L G CL        +  YM+ G L   +R++      N T +  +     VA  +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGM 205
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
            +L    +   VHRD               VADFG AR ++
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 16/187 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +D+ ++  IG+G    V  A   P  + VA+K+++  + + S  ++    E + +S   H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLF-----YVLRDDDEAIELNWTRRVNIVKSVAH 563
            NIV  Y   + K  ++ + + +  GS+       V + + ++  L+ +    I++ V  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHV--DSSNRTLR---AGT 618
            L YLH +     +HRD               +ADFG +  L    D +   +R    GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 619 YGYIAPD 625
             ++AP+
Sbjct: 190 PCWMAPE 196

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 19/189 (10%)
Query: 447 NATEDFHIRY----CIGTGGYGSVY--KAELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           ++T  F  RY     +G G +G V   K ++  G+  A+K + + + +     ES   E 
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREV 77
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           ++L  + H NI KLY F   K   + + E    G LF      DE I       V+  + 
Sbjct: 78  QLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARI 131
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTL-RA 616
           +   LS + +     IVHRD            +     + DFG +   H ++S +   + 
Sbjct: 132 IRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKI 189
Query: 617 GTYGYIAPD 625
           GT  YIAP+
Sbjct: 190 GTAYYIAPE 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 16/187 (8%)
Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +D+ ++  IG+G    V  A   P  + VA+K+++  + + S  ++    E + +S   H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 67
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLF-----YVLRDDDEAIELNWTRRVNIVKSVAH 563
            NIV  Y   + K  ++ + + +  GS+       V + + ++  L+ +    I++ V  
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHV--DSSNRTLR---AGT 618
            L YLH +     +HRD               +ADFG +  L    D +   +R    GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 619 YGYIAPD 625
             ++AP+
Sbjct: 185 PCWMAPE 191

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 7/169 (4%)
Query: 458 IGTGGYGSVYKAELPDGK-VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+   ++    D K V A K + +S        E    E  +  ++ H+++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
           F      +F + E   R SL   L    +A+     R    ++ +     YLH +    +
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 142
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           +HRD            E  + DFG A  +  D   +    GT  YIAP+
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE 191

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 11/172 (6%)
Query: 458 IGTGGYGSVYKAELPD-GKVVALKKL---HQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G + +VYKA   +  ++VA+KK+   H+SE +D     + + E ++L  + H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIG 76
Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
           L     HK  +  ++++ME   L  +++D+   +  +  +   ++      L YLH    
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW- 132
Query: 574 PSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             I+HRD               +ADFG A+     +     +  T  Y AP+
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPE 182

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 62/156 (39%), Gaps = 12/156 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 91
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 149
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           L    +   VHRD               VADFG AR
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 96
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR+      +   L     +++ + +A    Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVA---DFGTARLLHVDSSNR 612
           L  +     +HRD               VA   DFG A+ ++  S  R
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQ-SETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G+G +G V   +      VA+K + + S +ED  F      EA+ +  + H  +VK YG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFF-----QEAQTMMKLSHPKLVKFYG 70
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSI 576
            C  +  ++ + EY+  G L   LR   + +E   ++ + +   V   +++L    +   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLE---SHQF 125
Query: 577 VHRDXXXXXXXXXXXXEAFVADFGTARLL 605
           +HRD               V+DFG  R +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 57/154 (37%), Gaps = 8/154 (5%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           H    IG G +G VY   L   DGK +       +   D   V  F  E  ++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 511 IVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           ++ L G CL        +  YM+ G L   +R++     +     +     VA  + +L 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL- 154
Query: 570 HDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
              +   VHRD               VADFG AR
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 148
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 184

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 62/156 (39%), Gaps = 12/156 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 91
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 149
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           L    +   VHRD               VADFG AR
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 64/159 (40%), Gaps = 12/159 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 148
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLH 606
           L    +   VHRD               VADFG AR ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 184

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 13/180 (7%)
Query: 452 FHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFV--ESFQNEARVLSTVRHR 509
           F  +  +G+G +G V+   L + +   L+++ ++  +D + V  E  + E  VL ++ H 
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           NI+K++        M+ + E  E G L   ++        L+      ++K + +AL+Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 569 HHDCTPSIVHRDXXXX---XXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H   +  +VH+D                  + DFG A L   D  + T  AGT  Y+AP+
Sbjct: 141 H---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPE 196

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 85
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
             L    ++ + EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 136
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++HR+               + DFG    +  + S R+   GT  ++AP+
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 187

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLL-HVDSSNRT 613
           +    +A  + YL    +   +HRD               +ADFG AR + ++D   +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 62/156 (39%), Gaps = 12/156 (7%)
Query: 453 HIRYCIGTGGYGSVYKAEL--PDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           H    IG G +G VY   L   DGK +  A+K L++    D   V  F  E  ++    H
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 88
Query: 509 RNIVKLYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
            N++ L G CL        +  YM+ G L   +R++     +     +     VA  + +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 146
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           L    +   VHRD               VADFG AR
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 16/173 (9%)
Query: 458 IGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG+V+KA+  +  ++VALK++ + + +D     S   E  +L  ++H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS----VAHALSYLHHDC 572
                + +  ++E+ ++    Y           N      IVKS    +   L + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYF-------DSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 573 TPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           + +++HRD            E  +A+FG AR   +     +    T  Y  PD
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

>pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 15/151 (9%)
Query: 124 GTTPIE-IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP--STLFR 180
           G T IE I  L NL  L L+ N+++ + P  + NL  +  L +     G P+   S +  
Sbjct: 58  GVTTIEGIQYLNNLIGLELKDNQITDLTP--LKNLTKITELELS----GNPLKNVSAIAG 111
Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L +++ L L   Q     P  +  L NL  L +  N++T   P  L  LT+L YL +  N
Sbjct: 112 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNN 167
Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIP 271
           Q++   PL   N S L  L   DNKI  I P
Sbjct: 168 QVNDLTPL--ANLSKLTTLRADDNKISDISP 196

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLL-HVDSSNRT 613
           +    +A  + YL    +   +HRD               +ADFG AR + ++D   +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 458 IGTGGYGSVYKA-ELPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A     GK      VA+K L  +   D    E+  +E +++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE-----------LNWTRRVNIVK 559
           IV L G C H   +  I EY   G L   LR     +E           L+    ++   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 560 SVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            VA  +++L    + + +HRD             A + DFG AR +  DS+
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY 515
           +G G YG V+K+ +   G+VVA+KK+  +    +    +F+ E  +L+ +  H NIV L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 516 GF--CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
                 + R ++ +++YME   L  V+R    A  L    +  +V  +   + YLH   +
Sbjct: 76  NVLRADNDRDVYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLH---S 127
Query: 574 PSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
             ++HRD               VADFG +R
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE+   +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEED--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 68/170 (40%), Gaps = 21/170 (12%)
Query: 458 IGTGGYGSVYKA-ELPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A     GK      VA+K L  +   D    E+  +E +++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           IV L G C H   +  I EY   G L   LR     +E +      I  S A     LH 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTASTRDLLHF 169
Query: 571 D----------CTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
                       + + +HRD             A + DFG AR +  DS+
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 68/180 (37%), Gaps = 11/180 (6%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            ED+ +   +G G  G V  A      + VA+K +      D    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N+VK YG        +   EY   G LF  +  D    E +  R       +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVY 119
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPD 625
           LH      I HRD               ++DFG A +   ++  R L    GT  Y+AP+
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 15/184 (8%)
Query: 450 EDFHIRYCIGTGGYGSVY---KAELPD-GKVVALKKLHQSE-TEDSAFVESFQNEARVLS 504
           E+F +   +GTG YG V+   K    D GK+ A+K L ++   + +   E  + E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 505 TVRHRNIVKLYGFCLHKRC-MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVA 562
            +R    +    +       +  I +Y+  G LF  L   +   E      V I V  + 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 169
Query: 563 HALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR-AGTYGY 621
            AL +LH      I++RD               + DFG ++    D + R     GT  Y
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 622 IAPD 625
           +APD
Sbjct: 227 MAPD 230

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 28/178 (15%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G   +G VYK  L         + VA+K L   +  +    E F++EA + + ++H N+
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSL--FYVLR---------DDDEAIE--LNWTRRVNIV 558
           V L G     + +  I+ Y   G L  F V+R         DDD  ++  L     V++V
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 559 KSVAHALSYL--HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL 614
             +A  + YL  HH     +VH+D               ++D G  R ++     + L
Sbjct: 152 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 204

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQ---NEARVLSTVRHRNIV 512
            +G+G +G+V+K   +P+G+ + +    +   ED +  +SFQ   +    + ++ H +IV
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G C     +  + +Y+  GSL   +R    A+     LNW  ++      A  + YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSN 611
                  +VHR+            +  VADFG A LL  D   
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189

>pdb|4AW4|A Chain A, Engineered Variant Of Listeria Monocytogenes Inlb Internalin Domain With An Additional Leucine Rich Repeat Inserted Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 106 IGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV 165
           I  L NL  L LSNN +   +PI+   L N+ +L+L  NKL+ + P  + NLK+L WL +
Sbjct: 62  IQYLPNLTSLNLSNNQITDISPIQY--LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 117
Query: 166 MYNTVGGPIPSTLFRLTNLERL-FLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS 224
             N V         +      L   G +  NG +     +L  L  L +  NK+T    +
Sbjct: 118 DENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV-----HLPQLESLYLGNNKITDI--T 170
Query: 225 TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI 269
            L  LT L  L L  NQ+   +PL     + L  L LS N I  +
Sbjct: 171 VLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNHISDL 213

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQ---NEARVLSTVRHRNIV 512
            +G+G +G+V+K   +P+G+ + +    +   ED +  +SFQ   +    + ++ H +IV
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE----LNWTRRVNIVKSVAHALSYL 568
           +L G C     +  + +Y+  GSL   +R    A+     LNW  ++      A  + YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSN 611
                  +VHR+            +  VADFG A LL  D   
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 28/178 (15%)
Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G   +G VYK  L         + VA+K L   +  +    E F++EA + + ++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 512 VKLYGFCLHKRCMFFIYEYMERGSL--FYVLR---------DDDEAIE--LNWTRRVNIV 558
           V L G     + +  I+ Y   G L  F V+R         DDD  ++  L     V++V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 559 KSVAHALSYL--HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTL 614
             +A  + YL  HH     +VH+D               ++D G  R ++     + L
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 47/225 (20%)
Query: 411 LAFTIFGFILLLKGKSE--NLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYK 468
           L+ ++  F +L   K E     LV G   G+  +  ++ AT  FH++   G  GY +V  
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATA-FHLK---GRAGYTTV-- 56
Query: 469 AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY 528
                   V + K + S +E    +    +E  VL  V H +++KLYG C     +  I 
Sbjct: 57  -------AVKMLKENASPSE----LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105
Query: 529 EYMERGSLFYVLRD-----------------------DDEAIELNWTRRVNIVKSVAHAL 565
           EY + GSL   LR+                       D+ A+ +     ++    ++  +
Sbjct: 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG--DLISFAWQISQGM 163
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            YL      S+VHRD            +  ++DFG +R ++ + S
Sbjct: 164 QYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 72/180 (40%), Gaps = 32/180 (17%)
Query: 458 IGTGGYGSVYKA-ELPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A     GK      VA+K L  +   D    E+  +E +++S + +H N
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 96
Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAI--------------------ELN 550
           IV L G C H   +  I EY   G L   LR   EA+                     L 
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
               ++    VA  +++L    + + +HRD             A + DFG AR +  DS+
Sbjct: 157 LRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H++Y   +G G +GSV       L D  G +VA+K+L  S  +       FQ E ++
Sbjct: 9   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 65
Query: 503 LSTVRHRNIVKLYG--FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L  +    IVK  G  +   ++ +  + EY+  G L   L+       L+ +R +     
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 123
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    +   VHRD               +ADFG A+LL +D     +R
Sbjct: 124 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 175

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 20/170 (11%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 64
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            + +   +A  ++YL+ +     VHRD               + DFG  R
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/192 (20%), Positives = 81/192 (42%), Gaps = 11/192 (5%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           T+++ +   +G G +  V +  ++P G+  A K ++  +       +  + EAR+   ++
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLK 61
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H NIV+L+     +   + +++ +  G LF      ++ +   +    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           ++H     IVHRD            +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 625 DQRLSPPVNQKI 636
           +     P  + +
Sbjct: 176 EVLRKDPYGKPV 187

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H++Y   +G G +GSV       L D  G +VA+K+L  S  +       FQ E ++
Sbjct: 8   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 64
Query: 503 LSTVRHRNIVKLYG--FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L  +    IVK  G  +   ++ +  + EY+  G L   L+       L+ +R +     
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 122
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    +   VHRD               +ADFG A+LL +D     +R
Sbjct: 123 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 174

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H++Y   +G G +GSV       L D  G +VA+K+L  S  +       FQ E ++
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 77
Query: 503 LSTVRHRNIVKLYG--FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L  +    IVK  G  +   ++ +  + EY+  G L   L+       L+ +R +     
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 135
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    +   VHRD               +ADFG A+LL +D     +R
Sbjct: 136 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 437 GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 489
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 532

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/192 (20%), Positives = 81/192 (42%), Gaps = 11/192 (5%)
Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           T+++ +   +G G +  V +  ++P G+  A K ++  +       +  + EAR+   ++
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLK 61
Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H NIV+L+     +   + +++ +  G LF      ++ +   +    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 568 LHHDCTPSIVHRDXXXXXXXXXXXXEAF---VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           ++H     IVHRD            +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 625 DQRLSPPVNQKI 636
           +     P  + +
Sbjct: 176 EVLRKDPYGKPV 187

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 438 GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 490
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 533

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 134
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 66
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 180
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 181 YRKGGKGLL-PVRWMSP 196

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 79  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--XYKAQTHG 174

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRR------------V 555
           +NI+ L G C     ++ I EY  +G+L  Y+   +   +E ++               V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 88  LKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLS 147
           L  L L  N+LT  +P EI +L NL VL LS+N L  + P E+GS   L+  Y   N ++
Sbjct: 249 LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL-TSLPAELGSCFQLKYFYFFDNMVT 306
Query: 148 GVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL 181
             LP E GNL +L +L V     G P+     ++
Sbjct: 307 -TLPWEFGNLCNLQFLGVE----GNPLEKQFLKI 335

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
           I + +F+   L RL+L  N     +P EI NL NL  L +  N+LT ++P+ LG    L 
Sbjct: 239 ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLK 296
Query: 234 YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIR 267
           Y    F+ + + +P E GN   L  L +  N + 
Sbjct: 297 YFYF-FDNMVTTLPWEFGNLCNLQFLGVEGNPLE 329

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 72
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 186
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 187 YRKGGKGLL-PVRWMSP 202

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS---LRNLEELYLRS 143
           N +YLNL+ N++          LR+LE+L LS N +     IE+G+   L +L  L L  
Sbjct: 36  NTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRK---IEVGAFNGLPSLNTLELFD 92
Query: 144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLG---------CNQ 193
           N+L+ V  Q    L  L  L +  N +   IPS  F R+ +L RL LG            
Sbjct: 93  NRLTTVPTQAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLRRLDLGELKRLEYISEAA 151
Query: 194 FNGTIPRE-----IGNLKNLTHLSIIT---------NKLTGAIPSTLGHLTSLLYLDLSF 239
           F G +        + NLK++ +L+ +          N+L    P +   LTSL  L L  
Sbjct: 152 FEGLVNLRYLNLGMCNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMH 211
Query: 240 NQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD 272
            Q+ +       +  +L EL+LS N +  +  D
Sbjct: 212 AQVATIERNAFDDLKSLEELNLSHNNLMSLPHD 244

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 83/231 (35%), Gaps = 41/231 (17%)
Query: 432 VTGGYDGKILYEDLINATEDFHIRY---------CIGTGGYGSVYKAEL----PDGKVVA 478
           VTG  D +  Y D      D    +          +G+G +G V  A        G  + 
Sbjct: 18  VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 77
Query: 479 LKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLF 537
           +      E  DS+  E+  +E ++++ +  H NIV L G C     ++ I+EY   G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 538 YVLRDDDEA-----IELNWTRRVN---------------IVKSVAHALSYLHHDCTPSIV 577
             LR   E      IE    +R+                    VA  + +L      S V
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 194
Query: 578 HRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGT---YGYIAPD 625
           HRD               + DFG AR +  D SN  +R        ++AP+
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPE 244

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 146
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/112 (25%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 460 TGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL 519
            G YG +++ E+    +  L K H++      + ESF   A ++S + H+++V  YG C+
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLNYGVCV 82
Query: 520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
                  + E+++ GSL   L+ +   I + W  ++ + K +A A+ +L  +
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEEN 132

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 66
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY---ETDY 180
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 181 YRKGGKGLL-PVRWMSP 196

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 17/183 (9%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   IG G +G V   ++ +  ++ A+K L++ E    A    F+ E  VL     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR-----RVNIVKSVAH 563
           + I  L+     +  ++ + +Y   G L  +L   ++ +  +  R      V  + S+ H
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI-H 208
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS-NRTLRAGTYGYI 622
            L Y+H D  P  V  D               +ADFG+   ++ D +   ++  GT  YI
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIR---------LADFGSCLKMNDDGTVQSSVAVGTPDYI 259
Query: 623 APD 625
           +P+
Sbjct: 260 SPE 262

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 20/170 (11%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 73
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
            + +   +A  ++YL+ +     VHRD               + DFG  R
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 70
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 184
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 185 YRKGGKGLL-PVRWMSP 200

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 17/183 (9%)
Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   IG G +G V   ++ +  ++ A+K L++ E    A    F+ E  VL     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR-----RVNIVKSVAH 563
           + I  L+     +  ++ + +Y   G L  +L   ++ +  +  R      V  + S+ H
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI-H 192
Query: 564 ALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS-NRTLRAGTYGYI 622
            L Y+H D  P  V  D               +ADFG+   ++ D +   ++  GT  YI
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIR---------LADFGSCLKMNDDGTVQSSVAVGTPDYI 243
Query: 623 APD 625
           +P+
Sbjct: 244 SPE 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 89
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G GG+  V   E L DG   ALK++   E +D    E  Q EA +     H NI++L  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHPNILRLVA 93
Query: 517 FCLHKRC----MFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
           +CL +R      + +  + +RG+L+  + R  D+   L   + + ++  +   L  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151
Query: 572 CTPSIVHRDXXXXXXXXXXXXEAFVADFGT--ARLLHVDSSNRTL-------RAGTYGYI 622
                 HRD            +  + D G+     +HV+ S + L       +  T  Y 
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 623 APD 625
           AP+
Sbjct: 211 APE 213

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 92
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 87
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I EY  +G+L   LR           D +   E   T +  V
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 85  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 137
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 180

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 93  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 145
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 188

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 79  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 174

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 79
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 193
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 194 YRKGGKGLL-PVRWMSP 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 23/177 (12%)
Query: 458 IGTGGYGSVYK------AELPDGKVVA---LKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K HQ E            E  +  ++ +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 101
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            ++V  +GF      ++ + E   R SL   L    +A+     R    ++     + YL
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR--YFMRQTIQGVQYL 158
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H++    ++HRD            +  + DFG A  +  D   +    GT  YIAP+
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 450 EDFHIRYC--IGTGGYGSVYKAE---LPD--GKVVALKKLHQSETEDSAFVESFQNEARV 502
           E+ H++Y   +G G +GSV       L D  G +VA+K+L  S  +       FQ E ++
Sbjct: 5   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 61
Query: 503 LSTVRHRNIVKLYG--FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS 560
           L  +    IVK  G  +   +  +  + EY+  G L   L+       L+ +R +     
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 119
Query: 561 VAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR 615
           +   + YL    +   VHRD               +ADFG A+LL +D     +R
Sbjct: 120 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVR 171

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 23/177 (12%)
Query: 458 IGTGGYGSVYK------AELPDGKVVA---LKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K HQ E            E  +  ++ +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 101
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            ++V  +GF      ++ + E   R SL   L    +A+     R    ++     + YL
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR--YFMRQTIQGVQYL 158
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H++    ++HRD            +  + DFG A  +  D   +    GT  YIAP+
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE 212

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 73  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 125
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 168

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 72/179 (40%), Gaps = 11/179 (6%)
Query: 89  KYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSG 148
           + L+L  N +      E  S  +LE L L+ N +    P    +L NL  L LRSN+L  
Sbjct: 35  RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL 94
Query: 149 VLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNL 208
           +       L +L  L +  N +   +      L NL+ L +G N       R    L +L
Sbjct: 95  IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSL 154
Query: 209 THLSIITNKLTGAIPSTLGHLTSLLYL-----------DLSFNQLHSFIPLEIGNFSAL 256
             L++    LT      L HL  L+ L           D SF +L+    LEI ++  L
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 73
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 187
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 188 YRKGGKGLL-PVRWMSP 203

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 72
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 186
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 187 YRKGGKGLL-PVRWMSP 202

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 2/90 (2%)
Query: 183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL 242
           ++  L+L  NQF   +P+E+ N K+LT + +  N+++     +  ++T LL L LS+N+L
Sbjct: 32  DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 243 HSFIPLEIGNFSALAELDLSDNKIRGIIPD 272
               P       +L  L L  N I  ++P+
Sbjct: 91  RCIPPRTFDGLKSLRLLSLHGNDI-SVVPE 119

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS---LRNLEELYLRS 143
           N +YLNL+ N++          LR+LE+L LS N +     IE+G+   L +L  L L  
Sbjct: 36  NTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRK---IEVGAFNGLPSLNTLELFD 92
Query: 144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLG---------CNQ 193
           N+L+ V  Q    L  L  L +  N +   IPS  F R+ +L RL LG            
Sbjct: 93  NRLTTVPTQAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLRRLDLGELKRLEYISEAA 151
Query: 194 FNGTIPRE-----IGNLKNLTHLSIIT---------NKLTGAIPSTLGHLTSLLYLDLSF 239
           F G +        + NLK++ +L+ +          N+L    P +   LTSL  L L  
Sbjct: 152 FEGLVNLRYLNLGMCNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMH 211
Query: 240 NQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD 272
            Q+ +       +  +L EL+LS N +  +  D
Sbjct: 212 AQVATIERNAFDDLKSLEELNLSHNNLMSLPHD 244

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 78
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/112 (25%), Positives = 56/112 (50%), Gaps = 11/112 (9%)
Query: 460 TGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL 519
            G YG +++ E+    +  L K H++      + ESF   A ++S + H+++V  YG C 
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLNYGVCF 82
Query: 520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
                  + E+++ GSL   L+ +   I + W  ++ + K +A A+ +L  +
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEEN 132

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 82
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 69
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR    A+  N        ++
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 130 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 183
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 184 YRKGGKGLL-PVRWMSP 199

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 79
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR    A+  N        ++
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 193
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 194 YRKGGKGLL-PVRWMSP 209

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 85
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 47/225 (20%)
Query: 411 LAFTIFGFILLLKGKSE--NLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYK 468
           L+ ++  F +L   K E     LV G   G+  +  ++ AT  FH++   G  GY +V  
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATA-FHLK---GRAGYTTV-- 56
Query: 469 AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY 528
                   V + K + S +E    +    +E  VL  V H +++KLYG C     +  I 
Sbjct: 57  -------AVKMLKENASPSE----LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105
Query: 529 EYMERGSLFYVLRD-----------------------DDEAIELNWTRRVNIVKSVAHAL 565
           EY + GSL   LR+                       D+ A+ +     ++    ++  +
Sbjct: 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG--DLISFAWQISQGM 163
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            YL       +VHRD            +  ++DFG +R ++ + S
Sbjct: 164 QYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 75  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 127
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 170

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 95  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 190

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++         K+ ++E  D A  +    EA V+  + +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
           G C  +  M  + E  E G L   L+ +    + N    + +V  V+  + YL      +
Sbjct: 95  GICEAESWML-VMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 576 IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYG 620
            VHRD             A ++DFG ++ L  D +    +A T+G
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHG 190

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 458 IGTGGYGSVYKAE---LPDGK-----VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE   L   K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 86
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR-LLHVDSSNRT 613
           +    VA  + YL    +   +HRD               +ADFG AR + H+D   +T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 448 ATEDFHIRYCIGTGGYGSVYKA-------ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           A E   +   +G G +G VY+        + P+ +V A+K ++++ +        F NEA
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 101
Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELN-------WTR 553
            V+      ++V+L G     +    I E M RG L   LR     +E N        ++
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRT 613
            + +   +A  ++YL+ +     VHRD               + DFG  R ++       
Sbjct: 162 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDY 215
Query: 614 LRAGTYGYIAPDQRLSP 630
            R G  G + P + +SP
Sbjct: 216 YRKGGKG-LLPVRWMSP 231

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 47/225 (20%)
Query: 411 LAFTIFGFILLLKGKSE--NLKLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYK 468
           L+ ++  F +L   K E     LV G   G+  +  ++ AT  FH++   G  GY +V  
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATA-FHLK---GRAGYTTV-- 56
Query: 469 AELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY 528
                   V + K + S +E    +    +E  VL  V H +++KLYG C     +  I 
Sbjct: 57  -------AVKMLKENASPSE----LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105
Query: 529 EYMERGSLFYVLRD-----------------------DDEAIELNWTRRVNIVKSVAHAL 565
           EY + GSL   LR+                       D+ A+ +     ++    ++  +
Sbjct: 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG--DLISFAWQISQGM 163
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSS 610
            YL       +VHRD            +  ++DFG +R ++ + S
Sbjct: 164 QYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 28/181 (15%)
Query: 457 CIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQN-EARVLSTVRHRNIVKLY 515
            IG G +G V++A+L +   VA+KK+ Q         + F+N E +++  V+H N+V L 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVDLK 98
Query: 516 GFCL----HKRCMF--FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK----SVAHAL 565
            F       K  +F   + EY+       V R      +L  T  + ++K     +  +L
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPET----VYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 566 SYLHHDCTPSIVHRDXXXXXXXXXXXXEAF-VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           +Y+H   +  I HRD                + DFG+A++L     N +     Y Y AP
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAP 210
Query: 625 D 625
           +
Sbjct: 211 E 211

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 26/178 (14%)
Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V+K E    G  +A K +     +D    E  +NE  V++ + H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQLYD 153
Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA------HALSYLHH 570
               K  +  + EY++ G LF   R  DE+  L     +  +K +       H +  LH 
Sbjct: 154 AFESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 571 DCTPS---IVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           D  P     V+RD               + DFG AR  +       +  GT  ++AP+
Sbjct: 212 DLKPENILCVNRDAKQIK----------IIDFGLAR-RYKPREKLKVNFGTPEFLAPE 258

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 23/177 (12%)
Query: 458 IGTGGYGSVYK------AELPDGKVVA---LKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K HQ E            E  +  ++ +
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 85
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            ++V  +GF      ++ + E   R SL   L    +A+     R    ++     + YL
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR--YFMRQTIQGVQYL 142
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H++    ++HRD            +  + DFG A  +  D   +    GT  YIAP+
Sbjct: 143 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 196

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 14/174 (8%)
Query: 458 IGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G G +GSV +      K    VA+K L Q    + A  E    EA+++  + +  IV+L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            G C     +  + E    G L   L    E I +  +    ++  V+  + YL      
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK--- 129
Query: 575 SIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLR-AGTY--GYIAPD 625
           + VHRD             A ++DFG ++ L  D S  T R AG +   + AP+
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 87/196 (44%), Gaps = 39/196 (19%)
Query: 83  GSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS---LRNLEEL 139
           G  +N + LNL  N +          LR+LE+L LS N +     IEIG+   L NL  L
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT---IEIGAFNGLANLNTL 117
Query: 140 YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTI 198
            L  N+L+ +       L  L  L +  N +   IPS  F R+ +L RL           
Sbjct: 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRL----------- 165
Query: 199 PREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA- 257
             ++G LK L+++S       GA       L++L YL+L+   L      EI N + L  
Sbjct: 166 --DLGELKRLSYIS------EGAFEG----LSNLRYLNLAMCNLR-----EIPNLTPLIK 208
Query: 258 --ELDLSDNKIRGIIP 271
             ELDLS N +  I P
Sbjct: 209 LDELDLSGNHLSAIRP 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 28/178 (15%)
Query: 458 IGTGGYGSVYKAELPDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           IG G +G V K  +  G  +  A KK+ +   ED   V+ F+ E  ++ ++ H NI++LY
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 516 GFCLHKRCMFFIYEYMERGSLF------YVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
                   ++ + E    G LF       V R+ D A          I+K V  A++Y H
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSAVAYCH 123
Query: 570 HDCTPSIVHRDXXXX---XXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
                ++ HRD                  + DFG A         RT + GT  Y++P
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGTPYYVSP 177

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 23/177 (12%)
Query: 458 IGTGGYGSVYK------AELPDGKVVA---LKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K HQ E            E  +  ++ +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 101
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            ++V  +GF      ++ + E   R SL   L    +A+     R    ++     + YL
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR--YFMRQTIQGVQYL 158
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H++    ++HRD            +  + DFG A  +  D   +    GT  YIAP+
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 212

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 17/177 (9%)
Query: 454 IRYCIGTGGYGSV-----YKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           IR  +G G +G V     YK +    + VALK + +   + S      + E   L  +RH
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            +I+KLY        +  + EY   G LF  + +     E    R     + +  A+ Y 
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRR---FFQQIICAIEYC 124
Query: 569 HHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           H      IVHRD               +ADFG + ++  D +      G+  Y AP+
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPE 177

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 27/168 (16%)
Query: 458 IGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----------DDDEAIELNWTRR--V 555
           +NI+ L G C     ++ I  Y  +G+L   LR           D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDXXXXXXXXXXXXEAFVADFGTAR 603
           +    +A  + YL    +   +HRD               +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 28/178 (15%)
Query: 458 IGTGGYGSVYKAELPDGKVV--ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
           IG G +G V K  +  G  +  A KK+ +   ED   V+ F+ E  ++ ++ H NI++LY
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLY 89
Query: 516 GFCLHKRCMFFIYEYMERGSLF------YVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
                   ++ + E    G LF       V R+ D A          I+K V  A++Y H
Sbjct: 90  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSAVAYCH 140
Query: 570 HDCTPSIVHRDXXXX---XXXXXXXXEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
                ++ HRD                  + DFG A         RT + GT  Y++P
Sbjct: 141 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGTPYYVSP 194

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 3/119 (2%)
Query: 84  SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT-TPIEIGSLRNLEELYLR 142
           SL NL YL++   +           L +LEVL ++ NS      P     LRNL  L L 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 143 SNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPR 200
             +L  + P    +L SL  L++  N +   +P  +F RLT+L++++L  N ++ + PR
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	701
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-113
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-110
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-110
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-103
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-89
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-88
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-87
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-74
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-72
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-69
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-54
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-36
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-67
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-65
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-46
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-65
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-64
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-61
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-60
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-58
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-56
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-35
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-63
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-59
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-56
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-55
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-58
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-25
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-58
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-57
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-19
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-52
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-48
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-35
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-53
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-52
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-51
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-43
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-21
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-50
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-50
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-27
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-50
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-49
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-48
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-26
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-48
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-47
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-47
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-42
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-46
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-30
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-26
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-46
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-24
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-46
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-45
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-44
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-33
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-43
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-43
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-43
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-37
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-42
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-32
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-39
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-39
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-27
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-40
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-40
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-40
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-33
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-40
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-40
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-38
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-39
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-38
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-38
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-29
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-35
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-32
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-35
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-29
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-33
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-29
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-33
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-33
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-31
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-32
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-31
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-31
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-31
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-17
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-30
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-26
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-24
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-29
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-29
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-28
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-25
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-24
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-08
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-18
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-27
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-27
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-27
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-25
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-24
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-24
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-23
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-23
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-20
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-22
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-21
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-21
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-21
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-19
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-19
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-18
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-18
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-13
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-14
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-13
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-12
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	5e-12
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-10
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-10
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-10
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	5e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-10
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	8e-06
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	7e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  363 bits (934), Expect = e-115
 Identities = 125/362 (34%), Positives = 183/362 (50%), Gaps = 8/362 (2%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           ++ H+++    + G+  S   S    L+ LN+ +N   G IPP    L +L+YL+L  N 
Sbjct: 224 ALQHLDISGNKLSGDF-SRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENK 280

Query: 98  LTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQE-IG 155
            TG IP  + G+   L  L LS N  +G  P   GS   LE L L SN  SG LP + + 
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLFRLT-NLERLFLGCNQFNGTIPREIGN--LKNLTHLS 212
            ++ L  L + +N   G +P +L  L+ +L  L L  N F+G I   +       L  L 
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400

Query: 213 IITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD 272
           +  N  TG IP TL + + L+ L LSFN L   IP  +G+ S L +L L  N + G IP 
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 273 ELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLA 332
           EL  +  L+ L L  N L+G+IP  +    NL  + LS N+L+G  P  IG    L  L 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520

Query: 333 LNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRD 392
           L++NS  G IP E+G    L  LDL+ N  +GTIP  +      ++ N + G+   Y+++
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580

Query: 393 NP 394
           + 
Sbjct: 581 DG 582

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  357 bits (919), Expect = e-113
 Identities = 117/360 (32%), Positives = 175/360 (48%), Gaps = 13/360 (3%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           ++  +++   +    +  L       LQ+L++  N LSG     I + + LK LN+  N 
Sbjct: 201 NLEFLDVSSNNFSTGIPFL--GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEI-GSLRNLEELYLRSNKLSGVLPQEIGN 156
             G IP     L++L+ L L+ N   G  P  + G+   L  L L  N   G +P   G+
Sbjct: 259 FVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316

Query: 157 LKSLIWLSVMYNTVGGPIP-STLFRLTNLERLFLGCNQFNGTIPREIGNLK-NLTHLSII 214
              L  L++  N   G +P  TL ++  L+ L L  N+F+G +P  + NL  +L  L + 
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376

Query: 215 TNKLTGAIPSTLGH--LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD 272
           +N  +G I   L      +L  L L  N     IP  + N S L  L LS N + G IP 
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436

Query: 273 ELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLA 332
            L  LS L+ L L  N+L G+IP  +  +  L +L L  N L+G  P+G+ NCT L  ++
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496

Query: 333 LNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPT 388
           L++N L G IP  IG++  L  L LS+N+ SG IP  L       +LD++ N   G IP 
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  351 bits (902), Expect = e-110
 Identities = 123/403 (30%), Positives = 184/403 (45%), Gaps = 38/403 (9%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIG--SLSNLKYLNLRW 95
            +  ++L      GEL     +   +L  L+L +NN SG I P +     + L+ L L+ 
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403

Query: 96  NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG 155
           N  TG IP  + +   L  L+LS N L GT P  +GSL  L +L L  N L G +PQE+ 
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT 215
            +K+L  L + +N + G IPS L   TNL  + L  N+  G IP+ IG L+NL  L +  
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
           N  +G IP+ LG   SL++LDL+ N  +  IP  +   S      ++ N I G     + 
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIK 579

Query: 276 KLSNLQYLNLSSNL--LSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
                +  + + NL    G     + +L      +++     G       N   +  L +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTY 389
           ++N L G IP EIG +  L  L+L HN++SG+IP  +  +     LD+S N L+G IP  
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699

Query: 390 L--------------------------RDNPPNSFVGNKGLCG 406
           +                             PP  F+ N GLCG
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  350 bits (900), Expect = e-110
 Identities = 115/365 (31%), Positives = 172/365 (47%), Gaps = 17/365 (4%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI---GSLSNLKYLNLR 94
            +  + +   ++             +L+ L+L  N++SG+             LK+L + 
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186

Query: 95  WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
            N ++G +   +    NLE L +S+N+     P  +G    L+ L +  NKLSG   + I
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAI 243

Query: 155 GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSI 213
                L  L++  N   GPIP     L +L+ L L  N+F G IP  + G    LT L +
Sbjct: 244 STCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301

Query: 214 ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKIRGIIPD 272
             N   GA+P   G  + L  L LS N     +P++ +     L  LDLS N+  G +P+
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361

Query: 273 ELSKLS-NLQYLNLSSNLLSGQIPFAIGK--LFNLVSLDLSKNKLSGSFPTGIGNCTELQ 329
            L+ LS +L  L+LSSN  SG I   + +     L  L L  N  +G  P  + NC+EL 
Sbjct: 362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV 421

Query: 330 HLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGE 385
            L L+ N L GTIP  +G +  L++L L  N L G IP  L  +     L + FN+L GE
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481

Query: 386 IPTYL 390
           IP+ L
Sbjct: 482 IPSGL 486

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  332 bits (853), Expect = e-103
 Identities = 118/418 (28%), Positives = 185/418 (44%), Gaps = 53/418 (12%)

Query: 1   SEIERQALLNCGWWKDRIPH--------NTSDHCNWVGITCDYKGSITHIELVECSIKGE 52
              E   L++   +KD +P         +  + C + G+TC     +T I          
Sbjct: 10  LYREIHQLIS---FKDVLPDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSI---------- 55

Query: 53  LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNL 112
                     +L    L  N    ++   + SL+ L+ L L  +++ G++        +L
Sbjct: 56  ----------DLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASL 102

Query: 113 EVLYLSNNSLHGTTP--IEIGSLRNLEELYLRSNKLSGVLPQEIG-NLKSLIWLSVMYNT 169
             L LS NSL G       +GS   L+ L + SN L        G  L SL  L +  N+
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162

Query: 170 VGGPIPSTLFR---LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTL 226
           + G              L+ L +  N+ +G +   +    NL  L + +N  +  IP  L
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-L 219

Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
           G  ++L +LD+S N+L       I   + L  L++S N+  G IP     L +LQYL+L+
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLA 277

Query: 287 SNLLSGQIPFAI-GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPE 345
            N  +G+IP  + G    L  LDLS N   G+ P   G+C+ L+ LAL+ N+  G +P +
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337

Query: 346 -IGKILLLQNLDLSHNNLSGTIPMTLHPM-----FLDMSFNNLEGEIPTYLRDNPPNS 397
            + K+  L+ LDLS N  SG +P +L  +      LD+S NN  G I   L  NP N+
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  280 bits (718), Expect = 4e-89
 Identities = 83/313 (26%), Positives = 136/313 (43%), Gaps = 28/313 (8%)

Query: 102 IPKEIGSLRNL----EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV--LPQEIG 155
           I K++G+   L          N +  G           +  L L    L     +P  + 
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 156 NLKSLIWLSVM-YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSII 214
           NL  L +L +   N + GPIP  + +LT L  L++     +G IP  +  +K L  L   
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 215 TNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAE-LDLSDNKIRGIIPDE 273
            N L+G +P ++  L +L+ +    N++   IP   G+FS L   + +S N++ G IP  
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
            + L NL +++LS N+L G      G   N   + L+KN L+      +G    L  L L
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDN 393
            +N + GT+P  + ++  L +L++S NNL G IP          +    +          
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-------NLQRFDVS-------- 296

Query: 394 PPNSFVGNKGLCG 406
              ++  NK LCG
Sbjct: 297 ---AYANNKCLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  278 bits (713), Expect = 3e-88
 Identities = 94/341 (27%), Positives = 145/341 (42%), Gaps = 46/341 (13%)

Query: 1   SEIERQALLNCGWWKDRIPH--------NTSDHCN--WVGITCDYKG---SITHIELVEC 47
           +  ++QALL     K  + +         T+D CN  W+G+ CD       + +++L   
Sbjct: 4   NPQDKQALLQ---IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60

Query: 48  SIKGELG-SLNFSCFPNLQYLNLWN-NNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE 105
           ++        + +  P L +L +   NNL G IPP I  L+ L YL +   N++G IP  
Sbjct: 61  NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120

Query: 106 IGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV 165
           +  ++ L  L  S N+L GT P  I SL NL  +    N++SG +P   G+   L     
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----- 175

Query: 166 MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPST 225
                                + +  N+  G IP    NL NL  + +  N L G     
Sbjct: 176 ------------------FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216

Query: 226 LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNL 285
            G   +   + L+ N L   +  ++G    L  LDL +N+I G +P  L++L  L  LN+
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275

Query: 286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCT 326
           S N L G+IP   G L        + NK     P  +  CT
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  275 bits (706), Expect = 3e-87
 Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 11/300 (3%)

Query: 77  SIPPQIGSLSNL----KYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPI--EI 130
            I   +G+ + L       +       G +         +  L LS  +L    PI   +
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 131 GSLRNLEELYLRS-NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFL 189
            +L  L  LY+   N L G +P  I  L  L +L + +  V G IP  L ++  L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 190 GCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL-YLDLSFNQLHSFIPL 248
             N  +GT+P  I +L NL  ++   N+++GAIP + G  + L   + +S N+L   IP 
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 249 EIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLD 308
              N + LA +DLS N + G          N Q ++L+ N L+  +   +G   NL  LD
Sbjct: 193 TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250

Query: 309 LSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPM 368
           L  N++ G+ P G+     L  L ++ N+L G IP + G +        ++N      P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  262 bits (672), Expect = 1e-78
 Identities = 64/379 (16%), Positives = 130/379 (34%), Gaps = 49/379 (12%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
               +  N        +   +  +L +L  + +        +P  + +L  ++++ ++ N
Sbjct: 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283

Query: 121 SLH--------GTTPIEIGSLRNLEELYLRSNKL-SGVLPQEIGNLKSLIWLSVMYNTVG 171
                           +      ++ +Y+  N L +  +   +  +K L  L  +YN + 
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343

Query: 172 GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTL--GHL 229
           G +P+       L  L L  NQ         G  + + +LS   NKL   IP+      +
Sbjct: 344 GKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSV 401

Query: 230 TSLLYLDLSFNQLHSF-------IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQY 282
           + +  +D S+N++ S        +         ++ ++LS+N+I     +  S  S L  
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461

Query: 283 LNLSSNLLSG-------QIPFAIGKLFNLVSLDLSKNKLSGSFPT-GIGNCTELQHLALN 334
           +NL  N+L+                 + L S+DL  NKL+             L  + L+
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLS 521

Query: 335 HNSLDGTIPPEIGK------ILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEG 384
           +NS     P +           +    D   N      P  +        L +  N++  
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580

Query: 385 EIPT---------YLRDNP 394
            +            ++DNP
Sbjct: 581 -VNEKITPNISVLDIKDNP 598

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  259 bits (665), Expect = 2e-77
 Identities = 65/377 (17%), Positives = 126/377 (33%), Gaps = 49/377 (12%)

Query: 48  SIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG 107
            +   +  L       L+   + N+        +     N +Y          T   +  
Sbjct: 197 FVSKAVMRL-----TKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWD 246

Query: 108 SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL--------SGVLPQEIGNLKS 159
           +L++L  + + N       P  + +L  ++ + +  N+               +    + 
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

Query: 160 LIWLSVMYNT-VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKL 218
           +  + + YN     P+ ++L ++  L  L    NQ  G +P   G+   L  L++  N++
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365

Query: 219 TGAIPSTLGHLTSLLYLDLSFNQLHSF-IPLEIGNFSALAELDLSDNKIRGI-------I 270
           T    +  G    +  L  + N+L       +  + S ++ +D S N+I  +       +
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425

Query: 271 PDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG-------SFPTGIG 323
                K  N+  +NLS+N +S            L S++L  N L+               
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485

Query: 324 NCTELQHLALNHNSLDGTIPPEIGKILL--LQNLDLSHNNLSGTIPMTL----------H 371
           N   L  + L  N L   +  +     L  L  +DLS+N+ S   P              
Sbjct: 486 NTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543

Query: 372 PMFLDMSFNNLEGEIPT 388
               D   N    E P 
Sbjct: 544 RNQRDAQGNRTLREWPE 560

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  257 bits (659), Expect = 1e-76
 Identities = 71/415 (17%), Positives = 140/415 (33%), Gaps = 65/415 (15%)

Query: 21  NTSDHCNW-VGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIP 79
            T    NW      D  G+   + L                   +  L+L     SG +P
Sbjct: 53  GTQPGANWNFNKELDMWGAQPGVSLNSNG--------------RVTGLSLEGFGASGRVP 98

Query: 80  PQIGSLSNLKYLNLRWNNLTG----TIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR- 134
             IG L+ L+ L L  +          PK I +  + E           T          
Sbjct: 99  DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158

Query: 135 -NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQ 193
            +L +  + S+     + +          +  + N +   +   + RLT L + ++G + 
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217

Query: 194 FNG-------------------TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
           F                     T   +  NLK+LT + +        +P+ L  L  +  
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277

Query: 235 LDLSFNQLHSF--------IPLEIGNFSALAELDLSDNKIRGI-IPDELSKLSNLQYLNL 285
           ++++ N+  S            +      +  + +  N ++   +   L K+  L  L  
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337

Query: 286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP- 344
             N L G++P A G    L SL+L+ N+++       G   ++++L+  HN L   IP  
Sbjct: 338 LYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNI 395

Query: 345 -EIGKILLLQNLDLSHNNLSGTIPMTLHPM-----------FLDMSFNNLEGEIP 387
            +   + ++  +D S+N +         P+            +++S N +     
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  256 bits (657), Expect = 2e-76
 Identities = 65/381 (17%), Positives = 127/381 (33%), Gaps = 41/381 (10%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNL--------SGSIPPQIGSLSNLK 89
            +T +E+  C    +L +      P +Q +N+  N                       ++
Sbjct: 250 DLTDVEVYNCPNLTKLPT-FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308

Query: 90  YLNLRWNNL-TGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSG 148
            + + +NNL T  +   +  ++ L +L    N L G  P   GS   L  L L  N+++ 
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE 367

Query: 149 VLPQEIGNLKSLIWLSVMYNTVGG-PIPSTLFRLTNLERLFLGCNQFNG-------TIPR 200
           +     G  + +  LS  +N +   P       ++ +  +    N+           +  
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

Query: 201 EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF-------IPLEIGNF 253
                 N++ +++  N+++          + L  ++L  N L                N 
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487

Query: 254 SALAELDLSDNKIRGIIPD-ELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSL----- 307
             L  +DL  NK+  +  D   + L  L  ++LS N  S   P        L        
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546

Query: 308 -DLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTI 366
            D   N+    +P GI  C  L  L +  N +   +  +I     +  LD+  N      
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP--NISVLDIKDNPNISID 603

Query: 367 PMTLHPM----FLDMSFNNLE 383
              + P        + ++  +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  252 bits (645), Expect = 1e-74
 Identities = 55/436 (12%), Positives = 129/436 (29%), Gaps = 61/436 (13%)

Query: 22  TSDHCNWV---GITCDYKGSITHIELVECSIKG----ELGSL------------------ 56
             +   W    G++ +  G +T + L      G     +G L                  
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 57  -----NFSCFPNLQYLNLWNNNLSGSIPPQIG--SLSNLKYLNLRWNNLTGTIPKEIGSL 109
                  S   + +       +   +          S+L    +  +    +I K     
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182

Query: 110 RNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT 169
                +   +N++       +  L  L + Y+ ++        E    ++       Y  
Sbjct: 183 LKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQ 236

Query: 170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA-------- 221
                      L +L  + +        +P  +  L  +  +++  N+            
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSF-IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNL 280
             +       +  + + +N L +F +   +     L  L+   N++ G +P        L
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355

Query: 281 QYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG-SFPTGIGNCTELQHLALNHNSLD 339
             LNL+ N ++       G    + +L  + NKL          + + +  +  ++N + 
Sbjct: 356 ASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIG 415

Query: 340 G-------TIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPT 388
                    + P   K + + +++LS+N +S               +++  N L   IP 
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK 474

Query: 389 YLRDNPPNSFVGNKGL 404
               +   +F     L
Sbjct: 475 NSLKDENENFKNTYLL 490

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  195 bits (498), Expect = 4e-54
 Identities = 52/320 (16%), Positives = 100/320 (31%), Gaps = 45/320 (14%)

Query: 38  SITHIELVECSIKG---ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNL 93
            +  +E +   ++G     GS        L  LNL  N ++  IP    G    ++ L+ 
Sbjct: 331 KLGMLECLYNQLEGKLPAFGSE-----IKLASLNLAYNQITE-IPANFCGFTEQVENLSF 384

Query: 94  RWNNLTGTIPK--EIGSLRNLEVLYLSNNSLHGTT-------PIEIGSLRNLEELYLRSN 144
             N L   IP   +  S+  +  +  S N +                   N+  + L +N
Sbjct: 385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443

Query: 145 KLSGVLPQEIGNLKSLIWLSVMYN-------TVGGPIPSTLFRLTNLERLFLGCNQFNGT 197
           ++S    +       L  +++M N                      L  + L  N+    
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK- 502

Query: 198 IPREI--GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL------DLSFNQLHSFIPLE 249
           +  +     L  L  + +  N  +   P+   + ++L         D   N+     P  
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561

Query: 250 IGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDL 309
           I    +L +L +  N IR  + +++    N+  L++  N         +          L
Sbjct: 562 ITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618

Query: 310 SKNKLSGSFPTGIGNCTELQ 329
             +K        I  C  L 
Sbjct: 619 FYDK-----TQDIRGCDALD 633

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (272), Expect = 9e-25
 Identities = 29/199 (14%), Positives = 61/199 (30%), Gaps = 14/199 (7%)

Query: 203 GNLKNLTHLSIITNKLTGAIPSTLGHLTSLL---YLDLSFNQLHSFIPLEIGNFSALAEL 259
             +K+   L  I + L G   S  G  T        +   +   +   + + +   +  L
Sbjct: 27  EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGL 86

Query: 260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ----IPFAIGKLFNLVSLDLSKNKLS 315
            L      G +PD + +L+ L+ L L S+          P  I    +       +    
Sbjct: 87  SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQ 146

Query: 316 GSFPTGIG--NCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM 373
            +F       + ++L    +N +    +I       L    +    NN++  +   +  +
Sbjct: 147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRL 205

Query: 374 ----FLDMSFNNLEGEIPT 388
                  M  +    E   
Sbjct: 206 TKLRQFYMGNSPFVAENIC 224

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  248 bits (636), Expect = 5e-73
 Identities = 94/394 (23%), Positives = 147/394 (37%), Gaps = 28/394 (7%)

Query: 38  SITHIELVECSIKG-ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWN 96
           ++  + L    I+  +   L+     +L+ L L +N +    P    ++  L  L L   
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 97  NLTGTIPKEIG---SLRNLEVLYLSNNSLHGTTPIEIGSLR--NLEELYLRSNKLSGVLP 151
            L  ++ +++    +  ++  L LSN+ L  T+      L+  NL  L L  N L+ V  
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 152 QEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLG---------CNQFNGTIPREI 202
                L  L +  + YN +      +L  L N+  L L                      
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 203 GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF-----SALA 257
             LK L HL++  N + G   +    L +L YL LS +   S   L    F     S L 
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT-SLRTLTNETFVSLAHSPLH 384

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF-AIGKLFNLVSLDLSKNKLSG 316
            L+L+ NKI  I  D  S L +L+ L+L  N +  ++       L N+  + LS NK   
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444

Query: 317 SFPTGIGNCTELQHLALNHNSLDG--TIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM- 373
                      LQ L L   +L    + P     +  L  LDLS+NN++      L  + 
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504

Query: 374 ---FLDMSFNNLEGEIPTYLRDNPPNSFVGNKGL 404
               LD+  NNL           P     G   L
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  248 bits (636), Expect = 5e-73
 Identities = 82/378 (21%), Positives = 145/378 (38%), Gaps = 27/378 (7%)

Query: 43  ELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTI 102
           E+ +CS    L  +      N+  LNL +N L           S L  L++ +N ++   
Sbjct: 7   EVADCSHLK-LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 103 PKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIW 162
           P+    L  L+VL L +N L   +        NL EL+L SN +  +        K+LI 
Sbjct: 66  PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125

Query: 163 LSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKN--LTHLSIITNKLTG 220
           L + +N +      T  +L NL+ L L  N+       E+    N  L  L + +N++  
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185

Query: 221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSDNKIRGIIPDELS-- 275
             P     +  L  L L+  QL   +  ++      +++  L LS++++           
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH 335
           K +NL  L+LS N L+     +   L  L    L  N +   F   +     +++L L  
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

Query: 336 N---------SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNL 382
           +         SL          +  L++L++  N++ G        +    +L +S +  
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365

Query: 383 EGEIPTYLRDNPPNSFVG 400
                  LR     +FV 
Sbjct: 366 S------LRTLTNETFVS 377

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  247 bits (634), Expect = 1e-72
 Identities = 78/388 (20%), Positives = 134/388 (34%), Gaps = 29/388 (7%)

Query: 38  SITHIELVECSIKGEL-GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWN 96
           SI ++ L    +      +     + NL  L+L  NNL+         L  L+Y  L +N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282

Query: 97  NLTGTIPKEIGSLRNLEVLYLSNN---------SLHGTTPIEIGSLRNLEELYLRSNKLS 147
           N+       +  L N+  L L  +         SL          L+ LE L +  N + 
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342

Query: 148 GVLPQEIGNLKSLIWLSVMYNTV-GGPIPSTLFR---LTNLERLFLGCNQFNGTIPREIG 203
           G+       L +L +LS+  +      + +  F     + L  L L  N+ +        
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402

Query: 204 NLKNLTHLSIITNKLTGAIP-STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS 262
            L +L  L +  N++   +       L ++  + LS+N+             +L  L L 
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462

Query: 263 DNKIRGI--IPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS----- 315
              ++ +   P     L NL  L+LS+N ++      +  L  L  LDL  N L+     
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522

Query: 316 ---GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP 372
              G     +   + L  L L  N  D         +  L+ +DL  NNL+       + 
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582

Query: 373 M----FLDMSFNNLEGEIPTYLRDNPPN 396
                 L++  N +             N
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRN 610

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  238 bits (609), Expect = 3e-69
 Identities = 85/360 (23%), Positives = 136/360 (37%), Gaps = 29/360 (8%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLR---------WNNLTGTIPKEIGS 108
           F+  P L+Y  L  NN+       +  L N++YLNL+           +L          
Sbjct: 268 FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327

Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG----NLKSLIWLS 164
           L+ LE L + +N + G        L NL+ L L ++  S                L  L+
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387

Query: 165 VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIP-REIGNLKNLTHLSIITNKLTGAIP 223
           +  N +          L +LE L LG N+    +  +E   L+N+  + +  NK      
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447

Query: 224 STLGHLTSLLYLDLSFNQLHSF--IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
           ++   + SL  L L    L +    P        L  LDLS+N I  I  D L  L  L+
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507

Query: 282 YLNLSSNLLS--------GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
            L+L  N L+        G   + +  L +L  L+L  N           +  EL+ + L
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMF-----LDMSFNNLEGEIPT 388
             N+L+          + L++L+L  N ++        P F     LDM FN  +    +
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  197 bits (504), Expect = 1e-54
 Identities = 74/296 (25%), Positives = 109/296 (36%), Gaps = 17/296 (5%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIG----SLSNLKYLNL 93
            + H+ + +  I G + S  F+   NL+YL+L N+  S            + S L  LNL
Sbjct: 330 CLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 94  RWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT-TPIEIGSLRNLEELYLRSNKLSGVLPQ 152
             N ++         L +LEVL L  N +    T  E   L N+ E+YL  NK   +   
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448

Query: 153 EIGNLKSLIWLSVMYN--TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTH 210
               + SL  L +           PS    L NL  L L  N         +  L+ L  
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508

Query: 211 LSIITNKLT--------GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS 262
           L +  N L         G     L  L+ L  L+L  N           +   L  +DL 
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568

Query: 263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLF-NLVSLDLSKNKLSGS 317
            N +  +     +   +L+ LNL  NL++       G  F NL  LD+  N    +
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  143 bits (362), Expect = 8e-36
 Identities = 50/187 (26%), Positives = 71/187 (37%), Gaps = 9/187 (4%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKI 266
           +         KLT  +P  L   T++  L+L+ NQL          +S L  LD+  N I
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 267 RGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCT 326
             + P+   KL  L+ LNL  N LS           NL  L L  N +            
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 327 ELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM------FLDMSFN 380
            L  L L+HN L  T      ++  LQ L LS+N +       L          L++S N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 381 NLEGEIP 387
            ++   P
Sbjct: 182 QIKEFSP 188

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  237 bits (605), Expect = 2e-67
 Identities = 60/378 (15%), Positives = 122/378 (32%), Gaps = 53/378 (14%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
           + +  N        +      +L +L  + L        +P  +  L  L+ L ++ N  
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 123 HGTT---------PIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGG 172
                          +  +   ++  Y+  N L        +  +  L  L  ++N V  
Sbjct: 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR- 586

Query: 173 PIPSTLFRLTNLERLFLGCNQFNGTIPREIG-NLKNLTHLSIITNKLTGAIPST--LGHL 229
                      L  L L  NQ    IP +       +  L    NKL   IP+      +
Sbjct: 587 -HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSV 643

Query: 230 TSLLYLDLSFNQLHS-----FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLN 284
             +  +D S+N++ S        ++       + + LS N+I+    +  +  S +  + 
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703

Query: 285 LSSNLLS-------GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI--GNCTELQHLALNH 335
           LS+NL++                 + L ++DL  NKL+ S            L ++ +++
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSY 762

Query: 336 NSLDGTIPPEIGK------ILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGE 385
           N    + P +           +    D   N +    P  +        L +  N++  +
Sbjct: 763 NCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-K 820

Query: 386 IPT---------YLRDNP 394
           +            + DNP
Sbjct: 821 VDEKLTPQLYILDIADNP 838

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  229 bits (586), Expect = 8e-65
 Identities = 66/378 (17%), Positives = 129/378 (34%), Gaps = 44/378 (11%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSG---------SIPPQIGSLSNL 88
            +T +EL  C    +L        P LQ LN+  N              +     +   +
Sbjct: 492 DLTDVELYNCPNMTQL-PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

Query: 89  KYLNLRWNNLTGTIPKE--IGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL 146
           +   + +NNL    P    +  +  L +L   +N +        G+   L +L L  N++
Sbjct: 551 QIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQI 607

Query: 147 SGVLPQEIG-NLKSLIWLSVMYNTVGG-PIPSTLFRLTNLERLFLGCNQFNGTIPREIG- 203
              +P++       +  L   +N +   P       +  +  +    N+      R I  
Sbjct: 608 EE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISC 665

Query: 204 -----NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF-------IPLEIG 251
                   N + +++  N++           + +  + LS N + S              
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725

Query: 252 NFSALAELDLSDNKIRGIIPD-ELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
           N   L  +DL  NK+  +  D   + L  L  +++S N  S   P        L +  + 
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784

Query: 311 K------NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSG 364
                  N++   +PTGI  C  L  L +  N +   +  ++     L  LD++ N    
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP--QLYILDIADNPNI- 840

Query: 365 TIPMTLHPMFLDMSFNNL 382
           +I +T    +++     L
Sbjct: 841 SIDVTSVCPYIEAGMYVL 858

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  207 bits (529), Expect = 4e-57
 Identities = 61/366 (16%), Positives = 112/366 (30%), Gaps = 36/366 (9%)

Query: 48  SIKGELGSLNFSCFPNLQYLNLWNNNLS-----GSIPPQIGSLSNLKYLNLRWNNLTGTI 102
           ++ G+          N  +   WN N             + +   +  L+L      G +
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 103 PKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG------N 156
           P  IG L  L+VL    +S   +  +        +    R +++     +         N
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399

Query: 157 LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITN 216
           L  L+  ++  N    PI           ++    N+    I + I  L  L  +    +
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANS 458

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK 276
             T    +           +  + + +    L   N   L +++L +      +PD L  
Sbjct: 459 PFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513

Query: 277 LSNLQYLNLSSNLLSG---------QIPFAIGKLFNLVSLDLSKNKLSG-SFPTGIGNCT 326
           L  LQ LN++ N             ++         +    +  N L        +    
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573

Query: 327 ELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM-----FLDMSFNN 381
           +L  L   HN +        G  + L +L L +N +   IP            L  S N 
Sbjct: 574 KLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630

Query: 382 LEGEIP 387
           L+  IP
Sbjct: 631 LK-YIP 635

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  176 bits (448), Expect = 2e-46
 Identities = 43/282 (15%), Positives = 91/282 (32%), Gaps = 32/282 (11%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGS-LSNLKYLNLRWNNLTGTIPK--EIGSLRNLEV 114
           F     L  L L  N +   IP    +    ++ L    N L   IP      S+  +  
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648

Query: 115 LYLSNNSLHG-----TTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN- 168
           +  S N +       +  ++     N   + L  N++     +       +  + +  N 
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 169 ------TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI--GNLKNLTHLSIITNKLTG 220
                     P          L  + L  N+   ++  +     L  L+++ +  N  + 
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS 767

Query: 221 AIPSTLGHLTSLLYLDLSF------NQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEL 274
             P+   + + L    +        N++    P  I    +L +L +  N IR  + ++L
Sbjct: 768 -FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL 825

Query: 275 SKLSNLQYLNLSSN-LLSGQIPFAIGKL-FNLVSLDLSKNKL 314
                L  L+++ N  +S  +      +   +  L   K + 
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  141 bits (356), Expect = 7e-35
 Identities = 35/225 (15%), Positives = 63/225 (28%), Gaps = 30/225 (13%)

Query: 53  LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLT-------GTIPKE 105
             S++     N   + L  N +         + S +  + L  N +T             
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723

Query: 106 IGSLRNLEVLYLSNNSLHGTTP-IEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLS 164
             +   L  + L  N L   +      +L  L  + +  N  S   P +  N   L    
Sbjct: 724 YKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFG 782

Query: 165 VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS 224
           + +                        N+     P  I    +L  L I +N +   +  
Sbjct: 783 IRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDE 823

Query: 225 TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI 269
            L     L  LD++ N   S     +  +       L  +K + I
Sbjct: 824 KL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 36/323 (11%), Positives = 100/323 (30%), Gaps = 27/323 (8%)

Query: 85  LSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN 144
            SN++Y+++   N   +  +    L+ ++V Y  ++  H     +  + + ++      +
Sbjct: 152 FSNIRYVDVTVMN---SFNRVTTELKGMKVTYKEDSKEH--QNPDNANDKYMDIGVATCD 206

Query: 145 KLSGVLPQEIGNLKSLIWLSVMYNTVG----GPIPSTLF-----RLTNLERLFLGCNQFN 195
                LP     + +    S             +    F     +LT    + +   +  
Sbjct: 207 SAVW-LPAGTYQVVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETA 265

Query: 196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSA 255
             I            L     +      +   H  +    +   +       +++ N   
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGR 324

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS 315
           +  L L+    +G +PD + +L+ L+ L+  ++  +        +       +  K+++ 
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 316 GSFPTGIG------NCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT 369
             +           N ++L   A+N N     I  +    L    +    N ++  I   
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKA 443

Query: 370 LHPM----FLDMSFNNLEGEIPT 388
           +  +     +  + +    +   
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIA 466

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 13/112 (11%), Positives = 36/112 (32%), Gaps = 4/112 (3%)

Query: 48  SIKGELGSL-NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEI 106
           S   +  +      F      +   N +    P  I +  +L  L +  N++   + +++
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825

Query: 107 GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLK 158
                L +L +++N         +          L  +K   +   +   ++
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 22/229 (9%), Positives = 62/229 (27%), Gaps = 14/229 (6%)

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
            T L+ + +   + +               + + T      +P+    + +      S  
Sbjct: 170 TTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQSGI 229

Query: 241 QLH---------SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           +               +     +  A + +   +    I D  +  +  + L+  +    
Sbjct: 230 KRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYY 289

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
                      N  + +   +         + N   +  L+L      G +P  IG++  
Sbjct: 290 SGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTE 348

Query: 352 LQNLDLSHNNLSGTIPM----TLHPMFLDMSFNNLEGEIPTYLRDNPPN 396
           L+ L    ++ + +  +     L P   +   + +         D    
Sbjct: 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  218 bits (559), Expect = 1e-65
 Identities = 71/185 (38%), Positives = 103/185 (55%), Gaps = 4/185 (2%)

Query: 442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEAR 501
             +L  A+++F  +  +G GG+G VYK  L DG +VA+K+L   E         FQ E  
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQTEVE 79

Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEA-IELNWTRRVNIVKS 560
           ++S   HRN+++L GFC+       +Y YM  GS+   LR+  E+   L+W +R  I   
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTY 619
            A  L+YLH  C P I+HRD+ + NILL+   EA V DFG A+L+    ++ T    GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 620 GYIAP 624
           G+IAP
Sbjct: 200 GHIAP 204

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  222 bits (567), Expect = 8e-64
 Identities = 69/368 (18%), Positives = 122/368 (33%), Gaps = 26/368 (7%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSI---PPQIGSLSNLKYLNLR 94
            +  + L        +          L+   L                 +L  L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 95  WNNLT------GTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSG 148
              L         I      L N+    L + ++      +       + L L + K   
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ 318

Query: 149 VLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN--GTIPREIGNLK 206
               ++ +LK L      + +  G    +   L +LE L L  N  +  G   +      
Sbjct: 319 FPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNK 265
           +L +L +  N +   + S    L  L +LD   + L       +  +   L  LD+S   
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 266 IRGIIPDELSKLSNLQYLNLSSNLLSGQI-PFAIGKLFNLVSLDLSKNKLSGSFPTGIGN 324
            R       + LS+L+ L ++ N       P    +L NL  LDLS+ +L    PT   +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 325 CTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMF-----LDMSF 379
            + LQ L ++HN+           +  LQ LD S N++  +    L         L+++ 
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552

Query: 380 NNLEGEIP 387
           N+      
Sbjct: 553 NDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  221 bits (564), Expect = 2e-63
 Identities = 79/374 (21%), Positives = 132/374 (35%), Gaps = 25/374 (6%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLS------GSIPPQIGSLSNLKYL 91
            +  + L E   +G L   + S    L  L +    L+        I      L+N+   
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287

Query: 92  NLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLP 151
           +L    +              + L L N             L++L+ L   SNK      
Sbjct: 288 SLVSVTIERVKD--FSYNFGWQHLELVNCKF---GQFPTLKLKSLKRLTFTSNKGGNAFS 342

Query: 152 QEIGNLKSLIWLSVMYN--TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT 209
               +L SL +L +  N  +  G    + F  T+L+ L L  N    T+      L+ L 
Sbjct: 343 --EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399

Query: 210 HLSIITNKLTGAIP-STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRG 268
           HL    + L      S    L +L+YLD+S               S+L  L ++ N  + 
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 269 -IIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTE 327
             +PD  ++L NL +L+LS   L    P A   L +L  L++S N               
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519

Query: 328 LQHLALNHNSLDGTIPPEIGKIL-LLQNLDLSHNNLSGTIPMTLHPMFL------DMSFN 380
           LQ L  + N +  +   E+      L  L+L+ N+ + T        ++       +   
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 579

Query: 381 NLEGEIPTYLRDNP 394
            +E   P+  +  P
Sbjct: 580 RMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  214 bits (548), Expect = 4e-61
 Identities = 76/364 (20%), Positives = 118/364 (32%), Gaps = 43/364 (11%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
             + + L+L  N L         S   L+ L+L    +         SL +L  L L+ N
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT-VGGPIPSTLF 179
            +          L +L++L      L+ +    IG+LK+L  L+V +N      +P    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 180 RLTNLERLFLGCNQFNGTIPREIGNLKNLT----HLSIITNKLTGAIPSTLGHLTSLLYL 235
            LTNLE L L  N+       ++  L  +      L +  N +    P     +  L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKL 205

Query: 236 DLSFNQLHSFIP-LEIGNFSALAELDLSDNKIRG---IIPDELSKLSNLQYLNLSSNLLS 291
            L  N     +    I   + L    L   + R    +   + S L  L  L +    L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 292 ------GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL------- 338
                   I      L N+ S  L    +              QHL L +          
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLK 323

Query: 339 ------------DGTIPPEIGKILLLQNLDLSHNNLS--GTIPMTLHPM----FLDMSFN 380
                        G        +  L+ LDLS N LS  G    +        +LD+SFN
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 381 NLEG 384
            +  
Sbjct: 384 GVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (540), Expect = 5e-60
 Identities = 76/364 (20%), Positives = 116/364 (31%), Gaps = 28/364 (7%)

Query: 53  LGSLNFSCF--PNLQYLNLWNNNLSGSIPPQ-IGSLSNLKYLNLRWNNLTGTIPKE---I 106
           +  +    F    L  L L NN  S ++    I  L+ L+   L           E    
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 107 GSLRNLEVLYLSNNSL------HGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL 160
            +L  L  L +    L                L N+    L S  +  V           
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGW 306

Query: 161 IWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT- 219
             L ++    G      L  L  L           G       +L +L  L +  N L+ 
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361

Query: 220 -GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE-LSKL 277
            G    +    TSL YLDLSFN + + +         L  LD   + ++ +        L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420

Query: 278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHN 336
            NL YL++S              L +L  L ++ N    +F   I      L  L L+  
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480

Query: 337 SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTYLRD 392
            L+   P     +  LQ L++SHNN           +     LD S N++       L+ 
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540

Query: 393 NPPN 396
            P +
Sbjct: 541 FPSS 544

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  205 bits (523), Expect = 9e-58
 Identities = 64/345 (18%), Positives = 119/345 (34%), Gaps = 26/345 (7%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIP-----------------P 80
           +I    L       +     F+C  N+   +L +  +                       
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317

Query: 81  QIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH--GTTPIEIGSLRNLEE 138
           Q  +L       L + +  G        L +LE L LS N L   G          +L+ 
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGT 197
           L L  N +   +      L+ L  L   ++ +      ++F  L NL  L +        
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 198 IPREIGNLKNLTHLSIITNKLTGAI-PSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL 256
                  L +L  L +  N       P     L +L +LDLS  QL    P    + S+L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496

Query: 257 AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLF-NLVSLDLSKNKLS 315
             L++S N    +       L++LQ L+ S N +       +     +L  L+L++N  +
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556

Query: 316 GSFPTG--IGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLS 358
            +      +    + + L +    ++   P +   + +L +L+++
Sbjct: 557 CTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL-SLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  200 bits (510), Expect = 6e-56
 Identities = 74/405 (18%), Positives = 124/405 (30%), Gaps = 47/405 (11%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKY----LNL 93
           ++  + +    I+       FS   NL++L+L +N +       +  L  +      L+L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 94  RWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT-TPIEIGSLRNLEELYLRSNKLSG---V 149
             N +    P     +  L  L L NN          I  L  LE   L   +      +
Sbjct: 185 SLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 150 LPQEIGNLKSLIWLSVMYNT------VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG 203
              +   L+ L  L++              I      LTN+    L              
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FS 301

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
                 HL ++  K        L  L  L +         S + L      +L  LDLS 
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL-----PSLEFLDLSR 356

Query: 264 NKI--RGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG 321
           N +  +G         ++L+YL+LS N +   +      L  L  LD   + L       
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415

Query: 322 I-GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTI-PMTLHPM----FL 375
           +  +   L +L ++H             +  L+ L ++ N+      P     +    FL
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475

Query: 376 DMSFNNLEGEIPT-----------YLRDN-----PPNSFVGNKGL 404
           D+S   LE   PT            +  N         +     L
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  140 bits (354), Expect = 4e-35
 Identities = 50/182 (27%), Positives = 71/182 (39%), Gaps = 12/182 (6%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
                 IP  L    S   LDLSFN L         +F  L  LDLS  +I+ I      
Sbjct: 17  LNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH 335
            LS+L  L L+ N +      A   L +L  L   +  L+      IG+   L+ L + H
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 336 NSLDGT-IPPEIGKILLLQNLDLSHNNLSGTIP--------MTLHPMFLDMSFNNLEGEI 386
           N +    +P     +  L++LDLS N +             M L  + LD+S N +    
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193

Query: 387 PT 388
           P 
Sbjct: 194 PG 195

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  213 bits (544), Expect = 4e-63
 Identities = 93/329 (28%), Positives = 151/329 (45%), Gaps = 23/329 (6%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                 ++  L +    ++ SI   I  L+NL+YLNL  N +T   P  + +L  L  LY
Sbjct: 39  TQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           +  N +  T    + +L NL ELYL  + +S + P  + NL  +  L++  N       S
Sbjct: 95  IGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLS 149

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            L  +T L  L +  ++     P  I NL +L  LS+  N++    P  L  LTSL Y  
Sbjct: 150 PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT 205

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
              NQ+    P+   N + L  L + +NKI  + P  L+ LS L +L + +N +S  I  
Sbjct: 206 AYVNQITDITPV--ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-IN- 259

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
           A+  L  L  L++  N++S    + + N ++L  L LN+N L       IG +  L  L 
Sbjct: 260 AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317

Query: 357 LSHNNLSGTIPMTLHP--MFLDMSFNNLE 383
           LS N+++   P+         D +   ++
Sbjct: 318 LSQNHITDIRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  203 bits (519), Expect = 1e-59
 Identities = 72/335 (21%), Positives = 142/335 (42%), Gaps = 27/335 (8%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
             +         L   +++  +      L ++  L +    +     + I  L NLE L 
Sbjct: 17  PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           L+ N +  T    + +L  L  LY+ +NK++      + NL +L  L +  + +    P 
Sbjct: 73  LNGNQI--TDISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            L  LT +  L LG N  N +    + N+  L +L++  +K+    P  + +LT L  L 
Sbjct: 128 -LANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           L++NQ+    PL   + ++L       N+I  I P  ++ ++ L  L + +N ++   P 
Sbjct: 184 LNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL 239

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
               L  L  L++  N++S      + + T+L+ L +  N +  +    +  +  L +L 
Sbjct: 240 --ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLF 293

Query: 357 LSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIP 387
           L++N L       +  +     L +S N++    P
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  194 bits (495), Expect = 3e-56
 Identities = 75/301 (24%), Positives = 132/301 (43%), Gaps = 22/301 (7%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           ++ ++ L    I         S    L  L +  N ++      + +L+NL+ L L  +N
Sbjct: 67  NLEYLNLNGNQITD---ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDN 121

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNL 157
           ++   P  + +L  +  L L  N    +    + ++  L  L +  +K+  V P  I NL
Sbjct: 122 ISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANL 176

Query: 158 KSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK 217
             L  LS+ YN +    P  L  LT+L       NQ     P  + N+  L  L I  NK
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232

Query: 218 LTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL 277
           +T   P  L +L+ L +L++  NQ+     +   + + L  L++  N+I  I    L+ L
Sbjct: 233 ITDLSP--LANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNVGSNQISDISV--LNNL 286

Query: 278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNS 337
           S L  L L++N L  +    IG L NL +L LS+N ++   P  + + +++      +  
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

Query: 338 L 338
           +
Sbjct: 345 I 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  192 bits (490), Expect = 1e-55
 Identities = 73/333 (21%), Positives = 137/333 (41%), Gaps = 25/333 (7%)

Query: 64  LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH 123
              L      ++   P     L+      L+  ++T  +      L ++  L ++   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56

Query: 124 GTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTN 183
             +   I  L NLE L L  N+++ + P  + NL  L  L +  N +     S L  LTN
Sbjct: 57  -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 184 LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           L  L+L  +  +   P  + NL  +  L++  N       S L ++T L YL ++ +++ 
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN 303
              P  I N + L  L L+ N+I  I P  L+ L++L Y     N ++   P  +  +  
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222

Query: 304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           L SL +  NK++    + + N ++L  L +  N +  +    +  +  L+ L++  N +S
Sbjct: 223 LNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQIS 278

Query: 364 GTIPMTLHP--MFLDMSFNNLEGEIPTYLRDNP 394
               +        L ++ N L  E    +    
Sbjct: 279 DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  216 bits (553), Expect = 7e-62
 Identities = 71/352 (20%), Positives = 132/352 (37%), Gaps = 15/352 (4%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
           F     L  L L  N L       +     LK+L      ++      + + + LE LYL
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL--IWLSVMYNTVGGPIP 175
            +N +      +      L+ L  ++N +  +  +++ +L+    + L++  N + G I 
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IE 195

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGN--LKNLTHLSIITNKLTGAIPSTLGHL--TS 231
              F     + L  G  Q    I + + N  +++L   +          P+    L   S
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           +  ++L  +   +        FS L ELDL+   +  + P  L  LS L+ L LS+N   
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFE 314

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTG-IGNCTELQHLALNHNSLD--GTIPPEIGK 348
                +     +L  L +  N       TG + N   L+ L L+H+ ++       ++  
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 349 ILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTYLRDNPPN 396
           +  LQ+L+LS+N                  LD++F  L+ +       N   
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  215 bits (550), Expect = 2e-61
 Identities = 64/335 (19%), Positives = 113/335 (33%), Gaps = 13/335 (3%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
             + + L    N L          L NL +L+L    +         S   L+ L L+ N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            L       +   + L+ L+     +S +    + N K+L  L +  N +        F 
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSII--TNKLTGAIPSTLGHLTSLLYLDLS 238
              L+ L    N  +     ++ +L+  T+LS+    N + G I            L+  
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210

Query: 239 FNQLHSFIPLEIGN--FSALAELDLSDNKIRGIIPDELSKLS--NLQYLNLSSNLLSGQI 294
             Q    I   + N    +L      D     I P     L   +++ +NL  +      
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQN 354
                    L  LDL+   LS   P+G+   + L+ L L+ N  +            L +
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 355 LDLSHNNLSGTIPM-TLHPM----FLDMSFNNLEG 384
           L +  N     +    L  +     LD+S +++E 
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  211 bits (540), Expect = 4e-60
 Identities = 71/338 (21%), Positives = 122/338 (36%), Gaps = 9/338 (2%)

Query: 54  GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLE 113
                 C  +++ +NL  +             S L+ L+L   +L+  +P  +  L  L+
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVL-PQEIGNLKSLIWLSVMYN--TV 170
            L LS N       I   +  +L  L ++ N     L    + NL++L  L + ++    
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP-STLGHL 229
                  L  L++L+ L L  N+              L  L +   +L      S   +L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424

Query: 230 TSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGII---PDELSKLSNLQYLNLS 286
             L  L+LS + L            AL  L+L  N          + L  L  L+ L LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
              LS     A   L  +  +DLS N+L+ S    + +   + +L L  N +   +P  +
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLL 543

Query: 347 GKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEG 384
             +   + ++L  N L  T        +   +   LE 
Sbjct: 544 PILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLED 581

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  207 bits (528), Expect = 2e-58
 Identities = 69/352 (19%), Positives = 124/352 (35%), Gaps = 15/352 (4%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIG--SLSNLKYLNLRWNNLTGTIPKEIGSLR--NL 112
                   Q LN         I   +   ++ +L        +     P     L   ++
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
           E + L  +     +         L+EL L +  LS  LP  +  L +L  L +  N    
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFEN 315

Query: 173 PIPSTLFRLTNLERLFLGCNQFNGTIPRE-IGNLKNLTHLSIITNKLT--GAIPSTLGHL 229
               +     +L  L +  N     +    + NL+NL  L +  + +         L +L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375

Query: 230 TSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE-LSKLSNLQYLNLSSN 288
           + L  L+LS+N+  S           L  LDL+  +++          L  L+ LNLS +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 289 LLSGQIPFAIGKLFNLVSLDLSKNKLSGSF---PTGIGNCTELQHLALNHNSLDGTIPPE 345
           LL          L  L  L+L  N            +     L+ L L+   L       
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495

Query: 346 IGKILLLQNLDLSHNNLSGTIPMTLHPM---FLDMSFNNLEGEIPTYLRDNP 394
              + ++ ++DLSHN L+ +    L  +   +L+++ N++   +P+ L    
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILS 547

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  192 bits (490), Expect = 3e-53
 Identities = 69/313 (22%), Positives = 125/313 (39%), Gaps = 12/313 (3%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE-IGSLRNLEVLY 116
                 L+ L L  N           +  +L +L+++ N     +    + +L NL  L 
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356

Query: 117 LSNNSLH--GTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           LS++ +       +++ +L +L+ L L  N+   +  +       L  L + +  +    
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 175 PSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAI---PSTLGHLT 230
             + F+ L  L+ L L  +  + +  +    L  L HL++  N          ++L  L 
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
            L  L LSF  L S       +   +  +DLS N++     + LS L  + YLNL+SN +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535

Query: 291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL 350
           S  +P  +  L    +++L +N L  +      N   L+    N   L+ T         
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCT----CSNIYFLEWYKENMQKLEDTEDTLCENPP 591

Query: 351 LLQNLDLSHNNLS 363
           LL+ + LS   LS
Sbjct: 592 LLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  172 bits (439), Expect = 3e-46
 Identities = 60/346 (17%), Positives = 104/346 (30%), Gaps = 63/346 (18%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS 118
                 +  N  N  L+  IP  +   ++ + L   +N L          L NL  L L+
Sbjct: 9   IEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLT 65

Query: 119 NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTL 178
              ++        S   L+ L L +N L                           +  T 
Sbjct: 66  RCQIYWIHEDTFQSQHRLDTLVLTANPLIF-------------------------MAETA 100

Query: 179 FRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLS 238
                                      K L HL  I   ++      L +  +L  L L 
Sbjct: 101 LS-----------------------GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137

Query: 239 FNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ--YLNLSSNLLSGQIPF 296
            N + S    +      L  LD  +N I  +  +++S L       LNL+ N ++G I  
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEP 196

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCT--ELQHLALNHNSLDGTIPPEIGKI--LLL 352
                    SL+    +       G+ N T   L          +   P     +  + +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256

Query: 353 QNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTYLRDNP 394
           ++++L  +        T H       LD++  +L  E+P+ L    
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS 301

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  150 bits (380), Expect = 2e-38
 Identities = 47/232 (20%), Positives = 65/232 (28%), Gaps = 11/232 (4%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
           IP TL    + E L    N            L NLT L +   ++      T      L 
Sbjct: 27  IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 234 YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ 293
            L L+ N L       +    AL  L      I  I    L     L+ L L SN +S  
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144

Query: 294 IPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQH--LALNHNSLDGTIPPEIGKILL 351
                     L  LD   N +       + +  +  +  L LN N +   I P      +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAV 203

Query: 352 LQNLDLSHNNLSGTIPMTLHP------MFLDMSFNNLEGEIPTYLRDNPPNS 397
            Q+L+         I   L                + E   P         S
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  139 bits (352), Expect = 8e-35
 Identities = 54/265 (20%), Positives = 93/265 (35%), Gaps = 27/265 (10%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEI-GSLR 110
           +  +L      +LQ LNL  N               L+ L+L +  L     +    +L 
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
            L+VL LS++ L  ++      L  L+ L L+ N       Q+  +L++           
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT----------- 474

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
                     L  LE L L     +        +LK + H+ +  N+LT +    L HL 
Sbjct: 475 ----------LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
             +YL+L+ N +   +P  +   S    ++L  N +             L++   +   L
Sbjct: 525 G-IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC--SNIYF--LEWYKENMQKL 579

Query: 291 SGQIPFAIGKLFNLVSLDLSKNKLS 315
                        L  + LS   LS
Sbjct: 580 EDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  109 bits (275), Expect = 4e-25
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 8/208 (3%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
            +  ++L    +K +     F     L+ LNL ++ L  S       L  L++LNL+ N+
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460

Query: 98  LTGTIPKEIGS---LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
                 ++  S   L  LE+L LS   L         SL+ +  + L  N+L+    + +
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

Query: 155 GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSII 214
            +LK +  L++  N +   +PS L  L+    + L  N  + T      N+  L      
Sbjct: 521 SHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT----CSNIYFLEWYKEN 575

Query: 215 TNKLTGAIPSTLGHLTSLLYLDLSFNQL 242
             KL     +   +   L  + LS   L
Sbjct: 576 MQKLEDTEDTLCENPPLLRGVRLSDVTL 603

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  200 bits (510), Expect = 1e-58
 Identities = 84/298 (28%), Positives = 125/298 (41%), Gaps = 73/298 (24%)

Query: 442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKL----HQSETEDSAFVESFQ 497
             DL  AT +F  ++ IG G +G VYK  L DG  VALK+      Q   E       F+
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-------FE 83

Query: 498 NEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE-LNWTRRVN 556
            E   LS  RH ++V L GFC  +  M  IY+YME G+L   L   D     ++W +R+ 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLR 615
           I    A  L YLH   T +I+HRD+ S NILL+ N    + DFG ++    +D ++ +  
Sbjct: 144 ICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 616 -AGTYGYIAPD----QRLS-------------------PPVNQKI--------------- 636
             GT GYI P+     RL+                     + Q +               
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

Query: 637 ----IQDII--------------LVSTTALACLRSKPKSRPTMQRISQELEGKTPMKK 676
               ++ I+                  TA+ CL    + RP+M  +  +LE    +++
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  200 bits (512), Expect = 2e-57
 Identities = 90/333 (27%), Positives = 150/333 (45%), Gaps = 27/333 (8%)

Query: 54  GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLE 113
            +++ +    +  L      +       +  L+NL  +N   N LT   P  + +L  L 
Sbjct: 38  DTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 93

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
            + ++NN +       + +L NL  L L +N+++ + P  + NL +L  L +  NT+   
Sbjct: 94  DILMNNNQI--ADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI 149

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
               L  LT+L++L  G      T  + + NL  L  L I +NK++    S L  LT+L 
Sbjct: 150 SA--LSGLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE 202

Query: 234 YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ 293
            L  + NQ+    PL  G  + L EL L+ N+++ I    L+ L+NL  L+L++N +S  
Sbjct: 203 SLIATNNQISDITPL--GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL 258

Query: 294 IPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQ 353
            P  +  L  L  L L  N++S    + +   T L +L LN N L+   P  I  +  L 
Sbjct: 259 AP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISP--ISNLKNLT 312

Query: 354 NLDLSHNNLSGTIPMTLHP--MFLDMSFNNLEG 384
            L L  NN+S   P++       L    N +  
Sbjct: 313 YLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  195 bits (499), Expect = 1e-55
 Identities = 89/330 (26%), Positives = 143/330 (43%), Gaps = 25/330 (7%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
             +   NL  L L+NN ++   P  + +L+NL  L L  N ++      +  L +L+ L 
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
             N     T    + +L  LE L + SNK+S      +  L +L  L    N +    P 
Sbjct: 163 FGNQV---TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP- 216

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            L  LTNL+ L L  NQ        + +L NLT L +  N+++   P  L  LT L  L 
Sbjct: 217 -LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           L  NQ+ +  PL     +AL  L+L++N++  I P  +S L NL YL L  N +S   P 
Sbjct: 272 LGANQISNISPL--AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
            +  L  L  L    NK+S    + + N T +  L+  HN +  +    +  +  +  L 
Sbjct: 327 -VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI--SDLTPLANLTRITQLG 381

Query: 357 LSHNNLSGTIPMTLHPMFLDMSFNNLEGEI 386
           L+    +         + +  +  N+ G +
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  184 bits (468), Expect = 4e-51
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 23/309 (7%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
             S   +LQ L+   N ++   P  + +L+ L+ L++  N ++      +  L NLE L 
Sbjct: 151 ALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLI 205

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
            +NN +  +    +G L NL+EL L  N+L  +    + +L +L  L +  N +    P 
Sbjct: 206 ATNNQI--SDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP- 260

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            L  LT L  L LG NQ +   P  +  L  LT+L +  N+L    P  + +L +L YL 
Sbjct: 261 -LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           L FN +    P+   + + L  L   +NK+  +    L+ L+N+ +L+   N +S   P 
Sbjct: 316 LYFNNISDISPV--SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP- 370

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
            +  L  +  L L+    + + P        + +   N        P  I         D
Sbjct: 371 -LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPD 427

Query: 357 LSHNNLSGT 365
           ++ N  S T
Sbjct: 428 ITWNLPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  182 bits (464), Expect = 1e-50
 Identities = 89/326 (27%), Positives = 139/326 (42%), Gaps = 26/326 (7%)

Query: 64  LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH 123
           L    +  +     I     +L+      L   N+T T+      L  +  L      + 
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58

Query: 124 GTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTN 183
             +   +  L NL ++   +N+L+ + P  + NL  L+ + +  N +    P  L  LTN
Sbjct: 59  -KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113

Query: 184 LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           L  L L  NQ     P  + NL NL  L + +N ++    S L  LTSL  L    NQ+ 
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVT 168

Query: 244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN 303
              PL   N + L  LD+S NK+  I    L+KL+NL+ L  ++N +S   P  +G L N
Sbjct: 169 DLKPL--ANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTN 222

Query: 304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           L  L L+ N+L       + + T L  L L +N +    P  +  +  L  L L  N +S
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278

Query: 364 GTIPMTLHP--MFLDMSFNNLEGEIP 387
              P+        L+++ N LE   P
Sbjct: 279 NISPLAGLTALTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  160 bits (406), Expect = 9e-43
 Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 19/287 (6%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
             +   NL+ L   NN +S   P  +G L+NL  L+L  N L       + SL NL  L 
Sbjct: 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 249

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           L+NN +  +    +  L  L EL L +N++S + P  +  L +L  L +  N +    P 
Sbjct: 250 LANNQI--SNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP- 304

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            +  L NL  L L  N  +   P  + +L  L  L    NK++    S+L +LT++ +L 
Sbjct: 305 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLS 359

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
              NQ+    P  + N + + +L L+D        +  + +S    +   +  L    P 
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIP 343
            I    +    D++ N  S          ++   +     +  GT+ 
Sbjct: 416 TISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  196 bits (501), Expect = 2e-57
 Identities = 56/311 (18%), Positives = 101/311 (32%), Gaps = 19/311 (6%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
             + L    +         +         +    +          +  N ++   +  +L
Sbjct: 13  GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRAL 68

Query: 123 HGTTP-IEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL 181
             T   +E  +      L LRS  L    P +   L  L  +++    +   +P T+ + 
Sbjct: 69  KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQF 126

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLG---------HLTSL 232
             LE L L  N     +P  I +L  L  LSI        +P  L           L +L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
             L L +  + S +P  I N   L  L + ++ +  +    +  L  L+ L+L       
Sbjct: 186 QSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALR 243

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLL 352
             P   G    L  L L       + P  I   T+L+ L L        +P  I ++   
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 353 QNLDLSHNNLS 363
             + +  +  +
Sbjct: 304 CIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  163 bits (415), Expect = 3e-45
 Identities = 52/226 (23%), Positives = 81/226 (35%), Gaps = 17/226 (7%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
           +LQ++ +    L   +P  +   + L+ L L  N L   +P  I SL  L  L +     
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162

Query: 123 HGTTPIEIGS---------LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
               P  + S         L NL+ L L    +   LP  I NL++L  L +  + +   
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA- 220

Query: 174 IPSTLFRLTNLERLFL-GCNQFNGTIPREIGNLKNLTHLSII-TNKLTGAIPSTLGHLTS 231
           +   +  L  LE L L GC       P   G    L  L +   + L   +P  +  LT 
Sbjct: 221 LGPAIHHLPKLEELDLRGCTAL-RNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQ 278

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL 277
           L  LDL      S +P  I    A   + +  +    +        
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (344), Expect = 1e-35
 Identities = 44/251 (17%), Positives = 80/251 (31%), Gaps = 37/251 (14%)

Query: 148 GVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL--------------------TNLERL 187
           G       +      L    +T   P    L +                      N +  
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 188 FLGCNQFNGTIPREIGNLK--NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF 245
                         + +        L + +  L    P     L+ L ++ +    L   
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118

Query: 246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK----- 300
           +P  +  F+ L  L L+ N +R  +P  ++ L+ L+ L++ +     ++P  +       
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177

Query: 301 ----LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
               L NL SL L    +  S P  I N   L+ L + ++ L   + P I  +  L+ LD
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235

Query: 357 LSHNNLSGTIP 367
           L         P
Sbjct: 236 LRGCTALRNYP 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  126 bits (320), Expect = 3e-32
 Identities = 41/179 (22%), Positives = 65/179 (36%), Gaps = 11/179 (6%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGS---------LSNLKYLNLRWNNLTGTIPKEIGSLRNLE 113
            L+ L++        +P  + S         L NL+ L L W  +  ++P  I +L+NL+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
            L + N+ L       I  L  LEEL LR        P   G    L  L +   +    
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
           +P  + RLT LE+L L        +P  I  L     + +  +              + 
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  104 bits (261), Expect = 2e-24
 Identities = 29/190 (15%), Positives = 50/190 (26%), Gaps = 10/190 (5%)

Query: 196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSA 255
           G+      +     +L    +         L         D +             N + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 256 LAELDLSDNKIRGIIPDELSKLS--NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNK 313
                 +   ++    D L   +      L L S  L  Q P    +L +L  + +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 314 LSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM 373
           L    P  +     L+ L L  N L   +P  I  +  L+ L +        +P  L   
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 374 FLDMSFNNLE 383
                   L 
Sbjct: 174 DASGEHQGLV 183

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 22/123 (17%), Positives = 42/123 (34%), Gaps = 8/123 (6%)

Query: 38  SITHIELVECSIKG---ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLR 94
           ++  +++    +      +  L       L+ L+L       + PP  G  + LK L L+
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLP-----KLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261

Query: 95  WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
             +   T+P +I  L  LE L L         P  I  L     + +  +  + +     
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP 321

Query: 155 GNL 157
              
Sbjct: 322 VAR 324

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  185 bits (472), Expect = 2e-53
 Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 19/195 (9%)

Query: 442 YEDLINATEDFHIRYC------IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSA--FV 493
           + +L N T +F  R        +G GG+G VYK  + +   VA+KKL       +     
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75

Query: 494 ESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTR 553
           + F  E +V++  +H N+V+L GF      +  +Y YM  GSL   L   D    L+W  
Sbjct: 76  Q-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS---- 609
           R  I +  A+ +++LH +     +HRDI S NILL+    A ++DFG AR     +    
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191

Query: 610 SNRTLRAGTYGYIAP 624
           ++R    GT  Y+AP
Sbjct: 192 TSRI--VGTTAYMAP 204

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  192 bits (491), Expect = 3e-53
 Identities = 85/366 (23%), Positives = 133/366 (36%), Gaps = 29/366 (7%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           S  +I+L    +K  L S +FS F  LQ+L+L    +          L +L  L L  N 
Sbjct: 33  STKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGN 156
           +    P     L +LE L      L       IG L  L++L +  N +    LP    N
Sbjct: 92  IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

Query: 157 LKSLIWLSVMYNTVGGPIPSTLFRLTNL----ERLFLGCNQFNGTIPREIGNLKNLTHLS 212
           L +L+ + + YN +     + L  L         L +  N  +  I  +      L  L+
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210

Query: 213 IITNKLTGAIPSTLGH-LTSLLYLDLSFNQLHSFIPLEIGNFSALA--------ELDLSD 263
           +  N  +  I  T    L  L    L   +      LEI   S +         E  L+ 
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIG 323
                    +   L+N+  ++L+   +         K F   SL + + +L   FPT   
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQSLSIIRCQLK-QFPT--L 325

Query: 324 NCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM------FLDM 377
           +   L+ L L  N    +I  +   +  L  LDLS N LS +   +   +       LD+
Sbjct: 326 DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383

Query: 378 SFNNLE 383
           SFN   
Sbjct: 384 SFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  188 bits (480), Expect = 8e-52
 Identities = 80/379 (21%), Positives = 126/379 (33%), Gaps = 44/379 (11%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG-TIPKEIGSLRNLEVLY 116
           FS   +L+ L      L+      IG L  LK LN+  N +    +P    +L NL  + 
Sbjct: 100 FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD 159

Query: 117 LSNNSLHGTTPIEIGSLRN----LEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
           LS N +   T  ++  LR        L +  N +   +  +      L  L++  N    
Sbjct: 160 LSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSS 218

Query: 173 PIPSTLFR-LTNLERLFLGCNQFNGTIPREI---GNLKNLTHLSIIT-----NKLTGAIP 223
            I  T  + L  L    L   +F      EI     ++ L  ++I               
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278

Query: 224 STLGHLTSLLYLDLSFNQLHSFIP-------------------LEIGNFSALAELDLSDN 264
                L ++  + L+   +                            +   L  L L+ N
Sbjct: 279 VKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMN 338

Query: 265 KIRGIIPDELSKLSNLQYLNLSSNLLS--GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI 322
           K    I  +   L +L YL+LS N LS  G   ++     +L  LDLS N          
Sbjct: 339 KGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANF 395

Query: 323 GNCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIPMTLHPM----FLDM 377
               ELQHL   H++L           L  L  LD+S+ N           +     L M
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455

Query: 378 SFNNLEGEIPTYLRDNPPN 396
           + N+ +    + +  N  N
Sbjct: 456 AGNSFKDNTLSNVFANTTN 474

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (478), Expect = 2e-51
 Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 12/292 (4%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRN 111
               + F C  N+  ++L   ++       +      + L++    L          L  
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLDLPF 329

Query: 112 LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQ--EIGNLKSLIWLSVMYNT 169
           L+ L L+ N    +   +  +L +L  L L  N LS             SL  L + +N 
Sbjct: 330 LKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387

Query: 170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPRE-IGNLKNLTHLSIITNKLTGAIPSTLGH 228
               + +    L  L+ L    +            +L+ L +L I               
Sbjct: 388 AII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446

Query: 229 LTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSS 287
           LTSL  L ++ N         +  N + L  LDLS  ++  I       L  LQ LN+S 
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506

Query: 288 NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD 339
           N L         +L++L +LD S N++  S          L    L +NS+ 
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (476), Expect = 3e-51
 Identities = 61/317 (19%), Positives = 109/317 (34%), Gaps = 14/317 (4%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRN 111
           E   +   C   +    L   N       +   L+N+  ++L   ++     +++     
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFK 308

Query: 112 LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN--T 169
            + L +    L          L  L+ L L  NK S  +  +   L SL +L +  N  +
Sbjct: 309 WQSLSIIRCQL---KQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS 363

Query: 170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP-STLGH 228
             G    +     +L  L L  N     +      L+ L HL    + L      S    
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE-LSKLSNLQYLNLSS 287
           L  LLYLD+S+              ++L  L ++ N  +        +  +NL +L+LS 
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482

Query: 288 NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIG 347
             L          L  L  L++S N L     +       L  L  + N +  T    + 
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI-ETSKGILQ 541

Query: 348 KILL-LQNLDLSHNNLS 363
                L   +L++N+++
Sbjct: 542 HFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  186 bits (474), Expect = 5e-51
 Identities = 65/361 (18%), Positives = 115/361 (31%), Gaps = 24/361 (6%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLW------NNNLSGSIPPQIGSLSNLKYL 91
            +  + L        +          L    L         NL    P  +  L ++   
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 92  NLR--WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV 149
             R  + N       +   L N+  + L+  S+      ++      + L +   +L   
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF 322

Query: 150 LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPR--EIGNLKN 207
                 +L  L  L++  N   G I      L +L  L L  N  + +           +
Sbjct: 323 ---PTLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377

Query: 208 LTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKI 266
           L HL +  N     + +    L  L +LD   + L          +   L  LD+S    
Sbjct: 378 LRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436

Query: 267 RGIIPDELSKLSNLQYLNLSSNLLSGQIP-FAIGKLFNLVSLDLSKNKLSGSFPTGIGNC 325
           +         L++L  L ++ N               NL  LDLSK +L           
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496

Query: 326 TELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNN 381
             LQ L ++HN+L         ++  L  LD S N +  +  +  H      F +++ N+
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556

Query: 382 L 382
           +
Sbjct: 557 V 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  184 bits (470), Expect = 2e-50
 Identities = 67/340 (19%), Positives = 120/340 (35%), Gaps = 22/340 (6%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
             + + ++L  N L         + S L++L+L    +     K    L +L  L L+ N
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG-PIPSTLF 179
            +   +P     L +LE L     KL+ +    IG L +L  L+V +N +    +P+   
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 180 RLTNLERLFLGCNQFNGTIPREIGNLKNLT----HLSIITNKLTGAIPSTLGHLTSLLYL 235
            LTNL  + L  N        ++  L+        L +  N +   I         L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHEL 209

Query: 236 DLSFNQLHSFIP-LEIGNFSALAELDLSDNKIRG------IIPDELSKLSNLQY--LNLS 286
            L  N   S I    + N + L    L   + +         P  +  L ++      L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
                         L N+ ++ L+   +       +    + Q L++    L      ++
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLKQFPTLDL 327

Query: 347 GKILLLQNLDLSHNNLSGTIPMTLHP--MFLDMSFNNLEG 384
                L++L L+ N  S +      P   +LD+S N L  
Sbjct: 328 PF---LKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSF 364

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  179 bits (456), Expect = 1e-48
 Identities = 73/361 (20%), Positives = 131/361 (36%), Gaps = 27/361 (7%)

Query: 53  LGSLNFSCF--PNLQYLNLWNNNLSGSIPP-QIGSLSNLKYLNLRWN------NLTGTIP 103
           +  +    F    L  L L  N  S +I    + +L+ L    L         NL    P
Sbjct: 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252

Query: 104 KEIGSLRNL--EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
             +  L ++  +   L+  +      ++   L N+  + L    +  +  +++       
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQ 310

Query: 162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
            LS++   +       L     L+ L L  N+  G+I  +   L +L++L +  N L+ +
Sbjct: 311 SLSIIRCQLKQFPTLDL---PFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFS 365

Query: 222 IPSTLGHL--TSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIP-DELSKLS 278
              +   L   SL +LDLSFN     +         L  LD   + ++ +        L 
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424

Query: 279 NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNS 337
            L YL++S              L +L +L ++ N    +  + +  N T L  L L+   
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484

Query: 338 LDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTYLRDN 393
           L+         +  LQ L++SHNNL        + +     LD SFN +E          
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544

Query: 394 P 394
            
Sbjct: 545 K 545

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  141 bits (358), Expect = 1e-35
 Identities = 46/241 (19%), Positives = 83/241 (34%), Gaps = 15/241 (6%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
           +P  +   ++ + + L  N           N   L  L +   ++          L  L 
Sbjct: 26  VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 234 YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG- 292
            L L+ N + SF P      ++L  L   + K+  +    + +L  L+ LN++ N +   
Sbjct: 84  NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTEL----QHLALNHNSLDGTIPPEIGK 348
           ++P     L NLV +DLS N +       +    E       L ++ N +   I  +  +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQ 202

Query: 349 ILLLQNLDLSHNNLSGTIPMTLHPMF-----LDMSFNNLEGEIPTYLRDNPPNSFVGNKG 403
            + L  L L  N  S  I  T            +     + E    L    P+   G   
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN--LEIFEPSIMEGLCD 260

Query: 404 L 404
           +
Sbjct: 261 V 261

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  132 bits (334), Expect = 1e-32
 Identities = 33/193 (17%), Positives = 64/193 (33%), Gaps = 3/193 (1%)

Query: 54  GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE-IGSLRNL 112
            S +     +L++L+L  N     +      L  L++L+ + + L          SL  L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI-GNLKSLIWLSVMYNTVG 171
             L +S  +           L +L  L +  N         +  N  +L +L +    + 
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486

Query: 172 GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
                    L  L+ L +  N            L +L+ L    N++  +         S
Sbjct: 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKS 546

Query: 232 LLYLDLSFNQLHS 244
           L + +L+ N +  
Sbjct: 547 LAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  123 bits (312), Expect = 9e-30
 Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 13/197 (6%)

Query: 196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSA 255
           G++   I  + N+T    +  KL+  +P  +   +S   +DLSFN L         NFS 
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS 315
           L  LDLS  +I  I       L +L  L L+ N +    P +   L +L +L   + KL+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 316 GSFPTGIGNCTELQHLALNHNSLDG-TIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMF 374
                 IG    L+ L + HN +    +P     +  L ++DLS+N +       L  + 
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 375 --------LDMSFNNLE 383
                   LDMS N ++
Sbjct: 178 ENPQVNLSLDMSLNPID 194

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (468), Expect = 6e-53
 Identities = 57/175 (32%), Positives = 92/175 (52%), Gaps = 3/175 (1%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            D +I+  IG G +G+V++AE   G  VA+K L + +   +  V  F  E  ++  +RH 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILME-QDFHAERVNEFLREVAIMKRLRHP 94

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIV   G       +  + EY+ RGSL+ +L       +L+  RR+++   VA  ++YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           +   P IVHR++ S N+L++      V DFG +RL      +    AGT  ++AP
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  181 bits (462), Expect = 6e-52
 Identities = 58/324 (17%), Positives = 124/324 (38%), Gaps = 19/324 (5%)

Query: 62  PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS 121
              +   + +++L  ++     S  N+K L+L  N L+     ++     LE+L LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 122 LHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL 181
           L     +++ SL  L  L L +N +      E+    S+  L    N +   +  +  + 
Sbjct: 70  L--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ- 120

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG-AIPSTLGHLTSLLYLDLSFN 240
              + ++L  N+       + G    + +L +  N++             +L +L+L +N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK 300
            ++  +  ++  F+ L  LDLS NK+   +  E    + + +++L +N L   I  A+  
Sbjct: 180 FIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 301 LFNLVSLDLSKNKLS-GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH 359
             NL   DL  N    G+          +Q +A         +  +  +   +  L    
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYG 292

Query: 360 NNLSGTIPMTLHPMFLDMSFNNLE 383
                 +P       + +  ++  
Sbjct: 293 AYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  180 bits (459), Expect = 2e-51
 Identities = 55/288 (19%), Positives = 102/288 (35%), Gaps = 16/288 (5%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNL 136
           +I     + +  K   +  ++L   +     S  N++ L LS N L   +  ++     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 137 EELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG 196
           E L L SN L      ++ +L +L  L +  N V       L    ++E L    N  + 
Sbjct: 61  ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF-IPLEIGNFSA 255
            +       +   ++ +  NK+T       G  + + YLDL  N++ +        +   
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS 315
           L  L+L  N I  +        + L+ L+LSSN L+  +         +  + L  NKL 
Sbjct: 171 LEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 316 GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
                 +     L+H  L  N                +   ++   + 
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  156 bits (396), Expect = 9e-43
 Identities = 55/302 (18%), Positives = 111/302 (36%), Gaps = 38/302 (12%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
            + F  L+ LNL +N L       + SLS L+ L+L  N +      E+    ++E L+ 
Sbjct: 54  LAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
           +NN++   + +     +  + +YL +NK++ +   + G    + +L +  N         
Sbjct: 107 ANNNI---SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN--------- 154

Query: 178 LFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDL 237
              +  +                   +   L HL++  N +   +   +     L  LDL
Sbjct: 155 --EIDTVN------------FAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDL 198

Query: 238 SFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFA 297
           S N+L +F+  E  + + +  + L +NK+  +I   L    NL++ +L  N         
Sbjct: 199 SSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLR 255

Query: 298 IGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDL 357
                N     ++K  +          CT            +    P   +++ L +   
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315

Query: 358 SH 359
            H
Sbjct: 316 HH 317

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (354), Expect = 4e-37
 Identities = 43/260 (16%), Positives = 96/260 (36%), Gaps = 19/260 (7%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
           +      L+ L+L NN +      ++    +++ L+   NN++  +       +  + +Y
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIY 126

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIP 175
           L+NN +     ++ G    ++ L L+ N++  V   +   +  +L  L++ YN +   + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
             +     L+ L L  N+    +  E  +   +T +S+  NKL   I   L    +L + 
Sbjct: 186 GQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP 295
           DL  N  H    L            ++   ++  +  +  +   +  L          +P
Sbjct: 243 DLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLP 300

Query: 296 FAIGKLFNLVSLDLSKNKLS 315
                 F    + L  +   
Sbjct: 301 ----APFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (299), Expect = 1e-29
 Identities = 38/195 (19%), Positives = 74/195 (37%), Gaps = 16/195 (8%)

Query: 198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA 257
           I     N        +  + L  A+ S      ++  LDLS N L      ++  F+ L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
            L+LS N +   +   L  LS L+ L+L++N +       +    ++ +L  + N +S  
Sbjct: 62  LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 318 FPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSG-TIPMTLHPM--- 373
                G     +++ L +N +      + G    +Q LDL  N +               
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 374 -FLDMSFNNLEGEIP 387
             L++ +N +  ++ 
Sbjct: 172 EHLNLQYNFIY-DVK 185

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (281), Expect = 2e-27
 Identities = 34/167 (20%), Positives = 71/167 (42%), Gaps = 14/167 (8%)

Query: 221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNL 280
           AI     +        ++ + L   +     +   + ELDLS N +  I   +L+  + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 281 QYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDG 340
           + LNLSSN+L  +    +  L  L +LDL+ N +       +     ++ L   +N++  
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112

Query: 341 TIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLE 383
            +    G+    +N+ L++N ++    +         +LD+  N ++
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 6/166 (3%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSG-SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLR 110
            L  L+  C   +QYL+L  N +   +      S   L++LNL++N +   +  ++    
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT- 169
            L+ L LS+N L      E  S   +  + LR+NKL  ++ + +   ++L    +  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT 215
             G +     +   ++ +     +       E   +  L H     
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (452), Expect = 1e-50
 Identities = 63/263 (23%), Positives = 104/263 (39%), Gaps = 54/263 (20%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   +G G +G V KA+    K VA+K++           ++F  E R LS V H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 61

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKLYG CL+  C+  + EY E GSL+ VL   +          ++     +  ++YLH
Sbjct: 62  NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAF-VADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
                +++HRD+   N+LL +      + DFGTA  +    +N     G+  ++AP+   
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFE 176

Query: 629 SPPVNQK-------II------------------QDIILVSTTAL--------------- 648
               ++K       II                    I+                      
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236

Query: 649 --ACLRSKPKSRPTMQRISQELE 669
              C    P  RP+M+ I + + 
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKIMT 259

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  178 bits (453), Expect = 1e-50
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 26/198 (13%)

Query: 442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEAR 501
            E+L   +    +      G +G V+KA+    + VA+K     + +      S+QNE  
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ------SWQNEYE 68

Query: 502 V--LSTVRHRNIVKLYGFCLHKRC----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           V  L  ++H NI++  G           ++ I  + E+GSL   L+ +     ++W    
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELC 124

Query: 556 NIVKSVAHALSYLHHD-------CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           +I +++A  L+YLH D         P+I HRDI S N+LL +NL A +ADFG A      
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 609 SS--NRTLRAGTYGYIAP 624
            S  +   + GT  Y+AP
Sbjct: 185 KSAGDTHGQVGTRRYMAP 202

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  179 bits (457), Expect = 2e-50
 Identities = 73/334 (21%), Positives = 129/334 (38%), Gaps = 24/334 (7%)

Query: 55  SLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNL 112
                   N + +   N+ +   +P  +  S   ++ LNL    +   I          +
Sbjct: 38  GFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTI 95

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
           + LY+  N++    P    ++  L  L L  N LS +      N   L  LS+  N +  
Sbjct: 96  QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 155

Query: 173 PIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
            I    F+  T+L+ L L  N+    +   +  + +L H ++  N L+     TL    +
Sbjct: 156 -IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIA 206

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           +  LD S N ++    +       L  L L  N +       L     L  ++LS N L 
Sbjct: 207 VEELDASHNSINV---VRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE 261

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
             +     K+  L  L +S N+L  +          L+ L L+HN L   +     +   
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319

Query: 352 LQNLDLSHNNLSGTIPMTLHPM--FLDMSFNNLE 383
           L+NL L HN++  T+ ++ H     L +S N+ +
Sbjct: 320 LENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  164 bits (417), Expect = 7e-45
 Identities = 69/341 (20%), Positives = 137/341 (40%), Gaps = 27/341 (7%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIP--PQIGSLSNLKYLNLRWNNLTGTIPKEI-GS 108
           E   ++ +   +  + ++  +  +  +    +  +L+N K +  + + +   +P  +  S
Sbjct: 9   EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDS 67

Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
            R +E+L L++  +             +++LY+  N +  + P    N+  L  L +  N
Sbjct: 68  FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127

Query: 169 TVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTL 226
            +   +P  +F     L  L +  N     I  +      +L +L + +N+LT  +   L
Sbjct: 128 DLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--L 182

Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
             + SL + ++S+N L +          A+ ELD S N I  ++   +     L  L L 
Sbjct: 183 SLIPSLFHANVSYNLLSTLAIP-----IAVEELDASHNSIN-VVRGPV--NVELTILKLQ 234

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
            N L+      +     LV +DLS N+L             L+ L +++N L   +    
Sbjct: 235 HNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG 291

Query: 347 GKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLE 383
             I  L+ LDLSHN+L   +            L +  N++ 
Sbjct: 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  114 bits (287), Expect = 2e-27
 Identities = 45/273 (16%), Positives = 92/273 (33%), Gaps = 29/273 (10%)

Query: 150 LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNL 208
           +   +        + +   T           L N + +    +     +P  +  + + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRG 268
             L++   ++         +  ++  L + FN +    P    N   L  L L  N +  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 269 IIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTEL 328
           +          L  L++S+N L            +L +L LS N+L+      +     L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSL 188

Query: 329 QHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP--MFLDMSFNNLEGEI 386
            H  +++N L  T+   I     ++ LD SHN+++  +   ++     L +  NNL  + 
Sbjct: 189 FHANVSYNLLS-TLAIPIA----VEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DT 241

Query: 387 PT----------YLRDN-----PPNSFVGNKGL 404
                        L  N       + FV  + L
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  112 bits (282), Expect = 7e-27
 Identities = 44/238 (18%), Positives = 77/238 (32%), Gaps = 43/238 (18%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRN 111
            L  ++ S  P+L + N+  N LS      +     ++ L+   N++   +         
Sbjct: 176 RLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVE 227

Query: 112 LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG 171
           L +L L +N+L  T    + +   L E+ L  N+L                         
Sbjct: 228 LTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEK----------------------- 262

Query: 172 GPIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
             I    F  +  LERL++  N+    +      +  L  L +  N L   +        
Sbjct: 263 --IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
            L  L L  N + +   L++     L  L LS N         L    N+    +   
Sbjct: 319 RLENLYLDHNSIVT---LKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  175 bits (446), Expect = 4e-50
 Identities = 69/275 (25%), Positives = 109/275 (39%), Gaps = 63/275 (22%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAF----VESFQNEARVLS 504
            +      IG GG+G V+K   + D  VVA+K L   ++E         + FQ E  ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
            + H NIVKLYG   +   M  + E++  G L++ L   D+A  + W+ ++ ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALG 134

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF-----VADFGTARLLHVDSSNRTLRAGTY 619
           + Y+ +   P IVHRD+ S NI L S  E       VADFG ++      S      G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190

Query: 620 GYIAPD--QRLSPPVNQKI--------------------------IQDIILVSTTAL--- 648
            ++AP+          +K                           I+ I ++    L   
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250

Query: 649 --------------ACLRSKPKSRPTMQRISQELE 669
                          C    PK RP    I +EL 
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  179 bits (456), Expect = 2e-49
 Identities = 58/344 (16%), Positives = 123/344 (35%), Gaps = 19/344 (5%)

Query: 62  PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS 121
              +   + +++L  ++     S  N+K L+L  N L+     ++     LE+L LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 122 LHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL 181
           L     +++ SL  L  L L +N +      E+    S+  L    N +   +  +  + 
Sbjct: 70  L--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ- 120

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG-AIPSTLGHLTSLLYLDLSFN 240
              + ++L  N+       + G    + +L +  N++             +L +L+L +N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK 300
            ++  +  ++  F+ L  LDLS NK+   +  E    + + +++L +N L   I  A+  
Sbjct: 180 FIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 301 LFNLVSLDLSKNKLS-GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH 359
             NL   DL  N    G+          +Q   +   ++         +  +        
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQNEEECTVPTLGHYGA 293

Query: 360 NNLSGT-IPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNK 402
                   P     + L    + L     +             +
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  175 bits (446), Expect = 5e-48
 Identities = 61/335 (18%), Positives = 118/335 (35%), Gaps = 24/335 (7%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
                N++ L+L  N LS      +   + L+ LNL  N L  T+   + SL  L  L L
Sbjct: 30  RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
           +NN +      E+    ++E L+  +N +S V        +    + +  N +       
Sbjct: 88  NNNYVQ-----ELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLD 139

Query: 178 LFRLTNLERLFLGCNQFNG-TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
               + ++ L L  N+ +         +   L HL++  N +   +   +     L  LD
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           LS N+L +F+  E  + + +  + L +NK+  +I   L    NL++ +L  N        
Sbjct: 198 LSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTL 254

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
                 N     ++K  +          CT            +    P   +++ L+  +
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKE 314

Query: 357 LSHNNLSGTIPMTLHPMF--------LDMSFNNLE 383
            +  +  G+    L            +D       
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYR 349

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  174 bits (443), Expect = 1e-47
 Identities = 56/288 (19%), Positives = 102/288 (35%), Gaps = 16/288 (5%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNL 136
           +I     + +  K   +  ++L   +     S  N++ L LS N L   +  ++     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 137 EELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG 196
           E L L SN L   L   + +L +L  L +  N V       L    ++E L    N  + 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF-IPLEIGNFSA 255
            +       +   ++ +  NK+T       G  + + YLDL  N++ +        +   
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS 315
           L  L+L  N I  +        + L+ L+LSSN L+  +         +  + L  NKL 
Sbjct: 171 LEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 316 GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
                 +     L+H  L  N                +   ++   + 
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  161 bits (409), Expect = 5e-43
 Identities = 47/323 (14%), Positives = 108/323 (33%), Gaps = 20/323 (6%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
           +      L+ L+L NN +      ++    +++ L+   NN++  +       +  + +Y
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIY 126

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIP 175
           L+NN +     ++ G    ++ L L+ N++  V   +   +  +L  L++ YN +   + 
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK 185

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
             +     L+ L L  N+    +  E  +   +T +S+  NKL   I   L    +L + 
Sbjct: 186 GQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP 295
           DL  N  H    L            ++   ++ +      + +     +  +        
Sbjct: 243 DLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301

Query: 296 FAIGKLFNLVSLDLSKNKLSGS----FPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL- 350
               +L  L   + +     GS          N    + +         T+  ++     
Sbjct: 302 PFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQ 360

Query: 351 LLQNLDLSHNNLSGTIPMTLHPM 373
               L+     L   +       
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAH 383

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  136 bits (344), Expect = 2e-34
 Identities = 52/320 (16%), Positives = 100/320 (31%), Gaps = 16/320 (5%)

Query: 53  LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG-TIPKEIGSLRN 111
           +  ++ S     + + L NN ++       G  S ++YL+L+ N +      +   S   
Sbjct: 111 ISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 112 LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG 171
           LE L L  N ++     ++     L+ L L SNKL+  +  E  +   + W+S+  N + 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 172 GPIPSTLFRLTNLERLFLGCNQFN-GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
             I   L    NLE   L  N F+ GT+       + +  ++     +           T
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECT 284

Query: 231 SLLYLDLSFNQL-----HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNL 285
                                 L        A L    ++    +  E    +  + ++ 
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDA 343

Query: 286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDG--TIP 343
                   I     +    ++L+  K  L      G     EL                 
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403

Query: 344 PEIGKILLLQNLDLSHNNLS 363
            E   + LL+ +   +  + 
Sbjct: 404 EEQSPLQLLRAIVKRYEEMY 423

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  135 bits (341), Expect = 5e-34
 Identities = 48/318 (15%), Positives = 96/318 (30%), Gaps = 12/318 (3%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSG-SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLR 110
            L  L+  C   +QYL+L  N +   +      S   L++LNL++N +   +  ++    
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
            L+ L LS+N L      E  S   +  + LR+NKL  ++ + +   ++L    +  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
                   F   N     +          +        T                   L 
Sbjct: 250 HCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308

Query: 231 SLLYLDLSFNQLH----SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
           +L   + +           +  E  N +   E+D    + R +I     +      L   
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD-GTIPPE 345
              L  Q+         L                     + LQ L       +   +  +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQ 427

Query: 346 IGKILLLQNLDLSHNNLS 363
             +   +++ D+  +  +
Sbjct: 428 SVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  110 bits (277), Expect = 9e-26
 Identities = 34/167 (20%), Positives = 70/167 (41%), Gaps = 14/167 (8%)

Query: 221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNL 280
           AI     +        ++ + L   +     +   + ELDLS N +  I   +L+  + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 281 QYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDG 340
           + LNLSSN+L   +      L  L +LDL+ N +       +     ++ L   +N++  
Sbjct: 61  ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112

Query: 341 TIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLE 383
            +    G+    +N+ L++N ++    +         +LD+  N ++
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  168 bits (429), Expect = 8e-48
 Identities = 64/270 (23%), Positives = 107/270 (39%), Gaps = 57/270 (21%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSA-FVESFQNEARVLSTVRH 508
            +  +   IG GG+G VY+A    G  VA+K       ED +  +E+ + EA++ + ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI+ L G CL +  +  + E+   G L  VL        +     VN    +A  ++YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAF--------VADFGTARLLHVDSSNRTLRAGTYG 620
           H +    I+HRD+ S+NIL+   +E          + DFG AR  H   + +   AG Y 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYA 179

Query: 621 YIAPDQRLSPPVNQK-------II-----------------QDIILVSTTAL-------- 648
           ++AP+   +   ++        ++                      V+   L        
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239

Query: 649 ---------ACLRSKPKSRPTMQRISQELE 669
                     C    P SRP+   I  +L 
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  176 bits (447), Expect = 2e-47
 Identities = 73/344 (21%), Positives = 132/344 (38%), Gaps = 24/344 (6%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIP 103
           ++   +            N + +   N+ +   +P  +  S   ++ LNL    +   I 
Sbjct: 34  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EID 91

Query: 104 KEI-GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIW 162
                    ++ LY+  N++    P    ++  L  L L  N LS +      N   L  
Sbjct: 92  TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT 151

Query: 163 LSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
           LS+  N +   I    F+  T+L+ L L  N+    +   +  + +L H ++  N L+  
Sbjct: 152 LSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-- 205

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
              TL    ++  LD S N ++    +       L  L L  N +       L     L 
Sbjct: 206 ---TLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLTDT--AWLLNYPGLV 257

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
            ++LS N L   +     K+  L  L +S N+L  +          L+ L L+HN L   
Sbjct: 258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 315

Query: 342 IPPEIGKILLLQNLDLSHNNLSGTIPMTLHP--MFLDMSFNNLE 383
           +     +   L+NL L HN++  T+ ++ H     L +S N+ +
Sbjct: 316 VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (382), Expect = 8e-39
 Identities = 70/337 (20%), Positives = 133/337 (39%), Gaps = 32/337 (9%)

Query: 54  GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLE 113
           G   ++  P        ++NL                +++           E  +L N +
Sbjct: 3   GQQRYNVKPRQPEYKCIDSNLQ--------YDCVFYDVHIDMQTQDVYFGFEDITLNNQK 54

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
           ++   N+++       + S R +E L L   ++  +         ++  L + +N +   
Sbjct: 55  IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY- 113

Query: 174 IPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
           +P  +F+ +  L  L L  N  + ++PR I  N   LT LS+  N L      T    TS
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L  L LS N+L     +++    +L   ++S N +       L+    ++ L+ S N ++
Sbjct: 173 LQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI-GKIL 350
             +   +     L  L L  N L+      + N   L  + L++N L+  I      K+ 
Sbjct: 225 -VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ 278

Query: 351 LLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLE 383
            L+ L +S+N L   + +   P+     LD+S N+L 
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  110 bits (277), Expect = 1e-25
 Identities = 50/326 (15%), Positives = 98/326 (30%), Gaps = 53/326 (16%)

Query: 53  LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNL 112
           L  ++ S  P+L + N+  N LS      +     ++ L+   N++   +         L
Sbjct: 183 LTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVEL 234

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
            +L L +N+L  T    + +   L E+ L  N+L                          
Sbjct: 235 TILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEK------------------------ 268

Query: 173 PIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
            I    F  +  LERL++  N+    +      +  L  L +  N L   +         
Sbjct: 269 -IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L  L L  N + +   L++     L  L LS N         L    N+    +      
Sbjct: 326 LENLYLDHNSIVT---LKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 380

Query: 292 GQIPFAIGKLF----------NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
            +I + +              + +   ++   +        G C+    +    +     
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440

Query: 342 IPPEIGKILLLQNLDLSHNNLSGTIP 367
                  +   + L+   N L   + 
Sbjct: 441 TQQGGVPLQGNEQLEAEVNELRAEVQ 466

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  170 bits (432), Expect = 2e-46
 Identities = 73/336 (21%), Positives = 127/336 (37%), Gaps = 52/336 (15%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLR------------ 110
            LQ     ++NL+  +P +  ++ +       W+      P   G  R            
Sbjct: 12  FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70

Query: 111 -NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT 169
                L L+N  L  + P       +LE L    N L+  LP+   +LKSL+  +     
Sbjct: 71  RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 125

Query: 170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHL 229
           +    P        LE L +  NQ    +P E+ N   L  + +  N L   +P     L
Sbjct: 126 LSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSL 175

Query: 230 TSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL 289
               ++    NQL   +P E+ N   L  +   +N ++ +         +L+ +   +N+
Sbjct: 176 E---FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNI 226

Query: 290 LSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKI 349
           L  ++P  +  L  L ++    N L  + P    +   L+ L +  N L   +P      
Sbjct: 227 LE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT-DLPELPQS- 278

Query: 350 LLLQNLDLSHNNLSG--TIPMTLHPMFLDMSFNNLE 383
             L  LD+S N  SG   +P  L+  +L+ S N + 
Sbjct: 279 --LTFLDVSENIFSGLSELPPNLY--YLNASSNEIR 310

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  149 bits (379), Expect = 3e-39
 Identities = 70/323 (21%), Positives = 123/323 (38%), Gaps = 57/323 (17%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                  L+ +++ NN+L   +P       +L+++    N L   +P E+ +L  L  +Y
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIY 201

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
             NNSL            +LE +   +N L   LP E+ NL  L  +    N     + +
Sbjct: 202 ADNNSLKKL----PDLPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNN----LLKT 251

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
                 +LE L +  N     +P    +L  L     I + L+   P+       L YL+
Sbjct: 252 LPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLN 303

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
            S N++ S +     +   L EL++S+NK+   +P        L+ L  S N L+ ++P 
Sbjct: 304 ASSNEIRS-LCDLPPS---LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 354

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTE----------------LQHLALNHNSLDG 340
                 NL  L +  N L   FP    +  +                L+ L +  N L  
Sbjct: 355 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR- 409

Query: 341 TIPPEIGKILLLQNLDLSHNNLS 363
             P        +++L ++   + 
Sbjct: 410 EFPDIPES---VEDLRMNSERVV 429

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  141 bits (357), Expect = 3e-36
 Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 46/298 (15%)

Query: 102 IPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
           I     S   L+     +++L    P+E  ++++  E Y   ++     P   G  + + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
              +                     L L     + ++P       +L  L    N LT  
Sbjct: 62  VSRLRDC-----------LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-E 105

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPL---------------EIGNFSALAELDLSDNKI 266
           +P     L SLL  + +   L    PL               E+ N S L  +D+ +N +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL 165

Query: 267 RGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCT 326
           +  +PD      +L+++   +N L  ++P  +  L  L ++    N L    P    +  
Sbjct: 166 K-KLPDL---PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS-- 216

Query: 327 ELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM-FLDMSFNNLE 383
            L+ +   +N L     PE+  +  L  +   +N L  T+P     +  L++  N L 
Sbjct: 217 -LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  122 bits (308), Expect = 7e-30
 Identities = 54/274 (19%), Positives = 85/274 (31%), Gaps = 47/274 (17%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
                +L+ +   NN L     P++ +L  L  +    N L  T+P    SL  L V   
Sbjct: 211 PDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDN 267

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
               L    P    SL  L+      + L     +   NL  L       N     I S 
Sbjct: 268 YLTDL----PELPQSLTFLDVSENIFSGL----SELPPNLYYL-------NASSNEIRSL 312

Query: 178 LFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDL 237
                +LE L +  N+    +P     L+ L   S   N L   +P    +L  L    +
Sbjct: 313 CDLPPSLEELNVSNNKLI-ELPALPPRLERL-IAS--FNHLA-EVPELPQNLKQL---HV 364

Query: 238 SFNQLHSFIPLEIGN----------------FSALAELDLSDNKIRGIIPDELSKLSNLQ 281
            +N L    P    +                   L +L +  N +R   PD      +++
Sbjct: 365 EYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE---SVE 419

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS 315
            L ++S  +     FA      L       +   
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  112 bits (283), Expect = 1e-26
 Identities = 49/252 (19%), Positives = 87/252 (34%), Gaps = 47/252 (18%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                P L  +   NN L  ++P       +L+ LN+R N LT  +P+   SL  L+V  
Sbjct: 232 ELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSE 286

Query: 117 LSNNSLHGTTPIEIGSLR-----------------NLEELYLRSNKLSGVLPQEIGNLKS 159
              + L         +L                  +LEEL + +NKL   LP     L+ 
Sbjct: 287 NIFSGL----SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 341

Query: 160 LIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT 219
           LI     +N +   +P       NL++L +  N      P    ++++L       + L 
Sbjct: 342 LI---ASFNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMN----SHLA 389

Query: 220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSN 279
             +P    +L     L +  N L    P    +   + +L ++  ++             
Sbjct: 390 -EVPELPQNLK---QLHVETNPL-REFPDIPES---VEDLRMNSERVVDPYEFAHETTDK 441

Query: 280 LQYLNLSSNLLS 291
           L+      +   
Sbjct: 442 LEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 29/152 (19%), Positives = 51/152 (33%), Gaps = 22/152 (14%)

Query: 245 FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL--- 301
           FI     + + L E     + +   +P E   + +      + +      P   G+    
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 302 ----------FNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
                          L+L+   LS S P    +   L+ L  + NSL   +P     +  
Sbjct: 61  AVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKS 115

Query: 352 LQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLE 383
           L   + +   LS   P+  +   L +S N LE
Sbjct: 116 LLVDNNNLKALSDLPPLLEY---LGVSNNQLE 144

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  172 bits (438), Expect = 5e-46
 Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 44/311 (14%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRN 111
            L +L      ++  L + +NNL+ S+P        L+ L +  N LT ++P     L  
Sbjct: 51  GLTTLPDCLPAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLE 105

Query: 112 LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG 171
           L +       L             L +L++  N+L+  LP     L+ L  +S       
Sbjct: 106 LSIFSNPLTHL-------PALPSGLCKLWIFGNQLT-SLPVLPPGLQEL-SVSDNQLAS- 155

Query: 172 GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
             +P+    L  L       NQ   ++P     L     LS+  N+L  ++P+    L  
Sbjct: 156 --LPALPSELCKLW---AYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYK 205

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L       N+L S +P        L EL +S N++  + P   S    L+ L +S N L+
Sbjct: 206 L---WAYNNRLTS-LPALPSG---LKELIVSGNRLTSL-PVLPS---ELKELMVSGNRLT 254

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
             +P        L+SL + +N+L+   P  + + +    + L  N L      +  +   
Sbjct: 255 -SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--E 306

Query: 352 LQNLDLSHNNL 362
           + +       +
Sbjct: 307 ITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  146 bits (369), Expect = 5e-37
 Identities = 70/320 (21%), Positives = 120/320 (37%), Gaps = 52/320 (16%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSL-----------------SNLKYLNLRWNNLTGT 101
           +  P L+ L +  N L+ S+P     L                 S L  L +  N LT +
Sbjct: 78  ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-S 135

Query: 102 IPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
           +P        L+ L +S+N L  + P        L +L+  +N+L+  LP     L+ L 
Sbjct: 136 LPVLPP---GLQELSVSDNQL-ASLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL- 186

Query: 162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
             SV  N +   +P+     + L +L+   N+   ++P     L     L +  N+LT +
Sbjct: 187 --SVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-S 235

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
           +P     L  L    +S N+L S +P+       L  L +  N++  + P+ L  LS+  
Sbjct: 236 LPVLPSELKEL---MVSGNRLTS-LPMLPSG---LLSLSVYRNQLTRL-PESLIHLSSET 287

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
            +NL  N LS +      +   + S       +      G     E + L L     D  
Sbjct: 288 TVNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWL 342

Query: 342 IPPEIGKILLLQNLDLSHNN 361
           +P   G+        +    
Sbjct: 343 VPAREGEPAPADRWHMFGQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  133 bits (337), Expect = 6e-33
 Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 57/295 (19%)

Query: 126 TPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLE 185
             +          L +  + L+  LP  +     +  L +  N +   +P+       L 
Sbjct: 32  QKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELR 84

Query: 186 RLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHL--------------TS 231
            L +  NQ   ++P     L  L+  S     L  A+PS L  L                
Sbjct: 85  TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPG 142

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L  L +S NQL S +P        L +L   +N++   +P      S LQ L++S N L+
Sbjct: 143 LQELSVSDNQLAS-LPALPSE---LCKLWAYNNQLTS-LPML---PSGLQELSVSDNQLA 194

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
             +P        L  L    N+L+ S P        L+ L ++ N L  ++P    +   
Sbjct: 195 -SLPTLPS---ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRL-TSLPVLPSE--- 242

Query: 352 LQNLDLSHNNLSGTIPMTLHPM-FLDMSFNNLEGEIPT-----------YLRDNP 394
           L+ L +S N L+ ++PM    +  L +  N L   +P             L  NP
Sbjct: 243 LKELMVSGNRLT-SLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  108 bits (270), Expect = 1e-24
 Identities = 55/255 (21%), Positives = 89/255 (34%), Gaps = 42/255 (16%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSL-----------------SNLKYLNLRWNNLTGTIP 103
            P LQ L++ +N L+ S+P     L                 S L+ L++  N L  ++P
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLP 197

Query: 104 KEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL 163
                L  L        SL    P        L+EL +  N+L+  LP     LK L  +
Sbjct: 198 TLPSELYKLWAYNNRLTSL----PALPS---GLKELIVSGNRLTS-LPVLPSELKEL-MV 248

Query: 164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP 223
           S    T    +P      + L  L +  NQ    +P  + +L + T +++  N L+    
Sbjct: 249 SGNRLTS---LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301

Query: 224 STLGHLTSLLYLD---LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIP----DELSK 276
             L  +TS        + F+   +  P E       A   L   +     P        +
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ 361

Query: 277 LSNLQYLNLSSNLLS 291
             N    +L  + LS
Sbjct: 362 EDNADAFSLFLDRLS 376

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  174 bits (442), Expect = 9e-46
 Identities = 88/385 (22%), Positives = 145/385 (37%), Gaps = 32/385 (8%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWN 96
            +  +EL        +    F   PNL+ L+L ++ +   + P     L +L  L L + 
Sbjct: 49  QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFC 107

Query: 97  NLTGTI--PKEIGSLRNLEVLYLSNNSLHG-TTPIEIGSLRNLEELYLRSNKLSGVLPQE 153
            L+  +       +L+ L  L LS N +         G L +L+ +   SN++  V   E
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167

Query: 154 IGNL--KSLIWLSVMYNTVGGPIPSTL------FRLTNLERLFLGCNQFN---------- 195
           +  L  K+L + S+  N++   +          FR   LE L +  N +           
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227

Query: 196 --GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHL--TSLLYLDLSFNQLHSFIPLEIG 251
              +    +    ++       + +     +T   L  +S+ +LDLS   + S       
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287

Query: 252 NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK 311
               L  L+L+ NKI  I  +    L NLQ LNLS NLL          L  +  +DL K
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 312 NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH 371
           N ++           +LQ L L  N+L       I  I  + ++ LS N L     + L 
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLT 402

Query: 372 PMFLDMSFNNLEGEIPTYLRDNPPN 396
              + +S N LE     Y     P+
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPH 427

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  157 bits (399), Expect = 3e-40
 Identities = 80/383 (20%), Positives = 135/383 (35%), Gaps = 39/383 (10%)

Query: 32  TCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYL 91
           +C + G I             L  +        + L L  N +          L  L+ L
Sbjct: 1   SCSFDGRI-----AFYRFCN-LTQV-PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53

Query: 92  NLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVL 150
            L       TI KE   +L NL +L L ++ ++   P     L +L EL L    LS  +
Sbjct: 54  ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 151 PQE--IGNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNL-- 205
            ++    NLK+L  L +  N +        F  L +L+ +    NQ       E+  L  
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173

Query: 206 KNLTHLSIITNKLTGAIPSTLGHL------TSLLYLDLSFNQLHSFIP---------LEI 250
           K L+  S+  N L   +    G          L  LD+S N     I           + 
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233

Query: 251 GNFSA---LAELDLSDNKIRGIIPDELSKL--SNLQYLNLSSNLLSGQIPFAIGKLFNLV 305
            +      +       + I+    +  + L  S++++L+LS   +          L +L 
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293

Query: 306 SLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSG 364
            L+L+ NK++            LQ L L++N L   +       L  +  +DL  N+++ 
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAI 352

Query: 365 TIPMTLHPM----FLDMSFNNLE 383
               T   +     LD+  N L 
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  156 bits (396), Expect = 7e-40
 Identities = 81/402 (20%), Positives = 132/402 (32%), Gaps = 62/402 (15%)

Query: 38  SITHIELVECSIKGE-LGSLNFSCFPNLQYLNLWNNNLSG-SIPPQIGSLSNLKYLNLRW 95
            +  + L  C +    L    F     L  L+L  N +    + P  G L++LK ++   
Sbjct: 98  HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157

Query: 96  NNLTGTIPKEIGSLR--NLEVLYLSNNSLHGTTPIEIGSLRN------LEELYLRSNKLS 147
           N +      E+  L+   L    L+ NSL+    ++ G   N      LE L +  N  +
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217

Query: 148 GVLP------------QEIGNLKSLIWLSVMYNTVGGPIPSTLFRL--TNLERLFLGCNQ 193
             +               +     ++     ++ +  P  +T   L  +++  L L    
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277

Query: 194 FNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF 253
                 R    LK+L  L++  NK+          L +L  L+LS+N L           
Sbjct: 278 VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337

Query: 254 SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNK 313
             +A +DL  N I  I       L  LQ L+L  N L+      I  + ++  + LS NK
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK 392

Query: 314 LSGSFPTG----------------------IGNCTELQHLALNHNSLDGTIPPEIGKILL 351
           L  + P                        +     LQ L LN N        +      
Sbjct: 393 LV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451

Query: 352 -LQNLDLSHNNLSGTIPMTLHP---------MFLDMSFNNLE 383
            L+ L L  N L       L             L ++ N L 
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  153 bits (388), Expect = 7e-39
 Identities = 82/419 (19%), Positives = 143/419 (34%), Gaps = 57/419 (13%)

Query: 38  SITHIELVECSIKG-ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSN------LKY 90
           S+  I+     I       L       L + +L  N+L   +    G   N      L+ 
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208

Query: 91  LNLR------------WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR--NL 136
           L++              N ++ +    +    ++       +++          L   ++
Sbjct: 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268

Query: 137 EELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG 196
             L L    +  +  +    LK L  L++ YN +        + L NL+ L L  N    
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328

Query: 197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL 256
                   L  + ++ +  N +      T   L  L  LDL  N L +     I    ++
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSI 383

Query: 257 AELDLSDNKIRGIIPDELS---------------------KLSNLQYLNLSSNLLSG-QI 294
            ++ LS NK+  +    L+                     ++ +LQ L L+ N  S    
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPTGI-----GNCTELQHLALNHNSLDGTIPPEIGKI 349
                +  +L  L L +N L  ++ T +        + LQ L LNHN L+ ++PP +   
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSH 502

Query: 350 LL-LQNLDLSHNNLSGTIPMTLHPM--FLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLC 405
           L  L+ L L+ N L+      L      LD+S N L    P             NK +C
Sbjct: 503 LTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  168 bits (427), Expect = 1e-45
 Identities = 72/324 (22%), Positives = 123/324 (37%), Gaps = 11/324 (3%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIP 103
           V C  K    ++        + L+L  N +  ++      S  +L+ L L  N ++   P
Sbjct: 16  VLCHRKR-FVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEP 73

Query: 104 KEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL 163
               +L NL  L L +N L          L NL +L +  NK+  +L     +L +L  L
Sbjct: 74  GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133

Query: 164 SVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGA 221
            V  N +   I    F  L +LE+L L       +IP E   +L  L  L +    +   
Sbjct: 134 EVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAI 191

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
              +   L  L  L++S       +         L  L ++   +  +    +  L  L+
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDG 340
           +LNLS N +S      + +L  L  + L   +L+             L+ L ++ N L  
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT- 309

Query: 341 TIPPEIGKILL-LQNLDLSHNNLS 363
           T+   +   +  L+ L L  N L+
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  144 bits (366), Expect = 3e-37
 Identities = 71/351 (20%), Positives = 120/351 (34%), Gaps = 65/351 (18%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS 118
            C    + +         ++P  I   +  + L+L  N +      E  S  +LE L L+
Sbjct: 8   ECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64

Query: 119 NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTL 178
            N +    P    +L NL  L LRSN+L                           IP  +
Sbjct: 65  ENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-------------------------IPLGV 99

Query: 179 FRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLS 238
           F                         L NLT L I  NK+   +      L +L  L++ 
Sbjct: 100 FT-----------------------GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136

Query: 239 FNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI 298
            N L           ++L +L L    +  I  + LS L  L  L L    ++    ++ 
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 299 GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPE-IGKILLLQNLDL 357
            +L+ L  L++S      +          L  L++ H +L   +P   +  ++ L+ L+L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNL 255

Query: 358 SHNNLSGTIPMTLHPM----FLDMSFNNLEGEIPTYLRDNPPNSFVGNKGL 404
           S+N +S      LH +     + +    L   +        P +F G   L
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLA-VV-------EPYAFRGLNYL 298

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  167 bits (424), Expect = 1e-44
 Identities = 64/363 (17%), Positives = 126/363 (34%), Gaps = 21/363 (5%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQ-IGSLSNLKYLNLRWN 96
           S+ ++ L+    +    +  F    NLQ L + N      I       L++L  L ++  
Sbjct: 99  SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158

Query: 97  NLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGN 156
           +L     + + S+R++  L L  +       I    L ++  L LR   L+      +  
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218

Query: 157 LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITN 216
            +    +  +          +   L  L R  L  ++       E  +           +
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPS 272

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK 276
           +             ++  L +    L   +         +  + + ++K+  +       
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332

Query: 277 LSNLQYLNLSSNLLSGQI---PFAIGKLFNLVSLDLSKNKLSGSFPTGIG---NCTELQH 330
           L +L++L+LS NL+  +        G   +L +L LS+N L  S             L  
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTS 391

Query: 331 LALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS---GTIPMTLHPMFLDMSFNNLEGEIP 387
           L ++ N+    +P        ++ L+LS   +      IP TL    LD+S NNL+    
Sbjct: 392 LDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE--VLDVSNNNLD-SFS 447

Query: 388 TYL 390
            +L
Sbjct: 448 LFL 450

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  155 bits (393), Expect = 2e-40
 Identities = 64/368 (17%), Positives = 137/368 (37%), Gaps = 32/368 (8%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
            +   +    S+       ++ L+L  N ++      + + +NL+ L L+ + +  TI  
Sbjct: 10  CDGRSRS-FTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67

Query: 105 EI-GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIW 162
           +   SL +LE L LS+N L   +    G L +L+ L L  N    + +     NL +L  
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 163 LSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
           L +        I    F  LT+L  L +          + + +++++ HL++  ++    
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI----------IP 271
           +      L+S+ YL+L    L  F    +      + +     +   +          + 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 272 DELSKLSNLQYLNLSSNLLSGQIPFAIG--------KLFNLVSLDLSKNKLSGSFPTGIG 323
             + +LS +++ + + N L    P            +   +  L + +  L     T   
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307

Query: 324 NCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIPMTLHP-------MFL 375
              +++ + + ++ +   +P    + L  L+ LDLS N +                   L
Sbjct: 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 376 DMSFNNLE 383
            +S N+L 
Sbjct: 367 VLSQNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  134 bits (340), Expect = 2e-33
 Identities = 67/353 (18%), Positives = 115/353 (32%), Gaps = 39/353 (11%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
                ++ +L L  +  +  +      LS+++YL LR  NL       +        +  
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 118 SNNSLHGTTPI----------EIGSLRNLEELYLRSNKLSGVLPQEIGNLK--------S 159
                   T             I  L  +E      N L    P E   +         +
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 160 LIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT 219
           +  L +    +   + +    L  ++R+ +  ++          +LK+L  L +  N + 
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 220 GAIPST---LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA---ELDLSDNKIRGIIPDE 273
                     G   SL  L LS N L S +         L     LD+S N     +PD 
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRS-MQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
                 +++LNLSS  +   +   I     L  LD+S N L  SF   +     LQ L +
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR---LQELYI 458

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNL 382
           + N L     P+     +L  + +S N L          +     + +  N  
Sbjct: 459 SRNKL--KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  133 bits (336), Expect = 5e-33
 Identities = 64/317 (20%), Positives = 115/317 (36%), Gaps = 28/317 (8%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           ++   +     +      +    F      +   N L   +   I  LS +++ +   N 
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNG 265

Query: 98  LTGTIPKEIGSLR--------NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV 149
           L    P E   +          +  L++    L          L  ++ + + ++K+  V
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325

Query: 150 LPQEIGNLKSLIWLSVMYN---TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG--- 203
                 +LKSL +L +  N          +      +L+ L L  N    ++ +      
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILL 384

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
            LKNLT L I  N     +P +      + +L+LS   +     ++      L  LD+S+
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSN 440

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI- 322
           N +          L  LQ L +S N L   +P        L+ + +S+N+L  S P GI 
Sbjct: 441 NNLDSFSLF----LPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLK-SVPDGIF 493

Query: 323 GNCTELQHLALNHNSLD 339
              T LQ + L+ N  D
Sbjct: 494 DRLTSLQKIWLHTNPWD 510

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  161 bits (409), Expect = 2e-44
 Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 32/204 (15%)

Query: 442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEAR 501
             +     ++  +   IG G YG+VYK  L D + VA+K    +  +      +F NE  
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ------NFINEKN 57

Query: 502 V--LSTVRHRNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRR 554
           +  +  + H NI +                  + EY   GSL   L         +W   
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSS 113

Query: 555 VNIVKSVAHALSYLHHD------CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
             +  SV   L+YLH +        P+I HRD++S N+L+ ++    ++DFG +  L  +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 609 SSNR--------TLRAGTYGYIAP 624
              R            GT  Y+AP
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAP 197

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  158 bits (403), Expect = 3e-44
 Identities = 30/177 (16%), Positives = 66/177 (37%), Gaps = 11/177 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +  +    +     G ++K     G  + +K L   +   +     F  E   L    H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHP 67

Query: 510 NIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           N++ + G C          I  +M  GSL+ VL +      ++ ++ V     +A  +++
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAF 126

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LH    P I    ++S +++++ ++ A ++                 R     ++AP
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAP 177

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  158 bits (401), Expect = 2e-43
 Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 65/277 (23%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            D      +G G +G   K      G+V+ +K+L + + E      +F  E +V+  + H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEH 66

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            N++K  G     + + FI EY++ G+L  +++  D   +  W++RV+  K +A  ++YL
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYL 124

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL--------------HVDSSNRTL 614
           H   + +I+HRD++S+N L+  N    VADFG ARL+                D   R  
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 615 RAGTYGYIAP--------DQ----------------RLSP-----PVNQKIIQDII---- 641
             G   ++AP        D+                R++      P       ++     
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241

Query: 642 ---------LVSTTALACLRSKPKSRPTMQRISQELE 669
                          + C    P+ RP+  ++   LE
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  158 bits (402), Expect = 2e-43
 Identities = 66/317 (20%), Positives = 120/317 (37%), Gaps = 44/317 (13%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
           F C  +L+ +   +  L   +P  +    +   L+L+ N +T     +  +L+NL  L L
Sbjct: 27  FRCQCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLIL 83

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
            NN +   +P     L  LE LYL  N+L                           +P  
Sbjct: 84  INNKISKISPGAFAPLVKLERLYLSKNQLKE-------------------------LPEK 118

Query: 178 LFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAI--PSTLGHLTSLLY 234
           + +   L+ L +  N+    + + +   L  +  + + TN L  +         +  L Y
Sbjct: 119 MPK--TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
           + ++   + +   +  G   +L EL L  NKI  +    L  L+NL  L LS N +S   
Sbjct: 176 IRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL----DGTIPPEIGKIL 350
             ++    +L  L L+ NKL    P G+ +   +Q + L++N++         P      
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 291

Query: 351 L--LQNLDLSHNNLSGT 365
                 + L  N +   
Sbjct: 292 KASYSGVSLFSNPVQYW 308

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  157 bits (400), Expect = 4e-43
 Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 46/332 (13%)

Query: 41  HIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPP-QIGSLSNLKYLNLRWNNLT 99
           H+ +V+CS  G L  +     P+   L+L NN ++  I      +L NL  L L  N ++
Sbjct: 32  HLRVVQCSDLG-LEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS 89

Query: 100 GTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKS 159
              P     L  LE LYLS N L     +     + L+EL +  N+++            
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQL---KELPEKMPKTLQELRVHENEITK----------- 135

Query: 160 LIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQF-NGTIPREI-GNLKNLTHLSIITN 216
                         +  ++F  L  +  + LG N   +  I       +K L+++ I   
Sbjct: 136 --------------VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK 276
            +T  IP   G   SL  L L  N++       +   + LA+L LS N I  +    L+ 
Sbjct: 182 NIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238

Query: 277 LSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS----GSF--PTGIGNCTELQH 330
             +L+ L+L++N L  ++P  +     +  + L  N +S      F  P           
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297

Query: 331 LALNHNSLDGT-IPPEIGKIL-LLQNLDLSHN 360
           ++L  N +    I P   + + +   + L + 
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  142 bits (360), Expect = 1e-37
 Identities = 62/288 (21%), Positives = 110/288 (38%), Gaps = 22/288 (7%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGS-LSNLKYLNLRWN 96
               ++L    I  E+   +F    NL  L L NN +S  I P   + L  L+ L L  N
Sbjct: 53  DTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN 110

Query: 97  NLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL--SGVLPQEI 154
            L   +P+     + L+ L +  N +          L  +  + L +N L  SG+     
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 155 GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSI 213
             +K L ++ +    +   IP  L    +L  L L  N+    +       L NL  L +
Sbjct: 168 QGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223

Query: 214 ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI---- 269
             N ++     +L +   L  L L+ N+L   +P  + +   +  + L +N I  I    
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSND 282

Query: 270 --IPDELSKLSNLQYLNLSSNLLSGQI--PFAIGKLFNLVSLDLSKNK 313
              P   +K ++   ++L SN +      P     ++   ++ L   K
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  154 bits (390), Expect = 8e-42
 Identities = 71/316 (22%), Positives = 122/316 (38%), Gaps = 47/316 (14%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
           F C  +L+ +   +  L  ++P +I    +   L+L+ N+++     +   L++L  L L
Sbjct: 29  FGCHCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVL 85

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
            NN +          LR L++LY+  N L                           IP  
Sbjct: 86  VNNKISKIHEKAFSPLRKLQKLYISKNHLVE-------------------------IPPN 120

Query: 178 LFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAI--PSTLGHLTSLLY 234
           L    +L  L +  N+    +P+ +   L+N+  + +  N L  +   P     L  L Y
Sbjct: 121 LPS--SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNY 176

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
           L +S  +L     +       L EL L  NKI+ I  ++L + S L  L L  N +    
Sbjct: 177 LRISEAKLTG---IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE 233

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI-------G 347
             ++  L  L  L L  NKLS   P G+ +   LQ + L+ N++   +            
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGV 291

Query: 348 KILLLQNLDLSHNNLS 363
           K      + L +N + 
Sbjct: 292 KRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  127 bits (320), Expect = 2e-32
 Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 24/244 (9%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLY 116
           FS    LQ L +  N+L   IPP     S+L  L +  N +   +PK +   LRN+  + 
Sbjct: 98  FSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIE 153

Query: 117 LSNNSLHGTTPIEIGSLR--NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           +  N L   +  E G+     L  L +   KL+G+        ++L  L + +N +   I
Sbjct: 154 MGGNPLE-NSGFEPGAFDGLKLNYLRISEAKLTGIPK---DLPETLNELHLDHNKIQA-I 208

Query: 175 PSTLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
                 R + L RL LG NQ    I       L  L  L +  NKL+  +P+ L  L  L
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 233 LYLDLSFNQLHS-----FIPLEIG-NFSALAELDLSDNKI--RGIIPDELSKLSNLQYLN 284
             + L  N +       F P+  G   +    + L +N +    + P     +++   + 
Sbjct: 267 QVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326

Query: 285 LSSN 288
             + 
Sbjct: 327 FGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 38/200 (19%), Positives = 70/200 (35%), Gaps = 15/200 (7%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNL-SGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLR 110
           ++    FS   N+  + +  N L +    P       L YL +    LT  IPK      
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPE 193

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
            L  L+L +N +      ++     L  L L  N++  +    +  L +L  L +  N +
Sbjct: 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-------GNLKNLTHLSIITNKLTGAI- 222
              +P+ L  L  L+ ++L  N     +                   +S+  N +     
Sbjct: 254 SR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 223 -PSTLGHLTSLLYLDLSFNQ 241
            P+T   +T  L +     +
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  153 bits (388), Expect = 8e-42
 Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 26/191 (13%)

Query: 449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-- 506
             D  +  C+G G YG V++     G+ VA+K     +       +S+  E  + +TV  
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVML 59

Query: 507 RHRNIVKLYGFCLHKRC----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           RH NI+      +  R     ++ I  Y E GSL+  L+       L+    + IV S+A
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIA 115

Query: 563 HALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS----NRT 613
             L++LH +       P+I HRD+ S NIL+  N +  +AD G A +    ++       
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 614 LRAGTYGYIAP 624
            R GT  Y+AP
Sbjct: 176 PRVGTKRYMAP 186

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  152 bits (387), Expect = 2e-41
 Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 14/180 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   I   IG G +G VY      G+V A++ +     ++   +++F+ E       RH 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIER-DNEDQLKAFKREVMAYRQTRHE 89

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+V   G C+    +  I    +  +L+ V+RD    I L+  +   I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH 147

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR-----TLRAGTYGYIAP 624
                 I+H+D+ S N+  + N +  + DFG   +  V  + R      ++ G   ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  152 bits (387), Expect = 2e-41
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV--R 507
           +   +   IG G YG V+  +   G+ VA+K    +E        S+  E  +  TV  R
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE------EASWFRETEIYQTVLMR 89

Query: 508 HRNIVKLYGFCLHKRC----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           H NI+      +        ++ I +Y E GSL+  L+       L+    + +  S   
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVS 145

Query: 564 ALSYLH-----HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL---- 614
            L +LH         P+I HRD+ S NIL+  N    +AD G A     D++   +    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 615 RAGTYGYIAP 624
           R GT  Y+ P
Sbjct: 206 RVGTKRYMPP 215

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  156 bits (396), Expect = 1e-40
 Identities = 75/352 (21%), Positives = 118/352 (33%), Gaps = 36/352 (10%)

Query: 53  LGSLNFSCF--PNLQYLNLWNNNLSGSIPPQ-IGSLSNLKYLNL------RWNNLTGTIP 103
           +  +    F    L  L L NN  S ++    I  L+ L+   L         NL     
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 104 KEIGSLRNLEVLYLSNNSLHGTTPIEIGS---LRNLEELYLRSNKLSGVLP-QEIGNLKS 159
             +  L NL +       L       I     L N+    L S  +  V         + 
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308

Query: 160 LIWLSVMYNTVGGPIPSTL----------------FRLTNLERLFLGCNQFN--GTIPRE 201
           L  ++  +         +L                  L +LE L L  N  +  G   + 
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELD 260
                +L +L +  N +   + S    L  L +LD   + L       +  +   L  LD
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427

Query: 261 LSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI-PFAIGKLFNLVSLDLSKNKLSGSFP 319
           +S    R       + LS+L+ L ++ N       P    +L NL  LDLS+ +L    P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 320 TGIGNCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIPMTL 370
           T   + + LQ L +  N L  ++P  I   L  LQ + L  N    + P   
Sbjct: 488 TAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  154 bits (392), Expect = 3e-40
 Identities = 65/288 (22%), Positives = 107/288 (37%), Gaps = 16/288 (5%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIG--SLSNLKYLNLRW 95
           +I    L       +     F+C  N+   +L +  +   +          +L+ +N ++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKF 316

Query: 96  NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLS--GVLPQE 153
                        L++L+ L  ++N            L +LE L L  N LS  G   Q 
Sbjct: 317 GQFPT------LKLKSLKRLTFTSNKG--GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 154 IGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLS 212
                SL +L + +N V   + S    L  LE L    +         +  +L+NL +L 
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427

Query: 213 IITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIP 271
           I       A       L+SL  L ++ N        +I      L  LDLS  ++  + P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 272 DELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFP 319
              + LS+LQ LN++SN L         +L +L  + L  N    S P
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  152 bits (387), Expect = 2e-39
 Identities = 82/367 (22%), Positives = 126/367 (34%), Gaps = 47/367 (12%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKY----LNLRWNNLTGTIPKEIGSLRNLE 113
           FS   NL++L+L +N +       +  L  +      L+L  N +   I         L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLH 203

Query: 114 VLYLSNNSLHGTTPIE-IGSLRNLEELYLRSNKLSG---VLPQEIGNLKSLIWLSV---- 165
            L L NN          I  L  LE   L   +      +   +   L+ L  L++    
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 166 --MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN------------------- 204
               +     I      LTN+    L        +     N                   
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 205 -LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH--SFIPLEIGNFSALAELDL 261
            LK+L  L+  +NK   A   +   L SL +LDLS N L             ++L  LDL
Sbjct: 323 KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 262 SDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF-AIGKLFNLVSLDLSKNKLSGSFPT 320
           S N +   +      L  L++L+   + L     F     L NL+ LD+S      +F  
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 321 GIGNCTELQHLALNHNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIPMTLHPM----FL 375
                + L+ L +  NS      P+I  ++  L  LDLS   L    P   + +     L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 376 DMSFNNL 382
           +M+ N L
Sbjct: 500 NMASNQL 506

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  151 bits (383), Expect = 6e-39
 Identities = 68/357 (19%), Positives = 109/357 (30%), Gaps = 26/357 (7%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
            +C        +  +   + + L+L  N L         S   L+ L+L    +      
Sbjct: 12  YQCMELN-FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLS 164
              SL +L  L L+ N +          L +L++L      L+ +    IG+LK+L  L+
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 165 VMYNT-VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT----HLSIITNKLT 219
           V +N      +P     LTNLE L L  N+       ++  L  +      L +  N + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDL------SDNKIRGIIPD 272
             I         L  L L  N     +    I   + L    L      ++  +      
Sbjct: 191 F-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 273 ELSKLSNLQYLNLSSNLLSG---QIPFAIGKLFNLVSLDLSKNKLSGSFP-TGIGNCTEL 328
            L  L NL         L      I      L N+ S  L    +      +       L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309

Query: 329 QHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP--MFLDMSFNNLE 383
           + +                    L+ L  + N           P   FLD+S N L 
Sbjct: 310 ELVNCKFGQFPTLKLKS------LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  117 bits (294), Expect = 1e-27
 Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 12/199 (6%)

Query: 198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA 257
           IP  +    +  +L +  N L      +      L  LDLS  ++ +       + S L+
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKL-SG 316
            L L+ N I+ +     S LS+LQ L      L+    F IG L  L  L+++ N + S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 317 SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL-----LLQNLDLSHNNLSGTIPMTLH 371
             P    N T L+HL L+ N +  +I     ++L     L  +LDLS N ++   P    
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198

Query: 372 PM---FLDMSFNNLEGEIP 387
            +    L +  N     + 
Sbjct: 199 EIRLHKLTLRNNFDSLNVM 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  149 bits (378), Expect = 2e-40
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 11/177 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
               +   IG+G +G+VYK +   G V A+K L+         +++F+NE  VL   RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNV-TAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NI+   G+      +  + ++ E  SL++ L   +   +    + ++I +  A  + YLH
Sbjct: 81  NILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH 137

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH--VDSSNRTLRAGTYGYIAP 624
                SI+HRD+ SNNI L+ +    + DFG A        S      +G+  ++AP
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  152 bits (385), Expect = 5e-40
 Identities = 78/354 (22%), Positives = 138/354 (38%), Gaps = 34/354 (9%)

Query: 40  THIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNL 98
             +++ + +    + +  F    +L  L L  N     +       L+NL+ L L   NL
Sbjct: 57  QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNL 115

Query: 99  TGT-IPKEI-GSLRNLEVLYLSNNSLHGTTPIEI-GSLRNLEELYLRSNKLSGVLPQEIG 155
            G  +       L +LE+L L +N++    P     ++R    L L  NK+  +  +++ 
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175

Query: 156 NL--KSLIWLSVMYNT--------VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL 205
           N   K    L +   T        +G       F+ T++  L L  N F  ++ +   + 
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235

Query: 206 KNLTHLSIITNKLTGAIPSTLGH---------------LTSLLYLDLSFNQLHSFIPLEI 250
              T +  +    +  + S+ GH                + +   DLS +++ + +    
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF 295

Query: 251 GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
            +F+ L +L L+ N+I  I  +    L++L  LNLS N L          L  L  LDLS
Sbjct: 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355

Query: 311 KNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNL 362
            N +  +           L+ LAL+ N L  ++P  I   L  LQ + L  N  
Sbjct: 356 YNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  131 bits (330), Expect = 9e-33
 Identities = 70/315 (22%), Positives = 117/315 (37%), Gaps = 38/315 (12%)

Query: 58  FSCFPNLQYLNLWNNNL-SGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEV 114
           F+   NL+ L L   NL    +       L++L+ L LR NN+    P     ++R   V
Sbjct: 99  FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158

Query: 115 LYLSNNSLHGTTPIEIGSL--RNLEELYLRSNKLSGVLPQEIG--------NLKSLIWLS 164
           L L+ N +      ++ +   ++   L L S  L  +    +G           S+  L 
Sbjct: 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218

Query: 165 VMYNTVGGPIPSTLFRLTNLERL-------------FLGCNQFNGTIPREIGNLK--NLT 209
           +  N     +    F      ++               G   F          L+   + 
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278

Query: 210 HLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSDNKI 266
              +  +K+   + S   H T L  L L+ N+++    ++   F   + L +L+LS N +
Sbjct: 279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK---IDDNAFWGLTHLLKLNLSQNFL 335

Query: 267 RGIIPDELSKLSNLQYLNLSSNLLSGQIPF-AIGKLFNLVSLDLSKNKLSGSFPTGI-GN 324
             I       L  L+ L+LS N +   +   +   L NL  L L  N+L  S P GI   
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393

Query: 325 CTELQHLALNHNSLD 339
            T LQ + L+ N  D
Sbjct: 394 LTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  106 bits (267), Expect = 1e-24
 Identities = 54/284 (19%), Positives = 102/284 (35%), Gaps = 33/284 (11%)

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI-GNLKSLIWLSVMYNT 169
           ++  + LS NS+          L++L+ L +       V+       L SLI L + YN 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 170 VGGPIPSTLF-RLTNLERLFLGCNQFNGT-IPREI-GNLKNLTHLSIITNKLTGAIPSTL 226
               + +  F  L NLE L L     +G  +       L +L  L +  N +    P++ 
Sbjct: 91  FLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 227 -GHLTSLLYLDLSFNQLHSFIPLEIGNFSA--LAELDLSDNKIRGIIPDELS-------- 275
             ++     LDL+FN++ S    ++ NF       L LS   ++ +    L         
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSL-----DLSKNKLSGSFPTGIGNC----- 325
           K +++  L+LS N     +            +       S N  S    T   +      
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 326 -----TELQHLALNHNSLDGTIPPEIGKIL-LLQNLDLSHNNLS 363
                + ++   L+ + +   +   +      L+ L L+ N ++
Sbjct: 270 KGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN 312

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 34/195 (17%), Positives = 58/195 (29%), Gaps = 9/195 (4%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNK 265
           ++ ++ +  N +     ++   L  L +L +        I        S+L  L L  N+
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 266 IRGIIPDELSKLSNLQYLNLSSNLL-SGQIP-FAIGKLFNLVSLDLSKNKLSGSFPTGI- 322
              +     + L+NL+ L L+   L    +       L +L  L L  N +    P    
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 323 GNCTELQHLALNHNSLDGTIPPEIGKILL---LQNLDLSHNNLSGTIPMTLHPMFLDMSF 379
            N      L L  N +  +I  E            L LS   L   +           + 
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNP 208

Query: 380 NNLEGEIPTYLRDNP 394
                     L  N 
Sbjct: 209 FKNTSITTLDLSGNG 223

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 43/201 (21%), Positives = 67/201 (33%), Gaps = 18/201 (8%)

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEL-S 275
            L   +P    H+    Y+DLS N +             L  L +       +I +    
Sbjct: 21  GLH-QVPELPAHVN---YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFR 76

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF-PTGI-GNCTELQHLAL 333
            LS+L  L L  N        A   L NL  L L++  L G+          T L+ L L
Sbjct: 77  GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136

Query: 334 NHNSLDGTIPPEIGKILL--LQNLDLSHNNLSGTIP-------MTLHPMFLDMSFNNLEG 384
             N++   I P    + +     LDL+ N +  +I           H   L +S   L+ 
Sbjct: 137 RDNNIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQD 194

Query: 385 EIPTYLRDNPPNSFVGNKGLC 405
               +L      +   N  + 
Sbjct: 195 MNEYWLGWEKCGNPFKNTSIT 215

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.8 bits (197), Expect = 6e-16
 Identities = 42/207 (20%), Positives = 72/207 (34%), Gaps = 25/207 (12%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLK-----YLNLRWNNLTGTIPKEIGSLRN 111
           N     ++  L+L  N    S+  +              L+  +N  +           N
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266

Query: 112 ----------LEVLYLSNNSLHGTTPIEIGS---LRNLEELYLRSNKLSGVLPQEIGNLK 158
                     ++   LS + +     +         +LE+L L  N+++ +       L 
Sbjct: 267 FTFKGLEASGVKTCDLSKSKI---FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323

Query: 159 SLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITN 216
            L+ L++  N +G  I S +F  L  LE L L  N     +  +    L NL  L++ TN
Sbjct: 324 HLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTN 381

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           +L          LTSL  + L  N   
Sbjct: 382 QLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  148 bits (375), Expect = 5e-40
 Identities = 64/289 (22%), Positives = 95/289 (32%), Gaps = 41/289 (14%)

Query: 60  CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN 119
           C  +   +   +  L+ S+P  I   S+   L L  N L          L  L  L LS+
Sbjct: 5   CSCSGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS 61

Query: 120 NSLHGTTPIEIGS-----LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           N L   +     S       +L+ L L  N +                           +
Sbjct: 62  NGL---SFKGCCSQSDFGTTSLKYLDLSFNGVIT-------------------------M 93

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
            S    L  LE L    +         +  +L+NL +L I       A       L+SL 
Sbjct: 94  SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 153

Query: 234 YLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
            L ++ N        +I      L  LDLS  ++  + P   + LS+LQ LN+S N    
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGI--GNCTELQHLALNHNSLD 339
              F    L +L  LD S N +  +          + L  L L  N   
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  129 bits (326), Expect = 3e-33
 Identities = 67/257 (26%), Positives = 102/257 (39%), Gaps = 33/257 (12%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLS-GSIPPQIGS-LSNLKYLNLRW 95
           S T +EL    ++  L    F     L  L+L +N LS      Q     ++LKYL+L +
Sbjct: 29  SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87

Query: 96  NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEI-GSLRNLEELYLRSNKLSGVLPQEI 154
           N +  T+      L  LE L   +++L   +   +  SLRNL  L +             
Sbjct: 88  NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV------ 140

Query: 155 GNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLS 212
                                + +F  L++LE L +  N F      +I   L+NLT L 
Sbjct: 141 -------------------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 213 IITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD 272
           +   +L    P+    L+SL  L++S N   S         ++L  LD S N I      
Sbjct: 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241

Query: 273 ELSKL-SNLQYLNLSSN 288
           EL    S+L +LNL+ N
Sbjct: 242 ELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  123 bits (311), Expect = 2e-31
 Identities = 62/305 (20%), Positives = 101/305 (33%), Gaps = 61/305 (20%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL 146
           +   +      LT ++P  I    +   L L +N L          L  L +L L SN L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLK 206
           S                            S                              
Sbjct: 65  SFK-----------------------GCCSQSDF-----------------------GTT 78

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNK 265
           +L +L +  N +   + S    L  L +LD   + L       +  +   L  LD+S   
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 266 IRGIIPDELSKLSNLQYLNLSSN-LLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGN 324
            R       + LS+L+ L ++ N      +P    +L NL  LDLS+ +L         N
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196

Query: 325 C-TELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIPMTLHPMF-----LDM 377
             + LQ L ++HN+   ++     K L  LQ LD S N++  +    L         L++
Sbjct: 197 SLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

Query: 378 SFNNL 382
           + N+ 
Sbjct: 256 TQNDF 260

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  152 bits (385), Expect = 6e-40
 Identities = 67/332 (20%), Positives = 131/332 (39%), Gaps = 36/332 (10%)

Query: 53  LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNL 112
             +++      L  L+  N++++  +   I  L+ L  L    NN+T T+   +    NL
Sbjct: 33  TDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNL 87

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
             L   +N L   T +++  L  L  L   +NKL+ +   ++     L +L+   NT+  
Sbjct: 88  TYLACDSNKL---TNLDVTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLTE 141

Query: 173 PIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
              S   +LT L+     C+        ++     LT L    NK+T      +     L
Sbjct: 142 IDVSHNTQLTELD-----CHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLL 193

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
             L+   N +     L++     L  LD S NK+  I   +++ L+ L Y + S N L+ 
Sbjct: 194 NRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT- 246

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLL 352
           ++   +  L  L +L   +  L       + + T+L +           +  ++     L
Sbjct: 247 ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQL 299

Query: 353 QNLDLSHNNLSGTIPMTLHPM--FLDMSFNNL 382
             LD     ++  + ++ +P   +L ++   L
Sbjct: 300 YLLDCQAAGIT-ELDLSQNPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  151 bits (384), Expect = 6e-40
 Identities = 67/370 (18%), Positives = 121/370 (32%), Gaps = 55/370 (14%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                  L  L   +NN++ ++   +   +NL YL    N LT  +   +  L  L  L 
Sbjct: 59  GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
              N L   T +++     L  L    N L+ +   ++ +   L  L    N     +  
Sbjct: 113 CDTNKL---TKLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD- 165

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            +   T L  L    N+    +   +   K L  L+  TN +T  +   L     L +LD
Sbjct: 166 -VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
            S N+L     +++   + L   D S N +  +   ++S LS L  L+     L  +I  
Sbjct: 219 CSSNKLTE---IDVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EIDL 271

Query: 297 --------------------AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN 336
                                +     L  LD     ++      +    +L +L LN+ 
Sbjct: 272 THNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNT 328

Query: 337 SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM--FLDMSFNNLEGEIPTYLRDNP 394
            L   +   +     L++L   + ++     +   P       +           L +N 
Sbjct: 329 ELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNNS 385

Query: 395 PNSFVGNKGL 404
               V    L
Sbjct: 386 LTIAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  148 bits (375), Expect = 1e-38
 Identities = 63/321 (19%), Positives = 115/321 (35%), Gaps = 35/321 (10%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRN 111
           +L +L+ +    L YLN   N L+  +   +     L YLN   N LT  I   +     
Sbjct: 96  KLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQ 149

Query: 112 LEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG 171
           L  L    N     T +++     L  L    NK++ +   ++   K L  L+   N   
Sbjct: 150 LTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTN--- 201

Query: 172 GPIPS-TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
             I    L +   L  L    N+    I   +  L  LT+     N LT  +   +  L+
Sbjct: 202 -NITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLS 254

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
            L  L      L     +++ + + L        +   I   +++  + L  L+  +  +
Sbjct: 255 KLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGI 309

Query: 291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL 350
           +      + +   LV L L+  +L+      + + T+L+ L+  +  +       +GKI 
Sbjct: 310 T---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI--QDFSSVGKIP 361

Query: 351 LLQNLDLSHNNLSGTIPMTLH 371
            L N   +          TL 
Sbjct: 362 ALNNNFEAEGQTITMPKETLT 382

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  126 bits (319), Expect = 3e-31
 Identities = 55/333 (16%), Positives = 117/333 (35%), Gaps = 56/333 (16%)

Query: 40  THIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLT 99
           T +  ++C +  ++  L+ +    L  L+   N ++  +   +     L  LN   NN+T
Sbjct: 148 TQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204

Query: 100 GTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKS 159
             +   +     L  L  S+N L   T I++  L  L       N L+ +   ++  L  
Sbjct: 205 -KLD--LNQNIQLTFLDCSSNKL---TEIDVTPLTQLTYFDCSVNPLTEL---DVSTLSK 255

Query: 160 LIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT 219
           L  L  +              L  +                ++ +   L +      +  
Sbjct: 256 LTTLHCIQT-----------DLLEI----------------DLTHNTQLIYFQAEGCRKI 288

Query: 220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSN 279
             +   + H T L  LD     +     L++     L  L L++ ++  +   ++S  + 
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNTELTEL---DVSHNTK 340

Query: 280 LQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD 339
           L+ L+  +  +      ++GK+  L +   ++ +   + P        L  +A++ + LD
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLD 396

Query: 340 G-----TIPPEIGKILLLQNLDLSHNNLSGTIP 367
                  I P  G +       ++  NLS   P
Sbjct: 397 QFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  124 bits (313), Expect = 1e-30
 Identities = 57/275 (20%), Positives = 102/275 (37%), Gaps = 28/275 (10%)

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
           N      +   +  T  I    L  L  L   ++ ++ +    I  L  L  L    N +
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI 76

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
              +   L + TNL  L    N+    +   +  L  LT+L+  TNKLT      +    
Sbjct: 77  TT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNP 127

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
            L YL+ + N L     +++ + + L ELD   NK   I   +++  + L  L+ S N +
Sbjct: 128 LLTYLNCARNTLTE---IDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKI 182

Query: 291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL 350
           +      + +   L  L+   N ++      +    +L  L  + N L   I   +  + 
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233

Query: 351 LLQNLDLSHNNLSGTIPMTLHPM--FLDMSFNNLE 383
            L   D S N L+  + ++       L     +L 
Sbjct: 234 QLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL 267

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (375), Expect = 1e-39
 Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 26/190 (13%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARV--LSTVR 507
               ++  IG G +G V++ +   G+ VA+K     E        S+  EA +     +R
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR 94

Query: 508 HRNIVKLYGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           H NI+               ++ + +Y E GSLF  L        +     + +  S A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTAS 150

Query: 564 ALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL---- 614
            L++LH +       P+I HRD+ S NIL+  N    +AD G A      +    +    
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 615 RAGTYGYIAP 624
           R GT  Y+AP
Sbjct: 211 RVGTKRYMAP 220

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  146 bits (371), Expect = 3e-38
 Identities = 71/258 (27%), Positives = 104/258 (40%), Gaps = 10/258 (3%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
            SC      +     NL   +P  I   +N + LNL  N +          LR+LE+L L
Sbjct: 39  CSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
           S N +          L NL  L L  N+L+ +       L  L  L +  N +   IPS 
Sbjct: 96  SRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSY 154

Query: 178 LFR-LTNLERLFLG-CNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
            F  + +L RL LG   + +  I       L NL +L++    L   IP  L  L  L  
Sbjct: 155 AFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDE 211

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
           LDLS N L +  P        L +L +  ++I+ I  +    L +L  +NL+ N L+   
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271

Query: 295 PFAIGKLFNLVSLDLSKN 312
                 L +L  + L  N
Sbjct: 272 HDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (252), Expect = 7e-23
 Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 7/189 (3%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVL 115
           F+   NL  L L++N L+ +IP      LS LK L LR N +  +IP      + +L  L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165

Query: 116 YLS-NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
            L     L   +      L NL  L L    L  +    +  L  L  L +  N +    
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIR 223

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
           P +   L +L++L++  +Q          NL++L  +++  N LT         L  L  
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283

Query: 235 LDLSFNQLH 243
           + L  N  +
Sbjct: 284 IHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 2/89 (2%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL 115
           N +    L  L+L  N+LS +I P     L +L+ L +  + +         +L++L  +
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260

Query: 116 YLSNNSLHGTTPIEIGSLRNLEELYLRSN 144
            L++N+L          L +LE ++L  N
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 35/157 (22%), Positives = 57/157 (36%), Gaps = 24/157 (15%)

Query: 253 FSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKN 312
            +  +++      +R + PD +S  +N + LNL  N +      +   L +L  L LS+N
Sbjct: 42  SNQFSKVICVRKNLREV-PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 313 KLS----GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIP 367
            +     G+F         L  L L  N L  TIP      L  L+ L L +N +     
Sbjct: 99  HIRTIEIGAF----NGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPS 153

Query: 368 MTLHPM----FLDMSFNNLEGEIPTYLRDNPPNSFVG 400
              + +     LD+            L      +F G
Sbjct: 154 YAFNRIPSLRRLDLGELKR-------LSYISEGAFEG 183

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  146 bits (370), Expect = 4e-38
 Identities = 80/288 (27%), Positives = 115/288 (39%), Gaps = 42/288 (14%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS 118
           SC      +      LS  +P  I   SN +YLNL  NN+          L +LEVL L 
Sbjct: 51  SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 119 NNSLHGTTPIEIGS---LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP 175
            NS+     IE+G+   L +L  L L  N L+                          IP
Sbjct: 108 RNSI---RQIEVGAFNGLASLNTLELFDNWLTV-------------------------IP 139

Query: 176 STLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSII-TNKLTGAIPSTLGHLTSL 232
           S  F  L+ L  L+L  N    +IP      + +L  L +    KL          L +L
Sbjct: 140 SGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL 198

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
            YL+L    +   +P  +     L EL++S N    I P     LS+L+ L + ++ +S 
Sbjct: 199 KYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLD 339
               A   L +LV L+L+ N LS S P  +      L  L L+HN  +
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  127 bits (321), Expect = 1e-31
 Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 34/255 (13%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWN 96
           +  ++ L+E +I+  + +  F    +L+ L L  N++   I       L++L  L L  N
Sbjct: 76  NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133

Query: 97  NLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL-RSNKLSGVLPQEI 154
            LT  IP      L  L  L+L NN +          + +L  L L    KL        
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY------ 186

Query: 155 GNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSI 213
                              I    F  L NL+ L LG       +P  +  L  L  L +
Sbjct: 187 -------------------ISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEM 225

Query: 214 ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE 273
             N      P +   L+SL  L +  +Q+           ++L EL+L+ N +  +  D 
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285

Query: 274 LSKLSNLQYLNLSSN 288
            + L  L  L+L  N
Sbjct: 286 FTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  120 bits (303), Expect = 3e-29
 Identities = 67/314 (21%), Positives = 102/314 (32%), Gaps = 71/314 (22%)

Query: 86  SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNK 145
           +    +      L+  +P+ I    N   L L  N++          L +LE L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 146 LSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREIGN 204
           +                           I    F  L +L  L L  N            
Sbjct: 111 IRQ-------------------------IEVGAFNGLASLNTLELFDNW----------- 134

Query: 205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSD 263
              LT +                +L+ L  L L  N + S IP        +L  LDL +
Sbjct: 135 ---LTVIP----------SGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGE 180

Query: 264 -NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG- 321
             K+  I       L NL+YLNL    +   +P  +  L  L  L++S N        G 
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGS 237

Query: 322 IGNCTELQHLALNHNSLDGTIPPE-IGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFN 380
               + L+ L + ++ +   I       +  L  L+L+HNNLS     +L          
Sbjct: 238 FHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-----SLPHDLFT-PLR 290

Query: 381 NLEGEIPTYLRDNP 394
            L  E+  +L  NP
Sbjct: 291 YLV-EL--HLHHNP 301

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 85.6 bits (212), Expect = 8e-18
 Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 28/192 (14%)

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
               +  +   L S +P  I   S    L+L +N I+ I  D    L +L+ L L  N +
Sbjct: 55  QFSKVVCTRRGL-SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPPEIGKI 349
                 A   L +L +L+L  N L+   P+G     ++L+ L L +N +  +IP      
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNR 169

Query: 350 LL-LQNLDLSHNNLSGTIP-MTLHPM----FLDMSFNNLEGEIPT----------YLRDN 393
           +  L  LDL        I       +    +L++   N++ ++P            +  N
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGN 228

Query: 394 -----PPNSFVG 400
                 P SF G
Sbjct: 229 HFPEIRPGSFHG 240

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  141 bits (356), Expect = 1e-35
 Identities = 52/319 (16%), Positives = 102/319 (31%), Gaps = 60/319 (18%)

Query: 67  LNLWNNNLSGSIPPQIGS----LSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
            N + N +S        S               N     + +    +     L L+  +L
Sbjct: 15  QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNL 71

Query: 123 HGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT 182
             + P  +     +  L +  N L   LP+   +L+ L                      
Sbjct: 72  S-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD--------------------- 106

Query: 183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL 242
                    N+ + T+P    +LK   HL +  N+LT  +P     L    Y++   NQL
Sbjct: 107 ------ACDNRLS-TLPELPASLK---HLDVDNNQLT-MLPELPALLE---YINADNNQL 152

Query: 243 HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLF 302
              +P    +   L  L + +N++  + P+      +L+ L++S+NLL   +P    +  
Sbjct: 153 TM-LPELPTS---LEVLSVRNNQLTFL-PELPE---SLEALDVSTNLLE-SLPAVPVRNH 203

Query: 303 NL----VSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLS 358
           +     +     +N+++   P  I +      + L  N L   I   + +     +    
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262

Query: 359 HNNLSGTIPMTLHPMFLDM 377
               S +            
Sbjct: 263 RIYFSMSDGQQNTLHRPLA 281

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  132 bits (333), Expect = 1e-32
 Identities = 51/240 (21%), Positives = 93/240 (38%), Gaps = 29/240 (12%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
                 L L   NLS S+P  +     +  L +  N L  ++P+      +LE L   +N
Sbjct: 58  INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDN 110

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            L  T P       +L+ L + +N+L+ +LP+    L+   +++   N     +      
Sbjct: 111 RLS-TLPELPA---SLKHLDVDNNQLT-MLPELPALLE---YINADNN----QLTMLPEL 158

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL----LYLD 236
            T+LE L +  NQ    +P    +L+ L  +S  TN L  ++P+            ++  
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPESLEAL-DVS--TNLLE-SLPAVPVRNHHSEETEIFFR 213

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
              N++   IP  I +      + L DN +   I + LS+ +     +      S     
Sbjct: 214 CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (272), Expect = 5e-25
 Identities = 60/334 (17%), Positives = 110/334 (32%), Gaps = 51/334 (15%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSL-----------------SNLKYLNLR 94
            L SL  +  P +  L +  N L  S+P    SL                 ++LK+L++ 
Sbjct: 70  NLSSLPDNLPPQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVD 128

Query: 95  WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
            N LT  +P+       LE +   NN L            +LE L +R+N+L+  LP+  
Sbjct: 129 NNQLT-MLPELPA---LLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLT-FLPELP 179

Query: 155 GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLER----LFLGCNQFNGTIPREIGNLKNLTH 210
            +L++L  +S         +P+   R  + E          N+    IP  I +L     
Sbjct: 180 ESLEAL-DVSTNLLES---LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234

Query: 211 LSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAE-----LDLSDNK 265
           + +  N L+  I  +L   T+                 +      LA+        +   
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294

Query: 266 IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC 325
               I        +    +   + LS           +  +    + +++ ++   +   
Sbjct: 295 DVSQIWHAFEHEEHANTFSAFLDRLS--------DTVSARNTSGFREQVA-AWLEKLSAS 345

Query: 326 TELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH 359
            EL+       + D T   E    L   NL  + 
Sbjct: 346 AELRQQ-SFAVAADATESCEDRVALTWNNLRKTL 378

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 89.3 bits (221), Expect = 9e-19
 Identities = 47/260 (18%), Positives = 91/260 (35%), Gaps = 21/260 (8%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS 118
                L+Y+N  NN L+  +P      ++L+ L++R N LT  +P+      +LE L +S
Sbjct: 137 ELPALLEYINADNNQLT-MLPE---LPTSLEVLSVRNNQLT-FLPELPE---SLEALDVS 188

Query: 119 NNSLHGTTPIEIGSLRNLEE----LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
            N L  + P       + EE       R N+++  +P+ I +L     + +  N +   I
Sbjct: 189 TNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
             +L + T           F+ +  ++  N  +      +T        S +  +     
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFE 304

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
            +       S     + +  +         ++       L KLS    L   S  ++   
Sbjct: 305 HEEH-ANTFSAFLDRLSDTVSARNTSGFREQVAAW----LEKLSASAELRQQSFAVAADA 359

Query: 295 PFAIGKLFNLVSLDLSKNKL 314
             +      L   +L K  L
Sbjct: 360 TESCEDRVALTWNNLRKTLL 379

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  134 bits (339), Expect = 5e-35
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 20/283 (7%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS 118
               N   +    +N++ ++      L  +  L+     +T TI   +  L NL  L L 
Sbjct: 16  PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71

Query: 119 NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTL 178
           +N +    P++  +L  + EL L  N L  V    I  L+S+  L +    +    P  L
Sbjct: 72  DNQITDLAPLK--NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--L 125

Query: 179 FRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLS 238
             L+NL+ L+L  NQ     P  +  L NL +LSI   +++   P  L +L+ L  L   
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181

Query: 239 FNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI 298
            N++    PL   +   L E+ L +N+I  + P  L+  SNL  + L++  ++ Q  F  
Sbjct: 182 DNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYN 237

Query: 299 GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
             L  +V   +     +   P  I +        L  N     
Sbjct: 238 NNL--VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  117 bits (296), Expect = 2e-29
 Identities = 57/279 (20%), Positives = 106/279 (37%), Gaps = 42/279 (15%)

Query: 108 SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMY 167
           +L N   +    +++  T  +    L  +  L      ++ +  + +  L +LI L +  
Sbjct: 17  ALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 168 NTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLG 227
           N           ++T+L                 + NL  +T L +  N L     S + 
Sbjct: 73  N-----------QITDLA---------------PLKNLTKITELELSGNPLK--NVSAIA 104

Query: 228 HLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSS 287
            L S+  LDL+  Q+    PL     S L  L L  N+I  I P  L+ L+NLQYL++ +
Sbjct: 105 GLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGN 160

Query: 288 NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIG 347
             +S   P A   L  L +L    NK+S    + + +   L  + L +N +  +    + 
Sbjct: 161 AQVSDLTPLA--NLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQI--SDVSPLA 214

Query: 348 KILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEI 386
               L  + L++  ++       + + +        G  
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  112 bits (281), Expect = 2e-27
 Identities = 55/248 (22%), Positives = 100/248 (40%), Gaps = 18/248 (7%)

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT 215
            L + I ++   + V      T   L  +  L         TI   +  L NL  L +  
Sbjct: 17  ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
           N++T   P  L +LT +  L+LS N L +   +      ++  LDL+  +I  + P  L+
Sbjct: 73  NQITDLAP--LKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP--LA 126

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH 335
            LSNLQ L L  N ++  I   +  L NL  L +   ++S    T + N ++L  L  + 
Sbjct: 127 GLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADD 182

Query: 336 NSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP--MFLDMSFNNLEGEIPTYLRDN 393
           N +  +    +  +  L  + L +N +S   P+        + ++   +  +   Y  + 
Sbjct: 183 NKI--SDISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNL 240

Query: 394 PPNSFVGN 401
              + V  
Sbjct: 241 VVPNVVKG 248

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  131 bits (331), Expect = 1e-33
 Identities = 63/316 (19%), Positives = 115/316 (36%), Gaps = 48/316 (15%)

Query: 62  PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS 121
                    + +L+ SIP  +     +K L+L  N +T     ++    NL+ L L++N 
Sbjct: 31  DRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87

Query: 122 LHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTL 178
           +     IE     SL +LE L L  N LS                          + S+ 
Sbjct: 88  I---NTIEEDSFSSLGSLEHLDLSYNYLSN-------------------------LSSSW 119

Query: 179 FR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPS-TLGHLTSLLYL 235
           F+ L++L  L L  N +       +  +L  L  L +        I       LT L  L
Sbjct: 120 FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG--- 292
           ++  + L S+ P  + +   ++ L L   +   ++   +   S+++ L L    L     
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 293 -QIP----FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIG 347
            ++      ++ K F   ++ ++   L       +   + L  L  + N L  ++P  I 
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIF 297

Query: 348 KILL-LQNLDLSHNNL 362
             L  LQ + L  N  
Sbjct: 298 DRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  117 bits (296), Expect = 6e-29
 Identities = 60/286 (20%), Positives = 111/286 (38%), Gaps = 47/286 (16%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                NLQ L L +N ++ +I      SL +L++L+L +N L+                 
Sbjct: 72  LQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS----------------N 114

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI-GNLKSLIWLSVMYNTVGGPIP 175
           LS++            L +L  L L  N    +    +  +L  L  L V        I 
Sbjct: 115 LSSSWFKP--------LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166

Query: 176 STLF-RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
              F  LT LE L +  +      P+ + +++N++HL +   +    +   +   +S+  
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
           L+L    L +F                  +++     + L K    + + ++   L  Q+
Sbjct: 227 LELRDTDLDTF----------------HFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLD 339
              + ++  L+ L+ S+N+L  S P GI    T LQ + L+ N  D
Sbjct: 270 MKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 44/196 (22%), Positives = 76/196 (38%), Gaps = 10/196 (5%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKI 266
                   +  L  +IPS L    ++  LDLS N++      ++     L  L L+ N I
Sbjct: 32  RNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88

Query: 267 RGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNC 325
             I  D  S L +L++L+LS N LS         L +L  L+L  N       T +  + 
Sbjct: 89  NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148

Query: 326 TELQHLALNHNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIPMTLHPM----FLDMSFN 380
           T+LQ L + +      I  +    +  L+ L++  ++L    P +L  +     L +   
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208

Query: 381 NLEGEIPTYLRDNPPN 396
                +     D   +
Sbjct: 209 QHI-LLLEIFVDVTSS 223

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  132 bits (334), Expect = 6e-33
 Identities = 70/358 (19%), Positives = 126/358 (35%), Gaps = 31/358 (8%)

Query: 53  LGSLNFSCFPNLQYLNLWNNNLSGSIPPQ--IGSLSNLKYLNLRWNNLTGTIPKEIGSLR 110
           L  ++     NL++L+L  N    ++P     G++S LK+L L   +L  +    I  L 
Sbjct: 81  LVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
             +VL +   +       +   L++     L     +      I ++      ++  + +
Sbjct: 140 ISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 171 GG-----------PIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL---KNLTHLSIITN 216
                         I + L     L  L L   +        I  L     + + SI   
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257

Query: 217 KLTGAIPSTLGH-----LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIP 271
           KL G +           L +L    +  +            FS +   + + +  R +  
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317

Query: 272 DELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIG---NCTEL 328
              SK+S   +L+ S+NLL+  +    G L  L +L L  N+L                L
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSL 376

Query: 329 QHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIPMTLHPM--FLDMSFNNLE 383
           Q L ++ NS+              L +L++S N L+ TI   L P    LD+  N ++
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  114 bits (287), Expect = 5e-27
 Identities = 58/386 (15%), Positives = 118/386 (30%), Gaps = 57/386 (14%)

Query: 62  PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS 121
                LN+  N +S      I SLS L+ L +  N +           + LE L LS+N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 122 LHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
           L     I      NL+ L L  N    + + +E GN+  L +L +    +       +  
Sbjct: 81  LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L   + L +    +      +   L++    S+     T      +  ++     +L  +
Sbjct: 138 LNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195

Query: 241 QLHSFI--------------------------------------PLEIGNFSALAELDLS 262
            +   +                                       L++   + +    +S
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255

Query: 263 DNKIRGIIPDEL-----SKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
           + K++G +         + L  L    + S++      +      N+   + + +     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 318 FPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----- 372
                   +   HL  ++N L  T+    G +  L+ L L  N L   +           
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374

Query: 373 --MFLDMSFNNLEGEIPTYLRDNPPN 396
               LD+S N++  +          +
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKS 400

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  112 bits (282), Expect = 2e-26
 Identities = 50/288 (17%), Positives = 106/288 (36%), Gaps = 14/288 (4%)

Query: 9   LNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLN 68
           + C    ++  +  S              ++ +IE    S    +  L       + Y +
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF---IRILQLVWHTTVWYFS 253

Query: 69  LWNNNLSGSIPPQIGSLSN-----LKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH 123
           + N  L G +  +    S      L    +  +              N+ +   + +   
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313

Query: 124 GTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN--TVGGPIPSTLFRL 181
               +    +     L   +N L+  + +  G+L  L  L +  N       I     ++
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373

Query: 182 TNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
            +L++L +  N  +    +      K+L  L++ +N LT  I   L     +  LDL  N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
           ++ S IP ++    AL EL+++ N+++ +      +L++LQ + L +N
Sbjct: 432 KIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 99.6 bits (248), Expect = 4e-22
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 12/192 (6%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
           +  F N+   N   +            +S   +L+   N LT T+ +  G L  LE L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355

Query: 118 SNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEI-GNLKSLIWLSVMYNTVGGP 173
             N L             +++L++L +  N +S    +      KSL+ L++  N     
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI---- 410

Query: 174 IPSTLFR--LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
           +  T+FR     ++ L L  N+   +IP+++  L+ L  L++ +N+L          LTS
Sbjct: 411 LTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTS 469

Query: 232 LLYLDLSFNQLH 243
           L  + L  N   
Sbjct: 470 LQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.1 bits (200), Expect = 3e-16
 Identities = 38/149 (25%), Positives = 58/149 (38%), Gaps = 10/149 (6%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
           N L   +P  L        L++S N +      +I + S L  L +S N+I+ +      
Sbjct: 10  NGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG--IGNCTELQHLAL 333
               L+YL+LS N L   I        NL  LDLS N    + P     GN ++L+ L L
Sbjct: 67  FNQELEYLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGL 122

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHNNL 362
           +   L+          L +  + L     
Sbjct: 123 STTHLE-KSSVLPIAHLNISKVLLVLGET 150

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  127 bits (320), Expect = 9e-33
 Identities = 52/219 (23%), Positives = 78/219 (35%), Gaps = 6/219 (2%)

Query: 96  NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG 155
             L   +P  I      + ++L  N +         + RNL  L+L SN L+ +      
Sbjct: 21  QGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSI 213
            L  L  L +  N     +    F  L  L  L L        +   +   L  L +L +
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 214 ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE 273
             N L      T   L +L +L L  N++ S          +L  L L  N++  + P  
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKN 312
              L  L  L L +N LS     A+  L  L  L L+ N
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  122 bits (308), Expect = 4e-31
 Identities = 66/265 (24%), Positives = 96/265 (36%), Gaps = 44/265 (16%)

Query: 32  TCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKY 90
            C  +  +T      C  +G L ++        Q + L  N +S  +P     +  NL  
Sbjct: 7   VCYNEPKVT----TSCPQQG-LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTI 60

Query: 91  LNLRWNNLTGTIPKEI-GSLRNLEVLYLSNN----SLHGTTPIEIGSLRNLEELYLRSNK 145
           L L  N L   I       L  LE L LS+N    S+   T      L  L  L+L    
Sbjct: 61  LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPAT---FHGLGRLHTLHLDRCG 116

Query: 146 LSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-G 203
           L                           +   LFR L  L+ L+L  N     +P +   
Sbjct: 117 LQE-------------------------LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
           +L NLTHL +  N+++         L SL  L L  N++    P    +   L  L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSN 288
           N +  +  + L+ L  LQYL L+ N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  110 bits (277), Expect = 5e-27
 Identities = 59/225 (26%), Positives = 82/225 (36%), Gaps = 18/225 (8%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
           +P  +      +R+FL  N+ +          +NLT L + +N L     +    L  L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 234 YLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
            LDLS N     +          L  L L    ++ + P     L+ LQYL L  N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ- 142

Query: 293 QIPF-AIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPPEIGKIL 350
            +P      L NL  L L  N++S S P         L  L L+ N +   + P   + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDL 200

Query: 351 -LLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNP 394
             L  L L  NNLS  +P              L       L DNP
Sbjct: 201 GRLMTLYLFANNLS-ALPTEA--------LAPLRALQYLRLNDNP 236

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  104 bits (262), Expect = 5e-25
 Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 13/199 (6%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSL 109
            + + +F    NL  L L +N L+  I       L+ L+ L+L  N    ++       L
Sbjct: 46  HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104

Query: 110 RNLEVLYLSNNSLHGTTPIEIGS---LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM 166
             L  L+L    L     +  G    L  L+ LYL+ N L  +      +L +L  L + 
Sbjct: 105 GRLHTLHLDRCGL---QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161

Query: 167 YNTVGGPIPSTLFR-LTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPS 224
            N +   +P   FR L +L+RL L  N+    +      +L  L  L +  N L+     
Sbjct: 162 GNRISS-VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTE 219

Query: 225 TLGHLTSLLYLDLSFNQLH 243
            L  L +L YL L+ N   
Sbjct: 220 ALAPLRALQYLRLNDNPWV 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  132 bits (334), Expect = 1e-32
 Identities = 74/388 (19%), Positives = 135/388 (34%), Gaps = 45/388 (11%)

Query: 64  LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH 123
           +      +  +   I P   + +     NL+  ++T  +      L +++ +  +N+ + 
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 124 GTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTN 183
               I+   L N+ +L+L  NKL+     +I  L +L                      N
Sbjct: 57  SVQGIQ--YLPNVTKLFLNGNKLT-----DIKPLTNL---------------------KN 88

Query: 184 LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           L  LFL  N+        + +LK L  LS+  N ++    + L HL  L  L L  N++ 
Sbjct: 89  LGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT 144

Query: 244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN 303
               L     + L  L L DN+I  I    L+ L+ LQ L LS N +S  +  A+  L N
Sbjct: 145 DITVLS--RLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKN 198

Query: 304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           L  L+L   +          N      +     SL    P  I      +  ++  +   
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

Query: 364 GTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLK 423
            T  ++    +  ++    +      +       +  +  + G V          I   K
Sbjct: 257 FTNEVSF-IFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPK 315

Query: 424 GKSENLKLVTGGYDGKILYEDLINATED 451
             ++   +  G Y  K    +    T+ 
Sbjct: 316 PPTKQGYVFKGWYTEKNGGHEWNFNTDY 343

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  129 bits (325), Expect = 2e-31
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 42/280 (15%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
               F      NL   +++ ++      L+++  +    +++  ++ + I  L N+  L+
Sbjct: 16  PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 71

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           L+ N L    P+   +L+NL  L+L  NK+      ++ +LK                  
Sbjct: 72  LNGNKLTDIKPLT--NLKNLGWLFLDENKIK-----DLSSLKD----------------- 107

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
               L  L+ L L  N  +      + +L  L  L +  NK+T    + L  LT L  L 
Sbjct: 108 ----LKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLS 159

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           L  NQ+   +PL     + L  L LS N I  +    L+ L NL  L L S     +   
Sbjct: 160 LEDNQISDIVPLA--GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 215

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN 336
               L    ++  +   L    P  I +  + +   +  +
Sbjct: 216 HQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  112 bits (282), Expect = 3e-26
 Identities = 51/235 (21%), Positives = 97/235 (41%), Gaps = 16/235 (6%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
             +   ++  +   N+++  S+   I  L N+  L L  N LT   P  + +L+NL  L+
Sbjct: 38  TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           L  N +   + ++   L+ L+ L L  N +S +    + +L  L  L +  N +     +
Sbjct: 94  LDENKIKDLSSLK--DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TDIT 147

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            L RLT L+ L L  NQ   +    +  L  L +L +  N ++      L  L +L  L+
Sbjct: 148 VLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLE 203

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L   +  +       N      +  +D  +    P+ +S   + +  N+  +L  
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  126 bits (318), Expect = 1e-31
 Identities = 55/270 (20%), Positives = 91/270 (33%), Gaps = 63/270 (23%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED  +   IG G +G V+   L      VA+K   ++   D      F  EAR+L    H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSH 171

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIV+L G C  K+ ++ + E ++ G     LR +     L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYL 229

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG----------- 617
                   +HRD+++ N L+       ++DFG +R         +               
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 618 -----------------------TYG--------------YIAPDQRLSPPVN-QKIIQD 639
                                  + G              ++    RL  P      +  
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346

Query: 640 IILVSTTALACLRSKPKSRPTMQRISQELE 669
           ++        C   +P  RP+   I QEL+
Sbjct: 347 LM------EQCWAYEPGQRPSFSTIYQELQ 370

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  124 bits (312), Expect = 2e-31
 Identities = 54/303 (17%), Positives = 94/303 (31%), Gaps = 39/303 (12%)

Query: 24  DHCNWVGITCDYKGSITHIELVECSIKGELGSL-----------------NFSCFPNLQY 66
             CN+     D+  +   +   +  + G   SL                 +     +L+ 
Sbjct: 13  CSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKR 72

Query: 67  LNLWNNNLSGSIPPQ---IGSLSNLKYLNLRWNNLTGTIPKEIGSL--RNLEVLYLSNNS 121
           L +    +   I      +  +S L+ L L    +TGT P  +      +L +L L N S
Sbjct: 73  LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132

Query: 122 LHG----TTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
                     ++      L+ L +          +++    +L  L +  N   G     
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192

Query: 178 ----LFRLTNLERLFLGCNQFN---GTIPREIGNLKNLTHLSIITNKLTGAIP-STLGHL 229
                 +   L+ L L         G           L  L +  N L  A    +    
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252

Query: 230 TSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL 289
           + L  L+LSF  L        G  + L+ LDLS N++         +L  +  L+L  N 
Sbjct: 253 SQLNSLNLSFTGLKQVPK---GLPAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNP 307

Query: 290 LSG 292
              
Sbjct: 308 FLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  103 bits (259), Expect = 2e-24
 Identities = 53/251 (21%), Positives = 88/251 (35%), Gaps = 23/251 (9%)

Query: 155 GNLKSLIWLSVMYNTVGGPIP-STLFRLTNLERLFLGCNQFNGTIPR---EIGNLKNLTH 210
           G  +SL +L    +T       + + +  +L+RL +   +    I      +  +  L  
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 211 LSIITNKLTGAIPSTLG--HLTSLLYLDLSFNQLHSFIPL--EIGNFS--ALAELDLSDN 264
           L++   ++TG  P  L       L  L+L      +      E+  +    L  L ++  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 265 KIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI----GKLFNLVSLDLSKNK---LSGS 317
                  +++     L  L+LS N   G+          K   L  L L        SG 
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 318 FPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL-LLQNLDLSHNNLS---GTIPMTLHPM 373
                    +LQ L L+HNSL              L +L+LS   L      +P  L   
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS-- 277

Query: 374 FLDMSFNNLEG 384
            LD+S+N L+ 
Sbjct: 278 VLDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 35/178 (19%), Positives = 56/178 (31%), Gaps = 13/178 (7%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEI----G 107
            L  L     P L+ L++   +       Q+     L  L+L  N   G           
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198

Query: 108 SLRNLEVLYLSNN---SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEI-GNLKSLIWL 163
               L+VL L N    +  G       +   L+ L L  N L              L  L
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258

Query: 164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
           ++ +  +   +P  L     L  L L  N+ +   P     L  + +LS+  N    +
Sbjct: 259 NLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (312), Expect = 4e-31
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 22/184 (11%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKL---HQSETEDSAFVESFQNEARVLST 505
           E +     IG G +G     +   DG+   +K++     S  E     E  + E  VL+ 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLAN 79

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD-----DEAIELNWTRRVNIVKS 560
           ++H NIV+          ++ + +Y E G LF  +         E   L+W  ++     
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI----- 134

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYG 620
              AL ++H      I+HRDI S NI L  +    + DFG AR+L+          GT  
Sbjct: 135 -CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190

Query: 621 YIAP 624
           Y++P
Sbjct: 191 YLSP 194

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  121 bits (307), Expect = 5e-31
 Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 19/181 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   +G G +G+VY A E     ++ALK L +++ E +      + E  + S +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAH 563
            NI++LYG+      ++ I EY   G+++  L+     D+              +  +A+
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------AT--YITELAN 120

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
           ALSY H      ++HRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ 
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLP 175

Query: 624 P 624
           P
Sbjct: 176 P 176

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  122 bits (307), Expect = 8e-31
 Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 17/194 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            +F I   IG G +  VY+A  L DG  VALKK+   +  D+        E  +L  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD-------DEAIELNWTRRVNIVKSV 561
            N++K Y   +    +  + E  + G L  +++          E     +  +      +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGY 621
             AL ++H      ++HRDI   N+ + +     + D G  R     ++      GT  Y
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202

Query: 622 IAPDQRLSPPVNQK 635
           ++P++      N K
Sbjct: 203 MSPERIHENGYNFK 216

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  125 bits (315), Expect = 2e-30
 Identities = 66/374 (17%), Positives = 128/374 (34%), Gaps = 54/374 (14%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIP--KEIGSLRNLEVL 115
           F    +L+YL++ +N L  +I      +++L++L+L +N+    +P  KE G+L  L  L
Sbjct: 96  FLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFL 151

Query: 116 YLSNNSLHGTTPIEIGSLR-NLEELYLRSNKLSGVLPQEIGNLKSLI-WLSVMYNTV--- 170
            LS         + +  L  +   L L S  + G   + +    + +  L    N++   
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSV 211

Query: 171 ---GGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLK--------------------- 206
                       +L+N++     C +    +                             
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271

Query: 207 -----NLTHLSIITNKLTGAIP-----STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL 256
                 + +L+I    +T  I       +   L SL+   +               F+ +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331

Query: 257 AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG 316
               LS +    I        S+  +LN + N+ +  +      L  L +L L +N L  
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK- 390

Query: 317 SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL-----LLQNLDLSHNNLSGTIPMTLH 371
           +F         +  L     SL+ ++              +  L+LS N L+G++   L 
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449

Query: 372 PM--FLDMSFNNLE 383
           P    LD+  N + 
Sbjct: 450 PKVKVLDLHNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  113 bits (284), Expect = 2e-26
 Identities = 65/392 (16%), Positives = 118/392 (30%), Gaps = 56/392 (14%)

Query: 52  ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEIGSLR 110
           EL   + S    L+ L L +N +  S+   +     +L+YL++  N L   I      + 
Sbjct: 66  ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMA 121

Query: 111 NLEVLYLSNNSLHGTTPI--EIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           +L  L LS N      P+  E G+L  L  L L + K   +    + +L     L  + +
Sbjct: 122 SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180

Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGH 228
                  +   ++ N   L L  +  +    +   ++  L HL +   KL       L  
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240

Query: 229 L----------------------------------TSLLYLDLSFNQLHSFIPLEIGNFS 254
                                                + YL++    +   I  E   +S
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300

Query: 255 -----ALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDL 309
                +L    + +           S  + +    LS +              +   L+ 
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF 360

Query: 310 SKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT 369
           ++N  + S   G      LQ L L  N L             + +L+    +L+      
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHA 419

Query: 370 LHPMF--------LDMSFNNLEGEIPTYLRDN 393
                        L++S N L G +   L   
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLPPK 451

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  100 bits (250), Expect = 3e-22
 Identities = 46/276 (16%), Positives = 98/276 (35%), Gaps = 36/276 (13%)

Query: 21  NTSDHCNWVGITCDYKGSITHIELVECSIKG----ELGSLNFSCFPNLQYLNLWNNNLSG 76
            T+  C+       +   + ++ +   +I      E  + + +   +L   ++ N     
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNL 136
           S        + +    L  ++          S  +   L  + N    +      +L+ L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379

Query: 137 EELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN- 195
           + L L+ N            LK+                       N+  L       N 
Sbjct: 380 QTLILQRNG-----------LKNF--------------FKVALMTKNMSSLETLDVSLNS 414

Query: 196 ---GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN 252
                  R     +++  L++ +N LTG++   L     +  LDL  N++ S IP ++ +
Sbjct: 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTH 471

Query: 253 FSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
             AL EL+++ N+++ +      +L++LQY+ L  N
Sbjct: 472 LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 95.7 bits (238), Expect = 1e-20
 Identities = 62/397 (15%), Positives = 131/397 (32%), Gaps = 60/397 (15%)

Query: 36  KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRW 95
           +  I       C++   +GS+          ++  N NL+  +P  +      K L+L  
Sbjct: 5   RKPIVGSFHFVCALALIVGSMTPFSNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQ 61

Query: 96  NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQ 152
           N+++     +I  L  L VL LS+N +     ++       ++LE L +  N+L  +   
Sbjct: 62  NSISELRMPDISFLSELRVLRLSHNRI---RSLDFHVFLFNQDLEYLDVSHNRLQNISCC 118

Query: 153 EIGNLKSLIWLSV-MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLK-NLTH 210
            + +L+ L  LS   ++ +  P+      LT L  L L   +F       + +L  +   
Sbjct: 119 PMASLRHL-DLSFNDFDVL--PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCIL 175

Query: 211 LSIITNKLTGAIPSTLGHL-TSLLYLDLSFNQLHSFIPLEIGNFSALAEL---------- 259
           L +++  + G    +L    T++L+L    N L S       N     +L          
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235

Query: 260 ------------------------DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP 295
                                   + +      +   +      ++YLN+ +  ++ +I 
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEYLNIYNLTITERID 293

Query: 296 FAIG-----KLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL 350
                     L +L+   +       S         E+    L+ +              
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353

Query: 351 LLQNLDLSHNNLSGTIPMTLHPM----FLDMSFNNLE 383
               L+ + N  + ++      +     L +  N L+
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 19/263 (7%)

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
              + L L  N  +     +I  L  L  L +  N++             L YLD+S N+
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111

Query: 242 LHSFIPLEIGNFSALAELDLSDNKIRGI-IPDELSKLSNLQYLNLSSNLLSGQIPFAIGK 300
           L +   +     ++L  LDLS N    + +  E   L+ L +L LS+     Q+      
Sbjct: 112 LQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVA 167

Query: 301 LFNL--VSLDLSKNKLSGSFPTGIGN-CTELQHLALNHNSLDGTIPPEIG---KILLLQN 354
             +L  + LDL    + G     +    T + HL  + NSL              L L N
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 355 LDLSHNN----LSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQV 410
           + L+  N    ++    +T  P  L+++  ++E      ++      F   + +  ++ +
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL---FQFFWPRPV-EYLNI 283

Query: 411 LAFTIFGFILLLKGKSENLKLVT 433
              TI   I   +       L +
Sbjct: 284 YNLTITERIDREEFTYSETALKS 306

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 72.6 bits (178), Expect = 2e-13
 Identities = 34/143 (23%), Positives = 64/143 (44%), Gaps = 10/143 (6%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLT----GTIPKEIGSLRNL 112
             S    LQ L L  N L  +         N+  L     +L         +      ++
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
            VL LS+N L G+    +     ++ L L +N++   +P+++ +L++L  L+V  N +  
Sbjct: 431 LVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487

Query: 173 PIPSTLF-RLTNLERLFLGCNQF 194
            +P  +F RLT+L+ ++L  N +
Sbjct: 488 -VPDGVFDRLTSLQYIWLHDNPW 509

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score =  116 bits (294), Expect = 3e-30
 Identities = 40/184 (21%), Positives = 72/184 (39%), Gaps = 7/184 (3%)

Query: 86  SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNK 145
           S  K         + T       + +L  + L+N ++   T IE     N+++L + +  
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIH 77

Query: 146 LSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL 205
            +   P  I  L +L  L +M   V       L  LT+L  L +  +  + +I  +I  L
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 206 KNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNK 265
             +  + +  N     I   L  L  L  L++ F+ +H +  +E  +F  L +L      
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQT 192

Query: 266 IRGI 269
           I G 
Sbjct: 193 IGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score =  104 bits (262), Expect = 6e-26
 Identities = 31/186 (16%), Positives = 65/186 (34%), Gaps = 7/186 (3%)

Query: 179 FRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLS 238
              +  +    G    + T       + +LT++++    +T      + +  ++  L ++
Sbjct: 17  IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74

Query: 239 FNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI 298
                ++ P+     S L  L +    +       LS L++L  L++S +     I   I
Sbjct: 75  NIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 299 GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLS 358
             L  + S+DLS N         +    EL+ L +  + +       I     L  L   
Sbjct: 133 NTLPKVNSIDLSYNGAITD-IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189

Query: 359 HNNLSG 364
              + G
Sbjct: 190 SQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 30/181 (16%), Positives = 66/181 (36%), Gaps = 10/181 (5%)

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT 215
             K+ +   +  ++      +   ++ +L  + L            I    N+  L+I  
Sbjct: 21  TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
              T    + +  L++L  L +    + S     +   ++L  LD+S +     I  +++
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH 335
            L  +  ++LS N     I   +  L  L SL++  + +      GI +  +L  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190

Query: 336 N 336
            
Sbjct: 191 Q 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 40/186 (21%), Positives = 67/186 (36%), Gaps = 12/186 (6%)

Query: 132 SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGC 191
           + +      L  +  + +       + SL ++++    V       +    N++ L +  
Sbjct: 21  TFKAYLNGLLGQSSTANI---TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 192 NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG 251
                  P  I  L NL  L I+   +T      L  LTSL  LD+S +     I  +I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 252 NFSALAELDLSDN-KIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
               +  +DLS N  I  I+P  L  L  L+ LN+  + +       I     L  L   
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189

Query: 311 KNKLSG 316
              + G
Sbjct: 190 SQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 31/160 (19%), Positives = 65/160 (40%), Gaps = 10/160 (6%)

Query: 38  SITHIELVECSIKGELGSL-NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWN 96
           S+T+I L   ++      L       N++ L + N + +   P  I  LSNL+ L +   
Sbjct: 45  SLTYITLANINVT----DLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98

Query: 97  NLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGN 156
           ++T      +  L +L +L +S+++   +   +I +L  +  + L  N     +   +  
Sbjct: 99  DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157

Query: 157 LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG 196
           L  L  L++ ++ V       +     L +L+       G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 23/135 (17%), Positives = 53/135 (39%), Gaps = 11/135 (8%)

Query: 252 NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK 311
            F A     L  +    I     +++++L Y+ L++  ++      I    N+  L ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 312 NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH 371
              +      I   + L+ L +    +     P +  +  L  LD+SH+    +I   ++
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 372 PM----FLDMSFNNL 382
            +     +D+S+N  
Sbjct: 134 TLPKVNSIDLSYNGA 148

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  119 bits (301), Expect = 4e-30
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 37/204 (18%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
             DF     +G G +G V KA    D +  A+KK+  +E +    + +  +E  +L+++ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLN 60

Query: 508 HRNIVKLYGF-------------CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR 554
           H+ +V+ Y                  K  +F   EY E G+L+ ++  ++   + +   R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 555 VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH-------- 606
             + + +  ALSY+H      I+HRD+   NI ++ +    + DFG A+ +H        
Sbjct: 121 --LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 607 ------VDSSNRTLRAGTYGYIAP 624
                   S N T   GT  Y+A 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVAT 199

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  119 bits (300), Expect = 6e-30
 Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 32/216 (14%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            DF    C+G GG+G V++A+   D    A+K++     E +   E    E + L+ + H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEH 62

Query: 509 RNIVKLYGFCLHKRCMF---------FIY---EYMERGSLFYVLRDDDEAIELNWTRRVN 556
             IV+ +   L K             ++Y   +   + +L   +       E   +  ++
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS------- 609
           I   +A A+ +LH   +  ++HRD+  +NI    +    V DFG    +  D        
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 610 -----SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDI 640
                +  T + GT  Y++P+Q      + K+  DI
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV--DI 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (298), Expect = 6e-30
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 13/161 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            +      IG+G +G V+     +   VA+K + +    +  F+E    EA V+  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHP 63

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL- 568
            +V+LYG CL +  +  + E+ME G L   LR             + +   V   ++YL 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE 121

Query: 569 -HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                   ++HRD+++ N L+  N    V+DFG  R +  D
Sbjct: 122 EAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (297), Expect = 1e-29
 Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 25/190 (13%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLH---QSETEDSAFVESFQNEARVLST 505
           ED+ + Y IGTG YG   K     DGK++  K+L     +E E     +   +E  +L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRE 61

Query: 506 VRHRNIVKLYG-FCLHKRCMFFIY-EYMERGSLFYVLRDD-------DEAIELNWTRRVN 556
           ++H NIV+ Y           +I  EY E G L  V+          DE   L    ++ 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL- 120

Query: 557 IVKSVAHALSYLH--HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL 614
                  AL   H   D   +++HRD+   N+ L+      + DFG AR+L+ D+S    
Sbjct: 121 -----TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175

Query: 615 RAGTYGYIAP 624
             GT  Y++P
Sbjct: 176 FVGTPYYMSP 185

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  118 bits (297), Expect = 1e-29
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +D      +GTG +G V   +      VA+K + +         + F  EA+V+  + H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHE 79

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL- 568
            +V+LYG C  +R +F I EYM  G L   LR+          + + + K V  A+ YL 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137

Query: 569 -HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                    +HRD+++ N L+N      V+DFG +R +  D
Sbjct: 138 SKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (311), Expect = 1e-29
 Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 28/190 (14%)

Query: 455 RY----CIGTGGYGSVYKAE---LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           +Y    CI  GG G +Y A    + +G+ V LK L  S   D+        E + L+ V 
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV 137

Query: 508 HRNIVKLYGFCLH-----KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           H +IV+++ F  H         + + EY+   SL           +L     +  +  + 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEIL 192

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
            ALSYLH      +V+ D+   NI+L    +  + D G    +  +S       GT G+ 
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYLY--GTPGFQ 244

Query: 623 APDQRLSPPV 632
           AP+   + P 
Sbjct: 245 APEIVRTGPT 254

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (296), Expect = 2e-29
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 10/173 (5%)

Query: 455 RYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           R  +G G YG VY   +L +   +A+K   +    DS + +    E  +   ++H+NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIK---EIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCT 573
             G       +    E +  GSL  +LR     ++ N        K +   L YLH +  
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 142

Query: 574 PSIVHRDISSNNILLNS-NLEAFVADFGTA-RLLHVDSSNRTLRAGTYGYIAP 624
             IVHRDI  +N+L+N+ +    ++DFGT+ RL  ++    T   GT  Y+AP
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAP 192

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (295), Expect = 2e-29
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 21/178 (11%)

Query: 457 CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY 515
            IG G + +VYK  +      VA  +L   +   S   + F+ EA +L  ++H NIV+ Y
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFY 91

Query: 516 GFCL----HKRCMFFIYEYMERGSLFYVLRD----DDEAIELNWTRRVNIVKSVAHALSY 567
                    K+C+  + E M  G+L   L+       + +  +W R++         L +
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQI------LKGLQF 144

Query: 568 LHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LH   TP I+HRD+  +NI +        + D G A L    S  + +  GT  ++AP
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVI-GTPEFMAP 199

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  117 bits (294), Expect = 3e-29
 Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 40/258 (15%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
           +   F      NL   +++ ++      L+++  +    +++  ++ + I  L N+  L+
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           L+ N L    P+   +L+NL  L+L  NK+      ++ +LK                  
Sbjct: 75  LNGNKLTDIKPLA--NLKNLGWLFLDENKVK-----DLSSLKD----------------- 110

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
               L  L+ L L  N  +      + +L  L  L +  NK+T    + L  LT L  L 
Sbjct: 111 ----LKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLS 162

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           L  NQ+   +PL     + L  L LS N I  +    L+ L NL  L L S     +   
Sbjct: 163 LEDNQISDIVPLA--GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 218

Query: 297 AIGKLFNLVSLDLSKNKL 314
               L    ++  +   L
Sbjct: 219 HQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  113 bits (286), Expect = 4e-28
 Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 42/282 (14%)

Query: 84  SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS 143
           + +     NL+  ++T  +      L +++ +  +N+ +     I+   L N+ +L+L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77

Query: 144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG 203
           NKL+     +I  L +L                      NL  LFL  N+        + 
Sbjct: 78  NKLT-----DIKPLANL---------------------KNLGWLFLDENKVKDLSS--LK 109

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
           +LK L  LS+  N ++    + L HL  L  L L  N++     L     + L  L L D
Sbjct: 110 DLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLED 165

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIG 323
           N+I  I+P  L+ L+ LQ L LS N +S     A   L NL  L+L   +          
Sbjct: 166 NQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQS 221

Query: 324 NCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGT 365
           N      +     SL    P  I      +  ++  +    T
Sbjct: 222 NLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  104 bits (261), Expect = 7e-25
 Identities = 51/235 (21%), Positives = 98/235 (41%), Gaps = 16/235 (6%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
             +   ++  +   N+++  S+   I  L N+  L L  N LT   P  + +L+NL  L+
Sbjct: 41  TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           L  N +   + ++   L+ L+ L L  N +S +    + +L  L  L +  N +     +
Sbjct: 97  LDENKVKDLSSLK--DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TDIT 150

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            L RLT L+ L L  NQ   +    +  L  L +L +  N ++      L  L +L  L+
Sbjct: 151 VLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLE 206

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L   +  +       N      +  +D  +  + P+ +S   + +  N+  +L  
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  102 bits (256), Expect = 3e-24
 Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 18/251 (7%)

Query: 138 ELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT 197
           E       +  +           I  ++   +V      T   L +++++    +    +
Sbjct: 6   ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-S 60

Query: 198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA 257
           +   I  L N+T L +  NKLT   P  L +L +L +L L  N++     L+  +   L 
Sbjct: 61  VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLK--DLKKLK 115

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
            L L  N I  I    L  L  L+ L L +N ++  I   + +L  L +L L  N++S  
Sbjct: 116 SLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISD- 170

Query: 318 FPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDM 377
               +   T+LQ+L L+ N +   +   +  +  L  L+L               + +  
Sbjct: 171 -IVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227

Query: 378 SFNNLEGEIPT 388
           +  N +G + T
Sbjct: 228 TVKNTDGSLVT 238

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 20/107 (18%), Positives = 38/107 (35%), Gaps = 8/107 (7%)

Query: 257 AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG 316
           +E       I+ I  D+    +     NL    ++  +     +L ++  +  + + +  
Sbjct: 5   SETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60

Query: 317 SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
               GI     +  L LN N L   I P +  +  L  L L  N + 
Sbjct: 61  V--QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK 103

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  116 bits (293), Expect = 3e-29
 Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 9/159 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E+  +   +G+G +G V   +      VA+K + +    +  F +    EA+ +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHP 63

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +VK YG C  +  ++ + EY+  G L   LR   +   L  ++ + +   V   +++L 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE 121

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                  +HRD+++ N L++ +L   V+DFG  R +  D
Sbjct: 122 SH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (292), Expect = 4e-29
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 41/213 (19%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            DF     IG+GG+G V+KA+   DGK   +K++  +        E  + E + L+ + H
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63

Query: 509 RNIVKLYGF----------------CLHKRCMFFIYEYMERGSLFYVLRDD-----DEAI 547
            NIV   G                     +C+F   E+ ++G+L   +        D+ +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
            L    ++         + Y+H   +  +++RD+  +NI L    +  + DFG    L  
Sbjct: 124 ALELFEQI------TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDI 640
           D        GT  Y++P+Q  S    +++  D+
Sbjct: 175 DGKRTRS-KGTLRYMSPEQISSQDYGKEV--DL 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (292), Expect = 5e-29
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +G G +G+VY A E  +  ++ALK L +S+ E        + E  + S +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAH 563
            NI+++Y +   ++ ++ + E+  RG L+  L+     D+  +           ++ +A 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS------AT--FMEELAD 125

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
           AL Y H      ++HRDI   N+L+    E  +ADFG +  +H  S  R    GT  Y+ 
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLP 180

Query: 624 P 624
           P
Sbjct: 181 P 181

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 6e-29
 Identities = 58/182 (31%), Positives = 83/182 (45%), Gaps = 16/182 (8%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           +  E F     IG G +G V+K  +    KVVA+K +   E ED   +E  Q E  VLS 
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQ 76

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVA 562
                + K YG  L    ++ I EY+  GS   +L     D+  I         I++ + 
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREIL 129

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             L YLH +     +HRDI + N+LL+ + E  +ADFG A  L      R    GT  ++
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 186

Query: 623 AP 624
           AP
Sbjct: 187 AP 188

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  117 bits (295), Expect = 6e-29
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 17/181 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
             +     +G GG+   ++  +    +V A K + +S        E    E  +  ++ H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAH 563
           +++V  +GF      +F + E   R SL  + +      + EA      R    ++ +  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA------RY--YLRQIVL 152

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
              YLH +    ++HRD+   N+ LN +LE  + DFG A  +  D   + +  GT  YIA
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 624 P 624
           P
Sbjct: 210 P 210

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (294), Expect = 6e-29
 Identities = 44/175 (25%), Positives = 83/175 (47%), Gaps = 17/175 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV---VALKKLHQSETEDSAFVESFQNEARVLS 504
            +F     +G+G +G+VYK        KV   VA+K+L ++ +  +   +   +EA V++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMA 72

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           +V + ++ +L G CL    +  I + M  G L   +R+  + I       +N    +A  
Sbjct: 73  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKG 129

Query: 565 LSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           ++YL         +VHRD+++ N+L+ +     + DFG A+LL  +        G
Sbjct: 130 MNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (293), Expect = 7e-29
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 12/179 (6%)

Query: 452 FHIRYCIGTGGYGSVYKAELPD---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + +R  +G GG G VY+AE  D    ++VALK + ++ + D  F    Q EAR    ++ 
Sbjct: 36  YRLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            ++V ++ F      ++     +    L  +LR       L   R V IV+ +  AL   
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAA 150

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GTYGYIAPDQ 626
           H        HRD+   NIL++++  A++ DFG A     +   +     GT  Y+AP++
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  115 bits (291), Expect = 8e-29
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 17/181 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
             +     +G GG+   ++  +    +V A K + +S        E    E  +  ++ H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAIELNWTRRVNIVKSVAH 563
           +++V  +GF      +F + E   R SL  + +      + EA      R    ++ +  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA------RY--YLRQIVL 126

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
              YLH +    ++HRD+   N+ LN +LE  + DFG A  +  D   + +  GT  YIA
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 624 P 624
           P
Sbjct: 184 P 184

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  116 bits (293), Expect = 8e-29
 Identities = 55/173 (31%), Positives = 79/173 (45%), Gaps = 11/173 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV--VALKKLHQSETEDSAFVESFQNEARVLST 505
              HI   IG+G  G V    L  P  +   VA+K L    TE       F +EA ++  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H NI++L G     R    + EYME GSL   LR  D   +    + V +++ V   +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGM 164

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
            YL        VHRD+++ N+L++SNL   V+DFG +R+L  D        G 
Sbjct: 165 RYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  115 bits (290), Expect = 9e-29
 Identities = 50/160 (31%), Positives = 84/160 (52%), Gaps = 9/160 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            D  +++ +G G YG VY+       + VA+K L     ED+  VE F  EA V+  ++H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKH 68

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL 127

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                 + +HRD+++ N L+  N    VADFG +RL+  D
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  115 bits (290), Expect = 9e-29
 Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 15/170 (8%)

Query: 454 IRYCIGTGGYGSVYKAEL--PDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
               +G G +GSV +        ++ VA+K L Q   +     E    EA+++  + +  
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPY 71

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL-- 568
           IV+L G C     +  + E    G L   L    E  E+  +    ++  V+  + YL  
Sbjct: 72  IVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE 128

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
            +      VHRD+++ N+LL +   A ++DFG ++ L  D S  T R+  
Sbjct: 129 KN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  115 bits (290), Expect = 9e-29
 Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 14/175 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV--VALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E   P GK   VA+K L          ++ F  E   + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L           VA  +
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 134

Query: 566 SYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
            YL          +HRD+++ N+LL +     + DFG  R L  +  +  ++   
Sbjct: 135 GYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  116 bits (293), Expect = 1e-28
 Identities = 59/174 (33%), Positives = 86/174 (49%), Gaps = 12/174 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV---VALKKLHQSETEDSAFVESFQNEARVLS 504
                +  IG G +G VYK  L    GK    VA+K L    TE       F  EA ++ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
              H NI++L G     + M  I EYME G+L   LR+ D   E +  + V +++ +A  
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 159

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
           + YL +    + VHRD+++ NIL+NSNL   V+DFG +R+L  D       +G 
Sbjct: 160 MKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  115 bits (290), Expect = 1e-28
 Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 14/176 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP-----DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
                   +G G +G V            G+ VA+K L      +   +   + E  +L 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILR 78

Query: 505 TVRHRNIVKLYGFCLHKRC--MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
            + H NIVK  G C       +  I E++  GSL   L  +    ++N  +++     + 
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQIC 136

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
             + YL    +   VHRD+++ N+L+ S  +  + DFG  + +  D    T++   
Sbjct: 137 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (290), Expect = 1e-28
 Identities = 39/180 (21%), Positives = 85/180 (47%), Gaps = 15/180 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
             + I   IG+GG   V++      ++ A+K ++  E ++   ++S++NE   L+ ++  
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 86

Query: 510 N--IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           +  I++LY + +  + ++ + E      L   L+   ++I+    +     K++  A+  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 142

Query: 568 LHHDCTPSIVHRDISSNNILL-NSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAP 624
           +H      IVH D+   N L+ +  L+  + DFG A  +  D+++       GT  Y+ P
Sbjct: 143 IHQH---GIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  116 bits (292), Expect = 2e-28
 Identities = 55/173 (31%), Positives = 79/173 (45%), Gaps = 11/173 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGK--VVALKKLHQSETEDSAFVESFQNEARVLST 505
            +  I   +G G +G V    L  P  K   VA+K L    TE       F  EA ++  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H NI++L G     + +  + EYME GSL   LR  D   +    + V +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
            YL        VHRD+++ NIL+NSNL   V+DFG  R+L  D        G 
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  117 bits (295), Expect = 4e-28
 Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 9/160 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKV-VALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            D  +++ +G G YG VY+       + VA+K L +   E   F++    EA V+  ++H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 275

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL 334

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                 + +HR++++ N L+  N    VADFG +RL+  D
Sbjct: 335 EKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  113 bits (285), Expect = 5e-28
 Identities = 42/159 (26%), Positives = 79/159 (49%), Gaps = 9/159 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L Q         ++F  EA ++  ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQ 68

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY     +  ++ I EYME GSL   L+      +L   + +++   +A  ++++ 
Sbjct: 69  RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIE 126

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                + +HRD+ + NIL++  L   +ADFG ARL+  +
Sbjct: 127 ER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (285), Expect = 5e-28
 Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 15/166 (9%)

Query: 458 IGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G+G +G+V K      KV   VA+K L ++E  D A  +    EA V+  + +  IV++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL--HHDC 572
            G C  +     + E  E G L   L+ +     +     + +V  V+  + YL   +  
Sbjct: 84  IGICEAES-WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN-- 137

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
               VHRD+++ N+LL +   A ++DFG ++ L  D +    +   
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  113 bits (284), Expect = 6e-28
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 18/182 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF +   +G G +  VY+A  +  G  VA+K + +     +  V+  QNE ++   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR------DDDEAIELNWTRRVNIVKSVA 562
            +I++LY +      ++ + E    G +   L+       ++EA      R    +  + 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA------RH--FMHQII 122

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             + YLH      I+HRD++ +N+LL  N+   +ADFG A  L +         GT  YI
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179

Query: 623 AP 624
           +P
Sbjct: 180 SP 181

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (286), Expect = 1e-27
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 10/176 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF     +G G  G V+K    P G V+A K +H       A       E +VL     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             IV  YG       +    E+M+ GSL  VL+     I      +  +  +V   L+YL
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGK--VSIAVIKGLTYL 147

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
                  I+HRD+  +NIL+NS  E  + DFG +  L +DS   +   GT  Y++P
Sbjct: 148 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYMSP 199

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (283), Expect = 1e-27
 Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 12/179 (6%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
              +D+ ++  IG+G    V  A   P  + VA+K+++  + + S  ++    E + +S 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQ 69

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR-----VNIVKS 560
             H NIV  Y   + K  ++ + + +  GS+  +++      E             I++ 
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG-TARLLHVDSSNRTLRAGT 618
           V   L YLH +     +HRD+ + NILL  +    +ADFG +A L       R     T
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (282), Expect = 1e-27
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 20/182 (10%)

Query: 455 RY----CIGTGGYGSVYKAELPD---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           RY     +G GG  +VY AE  D      VA+K +     E    ++ F+ E    S + 
Sbjct: 12  RYKIVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H+NIV +        C + + EY+E  +L   +        L+    +N    +   + +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKH 126

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA---GTYGYIAP 624
            H      IVHRDI   NIL++SN    + DFG A+   +  ++ T      GT  Y +P
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSP 181

Query: 625 DQ 626
           +Q
Sbjct: 182 EQ 183

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  112 bits (281), Expect = 1e-27
 Identities = 57/212 (26%), Positives = 82/212 (38%), Gaps = 17/212 (8%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
            S   +   +N    NL+ ++PP +    +   L+L  N L       +     L  L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN--TVGGPIP 175
               L  T     G+L  L  L L  N+L   LP     L +L  L V +N  T    +P
Sbjct: 63  DRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS---LP 116

Query: 176 STLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPS-TLGHLTSL 232
                 L  L+ L+L  N+   T+P  +      L  LS+  N LT  +P+  L  L +L
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENL 174

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
             L L  N L++ IP        L    L  N
Sbjct: 175 DTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  110 bits (276), Expect = 8e-27
 Identities = 58/188 (30%), Positives = 74/188 (39%), Gaps = 8/188 (4%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
           +P  L    +   L L  N         +     LT L++   +LT  +    G L  L 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLG 80

Query: 234 YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ 293
            LDLS NQL S +PL      AL  LD+S N++  +    L  L  LQ L L  N L   
Sbjct: 81  TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139

Query: 294 IPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPPEIGKILLL 352
            P  +     L  L L+ N L+   P G+      L  L L  NSL  TIP       LL
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 353 QNLDLSHN 360
               L  N
Sbjct: 198 PFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 11/166 (6%)

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
            + +   ++     LT A+P  L        L LS N L++F    +  ++ L +L+L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI- 322
            ++  +       L  L  L+LS N L   +P     L  L  LD+S N+L+ S P G  
Sbjct: 65  AELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120

Query: 323 GNCTELQHLALNHNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIP 367
               ELQ L L  N L  T+PP +      L+ L L++NNL+  +P
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELP 164

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (284), Expect = 2e-27
 Identities = 39/180 (21%), Positives = 84/180 (46%), Gaps = 15/180 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH- 508
             + I   IG+GG   V++      ++ A+K ++  E ++   ++S++NE   L+ ++  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 67

Query: 509 -RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
              I++LY + +  + ++ + E      L   L+   ++I+    +     K++  A+  
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 123

Query: 568 LHHDCTPSIVHRDISSNNILL-NSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAP 624
           +H      IVH D+   N L+ +  L+  + DFG A  +  D+++       GT  Y+ P
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  111 bits (280), Expect = 2e-27
 Identities = 73/308 (23%), Positives = 103/308 (33%), Gaps = 83/308 (26%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS 118
                         N    IP  +    + K L+L +N L         S   L+VL LS
Sbjct: 4   VEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 119 NNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP 175
              +     IE G   SL +L  L L  N +                           + 
Sbjct: 61  RCEI---QTIEDGAYQSLSHLSTLILTGNPIQS-------------------------LA 92

Query: 176 STLF-RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
              F  L++L++L                    L  L              +GHL +L  
Sbjct: 93  LGAFSGLSSLQKLVAVETN--------------LASLE----------NFPIGHLKTLKE 128

Query: 235 LDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ 293
           L+++ N + SF   E   N + L  LDLS NKI+ I   +L  L  +  LNL        
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL-------- 180

Query: 294 IPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL-LL 352
                       SLDLS N ++     G      L+ LAL+ N L  ++P  I   L  L
Sbjct: 181 ------------SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSL 226

Query: 353 QNLDLSHN 360
           Q + L  N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  109 bits (275), Expect = 8e-27
 Identities = 65/252 (25%), Positives = 95/252 (37%), Gaps = 39/252 (15%)

Query: 96  NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG 155
            N    IP  +    + + L LS N L         S   L+ L L   ++         
Sbjct: 17  LNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT------- 66

Query: 156 NLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSI 213
                             I    +  L++L  L L  N    ++       L +L  L  
Sbjct: 67  ------------------IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107

Query: 214 ITNKLTGAIPS-TLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIP 271
           +   L  ++ +  +GHL +L  L+++ N + SF   E   N + L  LDLS NKI+ I  
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

Query: 272 DELSKLSNLQYLNLSSNLLSGQ---IPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTE 327
            +L  L  +  LNLS +L       I     K   L  L L  N+L  S P GI    T 
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTS 225

Query: 328 LQHLALNHNSLD 339
           LQ + L+ N  D
Sbjct: 226 LQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  103 bits (260), Expect = 8e-25
 Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 52/235 (22%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVL 115
           F  FP LQ L+L    +  +I      SLS+L  L L  N +  ++       L +L+ L
Sbjct: 48  FFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105

Query: 116 YLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP 175
                +L       IG L+ L+EL +  N +                           +P
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLP 142

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
                LTNLE L L  N+   +I     +L+ L  + ++                    L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLS-----------------L 182

Query: 236 DLSFNQLHSFIPLEIGNFS--ALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
           DLS N ++    ++ G F    L EL L  N+++ +      +L++LQ + L +N
Sbjct: 183 DLSLNPMNF---IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 57/216 (26%), Positives = 78/216 (36%), Gaps = 33/216 (15%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
                 IP  L    S   LDLSFN L         +F  L  LDLS  +I+ I      
Sbjct: 17  LNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALN 334
            LS+L  L L+ N +      A   L +L  L   +  L+ S      G+   L+ L + 
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132

Query: 335 HNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIP---------MTLHPMFLDMSFNNLEG 384
           HN +     PE    +  L++LDLS N +  +I          M L  + LD+S N +  
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190

Query: 385 EIPT-----------YLRDN-----PPNSFVGNKGL 404
            I              L  N     P   F     L
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSL 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  112 bits (283), Expect = 2e-27
 Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 13/173 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV---VALKKLHQSETEDSAFVESFQNEARVLS 504
            +F     +G+G +G+VYK        KV   VA+K+L ++ +  +   +   +EA V++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMA 72

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           +V + ++ +L G CL    +  I + M  G L   +R+  +   +     +N    +A  
Sbjct: 73  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 129

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           ++YL       +VHRD+++ N+L+ +     + DFG A+LL  +        G
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  112 bits (282), Expect = 2e-27
 Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 26/209 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + +     +G GG+  V   E L DG   ALK++   E +D    E  Q EA +     H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNH 85

Query: 509 RNIVKLYGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV-NIVKSVAH 563
            NI++L  +CL +R      + +  + +RG+L+  +    +        ++  ++  +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA------- 616
            L  +H        HRD+   NILL    +  + D G+     +                
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 617 --GTYGYIAP---DQRLSPPVNQKIIQDI 640
              T  Y AP     +    ++++   D+
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDER--TDV 229

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (281), Expect = 2e-27
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 9/171 (5%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            E + I   +G G +G VYKA     G + A K +     E+   +E +  E  +L+T  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCD 74

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H  IVKL G   H   ++ + E+   G++  ++ + D  +     +   + + +  AL++
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNF 132

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
           LH      I+HRD+ + N+L+    +  +ADFG +         R    GT
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  114 bits (287), Expect = 3e-27
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 13/164 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K +    T      ++F  EA V++ +RH 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHS 246

Query: 510 NIVKLYGFCLHKRCMFFI-YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           N+V+L G  + ++   +I  EYM +GSL   LR    +  L     +     V  A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL 305

Query: 569 -HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
             ++     VHRD+++ N+L++ +  A V+DFG  +        
Sbjct: 306 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  110 bits (278), Expect = 3e-27
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 13/164 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K +    T      ++F  EA V++ +RH 
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHS 74

Query: 510 NIVKLYGFCLHKRCMFFI-YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           N+V+L G  + ++   +I  EYM +GSL   LR    +  L     +     V  A+ YL
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL 133

Query: 569 -HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
             ++     VHRD+++ N+L++ +  A V+DFG  +        
Sbjct: 134 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (290), Expect = 4e-27
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 15/166 (9%)

Query: 458 IGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G G +GSV +      K    VA+K L Q   +     E    EA+++  + +  IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 401

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL--HHDC 572
            G C  +  +  + E    G L   L    E  E+  +    ++  V+  + YL   +  
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN-- 456

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
               VHR++++ N+LL +   A ++DFG ++ L  D S  T R+  
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  110 bits (278), Expect = 4e-27
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 15/167 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP-----DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
                   +G G +GSV            G+VVA+KKL  S  E    +  F+ E  +L 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILK 66

Query: 505 TVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           +++H NIVK  G C    +R +  I EY+  GSL   L+   E I+    + +     + 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQIC 124

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
             + YL    T   +HRD+++ NIL+ +     + DFG  ++L  D 
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (286), Expect = 5e-27
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 9/159 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L       +   E+F  EA+V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHE 239

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY     +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE 297

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                + VHRD+ + NIL+  NL   VADFG ARL+  +
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  111 bits (279), Expect = 5e-27
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 17/169 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP-----DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
                   +G G +GSV            G +VA+K+L  S  +       FQ E ++L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILK 79

Query: 505 TVRHRNIVKLYGFCLHKRC--MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
            +    IVK  G         +  + EY+  G L   L+     ++ +  R +     + 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQIC 137

Query: 563 HALSYLH-HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
             + YL    C    VHRD+++ NIL+ S     +ADFG A+LL +D  
Sbjct: 138 KGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  113 bits (285), Expect = 6e-27
 Identities = 41/159 (25%), Positives = 82/159 (51%), Gaps = 9/159 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+ A       VA+K +        AF+     EA V+ T++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +VKL+     +  ++ I E+M +GSL   L+ D+ + +    + ++    +A  ++++ 
Sbjct: 244 KLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE 301

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                + +HRD+ + NIL++++L   +ADFG AR++  +
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (278), Expect = 7e-27
 Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 11/190 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARV-LSTVR 507
           ED      IG G YGSV K    P G+++A+K++    T D    +    +  V + +  
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSD 79

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV--NIVKSVAHAL 565
              IV+ YG    +   +   E M   S     +     ++      +   I  +   AL
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
           ++L  +    I+HRDI  +NILL+ +    + DFG +  L VDS  +T  AG   Y+AP+
Sbjct: 139 NHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 195

Query: 626 QRLSPPVNQK 635
            R+ P  +++
Sbjct: 196 -RIDPSASRQ 204

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  110 bits (278), Expect = 7e-27
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGK----VVALKKLHQSETEDSAFVESFQNEARVLS 504
            +      +G+G +G+V+K    P+G+     V +K +       S   ++  +    + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIG 70

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           ++ H +IV+L G C     +  + +Y+  GSL   +R    A+       +N    +A  
Sbjct: 71  SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKG 127

Query: 565 LSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
           + YL  H      +VHR++++ N+LL S  +  VADFG A LL  D         
Sbjct: 128 MYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 9e-27
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 15/176 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP-----DGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
                   +G G +GSV            G+VVA+KKL  S  E    +  F+ E  +L 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILK 97

Query: 505 TVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           +++H NIVK  G C    +R +  I EY+  GSL   L+   E I+    + +     + 
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQIC 155

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
             + YL    T   +HRD+++ NIL+ +     + DFG  ++L  D     ++   
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  112 bits (281), Expect = 9e-27
 Identities = 38/180 (21%), Positives = 83/180 (46%), Gaps = 15/180 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH- 508
             + I   IG+GG   V++      ++ A+K ++  E ++   ++S++NE   L+ ++  
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 114

Query: 509 -RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
              I++LY + +  + ++ + E      L   L+   ++I+    +     K++  A+  
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 170

Query: 568 LHHDCTPSIVHRDISSNNILL-NSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAP 624
           +H      IVH D+   N L+ +  L+  + DFG A  +  D+++       G   Y+ P
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  109 bits (275), Expect = 1e-26
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 16/162 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV--VALKKLHQSETEDSAFVESFQNEARVLST 505
           ED  +   +G G +G VY+       G+   VA+K   +  T D+   E F +EA ++  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN--KEKFMSEAVIMKN 69

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + H +IVKL G    +   + I E    G L + L  +  ++++     V     +  A+
Sbjct: 70  LDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAM 126

Query: 566 SYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
           +YL   +      VHRDI+  NIL+ S     + DFG +R +
Sbjct: 127 AYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYI 163

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  113 bits (285), Expect = 1e-26
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 9/159 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L       +   E+F  EA+V+  +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHE 322

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY     +  ++ + EYM +GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 323 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE 380

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                + VHRD+ + NIL+  NL   VADFG ARL+  +
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (275), Expect = 1e-26
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 17/180 (9%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            + +     IG G  G+VY A ++  G+ VA+++++  +       E   NE  V+   +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENK 75

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHA 564
           + NIV      L    ++ + EY+  GSL  V+ +   D+  I         + +    A
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQA 128

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L +LH +    ++HRDI S+NILL  +    + DFG    +  + S R+   GT  ++AP
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  110 bits (276), Expect = 1e-26
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 13/186 (6%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
            +   + +   +G G   +V++      G + A+K  +         V+    E  VL  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63

Query: 506 VRHRNIVKLYGF--CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           + H+NIVKL+        R    I E+   GSL+ VL +   A  L  +  + +++ V  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSNRTLRAGTY 619
            +++L  +    IVHR+I   NI+     +      + DFG AR L  D    +L  GT 
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTE 179

Query: 620 GYIAPD 625
            Y+ PD
Sbjct: 180 EYLHPD 185

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (275), Expect = 2e-26
 Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 16/167 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
                   +G G +G V            G++VA+K L             ++ E  +L 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILR 88

Query: 505 TVRHRNIVKLYGFCLHKRC--MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           T+ H +I+K  G C       +  + EY+  GSL   L        +   + +   + + 
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQIC 144

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
             ++YLH       +HRD+++ N+LL+++    + DFG A+ +    
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (276), Expect = 2e-26
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 7/155 (4%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            + F     IG G +G+VY A ++ + +VVA+KK+  S  + +   +    E R L  +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H N ++  G  L +   + + EY   GS   +L    + ++        +       L+Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
           LH     +++HRD+ + NILL+      + DFG+A
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 2e-26
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 17/180 (9%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
                    IG G  G V  A E   G+ VA+K +   + +     E   NE  ++   +
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQ 100

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVNIVKSVAHA 564
           H N+V++Y   L    ++ + E+++ G+L  ++     ++E I         + ++V  A
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQA 153

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L+YLH      ++HRDI S++ILL  +    ++DFG    +  D   R    GT  ++AP
Sbjct: 154 LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  108 bits (272), Expect = 2e-26
 Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 14/164 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV--VALKKLHQSETEDSAFVESFQNEARVLST 505
           E   +  CIG G +G V++     P+     VA+K      ++     E F  EA  +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQ 72

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H +IVKL G       ++ I E    G L   L+    +++L     +     ++ AL
Sbjct: 73  FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTAL 129

Query: 566 SYL-HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           +YL         VHRDI++ N+L++SN    + DFG +R +   
Sbjct: 130 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (277), Expect = 2e-26
 Identities = 35/176 (19%), Positives = 68/176 (38%), Gaps = 24/176 (13%)

Query: 449 TEDFHIRYCIGTG--GYGSVYKA-ELPDGKVVALKK--LHQSETEDSAFVESFQNEARVL 503
              + +   IG G     +V  A   P G+ V +++  L     E    V   Q E  V 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM---VTFLQGELHVS 80

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD------DDEAIELNWTRRVNI 557
               H NIV      +    ++ +  +M  GS   ++        ++ AI         I
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI-------AYI 133

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT 613
           ++ V  AL Y+HH      VHR + +++IL++ + + +++   +   +      + 
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (273), Expect = 2e-26
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
            E F +   +G G YGSVYKA     G++VA+K++     E    ++    E  ++    
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESD--LQEIIKEISIMQQCD 82

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
             ++VK YG       ++ + EY   GS+  ++R  ++ +  +      I++S    L Y
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEY 140

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LH       +HRDI + NILLN+   A +ADFG A  L    + R    GT  ++AP
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (273), Expect = 3e-26
 Identities = 41/177 (23%), Positives = 74/177 (41%), Gaps = 10/177 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL-STVR 507
            D      +G+G  G V+K      G V+A+K++ +  + +    +    +  V+  +  
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNKEENKRILMDLDVVLKSHD 82

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
              IV+ +G  +    +F   E M   +     R     I      +  +  ++  AL Y
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGK--MTVAIVKALYY 139

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L       ++HRD+  +NILL+   +  + DFG +  L VD   +   AG   Y+AP
Sbjct: 140 LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAP 193

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (272), Expect = 3e-26
 Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 16/164 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLST 505
              H    IG G +G VY  E  D        A+K L +        VE+F  E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRG 78

Query: 506 VRHRNIVKLYGFCLHKRCMFF-IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           + H N++ L G  L    +   +  YM  G L   +R             ++    VA  
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARG 136

Query: 565 LSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           + YL          VHRD+++ N +L+ +    VADFG AR + 
Sbjct: 137 MEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDIL 175

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (271), Expect = 4e-26
 Identities = 45/185 (24%), Positives = 71/185 (38%), Gaps = 21/185 (11%)

Query: 443 EDLINATEDFHIRY---------CIGTGGYGSVYKAELPDGK----VVALKKLHQSETED 489
            +L+ A +   I            IG G +G VY   L D        A+K L++     
Sbjct: 9   PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 490 SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC-MFFIYEYMERGSLFYVLRDDDEAIE 548
              V  F  E  ++    H N++ L G CL        +  YM+ G L   +R++     
Sbjct: 69  E--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--N 124

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
                 +     VA  + YL    +   VHRD+++ N +L+      VADFG AR ++  
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

Query: 609 SSNRT 613
                
Sbjct: 182 EYYSV 186

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  108 bits (272), Expect = 5e-26
 Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 27/186 (14%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
                 +  +G G +G V++  +   G   A+K   +   E          E    + + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFR-----VEELVACAGLS 108

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHA 564
              IV LYG       +    E +E GSL  +++      E   L +             
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG------QALEG 162

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTARLLHVDSSNRTLRA-----GT 618
           L YLH      I+H D+ ++N+LL+S+   A + DFG A  L  D   ++L       GT
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 619 YGYIAP 624
             ++AP
Sbjct: 220 ETHMAP 225

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  107 bits (270), Expect = 8e-26
 Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 22/186 (11%)

Query: 455 RY----CIGTGGYGSVYKAELPD---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           RY     +G GG   V+ A   D    + VA+K L      D +F   F+ EA+  + + 
Sbjct: 13  RYELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70

Query: 508 HRNIVKLY--GF--CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           H  IV +Y  G          + + EY++  +L  ++  +     +   R + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA---GTYG 620
           AL++ H +    I+HRD+   NI++++     V DFG AR +    ++ T  A   GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 621 YIAPDQ 626
           Y++P+Q
Sbjct: 185 YLSPEQ 190

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  107 bits (269), Expect = 1e-25
 Identities = 41/181 (22%), Positives = 61/181 (33%), Gaps = 18/181 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           + F     +G G YG V+K     DG++ A+K+   S             E      V +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD----DEAIELNWTRRVNIVKSVAH 563
           H   V+L         ++   E     SL            EA    + R          
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR------DTLL 168

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
           AL++LH      +VH D+   NI L       + DFG    L    +    + G   Y+A
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMA 224

Query: 624 P 624
           P
Sbjct: 225 P 225

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  106 bits (266), Expect = 1e-25
 Identities = 38/178 (21%), Positives = 75/178 (42%), Gaps = 28/178 (15%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEAR 501
           ED      +G G +  ++K                V LK L ++    S   ESF   A 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64

Query: 502 VLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           ++S + H+++V  YG C+       + E+++ GSL   L+ +   I + W  ++ + K +
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122

Query: 562 AHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAF--------VADFGTARLLHVDS 609
           A A+ +L  +      ++H ++ + NILL    +          ++D G +  +    
Sbjct: 123 AAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  106 bits (266), Expect = 2e-25
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 20/194 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARV-LSTVR 507
           +D      +G G YG V K   +P G+++A+K++    T +S   +    +  + + TV 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 64

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN------IVKSV 561
               V  YG    +  ++   E M+  SL     D      ++  + +       I  S+
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSL-----DKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGY 621
             AL +LH     S++HRD+  +N+L+N+  +  + DFG +  L VD   + + AG   Y
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPY 175

Query: 622 IAPDQRLSPPVNQK 635
           +AP+ R++P +NQK
Sbjct: 176 MAPE-RINPELNQK 188

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  106 bits (267), Expect = 2e-25
 Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 21/172 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLST 505
           + F +   +G G +GSV +A+L         VA+K L       S  +E F  EA  +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKE 81

Query: 506 VRHRNIVKLYGFCLHKR------CMFFIYEYMERGSLFYVLRD---DDEAIELNWTRRVN 556
             H ++ KL G  L  R          I  +M+ G L   L      +    L     V 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 557 IVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
            +  +A  + YL   +      +HRD+++ N +L  ++   VADFG +R ++
Sbjct: 142 FMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  108 bits (270), Expect = 2e-25
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 13/186 (6%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
            +   + +   +G G   +V++      G + A+K  +         V+    E  VL  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63

Query: 506 VRHRNIVKLYGF--CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           + H+NIVKL+        R    I E+   GSL+ VL +   A  L  +  + +++ V  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSNRTLRAGTY 619
            +++L  +    IVHR+I   NI+     +      + DFG AR L  D    +L  GT 
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTE 179

Query: 620 GYIAPD 625
            Y+ PD
Sbjct: 180 EYLHPD 185

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (268), Expect = 3e-25
 Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 12/165 (7%)

Query: 458 IGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           IG G +G VY   L D        A+K L++        V  F  E  ++    H N++ 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 154

Query: 514 LYGFCLHKRC-MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
           L G CL        +  YM+ G L   +R++     +     +     VA  + +L    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK- 211

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
               VHRD+++ N +L+      VADFG AR ++    +      
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  108 bits (271), Expect = 3e-25
 Identities = 42/184 (22%), Positives = 82/184 (44%), Gaps = 23/184 (12%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHR 509
            F  +  +G G  G++    + D + VA+K++                E ++L     H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEHP 78

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           N+++ +     ++  +   E     +L  YV + D   + L     + +++     L++L
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134

Query: 569 HHDCTPSIVHRDISSNNILL-----NSNLEAFVADFGTARLLHVDSSNRTLR---AGTYG 620
           H     +IVHRD+  +NIL+     +  ++A ++DFG  + L V   + + R    GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 621 YIAP 624
           +IAP
Sbjct: 192 WIAP 195

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (267), Expect = 4e-25
 Identities = 27/197 (13%), Positives = 60/197 (30%), Gaps = 27/197 (13%)

Query: 449 TEDFHIRYCIGTGGYGSVYKAE------LPDGKVVALKKLHQSETEDSAFVESFQNEARV 502
           ++  ++ + +G G +  VY+A         + +   LK    +   +             
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMER 120

Query: 503 LSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE--LNWTRRVNIVKS 560
           L        +K Y   L +     + E    G+L   +       E  +     ++    
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-----------VADFGTARLLHVDS 609
           + + +  +H      I+H DI  +N +L +                + D G +  + +  
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 610 SNRTLRA--GTYGYIAP 624
                 A   T G+   
Sbjct: 238 KGTIFTAKCETSGFQCV 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (263), Expect = 6e-25
 Identities = 36/171 (21%), Positives = 70/171 (40%), Gaps = 20/171 (11%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESFQNEARVLST 505
               +   +G G +GSV +  L         VA+K +    +     +E F +EA  +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKD 92

Query: 506 VRHRNIVKLYGFCLHKR-----CMFFIYEYMERGSLFYVLR---DDDEAIELNWTRRVNI 557
             H N+++L G C+            I  +M+ G L   L     +     +     +  
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 558 VKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           +  +A  + YL   +      +HRD+++ N +L  ++   VADFG ++ ++
Sbjct: 153 MVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 1e-24
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 28/196 (14%)

Query: 443 EDLINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEAR 501
             L +    F +   +G G YG VYK   +  G++ A+K +  +  E+    E  + E  
Sbjct: 17  SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEIN 72

Query: 502 VLSTV-RHRNIVKLYGFCLHKRC------MFFIYEYMERGSLFYVLRDDDEAIELNWTRR 554
           +L     HRNI   YG  + K        ++ + E+   GS+        + I+      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNT 125

Query: 555 VN------IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           +       I + +   LS+LH      ++HRDI   N+LL  N E  + DFG +  L   
Sbjct: 126 LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

Query: 609 SSNRTLRAGTYGYIAP 624
              R    GT  ++AP
Sbjct: 183 VGRRNTFIGTPYWMAP 198

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (257), Expect = 3e-24
 Identities = 42/204 (20%), Positives = 74/204 (36%), Gaps = 42/204 (20%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV- 506
           T +FH    IG+G +GSV+K  +  DG + A+K+  +     S   ++   E    + + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVYAHAVLG 68

Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDD-------DEAIELNWTRRVNIVK 559
           +H ++V+ +        M    EY   GSL   + ++        EA   +         
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL------ 122

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV-------------------ADFG 600
            V   L Y+H     S+VH DI  +NI ++                           D G
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 601 TARLLHVDSSNRTLRAGTYGYIAP 624
               +    S+  +  G   ++A 
Sbjct: 180 HVTRI----SSPQVEEGDSRFLAN 199

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  103 bits (259), Expect = 3e-24
 Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 24/194 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSE--------------TEDSAFVES 495
            D+ I   +  G +  +   E  D K  ALKK  +S                   +  + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 496 FQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           F+NE ++++ +++   +   G   +   ++ IYEYME  S+           +       
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 556 N-----IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
                 I+KSV ++ SY+H++   +I HRD+  +NIL++ N    ++DFG +   ++   
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDK 205

Query: 611 NRTLRAGTYGYIAP 624
                 GTY ++ P
Sbjct: 206 KIKGSRGTYEFMPP 219

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =  103 bits (259), Expect = 3e-24
 Identities = 51/284 (17%), Positives = 92/284 (32%), Gaps = 39/284 (13%)

Query: 60  CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN 119
           C  + +      + ++  IP  +    N   L      L            +LE + +S 
Sbjct: 7   CHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 63

Query: 120 NSLHGTTPIEIG---SLRNLEELYL-RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP 175
           N +     IE     +L  L E+ + ++N L  + P+   NL +L +L +    +   +P
Sbjct: 64  NDV--LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LP 120

Query: 176 STLF-RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
                       L +  N    TI R   +   L+                       + 
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIER--NSFVGLSFE--------------------SVI 158

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSD-NKIRGIIPDELSKLSNLQYLNLSSNLLSGQ 293
           L L+ N +   I     N + L EL+LSD N +  +  D     S    L++S   +   
Sbjct: 159 LWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217

Query: 294 IPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNS 337
             + +  L  L +      K   +          L   +L + S
Sbjct: 218 PSYGLENLKKLRARSTYNLKKLPTL----EKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =   99 bits (249), Expect = 6e-23
 Identities = 49/282 (17%), Positives = 93/282 (32%), Gaps = 43/282 (15%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL 146
           + +    + + +T  IP ++   RN   L      L            +LE++ +  N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFL-GCNQFNGTIPREI-GN 204
             V+                              L  L  + +   N     I  E   N
Sbjct: 67  LEVIE-----------------------ADVFSNLPKLHEIRIEKANNLL-YINPEAFQN 102

Query: 205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN-QLHSFIPLEIGNFSALA----EL 259
           L NL +L I    +         H    + LD+  N  +H+   +E  +F  L+     L
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT---IERNSFVGLSFESVIL 159

Query: 260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFP 319
            L+ N I+ I     +     +     +N L              V LD+S+ ++  S P
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 218

Query: 320 TGI-GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHN 360
           +    N  +L+  +  +      +P  + K++ L    L++ 
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 91.0 bits (226), Expect = 5e-20
 Identities = 45/256 (17%), Positives = 83/256 (32%), Gaps = 23/256 (8%)

Query: 25  HCNWVGITCDYKG----------SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNL 74
           HC+     C              +   +  V   ++  +    FS F +L+ + +  N++
Sbjct: 8   HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDV 66

Query: 75  SGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIGS 132
              I   +  +L  L  + +   N    I  E   +L NL+ L +SN  +     +    
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126

Query: 133 LRNLEELYLRSN-KLSGVLPQEIGNLKS-LIWLSVMYNTVGGPIPSTLFRLTNLERL-FL 189
                 L ++ N  +  +       L    + L +  N +   I ++ F  T L+ L   
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLS 185

Query: 190 GCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPL 248
             N     +P ++         L I   ++       L +L  L         L     L
Sbjct: 186 DNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPTL 242

Query: 249 EIGNFSALAELDLSDN 264
           E     AL E  L+  
Sbjct: 243 E--KLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.9 bits (210), Expect = 6e-18
 Identities = 42/200 (21%), Positives = 69/200 (34%), Gaps = 11/200 (5%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS-TLGHLTSL 232
           IPS L    N   L     +             +L  + I  N +   I +    +L  L
Sbjct: 24  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 233 LYLDLS-FNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
             + +   N L    P    N   L  L +S+  I+ +             L++  N+  
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 292 GQIP---FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEI-G 347
             I    F  G  F  V L L+KN +         N T+L  L L+ N+    +P ++  
Sbjct: 142 HTIERNSFV-GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199

Query: 348 KILLLQNLDLSHNNLSGTIP 367
                  LD+S   +  ++P
Sbjct: 200 GASGPVILDISRTRIH-SLP 218

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.6 bits (178), Expect = 8e-14
 Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 16/163 (9%)

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
                +++   IP ++       EL     K+R I     S   +L+ + +S N +   I
Sbjct: 14  FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 295 PF-AIGKLFNLVSLDLSK-NKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPPEIGKILL 351
                  L  L  + + K N L          N   LQ+L +++  +   +P       L
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSL 128

Query: 352 -LQNLDLSHNNLSGTIP------MTLHPMFLDMSFNNLEGEIP 387
               LD+  N    TI       ++   + L ++ N ++ EI 
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  103 bits (258), Expect = 3e-24
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 22/164 (13%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++           VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 95

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR----DDDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR       +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 568 L--HHDCTPSIVHRDISSNNILLNSNLEAFV---ADFGTARLLH 606
           L  +H      +HRDI++ N LL       V    DFG AR ++
Sbjct: 156 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (256), Expect = 4e-24
 Identities = 55/282 (19%), Positives = 91/282 (32%), Gaps = 83/282 (29%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G   +G VYK  L           VA+K L           E F++EA + + ++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNV 74

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRVNIV 558
           V L G     + +  I+ Y   G L   L              D      L     V++V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 559 KSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA 616
             +A  + YL  HH     +VH+D+++ N+L+   L   ++D G  R ++     + L  
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 617 G----------------------------------TYG--------------YIAPDQRL 628
                                              +YG               I   Q L
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL 249

Query: 629 SPPVN-QKIIQDIILVSTTALACLRSKPKSRPTMQRISQELE 669
             P +    +  ++      + C    P  RP  + I   L 
Sbjct: 250 PCPDDCPAWVYALM------IECWNEFPSRRPRFKDIHSRLR 285

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 4e-24
 Identities = 41/183 (22%), Positives = 73/183 (39%), Gaps = 28/183 (15%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           IG G +  V +      G+  A+K     K   S        E  + EA +   ++H +I
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHPHI 88

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV-------NIVKSVAHA 564
           V+L         ++ ++E+M+   L        E ++      V       + ++ +  A
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAGTYGY 621
           L Y H +   +I+HRD+  + +LL S   +    +  FG A  L         R GT  +
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 622 IAP 624
           +AP
Sbjct: 200 MAP 202

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  102 bits (257), Expect = 4e-24
 Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 22/172 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVL 503
           E   +   +G G +G VY+              VA+K ++++ +        F NEA V+
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 82

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------DDDEAIELNWTRRVN 556
                 ++V+L G     +    I E M RG L   LR       ++      + ++ + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 557 IVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           +   +A  ++YL  +       VHRD+++ N ++  +    + DFG  R ++
Sbjct: 143 MAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  103 bits (258), Expect = 5e-24
 Identities = 14/198 (7%), Positives = 39/198 (19%), Gaps = 38/198 (19%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +  G    V+   ++   +  ALK          + +E         + +   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 517 FCLHKRCM--------------------------FFIYEYMERGSLFYVLRDDDEAIE-- 548
                                               +        L  +    D      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 549 --LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
                     +   +    + L       +VH   + +N+ +  +    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 607 VDSSNRTLRAGTYGYIAP 624
              +     +    Y   
Sbjct: 243 KVGTRGPASSVPVTYAPR 260

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (259), Expect = 8e-24
 Identities = 42/208 (20%), Positives = 82/208 (39%), Gaps = 36/208 (17%)

Query: 443 EDLINATEDFHIRYC----IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQN 498
            ++ N  +           +G G  G+V       G+ VA+K++         F +    
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALM 57

Query: 499 EARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLR---DDDEAIELNWTR 553
           E ++L+    H N+++ Y      R ++   E     +L   V      D+         
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-------------NLEAFVADFG 600
            +++++ +A  +++LH      I+HRD+   NIL+++             NL   ++DFG
Sbjct: 117 PISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 601 TARLLHVDSSNRTLR----AGTYGYIAP 624
             + L    S+        +GT G+ AP
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAP 201

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  105 bits (263), Expect = 1e-23
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 14/165 (8%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL--PDGKV--VALKKLHQSETEDSAFVESFQNEARVLST 505
           E   +  CIG G +G V++     P+     VA+K      ++     E F  EA  +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 447

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H +IVKL G       ++ I E    G L   L+    +++L     +     ++ AL
Sbjct: 448 FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 504

Query: 566 SYLH-HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
           +YL         VHRDI++ N+L++SN    + DFG +R +   +
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score =  100 bits (250), Expect = 1e-23
 Identities = 56/260 (21%), Positives = 93/260 (35%), Gaps = 43/260 (16%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                 N    NL   +++  +      LS ++  N   +N+       +    NL+ L+
Sbjct: 14  PDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
           LS+N +   +P++   L  LEEL +  N+L       +  + S                 
Sbjct: 70  LSHNQISDLSPLK--DLTKLEELSVNRNRLK-----NLNGIPSA---------------- 106

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
                  L RLFL  N+        + +LKNL  LSI  NKL       LG L+ L  LD
Sbjct: 107 ------CLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLD 156

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI-P 295
           L  N++ +   L       +  +DL+  K    + + +     L   N   +     I P
Sbjct: 157 LHGNEITNTGGLT--RLKKVNWIDLTGQK---CVNEPVKYQPELYITNTVKDPDGRWISP 211

Query: 296 FAIGKLFNLVSLDLSKNKLS 315
           + I    + V   +      
Sbjct: 212 YYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 48/253 (18%), Positives = 89/253 (35%), Gaps = 27/253 (10%)

Query: 117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS 176
                ++   P     L N  +  L    ++ ++ Q+   L  +   +   + +     +
Sbjct: 4   QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ--SLA 57

Query: 177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD 236
            +   TNL+ L L  NQ +   P  + +L  L  LS+  N+L     + +     L  L 
Sbjct: 58  GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK--NLNGIPSAC-LSRLF 112

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           L  N+L     L   +   L  L + +NK++ I    L  LS L+ L+L  N ++     
Sbjct: 113 LDNNELRDTDSLI--HLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGG- 167

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN--SLDGTI--PPEIGKILLL 352
            + +L  +  +DL+  K                 L + +     DG    P  I      
Sbjct: 168 -LTRLKKVNWIDLTGQKCVNE------PVKYQPELYITNTVKDPDGRWISPYYISNGGSY 220

Query: 353 QNLDLSHNNLSGT 365
            +  +       T
Sbjct: 221 VDGCVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 30/162 (18%), Positives = 65/162 (40%), Gaps = 13/162 (8%)

Query: 224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYL 283
                L + +  +L    +   +  +    S +   +  ++ I+ +    +   +NL+ L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 284 NLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIP 343
           +LS N +S  +   +  L  L  L +++N+L      GI +   L  L L++N L     
Sbjct: 69  HLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKN--LNGIPSAC-LSRLFLDNNEL--RDT 121

Query: 344 PEIGKILLLQNLDLSHNNLSGTIPMTLHP--MFLDMSFNNLE 383
             +  +  L+ L + +N L   + +        LD+  N + 
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT 163

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (258), Expect = 1e-23
 Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 31/194 (15%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESFQN 498
            +     Y +    G+G  G V  A E    K VA++     K       ++    + + 
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTR 553
           E  +L  + H  I+K+  F       + + E ME G LF  V+      +          
Sbjct: 190 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC------- 241

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSS 610
                  +  A+ YLH +    I+HRD+   N+LL+S  E     + DFG +++L   S 
Sbjct: 242 -KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

Query: 611 NRTLRAGTYGYIAP 624
            RTL  GT  Y+AP
Sbjct: 298 MRTL-CGTPTYLAP 310

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  102 bits (255), Expect = 1e-23
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 22/164 (13%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G VY+ ++           VA+K L +  +E       F  EA ++S   H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 136

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR----DDDEAIELNWTRRVNIVKSVAHALSY 567
           V+  G  L     F + E M  G L   LR       +   L     +++ + +A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 568 L--HHDCTPSIVHRDISSNNILLNSNLEAFV---ADFGTARLLH 606
           L  +H      +HRDI++ N LL       V    DFG AR ++
Sbjct: 197 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  100 bits (252), Expect = 1e-23
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 29/170 (17%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G V+ AE  +        +VA+K L   +   +A  + FQ EA +L+ ++H +I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKD-FQREAELLTNLQHEHI 79

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRVNIV 558
           VK YG C     +  ++EYM+ G L   LR                   EL  ++ ++I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 559 KSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
             +A  + YL   H      VHRD+++ N L+ +NL   + DFG +R ++
Sbjct: 140 SQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 1e-23
 Identities = 42/192 (21%), Positives = 82/192 (42%), Gaps = 31/192 (16%)

Query: 449 TEDFHIRYC----IGTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESFQN 498
              F   Y     +G G +  V +  ++  G+  A       KL   + +        + 
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------LER 59

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--V 555
           EAR+   ++H NIV+L+     +   + I++ +  G LF      ++ +    ++     
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADAS 113

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNR 612
           + ++ +  A+ + H      +VHR++   N+LL S L+     +ADFG A  +  +    
Sbjct: 114 HCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 613 TLRAGTYGYIAP 624
              AGT GY++P
Sbjct: 171 FGFAGTPGYLSP 182

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (250), Expect = 2e-23
 Identities = 21/156 (13%), Positives = 49/156 (31%), Gaps = 17/156 (10%)

Query: 455 RY----CIGTGGYGSVYKAELPD---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           RY      G       ++A   D    + VAL  +          ++   +    LS + 
Sbjct: 32  RYRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
              + ++      +     + E++  GSL  V          +    +  ++S+A A   
Sbjct: 90  KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADA 144

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
            H      +       + + ++ + +  +A   T  
Sbjct: 145 AHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  103 bits (258), Expect = 2e-23
 Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 15/188 (7%)

Query: 445 LINATEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNE 499
           + ++T  F  RY      G G +G V    +   G+  A+K + + + +     ES   E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
            ++L  + H NI+KLY F   K   + + E    G LF  +       E        I++
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAARIIR 133

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRA 616
            V   ++Y+H +    IVHRD+   N+LL S  +     + DFG +         +  + 
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KI 189

Query: 617 GTYGYIAP 624
           GT  YIAP
Sbjct: 190 GTAYYIAP 197

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  104 bits (260), Expect = 2e-23
 Identities = 44/185 (23%), Positives = 75/185 (40%), Gaps = 16/185 (8%)

Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            + ++  +GTGG+G V +      G+ VA+K+  Q  +  +   E +  E +++  + H 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHP 72

Query: 510 NIVKLY------GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           N+V                      EY E G L   L   +    L       ++  ++ 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAGTYG 620
           AL YLH +    I+HRD+   NI+L    +     + D G A+ L           GT  
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQ 188

Query: 621 YIAPD 625
           Y+AP+
Sbjct: 189 YLAPE 193

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (253), Expect = 3e-23
 Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 32/213 (15%)

Query: 428 NLKLVTGGYDGKILYEDLINATEDFHIRY----CIGTGGYGSVYKA-ELPDGKVVALK-- 480
           ++  +TGG       E ++NA+  F   Y     +G G +  V +      G   A K  
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 481 ---KLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLF 537
              KL   + +        + EAR+   ++H NIV+L+     +   + +++ +  G LF
Sbjct: 63  NTKKLSARDFQK------LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116

Query: 538 YVLRDDDEAIEL-NWTRRV--NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 594
                 ++ +    ++     + ++ +  +++Y H +    IVHR++   N+LL S  + 
Sbjct: 117 ------EDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 167

Query: 595 F---VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
               +ADFG A  ++   +     AGT GY++P
Sbjct: 168 AAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSP 199

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 22/187 (11%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
              F  RY I    G G +G V K  +    +  A+K ++++  ++     +   E  +L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELL 75

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNIVKS 560
             + H NI+KL+         + + E    G LF      DE I+   ++      I+K 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQ 129

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAG 617
           V   ++Y+H     +IVHRD+   NILL S  +     + DFG +     ++  +  R G
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIG 185

Query: 618 TYGYIAP 624
           T  YIAP
Sbjct: 186 TAYYIAP 192

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 3e-23
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 28/169 (16%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G V+ AE  +        +VA+K L   E  +SA  + FQ EA +L+ ++H++I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQD-FQREAELLTMLQHQHI 105

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR------------DDDEAIELNWTRRVNIVK 559
           V+ +G C   R +  ++EYM  G L   LR            +D     L   + + +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 560 SVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
            VA  + YL   H      VHRD+++ N L+   L   + DFG +R ++
Sbjct: 166 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 13/212 (6%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
            SC  N   ++  +  L+ +IP  I   ++ K L+L+ N L+    K    L  L +LYL
Sbjct: 12  CSCNNNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68

Query: 118 SNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           ++N L     +  G    L+NLE L++  NKL  +       L +L  L +  N +   +
Sbjct: 69  NDNKL---QTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-L 124

Query: 175 PSTLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
           P  +F  LT L  L LG N+   ++P+ +   L +L  L +  N+L          LT L
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
             L L  NQL         +   L  L L +N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 97.7 bits (244), Expect = 9e-23
 Identities = 66/212 (31%), Positives = 91/212 (42%), Gaps = 38/212 (17%)

Query: 135 NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQ 193
           + ++L L+SNKLS                          +PS  F RLT L  L+L  N+
Sbjct: 38  DTKKLDLQSNKLSS-------------------------LPSKAFHRLTKLRLLYLNDNK 72

Query: 194 FNGTIPREI-GNLKNLTHLSIITNKLTGAIPS-TLGHLTSLLYLDLSFNQLHSFIPLEIG 251
              T+P  I   LKNL  L +  NKL  A+P      L +L  L L  NQL S   L   
Sbjct: 73  LQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS---LPPR 127

Query: 252 NF---SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLD 308
            F   + L  L L  N+++ +      KL++L+ L L +N L      A  KL  L +L 
Sbjct: 128 VFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187

Query: 309 LSKNKLSGSFPTGI-GNCTELQHLALNHNSLD 339
           L  N+L    P G   +  +L+ L L  N  D
Sbjct: 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 21/196 (10%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
            KLT AIPS          LDL  N+L S         + L  L L+DNK++ +      
Sbjct: 26  KKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK 82

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALN 334
           +L NL+ L ++ N L         +L NL  L L +N+L  S P  +  + T+L +L+L 
Sbjct: 83  ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141

Query: 335 HNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDN 393
           +N L  ++P  +  K+  L+ L L +N L   +P           F+ L       L +N
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA--------FDKLTELKTLKLDNN 191

Query: 394 -----PPNSFVGNKGL 404
                P  +F   + L
Sbjct: 192 QLKRVPEGAFDSLEKL 207

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 5e-23
 Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 24/187 (12%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
             D +  Y +    G G +G V  A +       A KK+ +   ED   V+ F+ E  ++
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIM 60

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNIVKS 560
            ++ H NI++LY        ++ + E    G LF      +  +    +       I+K 
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF------ERVVHKRVFRESDAARIMKD 114

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAG 617
           V  A++Y H     ++ HRD+   N L  ++       + DFG A         RT + G
Sbjct: 115 VLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVG 170

Query: 618 TYGYIAP 624
           T  Y++P
Sbjct: 171 TPYYVSP 177

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 26/165 (15%)

Query: 458 IGTGGYGSVYKAELPDGKV---VALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVK 513
           IG G +G V KA +    +    A+K++ +  ++D      F  E  VL  +  H NI+ 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNIIN 90

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRVNIVKS 560
           L G C H+  ++   EY   G+L   LR              +  A  L+  + ++    
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 561 VAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           VA  + YL          +HRD+++ NIL+  N  A +ADFG +R
Sbjct: 151 VARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR 190

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 51/193 (26%), Positives = 79/193 (40%), Gaps = 31/193 (16%)

Query: 450 EDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESFQNE 499
           +     Y +    G+G  G V  A E    K VA+K     K       ++    + + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTRR 554
             +L  + H  I+K+  F       + + E ME G LF  V+      +           
Sbjct: 66  IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-------- 116

Query: 555 VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSN 611
                 +  A+ YLH +    I+HRD+   N+LL+S  E     + DFG +++L   S  
Sbjct: 117 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173

Query: 612 RTLRAGTYGYIAP 624
           RTL  GT  Y+AP
Sbjct: 174 RTL-CGTPTYLAP 185

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 42/192 (21%), Positives = 83/192 (43%), Gaps = 32/192 (16%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESFQN 498
           +  F   Y +    G G +  V +      G   A K     KL   + +        + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK------LER 54

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRRV-- 555
           EAR+   ++H NIV+L+     +   + +++ +  G LF      ++ +    ++     
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADAS 108

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNR 612
           + ++ +  +++Y H +    IVHR++   N+LL S  +     +ADFG A  ++   +  
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165

Query: 613 TLRAGTYGYIAP 624
              AGT GY++P
Sbjct: 166 GF-AGTPGYLSP 176

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 25/187 (13%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           T +    +      G+G +  V+   +   GK+ ALK + +S         S +NE  VL
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVL 60

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNIVKS 560
             ++H NIV L          + + + +  G LF      D  +E   +T +    +++ 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQ 114

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAG 617
           V  A+ YLH +    IVHRD+   N+L  +  E     + DFG ++     +   +   G
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACG 169

Query: 618 TYGYIAP 624
           T GY+AP
Sbjct: 170 TPGYVAP 176

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 27/172 (15%)

Query: 458 IGTGGYGSVYKAELPD------GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A             VA+K L  +   D    E+  +E +++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQHEN 111

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR-----------VNIVK 559
           IV L G C H   +  I EY   G L   LR     +E +               ++   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 560 SVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
            VA  +++L   +      +HRD+++ N+LL +   A + DFG AR +  DS
Sbjct: 172 QVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 43/191 (22%), Positives = 77/191 (40%), Gaps = 27/191 (14%)

Query: 449 TEDFHIRYC----IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
                  +     +G+G +G V+   E   G    +K +++  ++    +E  + E  VL
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVL 74

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR-------VN 556
            ++ H NI+K++        M+ + E  E G L       +  +      +         
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL------ERIVSAQARGKALSEGYVAE 128

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRT 613
           ++K + +AL+Y H      +VH+D+   NIL           + DFG A L   D  +  
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185

Query: 614 LRAGTYGYIAP 624
             AGT  Y+AP
Sbjct: 186 -AAGTALYMAP 195

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 12/177 (6%)

Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
                  +G G +G V+K  E   G  +A K +     +D    E  +NE  V++ + H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           N+++LY     K  +  + EY++ G LF   R  DE+  L     +  +K +   + ++H
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTARLLHVDSSNRTLRAGTYGYIAP 624
                 I+H D+   NIL  +     +   DFG AR        +    GT  ++AP
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN-FGTPEFLAP 257

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 99.3 bits (248), Expect = 3e-22
 Identities = 70/380 (18%), Positives = 128/380 (33%), Gaps = 54/380 (14%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLS----GSIPPQIGSLSNLKYLNL 93
            I  +++    +     +         Q + L +  L+      I   +     L  LNL
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 94  RWNNLTGTIPKEIGSL-----RNLEVLYLSNNSL--HGTTPI--EIGSLRNLEELYLRSN 144
           R N L       +          ++ L L N  L   G   +   + +L  L+EL+L  N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 145 KLSGVLPQEIG-----NLKSLIWLSVMYNTVG----GPIPSTLFRLTNLERLFLGCNQFN 195
            L     Q +          L  L + Y ++      P+ S L    + + L +  N  N
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 196 GTIPREIG-----NLKNLTHLSIITNKLT----GAIPSTLGHLTSLLYLDLSFNQLH--- 243
               R +      +   L  L + +  +T      +   +    SL  L L  N+L    
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 244 --SFIPLEIGNFSALAELDLSDNKIR----GIIPDELSKLSNLQYLNLSSNLLSGQIPFA 297
                P  +   S L  L + +  I     G +   L    +L+ L+L+ N L  +    
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 298 IGKLF-----NLVSLDLSKNKLSG----SFPTGIGNCTELQHLALNHNSLDGTIPPEIGK 348
           + +        L SL +     +      F + +     L  L +++N L+     E+ +
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363

Query: 349 ILL-----LQNLDLSHNNLS 363
            L      L+ L L+  ++S
Sbjct: 364 GLGQPGSVLRVLWLADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 72/389 (18%), Positives = 129/389 (33%), Gaps = 59/389 (15%)

Query: 33  CDYKGSITHIELVECSIKGE----LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSL--- 85
                    + L +C +       + S      P L  LNL +N L       +      
Sbjct: 24  LPLLQQCQVVRLDDCGLTEARCKDISSA-LRVNPALAELNLRSNELGDVGVHCVLQGLQT 82

Query: 86  --SNLKYLNLRWNNLTGT----IPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR----- 134
               ++ L+L+   LTG     +   + +L  L+ L+LS+N L       +         
Sbjct: 83  PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142

Query: 135 NLEELYLRSNKLSGVLPQEIG----NLKSLIWLSVMYNTVGGP----IPSTLFRLT-NLE 185
            LE+L L    LS    + +            L+V  N +       +   L      LE
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 186 RLFLGCNQFN----GTIPREIGNLKNLTHLSIITNKLTGA-----IPSTLGHLTSLLYLD 236
            L L            +   + +  +L  L++ +NKL         P  L   + L  L 
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262

Query: 237 LSFNQLH----SFIPLEIGNFSALAELDLSDNKI-----RGIIPDELSKLSNLQYLNLSS 287
           +    +       +   +    +L EL L+ N++     R +    L     L+ L + S
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322

Query: 288 NLLSGQ----IPFAIGKLFNLVSLDLSKNKLSGSFPTGIG-----NCTELQHLALNHNSL 338
              +          + +   L+ L +S N+L  +    +        + L+ L L    +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382

Query: 339 DGTIPPEIGKILL----LQNLDLSHNNLS 363
             +    +   LL    L+ LDLS+N L 
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 92.3 bits (230), Expect = 6e-20
 Identities = 69/384 (17%), Positives = 125/384 (32%), Gaps = 58/384 (15%)

Query: 38  SITHIELVECSIKGE----LGSLNFSCFPNLQYLNLWNNNLS----GSIPPQIGSLSNLK 89
           ++  + L    +       +     +    +Q L+L N  L+    G +   + +L  L+
Sbjct: 57  ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116

Query: 90  YLNLRWNNLTGTIPKEIGSLR-----NLEVLYLSNNSLHGTTPIEIGSL----RNLEELY 140
            L+L  N L     + +          LE L L   SL   +   + S+     + +EL 
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176

Query: 141 LRSNKLSGVLPQEIG-----NLKSLIWLSVMYNTVG----GPIPSTLFRLTNLERLFLGC 191
           + +N ++    + +      +   L  L +    V       +   +    +L  L LG 
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236

Query: 192 NQFNGTIPREIGN-----LKNLTHLSIITNKLT----GAIPSTLGHLTSLLYLDLSFNQL 242
           N+       E+          L  L I    +T    G +   L    SL  L L+ N+L
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296

Query: 243 -----HSFIPLEIGNFSALAELDLSDNKIRG----IIPDELSKLSNLQYLNLSSNLL--S 291
                       +     L  L +                L++   L  L +S+N L  +
Sbjct: 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

Query: 292 GQIPFAIGKLFN---LVSLDLSKNKLS----GSFPTGIGNCTELQHLALNHNSLDGTIPP 344
           G      G       L  L L+   +S     S    +     L+ L L++N L      
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416

Query: 345 EIGKIL-----LLQNLDLSHNNLS 363
           ++ + +     LL+ L L     S
Sbjct: 417 QLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 89.6 bits (223), Expect = 5e-19
 Identities = 62/324 (19%), Positives = 114/324 (35%), Gaps = 46/324 (14%)

Query: 86  SNLKYLNLRWNNLTGTIPKEIGS-LRNLEVLYLSNNSLHGTTPIEIGSL----RNLEELY 140
            +++ L+++   L+     E+   L+  +V+ L +  L      +I S       L EL 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 141 LRSNKLSGVLPQEIGN-LKS----LIWLSVMYNTVG----GPIPSTLFRLTNLERLFLGC 191
           LRSN+L  V    +   L++    +  LS+    +     G + STL  L  L+ L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 192 NQFNGTIPREIG-----NLKNLTHLSIITNKLT----GAIPSTLGHLTSLLYLDLSFNQL 242
           N       + +          L  L +    L+      + S L        L +S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 243 -----HSFIPLEIGNFSALAELDLSDNKIR----GIIPDELSKLSNLQYLNLSSNLL--S 291
                         +   L  L L    +       +   ++  ++L+ L L SN L   
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 292 GQIPFAIGKL---FNLVSLDLSKNKLS----GSFPTGIGNCTELQHLALNHNSLDGTIPP 344
           G      G L     L +L + +  ++    G     +     L+ L+L  N L      
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302

Query: 345 EIGKILL-----LQNLDLSHNNLS 363
            + + LL     L++L +   + +
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFT 326

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.9 bits (244), Expect = 4e-22
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 34/197 (17%)

Query: 447 NATEDFHIRY----CIGTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESF 496
            A ++F+ +Y     IG G    V +      G   A+K         S  +     E+ 
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 497 QNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
           + E  +L  V  H +I+ L         MF +++ M +G LF       + +    T +V
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-------DYL----TEKV 195

Query: 556 --------NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
                   +I++S+  A+S+LH +   +IVHRD+   NILL+ N++  ++DFG +  L  
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252

Query: 608 DSSNRTLRAGTYGYIAP 624
               R L  GT GY+AP
Sbjct: 253 GEKLREL-CGTPGYLAP 268

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 36/181 (19%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G G +G V KA     K       VA+K L ++ +     +    +E  VL  V H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQVNHPHV 88

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR---------------------DDDEAIELN 550
           +KLYG C     +  I EY + GSL   LR                     D  +   L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 551 WTRRVNIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
               ++    ++  + YL         +VHRD+++ NIL+    +  ++DFG +R ++ +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 609 S 609
            
Sbjct: 204 D 204

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.9 bits (244), Expect = 5e-22
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 16/209 (7%)

Query: 423 KGKSENLKLVTGGYDGKILYEDLINATEDFHIRYCI----GTGGYGSVYKA-ELPDGKVV 477
             K  +          K + + +       +  Y I    G+G +G V++  E   G+V 
Sbjct: 20  GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79

Query: 478 ALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLF 537
             K ++     D     + +NE  +++ + H  ++ L+     K  M  I E++  G LF
Sbjct: 80  VAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 538 YVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV- 596
              R   E  +++    +N ++     L ++H     SIVH DI   NI+  +   + V 
Sbjct: 137 D--RIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVK 191

Query: 597 -ADFGTARLLHVDSSNRTLRAGTYGYIAP 624
             DFG A  L+ D   +     T  + AP
Sbjct: 192 IIDFGLATKLNPDEIVKVT-TATAEFAAP 219

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.0 bits (247), Expect = 6e-22
 Identities = 53/191 (27%), Positives = 79/191 (41%), Gaps = 22/191 (11%)

Query: 445 LINATEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNE 499
           + +        Y      G+G YG V    +       A+K + ++    S+       E
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEE 86

Query: 500 ARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VN 556
             VL  + H NI+KLY F   KR  + + E  + G LF      DE I    +       
Sbjct: 87  VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF------DEIIHRMKFNEVDAAV 140

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRT 613
           I+K V   ++YLH     +IVHRD+   N+LL S  +     + DFG + +   +     
Sbjct: 141 IIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMK 196

Query: 614 LRAGTYGYIAP 624
            R GT  YIAP
Sbjct: 197 ERLGTAYYIAP 207

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 31/183 (16%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK--------VVALKKLHQSETEDSAFVESFQNEAR 501
           +   +   +G G +G V  AE              VA+K L    TE    +    +E  
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEME 92

Query: 502 VLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAI 547
           ++  + +H+NI+ L G C     ++ I EY  +G+L   LR             +     
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 548 ELNWTRRVNIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
           ++ +   V+    +A  + YL          +HRD+++ N+L+  N    +ADFG AR +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 606 HVD 608
           +  
Sbjct: 208 NNI 210

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 97.0 bits (242), Expect = 6e-22
 Identities = 45/193 (23%), Positives = 70/193 (36%), Gaps = 29/193 (15%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK---KLHQSETEDSAFVESFQNEA 500
            +     Y I    G+G +  V K  E   G   A K   K     +      E  + E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-----EAIELNWTRRV 555
            +L  V H NI+ L+    ++  +  I E +  G LF  L   +     EA         
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSN 611
             +K +   ++YLH      I H D+   NI+L           + DFG A  +      
Sbjct: 121 --IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 612 RTLRAGTYGYIAP 624
           + +  GT  ++AP
Sbjct: 176 KNI-FGTPEFVAP 187

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 36/178 (20%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           IG G +G V++A  P         +VA+K L +  + D      FQ EA +++   + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112

Query: 512 VKLYGFCLHKRCMFFIYEYMERGSLFYVLR---------------------DDDEAIELN 550
           VKL G C   + M  ++EYM  G L   LR                            L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 551 WTRRVNIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
              ++ I + VA  ++YL          VHRD+++ N L+  N+   +ADFG +R ++
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 27/182 (14%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVL 503
                   +G G +G V +A             VA+K L  S        E+  +E +VL
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVL 80

Query: 504 STV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---------------DDEAI 547
           S +  H NIV L G C        I EY   G L   LR                +D+ +
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
            L+    ++    VA  +++L    + + +HRD+++ NILL       + DFG AR +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 608 DS 609
           DS
Sbjct: 198 DS 199

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.1 bits (247), Expect = 8e-22
 Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 16/183 (8%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
            +     Y I    GTG +G V++  E   G   A K +      D    E+ + E + +
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTM 208

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           S +RH  +V L+        M  IYE+M  G LF   +  DE  +++    V  ++ V  
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCK 266

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTARLLHVDSSNRTLRAGTYGY 621
            L ++H +   + VH D+   NI+  +     +   DFG    L    S +    GT  +
Sbjct: 267 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEF 322

Query: 622 IAP 624
            AP
Sbjct: 323 AAP 325

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 98.7 bits (245), Expect = 1e-21
 Identities = 51/300 (17%), Positives = 92/300 (30%), Gaps = 38/300 (12%)

Query: 55  SLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEV 114
             +     +L   +L +     +         + K   L  +       ++  +   L  
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFR 353

Query: 115 LYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
             LS          E+ S + L+EL   +      +   +  L  L++            
Sbjct: 354 CELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE----------- 401

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLY 234
             TL   + L+ +                +     +L  + +K              +  
Sbjct: 402 KETLQYFSTLKAV----------------DPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445

Query: 235 LDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI 294
           L L+   L     LE      +  LDLS N++R + P  L+ L  L+ L  S N L   +
Sbjct: 446 LHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALE-NV 501

Query: 295 PFAIGKLFNLVSLDLSKNKLSGSFPT--GIGNCTELQHLALNHNSLDGTIPPEIGKILLL 352
              +  L  L  L L  N+L         + +C  L  L L  NSL         ++  +
Sbjct: 502 D-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.3 bits (161), Expect = 2e-11
 Identities = 40/250 (16%), Positives = 71/250 (28%), Gaps = 38/250 (15%)

Query: 162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA 221
            LSV + T  G    +   L +L    L       T         +     ++       
Sbjct: 282 PLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC-VLLKDRPEC 340

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
                     L   +LS  +       E+ +   L EL+  +      I   +  L  L 
Sbjct: 341 WCRDSATDEQLFRCELSVEKSTVL-QSELESCKELQELEPENKWCLLTIILLMRALDPLL 399

Query: 282 YLNLSSNLLSG---------------------QIPFAIGKLFNLVSLDLSKNKLSGSFPT 320
           Y   +    S                      +      +  ++  L L+   L+     
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LC 457

Query: 321 GIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM------- 373
            +     + HL L+HN L   +PP +  +  L+ L  S N L       +  +       
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-----NVDGVANLPRLQ 511

Query: 374 FLDMSFNNLE 383
            L +  N L+
Sbjct: 512 ELLLCNNRLQ 521

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 26/187 (13%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
            +     + +    G G    VY+  +    K  ALK L ++  +     +  + E  VL
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-----KIVRTEIGVL 102

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNIVKS 560
             + H NI+KL         +  + E +  G LF      D  +E   ++ R   + VK 
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQ 156

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAG 617
           +  A++YLH +    IVHRD+   N+L  +        +ADFG ++++      +T+  G
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CG 212

Query: 618 TYGYIAP 624
           T GY AP
Sbjct: 213 TPGYCAP 219

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.8 bits (244), Expect = 1e-21
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 22/190 (11%)

Query: 446 INATEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEA 500
           +     F  RY I    G G +G V K  +    +  A+K ++++  ++     +   E 
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREV 72

Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNI 557
            +L  + H NI+KL+         + + E    G LF      DE I+   ++      I
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARI 126

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTL 614
           +K V   ++Y+H     +IVHRD+   NILL S  +     + DFG +     ++  +  
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD- 182

Query: 615 RAGTYGYIAP 624
           R GT  YIAP
Sbjct: 183 RIGTAYYIAP 192

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 29/193 (15%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK---KLHQSETEDSAFVESFQNEA 500
            +     Y I    G+G +  V K  E   G   A K   K     +      E  + E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-----EAIELNWTRRV 555
            +L  V H N++ L+    ++  +  I E +  G LF  L   +     EA         
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSN 611
             +K +   ++YLH      I H D+   NI+L           + DFG A  +      
Sbjct: 121 --IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 612 RTLRAGTYGYIAP 624
           + +  GT  ++AP
Sbjct: 176 KNI-FGTPEFVAP 187

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 31/176 (17%)

Query: 458 IGTGGYGSVYKAELPDGK--------VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE              VA+K L    TE    +    +E  ++  + +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 146

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   LR             +     ++ +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 556 NIVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
           +    +A  + YL          +HRD+++ N+L+  N    +ADFG AR ++   
Sbjct: 207 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 9/178 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   IG G +  V   ++   G+V A+K +++ +      V  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 509 RNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           R I +L+ F    +  ++ + EY   G L  +L    E I     R    +  +  A+  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--LAEIVMAIDS 177

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GTYGYIAP 624
           +H       VHRDI  +NILL+      +ADFG+   L  D + R+L A GT  Y++P
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 35/224 (15%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HR 509
             +R  +  GG+  VY+A+ +  G+  ALK+L  +E E      +   E   +  +  H 
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGHP 86

Query: 510 NIVKLYGFCL-------HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           NIV+               +  F +   + +G L   L+  +    L+    + I     
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL-------- 614
            A+ ++H    P I+HRD+   N+LL++     + DFG+A  +                 
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 615 ----RAGTYGYIAP---DQRLSPPVNQKIIQDIILVSTTALACL 651
               R  T  Y  P   D   + P+ +K  QDI      AL C+
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEK--QDI-----WALGCI 242

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 27/171 (15%)

Query: 458 IGTGGYGSVYKAELPDGK--------VVALKKLHQSETEDSAFVESFQNEARVLSTV-RH 508
           +G G +G V  AE              VA+K L    TE    +    +E  ++  + +H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 134

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRV 555
           +NI+ L G C     ++ I EY  +G+L   L+               +   +L+    V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
           +    VA  + YL    +   +HRD+++ N+L+  +    +ADFG AR +H
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 29/195 (14%)

Query: 447 NATEDFHIRY----CIGTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFV-ES 495
           ++T  F+  Y     +G G    V +    P  K  A+K            E+   + E+
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 496 FQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIEL 549
              E  +L  V  H NI++L          F +++ M++G LF Y+       + E    
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--- 126

Query: 550 NWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
                  I++++   +  LH     +IVHRD+   NILL+ ++   + DFG +  L    
Sbjct: 127 -----RKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178

Query: 610 SNRTLRAGTYGYIAP 624
             R +  GT  Y+AP
Sbjct: 179 KLREV-CGTPSYLAP 192

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 30/175 (17%)

Query: 458 IGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G G +G V +A+          + VA+K L +  T       +  +E ++L  +  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92

Query: 511 IVKLYGFCLHKRC-MFFIYEYMERGSLFYVLR-------------DDDEAIELNWTRRVN 556
           +V L G C      +  I E+ + G+L   LR             +D     L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 557 IVKSVAHALSYL--HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
               VA  + +L          +HRD+++ NILL+      + DFG AR ++ D 
Sbjct: 153 YSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 42/232 (18%), Positives = 79/232 (34%), Gaps = 34/232 (14%)

Query: 62  PNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSN 119
           P+ Q L L   +L  +IP     +L N+  + +  +     +      +L  +  + + N
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 120 N-SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQE--IGNLKSLIWLSVMYNTVGGPIPS 176
             +L    P  +  L  L+ L + +  L  + P    + +      L +  N     IP 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 177 TLFR-LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
             F+ L N                           L +  N  T ++     + T L  +
Sbjct: 149 NAFQGLCNE-----------------------TLTLKLYNNGFT-SVQGYAFNGTKLDAV 184

Query: 236 DLSFNQLHSFIPLEI--GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNL 285
            L+ N+  + I  +   G +S  + LD+S   +  +    L  L  L   N 
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 36/213 (16%), Positives = 71/213 (33%), Gaps = 15/213 (7%)

Query: 133 LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGC 191
             + + L L    L  +      NL ++  + V  +     + S  F  L+ +  + +  
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 192 NQFNGTIPREI-GNLKNLTHLSIITNKLTGAIP--STLGHLTSLLYLDLSFNQLHSFIPL 248
            +    I  +    L  L  L I    L    P  + +        L+++ N   + IP+
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 249 EI--GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP---FAIGKLFN 303
               G  +    L L +N     +       + L  + L+ N     I    F  G    
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG-GVYSG 206

Query: 304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN 336
              LD+S+  ++ + P+       L+ L   + 
Sbjct: 207 PSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 40/208 (19%), Positives = 79/208 (37%), Gaps = 11/208 (5%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWN 96
           S   ++L+E  ++  + S  FS  PN+  + +  +     +      +LS + ++ +R  
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 97  NLTGTIPKEI-GSLRNLEVLYLSNNSLHG-TTPIEIGSLRNLEELYLRSNKLSGVLPQEI 154
                I  +    L  L+ L + N  L       ++ S      L +  N     +P   
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 155 --GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI--GNLKNLTH 210
             G     + L +  N     +    F  T L+ ++L  N++   I ++   G     + 
Sbjct: 151 FQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209

Query: 211 LSIITNKLTGAIPS-TLGHLTSLLYLDL 237
           L +    +T A+PS  L HL  L+  + 
Sbjct: 210 LDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 28/163 (17%), Positives = 53/163 (32%), Gaps = 11/163 (6%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDN-K 265
                 +    +   IPS      S   L L    L +       N   ++ + +S +  
Sbjct: 12  QEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67

Query: 266 IRGIIPDELSKLSNLQYLNLSSNLLSGQIP-FAIGKLFNLVSLDLSKNKLSGSFP--TGI 322
           ++ +       LS + ++ + +      I   A+ +L  L  L +    L   FP  T +
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126

Query: 323 GNCTELQHLALNHNSLDGTIPPEI--GKILLLQNLDLSHNNLS 363
            +      L +  N    +IP     G       L L +N  +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 29/193 (15%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK---KLHQSETEDSAFVESFQNEA 500
            E+    Y      G+G +  V K  E   G   A K   K     +      E  + E 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 501 RVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-----EAIELNWTRRV 555
            +L  ++H N++ L+    +K  +  I E +  G LF  L + +     EA E       
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF------ 119

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSN 611
             +K + + + YLH      I H D+   NI+L           + DFG A  +   +  
Sbjct: 120 --LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174

Query: 612 RTLRAGTYGYIAP 624
           + +  GT  ++AP
Sbjct: 175 KNI-FGTPEFVAP 186

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 6e-21
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 21/185 (11%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG V K      G++VA+KK  +S+ +D    +    E ++L  +RH N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDC 572
            C  K+  + ++E+++  ++   L      ++        +V+         + + H   
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ------VVQKYLFQIINGIGFCHSH- 143

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD-----QR 627
             +I+HRDI   NIL++ +    + DFG AR L            T  Y AP+      +
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201

Query: 628 LSPPV 632
               V
Sbjct: 202 YGKAV 206

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 92.6 bits (231), Expect = 6e-21
 Identities = 45/180 (25%), Positives = 73/180 (40%), Gaps = 25/180 (13%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALK---KLHQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G+G +  V K  +   GK  A K   K   S +      E  + E  +L  +RH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDD-----EAIELNWTRRVNIVKSVAHALSYL 568
           L+    +K  +  I E +  G LF  L + +     EA +         +K +   + YL
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--------LKQILDGVHYL 124

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           H      I H D+   NI+L           + DFG A  +   +  + +  GT  ++AP
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAP 180

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 54/197 (27%), Positives = 76/197 (38%), Gaps = 31/197 (15%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLH----------QSETEDSAFV 493
                  Y      G+G YG V    E       A+K +                   F 
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 494 ESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWT 552
           E   NE  +L ++ H NI+KL+     K+  + + E+ E G LF      ++ I    + 
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF------EQIINRHKFD 144

Query: 553 RR--VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHV 607
                NI+K +   + YLH     +IVHRDI   NILL +        + DFG +     
Sbjct: 145 ECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 608 DSSNRTLRAGTYGYIAP 624
           D   R  R GT  YIAP
Sbjct: 202 DYKLRD-RLGTAYYIAP 217

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 7/177 (3%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   IG G +G V   +L +  KV A+K L++ E    A    F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           + I  L+        ++ + +Y   G L  +L   ++ +     R    +  +  A+  +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIAIDSV 191

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GTYGYIAP 624
           H       VHRDI  +NIL++ N    +ADFG+   L  D + ++  A GT  YI+P
Sbjct: 192 H---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 18/181 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + F I   IG G +G V   +  D  K+ A+K +++ +  +   V +   E +++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 509 RNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK----SVAH 563
             +V L Y F   +  MF + + +  G L Y L+ +    E         VK     +  
Sbjct: 75  PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKE-------ETVKLFICELVM 126

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
           AL YL +     I+HRD+  +NILL+ +    + DF  A +L  ++   T+ AGT  Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMA 182

Query: 624 P 624
           P
Sbjct: 183 P 183

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 92.6 bits (230), Expect = 2e-20
 Identities = 50/229 (21%), Positives = 81/229 (35%), Gaps = 59/229 (25%)

Query: 449 TEDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALK-----KLHQSETEDSAFVESFQN 498
             +   +Y +    G G YG V  A E     + A+K     K+ Q   +D   VE  + 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKT 77

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV--- 555
           E R++  + H NI +LY     ++ +  + E    G L   L    +         V   
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137

Query: 556 ----------------------------------NIVKSVAHALSYLHHDCTPSIVHRDI 581
                                             NI++ +  AL YLH+     I HRDI
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDI 194

Query: 582 SSNNILLNSNLEAFV--ADFGTARLLHVDSSNRTLR----AGTYGYIAP 624
              N L ++N    +   DFG ++  +  ++         AGT  ++AP
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 32/178 (17%)

Query: 458 IGTGGYGSVYKAELPDGK------VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRN 510
           +G+G +G V  A             VA+K L +         E+  +E ++++ +  H N
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGSHEN 110

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLR--------------------DDDEAIELN 550
           IV L G C     ++ I+EY   G L   LR                    ++++   L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           +   +     VA  + +L      S VHRD+++ N+L+       + DFG AR +  D
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 16/155 (10%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG V+K      G++VA+KK  +SE +D    +    E R+L  ++H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDC 572
               KR +  ++EY +  ++ + L      +  +      +VKS+      A+++ H   
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH------LVKSITWQTLQAVNFCHKH- 121

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
             + +HRD+   NIL+  +    + DFG ARLL  
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 21/184 (11%)

Query: 450 EDFHIRYCI----GTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           ++ + +Y I    G G +G V++  E    K    K +    T+        + E  +L+
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILN 56

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR--VNIVKSVA 562
             RHRNI+ L+        +  I+E++    +F    +           R  V+ V  V 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVC 112

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTARLLHVDSSNRTLRAGTYG 620
            AL +LH     +I H DI   NI+  +   + +   +FG AR L    + R L      
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-FTAPE 168

Query: 621 YIAP 624
           Y AP
Sbjct: 169 YYAP 172

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 15/172 (8%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL-EKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDCT 573
              K+ +  ++E++++  L  +L   +  +E          KS        ++Y H    
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV------TAKSFLLQLLNGIAYCHDRR- 120

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             ++HRD+   N+L+N   E  +ADFG AR   +     T    T  Y APD
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 91.4 bits (227), Expect = 5e-20
 Identities = 50/174 (28%), Positives = 71/174 (40%), Gaps = 12/174 (6%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREI--GNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
           +P +L   +    L L  N     +  E     L NL  L +  N L          + +
Sbjct: 33  VPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           L YLDLS N LH+       +  AL  L L +N I  +  +    ++ LQ L LS N +S
Sbjct: 90  LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149

Query: 292 GQIPF----AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQH--LALNHNSLD 339
            + P        KL  L+ LDLS NKL     T +          L L++N L+
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 85.7 bits (212), Expect = 4e-18
 Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 21/192 (10%)

Query: 59  SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEI--GSLRNLEVLY 116
            C      L+     L  ++P  +   S    L+L  NNL+  +  E     L NL  L 
Sbjct: 17  LCAS--NILSCSKQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLL 70

Query: 117 LSNNSLHGTTPIEIGS---LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
           LS+N L     I   +   + NL  L L SN L  +      +L++L  L +  N +   
Sbjct: 71  LSHNHL---NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV- 126

Query: 174 IPSTLFR-LTNLERLFLGCNQFNGTIPREI----GNLKNLTHLSIITNKLTGAIPSTLGH 228
           +    F  +  L++L+L  NQ +   P E+      L  L  L + +NKL     + L  
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185

Query: 229 LTSLLYLDLSFN 240
           L + +   L  +
Sbjct: 186 LPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 84.5 bits (209), Expect = 9e-18
 Identities = 52/185 (28%), Positives = 72/185 (38%), Gaps = 18/185 (9%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDEL 274
            +L   +P +L   T+   LDLS N L            + L  L LS N +  I  +  
Sbjct: 28  QQLP-NVPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF 84

Query: 275 SKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLAL 333
             + NL+YL+LSSN L     F    L  L  L L  N +          +  +LQ L L
Sbjct: 85  VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYL 143

Query: 334 NHNSLDGTIPPEI----GKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTY 389
           + N +    P E+     K+  L  LDLS N L   +P         +      G    Y
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP---LTDLQKLPAWVKNG---LY 195

Query: 390 LRDNP 394
           L +NP
Sbjct: 196 LHNNP 200

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 36/140 (25%), Positives = 66/140 (47%), Gaps = 13/140 (9%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVL 115
            +   NL  L L +N+L+  I  +    + NL+YL+L  N+L  T+ + +   L+ LEVL
Sbjct: 60  PTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL 117

Query: 116 YLSNNSLHGTTPIEIGS---LRNLEELYLRSNKLSGVLP---QEIGNLKSLIWLSVMYNT 169
            L NN +     ++  +   +  L++LYL  N++S       ++   L  L+ L +  N 
Sbjct: 118 LLYNNHI---VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174

Query: 170 VGGPIPSTLFRLTNLERLFL 189
           +     + L +L    +  L
Sbjct: 175 LKKLPLTDLQKLPAWVKNGL 194

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 5e-20
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 9/177 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED+ +   IG G +G V         KV A+K L + E    +    F  E  +++    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +V+L+      R ++ + EYM  G L  ++ + D  +   W R       V  AL  +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TAEVVLALDAI 184

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA-GTYGYIAP 624
           H       +HRD+  +N+LL+ +    +ADFGT   ++ +   R   A GT  YI+P
Sbjct: 185 HSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 53/187 (28%), Positives = 78/187 (41%), Gaps = 27/187 (14%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAI----ELNWTRRVNIVK 559
              VKLY        ++F   Y + G L   +R     D+        E           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA--G 617
            +  AL YLH      I+HRD+   NILLN ++   + DFGTA++L  +S      +  G
Sbjct: 139 -IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 618 TYGYIAP 624
           T  Y++P
Sbjct: 195 TAQYVSP 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 41/201 (20%), Positives = 72/201 (35%), Gaps = 42/201 (20%)

Query: 449 TEDFHIRY-----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARV 502
           +  F   Y      +G G +  V     L   +  A+K + +              E  +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEM 63

Query: 503 LSTVR-HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN----- 556
           L   + HRN+++L  F   +   + ++E M  GS+          I     +R +     
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL-------SHI----HKRRHFNELE 112

Query: 557 ---IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSS 610
              +V+ VA AL +LH      I HRD+   NIL     +     + DF     + ++  
Sbjct: 113 ASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 611 NRTL-------RAGTYGYIAP 624
              +         G+  Y+AP
Sbjct: 170 CSPISTPELLTPCGSAEYMAP 190

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 91.7 bits (227), Expect = 7e-20
 Identities = 27/201 (13%), Positives = 55/201 (27%), Gaps = 39/201 (19%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLST----------- 505
           +G     +  +A     G+   +   + +E   S  ++  + E   L             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 506 -----------VRHRNIVKLYGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELN 550
                      V+     K+    L +R       F      + +L             +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 551 ----WTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH 606
                  R+ +   V   L+ LHH     +VH  +   +I+L+     F+  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 607 VDSSNRTLRAGTYG---YIAP 624
             +S  +     +      A 
Sbjct: 261 DGASAVSPIGRGFAPPETTAE 281

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.5 bits (223), Expect = 9e-20
 Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 15/172 (8%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF 517
           +G G YG VYKA+   G++VALK++   + ED     +   E  +L  + H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRL-DAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 518 CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDCT 573
              +RC+  ++E+ME+  L  VL ++   ++       + +K   +     +++ H    
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQD------SQIKIYLYQLLRGVAHCHQHR- 139

Query: 574 PSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
             I+HRD+   N+L+NS+    +ADFG AR   +   + T    T  Y APD
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 89.1 bits (222), Expect = 1e-19
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 16/173 (9%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG+V+KA      ++VALK++   + +D     S   E  +L  ++H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDC 572
                + +  ++E+ ++  L       +  ++        IVKS        L + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE------IVKSFLFQLLKGLGFCHSRN 121

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              ++HRD+   N+L+N N E  +A+FG AR   +     +    T  Y  PD
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 26/195 (13%)

Query: 445 LINATEDFHIRYCI-----GTGGYGSVYKA-ELPDGKVVALK--KLHQSETEDSAFVESF 496
              + E+F+  Y +     G G +  V +      G+  A K  K  +   +        
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEI 75

Query: 497 QNEARVLSTVRHR-NIVKLYGFCLHKRCMFFIYEYMERGSLF-YVLRDDDEAIELNWTRR 554
            +E  VL   +    ++ L+    +   +  I EY   G +F   L +  E      +  
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE----MVSEN 131

Query: 555 --VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDS 609
             + ++K +   + YLH +   +IVH D+   NILL+S        + DFG +R +    
Sbjct: 132 DVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 610 SNRTLRAGTYGYIAP 624
             R +  GT  Y+AP
Sbjct: 189 ELREI-MGTPEYLAP 202

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 23/175 (13%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY 515
           +G G +    K       +  A+K + +    ++      Q E   L     H NIVKL+
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEITALKLCEGHPNIVKLH 72

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNIVKSVAHALSYLHHDC 572
                +   F + E +  G LF      +   +  +++      I++ +  A+S++H   
Sbjct: 73  EVFHDQLHTFLVMELLNGGELF------ERIKKKKHFSETEASYIMRKLVSAVSHMHDV- 125

Query: 573 TPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
              +VHRD+   N+L     +     + DFG ARL   D+        T  Y AP
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 15/173 (8%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDC 572
               +  ++ ++E++ +  L   + D      +     + ++KS        L++ H   
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIP----LPLIKSYLFQLLQGLAFCHSHR 123

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
              ++HRD+   N+L+N+     +ADFG AR   V     T    T  Y AP+
Sbjct: 124 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 19/154 (12%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKL---HQSETEDSAFVESFQNEARVLSTVRHRNIVK 513
           +G G + +VYKA +    ++VA+KK+   H+SE +D     + + E ++L  + H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIG 76

Query: 514 LYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLH 569
           L     HK  +  ++++ME   L  +++D+   +        + +K+        L YLH
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP------SHIKAYMLMTLQGLEYLH 129

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
                 I+HRD+  NN+LL+ N    +ADFG A+
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 12/185 (6%)

Query: 446 INATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           ++++  F     +G G Y +VYK      G  VALK++   ++E+     + + E  ++ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIR-EISLMK 58

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH- 563
            ++H NIV+LY     +  +  ++E+M+   L   + D            +N+VK     
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQ 116

Query: 564 ---ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYG 620
               L++ H +    I+HRD+   N+L+N   +  + DFG AR   +  +  +    T  
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173

Query: 621 YIAPD 625
           Y APD
Sbjct: 174 YRAPD 178

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 18/208 (8%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
           +  S            F      NL   +++     Q   L+++  +    +++      
Sbjct: 3   ITVSTPI-KQIFPDDAFAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQG- 58

Query: 105 EIGSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
            I  L N+  L L  N LH     +I     L NL  L L  N+L  +       L +L 
Sbjct: 59  -IQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112

Query: 162 WLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG 220
            L ++ N +   +P  +F +LTNL  L L  NQ           L NLT L +  N+L  
Sbjct: 113 ELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ- 170

Query: 221 AIPS-TLGHLTSLLYLDLSFNQLHSFIP 247
           ++P      LT L  L L  NQL S +P
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLKS-VP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 52/188 (27%), Positives = 78/188 (41%), Gaps = 20/188 (10%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIG---SLSNLKYLNLR 94
            +  I+ +  +             PN++YL L  N L       I     L+NL YL L 
Sbjct: 39  ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILT 93

Query: 95  WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLP 151
            N L          L NL+ L L  N L     +  G    L NL  L L  N+L   LP
Sbjct: 94  GNQLQSLPNGVFDKLTNLKELVLVENQL---QSLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149

Query: 152 QEI-GNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNL 208
           + +   L +L  L + YN +   +P  +F +LT L+ L L  NQ   ++P  +   L +L
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSL 207

Query: 209 THLSIITN 216
            ++ +  N
Sbjct: 208 QYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 29/220 (13%)

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT--GAIPSTLGHLTSLLYLDLSF 239
               +  L        + +    L ++  +    + +     I     +L ++ YL L  
Sbjct: 19  AETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGG 72

Query: 240 NQLHSFIPLEIGNF---SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           N+LH      I      + L  L L+ N+++ +      KL+NL+ L L  N L      
Sbjct: 73  NKLHD-----ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDG 127

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPPEI-GKILLLQN 354
              KL NL  L+L+ N+L  S P G+    T L  L L++N L  ++P  +  K+  L++
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKD 185

Query: 355 LDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNP 394
           L L  N L  ++P        D  F+ L      +L DNP
Sbjct: 186 LRLYQNQLK-SVP--------DGVFDRLTSLQYIWLHDNP 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 22/178 (12%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG VYKA +    + VA+K++   E E+     +   E  +L  ++HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKELQHRNIIELKS 100

Query: 517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALSYLHHDC 572
              H   +  I+EY E   L   +   D+  +++    + ++KS  +     +++ H   
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVS----MRVIKSFLYQLINGVNFCHS-- 150

Query: 573 TPSIVHRDISSNNILLNSNLEAF-----VADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
               +HRD+   N+LL+ +  +      + DFG AR   +     T    T  Y  P+
Sbjct: 151 -RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.8 bits (217), Expect = 8e-19
 Identities = 29/200 (14%), Positives = 64/200 (32%), Gaps = 40/200 (20%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--------- 507
           +G     +  +A +   G+   +   + +E   S  ++  + E   L  +R         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 508 ----------------HRNIVKLYGFCLHKRCM--FFIYEYMERGSLFYVLRDDDEAIE- 548
                            + ++++         +  FF+Y  M+  +L             
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSST 199

Query: 549 ---LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL 605
              L    R+ +   V   L+ LHH     +VH  +   +I+L+     F+  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 606 HVDSSNRTLRAGTYGYIAPD 625
                 R + + + G+  P+
Sbjct: 257 ----GARVVSSVSRGFEPPE 272

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 17/181 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E +     +G G Y +VYK +      +VALK++   E E+ A   + + E  +L  ++H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKH 59

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----A 564
            NIV L+     ++ +  ++EY+++  L   L D    I ++       VK         
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH------NVKLFLFQLLRG 112

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L+Y H      ++HRD+   N+L+N   E  +ADFG AR   + +        T  Y  P
Sbjct: 113 LAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

Query: 625 D 625
           D
Sbjct: 170 D 170

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 24/179 (13%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALK-----KLHQSETEDSAFVESFQNEARVLSTVRHRNI 511
           +G+G +G V+ A      K V +K     K+ +    +   +     E  +LS V H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 512 VKLYGFCLHKRCMFFIYEYMERGS-LF-YVLR----DDDEAIELNWTRRVNIVKSVAHAL 565
           +K+     ++     + E    G  LF ++ R    D+  A          I + +  A+
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA------SY--IFRQLVSAV 143

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
            YL       I+HRDI   NI++  +    + DFG+A  L       T   GT  Y AP
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEYCAP 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 8/177 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
             F     +G GG+G V   ++   GK+ A KKL +   +         NE ++L  V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 509 RNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           R +V L  +    K  +  +   M  G L + +    +A      R V     +   L  
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLED 301

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           LH +    IV+RD+   NILL+ +    ++D G A  +    + +  R GT GY+AP
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAP 354

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 38/188 (20%), Positives = 72/188 (38%), Gaps = 27/188 (14%)

Query: 449 TEDFHIRY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           +  F   Y     IG G Y    +          A+K + +S+       +  +    +L
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILL 70

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL-NWTRR--VNIVKS 560
              +H NI+ L       + ++ + E M+ G L       D+ +    ++ R    ++ +
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL------DKILRQKFFSEREASAVLFT 124

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARLLHVDSSNRTLRA 616
           +   + YLH      +VHRD+  +NIL            + DFG A+ L  ++       
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 617 GTYGYIAP 624
            T  ++AP
Sbjct: 182 YTANFVAP 189

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 24/166 (14%)

Query: 454 IRYCIGTGGYGSVYKA---ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
               +G G YG VYKA   +  D K  ALK++  +    SA       E  +L  ++H N
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREIALLRELKHPN 79

Query: 511 IVKLYGFCLHK--RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN--IVKSVAH--- 563
           ++ L    L    R ++ +++Y E   L+++++    +       ++   +VKS+ +   
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 564 -ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF----VADFGTARL 604
             + YLH +    ++HRD+   NIL+           +AD G ARL
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 22/182 (12%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + F     +GTG +G V   +    G   A+K L + +      +E   NE R+L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS------VA 562
             +VKL         ++ + EY+  G +F  LR            R +   +      + 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---------GRFSEPHARFYAAQIV 151

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
               YLH      +++RD+   N+L++      V DFG A+   V     TL  GT   +
Sbjct: 152 LTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL-CGTPEAL 205

Query: 623 AP 624
           AP
Sbjct: 206 AP 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 30/182 (16%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
             +     IG G +G V+KA     G+ VALKK+   E E   F  +   E ++L  ++H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKH 75

Query: 509 RNIVKLYG--------FCLHKRCMFFIYEYME---RGSLFYVLRDDDEAIELNWTRRVNI 557
            N+V L          +   K  ++ ++++ E    G L       +  ++      ++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL------SNVLVKFT----LSE 125

Query: 558 VKSVAH----ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT 613
           +K V       L Y+H +    I+HRD+ + N+L+  +    +ADFG AR   +  +++ 
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 614 LR 615
            R
Sbjct: 183 NR 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 10/163 (6%)

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
            + E+L L               L  LT L++  N+L          LT L  L L+ NQ
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 242 LHSFIPLEIGNF---SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF-A 297
           L S   L +G F   + L +L L  N+++ +      +L+ L+ L L++N L   IP  A
Sbjct: 95  LAS---LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150

Query: 298 IGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLD 339
             KL NL +L LS N+L  S P G      +LQ + L  N  D
Sbjct: 151 FDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 60/218 (27%), Positives = 87/218 (39%), Gaps = 42/218 (19%)

Query: 30  GITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLK 89
           G TC+        + V+C  K  L S+      + + L+L +  L+         L+ L 
Sbjct: 9   GCTCNEGK-----KEVDCQGKS-LDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLT 62

Query: 90  YLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNK 145
           +LNL +N L  T+   +   L  L  L L+NN L     + +G    L  L++LYL  N+
Sbjct: 63  WLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL---ASLPLGVFDHLTQLDKLYLGGNQ 118

Query: 146 LSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREI-G 203
           L                           +PS +F RLT L+ L L  NQ   +IP     
Sbjct: 119 LKS-------------------------LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
            L NL  LS+ TN+L          L  L  + L  NQ
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 18/173 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V   E    G  VA+K L++ +      V   + E + L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
                   F + EY+  G LF Y+ +    ++ EA      RR  + + +  A+ Y H  
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RR--LFQQILSAVDYCHRH 130

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
               +VHRD+   N+LL++++ A +ADFG + ++      RT   G+  Y AP
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 179

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 46/180 (25%), Positives = 72/180 (40%), Gaps = 26/180 (14%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALK---KLHQSETEDSAFVESFQNEARVLSTVRHR--NI 511
           +G+GG+GSVY    + D   VA+K   K   S+  +         E  +L  V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 512 VKLYGFCLHKRCMFFIYEYME-RGSLF-YVLR----DDDEAIELNWTRRVNIVKSVAHAL 565
           ++L  +         I E  E    LF ++       ++ A      R       V  A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA------RS--FFWQVLEAV 162

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
            + H+     ++HRDI   NIL++ N  E  + DFG+  LL  D+       GT  Y  P
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDF-DGTRVYSPP 217

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.8 bits (210), Expect = 3e-17
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 7/178 (3%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + F     +G GG+G V+  ++   GK+ A KKL++   +     +    E ++L+ V  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 509 RNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS-VAHALS 566
           R IV L  +    K  +  +   M  G + Y + + DE        R     + +   L 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           +LH     +I++RD+   N+LL+ +    ++D G A  L    +     AGT G++AP
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 28/182 (15%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQN---EARVLSTVR----HR 509
           +G GG+G+V+    L D   VA+K + ++     + +        E  +L  V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGS-LF-YVLR----DDDEAIELNWTRRVNIVKSVAH 563
            +++L  +   +     + E       LF Y+       +  +      R       V  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS------RC--FFGQVVA 150

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
           A+ + H      +VHRDI   NIL++     A + DFG+  LLH D        GT  Y 
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDF-DGTRVYS 205

Query: 623 AP 624
            P
Sbjct: 206 PP 207

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 60/346 (17%), Positives = 113/346 (32%), Gaps = 67/346 (19%)

Query: 85  LSN--LKYLNLRWNNLTG----TIPKEIGSLRNLEVLYLSNNSL--HGTTPI--EIGSLR 134
           ++   ++  +L+ + +T     ++   +    +++ + LS N++       +   I S +
Sbjct: 1   MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 135 NLEELYLRSNKLS----------GVLPQEIGNLKSLIWLSVMYNTVGG----PIPSTLFR 180
           +LE                     +L Q +     L  + +  N  G     P+   L +
Sbjct: 61  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 181 LTNLERLFLGCNQF-------------NGTIPREIGNLKNLTHLSIITNKLTG----AIP 223
            T LE L+L  N                  + ++  N   L  +    N+L         
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180

Query: 224 STLGHLTSLLYLDLSFNQLHS-----FIPLEIGNFSALAELDLSDNKI--RGI--IPDEL 274
            T      L  + +  N +        +   +     L  LDL DN     G   +   L
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240

Query: 275 SKLSNLQYLNLSSNLLSGQ----IPFAIGKLFN--LVSLDLSKNKLSGSFPTGIG----- 323
               NL+ L L+  LLS +    +  A  KL N  L +L L  N++       +      
Sbjct: 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 300

Query: 324 NCTELQHLALNHNSL--DGTIPPEIGKIL----LLQNLDLSHNNLS 363
              +L  L LN N    +  +  EI ++       +  +L      
Sbjct: 301 KMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 46/319 (14%), Positives = 97/319 (30%), Gaps = 74/319 (23%)

Query: 134 RNLEELYLRSNKLSGV----LPQEIGNLKSLIWLSVMYNTVGGP----IPSTLFRLTNLE 185
            ++E   L+ + ++      +   +    S+  + +  NT+G      +   +    +LE
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 186 RLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF 245
                            G +K+    ++        +   L     L  + LS N     
Sbjct: 64  IAEFSDIF--------TGRVKDEIPEAL------RLLLQALLKCPKLHTVRLSDNAFGPT 109

Query: 246 IPLEIGNF----SALAELDLSDNKI-------------RGIIPDELSKLSNLQYLNLSSN 288
               + +F    + L  L L +N +                +  +      L+ +    N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169

Query: 289 LLSGQIPFAIGKLF----NLVSLDLSKNKL-----SGSFPTGIGNCTELQHLALNHNSL- 338
            L         K F     L ++ + +N +           G+  C EL+ L L  N+  
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

Query: 339 -DGTIPPEIGKILL----LQNLDLSHNN------------LSGTIPMTLHPMFLDMSFNN 381
             G+    +   L     L+ L L+                S    + L    L + +N 
Sbjct: 230 HLGSS--ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ--TLRLQYNE 285

Query: 382 LEGE----IPTYLRDNPPN 396
           +E +    + T + +  P+
Sbjct: 286 IELDAVRTLKTVIDEKMPD 304

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 47/164 (28%), Positives = 68/164 (41%), Gaps = 30/164 (18%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLH-QSETEDSAFVESFQNEA-------RVLSTVRH 508
           IG G YG+VYKA +   G  VALK +   +       +              R L    H
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPI---STVREVALLRRLEAFEH 73

Query: 509 RNIVKLYGFCLHKRC-----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
            N+V+L   C   R      +  ++E++++  L   L D      L        +K +  
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLP----AETIKDLMR 127

Query: 564 ----ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
                L +LH +C   IVHRD+   NIL+ S     +ADFG AR
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 19/173 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G +  V  A  +  G+ VA+K + +++  +   ++    E R++  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
               ++ ++ I EY   G +F Y++      + EA      R     + +  A+ Y H  
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA------RS--KFRQIVSAVQYCHQK 133

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
               IVHRD+ + N+LL++++   +ADFG +    V         G   Y AP
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAP 182

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.1 bits (203), Expect = 9e-17
 Identities = 45/183 (24%), Positives = 71/183 (38%), Gaps = 36/183 (19%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           +G G  G V +       +  ALK L     +D       + E  +     +  +IV++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRIV 121

Query: 516 GFC----LHKRCMFFIYEYMERGSLFY--VLRDDD-----EAIELNWTRRVNIVKSVAHA 564
                    ++C+  + E ++ G LF     R D      EA          I+KS+  A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA--------SEIMKSIGEA 173

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVDSSNRTLRAGTYGY 621
           + YLH     +I HRD+   N+L  S        + DFG A+     +S  T    T  Y
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYY 229

Query: 622 IAP 624
           +AP
Sbjct: 230 VAP 232

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 21/175 (12%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG V  A      + VA+K +      D    E+ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLRD----DDEAIELNWTRRVNIVKSVAHALSYLHHD 571
                   +   EY   G LF  +  D    + +A      +R      +   + YLH  
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QR--FFHQLMAGVVYLHGI 124

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAP 624
               I HRDI   N+LL+      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 18/173 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V   +    G  VA+K L++ +      V   + E + L   RH +I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
                  +F + EY+  G LF Y+ +    D+ E+      RR  + + +   + Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES------RR--LFQQILSGVDYCHRH 135

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
               +VHRD+   N+LL++++ A +ADFG + ++      RT   G+  Y AP
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 184

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 36/137 (26%), Positives = 52/137 (37%), Gaps = 8/137 (5%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSD 263
            +T + +  N +    P        L  +DLS NQ+     L    F    +L  L L  
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE---LAPDAFQGLRSLNSLVLYG 89

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI- 322
           NKI  +       L +LQ L L++N ++     A   L NL  L L  NKL  +   G  
Sbjct: 90  NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148

Query: 323 GNCTELQHLALNHNSLD 339
                +Q + L  N   
Sbjct: 149 SPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 5/153 (3%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIP 103
           V+C  KG L  +  +    +  + L  N +   IPP        L+ ++L  N ++  + 
Sbjct: 16  VDCRGKG-LTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELA 72

Query: 104 KEI-GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIW 162
            +    LR+L  L L  N +          L +L+ L L +NK++ +      +L +L  
Sbjct: 73  PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132

Query: 163 LSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN 195
           LS+  N +      T   L  ++ + L  N F 
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 38/159 (23%), Positives = 60/159 (37%), Gaps = 34/159 (21%)

Query: 135 NLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR-LTNLERLFLGCNQ 193
            + E+ L  N +                           IP   F     L R+ L  NQ
Sbjct: 33  TITEIRLEQNTIKV-------------------------IPPGAFSPYKKLRRIDLSNNQ 67

Query: 194 FNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN 252
            +  +  +    L++L  L +  NK+T    S    L SL  L L+ N+++    L +  
Sbjct: 68  IS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC---LRVDA 123

Query: 253 FSALAEL---DLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
           F  L  L    L DNK++ I     S L  +Q ++L+ N
Sbjct: 124 FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 41/139 (29%), Positives = 59/139 (42%), Gaps = 13/139 (9%)

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
           E+ L  N I+ I P   S    L+ ++LS+N +S   P A   L +L SL L  NK++  
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 318 FPTGI-GNCTELQHLALNHNSLDGTIPPEIGKILL-LQNLDLSHNNLSGTIPMTLHPMFL 375
            P  +      LQ L LN N +   +  +  + L  L  L L  N L  TI         
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIA-------- 144

Query: 376 DMSFNNLEGEIPTYLRDNP 394
             +F+ L      +L  NP
Sbjct: 145 KGTFSPLRAIQTMHLAQNP 163

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 38/172 (22%), Positives = 63/172 (36%), Gaps = 36/172 (20%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SL 133
            IP  +     +  + L  N +    P      + L  + LSNN +   + +       L
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI---SELAPDAFQGL 79

Query: 134 RNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCN 192
           R+L  L L  NK++                          +P +LF  L +L+ L L  N
Sbjct: 80  RSLNSLVLYGNKITE-------------------------LPKSLFEGLFSLQLLLLNAN 114

Query: 193 QFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           + N  +  +   +L NL  LS+  NKL      T   L ++  + L+ N   
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 59/185 (31%), Positives = 86/185 (46%), Gaps = 28/185 (15%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +GTG +G V+      +G+  A+K L +        VE   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-----DDDEAI----ELNWTRRVNIVK 559
             I++++G     + +F I +Y+E G LF +LR      +  A     E           
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----------- 114

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTY 619
            V  AL YLH      I++RD+   NILL+ N    + DFG A+  +V     TL  GT 
Sbjct: 115 -VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTL-CGTP 167

Query: 620 GYIAP 624
            YIAP
Sbjct: 168 DYIAP 172

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 10/178 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            +F     +G G +G V   +    G+  A+K L +        V     E RVL   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 509 RNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
             +  L  +       + F+ EY   G LF+ L  +    E    R       +  AL Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSALDY 263

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAP 624
           LH +   ++V+RD+   N++L+ +    + DFG  +  +   ++ +T   GT  Y+AP
Sbjct: 264 LHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAP 318

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.5 bits (201), Expect = 3e-16
 Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 14/180 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-- 506
            DF +   IG GG+G VY     D GK+ A+K L +   +         NE  +LS V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 507 -RHRNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
                IV +  +  H    + FI + M  G L Y L       E            +   
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILG 304

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
           L ++H+     +V+RD+   NILL+ +    ++D G A        +     GT+GY+AP
Sbjct: 305 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAP 359

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 44/180 (24%), Positives = 68/180 (37%), Gaps = 27/180 (15%)

Query: 450 EDFHI--RY----CIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQN----- 498
           E   +   Y     I +G YG+V      +G  VA+K++  +   D   V    +     
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNT-VSDGRTVNILSDSFLCK 74

Query: 499 ----EARVLSTVRHRNIVKLYGFCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIEL 549
               E R+L+   H NI+ L    +H           + E M    L  V+ D    I +
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--IVI 131

Query: 550 NWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
           +       +  +   L  LH      +VHRD+   NILL  N +  + DF  AR    D+
Sbjct: 132 SPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.8 bits (197), Expect = 6e-16
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 28/161 (17%)

Query: 458 IGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQN-EARVLSTVRHRNIVKLY 515
           IG G +G VY+A+L   G++VA+KK+ Q +         F+N E +++  + H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLR 113

Query: 516 GF------CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----AL 565
            F         +  +  + +Y+   +++ V R    A     T  V  VK   +    +L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSL 169

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTARLL 605
           +Y+H   +  I HRDI   N+LL+ +     + DFG+A+ L
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 32/164 (19%)

Query: 458 IGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEA-------RVLSTVRH 508
           IG G YG V+KA      G+ VALK++   +T +    E             R L T  H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGE----EGMPLSTIREVAVLRHLETFEH 73

Query: 509 RNIVKLY-----GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
            N+V+L+          +  +  ++E++++  L   L D      +        +K +  
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVP----TETIKDMMF 127

Query: 564 ----ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
                L +LH      +VHRD+   NIL+ S+ +  +ADFG AR
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 25/177 (14%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G YG V  A      + VA+K +      D    E+ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLRD----DDEAIELNWTRRV--NIVKSVAHALSYLH 569
                   +   EY   G LF  +  D    + +A      +R    ++      + YLH
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLM----AGVVYLH 122

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA--GTYGYIAP 624
                 I HRDI   N+LL+      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 31/200 (15%), Positives = 66/200 (33%), Gaps = 17/200 (8%)

Query: 453 HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIV 512
            I             K +    ++    +         + +++   + R +     +N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
                   K  ++   +   + +L   +       +      ++I   +A A+ +LH   
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK- 183

Query: 573 TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS------------NRTLRAGTYG 620
              ++HRD+  +NI    +    V DFG    +  D                T + GT  
Sbjct: 184 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 621 YIAPDQRLSPPVNQKIIQDI 640
           Y++P+Q      + K+  DI
Sbjct: 242 YMSPEQIHGNNYSHKV--DI 259

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 44/196 (22%), Positives = 67/196 (34%), Gaps = 40/196 (20%)

Query: 449 TEDFHIRY-----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARV 502
                  Y      +G G  G V +      G+  ALK L+ S           + E   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDH 74

Query: 503 LSTV-RHRNIVKLYGFC----LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR--- 554
                   +IV +          KRC+  I E ME G LF         I+    +    
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF-------SRIQERGDQAFTE 127

Query: 555 ---VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTARLLHVD 608
                I++ +  A+ +LH     +I HRD+   N+L  S  +     + DFG A+     
Sbjct: 128 REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETT 182

Query: 609 SSNRTLRAGTYGYIAP 624
            +       T  Y+AP
Sbjct: 183 QNALQTPCYTPYYVAP 198

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 27/181 (14%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVES-FQNEARVLSTVRHRNIVKLY 515
           +G G YG V +          A+K L + +       E+  + E ++L  +RH+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 516 GFCLH--KRCMFFIYEYMERGS--LF-YVLR---DDDEAIELNWTRRV--NIVKSVAHAL 565
               +  K+ M+ + EY   G   +   V        +A            ++      L
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA------HGYFCQLI----DGL 122

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYIA 623
            YLH      IVH+DI   N+LL +     ++  G A  LH  +++ T R   G+  +  
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 624 P 624
           P
Sbjct: 180 P 180

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 27/160 (16%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQN-EARVLSTVRHRNIVKLYG 516
           IG G +G V++A+L +   VA+KK+ Q +         F+N E +++  V+H N+V L  
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDLKA 99

Query: 517 F------CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH----ALS 566
           F         +  +  + EY+   +++   R   +      T  + ++K   +    +L+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLA 155

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTARLL 605
           Y+H   +  I HRDI   N+LL+       + DFG+A++L
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 19/173 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           +G G +G V  A      + VALK + +   + S      + E   L  +RH +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTRRVNIVKSVAHALSYLHHD 571
                  +  + EY   G LF Y++      +DE       RR    + +  A+ Y H  
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEG------RR--FFQQIICAIEYCHRH 127

Query: 572 CTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
               IVHRD+   N+LL+ NL   +ADFG + ++   +  +T   G+  Y AP
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAP 176

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 45/199 (22%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALK-----------------------KLHQSETEDSAFV 493
           IG G YG V  A    D    A+K                              +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 494 ESFQNEARVLSTVRHRNIVKLYG--FCLHKRCMFFIYEYMERGSLFYVLRDD----DEAI 547
           E    E  +L  + H N+VKL       ++  ++ ++E + +G +  V        D+A 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA- 139

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
                R     + +   + YLH+     I+HRDI  +N+L+  +    +ADFG +     
Sbjct: 140 -----RF--YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK- 188

Query: 608 DSSNRTLR--AGTYGYIAP 624
             S+  L    GT  ++AP
Sbjct: 189 -GSDALLSNTVGTPAFMAP 206

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 39/171 (22%), Positives = 70/171 (40%), Gaps = 30/171 (17%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN----EARVLSTVRHRNIV 512
            G G +G+V    E   G  VA+KK+ Q           F+N      + L+ + H NIV
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--------RFRNRELQIMQDLAVLHHPNIV 82

Query: 513 KLYGF-------CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS----V 561
           +L  +             +  + EY+   +L    R+              ++K     +
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN---YYRRQVAPPPILIKVFLFQL 138

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTARLLHVDSSN 611
             ++  LH   + ++ HRDI  +N+L+N ++    + DFG+A+ L     N
Sbjct: 139 IRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 32/135 (23%), Positives = 56/135 (41%), Gaps = 7/135 (5%)

Query: 182 TNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
                L L  N+F       I   L  L  ++   NK+T          + +  + L+ N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 241 QLHSFIPLEIGNF---SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFA 297
           +L +   ++   F    +L  L L  N+I  +  D    LS+++ L+L  N ++   P A
Sbjct: 92  RLEN---VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148

Query: 298 IGKLFNLVSLDLSKN 312
              L +L +L+L  N
Sbjct: 149 FDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 40/173 (23%), Positives = 59/173 (34%), Gaps = 37/173 (21%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIG---S 132
            IP  I        L L  N  T      I   L  L  +  SNN +   T IE G    
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI---TDIEEGAFEG 79

Query: 133 LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGC 191
              + E+ L SN+L                           +   +F  L +L+ L L  
Sbjct: 80  ASGVNEILLTSNRLEN-------------------------VQHKMFKGLESLKTLMLRS 114

Query: 192 NQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           N+    +  +    L ++  LS+  N++T   P     L SL  L+L  N  +
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 14/140 (10%)

Query: 258 ELDLSDNKIRGIIPD-ELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG 316
           EL L++N+   +       KL  L+ +N S+N ++     A      +  + L+ N+L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94

Query: 317 SFPTGI-GNCTELQHLALNHNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIPMTLHPMF 374
           +    +      L+ L L  N +   +  +    +  ++ L L  N ++ T+        
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVA------- 145

Query: 375 LDMSFNNLEGEIPTYLRDNP 394
              +F+ L       L  NP
Sbjct: 146 -PGAFDTLHSLSTLNLLANP 164

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 31/155 (20%), Positives = 55/155 (35%), Gaps = 22/155 (14%)

Query: 26  CNWVGITCDYKG----------SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLS 75
           C    + C  +               + L          +  F   P L+ +N  NN ++
Sbjct: 11  CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 76  GSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIGS- 132
             I        S +  + L  N L   +  ++   L +L+ L L +N +   T +   S 
Sbjct: 71  -DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI---TCVGNDSF 125

Query: 133 --LRNLEELYLRSNKLSGVLPQEIGNLKSL--IWL 163
             L ++  L L  N+++ V P     L SL  + L
Sbjct: 126 IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL 160

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 39/119 (32%), Positives = 54/119 (45%), Gaps = 9/119 (7%)

Query: 222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ 281
           IP       + LYLD   NQ    +P E+ N+  L  +DLS+N+I  +     S ++ L 
Sbjct: 29  IPRD----VTELYLD--GNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLD 339
            L LS N L    P     L +L  L L  N +S   P G   + + L HLA+  N L 
Sbjct: 82  TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 6e-11
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 9/111 (8%)

Query: 182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
            ++  L+L  NQF   +P+E+ N K+LT + +  N+++     +  ++T LL L LS+N+
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89

Query: 242 LHSFIPLEIGNF---SALAELDLSDNKIRGIIPDEL-SKLSNLQYLNLSSN 288
           L     +    F    +L  L L  N I   +P+   + LS L +L + +N
Sbjct: 90  LRC---IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 34/145 (23%), Positives = 56/145 (38%), Gaps = 37/145 (25%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SL 133
            +P  I    ++  L L  N  T  +PKE+ + ++L ++ LSNN +   + +      ++
Sbjct: 24  VLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI---STLSNQSFSNM 77

Query: 134 RNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCN 192
             L  L L  N+L                           IP   F  L +L  L L  N
Sbjct: 78  TQLLTLILSYNRLRC-------------------------IPPRTFDGLKSLRLLSLHGN 112

Query: 193 QFNGTIPREI-GNLKNLTHLSIITN 216
             +  +P     +L  L+HL+I  N
Sbjct: 113 DIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 14/126 (11%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
           V CS KG L  L      ++  L L  N  +  +P ++ +  +L  ++L  N ++ T+  
Sbjct: 15  VRCSNKG-LKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN 71

Query: 105 EI-GSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEI-GNLKS 159
           +   ++  L  L LS N L     I       L++L  L L  N +S V P+    +L +
Sbjct: 72  QSFSNMTQLLTLILSYNRL---RCIPPRTFDGLKSLRLLSLHGNDISVV-PEGAFNDLSA 127

Query: 160 L--IWL 163
           L  + +
Sbjct: 128 LSHLAI 133

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 28/177 (15%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG+G +G           ++VA+K + +    D    E+ Q E     ++RH NIV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83

Query: 517 FCLHKRCMFFIYEYMERGSLF-YVLR----DDDEAIELNWTRRV--NIVKSVAHALSYLH 569
             L    +  I EY   G L+  +       +DEA      R     ++      +SY H
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA------RFFFQQLL----SGVSYCH 133

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAF--VADFGTARLLHVDSSNRTLRAGTYGYIAP 624
                 I HRD+   N LL+ +      + DFG ++   + S  ++   GT  YIAP
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAP 186

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 58/353 (16%), Positives = 105/353 (29%), Gaps = 72/353 (20%)

Query: 62  PNLQYLNLWNNNLSGSIPPQIGSL-----SNLKYLNLRWNNLTGTIPKEIGSL-----RN 111
             +  L+L  NNL      ++        +++  LNL  N+L      E+  +      N
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 112 LEVLYLSNNSLHGTTPIEIGSL-----RNLEELYLRSNKLSGVLPQEIGN-LKSLIWLSV 165
           +  L LS N L   +  E+          +  L L  N  S     E      +L     
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL----- 136

Query: 166 MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL-----KNLTHLSIITNKLT- 219
                            ++  L L  N        E+  +      N+  L++  N L  
Sbjct: 137 ---------------PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181

Query: 220 ---GAIPSTLGHL-TSLLYLDLSFNQL-----HSFIPLEIGNFSALAELDLSDNKIRG-- 268
                +   L  +  S+  LDLS N L          +     + +  L+L  N + G  
Sbjct: 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241

Query: 269 --IIPDELSKLSNLQYLNLSSNLLSGQ-------IPFAIGKLFNLVSLDLSKNKLSGSFP 319
              +      L +LQ + L  +++          +  A   +  ++ +D +  ++  S  
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301

Query: 320 TGIGNCTELQHLALNHNSLDGTIPPEIGKILL----------LQNLDLSHNNL 362
             I N         +  SL         K             L+    +   L
Sbjct: 302 IPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 50/303 (16%), Positives = 103/303 (33%), Gaps = 50/303 (16%)

Query: 38  SITHIELVECSIKGE----LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSL-----SNL 88
           S+T + L   S+  +    L  +  +   N+  LNL  N LS     ++          +
Sbjct: 52  SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111

Query: 89  KYLNLRWNNLTGTIPKEIGSL-----RNLEVLYLSNNSLHGTTPIEIGSL-----RNLEE 138
             L+L WN+ +     E          ++  L L  N L   +  E+  +      N+  
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNS 171

Query: 139 LYLRSNKLSGVLPQEIGNL-----KSLIWLSVMYNTVGGPIPSTLFRL-----TNLERLF 188
           L LR N L+     E+         S+  L +  N +G    + L  +      ++  L 
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231

Query: 189 LGCNQFNGTIPREIGNL----KNLTHLSIITNKLTG-------AIPSTLGHLTSLLYLDL 237
           L  N  +G     +  L    K+L  + +  + +         A+ +   ++  ++ +D 
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK 291

Query: 238 SFNQLHSFIPLEIGNF-----SALAELDLSDNKI-----RGIIPDELSKLSNLQYLNLSS 287
           +  ++H    + I N             L +  +          ++L+    L+    + 
Sbjct: 292 NGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTC 351

Query: 288 NLL 290
             L
Sbjct: 352 KPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 59/318 (18%), Positives = 106/318 (33%), Gaps = 82/318 (25%)

Query: 86  SNLKYLNLRWNNLTGTIPKEIGSL-----RNLEVLYLSNNSLHGTTPIEIGSL-----RN 135
             +  L+L  NNL      E+         ++  L LS NSL      E+  +      N
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 136 LEELYLRSNKLSGVLPQEIGN-LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQF 194
           +  L L  N LS     E+   L ++                       +  L LG N F
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAI--------------------PFTITVLDLGWNDF 121

Query: 195 NGTIPREIGNL-----KNLTHLSIITNKLTG----AIPSTLGHL-TSLLYLDLSFNQLHS 244
           +     E          ++T L++  N L       +   L  +  ++  L+L  N    
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN--- 178

Query: 245 FIPLEIGNFSA--LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLF 302
                + + +   LA+   S                ++  L+LS+NLL  +    +  +F
Sbjct: 179 -----LASKNCAELAKFLASIPA-------------SVTSLDLSANLLGLKSYAELAYIF 220

Query: 303 -----NLVSLDLSKNKLSGS----FPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL-- 351
                ++VSL+L  N L G           +   LQ + L+++ +   +  E  K L   
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAA 279

Query: 352 ------LQNLDLSHNNLS 363
                 +  +D +   + 
Sbjct: 280 FPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 40/213 (18%)

Query: 210 HLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG-----NFSALAELDLSDN 264
           +  +  +  +  +         +  LDLS N L+S   +E+        +++  L+LS N
Sbjct: 2   NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61

Query: 265 KIRGIIPDELSKL-----SNLQYLNLSSNLLSGQIPFAIGKLF-----NLVSLDLSKNKL 314
            +     DEL ++     +N+  LNLS N LS +    + K        +  LDL  N  
Sbjct: 62  SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121

Query: 315 SGSFPTGIG------NCTELQHLALNHNSLDGTIPPEIGKILL-----LQNLDLSHNNLS 363
           S    +           + +  L L  N L      E+ +IL      + +L+L  NNL+
Sbjct: 122 SSKSSSEFKQAFSNLPAS-ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180

Query: 364 -----------GTIPMTLHPMFLDMSFNNLEGE 385
                       +IP ++    LD+S N L  +
Sbjct: 181 SKNCAELAKFLASIPASVT--SLDLSANLLGLK 211

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 45/219 (20%), Positives = 78/219 (35%), Gaps = 58/219 (26%)

Query: 451 DFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN----- 498
           D+ I  RY     IGTG YG V +A +  + +VVA+KK+             F++     
Sbjct: 48  DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL----------RVFEDLIDCK 97

Query: 499 ----EARVLSTVRHRNIVKLYGFCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIEL 549
               E  +L+ + H ++VK+    + K    F     + E  +               + 
Sbjct: 98  RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------------SDF 143

Query: 550 NWTRRVNIVKSVAH----------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF 599
               R  +  +  H           + Y+H   +  I+HRD+   N L+N +    V DF
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDF 200

Query: 600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQ 638
           G AR +    +  +    +      +    P       Q
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 13/179 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            DF     +G G +G V        G+  A+K L +        V     E+RVL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 509 RNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS-VAHALS 566
             +  L  +       + F+ EY   G LF+ L  +    E     R     + +  AL 
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALE 119

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAP 624
           YLH      +V+RDI   N++L+ +    + DFG  +  +   ++ +T   GT  Y+AP
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAP 174

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 44/212 (20%)

Query: 451 DFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN----- 498
            F +  RY     IG+G  G V  A +    + VA+KKL +           FQN     
Sbjct: 20  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP----------FQNQTHAK 69

Query: 499 ----EARVLSTVRHRNIVKLYG-FCLHKRCMFF--IY---EYMERGSLFYVLRDDDEAIE 548
               E  ++  V H+NI+ L   F   K    F  +Y   E M+  +L  V++ +     
Sbjct: 70  RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME----- 123

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           L+  R   ++  +   + +LH   +  I+HRD+  +NI++ S+    + DFG AR     
Sbjct: 124 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GT 179

Query: 609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDI 640
           S   T    T  Y AP+  L     + +  DI
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENV--DI 209

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 44/191 (23%), Positives = 75/191 (39%), Gaps = 52/191 (27%)

Query: 451 DFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN----- 498
           + H+   Y     IG G YG VY A +    K VA+KK+++           F++     
Sbjct: 21  NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR----------MFEDLIDCK 70

Query: 499 ----EARVLSTVRHRNIVKLYGFCLHKRCMFF--IYEYMERGSLFYVLRDDDEAIELNWT 552
               E  +L+ ++   I++LY   +    + F  +Y  +E       + D D    L   
Sbjct: 71  RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE-------IADSD----LKKL 119

Query: 553 RRVNIVKSVAH----------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
            +  I  +  H            +++H      I+HRD+   N LLN +    V DFG A
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 603 RLLHVDSSNRT 613
           R ++ +     
Sbjct: 177 RTINSEKDTNI 187

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 35/169 (20%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SL 133
           S+P  I   +N + L L  N +T   P    SL NL+ LYL +N L     + +G   SL
Sbjct: 33  SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL---GALPVGVFDSL 87

Query: 134 RNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCN 192
             L  L L +N+L             L              PS +F RL +L+ LF+ CN
Sbjct: 88  TQLTVLDLGTNQL-----------TVL--------------PSAVFDRLVHLKELFMCCN 122

Query: 193 QFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
           +    +PR I  L +LTHL++  N+L          L+SL +  L  N 
Sbjct: 123 KLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 9/132 (6%)

Query: 209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELD---LSDNK 265
             L +  N++T   P     L +L  L L  NQL +   L +G F +L +L    L  N+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA---LPVGVFDSLTQLTVLDLGTNQ 99

Query: 266 IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GN 324
           +  +      +L +L+ L +  N L+  +P  I +L +L  L L +N+L  S P G    
Sbjct: 100 LTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157

Query: 325 CTELQHLALNHN 336
            + L H  L  N
Sbjct: 158 LSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 67.4 bits (165), Expect = 8e-13
 Identities = 52/177 (29%), Positives = 70/177 (39%), Gaps = 36/177 (20%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
           V+C  K    S+      N Q L L +N ++   P    SL NLK L L  N L   +P 
Sbjct: 24  VDCRSKR-HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV 81

Query: 105 EI-GSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSL 160
            +  SL  L VL L  N L   T +       L +L+EL++  NK           L   
Sbjct: 82  GVFDSLTQLTVLDLGTNQL---TVLPSAVFDRLVHLKELFMCCNK-----------LTE- 126

Query: 161 IWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITN 216
                        +P  + RLT+L  L L  NQ   +IP      L +LTH  +  N
Sbjct: 127 -------------LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 3/118 (2%)

Query: 221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNL 280
           ++P+  G  T+   L L  NQ+    P    +   L EL L  N++  +       L+ L
Sbjct: 33  SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90

Query: 281 QYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL 338
             L+L +N L+        +L +L  L +  NKL+   P GI   T L HLAL+ N L
Sbjct: 91  TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 42/139 (30%), Positives = 60/139 (43%), Gaps = 14/139 (10%)

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI-GKLFNLVSLDLSKNKLSG 316
            L L DN+I  + P     L NL+ L L SN L   +P  +   L  L  LDL  N+L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 317 SFPTGI-GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFL 375
             P+ +      L+ L +  N L   +P  I ++  L +L L  N L  +IP        
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIP-------- 151

Query: 376 DMSFNNLEGEIPTYLRDNP 394
             +F+ L      YL  NP
Sbjct: 152 HGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 4/87 (4%)

Query: 278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHN 336
           +N Q L L  N ++   P     L NL  L L  N+L  + P G+  + T+L  L L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 337 SLDGTIPPEI-GKILLLQNLDLSHNNL 362
            L   +P  +  +++ L+ L +  N L
Sbjct: 99  QLT-VLPSAVFDRLVHLKELFMCCNKL 124

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 37/178 (20%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
           VEC  +G   S+         YL+L  N+L          L++L  L L  N L  ++P 
Sbjct: 12  VECYSQG-RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN 69

Query: 105 EI-GSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSL 160
            +   L +L  L LS N L     +  G    L  L+EL L +N+           L+SL
Sbjct: 70  GVFNKLTSLTYLNLSTNQL---QSLPNGVFDKLTQLKELALNTNQ-----------LQSL 115

Query: 161 IWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITN 216
                         P  +F +LT L+ L L  NQ   ++P  +   L +L ++ +  N
Sbjct: 116 --------------PDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 44/132 (33%), Positives = 62/132 (46%), Gaps = 8/132 (6%)

Query: 209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELD---LSDNK 265
           T+L + TN L          LTSL  L L  N+L S   L  G F+ L  L    LS N+
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS---LPNGVFNKLTSLTYLNLSTNQ 87

Query: 266 IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GN 324
           ++ +      KL+ L+ L L++N L         KL  L  L L +N+L  S P G+   
Sbjct: 88  LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146

Query: 325 CTELQHLALNHN 336
            T LQ++ L+ N
Sbjct: 147 LTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 4/124 (3%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
           ++   ++P+  G      YLDL  N L S         ++L +L L  NK++ +     +
Sbjct: 16  SQGRTSVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALN 334
           KL++L YLNLS+N L         KL  L  L L+ N+L  S P G+    T+L+ L L 
Sbjct: 74  KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132

Query: 335 HNSL 338
            N L
Sbjct: 133 QNQL 136

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 38/161 (23%), Positives = 60/161 (37%), Gaps = 35/161 (21%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY 515
           +G G  G V +       +  ALK L              + E  +     +  +IV++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 77

Query: 516 GFC----LHKRCMFFIYEYMERGSLFY--VLRDDD-----EAIELNWTRRVNIVKSVAHA 564
                    ++C+  + E ++ G LF     R D      EA          I+KS+  A
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA--------SEIMKSIGEA 129

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAF---VADFGTA 602
           + YLH     +I HRD+   N+L  S        + DFG A
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.6 bits (171), Expect = 7e-13
 Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 40/193 (20%)

Query: 451 DFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN----- 498
            ++I   +     +G G YG V  A   P G++VA+KK           +E F       
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK-----------IEPFDKPLFAL 54

Query: 499 ----EARVLSTVRHRNIVKLYGFCLHKRCMFF--IY---EYMERGSLFYVLRDDDEAIEL 549
               E ++L   +H NI+ ++          F  +Y   E M+   L  V+        L
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM----L 109

Query: 550 NWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS 609
           +       +     A+  LH     +++HRD+  +N+L+NSN +  V DFG AR++   +
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

Query: 610 SNRTLRAGTYGYI 622
           ++ +   G    +
Sbjct: 167 ADNSEPTGQQSGM 179

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 34/171 (19%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN--------- 498
              +     +G+G YG+V  A +   G  VA+KKL++           FQ+         
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP----------FQSELFAKRAYR 73

Query: 499 EARVLSTVRHRNIVKLYG-FCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIELNWT 552
           E R+L  +RH N++ L   F   +    F     +  +M    L  +++ +     L   
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGED 128

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           R   +V  +   L Y+H      I+HRD+   N+ +N + E  + DFG AR
Sbjct: 129 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 9e-13
 Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 35/171 (20%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN--------- 498
            + +     +G+G YGSV  A +   G+ VA+KKL +           FQ+         
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP----------FQSEIFAKRAYR 72

Query: 499 EARVLSTVRHRNIVKLYG-FCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIELNWT 552
           E  +L  ++H N++ L   F        F     +  +M+   L  ++      ++ +  
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEE 126

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           +   +V  +   L Y+H   +  +VHRD+   N+ +N + E  + DFG AR
Sbjct: 127 KIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 35/171 (20%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN--------- 498
            + +     IG+G  G V  A +    + VA+KKL +           FQN         
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP----------FQNQTHAKRAYR 110

Query: 499 EARVLSTVRHRNIVKLYG-FCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIELNWT 552
           E  ++  V H+NI+ L   F   K    F     + E M+  +L  V++ +     L+  
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHE 164

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           R   ++  +   + +LH   +  I+HRD+  +NI++ S+    + DFG AR
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 39/178 (21%), Positives = 71/178 (39%), Gaps = 34/178 (19%)

Query: 449 TEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN--------- 498
              +     IG G YG V  A +  +   VA+KK           +  F++         
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK-----------ISPFEHQTYCQRTLR 74

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIELNWTR 553
           E ++L   RH NI+ +                 + + ME   L+ +L+       L+   
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH----LSNDH 129

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
               +  +   L Y+H   + +++HRD+  +N+LLN+  +  + DFG AR+   D  +
Sbjct: 130 ICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSE-TEDSAFVESFQNEARVLS 504
           E F +   +G GGYG V++         GK+ A+K L ++    ++      + E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 505 TVRHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVA 562
            V+H  IV L Y F    + ++ I EY+  G LF  L  +   +E          +  ++
Sbjct: 77  EVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME----DTACFYLAEIS 131

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGY 621
            AL +LH      I++RD+   NI+LN      + DFG  +  +H  +   T   GT  Y
Sbjct: 132 MALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-CGTIEY 187

Query: 622 IAP 624
           +AP
Sbjct: 188 MAP 190

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 33/192 (17%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGK----VVALKKLHQSE-TEDSAFVESFQNEARVLS 504
           E+F +   +GTG YG V+      G     + A+K L ++   + +   E  + E +VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 505 TVRHRN-IVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDD---DE------AIELNWTR 553
            +R    +V L Y F    + +  I +Y+  G LF  L       E        E+    
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI---- 168

Query: 554 RVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT 613
                     AL +LH      I++RDI   NILL+SN    + DFG ++    D + R 
Sbjct: 169 --------VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 614 LR-AGTYGYIAP 624
               GT  Y+AP
Sbjct: 218 YDFCGTIEYMAP 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 52/197 (26%)

Query: 446 INATEDFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN 498
           +N    F +  RY     +G GG G V+ A +    K VA+KK+               +
Sbjct: 2   MNIHG-FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTD 48

Query: 499 ---------EARVLSTVRHRNIVKLY---------GFCLHKRCMFF-----IYEYMERGS 535
                    E +++  + H NIVK++                         + EYME   
Sbjct: 49  PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TD 107

Query: 536 LFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEA 594
           L  VL        L        +  +   L Y+H   + +++HRD+   N+ +N+ +L  
Sbjct: 108 LANVLEQGP----LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL 160

Query: 595 FVADFGTARLLHVDSSN 611
            + DFG AR++    S+
Sbjct: 161 KIGDFGLARIMDPHYSH 177

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 12/179 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           EDF +   +G G +G V+ AE     +  A+K L +        VE    E RVLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 508 HRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
           H  +  +   F   +  +FF+ EY+  G L Y ++   +      +R       +   L 
Sbjct: 77  HPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDL---SRATFYAAEIILGLQ 132

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAP 624
           +LH      IV+RD+  +NILL+ +    +ADFG  +  +  D+   T   GT  YIAP
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAP 187

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.5 bits (167), Expect = 4e-12
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 12/179 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
            DF+    +G G +G V  +E     ++ A+K L +        VE    E RVL+   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 508 HRNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
              + +L+  C      ++F+ EY+  G L Y ++      E      V     +A  L 
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAIGLF 456

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAP 624
           +L       I++RD+  +N++L+S     +ADFG  +  +    + +T   GT  YIAP
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTPDYIAP 511

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 68.0 bits (166), Expect = 5e-12
 Identities = 55/376 (14%), Positives = 117/376 (31%), Gaps = 40/376 (10%)

Query: 27  NWVGITCDYKGSITHIELVECSIK-GELGSLNFSCFPNLQYLNLWN-NNLSGSIPPQIGS 84
            WV    +    +  +      +   +L  L  +   +L+ L L   +  +      I +
Sbjct: 102 PWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVT 161

Query: 85  -LSNLKYLNLRWNNLTGTIPKEIGSL----RNLEVLYLSNNSLHGTTPIEIGSL----RN 135
               +K L +  ++ +    K +  L     +LEVL          +P ++ ++    R+
Sbjct: 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRS 221

Query: 136 LEELYLRSNKLSGV--LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQ 193
           L  + +   ++  +    +   NL+     S+  +         L     L RL L    
Sbjct: 222 LVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL-SYM 280

Query: 194 FNGTIPREIGNLKNLTHLSI-ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN 252
               +P        +  L +      T    + +    +L  L+         + +    
Sbjct: 281 GPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY 340

Query: 253 FSALAELDLSDNKIRGIIPDELSKLS------------NLQYLNLSSNLLSGQIPFAIGK 300
              L  L +        + DE   +S             L+Y+ +  + ++ +   +IG 
Sbjct: 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400

Query: 301 L------FNLVSLDLSKNKLSGSFPTGIG----NCTELQHLALNHNS--LDGTIPPEIGK 348
                  F LV LD  +         G+      C +L+  A       L       IG+
Sbjct: 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ 460

Query: 349 IL-LLQNLDLSHNNLS 363
               ++ + L +   S
Sbjct: 461 YSPNVRWMLLGYVGES 476

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 48/334 (14%), Positives = 101/334 (30%), Gaps = 39/334 (11%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG-SLRNLEVLY 116
              FPNL+ L L                +    +   W         EI  +LR L+ ++
Sbjct: 69  SRRFPNLRSLKLKGK----------PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVH 118

Query: 117 LSNNSL--HGTTPIEIGSLRNLEELYLRS-NKLSGVLPQEIG-NLKSLIWLSVMYNTVGG 172
                +       +      +LE L L   +  +      I  + + +  L +  ++   
Sbjct: 119 FRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSE 178

Query: 173 PIPSTLFRL----TNLERLFLGCNQFNG----TIPREIGNLKNLTHLSIITNKLT--GAI 222
                L  L    T+LE L     +F       +     N ++L  + +   ++      
Sbjct: 179 KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF 238

Query: 223 PSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQY 282
                +L       L+ +       + +     L  L LS       +P      + ++ 
Sbjct: 239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRK 297

Query: 283 LNLSS-NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT 341
           L+L    L +      I K  NL  L+                C +L+ L +   + +  
Sbjct: 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQG 357

Query: 342 IPPEIGKI------------LLLQNLDLSHNNLS 363
           +  E G +              L+ + +  ++++
Sbjct: 358 MEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 54/314 (17%), Positives = 102/314 (32%), Gaps = 42/314 (13%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
            I  ++L+   ++ E         PNL+ L   N      +         LK L +    
Sbjct: 294 QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGA 353

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG-N 156
               +  E G +    ++ L+               + LE + +  + ++    + IG  
Sbjct: 354 DEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSDITNESLESIGTY 401

Query: 157 LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG-NLKNLTHLSIIT 215
           LK+L                  FRL  L+R     +       R +    K L   +   
Sbjct: 402 LKNL----------------CDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445

Query: 216 N--KLTGAIPSTLG-HLTSLLYLDLSFNQLHSFIPLEIG-NFSALAELDLSDNKI--RGI 269
               LT    S +G +  ++ ++ L +        +E       L +L++       R I
Sbjct: 446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505

Query: 270 IPDELSKLSNLQYLNLSSNLLS--GQIPFAIGK-LFNLVSLDLSKNKLSGSFPTGIGNCT 326
               ++KL +L+YL +     S  GQ    + +  +N+  +   +         G     
Sbjct: 506 AAA-VTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVN--QQGEIREM 562

Query: 327 ELQHLALNHNSLDG 340
           E     L + SL G
Sbjct: 563 EHPAHILAYYSLAG 576

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 40/175 (22%)

Query: 451 DFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN----- 498
            + +  RY     +G+G YGSV  A +   G  VA+KKL +           FQ+     
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP----------FQSIIHAK 73

Query: 499 ----EARVLSTVRHRNIVKLYG-FCLHKRCMFF-----IYEYMERGSLFYVLRDDDEAIE 548
               E R+L  ++H N++ L   F   +    F     +   M    L  +++      +
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK----CQK 128

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR 603
           L       ++  +   L Y+H   +  I+HRD+  +N+ +N + E  + DFG AR
Sbjct: 129 LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 9e-12
 Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 37/200 (18%)

Query: 451 DFHI--RY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           D H+  +Y     +G G YG V+K+ +   G+VVA+KK+  +          FQN     
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA----------FQNSTDAQ 53

Query: 504 STVR----------HRNIVKLYGFCL--HKRCMFFIYEYMERGSLFYVLRDDDEAIELNW 551
            T R          H NIV L       + R ++ +++YME   L  V+R +     L  
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI----LEP 108

Query: 552 TRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN 611
             +  +V  +   + YLH   +  ++HRD+  +NILLN+     VADFG +R        
Sbjct: 109 VHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 612 RTLRAGTYGYIAPDQRLSPP 631
                 +      +     P
Sbjct: 166 TNNIPLSINENTENFDDDQP 185

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 57/405 (14%), Positives = 113/405 (27%), Gaps = 56/405 (13%)

Query: 9   LNCGWWKDRIPHNTSDHC-NWVGITCDYKGSITHIELVECSIKGELGSLN---FSCFPNL 64
           +  G      P            +    K       LV     G +        S +  L
Sbjct: 48  VFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107

Query: 65  QYLNLWNNNLSGSIPPQIG-SLSNLKYLNLRW-NNLTGTIPKEIGS-LRNLEVLYLSNNS 121
           + + L    ++      I  S  N K L L      +      I +  RNL+ L L  + 
Sbjct: 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD 167

Query: 122 LHGTTPIEIGSL----RNLEELYLR--SNKLS-GVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           +   +   +        +L  L +   ++++S   L + +    +L  L +        +
Sbjct: 168 VDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKL 227

Query: 175 PSTLFRLTNLERLFLGCNQFNGT------IPREIGNLKNLTHLSIITNKLTGAIPSTLGH 228
            + L R   LE L  G             +   +   K L  LS   + +   +P+    
Sbjct: 228 ATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287

Query: 229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
            + L  L+LS+                     +    +  ++     +   LQ L +   
Sbjct: 288 CSRLTTLNLSYAT-------------------VQSYDLVKLL----CQCPKLQRLWVLDY 324

Query: 289 LLSGQIPFAIGKLFNLVSLDLSK-NKLSGSFPTGIG---------NCTELQHLALNHNSL 338
           +    +        +L  L +             +           C +L+ +      +
Sbjct: 325 IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQM 384

Query: 339 DGTIPPEIGKIL-LLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNL 382
                  I +    +    L          +TL P  LD+ F  +
Sbjct: 385 TNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP--LDIGFGAI 427

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 42/306 (13%), Positives = 89/306 (29%), Gaps = 58/306 (18%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLW------NNNLSGSIPPQIGSLSNLKYL 91
           ++  ++L       +L +L     P L+ L           ++   +   +     L+ L
Sbjct: 212 NLKSLKLNRAVPLEKLATL-LQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270

Query: 92  NLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS-LRNLEELYLRSNKLSGVL 150
           +  W+ +   +P        L  L LS  ++     +++      L+ L++        L
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGL 330

Query: 151 PQEIGNLKSLIWLSVMYNTVGGPIPSTLF----------RLTNLERLFLGCNQFNGTIPR 200
                  K L  L V  +      P+                 LE +   C Q       
Sbjct: 331 EVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALI 390

Query: 201 EIG-NLKNLTHLSI----------ITNKLT-------------------------GAIPS 224
            I  N  N+T   +          +T +                                
Sbjct: 391 TIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEY 450

Query: 225 TLGHLTSLLYLDLSFNQLHSFIPLEIGNF-SALAELDLSDNKI--RGIIPDELSKLSNLQ 281
              +   +  L ++F          + +   +L +L++ D     + ++    SKL  ++
Sbjct: 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL-ANASKLETMR 509

Query: 282 YLNLSS 287
            L +SS
Sbjct: 510 SLWMSS 515

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 1e-11
 Identities = 25/213 (11%), Positives = 54/213 (25%), Gaps = 41/213 (19%)

Query: 448 ATEDFHIRYCIGTGGYGSVYKAELPDG----KVVALKKLHQSETEDSAFVESFQNEARVL 503
            TE       IG G +G V++          K++A++             E    E  + 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 504 STV---------RHRNIVKLYGFCLHK----RCMFFIYEYM--ERGSLFYVLR------- 541
             +         R    + L      +      +   +++    +GS             
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 542 -------------DDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL 588
                        +       +     +I+  +  +L+           HRD+   N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLL 195

Query: 589 NSNLEAFVADFGTARLLHVDSSNRTLRAGTYGY 621
                  +      +   + S    +    Y  
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 17/182 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
             F +   +G G +G V+  +        ++ A+K L ++  +    V + + E  +L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82

Query: 506 VRHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVAH 563
           V H  IVKL Y F    + ++ I +++  G LF  L  +    E      V   +  +A 
Sbjct: 83  VNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE----EDVKFYLAELAL 137

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYI 622
           AL +LH      I++RD+   NILL+      + DFG ++  +  +    +   GT  Y+
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CGTVEYM 193

Query: 623 AP 624
           AP
Sbjct: 194 AP 195

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 35/206 (16%), Positives = 71/206 (34%), Gaps = 67/206 (32%)

Query: 91  LNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE-IGSLRNLEELYLRSNKLSGV 149
           L+     +   +   + +L+  + L LS N++     I  +  + NL  L L  N +   
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI---EKISSLSGMENLRILSLGRNLIK-- 83

Query: 150 LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT 209
              +I NL ++                       LE L++  NQ        I +L    
Sbjct: 84  ---KIENLDAV--------------------ADTLEELWISYNQ--------IASLSG-- 110

Query: 210 HLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKIRG 268
                           +  L +L  L +S N++ ++  ++ +     L +L L+ N +  
Sbjct: 111 ----------------IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154

Query: 269 IIPDE----------LSKLSNLQYLN 284
              +           + +L NL+ L+
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 33/132 (25%), Positives = 54/132 (40%), Gaps = 11/132 (8%)

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
            + L      +   +   +    A   L LS N I  I    LS + NL+ L+L  NL+ 
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK 83

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL 351
            +I         L  L +S N++  +  +GI     L+ L +++N +      EI K+  
Sbjct: 84  -KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITN--WGEIDKLAA 138

Query: 352 LQNL---DLSHN 360
           L  L    L+ N
Sbjct: 139 LDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 31/118 (26%), Positives = 50/118 (42%), Gaps = 14/118 (11%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
           + S   NL+ L+L  N +   I         L+ L + +N +  ++   I  L NL VLY
Sbjct: 65  SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLY 121

Query: 117 LSNNSLHGTTPIE-IGSLRNLEELYLRSNKLSGVLPQE----------IGNLKSLIWL 163
           +SNN +     I+ + +L  LE+L L  N L     +           +  L +L  L
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 17/156 (10%)

Query: 67  LNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTT 126
           L+     +   +   + +L   K+L L  NN+   I   +  + NL +L L  N +    
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIE 86

Query: 127 PIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP-STLFRLTNLE 185
            ++      LEEL++  N+++ +    I  L +L  L +  N +        L  L  LE
Sbjct: 87  NLD-AVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143

Query: 186 RLFLGCNQFNGTIPRE----------IGNLKNLTHL 211
            L L  N                   +  L NL  L
Sbjct: 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 28/109 (25%), Positives = 50/109 (45%), Gaps = 12/109 (11%)

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
           EL      I  +    LS L   ++L LS+N +  +I  ++  + NL  L L +N +   
Sbjct: 29  ELHGMIPPIEKM-DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-K 84

Query: 318 FPTGIGNCTELQHLALNHN---SLDGTIPPEIGKILLLQNLDLSHNNLS 363
                     L+ L +++N   SL G     I K++ L+ L +S+N ++
Sbjct: 85  IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKIT 128

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 36/195 (18%), Positives = 67/195 (34%), Gaps = 52/195 (26%)

Query: 458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQN-EARVLSTVRHRNIVKLY 515
           +GTG +G V +  ++  GK  ALKK+ Q           ++N E  ++  + H NI+KL 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVLDHVNIIKLV 66

Query: 516 GF---CLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR----VNIVK--------- 559
            +      +                     ++    +         +N++          
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 560 ------------SVAH----------ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-V 596
                        +            A+ ++H   +  I HRDI   N+L+NS      +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 597 ADFGTARLLHVDSSN 611
            DFG+A+ L     +
Sbjct: 184 CDFGSAKKLIPSEPS 198

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 18/182 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVA---LKKLHQSETEDSAFVESFQNEARVLST 505
           ++F     +G G +G V  A + + G + A   LKK    + +D   VE    E R+LS 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD---VECTMTEKRILSL 79

Query: 506 V-RHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
              H  + +L   F    R +FF+ E++  G L + ++      E    R       +  
Sbjct: 80  ARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEIIS 135

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYI 622
           AL +LH      I++RD+  +N+LL+      +ADFG  +  +    +  T   GT  YI
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-CGTPDYI 191

Query: 623 AP 624
           AP
Sbjct: 192 AP 193

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 36/191 (18%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVA---LKKLHQSETEDSAFVESFQNEARVLS- 504
            DFH    IG G +G V  A         A   L+K    + ++    +   +E  VL  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE---EKHIMSERNVLLK 94

Query: 505 TVRHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDD---DE------AIELNWTRR 554
            V+H  +V L + F    + ++F+ +Y+  G LFY L+ +    E      A E      
Sbjct: 95  NVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAE------ 147

Query: 555 VNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRT 613
                 +A AL YLH     +IV+RD+   NILL+S     + DFG  +  +  +S+  T
Sbjct: 148 ------IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198

Query: 614 LRAGTYGYIAP 624
              GT  Y+AP
Sbjct: 199 F-CGTPEYLAP 208

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 61.3 bits (149), Expect = 4e-11
 Identities = 30/108 (27%), Positives = 46/108 (42%), Gaps = 3/108 (2%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           ++  + L  C           + F NL++L+L N  L  S+   +  L  LK L L  N 
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE-IGSLRNLEELYLRSN 144
           + G +      L NL  L LS N L   + +E +  L  L+ L L + 
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 57.1 bits (138), Expect = 9e-10
 Identities = 34/111 (30%), Positives = 45/111 (40%), Gaps = 4/111 (3%)

Query: 204 NLKNLTHLSIITNKLT-GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS 262
               +  L +   K   G I        +L +L L    L S   L       L +L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELS 79

Query: 263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFA-IGKLFNLVSLDLSKN 312
           +N+I G +     KL NL +LNLS N L        + KL  L SLDL   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 34/132 (25%), Positives = 49/132 (37%), Gaps = 10/132 (7%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKI 266
            +     I  +L    P+ +  L     LD   +       L    F  L  L L +  +
Sbjct: 7   GMDMKRRIHLELRNRTPAAVRELV----LDNCKSNDGKIEGL-TAEFVNLEFLSLINVGL 61

Query: 267 RGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPT--GIGN 324
             +    L KL  L+ L LS N + G +     KL NL  L+LS NKL     T   +  
Sbjct: 62  ISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKK 118

Query: 325 CTELQHLALNHN 336
              L+ L L + 
Sbjct: 119 LECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 36/147 (24%), Positives = 54/147 (36%), Gaps = 16/147 (10%)

Query: 49  IKGELGSLNFSCFPNLQYLNLWNNNLS-GSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG 107
           I  EL +   +    ++ L L N   + G I        NL++L+L  N    ++   + 
Sbjct: 14  IHLELRNRTPA---AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISVSN-LP 68

Query: 108 SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMY 167
            L  L+ L LS N + G   +    L NL  L L  NKL  +    +  LK L  L  + 
Sbjct: 69  KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLKSLD 126

Query: 168 NTVGGPI-------PSTLFRLTNLERL 187
                 +        S    L  L  L
Sbjct: 127 LF-NCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 33/160 (20%), Positives = 58/160 (36%), Gaps = 37/160 (23%)

Query: 132 SLRNLEELYLRSNKLSGVLPQEIG-NLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLG 190
           +   + EL L + K +    + +     +L +LS++           L  ++NL      
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG--------LISVSNLP----- 68

Query: 191 CNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE- 249
                         L  L  L +  N++ G +      L +L +L+LS N+L     LE 
Sbjct: 69  -------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115

Query: 250 IGNFSALAELDLSDNKI------RGIIPDELSKLSNLQYL 283
           +     L  LDL + ++      R  +      L  L YL
Sbjct: 116 LKKLECLKSLDLFNCEVTNLNDYRESV---FKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 26/113 (23%), Positives = 42/113 (37%), Gaps = 27/113 (23%)

Query: 252 NFSALAELDLSDNKIRGI-IPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
             +A+ EL L + K     I    ++  NL++L+L +  L   +   + KL  L  L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 311 KNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
           +N++ G           L HL                        +LS N L 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHL------------------------NLSGNKLK 108

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 24/111 (21%), Positives = 42/111 (37%), Gaps = 6/111 (5%)

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
           N      L +   K+   I +    L     +D S N++             L  L +++
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 73

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLS--GQIPFAIGKLFNLVSLDLSKN 312
           N+I  I       L +L  L L++N L   G +   +  L +L  L + +N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.1 bits (141), Expect = 5e-10
 Identities = 28/147 (19%), Positives = 47/147 (31%), Gaps = 27/147 (18%)

Query: 214 ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE 273
           +T +L         +      LDL   ++     L          +D SDN+IR +  D 
Sbjct: 4   LTAELIEQAAQ-YTNAVRDRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIRKL--DG 59

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
              L  L+ L +++N +          L +L  L L+ N         +    +L  LA 
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLAS 111

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHN 360
             +               L  L +  N
Sbjct: 112 LKS---------------LTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 25/142 (17%), Positives = 52/142 (36%), Gaps = 17/142 (11%)

Query: 55  SLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLT--GTIPKEIGSLRNL 112
           +  ++     + L+L    +   I     +L     ++   N +      P     LR L
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL----LRRL 66

Query: 113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG 172
           + L ++NN +         +L +L EL L +N L      ++  L SL  L+ +      
Sbjct: 67  KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCIL-RN 123

Query: 173 PI-------PSTLFRLTNLERL 187
           P+          ++++  +  L
Sbjct: 124 PVTNKKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.0 bits (125), Expect = 7e-08
 Identities = 19/105 (18%), Positives = 38/105 (36%), Gaps = 5/105 (4%)

Query: 259 LDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF 318
           + L+   I      + +     + L+L    +   I      L    ++D S N++    
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57

Query: 319 PTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
             G      L+ L +N+N +          +  L  L L++N+L 
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 28/162 (17%), Positives = 52/162 (32%), Gaps = 41/162 (25%)

Query: 132 SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGC 191
           +     EL LR  K+       I NL +                     L   + +    
Sbjct: 17  NAVRDRELDLRGYKIP-----VIENLGAT--------------------LDQFDAIDFSD 51

Query: 192 NQFNGTIPR--EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE 249
           N+    I +      L+ L  L +  N++          L  L  L L+ N L     L+
Sbjct: 52  NE----IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD 107

Query: 250 -IGNFSALAELDLSDNKI------RGIIPDELSKLSNLQYLN 284
            + +  +L  L +  N +      R  +   + K+  ++ L+
Sbjct: 108 PLASLKSLTYLCILRNPVTNKKHYRLYV---IYKVPQVRVLD 146

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 64.0 bits (155), Expect = 4e-11
 Identities = 24/101 (23%), Positives = 36/101 (35%), Gaps = 2/101 (1%)

Query: 215 TNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKIRGIIPDE 273
           T          L    +L  L +   Q    + L  +     L  L +  + +R + PD 
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKL 314
                 L  LNLS N L   + +   +  +L  L LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.8 bits (144), Expect = 1e-09
 Identities = 25/105 (23%), Positives = 42/105 (40%), Gaps = 5/105 (4%)

Query: 45  VECSIKGELGSL-NFSCFPNLQYLNLWNNNLSGSIPPQ-IGSLSNLKYLNLRWNNLTGTI 102
           + C+  G L SL +     NL  L + N      +  + +  L  L+ L +  + L   +
Sbjct: 13  LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71

Query: 103 PKEIGS-LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL 146
             +       L  L LS N+L  +   +     +L+EL L  N L
Sbjct: 72  APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 1e-09
 Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 2/93 (2%)

Query: 197 TIPREIGNLKNLTHLSIITNKLTGAIPS-TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSA 255
                +   +NLT L I   +    +    L  L  L  L +  + L    P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
           L+ L+LS N +  +    +  LS LQ L LS N
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLS-LQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.2 bits (140), Expect = 4e-09
 Identities = 18/99 (18%), Positives = 28/99 (28%), Gaps = 2/99 (2%)

Query: 71  NNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE-IGSLRNLEVLYLSNNSLHGTTPIE 129
             + +      +    NL  L +        +    +  L  L  L +  + L    P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 130 IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
                 L  L L  N L   L  +     SL  L +  N
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 23/101 (22%), Positives = 36/101 (35%), Gaps = 2/101 (1%)

Query: 240 NQLHSFIPLEIGNFSALAELDLSDNK-IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI 298
                     +     L EL + + + ++ +   +L  L  L+ L +  + L    P A 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 299 GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD 339
                L  L+LS N L  S          LQ L L+ N L 
Sbjct: 77  HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 26/95 (27%), Positives = 37/95 (38%), Gaps = 2/95 (2%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPRE-IGNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
               L    NL  L++   Q    +    +  L  L +L+I+ + L    P        L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIR 267
             L+LSFN L S     +   S L EL LS N + 
Sbjct: 83  SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 7e-08
 Identities = 18/96 (18%), Positives = 33/96 (34%), Gaps = 2/96 (2%)

Query: 101 TIPKEIGSLRNLEVLYLS-NNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKS 159
                +    NL  LY+     L      ++  L  L  L +  + L  V P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 160 LIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN 195
           L  L++ +N +   +     +  +L+ L L  N  +
Sbjct: 82  LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 4e-07
 Identities = 16/91 (17%), Positives = 31/91 (34%), Gaps = 3/91 (3%)

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTG-IGNCTELQHLALNHNSLDGTIPPE 345
           +   +      +    NL  L +   +         +    EL++L +  + L   + P+
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 346 IGKIL-LLQNLDLSHNNLSGTIPMTLHPMFL 375
                  L  L+LS N L      T+  + L
Sbjct: 75  AFHFTPRLSRLNLSFNALESLSWKTVQGLSL 105

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 2e-06
 Identities = 17/67 (25%), Positives = 27/67 (40%), Gaps = 3/67 (4%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGS-LSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY 116
                 L+ L +  + L   + P        L  LNL +N L  ++  +     +L+ L 
Sbjct: 52  LRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109

Query: 117 LSNNSLH 123
           LS N LH
Sbjct: 110 LSGNPLH 116

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 14/180 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           +DF +   IG G Y  V    L    ++ A+K + +    D   ++  Q E  V      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 508 HRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI-VKSVAHAL 565
           H  +V L   F    R +FF+ EY+  G L + ++   +  E             ++ AL
Sbjct: 69  HPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLAL 123

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAP 624
           +YLH      I++RD+  +N+LL+S     + D+G  +  L    +  T   GT  YIAP
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAP 179

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.4 bits (155), Expect = 6e-11
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 18/182 (9%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVA---LKKLHQSETEDSAFVESFQNEARVLST 505
            DF+    +G G +G V  +E     ++ A   LKK    + +D   VE    E RVL+ 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMVEKRVLAL 76

Query: 506 V-RHRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
             +   + +L   F    R ++F+ EY+  G L Y ++      E      V     +A 
Sbjct: 77  PGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAI 132

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYI 622
            L +L       I++RD+  +N++L+S     +ADFG  +  +    + +T   GT  YI
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTPDYI 188

Query: 623 AP 624
           AP
Sbjct: 189 AP 190

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV-R 507
           +DF +   IG G Y  V    L    ++ A++ + +    D   ++  Q E  V      
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 508 HRNIVKL-YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKS-VAHAL 565
           H  +V L   F    R +FF+ EY+  G L + ++   +  E           + ++ AL
Sbjct: 112 HPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLAL 166

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL-LHVDSSNRTLRAGTYGYIAP 624
           +YLH      I++RD+  +N+LL+S     + D+G  +  L    +  T   GT  YIAP
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAP 222

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 4e-10
 Identities = 94/649 (14%), Positives = 170/649 (26%), Gaps = 230/649 (35%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN------LTGTIPKEIGSLRNLEVLY 116
            + Y  L +   +    P + +   ++  +  +N+         +  +    LR    L 
Sbjct: 88  RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ--ALL 145

Query: 117 -LSNNS---LHG------TTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM 166
            L       + G      T          +      S K+   +  +I       WL++ 
Sbjct: 146 ELRPAKNVLIDGVLGSGKTW---------VALDVCLSYKVQCKMDFKI------FWLNL- 189

Query: 167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTH-LSIITNKLTGAIPST 225
                    S    L  L++L     Q +        +  N+   +  I  +L   + S 
Sbjct: 190 -----KNCNSPETVLEMLQKL---LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 226 LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNL 285
             +   LL L                        ++ + K                  NL
Sbjct: 242 P-YENCLLVLL-----------------------NVQNAKA-------------WNAFNL 264

Query: 286 SSNLLSGQIPFAIGKLFNLVSLDLS-KNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP 344
           S  +L             L +      + LS +  T         H++L+H+S     P 
Sbjct: 265 SCKIL-------------LTTRFKQVTDFLSAATTT---------HISLDHHS-MTLTPD 301

Query: 345 EIGKILLLQNLDLSHNNLS----GTIPMTL---------HP---------------MFLD 376
           E  K LLL+ LD    +L      T P  L                            ++
Sbjct: 302 E-VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 377 MSFNNLEGEIPTYLRDNPPNSFVGNKGLCGHVQVLAFTIFGFILLLKGKSENLKL---VT 433
            S N LE   P   R      F               ++F           +  +   + 
Sbjct: 361 SSLNVLE---PAEYRKM----FD------------RLSVF---------PPSAHIPTILL 392

Query: 434 GGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFV 493
                 ++  D++      H    +      S     +P    + L+   + E       
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPS---IYLELKVKLE------- 440

Query: 494 ESFQNEARVLSTVRHRNIVKLY----GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIEL 549
               NE  +     HR+IV  Y     F        ++ +Y      FY           
Sbjct: 441 ----NEYAL-----HRSIVDHYNIPKTFDSDDLIPPYLDQY------FY----------- 474

Query: 550 NWTRRVNIVKSVAHALSYL-HHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTARLLHV 607
                           S++ HH        R      + L+   LE  +    TA     
Sbjct: 475 ----------------SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASG 518

Query: 608 DSSNRTLRAGTY-GYIAPDQRLSPPVNQKIIQDII-LVSTTALACLRSK 654
              N   +   Y  YI  +     P  ++++  I+  +       + SK
Sbjct: 519 SILNTLQQLKFYKPYICDND----PKYERLVNAILDFLPKIEENLICSK 563

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 2e-06
 Identities = 65/392 (16%), Positives = 115/392 (29%), Gaps = 133/392 (33%)

Query: 9   LNCGWWKDRI-------PHNTS----DH-CN-WV----GITC------------DYKGSI 39
           L     +  +       P+        +  N        ++C            D+  + 
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284

Query: 40  --THIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQ-----------IGSLS 86
             THI L          S+  +       L  + +     +P +           I    
Sbjct: 285 TTTHISLDH-------HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES- 336

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN-- 144
            ++     W+N                  +++ + L  TT IE  SL  LE    R    
Sbjct: 337 -IRDGLATWDNW----------------KHVNCDKL--TTIIES-SLNVLEPAEYRKMFD 376

Query: 145 KLSGVLPQEI---GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT--IP 199
           +LS V P        L SLIW  V+ + V   + + L + + +E+          T  IP
Sbjct: 377 RLS-VFPPSAHIPTILLSLIWFDVIKSDVM-VVVNKLHKYSLVEK-----QPKESTISIP 429

Query: 200 -------REIGNLKNLTHLSIIT---------------NKLTGAIPSTLG-HLT------ 230
                   ++ N   L H SI+                  L     S +G HL       
Sbjct: 430 SIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488

Query: 231 -----SLLYLDLSF--NQL-HSFIPLEI--GNFSALAELDLSDNKIRGIIPDELSKLSNL 280
                 +++LD  F   ++ H            + L +L      I    P     ++ +
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI 548

Query: 281 -QYL-NLSSNLLSGQIPFAIGKLFNLVSLDLS 310
             +L  +  NL+         K  +L+ + L 
Sbjct: 549 LDFLPKIEENLI-------CSKYTDLLRIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 2e-05
 Identities = 74/521 (14%), Positives = 151/521 (28%), Gaps = 135/521 (25%)

Query: 234 YLDLSFNQLH----SFIPLEIGNFSALAELDLSDNKIRGIIPDEL-SKLSNLQYLNLSSN 288
           ++D    +        + +    F  +   D  D      + D   S LS  +      +
Sbjct: 6   HMDFETGEHQYQYKDILSVFEDAF--VDNFDCKD------VQDMPKSILSKEEI----DH 53

Query: 289 LLSGQIPFAIGKLFNLVSLDLSKNK-LSGSFPTGIGNCTELQHLALNHNSLDGTIPPE-I 346
           ++      A+     L    LSK + +   F   +        L +N+  L   I  E  
Sbjct: 54  II--MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV--------LRINYKFLMSPIKTEQR 103

Query: 347 GKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLE--GEIPTYLRDNPPNSFV---GN 401
              ++ +      + L     +     F   + + L+   ++   L +  P   V   G 
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQV-----FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158

Query: 402 KGLCGHVQVLAFTIFGFILLLKGKSENLKLVTGGYDGKILY---------EDLINATEDF 452
            G  G    +A      + +          V    D KI +         E ++   +  
Sbjct: 159 LG-SGK-TWVA------LDVCLSYK-----VQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205

Query: 453 HIR----YCIGTGGYGSVYKAELPDGKVVALKKLHQSET-----------EDSAFVESFQ 497
             +    +      + S  K  +   +   L++L +S+            +++    +F 
Sbjct: 206 LYQIDPNWTSR-SDHSSNIKLRIHSIQA-ELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263

Query: 498 NEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI 557
              ++L T R + +               I       +L       DE   L        
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTH----ISLDHHSMTL-----TPDEVKSL-------- 306

Query: 558 VKSVAHALSYLHHDCT--PSIVHRDISSNNILLNSNLEAFVADFGTAR---LLHVDSS-- 610
                  L YL       P    R++ + N    S +   + D   A      HV+    
Sbjct: 307 ------LLKYLDCRPQDLP----REVLTTNPRRLSIIAESIRDG-LATWDNWKHVNCDKL 355

Query: 611 NRTLRAGTYGYIAPDQRLSPPVNQK------IIQDIILVSTTALACLRSKPKSRPTMQRI 664
              + +           L P   +K      +      + T  L+ +         M  +
Sbjct: 356 TTIIESSL-------NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV-V 407

Query: 665 SQELEGKTPMKKGLKEISIS--------EMRNQEMFWLHES 697
             +L   + ++K  KE +IS        +++ +  + LH S
Sbjct: 408 VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 43/232 (18%), Positives = 78/232 (33%), Gaps = 72/232 (31%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           +   +   +G G +G V +A+          + VA+K L   E    +   +  +E ++L
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79

Query: 504 STV-RHRNIVKLYGFC----------------------LHKRCMFFIYEYMERGSLFYVL 540
             +  H N+V L G C                      L  +   F+  Y  +G+ F   
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV-PYKTKGARFRQG 138

Query: 541 RDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS------------------------- 575
           +D   AI ++  RR++ + S   + S    +                             
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198

Query: 576 ---------------IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR 612
                           +HRD+++ NILL+      + DFG AR ++ D    
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 41/208 (19%), Positives = 65/208 (31%), Gaps = 28/208 (13%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRW-N 96
            + H++L    I+        S    LQ L+L    LS  I   +   SNL  LNL   +
Sbjct: 94  RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153

Query: 97  NLTGTIPKEIGS-LRNLEVLYLSNNSLHGTTPIEI---GSLRNLEELYLRSNKLSGVLPQ 152
             +    + + S    L+ L LS         +++        + +L L          +
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG------YRK 207

Query: 153 EIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFL-GCNQFNGTIPREIGNLKNLTHL 211
            +     L  L                R  NL  L L           +E   L  L HL
Sbjct: 208 NLQK-SDLSTLV--------------RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252

Query: 212 SII-TNKLTGAIPSTLGHLTSLLYLDLS 238
           S+     +       LG + +L  L + 
Sbjct: 253 SLSRCYDIIPETLLELGEIPTLKTLQVF 280

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 51/239 (21%), Positives = 97/239 (40%), Gaps = 12/239 (5%)

Query: 103 PKEIGSLRNLEVLYLSNNSLHGTTPI-EIGSLRNLEELYLRSNKLS-GVLPQEIGNLKSL 160
           P   G L +  V+           P+ E  S   ++ + L ++ +    L   +     L
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 161 IWLSVMYNTVGGPIPSTLFRLTNLERLFL-GCNQFNGTIPREIG-NLKNLTHLSII-TNK 217
             LS+    +  PI +TL + +NL RL L GC+ F+    + +  +   L  L++     
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180

Query: 218 LT-GAIPSTLGHLTSLL-YLDLSFNQLH---SFIPLEIGNFSALAELDLSD-NKIRGIIP 271
            T   +   + H++  +  L+LS  + +   S +   +     L  LDLSD   ++    
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 240

Query: 272 DELSKLSNLQYLNLSS-NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQ 329
            E  +L+ LQ+L+LS    +  +    +G++  L +L +      G+          LQ
Sbjct: 241 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 44/200 (22%), Positives = 74/200 (37%), Gaps = 19/200 (9%)

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIP-REIGNLKNLTHLSIITNKLT-GAIPSTLGHLTSL 232
           P    RL +   +   C +     P  E  +   + H+ +  + +    +   L   + L
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLS------DNKIRGIIPDELSKLSNLQYLNLS 286
             L L   +L   I   +   S L  L+LS      +  ++ +    LS  S L  LNLS
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL----LSSCSRLDELNLS 176

Query: 287 --SNLLSGQIPFAIGKLF-NLVSLDLSK--NKLSGSFPTGIG-NCTELQHLALNH-NSLD 339
              +     +  A+  +   +  L+LS     L  S  + +   C  L HL L+    L 
Sbjct: 177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 236

Query: 340 GTIPPEIGKILLLQNLDLSH 359
                E  ++  LQ+L LS 
Sbjct: 237 NDCFQEFFQLNYLQHLSLSR 256

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 60.4 bits (145), Expect = 7e-10
 Identities = 25/172 (14%), Positives = 64/172 (37%), Gaps = 19/172 (11%)

Query: 157 LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG--NLKNLTHLSI- 213
           L ++  L+ +       +        NL+ L +       ++  +I   +L NL  L + 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 214 --ITNKLTGAIPSTL------GHLTSLLYLDLSFNQLHSFIPLEIGNFSALA---ELDLS 262
             + +       +            +L +L +   +  + +         L     +D+S
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 263 DNKIRG----IIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
              +      ++ D + K+ +L+++N+  N LS ++   + K    + +D+S
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP-MKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 55.7 bits (133), Expect = 2e-08
 Identities = 34/219 (15%), Positives = 73/219 (33%), Gaps = 25/219 (11%)

Query: 167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN------LKNLTHLSIITNKLTG 220
            + +   I     +  + E LF G   F       I        L  +  L+ +  K T 
Sbjct: 124 CSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN 183

Query: 221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG--NFSALAELDL---SDNKIRGIIPDELS 275
            +        +L  L++    L   +  +I   +   L +L L    ++       +   
Sbjct: 184 NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243

Query: 276 ------KLSNLQYLNLSSNLLSGQIPFAIGK---LFNLVSLDLSKNKLSGS----FPTGI 322
                 +  NL++L +        +     +   L  L ++D+S   L+          +
Sbjct: 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV 303

Query: 323 GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN 361
                L+ + + +N L   +  E+ K L +  +D+S + 
Sbjct: 304 DKIKHLKFINMKYNYLSDEMKKELQKSLPM-KIDVSDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 54.2 bits (129), Expect = 6e-08
 Identities = 20/118 (16%), Positives = 43/118 (36%), Gaps = 16/118 (13%)

Query: 53  LGSLNFSCFPNLQYLNLW--NNNLSGSIPPQI-------GSLSNLKYLNLRWNNLTGTIP 103
           +  +  S  PNL+ L L+    +        +           NLK+L +        + 
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269

Query: 104 KEIGS---LRNLEVLYLSNNSLHGTTPIEI----GSLRNLEELYLRSNKLSGVLPQEI 154
           +       L  LE + +S   L       +      +++L+ + ++ N LS  + +E+
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.4 bits (127), Expect = 1e-07
 Identities = 32/204 (15%), Positives = 64/204 (31%), Gaps = 36/204 (17%)

Query: 57  NFSCFPNLQYLNLWNNNLS---------GSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG 107
           N   F + + L   + +             + P + ++  L  L ++  N      K   
Sbjct: 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK--- 190

Query: 108 SLRNLEVLYLSNNSLHGTTPIEIGS--LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV 165
              NL+ L + +  L  +   +I    L NLE+L L           ++   + L     
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD- 249

Query: 166 MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN---LKNLTHLSIITNKLTG-- 220
                         R  NL+ L +   +    +         L  L  + I    LT   
Sbjct: 250 --------------RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295

Query: 221 --AIPSTLGHLTSLLYLDLSFNQL 242
              +   +  +  L ++++ +N L
Sbjct: 296 ARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 5e-07
 Identities = 12/84 (14%), Positives = 32/84 (38%), Gaps = 7/84 (8%)

Query: 46  ECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGS---LSNLKYLNLRWNNLTGT- 101
           +  +       +   FPNL++L + +      +         L  L+ +++    LT   
Sbjct: 236 DGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295

Query: 102 ---IPKEIGSLRNLEVLYLSNNSL 122
              +   +  +++L+ + +  N L
Sbjct: 296 ARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 5e-07
 Identities = 33/219 (15%), Positives = 66/219 (30%), Gaps = 24/219 (10%)

Query: 14  WKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL-WNN 72
             D       +   +      + G I   E     I+    S      P L  L +   N
Sbjct: 124 CSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN 183

Query: 73  NLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGS-----LRNLEVLYLSNNSLHGTTP 127
           NLS    P      NLK L +    L  ++ ++I       L  L +     +       
Sbjct: 184 NLSIGKKP----RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239

Query: 128 IEI------GSLRNLEELYLRSNKLSGVLPQEIGN---LKSLIWLSVMYNTVGG----PI 174
                        NL+ L +   +   V+ +       L  L  + +    +       +
Sbjct: 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL 299

Query: 175 PSTLFRLTNLERLFLGCNQFNGTIPREIGN-LKNLTHLS 212
              + ++ +L+ + +  N  +  + +E+   L     +S
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 33/128 (25%), Positives = 50/128 (39%), Gaps = 12/128 (9%)

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAEL---DLSDNKIRGIIPDE 273
            L   IP           L L+ N+L        G F  L  L   +L  N++ GI P+ 
Sbjct: 19  GLK-EIPR--DIPLHTTELLLNDNELGRISS--DGLFGRLPHLVKLELKRNQLTGIEPNA 73

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAI-GKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHL 331
               S++Q L L  N +  +I   +   L  L +L+L  N++S     G   +   L  L
Sbjct: 74  FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSL 131

Query: 332 ALNHNSLD 339
            L  N  +
Sbjct: 132 NLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 35/146 (23%), Positives = 52/146 (35%), Gaps = 37/146 (25%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGTTPIEIG---S 132
            IP  I    +   L L  N L       + G L +L  L L  N L   T IE      
Sbjct: 22  EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL---TGIEPNAFEG 76

Query: 133 LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGC 191
             +++EL L  NK+                           I + +F  L  L+ L L  
Sbjct: 77  ASHIQELQLGENKIKE-------------------------ISNKMFLGLHQLKTLNLYD 111

Query: 192 NQFNGTIPREI-GNLKNLTHLSIITN 216
           NQ +  +      +L +LT L++ +N
Sbjct: 112 NQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 26/89 (29%), Positives = 38/89 (42%), Gaps = 4/89 (4%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVL 115
           F   P+L  L L  N L+  I P      S+++ L L  N +   I  ++   L  L+ L
Sbjct: 50  FGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107

Query: 116 YLSNNSLHGTTPIEIGSLRNLEELYLRSN 144
            L +N +    P     L +L  L L SN
Sbjct: 108 NLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 32/137 (23%), Positives = 44/137 (32%), Gaps = 35/137 (25%)

Query: 65  QYLNLWNNNLSGSIPPQ--IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
             L L +N L   I      G L +L  L L+ N LTG  P       +++ L L  N +
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90

Query: 123 HGTTPIEIG---SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF 179
                I       L  L+ L L  N++                           +    F
Sbjct: 91  ---KEISNKMFLGLHQLKTLNLYDNQI-----------SC--------------VMPGSF 122

Query: 180 -RLTNLERLFLGCNQFN 195
             L +L  L L  N FN
Sbjct: 123 EHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 31/131 (23%), Positives = 56/131 (42%), Gaps = 29/131 (22%)

Query: 113 EVLYLSNNSLHGTTPIEI-GSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG 171
             L L++N L   +   + G L +L +L L+ N+L+G                       
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG----------------------- 68

Query: 172 GPIPSTLF-RLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHL 229
             I    F   ++++ L LG N+    I  ++   L  L  L++  N+++  +P +  HL
Sbjct: 69  --IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125

Query: 230 TSLLYLDLSFN 240
            SL  L+L+ N
Sbjct: 126 NSLTSLNLASN 136

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.0 bits (138), Expect = 8e-10
 Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)

Query: 204 NLKNLTHLSIITNKLT-GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS 262
              ++  L +  ++   G +         L +L      L S   L     + L +L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP--KLNKLKKLELS 72

Query: 263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSG-QIPFAIGKLFNLVSLDLSKN 312
           DN++ G +     K  NL +LNLS N +        + KL NL SLDL   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 35/124 (28%), Positives = 49/124 (39%), Gaps = 8/124 (6%)

Query: 214 ITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE 273
           I  +L    PS +  L     LD S +       L    F  L  L   +  +  I    
Sbjct: 7   IHLELRNRTPSDVKEL----VLDNSRSNEGKLEGL-TDEFEELEFLSTINVGLTSI--AN 59

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG-SFPTGIGNCTELQHLA 332
           L KL+ L+ L LS N +SG +     K  NL  L+LS NK+   S    +     L+ L 
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 333 LNHN 336
           L + 
Sbjct: 120 LFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 31/120 (25%), Positives = 49/120 (40%), Gaps = 8/120 (6%)

Query: 49  IKGELGSLNFSCFPNLQYLNLWNN-NLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG 107
           I  EL +   S   +++ L L N+ +  G +         L++L+     LT +I   + 
Sbjct: 7   IHLELRNRTPS---DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLP 61

Query: 108 SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMY 167
            L  L+ L LS+N + G   +      NL  L L  NK+       I  LK L  L  + 
Sbjct: 62  KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLD 119

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.9 bits (117), Expect = 5e-07
 Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 1/65 (1%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG-TIPKEIGSLRNLEVL 115
           N      L+ L L +N +SG +        NL +LNL  N +   +  + +  L NL+ L
Sbjct: 59  NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118

Query: 116 YLSNN 120
            L N 
Sbjct: 119 DLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 18/113 (15%), Positives = 40/113 (35%), Gaps = 27/113 (23%)

Query: 252 NFSALAELDLSDNKIRGI-IPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
             S + EL L +++     +     +   L++L+  +  L+                   
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------- 55

Query: 311 KNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS 363
              ++      +    +L+ L L+ N + G +     K   L +L+LS N + 
Sbjct: 56  --SIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 5e-05
 Identities = 29/142 (20%), Positives = 51/142 (35%), Gaps = 20/142 (14%)

Query: 152 QEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL---KNL 208
           +   ++K L+  +   N   G +         LE L              I NL     L
Sbjct: 14  RTPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKL 66

Query: 209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKI- 266
             L +  N+++G +        +L +L+LS N++     +E +     L  LDL + ++ 
Sbjct: 67  KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

Query: 267 -----RGIIPDELSKLSNLQYL 283
                R  +      L  L YL
Sbjct: 127 NLNDYRENV---FKLLPQLTYL 145

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 40/145 (27%), Positives = 54/145 (37%), Gaps = 36/145 (24%)

Query: 77  SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SL 133
           S+P  I S  +   L L  N L          L  L  L LS N +     +  G    L
Sbjct: 21  SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI---QSLPDGVFDKL 75

Query: 134 RNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCN 192
             L  LYL  NK           L+SL              P+ +F +LT L+ L L  N
Sbjct: 76  TKLTILYLHENK-----------LQSL--------------PNGVFDKLTQLKELALDTN 110

Query: 193 QFNGTIPREI-GNLKNLTHLSIITN 216
           Q   ++P  I   L +L  + + TN
Sbjct: 111 QLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 55.3 bits (134), Expect = 4e-09
 Identities = 42/124 (33%), Positives = 57/124 (45%), Gaps = 11/124 (8%)

Query: 217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSDNKIRGIIPDE 273
            LT ++P+  G  +S   L+L  N+L S   L  G F   + L +L LS N+I+ +    
Sbjct: 18  GLT-SVPT--GIPSSATRLELESNKLQS---LPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71

Query: 274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLA 332
             KL+ L  L L  N L         KL  L  L L  N+L  S P GI    T LQ + 
Sbjct: 72  FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIW 130

Query: 333 LNHN 336
           L+ N
Sbjct: 131 LHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 29/81 (35%), Positives = 41/81 (50%), Gaps = 2/81 (2%)

Query: 259 LDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF 318
           L+L  NK++ +      KL+ L  L+LS N +         KL  L  L L +NKL  S 
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SL 91

Query: 319 PTGI-GNCTELQHLALNHNSL 338
           P G+    T+L+ LAL+ N L
Sbjct: 92  PNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 4/89 (4%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVL 115
           F     L  L+L  N +  S+P  +   L+ L  L L  N L  ++P  +   L  L+ L
Sbjct: 48  FDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKEL 105

Query: 116 YLSNNSLHGTTPIEIGSLRNLEELYLRSN 144
            L  N L          L +L++++L +N
Sbjct: 106 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.0 bits (115), Expect = 1e-06
 Identities = 31/88 (35%), Positives = 40/88 (45%), Gaps = 6/88 (6%)

Query: 174 IPSTLF-RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS-TLGHLTS 231
           +P  +F +LT L +L L  NQ           L  LT L +  NKL  ++P+     LT 
Sbjct: 43  LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQ 101

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAEL 259
           L  L L  NQL S +P   G F  L  L
Sbjct: 102 LKELALDTNQLKS-VPD--GIFDRLTSL 126

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.1 bits (110), Expect = 7e-06
 Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 13/119 (10%)

Query: 278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHN 336
           S+   L L SN L         KL  L  L LS+N++  S P G+    T+L  L L+ N
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86

Query: 337 SLDGTIPPEI-GKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNP 394
            L  ++P  +  K+  L+ L L  N L  ++P        D  F+ L      +L  NP
Sbjct: 87  KLQ-SLPNGVFDKLTQLKELALDTNQLK-SVP--------DGIFDRLTSLQKIWLHTNP 135

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 35/191 (18%), Positives = 74/191 (38%), Gaps = 37/191 (19%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
              +D+ +   +G G Y  V++A  + + + V +K L     +          E ++L  
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIK-----REIKILEN 86

Query: 506 VR-HRNIVKLYGFCLHKRCMF---FIYEYMERG---SLFYVLRDDDEAIELNWTRRVNIV 558
           +R   NI+ L    +          ++E++       L+  L D D             +
Sbjct: 87  LRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-------------I 132

Query: 559 KSVAH----ALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSNRT 613
           +   +    AL Y H   +  I+HRD+  +N++++  + +  + D+G A   H       
Sbjct: 133 RFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YN 188

Query: 614 LRAGTYGYIAP 624
           +R  +  +  P
Sbjct: 189 VRVASRYFKGP 199

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 47/235 (20%), Positives = 85/235 (36%), Gaps = 35/235 (14%)

Query: 450 EDFHIRYCI----GTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLS 504
           + F+ RY +    G G + +V+ +  +   K VA+K +         + E+  +E R+L 
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLK 88

Query: 505 TVR--------HRNIVKLYG-FCL------HKRCMFFIYEYMERGSLFYVLRD-DDEAIE 548
           +VR           +V+L   F +      H  CM  ++E +    L   +   + + + 
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTH-ICM--VFEVL-GHHLLKWIIKSNYQGLP 144

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           L   ++  I++ V   L YLH  C   I+H DI   NILL+ N +        A      
Sbjct: 145 LPCVKK--IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTT--ALACLRSKPKSRPTM 661
            +     +      A          +    + + V       AC   K  +    
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 50/216 (23%)

Query: 434 GGYDGKILYEDLINATEDFHIRYCI----GTGGYGSVYKAE-LPDGKVVALKKLHQSETE 488
           GGY      E   +A      RY +    G G + +V+ A+ + +   VA+K +      
Sbjct: 5   GGYHPAFKGEPYKDA------RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV----RG 54

Query: 489 DSAFVESFQNEARVLSTVR-----------HRNIVKLYGFCLHKR------CMFFIYEYM 531
           D  + E+ ++E ++L  V              +I+KL     HK        M F  E +
Sbjct: 55  DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF--EVL 112

Query: 532 ERGSLFYVLRD-DDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS 590
              +L  +++  +   I L + ++  I K +   L Y+H  C   I+H DI   N+L+  
Sbjct: 113 -GENLLALIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEI 167

Query: 591 NLEAF------VADFGTARLLHVDSSN----RTLRA 616
                      +AD G A       +N    R  R+
Sbjct: 168 VDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 203

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 24/162 (14%)

Query: 455 RY----CIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           RY     IG G +G V KA      + VALK +   +     F      E R+L  +R +
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153

Query: 510 ------NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD-DDEAIELNWTRRVNIVKSVA 562
                 N++ +      +  +   +E +   +L+ +++    +   L   R+     S+ 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSIL 210

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAF--VADFGTA 602
             L  LH      I+H D+   NILL     +   V DFG++
Sbjct: 211 QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 37/135 (27%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRS 143
           +   +N +   L  ++P  I +  + + L+L+NN +   T +E G    L NL++LY  S
Sbjct: 13  DQTLVNCQNIRLA-SVPAGIPT--DKQRLWLNNNQI---TKLEPGVFDHLVNLQQLYFNS 66

Query: 144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREI 202
           NK           L ++              P+ +F +LT L +L L  N    +IPR  
Sbjct: 67  NK-----------LTAI--------------PTGVFDKLTQLTQLDLNDNHLK-SIPRGA 100

Query: 203 -GNLKNLTHLSIITN 216
             NLK+LTH+ +  N
Sbjct: 101 FDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 29/80 (36%), Positives = 38/80 (47%), Gaps = 2/80 (2%)

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
            L L++N+I  + P     L NLQ L  +SN L+        KL  L  LDL+ N L  S
Sbjct: 37  RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK-S 95

Query: 318 FPTGI-GNCTELQHLALNHN 336
            P G   N   L H+ L +N
Sbjct: 96  IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 12/88 (13%)

Query: 63  NLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNN 120
           + Q L L NN ++  + P +   L NL+ L    N LT  IP  +   L  L  L L++N
Sbjct: 34  DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91

Query: 121 SL----HGTTPIEIGSLRNLEELYLRSN 144
            L     G       +L++L  +YL +N
Sbjct: 92  HLKSIPRGA----FDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.2 bits (100), Expect = 1e-04
 Identities = 23/85 (27%), Positives = 41/85 (48%), Gaps = 6/85 (7%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSD 263
           +   L +  N++T   P    HL +L  L  + N+L +   +  G F   + L +LDL+D
Sbjct: 34  DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA---IPTGVFDKLTQLTQLDLND 90

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSN 288
           N ++ I       L +L ++ L +N
Sbjct: 91  NHLKSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 22/62 (35%), Positives = 33/62 (53%), Gaps = 2/62 (3%)

Query: 278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHN 336
           ++ Q L L++N ++   P     L NL  L  + NKL+ + PTG+    T+L  L LN N
Sbjct: 33  TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91

Query: 337 SL 338
            L
Sbjct: 92  HL 93

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 47/284 (16%), Positives = 92/284 (32%), Gaps = 36/284 (12%)

Query: 38  SITHIELVECSIKGE----LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGS-LSNLKYLN 92
           S+  + L    +       + ++  S    L  +NL +  L  +    +       + L 
Sbjct: 73  SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132

Query: 93  LRWNNLTGTIPKEIGSL-----RNLEVLYLSNNSLHGTTPIEIGSL----RNLEELYLRS 143
           L+ N+L     K++  L       +  L LSNN L       +        ++  L L  
Sbjct: 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLH 192

Query: 144 NKLS--GV--LPQEIGNLKSLIWLSVMYNTVGGP----IPSTLFRLTNLERLFLGCNQFN 195
             L   G+  L  ++   + L  L+V YN  G      +        +LE L L  N+ +
Sbjct: 193 TGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

Query: 196 GT----IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG 251
                 +    G  +    + +   + T         L+ +         L+S+    + 
Sbjct: 253 SEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQ------RNLNSWDRARVQ 306

Query: 252 NFSALAELDLSDNKIRGIIPDELSKL----SNLQYLNLSSNLLS 291
               L   DL D++   + P   ++L      ++ L        
Sbjct: 307 RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 36/186 (19%), Positives = 66/186 (35%), Gaps = 31/186 (16%)

Query: 205 LKNLTHLSIITNKLTG----AIPSTLGHLTSLL-YLDLSFNQL-----HSFIPLEIGNFS 254
           L +L  L++   ++T      + + LG     L  ++L+  QL      + +P+    F 
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV----FL 126

Query: 255 ALAELDLSDNKIR----GIIPDEL-SKLSNLQYLNLSSNLLSGQ----IPFAIGKLFNLV 305
              +L L  N +       + D L      +  L LS+N L+      +   +    ++ 
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186

Query: 306 SLDLSKNKLS----GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILL----LQNLDL 357
            L L    L           +    +LQ L + +N    T    + +       L+ L L
Sbjct: 187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246

Query: 358 SHNNLS 363
             N LS
Sbjct: 247 YFNELS 252

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 48/286 (16%), Positives = 92/286 (32%), Gaps = 39/286 (13%)

Query: 85  LSNLKYLNLRWNNLTGTIPKEIG-----SLRNLEVLYLSNNSL--HGTTPIEIGSLRNLE 137
           LS+L+ LNL    +T      +          L+ + L++  L   G   + +       
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL-LPVFLRAR 129

Query: 138 ELYLRSNKLSGVLPQEIG-----NLKSLIWLSVMYNTVGGP----IPSTLFRLTNLERLF 188
           +L L+ N L     +++      +   +  L +  N +       +   L   T++  L 
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLS 189

Query: 189 LGCNQFNGT----IPREIGNLKNLTHLSIITNKLTG----AIPSTLGHLTSLLYLDLSFN 240
           L            +  ++   + L  L++  N        A+        SL  L L FN
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249

Query: 241 QLHS----FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
           +L S     +    G     A + +S  +   +       LS +Q    S +    Q   
Sbjct: 250 ELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQ--- 306

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNC----TELQHLALNHNSL 338
              +   L+  DL  ++ +   P           E++ L     S 
Sbjct: 307 ---RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.5 bits (119), Expect = 4e-07
 Identities = 37/135 (27%), Positives = 59/135 (43%), Gaps = 37/135 (27%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---SLRNLEELYLRS 143
           +   ++    +L  ++P  I +    +VLYL +N +   T +E G    L  L  L L +
Sbjct: 10  SGTTVDCSGKSLA-SVPTGIPT--TTQVLYLYDNQI---TKLEPGVFDRLTQLTRLDLDN 63

Query: 144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF-RLTNLERLFLGCNQFNGTIPREI 202
           N+           L  L              P+ +F +LT L +L L  NQ   +IPR  
Sbjct: 64  NQ-----------LTVL--------------PAGVFDKLTQLTQLSLNDNQLK-SIPRGA 97

Query: 203 -GNLKNLTHLSIITN 216
             NLK+LTH+ ++ N
Sbjct: 98  FDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 27/80 (33%), Positives = 38/80 (47%), Gaps = 2/80 (2%)

Query: 258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS 317
            L L DN+I  + P    +L+ L  L+L +N L+        KL  L  L L+ N+L  S
Sbjct: 34  VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK-S 92

Query: 318 FPTGI-GNCTELQHLALNHN 336
            P G   N   L H+ L +N
Sbjct: 93  IPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 24/88 (27%), Positives = 42/88 (47%), Gaps = 12/88 (13%)

Query: 63  NLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNN 120
             Q L L++N ++  + P +   L+ L  L+L  N LT  +P  +   L  L  L L++N
Sbjct: 31  TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 121 SL----HGTTPIEIGSLRNLEELYLRSN 144
            L     G       +L++L  ++L +N
Sbjct: 89  QLKSIPRGA----FDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.4 bits (103), Expect = 5e-05
 Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 6/85 (7%)

Query: 207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSD 263
               L +  N++T   P     LT L  LDL  NQL     L  G F   + L +L L+D
Sbjct: 31  TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV---LPAGVFDKLTQLTQLSLND 87

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSN 288
           N+++ I       L +L ++ L +N
Sbjct: 88  NQLKSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 21/62 (33%), Positives = 30/62 (48%), Gaps = 2/62 (3%)

Query: 278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHN 336
           +  Q L L  N ++   P    +L  L  LDL  N+L+   P G+    T+L  L+LN N
Sbjct: 30  TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 337 SL 338
            L
Sbjct: 89  QL 90

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR- 509
           + I   IG G +G V KA    + + VA+K +   +    AF+   Q E R+L  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHD 111

Query: 510 -----NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEA-IELNWTRRVNIVKSVAH 563
                 IV L    + +  +  ++E +   +L+ +LR+ +   + LN TR+    + +  
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCT 168

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF--VADFGTA 602
           AL +L      SI+H D+   NILL +   +   + DFG++
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 6/126 (4%)

Query: 228 HLTSLLYLDLSFNQLHSFIP-LEI--GNFSALAELDLSDNKIRGI--IPDELSKLSNLQY 282
                  +D+  N+       L I   N   L  L+LS+N++  +  +   + K  NL+ 
Sbjct: 141 PDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 200

Query: 283 LNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT- 341
           LNLS N L  +      K   L  L L  N L  +F       + ++        LDG  
Sbjct: 201 LNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDGHE 260

Query: 342 IPPEIG 347
           +PP I 
Sbjct: 261 LPPPIA 266

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 9/90 (10%)

Query: 204 NLKNLTHLSIITNKLTG--AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           N+  L  L++  N+L     + S +    +L  L+LS N+L S   L+      L EL L
Sbjct: 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 227

Query: 262 SDNKIRGIIPDE-------LSKLSNLQYLN 284
             N +     D+         +   L  L+
Sbjct: 228 DGNSLCDTFRDQSTYISAIRERFPKLLRLD 257

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 30/188 (15%), Positives = 60/188 (31%), Gaps = 34/188 (18%)

Query: 430 KLVTGGYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETED 489
                G     L+  L+ + +   I   +G G   +V+           +K      T  
Sbjct: 71  TFTFIGLSLYSLHR-LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSF 129

Query: 490 SAFVESF---------------QNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERG 534
               E                 +NE R L  ++   + K+Y +  +   M    E ++  
Sbjct: 130 KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLM----ELIDAK 185

Query: 535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 594
            L+ V  ++ + +                 L  +       IVH D+S  N+L++     
Sbjct: 186 ELYRVRVENPDEVL-------------DMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GI 231

Query: 595 FVADFGTA 602
           ++ DF  +
Sbjct: 232 WIIDFPQS 239

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 33/175 (18%), Positives = 66/175 (37%), Gaps = 25/175 (14%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALK--KLHQSETEDSAFVESFQNEARVLSTVRH 508
           F +   +G G +G V   + + + K  A+K  +  +       +  S + EA +L  +++
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK------KYTRSAKIEADILKKIQN 90

Query: 509 R-----NIVKLYGFCLHKR--CMFFIYEYMERGSLFYVLRDDDEA-IELNWTRRVNIVKS 560
                 NIVK +G  ++    C+ F  E +   SL+ ++  ++     +   +       
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIF--EPLGP-SLYEIITRNNYNGFHIEDIKL--YCIE 145

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR 615
           +  AL+YL      S+ H D+   NILL+                         +
Sbjct: 146 ILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 34/161 (21%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLY 515
           IG G +G +++   L + + VA+K     E   S      ++E R    +     I  +Y
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSD-APQLRDEYRTYKLLAGCTGIPNVY 72

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA-------HALSYL 568
            F         + + +   SL  +L         +   R   VK+VA         +  +
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 569 HHDCTPSIVHRDISSNNILL------NSNLEAFVADFGTAR 603
           H     S+V+RDI  +N L+      N+N+  +V DFG  +
Sbjct: 123 H---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 27/151 (17%), Positives = 57/151 (37%), Gaps = 16/151 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLY 515
           IG+G +G +Y    +  G+ VA+K     E   +        E+++   ++    I  + 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTK-HPQLHIESKIYKMMQGGVGIPTIR 71

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
                      + E +   SL  +         L     + +   +   + Y+H     +
Sbjct: 72  WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSK---N 125

Query: 576 IVHRDISSNNILLNSNLEA---FVADFGTAR 603
            +HRD+  +N L+    +    ++ DFG A+
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 28/151 (18%), Positives = 63/151 (41%), Gaps = 16/151 (10%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLY 515
           IG+G +G +Y    +   + VA+K  +  +T+          E+++   ++    I  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHP----QLLYESKIYRILQGGTGIPNVR 69

Query: 516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS 575
            F +       + + +   SL  +       + L     + +   + + + ++H   + S
Sbjct: 70  WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVH---SKS 123

Query: 576 IVHRDISSNNILLNSNLEA---FVADFGTAR 603
            +HRDI  +N L+     A   ++ DFG A+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 31/172 (18%), Positives = 63/172 (36%), Gaps = 23/172 (13%)

Query: 452 FHIRYCIGTGGYGSVYKA--ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           + I   +G G +G V +          VALK +         + E+ + E  VL  ++ +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEK 76

Query: 510 ------NIVKLYGFCLHKR--CMFFIYEYMERGSLFYVLRDDDEA-IELNWTRRVNIVKS 560
                   V +  +       C+ F  E + + + F  L++++     L   R   +   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAF--ELLGK-NTFEFLKENNFQPYPLPHVRH--MAYQ 131

Query: 561 VAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR 612
           + HAL +LH      + H D+   NIL  ++    + +   +       +  
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	701
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.98
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.98
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.98
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.98
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.98
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.98
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.98
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.98
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.88
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.69
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.61
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.39
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.35
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.34
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.1
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.08
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.02
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.72
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.52
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.49
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.1
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.05
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.91
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.79
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.73
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.52
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.52
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.37
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.36
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.36
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.34
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.19
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.04
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.97
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.89
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.87
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.4
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.69
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.1
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.41
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.13

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.1e-51  Score=482.91  Aligned_cols=383  Identities=36%  Similarity=0.545  Sum_probs=240.3

Q ss_pred             HHHHHHHhcCCCCcCCCC-------C-CCCCCCCcceeEeCCCCCEEEEEecccccccc---cCC---------------
Q 041034            2 EIERQALLNCGWWKDRIP-------H-NTSDHCNWVGITCDYKGSITHIELVECSIKGE---LGS---------------   55 (701)
Q Consensus         2 ~~~~~~l~~~~~~~~~~~-------~-~~~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~---~~~---------------   55 (701)
                      ++||+|||+   ||+.+.       | .++|||+|.||+|+ .++|+.|+|+++.+.|.   +++               
T Consensus        11 ~~~~~all~---~k~~~~~~~~l~~W~~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~   86 (768)
T 3rgz_A           11 YREIHQLIS---FKDVLPDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSN   86 (768)
T ss_dssp             HHHHHHHHH---HHTTCSCTTSSTTCCTTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTT
T ss_pred             HHHHHHHHH---HHhhCCCcccccCCCCCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcC
Confidence            689999998   555432       1 36799999999999 79999999999988876   332               


Q ss_pred             -------cccCCCCCCcEEECCCCcceeeCCc--ccCCCCCCCEEECcCCcCcccCCccc-CCCCCCCEEECCCCCCCCC
Q 041034           56 -------LNFSCFPNLQYLNLWNNNLSGSIPP--QIGSLSNLKYLNLRWNNLTGTIPKEI-GSLRNLEVLYLSNNSLHGT  125 (701)
Q Consensus        56 -------~~~~~~~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~  125 (701)
                             ..|..+++|++|+|++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++.
T Consensus        87 ~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  166 (768)
T 3rgz_A           87 SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA  166 (768)
T ss_dssp             SCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEE
T ss_pred             CCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCc
Confidence                   3578889999999999999998888  88888888888888888877766554 4455555555555544433


Q ss_pred             -------------------------------------------------CccccCCccccceeecccccCCCCCcccccC
Q 041034          126 -------------------------------------------------TPIEIGSLRNLEELYLRSNKLSGVLPQEIGN  156 (701)
Q Consensus       126 -------------------------------------------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  156 (701)
                                                                       +|. ++.+++|++|+|++|++++..|..|++
T Consensus       167 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~  245 (768)
T 3rgz_A          167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAIST  245 (768)
T ss_dssp             THHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTT
T ss_pred             CChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhc
Confidence                                                             332 444444444444444444444444444


Q ss_pred             CCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCc-cccCccccccccccCCccccccCCCcccEE
Q 041034          157 LKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL-KNLTHLSIITNKLTGAIPSTLGHLTSLLYL  235 (701)
Q Consensus       157 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  235 (701)
                      +++|++|++++|.+.+.+|..  .+++|++|+|++|++++.+|..+..+ ++|++|+|++|++++.+|..|+.+++|++|
T Consensus       246 l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  323 (768)
T 3rgz_A          246 CTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL  323 (768)
T ss_dssp             CSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEE
T ss_pred             CCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEE
Confidence            444444444444444433332  33444444444455555566666554 777777777777777777777777777777


Q ss_pred             EeccCCCCCCCCcc-cCCCCcccEEEcCCCCCccccCcccCCCC-C--------------------------CcEEEccC
Q 041034          236 DLSFNQLHSFIPLE-IGNFSALAELDLSDNKIRGIIPDELSKLS-N--------------------------LQYLNLSS  287 (701)
Q Consensus       236 ~L~~N~l~~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~-~--------------------------L~~L~L~~  287 (701)
                      +|++|++++.+|.. +..+++|+.|+|++|++++.+|..+..++ +                          |+.|++++
T Consensus       324 ~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~  403 (768)
T 3rgz_A          324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN  403 (768)
T ss_dssp             ECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCS
T ss_pred             ECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCC
Confidence            77777777666654 66666666666666666666665554443 3                          44444444


Q ss_pred             ccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCC
Q 041034          288 NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       288 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      |.+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|++++|+++|.+|
T Consensus       404 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  483 (768)
T 3rgz_A          404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP  483 (768)
T ss_dssp             SEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred             CccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCC
Confidence            44444455555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCccc----cccccccCCCCCcCCCcCC
Q 041034          368 MTLHP----MFLDMSFNNLEGEIPTYLR  391 (701)
Q Consensus       368 ~~~~~----~~l~ls~N~l~g~~p~~~~  391 (701)
                      ..+..    .+|++++|+++|.+|.++.
T Consensus       484 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~  511 (768)
T 3rgz_A          484 SGLSNCTNLNWISLSNNRLTGEIPKWIG  511 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred             HHHhcCCCCCEEEccCCccCCcCChHHh
Confidence            54432    2455555555555555443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.1e-51  Score=480.44  Aligned_cols=372  Identities=39%  Similarity=0.579  Sum_probs=309.7

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcc-cCCCCCCCEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE-IGSLRNLEVL  115 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L  115 (701)
                      ..++.|++.+|.++|.++...+..+++|++|+|++|.+++.+|..|+.+++|++|+|++|.++|.+|.. |.++++|++|
T Consensus       269 ~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L  348 (768)
T 3rgz_A          269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL  348 (768)
T ss_dssp             TTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEE
T ss_pred             CCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEE
Confidence            356666666666666655544444466666666666666666666666666666666666666555544 5566666666


Q ss_pred             ECCCCCCCCCCccccC-------------------------C--ccccceeecccccCCCCCcccccCCCCCcEEEceec
Q 041034          116 YLSNNSLHGTTPIEIG-------------------------S--LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN  168 (701)
Q Consensus       116 ~Ls~N~l~~~~~~~~~-------------------------~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  168 (701)
                      +|++|++++.+|..+.                         .  +++|++|+|++|++++.+|..++++++|+.|++++|
T Consensus       349 ~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N  428 (768)
T 3rgz_A          349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN  428 (768)
T ss_dssp             ECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSS
T ss_pred             eCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCC
Confidence            6666655554444433                         3  556777777777777788888999999999999999


Q ss_pred             ccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCc
Q 041034          169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPL  248 (701)
Q Consensus       169 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  248 (701)
                      .+++.+|..+..+++|+.|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|+|++|++++.+|.
T Consensus       429 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~  508 (768)
T 3rgz_A          429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK  508 (768)
T ss_dssp             EEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred             cccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCCh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCccccc-----------------------------
Q 041034          249 EIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIG-----------------------------  299 (701)
Q Consensus       249 ~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----------------------------  299 (701)
                      +++.+++|+.|+|++|+++|.+|..++.+++|+.|++++|.++|.+|..+.                             
T Consensus       509 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (768)
T 3rgz_A          509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH  588 (768)
T ss_dssp             GGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCC
T ss_pred             HHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccc
Confidence            999999999999999999999999999999999999999999988776442                             


Q ss_pred             -----------------------------------------CccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCcc
Q 041034          300 -----------------------------------------KLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL  338 (701)
Q Consensus       300 -----------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  338 (701)
                                                               .+++|+.|||++|+++|.+|..+++++.|+.|+|++|++
T Consensus       589 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l  668 (768)
T 3rgz_A          589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI  668 (768)
T ss_dssp             SSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCcc
Confidence                                                     356789999999999999999999999999999999999


Q ss_pred             CCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccCCCCCcCCCcC--CCCCCCCcCCCcccccce
Q 041034          339 DGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNNLEGEIPTYL--RDNPPNSFVGNKGLCGHV  408 (701)
Q Consensus       339 ~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~l~g~~p~~~--~~~~~~~~~~~~~~~~~~  408 (701)
                      +|.+|..++.+++|+.|||++|+++|.+|..+..    .++|+|+|+++|.||...  ...+..+|.||+++||.+
T Consensus       669 ~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             CSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             CCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence            9999999999999999999999999999988764    479999999999999764  356677899999999976

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.1e-49  Score=455.42  Aligned_cols=380  Identities=21%  Similarity=0.294  Sum_probs=302.9

Q ss_pred             HHHHHHHhc------CCCCcC---------CCCCCCCCCCCc---ceeEeCCCCCEEEEEecccccccccCCcccCCCCC
Q 041034            2 EIERQALLN------CGWWKD---------RIPHNTSDHCNW---VGITCDYKGSITHIELVECSIKGELGSLNFSCFPN   63 (701)
Q Consensus         2 ~~~~~~l~~------~~~~~~---------~~~~~~~d~c~w---~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~   63 (701)
                      .+||+||.+      +..|+.         .|.. ++|||.|   .||+|+..++|+.|+|++++++|.+++ .++.+++
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~L~~  106 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQLTE  106 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGGCTT
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhcCcc
Confidence            368999975      234551         3543 5799999   999999889999999999999999985 7899999


Q ss_pred             CcEEECCCC-----------------------------------------------------------------------
Q 041034           64 LQYLNLWNN-----------------------------------------------------------------------   72 (701)
Q Consensus        64 L~~L~L~~n-----------------------------------------------------------------------   72 (701)
                      |++|+|++|                                                                       
T Consensus       107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l  186 (636)
T 4eco_A          107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT  186 (636)
T ss_dssp             CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred             ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence            999999988                                                                       


Q ss_pred             -------cceeeCCcccCCCCCCCEEECcCCcCccc-----------------CCcccC--CCCCCCEEECCCCCCCCCC
Q 041034           73 -------NLSGSIPPQIGSLSNLKYLNLRWNNLTGT-----------------IPKEIG--SLRNLEVLYLSNNSLHGTT  126 (701)
Q Consensus        73 -------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~  126 (701)
                             +++| +|+.|+++++|++|+|++|.+++.                 +|+.++  ++++|++|+|++|++.+.+
T Consensus       187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~  265 (636)
T 4eco_A          187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL  265 (636)
T ss_dssp             TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred             hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence                   4556 888999999999999999999986                 899999  9999999999999999999


Q ss_pred             ccccCCccccceeeccccc-CCC-CCcccccCC------CCCcEEEceecccCCCcCc--ccccccccceeEeeecccCC
Q 041034          127 PIEIGSLRNLEELYLRSNK-LSG-VLPQEIGNL------KSLIWLSVMYNTVGGPIPS--TLFRLTNLERLFLGCNQFNG  196 (701)
Q Consensus       127 ~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~  196 (701)
                      |..|+++++|++|+|++|+ +++ .+|..++.+      ++|++|++++|.++ .+|.  .+.++++|++|+|++|+++|
T Consensus       266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g  344 (636)
T 4eco_A          266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEG  344 (636)
T ss_dssp             CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEE
T ss_pred             hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCcc
Confidence            9999999999999999998 998 888888876      89999999999998 7787  89999999999999999998


Q ss_pred             CCCCCCCCccccCccccccccccCCccccccCCCc-ccEEEeccCCCCCCCCcccCCCC--cccEEEcCCCCCccccCcc
Q 041034          197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS-LLYLDLSFNQLHSFIPLEIGNFS--ALAELDLSDNKIRGIIPDE  273 (701)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~  273 (701)
                      .+| .++.+++|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|+.|++++|++++.+|..
T Consensus       345 ~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  421 (636)
T 4eco_A          345 KLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN  421 (636)
T ss_dssp             ECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred             chh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence            888 8888889999999999888 77888888888 888888888888 4777776644  7888888888888888877


Q ss_pred             cC-------CCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCC--------CCCCeeeccCCcc
Q 041034          274 LS-------KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC--------TELQHLALNHNSL  338 (701)
Q Consensus       274 l~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~L~~N~l  338 (701)
                      +.       .+++|+.|+|++|.+++..+..+..+++|+.|+|++|+++ .+|..+...        ++|+.|+|++|++
T Consensus       422 l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l  500 (636)
T 4eco_A          422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKL  500 (636)
T ss_dssp             SCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred             hcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcC
Confidence            77       6777888888888887433334445677777777777776 455433221        2667777777777


Q ss_pred             CCCCCcccc--ccccCCeEEcccccCcccCCCCccc----ccccc------ccCCCCCcCCCcCC
Q 041034          339 DGTIPPEIG--KILLLQNLDLSHNNLSGTIPMTLHP----MFLDM------SFNNLEGEIPTYLR  391 (701)
Q Consensus       339 ~~~~p~~~~--~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~l------s~N~l~g~~p~~~~  391 (701)
                      + .+|..+.  .+++|+.|+|++|++++ +|..+..    ..|++      ++|++.+.+|..+.
T Consensus       501 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~  563 (636)
T 4eco_A          501 T-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT  563 (636)
T ss_dssp             C-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG
T ss_pred             C-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHh
Confidence            6 5666665  66677777777777766 6655432    24555      45666666665543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=6.8e-48  Score=448.11  Aligned_cols=358  Identities=23%  Similarity=0.289  Sum_probs=269.8

Q ss_pred             HHHHHHHhc------CCCCcCCCCCCCCCC--CCc------------ceeEeCCCCCEEEEEecccccccccCCcccCCC
Q 041034            2 EIERQALLN------CGWWKDRIPHNTSDH--CNW------------VGITCDYKGSITHIELVECSIKGELGSLNFSCF   61 (701)
Q Consensus         2 ~~~~~~l~~------~~~~~~~~~~~~~d~--c~w------------~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~   61 (701)
                      .+|++||++      +..|+....+...++  |+|            .||+|+..++|+.|+|+++++.|.+++ .++.+
T Consensus       268 ~~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~-~l~~L  346 (876)
T 4ecn_A          268 IKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD-AIGQL  346 (876)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG-GGGGC
T ss_pred             hHHHHHHHHHHHHcCCCCCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch-HHhcc
Confidence            479999986      123332211111344  999            999999889999999999999999985 68999


Q ss_pred             CCCcEEEC-CCCcceee---------------------------------------------------------------
Q 041034           62 PNLQYLNL-WNNNLSGS---------------------------------------------------------------   77 (701)
Q Consensus        62 ~~L~~L~L-~~n~l~~~---------------------------------------------------------------   77 (701)
                      ++|+.|+| ++|.++|.                                                               
T Consensus       347 ~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~  426 (876)
T 4ecn_A          347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK  426 (876)
T ss_dssp             TTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCC
T ss_pred             ccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchh
Confidence            99999999 77755443                                                               


Q ss_pred             -------------CCcccCCCCCCCEEECcCCcCcc-----------------cCCcccC--CCCCCCEEECCCCCCCCC
Q 041034           78 -------------IPPQIGSLSNLKYLNLRWNNLTG-----------------TIPKEIG--SLRNLEVLYLSNNSLHGT  125 (701)
Q Consensus        78 -------------~~~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~Ls~N~l~~~  125 (701)
                                   +|..|+++++|++|+|++|+|++                 .+|+.++  ++++|++|+|++|++.+.
T Consensus       427 ~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~  506 (876)
T 4ecn_A          427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ  506 (876)
T ss_dssp             TTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCS
T ss_pred             hceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCcc
Confidence                         78889999999999999999998                 3888887  999999999999999999


Q ss_pred             CccccCCccccceeeccccc-CCC-CCcccccCCC-------CCcEEEceecccCCCcCc--ccccccccceeEeeeccc
Q 041034          126 TPIEIGSLRNLEELYLRSNK-LSG-VLPQEIGNLK-------SLIWLSVMYNTVGGPIPS--TLFRLTNLERLFLGCNQF  194 (701)
Q Consensus       126 ~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l  194 (701)
                      +|..|+++++|++|+|++|+ +++ .+|..+++++       +|+.|+|++|.++ .+|.  .+.++++|+.|+|++|++
T Consensus       507 iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l  585 (876)
T 4ecn_A          507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV  585 (876)
T ss_dssp             CCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCC
T ss_pred             ChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCc
Confidence            99999999999999999998 998 7888776665       9999999999998 7888  899999999999999999


Q ss_pred             CCCCCCCCCCccccCccccccccccCCccccccCCCc-ccEEEeccCCCCCCCCcccCCCCc--ccEEEcCCCCCccccC
Q 041034          195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS-LLYLDLSFNQLHSFIPLEIGNFSA--LAELDLSDNKIRGIIP  271 (701)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~--L~~L~L~~N~l~~~~p  271 (701)
                      + .+| .++.+++|+.|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..++.  |+.|+|++|++++.+|
T Consensus       586 ~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip  661 (876)
T 4ecn_A          586 R-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR  661 (876)
T ss_dssp             C-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSS
T ss_pred             c-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccc
Confidence            8 777 8999999999999999999 78888999998 999999999998 47777766543  8888888888877655


Q ss_pred             ccc---C--CCCCCcEEEccCccCCCCCcccc-cCccceeeecCCCCcCCCCCCCcccCC--------CCCCeeeccCCc
Q 041034          272 DEL---S--KLSNLQYLNLSSNLLSGQIPFAI-GKLFNLVSLDLSKNKLSGSFPTGIGNC--------TELQHLALNHNS  337 (701)
Q Consensus       272 ~~l---~--~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~L~~N~  337 (701)
                      ...   .  .+++|+.|+|++|.++ .+|..+ ..+++|+.|+|++|+++ .+|..+...        ++|+.|+|++|+
T Consensus       662 ~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~  739 (876)
T 4ecn_A          662 NISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNK  739 (876)
T ss_dssp             SCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSC
T ss_pred             cchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCC
Confidence            322   1  2235566666666665 333322 24555555555555555 344333221        145555555555


Q ss_pred             cCCCCCcccc--ccccCCeEEcccccCcccCCCC
Q 041034          338 LDGTIPPEIG--KILLLQNLDLSHNNLSGTIPMT  369 (701)
Q Consensus       338 l~~~~p~~~~--~l~~L~~l~ls~N~l~g~~p~~  369 (701)
                      |+ .+|..+.  .+++|+.|+|++|++++ +|..
T Consensus       740 L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~  771 (876)
T 4ecn_A          740 LT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ  771 (876)
T ss_dssp             CC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred             Cc-cchHHhhhccCCCcCEEEeCCCCCCc-cchh
Confidence            55 4454444  45555555555555554 4433

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-46  Score=391.30  Aligned_cols=194  Identities=26%  Similarity=0.383  Sum_probs=166.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++++.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+++.+|||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            47899999999999999999965 57999999999876543 34467899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||+||+|.+++..... ..+++..++.|+.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.+..
T Consensus       102 mEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             EeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            999999999999976432 2578999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ........+||+.|||||++.+.+++.++  ||||+||++|+
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~--DiwSlGvilye  217 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKS--DIWALGCVLYE  217 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHH--HHHHHHHHHHH
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHH--HHHHHHHHHHH
Confidence            33333456799999999999999998876  99999999996

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.9e-46  Score=385.34  Aligned_cols=208  Identities=25%  Similarity=0.379  Sum_probs=181.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+.|++.+.||+|+||+||+|.. .+|+.||||++.......   .+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46799999999999999999965 479999999997654333   35678999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||+||+|.+++...    .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.+..
T Consensus       150 mEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          150 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             ECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            9999999999999763    489999999999999999999999   999999999999999999999999999998866


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHh
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQEL  668 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l  668 (701)
                      ........+||+.|||||++.+.+++.++  ||||+||++|+|+.+.|. ...+..++++.+
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~--DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  282 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEV--DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  282 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHH--HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            65566677899999999999998888776  999999999998877643 233444444443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=382.72  Aligned_cols=216  Identities=25%  Similarity=0.465  Sum_probs=180.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .++|.+.++||+|+||+||+|++.      +++.||||+++...   ....++|.+|+++|++++|||||+++|+|.+++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            457888899999999999999753      47889999997542   344678999999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCC------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDE------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      ..|||||||++|+|.++++....            ..+++|.+++.|+.|||.||+|||++   +||||||||+|||+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence            99999999999999999976431            23589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------
Q 041034          591 NLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------  649 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------  649 (701)
                      ++.+||+|||+|+.......  ......||+.|||||++.+..++.++  ||||+|+++||                   
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~s--DvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES--DVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHH--HHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccc--cccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999987643322  22345799999999999999888776  99999999995                   


Q ss_pred             ------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                              ||+.+|.+||||+||++.|+...
T Consensus       272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                                    88899999999999988887654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-45  Score=379.07  Aligned_cols=194  Identities=22%  Similarity=0.336  Sum_probs=166.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .+++++.+.||+|+||+||+|.+.      +++.||||+++.....  ...++|.+|+.++++++|||||+++|+|.+++
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            355778899999999999999752      4678999999765432  33578999999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      ..++|||||++|+|.+++.....             ...++|.++..|+.|||.||+|||++   +||||||||+|||++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence            99999999999999999965321             23589999999999999999999999   999999999999999


Q ss_pred             CCCCeEEEeecCccccccCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          590 SNLEAFVADFGTARLLHVDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       590 ~~~~~kL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +++.+||+|||+|+......  .......||+.|||||++.+..++.++  ||||+|+++||
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ks--DVwSfGvvl~E  239 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS--DIWSYGVVLWE  239 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccc--hhhhHHHHHHH
Confidence            99999999999998764332  223445799999999999988888776  99999999996

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-45  Score=378.32  Aligned_cols=193  Identities=25%  Similarity=0.465  Sum_probs=166.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .++|.+.+.||+|+||+||+|++.      +++.||||+++...   ....++|.+|+++|++++|||||+++|++.+++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            467899999999999999999753      47789999997543   344678999999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCC----------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDD----------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL  592 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~  592 (701)
                      ..++|||||++|+|.++++...          ....++|.++..|+.|||.||+|||++   +||||||||+|||++.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            9999999999999999997642          234699999999999999999999999   999999999999999999


Q ss_pred             CeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          593 EAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .+||+|||+|+........  .....||+.|||||++.+..++.++  ||||+|+++||
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~--DVwS~Gvvl~E  222 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES--DVWSLGVVLWE  222 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh--hHHHHHHHHHH
Confidence            9999999999876433222  1234689999999999988888876  99999999996

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.3e-45  Score=368.70  Aligned_cols=212  Identities=23%  Similarity=0.376  Sum_probs=167.3

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.+....+....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999966 469999999998766555555678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+ +|+|.+++.+..   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999998755   599999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCCceeecccccccCCCCCCCCcCC-hhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhhcC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVN-QKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELEGK  671 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~~~  671 (701)
                       ......+||+.|||||++.+..+. .++  ||||+||++|+|+++.+ ....+..++.+.+...
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~--DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~  227 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEV--DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG  227 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChh--hhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence             233456899999999999888765 444  99999999999998874 4445666666655443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=386.91  Aligned_cols=208  Identities=25%  Similarity=0.381  Sum_probs=181.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+.|++.+.||+|+||.||+|.. .+|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            46799999999999999999965 479999999998654433   35688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||+||+|.++++..    .+++..+..|+.||+.||+|||++   |||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            9999999999999754    489999999999999999999999   999999999999999999999999999998866


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC-CCCHHHHHHHh
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS-RPTMQRISQEL  668 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~l  668 (701)
                      ........+||+.|||||++.+..|+.++  ||||+||++|+|+.+.|.. ..+..++++.+
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~--DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  359 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEV--DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  359 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHH--HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            65566677899999999999999898876  9999999999987776432 23333444433

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-45  Score=382.06  Aligned_cols=185  Identities=26%  Similarity=0.333  Sum_probs=161.8

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+.|++.++||+|+||+||+|+. .+|+.||||+++....        ..+|+.++++++|||||++++++.+++.+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45788999999999999999965 4699999999986532        24699999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTARLLH  606 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla~~~~  606 (701)
                      ||||+||+|.+++++..   .+++..+..++.||+.||+|||++   +||||||||+|||++.+| ++||+|||+|+.+.
T Consensus       129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999998654   599999999999999999999999   999999999999999987 69999999999875


Q ss_pred             cCCCC-----ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          607 VDSSN-----RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       607 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .+...     ....+||+.|||||++.+.+++.++  ||||+||++|+
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~--DiwSlGvilye  248 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV--DIWSSCCMMLH  248 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHH
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHH--HHHHHHHHHHH
Confidence            43221     2235799999999999999898876  99999999996

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-45  Score=374.16  Aligned_cols=214  Identities=25%  Similarity=0.354  Sum_probs=185.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|+. .+++.||||++.+....+....+.+.+|++++++++|||||++++++++++..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46799999999999999999955 57999999999765432233357789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||+||+|.+++.+.+   .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+..
T Consensus       111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999998654   599999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC-CCCHHHHHHHhhc
Q 041034          608 DS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS-RPTMQRISQELEG  670 (701)
Q Consensus       608 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~l~~  670 (701)
                      ..  ......+||+.|||||++.+.+++.++  ||||+||++|+|+.+.|.. ..+..++.+.+..
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~--DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  248 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK  248 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHH--HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            32  234456899999999999988888776  9999999999999998544 4566666655543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=373.70  Aligned_cols=215  Identities=26%  Similarity=0.433  Sum_probs=178.4

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++...+++++.+.||+|+||+||+|++.  ..||||+++.... .....+.|.+|+.++++++|||||+++|++.+ +.+
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            3445678899999999999999999874  3699999876443 34456889999999999999999999998865 568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      +||||||++|+|.++++....  .+++.++..|+.|||.||+|||++   +||||||||+|||+++++.+||+|||+|+.
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999999999976543  599999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCC--CCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHH------------------------------
Q 041034          605 LHVDS--SNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       605 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      .....  ......+||+.|||||++.+.   +++.++  ||||+|+++|+                              
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ks--DVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS--DVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHH--HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHH--HhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            64322  223456799999999998543   466665  99999999995                              


Q ss_pred             -----------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                       ||+.+|.+||||.||++.|+.
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                             888888888888888887764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-44  Score=371.89  Aligned_cols=195  Identities=24%  Similarity=0.405  Sum_probs=159.9

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc------
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR------  522 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  522 (701)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...  .....+.+.+|++++++++|||||++++++.+.+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            5699999999999999999965 479999999997543  3344578999999999999999999999987544      


Q ss_pred             ------EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          523 ------CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       523 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                            ..|+|||||++|+|.+++.........++..++.++.||+.||+|||++   |||||||||+|||++.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence                  3799999999999999998766555567788999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccccCCCC------------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          597 ADFGTARLLHVDSSN------------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       597 ~DFGla~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +|||+|+.+......            .+..+||+.|||||++.+.+++.++  ||||+||++|+|+
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~--DiwSlGvilyell  224 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV--DIFSLGLILFELL  224 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHH--HHHHHHHHHHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHH--HHHHHHHHHHHHc
Confidence            999999887543221            2335799999999999998888776  9999999999744

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-44  Score=364.65  Aligned_cols=209  Identities=23%  Similarity=0.366  Sum_probs=173.6

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CcEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KRCMFF  526 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  526 (701)
                      |++.+.||+|+||+||+|.+ .+++.||+|++...... ....+.|.+|++++++++|||||++++++.+    ++.+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            36678899999999999965 46899999999765433 3346789999999999999999999999875    356899


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~DFGla~~~  605 (701)
                      |||||++|+|.+++++..   .+++..+..++.||+.||+|||++ .++||||||||+|||++ .++.+||+|||+|+..
T Consensus       107 vmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            999999999999998654   589999999999999999999998 12399999999999997 4799999999999864


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhhc
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELEG  670 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~~  670 (701)
                      .  .......+||+.|||||++.+ +++.++  ||||+||++|+|+++.+..  .....++.+.+..
T Consensus       183 ~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~--DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~  244 (290)
T 3fpq_A          183 R--ASFAKAVIGTPEFMAPEMYEE-KYDESV--DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS  244 (290)
T ss_dssp             C--TTSBEESCSSCCCCCGGGGGT-CCCTHH--HHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred             C--CCccCCcccCccccCHHHcCC-CCCcHH--HHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc
Confidence            3  334456689999999999865 577665  9999999999999988543  3455666665544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2e-43  Score=388.78  Aligned_cols=365  Identities=22%  Similarity=0.240  Sum_probs=276.3

Q ss_pred             CCCCCCcce--eEeCCC---------CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeC-CcccCCCCCCC
Q 041034           22 TSDHCNWVG--ITCDYK---------GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSI-PPQIGSLSNLK   89 (701)
Q Consensus        22 ~~d~c~w~g--v~c~~~---------~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~   89 (701)
                      ..+.|.|.+  |.|+..         .+++.|++++|.+++. .+..|+.+++|++|+|++|.+.+.+ +..|..+++|+
T Consensus         4 ~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~   82 (455)
T 3v47_A            4 GTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAEL-NETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI   82 (455)
T ss_dssp             ---CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEE-CTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCC
T ss_pred             ccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcC-ChhHhccCccccEEECcCCcccceECcccccccccCC
Confidence            445676665  788743         4688899999988754 3446888999999999999887555 56788899999


Q ss_pred             EEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccc--cCCccccceeecccccCCCCCccc-ccCCCCCcEEEce
Q 041034           90 YLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE--IGSLRNLEELYLRSNKLSGVLPQE-IGNLKSLIWLSVM  166 (701)
Q Consensus        90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~  166 (701)
                      +|+|++|++++..|..|.++++|++|+|++|++++..+..  |..+++|++|+|++|++++..|.. +.++++|++|+++
T Consensus        83 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~  162 (455)
T 3v47_A           83 ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT  162 (455)
T ss_dssp             EEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECT
T ss_pred             EEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCC
Confidence            9999999999888888999999999999999998755544  888999999999999998887776 7889999999999


Q ss_pred             ecccCCCcCcccccc--cccceeEeeecccCCCCCCCC--------CCccccCccccccccccCCccccccCC---Cccc
Q 041034          167 YNTVGGPIPSTLFRL--TNLERLFLGCNQFNGTIPREI--------GNLKNLTHLSIITNKLTGAIPSTLGHL---TSLL  233 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~--------~~l~~L~~L~l~~N~l~~~~p~~l~~l---~~L~  233 (701)
                      +|.+++..+..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|++++..|..+..+   ++|+
T Consensus       163 ~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~  242 (455)
T 3v47_A          163 FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ  242 (455)
T ss_dssp             TCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEE
T ss_pred             CCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccccccee
Confidence            999988888888776  688889999998887655443        356789999999999888777766544   6677


Q ss_pred             EEEeccCCCCCCC----------CcccCC--CCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCc
Q 041034          234 YLDLSFNQLHSFI----------PLEIGN--FSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL  301 (701)
Q Consensus       234 ~L~L~~N~l~~~~----------~~~~~~--~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  301 (701)
                      .|++++|.+.+..          +..+..  .++|+.|++++|++++..|..+..+++|+.|+|++|.+++..|..+..+
T Consensus       243 ~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  322 (455)
T 3v47_A          243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL  322 (455)
T ss_dssp             EEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             eEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCc
Confidence            7777766544321          111111  2567777777777777777777777777777777777777777777777


Q ss_pred             cceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCcc----cccccc
Q 041034          302 FNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH----PMFLDM  377 (701)
Q Consensus       302 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~----~~~l~l  377 (701)
                      ++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|++++..+..+.    ...+++
T Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  402 (455)
T 3v47_A          323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL  402 (455)
T ss_dssp             TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEc
Confidence            7777777777777766677777777777777777777777777777777777777777777764443332    236777


Q ss_pred             ccCCCCCcCC
Q 041034          378 SFNNLEGEIP  387 (701)
Q Consensus       378 s~N~l~g~~p  387 (701)
                      ++|++++..|
T Consensus       403 ~~N~l~~~~~  412 (455)
T 3v47_A          403 HTNPWDCSCP  412 (455)
T ss_dssp             CSSCBCCCTT
T ss_pred             cCCCcccCCC
Confidence            7777777766

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.6e-44  Score=366.93  Aligned_cols=213  Identities=21%  Similarity=0.247  Sum_probs=175.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||+||+|+.    ..++.||||++++....... ..++.+|++++++++|||||++++++.+++..
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            36799999999999999999964    24788999999765432211 24678899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+|||||+||+|.+++.+..   .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            99999999999999998754   599999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhhc
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELEG  670 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~~  670 (701)
                      ...........+||+.|||||++.+.+++.++  ||||+||++|+|+++.|. ...+..++++.+..
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~--DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  240 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK  240 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccCCCccccccccCcccCCHHHhccCCCCCCC--cccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence            65444455567899999999999998888776  999999999999998844 44566665555433

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=406.92  Aligned_cols=380  Identities=24%  Similarity=0.243  Sum_probs=256.3

Q ss_pred             CCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeC-CcccCCCCCCCEEECcCCcCcccCC
Q 041034           25 HCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSI-PPQIGSLSNLKYLNLRWNNLTGTIP  103 (701)
Q Consensus        25 ~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p  103 (701)
                      .|+|..|++ ...+++.|+|+.|.+++. .+..|+.+++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|
T Consensus        13 ~~~L~~vP~-lp~~l~~LdLs~N~i~~i-~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p   90 (844)
T 3j0a_A           13 FCNLTQVPQ-VLNTTERLLLSFNYIRTV-TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP   90 (844)
T ss_dssp             CCCSSCCCS-SCTTCCEEEEESCCCCEE-CSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred             CCCCCCCCC-CCCCcCEEECCCCcCCcc-ChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence            367889988 778999999999999854 4457899999999999999766555 7789999999999999999999999


Q ss_pred             cccCCCCCCCEEECCCCCCCCCCccc--cCCccccceeecccccCCCCCc-ccccCCCCCcEEEceecccCCCcCccccc
Q 041034          104 KEIGSLRNLEVLYLSNNSLHGTTPIE--IGSLRNLEELYLRSNKLSGVLP-QEIGNLKSLIWLSVMYNTVGGPIPSTLFR  180 (701)
Q Consensus       104 ~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  180 (701)
                      +.|.++++|++|+|++|.+++..|..  |..+++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..
T Consensus        91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~  170 (844)
T 3j0a_A           91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP  170 (844)
T ss_dssp             TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred             hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence            99999999999999999999866654  8999999999999999988765 57999999999999999988877666654


Q ss_pred             c--cccceeEeeecccCC--------------------------------------------------------------
Q 041034          181 L--TNLERLFLGCNQFNG--------------------------------------------------------------  196 (701)
Q Consensus       181 l--~~L~~L~L~~N~l~~--------------------------------------------------------------  196 (701)
                      +  ++|+.|+|+.|.+.+                                                              
T Consensus       171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~  250 (844)
T 3j0a_A          171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH  250 (844)
T ss_dssp             HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred             ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence            4  334433333333333                                                              


Q ss_pred             ------------------------------CCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCC
Q 041034          197 ------------------------------TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFI  246 (701)
Q Consensus       197 ------------------------------~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  246 (701)
                                                    ..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus       251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  330 (844)
T 3j0a_A          251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY  330 (844)
T ss_dssp             SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred             ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence                                          22333444445555555555555444555555555555555555555544


Q ss_pred             CcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCc-------------------------------
Q 041034          247 PLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP-------------------------------  295 (701)
Q Consensus       247 ~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-------------------------------  295 (701)
                      |..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++...                               
T Consensus       331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~  410 (844)
T 3j0a_A          331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSE  410 (844)
T ss_dssp             SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCS
T ss_pred             HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeeccc
Confidence            5555555555555555555555545555555555555555555442100                               


Q ss_pred             ---------ccccCccceeeecCCCCcCCC------------------------------CCCCcccCCCCCCeeeccCC
Q 041034          296 ---------FAIGKLFNLVSLDLSKNKLSG------------------------------SFPTGIGNCTELQHLALNHN  336 (701)
Q Consensus       296 ---------~~~~~l~~L~~L~Ls~N~l~~------------------------------~~p~~~~~l~~L~~L~L~~N  336 (701)
                               ..+..+++|+.|+|++|++++                              ..|..|..+++|+.|+|++|
T Consensus       411 N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N  490 (844)
T 3j0a_A          411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN  490 (844)
T ss_dssp             CCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHH
T ss_pred             CccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCC
Confidence                     001133344444444444432                              11233555667777777777


Q ss_pred             ccCCCCCccccccccCCeEEcccccCcccCCCCcc--ccccccccCCCCCcCCCcCCCCCCCCcCCCccccc
Q 041034          337 SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH--PMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCG  406 (701)
Q Consensus       337 ~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~--~~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~~~~~  406 (701)
                      ++++..|..|..+++|+.|+|++|+|++..|..+.  ...||+++|++++.+|..+.....-.+.+|+..|.
T Consensus       491 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          491 YLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE  562 (844)
T ss_dssp             HHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred             cccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence            77777777777778888888888888765555443  24678888888888777655443334455555553

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.5e-43  Score=364.24  Aligned_cols=195  Identities=26%  Similarity=0.341  Sum_probs=156.8

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----EEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----CMF  525 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  525 (701)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++....    ....+..|+..+.+++|||||++++++.+++    .+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4688899999999999999987 589999999965421    1123345677778899999999999998653    689


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD-----CTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      ||||||++|+|.++++..    .++|..+.+++.|++.||+|||++     +.++||||||||+|||++.++.+||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999999864    489999999999999999999975     24589999999999999999999999999


Q ss_pred             CccccccCCCC----ceeecccccccCCCCCCCCcC----ChhhHHHHHHHHHHHHHcccC
Q 041034          601 TARLLHVDSSN----RTLRAGTYGYIAPDQRLSPPV----NQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       601 la~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~----~~~~~~Di~slg~i~~~cl~~  653 (701)
                      +|+........    ....+||+.|||||++.+...    .....+||||+|+++||++++
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg  214 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  214 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHC
Confidence            99876543221    223579999999999876421    122345999999999976543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-43  Score=371.84  Aligned_cols=222  Identities=23%  Similarity=0.352  Sum_probs=186.5

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC-Cceeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKL  514 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l  514 (701)
                      ..+++...++|++.+.||+|+||+||+|.+.      .++.||||+++.....  ...+.+.+|+++|++++| ||||++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3456777899999999999999999999653      2468999999865433  335789999999999975 999999


Q ss_pred             eeeeeeC-cEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 041034          515 YGFCLHK-RCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRD  580 (701)
Q Consensus       515 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~D  580 (701)
                      +|+|.++ +.+++|||||++|+|.++++....             ...+++..+..++.|||.||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9998764 568999999999999999975421             23489999999999999999999999   999999


Q ss_pred             CCCCcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------
Q 041034          581 ISSNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------  649 (701)
Q Consensus       581 lkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------  649 (701)
                      |||+|||+++++.+||+|||+|+.+..+...  .....||+.|||||++.+..++.++  ||||+|+++||         
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ks--DVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHTTTSCCSS
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcc--cEeehHHHHHHHHhCCCCCC
Confidence            9999999999999999999999876544332  2345689999999999988888776  99999999996         


Q ss_pred             -----------------------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                                         ||+.+|.+|||++||++.|+.
T Consensus       289 ~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          289 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence                                               777788888888888777654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.9e-42  Score=393.65  Aligned_cols=145  Identities=27%  Similarity=0.316  Sum_probs=132.4

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|+++++.+++ ++...|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus        32 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  110 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV  110 (606)
T ss_dssp             TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred             CCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence            579999999999986 4455789999999999999999999999999999999999999999999899999999999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCC-CCcccccCCCCCcEEEceecccCCCcCccccccc
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSG-VLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT  182 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  182 (701)
                      |++|++++..+..++.+++|++|+|++|++++ .+|..|+++++|++|++++|.+++..+..+..++
T Consensus       111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  177 (606)
T 3vq2_A          111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR  177 (606)
T ss_dssp             CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHH
T ss_pred             ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhh
Confidence            99999998888899999999999999999987 5699999999999999999999887776555444

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.2e-42  Score=395.19  Aligned_cols=350  Identities=21%  Similarity=0.308  Sum_probs=307.9

Q ss_pred             CCcceeEeC--CCCCEEEEEecccccccc-----------------cCCcccC--CCCCCcEEECCCCcceeeCCcccCC
Q 041034           26 CNWVGITCD--YKGSITHIELVECSIKGE-----------------LGSLNFS--CFPNLQYLNLWNNNLSGSIPPQIGS   84 (701)
Q Consensus        26 c~w~gv~c~--~~~~v~~l~l~~~~~~~~-----------------~~~~~~~--~~~~L~~L~L~~n~l~~~~~~~~~~   84 (701)
                      +...|++-.  .-.+++.|+|++|.++|.                 ++. .++  .+++|++|+|++|.+.+.+|..|++
T Consensus       193 n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~  271 (636)
T 4eco_A          193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKA  271 (636)
T ss_dssp             CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred             CCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence            345555322  235789999999999984                 544 455  8999999999999999999999999


Q ss_pred             CCCCCEEECcCCc-Ccc-cCCcccCCC------CCCCEEECCCCCCCCCCcc--ccCCccccceeecccccCCCCCcccc
Q 041034           85 LSNLKYLNLRWNN-LTG-TIPKEIGSL------RNLEVLYLSNNSLHGTTPI--EIGSLRNLEELYLRSNKLSGVLPQEI  154 (701)
Q Consensus        85 l~~L~~L~L~~n~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~  154 (701)
                      +++|++|+|++|+ ++| .+|..++.+      ++|++|+|++|+++ .+|.  .++.+++|++|+|++|+++|.+| .|
T Consensus       272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~  349 (636)
T 4eco_A          272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF  349 (636)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred             CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence            9999999999998 998 899888877      99999999999999 7887  89999999999999999998889 99


Q ss_pred             cCCCCCcEEEceecccCCCcCcccccccc-cceeEeeecccCCCCCCCCCCcc--ccCccccccccccCCcccccc----
Q 041034          155 GNLKSLIWLSVMYNTVGGPIPSTLFRLTN-LERLFLGCNQFNGTIPREIGNLK--NLTHLSIITNKLTGAIPSTLG----  227 (701)
Q Consensus       155 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~~l~----  227 (701)
                      +++++|+.|+|++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|++|++++|.+++.+|..+.    
T Consensus       350 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~  427 (636)
T 4eco_A          350 GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP  427 (636)
T ss_dssp             EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCS
T ss_pred             CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccc
Confidence            99999999999999998 88888999999 999999999999 7888887765  899999999999999999888    


Q ss_pred             ---CCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCccc-CCC-------CCCcEEEccCccCCCCCcc
Q 041034          228 ---HLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDEL-SKL-------SNLQYLNLSSNLLSGQIPF  296 (701)
Q Consensus       228 ---~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l-~~l-------~~L~~L~L~~N~l~~~~~~  296 (701)
                         .+++|++|+|++|++++..+..+..+++|+.|+|++|+|+ .+|..+ ..+       ++|+.|+|++|.++ .+|.
T Consensus       428 ~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~  505 (636)
T 4eco_A          428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSD  505 (636)
T ss_dssp             SCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCG
T ss_pred             ccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccCh
Confidence               8889999999999999754445667999999999999999 555543 333       29999999999999 7888


Q ss_pred             ccc--CccceeeecCCCCcCCCCCCCcccCCCCCCeeec------cCCccCCCCCccccccccCCeEEcccccCcccCCC
Q 041034          297 AIG--KLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL------NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPM  368 (701)
Q Consensus       297 ~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  368 (701)
                      .+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|      ++|++.+.+|..++.+++|+.|+|++|++ +.+|.
T Consensus       506 ~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~  583 (636)
T 4eco_A          506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNE  583 (636)
T ss_dssp             GGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCS
T ss_pred             hhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCH
Confidence            887  89999999999999997 8999999999999999      56889999999999999999999999999 78898


Q ss_pred             Cccc--cccccccCCCCC
Q 041034          369 TLHP--MFLDMSFNNLEG  384 (701)
Q Consensus       369 ~~~~--~~l~ls~N~l~g  384 (701)
                      .+..  ..||+++|++..
T Consensus       584 ~~~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          584 KITPNISVLDIKDNPNIS  601 (636)
T ss_dssp             CCCTTCCEEECCSCTTCE
T ss_pred             hHhCcCCEEECcCCCCcc
Confidence            7654  479999998863

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.3e-42  Score=375.83  Aligned_cols=360  Identities=19%  Similarity=0.169  Sum_probs=306.6

Q ss_pred             EEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccC-CcccCCCCCCCEEECCCC
Q 041034           42 IELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTI-PKEIGSLRNLEVLYLSNN  120 (701)
Q Consensus        42 l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N  120 (701)
                      ++..+++++. ++.    -.++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|
T Consensus        15 ~~c~~~~l~~-lp~----l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           15 AICINRGLHQ-VPE----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EECCSSCCSS-CCC----CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             cCcCCCCccc-CCC----CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            5556666653 333    2378999999999999999999999999999999999998554 678999999999999999


Q ss_pred             CCCCCCccccCCccccceeecccccCCCCCccc--ccCCCCCcEEEceecccCCCcCcc-cccccccceeEeeecccCCC
Q 041034          121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQE--IGNLKSLIWLSVMYNTVGGPIPST-LFRLTNLERLFLGCNQFNGT  197 (701)
Q Consensus       121 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~  197 (701)
                      ++++..|..|.++++|++|+|++|++++..+..  |.++++|++|+|++|.+++..|.. +.++++|++|++++|++++.
T Consensus        90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~  169 (455)
T 3v47_A           90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI  169 (455)
T ss_dssp             TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred             ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence            999999999999999999999999999866555  999999999999999999998876 89999999999999999999


Q ss_pred             CCCCCCCc--cccCccccccccccCCccccc--------cCCCcccEEEeccCCCCCCCCcccCCC---CcccEEEcCCC
Q 041034          198 IPREIGNL--KNLTHLSIITNKLTGAIPSTL--------GHLTSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSDN  264 (701)
Q Consensus       198 ~~~~~~~l--~~L~~L~l~~N~l~~~~p~~l--------~~l~~L~~L~L~~N~l~~~~~~~~~~~---~~L~~L~L~~N  264 (701)
                      .+..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|++++..|..+...   ++|+.|++++|
T Consensus       170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~  249 (455)
T 3v47_A          170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS  249 (455)
T ss_dssp             CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred             ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence            99999887  789999999999997665543        367899999999999999888766543   89999999999


Q ss_pred             CCccc----------cCcccCC--CCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeee
Q 041034          265 KIRGI----------IPDELSK--LSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLA  332 (701)
Q Consensus       265 ~l~~~----------~p~~l~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  332 (701)
                      .+.+.          .+..+..  .++|+.|++++|.+++.+|..+..+++|+.|+|++|++++..|..+..+++|++|+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  329 (455)
T 3v47_A          250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN  329 (455)
T ss_dssp             TTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEE
Confidence            76543          2222332  36899999999999999999999999999999999999998899999999999999


Q ss_pred             ccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccCCCCCcCCCcCCCCCC---CCcCCCcccc
Q 041034          333 LNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNNLEGEIPTYLRDNPP---NSFVGNKGLC  405 (701)
Q Consensus       333 L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~l~g~~p~~~~~~~~---~~~~~~~~~~  405 (701)
                      |++|++++..|..++.+++|+.|+|++|++++..|..+..    .+|++++|++++..+..+...+.   -...+|+-.|
T Consensus       330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  409 (455)
T 3v47_A          330 LSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  409 (455)
T ss_dssp             CCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence            9999999888999999999999999999999888876653    48999999999755544443332   2334555444


Q ss_pred             c
Q 041034          406 G  406 (701)
Q Consensus       406 ~  406 (701)
                      .
T Consensus       410 ~  410 (455)
T 3v47_A          410 S  410 (455)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.8e-41  Score=382.84  Aligned_cols=356  Identities=21%  Similarity=0.215  Sum_probs=309.6

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      ..++.|++++|.+++ +++..|+.+++|++|+|++|.+.+..|..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus        33 ~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  111 (606)
T 3t6q_A           33 NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF  111 (606)
T ss_dssp             TTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred             CcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence            578999999999986 4455799999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccc--eeEeeeccc
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLE--RLFLGCNQF  194 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l  194 (701)
                      |++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|++++|.+++..|..+..+++|+  .|++++|++
T Consensus       112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l  191 (606)
T 3t6q_A          112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI  191 (606)
T ss_dssp             CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred             ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence            999999988888999999999999999999986655666699999999999999998899999999999  899999999


Q ss_pred             CCCCCCCCCCc---------------------------------------------------cccCccccccccccCCcc
Q 041034          195 NGTIPREIGNL---------------------------------------------------KNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       195 ~~~~~~~~~~l---------------------------------------------------~~L~~L~l~~N~l~~~~p  223 (701)
                      ++..|..+...                                                   .+|+.|++++|.+++..+
T Consensus       192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~  271 (606)
T 3t6q_A          192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS  271 (606)
T ss_dssp             CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred             CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence            98777665431                                                   167788888888888888


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcc-cccCcc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF-AIGKLF  302 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~  302 (701)
                      ..|..+++|++|++++|+++. +|..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+.+.+|. .+..++
T Consensus       272 ~~~~~l~~L~~L~l~~n~l~~-lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~  350 (606)
T 3t6q_A          272 NTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE  350 (606)
T ss_dssp             TTTTTCTTCSEEECTTSCCSC-CCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred             HHhccccCCCEEeccCCccCC-CChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence            888999999999999999985 777888899999999999999988888889999999999999998876655 488889


Q ss_pred             ceeeecCCCCcCCCCC--CCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCC-cc----cccc
Q 041034          303 NLVSLDLSKNKLSGSF--PTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT-LH----PMFL  375 (701)
Q Consensus       303 ~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~----~~~l  375 (701)
                      +|++|++++|.+++..  |..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..|.. +.    ...|
T Consensus       351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  430 (606)
T 3t6q_A          351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL  430 (606)
T ss_dssp             TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred             cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence            9999999999998765  778888999999999999998888888889999999999999998876654 32    2478


Q ss_pred             ccccCCCCCcCCCcCCCCC
Q 041034          376 DMSFNNLEGEIPTYLRDNP  394 (701)
Q Consensus       376 ~ls~N~l~g~~p~~~~~~~  394 (701)
                      ++++|++++..|..+...+
T Consensus       431 ~l~~n~l~~~~~~~~~~l~  449 (606)
T 3t6q_A          431 NLSHSLLDISSEQLFDGLP  449 (606)
T ss_dssp             ECTTCCCBTTCTTTTTTCT
T ss_pred             ECCCCccCCcCHHHHhCCC
Confidence            8999999887776655443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.7e-42  Score=359.70  Aligned_cols=288  Identities=31%  Similarity=0.501  Sum_probs=188.7

Q ss_pred             CHHHHHHHhc------CCCCcCCCCCCCCCCCC--cceeEeCCC---CCEEEEEeccccccc--ccCCcccCCCCCCcEE
Q 041034            1 SEIERQALLN------CGWWKDRIPHNTSDHCN--WVGITCDYK---GSITHIELVECSIKG--ELGSLNFSCFPNLQYL   67 (701)
Q Consensus         1 ~~~~~~~l~~------~~~~~~~~~~~~~d~c~--w~gv~c~~~---~~v~~l~l~~~~~~~--~~~~~~~~~~~~L~~L   67 (701)
                      .++|++||++      +..+.+.|. .++|||.  |.||+|+..   ++|++|++++++++|  .++. .|..+++|++|
T Consensus         4 ~~~~~~aL~~~k~~~~~~~~l~~W~-~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~L   81 (313)
T 1ogq_A            4 NPQDKQALLQIKKDLGNPTTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL   81 (313)
T ss_dssp             CHHHHHHHHHHHHHTTCCGGGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEE
T ss_pred             CHHHHHHHHHHHHhcCCcccccCCC-CCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCCee
Confidence            3789999986      111222342 2568998  999999854   677777766666655  3332 34445555555


Q ss_pred             ECCC-CcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccC
Q 041034           68 NLWN-NNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL  146 (701)
Q Consensus        68 ~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  146 (701)
                      +|++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|++++..                    
T Consensus        82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------------------  141 (313)
T 1ogq_A           82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL--------------------  141 (313)
T ss_dssp             EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCC--------------------
T ss_pred             eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcC--------------------
Confidence            5552 5555555555555555555555555555555555555555555555555554444                    


Q ss_pred             CCCCcccccCCCCCcEEEceecccCCCcCccccccc-ccceeEeeecccCCCCCCCCCCccccCccccccccccCCcccc
Q 041034          147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT-NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPST  225 (701)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  225 (701)
                          |..|..+++|++|++++|.+++.+|..+..++ +|++|+|++|++++.+|..+..+. |++|++++|.+++..|..
T Consensus       142 ----p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~  216 (313)
T 1ogq_A          142 ----PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVL  216 (313)
T ss_dssp             ----CGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGG
T ss_pred             ----ChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHH
Confidence                44444455555555555555455555555555 666666666666666666666665 777777777777777777


Q ss_pred             ccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCcccee
Q 041034          226 LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLV  305 (701)
Q Consensus       226 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  305 (701)
                      +..+++|++|+|++|++++.+|. +..+++|+.|+|++|+|++.+|..+..+++|+.|+|++|+++|.+|.. ..+++|+
T Consensus       217 ~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~  294 (313)
T 1ogq_A          217 FGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFD  294 (313)
T ss_dssp             CCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSC
T ss_pred             HhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccC
Confidence            77777788888888887775554 677788888888888888888888888888888888888888888875 7788888


Q ss_pred             eecCCCCc-CCCC
Q 041034          306 SLDLSKNK-LSGS  317 (701)
Q Consensus       306 ~L~Ls~N~-l~~~  317 (701)
                      .|++++|. +.|.
T Consensus       295 ~l~l~~N~~lc~~  307 (313)
T 1ogq_A          295 VSAYANNKCLCGS  307 (313)
T ss_dssp             GGGTCSSSEEEST
T ss_pred             hHHhcCCCCccCC
Confidence            88888887 6653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=371.48  Aligned_cols=331  Identities=20%  Similarity=0.163  Sum_probs=300.1

Q ss_pred             CCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceee
Q 041034           61 FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELY  140 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  140 (701)
                      .++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+
T Consensus        31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  110 (477)
T 2id5_A           31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD  110 (477)
T ss_dssp             CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred             CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence            46899999999999999899999999999999999999999999999999999999999999988888899999999999


Q ss_pred             cccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccC
Q 041034          141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG  220 (701)
Q Consensus       141 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  220 (701)
                      |++|++++..+..|.++++|+.|+|++|.+.+..+..|.++++|+.|+|++|++++..+..+.++++|+.|+|++|.+.+
T Consensus       111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred             CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence            99999999999999999999999999999999999999999999999999999998777789999999999999999999


Q ss_pred             CccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccC
Q 041034          221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK  300 (701)
Q Consensus       221 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  300 (701)
                      ..+..|..+++|++|++++|.+.+.+|.......+|+.|+|++|+|++..+..+..+++|+.|+|++|.+++..+..+..
T Consensus       191 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  270 (477)
T 2id5_A          191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE  270 (477)
T ss_dssp             ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTT
T ss_pred             eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccc
Confidence            88889999999999999999998888887777789999999999999766578999999999999999999888888999


Q ss_pred             ccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCcccc---cccc
Q 041034          301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM---FLDM  377 (701)
Q Consensus       301 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~---~l~l  377 (701)
                      +++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+...   .+++
T Consensus       271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~  350 (477)
T 2id5_A          271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNF  350 (477)
T ss_dssp             CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCC
T ss_pred             cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhcccc
Confidence            9999999999999999999999999999999999999998877888999999999999999998876543211   2344


Q ss_pred             ccCCCCCcCCCcCC
Q 041034          378 SFNNLEGEIPTYLR  391 (701)
Q Consensus       378 s~N~l~g~~p~~~~  391 (701)
                      ..+.....-|..+.
T Consensus       351 ~~~~~~C~~p~~~~  364 (477)
T 2id5_A          351 NRQQPTCATPEFVQ  364 (477)
T ss_dssp             TTCCCBEEESGGGT
T ss_pred             CccCceeCCchHHc
Confidence            45554444454443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.7e-41  Score=382.60  Aligned_cols=370  Identities=23%  Similarity=0.236  Sum_probs=242.5

Q ss_pred             CCCcceeEeCCC------------CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEE
Q 041034           25 HCNWVGITCDYK------------GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLN   92 (701)
Q Consensus        25 ~c~w~gv~c~~~------------~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   92 (701)
                      .|.|.|+ |+..            .+++.|++++|.+++.. +..|+.+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIG-HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEEC-SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccC-hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence            4889888 7632            37899999999988643 44689999999999999999998889999999999999


Q ss_pred             CcCCcCcccCCcccCCCCCCCEEECCCCCCCCC-CccccCCccccceeecccccCCCCC-cccccCCCCCcEEEceeccc
Q 041034           93 LRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT-TPIEIGSLRNLEELYLRSNKLSGVL-PQEIGNLKSLIWLSVMYNTV  170 (701)
Q Consensus        93 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l  170 (701)
                      |++|++++..|..|+++++|++|+|++|++++. .|..++++++|++|+|++|++.+.+ +..|.++++|++|++++|.+
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            999999988888899999999999999999874 5678999999999999999854444 46899999999999999999


Q ss_pred             CCCcCccccccc------------------------ccceeEeeecccCCCC--CC-CCCCcc-----------------
Q 041034          171 GGPIPSTLFRLT------------------------NLERLFLGCNQFNGTI--PR-EIGNLK-----------------  206 (701)
Q Consensus       171 ~~~~~~~~~~l~------------------------~L~~L~L~~N~l~~~~--~~-~~~~l~-----------------  206 (701)
                      ++..|..+..++                        +|++|++++|++++..  |. ....++                 
T Consensus       161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  240 (549)
T 2z81_A          161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF  240 (549)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred             cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence            988888776654                        4555555555554421  00 000111                 


Q ss_pred             ----------------------------------------------------------------------ccCccccccc
Q 041034          207 ----------------------------------------------------------------------NLTHLSIITN  216 (701)
Q Consensus       207 ----------------------------------------------------------------------~L~~L~l~~N  216 (701)
                                                                                            +|+.|++++|
T Consensus       241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n  320 (549)
T 2z81_A          241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS  320 (549)
T ss_dssp             HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred             HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence                                                                                  1222222222


Q ss_pred             cccCCccccc-cCCCcccEEEeccCCCCCCCC---cccCCCCcccEEEcCCCCCccccC--cccCCCCCCcEEEccCccC
Q 041034          217 KLTGAIPSTL-GHLTSLLYLDLSFNQLHSFIP---LEIGNFSALAELDLSDNKIRGIIP--DELSKLSNLQYLNLSSNLL  290 (701)
Q Consensus       217 ~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l  290 (701)
                      +++ .+|..+ ..+++|++|+|++|++++.+|   ..++.+++|+.|+|++|+|++..+  ..+..+++|+.|++++|++
T Consensus       321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l  399 (549)
T 2z81_A          321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF  399 (549)
T ss_dssp             CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             ccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCC
Confidence            222 122222 234555555555555554332   224445555555555555554321  2345555555555555555


Q ss_pred             CCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCc
Q 041034          291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL  370 (701)
Q Consensus       291 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~  370 (701)
                      + .+|..+..+++|++|++++|+++ .+|..+.  ++|+.|+|++|++++.+    ..+++|++|+|++|+++ .+|...
T Consensus       400 ~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~  470 (549)
T 2z81_A          400 H-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDAS  470 (549)
T ss_dssp             C-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGG
T ss_pred             c-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCCcc
Confidence            5 34445555555555555555554 2332221  35555555555555432    46788999999999998 677642


Q ss_pred             c---ccccccccCCCCCcCCCcCCCCCC---CCcCCCccccc
Q 041034          371 H---PMFLDMSFNNLEGEIPTYLRDNPP---NSFVGNKGLCG  406 (701)
Q Consensus       371 ~---~~~l~ls~N~l~g~~p~~~~~~~~---~~~~~~~~~~~  406 (701)
                      .   ..+||+++|++++.+|..+...+.   -...+|+-.|.
T Consensus       471 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             GCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             cCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            2   247899999999888776544332   23445554443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.9e-40  Score=378.56  Aligned_cols=330  Identities=22%  Similarity=0.253  Sum_probs=211.7

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|++++|.+++ +.+..|+.+++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..|.++++|++|+
T Consensus        57 ~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~  135 (606)
T 3t6q_A           57 INLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY  135 (606)
T ss_dssp             TTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEE
T ss_pred             ccceEEECCCCccce-eChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEE
Confidence            478899999999986 4445689999999999999999999999999999999999999999988788899999999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCc--EEEceecccCCCcCcccccc-------------
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI--WLSVMYNTVGGPIPSTLFRL-------------  181 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l-------------  181 (701)
                      |++|++++.....+..+++|++|+|++|++++..|..|+.+++|+  .|++++|.+.+..|..+...             
T Consensus       136 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~  215 (606)
T 3t6q_A          136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL  215 (606)
T ss_dssp             CCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCH
T ss_pred             CCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhH
Confidence            999999986655666699999999999999988888888888888  77888887776655443210             


Q ss_pred             --------------------------------------cccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          182 --------------------------------------TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       182 --------------------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                                                            .+|+.|++++|.+++..+..|+.+++|++|++++|+++ .+|
T Consensus       216 ~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp  294 (606)
T 3t6q_A          216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP  294 (606)
T ss_dssp             HHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCC
T ss_pred             HHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCC
Confidence                                                  04455555555555555555555555555555555555 444


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCc-ccCCCCCCcEEEccCccCCCCC--cccccC
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPD-ELSKLSNLQYLNLSSNLLSGQI--PFAIGK  300 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~--~~~~~~  300 (701)
                      ..+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+.+|. .+..+++|+.|++++|.+++..  +..+..
T Consensus       295 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~  374 (606)
T 3t6q_A          295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN  374 (606)
T ss_dssp             SSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTT
T ss_pred             hhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhccc
Confidence            4555555555555555555554444455555555555555554433332 2444444555555544444333  334444


Q ss_pred             ccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCcc-ccccccCCeEEcccccCcccCCC
Q 041034          301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPE-IGKILLLQNLDLSHNNLSGTIPM  368 (701)
Q Consensus       301 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~g~~p~  368 (701)
                      +++|+.|++++|.+++..|..+..+++|+.|++++|++++..|.. +..+++|+.|++++|.+++..|.
T Consensus       375 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  443 (606)
T 3t6q_A          375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ  443 (606)
T ss_dssp             CTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT
T ss_pred             CCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH
Confidence            444444444444444444444444444444444444444433322 44444444444444444444333

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=379.70  Aligned_cols=356  Identities=25%  Similarity=0.253  Sum_probs=269.8

Q ss_pred             CCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCE
Q 041034           35 YKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEV  114 (701)
Q Consensus        35 ~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  114 (701)
                      ...+++.|+++++.+++ ++...|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|.++++|++
T Consensus        26 l~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  104 (570)
T 2z63_A           26 LPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK  104 (570)
T ss_dssp             SCSSCCEEECCSCCCCE-ECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred             ccccccEEEccCCccCc-cChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccc
Confidence            34578999999999985 44557899999999999999999888889999999999999999999888899999999999


Q ss_pred             EECCCCCCCCCCccccCCccccceeecccccCCCC-CcccccCCCCCcEEEceecccCCCcCccccccccc----ceeEe
Q 041034          115 LYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNL----ERLFL  189 (701)
Q Consensus       115 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L  189 (701)
                      |+|++|++++..+..++.+++|++|+|++|.+++. +|..|+++++|+.|++++|.+++..+..+..+++|    +.|++
T Consensus       105 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l  184 (570)
T 2z63_A          105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL  184 (570)
T ss_dssp             EECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred             ccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhccc
Confidence            99999999987777899999999999999999874 68999999999999999998877666655555555    44454


Q ss_pred             eecccCCCC-----------------------------------------------------------------------
Q 041034          190 GCNQFNGTI-----------------------------------------------------------------------  198 (701)
Q Consensus       190 ~~N~l~~~~-----------------------------------------------------------------------  198 (701)
                      ++|.+++..                                                                       
T Consensus       185 ~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  264 (570)
T 2z63_A          185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  264 (570)
T ss_dssp             TTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred             CCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence            444433222                                                                       


Q ss_pred             ----------CCCCCCccccCccccccccccCCccccc------------------------------------------
Q 041034          199 ----------PREIGNLKNLTHLSIITNKLTGAIPSTL------------------------------------------  226 (701)
Q Consensus       199 ----------~~~~~~l~~L~~L~l~~N~l~~~~p~~l------------------------------------------  226 (701)
                                |..+..+++|++|++++|.+++ +|..+                                          
T Consensus       265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~  343 (570)
T 2z63_A          265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE  343 (570)
T ss_dssp             EETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC
T ss_pred             hcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccc
Confidence                      2222333444444444444432 22211                                          


Q ss_pred             cCCCcccEEEeccCCCCCCC--CcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCc-ccccCccc
Q 041034          227 GHLTSLLYLDLSFNQLHSFI--PLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP-FAIGKLFN  303 (701)
Q Consensus       227 ~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~  303 (701)
                      ..+++|++|++++|++++..  |..+..+++|+.|++++|.+++..+. +..+++|+.|++++|.+++..| ..+..+++
T Consensus       344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  422 (570)
T 2z63_A          344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN  422 (570)
T ss_dssp             CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT
T ss_pred             ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC
Confidence            45677888888888887654  56677788888888888888765544 7778888888888888876655 46777788


Q ss_pred             eeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccC-CCCCccccccccCCeEEcccccCcccCCCCccc----cccccc
Q 041034          304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD-GTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMS  378 (701)
Q Consensus       304 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls  378 (701)
                      |+.|++++|.+++..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++|++++..|..+..    ..|+++
T Consensus       423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  502 (570)
T 2z63_A          423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA  502 (570)
T ss_dssp             CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCC
Confidence            888888888887777777788888888888888876 567777788888888888888888776766543    367888


Q ss_pred             cCCCCCcCCCcCCCC
Q 041034          379 FNNLEGEIPTYLRDN  393 (701)
Q Consensus       379 ~N~l~g~~p~~~~~~  393 (701)
                      +|++++..|..+...
T Consensus       503 ~n~l~~~~~~~~~~l  517 (570)
T 2z63_A          503 SNQLKSVPDGIFDRL  517 (570)
T ss_dssp             SSCCSCCCTTTTTTC
T ss_pred             CCcCCCCCHHHhhcc
Confidence            888877666554433

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.9e-41  Score=388.84  Aligned_cols=350  Identities=22%  Similarity=0.281  Sum_probs=302.5

Q ss_pred             CCcceeEeC--CCCCEEEEEecccccccc-----------------cCCc-ccCCCCCCcEEECCCCcceeeCCcccCCC
Q 041034           26 CNWVGITCD--YKGSITHIELVECSIKGE-----------------LGSL-NFSCFPNLQYLNLWNNNLSGSIPPQIGSL   85 (701)
Q Consensus        26 c~w~gv~c~--~~~~v~~l~l~~~~~~~~-----------------~~~~-~~~~~~~L~~L~L~~n~l~~~~~~~~~~l   85 (701)
                      +...|++-.  .-.+++.|+|++|.++|.                 ++.. .|..+++|++|+|++|.+.+.+|..|+++
T Consensus       435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L  514 (876)
T 4ecn_A          435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL  514 (876)
T ss_dssp             CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred             CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence            344555432  235789999999999982                 5442 24499999999999999999999999999


Q ss_pred             CCCCEEECcCCc-Ccc-cCCcccCCCC-------CCCEEECCCCCCCCCCcc--ccCCccccceeecccccCCCCCcccc
Q 041034           86 SNLKYLNLRWNN-LTG-TIPKEIGSLR-------NLEVLYLSNNSLHGTTPI--EIGSLRNLEELYLRSNKLSGVLPQEI  154 (701)
Q Consensus        86 ~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~  154 (701)
                      ++|++|+|++|+ ++| .+|..+++++       +|++|+|++|+++ .+|.  .|+.+++|++|+|++|+++ .+| .|
T Consensus       515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~  591 (876)
T 4ecn_A          515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF  591 (876)
T ss_dssp             SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC
T ss_pred             CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hh
Confidence            999999999998 998 7887666554       9999999999999 7887  8999999999999999999 777 99


Q ss_pred             cCCCCCcEEEceecccCCCcCcccccccc-cceeEeeecccCCCCCCCCCCccc--cCccccccccccCCccccc---c-
Q 041034          155 GNLKSLIWLSVMYNTVGGPIPSTLFRLTN-LERLFLGCNQFNGTIPREIGNLKN--LTHLSIITNKLTGAIPSTL---G-  227 (701)
Q Consensus       155 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~p~~l---~-  227 (701)
                      +++++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++++.+|...   . 
T Consensus       592 ~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~  669 (876)
T 4ecn_A          592 GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD  669 (876)
T ss_dssp             CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTT
T ss_pred             cCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhcc
Confidence            99999999999999998 88889999999 999999999999 78888887765  9999999999998776432   2 


Q ss_pred             -CCCcccEEEeccCCCCCCCCcc-cCCCCcccEEEcCCCCCccccCcccCC--------CCCCcEEEccCccCCCCCccc
Q 041034          228 -HLTSLLYLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKIRGIIPDELSK--------LSNLQYLNLSSNLLSGQIPFA  297 (701)
Q Consensus       228 -~l~~L~~L~L~~N~l~~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~--------l~~L~~L~L~~N~l~~~~~~~  297 (701)
                       .+++|+.|+|++|+++. +|.. +..+++|+.|+|++|+|+ .+|..+..        +++|+.|+|++|+++ .+|..
T Consensus       670 ~~~~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~  746 (876)
T 4ecn_A          670 YKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDD  746 (876)
T ss_dssp             CCCCCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGG
T ss_pred             ccCCCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHH
Confidence             34589999999999996 5554 458999999999999999 55655443        239999999999999 78888


Q ss_pred             cc--CccceeeecCCCCcCCCCCCCcccCCCCCCeeeccC------CccCCCCCccccccccCCeEEcccccCcccCCCC
Q 041034          298 IG--KLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH------NSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT  369 (701)
Q Consensus       298 ~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~  369 (701)
                      +.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|..
T Consensus       747 l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~  824 (876)
T 4ecn_A          747 FRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK  824 (876)
T ss_dssp             GSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC
T ss_pred             hhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh
Confidence            87  89999999999999997 899999999999999976      889999999999999999999999999 899987


Q ss_pred             ccc--cccccccCCCCCc
Q 041034          370 LHP--MFLDMSFNNLEGE  385 (701)
Q Consensus       370 ~~~--~~l~ls~N~l~g~  385 (701)
                      +..  ..||+++|++...
T Consensus       825 l~~~L~~LdLs~N~l~~i  842 (876)
T 4ecn_A          825 LTPQLYILDIADNPNISI  842 (876)
T ss_dssp             CCSSSCEEECCSCTTCEE
T ss_pred             hcCCCCEEECCCCCCCcc
Confidence            654  4799999998743

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1e-40  Score=380.89  Aligned_cols=366  Identities=22%  Similarity=0.230  Sum_probs=287.6

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|++++|.+++. ++..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+
T Consensus        56 ~~L~~L~Ls~n~l~~i-~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  134 (606)
T 3vq2_A           56 SELQWLDLSRCEIETI-EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN  134 (606)
T ss_dssp             TTCCEEECTTCCCCEE-CTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred             ccCcEEeCCCCccccc-CHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence            5789999999998854 444688999999999999999988899999999999999999999988888899999999999


Q ss_pred             CCCCCCCC-CCccccCCccccceeecccccCCCCCcccccCCCCCc----EEEceecccCCCcCc---------------
Q 041034          117 LSNNSLHG-TTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI----WLSVMYNTVGGPIPS---------------  176 (701)
Q Consensus       117 Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~---------------  176 (701)
                      |++|.+++ .+|..|+++++|++|+|++|++++..|..|+.+++|+    +|++++|.+++..+.               
T Consensus       135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n  214 (606)
T 3vq2_A          135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN  214 (606)
T ss_dssp             CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred             CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence            99999986 5688999999999999999998877766555444332    333333333322111               


Q ss_pred             --------------------------------------------------------------------------------
Q 041034          177 --------------------------------------------------------------------------------  176 (701)
Q Consensus       177 --------------------------------------------------------------------------------  176 (701)
                                                                                                      
T Consensus       215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~  294 (606)
T 3vq2_A          215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG  294 (606)
T ss_dssp             CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred             ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence                                                                                            


Q ss_pred             -------ccccccccceeEeeecccCCCCCC--------------------CCCCccccCccccccccccCC--cccccc
Q 041034          177 -------TLFRLTNLERLFLGCNQFNGTIPR--------------------EIGNLKNLTHLSIITNKLTGA--IPSTLG  227 (701)
Q Consensus       177 -------~~~~l~~L~~L~L~~N~l~~~~~~--------------------~~~~l~~L~~L~l~~N~l~~~--~p~~l~  227 (701)
                             .+..+++|+.|++++|++ +.+|.                    .+..+++|++|++++|++++.  .|..+.
T Consensus       295 ~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~  373 (606)
T 3vq2_A          295 VSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL  373 (606)
T ss_dssp             CCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHH
T ss_pred             ccchhhhhccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhc
Confidence                   222333444444444444 23331                    345667788888888888865  377888


Q ss_pred             CCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccC-cccCCCCCCcEEEccCccCCCCCcccccCccceee
Q 041034          228 HLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIP-DELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVS  306 (701)
Q Consensus       228 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  306 (701)
                      .+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+..+++|+.|++++|.+++..|..+..+++|+.
T Consensus       374 ~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  452 (606)
T 3vq2_A          374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT  452 (606)
T ss_dssp             CCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             cCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCE
Confidence            89999999999999887 56788889999999999999998877 67888999999999999999888888999999999


Q ss_pred             ecCCCCcCCC-CCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccCC
Q 041034          307 LDLSKNKLSG-SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNN  381 (701)
Q Consensus       307 L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~  381 (701)
                      |++++|.+++ .+|..+..+++|+.|+|++|++++..|..++.+++|+.|++++|++++..|..+..    ..||+++|+
T Consensus       453 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            9999999987 47888899999999999999999888888999999999999999999887776653    478999999


Q ss_pred             CCCcCCCcCCCCCC----CCcCCCccccc
Q 041034          382 LEGEIPTYLRDNPP----NSFVGNKGLCG  406 (701)
Q Consensus       382 l~g~~p~~~~~~~~----~~~~~~~~~~~  406 (701)
                      ++ .+|..+...+.    -...+|+-.|.
T Consensus       533 l~-~~p~~~~~l~~~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          533 IE-TSKGILQHFPKSLAFFNLTNNSVACI  560 (606)
T ss_dssp             CC-CEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred             Cc-ccCHhHhhhcccCcEEEccCCCcccC
Confidence            98 56665544432    13456665554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=367.46  Aligned_cols=346  Identities=20%  Similarity=0.239  Sum_probs=220.4

Q ss_pred             cceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccC
Q 041034           28 WVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG  107 (701)
Q Consensus        28 w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~  107 (701)
                      ...++-+...+++.|++++|.+++. ++..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|+++. +|..  
T Consensus        12 l~~ip~~~~~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--   87 (520)
T 2z7x_B           12 LIHVPKDLSQKTTILNISQNYISEL-WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--   87 (520)
T ss_dssp             CSSCCCSCCTTCSEEECCSSCCCCC-CHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--
T ss_pred             cccccccccccccEEECCCCccccc-ChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--
Confidence            3344433346888889998888753 33457888899999999999988888888899999999999998884 4544  


Q ss_pred             CCCCCCEEECCCCCCCC-CCccccCCccccceeecccccCCCCCcccccCCCCC--cEEEceeccc--CCCcCcccccc-
Q 041034          108 SLRNLEVLYLSNNSLHG-TTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL--IWLSVMYNTV--GGPIPSTLFRL-  181 (701)
Q Consensus       108 ~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l-  181 (701)
                      .+++|++|+|++|++++ ..|..|+.+++|++|+|++|++++   ..+..+++|  +.|++++|.+  .+..|..+..+ 
T Consensus        88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~  164 (520)
T 2z7x_B           88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN  164 (520)
T ss_dssp             CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred             ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccc
Confidence            78899999999999887 467888889999999999998876   456677777  8999999888  66666655542 


Q ss_pred             -------------------------c------------------------------------------------------
Q 041034          182 -------------------------T------------------------------------------------------  182 (701)
Q Consensus       182 -------------------------~------------------------------------------------------  182 (701)
                                               +                                                      
T Consensus       165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~  244 (520)
T 2z7x_B          165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV  244 (520)
T ss_dssp             EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHH
T ss_pred             cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHh
Confidence                                     2                                                      


Q ss_pred             ---ccceeEeeecccCCCCCCCC-----CCccccCccccccccccCCcc-ccccCC---CcccEEEeccCCCCCCCCccc
Q 041034          183 ---NLERLFLGCNQFNGTIPREI-----GNLKNLTHLSIITNKLTGAIP-STLGHL---TSLLYLDLSFNQLHSFIPLEI  250 (701)
Q Consensus       183 ---~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~p-~~l~~l---~~L~~L~L~~N~l~~~~~~~~  250 (701)
                         +|++|++++|+++|.+|..+     +.+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+....  .+
T Consensus       245 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~  320 (520)
T 2z7x_B          245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CP  320 (520)
T ss_dssp             HTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CC
T ss_pred             hhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--ch
Confidence               34444555555555555544     4444444444444444  222 111111   22333333333332211  01


Q ss_pred             CCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCC--CCcccccCccceeeecCCCCcCCCCCCCc-ccCCCC
Q 041034          251 GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG--QIPFAIGKLFNLVSLDLSKNKLSGSFPTG-IGNCTE  327 (701)
Q Consensus       251 ~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~  327 (701)
                      ..+++|+.|++++|++++.+|..+..+++|+.|+|++|++++  .+|..+..+++|+.|++++|.+++.+|.. +..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            455666666666666666666666666666666666666665  34455666666666666666666545543 555666


Q ss_pred             CCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccCCCCCcCCC
Q 041034          328 LQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNNLEGEIPT  388 (701)
Q Consensus       328 L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~l~g~~p~  388 (701)
                      |+.|+|++|++++.+|..+.  ++|+.|++++|+++ .+|..+..    ..|++++|+++ .+|.
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~  461 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD  461 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCT
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCH
Confidence            66666666666655555443  45666666666666 55544322    35666666666 3443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.1e-39  Score=368.65  Aligned_cols=333  Identities=22%  Similarity=0.244  Sum_probs=183.3

Q ss_pred             EEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCC
Q 041034           40 THIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN  119 (701)
Q Consensus        40 ~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~  119 (701)
                      ..++++++++++ +|..   -.++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|+.|.++++|++|+|++
T Consensus        34 ~~l~ls~~~L~~-ip~~---~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKD---LPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CEEECTTSCCCS-CCTT---SCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             cEEEcCCCCCcc-CCCC---CCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence            455556665553 3221   125566666666666655555566666666666666666655566666666666666666


Q ss_pred             CCCCCCCccccCCccccceeecccccCCCC-CcccccCCCCCcEEEceecccCCCcCccccccccc--ceeEeeeccc--
Q 041034          120 NSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNL--ERLFLGCNQF--  194 (701)
Q Consensus       120 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--  194 (701)
                      |+++ .+|..  .+++|++|+|++|++++. .|..|+++++|++|++++|.+++.   .+..+++|  +.|++++|++  
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            6665 23333  556666666666666552 345566666666666666665542   23333333  5666666655  


Q ss_pred             CCCCCCCCCCcc--------------------------------------------------------------------
Q 041034          195 NGTIPREIGNLK--------------------------------------------------------------------  206 (701)
Q Consensus       195 ~~~~~~~~~~l~--------------------------------------------------------------------  206 (701)
                      ++..|..+..+.                                                                    
T Consensus       184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~  263 (562)
T 3a79_B          184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW  263 (562)
T ss_dssp             CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred             cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence            444444443322                                                                    


Q ss_pred             -------------ccCccccccccccCCccccc-----cCCC--------------------------cccEEEeccCCC
Q 041034          207 -------------NLTHLSIITNKLTGAIPSTL-----GHLT--------------------------SLLYLDLSFNQL  242 (701)
Q Consensus       207 -------------~L~~L~l~~N~l~~~~p~~l-----~~l~--------------------------~L~~L~L~~N~l  242 (701)
                                   +|++|++++|.++|.+|..+     ..++                          +|++|++++|.+
T Consensus       264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~  343 (562)
T 3a79_B          264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF  343 (562)
T ss_dssp             HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred             HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence                         45555566666665555544     2222                          233344444433


Q ss_pred             CCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCC--CcccccCccceeeecCCCCcCCCCCCC
Q 041034          243 HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ--IPFAIGKLFNLVSLDLSKNKLSGSFPT  320 (701)
Q Consensus       243 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p~  320 (701)
                      ....  ....+++|+.|++++|++++.+|..+..+++|+.|+|++|++++.  +|..+..+++|+.|++++|++++.+|.
T Consensus       344 ~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  421 (562)
T 3a79_B          344 IHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD  421 (562)
T ss_dssp             CCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS
T ss_pred             cccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh
Confidence            2211  014556666666666666666666666666666666666666642  234566666666666666666654443


Q ss_pred             -cccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccCCCCCcCCC
Q 041034          321 -GIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNNLEGEIPT  388 (701)
Q Consensus       321 -~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~l~g~~p~  388 (701)
                       .+..+++|+.|+|++|++++.+|..+.  ++|+.|+|++|+++ .+|..+..    ..|++++|+++ .+|.
T Consensus       422 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~  490 (562)
T 3a79_B          422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD  490 (562)
T ss_dssp             CCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCT
T ss_pred             hhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCH
Confidence             355566666666666666655554443  45666666666666 45544321    35666666666 3444

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3e-39  Score=364.97  Aligned_cols=340  Identities=21%  Similarity=0.235  Sum_probs=277.1

Q ss_pred             CCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCE
Q 041034           35 YKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEV  114 (701)
Q Consensus        35 ~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  114 (701)
                      ...+++.|++++|.+++ +++..|+.+++|++|+|++|.+++..|..|+.+++|++|+|++|+++ .+|..  .+++|++
T Consensus        50 ~~~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~  125 (562)
T 3a79_B           50 LPPRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRH  125 (562)
T ss_dssp             SCTTCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSE
T ss_pred             CCCCcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCE
Confidence            34689999999999985 44457899999999999999999999999999999999999999999 55655  8999999


Q ss_pred             EECCCCCCCCC-CccccCCccccceeecccccCCCCCcccccCCCCC--cEEEceeccc--CCCcCccccccc-------
Q 041034          115 LYLSNNSLHGT-TPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL--IWLSVMYNTV--GGPIPSTLFRLT-------  182 (701)
Q Consensus       115 L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l~-------  182 (701)
                      |+|++|++++. .|..|+++++|++|+|++|++++.   .+..+++|  +.|++++|.+  ++..|..+..+.       
T Consensus       126 L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~  202 (562)
T 3a79_B          126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV  202 (562)
T ss_dssp             EECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEE
T ss_pred             EECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEE
Confidence            99999999974 468999999999999999999874   45555555  9999999999  777777666543       


Q ss_pred             --------------------------------------------------------------------------ccceeE
Q 041034          183 --------------------------------------------------------------------------NLERLF  188 (701)
Q Consensus       183 --------------------------------------------------------------------------~L~~L~  188 (701)
                                                                                                +|++|+
T Consensus       203 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~  282 (562)
T 3a79_B          203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN  282 (562)
T ss_dssp             ECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEE
T ss_pred             ecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEE
Confidence                                                                                      788889


Q ss_pred             eeecccCCCCCCCC-----CCccc--------------------------cCccccccccccCCccccccCCCcccEEEe
Q 041034          189 LGCNQFNGTIPREI-----GNLKN--------------------------LTHLSIITNKLTGAIPSTLGHLTSLLYLDL  237 (701)
Q Consensus       189 L~~N~l~~~~~~~~-----~~l~~--------------------------L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L  237 (701)
                      +++|+++|.+|..+     .+++.                          |++|++++|.+....  ....+++|++|++
T Consensus       283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l  360 (562)
T 3a79_B          283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNF  360 (562)
T ss_dssp             EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEEC
T ss_pred             EeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEEC
Confidence            99999998888876     44433                          555555555554221  1267888999999


Q ss_pred             ccCCCCCCCCcccCCCCcccEEEcCCCCCcc--ccCcccCCCCCCcEEEccCccCCCCCcc-cccCccceeeecCCCCcC
Q 041034          238 SFNQLHSFIPLEIGNFSALAELDLSDNKIRG--IIPDELSKLSNLQYLNLSSNLLSGQIPF-AIGKLFNLVSLDLSKNKL  314 (701)
Q Consensus       238 ~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l  314 (701)
                      ++|++++.+|..+.++++|+.|+|++|++++  .+|..+..+++|+.|++++|.+++.+|. .+..+++|+.|+|++|++
T Consensus       361 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l  440 (562)
T 3a79_B          361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML  440 (562)
T ss_dssp             CSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCC
T ss_pred             CCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCC
Confidence            9999998888888889999999999999986  3456788899999999999999874554 577888999999999999


Q ss_pred             CCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCC-ccc----cccccccCCCCCcCC
Q 041034          315 SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT-LHP----MFLDMSFNNLEGEIP  387 (701)
Q Consensus       315 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~----~~l~ls~N~l~g~~p  387 (701)
                      ++.+|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..    ..+++++|++++..|
T Consensus       441 ~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          441 TGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             Ccchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            887777654  68999999999988 77877778899999999999998 56654 332    468899999887654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.3e-39  Score=376.79  Aligned_cols=351  Identities=24%  Similarity=0.255  Sum_probs=279.0

Q ss_pred             CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEE
Q 041034           36 KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL  115 (701)
Q Consensus        36 ~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  115 (701)
                      ..+++.|+++++.+++ ++...|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|.++++|++|
T Consensus        24 ~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L  102 (680)
T 1ziw_A           24 PTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL  102 (680)
T ss_dssp             CTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEE
T ss_pred             CCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEE
Confidence            3579999999999986 455568999999999999999999999999999999999999999997777789999999999


Q ss_pred             ECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccc--cccccceeEeeecc
Q 041034          116 YLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLF--RLTNLERLFLGCNQ  193 (701)
Q Consensus       116 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~  193 (701)
                      +|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++..+..+.  .+++|+.|++++|+
T Consensus       103 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~  182 (680)
T 1ziw_A          103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ  182 (680)
T ss_dssp             ECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred             ECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCc
Confidence            9999999988889999999999999999999999999999999999999999999988877655  45899999999999


Q ss_pred             cCCCCCCCCCCc---------------------------cccCccccccccccCCccccccCCCc--ccEEEeccCCCCC
Q 041034          194 FNGTIPREIGNL---------------------------KNLTHLSIITNKLTGAIPSTLGHLTS--LLYLDLSFNQLHS  244 (701)
Q Consensus       194 l~~~~~~~~~~l---------------------------~~L~~L~l~~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~~  244 (701)
                      +++..|..+..+                           ++|+.|++++|.+++..|.++..++.  |++|+|++|++++
T Consensus       183 l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~  262 (680)
T 1ziw_A          183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV  262 (680)
T ss_dssp             CCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred             ccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence            998888776654                           45677788888888888888888765  9999999999998


Q ss_pred             CCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCC-----CCcc----cccCccceeeecCCCCcCC
Q 041034          245 FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG-----QIPF----AIGKLFNLVSLDLSKNKLS  315 (701)
Q Consensus       245 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----~~~~----~~~~l~~L~~L~Ls~N~l~  315 (701)
                      ..|..|+.+++|+.|+|++|++++..|..|..+++|+.|++++|...+     .+|.    .+..+++|+.|++++|.++
T Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            888888889999999999999988888888888888888888776554     2232    5667788888888888888


Q ss_pred             CCCCCcccCCCCCCeeeccCCccCCCC--Ccccccc--ccCCeEEcccccCcccCCCCccc----cccccccCCCCCcCC
Q 041034          316 GSFPTGIGNCTELQHLALNHNSLDGTI--PPEIGKI--LLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFNNLEGEIP  387 (701)
Q Consensus       316 ~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l--~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N~l~g~~p  387 (701)
                      +..|..|..+++|++|++++|.+.+..  +..+..+  ++|+.|++++|++++..|..+..    ..|++++|++++.+|
T Consensus       343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  422 (680)
T 1ziw_A          343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT  422 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred             CCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence            777777777777777777766543221  1112211  34555555555555544443321    245555555554444

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=360.74  Aligned_cols=337  Identities=22%  Similarity=0.293  Sum_probs=284.3

Q ss_pred             CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcc-cCCcccCCCCCCCE
Q 041034           36 KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG-TIPKEIGSLRNLEV  114 (701)
Q Consensus        36 ~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~  114 (701)
                      -.+++.|++++|.+++.. +..|+.+++|++|+|++|.++ .+|..  .+++|++|+|++|.+++ .+|..|+++++|++
T Consensus        44 l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~  119 (520)
T 2z7x_B           44 LSKLRILIISHNRIQYLD-ISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF  119 (520)
T ss_dssp             CTTCCEEECCSSCCCEEE-GGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCE
T ss_pred             cccccEEecCCCccCCcC-hHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceE
Confidence            357999999999998654 346899999999999999999 46665  89999999999999997 47899999999999


Q ss_pred             EECCCCCCCCCCccccCCcccc--ceeecccccC--CCCCcccccCCC--------------------------------
Q 041034          115 LYLSNNSLHGTTPIEIGSLRNL--EELYLRSNKL--SGVLPQEIGNLK--------------------------------  158 (701)
Q Consensus       115 L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~--------------------------------  158 (701)
                      |+|++|++++   ..+..+++|  ++|+|++|.+  .+..|..+..+.                                
T Consensus       120 L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~  196 (520)
T 2z7x_B          120 LGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN  196 (520)
T ss_dssp             EEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECC
T ss_pred             EEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecc
Confidence            9999999986   457778888  9999999999  777777776643                                


Q ss_pred             ---------------------------------------------------CCcEEEceecccCCCcCccc-----cccc
Q 041034          159 ---------------------------------------------------SLIWLSVMYNTVGGPIPSTL-----FRLT  182 (701)
Q Consensus       159 ---------------------------------------------------~L~~L~L~~N~l~~~~~~~~-----~~l~  182 (701)
                                                                         +|++|++++|.+++.+|..+     ..++
T Consensus       197 l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~  276 (520)
T 2z7x_B          197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK  276 (520)
T ss_dssp             EEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCC
T ss_pred             ccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCc
Confidence                                                               78889999999998999988     8999


Q ss_pred             ccceeEeeecccCCCCC-CCCCCc---cccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccE
Q 041034          183 NLERLFLGCNQFNGTIP-REIGNL---KNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAE  258 (701)
Q Consensus       183 ~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~  258 (701)
                      +|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+....  .+..+++|++|++++|++++.+|..++.+++|+.
T Consensus       277 ~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  352 (520)
T 2z7x_B          277 ALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELET  352 (520)
T ss_dssp             EEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCE
T ss_pred             eeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCE
Confidence            999999999999  455 444444   56999999999887532  1267889999999999999988888999999999


Q ss_pred             EEcCCCCCcc--ccCcccCCCCCCcEEEccCccCCCCCcc-cccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccC
Q 041034          259 LDLSDNKIRG--IIPDELSKLSNLQYLNLSSNLLSGQIPF-AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH  335 (701)
Q Consensus       259 L~L~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  335 (701)
                      |+|++|+|++  .+|..+..+++|+.|++++|.+++.+|. .+..+++|+.|++++|++++.+|..+.  ++|+.|+|++
T Consensus       353 L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~  430 (520)
T 2z7x_B          353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHS  430 (520)
T ss_dssp             EECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCS
T ss_pred             EEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCC
Confidence            9999999987  5667788999999999999999985665 477889999999999999888877665  7899999999


Q ss_pred             CccCCCCCccccccccCCeEEcccccCcccCCCC-cc----ccccccccCCCCCcCC
Q 041034          336 NSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT-LH----PMFLDMSFNNLEGEIP  387 (701)
Q Consensus       336 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~----~~~l~ls~N~l~g~~p  387 (701)
                      |+++ .+|..+..+++|+.|++++|+++ .+|.. +.    ...+++++|++++..+
T Consensus       431 N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          431 NKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             SCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             Cccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence            9998 88888889999999999999998 56654 32    2478999999987543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=348.11  Aligned_cols=199  Identities=26%  Similarity=0.361  Sum_probs=168.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------C
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH------K  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  521 (701)
                      .++|++++.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+++|+.++|||||++++++..      .
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            36799999999999999999965 5799999999976543 23445778899999999999999999998764      3


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      +..|+|||||+ |+|.+++....   .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            57899999996 58999997654   699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccC----CCCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          602 ARLLHVD----SSNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       602 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |+.+...    .......+||+.|+|||++.+..+ +.++  ||||+||++|+|+.+.|..
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~--DiWSlG~il~ell~G~~pF  263 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAI--DLWSVGCIFGEMLARRQLF  263 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHH--HHHHHHHHHHHHHHTSCSS
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChh--heehhHHHHHHHHHCCCCC
Confidence            9876432    222345689999999999877654 5554  9999999999988877543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.4e-39  Score=362.84  Aligned_cols=347  Identities=24%  Similarity=0.246  Sum_probs=257.7

Q ss_pred             eEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCC
Q 041034           31 ITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLR  110 (701)
Q Consensus        31 v~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  110 (701)
                      .+|.+.+.   .+.++++++. ++..   -.++|++|+|++|.+++..|..|+++++|++|+|++|++++..|+.|.+++
T Consensus         2 ~~C~~~~~---c~~~~~~l~~-ip~~---~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~   74 (549)
T 2z81_A            2 LSCDASGV---CDGRSRSFTS-IPSG---LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLG   74 (549)
T ss_dssp             CEECTTSE---EECTTSCCSS-CCSC---CCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             ccCCCCce---EECCCCcccc-cccc---CCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccc
Confidence            46888773   5777777773 4432   237999999999999999999999999999999999999999999999999


Q ss_pred             CCCEEECCCCCCCCCCccccCCccccceeecccccCCCC-CcccccCCCCCcEEEceecccCCCcC-cccccccccceeE
Q 041034          111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIP-STLFRLTNLERLF  188 (701)
Q Consensus       111 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  188 (701)
                      +|++|+|++|++++..|..|+++++|++|+|++|++++. .|..++++++|++|++++|.+.+.+| ..+.++++|++|+
T Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  154 (549)
T 2z81_A           75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE  154 (549)
T ss_dssp             TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence            999999999999999888899999999999999999974 67889999999999999999555554 6899999999999


Q ss_pred             eeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCC-----------------------
Q 041034          189 LGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF-----------------------  245 (701)
Q Consensus       189 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------------  245 (701)
                      +++|++++..|..++.+++|++|+++.|.+....+..+..+++|++|++++|++++.                       
T Consensus       155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~  234 (549)
T 2z81_A          155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV  234 (549)
T ss_dssp             EEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred             ccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence            999999998998888766655555555554322111122344444444444444431                       


Q ss_pred             --------------------------------------------------------------------------------
Q 041034          246 --------------------------------------------------------------------------------  245 (701)
Q Consensus       246 --------------------------------------------------------------------------------  245 (701)
                                                                                                      
T Consensus       235 l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~  314 (549)
T 2z81_A          235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR  314 (549)
T ss_dssp             EEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCE
T ss_pred             cchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceE
Confidence                                                                                            


Q ss_pred             ----------CCccc-CCCCcccEEEcCCCCCccccC---cccCCCCCCcEEEccCccCCCCCc--ccccCccceeeecC
Q 041034          246 ----------IPLEI-GNFSALAELDLSDNKIRGIIP---DELSKLSNLQYLNLSSNLLSGQIP--FAIGKLFNLVSLDL  309 (701)
Q Consensus       246 ----------~~~~~-~~~~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L  309 (701)
                                +|..+ ..+++|+.|+|++|++++.+|   ..++.+++|+.|+|++|++++..+  ..+..+++|++|++
T Consensus       315 L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~L  394 (549)
T 2z81_A          315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI  394 (549)
T ss_dssp             EEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEEC
T ss_pred             EEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEEC
Confidence                      22222 346677777777777776553   336667777777777777765432  34667777777777


Q ss_pred             CCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccccccccccCCCCCcCCCc
Q 041034          310 SKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTY  389 (701)
Q Consensus       310 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~l~ls~N~l~g~~p~~  389 (701)
                      ++|+++ .+|..+..+++|++|+|++|+++ .+|..+  .++|+.|++++|++++.++..-....|++++|+++ .+|..
T Consensus       395 s~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~  469 (549)
T 2z81_A          395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA  469 (549)
T ss_dssp             TTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCCG
T ss_pred             CCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCCc
Confidence            777777 56777777777777777777776 334333  24677778888877765443334457888888887 66653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-39  Score=341.70  Aligned_cols=199  Identities=26%  Similarity=0.347  Sum_probs=167.6

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYG  516 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  516 (701)
                      ++.+....++|++.+.||+|+||+||+|+.    ..++.||+|++.....     ..++.+|+++++.+ +||||+++++
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~   87 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKY   87 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEE
Confidence            344445678899999999999999999954    2468899999876532     25678999999998 6999999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeE
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAF  595 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~k  595 (701)
                      ++.+.+..|+||||+++|+|.++++      .+++.++..++.||+.||+|||++   |||||||||+|||++.+ +.+|
T Consensus        88 ~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           88 CFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence            9999999999999999999999984      388999999999999999999999   99999999999999876 7999


Q ss_pred             EEeecCccccccCC----------------------------CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHH
Q 041034          596 VADFGTARLLHVDS----------------------------SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTT  646 (701)
Q Consensus       596 L~DFGla~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i  646 (701)
                      |+|||+|+......                            ......+||+.|+|||++.+.+ ++.++  ||||+||+
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~--DiWSlG~i  236 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAI--DMWSAGVI  236 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHH--HHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCcc--chhhhHHH
Confidence            99999998653221                            1123357999999999987765 55554  99999999


Q ss_pred             HHHcccCCCC
Q 041034          647 ALACLRSKPK  656 (701)
Q Consensus       647 ~~~cl~~~P~  656 (701)
                      +|+|+.+.+.
T Consensus       237 l~ell~G~~P  246 (361)
T 4f9c_A          237 FLSLLSGRYP  246 (361)
T ss_dssp             HHHHHHTCSS
T ss_pred             HHHHHHCCCC
Confidence            9999999843

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.1e-38  Score=366.57  Aligned_cols=351  Identities=25%  Similarity=0.254  Sum_probs=197.7

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|++++|.+++.. +..|+.+++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus        49 ~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  127 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLE-PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD  127 (680)
T ss_dssp             TTCSEEECCSSCCCCCC-TTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred             CcCcEEECCCCccCccC-HHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence            35666666666665432 23455566666666666666644444566666666666666666655555666666666666


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCccccc--CCCCCcEEEceecccCCCcC-------------------
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIG--NLKSLIWLSVMYNTVGGPIP-------------------  175 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~-------------------  175 (701)
                      |++|.+++..|..+..+++|++|+|++|++++..+..+.  .+++|+.|++++|.+++..|                   
T Consensus       128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l  207 (680)
T 1ziw_A          128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL  207 (680)
T ss_dssp             CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred             CCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence            666666666666666666666666666666555554433  23455555555555544443                   


Q ss_pred             --------------------------------cccccccc--cceeEeeecccCCCCCCCCCCccccCccccccccccCC
Q 041034          176 --------------------------------STLFRLTN--LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA  221 (701)
Q Consensus       176 --------------------------------~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  221 (701)
                                                      ..|..++.  |+.|+|++|++++..|..|+.+++|++|++++|++++.
T Consensus       208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  287 (680)
T 1ziw_A          208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL  287 (680)
T ss_dssp             HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred             ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence                                            34444433  66666666666655556666666666666666666655


Q ss_pred             ccccccCCCcccEEEeccCCCCC-----CCCc----ccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEc-------
Q 041034          222 IPSTLGHLTSLLYLDLSFNQLHS-----FIPL----EIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNL-------  285 (701)
Q Consensus       222 ~p~~l~~l~~L~~L~L~~N~l~~-----~~~~----~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L-------  285 (701)
                      .|..|..+++|++|++++|...+     .+|.    .|..+++|+.|++++|++++..|..|.++++|+.|++       
T Consensus       288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~  367 (680)
T 1ziw_A          288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL  367 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC
T ss_pred             ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh
Confidence            55444444444444333332221     0111    3344455555555555555555555544444444443       


Q ss_pred             ---------------------cCccCCCCCcccccCccceeeecCCCCcCCCCCC-CcccCCCCCCeeeccCCccCCCCC
Q 041034          286 ---------------------SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFP-TGIGNCTELQHLALNHNSLDGTIP  343 (701)
Q Consensus       286 ---------------------~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p  343 (701)
                                           ++|++++..|.++..+++|+.|+|++|.+++.+| ..+..+++|+.|++++|++++..+
T Consensus       368 ~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  447 (680)
T 1ziw_A          368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR  447 (680)
T ss_dssp             CEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCT
T ss_pred             hhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeCh
Confidence                                 3444454555666667777777777777766554 456666777777777777666656


Q ss_pred             ccccccccCCeEEcccccCc--ccCCCCccc----cccccccCCCCCcCCC
Q 041034          344 PEIGKILLLQNLDLSHNNLS--GTIPMTLHP----MFLDMSFNNLEGEIPT  388 (701)
Q Consensus       344 ~~~~~l~~L~~l~ls~N~l~--g~~p~~~~~----~~l~ls~N~l~g~~p~  388 (701)
                      ..+..+++|+.|++++|.++  +.+|..+..    ..|++++|++++..|.
T Consensus       448 ~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~  498 (680)
T 1ziw_A          448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD  498 (680)
T ss_dssp             TTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             hhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChh
Confidence            66666666666666666655  344544332    2556666666554443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=374.34  Aligned_cols=335  Identities=24%  Similarity=0.212  Sum_probs=287.4

Q ss_pred             EecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccC-CcccCCCCCCCEEECCCCC
Q 041034           43 ELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTI-PKEIGSLRNLEVLYLSNNS  121 (701)
Q Consensus        43 ~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~  121 (701)
                      +.+.++++. +|.    ..++|+.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+
T Consensus        10 dcs~~~L~~-vP~----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A           10 FYRFCNLTQ-VPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             EESCCCSSC-CCS----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred             EccCCCCCC-CCC----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence            445666664 332    4578999999999999999999999999999999999666555 8899999999999999999


Q ss_pred             CCCCCccccCCccccceeecccccCCCCCccc--ccCCCCCcEEEceecccCCCcC-cccccccccceeEeeecccCCCC
Q 041034          122 LHGTTPIEIGSLRNLEELYLRSNKLSGVLPQE--IGNLKSLIWLSVMYNTVGGPIP-STLFRLTNLERLFLGCNQFNGTI  198 (701)
Q Consensus       122 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~  198 (701)
                      +++..|..|.++++|++|+|++|.+++..|..  |+++++|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..
T Consensus        85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~  164 (844)
T 3j0a_A           85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC  164 (844)
T ss_dssp             CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred             CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence            99999999999999999999999999866665  9999999999999999998765 57999999999999999999999


Q ss_pred             CCCCCCc--cccCccccccccccCCccccccCCCc------ccEEEeccCCCCCCCCcccCC------------------
Q 041034          199 PREIGNL--KNLTHLSIITNKLTGAIPSTLGHLTS------LLYLDLSFNQLHSFIPLEIGN------------------  252 (701)
Q Consensus       199 ~~~~~~l--~~L~~L~l~~N~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~~~~~~~------------------  252 (701)
                      +..+..+  ++|+.|+++.|.+.+..|..+..+++      |++|++++|.+++..+..+..                  
T Consensus       165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~  244 (844)
T 3j0a_A          165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG  244 (844)
T ss_dssp             SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCB
T ss_pred             HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccc
Confidence            9999888  88999999999999988888777766      999999999887665544321                  


Q ss_pred             --------------------CCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCC
Q 041034          253 --------------------FSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKN  312 (701)
Q Consensus       253 --------------------~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  312 (701)
                                          .++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|
T Consensus       245 ~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N  324 (844)
T 3j0a_A          245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN  324 (844)
T ss_dssp             CSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESC
T ss_pred             ccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCC
Confidence                                267899999999999888888999999999999999999888888999999999999999


Q ss_pred             cCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccccccccccCCCC
Q 041034          313 KLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLE  383 (701)
Q Consensus       313 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~l~ls~N~l~  383 (701)
                      .+++..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++ ++.......+++++|+++
T Consensus       325 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~l~  394 (844)
T 3j0a_A          325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHFIPSIPDIFLSGNKLV  394 (844)
T ss_dssp             CCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSSCCSCSEEEEESCCCC
T ss_pred             CCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccCCCCcchhccCCCCcc
Confidence            9998888899999999999999999988878888889999999999999874 333222334555666555

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=352.81  Aligned_cols=344  Identities=23%  Similarity=0.192  Sum_probs=308.5

Q ss_pred             CcceeEeCC----------CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCC
Q 041034           27 NWVGITCDY----------KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWN   96 (701)
Q Consensus        27 ~w~gv~c~~----------~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n   96 (701)
                      .|..|.|..          ...++.|+|+++.+++ ++...|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            467788863          2478899999999986 44557899999999999999999999999999999999999999


Q ss_pred             cCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCc
Q 041034           97 NLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS  176 (701)
Q Consensus        97 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  176 (701)
                      ++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|+.|+|++|.+++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            99988778899999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             ccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcc
Q 041034          177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL  256 (701)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L  256 (701)
                      .+..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+.+|.......+|++|+|++|++++..+..+..+++|
T Consensus       171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  250 (477)
T 2id5_A          171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL  250 (477)
T ss_dssp             HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred             HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence            89999999999999999999888899999999999999999988888888778899999999999998655688999999


Q ss_pred             cEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCC
Q 041034          257 AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN  336 (701)
Q Consensus       257 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  336 (701)
                      +.|+|++|.|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  330 (477)
T 2id5_A          251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN  330 (477)
T ss_dssp             CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred             CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence            99999999999998899999999999999999999999999999999999999999999877778899999999999999


Q ss_pred             ccCCCCCccccccccCCeEEcccccCcccCCCCccc
Q 041034          337 SLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP  372 (701)
Q Consensus       337 ~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~  372 (701)
                      ++.+.-+. .+-...+..+.+.++...+.-|..+..
T Consensus       331 ~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~~~~g  365 (477)
T 2id5_A          331 PLACDCRL-LWVFRRRWRLNFNRQQPTCATPEFVQG  365 (477)
T ss_dssp             CEECSGGG-HHHHTTTTSSCCTTCCCBEEESGGGTT
T ss_pred             CccCccch-HhHHhhhhccccCccCceeCCchHHcC
Confidence            99865332 122233445667777777777765543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.2e-39  Score=357.56  Aligned_cols=200  Identities=24%  Similarity=0.312  Sum_probs=171.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE---DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+....   ..........++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            47899999999999999999965 46999999999754321   122223334557778888999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+|||||+||+|.+++.+..   .+++..+..++.||+.||+|||++   |||||||||+|||++.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999998754   599999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCCCC
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPKSR  658 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~~R  658 (701)
                      +...  .....+||+.|||||++.. ..++.++  ||||+||++|+|+.+.|..+
T Consensus       342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~v--DiWSLGvilYEmLtG~~PF~  392 (689)
T 3v5w_A          342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSPFR  392 (689)
T ss_dssp             CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHH--HHHHHHHHHHHHHHSSCTTC
T ss_pred             cCCC--CCCCccCCcCccCHHHHhCCCCCCcHH--HHHHHHHHHHHHHhCCCCCC
Confidence            7533  2344689999999999864 5677766  99999999999999987653

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.9e-38  Score=360.56  Aligned_cols=334  Identities=21%  Similarity=0.184  Sum_probs=284.9

Q ss_pred             CCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceee
Q 041034           61 FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELY  140 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  140 (701)
                      +++++.|++++|.+....+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            57889999999999877777788999999999999999988888999999999999999999998888899999999999


Q ss_pred             cccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccC
Q 041034          141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG  220 (701)
Q Consensus       141 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  220 (701)
                      |++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|.+++.   .++.+++|+.|++++|.+++
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc
Confidence            999999988888889999999999999999999998999999999999999999875   35667889999999998875


Q ss_pred             CccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccC
Q 041034          221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK  300 (701)
Q Consensus       221 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  300 (701)
                      .     ...++|+.|++++|.+....+..   .++|+.|+|++|.+++.  ..+..+++|+.|+|++|.+++.+|..+..
T Consensus       207 l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  276 (597)
T 3oja_B          207 L-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVK  276 (597)
T ss_dssp             E-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred             c-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence            3     34568999999999998754332   36899999999999874  67889999999999999999988999999


Q ss_pred             ccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCcc-cccccccc
Q 041034          301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH-PMFLDMSF  379 (701)
Q Consensus       301 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~~~l~ls~  379 (701)
                      +++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..++.+++|+.|+|++|++++.-+..+. ...|++++
T Consensus       277 l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~  354 (597)
T 3oja_B          277 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSH  354 (597)
T ss_dssp             CSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCS
T ss_pred             ccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeC
Confidence            9999999999999985 6777788999999999999998 6888889999999999999999865333332 24799999


Q ss_pred             CCCCCcC-CCcCCCCCCCCcCCCccccccee
Q 041034          380 NNLEGEI-PTYLRDNPPNSFVGNKGLCGHVQ  409 (701)
Q Consensus       380 N~l~g~~-p~~~~~~~~~~~~~~~~~~~~~~  409 (701)
                      |++++.. +.++...+...+.++...|+...
T Consensus       355 N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          355 NDWDCNSLRALFRNVARPAVDDADQHCKIDY  385 (597)
T ss_dssp             SCEEHHHHHHHTTTCCTTTBCCCCCCCCTTC
T ss_pred             CCCCChhHHHHHHHHhhhccccccccCCcch
Confidence            9998753 33445556666777888887644

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-39  Score=358.18  Aligned_cols=210  Identities=23%  Similarity=0.367  Sum_probs=177.7

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++.....   ...+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999955 5799999999976442   2346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--CCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN--LEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~--~~~kL~DFGla~~~  605 (701)
                      ||||+||+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       233 ~E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EeecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999965432  589999999999999999999999   99999999999999854  89999999999987


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhh
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELE  669 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~  669 (701)
                      ... ......+||+.|||||++.+.+++..+  ||||+||++|+|+.+.|. .-.+..++++.+.
T Consensus       308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~--DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~  369 (573)
T 3uto_A          308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETLRNVK  369 (573)
T ss_dssp             CTT-SEEEEECSSGGGCCHHHHTTCCBCHHH--HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             cCC-CceeeeEECccccCHHHhCCCCCCcHH--HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            533 334456899999999999999888776  999999999986666532 3334444444443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=360.64  Aligned_cols=349  Identities=22%  Similarity=0.248  Sum_probs=291.6

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|++++|.+++ ++...|+.+++|++|+|++|.+++..|..|+.+++|++|+|++|++++..+..|+++++|++|+
T Consensus        52 ~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  130 (570)
T 2z63_A           52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN  130 (570)
T ss_dssp             SSCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEE
T ss_pred             CCceEEECCCCcCCc-cCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEe
Confidence            478999999999885 4555688999999999999999988888999999999999999999977766799999999999


Q ss_pred             CCCCCCCCC-CccccCCccccceeecccccCCCCCcccccCCCCC----cEEEceecccCCCc-----------------
Q 041034          117 LSNNSLHGT-TPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL----IWLSVMYNTVGGPI-----------------  174 (701)
Q Consensus       117 Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~-----------------  174 (701)
                      |++|.+++. +|..|+++++|++|++++|++++..+..++.+++|    ..|++++|.+.+..                 
T Consensus       131 L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n  210 (570)
T 2z63_A          131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN  210 (570)
T ss_dssp             CCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred             cCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence            999999874 68889999999999999998887766666655555    55555555443322                 


Q ss_pred             ----------------------------------------------------------------CcccccccccceeEee
Q 041034          175 ----------------------------------------------------------------PSTLFRLTNLERLFLG  190 (701)
Q Consensus       175 ----------------------------------------------------------------~~~~~~l~~L~~L~L~  190 (701)
                                                                                      |..+..+++|+.|+++
T Consensus       211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~  290 (570)
T 2z63_A          211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV  290 (570)
T ss_dssp             CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred             cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence                                                                            2333344555556555


Q ss_pred             ecccCCCCCCCC------------------------------------------CCccccCccccccccccCCc--cccc
Q 041034          191 CNQFNGTIPREI------------------------------------------GNLKNLTHLSIITNKLTGAI--PSTL  226 (701)
Q Consensus       191 ~N~l~~~~~~~~------------------------------------------~~l~~L~~L~l~~N~l~~~~--p~~l  226 (701)
                      +|.+++ +|..+                                          ..+++|++|++++|++++..  |..+
T Consensus       291 ~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~  369 (570)
T 2z63_A          291 SVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD  369 (570)
T ss_dssp             SCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHH
T ss_pred             Cccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccc
Confidence            555542 23222                                          45788999999999998654  7788


Q ss_pred             cCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccC-cccCCCCCCcEEEccCccCCCCCcccccCcccee
Q 041034          227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIP-DELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLV  305 (701)
Q Consensus       227 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  305 (701)
                      ..+++|++|++++|.+.+..+. +..+++|+.|++++|.+++..| ..+..+++|+.|++++|.+++..|..+..+++|+
T Consensus       370 ~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  448 (570)
T 2z63_A          370 FGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE  448 (570)
T ss_dssp             HTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             cccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCc
Confidence            9999999999999999985554 8999999999999999998776 5789999999999999999999999999999999


Q ss_pred             eecCCCCcCC-CCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc----cccccccC
Q 041034          306 SLDLSKNKLS-GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP----MFLDMSFN  380 (701)
Q Consensus       306 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~----~~l~ls~N  380 (701)
                      .|++++|.++ +.+|..+..+++|+.|+|++|++++..|..++.+++|+.|++++|++++..|..+..    ..+++++|
T Consensus       449 ~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N  528 (570)
T 2z63_A          449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN  528 (570)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCC
Confidence            9999999998 679999999999999999999999988999999999999999999999887766543    47999999


Q ss_pred             CCCCcCCC
Q 041034          381 NLEGEIPT  388 (701)
Q Consensus       381 ~l~g~~p~  388 (701)
                      +++|..|.
T Consensus       529 ~~~~~~~~  536 (570)
T 2z63_A          529 PWDCSCPR  536 (570)
T ss_dssp             CBCCCTTT
T ss_pred             cccCCCcc
Confidence            99998774

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=7.9e-38  Score=358.71  Aligned_cols=347  Identities=27%  Similarity=0.284  Sum_probs=234.9

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      ..++.|+|++|.+++ +++..|+.+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus        52 ~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~  130 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  130 (635)
T ss_dssp             TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred             cCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence            478999999999984 6666899999999999999999998889999999999999999999988888999999999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCC-CcccccCCCCCcEEEceecccCCCcCccccccc-------------
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT-------------  182 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------------  182 (701)
                      |++|++++..+..|+++++|++|+|++|++++. .|..++.+++|++|+|++|++++..+..+..+.             
T Consensus       131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~  210 (635)
T 4g8a_A          131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  210 (635)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence            999999998888999999999999999999864 688899999999999999998776554443222             


Q ss_pred             --------------------------------------------------------------------------------
Q 041034          183 --------------------------------------------------------------------------------  182 (701)
Q Consensus       183 --------------------------------------------------------------------------------  182 (701)
                                                                                                      
T Consensus       211 n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          211 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             CcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence                                                                                            


Q ss_pred             --------------------------------------ccceeEeeecccCCCCCC-------------------CCCCc
Q 041034          183 --------------------------------------NLERLFLGCNQFNGTIPR-------------------EIGNL  205 (701)
Q Consensus       183 --------------------------------------~L~~L~L~~N~l~~~~~~-------------------~~~~l  205 (701)
                                                            +|+.|++.+|.+.+..+.                   ....+
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l  370 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL  370 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC
T ss_pred             hcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc
Confidence                                                  122333333333322111                   12245


Q ss_pred             cccCccccccccccC--CccccccCCCcccEEEeccCCC-----------------------CCCCC-cccCCCCcccEE
Q 041034          206 KNLTHLSIITNKLTG--AIPSTLGHLTSLLYLDLSFNQL-----------------------HSFIP-LEIGNFSALAEL  259 (701)
Q Consensus       206 ~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l-----------------------~~~~~-~~~~~~~~L~~L  259 (701)
                      ++|+.|++++|.+..  ..+..+..+.+|++++++.|.+                       ....+ ..+..+++++.+
T Consensus       371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l  450 (635)
T 4g8a_A          371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  450 (635)
T ss_dssp             TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred             cccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence            677888888887743  2333333444444444444444                       33322 234455555555


Q ss_pred             EcCCCCCccccCcccCCCCCCcEEEccCccC-CCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCcc
Q 041034          260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLL-SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL  338 (701)
Q Consensus       260 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  338 (701)
                      +++.|.+.+..|..+..+++|+.|+|++|.+ .+..|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus       451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l  530 (635)
T 4g8a_A          451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  530 (635)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence            5555555555555555555566666655543 223455555555566666666666555555555556666666666666


Q ss_pred             CCCCCccccccccCCeEEcccccCcccCCCCccc-----cccccccCCCCC
Q 041034          339 DGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP-----MFLDMSFNNLEG  384 (701)
Q Consensus       339 ~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~-----~~l~ls~N~l~g  384 (701)
                      ++..|..|..+++|+.|+|++|+|++..|..+..     .+|++++|++.+
T Consensus       531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            5555555555556666666666665555544321     245555555543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.6e-38  Score=336.99  Aligned_cols=333  Identities=21%  Similarity=0.188  Sum_probs=256.0

Q ss_pred             CCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccccee
Q 041034           60 CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        60 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  139 (701)
                      .+++++.|++++|.+....+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+.+++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            35778888888888876655567888888888888888887777788888888888888888888888888888888888


Q ss_pred             ecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccccc
Q 041034          140 YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       140 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  219 (701)
                      +|++|+++...+..|.++++|++|++++|.+++..+..+..+++|++|++++|++++.   .++.+++|+.|++++|.++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence            8888888876666678888888888888888888888888888888888888888764   3566778888888888887


Q ss_pred             CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCccccc
Q 041034          220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIG  299 (701)
Q Consensus       220 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  299 (701)
                      +.     ...++|++|++++|.+... |..  .+++|+.|++++|.+++.  ..+..+++|+.|+|++|.+++..|..+.
T Consensus       200 ~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~  269 (390)
T 3o6n_A          200 TL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV  269 (390)
T ss_dssp             EE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             cc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence            42     3345788888888888774 332  347888888888888864  5678888888888888888887788888


Q ss_pred             CccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCcc-ccccccc
Q 041034          300 KLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH-PMFLDMS  378 (701)
Q Consensus       300 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~-~~~l~ls  378 (701)
                      .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..-...+. ...|+++
T Consensus       270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~  347 (390)
T 3o6n_A          270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLS  347 (390)
T ss_dssp             TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECC
T ss_pred             ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcC
Confidence            88888888888888874 5666677888888888888887 6677788888888888888888754222222 2478888


Q ss_pred             cCCCCCcCC-CcCCCCCCCCcCCCcccccc
Q 041034          379 FNNLEGEIP-TYLRDNPPNSFVGNKGLCGH  407 (701)
Q Consensus       379 ~N~l~g~~p-~~~~~~~~~~~~~~~~~~~~  407 (701)
                      +|++++.-. .+....+...+.++...|..
T Consensus       348 ~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~  377 (390)
T 3o6n_A          348 HNDWDCNSLRALFRNVARPAVDDADQHCKI  377 (390)
T ss_dssp             SSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred             CCCccchhHHHHHHHHHhhcccccCceecc
Confidence            888876422 22233344445555555654

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4e-37  Score=336.88  Aligned_cols=325  Identities=21%  Similarity=0.201  Sum_probs=277.4

Q ss_pred             CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEE
Q 041034           36 KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL  115 (701)
Q Consensus        36 ~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  115 (701)
                      -.+++.|+++++.+++. +  .+..+++|++|+|++|.+++. |  ++.+++|++|+|++|.+++. |  ++++++|++|
T Consensus        41 l~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L  111 (457)
T 3bz5_A           41 LATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL  111 (457)
T ss_dssp             HTTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred             cCCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE
Confidence            35789999999999874 3  588999999999999999975 4  89999999999999999975 3  8999999999


Q ss_pred             ECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC
Q 041034          116 YLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       116 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      +|++|++++. +  ++.+++|++|++++|++++.   .++++++|++|++++|...+.+  .+..+++|+.|++++|+++
T Consensus       112 ~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~  183 (457)
T 3bz5_A          112 NCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT  183 (457)
T ss_dssp             ECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccc
Confidence            9999999974 3  89999999999999999985   3889999999999999766665  4788999999999999999


Q ss_pred             CCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccC
Q 041034          196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                      + +|  ++.+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  ++.+++|+.|++++|++++..+..+.
T Consensus       184 ~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~  254 (457)
T 3bz5_A          184 E-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLS  254 (457)
T ss_dssp             C-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCT
T ss_pred             e-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCC
Confidence            7 44  88999999999999999975   48899999999999999999 56  88999999999999999987666665


Q ss_pred             CCC-------CCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCC--------cccCCCCCCeeeccCCccCC
Q 041034          276 KLS-------NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPT--------GIGNCTELQHLALNHNSLDG  340 (701)
Q Consensus       276 ~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~L~~N~l~~  340 (701)
                      .+.       +|+.|++++|.+.+.+|  ++.+++|+.|++++|.+.|.+|.        .+..+++|+.|++++|++++
T Consensus       255 ~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~  332 (457)
T 3bz5_A          255 KLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE  332 (457)
T ss_dssp             TCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC
T ss_pred             CCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccc
Confidence            554       56677777777777766  56789999999999998777764        25667899999999999998


Q ss_pred             CCCccccccccCCeEEcccccCcccCCCCc----------------cccccccccCCCCCcCCCcCCC
Q 041034          341 TIPPEIGKILLLQNLDLSHNNLSGTIPMTL----------------HPMFLDMSFNNLEGEIPTYLRD  392 (701)
Q Consensus       341 ~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~----------------~~~~l~ls~N~l~g~~p~~~~~  392 (701)
                      . +  ++.+++|+.|++++|+++| +|..-                ....+++++|+++|.||..+.+
T Consensus       333 l-~--l~~l~~L~~L~l~~N~l~~-l~~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~~~~  396 (457)
T 3bz5_A          333 L-D--VSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLD  396 (457)
T ss_dssp             C-C--CTTCTTCSEEECCSSCCCB-CTTGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred             c-c--cccCCcCcEEECCCCCCCC-ccccccccccCCcEEecceeeecCccccccCcEEEEcChhHhc
Confidence            4 3  8899999999999999997 33211                1135789999999999876554

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=323.60  Aligned_cols=214  Identities=28%  Similarity=0.508  Sum_probs=186.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   +....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            57899999999999999999965 46899999998653   344567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.++++....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999999987433  589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCc--------------eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------
Q 041034          608 DSSNR--------------TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------  649 (701)
Q Consensus       608 ~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------  649 (701)
                      .....              ....||+.|+|||++.+..++.+.  ||||+|+++++                        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV--DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH--HHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence            32211              135699999999999888877765  99999999984                        


Q ss_pred             --------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 --------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 --------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                          ||..+|.+|||+.++++.|+...
T Consensus       239 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                                77889999999999999988654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.2e-38  Score=325.68  Aligned_cols=224  Identities=30%  Similarity=0.473  Sum_probs=181.9

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++....++|++.+.||+|+||.||+|+. +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            344445578899999999999999999976 588999999976543 334457889999999999999999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEEee
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g--ivH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      +..++||||+++|+|.+++........+++..+..++.|++.||+|||++   |  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence            99999999999999999998765444589999999999999999999998   8  999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      |+++.............||+.|+|||++.+..++.+.  ||||+|+++|+                              
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  261 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS--DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP  261 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTH--HHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence            9998665443344456799999999999888887765  99999999985                              


Q ss_pred             -------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                   ||..+|.+|||++++++.|+...
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                         78888899999999988887543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.3e-37  Score=318.92  Aligned_cols=193  Identities=26%  Similarity=0.402  Sum_probs=171.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.......   .+.+.+|+.+++.++||||+++++++...+..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            357899999999999999999965 578999999997654433   3668899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++...
T Consensus        95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999999999764    488999999999999999999999   99999999999999999999999999998876


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..........||+.|+|||++.+..++.+.  ||||+|+++|+++.
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~  211 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV--DIWSLGIMAIEMIE  211 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHH--HHHHHHHHHHHHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHH--HHHHHHHHHHHHHh
Confidence            555555566899999999999888887765  99999999996443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=5.2e-37  Score=330.47  Aligned_cols=312  Identities=21%  Similarity=0.219  Sum_probs=278.2

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      ..++.+++.++.++ .++...|..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|+
T Consensus        45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            45677888888876 46666678899999999999999988888999999999999999999999899999999999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCC
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG  196 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (701)
                      |++|+++...+..|..+++|++|+|++|++++..|..|.++++|++|++++|.+++.   .+..+++|+.|++++|.+++
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence            999999977777789999999999999999999999999999999999999999876   36678999999999999885


Q ss_pred             CCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCC
Q 041034          197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK  276 (701)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~  276 (701)
                      .     ...++|++|++++|.++.. |..  ..++|++|++++|.+++.  ..+..+++|+.|+|++|.+++..|..|..
T Consensus       201 ~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~  270 (390)
T 3o6n_A          201 L-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVK  270 (390)
T ss_dssp             E-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred             c-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccc
Confidence            3     3346899999999999865 433  347999999999999984  57889999999999999999999999999


Q ss_pred             CCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEE
Q 041034          277 LSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD  356 (701)
Q Consensus       277 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~  356 (701)
                      +++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++.. |  +..+++|+.|+
T Consensus       271 l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~  345 (390)
T 3o6n_A          271 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLT  345 (390)
T ss_dssp             CSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEE
T ss_pred             cccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEE
Confidence            9999999999999985 5667788999999999999999 6787889999999999999999854 4  67889999999


Q ss_pred             cccccCcccCC
Q 041034          357 LSHNNLSGTIP  367 (701)
Q Consensus       357 ls~N~l~g~~p  367 (701)
                      +++|++++...
T Consensus       346 l~~N~~~~~~~  356 (390)
T 3o6n_A          346 LSHNDWDCNSL  356 (390)
T ss_dssp             CCSSCEEHHHH
T ss_pred             cCCCCccchhH
Confidence            99999997643

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.2e-36  Score=333.28  Aligned_cols=323  Identities=32%  Similarity=0.443  Sum_probs=186.1

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|++.+++++. ++  .+..+++|++|+|++|.+++..+  +..+++|++|+|++|.+++..+  +.++++|++|+
T Consensus        46 ~~l~~L~l~~~~i~~-l~--~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           46 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  118 (466)
T ss_dssp             HTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             ccccEEecCCCCCcc-Cc--chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence            356777777777663 33  25667778888888887775543  7777888888888888776544  77788888888


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCc-------------------ccccCCCCCcEEEceecccCCCcCcc
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLP-------------------QEIGNLKSLIWLSVMYNTVGGPIPST  177 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-------------------~~~~~l~~L~~L~L~~N~l~~~~~~~  177 (701)
                      |++|.+++..+  +..+++|++|+|++|.+++...                   ..+.++++|+.|++++|.+++.  ..
T Consensus       119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~  194 (466)
T 1o6v_A          119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SV  194 (466)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GG
T ss_pred             CCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hh
Confidence            88887776543  7777888888888887775321                   1134444555555555554433  22


Q ss_pred             cccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCccc
Q 041034          178 LFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA  257 (701)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~  257 (701)
                      +..+++|++|++++|++++..|  ++.+++|++|++++|++++.  ..+..+++|++|++++|.+++..+  +..+++|+
T Consensus       195 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  268 (466)
T 1o6v_A          195 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT  268 (466)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCC
Confidence            4455555555555555554433  44455555555555555532  234555555555555555555333  45555555


Q ss_pred             EEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCc
Q 041034          258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNS  337 (701)
Q Consensus       258 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  337 (701)
                      .|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|+
T Consensus       269 ~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~  342 (466)
T 1o6v_A          269 ELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK  342 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSC
T ss_pred             EEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCc
Confidence            55555555554332  5555555555555555554333  4455555555555555554443  4555555555555555


Q ss_pred             cCCCCCccccccccCCeEEcccccCcccCCCCc--cccccccccCCCCC
Q 041034          338 LDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL--HPMFLDMSFNNLEG  384 (701)
Q Consensus       338 l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~--~~~~l~ls~N~l~g  384 (701)
                      +++.  ..++.+++|+.|++++|++++..|..-  ....+++++|++++
T Consensus       343 l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          343 VSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred             cCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC
Confidence            5543  345555555555555555555554111  11245555555554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-37  Score=325.71  Aligned_cols=234  Identities=35%  Similarity=0.647  Sum_probs=199.8

Q ss_pred             CCcccHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeee
Q 041034          437 DGKILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       437 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      ...++++++....++|++.+.||+|+||.||+|...+++.||||++........  ...+.+|+.+++.++||||+++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEE
Confidence            346788999999999999999999999999999887899999999986543221  236889999999999999999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeE
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAF  595 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~k  595 (701)
                      ++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++.+||+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999987542 33589999999999999999999998777999999999999999999999


Q ss_pred             EEeecCccccccCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------
Q 041034          596 VADFGTARLLHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------  649 (701)
Q Consensus       596 L~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------  649 (701)
                      |+|||+++........ .....||+.|+|||.+.+..++.+.  ||||+|+++++                         
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT--DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHH--HHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccc--cchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999876533332 3334599999999998777776665  99999999884                         


Q ss_pred             -----------------------------------cccCCCCCCCCHHHHHHHhhcCCCc
Q 041034          650 -----------------------------------CLRSKPKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       650 -----------------------------------cl~~~P~~Rpt~~~i~~~l~~~~~~  674 (701)
                                                         |+..+|.+|||++|+++.|++....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence                                               6677899999999999999875543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-36  Score=345.82  Aligned_cols=311  Identities=21%  Similarity=0.215  Sum_probs=278.6

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEEC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL  117 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  117 (701)
                      .+..+++.++.++ .++...|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        52 ~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            4567778888776 456666788999999999999999998989999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCC
Q 041034          118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT  197 (701)
Q Consensus       118 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  197 (701)
                      ++|.+++..+..|..+++|++|+|++|.+++..|..|+++++|+.|+|++|.+++..   +..+++|+.|++++|.+++.
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l  207 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL  207 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc
Confidence            999999887778899999999999999999999999999999999999999998763   56678999999999999853


Q ss_pred             CCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCC
Q 041034          198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL  277 (701)
Q Consensus       198 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l  277 (701)
                           ...++|+.|++++|.++...+. +  .++|+.|+|++|.+++.  ..+..+++|+.|+|++|.|++..|..|..+
T Consensus       208 -----~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  277 (597)
T 3oja_B          208 -----AIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKM  277 (597)
T ss_dssp             -----ECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred             -----cCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCc
Confidence                 3456899999999999854333 2  36899999999999983  678999999999999999999999999999


Q ss_pred             CCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEc
Q 041034          278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDL  357 (701)
Q Consensus       278 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  357 (701)
                      ++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++. |  +..+++|+.|+|
T Consensus       278 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l  352 (597)
T 3oja_B          278 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTL  352 (597)
T ss_dssp             SSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEEC
T ss_pred             cCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEe
Confidence            999999999999996 5777788999999999999999 6888899999999999999999854 3  677889999999


Q ss_pred             ccccCcccCC
Q 041034          358 SHNNLSGTIP  367 (701)
Q Consensus       358 s~N~l~g~~p  367 (701)
                      ++|+++|..+
T Consensus       353 ~~N~~~~~~~  362 (597)
T 3oja_B          353 SHNDWDCNSL  362 (597)
T ss_dssp             CSSCEEHHHH
T ss_pred             eCCCCCChhH
Confidence            9999998654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-36  Score=314.30  Aligned_cols=196  Identities=27%  Similarity=0.394  Sum_probs=168.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            57899999999999999999965 46899999999876666666678899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          608 DSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       608 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ... ......||+.|+|||++.+..++.+.  ||||+|+++|++++
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~~l~~ll~  207 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLV  207 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTH--HHHHHHHHHHHHHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchH--hHHHHHHHHHHHHh
Confidence            322 23345699999999999888877765  99999999996443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.5e-37  Score=321.26  Aligned_cols=198  Identities=24%  Similarity=0.325  Sum_probs=172.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++.........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999654 6999999999764322222346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999997644   589999999999999999999999   999999999999999999999999999987544


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~  202 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGR  202 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTH--HHHHHHHHHHHHHHSS
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchh--hcccchhHHHHHhcCC
Confidence            44445566899999999999888887776  9999999999866655

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.7e-37  Score=321.23  Aligned_cols=194  Identities=23%  Similarity=0.406  Sum_probs=169.5

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            3467899999999999999999965 5799999999976543 2344577889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+|+..
T Consensus        91 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             EEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            9999999999999997654   589999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ... .......||+.|+|||++.+..+... ..||||+|+++++
T Consensus       165 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~e  206 (328)
T 3fe3_A          165 TVG-GKLDAFCGAPPYAAPELFQGKKYDGP-EVDVWSLGVILYT  206 (328)
T ss_dssp             SSS-CGGGTTSSSGGGCCHHHHHTCCCCSH-HHHHHHHHHHHHH
T ss_pred             CCC-CccccccCCcceeCcccccCCCcCCc-hhhhhhhHHHHHH
Confidence            533 23445679999999999988776532 2499999999996

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.5e-36  Score=344.07  Aligned_cols=345  Identities=24%  Similarity=0.258  Sum_probs=279.9

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      +++++|||++|+|+++.+..|.++++|++|||++|+|+++.|++|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            47999999999999888889999999999999999999988999999999999999999999888889999999999999


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCC-cCcccccccccceeEeeecccCCCCCCCCCCcc--------------
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP-IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLK--------------  206 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--------------  206 (701)
                      ++|++++..+..|+++++|++|+|++|.+.+. .|..+..+++|++|+|++|++++..+..+..+.              
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n  211 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  211 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence            99999999888999999999999999999764 678889999999999999998866554432221              


Q ss_pred             --------------------------------------------------------------------------------
Q 041034          207 --------------------------------------------------------------------------------  206 (701)
Q Consensus       207 --------------------------------------------------------------------------------  206 (701)
                                                                                                      
T Consensus       212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~  291 (635)
T 4g8a_A          212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL  291 (635)
T ss_dssp             CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred             cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence                                                                                            


Q ss_pred             -------------------------------------ccCccccccccccCCccc-------------------cccCCC
Q 041034          207 -------------------------------------NLTHLSIITNKLTGAIPS-------------------TLGHLT  230 (701)
Q Consensus       207 -------------------------------------~L~~L~l~~N~l~~~~p~-------------------~l~~l~  230 (701)
                                                           +|+.|++.+|.+.+..+.                   ....++
T Consensus       292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~  371 (635)
T 4g8a_A          292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP  371 (635)
T ss_dssp             CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred             cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence                                                 122233333333221111                   122467


Q ss_pred             cccEEEeccCCCCCC--CC-----------------------cccCCCCcccEEEcCCCCCccccC-cccCCCCCCcEEE
Q 041034          231 SLLYLDLSFNQLHSF--IP-----------------------LEIGNFSALAELDLSDNKIRGIIP-DELSKLSNLQYLN  284 (701)
Q Consensus       231 ~L~~L~L~~N~l~~~--~~-----------------------~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~  284 (701)
                      +|+.|++++|.+...  .+                       ..+..+++|+.++++.|++....+ ..+..+++++.++
T Consensus       372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~  451 (635)
T 4g8a_A          372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD  451 (635)
T ss_dssp             TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred             ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence            889999999988642  12                       223455667777777666654433 4577888999999


Q ss_pred             ccCccCCCCCcccccCccceeeecCCCCcC-CCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCc
Q 041034          285 LSSNLLSGQIPFAIGKLFNLVSLDLSKNKL-SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS  363 (701)
Q Consensus       285 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  363 (701)
                      ++.|.+.+..+..+..+++|+.|+|++|++ .+..|..+..+++|+.|+|++|+|++..|..|+.+++|++|+|++|+|+
T Consensus       452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~  531 (635)
T 4g8a_A          452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF  531 (635)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence            999999988888999999999999999985 4467889999999999999999999999999999999999999999999


Q ss_pred             ccCCCCccc----cccccccCCCCCcCCCcCCCCCC----CCcCCCccccc
Q 041034          364 GTIPMTLHP----MFLDMSFNNLEGEIPTYLRDNPP----NSFVGNKGLCG  406 (701)
Q Consensus       364 g~~p~~~~~----~~l~ls~N~l~g~~p~~~~~~~~----~~~~~~~~~~~  406 (701)
                      +..|..+..    .+||+++|++++..|..+...+.    -...+|+-.|.
T Consensus       532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            887766543    48999999999999988765532    13455665554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-36  Score=315.89  Aligned_cols=205  Identities=25%  Similarity=0.374  Sum_probs=176.3

Q ss_pred             CcccHHHHHhhhcC----------CccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC
Q 041034          438 GKILYEDLINATED----------FHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV  506 (701)
Q Consensus       438 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l  506 (701)
                      +.++++++..+++.          |...+.||+|+||.||+|... +|+.||||++.......   .+.+.+|+.+++++
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l   99 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDY   99 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhC
Confidence            34566776666553          777889999999999999765 79999999997654333   36788999999999


Q ss_pred             CCCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcE
Q 041034          507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNI  586 (701)
Q Consensus       507 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NI  586 (701)
                      +||||+++++++...+..++||||+++++|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||
T Consensus       100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A          100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999999999999999999999999999998753    489999999999999999999999   999999999999


Q ss_pred             EEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          587 LLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       587 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +++.++.+||+|||+++.............||+.|+|||.+.+..++.+.  ||||+|+++++++.+.
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Dv~slG~il~el~~g~  238 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV--DIWSLGIMVIEMVDGE  238 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSS
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            99999999999999998776554445556799999999999888777665  9999999999755544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-36  Score=318.97  Aligned_cols=198  Identities=24%  Similarity=0.389  Sum_probs=167.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (701)
                      .++|++.+.||+|+||.||+|... +++.||||++......  ...+.+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            467999999999999999999665 7999999999765432  23578899999999999999999999986543     


Q ss_pred             ----------------------------------------------------EEEEEEEccCCCCHHHHHhcCCCccCCC
Q 041034          523 ----------------------------------------------------CMFFIYEYMERGSLFYVLRDDDEAIELN  550 (701)
Q Consensus       523 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~  550 (701)
                                                                          ..++||||+++++|.+++.........+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                3899999999999999998876655678


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC------------Cceeeccc
Q 041034          551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS------------NRTLRAGT  618 (701)
Q Consensus       551 ~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~------------~~~~~~gt  618 (701)
                      +..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++.......            ......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            888999999999999999999   999999999999999999999999999987754321            22334699


Q ss_pred             ccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          619 YGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       619 ~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      +.|+|||++.+..++.+.  ||||+|+++++++.+
T Consensus       240 ~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~~  272 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKV--DIFSLGLILFELLYS  272 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHH--HHHHHHHHHHHHHSC
T ss_pred             cCccChHHhcCCCCcchh--hHHHHHHHHHHHHHc
Confidence            999999999888777665  999999999975554

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.1e-37  Score=322.13  Aligned_cols=203  Identities=35%  Similarity=0.591  Sum_probs=173.6

Q ss_pred             cccHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeee
Q 041034          439 KILYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFC  518 (701)
Q Consensus       439 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  518 (701)
                      ++.+.++....++|++.+.||+|+||.||+|...+++.||||++......   ..+.+.+|+.+++.++||||+++++++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34455666788999999999999999999999888999999998765432   257789999999999999999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                      .+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999876432 23589999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          598 DFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       598 DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      |||+++.......  ......||+.|+|||++.+..++.+.  ||||+|+++++
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~e  233 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS--DVYSFGVVLFE  233 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHH--HHHHHHHHHHH
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCccc--chHhHHHHHHH
Confidence            9999986543221  22344689999999998877777665  99999999885

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.5e-35  Score=313.84  Aligned_cols=303  Identities=27%  Similarity=0.426  Sum_probs=180.8

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.+++.++.++. ++  .+..+++|++|++++|.+++..+  +..+++|++|+|++|.+++.  +.|.++++|++|+
T Consensus        44 ~~L~~L~l~~~~i~~-~~--~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~  116 (347)
T 4fmz_A           44 ESITKLVVAGEKVAS-IQ--GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELY  116 (347)
T ss_dssp             TTCSEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred             ccccEEEEeCCcccc-ch--hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEE
Confidence            355666666666543 22  25556666666666666664322  66666666666666666642  2466666666666


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCC
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG  196 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (701)
                      |++|++++..+  +..+++|++|++++|.....++. +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+.+
T Consensus       117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~  191 (347)
T 4fmz_A          117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED  191 (347)
T ss_dssp             CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred             CcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence            66666664433  56666666666666654433332 6666666666666666655433  5566666666666666654


Q ss_pred             CCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCC
Q 041034          197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK  276 (701)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~  276 (701)
                      ..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|+.|++++|.+++.  +.+..
T Consensus       192 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~  263 (347)
T 4fmz_A          192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKD  263 (347)
T ss_dssp             CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTT
T ss_pred             ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhc
Confidence            332  5566666666666666664433  5566666666666666665433  55666666666666666643  34566


Q ss_pred             CCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEE
Q 041034          277 LSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD  356 (701)
Q Consensus       277 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~  356 (701)
                      +++|+.|++++|.+++.  ..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++++..|  +..+++|+.|+
T Consensus       264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~  339 (347)
T 4fmz_A          264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD  339 (347)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred             CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence            66666666666666643  245566666666666666666666666666666666666666665444  55666666666


Q ss_pred             cccccCc
Q 041034          357 LSHNNLS  363 (701)
Q Consensus       357 ls~N~l~  363 (701)
                      +++|+++
T Consensus       340 l~~N~i~  346 (347)
T 4fmz_A          340 FANQVIK  346 (347)
T ss_dssp             SSCC---
T ss_pred             hhhhccc
Confidence            6666654

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.2e-35  Score=327.52  Aligned_cols=307  Identities=30%  Similarity=0.446  Sum_probs=269.7

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      .+++.|++++|.+++..+   +..+++|++|++++|.+++..+  ++++++|++|+|++|.+++..+  +.++++|++|+
T Consensus        68 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~  140 (466)
T 1o6v_A           68 NNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE  140 (466)
T ss_dssp             TTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred             cCCCEEECCCCccCCchh---hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence            578999999999886533   8889999999999999987655  8999999999999999986643  88999999999


Q ss_pred             CCCCCCCCCCc-------------------cccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcc
Q 041034          117 LSNNSLHGTTP-------------------IEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST  177 (701)
Q Consensus       117 Ls~N~l~~~~~-------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  177 (701)
                      |++|.+++...                   ..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+.+..|  
T Consensus       141 l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--  216 (466)
T 1o6v_A          141 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--  216 (466)
T ss_dssp             EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             CCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--
Confidence            99998875421                   1367788999999999999875  358999999999999999998766  


Q ss_pred             cccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCccc
Q 041034          178 LFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA  257 (701)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~  257 (701)
                      +..+++|+.|++++|++++.  ..+..+++|++|++++|.+++..|  +..+++|++|++++|.+++..+  +..+++|+
T Consensus       217 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  290 (466)
T 1o6v_A          217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT  290 (466)
T ss_dssp             GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence            78899999999999999864  468899999999999999997765  8899999999999999998654  88999999


Q ss_pred             EEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCc
Q 041034          258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNS  337 (701)
Q Consensus       258 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  337 (701)
                      .|+|++|++++..|  +..+++|+.|+|++|.+++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|+
T Consensus       291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence            99999999997655  8899999999999999998776  78899999999999999975  478999999999999999


Q ss_pred             cCCCCCccccccccCCeEEcccccCcccCCCC
Q 041034          338 LDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT  369 (701)
Q Consensus       338 l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~  369 (701)
                      +++..|  +..+++|+.|++++|++++ +|..
T Consensus       365 l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~  393 (466)
T 1o6v_A          365 ISDLTP--LANLTRITQLGLNDQAWTN-APVN  393 (466)
T ss_dssp             CCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred             cCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence            998877  8899999999999999997 3543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.2e-36  Score=317.18  Aligned_cols=197  Identities=22%  Similarity=0.334  Sum_probs=169.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETED---SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++......   ....+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4578999999999999999999654 69999999998754321   1124678999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEEee
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADF  599 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~----~~kL~DF  599 (701)
                      .++||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999997644   589999999999999999999999   999999999999998776    7999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      |+++..... .......||+.|+|||++.+..++.+.  ||||+|+++|+++.+
T Consensus       164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslGvil~~ll~g  214 (361)
T 2yab_A          164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEA--DMWSIGVITYILLSG  214 (361)
T ss_dssp             SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHS
T ss_pred             CCceEcCCC-CccccCCCCccEECchHHcCCCCCccc--cHHHHHHHHHHHHhC
Confidence            999876543 233445799999999999888887765  999999999964433

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=326.47  Aligned_cols=194  Identities=21%  Similarity=0.316  Sum_probs=168.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            467899999999999999999954 57999999999876543 2335678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~~~kL~DFGla~  603 (701)
                      ||||+++|+|.+.+....   .+++..+..++.||+.||+|||++   ||+||||||+||+++   .++.+||+|||+|+
T Consensus        88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999988754   589999999999999999999999   999999999999998   46789999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      .............||+.|+|||++.+..++.+.  ||||+|+++|++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~--DIwSlGvilyel  206 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV--DLWACGVILYIL  206 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHH
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCcc--ccHHHHHHHHHH
Confidence            776554444556899999999999888887765  999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-36  Score=321.75  Aligned_cols=197  Identities=22%  Similarity=0.380  Sum_probs=167.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEc--------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ..++|++.+.||+|+||.||+|..        .++..||||+++...  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            357899999999999999999964        235679999997653  234467899999999999 899999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      .+.+..|+||||+++|+|.+++.....             ...+++..+..++.||+.||+|||++   ||+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999986531             12488999999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      |+++.++.+||+|||+|+.......  ......+|+.|+|||++.+..++.+.  ||||+|+++|+++
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--DvwslG~il~ell  299 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLMWEIF  299 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHH--HHHHHHHHHHHHH
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHH--HHHHHHHHHHHHH
Confidence            9999999999999999987643322  22334578899999999888877775  9999999999633

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-36  Score=322.90  Aligned_cols=201  Identities=22%  Similarity=0.357  Sum_probs=175.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++.........+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            568999999999999999999654 6889999999876544444446678899999887 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999997654   589999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.|..
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~--DiwslGvllyell~G~~Pf  253 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSPF  253 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHH--HHHHHHHHHHHHHhCCCCC
Confidence            444455567899999999999988887765  9999999999999887543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=317.60  Aligned_cols=216  Identities=28%  Similarity=0.421  Sum_probs=180.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|...    .+..||||+++....  ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            467999999999999999999663    345699999986532  34457899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999976432  589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCc---eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          605 LHVDSSNR---TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       605 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      ........   ....+|+.|+|||++.+..++.+.  ||||+|+++++                                
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  278 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS--DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG  278 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHH--HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHH--HHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence            75432221   223457789999999877777665  99999999985                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                                 ||..+|.+||++.++++.|+....
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                       667788888888888888776543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-36  Score=308.24  Aligned_cols=216  Identities=23%  Similarity=0.391  Sum_probs=183.6

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...++|++.+.||+|+||.||+|+..+++.||+|+++.....    .+++.+|+.++++++||||+++++++.+....++
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            346789999999999999999998888889999999865443    2668899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.++...
T Consensus        81 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             EEEccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecc
Confidence            9999999999999976432  589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          607 VDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       607 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                      ..... .....+|+.|+|||.+.+..++.+.  ||||+|+++++                                    
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS--DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT  233 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTH--HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhh--hhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence            33211 1223466789999998877777665  99999999985                                    


Q ss_pred             -------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 -------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 -------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                             |+..+|.+|||+.++++.|+....
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                   666777777777777777776553

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-36  Score=317.45  Aligned_cols=192  Identities=24%  Similarity=0.373  Sum_probs=164.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++.............+.+|+.+++.++||||+++++++.+++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999965 57899999998754322222235788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+ +|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 679999887654   589999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .. .....+||+.|+|||++.+..+... ..||||+|+++|+
T Consensus       161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~  200 (336)
T 3h4j_B          161 GN-FLKTSCGSPNYAAPEVINGKLYAGP-EVDVWSCGIVLYV  200 (336)
T ss_dssp             SB-TTCCCTTSTTTSCGGGSCCSGGGCH-HHHHHHHHHHHHH
T ss_pred             Cc-ccccccCCcCcCCHHHHcCCCCCCC-ccchhHHHHHHHH
Confidence            32 3344579999999999987766322 2499999999996

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.4e-36  Score=314.27  Aligned_cols=201  Identities=22%  Similarity=0.358  Sum_probs=177.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467999999999999999999664 6899999999876655556667889999999988 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+...
T Consensus        88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999997644   589999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.+..
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~~pf  210 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSPF  210 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCTT
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHH--hHHHHHHHHHHHHhCCCCc
Confidence            444445556899999999999888777665  9999999999999887543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.7e-37  Score=318.90  Aligned_cols=252  Identities=31%  Similarity=0.510  Sum_probs=221.0

Q ss_pred             CCCEEECcCCcCcc--cCCcccCCCCCCCEEECCC-CCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEE
Q 041034           87 NLKYLNLRWNNLTG--TIPKEIGSLRNLEVLYLSN-NSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL  163 (701)
Q Consensus        87 ~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  163 (701)
                      ++++|+|++|.+++  .+|..|.++++|++|+|++ |.+.+.+|..|+.+++|++|+|++|++++.+|..|.++++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            45566666666665  5666666666666666663 66666667777777777777777777777778888888888888


Q ss_pred             EceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCcc-ccCccccccccccCCccccccCCCcccEEEeccCCC
Q 041034          164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLK-NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL  242 (701)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  242 (701)
                      +|++|.+++.+|..+..+++|++|+|++|++++.+|..++.++ +|++|++++|++++.+|..+..++ |++|+|++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            8888888899999999999999999999999999999999998 999999999999999999999997 99999999999


Q ss_pred             CCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcc
Q 041034          243 HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI  322 (701)
Q Consensus       243 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  322 (701)
                      ++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|.. 
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-  287 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-  287 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence            999999999999999999999999988776 888999999999999999999999999999999999999999999986 


Q ss_pred             cCCCCCCeeeccCCc-cCCC
Q 041034          323 GNCTELQHLALNHNS-LDGT  341 (701)
Q Consensus       323 ~~l~~L~~L~L~~N~-l~~~  341 (701)
                      ..+++|+.|++++|+ +.|.
T Consensus       288 ~~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          288 GNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEEST
T ss_pred             ccccccChHHhcCCCCccCC
Confidence            889999999999998 5553

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-36  Score=312.76  Aligned_cols=193  Identities=25%  Similarity=0.322  Sum_probs=167.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            3578999999999999999999654 68899999987543    224668899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--CCCeEEEeecCccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTARL  604 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~--~~~~kL~DFGla~~  604 (701)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||++   ||+||||||+||+++.  ++.+||+|||+++.
T Consensus        79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            999999999999997643  2589999999999999999999999   9999999999999987  78999999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .... .......||+.|+|||++.+..++.+.  ||||+|+++|+++.
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~~ll~  198 (321)
T 1tki_A          154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTAT--DMWSLGTLVYVLLS  198 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTTCEECHHH--HHHHHHHHHHHHHH
T ss_pred             CCCC-CccccccCChhhcCcHHhcCCCCCchh--hHHHHHHHHHHHHh
Confidence            7533 334456799999999999887777665  99999999996433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8e-36  Score=310.71  Aligned_cols=200  Identities=28%  Similarity=0.441  Sum_probs=169.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...++|++.+.||+|+||+||+|...+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            346889999999999999999998888999999999765432 2234678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++ +|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+|+...
T Consensus        97 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            9999986 88888876442  589999999999999999999999   99999999999999999999999999998876


Q ss_pred             cCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..........||+.|+|||++.+. .++.+.  ||||+|+++++++.+.+
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~~ll~g~~  218 (311)
T 3niz_A          171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV--DIWSIGCIFAEMITGKP  218 (311)
T ss_dssp             SCCC---CCCCCCTTCCHHHHTTCCSCCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             CCcccccCCcccCCcCCHHHhcCCCCCCchH--HhHHHHHHHHHHHhCCC
Confidence            544445556799999999998763 455554  99999999999988764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-36  Score=307.31  Aligned_cols=194  Identities=24%  Similarity=0.393  Sum_probs=167.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.+.||+|+||.||+|...+++.||+|++......    .+++.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            35789999999999999999998878899999999875543    26688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999999976443  589999999999999999999999   999999999999999999999999999986542


Q ss_pred             CC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          608 DS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       608 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .. .......+|+.|+|||.+.+..++.+.  ||||+|+++++++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~ll~  202 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKS--DVWSFGVLMWEVFS  202 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHT
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchh--hhHHHHHHHHHHhc
Confidence            21 112233567889999998877777765  99999999996443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=4.1e-35  Score=308.39  Aligned_cols=268  Identities=27%  Similarity=0.332  Sum_probs=143.9

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++. +|..+.  ++|++|+|
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l  130 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRI  130 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCS-CCSSCC--TTCCEEEC
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCc-cCcccc--ccCCEEEC
Confidence            445555555555554444455555555555555555554445555555555555555555542 222222  44555555


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC--CCCCCCCCCccccCcccccccccc
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN--GTIPREIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~  219 (701)
                      ++|++++..+..|                        .++++|+.|++++|.++  +..+..+..+ +|++|++++|+++
T Consensus       131 ~~n~i~~~~~~~~------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~  185 (332)
T 2ft3_A          131 HDNRIRKVPKGVF------------------------SGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT  185 (332)
T ss_dssp             CSSCCCCCCSGGG------------------------SSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred             CCCccCccCHhHh------------------------CCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence            5555544444444                        44455555555555443  2344444444 5555555555555


Q ss_pred             CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCccccc
Q 041034          220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIG  299 (701)
Q Consensus       220 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  299 (701)
                      + +|..+.  ++|++|++++|.+++..+..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+.
T Consensus       186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~  261 (332)
T 2ft3_A          186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP  261 (332)
T ss_dssp             S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred             c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence            3 333332  45555555555555555555555566666666666665555555555666666666666665 4555555


Q ss_pred             CccceeeecCCCCcCCCCCCCcccC------CCCCCeeeccCCccC--CCCCccccccccCCeEEccccc
Q 041034          300 KLFNLVSLDLSKNKLSGSFPTGIGN------CTELQHLALNHNSLD--GTIPPEIGKILLLQNLDLSHNN  361 (701)
Q Consensus       300 ~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~ls~N~  361 (701)
                      .+++|+.|++++|++++..+..|..      ...|+.|++++|.+.  +..|..|..+++|+.+++++|+
T Consensus       262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            5666666666666665444444433      355777777777776  5566677777777777777764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=318.10  Aligned_cols=214  Identities=21%  Similarity=0.344  Sum_probs=175.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++++.........+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999654 6899999999765332233356778999999988 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+..
T Consensus       101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999997654   589999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhh
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELE  669 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~  669 (701)
                      ..........+||+.|+|||++.+..++.+.  ||||+|+++|+|+.+.+. ...+..++.+.+.
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  237 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  237 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCcc--CCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            4444445566899999999998877777665  999999999999998743 3345555444443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.9e-35  Score=310.59  Aligned_cols=305  Identities=29%  Similarity=0.431  Sum_probs=266.0

Q ss_pred             cCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccc
Q 041034           58 FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLE  137 (701)
Q Consensus        58 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  137 (701)
                      +..+++|+.|++++|.+.. ++ .+..+++|++|+|++|.+++..+  +..+++|++|+|++|.++..  ..+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence            4567899999999999985 34 48899999999999999996544  99999999999999999864  3699999999


Q ss_pred             eeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccc
Q 041034          138 ELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK  217 (701)
Q Consensus       138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  217 (701)
                      +|+|++|++++..+  +..+++|+.|++++|.....++. +..+++|++|++++|.+.+..+  +..+++|++|++++|.
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~  188 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ  188 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence            99999999997654  89999999999999976655544 8999999999999999986654  8899999999999999


Q ss_pred             ccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCccc
Q 041034          218 LTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFA  297 (701)
Q Consensus       218 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  297 (701)
                      +++..+  +..+++|++|++++|.+.+..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|.+++.  ..
T Consensus       189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~  260 (347)
T 4fmz_A          189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA  260 (347)
T ss_dssp             CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred             cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence            996544  8899999999999999998655  8889999999999999997654  89999999999999999864  46


Q ss_pred             ccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCc--ccccc
Q 041034          298 IGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTL--HPMFL  375 (701)
Q Consensus       298 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~--~~~~l  375 (701)
                      +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|..++.+++|+.|++++|++++..|...  ....+
T Consensus       261 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L  338 (347)
T 4fmz_A          261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSA  338 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEE
T ss_pred             HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhcccee
Confidence            88999999999999999964  468899999999999999999999999999999999999999998877221  12489


Q ss_pred             ccccCCCC
Q 041034          376 DMSFNNLE  383 (701)
Q Consensus       376 ~ls~N~l~  383 (701)
                      ++++|+++
T Consensus       339 ~l~~N~i~  346 (347)
T 4fmz_A          339 DFANQVIK  346 (347)
T ss_dssp             SSSCC---
T ss_pred             ehhhhccc
Confidence            99999885

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.4e-36  Score=318.07  Aligned_cols=196  Identities=20%  Similarity=0.341  Sum_probs=166.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE--DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999965 46899999998643211  1112467899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEEeecC
Q 041034          526 FIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGT  601 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~---~kL~DFGl  601 (701)
                      +||||+++++|.+++.... ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988876432 223589999999999999999999999   9999999999999986654   99999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ++.............||+.|+|||++.+..++.+.  ||||+|+++|+
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~~  225 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPV--DVWGCGVILFI  225 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchH--hhHHHHHHHHH
Confidence            98876544444556799999999999888777665  99999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-35  Score=307.00  Aligned_cols=205  Identities=32%  Similarity=0.529  Sum_probs=174.6

Q ss_pred             CcccHHHHHhhhcCCccc------eEEeeccceEEEEEEcCCCcEEEEEEecCCCc-cChHHHHHHHHHHHHHhcCCCCc
Q 041034          438 GKILYEDLINATEDFHIR------YCIGTGGYGSVYKAELPDGKVVALKKLHQSET-EDSAFVESFQNEARVLSTVRHRN  510 (701)
Q Consensus       438 ~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~n  510 (701)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||||++..... ......+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            467888999999988877      9999999999999987 688999999876432 22334578899999999999999


Q ss_pred             eeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       511 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      |+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||+|||++   ||+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999997654444699999999999999999999999   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          591 NLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ++.+||+|||+++........  .....||+.|+|||.+.+. ++.+  .||||+|+++++
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~--~Dv~slG~il~~  226 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPK--SDIYSFGVVLLE  226 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTH--HHHHHHHHHHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCcc--chhHHHHHHHHH
Confidence            999999999999876433222  2234689999999988653 4444  499999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=307.62  Aligned_cols=212  Identities=21%  Similarity=0.314  Sum_probs=168.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccC-----------------------hHHHHHHHHHHHHHh
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETED-----------------------SAFVESFQNEARVLS  504 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~  504 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.......                       ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            47899999999999999999965 468999999997654211                       112356889999999


Q ss_pred             cCCCCceeeeeeeeee--CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 041034          505 TVRHRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDIS  582 (701)
Q Consensus       505 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlk  582 (701)
                      +++||||+++++++.+  .+..++||||+++++|.+++...    .+++..+..++.|++.||+|||++   ||+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            9999999999999986  56899999999999998865432    589999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCC-hhhHHHHHHHHHHHHHcccCC-CCCCCC
Q 041034          583 SNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVN-QKIIQDIILVSTTALACLRSK-PKSRPT  660 (701)
Q Consensus       583 p~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~Di~slg~i~~~cl~~~-P~~Rpt  660 (701)
                      |+||+++.++.+||+|||+++.............||+.|+|||++.+.... .....||||+|+++++++.+. |.....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999998775444434456799999999998766531 122359999999999988776 333334


Q ss_pred             HHHHHHH
Q 041034          661 MQRISQE  667 (701)
Q Consensus       661 ~~~i~~~  667 (701)
                      ..++...
T Consensus       245 ~~~~~~~  251 (298)
T 2zv2_A          245 IMCLHSK  251 (298)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            4444333

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=7.2e-35  Score=306.31  Aligned_cols=269  Identities=23%  Similarity=0.286  Sum_probs=145.7

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      +.|+.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+++. +|..+.  ++|++|++
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l  128 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRV  128 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEEC
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEEC
Confidence            455566666666655555555556666666666666655555555556666666666665552 232222  45555555


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCC--CcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccccc
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGG--PIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  219 (701)
                      ++|++++..+..|.++++|+.|++++|.+..  ..+..+.++++|+.|++++|                        .++
T Consensus       129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n------------------------~l~  184 (330)
T 1xku_A          129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT------------------------NIT  184 (330)
T ss_dssp             CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS------------------------CCC
T ss_pred             CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC------------------------ccc
Confidence            5555555555555555555555555555532  33444444444444444444                        444


Q ss_pred             CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCccccc
Q 041034          220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIG  299 (701)
Q Consensus       220 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  299 (701)
                      . +|..+.  ++|++|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.++ .+|..+.
T Consensus       185 ~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~  260 (330)
T 1xku_A          185 T-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA  260 (330)
T ss_dssp             S-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred             c-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence            2 232222  45555555555555554555555555555555555555555555555555555555555555 4455555


Q ss_pred             CccceeeecCCCCcCCCCCCCcccC------CCCCCeeeccCCccCC--CCCccccccccCCeEEccccc
Q 041034          300 KLFNLVSLDLSKNKLSGSFPTGIGN------CTELQHLALNHNSLDG--TIPPEIGKILLLQNLDLSHNN  361 (701)
Q Consensus       300 ~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~ls~N~  361 (701)
                      .+++|++|++++|++++..+..|..      .+.|+.|++++|.+..  ..|..|..+..++.++|++|+
T Consensus       261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            5555666666666655444444432      3566777777777653  455667777777777777764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=311.04  Aligned_cols=196  Identities=22%  Similarity=0.337  Sum_probs=168.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETED---SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.......   ....+.+.+|+.++++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3567999999999999999999654 68999999997654321   1124678999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEEee
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADF  599 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~----~~kL~DF  599 (701)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999997643   589999999999999999999999   999999999999998877    8999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |+++...... ......||+.|+|||++.+..++.+.  ||||+|+++++++.
T Consensus       163 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~~ll~  212 (326)
T 2y0a_A          163 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEA--DMWSIGVITYILLS  212 (326)
T ss_dssp             TTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHH--HHHHHHHHHHHHHH
T ss_pred             CCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHH--HHHHHHHHHHHHHH
Confidence            9998765332 23345799999999999888777765  99999999996333

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6e-35  Score=319.63  Aligned_cols=300  Identities=22%  Similarity=0.250  Sum_probs=262.2

Q ss_pred             ccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccc
Q 041034           57 NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNL  136 (701)
Q Consensus        57 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  136 (701)
                      .++.+++|++|++++|.+++. | .++.+++|++|+|++|++++. |  ++.+++|++|+|++|++++. +  ++.+++|
T Consensus        37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L  108 (457)
T 3bz5_A           37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL  108 (457)
T ss_dssp             EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred             ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence            466789999999999999975 5 699999999999999999975 4  89999999999999999975 3  8999999


Q ss_pred             ceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccc
Q 041034          137 EELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITN  216 (701)
Q Consensus       137 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  216 (701)
                      ++|+|++|++++. |  ++.+++|++|++++|.+++.   .+..+++|++|++++|+..+.+  .++.+++|++|++++|
T Consensus       109 ~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n  180 (457)
T 3bz5_A          109 TYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN  180 (457)
T ss_dssp             CEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence            9999999999985 3  89999999999999999985   3888999999999999766666  4889999999999999


Q ss_pred             cccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcc
Q 041034          217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF  296 (701)
Q Consensus       217 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  296 (701)
                      ++++ +|  +..+++|+.|++++|++++.   .++.+++|+.|++++|++++ +|  +..+++|+.|++++|++++..+.
T Consensus       181 ~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~  251 (457)
T 3bz5_A          181 KITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS  251 (457)
T ss_dssp             CCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred             ccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence            9997 44  88999999999999999985   48899999999999999998 56  88999999999999999987766


Q ss_pred             cccCcc-------ceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCcc--------ccccccCCeEEccccc
Q 041034          297 AIGKLF-------NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPE--------IGKILLLQNLDLSHNN  361 (701)
Q Consensus       297 ~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--------~~~l~~L~~l~ls~N~  361 (701)
                      .+.++.       +|+.|++++|.+.|.+|  ++.+++|+.|+|++|++.+.+|..        +..+++|++|++++|+
T Consensus       252 ~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~  329 (457)
T 3bz5_A          252 TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTE  329 (457)
T ss_dssp             TCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCC
T ss_pred             HCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCc
Confidence            666655       56788889998888887  578899999999999987777642        5667899999999999


Q ss_pred             CcccCCCCc--cccccccccCCCCC
Q 041034          362 LSGTIPMTL--HPMFLDMSFNNLEG  384 (701)
Q Consensus       362 l~g~~p~~~--~~~~l~ls~N~l~g  384 (701)
                      |+| +|..-  ....||+++|+++|
T Consensus       330 l~~-l~l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          330 LTE-LDVSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             CSC-CCCTTCTTCSEEECCSSCCCB
T ss_pred             ccc-cccccCCcCcEEECCCCCCCC
Confidence            998 45221  22479999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=309.33  Aligned_cols=194  Identities=21%  Similarity=0.249  Sum_probs=159.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||+||+|... +++.||||++......... ......|+..+..+ +||||+++++++.+.+..++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            367999999999999999999665 7999999998765443332 34445555555544 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 6699998876542  589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ... ......||+.|+|||++.+ .++.+  .||||+|+++++++.+
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~--~DiwslG~il~el~~g  251 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPELLQG-SYGTA--ADVFSLGLTILEVACN  251 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTH--HHHHHHHHHHHHHHHT
T ss_pred             cCC-CCcccCCCccccCHhHhcC-CCCch--hhHHHHHHHHHHHHhC
Confidence            332 2334569999999999876 45555  4999999999986655

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.1e-36  Score=318.85  Aligned_cols=215  Identities=27%  Similarity=0.429  Sum_probs=175.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            468999999999999999999664    46789999997653  234457899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999976532  589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          605 LHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      .......   .....+++.|+|||++.+..++.+.  ||||+|+++++                                
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  274 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS--DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD  274 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchh--cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            6543221   1122357789999999877777765  99999999985                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                 ||..+|.+||++.++++.|+...
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                       77789999999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.3e-36  Score=317.62  Aligned_cols=199  Identities=25%  Similarity=0.381  Sum_probs=171.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999654 6899999999764322222346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999998654   589999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      . .......||+.|+|||++...   .++.+.  ||||+|+++|+|+.+.+.
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~--DiwSlG~il~elltG~~P  216 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRP  216 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTH--HHHHHHHHHHHHHHSSCS
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccc--eeechHHHHHHHHhCCCC
Confidence            3 334456799999999998643   355554  999999999998887643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-35  Score=314.31  Aligned_cols=197  Identities=21%  Similarity=0.367  Sum_probs=170.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            457899999999999999999965 46899999999875443 3345778999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~---~~~kL~DFGla~  603 (701)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.+   +.+||+|||+++
T Consensus       106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999987654   589999999999999999999999   99999999999999765   459999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..... .......||+.|+|||++.+..++.+.  ||||+|+++|+++.+.
T Consensus       180 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~~ll~g~  227 (362)
T 2bdw_A          180 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPV--DIWACGVILYILLVGY  227 (362)
T ss_dssp             CCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             EecCC-cccccCCCCccccCHHHHccCCCCchh--hHHHHHHHHHHHHHCC
Confidence            76532 233445799999999999888887765  9999999999755554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-35  Score=309.43  Aligned_cols=197  Identities=30%  Similarity=0.428  Sum_probs=172.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999654 7999999999764322222346778999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999998654   589999999999999999999999   999999999999999999999999999987542


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                         .....+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.+.
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~~p  202 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGYTP  202 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTH--HHHHHHHHHHHHHHSSCT
T ss_pred             ---ccccccCCccccCHhHhcCCCCCccc--chhhhHHHHHHHHhCCCC
Confidence               22345799999999999888887776  999999999998877643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-35  Score=316.12  Aligned_cols=199  Identities=28%  Similarity=0.394  Sum_probs=165.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHH-HhcCCCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARV-LSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++++...........+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999664 688999999987654433334566777776 577899999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999997644   588999999999999999999999   99999999999999999999999999998754


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.+
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~G~~  237 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLP  237 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchh--hhHHHHHHHHHHHcCCC
Confidence            444445566899999999999888887765  99999999999887764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.8e-36  Score=311.97  Aligned_cols=194  Identities=25%  Similarity=0.367  Sum_probs=163.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++......+  ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3578999999999999999999654 78999999997654322  23668899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999999987654   589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          607 VDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       607 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ...  .......||+.|+|||++.+..+... ..||||+|+++++|
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~l  201 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAM  201 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHH-HHHHHHHHHHHHHH
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCC-cccHHHHHHHHHHH
Confidence            322  22334579999999999877665332 24999999999963

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-35  Score=314.32  Aligned_cols=196  Identities=23%  Similarity=0.317  Sum_probs=171.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999654 6999999999764322222346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+....
T Consensus       120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999998654   589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .   .....||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.|
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~~  236 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYP  236 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcC--CEecccHhHhHHhhCCC
Confidence            2   2345799999999999888777665  99999999998777654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-35  Score=311.69  Aligned_cols=215  Identities=25%  Similarity=0.395  Sum_probs=179.9

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34688999999999999999999664 6899999999764321112245678899999876 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999997644   589999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhh
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELE  669 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~  669 (701)
                      ...........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.+. .-.+..++.+.+.
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  231 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  231 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChh--hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            54444445566899999999999888877665  999999999999998754 3345555554443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-36  Score=319.39  Aligned_cols=204  Identities=22%  Similarity=0.315  Sum_probs=170.1

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVK  513 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  513 (701)
                      ...+++...++|++.+.||+|+||.||+|.+      .+++.||||+++....  ....+.+.+|+++++++ +||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceee
Confidence            4456667789999999999999999999962      3468899999976543  33357789999999999 7999999


Q ss_pred             eeeeeeeCc-EEEEEEEccCCCCHHHHHhcCCC-----------------------------------------------
Q 041034          514 LYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDE-----------------------------------------------  545 (701)
Q Consensus       514 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------  545 (701)
                      +++++.+.+ ..++||||+++|+|.++++....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999988755 48999999999999999976532                                               


Q ss_pred             ----------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          546 ----------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       546 ----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                                      ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            11288999999999999999999999   99999999999999999999999999998764332


Q ss_pred             C--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          610 S--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       610 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      .  ......||+.|+|||++.+..++.+.  ||||+|+++++++
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~ell  289 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEIF  289 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHT
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchh--hhhhHHHHHHHHH
Confidence            2  22345688999999998887777665  9999999999744

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=304.16  Aligned_cols=200  Identities=25%  Similarity=0.459  Sum_probs=152.8

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46899999999999999999965 57999999999754322222346789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.....  .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||.+.....
T Consensus        90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999986432  589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........||+.|+|||.+.+..++.+.  ||||+|+++++++.+.+
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~  210 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLES--DVWSLGCMFYTLLIGRP  210 (278)
T ss_dssp             ---------------------------CT--HHHHHHHHHHHHHHSSC
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            43334445799999999999887777766  99999999999877653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-35  Score=314.27  Aligned_cols=201  Identities=26%  Similarity=0.418  Sum_probs=169.2

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeee
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF  517 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  517 (701)
                      .+....++|++.+.||+|+||.||+|...      +++.||||+++....  ....+.+.+|+.++++++||||++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34456789999999999999999999663      348899999986542  3446789999999999999999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCC---------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDE---------------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSI  576 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~gi  576 (701)
                      +.+.+..++||||+++|+|.+++.....                     ...+++..++.++.||+.||+|||++   ||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            9999999999999999999999976421                     13689999999999999999999999   99


Q ss_pred             EecCCCCCcEEEcCCCCeEEEeecCccccccCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          577 VHRDISSNNILLNSNLEAFVADFGTARLLHVDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       577 vH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +||||||+||+++.++.+||+|||+++......  .......+|+.|+|||++.+..++.+.  ||||+|+++|+++
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~el~  270 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES--DVWAYGVVLWEIF  270 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCccc--ccHHHHHHHHHHH
Confidence            999999999999999999999999998764322  222345688999999998877777665  9999999999633

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-35  Score=305.17  Aligned_cols=198  Identities=28%  Similarity=0.425  Sum_probs=165.9

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      ++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            579999999999999999998778999999999765432 2223667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+++ +|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9986 99999876432  588999999999999999999999   99999999999999999999999999998765444


Q ss_pred             CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .......||+.|+|||++.+.. ++.+.  ||||+|+++++++.+.|.
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~~l~~g~~p  200 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNGTPL  200 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccCchheeCCCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            4444557899999999986543 55554  999999999999988743

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-35  Score=310.21  Aligned_cols=200  Identities=26%  Similarity=0.390  Sum_probs=161.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ..++|++.+.||+|+||.||+|+.    .+++.||+|+++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            357899999999999999999965    47899999999865422 1223456788999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..|+||||+++++|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999999997644   588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.............||+.|+|||++.+..++.+.  ||||+|+++|+|+.+.+
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~  219 (327)
T 3a62_A          169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAP  219 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             cccccCCccccccCCCcCccCHhhCcCCCCCCcc--cchhHHHHHHHHHHCCC
Confidence            8654443334455799999999999887777665  99999999998777653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-36  Score=320.74  Aligned_cols=196  Identities=24%  Similarity=0.406  Sum_probs=165.8

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ....++|++.+.||+|+||.||+|... +++.||||+++...  .....+.+.+|++++++++||||+++++++.+.+..
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            344678999999999999999999765 78999999997643  233456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++...  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            99999999999999997643  2589999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          605 LHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       605 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ......  ......+++.|+|||.+....++.+.  ||||+|++++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~il~el  308 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSES--DVWSFGILLWET  308 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHH--HHHHHHHHHHHH
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchh--hHHHHHHHHHHH
Confidence            532211  11122357789999998877776665  999999999963

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.1e-36  Score=312.33  Aligned_cols=198  Identities=27%  Similarity=0.406  Sum_probs=162.5

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  522 (701)
                      ...++|++.+.||+|+||.||+|+.. ++.||||++....    .......+|+.++++++||||+++++++.+..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            34678999999999999999999775 7899999996543    22345667999999999999999999998743    


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeEecCCCCCcEEEcCCCCeE
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD-------CTPSIVHRDISSNNILLNSNLEAF  595 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~givH~Dlkp~NIll~~~~~~k  595 (701)
                      .+++||||+++|+|.++++..    .+++..+..++.|++.||+|||+.       +.++|+||||||+||+++.++.+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            479999999999999999764    489999999999999999999965       133899999999999999999999


Q ss_pred             EEeecCccccccCCCC--ceeecccccccCCCCCCCCcC---ChhhHHHHHHHHHHHHHcccC
Q 041034          596 VADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPV---NQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       596 L~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~~Di~slg~i~~~cl~~  653 (701)
                      |+|||+|+........  .....||+.|+|||++.+...   ......||||+|+++|+++++
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg  234 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR  234 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence            9999999876543322  223579999999999876422   122345999999999875554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.6e-34  Score=302.21  Aligned_cols=284  Identities=21%  Similarity=0.277  Sum_probs=200.0

Q ss_pred             CCcceeEeCCC----------CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcC
Q 041034           26 CNWVGITCDYK----------GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRW   95 (701)
Q Consensus        26 c~w~gv~c~~~----------~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   95 (701)
                      |.|..+.|...          .+++.|++++|.+++ +++..|..+++|++|+|++|.+++..|..|+.+++|++|+|++
T Consensus        33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            68999999632          378999999999985 4455689999999999999999999999999999999999999


Q ss_pred             CcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCC--CCCcccccCCCCCcEEEceecccCCC
Q 041034           96 NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLS--GVLPQEIGNLKSLIWLSVMYNTVGGP  173 (701)
Q Consensus        96 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~  173 (701)
                      |.++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|.++  +..+..+..+ +|++|++++|.+++ 
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-  186 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-  186 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence            9999 5555554  89999999999999888888999999999999999996  3667777777 77777777777765 


Q ss_pred             cCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCC
Q 041034          174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF  253 (701)
Q Consensus       174 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~  253 (701)
                      +|..+.  ++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|+++. +|..+..+
T Consensus       187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~l  263 (332)
T 2ft3_A          187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDL  263 (332)
T ss_dssp             CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCB-CCTTGGGC
T ss_pred             cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCee-cChhhhcC
Confidence            333332  566666666666666666666666666666666666666555566666666666666666663 45555566


Q ss_pred             CcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCC--CCCCCcccCCCCCCee
Q 041034          254 SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS--GSFPTGIGNCTELQHL  331 (701)
Q Consensus       254 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L  331 (701)
                      ++|+.|+|++|+|++..+..|..+.-                  ......|+.|++++|.+.  +..|..|..+++|+.|
T Consensus       264 ~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l  325 (332)
T 2ft3_A          264 KLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI  325 (332)
T ss_dssp             TTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTE
T ss_pred             ccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccchhhhh
Confidence            66666666666666554444443210                  000234555555555554  3444555555566666


Q ss_pred             eccCC
Q 041034          332 ALNHN  336 (701)
Q Consensus       332 ~L~~N  336 (701)
                      ++++|
T Consensus       326 ~l~~n  330 (332)
T 2ft3_A          326 QFGNY  330 (332)
T ss_dssp             EC---
T ss_pred             hcccc
Confidence            65555

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-35  Score=307.40  Aligned_cols=193  Identities=25%  Similarity=0.444  Sum_probs=160.3

Q ss_pred             hcCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  521 (701)
                      .++|++.+.||+|+||.||+|++     .+++.||||++....   ....+.+.+|+.++++++||||+++++++...  
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            57899999999999999999973     368899999997543   34457889999999999999999999998653  


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            458999999999999999977542  589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          602 ARLLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       602 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ++.......   ......++..|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~l~  211 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVAS--DVWSFGVVLYELF  211 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHH--HHHHHHHHHHHHH
Confidence            987654322   12233577789999998887777665  9999999988643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.7e-35  Score=311.31  Aligned_cols=201  Identities=23%  Similarity=0.343  Sum_probs=174.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++++.........+.+.+|..++..+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999665 5889999999764322222346778999999988 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|+..
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999997644   589999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ..........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.|.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~G~~P  220 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAP  220 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcc--cccchHHHHHHHHcCCCC
Confidence            4444445566899999999999888887665  999999999999988754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.6e-36  Score=326.91  Aligned_cols=199  Identities=23%  Similarity=0.320  Sum_probs=162.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.............+.+|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            356899999999999999999965 5799999999976433333334667889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||+ +   ||+||||||+|||++.++.+||+|||+|+..
T Consensus       226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999997654   58999999999999999999998 7   9999999999999999999999999999875


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ...........||+.|+|||++.+..++.+.  ||||+|+++++|+.+.
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~  346 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGR  346 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCcc--chhhhHHHHHHHhhCC
Confidence            5444445567899999999999888887765  9999999999876655

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.2e-35  Score=310.80  Aligned_cols=198  Identities=22%  Similarity=0.363  Sum_probs=175.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999664 5889999999876555556678899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999987643   589999999999999999999999   999999999999999999999999999987764


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .........||+.|+|||++.+..++.+.  ||||+|+++++++.+.
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~  238 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEV--DVWSIGCIMYTLLVGK  238 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHH--HHHHHHHHHHHHHHSS
T ss_pred             CcccccccCCCccccCHHHhccCCCCchh--hHHHHHHHHHHHHHCc
Confidence            44445556799999999998877776655  9999999999866654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-35  Score=323.26  Aligned_cols=210  Identities=24%  Similarity=0.408  Sum_probs=181.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999664 7999999999764332222356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999997644   589999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------------
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------------  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------------  649 (701)
                      . ......+||+.|+|||.+.+..+... ..||||+|+++|+                                      
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGP-EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSH-HHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCC-cceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence            3 33344579999999999987765322 2499999999985                                      


Q ss_pred             ---cccCCCCCCCCHHHHHH
Q 041034          650 ---CLRSKPKSRPTMQRISQ  666 (701)
Q Consensus       650 ---cl~~~P~~Rpt~~~i~~  666 (701)
                         ||..+|.+|||++|+++
T Consensus       247 i~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCchhCcCHHHHHh
Confidence               78888888999888886

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-35  Score=303.21  Aligned_cols=198  Identities=31%  Similarity=0.501  Sum_probs=168.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            457899999999999999999955 4678999999876443333335678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999997654   589999999999999999999998   99999999999999999999999999986543


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..  ......||+.|+|||.+.+..++.+.  ||||+|+++++++.+.+
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~  205 (279)
T 3fdn_A          161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKV--DLWSLGVLCYEFLVGKP  205 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             cc--cccccCCCCCccCHhHhccCCCCccc--hhHhHHHHHHHHHHCCC
Confidence            22  23445799999999999887777665  99999999998777653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-35  Score=303.89  Aligned_cols=220  Identities=25%  Similarity=0.370  Sum_probs=177.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......+....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999654 689999999987766666667889999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999998654   589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          607 VDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       607 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                      ... .......|++.|+|||.+.+..++.+.  ||||+|+++++                                    
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRA--DIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCC--HHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchH--hHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence            332 122345699999999999888777776  99999999985                                    


Q ss_pred             --------cccCCCCCCC-CHHHHHHHhhcCCCcc
Q 041034          650 --------CLRSKPKSRP-TMQRISQELEGKTPMK  675 (701)
Q Consensus       650 --------cl~~~P~~Rp-t~~~i~~~l~~~~~~~  675 (701)
                              ||..+|.+|| +++++++.++......
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                    6777777777 7777777777655433

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.1e-36  Score=310.40  Aligned_cols=199  Identities=23%  Similarity=0.409  Sum_probs=164.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  522 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......+......+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            357899999999999999999965 578999999998876666666788999999999999999999999987654    


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..|+||||+++++|.++++...   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            3599999999999999997654   589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          603 RLLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       603 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +.......   ......||+.|+|||++.+..++.+.  ||||+|+++|+|+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~~l~~ll~g~  216 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS--DVYSLGCVLYEVLTGE  216 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHH--HHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchH--hHHHHHHHHHHHHhCC
Confidence            87653322   22334689999999999888777765  9999999999755443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-35  Score=301.58  Aligned_cols=213  Identities=30%  Similarity=0.518  Sum_probs=166.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETED-SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... ++.||||+++...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            578999999999999999999874 8899999987654332 23357789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--------CCCeEEEee
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--------NLEAFVADF  599 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~--------~~~~kL~DF  599 (701)
                      |||+++++|.+++...    .+++..+..++.|++.||+|||++...+|+||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999998643    5899999999999999999999991112999999999999986        678999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      |.++......  .....||+.|+|||.+.+..++.+.  ||||+|+++++                              
T Consensus       161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (271)
T 3dtc_A          161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGS--DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP  236 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCCSHHH--HHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred             Cccccccccc--ccCCCCccceeCHHHhccCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence            9998764332  2245799999999998877777665  99999999985                              


Q ss_pred             -------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                   |+..+|.+|||+.|+++.|++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                         677777777777777777654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-35  Score=322.14  Aligned_cols=219  Identities=24%  Similarity=0.295  Sum_probs=179.9

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL  519 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  519 (701)
                      .+.++....++|++.+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            35566677899999999999999999999765 58899999997532211111234788999999999999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      +.+..|+||||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999986432  589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCC-ceeecccccccCCCCCC-----CCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHH
Q 041034          600 GTARLLHVDSSN-RTLRAGTYGYIAPDQRL-----SPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQ  666 (701)
Q Consensus       600 Gla~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~  666 (701)
                      |+|+........ ....+||+.|+|||++.     ...++.+.  ||||+|+++|+|+.+.|. ...+..++.+
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~--DvwSlGvil~elltG~~Pf~~~~~~~~~~  291 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC--DWWSLGVCMYEMLYGETPFYAESLVETYG  291 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHH--HHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcC--eeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence            999876543332 23357999999999986     44555554  999999999999998743 3334444433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=315.60  Aligned_cols=219  Identities=24%  Similarity=0.392  Sum_probs=185.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc--------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      ...++|.+.+.||+|+||.||+|..        ..++.||||+++....  ....+++.+|+++++++ +||||++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            3457899999999999999999964        2345799999976533  34457889999999999 89999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSN  584 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~  584 (701)
                      +.+.+..++||||+++|+|.+++.....             ...+++..+..++.||+.||+|||++   +|+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            9999999999999999999999986532             13589999999999999999999999   9999999999


Q ss_pred             cEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------
Q 041034          585 NILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------  649 (701)
Q Consensus       585 NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------  649 (701)
                      ||+++.++.+||+|||+|+.......  ......+|+.|+|||++.+..++.+.  ||||+|+++++             
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS--DVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh--HHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999987653321  22334578899999999888777765  99999999985             


Q ss_pred             ------------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ------------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ------------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                                    ||..+|.+|||++|+++.|++..
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                                          66778899999999999887653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.9e-35  Score=303.07  Aligned_cols=199  Identities=23%  Similarity=0.374  Sum_probs=176.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999664 5889999999876555556678899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||.++....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999987644   589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .........||+.|+|||.+.+..++.+.  |+||+|+++++++.+.+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~l~~g~~  213 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEV--DVWSIGCIMYTLLVGKP  213 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             CccccccccCCCCcCCcchhccCCCCchh--hHHHHHHHHHHHHhCCC
Confidence            44445556799999999999877776655  99999999999887663

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-35  Score=305.21  Aligned_cols=196  Identities=26%  Similarity=0.412  Sum_probs=165.8

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ....++|++.+.||+|+||.||+|...+++.||+|+++.....    .+++.+|++++++++||||+++++++.+.+..+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            3456789999999999999999998888889999999875543    266889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus        96 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEEeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999976332  589999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          606 HVDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       606 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .... .......+|+.|+|||.+.+..++.+.  ||||+|++++++++
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~~l~~l~t  216 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS--DIWAFGVLMWEIYS  216 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHH--HHHHHHHHHHHHHT
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchh--hHHHHHHHHHHHHh
Confidence            4221 112223467889999998877777665  99999999997543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-34  Score=298.35  Aligned_cols=191  Identities=29%  Similarity=0.473  Sum_probs=159.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHH----HHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFV----ESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...........    +.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            57899999999999999999965 5789999999976544332211    67899999999999999999999987766 


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCC-----eEE
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLE-----AFV  596 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g--ivH~Dlkp~NIll~~~~~-----~kL  596 (701)
                       ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +  |+||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             699999999999998876543  589999999999999999999998   8  999999999999988776     999


Q ss_pred             EeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          597 ADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       597 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +|||+++...   .......||+.|+|||++...........||||+|+++++
T Consensus       171 ~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~  220 (287)
T 4f0f_A          171 ADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT  220 (287)
T ss_dssp             CCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred             CCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence            9999997543   2344467999999999985433333334599999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.8e-35  Score=305.16  Aligned_cols=192  Identities=29%  Similarity=0.432  Sum_probs=157.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhc--CCCCceeeeeeeeee----C
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST--VRHRNIVKLYGFCLH----K  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~  521 (701)
                      ..++|++.+.||+|+||.||+|.. +++.||||++....      .+.+.+|.+++..  ++||||+++++++..    .
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            357899999999999999999987 68999999986532      2445556666655  799999999998654    3


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecCCCCCcEEEcCCCC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH--------HDCTPSIVHRDISSNNILLNSNLE  593 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~givH~Dlkp~NIll~~~~~  593 (701)
                      ...++||||+++|+|.++++..    .+++..+..++.|++.||+|||        +.   +|+||||||+||+++.++.
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred             ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence            5689999999999999999653    5899999999999999999999        77   9999999999999999999


Q ss_pred             eEEEeecCccccccCCCC----ceeecccccccCCCCCCCCcCC----hhhHHHHHHHHHHHHHcccC
Q 041034          594 AFVADFGTARLLHVDSSN----RTLRAGTYGYIAPDQRLSPPVN----QKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       594 ~kL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~----~~~~~Di~slg~i~~~cl~~  653 (701)
                      +||+|||+|+........    .....||+.|+|||++.+....    .....||||+|+++|+++++
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999999999876543222    2234799999999998776332    22345999999999887664

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-35  Score=311.57  Aligned_cols=190  Identities=23%  Similarity=0.352  Sum_probs=165.9

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999965 4689999999976532   2246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--CCCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~--~~~~kL~DFGla~~~  605 (701)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||++   ||+||||||+||+++.  ++.+||+|||+|+..
T Consensus       127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999987643  2589999999999999999999999   9999999999999974  478999999999877


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ... .......||+.|+|||++.+..++.+.  ||||+|+++|+
T Consensus       202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~e  242 (387)
T 1kob_A          202 NPD-EIVKVTTATAEFAAPEIVDREPVGFYT--DMWAIGVLGYV  242 (387)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTTCCBCHHH--HHHHHHHHHHH
T ss_pred             CCC-cceeeeccCCCccCchhccCCCCCCcc--cEeeHhHHHHH
Confidence            543 233455799999999999888877765  99999999996

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.5e-34  Score=300.22  Aligned_cols=280  Identities=20%  Similarity=0.291  Sum_probs=212.5

Q ss_pred             CCCcceeEeCC----------CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECc
Q 041034           25 HCNWVGITCDY----------KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLR   94 (701)
Q Consensus        25 ~c~w~gv~c~~----------~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   94 (701)
                      .|.|+.+.|..          ...++.|++++|.+++ ++...|+.+++|++|+|++|.+++..|..|+.+++|++|+|+
T Consensus        30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            46899999863          2468899999999986 445568999999999999999999889999999999999999


Q ss_pred             CCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCC--CCcccccCCCCCcEEEceecccCC
Q 041034           95 WNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSG--VLPQEIGNLKSLIWLSVMYNTVGG  172 (701)
Q Consensus        95 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~  172 (701)
                      +|.++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|.+..  ..+..|.++++|++|++++|.++.
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            99999 5565554  799999999999999888899999999999999999964  778899999999999999999975


Q ss_pred             CcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCC
Q 041034          173 PIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN  252 (701)
Q Consensus       173 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  252 (701)
                       +|..+.  ++|++|++++|++++..|..+..+++|++|++++|.+++..+..+..+++|++|+|++|+++. +|..+..
T Consensus       186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~l~~  261 (330)
T 1xku_A          186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLAD  261 (330)
T ss_dssp             -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTT
T ss_pred             -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCcc-CChhhcc
Confidence             444333  677788888887777767777777777777777777776666667777777777777777774 5666667


Q ss_pred             CCcccEEEcCCCCCccccCcccCCC------CCCcEEEccCccCCC--CCcccccCccceeeecCCCC
Q 041034          253 FSALAELDLSDNKIRGIIPDELSKL------SNLQYLNLSSNLLSG--QIPFAIGKLFNLVSLDLSKN  312 (701)
Q Consensus       253 ~~~L~~L~L~~N~l~~~~p~~l~~l------~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N  312 (701)
                      +++|+.|+|++|+|++..+..|+..      +.|+.|++++|.+..  ..|..|..+.+|+.++|++|
T Consensus       262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence            7777777777777776655555432      445555555555432  23334444444444444444

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-35  Score=320.12  Aligned_cols=206  Identities=24%  Similarity=0.320  Sum_probs=173.6

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      +.++....++|++.+.||+|+||.||+|+.. +++.||+|++++.........+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455667789999999999999999999664 689999999875321111112447889999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      .+..|+||||+++|+|.++++..    .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999999999764    489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCC-CceeecccccccCCCCCCCCc----CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          601 TARLLHVDSS-NRTLRAGTYGYIAPDQRLSPP----VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       601 la~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +|+....... .....+||+.|+|||++.+..    ++.+  .||||+|+++|+|+.+.|.
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~--~DiwSlGvilyell~G~~P  272 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE--CDWWSVGVFLYEMLVGDTP  272 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETH--HHHHHHHHHHHHHHHSSCT
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCc--ceEecchHHHHHHHhCCCC
Confidence            9987653322 223457999999999987655    4444  4999999999999988754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-35  Score=304.59  Aligned_cols=200  Identities=24%  Similarity=0.347  Sum_probs=168.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc--EEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR--CMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  525 (701)
                      .++|++.+.||+|+||.||+|... +++.||||++........  .+.+.+|++++++++||||+++++++....  ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            467999999999999999999664 589999999976443322  467789999999999999999999988755  789


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCCCeEEEeecC
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGT  601 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll----~~~~~~kL~DFGl  601 (701)
                      +||||+++++|.+++........+++..+..++.|++.||+|||++   ||+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999998765444599999999999999999999999   99999999999999    7788899999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCC--------CCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRL--------SPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |+...... ......||+.|+|||++.        +..++.+.  ||||+|+++++|+.+.+.
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--DiwslG~il~el~~g~~p  222 (319)
T 4euu_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV--DLWSIGVTFYHAATGSLP  222 (319)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTH--HHHHHHHHHHHHHHSSCS
T ss_pred             ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            98775433 233457999999999875        34555554  999999999987776543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-35  Score=309.44  Aligned_cols=224  Identities=25%  Similarity=0.417  Sum_probs=167.1

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcCC-Cc---EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELPD-GK---VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF  517 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  517 (701)
                      ++++....++|++.+.||+|+||.||+|.... ++   .||||+++...... ...+.+.+|+.++++++||||++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhce
Confidence            34445567899999999999999999997653 32   79999997654333 335788999999999999999999999


Q ss_pred             eeeCcEE------EEEEEccCCCCHHHHHhcCC---CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 041034          518 CLHKRCM------FFIYEYMERGSLFYVLRDDD---EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL  588 (701)
Q Consensus       518 ~~~~~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll  588 (701)
                      +......      ++||||+++|+|.+++....   ....+++..+..++.|++.||+|||++   ||+||||||+||++
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli  170 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML  170 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence            9877655      99999999999999986432   122589999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------
Q 041034          589 NSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------  649 (701)
Q Consensus       589 ~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------  649 (701)
                      +.++.+||+|||+|+.......  ......+++.|+|||.+.+..++.+.  ||||+|+++++                 
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHS--DVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCcc--chhhHHHHHHHHHhCCCCCccccChHHH
Confidence            9999999999999987643322  12234577889999998887777665  99999999985                 


Q ss_pred             --------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 --------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 --------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                ||..+|.+|||+.++++.+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          249 YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                      6667777777777777777653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-34  Score=302.31  Aligned_cols=219  Identities=22%  Similarity=0.345  Sum_probs=173.9

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......+....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999965 57999999999876555566678899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          528 YEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||+++++|.+++.... ....+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986521 123589999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------------
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------------  649 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------------  649 (701)
                      ..........|++.|+|||.+.+..++.+.  ||||+|+++++                                     
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchh--hHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            444444455799999999999887777665  99999999985                                     


Q ss_pred             --------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 --------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 --------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                              ||..+|.+||++.++++.+++..
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                    66677777777777777766543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.7e-35  Score=307.32  Aligned_cols=225  Identities=24%  Similarity=0.399  Sum_probs=183.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee--eC
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL--HK  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~  521 (701)
                      .++|++.+.||+|+||.||+|++     .+++.||||++....   ....+.+.+|++++++++||||+++++++.  +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            46899999999999999999973     468899999997653   334577899999999999999999999886  45


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            678999999999999999976432  589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------------------
Q 041034          602 ARLLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------------------  649 (701)
Q Consensus       602 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------------------  649 (701)
                      ++.......   ......+|+.|+|||++.+..++.+.  ||||+|+++++                             
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS--DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHH--HHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHH--hHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            987653322   12234578889999998877776665  99999999884                             


Q ss_pred             ----------------------------cccCCCCCCCCHHHHHHHhhcCCCccchhhhhhH
Q 041034          650 ----------------------------CLRSKPKSRPTMQRISQELEGKTPMKKGLKEISI  683 (701)
Q Consensus       650 ----------------------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~~~~  683 (701)
                                                  ||..+|.+|||+.++++.|+..............
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  313 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF  313 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------------
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccccc
Confidence                                        6777899999999999999987765554444333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3e-35  Score=306.85  Aligned_cols=198  Identities=23%  Similarity=0.369  Sum_probs=167.7

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ...++|.+.+.||+|+||.||+|..      .+++.||||++....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3467899999999999999999964      245789999997653  23445788999999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCC---------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDE---------------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHR  579 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~  579 (701)
                      .+..++||||+++++|.+++.....                     ...+++..+..++.||+.||+|||++   ||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            9999999999999999999986532                     12488999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          580 DISSNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       580 Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ||||+||+++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~  246 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS--DVWSFGVLLWEIV  246 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHH--HHHHHHHHHHHHH
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchh--hHHHHHHHHHHHH
Confidence            99999999999999999999999876433221  2234578889999998877777665  9999999999644

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=318.40  Aligned_cols=210  Identities=23%  Similarity=0.315  Sum_probs=176.6

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL  519 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  519 (701)
                      .+++.....++|++.+.||+|+||.||+|+. .+++.||+|++.+.........+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4556666789999999999999999999966 479999999997533222222345788999999999999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      +.+..|+||||+++|+|.+++.+...  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999976432  589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCC-ceeecccccccCCCCCC-------CCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          600 GTARLLHVDSSN-RTLRAGTYGYIAPDQRL-------SPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       600 Gla~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |+|+........ ....+||+.|+|||++.       ...++.+.  |+||+|+++|+|+.+.+..
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~--DiwSlGvilyelltG~~Pf  270 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC--DWWALGVFAYEMFYGQTPF  270 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHH--HHHHHHHHHHHHHHSSCTT
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHH--hhhHHhHHHHHHHhCCCCC
Confidence            999876543332 22357999999999886       33455554  9999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-35  Score=311.21  Aligned_cols=190  Identities=25%  Similarity=0.360  Sum_probs=157.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.......    +.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            3578999999999999999999664 78999999998654433    567899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--eEEEeecCccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--AFVADFGTARL  604 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~--~kL~DFGla~~  604 (701)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.  +||+|||+|+.
T Consensus        94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999997644   589999999999999999999999   9999999999999987765  99999999975


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .... .......||+.|+|||++.+..+.... +||||+|+++|+
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~-~DiwslG~il~e  210 (361)
T 3uc3_A          168 SVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKI-ADVWSCGVTLYV  210 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHH-HHHHHHHHHHHH
T ss_pred             cccc-CCCCCCcCCCCcCChhhhcCCCCCCCe-eeeehhHHHHHH
Confidence            4322 223345799999999998887776553 499999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.2e-35  Score=308.05  Aligned_cols=209  Identities=16%  Similarity=0.228  Sum_probs=179.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     +.+.+|+.+++++ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            46899999999999999999964 57899999998765432     4578899999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-----eEEEeecC
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-----AFVADFGT  601 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~-----~kL~DFGl  601 (701)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.     +||+|||+
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            99999 8999999986432  589999999999999999999999   9999999999999998877     99999999


Q ss_pred             ccccccCCCC-------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------
Q 041034          602 ARLLHVDSSN-------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------  649 (701)
Q Consensus       602 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------  649 (701)
                      |+.+......       .....||+.|+|||++.+..++.+.  ||||+|+++++                         
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRD--DLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchh--HHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9876543221       2345799999999999988887765  99999999996                         


Q ss_pred             -----------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                             |+..+|.+||+++++.+.++.
T Consensus       235 ~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          235 TKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence                                   555688889998888887753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-34  Score=297.49  Aligned_cols=197  Identities=23%  Similarity=0.373  Sum_probs=169.0

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            5799999999999999999965 46899999999865533 333567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++ ++.+.+.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+|+.....
T Consensus        81 e~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99986 66666554332  589999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccC-CC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRS-KP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~-~P  655 (701)
                      ........||+.|+|||++.+.. ++.+.  ||||+|+++++++.+ .|
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~~l~~~~~p  201 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSI--DMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHH--HHHHHHHHHHHHTTTSCC
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchH--HHHHHHHHHHHHHHcCCC
Confidence            55555667999999999987765 45554  999999999999854 44

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-35  Score=302.77  Aligned_cols=197  Identities=26%  Similarity=0.374  Sum_probs=162.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            368999999999999999999664 589999999876543 344467788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.++....
T Consensus        81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            99999999999887554   589999999999999999999999   999999999999999999999999999988764


Q ss_pred             CCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .........||+.|+|||.+.+ ..++.+.  ||||+|+++++++++.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~--Di~slG~il~~l~~g~  200 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPV--DVWAIGCVFAELLSGV  200 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcch--hhHHHHHHHHHHHhCC
Confidence            4444455679999999998865 4445554  9999999999877654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.1e-35  Score=304.04  Aligned_cols=195  Identities=23%  Similarity=0.386  Sum_probs=162.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  521 (701)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            45689999999999999999973     468899999998654322  247789999999999999999999999876  


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            668999999999999999965432  589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ++.......   ......+|..|+|||.+.+..++.+.  ||||+|++++++++
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~  224 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIAS--DVWSFGVTLHELLT  224 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHHHHT
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcch--hHHHHHHHHHHHHH
Confidence            987754432   12334578889999998877777654  99999999886443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=316.74  Aligned_cols=217  Identities=24%  Similarity=0.373  Sum_probs=181.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      .++|++.+.||+|+||.||+|...      +++.||||+++....  ......+.+|+.++++++||||+++++++.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            568999999999999999999742      467899999975433  333467889999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCC----CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeE
Q 041034          523 CMFFIYEYMERGSLFYVLRDDD----EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAF  595 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~---~~k  595 (701)
                      ..++||||+++|+|.+++....    ....+++..++.++.||+.||+|||++   ||+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999997643    123589999999999999999999999   999999999999999555   599


Q ss_pred             EEeecCccccccCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------
Q 041034          596 VADFGTARLLHVDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------  649 (701)
Q Consensus       596 L~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------  649 (701)
                      |+|||+|+......  .......+|+.|+|||++.+..++.+.  ||||+|+++++                        
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKT--DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHH--HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998653222  223345689999999998887777765  99999999985                        


Q ss_pred             -------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                         ||..+|.+||++.++++.++...
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                               67778888888888888876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-35  Score=310.07  Aligned_cols=211  Identities=23%  Similarity=0.377  Sum_probs=179.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccCh-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDS-----AFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++........     ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999964 5789999999987643211     1234567899999999999999999999999


Q ss_pred             cEEEEEEEccCCC-CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 RCMFFIYEYMERG-SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +..++||||+.+| +|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999998654   589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHH------------------------------
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      +++...... ......||+.|+|||++.+..+ +.+  .||||+|+++|+                              
T Consensus       176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~--~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPE--LEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHH--HHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHH
T ss_pred             cceECCCCC-ceeccCCCccccChhhhcCCCCCCCc--ccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHH
Confidence            998765433 3344679999999999887766 444  499999999985                              


Q ss_pred             -----cccCCCCCCCCHHHHHHH
Q 041034          650 -----CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 -----cl~~~P~~Rpt~~~i~~~  667 (701)
                           ||..+|.+|||++++++.
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          253 SLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence                 777788888888888774

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-34  Score=298.87  Aligned_cols=210  Identities=16%  Similarity=0.245  Sum_probs=181.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     +.+.+|+.+++.+ +|++++++++++.+....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            56799999999999999999964 57999999998754432     4577899999999 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-----eEEEeecC
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-----AFVADFGT  601 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~-----~kL~DFGl  601 (701)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.     +||+|||+
T Consensus        84 v~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            99999 8999999986542  589999999999999999999999   9999999999999987776     99999999


Q ss_pred             ccccccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------
Q 041034          602 ARLLHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------  649 (701)
Q Consensus       602 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------  649 (701)
                      |+.......       ......||+.|+|||.+.+..++.+.  ||||+|+++++                         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD--DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHH--HHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            987754322       12345699999999999888877665  99999999984                         


Q ss_pred             ------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                              ||..+|.+||+++++.+.++..
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence                                    8888999999999998888753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.1e-35  Score=308.44  Aligned_cols=193  Identities=25%  Similarity=0.360  Sum_probs=153.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||+++....     .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4678999999999999999999665 588999999976432     3567899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~DFGla~  603 (701)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.   ++.+||+|||+++
T Consensus       126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999997654   589999999999999999999999   9999999999999975   8899999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..... .......||+.|+|||++.+..++.+.  ||||+|+++|+++.+.
T Consensus       200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~  247 (349)
T 2w4o_A          200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEV--DMWSVGIITYILLCGF  247 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             ccCcc-cccccccCCCCccCHHHhcCCCCCccc--chHHHHHHHHHHHhCC
Confidence            76432 223345799999999999888777765  9999999999866654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.5e-35  Score=306.87  Aligned_cols=188  Identities=23%  Similarity=0.320  Sum_probs=146.6

Q ss_pred             ceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEEEccC
Q 041034          455 RYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      .+.||+|+||.||+|.. .+++.||||++....      ...+.+|+.+++.+. ||||+++++++.+....|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            37899999999999965 468999999996532      356788999999997 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---CeEEEeecCccccccCC
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---EAFVADFGTARLLHVDS  609 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~---~~kL~DFGla~~~~~~~  609 (701)
                      +|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++   .+||+|||+++......
T Consensus        90 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           90 GGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             SCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999999998754   589999999999999999999999   999999999999997665   89999999998766554


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .......||+.|+|||.+.+..++.+.  ||||+|+++++++.+.+.
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~--DiwslG~il~~ll~g~~p  208 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESC--DLWSLGVILYTMLSGQVP  208 (325)
T ss_dssp             --------------------CCCCHHH--HHHHHHHHHHHHHHSSCT
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCcc--chHHHHHHHHHHHhCCCC
Confidence            445556789999999999888887765  999999999998877643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-34  Score=296.16  Aligned_cols=197  Identities=21%  Similarity=0.369  Sum_probs=169.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            357899999999999999999965 46899999999765433 3345778899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~---~kL~DFGla~  603 (701)
                      ||||+++++|.+.+....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.   +||+|||.+.
T Consensus        83 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999998887654   589999999999999999999999   9999999999999986655   9999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..... .......||+.|+|||.+.+..++.+.  ||||+|+++++++.+.
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~~l~~g~  204 (284)
T 3kk8_A          157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPV--DIWACGVILYILLVGY  204 (284)
T ss_dssp             ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSS
T ss_pred             EcccC-ccccCCCCCcCCcCchhhcCCCCCccc--chHHHHHHHHHHHHCC
Confidence            76533 223345799999999999888777665  9999999999766654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-35  Score=311.30  Aligned_cols=198  Identities=26%  Similarity=0.382  Sum_probs=165.2

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      ++...++|++.+.||+|+||.||+|..      .+++.||||++.....  ....+.+.+|+.+++++ +||||++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345578999999999999999999964      2466899999975432  22347789999999999 89999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCCc--------------------cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDEA--------------------IELNWTRRVNIVKSVAHALSYLHHDCTPSIV  577 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~giv  577 (701)
                      +...+..++||||+++|+|.+++......                    ..+++..+..++.||+.||+|||++   ||+
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            99999999999999999999999765321                    2378999999999999999999999   999


Q ss_pred             ecCCCCCcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          578 HRDISSNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       578 H~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ||||||+||+++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.+.  ||||+|+++++
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~e  266 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS--DVWSYGILLWE  266 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHH
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhH--hHHHHHHHHHH
Confidence            9999999999999999999999999876543322  2234578899999998877777665  99999999996

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.2e-35  Score=304.88  Aligned_cols=201  Identities=24%  Similarity=0.370  Sum_probs=156.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|+++......  ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            3578999999999999999999664 68999999997654322  23667899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC---CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDD---EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      ||||++ |+|.+++....   ....+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            999998 59999886532   123588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .............||+.|+|||++.+. .++.+.  ||||+|+++++++.+.+.
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~el~~g~~p  208 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI--DIWSCGCILAEMITGKPL  208 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            775444444556799999999998764 455554  999999999999988753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.1e-35  Score=300.39  Aligned_cols=213  Identities=26%  Similarity=0.471  Sum_probs=182.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH------  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  520 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....       +.+.+|+.++++++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3567999999999999999999665 79999999997643       346789999999999999999998864      


Q ss_pred             ----------CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          521 ----------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       521 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                                ....++||||+++++|.+++.... ...+++..+..++.|++.||+|||++   ||+||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                      445899999999999999997643 22589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------
Q 041034          591 NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------  649 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------  649 (701)
                      ++.+||+|||+++...... ......||+.|+|||.+.+..++.+.  ||||+|+++++                     
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~  234 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEV--DLYALGLILAELLHVCDTAFETSKFFTDLRDG  234 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHH--HHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTT
T ss_pred             CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchh--hhHHHHHHHHHHHhcCCcchhHHHHHHHhhcc
Confidence            9999999999998765433 23345699999999998887776665  99999999984                     


Q ss_pred             ----------------cccCCCCCCCCHHHHHHHhhcCCCc
Q 041034          650 ----------------CLRSKPKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       650 ----------------cl~~~P~~Rpt~~~i~~~l~~~~~~  674 (701)
                                      ||..+|.+||++.|+++.+......
T Consensus       235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                            7888999999999999998766543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-35  Score=324.19  Aligned_cols=217  Identities=25%  Similarity=0.450  Sum_probs=183.0

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++...++|++.+.||+|+||.||+|...+++.||||+++.....    .+.+.+|+.++++++||||+++++++. .+..
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            45567889999999999999999998888899999999865432    478899999999999999999999986 5668


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            99999999999999997542 22578899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------------------
Q 041034          605 LHVDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------------------  649 (701)
Q Consensus       605 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------------------  649 (701)
                      ..... .......+++.|+|||.+....++.++  ||||+|+++++                                  
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  411 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS--DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  411 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHH--HHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            64221 111223467889999999877777665  99999999985                                  


Q ss_pred             ---------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ---------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ---------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                               ||..+|.+|||+++|++.|+...
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                     77777777888888877777654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-34  Score=302.26  Aligned_cols=195  Identities=23%  Similarity=0.337  Sum_probs=168.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccCh---HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDS---AFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++........   ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3567999999999999999999654 689999999986543221   124678999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEEee
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADF  599 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~----~~kL~DF  599 (701)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999997643   588999999999999999999999   999999999999999887    7999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      |+++...... ......||+.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~  212 (321)
T 2a2a_A          164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEA--DMWSIGVITYILL  212 (321)
T ss_dssp             TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHH
T ss_pred             ccceecCccc-cccccCCCCCccCcccccCCCCCCcc--ccHHHHHHHHHHH
Confidence            9998765432 23345799999999999887777665  9999999999633

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.4e-35  Score=301.77  Aligned_cols=211  Identities=23%  Similarity=0.413  Sum_probs=180.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CC-------cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DG-------KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      .++|++.+.||+|+||.||+|... ++       +.||+|++.....   ...+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            578999999999999999999554 23       4799999865432   234778999999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-------
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-------  593 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~-------  593 (701)
                      ++..++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.       
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            9999999999999999999987542  489999999999999999999999   9999999999999998877       


Q ss_pred             -eEEEeecCccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHH----------------------
Q 041034          594 -AFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALA----------------------  649 (701)
Q Consensus       594 -~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~----------------------  649 (701)
                       +||+|||.+.....    .....+|+.|+|||++.+ ..++.+.  ||||+|+++++                      
T Consensus       159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~--DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLAT--DKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHH--HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchh--HHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence             99999999975432    233468999999999876 4455554  99999999985                      


Q ss_pred             -------------------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 -------------------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 -------------------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                                         ||..+|.+|||+.++++.|++...
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                               788899999999999999988764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.8e-35  Score=307.34  Aligned_cols=193  Identities=26%  Similarity=0.403  Sum_probs=164.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|++.+.||+|+||.||+|.. .+++.||||++...........+.+.+|++++++++||||+++++++.+.+..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            345699999999999999999965 5799999999987655445556788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||++ |++.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       132 v~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            999997 588888764332  589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHHccc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..    ....||+.|+|||++.   ...++.+.  ||||+|+++++++.
T Consensus       206 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~--DiwslG~il~ell~  248 (348)
T 1u5q_A          206 PA----NSFVGTPYWMAPEVILAMDEGQYDGKV--DVWSLGITCIELAE  248 (348)
T ss_dssp             SB----CCCCSCGGGCCHHHHHTTSSCCBCTHH--HHHHHHHHHHHHHH
T ss_pred             CC----CcccCCcceeCHhhhccccCCCCCcHH--HHHHHHHHHHHHHh
Confidence            32    2357999999999874   34555554  99999999996433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.9e-35  Score=318.79  Aligned_cols=191  Identities=25%  Similarity=0.412  Sum_probs=163.0

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-EE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-CM  524 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~  524 (701)
                      +...++|++.+.||+|+||.||+|... ++.||||+++....     .+.+.+|+.++++++||||+++++++.+.+ ..
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            345678999999999999999999874 78999999986542     367899999999999999999999987655 79


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            999999999999999986542 2478999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ....   .....+++.|+|||.+.+..++.++  ||||+|+++++++
T Consensus       339 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~s--DvwslG~~l~el~  380 (450)
T 1k9a_A          339 ASST---QDTGKLPVKWTAPEALREKKFSTKS--DVWSFGILLWEIY  380 (450)
T ss_dssp             CC---------CCCTTTSCHHHHHSSCCCHHH--HHHHHHHHHHHHH
T ss_pred             cccc---ccCCCCCcceeCHHHhcCCCCCcHH--HHHHHHHHHHHHH
Confidence            4322   2223578899999999888777765  9999999999633

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-35  Score=304.73  Aligned_cols=220  Identities=27%  Similarity=0.454  Sum_probs=186.7

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ++++....++|++.+.||+|+||.||+|... +++.||+|++.....    ..+.+.+|+.++++++||||+++++++.+
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            3445566789999999999999999999665 588999999976432    24778899999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      .+..++||||+++++|.+++..... ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence            9999999999999999999986443 2589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------
Q 041034          601 TARLLHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       601 la~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      .++........ .....+|+.|+|||.+.+..++.+.  ||||+|+++++                              
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  234 (288)
T ss_dssp             GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred             cceeccCCccccccCCccccCcCChhhhccCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence            99876533221 2223567889999998877777665  99999999985                              


Q ss_pred             -------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                   |+..+|.+|||+.++++.|+..
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                         6666788888888888887654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-35  Score=303.73  Aligned_cols=211  Identities=28%  Similarity=0.458  Sum_probs=174.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .++|++.+.||+|+||.||+|... ++.||||++....     ..+.+.+|+.++++++||||+++++++.+  ..++||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            467999999999999999999874 7889999986432     24678999999999999999999999874  378999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC-eEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE-AFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~-~kL~DFGla~~~~~  607 (701)
                      ||+++|+|.+++........+++..+..++.|+++||+|||+.+..||+||||||+||+++.++. +||+|||+++....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999999987655445889999999999999999999932239999999999999998886 79999999976542


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------------
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------------  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------------  649 (701)
                      .   .....||+.|+|||++.+..++.+.  ||||+|+++++                                      
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          159 H---MTNNKGSAAWMAPEVFEGSNYSEKC--DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHH--HHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             c---cccCCCCCceEChhhhCCCCCCcHH--HHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            2   2334699999999999887777665  99999999984                                      


Q ss_pred             ------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                            ||..+|.+|||++++++.|+...
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence                  78889999999999999887644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-35  Score=301.22  Aligned_cols=196  Identities=24%  Similarity=0.337  Sum_probs=154.5

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ....++|++.+.||+|+||.||+|...    .+..||+|++....  .....+.+.+|+.++++++||||+++++++. .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            345678999999999999999999653    24579999987643  2344678899999999999999999999985 4


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      +..++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             CccEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence            568899999999999999976532  589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          602 ARLLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       602 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ++....... ......+++.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~ell  211 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS--DVWMFGVCMWEIL  211 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHH--HHHHHHHHHHHHH
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCcc--CchHHHHHHHHHH
Confidence            987653322 12334577899999998877777665  9999999999644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-35  Score=305.87  Aligned_cols=199  Identities=25%  Similarity=0.347  Sum_probs=168.7

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ....++|++.+.||+|+||.||+|..      .+++.||||+++....  ....+.+.+|+.+++++ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34567899999999999999999963      3578899999986543  23357889999999999 899999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC---------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE---------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                      .+.+..++||||+++|+|.+++.....               ...+++..+..++.|++.||+|||++   ||+||||||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence            999999999999999999999976532               12489999999999999999999999   999999999


Q ss_pred             CcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          584 NNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       584 ~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +||+++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ell  241 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES--DVWSYGIFLWELF  241 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHH--HHHHHHHHHHHHH
Confidence            9999999999999999999876543322  1233577899999998877777665  9999999999643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-35  Score=298.98  Aligned_cols=194  Identities=24%  Similarity=0.381  Sum_probs=167.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ..++|++.+.||+|+||.||+|...+++.||+|++......    .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            35789999999999999999998878889999999875433    26788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++.....  .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||.++....
T Consensus        82 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999999976532  588999999999999999999999   999999999999999999999999999986532


Q ss_pred             CC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          608 DS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       608 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .. .......+++.|+|||.+.+..++.+.  ||||+|+++++++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~  200 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKS--DVWSFGVLMWEVFS  200 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccChhhhcCCCccchh--chhhhHHHHHHHhc
Confidence            11 111223577889999998777776654  99999999997654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-34  Score=320.16  Aligned_cols=204  Identities=24%  Similarity=0.347  Sum_probs=177.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+....|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999664 6999999999764332222346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          528 YEYMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||++||+|.+++..... ...+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999876432 33589999999999999999999999   99999999999999999999999999998876


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .........+||+.|+|||++.+..++.+.  |+||+|+++|+|+.+.|..
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~--DiwSlGvilyelltG~~PF  389 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGPF  389 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCSS
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHH--hcCcchHHHHHHHhCCCCC
Confidence            544444455899999999999888887765  9999999999999887543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-34  Score=298.31  Aligned_cols=194  Identities=33%  Similarity=0.458  Sum_probs=170.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|++.+.||+|+||.||+|.. .+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            456799999999999999999965 578999999997654332  25778999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.+....
T Consensus        98 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence            99999999999999753    589999999999999999999999   99999999999999999999999999998776


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..........||+.|+|||.+.+..++.+.  ||||+|+++++++.
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~  214 (303)
T 3a7i_A          171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKA--DIWSLGITAIELAR  214 (303)
T ss_dssp             TTBCCBCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHH
T ss_pred             ccccccCccCCCcCccCHHHHhcCCCCchh--hhHHHHHHHHHHcc
Confidence            544444556799999999999887777665  99999999996333

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-35  Score=326.27  Aligned_cols=220  Identities=27%  Similarity=0.437  Sum_probs=188.3

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ++...++|++.+.||+|+||.||+|.+. +++.||||+++.....    .+.+.+|+.++++++||||+++++++.+.+.
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            3445678999999999999999999765 4889999999865432    4778999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.++++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence            9999999999999999986432 2589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------------
Q 041034          604 LLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------------  649 (701)
Q Consensus       604 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------------  649 (701)
                      ....... ......+++.|+|||.+....++.+.  ||||+|+++++                                 
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s--DvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  444 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC  444 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHH--HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHH--hHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            7643221 11223456789999998877777665  99999999985                                 


Q ss_pred             ----------cccCCCCCCCCHHHHHHHhhcCCCc
Q 041034          650 ----------CLRSKPKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       650 ----------cl~~~P~~Rpt~~~i~~~l~~~~~~  674 (701)
                                ||+.+|.+|||+.++++.|+.....
T Consensus       445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          445 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                      8888999999999999999887643

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-34  Score=307.61  Aligned_cols=197  Identities=17%  Similarity=0.234  Sum_probs=166.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEE------cCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC---CCceeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAE------LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR---HRNIVKLYGF  517 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  517 (701)
                      ...++|.+.+.||+|+||.||+|.      ..+++.||||++....      ..++.+|+.+++.++   |+||++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            446789999999999999999993      4468899999997643      256777888888886   9999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCC--CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-----
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDD--EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-----  590 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-----  590 (701)
                      +...+..++||||+++|+|.+++....  ....+++..+..++.||+.||+|||++   |||||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            999999999999999999999997421  123699999999999999999999998   9999999999999998     


Q ss_pred             ------CCCeEEEeecCccccccC--CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          591 ------NLEAFVADFGTARLLHVD--SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       591 ------~~~~kL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                            ++.+||+|||+|+.+...  ........||+.|+|||++.+..++.+.  ||||+|+++|+|+.+.
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~elltg~  282 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI--DYFGVAATVYCMLFGT  282 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHH--HHHHHHHHHHHHHHSS
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccc--cHHHHHHHHHHHHhCC
Confidence                  899999999999765422  2233445799999999999988877765  9999999999876654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-34  Score=309.62  Aligned_cols=198  Identities=19%  Similarity=0.274  Sum_probs=167.8

Q ss_pred             hhcCCccceEEeec--cceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          448 ATEDFHIRYCIGTG--GYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       448 ~~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ..++|++.+.||+|  +||.||+|+.. +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            45789999999999  99999999664 7999999999875433 34567888999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.+++...... .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.+..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999999765322 589999999999999999999999   999999999999999999999999999865


Q ss_pred             cccCC-------CCceeecccccccCCCCCCC--CcCChhhHHHHHHHHHHHHHccc
Q 041034          605 LHVDS-------SNRTLRAGTYGYIAPDQRLS--PPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       605 ~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .....       .......||+.|+|||++.+  ..++.+  .||||+|+++++|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--~DiwslG~il~el~~  232 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK--SDIYSVGITACELAN  232 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH--HHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcH--hHHHHHHHHHHHHHH
Confidence            43221       11223468999999999887  345555  499999999886443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.8e-33  Score=305.10  Aligned_cols=306  Identities=29%  Similarity=0.348  Sum_probs=158.0

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEEC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL  117 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  117 (701)
                      +++.|++++|.+++ ++.    .+++|++|++++|.+++. |..   .++|++|+|++|++++ +| .|+++++|++|++
T Consensus        92 ~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l  160 (454)
T 1jl5_A           92 HLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV  160 (454)
T ss_dssp             TCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence            44444554444443 221    124455555555555431 111   1455556666655554 44 3555566666666


Q ss_pred             CCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCC
Q 041034          118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT  197 (701)
Q Consensus       118 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  197 (701)
                      ++|++++ +|..   .++|++|+|++|++++ +| .++++++|+.|++++|.+++ +|...   ++|++|++++|+++ .
T Consensus       161 ~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~  229 (454)
T 1jl5_A          161 DNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-E  229 (454)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-S
T ss_pred             CCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-c
Confidence            6665554 2322   2355566666665554 23 35556666666666665554 22221   35566666666655 3


Q ss_pred             CCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCC
Q 041034          198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL  277 (701)
Q Consensus       198 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l  277 (701)
                      +| .++.+++|++|++++|++++ +|..   +++|++|++++|++++ +|..   +++|+.|++++|++++. |..   .
T Consensus       230 lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~  296 (454)
T 1jl5_A          230 LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---P  296 (454)
T ss_dssp             CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---C
T ss_pred             cc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---C
Confidence            44 25556666666666666654 3322   2456666666666655 3332   25566666666666542 111   1


Q ss_pred             CCCcEEEccCccCCCCCcccccCc-cceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEE
Q 041034          278 SNLQYLNLSSNLLSGQIPFAIGKL-FNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD  356 (701)
Q Consensus       278 ~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~  356 (701)
                      ++|+.|++++|.+++ ++    .+ ++|+.|++++|++++ +|..   +++|+.|++++|+++ .+|.   .+++|+.|+
T Consensus       297 ~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~  363 (454)
T 1jl5_A          297 PNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLH  363 (454)
T ss_dssp             TTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEE
T ss_pred             CcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEE
Confidence            456666666666653 11    22 477788888888875 5553   467888888888887 4565   367788888


Q ss_pred             cccccCcc--cCCCCccc-----------------cccccccCCCCC--cCCCcCC
Q 041034          357 LSHNNLSG--TIPMTLHP-----------------MFLDMSFNNLEG--EIPTYLR  391 (701)
Q Consensus       357 ls~N~l~g--~~p~~~~~-----------------~~l~ls~N~l~g--~~p~~~~  391 (701)
                      +++|+++|  .+|..+..                 ..||+++|+++|  .+|.++.
T Consensus       364 L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~  419 (454)
T 1jl5_A          364 VEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVE  419 (454)
T ss_dssp             CCSSCCSSCCCCCTTCCEEECCC---------------------------------
T ss_pred             CCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhhHh
Confidence            88888887  67765421                 246666666665  5555443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-35  Score=308.20  Aligned_cols=224  Identities=21%  Similarity=0.342  Sum_probs=188.7

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY  515 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  515 (701)
                      .++++...++|++.+.||+|+||.||+|...      +++.||+|++.....  ......+.+|+.+++.++||||++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            3455667789999999999999999999543      367899999976433  33356789999999999999999999


Q ss_pred             eeeeeCcEEEEEEEccCCCCHHHHHhcCCC-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE
Q 041034          516 GFCLHKRCMFFIYEYMERGSLFYVLRDDDE-------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL  588 (701)
Q Consensus       516 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll  588 (701)
                      +++.+.+..++||||+++|+|.+++.....       ...+++..+..++.|++.||+|||++   ||+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            999999999999999999999999875321       12578999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------
Q 041034          589 NSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------  649 (701)
Q Consensus       589 ~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------  649 (701)
                      +.++.+||+|||+++.......  ......+|+.|+|||.+.+..++.+.  ||||+|+++++                 
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~~g~~p~~~~~~~~~  249 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS--DVWSFGVVLWEIATLAEQPYQGLSNEQV  249 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchh--hHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence            9999999999999986643321  11223568899999998877777665  99999999984                 


Q ss_pred             --------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 --------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 --------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                                |+..+|.+|||+.|+++.|++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                                      78889999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-34  Score=295.36  Aligned_cols=212  Identities=18%  Similarity=0.317  Sum_probs=178.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--cEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK--RCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|... ++.||||+++..... ....+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            568999999999999999999874 889999999875433 34457799999999999999999999999877  77899


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g--ivH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||++   +  ++||||||+||+++.++.++|+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            9999999999999987542 2589999999999999999999998   7  99999999999999999999999998765


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChh-hHHHHHHHHHHHHH----------------------------------
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQK-IIQDIILVSTTALA----------------------------------  649 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~Di~slg~i~~~----------------------------------  649 (701)
                      ...     ....||+.|+|||.+.+...... ..+||||+|+++++                                  
T Consensus       163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS  237 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred             ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence            332     22468999999999877655431 23599999999995                                  


Q ss_pred             ---------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ---------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ---------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                               ||+.+|.+|||++++++.|++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                     6777777777777777777653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-34  Score=293.51  Aligned_cols=208  Identities=23%  Similarity=0.338  Sum_probs=174.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.......   .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            3567999999999999999999654 57899999997654433   4678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla~  603 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||++   +.++.+||+|||.+.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999987654   589999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHh
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQEL  668 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l  668 (701)
                      ...... ......||+.|+|||.+.+. ++.+.  ||||+|+++++|+.+. |...++..++...+
T Consensus       158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~--Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  219 (277)
T 3f3z_A          158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPEC--DEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI  219 (277)
T ss_dssp             ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eccCcc-chhccCCCCCccChHHhccc-CCchh--hehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            765332 33445799999999998664 55554  9999999999988775 33444444444443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-34  Score=304.68  Aligned_cols=217  Identities=23%  Similarity=0.421  Sum_probs=180.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEc--------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL--------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFC  518 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (701)
                      ..++|++.+.||+|+||.||+|..        .+++.||||++....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            457899999999999999999965        246789999997654  234457789999999999 899999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      .+.+..++||||+++|+|.+++.....             ...+++..+..++.||+.||+|||++   ||+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            999999999999999999999986532             12488999999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------  649 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------  649 (701)
                      |+++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.+.  ||||+|+++++              
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHH--HHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHH--HHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999999999999999987653322  12233577889999998777776665  99999999985              


Q ss_pred             -----------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -----------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -----------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                   ||..+|.+||++.++++.|++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          266 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                         6667788888888888877754

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.5e-33  Score=305.40  Aligned_cols=311  Identities=28%  Similarity=0.352  Sum_probs=227.2

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      ..++.|++++|.+++ ++..    .++|++|++++|.+++ +| .|+++++|++|++++|++++ +|..+   .+|++|+
T Consensus       111 ~~L~~L~l~~n~l~~-l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~  179 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIA  179 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEE
T ss_pred             CCCcEEECCCCccCc-ccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEE
Confidence            679999999999885 3221    2789999999999997 67 59999999999999999996 56544   5999999


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCC
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG  196 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (701)
                      |++|++++ +| .++.+++|++|++++|++++ +|...   ++|++|++++|.++ .+| .+..+++|++|++++|++++
T Consensus       180 L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~  251 (454)
T 1jl5_A          180 AGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT  251 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS
T ss_pred             CcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc
Confidence            99999997 45 69999999999999999997 34332   58999999999998 566 48999999999999999996


Q ss_pred             CCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCC
Q 041034          197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK  276 (701)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~  276 (701)
                       +|..   +++|++|++++|++++ +|..   .++|++|++++|++++. |..   .++|+.|++++|++++. +. +  
T Consensus       252 -l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~~-~--  315 (454)
T 1jl5_A          252 -LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-CD-L--  315 (454)
T ss_dssp             -CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-CC-C--
T ss_pred             -cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-cC-C--
Confidence             4543   4789999999999996 5554   37899999999999983 321   26899999999999963 32 1  


Q ss_pred             CCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCC--CCCcccccc-----
Q 041034          277 LSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDG--TIPPEIGKI-----  349 (701)
Q Consensus       277 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l-----  349 (701)
                      .++|+.|++++|++++ +|..   +++|+.|++++|+++ .+|.   .+++|++|++++|++++  .+|.+++.+     
T Consensus       316 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~  387 (454)
T 1jl5_A          316 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSH  387 (454)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-
T ss_pred             cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhccc
Confidence            2589999999999996 5654   589999999999999 5776   47899999999999999  899999888     


Q ss_pred             --------ccCCeEEcccccCcc--cCCCCccccccccccCCCCCcCCCcCCC
Q 041034          350 --------LLLQNLDLSHNNLSG--TIPMTLHPMFLDMSFNNLEGEIPTYLRD  392 (701)
Q Consensus       350 --------~~L~~l~ls~N~l~g--~~p~~~~~~~l~ls~N~l~g~~p~~~~~  392 (701)
                              ++|+.|++++|+++|  .+|.++.  .+.+.+|.+.+.+|.+...
T Consensus       388 ~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~--~L~~~~~~~~~~~~~~~~~  438 (454)
T 1jl5_A          388 LAEVPELPQNLKQLHVETNPLREFPDIPESVE--DLRMNSERVVDPYEFAHET  438 (454)
T ss_dssp             -----------------------------------------------------
T ss_pred             ccccccccCcCCEEECCCCcCCccccchhhHh--heeCcCcccCCccccCHHH
Confidence                    889999999999998  8887654  4677888898887766543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.9e-35  Score=299.27  Aligned_cols=198  Identities=24%  Similarity=0.418  Sum_probs=166.2

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      +++...++|++.+.||+|+||.||+|...+++.||+|++......    .+.+.+|++++++++||||+++++++.+ +.
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            344566889999999999999999998888889999999765432    3678899999999999999999999864 45


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.++
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            889999999999999997532 12589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          604 LLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       604 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ....... ......+++.|+|||.+.+..++.+.  ||||+|+++++++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~  205 (279)
T 1qpc_A          158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS--DVWSFGILLTEIVT  205 (279)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHH--HHHHHHHHHHHHHT
T ss_pred             cccCcccccccCCCCccCccChhhhccCCCCchh--hhHHHHHHHHHHHh
Confidence            7643221 11223467889999998777766665  99999999996443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.8e-35  Score=308.48  Aligned_cols=193  Identities=20%  Similarity=0.313  Sum_probs=164.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++......       ..+|++++.++ +||||+++++++.+.+..|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4678999999999999999999654 6899999999765432       34678888887 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC----CCeEEEeecC
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN----LEAFVADFGT  601 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~----~~~kL~DFGl  601 (701)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||++.++    +.+||+|||+
T Consensus        93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999997654   589999999999999999999999   99999999999998543    3599999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ++.............||+.|+|||++.+..++.+.  ||||+|+++|+++.+.+
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~g~~  218 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTGYT  218 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHH--HHHHHHHHHHHHHHSSC
T ss_pred             cccCcCCCCceeccCCCccccCHHHhcCCCCCCcc--CeeeHhHHHHHHhcCCC
Confidence            98776554445556799999999998776665554  99999999998666553

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-34  Score=306.93  Aligned_cols=205  Identities=25%  Similarity=0.357  Sum_probs=165.1

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE--DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      +....++|++.+.||+|+||.||+|.. .+++.||+|++......  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            456678899999999999999999965 56889999998754221  122357889999999999999999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCC-------------------------------------CccCCCHHHHHHHHHHHHHH
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDD-------------------------------------EAIELNWTRRVNIVKSVAHA  564 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~  564 (701)
                      +..++||||+++|+|.+++....                                     ....+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999985210                                     01124677888999999999


Q ss_pred             HHHHhcCCCCCeEecCCCCCcEEEcCCC--CeEEEeecCccccccCCC----CceeecccccccCCCCCCC--CcCChhh
Q 041034          565 LSYLHHDCTPSIVHRDISSNNILLNSNL--EAFVADFGTARLLHVDSS----NRTLRAGTYGYIAPDQRLS--PPVNQKI  636 (701)
Q Consensus       565 L~~LH~~~~~givH~Dlkp~NIll~~~~--~~kL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~  636 (701)
                      |+|||++   +|+||||||+||+++.++  .+||+|||+|+.+.....    ......||+.|+|||.+.+  ..++.+ 
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-  256 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK-  256 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH-
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH-
Confidence            9999999   999999999999998766  899999999987643221    2344579999999999865  344444 


Q ss_pred             HHHHHHHHHHHHHcccCC
Q 041034          637 IQDIILVSTTALACLRSK  654 (701)
Q Consensus       637 ~~Di~slg~i~~~cl~~~  654 (701)
                       .||||+|+++++++.+.
T Consensus       257 -~DiwslG~il~el~~g~  273 (345)
T 3hko_A          257 -CDAWSAGVLLHLLLMGA  273 (345)
T ss_dssp             -HHHHHHHHHHHHHHHSS
T ss_pred             -HHHHHHHHHHHHHHHCC
Confidence             49999999999877665

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.2e-35  Score=305.82  Aligned_cols=214  Identities=23%  Similarity=0.430  Sum_probs=174.5

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcE----EEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKV----VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+.....  ....+.+.+|+.++++++||||+++++++.+.. 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            467999999999999999999653 4443    58888765432  223478899999999999999999999998765 


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            7889999999999999987543  589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          604 LLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       604 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      ........  .....+|+.|+|||.+.+..++.+.  ||||+|+++++                                
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  243 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS--DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI  243 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchh--hhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCcc
Confidence            76543322  2234568899999999888777765  99999999985                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                 ||+.+|.+||++.++++.++...
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                       77788999999999999887643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-34  Score=319.40  Aligned_cols=203  Identities=23%  Similarity=0.309  Sum_probs=175.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            457899999999999999999965 4799999999976432222224667899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++..... ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+...
T Consensus       262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999976542 2489999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .. ......+||+.|+|||++.+..++.+.  ||||+|+++|+|+.+.|..
T Consensus       338 ~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~--DiwSLGvilyeLltG~~PF  385 (576)
T 2acx_A          338 EG-QTIKGRVGTVGYMAPEVVKNERYTFSP--DWWALGCLLYEMIAGQSPF  385 (576)
T ss_dssp             TT-CCEECCCSCGGGCCHHHHTTCEESSHH--HHHHHHHHHHHHHHSSCSS
T ss_pred             cC-ccccccCCCccccCHHHHcCCCCCccc--hHHHHHHHHHHHHhCCCCC
Confidence            33 233445899999999999888777665  9999999999999887543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-34  Score=297.69  Aligned_cols=209  Identities=26%  Similarity=0.470  Sum_probs=175.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999654 6889999998754322222346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999976542


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      .  ......|++.|+|||.+.+..++.+.  ||||+|+++++++.+. |...++..+..+.
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~pf~~~~~~~~~~~  223 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKV--DLWCAGVLCYEFLVGMPPFDSPSHTETHRR  223 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTH--HHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCccc--chhhHHHHHHHHHHCCCCCCCCCHhHHHHH
Confidence            2  23345799999999999888777665  9999999999988776 3333444444433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-34  Score=297.82  Aligned_cols=214  Identities=25%  Similarity=0.411  Sum_probs=176.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL-HKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  523 (701)
                      ..+|++.+.||+|+||.||+|...+    ...||+|.+....  .....+.+.+|+.++++++||||+++++++. .++.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            4568899999999999999996532    2358999987643  3344678899999999999999999999854 5567


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+|+
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            8999999999999999976432  588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCC----CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------
Q 041034          604 LLHVDS----SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       604 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      ......    .......+|+.|+|||.+.+..++.+.  ||||+|+++++                              
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS--DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP  254 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHH--HHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            764322    122334578899999999887777665  99999999985                              


Q ss_pred             -------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                   |+..+|.+|||+.++++.|++.
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                         6677778888888888877653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3e-34  Score=299.84  Aligned_cols=189  Identities=22%  Similarity=0.350  Sum_probs=160.9

Q ss_pred             cCC-ccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--C
Q 041034          450 EDF-HIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--K  521 (701)
Q Consensus       450 ~~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  521 (701)
                      ++| ++.+.||+|+||.||+|.+     .+++.||||+++...  .....+.+.+|++++++++||||+++++++.+  .
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            344 9999999999999998854     257899999998653  23446788999999999999999999999987  4


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||+++|+|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccc
Confidence            6789999999999999999764    389999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          602 ARLLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       602 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ++.......   ......+|+.|+|||.+.+..++.+.  ||||+|+++++
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~  229 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS--DVWSFGVTLYE  229 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHH--HHHHHHHHHHH
Confidence            987754322   12334578889999999877777655  99999999885

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-34  Score=298.09  Aligned_cols=193  Identities=26%  Similarity=0.425  Sum_probs=152.3

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      +...++|++.+.||+|+||.||+|...  ..||+|+++.... .....+.+.+|+.++++++||||+++++++ .....+
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            445678999999999999999999864  3699999976543 344467899999999999999999999975 455689


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        96 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999999965432  589999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccC--CCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHH
Q 041034          606 HVD--SSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ...  ........||+.|+|||.+.   +.+++.+.  ||||+|+++++
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~--Di~slG~il~e  217 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS--DVYAFGIVLYE  217 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHH--HHHHHHHHHHH
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCccc--chHHHHHHHHH
Confidence            421  22233456999999999886   44455554  99999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.8e-34  Score=295.43  Aligned_cols=200  Identities=21%  Similarity=0.322  Sum_probs=167.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++........ ....+.+|+..+..+ +||||+++++++.+++..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            3578999999999999999999664 799999999987544332 346788999999999 8999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCC-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-------------
Q 041034          526 FIYEYMERGSLFYVLRDDDE-AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-------------  591 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-------------  591 (701)
                      +||||+++++|.+++..... ...+++..+..++.||+.||+|||++   ||+||||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999976421 12589999999999999999999999   99999999999999844             


Q ss_pred             ------CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          592 ------LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       592 ------~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                            ..+||+|||.+.......    ...||+.|+|||.+.+..... ...||||+|+++++++.+.|.
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTH-HHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCC-chhhHHHHHHHHHHHhcCCCC
Confidence                  479999999998764322    235999999999987653322 235999999999998877653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.1e-35  Score=305.61  Aligned_cols=215  Identities=22%  Similarity=0.372  Sum_probs=177.4

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcE----EEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKV----VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+.......  ..+.+.+|+.++++++||||+++++++. .+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            467999999999999999999653 4544    7888775443221  1245678999999999999999999986 456


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+|+
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             cEEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            8899999999999999976532  588899999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          604 LLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       604 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      .......  ......+|+.|+|||++.+..++.+.  ||||+|+++|+                                
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS--DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI  241 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhh--HhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc
Confidence            7754322  23445688899999999877777665  99999999985                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                                 ||..+|.+||++.++++.|+....
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                       777889999999999999987553

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-34  Score=316.68  Aligned_cols=194  Identities=25%  Similarity=0.354  Sum_probs=152.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-----Cc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-----KR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~  522 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.... .+....+++.+|+.+++.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            47899999999999999999965 478999999997643 234446788999999999999999999999854     35


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..|+||||+. ++|.+++....   .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            7899999985 69999997654   589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCC---------------------------CceeecccccccCCCCC-CCCcCChhhHHHHHHHHHHHHHccc
Q 041034          603 RLLHVDSS---------------------------NRTLRAGTYGYIAPDQR-LSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       603 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +.......                           ..+..+||+.|+|||++ ....++.+.  ||||+||++|+|++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~--DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI--DVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh--HHHHHHHHHHHHHH
Confidence            87642211                           22345789999999975 455566665  99999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-34  Score=295.75  Aligned_cols=197  Identities=26%  Similarity=0.400  Sum_probs=162.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++........  .+.+.+|++++++++||||+++++++.+....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            46799999999999999999965 4689999999987543322  47789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCcc
Q 041034          528 YEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTAR  603 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla~  603 (701)
                      |||+++|+|.+++.... ....+++..+..++.|++.||+|||++   ||+||||||+||++   +.++.+||+|||+++
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999999886431 123589999999999999999999999   99999999999999   456889999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ...... ......||+.|+|||++.+ .++.+  .||||+|+++++++.+.
T Consensus       176 ~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~--~Di~slG~il~~ll~g~  222 (285)
T 3is5_A          176 LFKSDE-HSTNAAGTALYMAPEVFKR-DVTFK--CDIWSAGVVMYFLLTGC  222 (285)
T ss_dssp             C-----------CTTGGGCCHHHHTT-CCCHH--HHHHHHHHHHHHHHHSS
T ss_pred             ecCCcc-cCcCcccccCcCChHHhcc-CCCcc--cCeehHHHHHHHHHhCC
Confidence            765332 2344579999999998754 45554  49999999999877765

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.8e-35  Score=320.67  Aligned_cols=217  Identities=28%  Similarity=0.456  Sum_probs=176.7

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++...++|++.+.||+|+||.||+|.+.++..||||+++.....    .+.+.+|+.++++++||||+++++++.+ +..
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            34456789999999999999999998887888999999865432    3678999999999999999999999876 668


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            99999999999999997532 12589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------------------
Q 041034          605 LHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------------------  649 (701)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------------------  649 (701)
                      ...... ......+++.|+|||.+....++.+.  ||||+|+++++                                  
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s--DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  407 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  407 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccc--cHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            643221 12233567889999998877777665  99999999986                                  


Q ss_pred             ---------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ---------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ---------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                               ||..+|.+|||++++++.|+...
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                     66677777777777777776554

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=307.59  Aligned_cols=191  Identities=25%  Similarity=0.346  Sum_probs=159.5

Q ss_pred             ccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEcc
Q 041034          453 HIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      ...+.||+|+||.||+|.. .+|+.||+|+++....   ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3367899999999999965 5799999999986542   23577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE--cCCCCeEEEeecCccccccCC
Q 041034          532 ERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL--NSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll--~~~~~~kL~DFGla~~~~~~~  609 (701)
                      ++++|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+||++  +.++.+||+|||+++.+....
T Consensus       169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            9999999887543  2589999999999999999999999   99999999999999  567899999999998765332


Q ss_pred             CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                       ......||+.|+|||++.+..++.+.  ||||+|+++++++.+.
T Consensus       244 -~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~elltg~  285 (373)
T 2x4f_A          244 -KLKVNFGTPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGL  285 (373)
T ss_dssp             -BCCCCCSSCTTCCHHHHTTCBCCHHH--HHHHHHHHHHHHHHSS
T ss_pred             -ccccccCCCcEeChhhccCCCCCcHH--hHHHHHHHHHHHHhCC
Confidence             23345799999999999887777765  9999999999866655

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.4e-34  Score=309.93  Aligned_cols=199  Identities=25%  Similarity=0.380  Sum_probs=156.3

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ...++|.+.+.||+|+||.||+|.. .+++.||||++......     .......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3468899999999999999999955 56899999998764321     1122235789999999999999999999975 


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEE
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVA  597 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~---~~~kL~  597 (701)
                      .+..++||||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.+   +.+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            455899999999999999887654   589999999999999999999999   99999999999999754   459999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCC---CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS---PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |||+|+..... .......||+.|+|||++.+   ..++.+  .||||+|+++++|+.+.+
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~--~DiwslG~il~~lltg~~  342 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRA--VDCWSLGVILFICLSGYP  342 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHH--HHHHHHHHHHHHHHHSSC
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCch--hhhHhHHHHHHHHHHCCC
Confidence            99999876532 23344679999999999864   334444  599999999998766553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.6e-34  Score=293.94  Aligned_cols=211  Identities=23%  Similarity=0.374  Sum_probs=167.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999664 7999999998754322223356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999997654   589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHH
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQE  667 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~  667 (701)
                      .. ......+++.|+|||.+.+..+... ..|+||+|+++++++.+. |....+..++.+.
T Consensus       164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  222 (276)
T 2h6d_A          164 GE-FLRTSCGSPNYAAPEVISGRLYAGP-EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK  222 (276)
T ss_dssp             --------------CCTGGGTTSCCCHH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             Cc-ceecccCCccccCHHHHcCCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            32 2334568999999999887665322 359999999999987765 3333344444433

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=305.62  Aligned_cols=190  Identities=22%  Similarity=0.379  Sum_probs=158.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH--RNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++|  |||+++++++.+.+..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            467999999999999999999888899999999986543 34446788999999999986  999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||+ .+++|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++ ++.+||+|||+|+...
T Consensus        87 v~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            9995 5779999998754   589999999999999999999999   999999999999997 6789999999998765


Q ss_pred             cCCC--CceeecccccccCCCCCCC-----------CcCChhhHHHHHHHHHHHHH
Q 041034          607 VDSS--NRTLRAGTYGYIAPDQRLS-----------PPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       607 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~~Di~slg~i~~~  649 (701)
                      ....  ......||+.|+|||.+.+           ..++.+  .||||+|+++++
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~--~DiwslG~il~e  212 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK--SDVWSLGCILYY  212 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHH--HHHHHHHHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCch--hhHHHHHHHHHH
Confidence            4322  2234579999999998754           344555  499999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-34  Score=306.60  Aligned_cols=189  Identities=23%  Similarity=0.356  Sum_probs=152.3

Q ss_pred             hcCCccc-eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHh-cCCCCceeeeeeeeee----C
Q 041034          449 TEDFHIR-YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLS-TVRHRNIVKLYGFCLH----K  521 (701)
Q Consensus       449 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~  521 (701)
                      .++|.+. +.||+|+||.||+|.. .+++.||||++...        ..+.+|+.++. ..+||||+++++++..    .
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            4567776 7899999999999965 46899999999642        45677888874 4589999999999875    5


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVAD  598 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~D  598 (701)
                      ...|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++   ||+||||||+|||++.   ++.+||+|
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence            678999999999999999986532 2589999999999999999999999   9999999999999987   78999999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||+++..... ......+||+.|+|||++.+..++.+.  ||||+|+++|+++.
T Consensus       208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~ell~  258 (400)
T 1nxk_A          208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYILLC  258 (400)
T ss_dssp             CTTCEECC------------CTTCCGGGSCCCCSSSHH--HHHHHHHHHHHHHH
T ss_pred             cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcc--cHHHHHHHHHHHHh
Confidence            9999876432 223456799999999999888887765  99999999986433

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.7e-34  Score=291.35  Aligned_cols=198  Identities=24%  Similarity=0.360  Sum_probs=169.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            3578999999999999999999654 7899999999755432  234778999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||.+....
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999999987543   589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          607 VDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       607 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ...  .......||+.|+|||.+.+..+... ..||||+|+++++++.+.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~il~~l~~g~  205 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAGE  205 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHH-HHHHHHHHHHHHHHHHSS
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCC-cchHHHHHHHHHHHHhCC
Confidence            322  22334568999999999987665332 259999999999877765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.8e-34  Score=310.39  Aligned_cols=195  Identities=26%  Similarity=0.365  Sum_probs=162.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+++.+|+.+++.++||||+++++++...     
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            367899999999999999999965 468899999997643 2344467889999999999999999999999776     


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...|+||||+++ +|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          103 DELYIVLEIADS-DLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CCEEEEEECCSE-EHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCCc-CHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            579999999975 9999997654   589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC----------------------CceeecccccccCCCCC-CCCcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDSS----------------------NRTLRAGTYGYIAPDQR-LSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |+.......                      ..+..+||+.|+|||++ ....++.+.  ||||+||++++|+.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~--DiwSlG~il~ell~  247 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI--DIWSTGCIFAELLN  247 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHH--HHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccc--ccchHHHHHHHHHh
Confidence            987653321                      12456799999999985 445566555  99999999988774

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.7e-35  Score=299.95  Aligned_cols=200  Identities=29%  Similarity=0.438  Sum_probs=166.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  525 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+  ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            578999999999999999999654 7899999999865433 3446788999999999999999999998754  66899


Q ss_pred             EEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCcEEEcCCCCeEEEee
Q 041034          526 FIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDCTPS-----IVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g-----ivH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      +||||+++++|.+++.... ....+++..+..++.|++.||+|||++   +     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999997532 123489999999999999999999998   7     999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      |.++.............||+.|+|||.+.+..++.+.  ||||+|+++++++.+.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~  213 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS--DIWSLGCLLYELCALM  213 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHH--HHHHHHHHHHHHHHSS
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchh--hHHHHHHHHHHHHHCC
Confidence            9998765433223345689999999999887777665  9999999999866554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.5e-34  Score=297.74  Aligned_cols=223  Identities=23%  Similarity=0.379  Sum_probs=182.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----Cc
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KR  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~  522 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++..    ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            356899999999999999999965 579999999986532   3445788999999999999999999999873    44


Q ss_pred             EEEEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          523 CMFFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ..++||||+++|+|.+++... .....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            789999999999999998752 1123689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCC---------ceeecccccccCCCCCCCCc---CChhhHHHHHHHHHHHHH--------------------
Q 041034          602 ARLLHVDSSN---------RTLRAGTYGYIAPDQRLSPP---VNQKIIQDIILVSTTALA--------------------  649 (701)
Q Consensus       602 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~~~Di~slg~i~~~--------------------  649 (701)
                      ++........         .....||+.|+|||.+.+..   ++.+  .||||+|+++++                    
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~--~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER--TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH--HHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch--hhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            8765321111         11234799999999987654   3444  599999999984                    


Q ss_pred             ------------------------cccCCCCCCCCHHHHHHHhhcCCCccchh
Q 041034          650 ------------------------CLRSKPKSRPTMQRISQELEGKTPMKKGL  678 (701)
Q Consensus       650 ------------------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~  678 (701)
                                              ||..+|.+||++.++++.|+...+..+..
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence                                    88889999999999999999887655443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-34  Score=301.94  Aligned_cols=219  Identities=29%  Similarity=0.418  Sum_probs=178.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|++.+.||+|+||.||+|....     +..||||+++....  ......+.+|+.++++++||||+++++++.+.+.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            5678889999999999999996532     24599999976542  3345678999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999976432  589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------
Q 041034          604 LLHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------  649 (701)
Q Consensus       604 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------  649 (701)
                      ........   .....+|+.|+|||.+.+..++.+.  ||||+|+++++                               
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~  273 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS--DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  273 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchh--hhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc
Confidence            76533221   1223467889999999877777765  99999999985                               


Q ss_pred             ------------cccCCCCCCCCHHHHHHHhhcCCCccc
Q 041034          650 ------------CLRSKPKSRPTMQRISQELEGKTPMKK  676 (701)
Q Consensus       650 ------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~  676 (701)
                                  ||..+|.+||++.++++.|+.......
T Consensus       274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                        777889999999999998876554333

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-34  Score=303.51  Aligned_cols=200  Identities=23%  Similarity=0.361  Sum_probs=160.5

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|++.+.||+|+||.||+|.. .+++.||||+++..... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            4467899999999999999999954 57899999999765432 233466789999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-----CCCCeEEEeec
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-----SNLEAFVADFG  600 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-----~~~~~kL~DFG  600 (701)
                      +||||+++ +|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++     .++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999985 9999998754   589999999999999999999999   999999999999994     45569999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +|+.............||+.|+|||++.+.. ++.+.  ||||+|+++++++.+.|.
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~ell~g~~p  237 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV--DIWSIACIWAEMLMKTPL  237 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHH--HHHHHHHHHHHHHHCCCC
Confidence            9987765444455567899999999987644 55554  999999999999988754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5e-34  Score=312.94  Aligned_cols=194  Identities=25%  Similarity=0.321  Sum_probs=160.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+++.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            357899999999999999999954 568999999997653 2344467889999999999999999999998654     


Q ss_pred             -cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 -RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                       ...|+||||+++ ++.+.+..     .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence             467999999987 57666643     388999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +|+..... ......+||+.|+|||++.+..++.+.  ||||+|+++++|+.+.
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~ell~g~  260 (464)
T 3ttj_A          210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK  260 (464)
T ss_dssp             CC-----C-CCC----CCCTTCCHHHHTTCCCCTTH--HHHHHHHHHHHHHHSS
T ss_pred             eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHH--HHHHHHHHHHHHHhCC
Confidence            99876532 234456799999999999998888775  9999999998776544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5e-34  Score=292.94  Aligned_cols=197  Identities=23%  Similarity=0.363  Sum_probs=166.4

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETED---SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|+++......   ....+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999665 68999999987654321   11247789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEEeec
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADFG  600 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~----~~kL~DFG  600 (701)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999997643   589999999999999999999999   999999999999998876    89999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .+....... ......||+.|+|||.+.+..++.+.  ||||+|+++++++.+.
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~  208 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEA--DMWSIGVITYILLSGA  208 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             cceeccCCC-cccccCCCcCccCcceecCCCCCcch--hhhhHHHHHHHHHHCC
Confidence            998764332 23345699999999999887777665  9999999999866654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-34  Score=299.47  Aligned_cols=198  Identities=27%  Similarity=0.427  Sum_probs=159.5

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC--CCCceeeeeeeeeeC-
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV--RHRNIVKLYGFCLHK-  521 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-  521 (701)
                      -....++|++.+.||+|+||.||+|... ++.||||++....      ...+.+|.+++...  +||||+++++++... 
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3445678999999999999999999875 8999999986432      13344555555554  899999999999877 


Q ss_pred             ---cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCcEEEcCCCC
Q 041034          522 ---RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC-----TPSIVHRDISSNNILLNSNLE  593 (701)
Q Consensus       522 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~givH~Dlkp~NIll~~~~~  593 (701)
                         ...++||||+++|+|.++++..    .+++..+..++.|++.||+|||+++     .++|+||||||+||+++.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence               7899999999999999999764    4899999999999999999999651     338999999999999999999


Q ss_pred             eEEEeecCccccccCCCC----ceeecccccccCCCCCCCCcCChh----hHHHHHHHHHHHHHcccC
Q 041034          594 AFVADFGTARLLHVDSSN----RTLRAGTYGYIAPDQRLSPPVNQK----IIQDIILVSTTALACLRS  653 (701)
Q Consensus       594 ~kL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~----~~~Di~slg~i~~~cl~~  653 (701)
                      +||+|||+|+.+......    .....||+.|+|||++.+......    ..+||||+|+++|+++++
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            999999999876433222    123479999999999877655543    235999999999876544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-34  Score=307.10  Aligned_cols=215  Identities=17%  Similarity=0.273  Sum_probs=175.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCC------CcEEEEEEecCCCccChHH--------HHHHHHHHHHHhcCCCCceee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPD------GKVVALKKLHQSETEDSAF--------VESFQNEARVLSTVRHRNIVK  513 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~  513 (701)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++..........        ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999997653      4789999987654211100        112345666778889999999


Q ss_pred             eeeeeeeC----cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc
Q 041034          514 LYGFCLHK----RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN  589 (701)
Q Consensus       514 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~  589 (701)
                      +++++...    ...++||||+ +++|.+++.....  .+++..+..++.||+.||+|||++   ||+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99998764    4589999999 9999999987532  589999999999999999999999   999999999999999


Q ss_pred             --CCCCeEEEeecCccccccCCCC-------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------
Q 041034          590 --SNLEAFVADFGTARLLHVDSSN-------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------  649 (701)
Q Consensus       590 --~~~~~kL~DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------  649 (701)
                        .++.+||+|||+|+.+......       .....||+.|+|||++.+..++.+.  ||||+|+++|+           
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG--DLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchh--hHHHHHHHHHHHHhCCCCcccc
Confidence              8899999999999876533221       1234599999999999888877765  99999999984           


Q ss_pred             -----------------------------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------------------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------------------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                                               ||..+|.+||+++++.+.|+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          265 LKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             TTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence                                                     778899999999999988764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.8e-34  Score=304.65  Aligned_cols=214  Identities=20%  Similarity=0.238  Sum_probs=179.0

Q ss_pred             cccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-----CCcee
Q 041034          439 KILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-----HRNIV  512 (701)
Q Consensus       439 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  512 (701)
                      .+++++.....++|++.+.||+|+||.||+|.. .+++.||||+++..    ....+.+..|+.+++.++     ||||+
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            344555556678999999999999999999965 56899999999743    233466788999999986     99999


Q ss_pred             eeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC--
Q 041034          513 KLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS--  590 (701)
Q Consensus       513 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~--  590 (701)
                      ++++++...+..++||||+ +++|.+++...... .+++..+..++.||+.||+|||++   ||+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            9999999999999999999 88999999875432 589999999999999999999999   9999999999999975  


Q ss_pred             -----------------------CCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHH
Q 041034          591 -----------------------NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTA  647 (701)
Q Consensus       591 -----------------------~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~  647 (701)
                                             ++.+||+|||+|+.....   .....||+.|+|||++.+..++.+.  ||||+|+++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSS--DMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTH--HHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCcc--chHHHHHHH
Confidence                                   789999999999865322   2345799999999999988888776  999999999


Q ss_pred             HHcccCCCCC-CCCHHHHHH
Q 041034          648 LACLRSKPKS-RPTMQRISQ  666 (701)
Q Consensus       648 ~~cl~~~P~~-Rpt~~~i~~  666 (701)
                      |+++.+.+.. ..+..+.++
T Consensus       250 ~ell~g~~pf~~~~~~~~~~  269 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLA  269 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHH
T ss_pred             HHHHHCCCCCCCCcHHHHHH
Confidence            9999987543 334333333

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-34  Score=294.06  Aligned_cols=212  Identities=25%  Similarity=0.372  Sum_probs=177.2

Q ss_pred             CCccceEEeeccceEEEEEEcC-C---CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE-E
Q 041034          451 DFHIRYCIGTGGYGSVYKAELP-D---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM-F  525 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~  525 (701)
                      .|.+.+.||+|+||.||+|... +   +..||+|++....  .....+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            4667799999999999999642 2   2379999987543  334467889999999999999999999999876654 9


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+.+|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            99999999999999976432  588999999999999999999999   9999999999999999999999999999865


Q ss_pred             ccC----CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          606 HVD----SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       606 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      ...    ........+++.|+|||...+..++.+.  ||||+|+++++                                
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKS--DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY  252 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHH--HHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhh--chhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence            432    1222344688999999999888877765  99999999985                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                 |+..+|.+|||+.++++.|++.
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       7777888888888888877653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.2e-34  Score=307.05  Aligned_cols=189  Identities=21%  Similarity=0.377  Sum_probs=158.4

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--HRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++  ||||+++++++...+..|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            46999999999999999999887899999999976543 3445678999999999996  59999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      || +.+++|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++ ++.+||+|||+|+.+..
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 56789999998754   588999999999999999999999   999999999999995 58999999999987653


Q ss_pred             CCC--CceeecccccccCCCCCCC-----------CcCChhhHHHHHHHHHHHHH
Q 041034          608 DSS--NRTLRAGTYGYIAPDQRLS-----------PPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~~Di~slg~i~~~  649 (701)
                      ...  ......||+.|+|||++.+           ..++.+  .||||+|+++|+
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~--~DiwSlGvil~e  259 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK--SDVWSLGCILYY  259 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHH--HHHHHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCCh--hhHHHHHHHHHH
Confidence            322  1234579999999998765           234544  499999999985

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.2e-34  Score=303.72  Aligned_cols=277  Identities=24%  Similarity=0.277  Sum_probs=205.3

Q ss_pred             HHHHHHhc--------CCCCcCCCC---CCCCCCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCC
Q 041034            3 IERQALLN--------CGWWKDRIP---HNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWN   71 (701)
Q Consensus         3 ~~~~~l~~--------~~~~~~~~~---~~~~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~   71 (701)
                      .||+||++        ...|...|.   ....++|.|.|++|+...         .    .+   .....++++.|+|++
T Consensus        27 ~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~---------~----~l---~~~~~~~l~~L~L~~   90 (328)
T 4fcg_A           27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA---------D----LL---EDATQPGRVALELRS   90 (328)
T ss_dssp             CHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHH---------H----HH---HHHTSTTCCEEEEES
T ss_pred             hHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhH---------H----HH---hcccccceeEEEccC
Confidence            57899987        112233342   235678888888885211         0    00   012346788888888


Q ss_pred             CcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCc
Q 041034           72 NNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLP  151 (701)
Q Consensus        72 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  151 (701)
                      |.++ .+|+.++++++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..+..+++|++|+|++|++.+.+|
T Consensus        91 n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p  167 (328)
T 4fcg_A           91 VPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP  167 (328)
T ss_dssp             SCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCC
T ss_pred             CCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccC
Confidence            8887 67778888889999999999888 78888888888999999888888 667788888888888888888887777


Q ss_pred             ccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCc
Q 041034          152 QEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS  231 (701)
Q Consensus       152 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~  231 (701)
                      ..+...               ..+..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++
T Consensus       168 ~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~  230 (328)
T 4fcg_A          168 EPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK  230 (328)
T ss_dssp             SCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTT
T ss_pred             hhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCC
Confidence            765431               11233556777777777777777 667777777777777777777774 4556777788


Q ss_pred             ccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCC
Q 041034          232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK  311 (701)
Q Consensus       232 L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  311 (701)
                      |++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.+++..
T Consensus       231 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~  310 (328)
T 4fcg_A          231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP  310 (328)
T ss_dssp             CCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCG
T ss_pred             CCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCH
Confidence            88888888888777777788888888888888888778887788888888888888888888888888888888888777


Q ss_pred             CcCC
Q 041034          312 NKLS  315 (701)
Q Consensus       312 N~l~  315 (701)
                      |.+.
T Consensus       311 ~~~~  314 (328)
T 4fcg_A          311 HLQA  314 (328)
T ss_dssp             GGSC
T ss_pred             HHHH
Confidence            6654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7e-34  Score=302.74  Aligned_cols=204  Identities=25%  Similarity=0.408  Sum_probs=172.9

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcC-CCCceeeeee
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTV-RHRNIVKLYG  516 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~niv~l~~  516 (701)
                      ......++|++.+.||+|+||.||+|... +|+.||||++......     .....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            33455678999999999999999999764 7999999998765421     123356788999999999 7999999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                      ++......++||||+++++|.+++....   .+++..+..++.||+.||.|||+.   ||+||||||+||+++.++.+||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999997643   589999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccccCCCCceeecccccccCCCCCCC------CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          597 ADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS------PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       597 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +|||++..+... .......||+.|+|||++.+      ..++.+.  ||||+|+++|+|+.+.+.
T Consensus       242 ~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--Di~slG~il~ell~g~~p  304 (365)
T 2y7j_A          242 SDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEV--DLWACGVILFTLLAGSPP  304 (365)
T ss_dssp             CCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTH--HHHHHHHHHHHHHHSSCS
T ss_pred             EecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchh--hHHhHHHHHHHHHHCCCC
Confidence            999999876533 23344679999999998753      2344454  999999999998887643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8e-35  Score=306.38  Aligned_cols=200  Identities=24%  Similarity=0.354  Sum_probs=167.7

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcC-CC-----cEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeee
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELP-DG-----KVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYG  516 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  516 (701)
                      +++...++|++.+.||+|+||.||+|... .+     +.||+|.+.....  ....+.+.+|+.+++.+ +||||+++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            44556789999999999999999999653 23     4799999976542  33457789999999999 8999999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCC-----------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDE-----------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      ++.+.+..++||||+++|+|.+++.....           ...+++..+..++.|++.||+|||++   ||+||||||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  194 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN  194 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence            99999999999999999999999875321           22578999999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          586 ILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      |+++.++.+||+|||+++........  .....+|+.|+|||++.+..++.+.  ||||+|++++++
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el  259 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEI  259 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHH
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH--HHHHHHHHHHHH
Confidence            99999999999999999876543322  2234578899999998877777665  999999999963

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.5e-34  Score=299.77  Aligned_cols=201  Identities=21%  Similarity=0.368  Sum_probs=156.6

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeee
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFC  518 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  518 (701)
                      +++....++|.+.+.||+|+||.||+|...    .++.||+|+++..... ....+.+.+|+.++++++||||+++++++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            344555788999999999999999999543    3458999999765432 34457789999999999999999999999


Q ss_pred             eeCc-----EEEEEEEccCCCCHHHHHhcC---CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          519 LHKR-----CMFFIYEYMERGSLFYVLRDD---DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       519 ~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      .+..     ..++||||+++++|.+++...   .....+++..+..++.|++.||.|||++   ||+||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence            8755     359999999999999998532   1223689999999999999999999999   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          591 NLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ++.+||+|||+++.......  ......+++.|+|||.+.+..++.+.  ||||+|+++++
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~e  241 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS--DVWAFGVTMWE  241 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHH--HHHHHHHHHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchh--hhHHHHHHHHH
Confidence            99999999999987643321  22334578899999999887777765  99999999996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.9e-34  Score=293.29  Aligned_cols=199  Identities=26%  Similarity=0.369  Sum_probs=164.2

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|.....||+|+||.||+|.. .+++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            4566667999999999999965 5688999999976532   23477899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-CCCeEEEeecCcccccc
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHV  607 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-~~~~kL~DFGla~~~~~  607 (701)
                      ||+++++|.+++........+++..+..++.|++.||+|||++   |++||||||+||+++. ++.+||+|||.++....
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999998765444678999999999999999999999   9999999999999987 89999999999987654


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .........||+.|+|||.+.+.........||||+|+++++++.+.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  222 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK  222 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTS
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            33333455799999999998664422223359999999999866654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7e-34  Score=296.53  Aligned_cols=191  Identities=30%  Similarity=0.443  Sum_probs=161.9

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.....     .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            34678999999999999999999664 689999999976532     266889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++++|.+++.....  .+++..+..++.|++.||.|||++   |++||||||+||+++.++.+||+|||.+...
T Consensus       101 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999999874322  589999999999999999999999   9999999999999999999999999999877


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ...........||+.|+|||.+.+..++.+.  ||||+|+++++
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~  217 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVA--DIWSLGITAIE  217 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTH--HHHHHHHHHHH
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccc--cHHHHHHHHHH
Confidence            5544444556799999999999887777765  99999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.1e-34  Score=300.74  Aligned_cols=204  Identities=22%  Similarity=0.313  Sum_probs=169.4

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVK  513 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  513 (701)
                      ...++....++|++.+.||+|+||.||+|..      .+++.||||+++....  ....+.+.+|+.+++++ +||||++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeee
Confidence            3445556678999999999999999999963      3568899999976543  33456789999999999 6999999


Q ss_pred             eeeeeeeCc-EEEEEEEccCCCCHHHHHhcCCCc-------------cCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041034          514 LYGFCLHKR-CMFFIYEYMERGSLFYVLRDDDEA-------------IELNWTRRVNIVKSVAHALSYLHHDCTPSIVHR  579 (701)
Q Consensus       514 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~  579 (701)
                      +++++...+ ..++||||+++++|.+++......             ..+++..+..++.|++.||+|||++   ||+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999987754 589999999999999999865421             1278999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          580 DISSNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       580 Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ||||+||+++.++.+||+|||+++........  .....+|+.|+|||++.+..++.+.  ||||+|+++++++
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~  244 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEIF  244 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh--HHHHHHHHHHHHH
Confidence            99999999999999999999999876443322  2234578899999998877777665  9999999999644

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-34  Score=294.42  Aligned_cols=195  Identities=25%  Similarity=0.396  Sum_probs=164.0

Q ss_pred             hhcCCccce-EEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          448 ATEDFHIRY-CIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       448 ~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..++|.+.+ .||+|+||.||+|...   +++.||||+++...  .....+.+.+|+.++++++||||+++++++ ..+.
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            356777777 9999999999999653   57789999998653  334467899999999999999999999999 4566


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccccee
Confidence            8999999999999999975432  589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          604 LLHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       604 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ........   .....+|+.|+|||.+.+..++.+.  ||||+|++++++++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ellt  208 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS--DVWSYGVTMWEALS  208 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHH--HHHHHHHHHHHHHT
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchh--hHHHHHHHHHHHHc
Confidence            76533221   1223468899999998777776665  99999999997554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=301.43  Aligned_cols=203  Identities=27%  Similarity=0.429  Sum_probs=161.9

Q ss_pred             ccHHHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          440 ILYEDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       440 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      +.+.++....++|++.+.||+|+||.||+|.. .+++.||||++......    .+.+.+|+.+++++ +||||++++++
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            34455566788999999999999999999965 57899999999765433    26788999999998 79999999999


Q ss_pred             eee------CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          518 CLH------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       518 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      +..      .+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++   ||+||||||+||+++.+
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCC
Confidence            987      467899999999999999998653 23589999999999999999999999   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCC-----CCcCChhhHHHHHHHHHHHHHccc
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL-----SPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      +.+||+|||++..............||+.|+|||++.     +..++.+.  ||||+|+++++++.
T Consensus       166 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~--Di~slG~il~~l~~  229 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS--DLWSLGITAIEMAE  229 (326)
T ss_dssp             CCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTH--HHHHHHHHHHHHHH
T ss_pred             CCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccc--hHHHHHHHHHHHHh
Confidence            9999999999987654433344557999999999986     34455554  99999999996443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.9e-34  Score=296.04  Aligned_cols=196  Identities=23%  Similarity=0.365  Sum_probs=161.1

Q ss_pred             HHhhhcCCccce-EEeeccceEEEEEEc---CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          445 LINATEDFHIRY-CIGTGGYGSVYKAEL---PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       445 ~~~~~~~y~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      +....++|.+.+ .||+|+||.||+|.+   .+++.||||+++.... +....+++.+|+.+++.++||||+++++++ .
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            334467888888 999999999999943   2468899999986543 234467899999999999999999999998 5


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      .+..++||||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence            667899999999999999998754   589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          601 TARLLHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       601 la~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      +++........   .....+++.|+|||.+.+..++.+.  ||||+|++++++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l  213 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS--DVWSFGVLMWEA  213 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhh--hHHHHHHHHHHH
Confidence            99876543221   1223467889999998777766654  999999999963

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=301.71  Aligned_cols=216  Identities=24%  Similarity=0.436  Sum_probs=174.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcE----EEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKV----VALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .++|++.+.||+|+||.||+|.. .+++.    ||+|.+.......  ..+.+.+|+.++++++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            46899999999999999999965 34554    5777776543222  2477899999999999999999999998765 


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++|+||+++|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            7899999999999999987543  589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          604 LLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       604 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      ........  .....+|+.|+|||++.+..++.+.  ||||+|+++|+                                
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS--DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI  243 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHH--HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            76433221  2234567889999999888777765  99999999985                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhcCCCc
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~~~~~  674 (701)
                                 ||..+|.+||++.|+++.|++....
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                       7778899999999999998876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-34  Score=307.68  Aligned_cols=213  Identities=25%  Similarity=0.416  Sum_probs=167.9

Q ss_pred             cCCccceEEeeccceEEEEEEcC--CC--cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CcEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP--DG--KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-KRCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  524 (701)
                      ..|++.+.||+|+||.||+|...  ++  ..||+|.++...  +....+++.+|+.++++++||||+++++++.. ++..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            34778899999999999999653  22  468999987543  23446789999999999999999999998654 5678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence            999999999999999976543  578999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCC----CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------
Q 041034          605 LHVDSS----NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------  649 (701)
Q Consensus       605 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------  649 (701)
                      ......    ......+|+.|+|||.+.+..++.+.  ||||+|+++|+                               
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~  319 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS--DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  319 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHH--HHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            643221    12234577899999998887777765  99999999995                               


Q ss_pred             ------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                  ||..+|.+||++.++++.|+..
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                        6777888888888888887653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.1e-34  Score=301.02  Aligned_cols=209  Identities=21%  Similarity=0.308  Sum_probs=172.9

Q ss_pred             CcccHHHHHhhhcCCccc-eEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeee
Q 041034          438 GKILYEDLINATEDFHIR-YCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKL  514 (701)
Q Consensus       438 ~~~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l  514 (701)
                      +.+.|+......++|.+. +.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++.+. ||||+++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEE
Confidence            345566677788889988 89999999999999654 69999999998654322 22467889999999995 6999999


Q ss_pred             eeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---C
Q 041034          515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---N  591 (701)
Q Consensus       515 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~  591 (701)
                      ++++.+.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++   ||+||||||+||+++.   +
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A           95 HEVYENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             EEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB
T ss_pred             EEEEEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC
Confidence            9999999999999999999999999865422 2589999999999999999999999   9999999999999987   7


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +.+||+|||+++...... ......||+.|+|||++.+..++.+.  ||||+|+++++|+.+.
T Consensus       171 ~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~~ll~g~  230 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTAT--DMWNIGIIAYMLLTHT  230 (327)
T ss_dssp             CCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             CcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            899999999998765332 23345799999999999888777765  9999999999866654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-34  Score=297.40  Aligned_cols=202  Identities=29%  Similarity=0.398  Sum_probs=165.4

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc--ChHHHHHHHHHHHHHhcC---CCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE--DSAFVESFQNEARVLSTV---RHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||+||+|.. .+++.||||++......  .......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999975 46899999998743311  111124556777777766   499999999999875


Q ss_pred             c-----EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          522 R-----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       522 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                      .     ..++||||++ ++|.+++...... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            4     5899999997 5999999875432 489999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          597 ADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       597 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      +|||+|+...... ......||+.|+|||++.+..++.+.  ||||+|+++++++.+.|..
T Consensus       162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~~l~~g~~pf  219 (308)
T 3g33_A          162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPV--DMWSVGCIFAEMFRRKPLF  219 (308)
T ss_dssp             CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTH--HHHHHHHHHHHTTTSSCSC
T ss_pred             eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchH--HHHHHHHHHHHHHhCCCCC
Confidence            9999998764332 33445799999999999888887775  9999999999999887543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-34  Score=302.82  Aligned_cols=202  Identities=25%  Similarity=0.365  Sum_probs=162.3

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETED--SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ....++|++.+.||+|+||.||+|... +++.||||++.......  ....+.+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999765 58999999997643221  122346789999999999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++ +|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 89988876432  578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.............||+.|+|||++.+.. ++.+.  ||||+|+++++++.+.|
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~ell~g~~  211 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRVP  211 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHH--HHHHHHHHHHHHHHSSC
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchh--hhHhHHHHHHHHHHCCC
Confidence            88765544455567999999999986543 45554  99999999998776654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.6e-34  Score=302.21  Aligned_cols=199  Identities=24%  Similarity=0.387  Sum_probs=165.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            578999999999999999999664 589999999876543 344456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.++.....   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999988876544   589999999999999999999999   999999999999999999999999999987755


Q ss_pred             CCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .........||+.|+|||.+.+. .++.+  .||||+|+++++++.+.|.
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--~Di~slG~il~~l~~g~~p  224 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKA--VDVWAIGCLVTEMFMGEPL  224 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTH--HHHHHHHHHHHHHHHSSCS
T ss_pred             CccccCCCcCCccccCcccccCCCCcchH--HHHHHHHHHHHHHHhCCCC
Confidence            44445556799999999998765 44554  4999999999999888754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-34  Score=318.50  Aligned_cols=197  Identities=24%  Similarity=0.410  Sum_probs=168.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3567999999999999999999664 799999999976544333335788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla~  603 (701)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||++   +.++.+||+|||+|+
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999987654   589999999999999999999999   99999999999999   467899999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .+... .......||+.|+|||++.+ .++.+.  ||||+|+++|+++.+.
T Consensus       178 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~--DiwslG~il~~ll~g~  224 (484)
T 3nyv_A          178 HFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKC--DVWSTGVILYILLSGC  224 (484)
T ss_dssp             HBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHH--HHHHHHHHHHHHHHSS
T ss_pred             Ecccc-cccccCCCCccccCceeecC-CCCCcc--eeHHHHHHHHHHHHCC
Confidence            76533 23344579999999999866 455554  9999999999755544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-33  Score=293.89  Aligned_cols=189  Identities=25%  Similarity=0.441  Sum_probs=162.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            3568999999999999999999654 79999999998654322   3568899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla~  603 (701)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||++   +.++.+||+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999987644   589999999999999999999999   99999999999999   778999999999997


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      .....  ......||+.|+|||.+.+..++.+.  ||||+|+++++
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~  199 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEVLAQKPYSKAV--DCWSIGVITYI  199 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHH--HHHHHHHHHHH
T ss_pred             ecCCC--ccccccCCCCccChHHhccCCCCchh--hHHHHHHHHHH
Confidence            65322  23345699999999999888777665  99999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5e-35  Score=313.29  Aligned_cols=196  Identities=15%  Similarity=0.168  Sum_probs=157.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHH---HHHhcCCCCceeeee-------e
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEA---RVLSTVRHRNIVKLY-------G  516 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~  516 (701)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|+   +++++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999976 46999999999865444444567889999   555566899999998       5


Q ss_pred             eeeeCc-----------------EEEEEEEccCCCCHHHHHhcCCC----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 041034          517 FCLHKR-----------------CMFFIYEYMERGSLFYVLRDDDE----AIELNWTRRVNIVKSVAHALSYLHHDCTPS  575 (701)
Q Consensus       517 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g  575 (701)
                      ++.+++                 ..|+||||+ +|+|.+++.....    ...+++..+..++.||+.||+|||++   |
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            555443                 278999999 5799999976421    11244688889999999999999999   9


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCC-----------cCChhhHHHHHHHH
Q 041034          576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-----------PVNQKIIQDIILVS  644 (701)
Q Consensus       576 ivH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~~Di~slg  644 (701)
                      |+||||||+|||++.++.+||+|||+|+...   .......| +.|+|||++.+.           .++.+.  ||||+|
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~--DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF--DAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH--HHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhh--hHHHHH
Confidence            9999999999999999999999999998642   23344567 999999998776           666665  999999


Q ss_pred             HHHHHcccC
Q 041034          645 TTALACLRS  653 (701)
Q Consensus       645 ~i~~~cl~~  653 (701)
                      +++|+++.+
T Consensus       301 ~il~elltg  309 (377)
T 3byv_A          301 LVIYWIWCA  309 (377)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHHHC
Confidence            999974443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-33  Score=314.69  Aligned_cols=192  Identities=29%  Similarity=0.462  Sum_probs=161.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccCh----------HHHHHHHHHHHHHhcCCCCceeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDS----------AFVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      ..++|++.+.||+|+||.||+|... +++.||+|++........          ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999654 688999999986543211          23467899999999999999999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---C
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---E  593 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~---~  593 (701)
                      ++.+....++||||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999987654   589999999999999999999999   999999999999998775   6


Q ss_pred             eEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          594 AFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       594 ~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +||+|||+|+..... .......||+.|+|||++.+ .++.+.  ||||+|+++|+
T Consensus       188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~--DiwslG~il~~  239 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKC--DVWSCGVIMYI  239 (504)
T ss_dssp             EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHH--HHHHHHHHHHH
T ss_pred             EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchH--HHHHHHHHHHH
Confidence            999999999877543 23344579999999999864 455554  99999999996

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.7e-34  Score=314.95  Aligned_cols=191  Identities=24%  Similarity=0.414  Sum_probs=161.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||+||+|... +++.||||++....... .....+.+|+.++++++||||+++++++.+....++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            3578999999999999999999654 78999999986533221 124678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~~~kL~DFGla~  603 (701)
                      ||||+++|+|.+.+....   .+++..+..++.||+.||+|||++   ||+||||||+||+++   .++.+||+|||+|+
T Consensus        99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999887654   589999999999999999999999   999999999999995   45689999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ..... .......||+.|+|||++.+. ++.+.  ||||+|+++|+
T Consensus       173 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~--DiwslG~il~~  214 (486)
T 3mwu_A          173 CFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKC--DVWSAGVILYI  214 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGGGSC-CCHHH--HHHHHHHHHHH
T ss_pred             ECCCC-CccCCCcCCCCCCCHHHhCCC-CCchh--hHHHHHHHHHH
Confidence            76533 233445799999999998764 65554  99999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-33  Score=289.82  Aligned_cols=194  Identities=24%  Similarity=0.358  Sum_probs=164.8

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CcEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KRCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  524 (701)
                      ..|++.+.||+|+||.||+|.. .++..||+|++...... ....+.+.+|+.++++++||||+++++++..    ....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            3478889999999999999955 46889999998765433 3446788999999999999999999998875    4568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEc-CCCCeEEEeecC
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLN-SNLEAFVADFGT  601 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g--ivH~Dlkp~NIll~-~~~~~kL~DFGl  601 (701)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||++   +  |+||||||+||+++ .++.+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            99999999999999997643   588999999999999999999998   7  99999999999997 789999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.....  .......||+.|+|||.+.+. ++.+  .||||+|+++++++.+.+
T Consensus       179 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~--~Di~slG~~l~~l~~g~~  227 (290)
T 1t4h_A          179 ATLKRA--SFAKAVIGTPEFMAPEMYEEK-YDES--VDVYAFGMCMLEMATSEY  227 (290)
T ss_dssp             GGGCCT--TSBEESCSSCCCCCGGGGGTC-CCTH--HHHHHHHHHHHHHHHSSC
T ss_pred             cccccc--cccccccCCcCcCCHHHHhcc-CCCc--chHHHHHHHHHHHHhCCC
Confidence            976532  234455799999999988643 5554  499999999999888763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-34  Score=309.27  Aligned_cols=196  Identities=24%  Similarity=0.348  Sum_probs=163.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc--EEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR--CMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  525 (701)
                      .++|++.+.||+|+||.||+|... +++.||||++........  .+.+.+|++++++++||||+++++++.+..  ..+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            467999999999999999999664 589999999976443322  467789999999999999999999998755  789


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCCCeEEEeecC
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNLEAFVADFGT  601 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll----~~~~~~kL~DFGl  601 (701)
                      +||||+++|+|.+++........+++..+..++.|++.||+|||++   ||+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999998755444589999999999999999999999   99999999999999    7778899999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCC--------CcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLS--------PPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |+...... ......||+.|+|||++.+        ..++.  ..||||+|+++|+|+.
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--~~DiwSlG~il~el~t  218 (396)
T 4eut_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA--TVDLWSIGVTFYHAAT  218 (396)
T ss_dssp             CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHH--HHHHHHHHHHHHHHHH
T ss_pred             ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCc--HHHHHHHHHHHHHHHH
Confidence            98765432 2234569999999998754        22333  4599999999986444

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.3e-34  Score=301.07  Aligned_cols=235  Identities=22%  Similarity=0.322  Sum_probs=174.9

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeee----
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCL----  519 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~----  519 (701)
                      .....+|++.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++++. ||||+++++++.    
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            33456899999999999999999965 478999999986543   334577899999999996 999999999983    


Q ss_pred             ----eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCcEEEcCCCC
Q 041034          520 ----HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPS--IVHRDISSNNILLNSNLE  593 (701)
Q Consensus       520 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g--ivH~Dlkp~NIll~~~~~  593 (701)
                          .....++||||+. |+|.+++........+++..+..++.||+.||+|||++   +  |+||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSC
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCC
Confidence                4456899999996 69999887533333699999999999999999999998   7  999999999999999999


Q ss_pred             eEEEeecCccccccCCCC------------ceeecccccccCCCCC---CCCcCChhhHHHHHHHHHHHHH---------
Q 041034          594 AFVADFGTARLLHVDSSN------------RTLRAGTYGYIAPDQR---LSPPVNQKIIQDIILVSTTALA---------  649 (701)
Q Consensus       594 ~kL~DFGla~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~~~Di~slg~i~~~---------  649 (701)
                      +||+|||+++........            .....||+.|+|||++   .+..++.+.  ||||+|+++++         
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~--Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ--DIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHH--HHHHHHHHHHHHHHSSCCC-
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHH--hHHHHHHHHHHHHhCCCCCc
Confidence            999999999876532211            1134589999999998   444555554  99999999984         


Q ss_pred             ------------------------------cccCCCCCCCCHHHHHHHhhcCCCccchhhhhhHHHHhcc
Q 041034          650 ------------------------------CLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQ  689 (701)
Q Consensus       650 ------------------------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~  689 (701)
                                                    ||..+|.+||++.|+++.|+............++.++.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~~~~~~  324 (337)
T 3ll6_A          255 DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQ  324 (337)
T ss_dssp             -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCHHHHTC
T ss_pred             chhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHHHHHHH
Confidence                                          8899999999999999998876543333333334444433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-34  Score=302.92  Aligned_cols=215  Identities=18%  Similarity=0.249  Sum_probs=174.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChH--------HHHHHHHHHHHHhcCCCCceeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSA--------FVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      .++|++.+.||+|+||.||+|...    ++..||+|++.........        ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999664    5788999998865422110        1123667889999999999999999


Q ss_pred             eeee----CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC
Q 041034          517 FCLH----KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL  592 (701)
Q Consensus       517 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~  592 (701)
                      ++..    ....++||||+ +++|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9987    77899999999 999999997654   689999999999999999999999   999999999999998877


Q ss_pred             --CeEEEeecCccccccCCCC-------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------
Q 041034          593 --EAFVADFGTARLLHVDSSN-------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------  649 (701)
Q Consensus       593 --~~kL~DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------  649 (701)
                        .+||+|||+|+.+......       .....||+.|+|||++.+..++.+.  ||||+|+++|+              
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRS--DVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHH--HHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchh--hHHHHHHHHHHHHhCCCCccccccc
Confidence              9999999999876432211       1345799999999999888777765  99999999984              


Q ss_pred             --------------------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 --------------------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 --------------------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                                            ||..+|.+||+++++++.|+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence                                                  78889999999999999988755

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-33  Score=291.56  Aligned_cols=211  Identities=16%  Similarity=0.293  Sum_probs=174.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeee-eeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFC-LHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......     +.+.+|+.+++.++|++++..++++ .+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            457899999999999999999965 57899999987654432     3578899999999988777666555 6678889


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTA  602 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla  602 (701)
                      +||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+|
T Consensus        82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            999999 8899999975433  589999999999999999999999   99999999999999   78899999999999


Q ss_pred             cccccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------
Q 041034          603 RLLHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------  649 (701)
Q Consensus       603 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------  649 (701)
                      +.......       ......||+.|+|||.+.+..++.+.  ||||+|+++++                          
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD--DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchh--HHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence            87654322       12345799999999999888877665  99999999984                          


Q ss_pred             -----------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -----------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -----------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                             |+..+|.+|||++++++.++..
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence                                   7888999999999999988753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-34  Score=294.68  Aligned_cols=194  Identities=25%  Similarity=0.330  Sum_probs=160.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCC----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..++|++.+.||+|+||.||+|....    +..||+|.+.....  ....+.+.+|+.+++.++||||+++++++.++ .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence            46789999999999999999996432    34699999986532  33457899999999999999999999998754 4


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.++
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            6899999999999999976432  489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          604 LLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       604 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      ....... ......+++.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~ll  208 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTAS--DVWMFAVCMWEIL  208 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchh--ccHHHHHHHHHHH
Confidence            7653322 22334578899999998777777665  9999999998643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-33  Score=291.93  Aligned_cols=193  Identities=26%  Similarity=0.458  Sum_probs=158.3

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-------  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  520 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...    ....+.+.+|+.++++++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            56799999999999999999965 47999999999642    2345778999999999999999999998765       


Q ss_pred             ------CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCe
Q 041034          521 ------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA  594 (701)
Q Consensus       521 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~  594 (701)
                            ....++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence                  4578999999999999999986432  578899999999999999999999   99999999999999999999


Q ss_pred             EEEeecCccccccC--------------CCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHccc
Q 041034          595 FVADFGTARLLHVD--------------SSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       595 kL~DFGla~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||+|||.++.....              ........||+.|+|||.+.+. .++.+  .||||+|+++++++.
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Di~slG~il~~l~~  226 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK--IDMYSLGIIFFEMIY  226 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTH--HHHHHHHHHHHHHHS
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcch--hhHHHHHHHHHHHHh
Confidence            99999999876422              1122345689999999998754 45554  499999999998664

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.5e-33  Score=289.60  Aligned_cols=210  Identities=16%  Similarity=0.298  Sum_probs=178.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeee-eeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFC-LHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......     +.+.+|+.+++.++|++++..+.++ .+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            357899999999999999999965 57999999998765433     4578899999999988766655554 5677889


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTA  602 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla  602 (701)
                      +||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            999999 8899999975432  589999999999999999999999   99999999999999   48899999999999


Q ss_pred             cccccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------
Q 041034          603 RLLHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------  649 (701)
Q Consensus       603 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------  649 (701)
                      +.......       ......||+.|+|||.+.+..++.+.  ||||+|+++++                          
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD--DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcch--hhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            87654332       12345799999999999888877665  99999999984                          


Q ss_pred             -----------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                             ||..+|.+||+++++++.|+.
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence                                   888899999999999988875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.2e-34  Score=297.86  Aligned_cols=195  Identities=27%  Similarity=0.436  Sum_probs=160.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcE--EEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKV--VALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|... +++.  ||+|.++....  ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            478999999999999999999654 5664  49998875432  22346789999999999 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC-------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          525 FFIYEYMERGSLFYVLRDDD-------------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      ++||||+++++|.+++....             ....+++..+..++.|++.||+|||++   ||+||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997653             123689999999999999999999999   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +.+||+|||+++..... .......+++.|+|||++.+..++.+.  ||||+|+++++++
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ell  235 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNS--DVWSYGVLLWEIV  235 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHH--HHHHHHHHHHHHH
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchh--cchHHHHHHHHHH
Confidence            99999999999754322 122334578899999998777766665  9999999999643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-34  Score=323.23  Aligned_cols=217  Identities=28%  Similarity=0.461  Sum_probs=180.7

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++...++|++.+.||+|+||.||+|.+.+++.||||+++.....    .+.+.+|++++++++||||+++++++.+ +..
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            44556789999999999999999998887888999999865432    3678999999999999999999999876 668


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.++++... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             eEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            99999999999999997532 12488999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------------------
Q 041034          605 LHVDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------------------  649 (701)
Q Consensus       605 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------------------  649 (701)
                      ..... .......++..|+|||++....++.+.  ||||+|+++|+                                  
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s--DvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  490 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  490 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchh--hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            64221 111223467889999998877777665  99999999996                                  


Q ss_pred             ---------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ---------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ---------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                               ||..+|.+|||++++++.|+...
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                     66667777777777777766554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-33  Score=323.69  Aligned_cols=214  Identities=22%  Similarity=0.325  Sum_probs=181.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++++.........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999654 6889999999764322222246678899999988 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++|+|.++++...   .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999998654   589999999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhh
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELE  669 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~  669 (701)
                      ..........+||+.|+|||++.+..++.+.  ||||+|+++|+|+.+.|. ...+..++.+.+.
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~--DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  555 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  555 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccc--eEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            5444555567899999999999888887776  999999999999998754 3344444444443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.2e-34  Score=300.50  Aligned_cols=193  Identities=25%  Similarity=0.398  Sum_probs=151.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHH--HHHHHhcCCCCceeeeeeeee-----e
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQN--EARVLSTVRHRNIVKLYGFCL-----H  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~-----~  520 (701)
                      ..++|++.+.||+|+||.||+|+. +++.||||++.....      ..+..  |+..+..++||||+++++++.     .
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            357899999999999999999976 689999999975431      33333  444455689999999997543     2


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecCCCCCcEEEcCCCCe
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC------TPSIVHRDISSNNILLNSNLEA  594 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~givH~Dlkp~NIll~~~~~~  594 (701)
                      ....++||||+++|+|.+++....    .++..+..++.|++.||+|||+++      .++|+||||||+||+++.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            346799999999999999997653    588999999999999999999762      2289999999999999999999


Q ss_pred             EEEeecCccccccCCC--------CceeecccccccCCCCCCCCcCC-----hhhHHHHHHHHHHHHHcc
Q 041034          595 FVADFGTARLLHVDSS--------NRTLRAGTYGYIAPDQRLSPPVN-----QKIIQDIILVSTTALACL  651 (701)
Q Consensus       595 kL~DFGla~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~Di~slg~i~~~cl  651 (701)
                      ||+|||+|+.+.....        ......||+.|+|||++.+....     .....||||+|+++|+++
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell  229 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF  229 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence            9999999987643211        12234699999999998763221     122459999999987543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-33  Score=313.44  Aligned_cols=190  Identities=28%  Similarity=0.420  Sum_probs=157.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++........ ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            567999999999999999999664 689999999986543221 136788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEeecCccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVADFGTARL  604 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~DFGla~~  604 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.   ++.+||+|||+|+.
T Consensus       115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999887654   589999999999999999999999   9999999999999976   45599999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ..... ......||+.|+|||++.+ .++.+.  ||||+|+++|+
T Consensus       189 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~--DiwslG~il~~  229 (494)
T 3lij_A          189 FENQK-KMKERLGTAYYIAPEVLRK-KYDEKC--DVWSIGVILFI  229 (494)
T ss_dssp             CBTTB-CBCCCCSCTTTCCHHHHTT-CBCTHH--HHHHHHHHHHH
T ss_pred             CCCCc-cccccCCCcCeeCHHHHcc-cCCCch--hHHHHHHHHHH
Confidence            75432 3344579999999998764 455554  99999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.8e-34  Score=296.03  Aligned_cols=196  Identities=27%  Similarity=0.423  Sum_probs=160.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            34678999999999999999999665 58999999987653322   467889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +||||+++++|.+++.....  .+++..+..++.|++.||.|||++   |++||||||+||+++.++.+||+|||++...
T Consensus        93 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999875332  589999999999999999999999   9999999999999999999999999998654


Q ss_pred             ccCCCCceeecccccccCCCCCC-----CCcCChhhHHHHHHHHHHHHHccc
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRL-----SPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ...........||+.|+|||.+.     ...++.+  .||||+|+++++++.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Di~slG~il~~l~~  217 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK--ADIWSLGITLIEMAQ  217 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTH--HHHHHHHHHHHHHHH
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchh--hhHHHHHHHHHHHhc
Confidence            32222233456999999999873     4445554  499999999996443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.4e-34  Score=293.48  Aligned_cols=190  Identities=25%  Similarity=0.407  Sum_probs=155.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-cEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-RCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .++.||||+++...     ..+.+.+|+.++++++||||+++++++.+. +..++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            457899999999999999999977 48899999997543     246789999999999999999999987554 47899


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++++|.+++..... ..+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            9999999999999976432 2378999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ..   .....+++.|+|||.+.+..++.+.  ||||+|++++++++
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~t  209 (278)
T 1byg_A          169 ST---QDTGKLPVKWTAPEALREKKFSTKS--DVWSFGILLWEIYS  209 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHH--HHHHHHHHHHHHHT
T ss_pred             cc---ccCCCccccccCHHHhCCCCCCchh--cHHHHHHHHHHHHh
Confidence            32   2234578899999998877777665  99999999997543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.1e-34  Score=295.75  Aligned_cols=196  Identities=25%  Similarity=0.429  Sum_probs=153.9

Q ss_pred             hcCCccceEEeeccceEEEEEEc--CCCc--EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL--PDGK--VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|.+  .+++  .||||+++..........+.+.+|+.++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            46899999999999999999964  2333  68999998765444455688999999999999999999999998765 8


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            899999999999999976432  589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          605 LHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      .......   .....+|+.|+|||.+.+..++.+.  ||||+|+++++++.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~  219 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS--DTWMFGVTLWEMFT  219 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHHHHT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchh--hHHHHHHHHHHHHh
Confidence            6543321   2234578889999998777766654  99999999996443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-33  Score=300.83  Aligned_cols=195  Identities=26%  Similarity=0.338  Sum_probs=169.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            468999999999999999999654 68999999998653  344467889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+++  ||+||||||+||+++.++.+||+|||+++....
T Consensus       110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999997654   5899999999999999999999732  899999999999999999999999999976542


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .  ......||+.|+|||++.+..++.+.  ||||+|+++++++.+.
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~  227 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGTHYSVQS--DIWSMGLSLVEMAVGR  227 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTCCCSHHH--HHHHHHHHHHHHHHTS
T ss_pred             c--cccCCCCCCCeECHHHHcCCCCCchh--hHHHHHHHHHHHHhCC
Confidence            2  22345799999999999888777765  9999999999888765

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.7e-33  Score=298.29  Aligned_cols=206  Identities=24%  Similarity=0.362  Sum_probs=165.1

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCc--------cChHHHHHHHHHHHHHhcCCCCcee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSET--------EDSAFVESFQNEARVLSTVRHRNIV  512 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv  512 (701)
                      .++++....++|++.+.||+|+||.||+|...+++.||||++.....        .+....+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            46678888999999999999999999999888899999999865432        2234457899999999999999999


Q ss_pred             eeeeeeee-----CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 041034          513 KLYGFCLH-----KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL  587 (701)
Q Consensus       513 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIl  587 (701)
                      ++++++..     ....++||||++ |+|.+++.....  .+++..+..++.||+.||+|||++   ||+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            99999854     346899999998 588888875432  589999999999999999999999   9999999999999


Q ss_pred             EcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          588 LNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       588 l~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.+.  ||||+|+++++++.+.+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~~l~~g~~  232 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLV--DMWSAGCVMAEMFNRKA  232 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             EcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHh--HHHhHHHHHHHHHhCCC
Confidence            999999999999999865432 22344578999999998876 4455554  99999999998777653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=296.14  Aligned_cols=195  Identities=24%  Similarity=0.428  Sum_probs=163.8

Q ss_pred             hcCCccceEEeeccceEEEEEEc-----CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-----PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  522 (701)
                      .++|++.+.||+|+||.||+|.+     .+++.||||++....   ....+.+.+|+.++++++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            46789999999999999999973     368899999997643   234578899999999999999999999987654 


Q ss_pred             -EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          523 -CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       523 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                       ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence             68999999999999999987542  589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccC
Q 041034          602 ARLLHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       602 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      ++........   .....++..|+|||.+.+..++.+.  ||||+|+++++++++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~el~tg  244 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVAS--DVWSFGVVLYELFTY  244 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHHHHHT
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchh--hHHHHHHHHHHHHhc
Confidence            9877543321   1223567789999998877766654  999999998865543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-33  Score=299.14  Aligned_cols=193  Identities=26%  Similarity=0.373  Sum_probs=159.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (701)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+++.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            57899999999999999999965 579999999997643 23445678899999999999999999999987653     


Q ss_pred             -EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          523 -CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       523 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                       ..|+||||+ +++|.++++..    .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence             469999999 77999999763    489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |+.....   .....+|+.|+|||++.+ ..++.+.  ||||+|+++++++.+.|
T Consensus       175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~ell~g~~  224 (367)
T 1cm8_A          175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTV--DIWSVGCIMAEMITGKT  224 (367)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhh--hHHHHHHHHHHHHhCCC
Confidence            9876432   334578999999998876 4566655  99999999998766543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-33  Score=290.90  Aligned_cols=213  Identities=22%  Similarity=0.303  Sum_probs=172.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcCCCCceeeeeeeee--eCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVRHRNIVKLYGFCL--HKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999764 6889999999764321 1223577899999999999999999999984  45678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||++++ +.+++..... ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999886 7777765432 2689999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------------
Q 041034          605 LHVDS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------------  649 (701)
Q Consensus       605 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------------  649 (701)
                      .....  .......||+.|+|||+..+.........||||+|+++++                                 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP  238 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCH
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCH
Confidence            64322  1223456899999999987654433334599999999985                                 


Q ss_pred             --------cccCCCCCCCCHHHHHH
Q 041034          650 --------CLRSKPKSRPTMQRISQ  666 (701)
Q Consensus       650 --------cl~~~P~~Rpt~~~i~~  666 (701)
                              |+..+|.+|||++|+++
T Consensus       239 ~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          239 PLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence                    77777888888888775

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-33  Score=301.44  Aligned_cols=199  Identities=28%  Similarity=0.408  Sum_probs=158.1

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCc--
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKR--  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--  522 (701)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++..... .....+++.+|+.+++.+. ||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            3467899999999999999999954 5799999999875432 3344577889999999997 999999999997544  


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..|+||||+++ +|.+++...    .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+|
T Consensus        85 ~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           85 DVYLVFDYMET-DLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CEEEEEECCSE-EHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecccCc-CHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            78999999974 999998764    488999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccC---------------------CCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVD---------------------SSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.+...                     ....+..+||+.|+|||++.+ ..++.+.  ||||+|+++++|+.+.|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--DiwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI--DMWSLGCILGEILCGKPI  230 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChh--hHHHHHHHHHHHHhCCCC
Confidence            865321                     112234579999999999876 4555554  999999999999988754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=319.47  Aligned_cols=212  Identities=25%  Similarity=0.392  Sum_probs=171.4

Q ss_pred             hcCCccce-EEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRY-CIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .+++.+.+ .||+|+||.||+|.+.   ++..||||+++.....  ...+.+.+|++++++++||||+++++++.. +..
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            34455555 7999999999999553   4667999999865332  235789999999999999999999999976 568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEEEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            999999999999999975432  589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          605 LHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      .......   .....+++.|+|||++.+..++.++  ||||+|+++|+                                
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~s--DvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~  563 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS--DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE  563 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTT
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHH--HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            6433221   1223456899999999877777765  99999999986                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                 ||..+|.+||++.++++.|+.
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                       667777777777777777654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7e-34  Score=298.37  Aligned_cols=217  Identities=25%  Similarity=0.383  Sum_probs=177.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||.||+|..      .+++.||||++.....  .....++.+|+.++++++||||+++++++.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            457899999999999999999974      2477899999975432  33456789999999999999999999999999


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCC----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDE----AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEA  594 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~  594 (701)
                      ...++||||+++++|.+++.....    ...+++..+..++.|++.||+|||++   ||+||||||+||+++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            999999999999999999986532    13588999999999999999999999   9999999999999984   4469


Q ss_pred             EEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------------
Q 041034          595 FVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------------  649 (701)
Q Consensus       595 kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------------  649 (701)
                      ||+|||+++.......  ......+|+.|+|||.+.+..++.+.  ||||+|+++++                       
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT--DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchh--hHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999976543221  22334678999999998777777665  99999999995                       


Q ss_pred             --------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 --------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 --------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                          ||..+|.+||++.++++.++..
T Consensus       261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                                6667788888888888877654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-34  Score=304.51  Aligned_cols=201  Identities=26%  Similarity=0.348  Sum_probs=166.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  522 (701)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++..... .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999966    36899999998754311 111234567899999999 6999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..++||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999997654   589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +.+.... .......||+.|+|||++.+.........||||+|+++|+|+.+.+
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~  260 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS  260 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence            8664322 2233457999999999987644333334599999999999887764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-34  Score=301.27  Aligned_cols=207  Identities=17%  Similarity=0.260  Sum_probs=173.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC---------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceee------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP---------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVK------  513 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------  513 (701)
                      .++|++.+.||+|+||.||+|...         +++.||+|++...        +.+.+|++++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            468999999999999999999665         3789999998754        35678999999999999988      


Q ss_pred             ---------eeeeeee-CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 041034          514 ---------LYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISS  583 (701)
Q Consensus       514 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp  583 (701)
                               +++++.. ....++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++   ||+||||||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                     5666665 67899999999 999999998652 23699999999999999999999999   999999999


Q ss_pred             CcEEEcCCC--CeEEEeecCccccccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----
Q 041034          584 NNILLNSNL--EAFVADFGTARLLHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----  649 (701)
Q Consensus       584 ~NIll~~~~--~~kL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----  649 (701)
                      +||+++.++  .+||+|||+++.+.....       ......||+.|+|||.+.+..++.+.  ||||+|+++++     
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~  265 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS--DLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSC
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchh--hHHHHHHHHHHHHhCC
Confidence            999999998  999999999987653322       11334799999999999888777765  99999999985     


Q ss_pred             -----------------------------------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------------------------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------------------------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                                                     ||..+|.+||+++++++.|++
T Consensus       266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence                                                           677888888888888888765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.6e-33  Score=294.86  Aligned_cols=194  Identities=27%  Similarity=0.375  Sum_probs=164.1

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhc--CCCCceeeeeeeeeeCc-
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST--VRHRNIVKLYGFCLHKR-  522 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-  522 (701)
                      ....++|++.+.||+|+||.||+|.. +++.||||++....      .+.+.+|++++..  ++||||+++++++.... 
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            44567899999999999999999987 58999999986432      3567788888877  78999999999998775 


Q ss_pred             ---EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecCCCCCcEEEcCC
Q 041034          523 ---CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH--------HDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       523 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~givH~Dlkp~NIll~~~  591 (701)
                         ..++||||+++|+|.+++...    .+++..+..++.|++.||+|||        +.   +|+||||||+||+++.+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred             ccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence               799999999999999999764    4899999999999999999999        77   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCC----ceeecccccccCCCCCCCCcCC----hhhHHHHHHHHHHHHHcccC
Q 041034          592 LEAFVADFGTARLLHVDSSN----RTLRAGTYGYIAPDQRLSPPVN----QKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~----~~~~~Di~slg~i~~~cl~~  653 (701)
                      +.+||+|||+++........    .....||+.|+|||++.+....    .....||||+|+++|+++++
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            99999999999876543321    2334699999999998765322    11346999999999998876

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.9e-33  Score=289.49  Aligned_cols=199  Identities=24%  Similarity=0.355  Sum_probs=169.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCcc------ChHHHHHHHHHHHHHhcCC-CCceeeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETE------DSAFVESFQNEARVLSTVR-HRNIVKLYGFCL  519 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  519 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++......      .....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4678999999999999999999664 6899999999765321      1234567889999999996 999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      +.+..++||||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999997643   589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCC------CCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRL------SPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |.+....... ......|++.|+|||.+.      ...++.+  .||||+|+++++++.+.+
T Consensus       169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~--~Di~slG~~l~~l~~g~~  227 (298)
T 1phk_A          169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKE--VDMWSTGVIMYTLLAGSP  227 (298)
T ss_dssp             TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH--HHHHHHHHHHHHHHHSSC
T ss_pred             cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcc--cccHhHHHHHHHHHHCCC
Confidence            9998765332 334457999999999874      3334444  499999999999888764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-33  Score=294.04  Aligned_cols=197  Identities=20%  Similarity=0.334  Sum_probs=160.9

Q ss_pred             hcCCccc-eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEE
Q 041034          449 TEDFHIR-YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       449 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (701)
                      .+.|++. +.||+|+||.||+|.. .+++.||||++.......   .+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            4678885 7899999999999965 468999999997654322   46788999999985 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEEeecCc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGTA  602 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~---~kL~DFGla  602 (701)
                      +||||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++
T Consensus        88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999997654   589999999999999999999999   9999999999999988765   999999999


Q ss_pred             cccccCCC-------CceeecccccccCCCCCCC-----CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSS-------NRTLRAGTYGYIAPDQRLS-----PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.......       ......||+.|+|||++..     ..++.+  .||||+|+++++++.+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~--~DiwslG~il~~l~~g~~p  225 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR--CDLWSLGVILYILLSGYPP  225 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTT--HHHHHHHHHHHHHHHSSCS
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcc--cccHhHHHHHHHHHHCCCC
Confidence            86542211       1223459999999998864     234444  4999999999998887643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-33  Score=296.55  Aligned_cols=197  Identities=25%  Similarity=0.376  Sum_probs=159.3

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||.||+|... +++.||+|++.......  ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            57999999999999999999664 78999999997543221  1124557999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++ +|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           80 EYLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             ECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             ccccc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            99975 99998876543  589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ........||+.|+|||++.+ ..++.+.  ||||+|+++++|+.+.+.
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~~l~~g~~p  200 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQI--DMWGVGCIFYEMATGRPL  200 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            444455678999999999876 4455554  999999999999988743

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3e-33  Score=292.93  Aligned_cols=193  Identities=25%  Similarity=0.390  Sum_probs=156.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......     .......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            356899999999999999999965 46899999998764321     112234578999999999999999999998766


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEEe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVAD  598 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~---~kL~D  598 (701)
                      . .++||||+++++|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999987644   589999999999999999999999   9999999999999987654   99999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCC---CCcCChhhHHHHHHHHHHHHHc
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRL---SPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ||+++..... .......||+.|+|||++.   ...++.+  .||||+|+++++|
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~--~Di~slG~il~~l  212 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRA--VDCWSLGVILFIC  212 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTH--HHHHHHHHHHHHH
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCch--hhHHHHHHHHHHH
Confidence            9999876422 1223346899999999863   3444444  4999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.7e-33  Score=294.47  Aligned_cols=199  Identities=25%  Similarity=0.417  Sum_probs=165.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-------  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  520 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.+++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            47899999999999999999966 579999999987654332 223567899999999999999999999887       


Q ss_pred             -CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          521 -KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       521 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                       .+..++||||+++ ++.+.+.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence             3468999999986 78777765433  589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccC----CCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          600 GTARLLHVD----SSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       600 Gla~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |+|+.+...    ........||+.|+|||++.+. .++.+.  ||||+|+++++++++.|.
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--DiwslG~il~ell~g~~p  228 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI--DLWGAGCIMAEMWTRSPI  228 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHh--HHHHHHHHHHHHHhCCCC
Confidence            999876422    1223345689999999988764 345554  999999999999887754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.1e-33  Score=296.35  Aligned_cols=194  Identities=24%  Similarity=0.302  Sum_probs=158.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc-----
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR-----  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            57899999999999999999955 4689999999976432 3344577889999999999999999999987654     


Q ss_pred             -EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          523 -CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       523 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                       ..++||||+++ +|.+++..     .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence             78999999975 78888853     488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |+..... .......||+.|+|||++.+..++.+.  ||||+|+++++++.+.+
T Consensus       174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwslG~il~el~~g~~  224 (371)
T 2xrw_A          174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIKGGV  224 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             ccccccc-cccCCceecCCccCHHHhcCCCCCchH--hHHHHHHHHHHHHhCCC
Confidence            9876432 223345799999999999888887765  99999999999888764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.1e-33  Score=319.10  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=154.1

Q ss_pred             eEEeeccceEEEEEEc---CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          456 YCIGTGGYGSVYKAEL---PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      +.||+|+||.||+|.+   ..++.||||+++.... +....+++.+|+.++++++||||+++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999944   2467899999976533 23345789999999999999999999999865 45889999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC--
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS--  610 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~--  610 (701)
                      +|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.....  
T Consensus       453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999997654   589999999999999999999999   999999999999999999999999999987654322  


Q ss_pred             -CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          611 -NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       611 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                       ......+|+.|+|||++.+..++.+.  ||||+|+++++++
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~s--DvwSlGv~l~ell  566 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKS--DVWSFGVLMWEAF  566 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHH--HHHHHHHHHHHHH
Confidence             12233467889999999887777765  9999999999633

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-33  Score=294.97  Aligned_cols=286  Identities=23%  Similarity=0.258  Sum_probs=199.2

Q ss_pred             CCCCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCccc
Q 041034           22 TSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGT  101 (701)
Q Consensus        22 ~~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  101 (701)
                      ....|.|.|+ |+.         ++++++. +|.   .-.++|++|+|++|.+++..+..|.++++|++|+|++|++++.
T Consensus        26 ~~~~C~~~~~-c~~---------~~~~l~~-iP~---~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~   91 (353)
T 2z80_A           26 ASLSCDRNGI-CKG---------SSGSLNS-IPS---GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI   91 (353)
T ss_dssp             -CCEECTTSE-EEC---------CSTTCSS-CCT---TCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred             cCCCCCCCeE-eeC---------CCCCccc-ccc---cccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence            4566788776 542         3444442 322   2236888999999998877777888899999999999999888


Q ss_pred             CCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCc-ccccCCCCCcEEEceec-ccCCCcCcccc
Q 041034          102 IPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLP-QEIGNLKSLIWLSVMYN-TVGGPIPSTLF  179 (701)
Q Consensus       102 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~  179 (701)
                      .|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+ ..|.++++|++|++++| .++...+..+.
T Consensus        92 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  171 (353)
T 2z80_A           92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA  171 (353)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred             CHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence            88888888999999999998887666668888888888888888886554 46777788888888777 45555566677


Q ss_pred             cccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEE
Q 041034          180 RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAEL  259 (701)
Q Consensus       180 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L  259 (701)
                      ++++|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|++|++++|.+++..+..+..       
T Consensus       172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~-------  244 (353)
T 2z80_A          172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-------  244 (353)
T ss_dssp             TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------
T ss_pred             CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-------
Confidence            7777777777777777666667777777777777777665433333344666666666666666543332211       


Q ss_pred             EcCCCCCccccCcccCCCCCCcEEEccCccCCC----CCcccccCccceeeecCCCCcCCCCCCCc-ccCCCCCCeeecc
Q 041034          260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG----QIPFAIGKLFNLVSLDLSKNKLSGSFPTG-IGNCTELQHLALN  334 (701)
Q Consensus       260 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~  334 (701)
                                    ....+.++.++|++|.+++    .+|..+..+++|+.|+|++|+++ .+|.. +..+++|++|+|+
T Consensus       245 --------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~  309 (353)
T 2z80_A          245 --------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH  309 (353)
T ss_dssp             ----------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             --------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEee
Confidence                          1123445566666666654    35666777888888888888887 45555 4788888888888


Q ss_pred             CCccCCCCC
Q 041034          335 HNSLDGTIP  343 (701)
Q Consensus       335 ~N~l~~~~p  343 (701)
                      +|++.+..|
T Consensus       310 ~N~~~~~~~  318 (353)
T 2z80_A          310 TNPWDCSCP  318 (353)
T ss_dssp             SSCBCCCHH
T ss_pred             CCCccCcCC
Confidence            888886544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-33  Score=289.24  Aligned_cols=201  Identities=24%  Similarity=0.331  Sum_probs=152.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.++...++.++||||+++++++.+.+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            457899999999999999999965 57899999999765432 2223445555666888999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||+++ +|.+++... .....+++..+..++.|++.||+|||+++  ||+||||||+||+++.++.+||+|||+++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999975 888777542 11236899999999999999999999742  8999999999999999999999999999876


Q ss_pred             ccCCCCceeecccccccCCCCC----CCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQR----LSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .... ......||+.|+|||++    .+..++.+.  ||||+|+++++++.+.+
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~--Di~slG~il~~l~~g~~  211 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKS--DIWSLGITMIELAILRF  211 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHH--HHHHHHHHHHHHHHTSC
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHH--HHHHHHHHHHHHHHCCC
Confidence            5332 23334799999999995    444555554  99999999999877664

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-33  Score=300.77  Aligned_cols=194  Identities=8%  Similarity=0.046  Sum_probs=147.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHH---HHHhcCCCCceeeee-------ee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEA---RVLSTVRHRNIVKLY-------GF  517 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  517 (701)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++...........+.+.+|+   .+++. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            45699999999999999999965 47899999999987654455567788885   45555 799988855       33


Q ss_pred             eeeC-----------------cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 041034          518 CLHK-----------------RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRR------VNIVKSVAHALSYLHHDCTP  574 (701)
Q Consensus       518 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~  574 (701)
                      +..+                 ...|+||||++ |+|.+++.....  .+++..+      ..++.||+.||+|||++   
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            3322                 34899999998 799999986432  2344555      67889999999999999   


Q ss_pred             CeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCC--CcCChhhHHHHHHHHHHHHHccc
Q 041034          575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS--PPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       575 givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||+||||||+|||++.++.+||+|||+|+....   ......+|+.|+|||++.+  ..++.+.  ||||+|+++|+|+.
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~--DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHAL--NAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHH--HHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccc--cHHHHHHHHHHHHh
Confidence            999999999999999999999999999986532   2224567799999999977  5566555  99999999998766


Q ss_pred             CC
Q 041034          653 SK  654 (701)
Q Consensus       653 ~~  654 (701)
                      +.
T Consensus       289 g~  290 (371)
T 3q60_A          289 LF  290 (371)
T ss_dssp             SS
T ss_pred             CC
Confidence            54

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-33  Score=297.67  Aligned_cols=199  Identities=25%  Similarity=0.386  Sum_probs=169.1

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChH--------------HHHHHHHHHHHHhcCCCCceeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSA--------------FVESFQNEARVLSTVRHRNIVKL  514 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l  514 (701)
                      .++|++.+.||+|+||.||+|.. +++.||||++.........              ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999999987 8999999998754322111              12678999999999999999999


Q ss_pred             eeeeeeCcEEEEEEEccCCCCHHHH------HhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEE
Q 041034          515 YGFCLHKRCMFFIYEYMERGSLFYV------LRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNIL  587 (701)
Q Consensus       515 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIl  587 (701)
                      ++++.+.+..++||||+++++|.++      +.... ...+++..+..++.|++.||+|||+ +   ||+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      54421 2369999999999999999999998 8   9999999999999


Q ss_pred             EcCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          588 LNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       588 l~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ++.++.+||+|||.+......  ......||+.|+|||.+.+. .++. ...||||+|+++++++.+.+
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNG-AKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEH-HHHHHHHHHHHHHHHHHSSC
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCc-chhhHHHHHHHHHHHHhCCC
Confidence            999999999999999876432  33445799999999999877 4443 23599999999999887764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-32  Score=302.75  Aligned_cols=210  Identities=17%  Similarity=0.300  Sum_probs=179.7

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCcEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  526 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     .++.+|+++++.++| +++..+..++...+..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            47899999999999999999965 57999999988765433     346789999999986 666677777778889999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE---cCCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll---~~~~~~kL~DFGla~  603 (701)
                      ||||+ +++|.+++.....  .+++..++.|+.||+.||+|||++   +||||||||+|||+   +.++.+||+|||+|+
T Consensus        81 vme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            99999 8899999975433  589999999999999999999999   99999999999999   688999999999998


Q ss_pred             ccccCCCC-------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------
Q 041034          604 LLHVDSSN-------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------  649 (701)
Q Consensus       604 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------  649 (701)
                      .+......       .....||+.|+|||.+.+..++.+.  ||||||+++|+                           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~s--DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRD--DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHH--HHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence            77543321       2245799999999999988887765  99999999984                           


Q ss_pred             ----------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ----------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ----------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                            ||..+|.+||++.+|.+.|+..
T Consensus       233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                                  8889999999999999987654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=295.64  Aligned_cols=223  Identities=23%  Similarity=0.421  Sum_probs=180.1

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      ..+++....++|++.+.||+|+||.||+|...+  .||+|+++...... ...+.+.+|+.++++++||||+++++++.+
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            345556667899999999999999999997643  59999987653322 123557789999999999999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      .+..++||||+++++|.+++....  ..+++..+..++.|++.||+|||++   |++||||||+||+++ ++.+||+|||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             CCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence            999999999999999999997643  2588999999999999999999999   999999999999998 6799999999


Q ss_pred             CccccccC-----CCCceeecccccccCCCCCCCC---------cCChhhHHHHHHHHHHHHH-----------------
Q 041034          601 TARLLHVD-----SSNRTLRAGTYGYIAPDQRLSP---------PVNQKIIQDIILVSTTALA-----------------  649 (701)
Q Consensus       601 la~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~Di~slg~i~~~-----------------  649 (701)
                      +++.....     ........||+.|+|||.+...         .++.+  .||||+|+++++                 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~--~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH--SDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHH--HHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCch--hhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            98765321     1222334689999999987642         23444  599999999984                 


Q ss_pred             --------------------------cccCCCCCCCCHHHHHHHhhcCCCc
Q 041034          650 --------------------------CLRSKPKSRPTMQRISQELEGKTPM  674 (701)
Q Consensus       650 --------------------------cl~~~P~~Rpt~~~i~~~l~~~~~~  674 (701)
                                                ||..+|.+|||+.++++.|+.....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                                      8889999999999999999987644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.4e-32  Score=298.93  Aligned_cols=195  Identities=22%  Similarity=0.304  Sum_probs=166.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC------CCCceeeeeeeeee
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV------RHRNIVKLYGFCLH  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~  520 (701)
                      ...+|++.+.||+|+||.||+|.. .+++.||||++...    ....+.+.+|+++++.+      .|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            356799999999999999999955 46899999999754    23346677888888776      57799999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC--eEEEe
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE--AFVAD  598 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~--~kL~D  598 (701)
                      ....++||||+. ++|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.  +||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence            999999999996 599999876542 2489999999999999999999999   9999999999999999887  99999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ||+|+....   ......||+.|+|||++.+..++.+.  ||||+|+++++|+++.|.
T Consensus       246 FG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~elltG~~p  298 (429)
T 3kvw_A          246 FGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPI--DMWSLGCILAELLTGYPL  298 (429)
T ss_dssp             CTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             cccceecCC---cccccCCCCCccChHHHhCCCCCchH--HHHhHHHHHHHHHhCCCC
Confidence            999976532   22345799999999999888887765  999999999999888753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-33  Score=292.48  Aligned_cols=202  Identities=24%  Similarity=0.383  Sum_probs=150.1

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|++.+.||+|+||.||+|... +++.||||++......  ...+.+.+|+.++++++||||+++++++...+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            44678999999999999999999664 6899999998754322  23467889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcC-----CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          526 FIYEYMERGSLFYVLRDD-----DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +||||+++++|.+++...     .....+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            999999999999998641     1123589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCC-----CceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          601 TARLLHVDSS-----NRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       601 la~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      .++.......     ......||+.|+|||.+.+ ..++.+  .||||+|+++++++.+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--~Di~slG~il~~l~~g~~  225 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK--ADIWSFGITAIELATGAA  225 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTH--HHHHHHHHHHHHHHHSSC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCch--hhHHHHHHHHHHHHhCCC
Confidence            9976643221     1233469999999998764 334444  499999999999887653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.5e-33  Score=289.65  Aligned_cols=203  Identities=21%  Similarity=0.358  Sum_probs=163.7

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC--CCceeeeeeee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--HRNIVKLYGFC  518 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~  518 (701)
                      .++.+....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++  ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            34444555678999999999999999999888899999999976543 2344678899999999997  59999999999


Q ss_pred             eeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 041034          519 LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVAD  598 (701)
Q Consensus       519 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~D  598 (701)
                      .+.+..++||| +.+++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||++++ +.+||+|
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence            99999999999 55779999998754   589999999999999999999999   9999999999999964 8999999


Q ss_pred             ecCccccccCCC--CceeecccccccCCCCCCC-----------CcCChhhHHHHHHHHHHHHHcccCC
Q 041034          599 FGTARLLHVDSS--NRTLRAGTYGYIAPDQRLS-----------PPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       599 FGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ||+++.......  ......||+.|+|||.+.+           ..++.+  .||||+|+++++++.+.
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~--~Di~slG~il~el~~g~  236 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK--SDVWSLGCILYYMTYGK  236 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHH--HHHHHHHHHHHHHHHSS
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCch--HHHHHHHHHHHHHHhCC
Confidence            999987653322  1234568999999999865           234444  49999999999866554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=100.00  E-value=7.7e-33  Score=287.58  Aligned_cols=251  Identities=25%  Similarity=0.312  Sum_probs=169.4

Q ss_pred             CCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCccc--CC
Q 041034           26 CNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGT--IP  103 (701)
Q Consensus        26 c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~p  103 (701)
                      |.|.++.|+..+           ++ .++.   ...++|++|+|++|.++...+..|.++++|++|+|++|.++..  .|
T Consensus         7 C~~~~l~c~~~~-----------l~-~ip~---~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~   71 (306)
T 2z66_A            7 CSGTEIRCNSKG-----------LT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS   71 (306)
T ss_dssp             EETTEEECCSSC-----------CS-SCCS---CCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred             eCCCEEEcCCCC-----------cc-cCCC---CCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence            788888887432           22 1222   2236788888888888855555678888888888888888733  35


Q ss_pred             cccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCc-ccccCCCCCcEEEceecccCCCcCccccccc
Q 041034          104 KEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLP-QEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT  182 (701)
Q Consensus       104 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  182 (701)
                      ..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+.+..+..+..++
T Consensus        72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  150 (306)
T 2z66_A           72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS  150 (306)
T ss_dssp             HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT
T ss_pred             cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc
Confidence            66777888888888888887 355567788888888888888876654 5667777777777777777666666666666


Q ss_pred             ccceeEeeecccCC-CCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEc
Q 041034          183 NLERLFLGCNQFNG-TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL  261 (701)
Q Consensus       183 ~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L  261 (701)
                      +|++|+|++|.+++ .+|..+..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|+|
T Consensus       151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  230 (306)
T 2z66_A          151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY  230 (306)
T ss_dssp             TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEEC
T ss_pred             CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeEC
Confidence            66666666666665 45566666666666666666666555666666666666666666666655555556666666666


Q ss_pred             CCCCCccccCcccCCCC-CCcEEEccCccCCC
Q 041034          262 SDNKIRGIIPDELSKLS-NLQYLNLSSNLLSG  292 (701)
Q Consensus       262 ~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~  292 (701)
                      ++|++++..|..+..++ +|+.|+|++|.+++
T Consensus       231 ~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             TTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             CCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            66666666665565553 56666666666654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5e-33  Score=296.01  Aligned_cols=194  Identities=26%  Similarity=0.351  Sum_probs=148.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+++.+|+.+++.++||||+++++++...     
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            357899999999999999999954 5789999999976432 334457788999999999999999999998654     


Q ss_pred             -cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 -RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                       ...|+||||+ +++|.+++...    .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence             5679999999 67999988653    589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +|+.....   .....||+.|+|||.+.+ ..++.+.  ||||+|+++++++.+.|
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~ell~g~~  228 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGRT  228 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             cccccccc---CCCcCcCcCccChHHHcCCcCCCchh--hHHHHHHHHHHHHhCCC
Confidence            99875422   334579999999999876 4556555  99999999998877764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-32  Score=283.02  Aligned_cols=212  Identities=24%  Similarity=0.392  Sum_probs=173.9

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            44678999999999999999999664 68999999987644322 22467889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC---CCeEEEeecCc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN---LEAFVADFGTA  602 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~---~~~kL~DFGla  602 (701)
                      +||||+++++|.+++....   .+++..+..++.|++.||+|||++   |++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999999887544   589999999999999999999999   99999999999999754   47999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhh
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELE  669 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~  669 (701)
                      +...... ......+|+.|+|||.+.+. ++.+  .||||+|+++++++.+.+. .-.+..++.+.+.
T Consensus       172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~--~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (287)
T 2wei_A          172 TCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEK--CDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (287)
T ss_dssp             GTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTH--HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eeecCCC-ccccccCcccccChHHhcCC-CCCc--hhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            8764332 22334689999999988664 4444  4999999999998887643 3334445544443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.98  E-value=1.9e-32  Score=290.66  Aligned_cols=275  Identities=22%  Similarity=0.226  Sum_probs=190.9

Q ss_pred             cEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccc
Q 041034           65 QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN  144 (701)
Q Consensus        65 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  144 (701)
                      ...++++|+++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  110 (353)
T 2z80_A           34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN  110 (353)
T ss_dssp             SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence            34677888887 5566554  58899999999998777778888999999999999988887888888888888888888


Q ss_pred             cCCCCCcccccCCCCCcEEEceecccCCCcC-cccccccccceeEeeec-ccCCCCCCCCCCccccCccccccccccCCc
Q 041034          145 KLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP-STLFRLTNLERLFLGCN-QFNGTIPREIGNLKNLTHLSIITNKLTGAI  222 (701)
Q Consensus       145 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  222 (701)
                      ++++..+..|.++++|++|++++|.+++..+ ..+..+++|++|++++| .+++..+..+.++++|++|++++|++++..
T Consensus       111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  190 (353)
T 2z80_A          111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE  190 (353)
T ss_dssp             CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred             cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccC
Confidence            8887666667777777777777777765444 35666666666666666 344444455555555555555555555555


Q ss_pred             cccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccc---c
Q 041034          223 PSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAI---G  299 (701)
Q Consensus       223 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~---~  299 (701)
                      |..+..+++|++|++++|+++..                        .+..+..+++|+.|++++|.+++..+..+   .
T Consensus       191 ~~~l~~l~~L~~L~l~~n~l~~~------------------------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~  246 (353)
T 2z80_A          191 PKSLKSIQNVSHLILHMKQHILL------------------------LEIFVDVTSSVECLELRDTDLDTFHFSELSTGE  246 (353)
T ss_dssp             TTTTTTCSEEEEEEEECSCSTTH------------------------HHHHHHHTTTEEEEEEESCBCTTCCCC------
T ss_pred             HHHHhccccCCeecCCCCccccc------------------------hhhhhhhcccccEEECCCCcccccccccccccc
Confidence            55555555555555555555432                        22222334444555555554444332222   1


Q ss_pred             CccceeeecCCCCcCCC----CCCCcccCCCCCCeeeccCCccCCCCCcc-ccccccCCeEEcccccCcccCC
Q 041034          300 KLFNLVSLDLSKNKLSG----SFPTGIGNCTELQHLALNHNSLDGTIPPE-IGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       300 ~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      ....++.++|++|.+++    .+|..+..+++|+.|+|++|+++ .+|.. ++.+++|++|+|++|+++|.+|
T Consensus       247 ~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          247 TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            23456666777776665    47888999999999999999999 56665 5899999999999999999887

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.98  E-value=3.4e-32  Score=286.49  Aligned_cols=187  Identities=24%  Similarity=0.364  Sum_probs=136.6

Q ss_pred             hhcCCccce-EEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----C
Q 041034          448 ATEDFHIRY-CIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----K  521 (701)
Q Consensus       448 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~  521 (701)
                      ..++|.+.+ .||+|+||.||+|... +++.||||++....       ....+....++.++||||+++++++..    .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            467899855 6999999999999664 69999999996532       111222334566799999999999876    4


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVAD  598 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~D  598 (701)
                      ...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++   ||+||||||+||+++.   ++.+||+|
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            568999999999999999986542 3589999999999999999999999   9999999999999976   45699999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ||+++.....  ......||+.|+|||.+.+..++.+.  ||||+|+++++
T Consensus       175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~~  221 (336)
T 3fhr_A          175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYI  221 (336)
T ss_dssp             CTTCEEC------------------------CHHHHHH--HHHHHHHHHHH
T ss_pred             cccceecccc--ccccCCCCcCccChhhhCCCCCCchh--hHHHHHHHHHH
Confidence            9999866432  23345789999999999777766654  99999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.98  E-value=3.1e-32  Score=289.03  Aligned_cols=196  Identities=25%  Similarity=0.430  Sum_probs=162.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----  521 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++....  .......+.+|+.++++++||||+++++++...     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            4578999999999999999999654 68999999997543  334457788999999999999999999988754     


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...++||||++ ++|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            67899999997 4999998763    489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCC----------ceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          602 ARLLHVDSSN----------RTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       602 a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ++........          .....||+.|+|||++.+ ..++.+.  ||||+|+++++++.+.|
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--Di~slG~il~~l~~g~~  221 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM--DVWSCGCILAELFLRRP  221 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH--HHHHHHHHHHHHHHSSC
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchh--hHHHHHHHHHHHHhCCC
Confidence            9876432211          122468999999998654 4555554  99999999998776653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.98  E-value=9.7e-33  Score=314.83  Aligned_cols=197  Identities=24%  Similarity=0.333  Sum_probs=162.2

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcC----CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH  520 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (701)
                      .....++|++.+.||+|+||.||+|.+.    .+..||+|+++...  .....+.+.+|+.++++++||||+++++++.+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  462 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE  462 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3445678999999999999999999653    24679999987643  23445789999999999999999999999854


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                       +..++||||+++|+|.++++....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence             568999999999999999976432  589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc
Q 041034          601 TARLLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       601 la~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +|+....... ......+|+.|+|||.+.+..++.+.  ||||+|+++++++
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~--DiwSlG~il~ell  586 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS--DVWMFGVCMWEIL  586 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHH
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchh--hHHHHHHHHHHHH
Confidence            9987643322 12234577899999998877777665  9999999999644

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=2.4e-32  Score=283.83  Aligned_cols=277  Identities=25%  Similarity=0.234  Sum_probs=160.4

Q ss_pred             EEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCC--CccccCCccccceeeccc
Q 041034           66 YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT--TPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        66 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~  143 (701)
                      .+++++++++ .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|+++..  .+..+..+++|++|+|++
T Consensus        11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~   87 (306)
T 2z66_A           11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF   87 (306)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred             EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence            5666666665 3444332  4666666666666644444566666666666666666522  134444455555555555


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCC-CCCCCccccCccccccccccCCc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIP-REIGNLKNLTHLSIITNKLTGAI  222 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~  222 (701)
                      |.++.                         +|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..
T Consensus        88 n~i~~-------------------------l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  142 (306)
T 2z66_A           88 NGVIT-------------------------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF  142 (306)
T ss_dssp             CSEEE-------------------------EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred             Ccccc-------------------------ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence            55542                         22334444555555555555554333 34555566666666666666555


Q ss_pred             cccccCCCcccEEEeccCCCCC-CCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCc
Q 041034          223 PSTLGHLTSLLYLDLSFNQLHS-FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL  301 (701)
Q Consensus       223 p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  301 (701)
                      |..+..+++|++|++++|.+++ ..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+..+..+
T Consensus       143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  222 (306)
T 2z66_A          143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  222 (306)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred             hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence            5556666666666666666655 455566666666666666666666666666666666667776666666555566666


Q ss_pred             cceeeecCCCCcCCCCCCCcccCCC-CCCeeeccCCccCCCCC--ccccccccCCeEEcccccCcccCCCCc
Q 041034          302 FNLVSLDLSKNKLSGSFPTGIGNCT-ELQHLALNHNSLDGTIP--PEIGKILLLQNLDLSHNNLSGTIPMTL  370 (701)
Q Consensus       302 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~l~~L~~l~ls~N~l~g~~p~~~  370 (701)
                      ++|+.|+|++|++++..|..+..++ +|++|+|++|++++.-+  .....+...+.+.+..+.+.|..|..+
T Consensus       223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~  294 (306)
T 2z66_A          223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK  294 (306)
T ss_dssp             TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred             ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhh
Confidence            6666666666666666666666663 66666666666665322  112223334444455555555555443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.98  E-value=6.2e-32  Score=283.85  Aligned_cols=190  Identities=18%  Similarity=0.324  Sum_probs=164.4

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeee--CcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLH--KRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  524 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++...      .+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            47899999999999999999954 578999999997543      367889999999997 9999999999987  6678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCcc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTAR  603 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla~  603 (701)
                      ++||||+++++|.++++      .+++..+..++.|++.||+|||++   ||+||||||+||+++.++ .+||+|||+|+
T Consensus       109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            99999999999999885      378899999999999999999999   999999999999999776 89999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ...... ......+|+.|+|||.+.+ ..++.+.  ||||+|+++++|+.+.+.
T Consensus       180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~--DiwslG~il~~ll~g~~p  230 (330)
T 3nsz_A          180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP  230 (330)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHHTCSS
T ss_pred             EcCCCC-ccccccccccccChhhhcCCCcCCchh--hHHHHHHHHHHHHhCCCC
Confidence            765332 3344579999999999876 4455554  999999999999988743

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.98  E-value=3.5e-32  Score=286.63  Aligned_cols=194  Identities=19%  Similarity=0.336  Sum_probs=166.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc--CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCC------ceeeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL--PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR------NIVKLYGFCLH  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~  520 (701)
                      .++|++.+.||+|+||.||+|..  .+++.||||+++..    ....+.+.+|+.+++.++|+      +++++++++.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            57899999999999999999965  36889999999753    23457788999999888655      59999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC----------
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS----------  590 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~----------  590 (701)
                      .+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++   ||+||||||+||+++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999 7899999976542 2588999999999999999999999   9999999999999987          


Q ss_pred             ---------CCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          591 ---------NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       591 ---------~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                               ++.+||+|||+++.....   .....||+.|+|||++.+..++.+.  ||||+|+++++++.+.+.
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcch--hhHHHHHHHHHHHhCCCC
Confidence                     678999999999865322   2345799999999999888777765  999999999999888643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.98  E-value=1.3e-32  Score=288.39  Aligned_cols=201  Identities=28%  Similarity=0.418  Sum_probs=165.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc--CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC---CCCceeeeeeeee--
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL--PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVKLYGFCL--  519 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--  519 (701)
                      .+.++|++.+.||+|+||.||+|..  .+++.||+|++........ ....+.+|+.+++.+   +||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            4568899999999999999999976  4688999999875432211 113455677766665   8999999999987  


Q ss_pred             ---eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          520 ---HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       520 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                         .....++||||++ |+|.+++...... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence               5567899999998 5999999765432 489999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          597 ADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       597 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +|||.++...... ......||+.|+|||.+.+..++.+.  ||||+|+++++++.+.+.
T Consensus       162 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~--Di~slG~il~~l~~g~~p  218 (326)
T 1blx_A          162 ADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRKPL  218 (326)
T ss_dssp             CSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             ecCcccccccCCC-CccccccccceeCHHHHhcCCCCcch--hHHHHHHHHHHHHcCCCC
Confidence            9999998764322 23345789999999999887777665  999999999988776643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.98  E-value=6.4e-33  Score=289.01  Aligned_cols=213  Identities=23%  Similarity=0.338  Sum_probs=168.5

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccCh---HHHHHHHHHHHHHhcC----CCCceeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDS---AFVESFQNEARVLSTV----RHRNIVKLYGF  517 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~~  517 (701)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++........   .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44567899999999999999999966 4689999999976543221   1123456788888888    89999999999


Q ss_pred             eeeCcEEEEEEEc-cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeE
Q 041034          518 CLHKRCMFFIYEY-MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAF  595 (701)
Q Consensus       518 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~k  595 (701)
                      +.+.+..++|||| +.+++|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 78999999998644   589999999999999999999999   999999999999999 889999


Q ss_pred             EEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------
Q 041034          596 VADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------  649 (701)
Q Consensus       596 L~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------  649 (701)
                      |+|||+++.....  ......||+.|+|||.+.+..+... ..||||+|+++++                          
T Consensus       181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  257 (312)
T 2iwi_A          181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHAL-PATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS  257 (312)
T ss_dssp             ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHH-HHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSC
T ss_pred             EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCc-cchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCC
Confidence            9999999876532  2344569999999998876655432 2599999999985                          


Q ss_pred             ---------cccCCCCCCCCHHHHHHH
Q 041034          650 ---------CLRSKPKSRPTMQRISQE  667 (701)
Q Consensus       650 ---------cl~~~P~~Rpt~~~i~~~  667 (701)
                               ||..+|.+||+++|+++.
T Consensus       258 ~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          258 PDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     777888888888888763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=3.7e-32  Score=291.67  Aligned_cols=197  Identities=24%  Similarity=0.338  Sum_probs=159.7

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----  520 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  520 (701)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++......       ..+|+.+++.++||||+++++++..    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            45678999999999999999999954 57999999999765322       2479999999999999999999844    


Q ss_pred             ----------------------------------CcEEEEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHH
Q 041034          521 ----------------------------------KRCMFFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHAL  565 (701)
Q Consensus       521 ----------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L  565 (701)
                                                        ....++||||+++ +|.+.+... .....+++..+..++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              3348899999985 887777542 1123689999999999999999


Q ss_pred             HHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHH
Q 041034          566 SYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILV  643 (701)
Q Consensus       566 ~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~sl  643 (701)
                      +|||++   ||+||||||+||+++ .++.+||+|||+|+...... ......+|+.|+|||.+.+.. ++.+.  ||||+
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~--Diwsl  228 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSI--DLWSI  228 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHH--HHHHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcch--hhhhH
Confidence            999998   999999999999998 68899999999998764333 233457899999999887654 55554  99999


Q ss_pred             HHHHHHcccCCCC
Q 041034          644 STTALACLRSKPK  656 (701)
Q Consensus       644 g~i~~~cl~~~P~  656 (701)
                      |+++++|+.+.|.
T Consensus       229 G~il~ell~g~~p  241 (383)
T 3eb0_A          229 GCVFGELILGKPL  241 (383)
T ss_dssp             HHHHHHHHHSSCS
T ss_pred             HHHHHHHHhCCCC
Confidence            9999998887653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=2.5e-32  Score=294.55  Aligned_cols=196  Identities=24%  Similarity=0.328  Sum_probs=164.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC--------CCceeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--------HRNIVKLYGFCL  519 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~  519 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...    ....+.+.+|+.+++.++        |+||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            47899999999999999999954 56899999999753    334577889999999985        788999999987


Q ss_pred             ----eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC---
Q 041034          520 ----HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL---  592 (701)
Q Consensus       520 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~---  592 (701)
                          .....++||||+ ++++.+.+..... ..+++..+..++.||+.||+|||+++  ||+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence                556899999999 5577666654322 25899999999999999999999854  899999999999998775   


Q ss_pred             ----------------------------------------------CeEEEeecCccccccCCCCceeecccccccCCCC
Q 041034          593 ----------------------------------------------EAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ  626 (701)
Q Consensus       593 ----------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~  626 (701)
                                                                    .+||+|||.|+.....   .....||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence                                                          8999999999876432   234579999999999


Q ss_pred             CCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          627 RLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       627 ~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      +.+..++.++  ||||+|+++|+|+.+.+..
T Consensus       265 ~~~~~~~~~~--DiwslG~il~elltg~~pf  293 (397)
T 1wak_A          265 LIGSGYNTPA--DIWSTACMAFELATGDYLF  293 (397)
T ss_dssp             HHTSCCCTHH--HHHHHHHHHHHHHHSSCSC
T ss_pred             hcCCCCCcHH--HHHHHHHHHHHHhhCCCCC
Confidence            9888877765  9999999999999987544

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.98  E-value=3e-33  Score=292.55  Aligned_cols=195  Identities=22%  Similarity=0.286  Sum_probs=162.3

Q ss_pred             HhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccCh---HHHHHHHHHHHHHhcCC--CCceeeeeeeee
Q 041034          446 INATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDS---AFVESFQNEARVLSTVR--HRNIVKLYGFCL  519 (701)
Q Consensus       446 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  519 (701)
                      ....++|++.+.||+|+||.||+|.. .+++.||||++........   ...+.+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            44567899999999999999999954 5789999999976543210   11244677999999996  599999999999


Q ss_pred             eCcEEEEEEEccCC-CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEE
Q 041034          520 HKRCMFFIYEYMER-GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVA  597 (701)
Q Consensus       520 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~  597 (701)
                      +++..++||||+.+ ++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++ .++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 89999997644   589999999999999999999999   999999999999999 78999999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      |||+++.....  ......||+.|+|||++.+..+... ..||||+|+++++
T Consensus       193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~~Di~slG~il~e  241 (320)
T 3a99_A          193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGR-SAAVWSLGILLYD  241 (320)
T ss_dssp             CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHH-HHHHHHHHHHHHH
T ss_pred             eCccccccccc--cccCCCCCccCCChHHhccCCCCCc-cchHHhHHHHHHH
Confidence            99999876532  2334569999999998876655332 2499999999996

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.98  E-value=1.8e-32  Score=296.37  Aligned_cols=198  Identities=26%  Similarity=0.417  Sum_probs=150.0

Q ss_pred             hcCCcc-ceEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--Cc
Q 041034          449 TEDFHI-RYCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KR  522 (701)
Q Consensus       449 ~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  522 (701)
                      .+.|.+ .++||+|+||.||+|...   +++.||||++......     ..+.+|+.++++++||||+++++++..  ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            345666 557999999999999754   5789999999765432     467899999999999999999999954  67


Q ss_pred             EEEEEEEccCCCCHHHHHhcCC------CccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE----cCCC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDD------EAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL----NSNL  592 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll----~~~~  592 (701)
                      ..++||||+++ +|.+++....      ....+++..+..++.||+.||+|||++   ||+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            89999999975 8888775321      122489999999999999999999999   99999999999999    6779


Q ss_pred             CeEEEeecCccccccCC---CCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          593 EAFVADFGTARLLHVDS---SNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .+||+|||+|+......   .......||+.|+|||++.+.. ++.+.  ||||+|+++|+|+.+.|..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--DiwSlG~il~ell~g~~pf  236 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI--DIWAIGCIFAELLTSEPIF  236 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHH--HHHHHHHHHHHHHHSSCTT
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchh--hhHHHHHHHHHHHhCCCCC
Confidence            99999999998765322   2233457999999999987744 55554  9999999999999887543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=9.4e-32  Score=286.48  Aligned_cols=196  Identities=26%  Similarity=0.402  Sum_probs=164.8

Q ss_pred             hhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC----
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK----  521 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  521 (701)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++....  .....+.+.+|++++++++||||+++++++...    
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence            3456899999999999999999965 468899999997543  334457889999999999999999999998765    


Q ss_pred             -cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          522 -RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       522 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                       ...++||||+++ +|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          102 MKDVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence             368999999975 999998764    489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCC---ceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSN---RTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +++........   .....||+.|+|||++.+. .++.+.  ||||+|+++++++.+.
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~--DiwslG~il~ell~g~  229 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI--DIWSVGCILAEMLSNR  229 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHH--HHHHHHHHHHHHHHSS
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcch--hHHHHHHHHHHHHHCC
Confidence            99876533221   2345799999999986543 355554  9999999999877665

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=2e-32  Score=294.48  Aligned_cols=195  Identities=23%  Similarity=0.321  Sum_probs=157.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR------  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  522 (701)
                      ..+|++.+.||+|+||.||+|+...+..||+|++......       ..+|+.+++.++||||+++++++....      
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            4579999999999999999998877777999988764322       246999999999999999999986533      


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEEeecC
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGT  601 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~DFGl  601 (701)
                      ..++||||++++.+............+++..+..++.||+.||+|||++   ||+||||||+||+++ .++.+||+|||+
T Consensus       112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            3889999998754433332211223689999999999999999999999   999999999999999 789999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      |+...... ......+|+.|+|||.+.+.. ++.+.  ||||+|+++|+|+.+.|.
T Consensus       189 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwSlG~il~ell~g~~p  241 (394)
T 4e7w_A          189 AKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNI--DIWSTGCVMAELMQGQPL  241 (394)
T ss_dssp             CEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             cccccCCC-CCcccccCcCccCHHHHcCCCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            98764333 233457899999999886653 55554  999999999998877643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.7e-32  Score=296.34  Aligned_cols=191  Identities=22%  Similarity=0.329  Sum_probs=150.8

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...+|.+.+.||+|+||+||.....+++.||||++......      .+.+|+.+++++ +||||+++++++.+....|+
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            34568999999999999976555557899999999764432      346799999999 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-----CCCeEEEeecC
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-----NLEAFVADFGT  601 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-----~~~~kL~DFGl  601 (701)
                      ||||+++ +|.+++.....  ...+..+..++.||+.||+|||++   +|+||||||+||+++.     ...+||+|||+
T Consensus        96 v~E~~~g-~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           96 AIELCAA-TLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEECCSE-EHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEECCCC-CHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            9999974 99999986543  244456678999999999999999   9999999999999953     34688999999


Q ss_pred             ccccccCC---CCceeecccccccCCCCCCC---CcCChhhHHHHHHHHHHHHHccc
Q 041034          602 ARLLHVDS---SNRTLRAGTYGYIAPDQRLS---PPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       602 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      |+......   .......||+.|+|||++.+   ..++.+  .||||+|++++++++
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~--~DiwSlG~il~ellt  224 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT--VDIFSAGCVFYYVIS  224 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTH--HHHHHHHHHHHHHHT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcH--HHHHHHHHHHHHHHc
Confidence            98765332   22334579999999999874   333334  499999999998665

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=7.5e-32  Score=282.88  Aligned_cols=199  Identities=24%  Similarity=0.292  Sum_probs=143.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEAR-VLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.....  .....++..|+. +++.++||||+++++++.+.+..+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            357899999999999999999966 4789999999986542  223345556665 778889999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcC--CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          526 FIYEYMERGSLFYVLRDD--DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      +||||+++ +|.+++...  .....+++..+..++.|++.||.|||++.  ||+||||||+||+++.++.+||+|||+++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            99999986 888777631  11225899999999999999999999742  89999999999999999999999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCC----CCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRL----SPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ...... ......||+.|+|||.+.    +..++.+  .||||+|+++++++.+.
T Consensus       175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~--~Di~slG~il~~l~~g~  226 (327)
T 3aln_A          175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVR--SDVWSLGITLYELATGR  226 (327)
T ss_dssp             C-------------------------------CCSH--HHHHHHHHHHHHHHHSC
T ss_pred             eccccc-ccccCCCCccccCceeeccccCcCCCCch--hhHHHHHHHHHHHHHCC
Confidence            764332 223347999999999983    4445555  49999999999755543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=284.98  Aligned_cols=191  Identities=27%  Similarity=0.383  Sum_probs=159.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE----
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC----  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  523 (701)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            47899999999999999999965 469999999997644 234456788999999999999999999999987653    


Q ss_pred             --EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          524 --MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       524 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                        .++||||++ ++|.+++..     .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence              599999997 488877643     489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ++.....   .....+|+.|+|||.+.+ ..++.+.  ||||+|+++++++.+.
T Consensus       173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~--Di~slG~il~el~~g~  221 (353)
T 3coi_A          173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTV--DIWSVGCIMAEMLTGK  221 (353)
T ss_dssp             TTC-----------CCSBCCSCHHHHSCCSCCCTTH--HHHHHHHHHHHHHHSS
T ss_pred             ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchh--hHHHHHHHHHHHHhCC
Confidence            9865422   334578999999998876 4555554  9999999999877654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=1.4e-31  Score=285.80  Aligned_cols=192  Identities=27%  Similarity=0.387  Sum_probs=160.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE---
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM---  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  524 (701)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            57899999999999999999955 4689999999976543 344567889999999999999999999999876654   


Q ss_pred             ---EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          525 ---FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       525 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                         ++||||++ ++|.+++..     .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 588888743     489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ++.....   .....||+.|+|||.+.+ ..++.+.  ||||+|+++++++.+.+
T Consensus       191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~il~el~~g~~  240 (371)
T 4exu_A          191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTV--DIWSVGCIMAEMLTGKT  240 (371)
T ss_dssp             C-----------CTTCCCTTSCHHHHSCCSCCCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             ccccccC---cCCcccCccccCHHHhcCCCCCCcHH--hHHHHHHHHHHHHhCCC
Confidence            9865432   334578999999998876 5566655  99999999998777653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=6.5e-36  Score=329.35  Aligned_cols=349  Identities=21%  Similarity=0.175  Sum_probs=272.5

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCccee----eCCcccCCCCCCCEEECcCCcCcccCCccc-CCCC-
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSG----SIPPQIGSLSNLKYLNLRWNNLTGTIPKEI-GSLR-  110 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~-  110 (701)
                      .++++|+++++.++.......+..+++|++|+|++|.++.    .++..+..+++|++|+|++|.+++..+..+ ..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            3578899998888754333336778999999999999875    456778888999999999999986544433 3455 


Q ss_pred             ---CCCEEECCCCCCCC----CCccccCCccccceeecccccCCCCCccccc-----CCCCCcEEEceecccCCCc----
Q 041034          111 ---NLEVLYLSNNSLHG----TTPIEIGSLRNLEELYLRSNKLSGVLPQEIG-----NLKSLIWLSVMYNTVGGPI----  174 (701)
Q Consensus       111 ---~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----  174 (701)
                         +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+.     ..++|++|++++|.+++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               79999999999984    4578889999999999999998765444333     3568999999999998754    


Q ss_pred             CcccccccccceeEeeecccCCCCCCCCC-----CccccCccccccccccCC----ccccccCCCcccEEEeccCCCCCC
Q 041034          175 PSTLFRLTNLERLFLGCNQFNGTIPREIG-----NLKNLTHLSIITNKLTGA----IPSTLGHLTSLLYLDLSFNQLHSF  245 (701)
Q Consensus       175 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~  245 (701)
                      +..+..+++|++|++++|.++...+..+.     ..++|++|++++|.+++.    ++..+..+++|++|++++|.+++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            55667789999999999998765444443     256899999999999874    577788889999999999998764


Q ss_pred             C-----CcccCCCCcccEEEcCCCCCccc----cCcccCCCCCCcEEEccCccCCCCCcccccCc-----cceeeecCCC
Q 041034          246 I-----PLEIGNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL-----FNLVSLDLSK  311 (701)
Q Consensus       246 ~-----~~~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~  311 (701)
                      .     +..+..+++|+.|+|++|.+++.    ++..+..+++|+.|++++|.+++..+..+...     ++|+.|+|++
T Consensus       243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~  322 (461)
T 1z7x_W          243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  322 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCC
Confidence            2     23334688999999999999865    56777889999999999999976555444432     6899999999


Q ss_pred             CcCCCC----CCCcccCCCCCCeeeccCCccCCCCCccccc-----cccCCeEEcccccCcc----cCCCCc----cccc
Q 041034          312 NKLSGS----FPTGIGNCTELQHLALNHNSLDGTIPPEIGK-----ILLLQNLDLSHNNLSG----TIPMTL----HPMF  374 (701)
Q Consensus       312 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~l~ls~N~l~g----~~p~~~----~~~~  374 (701)
                      |.+++.    +|..+..+++|+.|+|++|++++..+..+..     .++|+.|++++|++++    .+|..+    ....
T Consensus       323 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~  402 (461)
T 1z7x_W          323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  402 (461)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             CCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccE
Confidence            999865    5666777899999999999998665555543     6789999999999986    566543    2357


Q ss_pred             cccccCCCCCc
Q 041034          375 LDMSFNNLEGE  385 (701)
Q Consensus       375 l~ls~N~l~g~  385 (701)
                      +|+++|++++.
T Consensus       403 L~l~~N~i~~~  413 (461)
T 1z7x_W          403 LDLSNNCLGDA  413 (461)
T ss_dssp             EECCSSSCCHH
T ss_pred             EECCCCCCCHH
Confidence            89999998753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=2.1e-31  Score=282.70  Aligned_cols=194  Identities=24%  Similarity=0.345  Sum_probs=163.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CC-cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc------eeeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DG-KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN------IVKLYGFCLH  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~  520 (701)
                      .++|++.+.||+|+||.||+|... ++ +.||+|+++..    ....+.+.+|+.+++.++|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            578999999999999999999653 44 68999999753    233567888999999987655      8999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEE------------
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILL------------  588 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll------------  588 (701)
                      .+..++||||+ ++++.+++..... ..+++..+..++.||+.||+|||++   ||+||||||+||++            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            99999999999 5577777765432 2589999999999999999999999   99999999999999            


Q ss_pred             -------cCCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          589 -------NSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       589 -------~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                             +.++.+||+|||+++.....   .....||+.|+|||++.+..++.+.  ||||+|+++++++.+.+.
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPC--DVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCcc--chHHHHHHHHHHHhCCCC
Confidence                   56789999999999865322   2345799999999999888877765  999999999998887643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=5e-32  Score=293.86  Aligned_cols=195  Identities=25%  Similarity=0.359  Sum_probs=157.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (701)
                      ..+|++.+.||+|+||.||+|... +++.||||++.....       ...+|+++++.++||||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            346899999999999999999664 699999999876432       234699999999999999999988542      


Q ss_pred             cEEEEEEEccCCCCHHHHHhcC-CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEee
Q 041034          522 RCMFFIYEYMERGSLFYVLRDD-DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADF  599 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DF  599 (701)
                      ...++||||+++ ++.+.+... .....+++..+..++.||+.||+|||++   ||+||||||+|||++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence            246799999986 676665431 1123689999999999999999999998   99999999999999965 56899999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |+|+.+.... ......||+.|+|||++.+. .++.+.  ||||+|+++|+|+.+.|..
T Consensus       202 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwSlG~il~ell~G~~pf  257 (420)
T 1j1b_A          202 GSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQPIF  257 (420)
T ss_dssp             TTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHH--HHHHHHHHHHHHHHSSCSS
T ss_pred             hhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchh--hhHHHHHHHHHHHhCCCCC
Confidence            9998764332 23345789999999998664 455554  9999999999999887543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=3.2e-34  Score=316.68  Aligned_cols=239  Identities=25%  Similarity=0.263  Sum_probs=160.7

Q ss_pred             cCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCc
Q 041034           82 IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI  161 (701)
Q Consensus        82 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  161 (701)
                      ...+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.+++..+          
T Consensus        30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~----------   97 (487)
T 3oja_A           30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV----------   97 (487)
T ss_dssp             STTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE----------
T ss_pred             cccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC----------
Confidence            3344477777777777777767777777777777777777776554  6667777777777776653321          


Q ss_pred             EEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCC
Q 041034          162 WLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ  241 (701)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~  241 (701)
                                         .++|+.|+|++|.+++..+..   +++|++|+|++|.+++..|..++.+++|++|+|++|.
T Consensus        98 -------------------~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (487)
T 3oja_A           98 -------------------GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (487)
T ss_dssp             -------------------CTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSC
T ss_pred             -------------------CCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCC
Confidence                               145555555555555443332   3456666666666666666666667777777777777


Q ss_pred             CCCCCCcccC-CCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCC
Q 041034          242 LHSFIPLEIG-NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPT  320 (701)
Q Consensus       242 l~~~~~~~~~-~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  320 (701)
                      +++.+|..+. .+++|+.|+|++|.|++..+  +..+++|+.|+|++|.+++..| .+..+++|+.|+|++|.|++ +|.
T Consensus       156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~  231 (487)
T 3oja_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEK  231 (487)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECT
T ss_pred             CCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cch
Confidence            7776666654 56777777777777775532  3347777777777777775433 47777777777777777774 666


Q ss_pred             cccCCCCCCeeeccCCccC-CCCCccccccccCCeEEcc
Q 041034          321 GIGNCTELQHLALNHNSLD-GTIPPEIGKILLLQNLDLS  358 (701)
Q Consensus       321 ~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~ls  358 (701)
                      .+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       232 ~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             hhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            7777778888888888877 5666777777777777665

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.2e-31  Score=308.71  Aligned_cols=183  Identities=28%  Similarity=0.404  Sum_probs=155.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcC--CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE---
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP--DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC---  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  523 (701)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++....  .....+.+.+|+.++++++||||+++++++.+.+.   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            478999999999999999999664  68999999987543  33445778999999999999999999999987654   


Q ss_pred             --EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          524 --MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       524 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                        .|+||||+++++|.+++..     .+++..++.++.||+.||.|||++   ||+||||||+||+++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence              7999999999999987754     489999999999999999999999   99999999999999875 999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ++.....    ....||+.|+|||++.+.. +.  .+||||+|+++++
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~--~sDi~slG~~l~~  268 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TV--ATDIYTVGRTLAA  268 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHCS-CH--HHHHHHHHHHHHH
T ss_pred             chhcccC----CccCCCccccCHHHHcCCC-CC--ceehhhhHHHHHH
Confidence            9876432    3457999999999886654 33  4599999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=2e-32  Score=288.34  Aligned_cols=192  Identities=17%  Similarity=0.170  Sum_probs=155.3

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc-----ChHHHHHHHHHHHHHhcCC---------------
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE-----DSAFVESFQNEARVLSTVR---------------  507 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------------  507 (701)
                      ..++|++.+.||+|+||+||+|+. +|+.||||++......     .....+.+.+|+.+++.++               
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            357899999999999999999987 6899999999865421     1223467888999888886               


Q ss_pred             -----------CCceeeeeeeeee-------------CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHH
Q 041034          508 -----------HRNIVKLYGFCLH-------------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH  563 (701)
Q Consensus       508 -----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~  563 (701)
                                 ||||+++++++.+             .+..|+||||+++|++.+.+.+.    .+++..+..++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHH
Confidence                       5555555555554             67899999999999776666442    4899999999999999


Q ss_pred             HHHHHh-cCCCCCeEecCCCCCcEEEcCCC--------------------CeEEEeecCccccccCCCCceeeccccccc
Q 041034          564 ALSYLH-HDCTPSIVHRDISSNNILLNSNL--------------------EAFVADFGTARLLHVDSSNRTLRAGTYGYI  622 (701)
Q Consensus       564 ~L~~LH-~~~~~givH~Dlkp~NIll~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~gt~~y~  622 (701)
                      ||+||| ++   +|+||||||+|||++.++                    .+||+|||+|+.....     ...||+.|+
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~  244 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeeccc
Confidence            999999 88   999999999999999887                    8999999999876432     347999999


Q ss_pred             CCCCCCCCcCChhhHHHHHHHHHH-HHHcccCCC
Q 041034          623 APDQRLSPPVNQKIIQDIILVSTT-ALACLRSKP  655 (701)
Q Consensus       623 aPE~~~~~~~~~~~~~Di~slg~i-~~~cl~~~P  655 (701)
                      |||++.+.. +.+  .||||++.+ .+++|.+.+
T Consensus       245 aPE~~~g~~-~~~--~Diwsl~~~~~~~~~~g~~  275 (336)
T 2vuw_A          245 DEDLFTGDG-DYQ--FDIYRLMKKENNNRWGEYH  275 (336)
T ss_dssp             CSGGGCCCS-SHH--HHHHHHHHHHHTTCTTSCC
T ss_pred             ChhhhcCCC-ccc--eehhhhhCCCCcccccccC
Confidence            999998766 444  599998776 666776654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=3.1e-31  Score=282.07  Aligned_cols=203  Identities=21%  Similarity=0.280  Sum_probs=153.1

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK  521 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (701)
                      .......++|++.+.||+|+||.||+|.. .+++.||||++.......    ....+|+..++.++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            34456678999999999999999999966 468999999987654332    3456778888889999999999998653


Q ss_pred             c-------EEEEEEEccCCCCHHHHHhc-CCCccCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEecCCCCCcEEEcC-
Q 041034          522 R-------CMFFIYEYMERGSLFYVLRD-DDEAIELNWTRRVNIVKSVAHALSYLH--HDCTPSIVHRDISSNNILLNS-  590 (701)
Q Consensus       522 ~-------~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~givH~Dlkp~NIll~~-  590 (701)
                      +       ..++||||+++ ++.+.+.. ......+++..+..++.|++.||.|||  ++   ||+||||||+||+++. 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence            3       38899999987 55544432 122236889999999999999999999  77   9999999999999996 


Q ss_pred             CCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          591 NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ++.+||+|||+|+...... ......||+.|+|||++.+.. ++.+.  ||||+|+++++++.+.+.
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~--Di~slG~il~ell~g~~p  231 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAV--DIWSVGCIFAEMMLGEPI  231 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHH--HHHHHHHHHHHHHHSSCS
T ss_pred             CCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHH--HHHHHHHHHHHHHhCCCC
Confidence            8999999999998765433 233457899999999886554 55554  999999999999888744

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=279.20  Aligned_cols=196  Identities=21%  Similarity=0.317  Sum_probs=143.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.++..+++.++||||+++++++.+.+..++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            4578999999999999999999664 7899999999865432 2223444555667888899999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||+ ++.+..+.....  ..+++..+..++.|++.||+|||+ .   |++||||||+||+++.++.+||+|||+++..
T Consensus       102 v~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99999 556666654322  258999999999999999999998 5   8999999999999999999999999999776


Q ss_pred             ccCCCCceeecccccccCCCCCC-----CCcCChhhHHHHHHHHHHHHHcccC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRL-----SPPVNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      .... ......||+.|+|||.+.     ...++.+  .||||+|+++++++.+
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~Di~slG~il~~l~~g  225 (318)
T 2dyl_A          176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIR--ADVWSLGISLVELATG  225 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTH--HHHHHHHHHHHHHHHS
T ss_pred             cCCc-cccccCCCccccChhhcccccccccCCccc--cchhhHHHHHHHHHhC
Confidence            4332 233456999999999985     3344444  4999999999964443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=3.2e-31  Score=272.34  Aligned_cols=237  Identities=25%  Similarity=0.248  Sum_probs=123.1

Q ss_pred             CCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCC-CCCCCccccCCcccccee
Q 041034           61 FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS-LHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L  139 (701)
                      .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+ ++...+..|..+++|++|
T Consensus        31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L  110 (285)
T 1ozn_A           31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (285)
T ss_dssp             CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence            3556666666666665555556666666666666666665555566666666666666664 554445555555555555


Q ss_pred             ecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccccc
Q 041034          140 YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       140 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  219 (701)
                      +|++|++++..|..|.++++|+                        +|+|++|++++..+..++.+++|++|+|++|+++
T Consensus       111 ~l~~n~l~~~~~~~~~~l~~L~------------------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  166 (285)
T 1ozn_A          111 HLDRCGLQELGPGLFRGLAALQ------------------------YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS  166 (285)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCC------------------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCEECHhHhhCCcCCC------------------------EEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence            5555555544444444444444                        4444444444333334444444555555555544


Q ss_pred             CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCccccc
Q 041034          220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIG  299 (701)
Q Consensus       220 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  299 (701)
                      +..+..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|++++|.+....+.. .
T Consensus       167 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~  245 (285)
T 1ozn_A          167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-P  245 (285)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-H
T ss_pred             ccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-H
Confidence            443444555555555555555555544555555555555555555555444444555555555555555554332211 1


Q ss_pred             CccceeeecCCCCcCCCCCCCcc
Q 041034          300 KLFNLVSLDLSKNKLSGSFPTGI  322 (701)
Q Consensus       300 ~l~~L~~L~Ls~N~l~~~~p~~~  322 (701)
                      -+..++.+..+.|.+....|..+
T Consensus       246 ~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          246 LWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             HHHHHHHCCSEECCCBEEESGGG
T ss_pred             HHHHHHhcccccCccccCCchHh
Confidence            11223344444444444444433

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=1.8e-31  Score=285.27  Aligned_cols=195  Identities=22%  Similarity=0.356  Sum_probs=163.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-----------CCceeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-----------HRNIVKLYG  516 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~  516 (701)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....    ...+.+.+|+.++++++           ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            46899999999999999999965 578999999997532    33467888999998886           899999999


Q ss_pred             eeeeCc----EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---
Q 041034          517 FCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---  589 (701)
Q Consensus       517 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---  589 (701)
                      ++...+    ..++||||+ +++|.+++...... .+++..+..++.||+.||+|||+++  ||+||||||+||+++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            998654    789999999 88999999864332 5899999999999999999999853  899999999999994   


Q ss_pred             ---CCCCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          590 ---SNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       590 ---~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                         ..+.+||+|||+|+.....   .....||+.|+|||++.+..++.+.  ||||+|+++|+++++.+.
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~--Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGA--DIWSTACLIFELITGDFL  234 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHH--HHHHHHHHHHHHHHSSCC
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchH--hHHHHHHHHHHHHhCCCC
Confidence               3458999999999876432   2334799999999999888777665  999999999988877643

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.2e-30  Score=273.21  Aligned_cols=234  Identities=23%  Similarity=0.233  Sum_probs=158.7

Q ss_pred             CCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEE
Q 041034           85 LSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLS  164 (701)
Q Consensus        85 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  164 (701)
                      .+++++|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            578899999999998 67777888999999999999988 77888888888888888888888 5677777777777777


Q ss_pred             ceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCC
Q 041034          165 VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHS  244 (701)
Q Consensus       165 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  244 (701)
                      |++|.+.+.+|..+...               ..+..+.++++|++|+|++|+++ .+|..+..+++|++|+|++|++++
T Consensus       157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA  220 (328)
T ss_dssp             EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred             CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence            77776666666554431               11223455666777777777666 556666666666666666666665


Q ss_pred             CCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccC
Q 041034          245 FIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGN  324 (701)
Q Consensus       245 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  324 (701)
                       +|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+++
T Consensus       221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence             4445666666666666666666666666666666666666666665555555555555555555555555555555555


Q ss_pred             CCCCCeeeccCCcc
Q 041034          325 CTELQHLALNHNSL  338 (701)
Q Consensus       325 l~~L~~L~L~~N~l  338 (701)
                      +++|+.+++..|.+
T Consensus       300 L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          300 LPANCIILVPPHLQ  313 (328)
T ss_dssp             SCTTCEEECCGGGS
T ss_pred             ccCceEEeCCHHHH
Confidence            55555555555444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=2e-31  Score=290.38  Aligned_cols=193  Identities=21%  Similarity=0.307  Sum_probs=149.3

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....      .+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            3455678899999999987766679999999986532      35678899999876 8999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCcc----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-------------
Q 041034          529 EYMERGSLFYVLRDDDEAI----ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-------------  591 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-------------  591 (701)
                      ||+. |+|.+++.......    ..++..+..++.||+.||+|||++   ||+||||||+||+++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            9996 59999998653211    113335678999999999999999   99999999999999754             


Q ss_pred             CCeEEEeecCccccccCCCC----ceeecccccccCCCCCCC-------CcCChhhHHHHHHHHHHHHHccc-CC
Q 041034          592 LEAFVADFGTARLLHVDSSN----RTLRAGTYGYIAPDQRLS-------PPVNQKIIQDIILVSTTALACLR-SK  654 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~~~Di~slg~i~~~cl~-~~  654 (701)
                      +.+||+|||+|+........    .....||+.|+|||++.+       ..++.+  .||||+|++++++++ +.
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS--IDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH--HHHHHHHHHHHHHHTTSC
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh--hhhHhHHHHHHHHHhCCC
Confidence            48999999999877543221    234579999999998865       344444  499999999999887 44

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=2.8e-31  Score=272.79  Aligned_cols=224  Identities=25%  Similarity=0.244  Sum_probs=124.2

Q ss_pred             cEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccc
Q 041034           65 QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN  144 (701)
Q Consensus        65 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  144 (701)
                      +.++.++++++ .+|..+  .++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            35566666655 334322  245666666666665555555555555555555555555544444555555555555444


Q ss_pred             c-CCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          145 K-LSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       145 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      . +.                        ...|..+..+++|++|++++|++++..|..+.++++|++|++++|++++..+
T Consensus        91 ~~l~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  146 (285)
T 1ozn_A           91 AQLR------------------------SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD  146 (285)
T ss_dssp             TTCC------------------------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCcc------------------------ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCH
Confidence            3 33                        3333444455555556666666655555566666666666666666665555


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN  303 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  303 (701)
                      ..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..+..+..+++
T Consensus       147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  226 (285)
T 1ozn_A          147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence            55666666666666666666544445555556666666666655555555555555555555555555444444555555


Q ss_pred             eeeecCCCCcCC
Q 041034          304 LVSLDLSKNKLS  315 (701)
Q Consensus       304 L~~L~Ls~N~l~  315 (701)
                      |+.|+|++|.+.
T Consensus       227 L~~L~l~~N~~~  238 (285)
T 1ozn_A          227 LQYLRLNDNPWV  238 (285)
T ss_dssp             CCEEECCSSCEE
T ss_pred             cCEEeccCCCcc
Confidence            555555555444

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=2e-30  Score=266.23  Aligned_cols=187  Identities=13%  Similarity=0.115  Sum_probs=159.6

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||.||+|... +++.||||++......+....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999664 5899999999887666666678899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.++++..     ....++.+++.|++.||+|||++   ||+||||||+||+++.++.+||+++|.      
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT------  175 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc------
Confidence            9999999999999542     34567889999999999999999   999999999999999999999985543      


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------------
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------------  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------------  649 (701)
                                    ++|       ++.+  .||||+|+++|+                                      
T Consensus       176 --------------~~~-------~~~~--~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T 3uqc_A          176 --------------MPD-------ANPQ--DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI  232 (286)
T ss_dssp             --------------CTT-------CCHH--HHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred             --------------cCC-------CCch--hHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence                          222       3333  388888888774                                      


Q ss_pred             ----------cccCCCCCCCCHHHHHHHhhcCCC
Q 041034          650 ----------CLRSKPKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       650 ----------cl~~~P~~Rpt~~~i~~~l~~~~~  673 (701)
                                ||+.||.+| |+.|+++.|++...
T Consensus       233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence                      788888888 88888888876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=5.8e-31  Score=274.96  Aligned_cols=195  Identities=25%  Similarity=0.345  Sum_probs=156.8

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee--------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL--------  519 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------  519 (701)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            578999999999999999999665 58999999987543   344678899999999999999999998873        


Q ss_pred             ------eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCC
Q 041034          520 ------HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNL  592 (701)
Q Consensus       520 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~  592 (701)
                            +....++||||++ |+|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+||+++ +++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                  3467899999998 5999998653    488999999999999999999999   999999999999997 567


Q ss_pred             CeEEEeecCccccccCC---CCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          593 EAFVADFGTARLLHVDS---SNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       593 ~~kL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      .+||+|||+++......   .......+|+.|+|||.+.+ ..++.+.  ||||+|+++++++.+.+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~--Di~slG~il~el~~g~~p  224 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI--DMWAAGCIFAEMLTGKTL  224 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHH--HHHHHHHHHHHHHHSSCS
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchh--hhHhHHHHHHHHHhCCCC
Confidence            99999999998764321   12233457999999998765 4455554  999999999999988743

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=3.1e-30  Score=283.04  Aligned_cols=246  Identities=27%  Similarity=0.266  Sum_probs=114.3

Q ss_pred             cEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccc
Q 041034           65 QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN  144 (701)
Q Consensus        65 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  144 (701)
                      +.++.++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            44555555544 3343332  35555555555555555555555555555555555555555555555555555555555


Q ss_pred             cCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeec-ccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          145 KLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCN-QFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       145 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      ++++..+..|.++++|++|+|++|.++...+..|.++++|+.|+|++| .+....+..|.++++|++|+|++|+++    
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~----  209 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK----  209 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS----
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc----
Confidence            555444444555555555555555544444444444444444444442 222222223444444444444444443    


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN  303 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  303 (701)
                                          +. | .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..|..+++
T Consensus       210 --------------------~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  267 (452)
T 3zyi_A          210 --------------------DM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS  267 (452)
T ss_dssp             --------------------SC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             --------------------cc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence                                31 1 2333444444444444444444444444444444444444444444444444444


Q ss_pred             eeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccC
Q 041034          304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       304 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      |+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus       268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            444444444444333334444444444444444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=4e-30  Score=281.09  Aligned_cols=106  Identities=25%  Similarity=0.273  Sum_probs=50.7

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+++...+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            34455555555555444444555555555555555554444444555555555555555554444444444444444444


Q ss_pred             ccccCCCCCcccccCCCCCcEEEcee
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMY  167 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~  167 (701)
                      ++|+++...+..|.++++|+.|+|++
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~  169 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGE  169 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCC
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCC
Confidence            44444444333444444444444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=3.3e-30  Score=281.77  Aligned_cols=248  Identities=24%  Similarity=0.297  Sum_probs=173.7

Q ss_pred             CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEce
Q 041034           87 NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM  166 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  166 (701)
                      ....++.++++++ .+|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            4568888888888 5666554  688999999999988888888899999999999999888878888888888888888


Q ss_pred             ecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccc-cccCCccccccCCCcccEEEeccCCCCCC
Q 041034          167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITN-KLTGAIPSTLGHLTSLLYLDLSFNQLHSF  245 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  245 (701)
                      +|.++...+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+++. 
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-  199 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-  199 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-
Confidence            88887776667777777777777777777666667777777777777763 3443334456666777777777776665 


Q ss_pred             CCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCC
Q 041034          246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC  325 (701)
Q Consensus       246 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  325 (701)
                      +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            33 35566666666666666666666666666666666666666665555555556666666666666655444455555


Q ss_pred             CCCCeeeccCCccC
Q 041034          326 TELQHLALNHNSLD  339 (701)
Q Consensus       326 ~~L~~L~L~~N~l~  339 (701)
                      ++|+.|+|++|.+.
T Consensus       279 ~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          279 HHLERIHLHHNPWN  292 (440)
T ss_dssp             TTCCEEECCSSCEE
T ss_pred             cCCCEEEcCCCCcc
Confidence            55555555555544

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=3.4e-30  Score=282.72  Aligned_cols=254  Identities=22%  Similarity=0.220  Sum_probs=197.7

Q ss_pred             CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEce
Q 041034           87 NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM  166 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  166 (701)
                      ....++.+++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++       
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~-------  124 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS-------  124 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT-------
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCccc-------
Confidence            3567777777777 4555443  57777777777777766767777777777777777766555555555554       


Q ss_pred             ecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEecc-CCCCCC
Q 041034          167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSF-NQLHSF  245 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~  245 (701)
                                       |++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++ |.+...
T Consensus       125 -----------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i  187 (452)
T 3zyi_A          125 -----------------LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI  187 (452)
T ss_dssp             -----------------CCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             -----------------CCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcccc
Confidence                             55555555555544445566666666666666666655556677777888888887 445444


Q ss_pred             CCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCC
Q 041034          246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC  325 (701)
Q Consensus       246 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  325 (701)
                      .+..|.++++|+.|+|++|+|++. | .+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..|..+
T Consensus       188 ~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  265 (452)
T 3zyi_A          188 SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL  265 (452)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC
Confidence            455788999999999999999965 4 58899999999999999999999999999999999999999999999999999


Q ss_pred             CCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCC
Q 041034          326 TELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT  369 (701)
Q Consensus       326 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~  369 (701)
                      ++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+.....
T Consensus       266 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred             CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence            99999999999999888888999999999999999999887654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=5.2e-31  Score=295.22  Aligned_cols=200  Identities=25%  Similarity=0.343  Sum_probs=169.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------C
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH------K  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  521 (701)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  .....+.+.+|+.++++++||||+++++++..      .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            47899999999999999999965 468999999987643  33446788999999999999999999998765      6


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCC---eEEEe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVAD  598 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~---~kL~D  598 (701)
                      +..++||||+++|+|.+++........+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence            67899999999999999998765544688899999999999999999999   9999999999999997765   89999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ||.++...... ......||+.|+|||.+.+..++.+.  ||||+|+++|+++.+.+.
T Consensus       168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ks--DIwSLGviLyeLltG~~P  222 (676)
T 3qa8_A          168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFRP  222 (676)
T ss_dssp             CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTH--HHHHHHHHHHHHHSSCSS
T ss_pred             ccccccccccc-ccccccCCcccCChHHhccCCCCchh--HHHHHHHHHHHHHHCCCC
Confidence            99998765332 33445799999999999888887775  999999999998887544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=2e-30  Score=278.04  Aligned_cols=213  Identities=22%  Similarity=0.310  Sum_probs=173.3

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CC-----ceeeeee
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HR-----NIVKLYG  516 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~  516 (701)
                      +-....++|++.+.||+|+||.||+|.. .+++.||||+++..    ....+.+.+|+.+++.++ |+     +|+++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3344578999999999999999999965 46889999999753    233567788888888875 44     5999999


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCe
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEA  594 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~--~~~~~  594 (701)
                      ++...+..++||||+++ +|.+++...... .+++..+..++.|++.||.|||.+ ..||+||||||+|||++  .++.+
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            99999999999999965 999999865422 589999999999999999999953 23999999999999995  47889


Q ss_pred             EEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC-CCCHHHHHHHh
Q 041034          595 FVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS-RPTMQRISQEL  668 (701)
Q Consensus       595 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~-Rpt~~~i~~~l  668 (701)
                      ||+|||+|+.....   .....||+.|+|||++.+.+++.+.  ||||+|+++++++.+.|.. ..+..+.+..+
T Consensus       201 kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~--DiwSlG~il~elltg~~pf~~~~~~~~~~~i  270 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAI--DMWSLGCILVEMHTGEPLFSGANEVDQMNKI  270 (382)
T ss_dssp             EECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEeccCceecccc---cccccCCccccChHHHcCCCCCcHH--HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999876432   2345799999999999888887665  9999999999999998544 34444444443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=4e-34  Score=315.06  Aligned_cols=329  Identities=21%  Similarity=0.185  Sum_probs=266.5

Q ss_pred             CCEEEEEeccccccccc---CCcccCCCCCCcEEECCCCcceeeCCccc-CCCC----CCCEEECcCCcCcc----cCCc
Q 041034           37 GSITHIELVECSIKGEL---GSLNFSCFPNLQYLNLWNNNLSGSIPPQI-GSLS----NLKYLNLRWNNLTG----TIPK  104 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~---~~~~~~~~~~L~~L~L~~n~l~~~~~~~~-~~l~----~L~~L~L~~n~l~~----~~p~  104 (701)
                      .+++.|++++|++++..   -...+..+++|++|+|++|.+....+..+ ..++    +|++|+|++|+++.    .+|.
T Consensus        28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~  107 (461)
T 1z7x_W           28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS  107 (461)
T ss_dssp             TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence            46889999999987421   11245678999999999999986544333 3344    79999999999984    5688


Q ss_pred             ccCCCCCCCEEECCCCCCCCCCccccC-----CccccceeecccccCCCCC----cccccCCCCCcEEEceecccCCCcC
Q 041034          105 EIGSLRNLEVLYLSNNSLHGTTPIEIG-----SLRNLEELYLRSNKLSGVL----PQEIGNLKSLIWLSVMYNTVGGPIP  175 (701)
Q Consensus       105 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~  175 (701)
                      .+..+++|++|+|++|.+++..+..+.     ..++|++|+|++|++++..    +..+..+++|++|++++|.++...+
T Consensus       108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  187 (461)
T 1z7x_W          108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV  187 (461)
T ss_dssp             HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred             HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence            999999999999999999765444433     3568999999999998743    6677788999999999999876655


Q ss_pred             ccccc-----ccccceeEeeecccCCC----CCCCCCCccccCccccccccccCCc-----cccccCCCcccEEEeccCC
Q 041034          176 STLFR-----LTNLERLFLGCNQFNGT----IPREIGNLKNLTHLSIITNKLTGAI-----PSTLGHLTSLLYLDLSFNQ  241 (701)
Q Consensus       176 ~~~~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----p~~l~~l~~L~~L~L~~N~  241 (701)
                      ..+..     .++|++|+|++|.+++.    ++..+..+++|++|++++|.+++..     +..+..+++|++|++++|.
T Consensus       188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~  267 (461)
T 1z7x_W          188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG  267 (461)
T ss_dssp             HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence            55543     56999999999999874    4677788899999999999998643     3334468999999999999


Q ss_pred             CCCC----CCcccCCCCcccEEEcCCCCCccccCcccCC-----CCCCcEEEccCccCCCC----CcccccCccceeeec
Q 041034          242 LHSF----IPLEIGNFSALAELDLSDNKIRGIIPDELSK-----LSNLQYLNLSSNLLSGQ----IPFAIGKLFNLVSLD  308 (701)
Q Consensus       242 l~~~----~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~  308 (701)
                      +++.    ++..+..+++|+.|+|++|.+++..+..+..     .++|+.|++++|.+++.    ++..+..+++|+.|+
T Consensus       268 l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~  347 (461)
T 1z7x_W          268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ  347 (461)
T ss_dssp             CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred             CCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEE
Confidence            9875    4666777999999999999998765544443     36999999999999876    456677789999999


Q ss_pred             CCCCcCCCCCCCcccC-----CCCCCeeeccCCccCC----CCCccccccccCCeEEcccccCccc
Q 041034          309 LSKNKLSGSFPTGIGN-----CTELQHLALNHNSLDG----TIPPEIGKILLLQNLDLSHNNLSGT  365 (701)
Q Consensus       309 Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~l~ls~N~l~g~  365 (701)
                      |++|.+++..+..+..     .++|++|+|++|++++    .+|..+..+++|++|++++|++++.
T Consensus       348 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          348 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            9999998765554443     6799999999999986    7888999999999999999999854

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.97  E-value=6.7e-32  Score=281.10  Aligned_cols=248  Identities=23%  Similarity=0.237  Sum_probs=139.6

Q ss_pred             cCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCC-CCCccccC-------CccccceeecccccCCCCCccc
Q 041034           82 IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH-GTTPIEIG-------SLRNLEELYLRSNKLSGVLPQE  153 (701)
Q Consensus        82 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~  153 (701)
                      ++..++|++|++++|.+  .+|..+...  |+.|+|++|+++ ..+|..+.       .+++|++|+|++|++++..|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            34445566666666666  445544432  666666666663 33343333       4566666666666666666655


Q ss_pred             c--cCCCCCcEEEceecccCCCcCcccccc-----cccceeEeeecccCCCCCCCCCCccccCccccccccccCC--ccc
Q 041034          154 I--GNLKSLIWLSVMYNTVGGPIPSTLFRL-----TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA--IPS  224 (701)
Q Consensus       154 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~  224 (701)
                      +  ..+++|++|+|++|.+++. |..+..+     ++|++|+|++|++++..|..++.+++|++|+|++|++.+.  .|.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            4  5666666666666666655 5555555     6666666666666666666666666666666666666543  222


Q ss_pred             cc--cCCCcccEEEeccCCCCCC--CC-cccCCCCcccEEEcCCCCCccccC-cccCCCCCCcEEEccCccCCCCCcccc
Q 041034          225 TL--GHLTSLLYLDLSFNQLHSF--IP-LEIGNFSALAELDLSDNKIRGIIP-DELSKLSNLQYLNLSSNLLSGQIPFAI  298 (701)
Q Consensus       225 ~l--~~l~~L~~L~L~~N~l~~~--~~-~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~  298 (701)
                      .+  ..+++|++|+|++|+|++.  ++ ..+..+++|+.|+|++|+|++..| ..+..+++|+.|+|++|.|+ .+|..+
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~  272 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL  272 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence            33  5566666666666666531  11 222345566666666666665543 33444555666666666555 444444


Q ss_pred             cCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccC
Q 041034          299 GKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       299 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      .  ++|+.|+|++|+|++. |. +..+++|+.|+|++|+++
T Consensus       273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            3  4555555555555543 33 555555555555555554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.97  E-value=6.7e-32  Score=281.09  Aligned_cols=250  Identities=24%  Similarity=0.209  Sum_probs=209.3

Q ss_pred             ccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCC-CCCccccc-------CCCCCcEEEceecccCCCcCc
Q 041034          105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLS-GVLPQEIG-------NLKSLIWLSVMYNTVGGPIPS  176 (701)
Q Consensus       105 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~  176 (701)
                      .++..++|+.|++++|.+  .+|..+...  |+.|+|++|+++ ..+|..+.       ++++|++|+|++|.+++.+|.
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            456678899999999999  667666554  999999999994 55666665       789999999999999998888


Q ss_pred             cc--ccccccceeEeeecccCCCCCCCCCCc-----cccCccccccccccCCccccccCCCcccEEEeccCCCCCC--CC
Q 041034          177 TL--FRLTNLERLFLGCNQFNGTIPREIGNL-----KNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF--IP  247 (701)
Q Consensus       177 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~  247 (701)
                      .+  ..+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+.+++|++|+|++|++.+.  .+
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI  192 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred             HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence            76  8899999999999999977 7778777     8999999999999988889999999999999999998774  23


Q ss_pred             ccc--CCCCcccEEEcCCCCCccc--cC-cccCCCCCCcEEEccCccCCCCCc-ccccCccceeeecCCCCcCCCCCCCc
Q 041034          248 LEI--GNFSALAELDLSDNKIRGI--IP-DELSKLSNLQYLNLSSNLLSGQIP-FAIGKLFNLVSLDLSKNKLSGSFPTG  321 (701)
Q Consensus       248 ~~~--~~~~~L~~L~L~~N~l~~~--~p-~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~  321 (701)
                      ..+  ..+++|+.|+|++|+|++.  ++ ..+..+++|+.|+|++|.+++.+| ..+..+++|+.|+|++|+|+ .+|..
T Consensus       193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~  271 (312)
T 1wwl_A          193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG  271 (312)
T ss_dssp             HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred             HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence            333  7889999999999999842  22 344678899999999999998775 45666889999999999998 78887


Q ss_pred             ccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcc
Q 041034          322 IGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSG  364 (701)
Q Consensus       322 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g  364 (701)
                      +.  ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus       272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            76  8899999999999866 65 8889999999999999875

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=5.3e-32  Score=282.53  Aligned_cols=266  Identities=23%  Similarity=0.248  Sum_probs=181.6

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  143 (701)
                      ++.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+  +..+++|++|+|++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            4455666666665555555666677777777777776666677777777777777777765443  66666666666666


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      |++++..                             ..++|++|++++|++++..+..   +++|++|++++|++++..|
T Consensus        90 n~l~~l~-----------------------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~  137 (317)
T 3o53_A           90 NYVQELL-----------------------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRD  137 (317)
T ss_dssp             SEEEEEE-----------------------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGG
T ss_pred             Ccccccc-----------------------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccc
Confidence            6665321                             1245555555555555443332   3456667777777776666


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccC-CCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCcc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIG-NFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLF  302 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  302 (701)
                      ..+..+++|++|+|++|.+++..+..+. .+++|+.|+|++|.|++..  ....+++|+.|+|++|.+++. |..+..++
T Consensus       138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~  214 (317)
T 3o53_A          138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAA  214 (317)
T ss_dssp             BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred             hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcc-hhhhcccC
Confidence            6677777777777777777776555553 5677778888888777552  233477888888888888754 44577788


Q ss_pred             ceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccC-CCCCccccccccCCeEEcccc-cCcccCC
Q 041034          303 NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD-GTIPPEIGKILLLQNLDLSHN-NLSGTIP  367 (701)
Q Consensus       303 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~ls~N-~l~g~~p  367 (701)
                      +|+.|+|++|+++ .+|..+..+++|+.|+|++|++. +.+|..+..+++|+.|++++| .++|..|
T Consensus       215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            8888888888887 56777888888888888888888 677788888888888888844 4555444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=1.4e-29  Score=261.93  Aligned_cols=165  Identities=23%  Similarity=0.389  Sum_probs=138.8

Q ss_pred             hcCCccc-eEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHH-hcCCCCceeeeeeeeee----C
Q 041034          449 TEDFHIR-YCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVL-STVRHRNIVKLYGFCLH----K  521 (701)
Q Consensus       449 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~  521 (701)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|++...        ..+.+|+.++ +..+||||+++++++..    .
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            4667777 7899999999999965 57899999999642        4567788887 66689999999999887    6


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVAD  598 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~D  598 (701)
                      ...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence            789999999999999999987542 2589999999999999999999999   9999999999999998   78999999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ||+|.....                      ..++.+  .||||+|+++++
T Consensus       164 fg~a~~~~~----------------------~~~~~~--~DiwslG~il~e  190 (299)
T 3m2w_A          164 FGFAKETTG----------------------EKYDKS--CDMWSLGVIMYI  190 (299)
T ss_dssp             CTTCEECTT----------------------CGGGGH--HHHHHHHHHHHH
T ss_pred             ccccccccc----------------------ccCCch--hhHHHHHHHHHH
Confidence            999975421                      123333  488888888885

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=5e-32  Score=282.71  Aligned_cols=267  Identities=22%  Similarity=0.182  Sum_probs=187.5

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEEC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL  117 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  117 (701)
                      ++...+++.+.+...+. ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|  |..+++|++|+|
T Consensus        11 ~l~i~~ls~~~l~~~~~-~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALA-SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             EEEEESCCTTTHHHHHH-HHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             ceeEeeccccchhhhHH-HHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            34445556665543222 235667899999999999998888899999999999999999997765  999999999999


Q ss_pred             CCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCC
Q 041034          118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT  197 (701)
Q Consensus       118 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  197 (701)
                      ++|++++..     ..++|++|++++|++++..+..   +++|++|++++|.+++..+..+..+++|++|+|++|++++.
T Consensus        88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  159 (317)
T 3o53_A           88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV  159 (317)
T ss_dssp             CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred             cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence            999998543     3489999999999998765543   46677888888888777777777777777777777777766


Q ss_pred             CCCCC-CCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCC
Q 041034          198 IPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSK  276 (701)
Q Consensus       198 ~~~~~-~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~  276 (701)
                      .+..+ ..+++|++|+|++|.+++. |. ...+++|++|+|++|++++. |..+..+++|+.|+|++|+|+ .+|..+..
T Consensus       160 ~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~  235 (317)
T 3o53_A          160 NFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRF  235 (317)
T ss_dssp             EGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred             cHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhc
Confidence            55555 3566677777777776644 22 22366666666666666653 334666666666666666666 34555666


Q ss_pred             CCCCcEEEccCccCC-CCCcccccCccceeeecCCC-CcCCCCCC
Q 041034          277 LSNLQYLNLSSNLLS-GQIPFAIGKLFNLVSLDLSK-NKLSGSFP  319 (701)
Q Consensus       277 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p  319 (701)
                      +++|+.|++++|.++ +.+|..+..+++|+.|++++ +.++|..|
T Consensus       236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             CCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            666666666666666 45555556666666666652 33444333

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=3e-29  Score=282.59  Aligned_cols=264  Identities=28%  Similarity=0.310  Sum_probs=186.7

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  143 (701)
                      ++.|++++|+++ .+|..+.  ++|++|+|++|.|+. +|.   .+++|++|+|++|++++ +|.   .+++|++|+|++
T Consensus        42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  110 (622)
T 3g06_A           42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFS  110 (622)
T ss_dssp             CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECS
T ss_pred             CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcC
Confidence            556777777776 5555554  677777777777763 443   45677777777777764 332   567777777777


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      |++++..+    .+++|+.|++++|.+++ +|..   +++|++|+|++|++++ +|.   .+++|+.|++++|.|++ +|
T Consensus       111 N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~  177 (622)
T 3g06_A          111 NPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP  177 (622)
T ss_dssp             CCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred             CcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc
Confidence            77775433    45677777777777765 3332   3678888888888774 343   23567788888888875 44


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN  303 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  303 (701)
                         ..+++|+.|+|++|+|++ +|..   +++|+.|++++|.|+. +|..   +++|+.|+|++|.|++ +|   ..+++
T Consensus       178 ---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~  242 (622)
T 3g06_A          178 ---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSE  242 (622)
T ss_dssp             ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred             ---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCc
Confidence               446778888888888887 4432   4678888888888874 4432   4778888888888885 45   34578


Q ss_pred             eeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCcc
Q 041034          304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLH  371 (701)
Q Consensus       304 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~  371 (701)
                      |+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++|.+|..+.
T Consensus       243 L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~  305 (622)
T 3g06_A          243 LKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR  305 (622)
T ss_dssp             CCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred             CcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence            888888888888 4665   5678888888888888 7788888888888888888888887776543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.7e-30  Score=281.21  Aligned_cols=192  Identities=17%  Similarity=0.172  Sum_probs=144.4

Q ss_pred             hhcCCccceEEeeccceEEEEEE-cCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC-Cceeeee----------
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLY----------  515 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~----------  515 (701)
                      ....|...+.||+|+||.||+|. ..+|+.||||++...........+.+.+|+.+++.++| ++...+.          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34567888999999999999996 45799999999985544443445778999999999987 3221111          


Q ss_pred             -----------eeeee-----CcEEEEEEEccCCCCHHHHHhcC----CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 041034          516 -----------GFCLH-----KRCMFFIYEYMERGSLFYVLRDD----DEAIELNWTRRVNIVKSVAHALSYLHHDCTPS  575 (701)
Q Consensus       516 -----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~g  575 (701)
                                 .++..     ....+++|+++ +++|.++++..    .....+++..+..++.||+.||+|||++   +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                       11111     12357778876 56999988521    1223578889999999999999999999   9


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCceeecccccccCCCCC----------CCCcCChhhHHHHHHHHH
Q 041034          576 IVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR----------LSPPVNQKIIQDIILVST  645 (701)
Q Consensus       576 ivH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~~Di~slg~  645 (701)
                      |+||||||+|||++.++.+||+|||+|+.....   .....| +.|+|||++          ....++.+.  ||||+|+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~--DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF--DTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH--HHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchh--hHHHHHH
Confidence            999999999999999999999999999875433   334567 999999998          444455554  9999999


Q ss_pred             HHHH
Q 041034          646 TALA  649 (701)
Q Consensus       646 i~~~  649 (701)
                      ++|+
T Consensus       306 il~e  309 (413)
T 3dzo_A          306 AIYW  309 (413)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9995

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.2e-29  Score=283.73  Aligned_cols=283  Identities=25%  Similarity=0.301  Sum_probs=235.0

Q ss_pred             CCCCCCcceeE--------eCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEEC
Q 041034           22 TSDHCNWVGIT--------CDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNL   93 (701)
Q Consensus        22 ~~d~c~w~gv~--------c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   93 (701)
                      +.++|.|.|..        |. ...++.|++++++++ .++...   .++|+.|+|++|.|+ .+|.   .+++|++|+|
T Consensus        18 ~~~~~~~~~r~~~~~~~~~c~-~~~l~~L~ls~n~L~-~lp~~l---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L   88 (622)
T 3g06_A           18 AAPAEESRGRAAVVQKMRACL-NNGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNNLT-SLPA---LPPELRTLEV   88 (622)
T ss_dssp             TCCGGGHHHHHHHHHHHHHHH-HHCCCEEECCSSCCS-CCCSCC---CTTCSEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred             cCCcchhccccccCccccccc-CCCCcEEEecCCCcC-ccChhh---CCCCcEEEecCCCCC-CCCC---cCCCCCEEEc
Confidence            45789997632        32 235889999999998 455422   289999999999998 4565   5789999999


Q ss_pred             cCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCC
Q 041034           94 RWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP  173 (701)
Q Consensus        94 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  173 (701)
                      ++|+|++ +|.   .+++|++|+|++|++++..+    .+++|+.|+|++|+++++ |..   +++|++|+|++|.+++.
T Consensus        89 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~l  156 (622)
T 3g06_A           89 SGNQLTS-LPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLASL  156 (622)
T ss_dssp             CSCCCSC-CCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSCC
T ss_pred             CCCcCCc-CCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCCc
Confidence            9999995 554   77999999999999996544    678999999999999974 443   48999999999999864


Q ss_pred             cCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCC
Q 041034          174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF  253 (701)
Q Consensus       174 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~  253 (701)
                       |.   .+++|+.|++++|++++ +|   ..+++|+.|++++|+|++ +|..   +++|+.|++++|.++. +|.   .+
T Consensus       157 -~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~---~~  220 (622)
T 3g06_A          157 -PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPA---LP  220 (622)
T ss_dssp             -CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCC---CC
T ss_pred             -CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCC---CC
Confidence             33   34789999999999996 55   456889999999999996 4543   4789999999999997 453   35


Q ss_pred             CcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeec
Q 041034          254 SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL  333 (701)
Q Consensus       254 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  333 (701)
                      ++|+.|+|++|+|++ +|   ..+++|+.|+|++|.|+ .+|.   .+++|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            899999999999996 55   45689999999999999 4555   5789999999999999 78999999999999999


Q ss_pred             cCCccCCCCCccccccc
Q 041034          334 NHNSLDGTIPPEIGKIL  350 (701)
Q Consensus       334 ~~N~l~~~~p~~~~~l~  350 (701)
                      ++|++++.+|..+..++
T Consensus       292 ~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          292 EGNPLSERTLQALREIT  308 (622)
T ss_dssp             CSCCCCHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHhcc
Confidence            99999999888887765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.8e-30  Score=289.18  Aligned_cols=206  Identities=14%  Similarity=0.085  Sum_probs=147.3

Q ss_pred             EeeccceEEEEE-EcCCCcEEEEEEecCCCcc-------ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEEEEEE
Q 041034          458 IGTGGYGSVYKA-ELPDGKVVALKKLHQSETE-------DSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       458 lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .+.|+.|.+..+ +.--|+.||+|++......       .....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456666666655 3335889999999765321       123356799999999999 6999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++|++|.+++.+..   +++..   +|+.||+.||+|+|++   |||||||||+|||++++|.+||+|||+|+....+
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999998765   45554   4899999999999999   9999999999999999999999999999987665


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcc----------cCCCCCCCCHHHHHHHhhcCCCcc
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACL----------RSKPKSRPTMQRISQELEGKTPMK  675 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl----------~~~P~~Rpt~~~i~~~l~~~~~~~  675 (701)
                      .......+||+.|+|||++.+.. ...  .|+|++|++.+.|+          ...|..++++..+...+....+.+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~~-~~~--~d~~s~g~~~~~l~~~~~~~~~~l~~~~~~~~~~~~l~~~l~~~~~~~  466 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAENK-SWN--GFWRSAPVHPFNLPQPWSNWLYAVWQEPVERWNFVLLLALFEKKAKLP  466 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC--------------------CCCCTTHHHHHHHHHTSCGGGCSHHHHHHHHHTGGGSC
T ss_pred             CccccCceechhhccHHHhCCCC-CCc--ccccccccchhhhccccchhHHHhhcCCCCCCcHHHHHHHHhCCCCCC
Confidence            55566678999999999997653 333  39999999877654          346777888888888776655443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=2.1e-30  Score=286.12  Aligned_cols=219  Identities=23%  Similarity=0.175  Sum_probs=146.1

Q ss_pred             CCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccce
Q 041034           59 SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEE  138 (701)
Q Consensus        59 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  138 (701)
                      ..+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+++..|  |..+++|++|+|++|.+++..+     .++|++
T Consensus        31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~  103 (487)
T 3oja_A           31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET  103 (487)
T ss_dssp             TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred             ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence            345689999999999999888999999999999999999998776  9999999999999999986443     389999


Q ss_pred             eecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCC-CccccCcccccccc
Q 041034          139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG-NLKNLTHLSIITNK  217 (701)
Q Consensus       139 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~  217 (701)
                      |+|++|.+++..+..   +++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++.+|..+. .+++|++|+|++|.
T Consensus       104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            999999999876543   45666777777776666666666666666666666666655555443 45555555555555


Q ss_pred             ccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCC
Q 041034          218 LTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       218 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      |++..+  +..+++|++|+|++|.|++. |..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+.
T Consensus       181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~  250 (487)
T 3oja_A          181 IYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH  250 (487)
T ss_dssp             CCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred             cccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence            554311  22344555555555555442 2224444444444444444443 3334444444444444444444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.96  E-value=2.7e-28  Score=248.32  Aligned_cols=218  Identities=26%  Similarity=0.326  Sum_probs=128.2

Q ss_pred             CCCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccC
Q 041034           23 SDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTI  102 (701)
Q Consensus        23 ~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  102 (701)
                      .|+|.|.|+.|.-.+.++.+++++++++.                          +|..+.  ++|++|+|++|++++..
T Consensus         2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~--------------------------ip~~~~--~~l~~L~l~~n~l~~~~   53 (270)
T 2o6q_A            2 EALCKKDGGVCSCNNNKNSVDCSSKKLTA--------------------------IPSNIP--ADTKKLDLQSNKLSSLP   53 (270)
T ss_dssp             CCCBGGGTCSBEEETTTTEEECTTSCCSS--------------------------CCSCCC--TTCSEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeCCCCCEEEccCCCCCc--------------------------cCCCCC--CCCCEEECcCCCCCeeC
Confidence            47999999988644444455555555442                          333222  34455555555554444


Q ss_pred             CcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCccccccc
Q 041034          103 PKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT  182 (701)
Q Consensus       103 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  182 (701)
                      +..|.++++|++|+|++|+++...+..|..+++|++|+|++|++++..+..|.++++|++|++++|.+++..+..|..++
T Consensus        54 ~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  133 (270)
T 2o6q_A           54 SKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT  133 (270)
T ss_dssp             TTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             HHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCc
Confidence            44455555555555555555444444444555555555555555544444555555555555555555555555555666


Q ss_pred             ccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcC
Q 041034          183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS  262 (701)
Q Consensus       183 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~  262 (701)
                      +|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus       134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  213 (270)
T 2o6q_A          134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ  213 (270)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEec
Confidence            66666666666665555556666666777777776666656666677777777777777776555566777777777777


Q ss_pred             CCCCcc
Q 041034          263 DNKIRG  268 (701)
Q Consensus       263 ~N~l~~  268 (701)
                      +|.+..
T Consensus       214 ~N~~~c  219 (270)
T 2o6q_A          214 ENPWDC  219 (270)
T ss_dssp             SSCBCC
T ss_pred             CCCeeC
Confidence            777653

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=3.1e-27  Score=241.37  Aligned_cols=206  Identities=26%  Similarity=0.287  Sum_probs=116.4

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            45677777777777666666677777777777777776666666667777777777777776666666666666666666


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCC-cCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP-IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG  220 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  220 (701)
                      ++|++++..+..+..+++|++|++++|.+++. +|..+..+++|+                        +|++++|++++
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~------------------------~L~Ls~N~l~~  163 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE------------------------HLDLSSNKIQS  163 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCC------------------------EEECCSSCCCE
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCC------------------------EEECCCCCCCc
Confidence            66666655554555555555555555554432 233444444444                        44444444443


Q ss_pred             CccccccCCCccc----EEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCC
Q 041034          221 AIPSTLGHLTSLL----YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG  292 (701)
Q Consensus       221 ~~p~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  292 (701)
                      ..+..+..+++|+    .|++++|.+++..+..+. ..+|+.|+|++|+|++..+..|..+++|+.|+|++|.+++
T Consensus       164 ~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             ECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             CCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            3333333333333    555555555553333332 2355555555555555444445555555555555555554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=4.4e-27  Score=240.22  Aligned_cols=227  Identities=26%  Similarity=0.265  Sum_probs=117.7

Q ss_pred             EECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccC
Q 041034           67 LNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL  146 (701)
Q Consensus        67 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  146 (701)
                      ++..+.++. .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l   88 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (276)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence            444555554 3444332  3566666666666655555666666666666666666555555555555555555555555


Q ss_pred             CCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCC-cccc
Q 041034          147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA-IPST  225 (701)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~  225 (701)
                      ++..+.                        .|.++++|++|++++|++++..+..++.+++|++|++++|.+++. +|..
T Consensus        89 ~~~~~~------------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~  144 (276)
T 2z62_A           89 QSLALG------------------------AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY  144 (276)
T ss_dssp             CEECTT------------------------TTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred             CccChh------------------------hhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchh
Confidence            443333                        344444444444555554444444455555555555555555542 3555


Q ss_pred             ccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCc-EEEccCccCCCCCcccccCccce
Q 041034          226 LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ-YLNLSSNLLSGQIPFAIGKLFNL  304 (701)
Q Consensus       226 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L  304 (701)
                      +..+++|++|+|++|++++..+..+..+++|+                     .|. .|++++|.+++..+..+. ..+|
T Consensus       145 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~---------------------~l~l~L~ls~n~l~~~~~~~~~-~~~L  202 (276)
T 2z62_A          145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP---------------------LLNLSLDLSLNPMNFIQPGAFK-EIRL  202 (276)
T ss_dssp             GGGCTTCCEEECCSSCCCEECGGGGHHHHTCT---------------------TCCEEEECCSSCCCEECTTSSC-SCCE
T ss_pred             hccCCCCCEEECCCCCCCcCCHHHhhhhhhcc---------------------ccceeeecCCCcccccCccccC-CCcc
Confidence            66666666666666666655444444444444                     000 444444444433332222 2245


Q ss_pred             eeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCC
Q 041034          305 VSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTI  342 (701)
Q Consensus       305 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  342 (701)
                      +.|+|++|++++..+..+..+++|+.|+|++|++++..
T Consensus       203 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             EEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             cEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence            55555555555444444455555666666666655443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=2.2e-27  Score=241.81  Aligned_cols=138  Identities=28%  Similarity=0.380  Sum_probs=62.2

Q ss_pred             ccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEE
Q 041034          205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLN  284 (701)
Q Consensus       205 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  284 (701)
                      +++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|+
T Consensus       108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  187 (272)
T 3rfs_A          108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR  187 (272)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence            33333333333333333333333444444444444444443333344444444444444444444444444444444444


Q ss_pred             ccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCcccccc
Q 041034          285 LSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKI  349 (701)
Q Consensus       285 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  349 (701)
                      +++|.+++..+..+..+++|+.|+|++|.+.+.       +++|+.|++..|+++|.+|.+++.+
T Consensus       188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             CCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            444444444444444444555555555544432       2345555555555555555555544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1e-25  Score=229.23  Aligned_cols=202  Identities=29%  Similarity=0.312  Sum_probs=138.0

Q ss_pred             CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEce
Q 041034           87 NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM  166 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  166 (701)
                      +++++++++++++ .+|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|+++...+..|.++++|++|+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            4678888888888 4565553  678888888888887777788888888888888888887766667777777777777


Q ss_pred             ecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCC
Q 041034          167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFI  246 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  246 (701)
                      +|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            77777666666666677777777777666666666666666666666666666555555566666666666666666555


Q ss_pred             CcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCC
Q 041034          247 PLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       247 ~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      +..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            555555666666666666665554445555555666666655554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=1.6e-26  Score=235.43  Aligned_cols=187  Identities=32%  Similarity=0.326  Sum_probs=97.8

Q ss_pred             CCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCc
Q 041034          202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ  281 (701)
Q Consensus       202 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~  281 (701)
                      +..+++|++|++++|.+++.  ..+..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+
T Consensus        59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  136 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT  136 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence            34444444444444444431  2344455555555555555554444445555555555555555544444455555555


Q ss_pred             EEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEccccc
Q 041034          282 YLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN  361 (701)
Q Consensus       282 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~  361 (701)
                      .|++++|.+++..+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|++++..|..++.+++|+.|++++|+
T Consensus       137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (272)
T 3rfs_A          137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  216 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence            55555555554444444555555555555555554444445555555555555555555555555555555555555555


Q ss_pred             CcccCCCCccccccccccCCCCCcCCCcCCCC
Q 041034          362 LSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDN  393 (701)
Q Consensus       362 l~g~~p~~~~~~~l~ls~N~l~g~~p~~~~~~  393 (701)
                      ++|.+|.   ..+++++.|+++|.+|.++...
T Consensus       217 ~~~~~~~---l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          217 WDCTCPG---IRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             BCCCTTT---THHHHHHHHHTGGGBBCTTSCB
T ss_pred             ccccCcH---HHHHHHHHHhCCCcccCccccc
Confidence            5555542   2345555666666666554433

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.94  E-value=6.9e-29  Score=264.00  Aligned_cols=130  Identities=21%  Similarity=0.173  Sum_probs=86.9

Q ss_pred             EEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCC----cccCCCC-CCCEEECCCCCCCCCCccccCCc-----cc
Q 041034           66 YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIP----KEIGSLR-NLEVLYLSNNSLHGTTPIEIGSL-----RN  135 (701)
Q Consensus        66 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~  135 (701)
                      +++|+.|++++.+|..+...++|++|+|++|.+++..+    +.|..++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            45677888887777777766778888888888876665    6677777 78888888888877766666664     77


Q ss_pred             cceeecccccCCCCCcccccC----C-CCCcEEEceecccCCCcCccccc-----ccccceeEeeecccC
Q 041034          136 LEELYLRSNKLSGVLPQEIGN----L-KSLIWLSVMYNTVGGPIPSTLFR-----LTNLERLFLGCNQFN  195 (701)
Q Consensus       136 L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~  195 (701)
                      |++|+|++|++++..+..+..    + ++|++|+|++|.+++..+..+..     .++|++|+|++|+++
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  151 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG  151 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence            777777777777665554333    2 56666666666665554444332     135555555555555

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=3e-25  Score=227.87  Aligned_cols=202  Identities=23%  Similarity=0.211  Sum_probs=98.6

Q ss_pred             CCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccce
Q 041034           59 SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEE  138 (701)
Q Consensus        59 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  138 (701)
                      +.+++++.+++++|+++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..+.  +.+++|++
T Consensus         7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~   81 (290)
T 1p9a_G            7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT   81 (290)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred             cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence            34445555555555554 2333332  3455555555555544444555555555555555554432221  33344444


Q ss_pred             eecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccc
Q 041034          139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKL  218 (701)
Q Consensus       139 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  218 (701)
                      |+|++|+++                         .+|..+..+++|++|+|++|++++..+..|.++++|++|+|++|+|
T Consensus        82 L~Ls~N~l~-------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l  136 (290)
T 1p9a_G           82 LDLSHNQLQ-------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL  136 (290)
T ss_dssp             EECCSSCCS-------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCcCC-------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCC
Confidence            444444333                         2233344444555555555555544444455555555555555555


Q ss_pred             cCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCC
Q 041034          219 TGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       219 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      ++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            5444444555555555555555555544444455555555555555555 34444444555555555555554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=9.4e-28  Score=255.23  Aligned_cols=223  Identities=22%  Similarity=0.159  Sum_probs=129.0

Q ss_pred             EEecccccccccCCcccCCCCCCcEEECCCCcceeeCC----cccCCCC-CCCEEECcCCcCcccCCcccCCC-----CC
Q 041034           42 IELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIP----PQIGSLS-NLKYLNLRWNNLTGTIPKEIGSL-----RN  111 (701)
Q Consensus        42 l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~  111 (701)
                      .+++.++++|.++. .+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|.+++..+..|..+     ++
T Consensus         3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            35566666665543 23444557777777777776555    5666677 77777777777776666666554     77


Q ss_pred             CCEEECCCCCCCCCCccccCCc-----cccceeecccccCCCCCccccc----C-CCCCcEEEceecccCCCcCcc----
Q 041034          112 LEVLYLSNNSLHGTTPIEIGSL-----RNLEELYLRSNKLSGVLPQEIG----N-LKSLIWLSVMYNTVGGPIPST----  177 (701)
Q Consensus       112 L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~~----  177 (701)
                      |++|+|++|++++..+..+...     ++|++|+|++|++++..+..+.    . .++|++|+|++|.+++..+..    
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            7777777777776666544333     6777777777777766554433    3 257777777777776543332    


Q ss_pred             ccccc-ccceeEeeecccCCCCCCCCCC----c-cccCccccccccccCC----ccccccC-CCcccEEEeccCCCCCCC
Q 041034          178 LFRLT-NLERLFLGCNQFNGTIPREIGN----L-KNLTHLSIITNKLTGA----IPSTLGH-LTSLLYLDLSFNQLHSFI  246 (701)
Q Consensus       178 ~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~----~p~~l~~-l~~L~~L~L~~N~l~~~~  246 (701)
                      +..++ +|++|+|++|++++..+..+..    + ++|++|+|++|.|++.    ++..+.. .++|++|+|++|.+++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            23333 6666666666666544433322    2 3555566666655542    2333333 235555555555555432


Q ss_pred             C----cccCCCCcccEEEcCCCC
Q 041034          247 P----LEIGNFSALAELDLSDNK  265 (701)
Q Consensus       247 ~----~~~~~~~~L~~L~L~~N~  265 (701)
                      +    ..+..+++|+.|+|++|.
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~  264 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDI  264 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHH
T ss_pred             HHHHHHHHhcCCCccEEEeccCC
Confidence            2    122344445555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.93  E-value=1.8e-25  Score=224.89  Aligned_cols=190  Identities=25%  Similarity=0.251  Sum_probs=99.7

Q ss_pred             CCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCC
Q 041034           24 DHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIP  103 (701)
Q Consensus        24 d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p  103 (701)
                      +||.|.|++|...  .                         +.++++++.++ .+|..+.  ++|++|+|++|++++..+
T Consensus         3 ~Cp~~~gC~C~~~--~-------------------------~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~   52 (251)
T 3m19_A            3 TCETVTGCTCNEG--K-------------------------KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSD   52 (251)
T ss_dssp             -CHHHHSSEEEGG--G-------------------------TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCC--C-------------------------eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCH
Confidence            5889999999521  1                         23444455544 3343333  456666666666665555


Q ss_pred             cccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccc
Q 041034          104 KEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTN  183 (701)
Q Consensus       104 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  183 (701)
                      ..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++
T Consensus        53 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  132 (251)
T 3m19_A           53 ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK  132 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCc
Confidence            56666666666666666666555555666666666666666665555555555555555555555444444444444444


Q ss_pred             cceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCC
Q 041034          184 LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH  243 (701)
Q Consensus       184 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  243 (701)
                      |++|+|++|++++..+..|+.+++|++|+|++|++++..+..+..+++|++|+|++|++.
T Consensus       133 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          133 LKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             ccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            444554444444443334444444444444444444433334444444444444444443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=3.6e-25  Score=227.28  Aligned_cols=202  Identities=24%  Similarity=0.185  Sum_probs=145.5

Q ss_pred             eCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCC
Q 041034           33 CDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNL  112 (701)
Q Consensus        33 c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  112 (701)
                      |....+++.+++.+++++. ++.   .-.++++.|+|++|.+++..+..|..+++|++|+|++|.+++..+.  ..+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~---~~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCS---CCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             ccccCCccEEECCCCCCCc-CCC---CCCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            4445578888888888874 333   2237899999999999999899999999999999999999976543  789999


Q ss_pred             CEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeec
Q 041034          113 EVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCN  192 (701)
Q Consensus       113 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  192 (701)
                      ++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            99999999998 66778889999999999999998877777777777777777777776665555556666666666666


Q ss_pred             ccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCC
Q 041034          193 QFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQL  242 (701)
Q Consensus       193 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  242 (701)
                      ++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus       159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence            655444444445555555555555554 3344444444444444444444

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.92  E-value=1.8e-28  Score=278.72  Aligned_cols=322  Identities=13%  Similarity=0.029  Sum_probs=171.0

Q ss_pred             CCCCcEEECCCCcceee----CCcccCCCCCCCEEECcCCcCc----ccCCcccCCCCCCCEEECCCCCCCCCCccccCC
Q 041034           61 FPNLQYLNLWNNNLSGS----IPPQIGSLSNLKYLNLRWNNLT----GTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS  132 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  132 (701)
                      +++|++|+|++|.+++.    ++..+..+++|++|+|++|.++    +.++..+.++++|++|+|++|.+.+ ++..+..
T Consensus       163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~  241 (592)
T 3ogk_B          163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA  241 (592)
T ss_dssp             CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred             CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence            34444444444444332    2222333444444444444443    1222233344445555554444443 3333444


Q ss_pred             ccccceeecccccCC---CCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCC-CCCCCcccc
Q 041034          133 LRNLEELYLRSNKLS---GVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIP-REIGNLKNL  208 (701)
Q Consensus       133 l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L  208 (701)
                      +++|++|+++.+...   +..+..+..+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|
T Consensus       242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L  320 (592)
T 3ogk_B          242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL  320 (592)
T ss_dssp             CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred             hhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence            444444444432111   1222334444455555544432 24456667778888888888888664333 335677788


Q ss_pred             Ccccccccccc-CCccccccCCCcccEEEec-----------cCCCCCCCCc-ccCCCCcccEEEcCCCCCccccCcccC
Q 041034          209 THLSIITNKLT-GAIPSTLGHLTSLLYLDLS-----------FNQLHSFIPL-EIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       209 ~~L~l~~N~l~-~~~p~~l~~l~~L~~L~L~-----------~N~l~~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                      ++|+++ |.+. +.++..+..+++|++|+|+           .|.+++.... ....+++|+.|+++.|.+++..+..+.
T Consensus       321 ~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~  399 (592)
T 3ogk_B          321 EVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG  399 (592)
T ss_dssp             CEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHH
T ss_pred             CEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHH
Confidence            888887 3333 2333344566777778777           3555542222 223467777777777777766555555


Q ss_pred             C-CCCCcEEEcc----CccCCCC-----CcccccCccceeeecCCCCc--CCCCCCCccc-CCCCCCeeeccCCccCC-C
Q 041034          276 K-LSNLQYLNLS----SNLLSGQ-----IPFAIGKLFNLVSLDLSKNK--LSGSFPTGIG-NCTELQHLALNHNSLDG-T  341 (701)
Q Consensus       276 ~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~L~~N~l~~-~  341 (701)
                      . +++|+.|+++    .|.+++.     ++..+.++++|+.|+++.|.  +++..+..+. .+++|+.|+|++|++++ .
T Consensus       400 ~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~  479 (592)
T 3ogk_B          400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG  479 (592)
T ss_dssp             HHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHH
T ss_pred             hhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHH
Confidence            4 6777777775    5666653     23334556677777776432  5444333333 25667777777777664 2


Q ss_pred             CCccccccccCCeEEcccccCccc-CCCC----ccccccccccCCCCCc
Q 041034          342 IPPEIGKILLLQNLDLSHNNLSGT-IPMT----LHPMFLDMSFNNLEGE  385 (701)
Q Consensus       342 ~p~~~~~l~~L~~l~ls~N~l~g~-~p~~----~~~~~l~ls~N~l~g~  385 (701)
                      ++..+..+++|+.|+|++|++++. ++..    -...+|++++|++++.
T Consensus       480 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          480 LMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            344445666777777777776543 2211    1123567777776654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=232.89  Aligned_cols=224  Identities=21%  Similarity=0.151  Sum_probs=169.5

Q ss_pred             CCCEEECcCCcCcccCC-c--ccCCCCCCCEEECCCCCCCCCCcccc--CCccccceeecccccCCCCCc----ccccCC
Q 041034           87 NLKYLNLRWNNLTGTIP-K--EIGSLRNLEVLYLSNNSLHGTTPIEI--GSLRNLEELYLRSNKLSGVLP----QEIGNL  157 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p-~--~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l  157 (701)
                      .++.|.+.++.++...- .  .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            46777777766652210 0  12234668888888888887777777  778888888888888876544    345577


Q ss_pred             CCCcEEEceecccCCCcCcccccccccceeEeeecccCCC--C--CCCCCCccccCccccccccccCCccc----cccCC
Q 041034          158 KSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT--I--PREIGNLKNLTHLSIITNKLTGAIPS----TLGHL  229 (701)
Q Consensus       158 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l  229 (701)
                      ++|++|+|++|.+++..+..+..+++|++|+|++|++.+.  +  +..++.+++|++|+|++|+++. ++.    .+..+
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l  223 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG  223 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence            8888888888888888788888888888888888887642  1  2334778889999999999873 232    25678


Q ss_pred             CcccEEEeccCCCCCCCCcccCCC---CcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceee
Q 041034          230 TSLLYLDLSFNQLHSFIPLEIGNF---SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVS  306 (701)
Q Consensus       230 ~~L~~L~L~~N~l~~~~~~~~~~~---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  306 (701)
                      ++|++|+|++|++++..|..+..+   ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|++++. |. +..+++|+.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~  298 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN  298 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence            899999999999998878777766   69999999999999 5677664  7899999999999864 33 577889999


Q ss_pred             ecCCCCcCCC
Q 041034          307 LDLSKNKLSG  316 (701)
Q Consensus       307 L~Ls~N~l~~  316 (701)
                      |+|++|+++.
T Consensus       299 L~L~~N~l~~  308 (310)
T 4glp_A          299 LTLDGNPFLV  308 (310)
T ss_dssp             EECSSTTTSC
T ss_pred             EECcCCCCCC
Confidence            9999999874

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=6.9e-25  Score=218.85  Aligned_cols=178  Identities=19%  Similarity=0.242  Sum_probs=91.3

Q ss_pred             CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCC-CCCCCccccCCccccceeeccc-ccCCCCCcccccCCCCCcEEE
Q 041034           87 NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS-LHGTTPIEIGSLRNLEELYLRS-NKLSGVLPQEIGNLKSLIWLS  164 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~  164 (701)
                      +|++|+|++|++++..+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            66777777777766666566666666666666665 6655555566666666666665 555544444444444444444


Q ss_pred             ceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccC---ccccccc-cccCCccccccCCCccc-EEEecc
Q 041034          165 VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT---HLSIITN-KLTGAIPSTLGHLTSLL-YLDLSF  239 (701)
Q Consensus       165 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~p~~l~~l~~L~-~L~L~~  239 (701)
                      +++|                        ++++ +|. +..+++|+   +|++++| ++++..+..|..+++|+ +|++++
T Consensus       112 l~~n------------------------~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C          112 IFNT------------------------GLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             EEEE------------------------CCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred             CCCC------------------------CCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence            4444                        4443 222 33344443   4444444 44443334444444455 555555


Q ss_pred             CCCCCCCCcccCCCCcccEEEcCCCC-CccccCcccCCC-CCCcEEEccCccCC
Q 041034          240 NQLHSFIPLEIGNFSALAELDLSDNK-IRGIIPDELSKL-SNLQYLNLSSNLLS  291 (701)
Q Consensus       240 N~l~~~~~~~~~~~~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~L~~N~l~  291 (701)
                      |+++...+..+.. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|+++
T Consensus       166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            5544322222222 445555555552 444444444444 44555555444444

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.92  E-value=2e-27  Score=250.10  Aligned_cols=267  Identities=16%  Similarity=0.145  Sum_probs=164.8

Q ss_pred             CCCcceeEeCCCCCEEEEEecccccccccCCcccCCC--CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCccc-
Q 041034           25 HCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCF--PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGT-  101 (701)
Q Consensus        25 ~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-  101 (701)
                      |..|.++.|+ ...++.++++++.+.+.    .+..+  +.++.|++++|.+.+..+. +..+++|++|+|++|.+++. 
T Consensus        36 c~~W~~~~~~-~~~~~~l~l~~~~~~~~----~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~  109 (336)
T 2ast_B           36 CKRWYRLASD-ESLWQTLDLTGKNLHPD----VTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST  109 (336)
T ss_dssp             CHHHHHHHTC-STTSSEEECTTCBCCHH----HHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred             HHHHHHHhcC-chhheeeccccccCCHH----HHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence            3469888876 33466677766655421    23333  5666677776666655444 44566666666666666654 


Q ss_pred             CCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccc-cCCCC-CcccccCCCCCcEEEceec-ccCCCcCccc
Q 041034          102 IPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN-KLSGV-LPQEIGNLKSLIWLSVMYN-TVGGPIPSTL  178 (701)
Q Consensus       102 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~  178 (701)
                      +|..+..+++|++|+|++|++++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++.     
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-----  184 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-----  184 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-----
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH-----
Confidence            5556666666666666666666555556666666666666666 45432 3444444455555555554 44332     


Q ss_pred             ccccccceeEeeecccCCCCCCCCCCcc-ccCccccccc--ccc-CCccccccCCCcccEEEeccCC-CCCCCCcccCCC
Q 041034          179 FRLTNLERLFLGCNQFNGTIPREIGNLK-NLTHLSIITN--KLT-GAIPSTLGHLTSLLYLDLSFNQ-LHSFIPLEIGNF  253 (701)
Q Consensus       179 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N--~l~-~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~~  253 (701)
                                        .++..+..++ +|++|++++|  .++ +.+|..+..+++|++|++++|. +++..+..+..+
T Consensus       185 ------------------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l  246 (336)
T 2ast_B          185 ------------------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL  246 (336)
T ss_dssp             ------------------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred             ------------------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence                              0233344455 5566666665  333 3455566677788888888887 666666677777


Q ss_pred             CcccEEEcCCCC-CccccCcccCCCCCCcEEEccCccCCCCCcccccCc-cceeeecCCCCcCCCCCCCcccC
Q 041034          254 SALAELDLSDNK-IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL-FNLVSLDLSKNKLSGSFPTGIGN  324 (701)
Q Consensus       254 ~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~  324 (701)
                      ++|+.|+|++|. +.......+..+++|+.|++++| ++..   .+..+ .+|..|++++|++++..|..+++
T Consensus       247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence            888888888884 33222235777888888888888 4422   33334 34777788999999888887765

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=9.2e-25  Score=217.96  Aligned_cols=197  Identities=20%  Similarity=0.179  Sum_probs=139.7

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCc-CcccCCcccCCCCCCCEEECCC-CCCCCCCccccCCcccccee
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN-LTGTIPKEIGSLRNLEVLYLSN-NSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L  139 (701)
                      ++|++|+|++|++++..+..|+.+++|++|+|++|. ++++.+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            489999999999998888899999999999999997 9988888999999999999999 99998888899999999999


Q ss_pred             ecccccCCCCCcccccCCCCCc---EEEceec-ccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccC-ccccc
Q 041034          140 YLRSNKLSGVLPQEIGNLKSLI---WLSVMYN-TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT-HLSII  214 (701)
Q Consensus       140 ~L~~n~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~  214 (701)
                      +|++|++++ +|. |..+++|+   +|++++| .+++..+..|..+++                        |+ +|+++
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~------------------------L~~~L~l~  164 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN------------------------ETLTLKLY  164 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBS------------------------SEEEEECC
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhc------------------------ceeEEEcC
Confidence            999999987 454 66666665   5555555 554444444444444                        44 45555


Q ss_pred             cccccCCccccccCCCcccEEEeccCC-CCCCCCcccCCC-CcccEEEcCCCCCccccCcccCCCCCCcEEEccCc
Q 041034          215 TNKLTGAIPSTLGHLTSLLYLDLSFNQ-LHSFIPLEIGNF-SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN  288 (701)
Q Consensus       215 ~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  288 (701)
                      +|+++...+..+.. ++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|+|++..+.   .+++|+.|+++++
T Consensus       165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            55544222222222 556666666663 655445555666 6666666666666643222   3455666666554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=1.9e-27  Score=255.33  Aligned_cols=256  Identities=21%  Similarity=0.231  Sum_probs=162.4

Q ss_pred             eCCcccCCCCCCCEEECcCCcCcccCC----cccCCCCCCCEEECCCCC---CCCCCcccc-------CCccccceeecc
Q 041034           77 SIPPQIGSLSNLKYLNLRWNNLTGTIP----KEIGSLRNLEVLYLSNNS---LHGTTPIEI-------GSLRNLEELYLR  142 (701)
Q Consensus        77 ~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~Ls~N~---l~~~~~~~~-------~~l~~L~~L~L~  142 (701)
                      .++..+..+++|++|+|++|.+++..+    ..|..+++|++|+|++|.   +++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            345556666777777777777765433    345667777777777753   333444333       455666666666


Q ss_pred             cccCCC----CCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccc
Q 041034          143 SNKLSG----VLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKL  218 (701)
Q Consensus       143 ~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  218 (701)
                      +|.+++    .+|..+..+++|++|+|++|.++...+..+...  |..  +..|++.+.       .++|++|+|++|++
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~--l~~~~~~~~-------~~~L~~L~L~~n~l  171 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQE--LAVNKKAKN-------APPLRSIICGRNRL  171 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHH--HHHHHHHHT-------CCCCCEEECCSSCC
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHH--Hhhhhhccc-------CCCCcEEECCCCCC
Confidence            666665    344555555556666666555543322222211  000  001111110       05666666666666


Q ss_pred             c-CCcc---ccccCCCcccEEEeccCCCCC-----CCCcccCCCCcccEEEcCCCCCc----cccCcccCCCCCCcEEEc
Q 041034          219 T-GAIP---STLGHLTSLLYLDLSFNQLHS-----FIPLEIGNFSALAELDLSDNKIR----GIIPDELSKLSNLQYLNL  285 (701)
Q Consensus       219 ~-~~~p---~~l~~l~~L~~L~L~~N~l~~-----~~~~~~~~~~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L  285 (701)
                      + +.+|   ..+..+++|++|+|++|+++.     ..|..+..+++|+.|+|++|.|+    +.+|..+..+++|+.|+|
T Consensus       172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L  251 (386)
T 2ca6_A          172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  251 (386)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence            5 2333   356667778888888887772     33446777888888888888886    567777888888888888


Q ss_pred             cCccCCCC----Cccccc--CccceeeecCCCCcCCC----CCCCcc-cCCCCCCeeeccCCccCCCCC
Q 041034          286 SSNLLSGQ----IPFAIG--KLFNLVSLDLSKNKLSG----SFPTGI-GNCTELQHLALNHNSLDGTIP  343 (701)
Q Consensus       286 ~~N~l~~~----~~~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~p  343 (701)
                      ++|.+++.    ++..+.  .+++|+.|+|++|.+++    .+|..+ .++++|++|+|++|++++..+
T Consensus       252 ~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            88888765    455553  37888889999888886    477777 567899999999999987664

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.92  E-value=1.3e-26  Score=243.92  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=171.4

Q ss_pred             CcEEECCCCcceeeCCcccCCC--CCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCC-CccccCCccccceee
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSL--SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT-TPIEIGSLRNLEELY  140 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~  140 (701)
                      ++.|++++|.+.   +..+..+  ++++.|++++|.+++..+. +..+++|++|+|++|.+++. .+..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            455555555544   2333444  4555555555555544433 33455555555555555433 444444455555555


Q ss_pred             cccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeec-ccCC-CCCCCCCCccccCccccccc-c
Q 041034          141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCN-QFNG-TIPREIGNLKNLTHLSIITN-K  217 (701)
Q Consensus       141 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~-~~~~~~~~l~~L~~L~l~~N-~  217 (701)
                      |++|+++                        +..+..++.+++|++|+|++| .+++ .++..+.++++|++|++++| .
T Consensus       125 L~~~~l~------------------------~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~  180 (336)
T 2ast_B          125 LEGLRLS------------------------DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD  180 (336)
T ss_dssp             CTTCBCC------------------------HHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred             CcCcccC------------------------HHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence            5555444                        444445555556666666666 4543 24445667788888888888 8


Q ss_pred             ccCC-ccccccCCC-cccEEEeccC--CCC-CCCCcccCCCCcccEEEcCCCC-CccccCcccCCCCCCcEEEccCcc-C
Q 041034          218 LTGA-IPSTLGHLT-SLLYLDLSFN--QLH-SFIPLEIGNFSALAELDLSDNK-IRGIIPDELSKLSNLQYLNLSSNL-L  290 (701)
Q Consensus       218 l~~~-~p~~l~~l~-~L~~L~L~~N--~l~-~~~~~~~~~~~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~-l  290 (701)
                      +++. ++..+..++ +|++|++++|  .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+.|++++|. +
T Consensus       181 l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~  260 (336)
T 2ast_B          181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI  260 (336)
T ss_dssp             CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred             cChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCC
Confidence            8764 577788899 9999999999  565 4466677889999999999999 887888899999999999999995 3


Q ss_pred             CCCCcccccCccceeeecCCCCcCCCCCCCcccCC-CCCCeeeccCCccCCCCCccccc
Q 041034          291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC-TELQHLALNHNSLDGTIPPEIGK  348 (701)
Q Consensus       291 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~  348 (701)
                      +......+..+++|+.|++++| ++.   ..+..+ ..|..|++++|++++..|..++.
T Consensus       261 ~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          261 IPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence            3222236788999999999999 442   234444 34888899999999999988774

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=9.3e-28  Score=257.74  Aligned_cols=247  Identities=21%  Similarity=0.211  Sum_probs=181.0

Q ss_pred             cCCcccCCCCCCCEEECCCCCCCCCCc----cccCCccccceeecccccC---CCCCcccc-------cCCCCCcEEEce
Q 041034          101 TIPKEIGSLRNLEVLYLSNNSLHGTTP----IEIGSLRNLEELYLRSNKL---SGVLPQEI-------GNLKSLIWLSVM  166 (701)
Q Consensus       101 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~n~l---~~~~~~~~-------~~l~~L~~L~L~  166 (701)
                      .++..+..+++|++|+|++|+++...+    ..+..+++|++|+|++|.+   ++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            456677788889999999998886644    3466788888888888644   34445444       344555555555


Q ss_pred             ecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcccc----ccCC---------Cccc
Q 041034          167 YNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPST----LGHL---------TSLL  233 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~----l~~l---------~~L~  233 (701)
                      +|.+++....                    .+|..+..+++|++|+|++|.+++..+..    +..+         ++|+
T Consensus       103 ~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~  162 (386)
T 2ca6_A          103 DNAFGPTAQE--------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  162 (386)
T ss_dssp             SCCCCTTTHH--------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             CCcCCHHHHH--------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence            5555441000                    23334444455555555555554322222    2222         8999


Q ss_pred             EEEeccCCCC-CCCC---cccCCCCcccEEEcCCCCCc--c---ccCcccCCCCCCcEEEccCccCC----CCCcccccC
Q 041034          234 YLDLSFNQLH-SFIP---LEIGNFSALAELDLSDNKIR--G---IIPDELSKLSNLQYLNLSSNLLS----GQIPFAIGK  300 (701)
Q Consensus       234 ~L~L~~N~l~-~~~~---~~~~~~~~L~~L~L~~N~l~--~---~~p~~l~~l~~L~~L~L~~N~l~----~~~~~~~~~  300 (701)
                      +|+|++|+++ +.++   ..+..+++|+.|+|++|+|+  |   ..|..+..+++|+.|+|++|.++    +.+|..+..
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~  242 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  242 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence            9999999998 3344   35678899999999999998  3   45558899999999999999996    577888999


Q ss_pred             ccceeeecCCCCcCCCC----CCCcc--cCCCCCCeeeccCCccCC----CCCccc-cccccCCeEEcccccCcccCC
Q 041034          301 LFNLVSLDLSKNKLSGS----FPTGI--GNCTELQHLALNHNSLDG----TIPPEI-GKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       301 l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      +++|+.|+|++|.+++.    +|..+  +.+++|++|+|++|++++    .+|..+ .++++|+.|++++|++++..|
T Consensus       243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            99999999999999875    56666  448999999999999997    488887 668999999999999998765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=3.4e-25  Score=230.17  Aligned_cols=225  Identities=20%  Similarity=0.191  Sum_probs=155.5

Q ss_pred             CCCCEEECCCCCCCCCCcc---ccCCccccceeecccccCCCCCcccc--cCCCCCcEEEceecccCCCcC----ccccc
Q 041034          110 RNLEVLYLSNNSLHGTTPI---EIGSLRNLEELYLRSNKLSGVLPQEI--GNLKSLIWLSVMYNTVGGPIP----STLFR  180 (701)
Q Consensus       110 ~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~  180 (701)
                      ..++.|.+.++.++...-.   .+..+++|++|+|++|++++..|..+  ..+++|++|+|++|.+++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            3467777777766532111   12234568888888888877777777  777788888888888776544    33456


Q ss_pred             ccccceeEeeecccCCCCCCCCCCccccCccccccccccCC--c--cccccCCCcccEEEeccCCCCCCCCc----ccCC
Q 041034          181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA--I--PSTLGHLTSLLYLDLSFNQLHSFIPL----EIGN  252 (701)
Q Consensus       181 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~~~----~~~~  252 (701)
                      +++|++|+|++|++++..+..++.+++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++.. +.    .+..
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HHHHHHHHhc
Confidence            77788888888888777777777788888888888876542  2  22335677788888888887642 22    2456


Q ss_pred             CCcccEEEcCCCCCccccCcccCCC---CCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCC
Q 041034          253 FSALAELDLSDNKIRGIIPDELSKL---SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQ  329 (701)
Q Consensus       253 ~~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  329 (701)
                      +++|+.|+|++|+|++..|..+..+   ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            6778888888888877767666665   57888888888887 5566554  6788888888888753 33 56677788


Q ss_pred             eeeccCCccCC
Q 041034          330 HLALNHNSLDG  340 (701)
Q Consensus       330 ~L~L~~N~l~~  340 (701)
                      .|+|++|+++.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            88888887763

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.91  E-value=2.6e-28  Score=277.43  Aligned_cols=299  Identities=14%  Similarity=0.060  Sum_probs=190.3

Q ss_pred             CCCCCCEEECcCCcCccc----CCcccCCCCCCCEEECCCCCCCCC----CccccCCccccceeecccccCCCCCccccc
Q 041034           84 SLSNLKYLNLRWNNLTGT----IPKEIGSLRNLEVLYLSNNSLHGT----TPIEIGSLRNLEELYLRSNKLSGVLPQEIG  155 (701)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  155 (701)
                      .+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+++.    ++..+.++++|++|+|++|.+.+ +|..+.
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~  240 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK  240 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence            344444444444444333    122233344455555555444421    12223344455555555554443 334444


Q ss_pred             CCCCCcEEEceecccC---CCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc-ccccCCCc
Q 041034          156 NLKSLIWLSVMYNTVG---GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP-STLGHLTS  231 (701)
Q Consensus       156 ~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~  231 (701)
                      ++++|+.|+++.+...   +..+..+..+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++
T Consensus       241 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~  319 (592)
T 3ogk_B          241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN  319 (592)
T ss_dssp             HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred             hhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence            4555555555432211   2223344555566666665542 23566777888999999999999876443 44688999


Q ss_pred             ccEEEeccCCCCC-CCCcccCCCCcccEEEcC-----------CCCCcccc-CcccCCCCCCcEEEccCccCCCCCcccc
Q 041034          232 LLYLDLSFNQLHS-FIPLEIGNFSALAELDLS-----------DNKIRGII-PDELSKLSNLQYLNLSSNLLSGQIPFAI  298 (701)
Q Consensus       232 L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~L~-----------~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~~~~~  298 (701)
                      |++|+++ |.+.. .++..+..+++|+.|+|+           .|.+++.. +..+..+++|+.|+++.|.+++..+..+
T Consensus       320 L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l  398 (592)
T 3ogk_B          320 LEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI  398 (592)
T ss_dssp             CCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHH
T ss_pred             CCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHH
Confidence            9999999 44443 334444678999999999           46777542 2234568999999999999998777777


Q ss_pred             cC-ccceeeecCC----CCcCCCC-----CCCcccCCCCCCeeeccCC--ccCCCCCccccc-cccCCeEEcccccCccc
Q 041034          299 GK-LFNLVSLDLS----KNKLSGS-----FPTGIGNCTELQHLALNHN--SLDGTIPPEIGK-ILLLQNLDLSHNNLSGT  365 (701)
Q Consensus       299 ~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~~~~~-l~~L~~l~ls~N~l~g~  365 (701)
                      +. +++|+.|+++    .|.+++.     ++..+..+++|++|+|++|  .+++..+..++. +++|++|+|++|++++.
T Consensus       399 ~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~  478 (592)
T 3ogk_B          399 GTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE  478 (592)
T ss_dssp             HHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHH
T ss_pred             HhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHH
Confidence            65 8899999996    7788864     3334677899999999854  366655555554 78999999999999862


Q ss_pred             -CCCC----ccccccccccCCCCCc
Q 041034          366 -IPMT----LHPMFLDMSFNNLEGE  385 (701)
Q Consensus       366 -~p~~----~~~~~l~ls~N~l~g~  385 (701)
                       ++..    -....|++++|++++.
T Consensus       479 ~~~~~~~~~~~L~~L~l~~n~l~~~  503 (592)
T 3ogk_B          479 GLMEFSRGCPNLQKLEMRGCCFSER  503 (592)
T ss_dssp             HHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred             HHHHHHhcCcccCeeeccCCCCcHH
Confidence             3322    2245899999998754

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.8e-26  Score=251.74  Aligned_cols=180  Identities=17%  Similarity=0.208  Sum_probs=134.1

Q ss_pred             ccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          453 HIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS-----AFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ...+.||+|+||.||+|.. .++.+|+|+.........     ...+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999955 578899998765443322     2245689999999999999999766666677778999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++++|.+++..           +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+|+....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999865           457999999999999999   9999999999999998  999999999998753


Q ss_pred             CCCC-------ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          608 DSSN-------RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       608 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ....       .....||+.|+|||++...........|+|+...-.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~  530 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMK  530 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHH
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHH
Confidence            2211       12457999999999987632222222377876554443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.5e-23  Score=210.75  Aligned_cols=183  Identities=22%  Similarity=0.290  Sum_probs=146.7

Q ss_pred             cccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEc
Q 041034          182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL  261 (701)
Q Consensus       182 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L  261 (701)
                      .+.+.++++++.++ .+|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            35667777777777 4555554  57888888888888777777888888888888888888877777888888888888


Q ss_pred             CCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCC
Q 041034          262 SDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT  341 (701)
Q Consensus       262 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  341 (701)
                      ++|+|++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|+|++..+..+..+++|++|+|++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            88888877777788888888888888888877666778888888888888888876666788888888888888888877


Q ss_pred             CCccccccccCCeEEcccccCcccCC
Q 041034          342 IPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       342 ~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      .+..+..+++|+.|+|++|+++|..+
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence            77788888888888888888887733

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.90  E-value=1.5e-23  Score=204.47  Aligned_cols=185  Identities=24%  Similarity=0.278  Sum_probs=153.8

Q ss_pred             CCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCc
Q 041034           25 HCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK  104 (701)
Q Consensus        25 ~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~  104 (701)
                      .|.|.+|.|+..+           ++ .+   .....++|++|+|++|++++..+..|+.+++|++|+|++|++++..+.
T Consensus         6 ~C~~~~v~c~~~~-----------l~-~~---p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~   70 (208)
T 2o6s_A            6 SCSGTTVECYSQG-----------RT-SV---PTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG   70 (208)
T ss_dssp             EEETTEEECCSSC-----------CS-SC---CSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred             EECCCEEEecCCC-----------cc-CC---CCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence            4789999997543           21 11   123356899999999999977777789999999999999999977777


Q ss_pred             ccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCccccccccc
Q 041034          105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNL  184 (701)
Q Consensus       105 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  184 (701)
                      .|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|+.|++++|.+++..+..+..+++|
T Consensus        71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  150 (208)
T 2o6s_A           71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL  150 (208)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc
Confidence            88999999999999999998877788999999999999999998888888899999999999999988777778888899


Q ss_pred             ceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCc
Q 041034          185 ERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS  231 (701)
Q Consensus       185 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~  231 (701)
                      +.|+|++|.+.+.       +++|++|+++.|+++|.+|+.++.++.
T Consensus       151 ~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          151 QYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             cEEEecCCCeecC-------CCCHHHHHHHHHhCCceeeccCccccC
Confidence            9999998877643       457888888888888888888776654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=3e-23  Score=219.27  Aligned_cols=239  Identities=18%  Similarity=0.172  Sum_probs=116.5

Q ss_pred             EEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCc-cccCCccccce-eeccc
Q 041034           66 YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTP-IEIGSLRNLEE-LYLRS  143 (701)
Q Consensus        66 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~-L~L~~  143 (701)
                      +++.++++++ .+|..+  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|.+ +.+++
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            4666666666 455544  2466777777777765555566677777777777776654333 34555655543 44445


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      |+++.+.|..|.++++|++|++++|.+....+..+....++..|++.++                       |++....+
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~-----------------------~~i~~l~~  146 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN-----------------------INIHTIER  146 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC-----------------------TTCCEECT
T ss_pred             CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc-----------------------cccccccc
Confidence            5555555555555555555555555554444444444444444444321                       23332222


Q ss_pred             ccccCCC-cccEEEeccCCCCCCCCcccCCCCcccEEEcCC-CCCccccCcccCCCCCCcEEEccCccCCCCCcccccCc
Q 041034          224 STLGHLT-SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD-NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKL  301 (701)
Q Consensus       224 ~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  301 (701)
                      ..|..+. .++.|+|++|+|+.+ |.......+|+.|++++ |.++.+.++.|..+++|+.|+|++|+|+...+..+.++
T Consensus       147 ~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L  225 (350)
T 4ay9_X          147 NSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL  225 (350)
T ss_dssp             TSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTC
T ss_pred             cchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccc
Confidence            3333332 344555555555542 22222334555555543 33443333345555555555555555553333333333


Q ss_pred             cceeeecCCCCcCCCCCCCcccCCCCCCeeeccC
Q 041034          302 FNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH  335 (701)
Q Consensus       302 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  335 (701)
                      .+|+.+++  ++++ .+|. +.++++|+.+++++
T Consensus       226 ~~L~~l~~--~~l~-~lP~-l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          226 KKLRARST--YNLK-KLPT-LEKLVALMEASLTY  255 (350)
T ss_dssp             CEEECTTC--TTCC-CCCC-TTTCCSCCEEECSC
T ss_pred             hHhhhccC--CCcC-cCCC-chhCcChhhCcCCC
Confidence            33333322  1122 3442 44455555555543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.2e-23  Score=218.09  Aligned_cols=192  Identities=29%  Similarity=0.418  Sum_probs=85.9

Q ss_pred             CCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEE
Q 041034           84 SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL  163 (701)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  163 (701)
                      .+++|++|++++|.++. +| .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  ..+..+++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence            34555555555555543 22 34555555555555555554333  55555555555555555432  134444444444


Q ss_pred             EceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCC
Q 041034          164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH  243 (701)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  243 (701)
                      ++++|.+++..  .+..+++|++|++++|++++..+  ++.+++|++|++++|++++..+  +..+++|+.|++++|+++
T Consensus       113 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  186 (308)
T 1h6u_A          113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS  186 (308)
T ss_dssp             ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence            44444443321  14444444444444444443222  3344444444444444443222  444444444444444444


Q ss_pred             CCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCC
Q 041034          244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       244 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      +..+  +..+++|+.|+|++|++++..|  +..+++|+.|+|++|.++
T Consensus       187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred             cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence            4222  3344444444444444443321  344444444444444443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.6e-23  Score=217.21  Aligned_cols=195  Identities=29%  Similarity=0.397  Sum_probs=172.3

Q ss_pred             cCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccc
Q 041034           58 FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLE  137 (701)
Q Consensus        58 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  137 (701)
                      ++.+++|++|++++|.++. ++ .+..+++|++|+|++|.+++..+  +..+++|++|+|++|++++.  ..+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence            4457889999999999985 44 68899999999999999996655  99999999999999999864  3689999999


Q ss_pred             eeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccc
Q 041034          138 ELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK  217 (701)
Q Consensus       138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  217 (701)
                      +|+|++|++++..  .+..+++|++|++++|.+++..+  +..+++|+.|+|++|++++..+  +..+++|++|++++|+
T Consensus       111 ~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          111 TLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK  184 (308)
T ss_dssp             EEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence            9999999999753  38999999999999999987655  8899999999999999997544  8999999999999999


Q ss_pred             ccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCcc
Q 041034          218 LTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRG  268 (701)
Q Consensus       218 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~  268 (701)
                      +++..+  +..+++|++|+|++|++++..+  +..+++|+.|+|++|++++
T Consensus       185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            997654  8899999999999999998653  8899999999999999985

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=2e-23  Score=220.63  Aligned_cols=224  Identities=17%  Similarity=0.137  Sum_probs=173.8

Q ss_pred             CCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCC-cccCCCCCCCE-EECCCCCCCCCCccccCCccccce
Q 041034           61 FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIP-KEIGSLRNLEV-LYLSNNSLHGTTPIEIGSLRNLEE  138 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~  138 (701)
                      .+++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| .+|.++++|+. ++++.|+++...|..|..+++|++
T Consensus        29 ~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~  108 (350)
T 4ay9_X           29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY  108 (350)
T ss_dssp             CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCE
T ss_pred             CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccc
Confidence            3689999999999997777789999999999999999876655 57899998875 677789999999999999999999


Q ss_pred             eecccccCCCCCcccccCCCCCcEEEcee-cccCCCcCccccccc-ccceeEeeecccCCCCCCCCCCccccCcccccc-
Q 041034          139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMY-NTVGGPIPSTLFRLT-NLERLFLGCNQFNGTIPREIGNLKNLTHLSIIT-  215 (701)
Q Consensus       139 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-  215 (701)
                      |++++|+++...+..+....++..|++.+ |.+....+..|..+. .++.|+|++|+|+.. |.......+|++|++++ 
T Consensus       109 L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~  187 (350)
T 4ay9_X          109 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDN  187 (350)
T ss_dssp             EEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTC
T ss_pred             ccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccC
Confidence            99999999988888888888999999976 567666666677664 588889999998854 44444556788888864 


Q ss_pred             ccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCcc
Q 041034          216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL  289 (701)
Q Consensus       216 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  289 (701)
                      |.++...++.|..+++|++|||++|+|+...+..|   .+|+.|.+.++.--..+|. +..+++|+.++++++.
T Consensus       188 n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP~-l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPS  257 (350)
T ss_dssp             TTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCCC-TTTCCSCCEEECSCHH
T ss_pred             CcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCCC-chhCcChhhCcCCCCc
Confidence            66665555677888888888888888887544444   4445555444433335563 7777888888877654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=3.4e-22  Score=194.77  Aligned_cols=157  Identities=28%  Similarity=0.255  Sum_probs=77.0

Q ss_pred             ccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEcc
Q 041034          207 NLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS  286 (701)
Q Consensus       207 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  286 (701)
                      +|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            45555555555554444444455555555555555554444444455555555555555554444444555555555555


Q ss_pred             CccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccC
Q 041034          287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTI  366 (701)
Q Consensus       287 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~  366 (701)
                      +|.+++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|.+.+.       ++.|++|+++.|+++|.+
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i  181 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV  181 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence            5555544444444455555555555555543333344455555555555544432       223444455555555554


Q ss_pred             CCCc
Q 041034          367 PMTL  370 (701)
Q Consensus       367 p~~~  370 (701)
                      |..+
T Consensus       182 p~~~  185 (208)
T 2o6s_A          182 RNSA  185 (208)
T ss_dssp             BCTT
T ss_pred             eccC
Confidence            4443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.88  E-value=2.6e-22  Score=223.26  Aligned_cols=189  Identities=29%  Similarity=0.343  Sum_probs=108.7

Q ss_pred             CCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecc
Q 041034           63 NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLR  142 (701)
Q Consensus        63 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  142 (701)
                      +|+.|+|++|++++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            46666666666665 454442  56666666666666 344   334566666666666654 333 333  55555555


Q ss_pred             cccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCc
Q 041034          143 SNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAI  222 (701)
Q Consensus       143 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  222 (701)
                      +|+|++ +|                        .   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +
T Consensus       129 ~N~l~~-lp------------------------~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          129 NNQLTM-LP------------------------E---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             SSCCSC-CC------------------------C---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             CCcCCC-CC------------------------C---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-c
Confidence            555554 22                        2   23455555555555553 333   34556666666666654 4


Q ss_pred             cccccCCCcccEEEeccCCCCCCCCcccCCCCcc-------cEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCc
Q 041034          223 PSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL-------AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP  295 (701)
Q Consensus       223 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L-------~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  295 (701)
                      |. |.  ++|++|+|++|+|+. +|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|
T Consensus       176 p~-l~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          176 PE-LP--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             CC-CC--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             ch-hh--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence            44 43  566666666666664 444 433  55       77777777777 466666677777777777777777777


Q ss_pred             ccccCccc
Q 041034          296 FAIGKLFN  303 (701)
Q Consensus       296 ~~~~~l~~  303 (701)
                      ..+..+..
T Consensus       248 ~~l~~l~~  255 (571)
T 3cvr_A          248 ESLSQQTA  255 (571)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            66665443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.88  E-value=9.7e-26  Score=256.26  Aligned_cols=342  Identities=15%  Similarity=0.098  Sum_probs=158.8

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCC-cceee-CCcccCCCCCCCEEECcCCcCcccCCccc----CCCCC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNN-NLSGS-IPPQIGSLSNLKYLNLRWNNLTGTIPKEI----GSLRN  111 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~~----~~l~~  111 (701)
                      ++++|++++|.+++.........+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+    ..+++
T Consensus       106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~  185 (594)
T 2p1m_B          106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS  185 (594)
T ss_dssp             TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred             CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence            44555555554443221111113455555555555 33321 22223345555555555555543332222    23445


Q ss_pred             CCEEECCCCCCCCCCccc----cCCccccceeecccc-cCCCCCcccccCCCCCcEEEceecc-----------------
Q 041034          112 LEVLYLSNNSLHGTTPIE----IGSLRNLEELYLRSN-KLSGVLPQEIGNLKSLIWLSVMYNT-----------------  169 (701)
Q Consensus       112 L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~-----------------  169 (701)
                      |++|+|++|. .......    +..+++|++|+|++| .+.+ ++..+..+++|+.|+++.+.                 
T Consensus       186 L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~  263 (594)
T 2p1m_B          186 LVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG  263 (594)
T ss_dssp             CCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred             CcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence            5555555554 1111111    122355555555555 2222 44444445555555433321                 


Q ss_pred             ---------cC----CCcCcccccccccceeEeeecccCCCC-CCCCCCccccCccccccccccCC-ccccccCCCcccE
Q 041034          170 ---------VG----GPIPSTLFRLTNLERLFLGCNQFNGTI-PREIGNLKNLTHLSIITNKLTGA-IPSTLGHLTSLLY  234 (701)
Q Consensus       170 ---------l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~  234 (701)
                               +.    +.++..+..+++|+.|+|++|.+++.. +..+..+++|++|++++| ++.. ++.....+++|++
T Consensus       264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~  342 (594)
T 2p1m_B          264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE  342 (594)
T ss_dssp             CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred             CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence                     00    011222224455666666555544321 112334555666666555 3221 1111223556666


Q ss_pred             EEec---------cCCCCCCCCcccC-CCCcccEEEcCCCCCccccCcccC-CCCCCcEEEcc--C----ccCCCCC---
Q 041034          235 LDLS---------FNQLHSFIPLEIG-NFSALAELDLSDNKIRGIIPDELS-KLSNLQYLNLS--S----NLLSGQI---  294 (701)
Q Consensus       235 L~L~---------~N~l~~~~~~~~~-~~~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~--~----N~l~~~~---  294 (701)
                      |+++         .|.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++  +    |.+++..   
T Consensus       343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~  422 (594)
T 2p1m_B          343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI  422 (594)
T ss_dssp             EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred             EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence            6652         2333332222222 256666666666666654444443 36667777766  3    4444211   


Q ss_pred             --cccccCccceeeecCCCCcCCCCCCCcccC-CCCCCeeeccCCccCCCCCccc-cccccCCeEEcccccCcccCCCC-
Q 041034          295 --PFAIGKLFNLVSLDLSKNKLSGSFPTGIGN-CTELQHLALNHNSLDGTIPPEI-GKILLLQNLDLSHNNLSGTIPMT-  369 (701)
Q Consensus       295 --~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~ls~N~l~g~~p~~-  369 (701)
                        +..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+.. 
T Consensus       423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~  501 (594)
T 2p1m_B          423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN  501 (594)
T ss_dssp             HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT
T ss_pred             HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH
Confidence              11244556677777755 555444444443 6667777777777654434333 45667777777777764332211 


Q ss_pred             ----ccccccccccCCCC
Q 041034          370 ----LHPMFLDMSFNNLE  383 (701)
Q Consensus       370 ----~~~~~l~ls~N~l~  383 (701)
                          -....|++++|+++
T Consensus       502 ~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          502 ASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             GGGGGGSSEEEEESSCCB
T ss_pred             HHhCCCCCEEeeeCCCCC
Confidence                11235666666653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=3.3e-22  Score=203.91  Aligned_cols=154  Identities=16%  Similarity=0.163  Sum_probs=121.0

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccCh---------------HHHHHHHHHHHHHhcCC
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDS---------------AFVESFQNEARVLSTVR  507 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~  507 (701)
                      ..+......|.+.+.||+|+||.||+|...+|+.||+|+++.......               .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344455667788899999999999999777799999999975432110               23567899999999999


Q ss_pred             CCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEE
Q 041034          508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNIL  587 (701)
Q Consensus       508 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIl  587 (701)
                        | +++.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||++   ||+||||||+||+
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence              5 677765543 45699999999999988 422         12346999999999999999   9999999999999


Q ss_pred             EcCCCCeEEEeecCccccccCCCCceeecccccccCCCCC
Q 041034          588 LNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR  627 (701)
Q Consensus       588 l~~~~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~  627 (701)
                      ++ ++.+||+|||+|+.             +..|.|||.+
T Consensus       226 l~-~~~vkl~DFG~a~~-------------~~~~~a~e~l  251 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE-------------VGEEGWREIL  251 (282)
T ss_dssp             EE-TTEEEECCCTTCEE-------------TTSTTHHHHH
T ss_pred             EE-CCcEEEEECCCCeE-------------CCCCCHHHHH
Confidence            99 99999999999963             3346777764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=2.5e-22  Score=223.38  Aligned_cols=189  Identities=24%  Similarity=0.354  Sum_probs=105.5

Q ss_pred             CCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEee
Q 041034          111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLG  190 (701)
Q Consensus       111 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  190 (701)
                      +|+.|+|++|++++ +|..+  +++|++|+|++|+|+. +|   ..                        +++|+.|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~-ip---~~------------------------l~~L~~L~Ls  108 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALIS-LP---EL------------------------PASLEYLDAC  108 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSC-CC---CC------------------------CTTCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcc-cc---cc------------------------cCCCCEEEcc
Confidence            56666666666654 33333  2455555555555552 22   12                        3445555555


Q ss_pred             ecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCcccc
Q 041034          191 CNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGII  270 (701)
Q Consensus       191 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~  270 (701)
                      +|+|++ +|. +.+  +|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +
T Consensus       109 ~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          109 DNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             SSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             CCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-c
Confidence            555554 333 333  55555555555554 333   34566666666666665 333   34566666666666665 4


Q ss_pred             CcccCCCCCCcEEEccCccCCCCCcccccCccce-------eeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCC
Q 041034          271 PDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNL-------VSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIP  343 (701)
Q Consensus       271 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  343 (701)
                      |. |.  ++|+.|+|++|.|+ .+|. +..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus       176 p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          176 PE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             CC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             ch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence            44 44  56666666666666 4444 433  45       77777777776 466666667777777777777776666


Q ss_pred             cccccccc
Q 041034          344 PEIGKILL  351 (701)
Q Consensus       344 ~~~~~l~~  351 (701)
                      ..+..++.
T Consensus       248 ~~l~~l~~  255 (571)
T 3cvr_A          248 ESLSQQTA  255 (571)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            66665443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.86  E-value=8.8e-25  Score=248.35  Aligned_cols=325  Identities=17%  Similarity=0.157  Sum_probs=233.3

Q ss_pred             CCEEEEEeccc-ccccccCCcccCCCCCCcEEECCCCcceeeCCccc----CCCCCCCEEECcCCc--Cccc-CCcccCC
Q 041034           37 GSITHIELVEC-SIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQI----GSLSNLKYLNLRWNN--LTGT-IPKEIGS  108 (701)
Q Consensus        37 ~~v~~l~l~~~-~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~n~--l~~~-~p~~~~~  108 (701)
                      .++++|++.+| .++.......+..+++|++|+|++|.+++..+..+    ..+++|++|+|++|.  ++.. ++..+.+
T Consensus       130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~  209 (594)
T 2p1m_B          130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR  209 (594)
T ss_dssp             TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHH
T ss_pred             CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHh
Confidence            47899999988 44432111223468999999999999887554433    467899999999997  3311 2222345


Q ss_pred             CCCCCEEECCCC-CCCCCCccccCCccccceeeccccc--------------------------CCCC----CcccccCC
Q 041034          109 LRNLEVLYLSNN-SLHGTTPIEIGSLRNLEELYLRSNK--------------------------LSGV----LPQEIGNL  157 (701)
Q Consensus       109 l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~n~--------------------------l~~~----~~~~~~~l  157 (701)
                      +++|++|+|++| .+.+ ++..+..+++|++|+++.+.                          +...    ++..+..+
T Consensus       210 ~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~  288 (594)
T 2p1m_B          210 CPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC  288 (594)
T ss_dssp             CTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred             CCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence            799999999999 4443 66677788888888865542                          2211    33333467


Q ss_pred             CCCcEEEceecccCCCcCc-ccccccccceeEeeecccCCC-CCCCCCCccccCccccc---------cccccCCccccc
Q 041034          158 KSLIWLSVMYNTVGGPIPS-TLFRLTNLERLFLGCNQFNGT-IPREIGNLKNLTHLSII---------TNKLTGAIPSTL  226 (701)
Q Consensus       158 ~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~---------~N~l~~~~p~~l  226 (701)
                      ++|+.|+|++|.+++.... .+..+++|+.|++++| ++.. ++.....+++|++|+++         .+.+++.....+
T Consensus       289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l  367 (594)
T 2p1m_B          289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV  367 (594)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred             CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence            8999999999997654332 3567899999999988 4422 22223357889999883         456665433334


Q ss_pred             c-CCCcccEEEeccCCCCCCCCcccC-CCCcccEEEcC--C----CCCccc-----cCcccCCCCCCcEEEccCccCCCC
Q 041034          227 G-HLTSLLYLDLSFNQLHSFIPLEIG-NFSALAELDLS--D----NKIRGI-----IPDELSKLSNLQYLNLSSNLLSGQ  293 (701)
Q Consensus       227 ~-~l~~L~~L~L~~N~l~~~~~~~~~-~~~~L~~L~L~--~----N~l~~~-----~p~~l~~l~~L~~L~L~~N~l~~~  293 (701)
                      . .+++|++|+++.|.+++..+..+. .+++|+.|+|+  +    |.+++.     ++..+..+++|+.|+|++ .+++.
T Consensus       368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~  446 (594)
T 2p1m_B          368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDK  446 (594)
T ss_dssp             HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHH
T ss_pred             HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHH
Confidence            3 489999999999999876555554 58999999999  4    666632     222366789999999987 77766


Q ss_pred             CcccccC-ccceeeecCCCCcCCCCCCCcc-cCCCCCCeeeccCCccCCCCCc-cccccccCCeEEcccccCcc
Q 041034          294 IPFAIGK-LFNLVSLDLSKNKLSGSFPTGI-GNCTELQHLALNHNSLDGTIPP-EIGKILLLQNLDLSHNNLSG  364 (701)
Q Consensus       294 ~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~l~ls~N~l~g  364 (701)
                      .+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|+++.
T Consensus       447 ~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             HHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence            5666665 8899999999999986655555 6689999999999999654433 44568999999999999853

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=1.4e-21  Score=219.77  Aligned_cols=188  Identities=26%  Similarity=0.387  Sum_probs=103.7

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  143 (701)
                      +..+.+..+.+....+  +..|++|+.|+|++|.+... | .|..+++|+.|+|++|++++..+  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            4445566666654433  45667777777777777643 3 46777777777777777776554  66777777777777


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      |.+++.  ..+..+++|+.|+|++|.+.+.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|+|++..|
T Consensus        97 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           97 NKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            777653  2455666666666666665542  2355555555555555555533  334444444444444444444333


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIR  267 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~  267 (701)
                        +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++.
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence              44444444444444444442  12344444444444444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=2.9e-21  Score=217.26  Aligned_cols=194  Identities=29%  Similarity=0.388  Sum_probs=124.8

Q ss_pred             CCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEc
Q 041034           86 SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV  165 (701)
Q Consensus        86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  165 (701)
                      ..+..+.++.+.+.+..+  +..+++|+.|+|++|.+... + .+..+++|+.|+|++|++++..|  +..+++|+.|+|
T Consensus        21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L   94 (605)
T 1m9s_A           21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL   94 (605)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred             HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence            345555666666665433  45566677777777776643 2 46667777777777777766544  666777777777


Q ss_pred             eecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCC
Q 041034          166 MYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF  245 (701)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  245 (701)
                      ++|.+.+.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|+|++.
T Consensus        95 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~  168 (605)
T 1m9s_A           95 DENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  168 (605)
T ss_dssp             CSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred             cCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence            77776553  2566667777777777776643  3466667777777777777654  4566667777777777777665


Q ss_pred             CCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCc
Q 041034          246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP  295 (701)
Q Consensus       246 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  295 (701)
                      .|  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+++...
T Consensus       169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred             hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence            44  66677777777777777653  346667777777777777665433

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=2e-20  Score=185.01  Aligned_cols=159  Identities=28%  Similarity=0.317  Sum_probs=110.0

Q ss_pred             CCCCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCccc
Q 041034           22 TSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGT  101 (701)
Q Consensus        22 ~~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  101 (701)
                      +.+.|+|.+|.|...+           ++ .++.   ...++|++|+|++|.|++..|..|..+++|++|+|++|+|+..
T Consensus        15 ~~~~Cs~~~v~c~~~~-----------l~-~ip~---~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i   79 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSKR-----------HA-SVPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL   79 (229)
T ss_dssp             TTCEEETTEEECTTSC-----------CS-SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCEEeCCEeEccCCC-----------cC-ccCC---CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence            5678999999997432           21 1222   2236778888888888877777778888888888888888766


Q ss_pred             CCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccc
Q 041034          102 IPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRL  181 (701)
Q Consensus       102 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  181 (701)
                      .+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|.+++..+..|..+
T Consensus        80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  158 (229)
T 3e6j_A           80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL  158 (229)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred             ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence            6666777888888888888887766666777777777777777777 455666666666666666666665555555556


Q ss_pred             cccceeEeeecccCC
Q 041034          182 TNLERLFLGCNQFNG  196 (701)
Q Consensus       182 ~~L~~L~L~~N~l~~  196 (701)
                      ++|+.|+|++|.+.+
T Consensus       159 ~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          159 SSLTHAYLFGNPWDC  173 (229)
T ss_dssp             TTCCEEECTTSCBCT
T ss_pred             CCCCEEEeeCCCccC
Confidence            666666666665553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=3.7e-21  Score=197.55  Aligned_cols=171  Identities=29%  Similarity=0.406  Sum_probs=86.7

Q ss_pred             CCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEE
Q 041034           84 SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL  163 (701)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  163 (701)
                      .+++|++|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  .           
T Consensus        44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~-----------  106 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--S-----------  106 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--G-----------
T ss_pred             hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--h-----------
Confidence            455555555555555533 2 25555555555555555554333  45555555555555555431  1           


Q ss_pred             EceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCC
Q 041034          164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH  243 (701)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  243 (701)
                                   .+..+++|++|+|++|++++.  ..+..+++|++|++++|++++.  ..+..+++|++|+|++|+++
T Consensus       107 -------------~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~  169 (291)
T 1h6t_A          107 -------------SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  169 (291)
T ss_dssp             -------------GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             -------------hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence                         133444444444444444432  2344444555555555555433  34555555666666666555


Q ss_pred             CCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCC
Q 041034          244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG  292 (701)
Q Consensus       244 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  292 (701)
                      +..+  +..+++|+.|+|++|.|++. | .+..+++|+.|++++|.++.
T Consensus       170 ~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          170 DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             cchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            5433  55555666666666655542 2 25555556666666655553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=1.3e-20  Score=185.09  Aligned_cols=156  Identities=20%  Similarity=0.211  Sum_probs=107.0

Q ss_pred             ccccccccccCCccccccCCCcccEEEeccCCCCCCCC-cccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCc
Q 041034          210 HLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIP-LEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN  288 (701)
Q Consensus       210 ~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  288 (701)
                      .+++++|.++. +|..+.  ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            45555555542 343332  234566666666666533 34566677777777777777666666777777777777777


Q ss_pred             cCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCC
Q 041034          289 LLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPM  368 (701)
Q Consensus       289 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  368 (701)
                      .+++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+++|.++.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            77766666677777777777777777776677777777777777777777777777777777888888888888776664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=2e-20  Score=183.73  Aligned_cols=155  Identities=23%  Similarity=0.293  Sum_probs=109.2

Q ss_pred             ccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCcc
Q 041034          210 HLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL  289 (701)
Q Consensus       210 ~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  289 (701)
                      .+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|.
T Consensus        15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            4555555555 3344333  456777777777776656667777777777777777776667777777777777777777


Q ss_pred             CCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCC
Q 041034          290 LSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       290 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      |+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..+
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            775555556777777777777777777777777777778888888888777666677777888888888888876654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=1.1e-20  Score=200.34  Aligned_cols=180  Identities=24%  Similarity=0.181  Sum_probs=133.5

Q ss_pred             ceeEeeecccCCCCCCCCCCccccCccccccccccCCcccccc-CCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCC
Q 041034          185 ERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLG-HLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD  263 (701)
Q Consensus       185 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~  263 (701)
                      +.+++++|+++ .+|..+.  ..++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            56777777776 3555443  3477778888887776666676 778888888888888877667777888888888888


Q ss_pred             CCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcc---cCCCCCCeeeccCCccCC
Q 041034          264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI---GNCTELQHLALNHNSLDG  340 (701)
Q Consensus       264 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~  340 (701)
                      |+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+   ..+++|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            88877777777888888888888888887777778888888888888888875333333   567888888888888886


Q ss_pred             CCCcccccccc--CCeEEcccccCcccCC
Q 041034          341 TIPPEIGKILL--LQNLDLSHNNLSGTIP  367 (701)
Q Consensus       341 ~~p~~~~~l~~--L~~l~ls~N~l~g~~p  367 (701)
                      ..+..+..++.  |+.|+|++|++.+...
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             cCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            55567777776  4788999998887654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=9e-22  Score=227.00  Aligned_cols=258  Identities=22%  Similarity=0.187  Sum_probs=102.0

Q ss_pred             HHHHHHHhc------CCCCcCCCC--CCCCCCCCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCc
Q 041034            2 EIERQALLN------CGWWKDRIP--HNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNN   73 (701)
Q Consensus         2 ~~~~~~l~~------~~~~~~~~~--~~~~d~c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~   73 (701)
                      +.+|++|+.      +..|+...+  ...+..+.|.+++++. ++++.++|..+.+... +      ...|+.++|+.|.
T Consensus       131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~-~------~~~l~~l~Ls~~~  202 (727)
T 4b8c_D          131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEA-N------QALLQHKKLSQYS  202 (727)
T ss_dssp             -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred             ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcc-h------hhHhhcCccCccc
Confidence            346777764      123444332  2334567898888874 5788888877776542 1      1234555666655


Q ss_pred             ceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCccc
Q 041034           74 LSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQE  153 (701)
Q Consensus        74 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  153 (701)
                      |.+              ++++.|.+. ..|+.|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..
T Consensus       203 i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~  265 (727)
T 4b8c_D          203 IDE--------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAE  265 (727)
T ss_dssp             ----------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGG
T ss_pred             ccC--------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChh
Confidence            542              244445554 55566666677777777777666 44445556667777777777776 55666


Q ss_pred             ccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCc-c
Q 041034          154 IGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS-L  232 (701)
Q Consensus       154 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~-L  232 (701)
                      |+++++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +
T Consensus       266 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~  343 (727)
T 4b8c_D          266 IKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTG  343 (727)
T ss_dssp             GGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHH
T ss_pred             hhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhh
Confidence            677777777777777776 55666777777777777777776 55666777777777777777777777766654322 2


Q ss_pred             cEEEeccCCCCCCCCcccCCCCcccEEEcCCC--------CCccccCcccCCCCCCcEEEccCccCCC
Q 041034          233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDN--------KIRGIIPDELSKLSNLQYLNLSSNLLSG  292 (701)
Q Consensus       233 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N--------~l~~~~p~~l~~l~~L~~L~L~~N~l~~  292 (701)
                      ..|+|++|.+++.+|..      |+.|+++.|        .+.+..+..+..+..+....+++|-+.+
T Consensus       344 ~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          344 LIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             HHHHHHHCCCCCCCCCC-----------------------------------------------CCCG
T ss_pred             hHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence            34667777777766643      445555555        3444444455566667777778887753

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=1.3e-20  Score=193.36  Aligned_cols=173  Identities=26%  Similarity=0.341  Sum_probs=124.1

Q ss_pred             cCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccc
Q 041034           58 FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLE  137 (701)
Q Consensus        58 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  137 (701)
                      ++.+++|+.|++++|.+... + .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  ..+..+++|+
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~  115 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLK  115 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCC
T ss_pred             hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCC
Confidence            45678899999999999854 3 48889999999999999997655  99999999999999999863  3489999999


Q ss_pred             eeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccc
Q 041034          138 ELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNK  217 (701)
Q Consensus       138 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  217 (701)
                      +|+|++|++++.  ..+..+++|+.|++++|.+++.  ..+..+++|+.|+|++|++++..+  +..+++|++|++++|.
T Consensus       116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence            999999999874  4567777777777777777654  445566666666666666654433  5555555555555555


Q ss_pred             ccCCccccccCCCcccEEEeccCCCCC
Q 041034          218 LTGAIPSTLGHLTSLLYLDLSFNQLHS  244 (701)
Q Consensus       218 l~~~~p~~l~~l~~L~~L~L~~N~l~~  244 (701)
                      |++. | .+..+++|+.|++++|+++.
T Consensus       190 i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          190 ISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCCC-h-hhccCCCCCEEECcCCcccC
Confidence            5532 2 24445555555555555443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.83  E-value=1.4e-22  Score=226.63  Aligned_cols=217  Identities=20%  Similarity=0.162  Sum_probs=161.4

Q ss_pred             CCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccce
Q 041034          107 GSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLER  186 (701)
Q Consensus       107 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  186 (701)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|......|..           +..+.+.+.+|..+..+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence            45667777777777775 56667777777777777555421111110           1122245667778888888888


Q ss_pred             eE-eeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCC
Q 041034          187 LF-LGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNK  265 (701)
Q Consensus       187 L~-L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~  265 (701)
                      |+ ++.|.+           .+|..+.+++|.++...+      ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+
T Consensus       414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence            88 677654           357778888888875433      248889999999988 565 8889999999999999


Q ss_pred             CccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCC-CCcccCCCCCCeeeccCCccCCCCCc
Q 041034          266 IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF-PTGIGNCTELQHLALNHNSLDGTIPP  344 (701)
Q Consensus       266 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~  344 (701)
                      |+ .+|..++.+++|+.|+|++|.|++ +| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++..|.
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            98 778889999999999999999986 56 7888999999999999998776 88899999999999999999876553


Q ss_pred             c---ccccccCCeEEc
Q 041034          345 E---IGKILLLQNLDL  357 (701)
Q Consensus       345 ~---~~~l~~L~~l~l  357 (701)
                      .   +..+++|+.|++
T Consensus       552 ~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          552 QERLAEMLPSVSSILT  567 (567)
T ss_dssp             TTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHCcccCccCC
Confidence            2   344778888864

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=1.2e-20  Score=200.20  Aligned_cols=108  Identities=27%  Similarity=0.254  Sum_probs=49.1

Q ss_pred             CCEEECcCCcCcccCCcccC-CCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEce
Q 041034           88 LKYLNLRWNNLTGTIPKEIG-SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVM  166 (701)
Q Consensus        88 L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  166 (701)
                      ++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44455555554444444444 44455555555554444444444444444444444444444434344444444444444


Q ss_pred             ecccCCCcCcccccccccceeEeeecccC
Q 041034          167 YNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      +|.+++..|..|..+++|+.|+|++|+|+
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  149 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS  149 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCC
Confidence            44443333334444444444444444444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=6.8e-20  Score=181.15  Aligned_cols=155  Identities=25%  Similarity=0.309  Sum_probs=97.1

Q ss_pred             CccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCc
Q 041034          209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN  288 (701)
Q Consensus       209 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  288 (701)
                      +.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            34455555554 3333332  55666666666666655556666666666666666665555555566666666666666


Q ss_pred             cCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCC
Q 041034          289 LLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       289 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      +|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+++|..+
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            666555555666666666666666666 566666667777777777777765555566667777777777777776654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=5.1e-20  Score=180.80  Aligned_cols=134  Identities=22%  Similarity=0.277  Sum_probs=93.0

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            56777777777777666667777777777777777777777777777777777777777777666666667777777777


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      ++|++++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|.+.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            777777666666666666666666666666655555666666666666666554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=6.5e-23  Score=229.36  Aligned_cols=218  Identities=21%  Similarity=0.161  Sum_probs=148.7

Q ss_pred             cCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCc
Q 041034           82 IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLI  161 (701)
Q Consensus        82 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  161 (701)
                      +..+++|+.|+|++|+++ .+|+.++++++|+.|++++|......|           ..+..+.+.+..|..++++++|+
T Consensus       345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~-----------~ll~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII-----------LLMRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH-----------HHHHHHCTGGGHHHHHHHHHHHH
T ss_pred             cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH-----------HHHHhcccccCCHHHHHHHHhcc
Confidence            367899999999999998 789999999999999997765210011           01112233445566666666666


Q ss_pred             EEE-ceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccC
Q 041034          162 WLS-VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN  240 (701)
Q Consensus       162 ~L~-L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N  240 (701)
                      .|+ ++.|.+           ..|+.+.+++|.++...+      ..|+.|+|++|+|++ +|. ++.+++|++|+|++|
T Consensus       413 ~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N  473 (567)
T 1dce_A          413 AVDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN  473 (567)
T ss_dssp             HHCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred             cCcchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence            665 444433           356666666666664322      136777777777775 455 777777777777777


Q ss_pred             CCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCC-cccccCccceeeecCCCCcCCCCCC
Q 041034          241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQI-PFAIGKLFNLVSLDLSKNKLSGSFP  319 (701)
Q Consensus       241 ~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p  319 (701)
                      +|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|.|++.. |..++.+++|+.|+|++|.+++..|
T Consensus       474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            777 467777777777777777777776 45 6777777777888777777665 7777777778888888887776544


Q ss_pred             Cc---ccCCCCCCeeec
Q 041034          320 TG---IGNCTELQHLAL  333 (701)
Q Consensus       320 ~~---~~~l~~L~~L~L  333 (701)
                      ..   +..+++|+.|++
T Consensus       551 ~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          551 IQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CTTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHHCcccCccCC
Confidence            22   223677777764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=6.1e-20  Score=180.25  Aligned_cols=133  Identities=25%  Similarity=0.264  Sum_probs=71.3

Q ss_pred             CCcEEECCCCcceeeCC-cccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           63 NLQYLNLWNNNLSGSIP-PQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        63 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      .++.|+|++|.|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus        33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  112 (220)
T 2v70_A           33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML  112 (220)
T ss_dssp             TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred             CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence            44556666666555433 23555555555555555555555555555555555555555555555555555555555555


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      ++|++++..|..|.++++|+.|+|++|.+++..|..|..+++|+.|+|++|.+.
T Consensus       113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A          113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            555555555555555555555555555554444444444444444444444444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=1.6e-20  Score=216.59  Aligned_cols=153  Identities=26%  Similarity=0.304  Sum_probs=104.2

Q ss_pred             cCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCC
Q 041034          174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNF  253 (701)
Q Consensus       174 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~  253 (701)
                      .+..+..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|.|+ .+|..|+.+
T Consensus       216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l  292 (727)
T 4b8c_D          216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC  292 (727)
T ss_dssp             ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred             ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence            3445556666666666666666 45555566777888888888877 67777888888888888888888 467778888


Q ss_pred             CcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccc-eeeecCCCCcCCCCCCCcccCCCCCCeee
Q 041034          254 SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN-LVSLDLSKNKLSGSFPTGIGNCTELQHLA  332 (701)
Q Consensus       254 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  332 (701)
                      ++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..      |+.|+
T Consensus       293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~  365 (727)
T 4b8c_D          293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIE  365 (727)
T ss_dssp             TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------
T ss_pred             CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeE
Confidence            88888888888887 66777888888888888888888888877755432 234788888888887764      45566


Q ss_pred             ccCC
Q 041034          333 LNHN  336 (701)
Q Consensus       333 L~~N  336 (701)
                      +++|
T Consensus       366 l~~n  369 (727)
T 4b8c_D          366 INTD  369 (727)
T ss_dssp             ----
T ss_pred             eecc
Confidence            6666

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.80  E-value=1e-20  Score=191.16  Aligned_cols=171  Identities=26%  Similarity=0.336  Sum_probs=101.9

Q ss_pred             CCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEE
Q 041034           84 SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL  163 (701)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  163 (701)
                      .+.+++.+++++|.+++..  .+..+++|++|++++|+++.. + .+..+++|++|+|++|++++..+  +.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3556677777777777543  466777777777777777643 3 56667777777777777765544  5556666666


Q ss_pred             EceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCC
Q 041034          164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLH  243 (701)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  243 (701)
                      +|++|++++..+                          +.. ++|++|+|++|++++.  +.+..+++|++|+|++|+++
T Consensus        91 ~L~~N~l~~l~~--------------------------~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~  141 (263)
T 1xeu_A           91 SVNRNRLKNLNG--------------------------IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK  141 (263)
T ss_dssp             ECCSSCCSCCTT--------------------------CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCC
T ss_pred             ECCCCccCCcCc--------------------------ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCC
Confidence            655555544211                          111 4455555555555532  23555566666666666665


Q ss_pred             CCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCC
Q 041034          244 SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ  293 (701)
Q Consensus       244 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  293 (701)
                      +. + .+..+++|+.|+|++|+|++.  ..+..+++|+.|++++|.+++.
T Consensus       142 ~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          142 SI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             BC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            53 2 455566666666666666654  4566666666666666666544

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1.5e-19  Score=182.04  Aligned_cols=140  Identities=23%  Similarity=0.273  Sum_probs=107.3

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcE--EEEEEecCCCccC---------------------hHHHHHHHHHHHHHhcC
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKV--VALKKLHQSETED---------------------SAFVESFQNEARVLSTV  506 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l  506 (701)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||+++......                     ......+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999976 67888  9999876542110                     11124678999999999


Q ss_pred             CCCce--eeeeeeeeeCcEEEEEEEccCC-C----CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEe
Q 041034          507 RHRNI--VKLYGFCLHKRCMFFIYEYMER-G----SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH-HDCTPSIVH  578 (701)
Q Consensus       507 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~givH  578 (701)
                      .|+++  +.++++    ...++||||+.+ |    +|.++...      .++..+..++.|++.||.||| +.   ||+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            88754  334432    346899999942 3    67666432      223456789999999999999 88   9999


Q ss_pred             cCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          579 RDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       579 ~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999988  9999999999754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=4.4e-20  Score=186.53  Aligned_cols=171  Identities=25%  Similarity=0.304  Sum_probs=120.5

Q ss_pred             CCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccccee
Q 041034           60 CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        60 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  139 (701)
                      .+.++..+++++|.++...  .+..+++|++|++++|.++. +| .+..+++|++|+|++|++++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3456778899999998654  58889999999999999984 45 78999999999999999997766  9999999999


Q ss_pred             ecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccccc
Q 041034          140 YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       140 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  219 (701)
                      +|++|++++..+  +.. ++|+.|+|++|.+++.  ..+..+++|+.|+|++|++++.                      
T Consensus        91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~----------------------  143 (263)
T 1xeu_A           91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI----------------------  143 (263)
T ss_dssp             ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC----------------------
T ss_pred             ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC----------------------
Confidence            999999997533  222 7777777777777653  2355555555555555555432                      


Q ss_pred             CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccc
Q 041034          220 GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI  269 (701)
Q Consensus       220 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~  269 (701)
                         + .+..+++|++|+|++|++++.  ..+..+++|+.|++++|.+++.
T Consensus       144 ---~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          144 ---V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             ---G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ---h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence               1 344455555555555555553  3455555555555555555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=7.5e-19  Score=169.40  Aligned_cols=152  Identities=18%  Similarity=0.205  Sum_probs=77.5

Q ss_pred             ccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEE
Q 041034          205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLN  284 (701)
Q Consensus       205 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  284 (701)
                      +++|++|++++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|+.|++++|++++..|..++.+++|+.|+
T Consensus        43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            344444444444444 222 34444555555555554432  12444555555555555555554555555555555555


Q ss_pred             ccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCc
Q 041034          285 LSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS  363 (701)
Q Consensus       285 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  363 (701)
                      +++|.+++..|..+..+++|+.|++++|.+.+.+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence            55555555455555555555555555555222333 45555666666666666653 22 4555666666666666654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=7e-19  Score=169.59  Aligned_cols=156  Identities=20%  Similarity=0.260  Sum_probs=137.3

Q ss_pred             ccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcc
Q 041034          177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL  256 (701)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L  256 (701)
                      ....+++|+.|++++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..++.+++|
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            4477899999999999998 555 68999999999999997763  3478999999999999999999888999999999


Q ss_pred             cEEEcCCCCCccccCcccCCCCCCcEEEccCcc-CCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccC
Q 041034          257 AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL-LSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH  335 (701)
Q Consensus       257 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  335 (701)
                      +.|+|++|++++..|..+..+++|+.|++++|. ++ .+| .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~  190 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS  190 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence            999999999999888999999999999999998 65 555 68999999999999999996 44 789999999999999


Q ss_pred             CccCC
Q 041034          336 NSLDG  340 (701)
Q Consensus       336 N~l~~  340 (701)
                      |++.+
T Consensus       191 N~i~~  195 (197)
T 4ezg_A          191 QTIGG  195 (197)
T ss_dssp             C----
T ss_pred             cccCC
Confidence            99864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=6.9e-19  Score=168.84  Aligned_cols=132  Identities=24%  Similarity=0.299  Sum_probs=77.4

Q ss_pred             CccccccccccCCccccccCCCcccEEEeccCCCCCCCCc-ccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccC
Q 041034          209 THLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPL-EIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSS  287 (701)
Q Consensus       209 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  287 (701)
                      ++|++++|+++ .+|..+..  +|++|+|++|+|++..+. .|..+++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            45666666664 44444432  566666666666654443 355666666666666666665566666666666666666


Q ss_pred             ccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCC
Q 041034          288 NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIP  343 (701)
Q Consensus       288 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  343 (701)
                      |+|++..+..|..+++|+.|+|++|+|++..|..+..+++|++|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            66665555555556666666666666665555555555666666666665555433

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=1.6e-18  Score=166.33  Aligned_cols=130  Identities=30%  Similarity=0.366  Sum_probs=67.1

Q ss_pred             ceeEeeecccCCCCCCCCCCccccCccccccccccCCccc-cccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCC
Q 041034          185 ERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS-TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD  263 (701)
Q Consensus       185 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~  263 (701)
                      +.+++++|+++ .+|..+..  +|++|++++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            44555555553 33433322  455555555555544332 245555555555555555555455555555555555555


Q ss_pred             CCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCC
Q 041034          264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS  317 (701)
Q Consensus       264 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  317 (701)
                      |+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            555555555555555555555555555555555555555555555555555543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=2.3e-18  Score=180.22  Aligned_cols=101  Identities=18%  Similarity=0.123  Sum_probs=46.4

Q ss_pred             CCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCc-EEEccCccCCCCCcccccCccceeee
Q 041034          229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQ-YLNLSSNLLSGQIPFAIGKLFNLVSL  307 (701)
Q Consensus       229 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L  307 (701)
                      +++|+.|+|++|+++.+.+..|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++...+.+|.++++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            344555555554444444444444555555555444 4434444444444454 444444 3433333444444444444


Q ss_pred             cCCCCcCCCCCCCcccCCCCCCee
Q 041034          308 DLSKNKLSGSFPTGIGNCTELQHL  331 (701)
Q Consensus       308 ~Ls~N~l~~~~p~~~~~l~~L~~L  331 (701)
                      ++++|+++..-+.+|.++++|+.|
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEE
T ss_pred             EeCCCccCccchhhhcCCcchhhh
Confidence            444444443333344444444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=2.6e-19  Score=187.41  Aligned_cols=283  Identities=13%  Similarity=0.079  Sum_probs=181.6

Q ss_pred             CCCCcEEECCCCcceeeCCcccCC-CCCCCEEECcCCcCc--ccCCcccCCCCCCCEEECCCCCCCCCCccccCC-----
Q 041034           61 FPNLQYLNLWNNNLSGSIPPQIGS-LSNLKYLNLRWNNLT--GTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS-----  132 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----  132 (701)
                      +++++.|.++++ +...-...+.. +++|++|||++|++.  ...+..+   +.++.+.+..|.+   .+..|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccc
Confidence            345667766543 21111112222 667777777777776  2222222   2244455555532   2344555     


Q ss_pred             ---ccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecc----cCCCCCCCCCCc
Q 041034          133 ---LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQ----FNGTIPREIGNL  205 (701)
Q Consensus       133 ---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l  205 (701)
                         +++|+.|+|.+ .++.+.+.+|.++++|+.|++.+|.+....+..|.++.++..+.++.+.    ........|.++
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~  175 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG  175 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence               67777777776 6666666667777777777777776666666666666666555554421    122223334444


Q ss_pred             cccC-ccccccccccCCccccc----cCCCcccEEEeccCCCCCCCCccc-CCCCcccEEEcCCCCCccccCcccCCCCC
Q 041034          206 KNLT-HLSIITNKLTGAIPSTL----GHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDELSKLSN  279 (701)
Q Consensus       206 ~~L~-~L~l~~N~l~~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~~-~~~~~L~~L~L~~N~l~~~~p~~l~~l~~  279 (701)
                      ..|+ .+.+....   .++..+    ....++..+.+.++-... ....+ ..+++|+.|+|++|+++.+.+.+|.++++
T Consensus       176 ~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~-~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~  251 (329)
T 3sb4_A          176 EPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNA-DFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY  251 (329)
T ss_dssp             CCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHH-HHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred             cccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHH-HHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence            4444 22222211   111111    134566777776653221 11111 23789999999999999888889999999


Q ss_pred             CcEEEccCccCCCCCcccccCcccee-eecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEc
Q 041034          280 LQYLNLSSNLLSGQIPFAIGKLFNLV-SLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDL  357 (701)
Q Consensus       280 L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  357 (701)
                      |+.|+|.+| ++...+.+|.++.+|+ .|++.+ .++..-+.+|.+|++|+.|++++|+++..-+..|.++++|+.++.
T Consensus       252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            999999998 8767778899999999 999998 787667789999999999999999999777789999999999874

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.72  E-value=1.9e-16  Score=169.32  Aligned_cols=270  Identities=9%  Similarity=0.026  Sum_probs=139.0

Q ss_pred             CCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceee
Q 041034           61 FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELY  140 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  140 (701)
                      +..++.+.+.+ .++.+...+|.+. +|+.++|..| ++.+...+|.+ .+|+.+.|.+ .++.+.+.+|.++++|+.++
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            35566666643 3444555566654 5777776655 55555556666 3577777764 55555556666666677777


Q ss_pred             cccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccC
Q 041034          141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG  220 (701)
Q Consensus       141 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  220 (701)
                      |.+|+++.+...+|. ..+|+.+.|..+ +......+|.++++|+.++|..| ++.....+|.+ .+|+.+.+ .|.++.
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~  261 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN  261 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence            666666655555555 356666666532 44444555556666666665543 33333444444 45555555 333443


Q ss_pred             CccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccC
Q 041034          221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK  300 (701)
Q Consensus       221 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  300 (701)
                      ..+.+|.++++|+.+++.+|.+..                   +.+..+.+.+|.++++|+.++|. |.++.....+|.+
T Consensus       262 I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~  321 (401)
T 4fdw_A          262 IASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGG  321 (401)
T ss_dssp             ECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTT
T ss_pred             EChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcC
Confidence            444455555555555555544430                   00002333444445555555554 2244333344444


Q ss_pred             ccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccc-cCCeEEcccccC
Q 041034          301 LFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL-LLQNLDLSHNNL  362 (701)
Q Consensus       301 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~ls~N~l  362 (701)
                      +.+|+.|+|..| ++..-+.+|.++ +|+.|++++|.+....+..|..++ .++.|++..|.+
T Consensus       322 c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          322 NRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             CCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             CCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            555555555332 333334445555 555555555555433344444442 455555555443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=8.7e-18  Score=175.45  Aligned_cols=142  Identities=11%  Similarity=0.124  Sum_probs=100.8

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc--------------C-hHH----HHHHHHHHHHHhcCCCCc
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE--------------D-SAF----VESFQNEARVLSTVRHRN  510 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~-~~~----~~~~~~E~~~l~~l~h~n  510 (701)
                      .=|++...||+|++|.||+|...+|+.||||+++.....              . ...    .-...+|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            349999999999999999999889999999987643211              0 000    111234666666664443


Q ss_pred             eeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       511 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      +....-+...  ..++||||++|++|.++...         .....++.|++.+|.|||++   |||||||||.|||+++
T Consensus       175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            3221111111  23699999999888654321         12356889999999999999   9999999999999987


Q ss_pred             CC----------CeEEEeecCcccc
Q 041034          591 NL----------EAFVADFGTARLL  605 (701)
Q Consensus       591 ~~----------~~kL~DFGla~~~  605 (701)
                      ++          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999988654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.70  E-value=2.7e-17  Score=154.06  Aligned_cols=133  Identities=25%  Similarity=0.205  Sum_probs=83.2

Q ss_pred             CCCCcEEECCCCcce-eeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccccee
Q 041034           61 FPNLQYLNLWNNNLS-GSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  139 (701)
                      .++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++.  ..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            356777777777776 56666667777777777777777654  566667777777777777766566666666677777


Q ss_pred             ecccccCCCCC-cccccCCCCCcEEEceecccCCCcC---cccccccccceeEeeecccC
Q 041034          140 YLRSNKLSGVL-PQEIGNLKSLIWLSVMYNTVGGPIP---STLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       140 ~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~  195 (701)
                      +|++|++++.. +..+..+++|+.|++++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            77777666542 2455555555555555555554433   34455555555555555544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.69  E-value=1.4e-16  Score=150.59  Aligned_cols=134  Identities=24%  Similarity=0.262  Sum_probs=95.6

Q ss_pred             CCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcc
Q 041034           26 CNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE  105 (701)
Q Consensus        26 c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~  105 (701)
                      |.|.++.|+..           +++. ++   ....++|+.|++++|++++..+..|+.+++|++|+|++|++++..+..
T Consensus         7 C~~~~l~~~~~-----------~l~~-~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (177)
T 2o6r_A            7 CSGTEIRCNSK-----------GLTS-VP---TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV   71 (177)
T ss_dssp             EETTEEECCSS-----------CCSS-CC---TTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             eCCCEEEecCC-----------CCcc-CC---CCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence            67888887633           2221 21   223467788888888887666666777888888888888887766667


Q ss_pred             cCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCc
Q 041034          106 IGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI  174 (701)
Q Consensus       106 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  174 (701)
                      |.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.+..
T Consensus        72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            778888888888888887777667777778888888888777666666677777777777777666544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.69  E-value=4.7e-16  Score=166.31  Aligned_cols=228  Identities=12%  Similarity=0.066  Sum_probs=174.6

Q ss_pred             cCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCC
Q 041034           53 LGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGS  132 (701)
Q Consensus        53 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  132 (701)
                      ++...|... +|+.+.+..+ ++.+...+|.+. +|+.++|.. .++.+.+.+|.++++|+.++|++|+++.+....|. 
T Consensus       127 I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-  201 (401)
T 4fdw_A          127 IPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-  201 (401)
T ss_dssp             ECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-
T ss_pred             ehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-
Confidence            455567774 7999999876 777777888885 799999986 78778888999999999999999999977777777 


Q ss_pred             ccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccc
Q 041034          133 LRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLS  212 (701)
Q Consensus       133 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  212 (701)
                      .++|+.+.|..+ +..+...+|.++++|+.+.+..| ++.....+|.+ ++|+.+.| .|.++.....+|.++++|+.+.
T Consensus       202 ~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~  277 (401)
T 4fdw_A          202 YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVT  277 (401)
T ss_dssp             TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEE
T ss_pred             ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEE
Confidence            589999999854 88788899999999999999875 66566667777 89999999 5667767788999999999999


Q ss_pred             ccccccc-----CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccC
Q 041034          213 IITNKLT-----GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSS  287 (701)
Q Consensus       213 l~~N~l~-----~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  287 (701)
                      +.+|.+.     ...+.+|.+|++|+.++|. +.++.+...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++
T Consensus       278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~  354 (401)
T 4fdw_A          278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEG  354 (401)
T ss_dssp             EESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECC
T ss_pred             eCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcC
Confidence            9998775     3445566666667776666 3455555556666666666666433 444555556665 666666666


Q ss_pred             ccCCC
Q 041034          288 NLLSG  292 (701)
Q Consensus       288 N~l~~  292 (701)
                      |.+..
T Consensus       355 n~~~~  359 (401)
T 4fdw_A          355 TTPPQ  359 (401)
T ss_dssp             SSCCB
T ss_pred             CCCcc
Confidence            55543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=6.6e-17  Score=151.39  Aligned_cols=132  Identities=21%  Similarity=0.218  Sum_probs=68.7

Q ss_pred             CCCcEEEceecccC-CCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEE
Q 041034          158 KSLIWLSVMYNTVG-GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLD  236 (701)
Q Consensus       158 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  236 (701)
                      ++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555554 44455555555666666666655543  4455555555555555555554555555555555555


Q ss_pred             eccCCCCCCCC-cccCCCCcccEEEcCCCCCccccC---cccCCCCCCcEEEccCccCC
Q 041034          237 LSFNQLHSFIP-LEIGNFSALAELDLSDNKIRGIIP---DELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       237 L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~L~~N~l~  291 (701)
                      |++|++++..+ ..+..+++|+.|++++|.+++..+   ..+..+++|+.|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            55555555311 344455555555555555553333   24444555555555555444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=2.2e-16  Score=149.18  Aligned_cols=133  Identities=27%  Similarity=0.277  Sum_probs=80.4

Q ss_pred             ccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCC
Q 041034          232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK  311 (701)
Q Consensus       232 L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  311 (701)
                      .+.+++++|+++. +|..+  .++|+.|++++|++++..+..|..+++|+.|++++|.+++..+..+..+++|+.|+|++
T Consensus         9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            3455555555554 23222  24566666666666655555556666666666666666655555556666666666666


Q ss_pred             CcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCC
Q 041034          312 NKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       312 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      |++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|+++|.+|
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            66665555556666666666776666665444445666677777777777766555

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=1.7e-16  Score=152.03  Aligned_cols=132  Identities=25%  Similarity=0.309  Sum_probs=93.9

Q ss_pred             cEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCC
Q 041034          233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKN  312 (701)
Q Consensus       233 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  312 (701)
                      +++++++|.++. +|..+  .++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~~-ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLKV-LPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCSS-CCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCCc-CCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            456666666665 44433  246777777777776 45666777777777777777777666667777777777777777


Q ss_pred             cCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCC
Q 041034          313 KLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPM  368 (701)
Q Consensus       313 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  368 (701)
                      +|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+....
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l  144 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM  144 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence            77766666777777888888888888765555677788888888888888776553

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=3.7e-17  Score=149.79  Aligned_cols=128  Identities=22%  Similarity=0.206  Sum_probs=88.8

Q ss_pred             CCCCcEEECCCCcce-eeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccccee
Q 041034           61 FPNLQYLNLWNNNLS-GSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        61 ~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  139 (701)
                      .++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            366777788887777 66777777777778888877777755  567777777777777777776666666677777777


Q ss_pred             ecccccCCCC-CcccccCCCCCcEEEceecccCCCcC---cccccccccceeEee
Q 041034          140 YLRSNKLSGV-LPQEIGNLKSLIWLSVMYNTVGGPIP---STLFRLTNLERLFLG  190 (701)
Q Consensus       140 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~  190 (701)
                      +|++|++++. .+..+..+++|++|++++|.+++..+   ..+..+++|+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            7777777753 33566666666666666666655544   345556666666554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=6.4e-17  Score=148.23  Aligned_cols=127  Identities=24%  Similarity=0.201  Sum_probs=88.3

Q ss_pred             CcccEEEeccCCCC-CCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeec
Q 041034          230 TSLLYLDLSFNQLH-SFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLD  308 (701)
Q Consensus       230 ~~L~~L~L~~N~l~-~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  308 (701)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            55667777777766 45666666677777777777777655  5566777777777777777766666666677777777


Q ss_pred             CCCCcCCCC-CCCcccCCCCCCeeeccCCccCCCCC---ccccccccCCeEEcc
Q 041034          309 LSKNKLSGS-FPTGIGNCTELQHLALNHNSLDGTIP---PEIGKILLLQNLDLS  358 (701)
Q Consensus       309 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls  358 (701)
                      +++|.+++. .|..+..+++|++|++++|++++..+   ..++.+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            777777652 33667777777777777777776554   467777777777765

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=2.5e-16  Score=150.97  Aligned_cols=108  Identities=23%  Similarity=0.332  Sum_probs=52.0

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ++|++|+|++|.|+ .+|..|..+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            34455555555554 33444445555555555555555444444555555555555555555444444444444555555


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceeccc
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTV  170 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  170 (701)
                      ++|+++...+..|..+++|+.|+|++|.+
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence            54444444444444444444444444444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.61  E-value=1.3e-17  Score=160.84  Aligned_cols=153  Identities=22%  Similarity=0.287  Sum_probs=88.5

Q ss_pred             CccccceeecccccCCCCCcc------cccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCc
Q 041034          132 SLRNLEELYLRSNKLSGVLPQ------EIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNL  205 (701)
Q Consensus       132 ~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  205 (701)
                      ....++.++++.|.+++..|.      .|..+++|++|++++|.+++ +| .+..+++|+.|++++|+++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            344555555555555555444      55556666666666666655 33 5666666666666666665 445555555


Q ss_pred             cccCccccccccccCCccccccCCCcccEEEeccCCCCCCCC-cccCCCCcccEEEcCCCCCccccCcc----------c
Q 041034          206 KNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIP-LEIGNFSALAELDLSDNKIRGIIPDE----------L  274 (701)
Q Consensus       206 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~----------l  274 (701)
                      ++|++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+++..|..          +
T Consensus        93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  170 (198)
T 1ds9_A           93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV  170 (198)
T ss_dssp             HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred             CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence            666666666666664 33 45666666666666666665322 34566666666666666666554432          4


Q ss_pred             CCCCCCcEEEccCccCC
Q 041034          275 SKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       275 ~~l~~L~~L~L~~N~l~  291 (701)
                      ..+++|+.|+  +|.++
T Consensus       171 ~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          171 KRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHCSSCSEEC--CGGGT
T ss_pred             HhCCCcEEEC--CcccC
Confidence            5555666554  44444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=7.9e-18  Score=162.33  Aligned_cols=133  Identities=21%  Similarity=0.267  Sum_probs=68.7

Q ss_pred             CCCCCCEEECcCCcCcccCCc------ccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCC
Q 041034           84 SLSNLKYLNLRWNNLTGTIPK------EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNL  157 (701)
Q Consensus        84 ~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  157 (701)
                      ....++.++++.+.++|..|.      .|..+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            344555555555555555544      55566666666666666654 33 5555666666666666655 334444444


Q ss_pred             CCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCC-CCCCCccccCccccccccccCC
Q 041034          158 KSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIP-REIGNLKNLTHLSIITNKLTGA  221 (701)
Q Consensus       158 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~  221 (701)
                      ++|++|++++|.+++. | .+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++.
T Consensus        93 ~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~  155 (198)
T 1ds9_A           93 DTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred             CcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence            5555555555555442 2 34455555555555555543211 2344444455555555544443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=1.8e-15  Score=142.71  Aligned_cols=132  Identities=22%  Similarity=0.214  Sum_probs=92.7

Q ss_pred             ccCCCcccEEEeccCCCCCCCCcccCCC-CcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccce
Q 041034          226 LGHLTSLLYLDLSFNQLHSFIPLEIGNF-SALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNL  304 (701)
Q Consensus       226 l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  304 (701)
                      +..+++|+.|++++|+++.. |. +..+ ++|+.|+|++|.|++.  ..+..+++|+.|+|++|.+++..+..+..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            45566777777777777753 43 3333 3777777777777754  467777777777777777775544445777777


Q ss_pred             eeecCCCCcCCCCCCC--cccCCCCCCeeeccCCccCCCCCcc----ccccccCCeEEcccccCc
Q 041034          305 VSLDLSKNKLSGSFPT--GIGNCTELQHLALNHNSLDGTIPPE----IGKILLLQNLDLSHNNLS  363 (701)
Q Consensus       305 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~l~ls~N~l~  363 (701)
                      +.|+|++|+++ .+|.  .+..+++|+.|++++|+++ .+|..    ++.+++|+.||+++|...
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            77777777775 4555  6777788888888888887 45553    778888888888887764

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=2.5e-15  Score=141.81  Aligned_cols=109  Identities=24%  Similarity=0.305  Sum_probs=57.4

Q ss_pred             cCCCCCCcEEECCCCcceeeCCcccCCCC-CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccc
Q 041034           58 FSCFPNLQYLNLWNNNLSGSIPPQIGSLS-NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNL  136 (701)
Q Consensus        58 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  136 (701)
                      +..+++|+.|++++|.++. +|. +..+. +|++|+|++|.+++.  +.|..+++|++|+|++|++++..+..|..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            3445556666666666653 233 33333 666666666666644  455566666666666666654444444555566


Q ss_pred             ceeecccccCCCCCcc--cccCCCCCcEEEceecccC
Q 041034          137 EELYLRSNKLSGVLPQ--EIGNLKSLIWLSVMYNTVG  171 (701)
Q Consensus       137 ~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~  171 (701)
                      ++|+|++|+++. +|.  .+..+++|+.|++++|.++
T Consensus        91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC
Confidence            666666665543 222  4444444444444444443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.54  E-value=1.4e-13  Score=147.58  Aligned_cols=295  Identities=13%  Similarity=0.033  Sum_probs=177.1

Q ss_pred             ccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccC
Q 041034           52 ELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG  131 (701)
Q Consensus        52 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  131 (701)
                      .++...|..+.+|+.+.|.. .++.+...+|.++++|+.++|..+ ++.+...+|.++++|+.+.+..+ +......+|.
T Consensus        61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~  137 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK  137 (394)
T ss_dssp             EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred             EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence            36677899999999999975 477677788999999999999765 66566778999999998887654 4334444555


Q ss_pred             CccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcc
Q 041034          132 SLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHL  211 (701)
Q Consensus       132 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  211 (701)
                      +...++.......  ......+|.++++|+.+.+..+ +.......|.++++|+.+.+..| ++.....+|.++..|+.+
T Consensus       138 ~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i  213 (394)
T 4fs7_A          138 GCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENM  213 (394)
T ss_dssp             TCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBC
T ss_pred             cccccccccCccc--cccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhcccccccee
Confidence            5543333322222  2233456666666776666543 23344455666666666666554 333444556666666665


Q ss_pred             cccccccc---------------------CCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCcccc
Q 041034          212 SIITNKLT---------------------GAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGII  270 (701)
Q Consensus       212 ~l~~N~l~---------------------~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~  270 (701)
                      .+..+...                     ......+..+.+|+.+.+..+.. ......|..+..++.+....+.+.   
T Consensus       214 ~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~---  289 (394)
T 4fs7_A          214 EFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVP---  289 (394)
T ss_dssp             CCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEEC---
T ss_pred             ecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceeec---
Confidence            55444321                     12223344455555555554432 223344555555555555444322   


Q ss_pred             CcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccc
Q 041034          271 PDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL  350 (701)
Q Consensus       271 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  350 (701)
                      ...|..+.+|+.+.+.++ ++.....+|.++.+|+.++|.++ ++..-..+|.++++|+.+++..| ++..-..+|.++.
T Consensus       290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~  366 (394)
T 4fs7_A          290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI  366 (394)
T ss_dssp             TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred             cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence            235666667777777554 44344556667777777777543 55344556777777777777665 5544455677777


Q ss_pred             cCCeEEcccc
Q 041034          351 LLQNLDLSHN  360 (701)
Q Consensus       351 ~L~~l~ls~N  360 (701)
                      +|+.+++..+
T Consensus       367 ~L~~i~lp~~  376 (394)
T 4fs7_A          367 NLKKVELPKR  376 (394)
T ss_dssp             TCCEEEEEGG
T ss_pred             CCCEEEECCC
Confidence            7777776543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.54  E-value=1.9e-13  Score=146.39  Aligned_cols=301  Identities=14%  Similarity=0.113  Sum_probs=218.6

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCc--------------------
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN--------------------   97 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--------------------   97 (701)
                      .++++.+.. +++ .++...|..+++|+.++|.++ ++.+...+|.++++|+.+.+..+-                    
T Consensus        72 ~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~~  148 (394)
T 4fs7_A           72 KVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIPE  148 (394)
T ss_dssp             TEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECCT
T ss_pred             CceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccCc
Confidence            577777753 344 567778999999999999765 666677789999988887775431                    


Q ss_pred             -CcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCc
Q 041034           98 -LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPS  176 (701)
Q Consensus        98 -l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  176 (701)
                       +..+...+|.++++|+.+.+.++- ..+....|.++++|+.+.+..| +..+...+|.+...|+.+.+..+..  .+..
T Consensus       149 ~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~--~i~~  224 (394)
T 4fs7_A          149 GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLY--YLGD  224 (394)
T ss_dssp             TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCC--EECT
T ss_pred             cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCce--Eeeh
Confidence             111223456677777777776543 3355566777777777777665 5555566777777777776655433  1223


Q ss_pred             ccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcc
Q 041034          177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL  256 (701)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L  256 (701)
                      .+...++|+.+.+..+ ++......+..+..|+.+.+..+... .....|..+..++.+....+.+.   ...|..+.+|
T Consensus       225 ~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L  299 (394)
T 4fs7_A          225 FALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSL  299 (394)
T ss_dssp             TTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTC
T ss_pred             hhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccc
Confidence            3444567777777543 33344567888889999999877554 66678889999999998877643   3568889999


Q ss_pred             cEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCC
Q 041034          257 AELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN  336 (701)
Q Consensus       257 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  336 (701)
                      +.+.+.++ ++.+...+|.++++|+.++|.++ ++.....+|.++.+|+.+++..| ++..-..+|.++++|+.+++..+
T Consensus       300 ~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          300 TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             cccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            99999865 67677788999999999999755 76566778999999999999877 76566778999999999999865


Q ss_pred             ccCCCCCccccccccCCeE
Q 041034          337 SLDGTIPPEIGKILLLQNL  355 (701)
Q Consensus       337 ~l~~~~p~~~~~l~~L~~l  355 (701)
                       ++ .+...|.++++|+.+
T Consensus       377 -~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          377 -LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             -GG-GGGGGBCTTCEEEEE
T ss_pred             -CE-EhhheecCCCCCcEE
Confidence             33 345677777777754

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=4.1e-14  Score=132.44  Aligned_cols=105  Identities=30%  Similarity=0.312  Sum_probs=56.9

Q ss_pred             ccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCC
Q 041034          232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSK  311 (701)
Q Consensus       232 L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  311 (701)
                      .+.+++++|.++. +|..+  .++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4556666666655 34333  25556666666666655555555555555555555555544444445555555555555


Q ss_pred             CcCCCCCCCcccCCCCCCeeeccCCccC
Q 041034          312 NKLSGSFPTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       312 N~l~~~~p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      |+|++..+..|..+++|++|+|++|+++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            5555444444555555555555555554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=5.4e-14  Score=131.64  Aligned_cols=105  Identities=26%  Similarity=0.278  Sum_probs=64.7

Q ss_pred             EEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccccc
Q 041034           66 YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNK  145 (701)
Q Consensus        66 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~  145 (701)
                      .|++++|.++. +|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            45555555552 444332  566666666666666666666666666666666666666555556666666666666666


Q ss_pred             CCCCCcccccCCCCCcEEEceecccCCC
Q 041034          146 LSGVLPQEIGNLKSLIWLSVMYNTVGGP  173 (701)
Q Consensus       146 l~~~~~~~~~~l~~L~~L~L~~N~l~~~  173 (701)
                      |++..+..|.++++|+.|+|++|.+...
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            6665555566666666666666665543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.50  E-value=9.9e-14  Score=130.30  Aligned_cols=104  Identities=29%  Similarity=0.336  Sum_probs=68.5

Q ss_pred             EEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccccc
Q 041034           66 YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNK  145 (701)
Q Consensus        66 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~  145 (701)
                      .+++++|++. .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            4566666664 4555443  667777777777776666677777777777777777776655556667777777777777


Q ss_pred             CCCCCcccccCCCCCcEEEceecccCC
Q 041034          146 LSGVLPQEIGNLKSLIWLSVMYNTVGG  172 (701)
Q Consensus       146 l~~~~~~~~~~l~~L~~L~L~~N~l~~  172 (701)
                      |++..+..|..+++|+.|+|++|.+..
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             cceeCHHHhccccCCCEEEeCCCCccc
Confidence            766555556666666666666666654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=1.4e-13  Score=129.38  Aligned_cols=104  Identities=30%  Similarity=0.343  Sum_probs=61.0

Q ss_pred             cEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCC
Q 041034          233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKN  312 (701)
Q Consensus       233 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  312 (701)
                      +.+++++|+++. +|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            566666666654 444432  56666666666666666666666666666666666666544444555566666666666


Q ss_pred             cCCCCCCCcccCCCCCCeeeccCCccC
Q 041034          313 KLSGSFPTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       313 ~l~~~~p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      +|++..+..|..+++|++|+|++|++.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            665443334555555555555555555

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.39  E-value=6.3e-12  Score=134.59  Aligned_cols=299  Identities=11%  Similarity=0.120  Sum_probs=195.1

Q ss_pred             ccCCcccCCCC-CCcEEECCCCcceeeCCcccCCCCCCCEEECcCCc---CcccCCcccCCCCCCCEEECCCCCCCCCCc
Q 041034           52 ELGSLNFSCFP-NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN---LTGTIPKEIGSLRNLEVLYLSNNSLHGTTP  127 (701)
Q Consensus        52 ~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  127 (701)
                      .++...|..+. .|+.+.+..+ ++.+...+|.++++|+.+.+..|.   ++.+-..+|.++.+|+.+.+..+ ++.+..
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~  130 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS  130 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred             EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence            35666787764 5999999754 777778889999999999998764   66566778888999998888755 555666


Q ss_pred             cccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccc
Q 041034          128 IEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKN  207 (701)
Q Consensus       128 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  207 (701)
                      ..|..+.+|+.+.+..+ +..+...+|.+..+|+.+.+..+ +.......|. ..+|+.+.+..+-.. ....+|..+.+
T Consensus       131 ~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~  206 (394)
T 4gt6_A          131 EAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFA  206 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTT
T ss_pred             hhhhhhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccc
Confidence            78888999999998754 44466678888888998888655 4333344444 467888887654332 44556666666


Q ss_pred             cCccccccccccCCcccc--------------ccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcc
Q 041034          208 LTHLSIITNKLTGAIPST--------------LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE  273 (701)
Q Consensus       208 L~~L~l~~N~l~~~~p~~--------------l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~  273 (701)
                      ++......+..... ...              +.....+..+.+. +.+..+...+|.++..|+.+.+.++..+ +...+
T Consensus       207 l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~a  283 (394)
T 4gt6_A          207 LSTITSDSESYPAI-DNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGA  283 (394)
T ss_dssp             CCEEEECCSSSCBS-SSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTT
T ss_pred             cceecccccccccc-cceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcc
Confidence            66665554433211 111              1111223333332 2233333456677777777777655443 55566


Q ss_pred             cCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCC
Q 041034          274 LSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQ  353 (701)
Q Consensus       274 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  353 (701)
                      |.++++|+.+.+. +.++.....+|.++.+|+.++|..+ ++..-..+|.+|++|+.+.|..+ ++..-..+|.++++|+
T Consensus       284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~  360 (394)
T 4gt6_A          284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALN  360 (394)
T ss_dssp             TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCC
T ss_pred             cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCC
Confidence            7777777777775 4455445566777777777777654 54344566777777777777644 5544456677777777


Q ss_pred             eEEcccccC
Q 041034          354 NLDLSHNNL  362 (701)
Q Consensus       354 ~l~ls~N~l  362 (701)
                      .+++.+|..
T Consensus       361 ~i~~~~~~~  369 (394)
T 4gt6_A          361 NIEYSGSRS  369 (394)
T ss_dssp             EEEESSCHH
T ss_pred             EEEECCcee
Confidence            777777643

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.36  E-value=4.5e-15  Score=157.10  Aligned_cols=38  Identities=21%  Similarity=0.282  Sum_probs=20.6

Q ss_pred             CCCCEEECCCCCCCCCCccccCCc-----cccceeecccccCC
Q 041034          110 RNLEVLYLSNNSLHGTTPIEIGSL-----RNLEELYLRSNKLS  147 (701)
Q Consensus       110 ~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~  147 (701)
                      ++|+.|+|++|.++......+...     ++|++|+|++|.++
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~  114 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD  114 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCC
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCC
Confidence            556677777777664333333222     45556666655554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=1.3e-12  Score=137.51  Aligned_cols=108  Identities=25%  Similarity=0.280  Sum_probs=58.0

Q ss_pred             CCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCC-CcceeeCCcccCCCCCCCEEECcCCcCcccCCc
Q 041034           26 CNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWN-NNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK  104 (701)
Q Consensus        26 c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~  104 (701)
                      |.|..|.|...+          ++++ +|.  +..+++|+.|+|++ |.|++..+..|+.|++|++|+|++|+|++..|.
T Consensus         8 C~~~~v~~~~~n----------~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A            8 HGSSGLRCTRDG----------ALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             SSSSCEECCSSC----------CCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred             ccCCEEEcCCCC----------CCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence            777777665321          2332 333  44555555555553 555555555555555555555555555555555


Q ss_pred             ccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCC
Q 041034          105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLS  147 (701)
Q Consensus       105 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  147 (701)
                      .|.+|++|++|+|++|+|++..+..|..++ |+.|+|.+|.+.
T Consensus        75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            555555555555555555544444444443 555555555544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.35  E-value=4e-15  Score=157.53  Aligned_cols=65  Identities=22%  Similarity=0.171  Sum_probs=42.3

Q ss_pred             CCCCCEEECcCCcCcccCCcccCC-----CCCCCEEECCCCCCCCCCcccc-CCccccceeecccccCCCC
Q 041034           85 LSNLKYLNLRWNNLTGTIPKEIGS-----LRNLEVLYLSNNSLHGTTPIEI-GSLRNLEELYLRSNKLSGV  149 (701)
Q Consensus        85 l~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~  149 (701)
                      +++|++|+|++|.++......+..     .++|++|+|++|.++......+ ..+++|++|+|++|+++..
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~  141 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPE  141 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHH
Confidence            356888888888887544333322     2688888888888865433333 2456677777777776543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.34  E-value=1.6e-12  Score=136.63  Aligned_cols=131  Identities=20%  Similarity=0.123  Sum_probs=61.6

Q ss_pred             EEeccC-CCCCCCCcccCCCCcccEEEcCC-CCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCC
Q 041034          235 LDLSFN-QLHSFIPLEIGNFSALAELDLSD-NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKN  312 (701)
Q Consensus       235 L~L~~N-~l~~~~~~~~~~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  312 (701)
                      ++++++ +|++ +|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            344444 4444 333 44555555555553 5555444445555555555555555555555555555555555555555


Q ss_pred             cCCCCCCCcccCCCCCCeeeccCCccCCCCC-ccccccccCCeEEcccccCcccCCC
Q 041034          313 KLSGSFPTGIGNCTELQHLALNHNSLDGTIP-PEIGKILLLQNLDLSHNNLSGTIPM  368 (701)
Q Consensus       313 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~  368 (701)
                      +|++..+..+..++ |+.|+|++|++...-. .+|..........+..+++++.-|.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            55533333333333 5555555555553211 1222222222333444555555444

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=2.5e-12  Score=129.47  Aligned_cols=148  Identities=14%  Similarity=0.080  Sum_probs=114.9

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRC  523 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  523 (701)
                      +......|.+...++.|+.+.||++... ++.+++|+........   ...+.+|+.+++.+. +..++++++++.+.+.
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            3445578988888998999999999764 6889999987532111   135788999998884 6778899999998899


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC-------------------------------  572 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------  572 (701)
                      .|+||||++|.++.+.+..        ......++.+++++|+.||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999999876321        1123468899999999999810                               


Q ss_pred             -------------------------CCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          573 -------------------------TPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       573 -------------------------~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                                               ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                     13589999999999998765567999998753

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.31  E-value=6.8e-11  Score=126.52  Aligned_cols=279  Identities=9%  Similarity=0.070  Sum_probs=206.7

Q ss_pred             ceeeCCcccCCCC-CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCC---CCCCCccccCCccccceeecccccCCCC
Q 041034           74 LSGSIPPQIGSLS-NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS---LHGTTPIEIGSLRNLEELYLRSNKLSGV  149 (701)
Q Consensus        74 l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~L~~n~l~~~  149 (701)
                      ++.+...+|.++. .|+.+.+-.+ ++.+-..+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I  128 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI  128 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence            4455667788874 6999999754 776778899999999999998874   66666788999999999988765 5667


Q ss_pred             CcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCC
Q 041034          150 LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHL  229 (701)
Q Consensus       150 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l  229 (701)
                      ...+|.+..+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.....+|.. ..|+.+.+..+-.. ....+|..+
T Consensus       129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c  204 (394)
T 4gt6_A          129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSEC  204 (394)
T ss_dssp             CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTC
T ss_pred             hhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhc
Confidence            7788999999999999743 44555678889999999999765 44344556654 57888888765433 556778888


Q ss_pred             CcccEEEeccCCCCCCCCcc-------------cCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcc
Q 041034          230 TSLLYLDLSFNQLHSFIPLE-------------IGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF  296 (701)
Q Consensus       230 ~~L~~L~L~~N~l~~~~~~~-------------~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  296 (701)
                      .++.......+......-..             +.....+..+.+. +.+..+...+|.++.+|+.+.+.++..+ ....
T Consensus       205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~  282 (394)
T 4gt6_A          205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTG  282 (394)
T ss_dssp             TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTT
T ss_pred             cccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCc
Confidence            99999888776654321111             1122334444443 3344455678999999999999876553 5567


Q ss_pred             cccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCc
Q 041034          297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLS  363 (701)
Q Consensus       297 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  363 (701)
                      +|.++.+|+.+.+. +.++..-..+|.++.+|+.++|..+ ++..-..+|..+.+|+.+.|..+ ++
T Consensus       283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~  346 (394)
T 4gt6_A          283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT  346 (394)
T ss_dssp             TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC
T ss_pred             ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC
Confidence            88899999999996 4566555678999999999999865 65455678999999999999754 44

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=2.3e-11  Score=122.19  Aligned_cols=140  Identities=15%  Similarity=0.111  Sum_probs=102.7

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc--eeeeeeeeeeCcEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN--IVKLYGFCLHKRCMF  525 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~  525 (701)
                      ...+|.+....+.|..+.||++...+|+.+++|......      ...+.+|+.+++.+.+.+  +++++++...++..+
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            344555544434566699999987778889999976541      145678899888885433  567888888888899


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC---------------------------------  572 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------  572 (701)
                      +||||++|.++.  ...      .+   ...++.++++.|..||+..                                 
T Consensus        92 ~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            999999998874  211      11   2256788888888888741                                 


Q ss_pred             ----------------------CCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          573 ----------------------TPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       573 ----------------------~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                                            ...++|+|++|.||+++++..+.|+|||.|..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  11399999999999998776667999998754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.10  E-value=4.2e-09  Score=111.87  Aligned_cols=285  Identities=13%  Similarity=0.089  Sum_probs=132.2

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      .+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ ++.+...+|.. .+|+.+.+
T Consensus        46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l  120 (379)
T 4h09_A           46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF  120 (379)
T ss_dssp             GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred             cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence            4455555532 344444455555555555555432 443444455544 4555544432 33233333333 24555555


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCC------------CCCCCCCCccccC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNG------------TIPREIGNLKNLT  209 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~~~~~~~l~~L~  209 (701)
                      ..+ +..+...+|.+. +|..+.+.. .++......|..+.+++.+.+..+....            .....+.....+.
T Consensus       121 p~~-~~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (379)
T 4h09_A          121 PGA-TTEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGT  197 (379)
T ss_dssp             CTT-CCEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCS
T ss_pred             CCc-cccccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccccccccc
Confidence            433 222222333332 233333222 1222233344444444444443322110            1111122223333


Q ss_pred             ccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCcc
Q 041034          210 HLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL  289 (701)
Q Consensus       210 ~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  289 (701)
                      .+.+..+. .......+..+.+|+.+.+..+ +.......|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ 
T Consensus       198 ~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-  273 (379)
T 4h09_A          198 EFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-  273 (379)
T ss_dssp             EEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-
T ss_pred             ccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-
Confidence            33332221 1123344555566666665443 33334445556666666666554 44444555666666666666543 


Q ss_pred             CCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEccc
Q 041034          290 LSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH  359 (701)
Q Consensus       290 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~  359 (701)
                      +......+|.++.+|+.+.+.++.++..-..+|.++.+|+.+.|..+ ++..-..+|.++.+|+.+.+..
T Consensus       274 i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          274 VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence            33333445566666666666666665444556666666666666543 4433344566666666666543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.08  E-value=1.8e-10  Score=121.55  Aligned_cols=144  Identities=19%  Similarity=0.291  Sum_probs=107.2

Q ss_pred             ccceEEeeccceEEEEEEcCCCcEEEEEEec--CCCccChHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeC---cEEE
Q 041034          453 HIRYCIGTGGYGSVYKAELPDGKVVALKKLH--QSETEDSAFVESFQNEARVLSTVR--HRNIVKLYGFCLHK---RCMF  525 (701)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~  525 (701)
                      ...+.++.|.++.||++... +..+++|+..  .....  .....+.+|+.+++.+.  +..+++++.++.+.   +..|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            34678899999999999875 4678888876  33211  11256788999999887  45688899888776   4589


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC---------------------------------  572 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------  572 (701)
                      +||||++|..+.+..     ...++..++..++.+++++|+.||+..                                 
T Consensus       118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            999999997774321     113677888899999999999999731                                 


Q ss_pred             ----------------------CCCeEecCCCCCcEEEcCCCC--eEEEeecCccc
Q 041034          573 ----------------------TPSIVHRDISSNNILLNSNLE--AFVADFGTARL  604 (701)
Q Consensus       573 ----------------------~~givH~Dlkp~NIll~~~~~--~kL~DFGla~~  604 (701)
                                            ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  247999999999999987753  58999998864

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.06  E-value=3.8e-09  Score=112.21  Aligned_cols=285  Identities=13%  Similarity=0.089  Sum_probs=199.4

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEEC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL  117 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  117 (701)
                      .++.+.+.. +++ .++...|..+.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|.. .+|+.+.+
T Consensus        47 ~i~~v~ip~-~vt-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l  120 (379)
T 4h09_A           47 RISEVRVNS-GIT-SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF  120 (379)
T ss_dssp             GCSEEEECT-TEE-EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred             CCEEEEeCC-Ccc-ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence            355555532 333 467778999999999999754 776777788887 6888887644 55455566765 48999999


Q ss_pred             CCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCC------------cCcccccccccc
Q 041034          118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP------------IPSTLFRLTNLE  185 (701)
Q Consensus       118 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------~~~~~~~l~~L~  185 (701)
                      ..+ ++......|.+. +|+.+.+..+ ++.+...+|.+...++.+.+..+.....            ....+.....+.
T Consensus       121 p~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (379)
T 4h09_A          121 PGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGT  197 (379)
T ss_dssp             CTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCS
T ss_pred             CCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccc
Confidence            865 333444455543 5666666543 4555667788888888887765433211            112233344455


Q ss_pred             eeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCC
Q 041034          186 RLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNK  265 (701)
Q Consensus       186 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~  265 (701)
                      .+.+..+. .......+....+|+.+.+..+ +......++.++.+|+.+.+..+ ++.+....|.++.+|+.+.+..+ 
T Consensus       198 ~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-  273 (379)
T 4h09_A          198 EFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-  273 (379)
T ss_dssp             EEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-
T ss_pred             ccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-
Confidence            55443322 2234456677788888887655 44455677888999999999876 66666778889999999999754 


Q ss_pred             CccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCC
Q 041034          266 IRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHN  336 (701)
Q Consensus       266 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  336 (701)
                      +......+|.++++|+.+.+.++.++.....+|.++.+|+.+.|..+ ++..-..+|.++++|+.+.+..+
T Consensus       274 i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          274 VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            66566678999999999999999888666788999999999999765 66455678999999999988654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.06  E-value=1.7e-11  Score=128.63  Aligned_cols=84  Identities=19%  Similarity=0.359  Sum_probs=52.7

Q ss_pred             CCCcccEEEeccCCCCCCCCccc---CCCCcccEEEcCCCCCccc----cCcccCCCCCCcEEEccCccCCCCCcccccC
Q 041034          228 HLTSLLYLDLSFNQLHSFIPLEI---GNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNLSSNLLSGQIPFAIGK  300 (701)
Q Consensus       228 ~l~~L~~L~L~~N~l~~~~~~~~---~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  300 (701)
                      .+++|++|+|++|.+.+..+..+   ..+++|+.|+|+.|.|++.    ++..+..+++|+.|+|++|.++...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            35677777777777664322222   2467888888888887764    3334456678888888888877543333332


Q ss_pred             -ccceeeecCCCCc
Q 041034          301 -LFNLVSLDLSKNK  313 (701)
Q Consensus       301 -l~~L~~L~Ls~N~  313 (701)
                       +  ...+++++++
T Consensus       330 al--g~~~~~~~~~  341 (362)
T 2ra8_A          330 SL--PMKIDVSDSQ  341 (362)
T ss_dssp             HC--CSEEECCSBC
T ss_pred             Hc--CCEEEecCCc
Confidence             1  3557777776

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.02  E-value=4.1e-11  Score=125.66  Aligned_cols=162  Identities=19%  Similarity=0.189  Sum_probs=76.1

Q ss_pred             ccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcccccc--CCCcccEEEecc--CCCCCCCCcccCC
Q 041034          177 TLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLG--HLTSLLYLDLSF--NQLHSFIPLEIGN  252 (701)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~--~l~~L~~L~L~~--N~l~~~~~~~~~~  252 (701)
                      .+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+...     
T Consensus       167 ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~-----  238 (362)
T 2ra8_A          167 VLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD-----  238 (362)
T ss_dssp             HHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC-----
T ss_pred             HHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh-----
Confidence            3445566777777665211 1222 22 56666676666665533322332  466666666642  22111000     


Q ss_pred             CCcccEEEcCCCCCccccCccc--CCCCCCcEEEccCccCCCCCccccc---CccceeeecCCCCcCCCC----CCCccc
Q 041034          253 FSALAELDLSDNKIRGIIPDEL--SKLSNLQYLNLSSNLLSGQIPFAIG---KLFNLVSLDLSKNKLSGS----FPTGIG  323 (701)
Q Consensus       253 ~~~L~~L~L~~N~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~  323 (701)
                                   +.+ +...+  ..+++|+.|+|++|.+.+..+..+.   .+++|++|+|+.|.+++.    ++..+.
T Consensus       239 -------------~~~-l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~  304 (362)
T 2ra8_A          239 -------------MNV-FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD  304 (362)
T ss_dssp             -------------GGG-TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHH
T ss_pred             -------------HHH-HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcc
Confidence                         000 00001  1244555555555555432222221   355666666666666542    333344


Q ss_pred             CCCCCCeeeccCCccCCCCCccccccccCCeEEccccc
Q 041034          324 NCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN  361 (701)
Q Consensus       324 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~  361 (701)
                      .+++|+.|+|++|.++...-..+...- ...+++++|+
T Consensus       305 ~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          305 KIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             HHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             cCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            556777777777766532222222210 2556777765

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.89  E-value=5.3e-12  Score=125.55  Aligned_cols=92  Identities=24%  Similarity=0.202  Sum_probs=50.5

Q ss_pred             cCCCCCCCE--EECcCCcCc---ccCCcccCCCCCCCEEECCCCCCCCC--CccccCCccccceeecccccCCCCCcccc
Q 041034           82 IGSLSNLKY--LNLRWNNLT---GTIPKEIGSLRNLEVLYLSNNSLHGT--TPIEIGSLRNLEELYLRSNKLSGVLPQEI  154 (701)
Q Consensus        82 ~~~l~~L~~--L~L~~n~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  154 (701)
                      |...+.|+.  ++++.|...   +.++....++++|+.|+|++|+|++.  +|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            334444544  556666432   22222224566777777777777763  345556677777777777777654  223


Q ss_pred             cCCC--CCcEEEceecccCCCcC
Q 041034          155 GNLK--SLIWLSVMYNTVGGPIP  175 (701)
Q Consensus       155 ~~l~--~L~~L~L~~N~l~~~~~  175 (701)
                      ..++  +|++|+|++|.+.+.+|
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhcccCCcceEEccCCcCccccC
Confidence            3333  55666666665554433

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.64  E-value=5e-08  Score=100.13  Aligned_cols=137  Identities=23%  Similarity=0.246  Sum_probs=100.7

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCc--eeeeeeeeeeCc---EEEEEE
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRN--IVKLYGFCLHKR---CMFFIY  528 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~  528 (701)
                      ++.++.|....||++.    +.+++|+....     .....+.+|+++++.+. +..  +++++.+.....   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            5668999999999873    56889986432     23467889999998873 322  455555544333   348999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD-------------------------------------  571 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------------------------------------  571 (701)
                      ||++|.++.+....     .++..++..++.+++..++.||+.                                     
T Consensus        96 ~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             ECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             cccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            99999888653321     367777888899999999999861                                     


Q ss_pred             ------------------CCCCeEecCCCCCcEEEcC--CCCeEEEeecCcccc
Q 041034          572 ------------------CTPSIVHRDISSNNILLNS--NLEAFVADFGTARLL  605 (701)
Q Consensus       572 ------------------~~~givH~Dlkp~NIll~~--~~~~kL~DFGla~~~  605 (701)
                                        ..+.++|+|++|.||++++  ...+.|+||+.+..-
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                              1135899999999999988  456789999998653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=5.7e-07  Score=92.22  Aligned_cols=138  Identities=17%  Similarity=0.102  Sum_probs=97.1

Q ss_pred             cceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCC---ceeeeeeeee-eCcEEEEEEE
Q 041034          454 IRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR---NIVKLYGFCL-HKRCMFFIYE  529 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e  529 (701)
                      ..+.++.|....||+.    ++.+++|+...     ......+.+|.++++.+.+.   .+++++.++. ..+..++|||
T Consensus        23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             CEEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            3567888998999998    56788887432     23356789999999998642   3667777764 4456789999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHD--------------------------------------  571 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------------------  571 (701)
                      |++|.++.+..-.     .++..+...++.++++.|+.||+.                                      
T Consensus        94 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           94 KVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             ccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9999887653211     134445555556666666555542                                      


Q ss_pred             -------------------CCCCeEecCCCCCcEEEcC---CCCe-EEEeecCcccc
Q 041034          572 -------------------CTPSIVHRDISSNNILLNS---NLEA-FVADFGTARLL  605 (701)
Q Consensus       572 -------------------~~~givH~Dlkp~NIll~~---~~~~-kL~DFGla~~~  605 (701)
                                         ..+.++|+|++|.||+++.   ++.+ .|+||+.+..-
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               1235699999999999987   4565 79999988653

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.54  E-value=5.4e-09  Score=103.88  Aligned_cols=139  Identities=24%  Similarity=0.239  Sum_probs=90.9

Q ss_pred             CCCCcceeEeCCCC-CEEEEEecc---cccccccC-----------------------CcccCCCCCCcE--EECCCCcc
Q 041034           24 DHCNWVGITCDYKG-SITHIELVE---CSIKGELG-----------------------SLNFSCFPNLQY--LNLWNNNL   74 (701)
Q Consensus        24 d~c~w~gv~c~~~~-~v~~l~l~~---~~~~~~~~-----------------------~~~~~~~~~L~~--L~L~~n~l   74 (701)
                      ..|.|.|+.|+..+ +|+.+....   .++.+.+.                       -..|...+.|..  ++++.|..
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~  155 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR  155 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred             HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence            45889999998654 454433322   22222222                       111233344444  56677743


Q ss_pred             e---eeCCcccCCCCCCCEEECcCCcCcc--cCCcccCCCCCCCEEECCCCCCCCCCccccCCcc--ccceeecccccCC
Q 041034           75 S---GSIPPQIGSLSNLKYLNLRWNNLTG--TIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR--NLEELYLRSNKLS  147 (701)
Q Consensus        75 ~---~~~~~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~n~l~  147 (701)
                      .   +.++....++++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.
T Consensus       156 ~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          156 SCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             HHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred             HHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence            2   2223333568999999999999998  4567778999999999999999976  3344444  9999999999998


Q ss_pred             CCCcc-------cccCCCCCcEEE
Q 041034          148 GVLPQ-------EIGNLKSLIWLS  164 (701)
Q Consensus       148 ~~~~~-------~~~~l~~L~~L~  164 (701)
                      +..|.       .+..+++|+.||
T Consensus       234 ~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          234 DTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             cccCcchhHHHHHHHHCcccCeEC
Confidence            76552       344555555554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.52  E-value=3.9e-07  Score=91.69  Aligned_cols=136  Identities=18%  Similarity=0.193  Sum_probs=99.3

Q ss_pred             eEEeeccce-EEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEEEEEEccC
Q 041034          456 YCIGTGGYG-SVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       456 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      +.+..|..+ .||+.... ++..+++|+-...      ....+.+|..+++.+. +--++++++++.+.+..|+|||+++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            445556555 69998664 5678999986543      2356788999988874 4447789999999999999999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC----------------------------------------  572 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------  572 (701)
                      |.++.+......       .....+..+++..|..||...                                        
T Consensus       104 G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          104 GKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             SEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            988877654321       223346667777777777531                                        


Q ss_pred             ---------------CCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          573 ---------------TPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       573 ---------------~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                                     .+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                           12379999999999999877677999998854

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.49  E-value=1.6e-08  Score=95.50  Aligned_cols=89  Identities=19%  Similarity=0.212  Sum_probs=43.8

Q ss_pred             CCCCCCcEEECCCC-ccee----eCCcccCCCCCCCEEECcCCcCccc----CCcccCCCCCCCEEECCCCCCCCC----
Q 041034           59 SCFPNLQYLNLWNN-NLSG----SIPPQIGSLSNLKYLNLRWNNLTGT----IPKEIGSLRNLEVLYLSNNSLHGT----  125 (701)
Q Consensus        59 ~~~~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  125 (701)
                      ...+.|++|+|++| .|..    .+...+...++|++|+|++|.|...    +...+...++|++|+|++|.|...    
T Consensus        33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~  112 (185)
T 1io0_A           33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA  112 (185)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence            44556666666666 5542    1233344455566666666665431    223333445566666666655432    


Q ss_pred             CccccCCccccceeec--ccccCC
Q 041034          126 TPIEIGSLRNLEELYL--RSNKLS  147 (701)
Q Consensus       126 ~~~~~~~l~~L~~L~L--~~n~l~  147 (701)
                      +...+...++|++|+|  ++|.++
T Consensus       113 l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          113 LVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHhCCCceEEEecCCCCCCC
Confidence            1223334444555555  445444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.47  E-value=1.5e-08  Score=95.80  Aligned_cols=119  Identities=17%  Similarity=0.160  Sum_probs=77.6

Q ss_pred             eCCcccCCCCCCCEEECcCC-cCccc----CCcccCCCCCCCEEECCCCCCCCCC----ccccCCccccceeecccccCC
Q 041034           77 SIPPQIGSLSNLKYLNLRWN-NLTGT----IPKEIGSLRNLEVLYLSNNSLHGTT----PIEIGSLRNLEELYLRSNKLS  147 (701)
Q Consensus        77 ~~~~~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~  147 (701)
                      .+...+...+.|++|+|++| .+...    +...+...++|++|+|++|+|....    ...+...++|++|+|++|.++
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            44556777889999999999 88742    3455677789999999999987432    233445577888888888887


Q ss_pred             CC----CcccccCCCCCcEEEc--eecccCCCc----CcccccccccceeEeeecccC
Q 041034          148 GV----LPQEIGNLKSLIWLSV--MYNTVGGPI----PSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       148 ~~----~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      ..    +..++...++|++|+|  ++|.++...    ...+...++|++|+|++|.+.
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            43    3445555666777777  666665432    222333355555555555543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=1.1e-06  Score=92.32  Aligned_cols=80  Identities=11%  Similarity=0.036  Sum_probs=55.1

Q ss_pred             ceEE-eeccceEEEEEEcC-------CCcEEEEEEecCCC---ccChHHHHHHHHHHHHHhcCC-C--Cceeeeeeeeee
Q 041034          455 RYCI-GTGGYGSVYKAELP-------DGKVVALKKLHQSE---TEDSAFVESFQNEARVLSTVR-H--RNIVKLYGFCLH  520 (701)
Q Consensus       455 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~  520 (701)
                      .+.| +.|....+|++...       +++.+++|+.....   ...   ...+.+|+.+++.+. +  -.+++++.++.+
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4667 78888999998654       26789999875432   100   134677888888774 2  357788887765


Q ss_pred             C---cEEEEEEEccCCCCHH
Q 041034          521 K---RCMFFIYEYMERGSLF  537 (701)
Q Consensus       521 ~---~~~~lv~e~~~~gsL~  537 (701)
                      .   +..|+||||++|.++.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            4   3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.10  E-value=6e-06  Score=85.91  Aligned_cols=141  Identities=18%  Similarity=0.294  Sum_probs=80.1

Q ss_pred             eEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC--CCceeeeee------eeeeCcEEEEE
Q 041034          456 YCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--HRNIVKLYG------FCLHKRCMFFI  527 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv  527 (701)
                      +.|+.|..+.||++...+| .+++|+.....       ..+..|..+++.+.  .-.+++++.      +....+..++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            4566677899999976554 58999887521       23334555555442  113344443      12346678999


Q ss_pred             EEccCCCCHH-----------H---HHhcC---C--C-c-----cCCCHHHH----------------------------
Q 041034          528 YEYMERGSLF-----------Y---VLRDD---D--E-A-----IELNWTRR----------------------------  554 (701)
Q Consensus       528 ~e~~~~gsL~-----------~---~l~~~---~--~-~-----~~l~~~~~----------------------------  554 (701)
                      |||++|.++.           +   .++..   .  . .     ....|...                            
T Consensus       110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  189 (346)
T 2q83_A          110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL  189 (346)
T ss_dssp             EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence            9999986432           0   11110   0  0 0     01122211                            


Q ss_pred             ---HHHHHHHHHHHHHHhc----------CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          555 ---VNIVKSVAHALSYLHH----------DCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       555 ---~~i~~qi~~~L~~LH~----------~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                         ..+..++..++++|++          .....++|+|++|.||+++.++.+.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence               1111223445666653          1244899999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.05  E-value=6.1e-06  Score=87.93  Aligned_cols=79  Identities=10%  Similarity=0.087  Sum_probs=50.2

Q ss_pred             cceEEeeccceEEEEEEcC-CCcEEEEEEecCCCc-cC---hHHHHHHHHHHHHHhcCCC---CceeeeeeeeeeCcEEE
Q 041034          454 IRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSET-ED---SAFVESFQNEARVLSTVRH---RNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~  525 (701)
                      ..+.+|.|..+.||++... +++.|+||...+... ..   ....+++..|.++++.+..   ..+++++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3567899999999999654 468899998764321 00   0112456778888887632   345566654  334457


Q ss_pred             EEEEccCCC
Q 041034          526 FIYEYMERG  534 (701)
Q Consensus       526 lv~e~~~~g  534 (701)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=3.2e-05  Score=78.95  Aligned_cols=139  Identities=17%  Similarity=0.213  Sum_probs=93.0

Q ss_pred             cceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCcEEEEEEEc
Q 041034          454 IRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR---HRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      ..+.|+.|....+|+... +++.+++|+.....      ...+..|...|+.+.   ...++++++++...+..++||||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            456789999999999986 46788899876431      366788988888874   36788999988888889999999


Q ss_pred             cCCCCHH--------H---HHhcCCC--c-----------------cCCCHHHHH---HHHH----------------HH
Q 041034          531 MERGSLF--------Y---VLRDDDE--A-----------------IELNWTRRV---NIVK----------------SV  561 (701)
Q Consensus       531 ~~~gsL~--------~---~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------qi  561 (701)
                      +++..+.        +   .++....  .                 ..-+|....   ++..                ++
T Consensus       113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l  192 (312)
T 3jr1_A          113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI  192 (312)
T ss_dssp             CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred             ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence            9987542        1   1222111  0                 012454321   1111                11


Q ss_pred             HHH-HHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          562 AHA-LSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       562 ~~~-L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +.. ...|.. ...+.+||+|+.+.|++++.++ +.|+||.
T Consensus       193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111 223421 2256899999999999999887 8899984

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.91  E-value=2.5e-06  Score=78.51  Aligned_cols=82  Identities=10%  Similarity=0.096  Sum_probs=36.4

Q ss_pred             CCCEEECcCCcCcccCCcccCCCCCCCEEECCCCC-CCCCCccccCCc----cccceeeccccc-CCCCCcccccCCCCC
Q 041034           87 NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNS-LHGTTPIEIGSL----RNLEELYLRSNK-LSGVLPQEIGNLKSL  160 (701)
Q Consensus        87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L  160 (701)
                      +|++|||+++.|+..--..+.++++|+.|+|++|. ++...-..++.+    ++|++|+|++|. ++...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555443333344455555555555552 433222223332    245555555543 443322333444444


Q ss_pred             cEEEceec
Q 041034          161 IWLSVMYN  168 (701)
Q Consensus       161 ~~L~L~~N  168 (701)
                      +.|+|++|
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            44444444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.83  E-value=3.6e-06  Score=77.48  Aligned_cols=83  Identities=16%  Similarity=0.192  Sum_probs=48.5

Q ss_pred             CCCCEEECCCCCCCCCCccccCCccccceeeccccc-CCCCCcccccCC----CCCcEEEceecc-cCCCcCcccccccc
Q 041034          110 RNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNK-LSGVLPQEIGNL----KSLIWLSVMYNT-VGGPIPSTLFRLTN  183 (701)
Q Consensus       110 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~  183 (701)
                      .+|+.|||+++.++...-..+.++++|++|+|++|. ++...-..+..+    ++|++|+|++|. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            468888888888776555566777778888887774 554333334433    245555555553 44333333444555


Q ss_pred             cceeEeeec
Q 041034          184 LERLFLGCN  192 (701)
Q Consensus       184 L~~L~L~~N  192 (701)
                      |++|+|+++
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            555555443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.79  E-value=6.2e-05  Score=80.68  Aligned_cols=77  Identities=10%  Similarity=0.122  Sum_probs=46.4

Q ss_pred             cceEEeeccceEEEEEEcCCCcEEEEEEecCCCc------cChHHHHHHHHHHHHHh-cCCCCceeeeeeeeeeCcEEEE
Q 041034          454 IRYCIGTGGYGSVYKAELPDGKVVALKKLHQSET------EDSAFVESFQNEARVLS-TVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.+|.|..+.||++.. +++.++||...+...      ........+..|+..+. ......+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            467789999999999965 567899995432111      00001123333433322 22234677777765  456789


Q ss_pred             EEEcc-CC
Q 041034          527 IYEYM-ER  533 (701)
Q Consensus       527 v~e~~-~~  533 (701)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.73  E-value=9.5e-05  Score=74.76  Aligned_cols=78  Identities=18%  Similarity=0.208  Sum_probs=56.6

Q ss_pred             CCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC---CceeeeeeeeeeCcEEEEE
Q 041034          451 DFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH---RNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv  527 (701)
                      ....++.+|.|..+.||+++..||+.|++|+........   ...+..|++.|+.+..   --+++++++.  .  .++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            345578899999999999999999999999876543322   2457789988888742   2355666542  2  3689


Q ss_pred             EEccCCCC
Q 041034          528 YEYMERGS  535 (701)
Q Consensus       528 ~e~~~~gs  535 (701)
                      |||++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.52  E-value=0.00021  Score=73.93  Aligned_cols=142  Identities=18%  Similarity=0.186  Sum_probs=74.1

Q ss_pred             ceEEeeccceE-EEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCcEEEEEEEcc
Q 041034          455 RYCIGTGGYGS-VYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--HRNIVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       455 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~  531 (701)
                      .+.++.|+... +|+....+++.+++|.......      ..+..|+.+++.+.  .-.+++++.+..+.+  +++||++
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            34566565554 6677664477788886654321      12344566666553  234566776643333  6899999


Q ss_pred             CCCCHHHHHhcCC---------------------C--ccCCCHHHHH-------H-------------HHHHHHHHHHHH
Q 041034          532 ERGSLFYVLRDDD---------------------E--AIELNWTRRV-------N-------------IVKSVAHALSYL  568 (701)
Q Consensus       532 ~~gsL~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~qi~~~L~~L  568 (701)
                      .+.++.+++....                     .  ...++.....       .             ....+...++.+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            7766654432110                     0  0012211100       0             001111222222


Q ss_pred             h---cCCCCCeEecCCCCCcEEEcCC----CCeEEEeecCccc
Q 041034          569 H---HDCTPSIVHRDISSNNILLNSN----LEAFVADFGTARL  604 (701)
Q Consensus       569 H---~~~~~givH~Dlkp~NIll~~~----~~~kL~DFGla~~  604 (701)
                      .   ......++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1   1123479999999999999874    6789999998865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.0007  Score=69.64  Aligned_cols=143  Identities=13%  Similarity=0.144  Sum_probs=82.4

Q ss_pred             ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC--Cceeeeeee-----eeeCcEEEEE
Q 041034          455 RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH--RNIVKLYGF-----CLHKRCMFFI  527 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv  527 (701)
                      ...++ |....||++...+|+.+++|........    ...+..|..+++.+..  -.+++++..     ....+..+++
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            34566 8888999997777878999998754221    2456667777777642  224455443     1234567899


Q ss_pred             EEccCCCCHH-----HH---------Hhc----CC--CccCCCHHHH----------------------HHHHHHHHHHH
Q 041034          528 YEYMERGSLF-----YV---------LRD----DD--EAIELNWTRR----------------------VNIVKSVAHAL  565 (701)
Q Consensus       528 ~e~~~~gsL~-----~~---------l~~----~~--~~~~l~~~~~----------------------~~i~~qi~~~L  565 (701)
                      |+|++|..+.     .+         ++.    ..  .....++...                      ...+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999875431     11         111    00  0011222111                      01111222222


Q ss_pred             HHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          566 SYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       566 ~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ...-. .....++|+|++|.||+++ + .+.++||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22211 1234689999999999998 4 899999988754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.52  E-value=0.0011  Score=68.05  Aligned_cols=159  Identities=11%  Similarity=0.081  Sum_probs=87.6

Q ss_pred             ccHHHHHhhhcCCcc-----ceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCC--cee
Q 041034          440 ILYEDLINATEDFHI-----RYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR--NIV  512 (701)
Q Consensus       440 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv  512 (701)
                      ++-+++....+.|.+     .+.|+.|....+|++...+| .+++|.......     .+.+..|+.+++.+...  .++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCC
Confidence            344555555555654     34566788889999976555 688998875311     13445677777666321  234


Q ss_pred             eeeee------eeeCcEEEEEEEccCCCCHHH--------------HHhcC----CCcc--C---CCHHHHHH-------
Q 041034          513 KLYGF------CLHKRCMFFIYEYMERGSLFY--------------VLRDD----DEAI--E---LNWTRRVN-------  556 (701)
Q Consensus       513 ~l~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~--~---l~~~~~~~-------  556 (701)
                      +++..      ....+..+++|+|++|..+..              .++..    ....  .   ..|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            44422      123456789999999864311              01111    0000  0   11222100       


Q ss_pred             -----HHHHHHHHHHHHhcC----CCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          557 -----IVKSVAHALSYLHHD----CTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       557 -----i~~qi~~~L~~LH~~----~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                           +...+...++++++.    ...+++|+|++|.||+++++..+.++||+.+..
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 011234455555532    234799999999999998775568999998754

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.37  E-value=1.9e-05  Score=74.11  Aligned_cols=13  Identities=15%  Similarity=0.235  Sum_probs=6.4

Q ss_pred             CCCCCeeeccCCc
Q 041034          325 CTELQHLALNHNS  337 (701)
Q Consensus       325 l~~L~~L~L~~N~  337 (701)
                      -+.|+.|+++.|.
T Consensus       156 N~tL~~L~l~~~~  168 (197)
T 1pgv_A          156 NESLLRVGISFAS  168 (197)
T ss_dssp             CSSCCEEECCCCC
T ss_pred             CCCcCeEeccCCC
Confidence            3445555555443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.36  E-value=0.00045  Score=70.21  Aligned_cols=141  Identities=13%  Similarity=0.101  Sum_probs=76.3

Q ss_pred             CccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCcEEEEEEEc
Q 041034          452 FHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI-VKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  530 (701)
                      +.-.+.|+.|....+|++     +.+++|+........    ....+|+.+++.+....+ ++++++..  +.-++|+||
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~   88 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRY   88 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEEC
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEee
Confidence            344788999999999999     568889876532110    122457777766642222 56665543  334689999


Q ss_pred             c-CCCCHHH------------------HHhcCCCc--cCCCH-HHHHHHHHH--------------HHHHHH----HHhc
Q 041034          531 M-ERGSLFY------------------VLRDDDEA--IELNW-TRRVNIVKS--------------VAHALS----YLHH  570 (701)
Q Consensus       531 ~-~~gsL~~------------------~l~~~~~~--~~l~~-~~~~~i~~q--------------i~~~L~----~LH~  570 (701)
                      + ++.++..                  .++.....  ...+. .....+..+              +...+.    .+..
T Consensus        89 i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~  168 (301)
T 3dxq_A           89 IAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA  168 (301)
T ss_dssp             CTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence            9 6544321                  01111100  00111 111111100              111111    1111


Q ss_pred             -CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          571 -DCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       571 -~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                       .....++|+|+.|.||+ ..++.+.++||..|..
T Consensus       169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             cCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence             12335899999999999 5667889999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.36  E-value=0.00024  Score=76.15  Aligned_cols=73  Identities=18%  Similarity=0.174  Sum_probs=49.1

Q ss_pred             cceEEeeccceEEEEEEcCC--------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEE
Q 041034          454 IRYCIGTGGYGSVYKAELPD--------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  524 (701)
                      ..+.|+.|-...||++...+        ++.+++|+.....  .   .+.+.+|..+++.+. +.-.+++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35678888889999997653        5789999884321  1   134457888888774 3234667766542    


Q ss_pred             EEEEEccCCCC
Q 041034          525 FFIYEYMERGS  535 (701)
Q Consensus       525 ~lv~e~~~~gs  535 (701)
                      .+||||++|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998743

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.34  E-value=3.1e-05  Score=72.57  Aligned_cols=63  Identities=19%  Similarity=0.180  Sum_probs=28.6

Q ss_pred             CCCCcEEECCCC-ccee----eCCcccCCCCCCCEEECcCCcCcccC----CcccCCCCCCCEEECCCCCCC
Q 041034           61 FPNLQYLNLWNN-NLSG----SIPPQIGSLSNLKYLNLRWNNLTGTI----PKEIGSLRNLEVLYLSNNSLH  123 (701)
Q Consensus        61 ~~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~Ls~N~l~  123 (701)
                      -+.|++|+|++| .|..    .+-..+..-+.|+.|+|++|+|...-    .+.+..-+.|++|+|++|.|.
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            345555555553 4432    12233444445555555555554221    122223345555555555554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.29  E-value=0.00036  Score=73.08  Aligned_cols=142  Identities=19%  Similarity=0.247  Sum_probs=84.1

Q ss_pred             ceEEeeccceEEEEEEcC--------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEE
Q 041034          455 RYCIGTGGYGSVYKAELP--------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (701)
                      ++.+..|-...+|++...        +++.|++|+.-... ..   ...+.+|.++++.+. +.-.+++++++.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            466777888999999764        25789999863321 11   355668999888874 3334667776543    2


Q ss_pred             EEEEccCCCCHHH--------------H---HhcCCC--ccCCC--HHHHHHHHHHHHH-------------------HH
Q 041034          526 FIYEYMERGSLFY--------------V---LRDDDE--AIELN--WTRRVNIVKSVAH-------------------AL  565 (701)
Q Consensus       526 lv~e~~~~gsL~~--------------~---l~~~~~--~~~l~--~~~~~~i~~qi~~-------------------~L  565 (701)
                      +||||++|.++..              .   ++....  .....  +.++.++..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999865421              0   111110  11122  4455555544322                   23


Q ss_pred             HHHh----cC-CCCCeEecCCCCCcEEEcCC----CCeEEEeecCccc
Q 041034          566 SYLH----HD-CTPSIVHRDISSNNILLNSN----LEAFVADFGTARL  604 (701)
Q Consensus       566 ~~LH----~~-~~~givH~Dlkp~NIll~~~----~~~kL~DFGla~~  604 (701)
                      .+|.    .. ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    21 23468999999999999876    7899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.19  E-value=0.001  Score=71.63  Aligned_cols=75  Identities=17%  Similarity=0.101  Sum_probs=48.0

Q ss_pred             cceEEeeccceEEEEEEcCC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCcEEEEEEEcc
Q 041034          454 IRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLYGFCLHKRCMFFIYEYM  531 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  531 (701)
                      ..+.|+.|-...+|++...+ ++.+++|+.......-    -...+|..+++.+...+ .+++++++.  +  .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            35678888889999997754 5788899875432110    11257888888886433 356777763  2  2599999


Q ss_pred             CCCCH
Q 041034          532 ERGSL  536 (701)
Q Consensus       532 ~~gsL  536 (701)
                      +|.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.04  E-value=0.00098  Score=58.24  Aligned_cols=60  Identities=22%  Similarity=0.288  Sum_probs=45.3

Q ss_pred             eecCCCCcCC-CCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCC
Q 041034          306 SLDLSKNKLS-GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       306 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      .++.+++.++ ..+|..+.  ++|+.|+|++|+|+..-+..|..+++|+.|+|++|++.+..-
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~   72 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR   72 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence            5777777776 35665443  468888888888886666778888889999999999887654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.97  E-value=0.0015  Score=67.66  Aligned_cols=31  Identities=23%  Similarity=0.477  Sum_probs=27.7

Q ss_pred             CCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          574 PSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       574 ~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ..++|+|+.|.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4789999999999999888899999988764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.89  E-value=0.0014  Score=57.27  Aligned_cols=56  Identities=25%  Similarity=0.280  Sum_probs=33.2

Q ss_pred             EEECCCCcce-eeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCC
Q 041034           66 YLNLWNNNLS-GSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLH  123 (701)
Q Consensus        66 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  123 (701)
                      .++.++++++ ..+|..+.  ++|++|+|++|+|+.+.+..|..+++|++|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3455555554 23343322  35677777777777666666667777777777777664

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.87  E-value=0.00064  Score=71.31  Aligned_cols=73  Identities=15%  Similarity=0.086  Sum_probs=43.5

Q ss_pred             ceEEeeccceEEEEEEcCC---------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCcEE
Q 041034          455 RYCIGTGGYGSVYKAELPD---------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLYGFCLHKRCM  524 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~  524 (701)
                      .+.++.|....+|++...+         ++.+++|+.......    ......|..+++.+.... ++++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4567788889999997653         268888887543211    112356777777774222 45666554  22  


Q ss_pred             EEEEEccCCCC
Q 041034          525 FFIYEYMERGS  535 (701)
Q Consensus       525 ~lv~e~~~~gs  535 (701)
                      ++||||++|.+
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.96  E-value=0.011  Score=62.80  Aligned_cols=141  Identities=11%  Similarity=0.079  Sum_probs=83.9

Q ss_pred             ceEEeeccceEEEEEEcCC--------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEEE
Q 041034          455 RYCIGTGGYGSVYKAELPD--------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (701)
                      ++.+..|-...+|++...+        ++.|++|+.......    .-...+|..+++.+. +.-.+++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            5667778889999997653        578999986543211    112356888877774 33345666543  22  6


Q ss_pred             EEEEccCCCCHHH--------------H---HhcC-------C---CccCCCHHHHHHHHHHH-----------------
Q 041034          526 FIYEYMERGSLFY--------------V---LRDD-------D---EAIELNWTRRVNIVKSV-----------------  561 (701)
Q Consensus       526 lv~e~~~~gsL~~--------------~---l~~~-------~---~~~~l~~~~~~~i~~qi-----------------  561 (701)
                      +||||++|.++..              .   ++..       .   ...+.-+.++.++..++                 
T Consensus       147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~  226 (424)
T 3mes_A          147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS  226 (424)
T ss_dssp             EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred             EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence            8999999865321              0   0110       0   01111244444443322                 


Q ss_pred             --HHHHHHHhc---------------------CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          562 --AHALSYLHH---------------------DCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       562 --~~~L~~LH~---------------------~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                        ...+.+|.+                     .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus       227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence              222333321                     11236899999999999 7788999999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.69  E-value=0.24  Score=46.51  Aligned_cols=95  Identities=17%  Similarity=0.051  Sum_probs=59.5

Q ss_pred             CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCCcee
Q 041034          535 SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL  614 (701)
Q Consensus       535 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  614 (701)
                      +|.++++..+.  ++++.+++.+++|.+.+|.-+-.+.  .-..+=+.|..|++..+|.|...+ +.+.           
T Consensus        34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            89999987654  6999999999999999988762110  111233457899999999887653 1110           


Q ss_pred             ecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          615 RAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                       .....+.|||.... ....+  .-||+||+++|.
T Consensus        98 -~~~~~~~~pe~~~~-~~te~--~~IysLG~tLY~  128 (229)
T 2yle_A           98 -AGEPPPVAGKLGYS-QCMET--EVIESLGIIIYK  128 (229)
T ss_dssp             ----------CCSSS-SSCHH--HHHHHHHHHHHH
T ss_pred             -ccccCCCChhhccc-cchHH--HHHHHHHHHHHH
Confidence             12335678887642 22233  489999999995

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.10  E-value=0.13  Score=54.31  Aligned_cols=30  Identities=27%  Similarity=0.438  Sum_probs=25.2

Q ss_pred             CeEecCCCCCcEEE------cCCCCeEEEeecCccc
Q 041034          575 SIVHRDISSNNILL------NSNLEAFVADFGTARL  604 (701)
Q Consensus       575 givH~Dlkp~NIll------~~~~~~kL~DFGla~~  604 (701)
                      .++|+|+.+.||++      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4457899999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.41  E-value=0.94  Score=42.48  Aligned_cols=84  Identities=2%  Similarity=0.054  Sum_probs=61.9

Q ss_pred             CCCceeeeeeeeeeCcEEEEEEEccCCC-CHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCc
Q 041034          507 RHRNIVKLYGFCLHKRCMFFIYEYMERG-SLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       507 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~N  585 (701)
                      .||+.++. .+-.+.+.+.+.++.-+.+ +... ++      ..+...+++++..|+....+++.     -+|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            57888765 4556667766666654422 2222 22      47778999999999998877764     4889999999


Q ss_pred             EEEcCCCCeEEEeecCcc
Q 041034          586 ILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla~  603 (701)
                      |+++.++.+++.-.|+..
T Consensus       110 L~f~~~~~p~i~~RGik~  127 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQN  127 (215)
T ss_dssp             EEECTTSCEEESCCEETT
T ss_pred             EEEcCCCCEEEEEccCcc
Confidence            999999999998777653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.13  E-value=1.6  Score=41.03  Aligned_cols=83  Identities=12%  Similarity=0.117  Sum_probs=60.3

Q ss_pred             CCCceeeeeeeeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCCc
Q 041034          507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS-YLHHDCTPSIVHRDISSNN  585 (701)
Q Consensus       507 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~givH~Dlkp~N  585 (701)
                      .||++  -..+-.+++.+.+.++.-+++.-...++      ..+...+++++..|+.... +++     .-+|--+.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            57877  3334466777777777654433233332      3677889999999888777 666     45888999999


Q ss_pred             EEEcCCCCeEEEeecCc
Q 041034          586 ILLNSNLEAFVADFGTA  602 (701)
Q Consensus       586 Ill~~~~~~kL~DFGla  602 (701)
                      |+++.++.+++.-.|+-
T Consensus       115 L~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EEECTTCCEEESCCEET
T ss_pred             EEEeCCCcEEEEEcCCc
Confidence            99999999999877754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	701
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-43
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-43
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-40
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-37
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-29
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-29
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-25
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-07
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-25
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-25
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-24
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-19
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-16
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-15
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-14
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-12
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-12
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-12
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-11
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-07
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	7e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 8e-47
 Identities = 59/270 (21%), Positives = 105/270 (38%), Gaps = 59/270 (21%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
               +   IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHV 64

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NI+   G+      +  + ++ E  SL++ L   +   +    + ++I +  A  + YLH
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH 121

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPDQR 627
                SI+HRD+ SNNI L+ +L   + DFG A +    S +      +G+  ++AP+  
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 628 LS--------------------------PPVNQKIIQDIIL------------------- 642
                                        P +    +D I+                   
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 643 ---VSTTALACLRSKPKSRPTMQRISQELE 669
              +      CL+ K   RP   +I   +E
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-46
 Identities = 56/262 (21%), Positives = 102/262 (38%), Gaps = 51/262 (19%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L Q         ++F  EA ++  ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY     +  ++ I EYME GSL   L+     I+L   + +++   +A  ++++ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN-RTLRAGTYGYIAPDQRL 628
                  +HRD+ + NIL++  L   +ADFG ARL+  +    R        + AP+   
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 629 SPPVNQK----------------------------IIQDII-------------LVSTTA 647
                 K                            +IQ++               +    
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243

Query: 648 LACLRSKPKSRPTMQRISQELE 669
             C + +P+ RPT   +   LE
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 51/190 (26%), Positives = 77/190 (40%), Gaps = 10/190 (5%)

Query: 448 ATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
             +DF     +G G  G V+K    P G V+A K +H       A       E +VL   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC 61

Query: 507 RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALS 566
               IV  YG       +    E+M+ GSL  VL+       +       +  +V   L+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118

Query: 567 YLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           YL       I+HRD+  +NIL+NS  E  + DFG +  L    S      GT  Y++P++
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPER 174

Query: 627 RLSPPVNQKI 636
                 + + 
Sbjct: 175 LQGTHYSVQS 184

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-46
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 11/207 (5%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF I   +G G +G+VY A       ++ALK L +++ E +      + E  + S +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NI++LYG+      ++ I EY   G+++  L+      + +  R    +  +A+ALSY 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
           H      ++HRDI   N+LL S  E  +ADFG +   H  SS RT   GT  Y+ P+   
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 629 SPPVNQKIIQDIILVSTTALACLRSKP 655
               ++K+  D+  +       L  KP
Sbjct: 178 GRMHDEKV--DLWSLGVLCYEFLVGKP 202

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-45
 Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 7/193 (3%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED+ + Y IGTG YG   K     DGK++  K+L    +   A  +   +E  +L  ++H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62

Query: 509 RNIVKLYGFCLHK--RCMFFIYEYMERGSLFYVLRDDDEAIE-LNWTRRVNIVKSVAHAL 565
            NIV+ Y   + +    ++ + EY E G L  V+    +  + L+    + ++  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 566 SYLH--HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
              H   D   +++HRD+   N+ L+      + DFG AR+L+ D+S      GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 624 PDQRLSPPVNQKI 636
           P+Q      N+K 
Sbjct: 183 PEQMNRMSYNEKS 195

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (396), Expect = 1e-43
 Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 63/288 (21%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            D  +++ +G G YG VY+         VA+K L     ED+  VE F  EA V+  ++H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKH 72

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            N+V+L G C  +   + I E+M  G+L   LR+ +   E++    + +   ++ A+ YL
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL 131

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR-TLRAGTYGYIAP--- 624
                 + +HRD+++ N L+  N    VADFG +RL+  D+            + AP   
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 625 -----------------------------------------DQRLSPPVNQKIIQDIILV 643
                                                    ++       +   + +  +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248

Query: 644 STTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEM 691
                AC +  P  RP+   I Q  E         +E SIS+   +E+
Sbjct: 249 ---MRACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKEL 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)

Query: 438 GKILYEDLINATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESF 496
            ++ ++D  +  + F     IG G +G+VY A  + + +VVA+KK+  S  + +   +  
Sbjct: 5   AELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 497 QNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVN 556
             E R L  +RH N ++  G  L +   + + EY    +   +         L       
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAA 119

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA 616
           +       L+YLH     +++HRD+ + NILL+      + DFG+A ++   +S      
Sbjct: 120 VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FV 172

Query: 617 GTYGYIAPDQRLSPPVNQ 634
           GT  ++AP+  L+    Q
Sbjct: 173 GTPYWMAPEVILAMDEGQ 190

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-43
 Identities = 58/262 (22%), Positives = 98/262 (37%), Gaps = 51/262 (19%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           +D      +GTG +G V   +      VA+K + +    +    + F  EA+V+  + H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LYG C  +R +F I EYM  G L   LR+          + + + K V  A+ YL 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGYIAP---- 624
                  +HRD+++ N L+N      V+DFG +R +  D    ++       +  P    
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 625 DQRLSPPVN----------------------------QKIIQDIIL---------VSTTA 647
             + S   +                            + I Q + L         V T  
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234

Query: 648 LACLRSKPKSRPTMQRISQELE 669
            +C   K   RPT + +   + 
Sbjct: 235 YSCWHEKADERPTFKILLSNIL 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-43
 Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 70/284 (24%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K +      + A  ++F  EA V++ +RH 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 60

Query: 510 NIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           N+V+L G  +  K  ++ + EYM +GSL   LR    ++ L     +     V  A+ YL
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
                 + VHRD+++ N+L++ +  A V+DFG  +     SS +        + AP+   
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173

Query: 629 SPPVNQKI------------------------IQDIIL-----------------VSTTA 647
               + K                         ++D++                  V    
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233

Query: 648 LACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEMRNQEM 691
             C       RP+  ++ ++LE                ++  E+
Sbjct: 234 KNCWHLDAAMRPSFLQLREQLE---------------HIKTHEL 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (394), Expect = 3e-43
 Identities = 70/287 (24%), Positives = 103/287 (35%), Gaps = 66/287 (22%)

Query: 442 YEDLINATEDFH---------IRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETE 488
           +ED   A  +F          I   IG G +G V    L         VA+K L    TE
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 489 DSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE 548
                  F +EA ++    H N++ L G       +  I E+ME GSL   LR +D    
Sbjct: 69  KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
               + V +++ +A  + YL        VHRD+++ NIL+NSNL   V+DFG +R L  D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 609 SSNRTLRA-----GTYGYIAPDQRLSPPVN------------------------------ 633
           +S+ T  +         + AP+                                      
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 634 --QKIIQDIIL---------VSTTALACLRSKPKSRPTMQRISQELE 669
               I QD  L         +    L C +     RP   +I   L+
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-43
 Identities = 53/262 (20%), Positives = 97/262 (37%), Gaps = 51/262 (19%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            +      IG+G +G V+     +   VA+K + +    +    E F  EA V+  + H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LYG CL +  +  ++E+ME G L   LR             + +   V      + 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEG---MA 115

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGYIAPDQRL 628
           +     ++HRD+++ N L+  N    V+DFG  R +  D    +        + +P+   
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 629 SPPVNQK----------------------------IIQDII---------LVSTTA---- 647
               + K                            +++DI          L ST      
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235

Query: 648 LACLRSKPKSRPTMQRISQELE 669
             C + +P+ RP   R+ ++L 
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLA 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 5e-43
 Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 51/262 (19%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E   +   +G G +G V+         VA+K L           E+F  EA+V+  +RH 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            +V+LY     +  ++ + EYM +GSL   L+ +         + V++   +A  ++Y+ 
Sbjct: 73  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE 130

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD-SSNRTLRAGTYGYIAPDQRL 628
                  VHRD+ + NIL+  NL   VADFG ARL+  +  + R        + AP+  L
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 629 SPPVNQKI---------------------------IQDIIL--------------VSTTA 647
                 K                            + D +               +    
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247

Query: 648 LACLRSKPKSRPTMQRISQELE 669
             C R +P+ RPT + +   LE
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLE 269

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-42
 Identities = 55/275 (20%), Positives = 95/275 (34%), Gaps = 56/275 (20%)

Query: 443 EDLINATEDFHIR-YCIGTGGYGSVYKAEL---PDGKVVALKKLHQSETEDSAFVESFQN 498
           + L    ++  I    +G G +GSV +           VA+K L Q    + A  E    
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58

Query: 499 EARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIV 558
           EA+++  + +  IV+L G C     +  + E    G L   L    E  E+  +    ++
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR--- 615
             V+  + YL      + VHRD+++ N+LL +   A ++DFG ++ L  D S  T R   
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 616 AGTYGYIAPDQRLSPPVN--------------------------------QKIIQDIIL- 642
                + AP+       +                                  I Q   + 
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232

Query: 643 --------VSTTALACLRSKPKSRPTMQRISQELE 669
                   +      C   K + RP    + Q + 
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-42
 Identities = 55/250 (22%), Positives = 107/250 (42%), Gaps = 17/250 (6%)

Query: 442 YEDL---INATEDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQ 497
           YE +   +N  + + I   +G G +G VYKA+  +   + A K +     E+   +E + 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYM 57

Query: 498 NEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNI 557
            E  +L++  H NIVKL     ++  ++ + E+   G++  V+ + +    L  ++   +
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115

Query: 558 VKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAG 617
            K    AL+YLH      I+HRD+ + NIL   + +  +ADFG +         R    G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172

Query: 618 TYGYIAPDQRLSPPVNQKIIQ---DIILVSTTALACLRSKP--KSRPTMQRISQELEGKT 672
           T  ++AP+  +      +      D+  +  T +     +P       M+ + +  + + 
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232

Query: 673 PMKKGLKEIS 682
           P        S
Sbjct: 233 PTLAQPSRWS 242

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-41
 Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 15/232 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           ED+ +   +G G YG V  A      + VA+K +      D    E+ + E  +   + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            N+VK YG        +   EY   G LF  +  D   I +           +   + YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYL 119

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL--RAGTYGYIAPDQ 626
           H      I HRDI   N+LL+      ++DFG A +   ++  R L    GT  Y+AP+ 
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 627 RLSPPVNQKIIQDIILVSTTALACLRSKPK---SRPTMQRISQELEGKTPMK 675
                 + + + D+        A L  +        + Q  S   E KT + 
Sbjct: 177 LKRREFHAEPV-DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-40
 Identities = 58/290 (20%), Positives = 95/290 (32%), Gaps = 77/290 (26%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
                   +G G +G V +A             VA+K L  S        E+  +E +VL
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 504 STV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD---------------DDEAI 547
           S +  H NIV L G C        I EY   G L   LR                +D+ +
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
            L+    ++    VA  +++L      + +HRD+++ NILL       + DFG AR +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 608 DSSN--RTLRAGTYGYIAP----------------------------------------- 624
           DS+   +        ++AP                                         
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 625 ----DQRLSPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEG 670
                +       +    ++  +      C  + P  RPT ++I Q +E 
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDI---MKTCWDADPLKRPTFKQIVQLIEK 304

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-40
 Identities = 52/189 (27%), Positives = 78/189 (41%), Gaps = 9/189 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L +        V     E  V+S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
              VKLY        ++F   Y + G L   +R        + T        +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYIAPDQ 626
           H      I+HRD+   NILLN ++   + DFGTA++L  +S         GT  Y++P+ 
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 627 RLSPPVNQK 635
                  + 
Sbjct: 182 LTEKSACKS 190

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 54/239 (22%), Positives = 106/239 (44%), Gaps = 15/239 (6%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           +  + +     IG G  G+VY A ++  G+ VA+++++  +       E   NE  V+  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRE 73

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
            ++ NIV      L    ++ + EY+  GSL  V+ +       +  +   + +    AL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            +LH +    ++HRDI S+NILL  +    + DFG    +  + S R+   GT  ++AP+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 626 QRLSPPVNQKIIQDIILVSTTALACLRSKP--KSRPTMQRISQELEGKTPMKKGLKEIS 682
                    K+  DI  +   A+  +  +P   +   ++ +       TP  +  +++S
Sbjct: 187 VVTRKAYGPKV--DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 60/298 (20%), Positives = 99/298 (33%), Gaps = 75/298 (25%)

Query: 442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVES 495
              L     +      IG G +G V++A  P         +VA+K L +  + D      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62

Query: 496 FQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRD------------- 542
           FQ EA +++   + NIVKL G C   + M  ++EYM  G L   LR              
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 543 --------DDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEA 594
                         L+   ++ I + VA  ++YL        VHRD+++ N L+  N+  
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVV 179

Query: 595 FVADFGTARLLHVDSSNR--TLRAGTYGYIAPDQRLSPPVN------------------- 633
            +ADFG +R ++     +     A    ++ P+                           
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 634 -------------QKIIQDIIL---------VSTTALACLRSKPKSRPTMQRISQELE 669
                          +    IL         +      C    P  RP+   I + L+
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-40
 Identities = 55/269 (20%), Positives = 91/269 (33%), Gaps = 55/269 (20%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP----DGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           +D  +   +G G +G V + E          VA+K L          ++ F  E   + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           + HRN+++LYG  L    M  + E    GSL   LR       L    R      VA  +
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN---RTLRAGTYGYI 622
            YL        +HRD+++ N+LL +     + DFG  R L  +  +   +  R   + + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 623 APDQRLSPPVNQK----------------------------IIQDIIL------------ 642
           AP+   +   +                              I+  I              
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 643 --VSTTALACLRSKPKSRPTMQRISQELE 669
             +    + C   KP+ RPT   +   L 
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 7e-40
 Identities = 50/259 (19%), Positives = 93/259 (35%), Gaps = 55/259 (21%)

Query: 458 IGTGGYGSVYKAELPD---GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKL 514
           +G+G +G+V K         K VA+K L  +E  D A  +    EA V+  + +  IV++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
            G C  +  M  + E  E G L   L+ +     +     + +V  V+  + YL      
Sbjct: 74  IGICEAESWM-LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---S 126

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR---AGTYGYIAPDQRLSPP 631
           + VHRD+++ N+LL +   A ++DFG ++ L  D +    +        + AP+      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 632 VNQKI---------------------------IQDIIL--------------VSTTALAC 650
            + K                            +  ++               +      C
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 246

Query: 651 LRSKPKSRPTMQRISQELE 669
                ++RP    +   L 
Sbjct: 247 WTYDVENRPGFAAVELRLR 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 8e-40
 Identities = 56/291 (19%), Positives = 94/291 (32%), Gaps = 76/291 (26%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD------GKVVALKKLHQSETEDSAFVESFQNEARVL 503
           E+      +G+G +G V  A             VA+K L   E  DS+  E+  +E +++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMM 94

Query: 504 STV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIE-------------- 548
           + +  H NIV L G C     ++ I+EY   G L   LR   E                 
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 549 ------LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA 602
                 L +   +     VA  + +L      S VHRD+++ N+L+       + DFG A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 603 RLLHVDSSNRTLR--AGTYGYIAPDQRLSPPVNQK------------------------- 635
           R +  DS+            ++AP+         K                         
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 636 ---IIQDIIL--------------VSTTALACLRSKPKSRPTMQRISQELE 669
                  +I               +     +C     + RP+   ++  L 
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 16/204 (7%)

Query: 458 IGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYG 516
           IG G + +VYK    +    VA  +L   +   S   + F+ EA +L  ++H NIV+ Y 
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 517 FCL----HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC 572
                   K+C+  + E M  G+L   L+       +      +  + +   L +LH   
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 573 TPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPP 631
            P I+HRD+  +NI +        + D G A L    +S      GT  ++AP+      
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM-YEEK 188

Query: 632 VNQKIIQDIILVSTTALACLRSKP 655
            ++ +  D+       L    S+ 
Sbjct: 189 YDESV--DVYAFGMCMLEMATSEY 210

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-38
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 8/189 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLS-TVR 507
           EDF +   +G G +G V+ AE     +  A+K L +        VE    E RVLS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 508 HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSY 567
           H  +  ++     K  +FF+ EY+  G L Y ++   +    + +R       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 568 LHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQR 627
           LH      IV+RD+  +NILL+ +    +ADFG  +   +  +      GT  YIAP+  
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 628 LSPPVNQKI 636
           L    N  +
Sbjct: 176 LGQKYNHSV 184

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 65/295 (22%), Positives = 104/295 (35%), Gaps = 64/295 (21%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG---KVVALKKLHQSETEDSAFVESFQNEARVLSTV 506
            D   +  IG G +G V KA +         A+K++ +  ++D      F  E  VL  +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67

Query: 507 -RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAIELNWT 552
             H NI+ L G C H+  ++   EY   G+L   LR              +  A  L+  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 553 RRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR 612
           + ++    VA  + YL        +HRD+++ NIL+  N  A +ADFG +R   V     
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 613 TLRAGTYGYIAPDQ------------------------RLSPP--------VNQKIIQDI 640
             R     ++A +                             P        + +K+ Q  
Sbjct: 185 MGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 641 IL---------VSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEISISEM 686
            L         V      C R KP  RP+  +I   L      +K     ++ E 
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (359), Expect = 3e-38
 Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 10/230 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           +DF I   +GTG +G V+      +G+  A+K L +        VE   +E  +LS V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             I++++G     + +F I +Y+E G LF +LR                V         L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
            +  +  I++RD+   NILL+ N    + DFG A+ +           GT  YIAP+   
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174

Query: 629 SPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGL 678
           + P N+ I      +    +    +      TM+   + L  +       
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 224

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (361), Expect = 4e-38
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 14/209 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + + I   +GTG +G V++  E   G   A K +      D    E+ + E + +S +RH
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 82

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +V L+        M  IYE+M  G LF  +   DE  +++    V  ++ V   L ++
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 569 HHDCTPSIVHRDISSNNILLNS--NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           H +     VH D+   NI+  +  + E  + DFG    L    S +    GT  + AP+ 
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEV 196

Query: 627 RLSPPVNQKIIQDIILVSTTALACLRSKP 655
               PV      D+  V   +   L    
Sbjct: 197 AEGKPVGYYT--DMWSVGVLSYILLSGLS 223

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (358), Expect = 9e-38
 Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 12/187 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + + I   +G+G +G V++  E   G+V   K ++     D     + +NE  +++ + H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             ++ L+     K  M  I E++  G LF  +  +D   +++    +N ++     L ++
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHM 143

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           H     SIVH DI   NI+  +   + V   DFG A  L+       +   T  + AP+ 
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEI 199

Query: 627 RLSPPVN 633
               PV 
Sbjct: 200 VDREPVG 206

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 50/289 (17%), Positives = 104/289 (35%), Gaps = 63/289 (21%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           E   +   +G G +G VY+              VA+K ++++ +        F NEA V+
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 504 STVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------DDDEAIELNWTRRVN 556
                 ++V+L G     +    I E M RG L   LR       ++      + ++ + 
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 557 IVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNR--TL 614
           +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG  R ++     R    
Sbjct: 138 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 615 RAGTYGYIAPDQRLSPPVN--------------------------------QKIIQDIIL 642
                 +++P+                                        + +++  +L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 643 ---------VSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEIS 682
                    +      C +  PK RP+   I   ++ +  M+ G +E+S
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREVS 301

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 16/215 (7%)

Query: 449 TEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR 507
           ++ + +   +G GG   V+ A  L   + VA+K L      D +F   F+ EA+  + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 508 HRNIVKLYGFCLHK----RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           H  IV +Y     +       + + EY++  +L  ++  +     +   R + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR---AGTYG 620
           AL++ H      I+HRD+   NI++++     V DFG AR +    ++ T      GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 621 YIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP 655
           Y++P+Q     V+ +   D+  +       L  +P
Sbjct: 180 YLSPEQARGDSVDARS--DVYSLGCVLYEVLTGEP 212

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-37
 Identities = 65/285 (22%), Positives = 101/285 (35%), Gaps = 62/285 (21%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDG-----KVVALKKLHQSETEDSAFVESFQNEARVLS 504
                +  IG G +G VYK  L          VA+K L    TE       F  EA ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
              H NI++L G     + M  I EYME G+L   LR+ D   E +  + V +++ +A  
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAG 122

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRA---GTYGY 621
           +    +    + VHRD+++ NIL+NSNL   V+DFG +R+L  D       +       +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 622 IAP--------------------------------------------DQRLSPPVNQKII 637
            AP                                            +     P      
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239

Query: 638 QDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGLKEIS 682
             I  +    + C + +   RP    I   L+        LK ++
Sbjct: 240 SAIYQL---MMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-37
 Identities = 47/193 (24%), Positives = 75/193 (38%), Gaps = 22/193 (11%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
               ++  IG G +G V++ +   G+ VA+K     E          + E      +RH 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHE 57

Query: 510 NIVKLYGFCLHKR----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           NI+               ++ + +Y E GSLF  L        +     + +  S A  L
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGL 113

Query: 566 SYLHHDC-----TPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN----RTLRA 616
           ++LH +       P+I HRD+ S NIL+  N    +AD G A      +         R 
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 617 GTYGYIAPDQRLS 629
           GT  Y+AP+    
Sbjct: 174 GTKRYMAPEVLDD 186

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (350), Expect = 4e-37
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 13/194 (6%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           +  + +  R  +GTG +  V  AE     K+VA+K + +   E      S +NE  VL  
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHK 63

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
           ++H NIV L         ++ I + +  G LF  + +              ++  V  A+
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAV 120

Query: 566 SYLHHDCTPSIVHRDISSNNILL---NSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
            YLH      IVHRD+   N+L    + + +  ++DFG +++    S   T   GT GY+
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYV 176

Query: 623 APDQRLSPPVNQKI 636
           AP+     P ++ +
Sbjct: 177 APEVLAQKPYSKAV 190

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 7e-37
 Identities = 52/266 (19%), Positives = 88/266 (33%), Gaps = 54/266 (20%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLST 505
           E   +  CIG G +G V++            VA+K      ++     E F  EA  +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64

Query: 506 VRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             H +IVKL G    +  ++ I E    G L            L+    +     ++ AL
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTAL 121

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR-AGTYGYIAP 624
           +YL        VHRDI++ N+L++SN    + DFG +R +   +  +  +      ++AP
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 625 DQRLS------------------------PPVNQKIIQDIIL-----------------V 643
           +                             P       D+I                  +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238

Query: 644 STTALACLRSKPKSRPTMQRISQELE 669
            +    C    P  RP    +  +L 
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 18/239 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E + I   +G G +G V++  E    K    K +    T+        + E  +L+  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           RNI+ L+        +  I+E++    +F  +     A ELN    V+ V  V  AL +L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFL 118

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFV--ADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
           H     +I H DI   NI+  +   + +   +FG AR L    + R L      Y AP+ 
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEV 174

Query: 627 RLSPPVNQKIIQDIILVSTTALACLRSKP--KSRPTMQRISQELEGK-TPMKKGLKEIS 682
                V+     D+  + T     L       +    Q I   +  + T  ++  KEIS
Sbjct: 175 HQHDVVSTAT--DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-35
 Identities = 48/230 (20%), Positives = 82/230 (35%), Gaps = 7/230 (3%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
            DF     +G G +G V        G+  A+K L +        V     E+RVL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +  L         + F+ EY   G LF+ L  +         R       +  A   L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSA---L 118

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
            +  +  +V+RDI   N++L+ +    + DFG  +    D +      GT  Y+AP+   
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 629 SPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGL 678
                + +    + V    + C R    ++   +     L  +    + L
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-35
 Identities = 53/268 (19%), Positives = 102/268 (38%), Gaps = 56/268 (20%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKV----VALKKLHQSETEDSAFVESFQNEARVLS 504
            +F     +G+G +G+VYK   +P+G+     VA+K+L ++ +      +   +EA V++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 66

Query: 505 TVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
           +V + ++ +L G CL    +  I + M  G L   +R+  + I       +N    +A  
Sbjct: 67  SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKG 123

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR--AGTYGYI 622
           ++YL       +VHRD+++ N+L+ +     + DFG A+LL  +              ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 623 APDQRLSPPVNQKI---------------------------IQDIIL------------- 642
           A +  L      +                            I  I+              
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 240

Query: 643 -VSTTALACLRSKPKSRPTMQRISQELE 669
            V    + C      SRP  + +  E  
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 51/279 (18%), Positives = 93/279 (33%), Gaps = 59/279 (21%)

Query: 443 EDLINATEDFHIRY--CIGTGGYGSVYKAELPDGK----VVALKKLHQSETEDSAFVESF 496
           + ++       + +   IG G +G VY   L D        A+K L++    D   V  F
Sbjct: 18  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQF 75

Query: 497 QNEARVLSTVRHRNIVKLYGFCLH-KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
             E  ++    H N++ L G CL  +     +  YM+ G L   +R++     +      
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS----SN 611
            +  +       +    +   VHRD+++ N +L+      VADFG AR ++        N
Sbjct: 136 GLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 612 RTLRAGTYGYIAPDQRLS------------------------PPVNQKIIQDIIL----- 642
           +T       ++A +   +                        PP       DI +     
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

Query: 643 ------------VSTTALACLRSKPKSRPTMQRISQELE 669
                       +    L C   K + RP+   +   + 
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 15/194 (7%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLH------QSETEDSAFVESFQNEARV 502
           E++  +  +G G    V +    P  K  A+K +        S  E     E+   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 503 LSTVR-HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSV 561
           L  V  H NI++L          F +++ M++G LF  L    E + L+      I++++
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119

Query: 562 AHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGY 621
              +  LH      IVHRD+   NILL+ ++   + DFG +  L           GT  Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSY 175

Query: 622 IAPDQRLSPPVNQK 635
           +AP+       +  
Sbjct: 176 LAPEIIECSMNDNH 189

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (334), Expect = 2e-34
 Identities = 48/181 (26%), Positives = 73/181 (40%), Gaps = 12/181 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR- 507
            DF +   IG GG+G VY     D GK+ A+K L +   +         NE  +LS V  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 508 --HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
                IV +         + FI + M  G L Y L       E +          +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGL 120

Query: 566 SYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPD 625
            ++H+     +V+RD+   NILL+ +    ++D G A              GT+GY+AP+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPE 175

Query: 626 Q 626
            
Sbjct: 176 V 176

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-33
 Identities = 51/285 (17%), Positives = 99/285 (34%), Gaps = 70/285 (24%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELP--------DGKVVALKKLHQSETEDSAFVESFQNEAR 501
           +   +   +G G +G V  AE              VA+K L    TE    +    +E  
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEME 70

Query: 502 VLSTV-RHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLR-------------DDDEAI 547
           ++  + +H+NI+ L G C     ++ I EY  +G+L   L+               +   
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 548 ELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV 607
           +L+    V+    VA  + YL        +HRD+++ N+L+  +    +ADFG AR +H 
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 608 DSSNRTLRA--GTYGYIAPDQRLSPPVNQKI---------------------------IQ 638
               +          ++AP+         +                            + 
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 639 DIIL--------------VSTTALACLRSKPKSRPTMQRISQELE 669
            ++               +      C  + P  RPT +++ ++L+
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (321), Expect = 1e-33
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 7/180 (3%)

Query: 450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL-EKEDEGIPSTTIREISILKELKHS 60

Query: 510 NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
           NIVKLY     K+ +  ++E++++     +   +     L      + +  + + ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117

Query: 570 HDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLS 629
                 ++HRD+   N+L+N   E  +ADFG AR   +     T    T  Y APD  + 
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-33
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 9/172 (5%)

Query: 458 IGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDS--AFVESFQNEARVLSTVRHRNIVKL 514
           +G G + +VYKA      ++VA+KK+      ++      +   E ++L  + H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 515 YGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTP 574
                HK  +  ++++ME      +    D ++ L  +     +      L YLH     
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
            I+HRD+  NN+LL+ N    +ADFG A+     +   T +  T  Y AP+ 
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 7e-33
 Identities = 41/198 (20%), Positives = 76/198 (38%), Gaps = 15/198 (7%)

Query: 447 NATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDS---AFVESFQNEARV 502
           N  + +     +G+G +  V K  E   G   A K + +  T+ S      E  + E  +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 503 LSTVRHRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           L  ++H N++ L+    +K  +  I E +  G LF      D   E          + + 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELF------DFLAEKESLTEEEATEFLK 120

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSN----LEAFVADFGTARLLHVDSSNRTLRAGT 618
             L+ +++  +  I H D+   NI+L           + DFG A  +    +      GT
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGT 179

Query: 619 YGYIAPDQRLSPPVNQKI 636
             ++AP+     P+  + 
Sbjct: 180 PEFVAPEIVNYEPLGLEA 197

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-32
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 7/181 (3%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
            NIVKL      +  ++ ++E++ +    ++       I L   +       +   L  L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
               +  ++HRD+   N+L+N+     +ADFG AR   V     T    T  Y AP+  L
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 629 S 629
            
Sbjct: 176 G 176

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 52/285 (18%), Positives = 96/285 (33%), Gaps = 70/285 (24%)

Query: 450 EDFHIRYCIGTGGYGSVYKA------ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           +   +   +G G +G V +A      +    + VA+K L +  T       +  +E ++L
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKIL 70

Query: 504 S-TVRHRNIVKLYGFCLHK-RCMFFIYEYMERGSLFYVLR-------------DDDEAIE 548
                H N+V L G C      +  I E+ + G+L   LR             +D     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           L     +     VA  + +L        +HRD+++ NILL+      + DFG AR ++ D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 609 SSN--RTLRAGTYGYIA---------------------------------PDQRLSPPVN 633
                +        ++A                                 P  ++     
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 634 QKIIQDIIL---------VSTTALACLRSKPKSRPTMQRISQELE 669
           +++ +   +         +  T L C   +P  RPT   + + L 
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 4e-31
 Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 10/230 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + F     +GTG +G V   +    G   A+K L + +      +E   NE R+L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
             +VKL         ++ + EY+  G +F  LR        +          +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRL 628
           H      +++RD+   N+L++      V DFG A+             GT   +AP+  L
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211

Query: 629 SPPVNQKIIQDIILVSTTALACLRSKPKSRPTMQRISQELEGKTPMKKGL 678
           S   N+ +    + V    +A       +   +Q   + + GK       
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 8e-31
 Identities = 41/190 (21%), Positives = 78/190 (41%), Gaps = 17/190 (8%)

Query: 445 LINATEDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
           + +    +     IG G YG V  A +  +   VA+KK+   E +   + +    E ++L
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKIL 60

Query: 504 STVRHRNIVKLYGFCLHKRC----MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVK 559
              RH NI+ +               ++  ++    L+ +L+       L+       + 
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLY 116

Query: 560 SVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTL---RA 616
            +   L Y+H     +++HRD+  +N+LLN+  +  + DFG AR+   D  +        
Sbjct: 117 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 617 GTYGYIAPDQ 626
            T  Y AP+ 
Sbjct: 174 ATRWYRAPEI 183

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 2e-30
 Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 8/178 (4%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + +     IG G YG+V+KA+     ++VALK++   + +D     S   E  +L  ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60

Query: 509 RNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYL 568
           +NIV+L+      + +  ++E+ ++    Y    +             +   +   L  L
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114

Query: 569 HHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQ 626
               + +++HRD+   N+L+N N E  +A+FG AR   +     +    T  Y  PD 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 4e-30
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 20/198 (10%)

Query: 445 LINATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVL 503
             +    +     IG G +G V+KA     G+ VALKK+   E E   F  +   E ++L
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKIL 63

Query: 504 STVRHRNIVKLYGFCL--------HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
             ++H N+V L   C          K  ++ ++++ E      +     +   L+  +RV
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV 122

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS----N 611
                +   L+ L++     I+HRD+ + N+L+  +    +ADFG AR   +  +     
Sbjct: 123 -----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 612 RTLRAGTYGYIAPDQRLS 629
            T R  T  Y  P+  L 
Sbjct: 178 YTNRVVTLWYRPPELLLG 195

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 8e-30
 Identities = 54/255 (21%), Positives = 93/255 (36%), Gaps = 48/255 (18%)

Query: 451 DFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVES---FQNEARVLSTV 506
            + +   +G+GG+GSVY    + D   VA+K + +    D   + +      E  +L  V
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 507 R--HRNIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHA 564
                 +++L  +         I E  E     +    +  A  L      +    V  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 122

Query: 565 LSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFGTARLLHVDSSNRTLRAGTYGYIA 623
           + + H+     ++HRDI   NIL++ N  E  + DFG+  LL    +  T   GT  Y  
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 177

Query: 624 PDQ--------------------------RLSPPVNQKIIQDIIL----VSTTA----LA 649
           P+                            +    +++II+  +     VS+        
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237

Query: 650 CLRSKPKSRPTMQRI 664
           CL  +P  RPT + I
Sbjct: 238 CLALRPSDRPTFEEI 252

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 13/213 (6%)

Query: 450 EDFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSE-TEDSAFVESFQNEARVLS 504
           E+F +   +GTG YG V+          GK+ A+K L ++   + +   E  + E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 505 TVRHR-NIVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
            +R    +V L+     +  +  I +Y+  G LF  L   +   E      V        
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRT-LRAGTYGYI 622
            +  L H     I++RDI   NILL+SN    + DFG ++    D + R     GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 623 APDQRLSPPVNQKIIQDIILVSTTALACLRSKP 655
           APD             D   +       L    
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 68/277 (24%), Positives = 109/277 (39%), Gaps = 12/277 (4%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
           V+CS  G L  +     P+   L+L NN ++        +L NL  L L  N ++   P 
Sbjct: 15  VQCSDLG-LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73

Query: 105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLS 164
               L  LE LYLS N L         +L+ L        K+   +   + N   ++ L 
Sbjct: 74  AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELG 132

Query: 165 VMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPS 224
                  G        +  L  + +       TIP+  G   +LT L +  NK+T    +
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAA 189

Query: 225 TLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLN 284
           +L  L +L  L LSFN + +     + N   L EL L++NK+   +P  L+    +Q + 
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248

Query: 285 LSSNLLSG------QIPFAIGKLFNLVSLDLSKNKLS 315
           L +N +S         P    K  +   + L  N + 
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  105 bits (262), Expect = 1e-25
 Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 11/284 (3%)

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
           +L V+  S+  L    P ++    +   L L++NK++ +   +  NLK+L  L ++ N +
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLT 230
               P     L  LERL+L  NQ      +    L+ L        K+  ++ + L +  
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQM 126

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLL 290
            ++ L  +  +              L+ + ++D  I  I         +L  L+L  N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKI 183

Query: 291 SGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL 350
           +     ++  L NL  L LS N +S      + N   L+ L LN+N L   +P  +    
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242

Query: 351 LLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNP 394
            +Q + L +NN+S        P   +    +  G     L  NP
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG---VSLFSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 43/229 (18%), Positives = 78/229 (34%), Gaps = 24/229 (10%)

Query: 11  CGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLW 70
               ++   H          +       I             + +  F     L Y+ + 
Sbjct: 99  PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158

Query: 71  NNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEI 130
           + N++ +IP   G   +L  L+L  N +T      +  L NL  L LS NS+       +
Sbjct: 159 DTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215

Query: 131 GSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLG 190
            +  +L EL+L +NKL  V P  + + K +  + +  N +   I S  F           
Sbjct: 216 ANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISA-IGSNDFCP--------- 264

Query: 191 CNQFNGTIPREIGNLKNLTHLSIITNKLT--GAIPSTLGHLTSLLYLDL 237
                   P       + + +S+ +N +      PST   +     + L
Sbjct: 265 --------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.4 bits (119), Expect = 3e-07
 Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 3/118 (2%)

Query: 279 NLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSL 338
           +L+ +  S   L  ++P  +    +   LDL  NK++        N   L  L L +N +
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 339 DGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPN 396
               P     ++ L+ L LS N L          +       N   ++   + +    
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 4e-29
 Identities = 42/196 (21%), Positives = 76/196 (38%), Gaps = 23/196 (11%)

Query: 450 EDFHI-RYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV- 506
           +D+ +    +G G  G V +       +  ALK L              + E  +     
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRAS 62

Query: 507 RHRNIVKLYGFC----LHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           +  +IV++          ++C+  + E ++ G LF  ++D  +           I+KS+ 
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIG 121

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLE---AFVADFGTARLLHVDSSNRTLRAGTY 619
            A+ YLH     +I HRD+   N+L  S        + DFG A+     +S  T    T 
Sbjct: 122 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTP 177

Query: 620 GYIAPDQRLSPPVNQK 635
            Y+AP+       ++ 
Sbjct: 178 YYVAPEVLGPEKYDKS 193

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 4e-29
 Identities = 43/194 (22%), Positives = 75/194 (38%), Gaps = 18/194 (9%)

Query: 451 DFHIRYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR 509
            +     IG G +G VY+A+L D G++VA+KK+ Q +            E +++  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73

Query: 510 NIVKLYGFCLH------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAH 563
           NIV+L  F         +  +  + +Y+                 L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 564 ALSYLHHDCTPSIVHRDISSNNILLNSNLEAF-VADFGTARLLHVDSSNRTLRAGTYGYI 622
           +L+Y+H      I HRDI   N+LL+ +     + DFG+A+ L     N +     Y   
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 623 APDQRLSPPVNQKI 636
                 +      I
Sbjct: 191 PELIFGATDYTSSI 204

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-29
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 17/217 (7%)

Query: 448 ATEDFHIRYCIGTGGYGSVYKAE--LPDGKVVALKKLHQSETEDSAFVESFQ--NEARVL 503
           A + +     IG G YG V+KA      G+ VALK++     E+   + + +     R L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 504 STVRHRNIVKLYGFCLHKR-----CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIV 558
            T  H N+V+L+  C   R      +  ++E++++    Y+ +  +  +     +   ++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MM 122

Query: 559 KSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGT 618
             +   L +LH      +VHRD+   NIL+ S+ +  +ADFG AR+     +  +    T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178

Query: 619 YGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP 655
             Y AP+  L       +  D+  V        R KP
Sbjct: 179 LWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRKP 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (281), Expect = 4e-28
 Identities = 28/195 (14%), Positives = 69/195 (35%), Gaps = 21/195 (10%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + +   IG+G +G +Y    +  G+ VA+K                  E+++   ++   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
            +    +C  +     +   +   SL  +        + +    + +   +   + Y+H 
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS 121

Query: 571 DCTPSIVHRDISSNNILLNS---NLEAFVADFGTARLLHVDSSN-------RTLRAGTYG 620
               + +HRD+  +N L+         ++ DFG A+      ++            GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 621 YIAPDQRLSPPVNQK 635
           Y + +  L    +++
Sbjct: 179 YASINTHLGIEQSRR 193

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  111 bits (279), Expect = 1e-27
 Identities = 33/187 (17%), Positives = 74/187 (39%), Gaps = 21/187 (11%)

Query: 450 EDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR- 507
           +D+ +   +G G Y  V++A  + + + V +K L   + +        + E ++L  +R 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRG 88

Query: 508 HRNIVKLYGFCLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHAL 565
             NI+ L         R    ++E++       + +       L        +  +  AL
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKAL 142

Query: 566 SYLHHDCTPSIVHRDISSNNILLNS-NLEAFVADFGTARLLHVDSSNRTLRAGTYGYIAP 624
            Y H      I+HRD+  +N++++  + +  + D+G A   H       +R  +  +  P
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGP 198

Query: 625 DQRLSPP 631
           +  +   
Sbjct: 199 ELLVDYQ 205

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 6e-27
 Identities = 49/236 (20%), Positives = 91/236 (38%), Gaps = 25/236 (10%)

Query: 450 EDFHIRYCIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH 508
           + +     IG+G  G V  A +    + VA+KKL +   ++    +    E  ++  V H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75

Query: 509 RNIVKLYGFCLHKRCM------FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVA 562
           +NI+ L      ++ +      + + E M+      +  + D        R   ++  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQML 129

Query: 563 HALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLRAGTYGYI 622
             + +LH      I+HRD+  +NI++ S+    + DFG AR     S   T    T  Y 
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185

Query: 623 APDQRLSPPVNQKIIQDIILVSTTALACLRSKP-----KSRPTMQRISQELEGKTP 673
           AP+  L     + +  DI  V       +R K             ++ ++L    P
Sbjct: 186 APEVILGMGYKENV--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 40/252 (15%), Positives = 87/252 (34%), Gaps = 34/252 (13%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + +   IG G +G +++   L + + VA+K   +            ++E R    +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCT 61

Query: 511 -IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLH 569
            I  +Y F         + + +       +        + +        K +   +  +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 118

Query: 570 HDCTPSIVHRDISSNNILLNSNL-----EAFVADFGTARLL-------HVDSSNRTLRAG 617
                S+V+RDI  +N L+           +V DFG  +         H+    +   +G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 618 TYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-----KSRPTMQRISQELEGK- 671
           T  Y++ +  L    +++   D+  +    +  LR        K+    Q+  +  E K 
Sbjct: 176 TARYMSINTHLGREQSRRD--DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

Query: 672 -TPMKKGLKEIS 682
            TP+++      
Sbjct: 234 STPLRELCAGFP 245

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-26
 Identities = 46/225 (20%), Positives = 81/225 (36%), Gaps = 24/225 (10%)

Query: 442 YEDLINATEDFHIRY----CIGTGGYGSVYKA-ELPDGKVVALKKLHQSETEDSAFVESF 496
            +++     +    Y     +G+G YG+V  A +   G  VA+KKL++   +   F +  
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRA 64

Query: 497 QNEARVLSTVRHRNIVKLYGFCLHKRCM------FFIYEYMERGSLFYVLRDDDEAIELN 550
             E R+L  +RH N++ L         +      + +  +M       +  +     +L 
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KLG 119

Query: 551 WTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS 610
             R   +V  +   L Y+H        HRD+   N+ +N + E  + DFG AR    DS 
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR--QADSE 174

Query: 611 NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP 655
                   +              Q +  DI  V       +  K 
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTV--DIWSVGCIMAEMITGKT 217

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  106 bits (264), Expect = 3e-25
 Identities = 79/339 (23%), Positives = 128/339 (37%), Gaps = 47/339 (13%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
            +  L      +  SI   +  L+NL  +N   N LT   P  + +L  L  + ++NN +
Sbjct: 45  QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100

Query: 123 HGTTPIEIGSLRNLEELYLRSNKLSGVLPQ------------EIGNLKSLIWLSVMYNTV 170
              TP+   +      L+         L               I ++ +L  L+ +    
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHL 229
            G   + L  L NL  L       N      +   L NL  L    N+++   P     L
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--IL 218

Query: 230 TSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNL 289
           T+L  L L+ NQL       + + + L +LDL++N+I  + P  LS L+ L  L L +N 
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 290 LSGQIPFA--------------------IGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQ 329
           +S   P A                    I  L NL  L L  N +S   P  + + T+LQ
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332

Query: 330 HLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPM 368
            L   +N +  +    +  +  +  L   HN +S   P+
Sbjct: 333 RLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPL 369

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  104 bits (259), Expect = 1e-24
 Identities = 83/364 (22%), Positives = 135/364 (37%), Gaps = 52/364 (14%)

Query: 31  ITCDYKGSITHIELVECSIKGELGSL-NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLK 89
           ++      +T ++     IK    S+       NL  +N  NN L+   P  + +L+ L 
Sbjct: 38  VSQTDLDQVTTLQADRLGIK----SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 91

Query: 90  YLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIG---------SLRNLEELY 140
            + +  N +    P    +      L+ +  +                   ++ ++  L 
Sbjct: 92  DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALS 151

Query: 141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTV----GGPIPSTLFRLTNLERLFLGCNQFNG 196
             ++        ++ +LK L  L+ +             S L +LTNLE L    NQ + 
Sbjct: 152 GLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISD 211

Query: 197 TIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSAL 256
             P  I    NL  LS+  N+L      TL  LT+L  LDL+ NQ+ +  PL     + L
Sbjct: 212 ITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKL 265

Query: 257 AELDLSDNKIRGIIP--------------------DELSKLSNLQYLNLSSNLLSGQIPF 296
            EL L  N+I  I P                      +S L NL YL L  N +S   P 
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV 325

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLD 356
               L  L  L  + NK+S    + + N T +  L+  HN +    P  +  +  +  L 
Sbjct: 326 --SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379

Query: 357 LSHN 360
           L+  
Sbjct: 380 LNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  100 bits (250), Expect = 2e-23
 Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 17/304 (5%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
           N     D  P     +   + +  +    I  ++ +    + EL S   S    L  L  
Sbjct: 96  NNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 155

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNN-LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPI 128
                 G+    +  L+NL  L     +    +    +  L NLE L  +NN +   TP+
Sbjct: 156 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 215

Query: 129 EIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLF 188
            I +  NL+EL L  N+L       + +L +L  L +  N +    P  L  LT L  L 
Sbjct: 216 GILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 269

Query: 189 LGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPL 248
           LG NQ +   P  +  L  LT+L +  N+L    P +  +L +L YL L FN +    P 
Sbjct: 270 LGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP- 324

Query: 249 EIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLD 308
            + + + L  L  ++NK+       L+ L+N+ +L+   N +S   P     L  +  L 
Sbjct: 325 -VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLG 379

Query: 309 LSKN 312
           L+  
Sbjct: 380 LNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.1 bits (209), Expect = 3e-18
 Identities = 72/363 (19%), Positives = 128/363 (35%), Gaps = 73/363 (20%)

Query: 84  SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS 143
           +L+      L   N+T T+ +    L  +  L      +     +E   L NL ++   +
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSN 75

Query: 144 NKLSGVLPQEIGNLKSLIWLSV------------------------------------MY 167
           N+L+ + P  + NL  L+ + +                                      
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 168 NTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLT-HLSIITNKLTGAIPSTL 226
                   +T+  ++ L  L        G    ++  L NLT    +  +    +  S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
             LT+L  L  + NQ+    P  +G  + L EL L+ N+++ I    L+ L+NL  L+L+
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 249

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFP--------------------TGIGNCT 326
           +N +S   P     L  L  L L  N++S   P                    + I N  
Sbjct: 250 NNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 327 ELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM--FLDMSFNNLEG 384
            L +L L  N++    P  +  +  LQ L  ++N +S    +       +L    N +  
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISD 365

Query: 385 EIP 387
             P
Sbjct: 366 LTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 64.6 bits (156), Expect = 1e-11
 Identities = 16/118 (13%), Positives = 38/118 (32%), Gaps = 4/118 (3%)

Query: 3   IERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFP 62
           +    + N             +             ++ ++  +             S   
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLT 329

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
            LQ L   NN +S      + +L+N+ +L+   N ++   P  + +L  +  L L++ 
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 3e-04
 Identities = 15/99 (15%), Positives = 34/99 (34%), Gaps = 8/99 (8%)

Query: 263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI 322
           D  I  I  D    L+      L    ++  +      L  + +L   +  +      G+
Sbjct: 9   DTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGV 62

Query: 323 GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN 361
                L  +  ++N L    P  +  +  L ++ +++N 
Sbjct: 63  EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 5e-25
 Identities = 47/227 (20%), Positives = 85/227 (37%), Gaps = 18/227 (7%)

Query: 435 GYDGKILYEDLINATEDFHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFV 493
            +  + L + +    E +     +G+G YGSV  A     G  VA+KKL +   +     
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHA 61

Query: 494 ESFQNEARVLSTVRHRNIVKLYGFCLHKRCM-----FFIYEYMERGSLFYVLRDDDEAIE 548
           +    E R+L  ++H N++ L       R +      ++  ++    L  +++      +
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----K 117

Query: 549 LNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD 608
           L       ++  +   L Y+H        HRD+  +N+ +N + E  + DFG AR  H D
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTD 172

Query: 609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP 655
                  A  +             NQ +  DI  V       L  + 
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGRT 217

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 9e-25
 Identities = 62/273 (22%), Positives = 98/273 (35%), Gaps = 6/273 (2%)

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
                   L    P+ I +    + ++L  N++S V        ++L  L +  N +   
Sbjct: 15  TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTI-PREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
             +    L  LE+L L  N    ++ P     L  L  L +    L    P     L +L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
            YL L  N L +       +   L  L L  N+I  +       L +L  L L  N ++ 
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLL 352
             P A   L  L++L L  N LS      +     LQ+L LN N               L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWL 250

Query: 353 QNLDLSHNNLSGTIPMTLHPM-FLDMSFNNLEG 384
           Q    S + +  ++P  L       ++ N+L+G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (240), Expect = 7e-23
 Identities = 60/286 (20%), Positives = 94/286 (32%), Gaps = 34/286 (11%)

Query: 32  TCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYL 91
            C  +  +T      C  +G L ++        Q + L  N +S        +  NL  L
Sbjct: 7   VCYNEPKVT----TSCPQQG-LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 92  NLRWNN-------------------------LTGTIPKEIGSLRNLEVLYLSNNSLHGTT 126
            L  N                          L    P     L  L  L+L    L    
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 127 PIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLER 186
           P     L  L+ LYL+ N L  +      +L +L  L +  N +          L +L+R
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181

Query: 187 LFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFI 246
           L L  N+     P    +L  L  L +  N L+      L  L +L YL L+ N      
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241

Query: 247 PLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
                 ++ L +   S +++   +P     L+      L++N L G
Sbjct: 242 RA-RPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (202), Expect = 7e-18
 Identities = 46/242 (19%), Positives = 75/242 (30%), Gaps = 5/242 (2%)

Query: 1   SEIERQALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSC 60
           S +   +   C        H+                           +   +    F  
Sbjct: 45  SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL-RSVDPATFHG 103

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
              L  L+L    L    P     L+ L+YL L+ N L          L NL  L+L  N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            +          L +L+ L L  N+++ V P    +L  L+ L +  N +       L  
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L  L+ L L  N +     R       L      ++++  ++P     L       L+ N
Sbjct: 224 LRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAAN 279

Query: 241 QL 242
            L
Sbjct: 280 DL 281

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  101 bits (252), Expect = 3e-24
 Identities = 85/340 (25%), Positives = 129/340 (37%), Gaps = 44/340 (12%)

Query: 1   SEIERQALLNCGWWKDRIPH--------NTSDHCN--WVGITCDYKGSITHIELVECSIK 50
           +  ++QALL     K  + +         T+D CN  W+G+ CD       +        
Sbjct: 4   NPQDKQALLQ---IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRV-------- 52

Query: 51  GELGSLNFSCFPNLQYLNLWNNNLSG--SIPPQIGSLSNLKYLNLRWN-NLTGTIPKEIG 107
                           L+L   NL     IP  + +L  L +L +    NL G IP  I 
Sbjct: 53  --------------NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 108 SLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMY 167
            L  L  LY+++ ++ G  P  +  ++ L  L    N LSG LP  I +L +L+ ++   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

Query: 168 NTVGGPIPSTLFRLTNLERLFLGC-NQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTL 226
           N + G IP +    + L        N+  G IP    NL               A     
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218

Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
               +            +F   ++G    L  LDL +N+I G +P  L++L  L  LN+S
Sbjct: 219 SDKNT--QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCT 326
            N L G+IP   G L        + NK     P  +  CT
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.8 bits (195), Expect = 7e-17
 Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 7/265 (2%)

Query: 107 GSLRNLEVLYLSNNSLHGTTPI--EIGSLRNLEELYLRSN-KLSGVLPQEIGNLKSLIWL 163
                +  L LS  +L    PI   + +L  L  LY+     L G +P  I  L  L +L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP 223
            + +  V G IP  L ++  L  L    N  +GT+P  I +L NL  ++   N+++GAIP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 224 STLGHLTSLLYLDLSF-NQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQY 282
            + G  + L        N+L   IP    N +        +           S  +  + 
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 283 LNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTI 342
               ++L        + K  N +  DL  N++ G+ P G+     L  L ++ N+L G I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 343 PPEIGKILLLQNLDLSHNNLSGTIP 367
            P+ G +        ++N      P
Sbjct: 285 -PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.1 bits (175), Expect = 3e-14
 Identities = 63/291 (21%), Positives = 105/291 (36%), Gaps = 22/291 (7%)

Query: 119 NNSLHGTTPIEIGSLRNLEELYLRSNKLSGV--LPQEIGNLKSLIWLSVMYNT-VGGPIP 175
           N +  G           +  L L    L     +P  + NL  L +L +     + GPIP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
             + +LT L  L++     +G IP  +  +K L  L    N L+G +P ++  L +L+ +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP 295
               N++   IP   G+FS L          R       +  +        S  +     
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDA 213

Query: 296 FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNL 355
             +                       +G    L  L L +N + GT+P  + ++  L +L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 356 DLSHNNLSGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCG 406
           ++S NNL G IP   +    D+S                  ++  NK LCG
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVS------------------AYANNKCLCG 306

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.5 bits (229), Expect = 3e-22
 Identities = 27/165 (16%), Positives = 52/165 (31%), Gaps = 17/165 (10%)

Query: 458 IGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFV-------ESFQNEARVLSTVRHRN 510
           +G G   +V+           +K      T               F   A   +    R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 511 IVKLYGFCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH 570
           + KL G  + K   +         ++   L D  E   +       ++  +   ++  +H
Sbjct: 68  LQKLQGLAVPKVYAWE------GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 571 DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSNRTLR 615
                IVH D+S  N+L+ S    ++ DF  +  +  +     L 
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILE 162

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.8 bits (216), Expect = 3e-19
 Identities = 39/209 (18%), Positives = 79/209 (37%), Gaps = 33/209 (15%)

Query: 452 FHIRYCIGTGGYGSVYKAE-LPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN 510
           + +   +G G + +V+ A+ + +   VA+K +      D  + E+ ++E ++L  V   +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 70

Query: 511 IVKLYGFCLH---------------KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRV 555
             K      +                  +  ++E +    L  + + +   I L + ++ 
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ- 129

Query: 556 NIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN------LEAFVADFGTARLLHVDS 609
            I K +   L Y+H  C   I+H DI   N+L+         ++  +AD G A       
Sbjct: 130 -ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--- 183

Query: 610 SNRTLRAGTYGYIAPDQRLSPPVNQKIIQ 638
            + T    T  Y +P+  L  P       
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADI 212

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.7 bits (187), Expect = 4e-16
 Identities = 41/208 (19%), Positives = 71/208 (34%), Gaps = 7/208 (3%)

Query: 81  QIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELY 140
           ++  +++   +N    NLT  +P ++   ++  +L+LS N L+  +   +     L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 141 LRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPR 200
           L   +      Q  G L  L  L + +N +                     N+       
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV-SFNRLTSLPLG 118

Query: 201 EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELD 260
            +  L  L  L +  N+L    P  L     L  L L+ N L       +     L  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 261 LSDNKIRGIIPDELSKLSNLQYLNLSSN 288
           L +N +   IP        L +  L  N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.5 bits (184), Expect = 1e-15
 Identities = 47/207 (22%), Positives = 69/207 (33%), Gaps = 7/207 (3%)

Query: 58  FSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL 117
            S   +   +N    NL+ ++PP +    +   L+L  N L       +     L  L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST 177
               L          L  L  L L  N+L  +           +   V +N +       
Sbjct: 63  DRAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGA 119

Query: 178 LFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDL 237
           L  L  L+ L+L  N+     P  +     L  LS+  N LT      L  L +L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 238 SFNQLHSFIPLEIGNFSALAELDLSDN 264
             N L++ IP        L    L  N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.4 bits (168), Expect = 1e-13
 Identities = 50/211 (23%), Positives = 73/211 (34%), Gaps = 6/211 (2%)

Query: 33  CDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLN 92
           C+     +H+E V C  +  L +L      +   L+L  N L       +   + L  LN
Sbjct: 4   CEVSKVASHLE-VNCDKRN-LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 93  LRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQ 152
           L    LT         L  L  L LS+N L     +       L  L +  N+L+ +   
Sbjct: 62  LDRAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLG 118

Query: 153 EIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLS 212
            +  L  L  L +  N +    P  L     LE+L L  N         +  L+NL  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 213 IITNKLTGAIPSTLGHLTSLLYLDLSFNQLH 243
           +  N L   IP        L +  L  N   
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 5e-08
 Identities = 41/207 (19%), Positives = 61/207 (29%), Gaps = 49/207 (23%)

Query: 201 EIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELD 260
           E+  + +   ++     LT A+P  L        L LS N L++F    +  ++ L +L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 261 LSDNK---------------------------------------------IRGIIPDELS 275
           L   +                                             +  +    L 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNH 335
            L  LQ L L  N L    P  +     L  L L+ N L+      +     L  L L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 336 NSLDGTIPPEIGKILLLQNLDLSHNNL 362
           NS   TIP       LL    L  N  
Sbjct: 182 NS-LYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 4e-06
 Identities = 31/137 (22%), Positives = 42/137 (30%), Gaps = 1/137 (0%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
             G        + S +                +  V  +    L          LQ L L
Sbjct: 72  VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE 129
             N L    P  +     L+ L+L  NNLT      +  L NL+ L L  NSL+ T P  
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190

Query: 130 IGSLRNLEELYLRSNKL 146
                 L   +L  N  
Sbjct: 191 FFGSHLLPFAFLHGNPW 207

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.9 bits (172), Expect = 5e-14
 Identities = 46/272 (16%), Positives = 94/272 (34%), Gaps = 16/272 (5%)

Query: 65  QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHG 124
           Q L+L   NL   +  ++ S   +       + +   +  E  S   ++ + LSN+ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 125 TTPIEI-GSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMY--NTVGGPIPSTLFRL 181
           +T   I      L+ L L   +LS  +   +    +L+ L++          + + L   
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 182 TNLERL------FLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
           + L+ L                +      +  L       N     + + +    +L++L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 236 DLSFNQLHS-FIPLEIGNFSALAELDLSD-NKIRGIIPDELSKLSNLQYLNLSSNLLSGQ 293
           DLS + +       E    + L  L LS    I      EL ++  L+ L +   +  G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 294 IPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNC 325
           +      L +   L ++ +  +      IGN 
Sbjct: 241 LQLLKEALPH---LQINCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.3 bits (160), Expect = 2e-12
 Identities = 50/268 (18%), Positives = 95/268 (35%), Gaps = 16/268 (5%)

Query: 91  LNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV- 149
           L+L   NL   +   + S + +       + +      E  S   ++ + L ++ +    
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62

Query: 150 LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERL--FLGCNQFNGTIPREIGNLKN 207
           L   +     L  LS+    +  PI +TL + +NL RL            +   + +   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 208 LTHLSIITNKLTG------AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL 261
           L  L++             A+      +T L       N   S +   +     L  LDL
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 262 SDN-KIRGIIPDELSKLSNLQYLNLSS-NLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFP 319
           SD+  ++     E  +L+ LQ+L+LS    +  +    +G++  L +L +      G+  
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 320 TGIGNCTELQHLALNHNSLDGTIPPEIG 347
                   LQ   +N +       P IG
Sbjct: 243 LLKEALPHLQ---INCSHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 39/225 (17%), Positives = 65/225 (28%), Gaps = 13/225 (5%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
            + H++L    I+        S    LQ L+L    LS  I   +   SNL  LNL   +
Sbjct: 47  RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNL 157
                  +        +  L+ +     T   +          +    LSG       + 
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166

Query: 158 KSLIWLSVMYNT---------VGGPIPSTLFRLTNLERLFL-GCNQFNGTIPREIGNLKN 207
            S +                 +        F+L  L+ L L  C         E+G +  
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 208 LTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGN 252
           L  L +      G +      L     L ++ +   +     IGN
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 15/94 (15%), Positives = 32/94 (34%), Gaps = 7/94 (7%)

Query: 306 SLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGT 365
           +LDL+   L       + +   +       + +D  +  E      +Q++DLS++ +  +
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61

Query: 366 IPMTL-----HPMFLDMSFNNLEGEIPTYLRDNP 394
               +         L +    L   I   L  N 
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.003
 Identities = 17/109 (15%), Positives = 36/109 (33%), Gaps = 7/109 (6%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGS----ITHIELVECSIKGELGSLNFSCFPNLQ 65
                   + H        +   C  +      + H+ L  C        L     P L+
Sbjct: 169 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228

Query: 66  YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEV 114
            L ++     G++     +L +L+   +  ++ T      IG+ +N E+
Sbjct: 229 TLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 274

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.1 bits (157), Expect = 2e-12
 Identities = 38/226 (16%), Positives = 76/226 (33%), Gaps = 18/226 (7%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
             N   +    +N++ ++      L  +  L+     +T    + +  L NL  L L +N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            +    P++  +     EL     K    +          +  + + +       S L  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L          +   G    +  ++ N     +            L +L+ L  L    N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT----------PLANLSKLTTLKADDN 183

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
           ++    PL   +   L E+ L +N+I  + P  L+  SNL  + L+
Sbjct: 184 KISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.5 bits (153), Expect = 8e-12
 Identities = 42/227 (18%), Positives = 73/227 (32%), Gaps = 18/227 (7%)

Query: 84  SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS 143
           +L+N   +    +N+T T+ +    L  +  L      +     ++   L NL  L L+ 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKD 72

Query: 144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIG 203
           N+++ + P +     + + LS         I       T         +         + 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
            L    +     + L G                             + N S L  L   D
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLS 310
           NKI  I P  L+ L NL  ++L +N +S   P       NL  + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.7 bits (130), Expect = 7e-09
 Identities = 17/111 (15%), Positives = 37/111 (33%), Gaps = 4/111 (3%)

Query: 9   LNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLN 68
            +                            +T+++ +             +    L  L 
Sbjct: 120 TDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK 179

Query: 69  LWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN 119
             +N +S   P  + SL NL  ++L+ N ++   P  + +  NL ++ L+N
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.3 bits (129), Expect = 8e-09
 Identities = 33/210 (15%), Positives = 66/210 (31%), Gaps = 16/210 (7%)

Query: 54  GSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLE 113
            ++  +    +  L+ +   ++ +I   +  L+NL  L L+ N +T   P +  +     
Sbjct: 33  DTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAPLKNLTKITEL 90

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
            L  +                        ++         +  L   +      + + G 
Sbjct: 91  ELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGL 150

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
                                  +    + NL  LT L    NK++   P  L  L +L+
Sbjct: 151 TNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLI 198

Query: 234 YLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
            + L  NQ+    PL   N S L  + L++
Sbjct: 199 EVHLKNNQISDVSPL--ANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 6e-06
 Identities = 36/203 (17%), Positives = 73/203 (35%), Gaps = 20/203 (9%)

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L N  ++  G +    T+ +   +L  +T LS     +T      + +L +L+ L+L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK 300
           Q+    PL+        EL  +  K    I    S  +        +++        +  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 301 LFNLVSLDLSKNKL--------------SGSFPTGIGNCTELQHLALNHNSLDGTIPPEI 346
           L+  ++   + + L                S  T + N ++L  L  + N +    P  +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 347 GKILLLQNLDLSHNNLSGTIPMT 369
             +  L  + L +N +S   P+ 
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLA 214

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 22/133 (16%), Positives = 37/133 (27%), Gaps = 7/133 (5%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
                  +           +       G      L     +                  L
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN---ISPLAGLTNLQYL 156

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE 129
              N   S    + +LS L  L    N ++   P  + SL NL  ++L NN +   +P+ 
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL- 213

Query: 130 IGSLRNLEELYLR 142
             +  NL  + L 
Sbjct: 214 -ANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 14/87 (16%), Positives = 28/87 (32%), Gaps = 2/87 (2%)

Query: 8   LLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYL 67
           + N                N          +++ +  ++            +  PNL  +
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEV 200

Query: 68  NLWNNNLSGSIPPQIGSLSNLKYLNLR 94
           +L NN +S   P  + + SNL  + L 
Sbjct: 201 HLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 7e-05
 Identities = 22/156 (14%), Positives = 46/156 (29%), Gaps = 4/156 (2%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
           N       + + T      +        S         ++      +             
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE 129
                   I              L   N   +    + +L  L  L   +N +  +    
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI--SDISP 190

Query: 130 IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSV 165
           + SL NL E++L++N++S V P  + N  +L  +++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 64.3 bits (155), Expect = 3e-12
 Identities = 38/222 (17%), Positives = 78/222 (35%), Gaps = 22/222 (9%)

Query: 72  NNLSGSIPPQIG------SLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT 125
            + + ++P  I       + +     NL+  ++T  + +    L +++ +  +N+ +   
Sbjct: 4   GSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV 61

Query: 126 TPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLE 185
             I+   L N+ +L+L  NKL+      I  L +L  L  ++         +  +     
Sbjct: 62  QGIQ--YLPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKL 114

Query: 186 RLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSF 245
           +     +     I   +   +  +            + S L  L +L   D   + +   
Sbjct: 115 KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL 174

Query: 246 IPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSS 287
                   + L  L LS N I  +    L+ L NL  L L S
Sbjct: 175 -----AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 2e-08
 Identities = 34/202 (16%), Positives = 64/202 (31%), Gaps = 16/202 (7%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
           F      NL   +++ ++      L+++  +    +++       I  L N+  L+L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            L           + L  L             +  +    +      +     I      
Sbjct: 79  KLTDI--------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           +   +   L       T    +  L  L  LS+  N+++  +P  L  LT L  L LS N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188

Query: 241 QLHSFIPLEIGNFSALAELDLS 262
            +     L       L  L+L 
Sbjct: 189 HISDLRAL--AGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 31/179 (17%), Positives = 55/179 (30%), Gaps = 15/179 (8%)

Query: 63  NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSL 122
           ++  +   N+++       I  L N+  L L  N LT   P     L NL+ L       
Sbjct: 47  SIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDE 99

Query: 123 HGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT 182
           +    +         +     +        +I  L  L  L  +Y         T+    
Sbjct: 100 NKVKDLSSLKDLKKLKSLSLEHN----GISDINGLVHLPQLESLYLGNNKITDITVLSRL 155

Query: 183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQ 241
                    +     I   +  L  L +L +  N ++      L  L +L  L+L  +Q
Sbjct: 156 TKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 1e-04
 Identities = 21/110 (19%), Positives = 43/110 (39%), Gaps = 4/110 (3%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
           +    KD     +    +      +    +  +E +             S    L  L+L
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL 163

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN 119
            +N +S  +P  +  L+ L+ L L  N+++    + +  L+NL+VL L +
Sbjct: 164 EDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 1e-04
 Identities = 45/222 (20%), Positives = 74/222 (33%), Gaps = 20/222 (9%)

Query: 116 YLSNNSLHGTTPI-EIGSLRNLEEL---YLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG 171
            L + ++   TPI +I S     E     L+   ++  + Q    L S+  +    + + 
Sbjct: 2   PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59

Query: 172 GPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTS 231
                 +  L N+ +LFL  N+              L +L  +                 
Sbjct: 60  SVQG--IQYLPNVTKLFLNGNKLTDIK--------PLANLKNLGWLFLDENKVKDLSSLK 109

Query: 232 LLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS 291
            L    S +  H+ I    G         L     +      LS+L+ L  L+L  N +S
Sbjct: 110 DLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169

Query: 292 GQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLAL 333
             +P     L  L +L LSKN +S      +     L  L L
Sbjct: 170 DIVPL--AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 28/209 (13%), Positives = 68/209 (32%), Gaps = 24/209 (11%)

Query: 168 NTVGGPIP-STLFRLTNLE---RLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP 223
            T+  P P   +F         +  L        + +    L ++  +    + +     
Sbjct: 6   ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG 63

Query: 224 STLGHLTSLLYLDLSFNQL---HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNL 280
             + +L ++  L L+ N+L        L+   +  L E  + D      +    S     
Sbjct: 64  --IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH 121

Query: 281 QYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGS-----------FPTGIGNCTELQ 329
             ++  + L+      ++    N ++     ++L+                 +   T+LQ
Sbjct: 122 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 181

Query: 330 HLALNHNSLDGTIPPEIGKILLLQNLDLS 358
           +L L+ N +  +    +  +  L  L+L 
Sbjct: 182 NLYLSKNHI--SDLRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 39/176 (22%), Positives = 61/176 (34%), Gaps = 15/176 (8%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNN 97
           SI  I      IK   G       PN+  L L  N L+   P     L+NLK L   + +
Sbjct: 47  SIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLD 98

Query: 98  LTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNL 157
                              L + SL      +I  L +L +L       + +    + + 
Sbjct: 99  ENKVKDLSSLKDLK----KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR 154

Query: 158 KSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSI 213
            + +    + +     I   L  LT L+ L+L  N    +  R +  LKNL  L +
Sbjct: 155 LTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 32/189 (16%), Positives = 62/189 (32%), Gaps = 26/189 (13%)

Query: 197 TIPREIG------NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI 250
           T+P  I               ++    +T A+  T   L S+  +  + + + S   ++ 
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQ- 65

Query: 251 GNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN---------------LLSGQIP 295
                + +L L+ NK+  I P    K     +L+ +                  L     
Sbjct: 66  -YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 296 FAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNL 355
             I  L +L  L+      +      + +           ++    I P +  +  LQNL
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNL 183

Query: 356 DLSHNNLSG 364
            LS N++S 
Sbjct: 184 YLSKNHISD 192

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 62.9 bits (151), Expect = 4e-11
 Identities = 28/155 (18%), Positives = 48/155 (30%), Gaps = 9/155 (5%)

Query: 6   QALLNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQ 65
             L       + +        +   +           EL +     ++    FS    L 
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263

Query: 66  YLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGT 125
               + N  S  I        +L+ LN+  N L   +P        LE L  S N L   
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAEV 319

Query: 126 TPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL 160
                   +NL++L++  N L    P    +++ L
Sbjct: 320 PE----LPQNLKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.0 bits (120), Expect = 3e-07
 Identities = 53/321 (16%), Positives = 93/321 (28%), Gaps = 24/321 (7%)

Query: 86  SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNK 145
                L L    L+ ++P+      +LE L  S NSL    P    SL++L         
Sbjct: 38  RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 146 LSGVLPQEIGNLKSLIW-----------LSVMYNTVGGPIPSTLFRLTNLERLFLGCNQF 194
           LS + P       S                 + +     +        +LE +  G NQ 
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 195 NGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFS 254
                 +        +    + K    +P +L  + +   +     +L +   L      
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 255 ALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKL 314
                 L D        +              S             L  L       N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 315 SGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM- 373
           S    +       L+ L +++N L   +P    +   L+ L  S N+L+  +P     + 
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLK 327

Query: 374 FLDMSFNNLEG--EIPTYLRD 392
            L + +N L    +IP  + D
Sbjct: 328 QLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 3e-07
 Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 14/115 (12%)

Query: 9   LNCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFS--------- 59
           L        +  N     + +     Y  + ++     C +   L  LN S         
Sbjct: 242 LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA 301

Query: 60  CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEV 114
             P L+ L    N+L+  +P       NLK L++ +N L    P    S+ +L +
Sbjct: 302 LPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 4e-07
 Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)

Query: 237 LSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPF 296
              N   + I        +L EL++S+NK+   +P        L+ L  S N L+ ++P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE 321

Query: 297 AIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQ 329
                 NL  L +  N L   FP    +  +L+
Sbjct: 322 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 4e-07
 Identities = 21/89 (23%), Positives = 34/89 (38%), Gaps = 9/89 (10%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS 275
           N  +  I S      SL  L++S N+L   +P        L  L  S N +  +      
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLAEVPEL--- 322

Query: 276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNL 304
              NL+ L++  N L  + P     + +L
Sbjct: 323 -PQNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 35/223 (15%), Positives = 49/223 (21%), Gaps = 33/223 (14%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
           N  +       N S                 +  L E      L  L      N     L
Sbjct: 160 NLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTL 219

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE 129
            +   S        +         +              L  L       N+        
Sbjct: 220 PDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL 279

Query: 130 IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFL 189
                +LEEL + +NKL                           +P+       LERL  
Sbjct: 280 CDLPPSLEELNVSNNKLIE-------------------------LPALP---PRLERLIA 311

Query: 190 GCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
             N     +P    NLK    L +  N L    P     +  L
Sbjct: 312 SFNHLA-EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 25/105 (23%), Positives = 38/105 (36%), Gaps = 8/105 (7%)

Query: 303 NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNL 362
               L+L+   LS S P    +   L+ L  + NSL   +P        L++L + +NNL
Sbjct: 39  QAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQS---LKSLLVDNNNL 90

Query: 363 SGTIPMTLHPMFLDMSFNNLEGEIPTYLRDNPPNSFVGNKGLCGH 407
                +     +L +S N LE               V N  L   
Sbjct: 91  KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKL 135

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 29/107 (27%), Positives = 42/107 (39%), Gaps = 6/107 (5%)

Query: 259 LDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSF 318
           L L+   +  +    L +L  + +L+LS N L    P A+  L  L  L  S N      
Sbjct: 3   LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57

Query: 319 PTGIGNCTELQHLALNHNSL-DGTIPPEIGKILLLQNLDLSHNNLSG 364
             G+ N   LQ L L +N L        +     L  L+L  N+L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 30/128 (23%), Positives = 56/128 (43%), Gaps = 9/128 (7%)

Query: 65  QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHG 124
           + L+L + +L+  +   +  L  + +L+L  N L    P  + +LR LEVL  S+N    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55

Query: 125 TTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMYN---TVGGPIPSTLFR 180
                + +L  L+EL L +N+L      Q + +   L+ L++  N      G        
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 181 LTNLERLF 188
           L ++  + 
Sbjct: 116 LPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 30/107 (28%), Positives = 42/107 (39%), Gaps = 6/107 (5%)

Query: 211 LSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGII 270
           L +    LT  +   L  L  + +LDLS N+L +  P  +     L  L  SDN +  + 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 271 PDELSKLSNLQYLNLSSNLL-SGQIPFAIGKLFNLVSLDLSKNKLSG 316
                 L  LQ L L +N L        +     LV L+L  N L  
Sbjct: 60  GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 1e-06
 Identities = 22/114 (19%), Positives = 40/114 (35%), Gaps = 7/114 (6%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
           +   L +L  +  L L  N+     P  +  L+ L  L    N L       + +L  L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--NVDGVANLPRLQ 68

Query: 234 YLDLSFNQLHSFIPLE-IGNFSALAELDLSDNKIRGI---IPDELSKLSNLQYL 283
            L L  N+L     ++ + +   L  L+L  N +             L ++  +
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 1e-06
 Identities = 26/146 (17%), Positives = 44/146 (30%), Gaps = 28/146 (19%)

Query: 114 VLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
           VL+L++  L  T    +  L  +  L L  N+L  + P  +  L+ L  L    N +   
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLL 233
                     L+ L L  N+   +                            L     L+
Sbjct: 59  DGVANLP--RLQELLLCNNRLQQSAA-----------------------IQPLVSCPRLV 93

Query: 234 YLDLSFNQLHSFIPLEIGNFSALAEL 259
            L+L  N L     ++      L  +
Sbjct: 94  LLNLQGNSLCQEEGIQERLAEMLPSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 1e-04
 Identities = 21/109 (19%), Positives = 38/109 (34%), Gaps = 27/109 (24%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNL----------------------KYLNLR 94
           +      + +L+L +N L   +PP + +L  L                      + L L 
Sbjct: 15  HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73

Query: 95  WNNLTGT-IPKEIGSLRNLEVLYLSNNSLHGTTPIE---IGSLRNLEEL 139
            N L  +   + + S   L +L L  NSL     I+      L ++  +
Sbjct: 74  NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 5e-04
 Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 2/89 (2%)

Query: 25  HCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQ-IG 83
             N +        ++  +E+++ S          +  P LQ L L NN L  S   Q + 
Sbjct: 28  SHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLV 87

Query: 84  SLSNLKYLNLRWNNLTGTIPKEIGSLRNL 112
           S   L  LNL+ N+L          L  +
Sbjct: 88  SCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 9e-09
 Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 5/91 (5%)

Query: 63  NLQYLNLWNNNLSGSIPPQI-GSLSNLKYLNLRWNNLTGTIPKEIGS----LRNLEVLYL 117
           ++Q L++    LS +   ++   L   + + L    LT    K+I S       L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSG 148
            +N L       +          ++   L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 1e-08
 Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 5/109 (4%)

Query: 279 NLQYLNLSSNLLS-GQIPFAIGKLFNLVSLDLSKNKLSG----SFPTGIGNCTELQHLAL 333
           ++Q L++    LS  +    +  L     + L    L+        + +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 334 NHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFNNL 382
             N L       + + L   +  +   +L            L  +   L
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 111

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.4 bits (126), Expect = 6e-08
 Identities = 19/134 (14%), Positives = 38/134 (28%), Gaps = 9/134 (6%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
                        S   + +               +E +   EL          L+ L L
Sbjct: 317 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 376

Query: 70  WNNNLSG----SIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGS-----LRNLEVLYLSNN 120
            + ++S     S+   + +  +L+ L+L  N L      ++          LE L L + 
Sbjct: 377 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 436

Query: 121 SLHGTTPIEIGSLR 134
                    + +L 
Sbjct: 437 YWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 21/106 (19%), Positives = 31/106 (29%), Gaps = 15/106 (14%)

Query: 243 HSFIPLEIGNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNLSSNLLSGQIPFAI 298
                      S L  L L+D  +       +   L    +L+ L+LS+N L       +
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417

Query: 299 GKLF-----NLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD 339
            +        L  L L     S            LQ L  +  SL 
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 1e-06
 Identities = 18/91 (19%), Positives = 27/91 (29%), Gaps = 5/91 (5%)

Query: 231 SLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNL 285
            +  LD+   +L      E+         + L D  +       I   L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSG 316
            SN L       + +     S  + K  L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 9/95 (9%)

Query: 38  SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSG----SIPPQIGSLSNLKYLNL 93
            I  +++    +     +         Q + L +  L+      I   +     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 94  RWNNLTGTIPKEIGSL-----RNLEVLYLSNNSLH 123
           R N L       +          ++ L L N  L 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 2e-06
 Identities = 16/92 (17%), Positives = 33/92 (35%), Gaps = 10/92 (10%)

Query: 183 NLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTG----AIPSTLGHLTSLLYLDL 237
           +++ L + C + +     E+   L+    + +    LT      I S L    +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 238 SFNQLHSFIPLEIG-----NFSALAELDLSDN 264
             N+L       +          + +L L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 2e-06
 Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 9/77 (11%)

Query: 303 NLVSLDLSKNKLSG----SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKIL-----LLQ 353
            L  L L+   +S     S    +     L+ L L++N L      ++ + +     LL+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 354 NLDLSHNNLSGTIPMTL 370
            L L     S  +   L
Sbjct: 430 QLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 3e-06
 Identities = 15/82 (18%), Positives = 27/82 (32%), Gaps = 9/82 (10%)

Query: 278 SNLQYLNLSSNLLSGQ----IPFAIGKLFNLVSLDLSKNKLSGSFPTGIG-----NCTEL 328
           S L+ L L+   +S      +   +    +L  LDLS N L  +    +          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 329 QHLALNHNSLDGTIPPEIGKIL 350
           + L L        +   +  + 
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 6e-06
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 9/83 (10%)

Query: 204 NLKNLTHLSIITNKLTG----AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIG-----NFS 254
               L  L +    ++     ++ +TL    SL  LDLS N L     L++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 255 ALAELDLSDNKIRGIIPDELSKL 277
            L +L L D      + D L  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 10/92 (10%)

Query: 207 NLTHLSIITNKLTGA-IPSTLGHLTSLLYLDLSFNQLH----SFIPLEIGNFSALAELDL 261
           ++  L I   +L+ A     L  L     + L    L       I   +    ALAEL+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 262 SDNKIRGIIPDELSKL-----SNLQYLNLSSN 288
             N++  +    + +        +Q L+L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 4e-05
 Identities = 25/208 (12%), Positives = 52/208 (25%), Gaps = 41/208 (19%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
                 +                              CS    + + N          N 
Sbjct: 292 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 351

Query: 70  WNNNLSGSIPPQIGSL-SNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPI 128
             +     +   +G   S L+ L L   +++ +    + +                    
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT------------------- 392

Query: 129 EIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLF 188
            + +  +L EL L +N L      ++         SV                  LE+L 
Sbjct: 393 -LLANHSLRELDLSNNCLGDAGILQLVE-------SVRQPG------------CLLEQLV 432

Query: 189 LGCNQFNGTIPREIGNL-KNLTHLSIIT 215
           L    ++  +   +  L K+   L +I+
Sbjct: 433 LYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 14/111 (12%), Positives = 28/111 (25%), Gaps = 21/111 (18%)

Query: 111 NLEVLYLSNNSLHGTTPIEI-GSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT 169
           +++ L +    L      E+   L+  + + L    L+    ++I +             
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50

Query: 170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG 220
                   L     L  L L  N+        +          I    L  
Sbjct: 51  --------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (124), Expect = 3e-08
 Identities = 27/233 (11%), Positives = 54/233 (23%), Gaps = 7/233 (3%)

Query: 60  CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSN 119
           C  + +      + ++  IP  +    N   L      L            +LE + +S 
Sbjct: 6   CHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62

Query: 120 NS----LHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIP 175
           N     +       +  L  +      +         +       + +S         + 
Sbjct: 63  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122

Query: 176 STLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL 235
                   L  +    N         +G       L +  N +                 
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
               N L           S    LD+S  +I  +    L  L  L+  +  + 
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.3 bits (118), Expect = 2e-07
 Identities = 29/231 (12%), Positives = 66/231 (28%), Gaps = 7/231 (3%)

Query: 87  NLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL 146
           + +    + + +T  IP ++   RN   L      L            +LE++ +  N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN----GTIPREI 202
             V+  ++ +    +    +         +           +L  +         + +  
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 203 GNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLS 262
              K L  +    N  T    S +G     + L L+ N +                    
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNK 313
           +N +  +  D     S    L++S   +     + +  L  L +      K
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.5 bits (116), Expect = 4e-07
 Identities = 27/225 (12%), Positives = 54/225 (24%), Gaps = 5/225 (2%)

Query: 45  VECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPK 104
             C     +  +      N   L      L            +L+ + +  N++   I  
Sbjct: 13  FLCQESK-VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71

Query: 105 EIGSLRNLEVLYL----SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL 160
           ++ S             +N         +         +     K    + +     K L
Sbjct: 72  DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131

Query: 161 IWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG 220
           + +    N       S +        L+L  N             +         N L  
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191

Query: 221 AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNK 265
                    +  + LD+S  ++HS     + N   L      + K
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 9e-07
 Identities = 36/238 (15%), Positives = 65/238 (27%), Gaps = 10/238 (4%)

Query: 111 NLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTV 170
           +  V     + +   T I     RN  EL     KL  +          L  + +  N V
Sbjct: 9   SNRVFLCQESKV---TEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 171 GGPIPSTLFRLTNLERLFLGCNQFNG----TIPREIGNLKNLTHLSIITNKLTGAIPSTL 226
              I + +F               N         +         +S    K    +    
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLS 286
                LL +  + N         +G       L L+ N I+ I     +     +     
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 287 SNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP 344
           +N L              V LD+S+ ++      G+ N  +L+  +  +      +P 
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 1e-04
 Identities = 11/94 (11%), Positives = 28/94 (29%), Gaps = 3/94 (3%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
               ++  I     +    +         +  + L + +   EL +  F        L++
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIP 103
               +       + +L  L+  +    NL   +P
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 3e-04
 Identities = 16/136 (11%), Positives = 30/136 (22%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
           N    +  +  NT                +        +I     +           L L
Sbjct: 101 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 160

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIE 129
             N +              +      NNL               +L +S   +H      
Sbjct: 161 NKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220

Query: 130 IGSLRNLEELYLRSNK 145
           + +L+ L      + K
Sbjct: 221 LENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 6e-04
 Identities = 29/239 (12%), Positives = 61/239 (25%), Gaps = 17/239 (7%)

Query: 25  HCNWVGITCDYKG----------SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNL 74
           HC+     C              +   +  V   ++  +    FS F +L+ + +  N++
Sbjct: 7   HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDV 65

Query: 75  SGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLR 134
              I   + S     +                       + YL  ++       ++  + 
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 135 NLEELYLRSNKLSGVLPQEIGNLKSLIW----LSVMYNTVGGPIPSTLFRLTNLERLFLG 190
           +L+++ L       +   E  +   L +    L +  N +              E     
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 191 CNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE 249
            N                  L I   ++       L +L  L         L     LE
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPTLE 242

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.8 bits (122), Expect = 1e-07
 Identities = 48/323 (14%), Positives = 92/323 (28%), Gaps = 33/323 (10%)

Query: 67  LNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTG----TIPKEIGSLRNLEVLYLSNNSL 122
           L+        S+   +    ++K + L  N +       + + I S ++LE+   S+   
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 123 HGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLT 182
                    +LR L +  L+  KL  V   +     +     + + +   P+        
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 183 NLERLFLGCNQFNGTIPREIGNLKNLTHLSI-------ITNKLTGAIPSTLGHLTSLLYL 235
            L                     KN   L         + N        T      L  +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDL---------SDNKIRGIIPDELSKLSNLQYLNLS 286
            +  N +       +         +L           +     +   L    NL+ L L+
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251

Query: 287 SNLLSGQIPFAIGKLF------NLVSLDLSKNKLSGSFPTGI-----GNCTELQHLALNH 335
             LLS +   A+   F       L +L L  N++       +         +L  L LN 
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311

Query: 336 NSL--DGTIPPEIGKILLLQNLD 356
           N    +  +  EI ++   +   
Sbjct: 312 NRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 14/110 (12%), Positives = 35/110 (31%), Gaps = 11/110 (10%)

Query: 13  WWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGE-----LGSLNFSCFPNLQYL 67
               +    T    + + I      ++  + L +C +        + + +      LQ L
Sbjct: 219 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 278

Query: 68  NLWNNNLSGSIPPQIGS-----LSNLKYLNLRWNNLTGTIPKEIGSLRNL 112
            L  N +       + +     + +L +L L  N  +      +  +R +
Sbjct: 279 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 8e-04
 Identities = 23/163 (14%), Positives = 48/163 (29%), Gaps = 13/163 (7%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
           N            +   + +  T     +    E +E  +   L         +LQ    
Sbjct: 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 227

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIG------SLRNLEVLYLSNNSLH 123
            +   S ++   + S  NL+ L L    L+      +           L+ L L  N + 
Sbjct: 228 THLG-SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286

Query: 124 GTTPIEIGS-----LRNLEELYLRSNKLSGVLPQEIGNLKSLI 161
                 + +     + +L  L L  N+ S      +  ++ + 
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVF 328

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 11/87 (12%), Positives = 25/87 (28%), Gaps = 5/87 (5%)

Query: 256 LAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQ----IPFAIGKLFNLVSLDLSK 311
           L    ++    + +    L +  +++ + LS N +  +    +   I    +L   + S 
Sbjct: 10  LKLDAITTEDEKSVF-AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 312 NKLSGSFPTGIGNCTELQHLALNHNSL 338
                           L    L    L
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 1e-07
 Identities = 46/199 (23%), Positives = 74/199 (37%), Gaps = 16/199 (8%)

Query: 85  LSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN 144
           L+      L   N+T T+ +    L  +  L      +     +E   L NL ++   +N
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNN 72

Query: 145 KLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGN 204
           +L+ +          L  L+ + + +                   G   FN  I      
Sbjct: 73  QLTDI--------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124

Query: 205 LKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDN 264
                   +  +  T +  S L  LTSL  L+ S NQ+    PL   N + L  LD+S N
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPL--ANLTTLERLDISSN 182

Query: 265 KIRGIIPDELSKLSNLQYL 283
           K+  I    L+KL+NL+ L
Sbjct: 183 KVSDI--SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.0 bits (110), Expect = 2e-06
 Identities = 33/199 (16%), Positives = 63/199 (31%), Gaps = 16/199 (8%)

Query: 61  FPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNN 120
                   L   N++ ++      L  +  L      +       +  L NL  +  SNN
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72

Query: 121 SLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFR 180
            L   TP++  +      +          L          ++ + + +       + L R
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
           L          +  +G    +  N  +        N++T   P  L +LT+L  LD+S N
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSS--------NQVTDLKP--LANLTTLERLDISSN 182

Query: 241 QLHSFIPLEIGNFSALAEL 259
           ++     L     + L  L
Sbjct: 183 KVSDISVL--AKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 34/199 (17%), Positives = 62/199 (31%), Gaps = 16/199 (8%)

Query: 109 LRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN 168
           L       L   ++  T  +    L  +  L      +  +    +  L +L  ++   N
Sbjct: 17  LAEKMKTVLGKTNV--TDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72

Query: 169 TVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGH 228
            +    P           +          +             + IT+       + L  
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 229 LTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSN 288
           L          + L     L+  NFS         N++  + P  L+ L+ L+ L++SSN
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFS--------SNQVTDLKP--LANLTTLERLDISSN 182

Query: 289 LLSGQIPFAIGKLFNLVSL 307
            +S      + KL NL SL
Sbjct: 183 KVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.3 bits (90), Expect = 7e-04
 Identities = 14/106 (13%), Positives = 30/106 (28%), Gaps = 2/106 (1%)

Query: 10  NCGWWKDRIPHNTSDHCNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNL 69
                      N +    +     D         L    +     S   +         L
Sbjct: 96  IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 155

Query: 70  WNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL 115
             ++   +    + +L+ L+ L++  N ++      +  L NLE L
Sbjct: 156 NFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 12/78 (15%), Positives = 24/78 (30%), Gaps = 6/78 (7%)

Query: 263 DNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI 322
           D  I  I  D    L+      L    ++  +      L  + +L   +  +      G+
Sbjct: 5   DTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGV 58

Query: 323 GNCTELQHLALNHNSLDG 340
                L  +  ++N L  
Sbjct: 59  EYLNNLTQINFSNNQLTD 76

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 3e-07
 Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 6/138 (4%)

Query: 236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIP 295
           +L   Q+   + L +      ++  L    +R     +L   +    LN  S++ +  + 
Sbjct: 3   ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLR 58

Query: 296 FAIGKLFNLVSLDLSKNKLSG--SFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQ 353
                +  L+SL+LS N+L       + +     L+ L L+ N L      +  K L L+
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 354 NLDLSHNNLSGTIPMTLH 371
            L L  N+LS T      
Sbjct: 119 ELWLDGNSLSDTFRDQST 136

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (113), Expect = 5e-07
 Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 6/153 (3%)

Query: 198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA 257
           +   +    + +  ++    L       L      + L+   +   + + +   N   L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELL 68

Query: 258 ELDLSDNKIRGI--IPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS 315
            L+LS+N++  +  +   + K  NL+ LNLS N L  +      K   L  L L  N LS
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 316 GSFPTGIGNCTELQHLALNHNSLDG-TIPPEIG 347
            +F       + ++        LDG  +PP I 
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (111), Expect = 9e-07
 Identities = 28/133 (21%), Positives = 45/133 (33%), Gaps = 12/133 (9%)

Query: 173 PIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTG--AIPSTLGHLT 230
                L        L    +    T+     N+  L  L++  N+L     + S +    
Sbjct: 33  RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91

Query: 231 SLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE-------LSKLSNLQYL 283
           +L  L+LS N+L S   L+      L EL L  N +     D+         +   L  L
Sbjct: 92  NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151

Query: 284 NLSSNLLSGQIPF 296
           +   + L   I F
Sbjct: 152 D--GHELPPPIAF 162

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.0 bits (108), Expect = 2e-06
 Identities = 23/109 (21%), Positives = 43/109 (39%), Gaps = 3/109 (2%)

Query: 57  NFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGT--IPKEIGSLRNLEV 114
           +         LN   ++++ ++     ++  L  LNL  N L     +   +    NL++
Sbjct: 37  DLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95

Query: 115 LYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL 163
           L LS N L     ++      LEEL+L  N LS     +   + ++   
Sbjct: 96  LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 4e-06
 Identities = 28/141 (19%), Positives = 50/141 (35%), Gaps = 14/141 (9%)

Query: 56  LNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL 115
           ++     + Q L+L          P + + +    LN R +++  T+     ++  L  L
Sbjct: 16  MSKRYDGSQQALDLKGLR----SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSL 70

Query: 116 YLSNNSLHGTTPIE--IGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGP 173
            LSNN L+    +   +    NL+ L L  N+L      +      L  L +  N++   
Sbjct: 71  NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130

Query: 174 IPST-------LFRLTNLERL 187
                        R   L RL
Sbjct: 131 FRDQSTYISAIRERFPKLLRL 151

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 10/134 (7%)

Query: 260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFP 319
           +L   ++   +   +SK  +     L    L  +    +      V L+   + ++ +  
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58

Query: 320 TGIGNCTELQHLALNHNSLDGT--IPPEIGKILLLQNLDLSHNNLS----GTIPMTLHPM 373
               N  EL  L L++N L     +   + K   L+ L+LS N L           L   
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 374 FLDMSFNNLEGEIP 387
            L +  N+L     
Sbjct: 119 ELWLDGNSLSDTFR 132

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (110), Expect = 1e-06
 Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 7/136 (5%)

Query: 80  PQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL 139
            Q  +    + L+LR   +   I     +L   + +  S+N +          LR L+ L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 140 YLRSNKLSGVLPQEIGNLKSLIWLSV-MYNTVGGPIPSTLFRLTNLERLFLG---CNQFN 195
            + +N++  +       L  L  L +   + V       L  L +L  L +         
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 196 GTIPREIGNLKNLTHL 211
                 I  +  +  L
Sbjct: 129 HYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (104), Expect = 7e-06
 Identities = 19/137 (13%), Positives = 45/137 (32%), Gaps = 7/137 (5%)

Query: 55  SLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEV 114
           +  ++     + L+L    +   I     +L     ++   N +          LR L+ 
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKT 67

Query: 115 LYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPI 174
           L ++NN +         +L +L EL L +N L  +   +       +    +        
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 175 P----STLFRLTNLERL 187
                  ++++  +  L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (103), Expect = 1e-05
 Identities = 20/138 (14%), Positives = 44/138 (31%), Gaps = 5/138 (3%)

Query: 261 LSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPT 320
           L+   I      + +     + L+L    +   I      L    ++D S N++      
Sbjct: 3   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57

Query: 321 GIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPMFLDMSFN 380
           G      L+ L +N+N +          +  L  L L++N+L     +        +++ 
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 381 NLEGEIPTYLRDNPPNSF 398
            +     T  +       
Sbjct: 118 CILRNPVTNKKHYRLYVI 135

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 6e-04
 Identities = 23/135 (17%), Positives = 40/135 (29%), Gaps = 7/135 (5%)

Query: 181 LTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN 240
                 L L   +    I      L     +    N++          L  L  L ++ N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73

Query: 241 QLHSFIPLEIGNFSALAELDLSDNKIRGIIPDE----LSKLSNLQYLNLSSNLLSGQIPF 296
           ++             L EL L++N +  +   +    L  L+ L  L            +
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 297 AIGKLFNLVSLDLSK 311
            I K+  +  LD  K
Sbjct: 134 VIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.003
 Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 3/88 (3%)

Query: 204 NLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD 263
           N      L +   K+   I +    L     +D S N++             L  L +++
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVNN 72

Query: 264 NKIRGIIPDELSKLSNLQYLNLSSNLLS 291
           N+I  I       L +L  L L++N L 
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLV 100

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 2e-06
 Identities = 25/152 (16%), Positives = 45/152 (29%), Gaps = 4/152 (2%)

Query: 80  PQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS-NNSLHGTTPIEIGSLRNLEE 138
           P          L    +         +    NL  LY+     L      ++  L  L  
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN-GT 197
           L +  + L  V P        L  L++ +N +   +     +  +L+ L L  N  +   
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHL 229
             R +   +      +   KL       L H+
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 43.3 bits (100), Expect = 3e-05
 Identities = 35/169 (20%), Positives = 59/169 (34%), Gaps = 6/169 (3%)

Query: 216 NKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEI-GNFSALAELDLSDNKIRGIIPDEL 274
             L   IP  +        L L+ N+L       + G    L +L+L  N++ GI P+  
Sbjct: 18  RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74

Query: 275 SKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALN 334
              S++Q L L  N +          L  L +L+L  N++S   P    +   L  L L 
Sbjct: 75  EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134

Query: 335 HNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHPM-FLDMSFNNL 382
            N  +            L+   L+        P  +  +   D+  +  
Sbjct: 135 SNPFNCNCHLAWFA-EWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.6 bits (93), Expect = 2e-04
 Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 7/167 (4%)

Query: 174 IPSTLFRLTNLERLFLGCNQFNGTIPREI-GNLKNLTHLSIITNKLTGAIPSTLGHLTSL 232
           IP  +    +   L L  N+        + G L +L  L +  N+LTG  P+     + +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 233 LYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG 292
             L L  N++             L  L+L DN+I  ++P     L++L  LNL+SN  + 
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140

Query: 293 QIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD 339
                      L    L+        P+ + +   +Q   L H+   
Sbjct: 141 NCHL-AWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 18/75 (24%), Positives = 29/75 (38%), Gaps = 10/75 (13%)

Query: 48  SIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPP------QIGSLSNLKYLNLRWNNLTGT 101
           +IK  +    F    ++         L G IPP       + +L   K+L L  NN+   
Sbjct: 6   TIKDAIR--IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-K 62

Query: 102 IPKEIGSLRNLEVLY 116
           I   +  + NL +L 
Sbjct: 63  IS-SLSGMENLRILS 76

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	701
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.81
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.73
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.71
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.6
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.56
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.36
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.5
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.22
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.77
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.75
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.67
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.5
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.09
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.08
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.05
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.0

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=364.56  Aligned_cols=213  Identities=30%  Similarity=0.472  Sum_probs=185.6

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++.+....+....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999966 468999999997654333334577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |||++|+|.+++....   .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.... 
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence            9999999999998654   589999999999999999999999   999999999999999999999999999987643 


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhhcCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELEGKT  672 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~~~~  672 (701)
                       .......||+.|+|||++.+.+++.++  ||||+|+++|+|+++. |....+..++.+.+....
T Consensus       159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~--DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  220 (263)
T d2j4za1         159 -SRRTTLCGTLDYLPPEMIEGRMHDEKV--DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE  220 (263)
T ss_dssp             -CCCEETTEEGGGCCHHHHTTCCCCTTH--HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             -CcccccCCCCcccCHHHHcCCCCCchh--hhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence             334456799999999999998888776  9999999999999887 555567777777665544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=365.21  Aligned_cols=194  Identities=26%  Similarity=0.402  Sum_probs=173.7

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++......   .+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            45799999999999999999965 479999999997654333   36789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||++|+|.+++.+.    .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.+..
T Consensus        96 mEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            9999999999988764    489999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ........+||+.|+|||++.+.+++.++  ||||+|+++|+|+++.
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~--DiwSlGvilyemltG~  213 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKV--DIWSLGIMAIEMIEGE  213 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHH--HHHHHHHHHHHHHHSS
T ss_pred             ccccccccccCCCccChhhhcCCCCCchh--ceehHhHHHHHHhhCC
Confidence            55556667899999999999998887765  9999999999766554

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=362.99  Aligned_cols=198  Identities=24%  Similarity=0.358  Sum_probs=169.7

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......  ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            46899999999999999999965 47999999999765432  2246789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999997644   599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CC--CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          608 DS--SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       608 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ..  ......+||+.|+|||++.+.++.... .||||+|+++|+|+++.|
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~-~DiwSlGvilyeml~G~~  204 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGEL  204 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHH-HHHHHHHHHHHHHHHSSC
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCc-eeeeHhHHHHHHHHhCCC
Confidence            32  223456799999999999887765432 499999999999887753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=362.04  Aligned_cols=211  Identities=25%  Similarity=0.435  Sum_probs=176.2

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .++|++.+.||+|+||+||+|++.+++.||||+++.....    .+++.+|++++++++||||++++|++.+++..++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            4679999999999999999999888899999999865433    367899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|+|.+++.....  .+++..+..++.|+|.||+|||++   +|+||||||+||++++++.+||+|||+|+.....
T Consensus        80 E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            99999999999876543  588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------------
Q 041034          609 SSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------------  649 (701)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------------  649 (701)
                      ... .....||+.|+|||++.+..++.++  ||||+|+++|+                                      
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~--DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  232 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKS--DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY  232 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHH--HHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             CceeecceecCcccCChHHhcCCCCCchh--hhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHH
Confidence            322 2345689999999999988888775  99999999995                                      


Q ss_pred             -----cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                           ||+.+|.+|||++||++.|++
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                 888888888888888887764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-44  Score=366.09  Aligned_cols=222  Identities=27%  Similarity=0.454  Sum_probs=193.0

Q ss_pred             cHHHHHhhhcCCccceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 041034          441 LYEDLINATEDFHIRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCL  519 (701)
Q Consensus       441 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  519 (701)
                      .|++++...++|++.+.||+|+||+||+|.+. +++.||||+++.....    .+++.+|++++++++||||+++++++.
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT   83 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEe
Confidence            34556666789999999999999999999664 5889999999765432    367899999999999999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                      +++..++||||+++|+|.+++..... ..+++..+..++.|||.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus        84 ~~~~~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          84 REPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eCCeeEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccc
Confidence            99999999999999999999976433 3689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCCC-ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------------------------
Q 041034          600 GTARLLHVDSSN-RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------------------------  649 (701)
Q Consensus       600 Gla~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------------------------  649 (701)
                      |+|+....+... .....|++.|+|||.+.+..++.++  ||||+|+++|+                             
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~--DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~  237 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER  237 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHH--HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cceeecCCCCceeeccccccccccChHHHcCCCCCchh--hhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            999877543322 2234588999999999888888776  99999999985                             


Q ss_pred             --------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 --------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 --------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                    ||+.+|.+|||++|+++.|+...
T Consensus       238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                          99999999999999999887654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-44  Score=360.68  Aligned_cols=219  Identities=26%  Similarity=0.413  Sum_probs=170.6

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CcEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH--KRCMF  525 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  525 (701)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|++++++++||||+++++++.+  .+..|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            47899999999999999999965 57999999999876543 3446778999999999999999999999865  45689


Q ss_pred             EEEEccCCCCHHHHHhcCC-CccCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          526 FIYEYMERGSLFYVLRDDD-EAIELNWTRRVNIVKSVAHALSYLHHDC--TPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      +|||||++|+|.+++.+.. ....+++..++.++.||+.||+|||++.  ..+|+||||||+|||++.++.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999986532 1236999999999999999999999861  114999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhhc
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELEG  670 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~~  670 (701)
                      +.+..+........||+.|+|||++.+..++.++  ||||+|+++|+|+++.+ ....+..++.+.+..
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~--DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~  228 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKS--DIWSLGCLLYELCALMPPFTAFSQKELAGKIRE  228 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHH--HHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            9876555555567899999999999988888776  99999999999988774 444566666666543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=363.12  Aligned_cols=195  Identities=25%  Similarity=0.424  Sum_probs=167.9

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      +++...++|++.+.||+|+||+||+|.+++++.||||+++.....    .+.+.+|+.++++++||||++++|++.+ +.
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~   81 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence            344566889999999999999999999888899999999765432    3678999999999999999999998765 45


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+++|+|.+++.... ...+++..++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence            789999999999999876543 23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          604 LLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       604 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ....... ......||+.|+|||++.+..++.++  ||||+|+++|+
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~s--DvwS~Gvvl~e  202 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS--DVWSFGILLTE  202 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHH--HHHHHHHHHHH
T ss_pred             EccCCccccccccCCcccccChHHHhCCCCCchh--hhhhhHHHHHH
Confidence            7753321 22345689999999999888787765  99999999996

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=358.87  Aligned_cols=215  Identities=27%  Similarity=0.441  Sum_probs=176.2

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++...++|++.+.||+|+||+||+|+..  ..||||+++...... ...+.|.+|+.++++++||||+++++++.+ +..
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            4455788999999999999999999864  369999997654433 346789999999999999999999998754 557


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|+|.+++.....  .+++..+..++.|||+||+|||++   +||||||||+|||++.++.+||+|||+|+.
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence            999999999999999976543  589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCC--CCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHH------------------------------
Q 041034          605 LHVDS--SNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALA------------------------------  649 (701)
Q Consensus       605 ~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~------------------------------  649 (701)
                      .....  .......||+.|+|||++.+.   +++.+  +||||+|+++|+                              
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~--sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ--SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHH--HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCch--hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence            65322  223445799999999998653   34555  499999999996                              


Q ss_pred             -----------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                       ||..+|.+|||++||++.|+.
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                             777777788888777777663

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-43  Score=363.48  Aligned_cols=213  Identities=29%  Similarity=0.452  Sum_probs=171.6

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCc---EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGK---VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMF  525 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (701)
                      ++|++.+.||+|+||+||+|.+. +++   .||||++.....  ....++|.+|+.++++++|||||+++|++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            56778899999999999999764 332   588998876443  344578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      +|||||++|+|.+++.....  .+++.++..++.|||+||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999998876443  589999999999999999999999   9999999999999999999999999999877


Q ss_pred             ccCCCC-----ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------
Q 041034          606 HVDSSN-----RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------  649 (701)
Q Consensus       606 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------  649 (701)
                      ......     .....||+.|+|||.+.+..++.++  ||||+|+++|+                               
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~s--DvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  256 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSAS--DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM  256 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCccc--ccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            543221     1123578999999999888888775  99999999995                               


Q ss_pred             ------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                  ||+.+|.+|||++||++.|++.
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                        8888888888888888887754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=360.24  Aligned_cols=197  Identities=25%  Similarity=0.394  Sum_probs=168.2

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      +.+.|++.+.||+|+||+||+|+. .+++.||||++.......   .+.+.+|++++++++||||+++++++.+++..++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            346799999999999999999965 468999999997654322   4678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      |||||++|+|.+++.+...  .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccC
Confidence            9999999999999765432  589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCCCCceeecccccccCCCCCC-----CCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRL-----SPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ..........||+.|+|||++.     ..+++.+  .||||+||++|+|+++.
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k--~DiwSlGvilyemltg~  212 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK--ADVWSLGITLIEMAEIE  212 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTH--HHHHHHHHHHHHHHHSS
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChh--hhHHHHHHHHHHHhhCC
Confidence            3333334467999999999874     3344555  49999999999766554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-43  Score=359.46  Aligned_cols=206  Identities=26%  Similarity=0.421  Sum_probs=180.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .+.|+..+.||+|+||+||+|.. .+++.||||++......+....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            34699999999999999999965 57899999999877655556667899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||++|++..++....   .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999999987766543   589999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCceeecccccccCCCCCCCC---cCChhhHHHHHHHHHHHHH-----------------------------------
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSP---PVNQKIIQDIILVSTTALA-----------------------------------  649 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Di~slg~i~~~-----------------------------------  649 (701)
                          .....||+.|+|||++.+.   +++.++  ||||+|+++|+                                   
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~--DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~  241 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKV--DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE  241 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHH--HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchh--hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH
Confidence                2345799999999998643   355554  99999999995                                   


Q ss_pred             --------cccCCCCCCCCHHHHHH
Q 041034          650 --------CLRSKPKSRPTMQRISQ  666 (701)
Q Consensus       650 --------cl~~~P~~Rpt~~~i~~  666 (701)
                              ||..||.+|||++|+++
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHHh
Confidence                    88888888888888876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-43  Score=348.75  Aligned_cols=211  Identities=25%  Similarity=0.404  Sum_probs=178.0

Q ss_pred             hcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      .++|++.+.||+|+||+||+|++++++.||||+++.....    .+++.+|+.++++++||||++++|++.+++..++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            3689999999999999999999888889999999876543    367899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+++|++.+++.....  .+++..+.+++.|+++||+|||++   ||+||||||+||++++++.+||+|||+|+.....
T Consensus        79 Ey~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             ECCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            99999999999766433  588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-C-CCCCCCCHHHHHHHhhc
Q 041034          609 SS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-S-KPKSRPTMQRISQELEG  670 (701)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~-~P~~Rpt~~~i~~~l~~  670 (701)
                      .. ......||+.|+|||.+.+..++.++  ||||+|+++|++++ + .|...-+..++.+.+..
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ks--DiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~  216 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKS--DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ  216 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcce--eecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence            32 23345689999999999888888765  99999999997443 2 24444444444444433

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=366.31  Aligned_cols=196  Identities=27%  Similarity=0.345  Sum_probs=172.9

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|+++....  ....+++.+|+.++++++||||++++++|.+++..|+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467899999999999999999965 5789999999986543  2335788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~  605 (701)
                      ||||+++|+|.+++.+..   .+++..+..++.|++.||+|||+ +   ||+||||||+|||++.++.+||+|||+|+.+
T Consensus        82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999997654   58999999999999999999996 5   8999999999999999999999999999876


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      ...  .....+||+.|+|||++.+.+++.++  ||||+||++++|+.+.+
T Consensus       156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~--DiWSlGvil~ell~G~~  201 (322)
T d1s9ja_         156 IDS--MANSFVGTRSYMSPERLQGTHYSVQS--DIWSMGLSLVEMAVGRY  201 (322)
T ss_dssp             HHH--TC---CCSSCCCCHHHHHCSCCCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             CCC--ccccccCCccccCchHHcCCCCCcHH--HHHHHHHHHHHHHHCCC
Confidence            432  23346899999999999999998876  99999999999988753

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-43  Score=355.45  Aligned_cols=220  Identities=29%  Similarity=0.419  Sum_probs=181.7

Q ss_pred             hcCCccceEEeeccceEEEEEEcCC-C----cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELPD-G----KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      .+.|++.+.||+|+||+||+|.+.. +    ..||||++.....  .....+|.+|++++++++|||||+++|++.+.+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            4678999999999999999996543 2    4699999976543  3345678999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||++++++.+++.....  .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            9999999999999998876543  589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------
Q 041034          604 LLHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------  649 (701)
Q Consensus       604 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------  649 (701)
                      .......   ......||+.|+|||++.+..++.++  ||||+|+++|+                               
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s--DI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~  236 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS--DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  236 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcc--cccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence            7654322   22334689999999999888888775  99999999995                               


Q ss_pred             ------------cccCCCCCCCCHHHHHHHhhcCCCccch
Q 041034          650 ------------CLRSKPKSRPTMQRISQELEGKTPMKKG  677 (701)
Q Consensus       650 ------------cl~~~P~~Rpt~~~i~~~l~~~~~~~~~  677 (701)
                                  ||..+|.+||||.||++.|++....++.
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~  276 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  276 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence                        9999999999999999998865544433

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-43  Score=359.13  Aligned_cols=192  Identities=27%  Similarity=0.415  Sum_probs=152.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ..+.|++.+.||+|+||+||+|.. .+++.||||++........  .+.+.+|+.++++++||||+++++++.+++..|+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456799999999999999999965 4689999999986554322  3568899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEEeecCcc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTAR  603 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~~~kL~DFGla~  603 (701)
                      |||||+||+|.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||++.   +++.+||+|||+|+
T Consensus        85 vmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999997654   599999999999999999999999   999999999999994   57899999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ..... ......+||+.|+|||++.+.+++.++  ||||+|+++|+|
T Consensus       159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~--DiwSlGvilyel  202 (307)
T d1a06a_         159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAV--DCWSIGVIAYIL  202 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHH--HHHHHHHHHHHH
T ss_pred             EccCC-CeeeeeeeCccccCcHHHcCCCCCcHH--HhhhhhHHHHHH
Confidence            76433 233446799999999999998888775  999999999963

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-42  Score=346.24  Aligned_cols=210  Identities=23%  Similarity=0.363  Sum_probs=173.0

Q ss_pred             CccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CcEEEE
Q 041034          452 FHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH----KRCMFF  526 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  526 (701)
                      |++.+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            36677899999999999965 46889999999765433 3345789999999999999999999999865    456899


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc-CCCCeEEEeecCcccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN-SNLEAFVADFGTARLL  605 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~-~~~~~kL~DFGla~~~  605 (701)
                      ||||+++|+|.+++.+..   .+++..+..++.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+..
T Consensus        90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            999999999999997654   589999999999999999999998 12399999999999996 5789999999999864


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhhcC
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS--RPTMQRISQELEGK  671 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~--Rpt~~~i~~~l~~~  671 (701)
                      .  .......+||+.|+|||++.+ +++.++  ||||+|+++|+|+.+.+..  ..+..++.+.+...
T Consensus       166 ~--~~~~~~~~GT~~Y~aPE~~~~-~~~~~~--DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~  228 (270)
T d1t4ha_         166 R--ASFAKAVIGTPEFMAPEMYEE-KYDESV--DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  228 (270)
T ss_dssp             C--TTSBEESCSSCCCCCGGGGGT-CCCTHH--HHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             c--CCccCCcccCccccCHHHhCC-CCCCcC--chhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence            3  333455689999999999865 466665  9999999999999987432  34566666665543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=349.61  Aligned_cols=214  Identities=25%  Similarity=0.360  Sum_probs=180.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+++.||||++.+....+....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            36799999999999999999965 57999999999764332223357789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||++   +||||||||+||++++++.+||+|||+|+.+..
T Consensus        87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999987654   589999999999999999999999   999999999999999999999999999988753


Q ss_pred             CCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHHHhhc
Q 041034          608 DSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQELEG  670 (701)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~~l~~  670 (701)
                      ...  .....+||+.|+|||++.+..++.++  ||||+||++|+|+.+.+. ...+..++.+.+..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~--DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  224 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK  224 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             CCcccccccccCCccccCceeeccCCCCccc--ceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc
Confidence            322  23445799999999999998888765  999999999999988744 33455666555443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=353.21  Aligned_cols=213  Identities=23%  Similarity=0.298  Sum_probs=185.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++++.||+|+||.||+|+. .+|+.||||++++.........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999965 57999999999765432233357788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      ||||++|+|.+++....   .+++..++.++.||+.||+|||++   |||||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999998755   589999999999999999999999   999999999999999999999999999997765


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhh
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELE  669 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~  669 (701)
                      ........+||+.|+|||++.+.+++.++  ||||+||++|+|+.+.| ..-.+..++.+.+.
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~--DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~  218 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhh--cccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence            55555667899999999999999998876  99999999999999874 34445555555443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.7e-42  Score=356.09  Aligned_cols=190  Identities=25%  Similarity=0.401  Sum_probs=167.7

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.....   ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46899999999999999999965 5799999999976532   3357789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~--~~~~~kL~DFGla~~~  605 (701)
                      ||||++|+|.+++.....  .+++..+..++.||+.||+|||++   |||||||||+|||++  .++.+||+|||+|+.+
T Consensus       102 mE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999999865432  589999999999999999999999   999999999999996  4589999999999887


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ... .......||+.|+|||++.+.+++.++  ||||+||++|+
T Consensus       177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~--DiwSlGvilye  217 (350)
T d1koaa2         177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYT--DMWSVGVLSYI  217 (350)
T ss_dssp             CTT-SCEEEECSCTTTCCHHHHHTCCBCHHH--HHHHHHHHHHH
T ss_pred             ccc-cccceecCcccccCHHHHcCCCCChhH--hhhhhhHHHHH
Confidence            543 334456899999999999998888765  99999999996

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=352.20  Aligned_cols=215  Identities=28%  Similarity=0.469  Sum_probs=180.5

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEE
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (701)
                      ...++|++.+.||+|+||+||+|.+++++.||||+++.....    .+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            345789999999999999999998888889999999765433    3678999999999999999999999865 55789


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|..++..... ..++|.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        89 v~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence            9999999999988875422 2589999999999999999999999   99999999999999999999999999998764


Q ss_pred             cCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          607 VDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       607 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                      ... .......||+.|+|||.+....++.++  ||||+|+++|+                                    
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks--DI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKS--DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  242 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHH--hhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHH
Confidence            332 233445799999999999888888765  99999999995                                    


Q ss_pred             -------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 -------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 -------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                             ||+.+|.+||++++|++.|+...
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                   89999999999999998887654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=349.54  Aligned_cols=191  Identities=25%  Similarity=0.397  Sum_probs=162.7

Q ss_pred             hcCCccceE-EeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYC-IGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|.+.+. ||+|+||+||+|.+.   ++..||||+++...  .....++|.+|++++++++||||++++|++.+ +..
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            467777774 999999999999653   35579999997654  33446789999999999999999999999865 457


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            899999999999999865432  589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCC---CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          605 LHVDSS---NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       605 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +.....   ......||+.|+|||++.+..++.++  ||||+|+++|+
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks--DVwS~Gv~l~E  204 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS--DVWSYGVTMWE  204 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHH--HHHHHHHHHHH
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccc--hhhcchHHHHH
Confidence            754322   12334689999999999888887775  99999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=347.88  Aligned_cols=199  Identities=22%  Similarity=0.334  Sum_probs=172.5

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETED---SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRC  523 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (701)
                      ..++|++.+.||+|+||+||+|.. .+|+.||||++++.....   ....+.+.+|+.++++++||||+++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            357899999999999999999965 579999999997643321   2235788999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC----CeEEEee
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL----EAFVADF  599 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~----~~kL~DF  599 (701)
                      .|+|||||++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++    .+|++||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            999999999999999997654   599999999999999999999999   999999999999998776    5999999


Q ss_pred             cCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          600 GTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       600 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      |+|+..... .......||+.|+|||++.+..++.++  ||||+|+++|+|+.+.+
T Consensus       162 G~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~--DiwSlGvilyell~g~~  214 (293)
T d1jksa_         162 GLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEA--DMWSIGVITYILLSGAS  214 (293)
T ss_dssp             TTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             hhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcc--cchhhhHHHHHHHcCCC
Confidence            999877533 233445799999999999888887775  99999999998766653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-41  Score=354.49  Aligned_cols=191  Identities=23%  Similarity=0.342  Sum_probs=168.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++....   ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35799999999999999999965 5799999999976542   2246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc--CCCCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN--SNLEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~--~~~~~kL~DFGla~~~  605 (701)
                      ||||++|+|.+++.....  .+++..+..++.||+.||+|||++   |||||||||+|||++  .++.+||+|||+|+.+
T Consensus       105 mE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            999999999988765432  589999999999999999999999   999999999999997  5789999999999987


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                      ... .......||+.|+|||++.+.+++.++  ||||+||++|+|
T Consensus       180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvilyel  221 (352)
T d1koba_         180 NPD-EIVKVTTATAEFAAPEIVDREPVGFYT--DMWAIGVLGYVL  221 (352)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTTCCBCHHH--HHHHHHHHHHHH
T ss_pred             CCC-CceeeccCcccccCHHHHcCCCCCCcc--chHHHHHHHHHH
Confidence            543 334556899999999999998888776  999999999963

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-42  Score=355.38  Aligned_cols=199  Identities=25%  Similarity=0.374  Sum_probs=165.7

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCC-C-----cEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPD-G-----KVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCL  519 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (701)
                      ...++|++.+.||+|+||+||+|+... +     ..||+|++......  .....+.+|+.+++++ +|||||++++++.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            455789999999999999999996532 2     36999998764322  2346789999999998 8999999999999


Q ss_pred             eCcEEEEEEEccCCCCHHHHHhcCCC--------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041034          520 HKRCMFFIYEYMERGSLFYVLRDDDE--------------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHR  579 (701)
Q Consensus       520 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~  579 (701)
                      +.+..++|||||++|+|.++++....                    ...+++..++.++.||++||+|||++   +||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999976432                    12488999999999999999999999   99999


Q ss_pred             CCCCCcEEEcCCCCeEEEeecCccccccCCCCc--eeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc
Q 041034          580 DISSNNILLNSNLEAFVADFGTARLLHVDSSNR--TLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR  652 (701)
Q Consensus       580 Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~  652 (701)
                      ||||+||+++.++.+||+|||+|+.........  ....||+.|+|||++.+..++.++  ||||+|+++|+|++
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~--DiwS~Gvil~emlt  261 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS--DVWSYGILLWEIFS  261 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHTT
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcce--eccchhHHHHHHHh
Confidence            999999999999999999999998765443322  234689999999999888888776  99999999998654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=344.32  Aligned_cols=185  Identities=25%  Similarity=0.384  Sum_probs=155.0

Q ss_pred             eEEeeccceEEEEEEcC---CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEccC
Q 041034          456 YCIGTGGYGSVYKAELP---DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEYME  532 (701)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (701)
                      +.||+|+||+||+|.+.   .++.||||+++.... +....+++.+|++++++++||||++++|++.++ ..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            47999999999999653   356899999976543 344567899999999999999999999998654 5789999999


Q ss_pred             CCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCCC-
Q 041034          533 RGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSSN-  611 (701)
Q Consensus       533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~-  611 (701)
                      +|+|.++++...   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+...... 
T Consensus        91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999998654   589999999999999999999999   9999999999999999999999999999876543222 


Q ss_pred             --ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHc
Q 041034          612 --RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALAC  650 (701)
Q Consensus       612 --~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~c  650 (701)
                        .....||+.|+|||.+.+..++.++  ||||+|+++|++
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~s--DiwS~Gv~l~el  203 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKS--DVWSFGVLMWEA  203 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchh--hhccchhhhhHH
Confidence              2234689999999999888877765  999999999963

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-42  Score=350.63  Aligned_cols=223  Identities=26%  Similarity=0.421  Sum_probs=189.3

Q ss_pred             HHHHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeee
Q 041034          442 YEDLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLY  515 (701)
Q Consensus       442 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  515 (701)
                      +.+++.+.++|++.+.||+|+||+||+|+..      +++.||||+++....  ....+++.+|+.++++++||||++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccce
Confidence            4567778899999999999999999999653      457899999976443  34467899999999999999999999


Q ss_pred             eeeeeCcEEEEEEEccCCCCHHHHHhcCC---------------------CccCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 041034          516 GFCLHKRCMFFIYEYMERGSLFYVLRDDD---------------------EAIELNWTRRVNIVKSVAHALSYLHHDCTP  574 (701)
Q Consensus       516 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  574 (701)
                      +++.+.+..++||||+++|+|.+++....                     ....+++..+..++.|++.||+|||++   
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---  159 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---  159 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence            99999999999999999999999996432                     122488999999999999999999999   


Q ss_pred             CeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---
Q 041034          575 SIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---  649 (701)
Q Consensus       575 givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---  649 (701)
                      +||||||||+|||++.++.+||+|||+|+.......  ..+...||+.|+|||.+.+..++.++  ||||+|+++|+   
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ks--DVwS~Gvvl~ell~  237 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES--DVWAYGVVLWEIFS  237 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhh--hhccchhhHHHHHc
Confidence            999999999999999999999999999987643322  23345689999999999988888765  99999999995   


Q ss_pred             ----------------------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ----------------------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ----------------------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                              ||+.+|.+||||.||++.|++.
T Consensus       238 ~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         238 YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                                                    8888888888888888887764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-41  Score=341.46  Aligned_cols=210  Identities=22%  Similarity=0.387  Sum_probs=173.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----E
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----C  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  523 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++.....+....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999965 579999999998877666677788999999999999999999999987643    4


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .|+||||++|++|.+++....   .+++.++..++.||+.||+|||++   ||+||||||+||+++.++.++++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            899999999999999987654   589999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCC---CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCCHHHHHH
Q 041034          604 LLHVDS---SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPTMQRISQ  666 (701)
Q Consensus       604 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt~~~i~~  666 (701)
                      ......   ......+||+.|+|||++.+.+++.++  ||||+|+++|+|+++.|. ...+..++..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~--DiwSlGvilyelltG~~Pf~~~~~~~~~~  224 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS--DVYSLGCVLYEVLTGEPPFTGDSPVSVAY  224 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcce--ecccchHHHHHHHhCCCCCCCcCHHHHHH
Confidence            654322   223445799999999999988888775  999999999998887743 3344444443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.5e-41  Score=345.83  Aligned_cols=195  Identities=30%  Similarity=0.434  Sum_probs=173.4

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++++.........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999965 569999999997644333333577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||++||++.+++....   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999988765   578899999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                         ....+||+.|+|||++.+.+++.++  ||||+|+++|+|+++.+
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~--DiwSlGvilyemltG~~  199 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGYT  199 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTH--HHHHHHHHHHHHHHSSC
T ss_pred             ---cccccCcccccCHHHHcCCCCCchh--hccccchhHHHHHhCCC
Confidence               3346799999999999998888776  99999999999988764

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.9e-41  Score=349.88  Aligned_cols=287  Identities=30%  Similarity=0.503  Sum_probs=190.3

Q ss_pred             CHHHHHHHhcCCCCcCCCC--------CCCCCCCC--cceeEeCCCC---CEEEEEecccccccccCCcccCCCCCCcEE
Q 041034            1 SEIERQALLNCGWWKDRIP--------HNTSDHCN--WVGITCDYKG---SITHIELVECSIKGELGSLNFSCFPNLQYL   67 (701)
Q Consensus         1 ~~~~~~~l~~~~~~~~~~~--------~~~~d~c~--w~gv~c~~~~---~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L   67 (701)
                      .|+||+|||+   ||+.+.        ..++|||.  |.||+|+..+   ||++|+|++++++|..              
T Consensus         4 ~~~e~~aLl~---~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~--------------   66 (313)
T d1ogqa_           4 NPQDKQALLQ---IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY--------------   66 (313)
T ss_dssp             CHHHHHHHHH---HHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCE--------------
T ss_pred             CHHHHHHHHH---HHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCC--------------
Confidence            4899999987   333221        12679994  9999998643   6777777666665421              


Q ss_pred             ECCCCcceeeCCcccCCCCCCCEEECcC-CcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccC
Q 041034           68 NLWNNNLSGSIPPQIGSLSNLKYLNLRW-NNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL  146 (701)
Q Consensus        68 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  146 (701)
                               .+|+.+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+++|+.+++++|.+
T Consensus        67 ---------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~  137 (313)
T d1ogqa_          67 ---------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL  137 (313)
T ss_dssp             ---------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred             ---------CCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccc
Confidence                     3555666666666666664 566666666666666666666666666666665666666666666666666


Q ss_pred             CCCCcccccCCCCCcEEEceecccCCCcCccccccccc-ceeEeeecccCCCCCCCCCCccccCccccccccccCCcccc
Q 041034          147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNL-ERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPST  225 (701)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  225 (701)
                      .+.+|..+.++++|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..
T Consensus       138 ~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~  216 (313)
T d1ogqa_         138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVL  216 (313)
T ss_dssp             ESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGG
T ss_pred             cccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccc
Confidence            66666666666666666666666666666666555554 566666677766666666655433 5677777777777777


Q ss_pred             ccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCcccee
Q 041034          226 LGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLV  305 (701)
Q Consensus       226 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  305 (701)
                      +..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|. ++++.+|+
T Consensus       217 ~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~  294 (313)
T d1ogqa_         217 FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFD  294 (313)
T ss_dssp             CCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSC
T ss_pred             cccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCC
Confidence            7777777777777777776443 466677777777777777777777777777777777777777777763 46677777


Q ss_pred             eecCCCCc-CCC
Q 041034          306 SLDLSKNK-LSG  316 (701)
Q Consensus       306 ~L~Ls~N~-l~~  316 (701)
                      .+++++|+ ++|
T Consensus       295 ~l~l~~N~~l~g  306 (313)
T d1ogqa_         295 VSAYANNKCLCG  306 (313)
T ss_dssp             GGGTCSSSEEES
T ss_pred             HHHhCCCccccC
Confidence            77777776 454

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-40  Score=334.64  Aligned_cols=212  Identities=22%  Similarity=0.328  Sum_probs=177.8

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccC------hHHHHHHHHHHHHHhcCC-CCceeeeeeeeee
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETED------SAFVESFQNEARVLSTVR-HRNIVKLYGFCLH  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  520 (701)
                      .++|++.+.||+|+||+||+|+. .+++.||||+++......      ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999965 579999999998754322      233457889999999997 9999999999999


Q ss_pred             CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          521 KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       521 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      ++..|+||||+++|+|.++++...   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999997654   589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCC------cCChhhHHHHHHHHHHHHHcccCCC-CCCCCHHHHHHHhh
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSP------PVNQKIIQDIILVSTTALACLRSKP-KSRPTMQRISQELE  669 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~Di~slg~i~~~cl~~~P-~~Rpt~~~i~~~l~  669 (701)
                      +|+.+.... ......||+.|+|||.+.+.      .++.+  .||||+|+++|+|+++.+ ..-.+..++.+.+.
T Consensus       156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~--~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~  228 (277)
T d1phka_         156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKE--VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  228 (277)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH--HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCch--heEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence            999875433 34456799999999987532      23444  599999999999998874 33344455554443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=338.98  Aligned_cols=208  Identities=26%  Similarity=0.442  Sum_probs=170.0

Q ss_pred             hhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CcEEEE
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-KRCMFF  526 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  526 (701)
                      ..++|++.+.||+|+||.||+|++ .|+.||||+++....     .+.+.+|++++++++||||++++|++.+ .+.+++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            356789999999999999999988 478999999976432     3678999999999999999999999865 456899


Q ss_pred             EEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccc
Q 041034          527 IYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLH  606 (701)
Q Consensus       527 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~  606 (701)
                      ||||+++|+|.+++..... ..+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999999975422 2589999999999999999999999   99999999999999999999999999998754


Q ss_pred             cCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------------------------
Q 041034          607 VDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------------------------  649 (701)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------------------------  649 (701)
                      ..   .....+|+.|+|||.+.+..++.++  ||||||+++|+                                     
T Consensus       155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~s--DIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (262)
T d1byga_         155 ST---QDTGKLPVKWTAPEALREKKFSTKS--DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV  229 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred             CC---CccccccccCCChHHHhCCCCChHH--HHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            32   2334689999999999888887765  99999999996                                     


Q ss_pred             ------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 ------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 ------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                            ||..||.+|||+.+++++|+.
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence                  777777777777777776654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-40  Score=341.21  Aligned_cols=189  Identities=26%  Similarity=0.334  Sum_probs=166.2

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++.....    ...+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            57899999999999999999965 46899999999765422    35678999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC--CCeEEEeecCcccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN--LEAFVADFGTARLL  605 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~--~~~kL~DFGla~~~  605 (701)
                      ||||+||+|.+++.....  .+++.++..++.||+.||+|||++   ||+||||||+|||++.+  ..+||+|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            999999999999976432  589999999999999999999999   99999999999999854  58999999999876


Q ss_pred             ccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          606 HVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ... .......+|+.|+|||...+..++.++  ||||+|+++|+
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~--DiWSlGvily~  195 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTAT--DMWSLGTLVYV  195 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHH--HHHHHHHHHHH
T ss_pred             ccC-CcccccccccccccchhccCCCCCchh--hcccHHHHHHH
Confidence            432 334456799999999999988888776  99999999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=341.49  Aligned_cols=216  Identities=26%  Similarity=0.413  Sum_probs=185.1

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHh-cCCCCceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLS-TVRHRNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  527 (701)
                      ++|++.+.||+|+||+||+|.. .+++.||||++++.........+.+.+|+.++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6799999999999999999965 479999999997543222222456667777665 68999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcccccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHV  607 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~  607 (701)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999998654   589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC-CCCCCCHHHHHHHhhcCCC
Q 041034          608 DSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK-PKSRPTMQRISQELEGKTP  673 (701)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~-P~~Rpt~~~i~~~l~~~~~  673 (701)
                      .........||+.|+|||++.+.+++.++  ||||+||++|+|+.+. |....+..++.+.+....+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  220 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP  220 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchh--hhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            55556667899999999999999888765  9999999999999987 4555678887777655443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=339.60  Aligned_cols=214  Identities=24%  Similarity=0.369  Sum_probs=169.7

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcCC----CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELPD----GKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR  522 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (701)
                      ...++|++.+.||+|+||+||+|.+..    +..||||+++...  .....+.+.+|+.++++++||||+++++++. ++
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            445789999999999999999996532    3568899886543  3444678999999999999999999999986 46


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..|+||||+++|++.+++.....  .+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||+|
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             eEEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence            68999999999999998765443  589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCC-CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH--------------------------------
Q 041034          603 RLLHVDSS-NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA--------------------------------  649 (701)
Q Consensus       603 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~--------------------------------  649 (701)
                      +....... ......||+.|+|||.+.+..++.++  ||||+|+++|+                                
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~--DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~  233 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS--DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN  233 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHH--HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred             eeccCCcceeccceecCcccchhhHhccCCCCCcc--ccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            87653322 23345689999999999888888775  99999999996                                


Q ss_pred             -----------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 -----------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 -----------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                 ||..+|.+|||++||++.|+.
T Consensus       234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                       777777777777777777654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-40  Score=348.25  Aligned_cols=193  Identities=23%  Similarity=0.306  Sum_probs=162.8

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETED---SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.+.....   ........+|+.+++.++||||+++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36899999999999999999965 469999999987543221   11122334457788888999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      |+||||+++|+|.+++....   .+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999997654   588999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCceeecccccccCCCCCCC-CcCChhhHHHHHHHHHHHHHcc
Q 041034          605 LHVDSSNRTLRAGTYGYIAPDQRLS-PPVNQKIIQDIILVSTTALACL  651 (701)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Di~slg~i~~~cl  651 (701)
                      +...  ......||+.|+|||++.. ..++.++  ||||+||++|+|+
T Consensus       157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~--DiwSlGvilyeml  200 (364)
T d1omwa3         157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLL  200 (364)
T ss_dssp             CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHH--HHHHHHHHHHHHH
T ss_pred             cCCC--cccccccccccchhHHhhcCCCCCccc--chhHHHHHHHHHH
Confidence            6533  2344579999999999864 4566665  9999999999633

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-41  Score=338.95  Aligned_cols=212  Identities=23%  Similarity=0.383  Sum_probs=163.3

Q ss_pred             hcCCccceEEeeccceEEEEEEcC--CC--cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP--DG--KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||+||+|+..  ++  ..||||++++....+....++|.+|+.++++++||||++++|++.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            367999999999999999999642  23  36899999876655566678899999999999999999999999764 67


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      ++||||+++|++.+++.....  .+++..++.++.|||+||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            899999999999988876432  589999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCC---ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHccc-C-CCCCCCCHHHHHHHh
Q 041034          605 LHVDSSN---RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLR-S-KPKSRPTMQRISQEL  668 (701)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~-~-~P~~Rpt~~~i~~~l  668 (701)
                      .......   .....|+..|+|||.+.+..++.++  ||||+|+++|+|++ + .|....+..++.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~--Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i  227 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS--DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  227 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHH--HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcch--hhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence            7543322   2234578899999999888877765  99999999998554 2 344455555555554

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-40  Score=344.06  Aligned_cols=232  Identities=22%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++++.||+|+||.||+|+. .+|+.||||++.+....+....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6799999999999999999965 579999999997543333333567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+.+|+|.+++....   .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999997654   589999999999999999999999   9999999999999999999999999999877432


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC-CCCC----------------------HHHHH
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK-SRPT----------------------MQRIS  665 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~-~Rpt----------------------~~~i~  665 (701)
                         .....||+.|+|||++.+..++.++  ||||+||++|+|+++.+. .-.+                      +.+++
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~--DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHH--HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             ---cccccCccccCCHHHHcCCCCCccc--cccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence               2345799999999999998888765  999999999999887633 2223                      44444


Q ss_pred             HHhhcCCCccc-hhhhhhHHHHhcccce
Q 041034          666 QELEGKTPMKK-GLKEISISEMRNQEMF  692 (701)
Q Consensus       666 ~~l~~~~~~~~-~~~~~~~~~~~~~~~~  692 (701)
                      +.+-...|.++ .-.+.++.++..++||
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f  297 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccc
Confidence            44444554444 2223466777777776

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=342.28  Aligned_cols=221  Identities=23%  Similarity=0.361  Sum_probs=172.6

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeee
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLY  515 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  515 (701)
                      .+++...++|++.+.||+|+||.||+|.+.      +++.||||+++....  ....+.+.+|+.++.++ +|+||++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            344555688999999999999999999642      346899999976443  23346778888888777 689999999


Q ss_pred             eeeeeC-cEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 041034          516 GFCLHK-RCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDI  581 (701)
Q Consensus       516 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dl  581 (701)
                      +++.++ ...++|||||++|+|.++++....             ...+++..+..++.||+.||+|||++   +||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence            987664 468999999999999999975421             22488999999999999999999999   9999999


Q ss_pred             CCCcEEEcCCCCeEEEeecCccccccCCC--CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------
Q 041034          582 SSNNILLNSNLEAFVADFGTARLLHVDSS--NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------  649 (701)
Q Consensus       582 kp~NIll~~~~~~kL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------  649 (701)
                      ||+|||++.++.+||+|||+|+.......  ......||+.|+|||.+.+..++.++  ||||+|+++|+          
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s--DiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccc--ceeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999987643322  23345799999999999888887775  99999999996          


Q ss_pred             ----------------------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 ----------------------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 ----------------------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                                        ||+.+|.+|||++|+++.|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                                              777777777777777777664

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-40  Score=339.89  Aligned_cols=186  Identities=23%  Similarity=0.359  Sum_probs=159.4

Q ss_pred             hcCCccce-EEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhc-CCCCceeeeeeeeee----C
Q 041034          449 TEDFHIRY-CIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLST-VRHRNIVKLYGFCLH----K  521 (701)
Q Consensus       449 ~~~y~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~  521 (701)
                      .++|++.. .||+|+||+||+|.. .+++.||||+++..        ..+.+|+.++.+ .+||||++++++|.+    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            46898875 599999999999965 57999999998643        456789998755 489999999999875    4


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC---CCCeEEEe
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS---NLEAFVAD  598 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~---~~~~kL~D  598 (701)
                      ..+|+|||||+||+|.+++..... ..+++.++..++.||+.||+|||++   ||+||||||+|||++.   ++.+||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence            678999999999999999976432 3699999999999999999999999   9999999999999975   56799999


Q ss_pred             ecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          599 FGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       599 FGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      ||+|+...... ......||+.|+|||++.+..++.++  ||||+||++|+
T Consensus       158 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~--DiwSlGvily~  205 (335)
T d2ozaa1         158 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYI  205 (335)
T ss_dssp             CTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHH--HHHHHHHHHHH
T ss_pred             cceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHH--HHHhhchhHHH
Confidence            99998765433 34456799999999999988888775  99999999995

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-40  Score=340.83  Aligned_cols=212  Identities=24%  Similarity=0.431  Sum_probs=176.2

Q ss_pred             cCCccceEEeeccceEEEEEEcC-CCc----EEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELP-DGK----VVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (701)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|+++.....  ...+++.+|++++++++||||++++|++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            56999999999999999999653 444    5899988754332  2357899999999999999999999999865 46


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      +++|||+.+|+|.+++.....  .+++..++.++.|||.||+|||++   +||||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence            788999999999998876543  589999999999999999999999   999999999999999999999999999988


Q ss_pred             cccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH---------------------------------
Q 041034          605 LHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA---------------------------------  649 (701)
Q Consensus       605 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~---------------------------------  649 (701)
                      .......  .....||+.|+|||.+.+..++.++  ||||+|+++|+                                 
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s--DvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~  238 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS--DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  238 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTB
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhh--hhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            7543332  2334689999999999888887765  99999999985                                 


Q ss_pred             ----------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ----------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ----------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                ||..+|.+|||+.||++.++..
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                      9999999999999999887643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-40  Score=337.65  Aligned_cols=216  Identities=28%  Similarity=0.459  Sum_probs=180.9

Q ss_pred             hcCCccceEEeeccceEEEEEEcC-CCc--EEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAELP-DGK--VVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (701)
                      .++|++.+.||+|+||+||+|.+. ++.  .||||+++.....  ...+.+.+|+++++++ +||||+++++++.+.+..
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            368999999999999999999664 344  4788887654332  2346789999999999 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcC-------------CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC
Q 041034          525 FFIYEYMERGSLFYVLRDD-------------DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN  591 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~  591 (701)
                      ++||||+++|+|.++++..             .....+++..+.+++.|||.||.|+|++   +|+||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            9999999999999999754             2234699999999999999999999999   99999999999999999


Q ss_pred             CCeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH----------------------
Q 041034          592 LEAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA----------------------  649 (701)
Q Consensus       592 ~~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~----------------------  649 (701)
                      +.+||+|||+|+....... .....||+.|+|||.+.+..++.++  ||||||+++|+                      
T Consensus       164 ~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~s--DvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~  240 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNS--DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  240 (309)
T ss_dssp             GCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHH--HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccc--eeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999999986643322 2344689999999999888887765  99999999995                      


Q ss_pred             ---------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ---------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ---------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                           ||..+|.+||||+||++.|++..
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                                 99999999999999999877643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-40  Score=338.70  Aligned_cols=220  Identities=26%  Similarity=0.383  Sum_probs=188.3

Q ss_pred             HHhhhcCCccceEEeeccceEEEEEEc------CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          445 LINATEDFHIRYCIGTGGYGSVYKAEL------PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       445 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      ++...++|++.+.||+|+||.||+|.+      .+++.||||+++....  ......+.+|+.+++++ +||||++++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            445568999999999999999999964      3467899999986543  33456789999999999 69999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCC---------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDE---------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDIS  582 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlk  582 (701)
                      +.+++..++|||||++|+|.++++....               ...+++..+..++.||+.||+|||++   ++||||||
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK  172 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence            9999999999999999999999975431               22588999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-----------
Q 041034          583 SNNILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-----------  649 (701)
Q Consensus       583 p~NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-----------  649 (701)
                      |+||+++.++.+|++|||.++........  .....||+.|+|||.+.+..++.++  ||||+|+++|+           
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DIwS~G~~l~ellt~g~p~~~~  250 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES--DVWSYGIFLWELFSLGSSPYPG  250 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcc--cccchHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999877543322  2335789999999999888887775  99999999995           


Q ss_pred             ---------------------------------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 ---------------------------------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 ---------------------------------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                                                       ||+.+|.+|||++||+++|++.
T Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             CCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                                             8888999999999998888753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-40  Score=336.31  Aligned_cols=196  Identities=24%  Similarity=0.324  Sum_probs=162.6

Q ss_pred             cceEEeeccceEEEEEEcC-CCcEEEEEEecCCCccC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEEc
Q 041034          454 IRYCIGTGGYGSVYKAELP-DGKVVALKKLHQSETED--SAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYEY  530 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (701)
                      .++.||+|+||+||+|+.. +|+.||||+++......  ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4688999999999999764 68999999997654322  22235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCCC
Q 041034          531 MERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDSS  610 (701)
Q Consensus       531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~  610 (701)
                      ++++++..+.....   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||.|+.......
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99987776654433   588899999999999999999999   999999999999999999999999999988765555


Q ss_pred             CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          611 NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .....+||+.|+|||++... .++.++  ||||+||++|+|+.+.|..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~--DiwSlGvil~el~~g~~pf  201 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRVPFL  201 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHH--HHHHHHHHHHHHHHSSCSS
T ss_pred             cccceecChhhccHHHHccCCCCChhh--hhhhcchHHHHHHhCcCCC
Confidence            55556899999999987654 456655  9999999999999887543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-40  Score=338.22  Aligned_cols=222  Identities=21%  Similarity=0.339  Sum_probs=190.3

Q ss_pred             HHHhhhcCCccceEEeeccceEEEEEEcC------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeee
Q 041034          444 DLINATEDFHIRYCIGTGGYGSVYKAELP------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGF  517 (701)
Q Consensus       444 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  517 (701)
                      +++...++|++.+.||+|+||+||+|.+.      +++.||||+++....  ......+.+|+.++++++||||++++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            45556789999999999999999999653      357899999976543  3345678999999999999999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcC-------CCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDD-------DEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS  590 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~  590 (701)
                      +..++..++||||+++|+|.+++...       .....+++..+.+++.|+|+||.|||++   +|+||||||+|||++.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence            99999999999999999999988643       1223478999999999999999999999   9999999999999999


Q ss_pred             CCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------------
Q 041034          591 NLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------------  649 (701)
Q Consensus       591 ~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------------  649 (701)
                      ++.+||+|||+|+........  .....||+.|+|||.+.+..++.+.  ||||+|+++++                   
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~--Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS--DVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHH--HHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCccc--ccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999876543322  2334689999999999888888765  99999999984                   


Q ss_pred             ------------------------cccCCCCCCCCHHHHHHHhhcCC
Q 041034          650 ------------------------CLRSKPKSRPTMQRISQELEGKT  672 (701)
Q Consensus       650 ------------------------cl~~~P~~Rpt~~~i~~~l~~~~  672 (701)
                                              ||+.+|.+|||+.+|++.|++..
T Consensus       247 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                                    99999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=333.47  Aligned_cols=200  Identities=26%  Similarity=0.359  Sum_probs=167.1

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++++.||+|+||+||+|.. .+|+.||||+++..... ....+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            6899999999999999999965 57999999999764322 233477899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      ||+.+ ++.+++..... ..+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||.|+.....
T Consensus        81 e~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99976 45444433322 2589999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ........||+.|+|||......+.... .||||+|+++|+|+.+.+.
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~-~DiwSlGvily~m~~G~~P  202 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTA-VDIWSLGCIFAEMVTRRAL  202 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTH-HHHHHHHHHHHHHHHSSCS
T ss_pred             cccceeecccceeeehhhhccccCCCcc-ccccccchhhhHHhhCCCC
Confidence            5555566899999999987776654332 4999999999999988754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=332.54  Aligned_cols=193  Identities=25%  Similarity=0.332  Sum_probs=154.7

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----EEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----CMF  525 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  525 (701)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++....    .......|+..+.+++||||+++++++.+.+    .+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            5688899999999999999986 689999999865421    1122344666667889999999999998653    689


Q ss_pred             EEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          526 FIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC-----TPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       526 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                      +||||+++|+|.+++++.    .++|..+..++.|+|.||+|+|+..     ..|||||||||+|||++.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999999864    4899999999999999999999631     2499999999999999999999999999


Q ss_pred             CccccccCCC----CceeecccccccCCCCCCCCcCC----hhhHHHHHHHHHHHHHcc
Q 041034          601 TARLLHVDSS----NRTLRAGTYGYIAPDQRLSPPVN----QKIIQDIILVSTTALACL  651 (701)
Q Consensus       601 la~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~----~~~~~Di~slg~i~~~cl  651 (701)
                      +++.......    ......||+.|+|||++.+....    ....+||||||+++|+++
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~  212 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  212 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence            9987754322    22345799999999998765321    233459999999998633

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-39  Score=330.94  Aligned_cols=208  Identities=25%  Similarity=0.425  Sum_probs=178.0

Q ss_pred             ceEEeeccceEEEEEEcCC--C--cEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CcEEEEEEE
Q 041034          455 RYCIGTGGYGSVYKAELPD--G--KVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-KRCMFFIYE  529 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  529 (701)
                      .++||+|+||+||+|.+.+  +  ..||||+++...  +....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            5789999999999997643  2  258999997533  34456889999999999999999999999875 568999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      ||++|+|.+++.....  ..++..++.++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999876543  577889999999999999999999   99999999999999999999999999998764332


Q ss_pred             C----CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH------------------------------------
Q 041034          610 S----NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA------------------------------------  649 (701)
Q Consensus       610 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~------------------------------------  649 (701)
                      .    ......||+.|+|||.+.+..++.+.  ||||+|+++|+                                    
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks--DI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~  262 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKS--DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  262 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHH
T ss_pred             cccceecccccccccccChHHHhcCCCCChh--HhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHH
Confidence            2    12234689999999998888887776  99999999995                                    


Q ss_pred             -------cccCCCCCCCCHHHHHHHhhcC
Q 041034          650 -------CLRSKPKSRPTMQRISQELEGK  671 (701)
Q Consensus       650 -------cl~~~P~~Rpt~~~i~~~l~~~  671 (701)
                             ||+.||.+||+|.||++.|++.
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   9999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-40  Score=332.20  Aligned_cols=197  Identities=22%  Similarity=0.294  Sum_probs=163.0

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccCh---HHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCc
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDS---AFVESFQNEARVLSTVR--HRNIVKLYGFCLHKR  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  522 (701)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......+.   ....++.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36799999999999999999965 5799999999976432211   11234678999999986  899999999999999


Q ss_pred             EEEEEEEccCC-CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCC-CCeEEEeec
Q 041034          523 CMFFIYEYMER-GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSN-LEAFVADFG  600 (701)
Q Consensus       523 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~-~~~kL~DFG  600 (701)
                      ..++||||+.+ +++.+++....   .+++..+..++.||+.||+|||++   ||+||||||+||+++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999999976 57888887644   589999999999999999999999   99999999999999854 799999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      +|+....  ...+...||+.|+|||++.+.++.... .||||+|+++|+|+++.
T Consensus       157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~-~DiwSlGvilyell~g~  207 (273)
T d1xwsa_         157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRS-AAVWSLGILLYDMVCGD  207 (273)
T ss_dssp             TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHH-HHHHHHHHHHHHHHHSS
T ss_pred             cceeccc--ccccccccCCCcCCHHHHcCCCCCCcc-cccccceeeehhHhhCC
Confidence            9987542  234456799999999998776664432 49999999999754443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=334.43  Aligned_cols=217  Identities=24%  Similarity=0.393  Sum_probs=178.0

Q ss_pred             hhhcCCccceEEeeccceEEEEEEcC--------CCcEEEEEEecCCCccChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 041034          447 NATEDFHIRYCIGTGGYGSVYKAELP--------DGKVVALKKLHQSETEDSAFVESFQNEARVLSTV-RHRNIVKLYGF  517 (701)
Q Consensus       447 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (701)
                      ...++|++.+.||+|+||.||+|+..        ++..||||+++....  .....++.+|+..+.++ +||||++++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            44678999999999999999999642        134799999986543  33357788899988888 79999999999


Q ss_pred             eeeCcEEEEEEEccCCCCHHHHHhcCCC-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 041034          518 CLHKRCMFFIYEYMERGSLFYVLRDDDE-------------AIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSN  584 (701)
Q Consensus       518 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~  584 (701)
                      +.+++..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||++   +||||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            9999999999999999999999975531             23589999999999999999999999   9999999999


Q ss_pred             cEEEcCCCCeEEEeecCccccccCCCC--ceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH-------------
Q 041034          585 NILLNSNLEAFVADFGTARLLHVDSSN--RTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA-------------  649 (701)
Q Consensus       585 NIll~~~~~~kL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~-------------  649 (701)
                      |||++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.++  ||||||+++|+             
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~--DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS--DVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHH--HHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchh--hhHHhHHHHHHhccCCCCCCCCCC
Confidence            999999999999999999877543322  2335689999999999888888876  99999999996             


Q ss_pred             ------------------------------cccCCCCCCCCHHHHHHHhhc
Q 041034          650 ------------------------------CLRSKPKSRPTMQRISQELEG  670 (701)
Q Consensus       650 ------------------------------cl~~~P~~Rpt~~~i~~~l~~  670 (701)
                                                    ||+.+|.+|||+.||++.|++
T Consensus       243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                                          777777777777777777654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.2e-39  Score=328.59  Aligned_cols=199  Identities=27%  Similarity=0.396  Sum_probs=167.9

Q ss_pred             cCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIYE  529 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (701)
                      ++|++.+.||+|+||+||+|+.++|+.||||+++..... ....+++.+|+.++++++||||+++++++.+++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            689999999999999999998888999999999765432 2234788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccCC
Q 041034          530 YMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVDS  609 (701)
Q Consensus       530 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~~  609 (701)
                      |+.++.+..+.....   .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+|++|||.|.......
T Consensus        81 ~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            998877766665443   699999999999999999999999   99999999999999999999999999998876555


Q ss_pred             CCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          610 SNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      .......+++.|+|||.+.+... +.++  ||||+|+++++|+.+.+..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~--DiwslGv~l~el~~G~~pf  201 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTI--DIWSVGCIFAEMVNGTPLF  201 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHH--HHHHHHHHHHHHHHSSCSC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcce--eehhcCcHHHHHHHCCCCC
Confidence            55555679999999999876544 4554  9999999999999887544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-38  Score=322.21  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=163.1

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CC-CcEEEEEEecCCCccChHHHHHHHHHHHHHhcC---CCCceeeeeeeeee--
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PD-GKVVALKKLHQSETEDSAFVESFQNEARVLSTV---RHRNIVKLYGFCLH--  520 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--  520 (701)
                      ..++|++++.||+|+||+||+|+. .+ ++.||||+++.....+. ....+.+|+.+++.+   +||||+++++++..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            357899999999999999999965 44 66799999875432211 123455677776655   79999999999853  


Q ss_pred             ---CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEE
Q 041034          521 ---KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVA  597 (701)
Q Consensus       521 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~  597 (701)
                         ....+++|||++++++........  ..+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence               346899999999877655444332  2589999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCCC
Q 041034          598 DFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPKS  657 (701)
Q Consensus       598 DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~~  657 (701)
                      |||+++..... .......||+.|+|||++.+.+++.++  ||||+||++|+|+.+.|..
T Consensus       159 dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~--DiwSlG~il~ell~g~~pf  215 (305)
T d1blxa_         159 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRKPLF  215 (305)
T ss_dssp             SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHH--HHHHHHHHHHHHHHSSCSC
T ss_pred             chhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhe--hhhchHHHHHHHHHCCCCC
Confidence            99999865433 234456799999999999999888876  9999999999999887543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=314.90  Aligned_cols=196  Identities=23%  Similarity=0.359  Sum_probs=172.2

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCcEEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKRCMFFIY  528 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (701)
                      ++|++++.||+|+||+||+|+. .+++.||||+++.... .....+++.+|+.+++.++||||+++++++.+....++||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            5899999999999999999965 5789999999976543 3345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCccccccC
Q 041034          529 EYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTARLLHVD  608 (701)
Q Consensus       529 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~~~~~  608 (701)
                      |++.++++..++....   .+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999999988877654   588999999999999999999999   9999999999999999999999999999987655


Q ss_pred             CCCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHHcccCC
Q 041034          609 SSNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      ........+++.|+|||.+..... +.++  ||||+|+++++++.+.
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~--DiwSlG~il~ell~g~  199 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSI--DMWSAGCIFAELANAG  199 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHH--HHHHHHHHHHHHTTTS
T ss_pred             CccceeeccccchhhhhHhccCCCCCchh--hccccchHHHHHhhCC
Confidence            555555678899999998876654 5554  9999999999998764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-37  Score=322.34  Aligned_cols=192  Identities=26%  Similarity=0.356  Sum_probs=157.6

Q ss_pred             hhcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----
Q 041034          448 ATEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----  522 (701)
Q Consensus       448 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  522 (701)
                      ..++|++++.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+++|++++||||++++++|...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            357899999999999999999965 5699999999986543 3455678899999999999999999999997654    


Q ss_pred             --EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeec
Q 041034          523 --CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFG  600 (701)
Q Consensus       523 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFG  600 (701)
                        .+|+||||+ +.+|..+.+..    .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+|++|||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence              579999999 55888877653    499999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccC
Q 041034          601 TARLLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRS  653 (701)
Q Consensus       601 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~  653 (701)
                      .|+....   ..+...||+.|+|||.+.+.. ++.++  ||||+||++++|+.+
T Consensus       167 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwSlGvil~ell~g  215 (346)
T d1cm8a_         167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTV--DIWSVGCIMAEMITG  215 (346)
T ss_dssp             TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTH--HHHHHHHHHHHHHHS
T ss_pred             ceeccCC---ccccccccccccCHHHHcCCCCCCccc--hhhcchHHHHHHHHC
Confidence            9987643   234567999999999987654 44554  999999999865544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-37  Score=319.41  Aligned_cols=195  Identities=24%  Similarity=0.351  Sum_probs=158.5

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCc----E
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHKR----C  523 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  523 (701)
                      .++|++++.||+|+||+||+|.. .+|+.||||++....  .....+++.+|+.+|++++||||+++++++..+.    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            46799999999999999999954 589999999997543  3445678899999999999999999999987643    2


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .+++++|+.+|+|.+++...    .+++..+..++.|++.||+|||++   |||||||||+|||++.++.+||+|||+|+
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            34445566789999999754    489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCC---CceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDSS---NRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .......   .....+||+.|+|||.+.... ++.+  .||||+|+++++|+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~--~DiwSlG~il~eml~g~  210 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS--IDIWSVGCILAEMLSNR  210 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTH--HHHHHHHHHHHHHHHSS
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCch--hhhhccCceehHHhhCC
Confidence            7643322   234457999999999985544 4444  49999999999766543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-37  Score=323.92  Aligned_cols=192  Identities=24%  Similarity=0.341  Sum_probs=156.2

Q ss_pred             CCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------cE
Q 041034          451 DFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK------RC  523 (701)
Q Consensus       451 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  523 (701)
                      +|+..++||+|+||+||+|+. .+|+.||||++......       ..+|++++++++||||+++++++...      .+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            688999999999999999966 46999999999765422       34799999999999999999998543      35


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTA  602 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla  602 (701)
                      .++||||++++.+..+.........+++..+..++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+|
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            799999998764444333222233699999999999999999999998   999999999999999775 8999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                      +...... ......||+.|+|||.+.+. .++.++  ||||+||++|+++.+.|
T Consensus       171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~--DIwSlG~il~el~~g~~  221 (350)
T d1q5ka_         171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQP  221 (350)
T ss_dssp             EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHH--HHHHHHHHHHHHHHTSC
T ss_pred             hhccCCc-ccccccccccccChHHhhcccCCCcce--eecccceEEEehhhCCC
Confidence            8765433 33345799999999987654 456655  99999999998776654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-36  Score=307.13  Aligned_cols=194  Identities=18%  Similarity=0.276  Sum_probs=165.6

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRH-RNIVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  527 (701)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......     +.+.+|+++++.++| +|++.+++++.+....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            6799999999999999999965 46899999988664432     346788899999975 8999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcC-----CCCeEEEeecCc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNS-----NLEAFVADFGTA  602 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~-----~~~~kL~DFGla  602 (701)
                      |||+ +++|.++++....  .+++.++..++.|++.||+|||++   ||+||||||+||+++.     ++.+||+|||+|
T Consensus        80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence            9999 6799999876543  589999999999999999999999   9999999999999974     578999999999


Q ss_pred             cccccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      +.+.....       ......||+.|+|||++.+.+++.+.  ||||+|+++|+|+++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~--DiwSlG~~l~elltg~~P  212 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD--DLEALGHVFMYFLRGSLP  212 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHH--HHHHHHHHHHHHHHSSCT
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHH--HHHHhhHHHHHHHhCCCc
Confidence            87653221       22345799999999999998888775  999999999998887643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-36  Score=308.37  Aligned_cols=187  Identities=16%  Similarity=0.275  Sum_probs=154.5

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCcEEEEE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRN-IVKLYGFCLHKRCMFFI  527 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  527 (701)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++......     +++.+|+++++.++|++ |+.+.+++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            5699999999999999999965 56899999998765432     35678999999998766 55556666788899999


Q ss_pred             EEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEc---CCCCeEEEeecCccc
Q 041034          528 YEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLN---SNLEAFVADFGTARL  604 (701)
Q Consensus       528 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~---~~~~~kL~DFGla~~  604 (701)
                      |||+. +++.+.+.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++   .+..+||+|||+|+.
T Consensus        82 me~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          82 MELLG-PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EECCC-CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEcC-CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99994 577776654432  589999999999999999999999   999999999999985   456799999999998


Q ss_pred             cccCCC-------CceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHH
Q 041034          605 LHVDSS-------NRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALA  649 (701)
Q Consensus       605 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~  649 (701)
                      +.....       ......||+.|+|||+..+.+++.++  ||||+|+++++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~~l~e  205 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD--DLESLGYVLMY  205 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHH--HHHHHHHHHHH
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChh--hEEecCHHHHH
Confidence            754322       12345799999999999988888775  99999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-37  Score=317.20  Aligned_cols=199  Identities=27%  Similarity=0.359  Sum_probs=166.8

Q ss_pred             cCCccceEEeeccceEEEEEEc----CCCcEEEEEEecCCCcc-ChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCcE
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL----PDGKVVALKKLHQSETE-DSAFVESFQNEARVLSTVRH-RNIVKLYGFCLHKRC  523 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  523 (701)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++..... +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999954    25889999998754321 12223567899999999976 899999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCcc
Q 041034          524 MFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTAR  603 (701)
Q Consensus       524 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~  603 (701)
                      .++||||+.+|+|.+++....   .+++..+..++.||+.||+|+|++   +|+||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999998765   477899999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCC-CCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCC
Q 041034          604 LLHVDS-SNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSK  654 (701)
Q Consensus       604 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~  654 (701)
                      .+.... .......|++.|+|||.+.+........+||||+||++|+|+.+.
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~  229 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  229 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence            764322 233445799999999998776544444459999999999987765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-36  Score=309.51  Aligned_cols=201  Identities=23%  Similarity=0.383  Sum_probs=162.3

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-------
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH-------  520 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  520 (701)
                      .++|++++.||+|+||+||+|.. .+|+.||||++...... ....+++.+|+.++++++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            57899999999999999999965 57999999998765432 2234678899999999999999999998855       


Q ss_pred             -CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 041034          521 -KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADF  599 (701)
Q Consensus       521 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DF  599 (701)
                       .+..++||||++++.+........   .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence             345899999998876655543332   588999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCC----CceeecccccccCCCCCCCC-cCChhhHHHHHHHHHHHHHcccCCCCCC
Q 041034          600 GTARLLHVDSS----NRTLRAGTYGYIAPDQRLSP-PVNQKIIQDIILVSTTALACLRSKPKSR  658 (701)
Q Consensus       600 Gla~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Di~slg~i~~~cl~~~P~~R  658 (701)
                      |+|+.+.....    .....+||+.|+|||.+.+. .++.++  ||||+|+++++++.+.|..+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~--DiwSlGvil~el~~g~~pf~  223 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI--DLWGAGCIMAEMWTRSPIMQ  223 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHH--HHHHHHHHHHHHHHSSCSCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHH--HcccCCceeeeHhhCCCCCC
Confidence            99987643221    22334699999999998765 455655  99999999999998876543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-35  Score=308.77  Aligned_cols=190  Identities=18%  Similarity=0.323  Sum_probs=161.7

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeee--CcEE
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLH--KRCM  524 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  524 (701)
                      .++|++++.||+|+||+||+|+. .+++.||||+++...      .+++.+|+.+|++++ ||||+++++++..  ....
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            36799999999999999999965 579999999997543      367889999999995 9999999999874  3568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCC-CeEEEeecCcc
Q 041034          525 FFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNL-EAFVADFGTAR  603 (701)
Q Consensus       525 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~-~~kL~DFGla~  603 (701)
                      ++||||+++++|.++.+      .+++..+..++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+|+
T Consensus       108 ~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence            99999999999977642      489999999999999999999999   999999999999998655 68999999998


Q ss_pred             ccccCCCCceeecccccccCCCCCCCCc-CChhhHHHHHHHHHHHHHcccCCCC
Q 041034          604 LLHVDSSNRTLRAGTYGYIAPDQRLSPP-VNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ..... .......+|+.|+|||...+.. ++.++  ||||+|+++++++.+.+.
T Consensus       179 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~--DiwslG~~l~e~~~g~~p  229 (328)
T d3bqca1         179 FYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP  229 (328)
T ss_dssp             ECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHH--HHHHHHHHHHHHHHTCSS
T ss_pred             eccCC-CcccccccCccccCcccccCCCCCCccc--chhhhhhhhHHhccCCCC
Confidence            76543 3344567999999999977654 45554  999999999999888643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=310.82  Aligned_cols=195  Identities=26%  Similarity=0.302  Sum_probs=155.3

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------C
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLH------K  521 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  521 (701)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++..... ......++.+|+.++++++||||+++++++..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            47899999999999999999965 4699999999987654 34445778999999999999999999999864      3


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecC
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGT  601 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGl  601 (701)
                      ...|+||||+.++ +.+.+..     .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|||+
T Consensus        95 ~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            6889999999775 4444432     488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCCC
Q 041034          602 ARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ++.... ........+|+.|+|||++.+..++.+.  ||||+||++++|+.+.|.
T Consensus       166 ~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~--DiwSlG~~l~ell~g~~p  217 (355)
T d2b1pa1         166 ARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHKIL  217 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTH--HHHHHHHHHHHHHHSSCS
T ss_pred             hhcccc-ccccccccccccccChhhhcCCCCCCCc--ccccccchHHHHhhCCCC
Confidence            887643 2334456799999999999988888776  999999999976666543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-35  Score=306.44  Aligned_cols=195  Identities=25%  Similarity=0.315  Sum_probs=161.1

Q ss_pred             hcCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----c
Q 041034          449 TEDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNIVKLYGFCLHK-----R  522 (701)
Q Consensus       449 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  522 (701)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.... +....+++.+|+.++++++||||+++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            67899999999999999999964 5799999999986543 334456789999999999999999999998643     3


Q ss_pred             EEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEEEeecCc
Q 041034          523 CMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFVADFGTA  602 (701)
Q Consensus       523 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL~DFGla  602 (701)
                      ..+++|+|+.+|+|.+++...    .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+|++|||.|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            456677788899999999653    499999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeecccccccCCCCCCCCcC-ChhhHHHHHHHHHHHHHcccCCCC
Q 041034          603 RLLHVDSSNRTLRAGTYGYIAPDQRLSPPV-NQKIIQDIILVSTTALACLRSKPK  656 (701)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Di~slg~i~~~cl~~~P~  656 (701)
                      ......   .....||+.|+|||...+..+ +.++  ||||+|+++|+|+.+.|.
T Consensus       169 ~~~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~--DiwSlGv~l~~ll~g~~p  218 (348)
T d2gfsa1         169 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGRTL  218 (348)
T ss_dssp             -CCTGG---GSSSCHHHHTSCHHHHTTCSCCCTTH--HHHHHHHHHHHHHHSSCS
T ss_pred             cccCcc---cccccccccccCchhhcCCccCCccc--chhhhhHHHHHHHhCCCC
Confidence            765422   334579999999998766554 4454  999999999988777643

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5.5e-34  Score=294.67  Aligned_cols=248  Identities=31%  Similarity=0.492  Sum_probs=121.5

Q ss_pred             CCCEEECcCCcCcc--cCCcccCCCCCCCEEECCC-CCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEE
Q 041034           87 NLKYLNLRWNNLTG--TIPKEIGSLRNLEVLYLSN-NSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWL  163 (701)
Q Consensus        87 ~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  163 (701)
                      +++.|+|++|.++|  .+|+.+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            45555555555554  2445555555555555543 44544445445555555555555554444444444444444444


Q ss_pred             EceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcc-cEEEeccCCC
Q 041034          164 SVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL-LYLDLSFNQL  242 (701)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L-~~L~L~~N~l  242 (701)
                      ++++|.+.+                        .+|..+++++.|+++++++|.+++.+|+.+..+.++ +.+++++|++
T Consensus       131 ~l~~N~~~~------------------------~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l  186 (313)
T d1ogqa_         131 DFSYNALSG------------------------TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL  186 (313)
T ss_dssp             ECCSSEEES------------------------CCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred             ccccccccc------------------------cCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence            444444444                        444444444444444444444444444444443332 4444444444


Q ss_pred             CCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcc
Q 041034          243 HSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGI  322 (701)
Q Consensus       243 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  322 (701)
                      ++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.+++++|.+++.+| .+..+++|+.|+|++|+++|.+|..+
T Consensus       187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l  264 (313)
T d1ogqa_         187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL  264 (313)
T ss_dssp             EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred             cccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHH
Confidence            44444444333322 35555555555555555555555555555555554433 34445555555555555555555555


Q ss_pred             cCCCCCCeeeccCCccCCCCCccccccccCCeEEccccc
Q 041034          323 GNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNN  361 (701)
Q Consensus       323 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~  361 (701)
                      +++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus       265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            5555555555555555555553 3455555555555554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=5e-31  Score=278.17  Aligned_cols=194  Identities=21%  Similarity=0.283  Sum_probs=153.5

Q ss_pred             cCCccceEEeeccceEEEEEEc-CCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-----------CCceeeeeee
Q 041034          450 EDFHIRYCIGTGGYGSVYKAEL-PDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-----------HRNIVKLYGF  517 (701)
Q Consensus       450 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~  517 (701)
                      .+|++++.||+|+||+||+|+. .+|+.||||+++...    ...+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            4599999999999999999965 579999999997543    33467788998888775           5789999988


Q ss_pred             eee--CcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCC--
Q 041034          518 CLH--KRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNL--  592 (701)
Q Consensus       518 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~--  592 (701)
                      +..  ....+++|+++..+..............+++..+..++.||+.||+|||+ .   ||+||||||+|||++.++  
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence            764  45667777776655443333333333468999999999999999999997 6   999999999999998654  


Q ss_pred             ----CeEEEeecCccccccCCCCceeecccccccCCCCCCCCcCChhhHHHHHHHHHHHHHcccCCC
Q 041034          593 ----EAFVADFGTARLLHVDSSNRTLRAGTYGYIAPDQRLSPPVNQKIIQDIILVSTTALACLRSKP  655 (701)
Q Consensus       593 ----~~kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di~slg~i~~~cl~~~P  655 (701)
                          .++++|||.|......   ....+||+.|+|||+.....++.++  |+||+|+++++++.+.+
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~--DiwSlG~il~el~~g~~  227 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGA--DIWSTACLIFELITGDF  227 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHH--HHHHHHHHHHHHHHSSC
T ss_pred             cccceeeEeecccccccccc---cccccccccccChhhccccCCCccc--cccchHHHHHHHHHCCC
Confidence                4899999999865432   2345799999999999888887765  99999999987665543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.1e-28  Score=261.91  Aligned_cols=319  Identities=31%  Similarity=0.411  Sum_probs=190.1

Q ss_pred             CCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEE
Q 041034           37 GSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLY  116 (701)
Q Consensus        37 ~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  116 (701)
                      ..++.|++.+++++. +.  .+..+++|++|+|++|+|++..  .++++++|++|++++|++++..  .++++++|+.|+
T Consensus        44 ~~l~~L~l~~~~I~~-l~--gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~  116 (384)
T d2omza2          44 DQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT  116 (384)
T ss_dssp             TTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCC-cc--ccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--cccccccccccc
Confidence            467888888887763 22  3567788888888888887543  2788888888888888887553  377888888888


Q ss_pred             CCCCCCCCCCccccCCccccceeecccccCCCCCccc-------------------ccCCCCCcEEEceecccCCCcCcc
Q 041034          117 LSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQE-------------------IGNLKSLIWLSVMYNTVGGPIPST  177 (701)
Q Consensus       117 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------~~~l~~L~~L~L~~N~l~~~~~~~  177 (701)
                      +++|.+++..+  ......+..+....|.+....+..                   +.............|...  ....
T Consensus       117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  192 (384)
T d2omza2         117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISV  192 (384)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC--CCGG
T ss_pred             ccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc--cccc
Confidence            88888775443  233444555555555443222111                   111122222222222221  2234


Q ss_pred             cccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCccc
Q 041034          178 LFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALA  257 (701)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~  257 (701)
                      +..+++++.+++++|.+++..|  +...++|++|++++|+++..  +.+..+++|+.|++++|.+++..+  +..+++|+
T Consensus       193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~  266 (384)
T d2omza2         193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT  266 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             cccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCC
Confidence            4556666666676666665443  34456666667777666642  245666667777777776666432  55666677


Q ss_pred             EEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCc
Q 041034          258 ELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNS  337 (701)
Q Consensus       258 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  337 (701)
                      .|++++|++++..  .+..++.++.++++.|.+++.  ..+..+++++.|++++|++++..  .+..+++|++|++++|+
T Consensus       267 ~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~  340 (384)
T d2omza2         267 ELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNK  340 (384)
T ss_dssp             EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSC
T ss_pred             EeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCC
Confidence            7777766666442  255666666666666666642  23555666666677766666532  25666667777777766


Q ss_pred             cCCCCCccccccccCCeEEcccccCcccCCCC-c-cccccccccC
Q 041034          338 LDGTIPPEIGKILLLQNLDLSHNNLSGTIPMT-L-HPMFLDMSFN  380 (701)
Q Consensus       338 l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~-~~~~l~ls~N  380 (701)
                      |++ ++ .++.+++|++|++++|++++..|-. + ....|++++|
T Consensus       341 l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N  383 (384)
T d2omza2         341 VSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred             CCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence            653 33 4666666777777776666544411 1 1234566555

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=4.6e-28  Score=257.15  Aligned_cols=305  Identities=29%  Similarity=0.404  Sum_probs=242.4

Q ss_pred             CCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccce
Q 041034           59 SCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEE  138 (701)
Q Consensus        59 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  138 (701)
                      +.+.+|++|++++|+|+..  +.+..+++|++|+|++|+|++..|  |+++++|++|+|++|++.+..+  ++.+++|+.
T Consensus        41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~  114 (384)
T d2omza2          41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG  114 (384)
T ss_dssp             HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--ccccccccc
Confidence            3457899999999999853  458889999999999999996643  9999999999999999987554  889999999


Q ss_pred             eecccccCCCCCcccccCCCCCcEEEceecccCCCcCcc-------------------cccccccceeEeeecccCCCCC
Q 041034          139 LYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPST-------------------LFRLTNLERLFLGCNQFNGTIP  199 (701)
Q Consensus       139 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------------~~~l~~L~~L~L~~N~l~~~~~  199 (701)
                      |++++|.+++..+  ......+..+....|.+....+..                   +...+.........|...  ..
T Consensus       115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  190 (384)
T d2omza2         115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DI  190 (384)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC--CC
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc--cc
Confidence            9999999987644  345567777777777765443222                   122223333333333332  34


Q ss_pred             CCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCC
Q 041034          200 REIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSN  279 (701)
Q Consensus       200 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~  279 (701)
                      ..+..+++++.+++++|.+++..|  +..+++|++|++++|+++..  ..+..+++|+.|++++|.+++..+  +..+++
T Consensus       191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~  264 (384)
T d2omza2         191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTK  264 (384)
T ss_dssp             GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred             cccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--cccccc
Confidence            456778899999999999997655  46678999999999999873  367889999999999999997643  888999


Q ss_pred             CcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEccc
Q 041034          280 LQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSH  359 (701)
Q Consensus       280 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~  359 (701)
                      |+.|++++|++++..  .+..+..++.++++.|.+++.  ..+..+++++.|++++|++++..  .+..+++|+.|++++
T Consensus       265 L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~  338 (384)
T d2omza2         265 LTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN  338 (384)
T ss_dssp             CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred             CCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCC
Confidence            999999999998654  377889999999999999863  35788999999999999999753  388999999999999


Q ss_pred             ccCcccCCCCcc----ccccccccCCCCCcCC
Q 041034          360 NNLSGTIPMTLH----PMFLDMSFNNLEGEIP  387 (701)
Q Consensus       360 N~l~g~~p~~~~----~~~l~ls~N~l~g~~p  387 (701)
                      |++++ +| .+.    ..+|++++|++++.+|
T Consensus       339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence            99985 44 232    3589999999997654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=1.6e-27  Score=244.74  Aligned_cols=244  Identities=26%  Similarity=0.363  Sum_probs=152.7

Q ss_pred             CCcceeEeCCCCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcc
Q 041034           26 CNWVGITCDYKGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKE  105 (701)
Q Consensus        26 c~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~  105 (701)
                      |.|.+|.|+..+           ++ .+|. .+  .+++++|+|++|+|+...+..|.++++|++|++++|.+....|..
T Consensus        10 c~~~~~~C~~~~-----------L~-~lP~-~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~   74 (305)
T d1xkua_          10 CHLRVVQCSDLG-----------LE-KVPK-DL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   74 (305)
T ss_dssp             EETTEEECTTSC-----------CC-SCCC-SC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             ecCCEEEecCCC-----------CC-ccCC-CC--CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence            678888887422           22 2232 11  357888888888888665567888888888888888888777888


Q ss_pred             cCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccC--CCcCcccccccc
Q 041034          106 IGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVG--GPIPSTLFRLTN  183 (701)
Q Consensus       106 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~  183 (701)
                      |.++++|++|++++|+++.... .  ....|+.|++.+|.+.+..+..+.....+..++...|...  ...+..+..+++
T Consensus        75 f~~l~~L~~L~l~~n~l~~l~~-~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~  151 (305)
T d1xkua_          75 FAPLVKLERLYLSKNQLKELPE-K--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK  151 (305)
T ss_dssp             TTTCTTCCEEECCSSCCSBCCS-S--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT
T ss_pred             hhCCCccCEecccCCccCcCcc-c--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccc
Confidence            8888888888888888874433 2  2356777888888887776666777777777777666442  223445556666


Q ss_pred             cceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCC
Q 041034          184 LERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSD  263 (701)
Q Consensus       184 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~  263 (701)
                      |+.+++++|.++. +|..+  .++|+.|++++|.+++..+..+..++.+++|++++|.+++..+..+.++++|++|+|++
T Consensus       152 L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~  228 (305)
T d1xkua_         152 LSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN  228 (305)
T ss_dssp             CCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS
T ss_pred             cCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccc
Confidence            6666666666552 33222  34555555555555555555555555555555555555554455555555555555555


Q ss_pred             CCCccccCcccCCCCCCcEEEccCccCC
Q 041034          264 NKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       264 N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      |+|+ .+|.+|..+++|+.|+|++|+|+
T Consensus       229 N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         229 NKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             SCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             cccc-ccccccccccCCCEEECCCCccC
Confidence            5554 23445555555555555555554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=1.9e-27  Score=244.31  Aligned_cols=268  Identities=25%  Similarity=0.316  Sum_probs=165.4

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeeccc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRS  143 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  143 (701)
                      .+.+|-++++++ .+|..+.  ++|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            456777888887 5676664  6799999999999877667899999999999999999988888899999999999999


Q ss_pred             ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCcc
Q 041034          144 NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIP  223 (701)
Q Consensus       144 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  223 (701)
                      |+++..... +  ...+..|.+.+|.+.+..+..+.....+..++...|....                      ....+
T Consensus        89 n~l~~l~~~-~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~----------------------~~~~~  143 (305)
T d1xkua_          89 NQLKELPEK-M--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIEN  143 (305)
T ss_dssp             SCCSBCCSS-C--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCT
T ss_pred             CccCcCccc-h--hhhhhhhhccccchhhhhhhhhhccccccccccccccccc----------------------cCCCc
Confidence            988854332 2  3466777777777766655555555666666665554321                      11222


Q ss_pred             ccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccc
Q 041034          224 STLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFN  303 (701)
Q Consensus       224 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  303 (701)
                      ..+..+++|+.+++++|.+.. +|..  .+++|+.|++++|.+++..+..|..++.++.|++++|.+++..+..+.++++
T Consensus       144 ~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~  220 (305)
T d1xkua_         144 GAFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH  220 (305)
T ss_dssp             TGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred             cccccccccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence            333444445555555555443 2222  1345555555555555555555555555555555555555554555555555


Q ss_pred             eeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCc------cccccccCCeEEcccccCc
Q 041034          304 LVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPP------EIGKILLLQNLDLSHNNLS  363 (701)
Q Consensus       304 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~l~ls~N~l~  363 (701)
                      |++|+|++|+|+ .+|.++..+++|++|+|++|+|+..-..      ....+.+|+.|+|++|+++
T Consensus       221 L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         221 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             ceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            555555555555 3455555555555555555555532111      1234455666666666664

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.9e-28  Score=245.29  Aligned_cols=268  Identities=24%  Similarity=0.247  Sum_probs=148.7

Q ss_pred             EEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecc
Q 041034           90 YLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNT  169 (701)
Q Consensus        90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  169 (701)
                      .++.++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|++..+.+..+.++..+..+...   
T Consensus        15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~---   88 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS---   88 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC---
T ss_pred             EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc---
Confidence            4556666666 4454442  456777777777766655666667777777776666665555555555555544432   


Q ss_pred             cCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcc
Q 041034          170 VGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLE  249 (701)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  249 (701)
                                          ..|.++...+..|.++++|++|++++|.+....+..+..+++|+.+++++|+|+++.+..
T Consensus        89 --------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~  148 (284)
T d1ozna_          89 --------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT  148 (284)
T ss_dssp             --------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             --------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH
Confidence                                123333333444555555555555555554444444555555555555555555544455


Q ss_pred             cCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCC
Q 041034          250 IGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQ  329 (701)
Q Consensus       250 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  329 (701)
                      |..+++|+.|++++|+|++..+.+|.++++|+.+++++|++++..|..|..+++|+.|++++|++.+..|..|..+++|+
T Consensus       149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~  228 (284)
T d1ozna_         149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ  228 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred             hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence            55555555555555555555555555555566666665555555555555555555555555555555555555556666


Q ss_pred             eeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc-cccccccCCCCC
Q 041034          330 HLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP-MFLDMSFNNLEG  384 (701)
Q Consensus       330 ~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~-~~l~ls~N~l~g  384 (701)
                      +|+|++|++.+.-+- ..-...++.+....+++++..|..+.. ...+++.+.|+|
T Consensus       229 ~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g~~l~~l~~~~l~g  283 (284)
T d1ozna_         229 YLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG  283 (284)
T ss_dssp             EEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCC
T ss_pred             EEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcCCccccCCHHHCCC
Confidence            666666665543221 111123444555566666666665543 345566666654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.1e-28  Score=244.29  Aligned_cols=206  Identities=27%  Similarity=0.278  Sum_probs=113.0

Q ss_pred             CCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECC-CCCCCCCCccccCCccccceeec
Q 041034           63 NLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLS-NNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        63 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      .+++|+|++|+|++..+..|.++++|++|++++|++.+..+..+.++..++.++.+ .|.++...+.+|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            45555555555554444445555555555555555555555555555555555443 33444444444444444444444


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA  221 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  221 (701)
                      ++|.+.                        ...+..+..+++|+.+++++|++++..+..|..+++|++|++++|++++.
T Consensus       113 ~~n~~~------------------------~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l  168 (284)
T d1ozna_         113 DRCGLQ------------------------ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (284)
T ss_dssp             TTSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccc------------------------cccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence            444444                        33444444455555555555555544455555555555666666655555


Q ss_pred             ccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCC
Q 041034          222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSG  292 (701)
Q Consensus       222 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  292 (701)
                      .+.+|.++++|+.+++++|++++..|..|.++++|+.|++++|++.+..|..|..+++|++|+|++|.+..
T Consensus       169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            55555556666666666666665555566666666666666666665555556666666666666666554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.2e-24  Score=216.29  Aligned_cols=182  Identities=30%  Similarity=0.243  Sum_probs=134.0

Q ss_pred             cccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEc
Q 041034          182 TNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDL  261 (701)
Q Consensus       182 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L  261 (701)
                      ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|++++ .+..+..+++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-cccccccccccccccc
Confidence            356666666666665555566666666667777766663 23 24567777777777777776 4556777777888888


Q ss_pred             CCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCC
Q 041034          262 SDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGT  341 (701)
Q Consensus       262 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  341 (701)
                      ++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .
T Consensus       108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~  186 (266)
T d1p9ag_         108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T  186 (266)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred             cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence            888777777777777778888888888887666667777788888888888888777777788888888888888887 7


Q ss_pred             CCccccccccCCeEEcccccCcccCC
Q 041034          342 IPPEIGKILLLQNLDLSHNNLSGTIP  367 (701)
Q Consensus       342 ~p~~~~~l~~L~~l~ls~N~l~g~~p  367 (701)
                      +|..+..+++|+.|+|++|++.+...
T Consensus       187 lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         187 IPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cChhHCCCCCCCEEEecCCCCCCCcc
Confidence            78777788888888888888877643

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.6e-24  Score=213.99  Aligned_cols=199  Identities=23%  Similarity=0.213  Sum_probs=114.0

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeec
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYL  141 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  141 (701)
                      ..+..++.++++++ .+|+.+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|++|+|
T Consensus        10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEEC
T ss_pred             CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccc
Confidence            34455666666666 3455443  3566666666666655555666666666666666666532 2 2344555555555


Q ss_pred             ccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCC
Q 041034          142 RSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA  221 (701)
Q Consensus       142 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  221 (701)
                      ++|+++..                         +..+..+++|+.|++++|.+....+..+..+.++++|++++|.++..
T Consensus        85 s~N~l~~~-------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l  139 (266)
T d1p9ag_          85 SHNQLQSL-------------------------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL  139 (266)
T ss_dssp             CSSCCSSC-------------------------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred             cccccccc-------------------------ccccccccccccccccccccceeecccccccccccccccccccccee
Confidence            55555422                         22344444555555555555544445555555566666666666555


Q ss_pred             ccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCC
Q 041034          222 IPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLS  291 (701)
Q Consensus       222 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  291 (701)
                      .+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            5555555666666666666666655555666666666666666666 45555556666666666666654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=3.2e-22  Score=189.66  Aligned_cols=137  Identities=18%  Similarity=0.248  Sum_probs=107.2

Q ss_pred             CccceEEeeccceEEEEEEcCCCcEEEEEEecCCCcc---------------ChHHHHHHHHHHHHHhcCCCCceeeeee
Q 041034          452 FHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETE---------------DSAFVESFQNEARVLSTVRHRNIVKLYG  516 (701)
Q Consensus       452 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~l~~  516 (701)
                      +.+.+.||+|+||+||+|...+|+.||||+++.....               .........+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            4568999999999999998888999999987643211               0112234567889999999999998876


Q ss_pred             eeeeCcEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCcEEEcCCCCeEE
Q 041034          517 FCLHKRCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDCTPSIVHRDISSNNILLNSNLEAFV  596 (701)
Q Consensus       517 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~givH~Dlkp~NIll~~~~~~kL  596 (701)
                      +..    .+++|||+++..+.+          ++......++.|++.+++|||++   ||+||||||+|||++++ .++|
T Consensus        82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            632    369999998855432          33344567999999999999999   99999999999999865 5899


Q ss_pred             EeecCccccc
Q 041034          597 ADFGTARLLH  606 (701)
Q Consensus       597 ~DFGla~~~~  606 (701)
                      +|||.|+...
T Consensus       144 iDFG~a~~~~  153 (191)
T d1zara2         144 IDFPQSVEVG  153 (191)
T ss_dssp             CCCTTCEETT
T ss_pred             EECCCcccCC
Confidence            9999997653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=1.7e-18  Score=180.05  Aligned_cols=298  Identities=25%  Similarity=0.281  Sum_probs=174.2

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEEC
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYL  117 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  117 (701)
                      +++.|+|++++++. +|.    ..++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .+++.   .+.|++|+|
T Consensus        39 ~l~~LdLs~~~L~~-lp~----~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPE----LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCSC-CCS----CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             CCCEEEeCCCCCCC-CCC----CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            46678888888763 443    2467888888888887 556543   56788888888877 33321   145888888


Q ss_pred             CCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCC
Q 041034          118 SNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGT  197 (701)
Q Consensus       118 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  197 (701)
                      ++|.+... | .++.+++|+.|++++|.+.....    ....+..+.+..+...  .+..+..++.++.|++++|.+...
T Consensus       106 ~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~  177 (353)
T d1jl5a_         106 SNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL  177 (353)
T ss_dssp             CSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred             cccccccc-c-chhhhccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceeccccccccccc
Confidence            88888743 4 35678888888888888764322    2345566666655543  234566777888888888877633


Q ss_pred             CCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCC
Q 041034          198 IPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKL  277 (701)
Q Consensus       198 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l  277 (701)
                       +...   ...+.+...++.+. .+| .+..++.|+.+++++|.... .+.   ...++..+.+.+|.+... +.   ..
T Consensus       178 -~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~---~~  243 (353)
T d1jl5a_         178 -PDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PE---LP  243 (353)
T ss_dssp             -CCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CC---CC
T ss_pred             -cccc---cccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccccccccccc-cc---cc
Confidence             2221   22345555555554 333 35678888888888888765 332   345677788888887643 22   23


Q ss_pred             CCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEc
Q 041034          278 SNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDL  357 (701)
Q Consensus       278 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l  357 (701)
                      ..+...++..|.+.+.. ..   .......++..|.+.+ ++   ..+++|++|+|++|+|+ .+|..   +++|+.|+|
T Consensus       244 ~~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L  311 (353)
T d1jl5a_         244 QSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIA  311 (353)
T ss_dssp             TTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEEC
T ss_pred             ccccccccccccccccc-cc---cchhcccccccCcccc-cc---ccCCCCCEEECCCCccC-ccccc---cCCCCEEEC
Confidence            45556666665554211 00   0122333444444432 11   12345556666666555 34432   345555666


Q ss_pred             ccccCcccCCCCcc-ccccccccCCCC
Q 041034          358 SHNNLSGTIPMTLH-PMFLDMSFNNLE  383 (701)
Q Consensus       358 s~N~l~g~~p~~~~-~~~l~ls~N~l~  383 (701)
                      ++|+|+ .+|.... ...|++++|+++
T Consensus       312 ~~N~L~-~l~~~~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         312 SFNHLA-EVPELPQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred             CCCcCC-ccccccCCCCEEECcCCcCC
Confidence            666555 4444332 234556666655

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.82  E-value=2.2e-18  Score=179.22  Aligned_cols=285  Identities=28%  Similarity=0.298  Sum_probs=208.0

Q ss_pred             CCCEEEEEecccccccccCCcccCCCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEE
Q 041034           36 KGSITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVL  115 (701)
Q Consensus        36 ~~~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  115 (701)
                      .++++.|++++++++ .++.    .+.+|+.|++++|+++. ++. +  .+.|++|+|++|.++. +|. ++.+++|+.|
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L  125 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQLEK-LPE-LQNSSFLKII  125 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSCCSS-CCC-CTTCTTCCEE
T ss_pred             CCCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccch-hhh-h--cccccccccccccccc-ccc-hhhhccceee
Confidence            357899999999998 4543    35789999999999973 332 1  1469999999999984 554 6889999999


Q ss_pred             ECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccC
Q 041034          116 YLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFN  195 (701)
Q Consensus       116 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (701)
                      ++++|.+.....    ....+..|.+..+...  .+..+..++.++.|.+..|.+......    ....+.+.++++.+.
T Consensus       126 ~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~----~~~~~~l~~~~~~~~  195 (353)
T d1jl5a_         126 DVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNILE  195 (353)
T ss_dssp             ECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCC----CTTCCEEECCSSCCS
T ss_pred             cccccccccccc----ccccccchhhcccccc--ccccccccccceecccccccccccccc----ccccccccccccccc
Confidence            999999874332    3456777777766654  345678899999999999988654322    223456666666655


Q ss_pred             CCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccC
Q 041034          196 GTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELS  275 (701)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~  275 (701)
                       .++ .+..++.|+.+++++|.... +|.   ...++..+.+..|.+... +.   ....+..+++..|.+.+.. . + 
T Consensus       196 -~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~-~-l-  262 (353)
T d1jl5a_         196 -ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGLS-E-L-  262 (353)
T ss_dssp             -SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEES-C-C-
T ss_pred             -ccc-cccccccccccccccccccc-ccc---cccccccccccccccccc-cc---ccccccccccccccccccc-c-c-
Confidence             333 46778999999999998874 343   346788999999998763 22   2456778888888776431 1 1 


Q ss_pred             CCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeE
Q 041034          276 KLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNL  355 (701)
Q Consensus       276 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l  355 (701)
                       .......++..|.+.+. +   ..+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +.+|+.|
T Consensus       263 -~~~~~~~~~~~~~~~~~-~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L  329 (353)
T d1jl5a_         263 -PPNLYYLNASSNEIRSL-C---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQL  329 (353)
T ss_dssp             -CTTCCEEECCSSCCSEE-C---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEE
T ss_pred             -cchhcccccccCccccc-c---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEE
Confidence             13456777888877643 2   23578999999999998 67754   578999999999998 67754   4579999


Q ss_pred             EcccccCcccCCC
Q 041034          356 DLSHNNLSGTIPM  368 (701)
Q Consensus       356 ~ls~N~l~g~~p~  368 (701)
                      ++++|+++ .+|.
T Consensus       330 ~L~~N~L~-~lp~  341 (353)
T d1jl5a_         330 HVEYNPLR-EFPD  341 (353)
T ss_dssp             ECCSSCCS-SCCC
T ss_pred             ECcCCcCC-CCCc
Confidence            99999988 5664

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=9.4e-20  Score=179.48  Aligned_cols=218  Identities=17%  Similarity=0.163  Sum_probs=110.1

Q ss_pred             cEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCC-ccccCCccccceeeccc
Q 041034           65 QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTT-PIEIGSLRNLEELYLRS  143 (701)
Q Consensus        65 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~  143 (701)
                      +.++.++++++ .+|+.+.  +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+ +..|.+++++++|.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            35666666666 5554442  45677777777776555556667777777777777665433 33455666666665543


Q ss_pred             -ccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCc
Q 041034          144 -NKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAI  222 (701)
Q Consensus       144 -n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  222 (701)
                       |.+....+..|.++++|+.|++++|.+....+.                       ..+..+..+..+...++.+....
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-----------------------~~~~~l~~l~~~~~~n~~l~~i~  144 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-----------------------HKIHSLQKVLLDIQDNINIHTIE  144 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC-----------------------TTTCBSSCEEEEEESCTTCCEEC
T ss_pred             cccccccccccccccccccccccchhhhcccccc-----------------------ccccccccccccccccccccccc
Confidence             445444444444444444444444444322111                       11122233333333344444333


Q ss_pred             cccccCCC-cccEEEeccCCCCCCCCcccCCCCcccEE-EcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccC
Q 041034          223 PSTLGHLT-SLLYLDLSFNQLHSFIPLEIGNFSALAEL-DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGK  300 (701)
Q Consensus       223 p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  300 (701)
                      +..|..++ .++.|++++|+++...+..+ ..++++.+ ++++|+|+...+..|.++++|+.|+|++|+|+...+..|.+
T Consensus       145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~  223 (242)
T d1xwdc1         145 RNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN  223 (242)
T ss_dssp             TTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred             ccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence            33333332 45555666666555333333 23333333 34555565444444556666666666666665444444555


Q ss_pred             ccceeeecC
Q 041034          301 LFNLVSLDL  309 (701)
Q Consensus       301 l~~L~~L~L  309 (701)
                      +++|+.+++
T Consensus       224 l~~L~~l~~  232 (242)
T d1xwdc1         224 LKKLRARST  232 (242)
T ss_dssp             CCEEESSSE
T ss_pred             CcccccCcC
Confidence            555555554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=6.5e-20  Score=180.66  Aligned_cols=196  Identities=16%  Similarity=0.144  Sum_probs=125.1

Q ss_pred             CCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccC-CcccCCCCCCCEEECCC-CCCCCCCccccCCcccccee
Q 041034           62 PNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTI-PKEIGSLRNLEVLYLSN-NSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L  139 (701)
                      +++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.. |++....+..|.++++|++|
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            58999999999999777778999999999999999987654 55789999999999864 68888888899999999999


Q ss_pred             ecccccCCCCCcc-cccCCCCCcEEEceecccCCCcCccccccc-ccceeEeeecccCCCCCCCCCCccccC-ccccccc
Q 041034          140 YLRSNKLSGVLPQ-EIGNLKSLIWLSVMYNTVGGPIPSTLFRLT-NLERLFLGCNQFNGTIPREIGNLKNLT-HLSIITN  216 (701)
Q Consensus       140 ~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~~N  216 (701)
                      ++++|++....+. .+..++.+..+...++.+....+..|..++ .++.|++++|+++...+..+. ..+++ .+++++|
T Consensus       109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n  187 (242)
T d1xwdc1         109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNN  187 (242)
T ss_dssp             EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCT
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhcccccccc
Confidence            9999999755332 334455555555566666554444444443 455555555555533332222 22222 2233444


Q ss_pred             cccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccE
Q 041034          217 KLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAE  258 (701)
Q Consensus       217 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~  258 (701)
                      +++...+..|.++++|++|+|++|+|+...+..|.++++|+.
T Consensus       188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  229 (242)
T d1xwdc1         188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA  229 (242)
T ss_dssp             TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEES
T ss_pred             ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccccc
Confidence            444333333444444444444444444333333333333333

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=5.7e-20  Score=179.15  Aligned_cols=202  Identities=28%  Similarity=0.380  Sum_probs=95.6

Q ss_pred             EECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccC
Q 041034           67 LNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL  146 (701)
Q Consensus        67 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  146 (701)
                      ++++.+.+++.+  .+..+.+|++|++.+|+|+..  +.+..+++|++|+|++|++++..|  +..+++|++|++++|.+
T Consensus        24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~   97 (227)
T d1h6ua2          24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (227)
T ss_dssp             HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence            344444444432  234455566666666666532  235566666666666666654433  55556666666666555


Q ss_pred             CCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccc
Q 041034          147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTL  226 (701)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l  226 (701)
                      +..  ..+.++++|+.+++++|...+..  .+...+.+..+.++.+                        .+....  .+
T Consensus        98 ~~i--~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~------------------------~~~~~~--~~  147 (227)
T d1h6ua2          98 KNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLN------------------------QITNIS--PL  147 (227)
T ss_dssp             SCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSS------------------------CCCCCG--GG
T ss_pred             ccc--ccccccccccccccccccccccc--hhccccchhhhhchhh------------------------hhchhh--hh
Confidence            432  23444555555555444443221  1233334444444444                        433221  23


Q ss_pred             cCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceee
Q 041034          227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVS  306 (701)
Q Consensus       227 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  306 (701)
                      ..+++|+.|++++|.+.+..  .+.++++|+.|+|++|++++. + .++++++|++|+|++|++++..  .+.++++|+.
T Consensus       148 ~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~  221 (227)
T d1h6ua2         148 AGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFI  221 (227)
T ss_dssp             GGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCE
T ss_pred             ccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCE
Confidence            34444455555554444321  244445555555555555432 1 2445555555555555555322  1445555555


Q ss_pred             ecCC
Q 041034          307 LDLS  310 (701)
Q Consensus       307 L~Ls  310 (701)
                      |+++
T Consensus       222 L~ls  225 (227)
T d1h6ua2         222 VTLT  225 (227)
T ss_dssp             EEEE
T ss_pred             EEee
Confidence            5543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=6.8e-20  Score=178.60  Aligned_cols=187  Identities=27%  Similarity=0.350  Sum_probs=111.4

Q ss_pred             CCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEE
Q 041034          156 NLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYL  235 (701)
Q Consensus       156 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  235 (701)
                      .+.+|+.|++.+|.++..  ..+..+++|++|++++|++++..|  +..+++|+++++++|.++..  ..+..+++|+++
T Consensus        39 ~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l  112 (227)
T d1h6ua2          39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (227)
T ss_dssp             HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--cccccccccccc
Confidence            344444444444444432  234555555555555555554332  55556666666666665532  235566666777


Q ss_pred             EeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCC
Q 041034          236 DLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLS  315 (701)
Q Consensus       236 ~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  315 (701)
                      ++++|...+..  .+...+.++.+.++++.+....  .+..+++|+.|++++|.+++..  .+.++++|+.|+|++|+++
T Consensus       113 ~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~  186 (227)
T d1h6ua2         113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS  186 (227)
T ss_dssp             ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             ccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccC
Confidence            77666665532  2445566677777777665432  3556667777777777766432  3666777777777777776


Q ss_pred             CCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcc
Q 041034          316 GSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLS  358 (701)
Q Consensus       316 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls  358 (701)
                      + +| .++++++|++|+|++|++++ ++ .++.+++|+.|+++
T Consensus       187 ~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         187 D-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT  225 (227)
T ss_dssp             C-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred             C-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence            4 33 26677777777777777764 33 26677777777776

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=2.1e-19  Score=170.03  Aligned_cols=153  Identities=21%  Similarity=0.233  Sum_probs=73.9

Q ss_pred             cccEEEeccCCCCCCC-CcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecC
Q 041034          231 SLLYLDLSFNQLHSFI-PLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDL  309 (701)
Q Consensus       231 ~L~~L~L~~N~l~~~~-~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  309 (701)
                      ++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|+.|+|++|+|++..|.+|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            3444444444444322 233444445555555555554444444444555555555555555444444455555555555


Q ss_pred             CCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCcccCCCCccc-cccccccCCCCC
Q 041034          310 SKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGTIPMTLHP-MFLDMSFNNLEG  384 (701)
Q Consensus       310 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~-~~l~ls~N~l~g  384 (701)
                      ++|+|++..|..|..+++|++|+|++|.+.+..+.. .-...++.+.+..|.+++..|..+.. ..+|++.|.|..
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKC  184 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCC
T ss_pred             CCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCChhhcCCEeeecCHhhCcC
Confidence            555555444444555555555555555554322211 11122444455566666666655443 245666666653

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=1.5e-19  Score=171.20  Aligned_cols=155  Identities=28%  Similarity=0.320  Sum_probs=70.5

Q ss_pred             ccCccccccccccC-CccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEc
Q 041034          207 NLTHLSIITNKLTG-AIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNL  285 (701)
Q Consensus       207 ~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  285 (701)
                      ++++|+|++|+|++ ..+..|..+++|+.|+|++|++....+..|..+++|+.|+|++|+|++..|.+|.++++|+.|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            44444444444443 22333444444555555555554444444444445555555555554444444444555555555


Q ss_pred             cCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccCCCCCccccccccCCeEEcccccCccc
Q 041034          286 SSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLDGTIPPEIGKILLLQNLDLSHNNLSGT  365 (701)
Q Consensus       286 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~  365 (701)
                      ++|+|++..+.+|..+++|++|+|++|.+....+.. .-...++.+.+..|.+....|..+   ..++.++|+.|.|++.
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred             CCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCC
Confidence            555554444444444455555555555444222110 001223344444555544444332   2344455555555544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.4e-18  Score=166.73  Aligned_cols=163  Identities=30%  Similarity=0.417  Sum_probs=75.7

Q ss_pred             CCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEe
Q 041034          110 RNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFL  189 (701)
Q Consensus       110 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  189 (701)
                      .+|+.|++++|.++...  .+..+++|++|+|++|++++..  .++++++|++|++++|++++. + .+..+++|+.|++
T Consensus        46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEEC
T ss_pred             cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-c-ccccccccccccc
Confidence            34444444444444322  1334444444444444444322  133444444444444444321 1 2444444555555


Q ss_pred             eecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccc
Q 041034          190 GCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI  269 (701)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~  269 (701)
                      ++|.+...  ..+..++.|+.++++.|.+++.  ..+..+++|+++++++|++++..  .+.++++|+.|+|++|+|+. 
T Consensus       120 ~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-  192 (210)
T d1h6ta2         120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-  192 (210)
T ss_dssp             TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-
T ss_pred             cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-
Confidence            44444321  2344445555555555555432  23444555666666666655432  25555566666666666553 


Q ss_pred             cCcccCCCCCCcEEEcc
Q 041034          270 IPDELSKLSNLQYLNLS  286 (701)
Q Consensus       270 ~p~~l~~l~~L~~L~L~  286 (701)
                      +| .+.++++|+.|+|+
T Consensus       193 l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         193 LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CG-GGTTCTTCSEEEEE
T ss_pred             Ch-hhcCCCCCCEEEcc
Confidence            22 35555666666554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=2.1e-18  Score=165.50  Aligned_cols=166  Identities=26%  Similarity=0.372  Sum_probs=111.2

Q ss_pred             cccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEE
Q 041034          180 RLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAEL  259 (701)
Q Consensus       180 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L  259 (701)
                      .+.+|+.|++++|.++...  .+..+++|++|+|++|+|++..  .++.+++|++|++++|+|++ +| .+..+++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence            3455666666666665332  3556667777777777776532  25667777777777777766 33 46677777777


Q ss_pred             EcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCcCCCCCCCcccCCCCCCeeeccCCccC
Q 041034          260 DLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNKLSGSFPTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       260 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      ++++|.+...  ..+..+++|+.+++++|.+++.  ..+..+++|+.+++++|++++. + .+.++++|+.|+|++|+++
T Consensus       118 ~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence            7777776632  3466777777777777777642  3455677778888888877743 3 2677788888888888876


Q ss_pred             CCCCccccccccCCeEEccc
Q 041034          340 GTIPPEIGKILLLQNLDLSH  359 (701)
Q Consensus       340 ~~~p~~~~~l~~L~~l~ls~  359 (701)
                       .+| .+..+++|++|+|++
T Consensus       192 -~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         192 -DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -BCG-GGTTCTTCSEEEEEE
T ss_pred             -CCh-hhcCCCCCCEEEccC
Confidence             344 577778888888764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=2.8e-18  Score=163.25  Aligned_cols=159  Identities=31%  Similarity=0.433  Sum_probs=67.2

Q ss_pred             CCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEe
Q 041034          110 RNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFL  189 (701)
Q Consensus       110 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  189 (701)
                      .+|++|++++|.++..  ..+..+++|++|+|++|++++..|  ++++++|++|++++|.+....  .+.+++.|+.|++
T Consensus        40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l  113 (199)
T d2omxa2          40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL  113 (199)
T ss_dssp             TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred             cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--ccccccccccccc
Confidence            3444444444444321  123334444444444444443221  334444444444444332211  2334444444444


Q ss_pred             eecccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccc
Q 041034          190 GCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGI  269 (701)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~  269 (701)
                      ++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++..  .++++++|+.|++++|+|++.
T Consensus       114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i  187 (199)
T d2omxa2         114 FNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI  187 (199)
T ss_dssp             CSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred             cccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCCC
Confidence            44444322  123444445555555554442 1 23444455555555555554421  244455555555555555432


Q ss_pred             cCcccCCCCCCcE
Q 041034          270 IPDELSKLSNLQY  282 (701)
Q Consensus       270 ~p~~l~~l~~L~~  282 (701)
                       + .++.+++|+.
T Consensus       188 -~-~l~~L~~L~~  198 (199)
T d2omxa2         188 -S-VLAKLTNLES  198 (199)
T ss_dssp             -G-GGGGCTTCSE
T ss_pred             -c-cccCCCCCCc
Confidence             1 2444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3.6e-18  Score=162.48  Aligned_cols=177  Identities=25%  Similarity=0.391  Sum_probs=124.1

Q ss_pred             EECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccC
Q 041034           67 LNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKL  146 (701)
Q Consensus        67 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l  146 (701)
                      +.++.+.+++.++  ...+++|++|++++|.++..  +.+..+++|++|+|++|++++..+  +.++++|++|++++|.+
T Consensus        23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~   96 (199)
T d2omxa2          23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI   96 (199)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence            3455666655433  23456777777777777643  246677777777777777775543  67777777777777777


Q ss_pred             CCCCcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccc
Q 041034          147 SGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTL  226 (701)
Q Consensus       147 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l  226 (701)
                      ....  .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++...  ..+..+++|++|++++|++++..  .+
T Consensus        97 ~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l  168 (199)
T d2omxa2          97 ADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PL  168 (199)
T ss_dssp             CCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GG
T ss_pred             cccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cc
Confidence            6442  367777777777777777554  2466778888888888887642  35777888888888888888642  37


Q ss_pred             cCCCcccEEEeccCCCCCCCCcccCCCCcccEE
Q 041034          227 GHLTSLLYLDLSFNQLHSFIPLEIGNFSALAEL  259 (701)
Q Consensus       227 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L  259 (701)
                      +++++|++|++++|++++. + .++.+++|+.|
T Consensus       169 ~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         169 ANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             TTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             cCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            8888888888888888873 3 46777787765

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=9.1e-21  Score=204.81  Aligned_cols=348  Identities=20%  Similarity=0.136  Sum_probs=218.2

Q ss_pred             CEEEEEecccccccccCCcccCCCCCCcEEECCCCccee----eCCcccCCCCCCCEEECcCCcCccc----CCcccC-C
Q 041034           38 SITHIELVECSIKGELGSLNFSCFPNLQYLNLWNNNLSG----SIPPQIGSLSNLKYLNLRWNNLTGT----IPKEIG-S  108 (701)
Q Consensus        38 ~v~~l~l~~~~~~~~~~~~~~~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~-~  108 (701)
                      +++.||++.+++++.--...+..+++++.|+|++|+|+.    .+...+..+++|++|||++|.|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            578899998888753222335667899999999998873    3455677889999999999998632    223333 3


Q ss_pred             CCCCCEEECCCCCCCCC----CccccCCccccceeecccccCCCCCcccc------------------------------
Q 041034          109 LRNLEVLYLSNNSLHGT----TPIEIGSLRNLEELYLRSNKLSGVLPQEI------------------------------  154 (701)
Q Consensus       109 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~------------------------------  154 (701)
                      ..+|++|+|++|+++..    ++..+..+++|++|+|++|.++......+                              
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  162 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence            35799999999998754    34567788999999999998753211111                              


Q ss_pred             ---cCCCCCcEEEceecccCCCcCcc----cc-cccccceeEeeecccCCCC----CCCCCCccccCccccccccccC--
Q 041034          155 ---GNLKSLIWLSVMYNTVGGPIPST----LF-RLTNLERLFLGCNQFNGTI----PREIGNLKNLTHLSIITNKLTG--  220 (701)
Q Consensus       155 ---~~l~~L~~L~L~~N~l~~~~~~~----~~-~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~--  220 (701)
                         .....++.++++.+.........    +. .......+++..+.+....    ...+...+.++.++++.|.+..  
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence               11234555555544432110000    00 1123445555555443211    1123345678888888887642  


Q ss_pred             ---CccccccCCCcccEEEeccCCCCCCC----CcccCCCCcccEEEcCCCCCccccCccc-----CCCCCCcEEEccCc
Q 041034          221 ---AIPSTLGHLTSLLYLDLSFNQLHSFI----PLEIGNFSALAELDLSDNKIRGIIPDEL-----SKLSNLQYLNLSSN  288 (701)
Q Consensus       221 ---~~p~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~~~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N  288 (701)
                         ..+.......+++.+++++|.+....    ...+...+.++.+++++|.+++.....+     .....|+.+++++|
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~  322 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC  322 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence               22333445677888899888886532    1234456788888888888864322221     23457888888888


Q ss_pred             cCCCCCcccc----cCccceeeecCCCCcCCCC----CCCccc-CCCCCCeeeccCCccCCC----CCccccccccCCeE
Q 041034          289 LLSGQIPFAI----GKLFNLVSLDLSKNKLSGS----FPTGIG-NCTELQHLALNHNSLDGT----IPPEIGKILLLQNL  355 (701)
Q Consensus       289 ~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~l  355 (701)
                      .++......+    ....+|++|+|++|++++.    ++..+. ..+.|++|+|++|+|+..    +...+..+++|++|
T Consensus       323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L  402 (460)
T d1z7xw1         323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL  402 (460)
T ss_dssp             CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred             chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence            8875543333    3445788899998888642    233333 356788899999888742    34456667888999


Q ss_pred             EcccccCcccCCCC--------c-cccccccccCCCCCc
Q 041034          356 DLSHNNLSGTIPMT--------L-HPMFLDMSFNNLEGE  385 (701)
Q Consensus       356 ~ls~N~l~g~~p~~--------~-~~~~l~ls~N~l~g~  385 (701)
                      +|++|+++......        . ....+++++|++...
T Consensus       403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence            99998887431111        1 124677777777643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=5.5e-21  Score=206.54  Aligned_cols=324  Identities=20%  Similarity=0.171  Sum_probs=218.2

Q ss_pred             CCCcEEECCCCcceeeC-CcccCCCCCCCEEECcCCcCcc----cCCcccCCCCCCCEEECCCCCCCCC----CccccC-
Q 041034           62 PNLQYLNLWNNNLSGSI-PPQIGSLSNLKYLNLRWNNLTG----TIPKEIGSLRNLEVLYLSNNSLHGT----TPIEIG-  131 (701)
Q Consensus        62 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~-  131 (701)
                      ++|+.||++.|++++.. ...+..+++|++|+|++|+|+.    .++..+..+++|++|||++|+|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36889999999998632 3446678999999999999983    3455678899999999999998632    122232 


Q ss_pred             CccccceeecccccCCCC----CcccccCCCCCcEEEceecccCCCcCccc-----------------------------
Q 041034          132 SLRNLEELYLRSNKLSGV----LPQEIGNLKSLIWLSVMYNTVGGPIPSTL-----------------------------  178 (701)
Q Consensus       132 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----------------------------  178 (701)
                      ..++|++|+|++|+++..    ++..+..+++|++|+|++|.++......+                             
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  161 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  161 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence            235899999999999754    46678889999999999998754211111                             


Q ss_pred             ----ccccccceeEeeecccCCCC----CCCC-CCccccCccccccccccCC----ccccccCCCcccEEEeccCCCCCC
Q 041034          179 ----FRLTNLERLFLGCNQFNGTI----PREI-GNLKNLTHLSIITNKLTGA----IPSTLGHLTSLLYLDLSFNQLHSF  245 (701)
Q Consensus       179 ----~~l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~  245 (701)
                          .....++.++++++......    ...+ ..-.....+++..+.+...    ....+...+.++.+++++|.+...
T Consensus       162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence                11234555555544432110    0000 0112344556666655422    112345568899999999987542


Q ss_pred             -----CCcccCCCCcccEEEcCCCCCccc----cCcccCCCCCCcEEEccCccCCCCCcccc-----cCccceeeecCCC
Q 041034          246 -----IPLEIGNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNLSSNLLSGQIPFAI-----GKLFNLVSLDLSK  311 (701)
Q Consensus       246 -----~~~~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~  311 (701)
                           .+........++.|++++|.+...    ....+...+.++.+++++|.++......+     .....|+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~  321 (460)
T d1z7xw1         242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  321 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence                 233445678999999999998744    22345668899999999999974332222     2346799999999


Q ss_pred             CcCCCCCCCc----ccCCCCCCeeeccCCccCCC----CCcccc-ccccCCeEEcccccCccc----CCCC----ccccc
Q 041034          312 NKLSGSFPTG----IGNCTELQHLALNHNSLDGT----IPPEIG-KILLLQNLDLSHNNLSGT----IPMT----LHPMF  374 (701)
Q Consensus       312 N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~l~ls~N~l~g~----~p~~----~~~~~  374 (701)
                      |.++......    +...++|+.|+|++|+++..    ++..+. ..+.|++|+|++|+++..    ++..    -...+
T Consensus       322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~  401 (460)
T d1z7xw1         322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  401 (460)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence            9988553332    34557899999999998743    233333 356799999999999743    2222    12358


Q ss_pred             cccccCCCCCc
Q 041034          375 LDMSFNNLEGE  385 (701)
Q Consensus       375 l~ls~N~l~g~  385 (701)
                      ||+++|+++..
T Consensus       402 L~Ls~N~i~~~  412 (460)
T d1z7xw1         402 LDLSNNCLGDA  412 (460)
T ss_dssp             EECCSSSCCHH
T ss_pred             EECCCCcCCHH
Confidence            99999999753

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=4.6e-17  Score=163.77  Aligned_cols=179  Identities=19%  Similarity=0.189  Sum_probs=79.8

Q ss_pred             CCCCEEECCCCCCCCC-CccccCCccccceeecccccCCCCCcccccCCCCCcEEEceec-ccCCC-cCcccccccccce
Q 041034          110 RNLEVLYLSNNSLHGT-TPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYN-TVGGP-IPSTLFRLTNLER  186 (701)
Q Consensus       110 ~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~  186 (701)
                      .+|++|||++|.++.. +...+..+++|++|+|++|.+++..+..++.+++|++|++++| .++.. +...+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            3444444444444322 1222334444444444444444333444444444444444442 22211 1111223455555


Q ss_pred             eEeeec-ccCCC-CCCCCCC-ccccCccccccc--cccCC-ccccccCCCcccEEEeccC-CCCCCCCcccCCCCcccEE
Q 041034          187 LFLGCN-QFNGT-IPREIGN-LKNLTHLSIITN--KLTGA-IPSTLGHLTSLLYLDLSFN-QLHSFIPLEIGNFSALAEL  259 (701)
Q Consensus       187 L~L~~N-~l~~~-~~~~~~~-l~~L~~L~l~~N--~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~L~~L  259 (701)
                      |+++++ .++.. +...+.. .++|+.|+++++  .++.. +...+.++++|++|++++| .+++.....+..+++|+.|
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence            555543 22210 0011111 234555555543  22211 1222344566666666664 3555455555666666666


Q ss_pred             EcCCC-CCccccCcccCCCCCCcEEEccCc
Q 041034          260 DLSDN-KIRGIIPDELSKLSNLQYLNLSSN  288 (701)
Q Consensus       260 ~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N  288 (701)
                      +|++| .|++.....++++++|+.|+++++
T Consensus       206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            66663 455554455666666666666665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.57  E-value=9.2e-17  Score=166.59  Aligned_cols=237  Identities=20%  Similarity=0.190  Sum_probs=120.8

Q ss_pred             CCCCCCcEEECCCCccee----eCCcccCCCCCCCEEECcCCcCccc----------CCcccCCCCCCCEEECCCCCCCC
Q 041034           59 SCFPNLQYLNLWNNNLSG----SIPPQIGSLSNLKYLNLRWNNLTGT----------IPKEIGSLRNLEVLYLSNNSLHG  124 (701)
Q Consensus        59 ~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----------~p~~~~~l~~L~~L~Ls~N~l~~  124 (701)
                      .....|+.|+|++|.|..    .+...+...++|+.|+++++.+...          +...+...++|+.|+|++|.++.
T Consensus        28 ~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  107 (344)
T d2ca6a1          28 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP  107 (344)
T ss_dssp             HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred             hhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccc
Confidence            445667777777777643    2334566677777777776644311          12334556777777777777765


Q ss_pred             CCc----cccCCccccceeecccccCCCCCcccc-------------cCCCCCcEEEceecccCCCcCccccccccccee
Q 041034          125 TTP----IEIGSLRNLEELYLRSNKLSGVLPQEI-------------GNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERL  187 (701)
Q Consensus       125 ~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  187 (701)
                      ...    ..+...++|++|++++|.+.......+             ...+.|+.+++++|.++......          
T Consensus       108 ~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~----------  177 (344)
T d2ca6a1         108 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE----------  177 (344)
T ss_dssp             TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH----------
T ss_pred             ccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccc----------
Confidence            422    233455677777777776542111111             12334444555444443211111          


Q ss_pred             EeeecccCCCCCCCCCCccccCccccccccccCC-----ccccccCCCcccEEEeccCCCCCC----CCcccCCCCcccE
Q 041034          188 FLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGA-----IPSTLGHLTSLLYLDLSFNQLHSF----IPLEIGNFSALAE  258 (701)
Q Consensus       188 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-----~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~~~~L~~  258 (701)
                                +...+...+.|++|+|++|+|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++
T Consensus       178 ----------l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~  247 (344)
T d2ca6a1         178 ----------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE  247 (344)
T ss_dssp             ----------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred             ----------ccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchh
Confidence                      111122334455555555554421     223344555666666666665432    1223445566666


Q ss_pred             EEcCCCCCccccCccc----C--CCCCCcEEEccCccCCCCC----ccccc-CccceeeecCCCCcCC
Q 041034          259 LDLSDNKIRGIIPDEL----S--KLSNLQYLNLSSNLLSGQI----PFAIG-KLFNLVSLDLSKNKLS  315 (701)
Q Consensus       259 L~L~~N~l~~~~p~~l----~--~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~  315 (701)
                      |+|++|.|++.....+    .  ..+.|+.|++++|.++...    ...+. +.++|+.|+|++|++.
T Consensus       248 L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            6666666654322222    1  1245666777776665322    22221 3456677777777765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=6.6e-17  Score=162.60  Aligned_cols=223  Identities=20%  Similarity=0.192  Sum_probs=109.6

Q ss_pred             CEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCC-CcccccCCCCCcEEEcee
Q 041034           89 KYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGV-LPQEIGNLKSLIWLSVMY  167 (701)
Q Consensus        89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~  167 (701)
                      ++|||+++.+.......+.. ..+..+.++...+..... ......+|++|||++|.++.. +...+..+++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            35666666554222111111 234556666555442222 233445777777777776543 233455666666666666


Q ss_pred             cccCCCcCcccccccccceeEeeec-ccCCCCCCCCCCccccCccccccccccCCccccccCCCcccEEEeccC-CCCCC
Q 041034          168 NTVGGPIPSTLFRLTNLERLFLGCN-QFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFN-QLHSF  245 (701)
Q Consensus       168 N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~  245 (701)
                      |.+++..+..++.+++|++|+++++ .++...                       +...+..+++|++|+++++ .++..
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~-----------------------l~~l~~~~~~L~~L~ls~c~~~~~~  137 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-----------------------LQTLLSSCSRLDELNLSWCFDFTEK  137 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-----------------------HHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccc-----------------------cchhhHHHHhccccccccccccccc
Confidence            6665555555555566666666552 332110                       1111223445555555543 22211


Q ss_pred             -CCcccC-CCCcccEEEcCCC--CCccc-cCcccCCCCCCcEEEccCc-cCCCCCcccccCccceeeecCCCC-cCCCCC
Q 041034          246 -IPLEIG-NFSALAELDLSDN--KIRGI-IPDELSKLSNLQYLNLSSN-LLSGQIPFAIGKLFNLVSLDLSKN-KLSGSF  318 (701)
Q Consensus       246 -~~~~~~-~~~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~  318 (701)
                       +...+. ..++|+.|+++++  .++.. +...+.++++|+.|++++| .+++.....+.++++|++|+|++| .+++..
T Consensus       138 ~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~  217 (284)
T d2astb2         138 HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET  217 (284)
T ss_dssp             HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG
T ss_pred             cchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHH
Confidence             111111 1245555555543  23221 1222234556666666654 355455555556666666666663 455444


Q ss_pred             CCcccCCCCCCeeeccCC
Q 041034          319 PTGIGNCTELQHLALNHN  336 (701)
Q Consensus       319 p~~~~~l~~L~~L~L~~N  336 (701)
                      ...++++++|+.|+++++
T Consensus       218 l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         218 LLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GGGGGGCTTCCEEECTTS
T ss_pred             HHHHhcCCCCCEEeeeCC
Confidence            455566666666666665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.56  E-value=4e-17  Score=169.32  Aligned_cols=252  Identities=21%  Similarity=0.205  Sum_probs=166.0

Q ss_pred             CCcccCCCCCCCEEECcCCcCccc----CCcccCCCCCCCEEECCCCCCCCCC----------ccccCCccccceeeccc
Q 041034           78 IPPQIGSLSNLKYLNLRWNNLTGT----IPKEIGSLRNLEVLYLSNNSLHGTT----------PIEIGSLRNLEELYLRS  143 (701)
Q Consensus        78 ~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----------~~~~~~l~~L~~L~L~~  143 (701)
                      +...+.....|+.|+|++|.+...    +...+...++|+.|+++++......          ...+...++|++|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            345566778899999999988642    3345677889999999887654322          12244556777777777


Q ss_pred             ccCCCC----CcccccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCcccccccccc
Q 041034          144 NKLSGV----LPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       144 n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  219 (701)
                      |.++..    +...+...++|+.|++++|.++......++.  .|..+....         .....+.|+.|++++|.++
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~---------~~~~~~~L~~l~l~~n~i~  171 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNK---------KAKNAPPLRSIICGRNRLE  171 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHH---------HHHTCCCCCEEECCSSCCT
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccc--ccccccccc---------ccccCcccceeeccccccc
Confidence            777653    2223334556666666666553211111110  111111100         1123456788888888876


Q ss_pred             CC----ccccccCCCcccEEEeccCCCCCC-----CCcccCCCCcccEEEcCCCCCccc----cCcccCCCCCCcEEEcc
Q 041034          220 GA----IPSTLGHLTSLLYLDLSFNQLHSF-----IPLEIGNFSALAELDLSDNKIRGI----IPDELSKLSNLQYLNLS  286 (701)
Q Consensus       220 ~~----~p~~l~~l~~L~~L~L~~N~l~~~-----~~~~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~  286 (701)
                      ..    +...+..+++|+.|+|++|+|+..     +...+..+++|+.|+|++|.|+..    +...+..+++|++|+|+
T Consensus       172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls  251 (344)
T d2ca6a1         172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  251 (344)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhh
Confidence            32    334456678999999999998752     234567789999999999998743    44567789999999999


Q ss_pred             CccCCCCCcccc----c--CccceeeecCCCCcCCCC----CCCccc-CCCCCCeeeccCCccCC
Q 041034          287 SNLLSGQIPFAI----G--KLFNLVSLDLSKNKLSGS----FPTGIG-NCTELQHLALNHNSLDG  340 (701)
Q Consensus       287 ~N~l~~~~~~~~----~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~  340 (701)
                      +|.|++.....+    .  ....|++|++++|+|+..    +...+. +++.|++|+|++|++..
T Consensus       252 ~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             cCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            999986433333    2  246799999999998743    233332 56889999999999973

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.5e-15  Score=138.40  Aligned_cols=85  Identities=20%  Similarity=0.169  Sum_probs=36.7

Q ss_pred             CCCCCcEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCcccccee
Q 041034           60 CFPNLQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEEL  139 (701)
Q Consensus        60 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  139 (701)
                      +...+++|+|++|+|+.+ +..+..+++|++|+|++|.|+..  +.|..+++|++|+|++|+++...+..+..+++|+.|
T Consensus        16 n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence            334444444444444422 33333444444444444444422  124444444444444444443333333344444444


Q ss_pred             ecccccCC
Q 041034          140 YLRSNKLS  147 (701)
Q Consensus       140 ~L~~n~l~  147 (701)
                      +|++|+++
T Consensus        93 ~L~~N~i~  100 (162)
T d1a9na_          93 ILTNNSLV  100 (162)
T ss_dssp             ECCSCCCC
T ss_pred             eecccccc
Confidence            44444443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=2.3e-15  Score=137.22  Aligned_cols=130  Identities=18%  Similarity=0.131  Sum_probs=108.9

Q ss_pred             ccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCC
Q 041034           81 QIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSL  160 (701)
Q Consensus        81 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  160 (701)
                      .|.+..+|++|||++|+|+. +|..+..+++|++|+|++|+|+..  ..|..+++|++|+|++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            46678899999999999985 467778899999999999999854  358899999999999999998777778889999


Q ss_pred             cEEEceecccCCCcC-cccccccccceeEeeecccCCCC---CCCCCCccccCcccc
Q 041034          161 IWLSVMYNTVGGPIP-STLFRLTNLERLFLGCNQFNGTI---PREIGNLKNLTHLSI  213 (701)
Q Consensus       161 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~l  213 (701)
                      +.|++++|.+..... ..+..+++|++|++++|.++...   +..+..+++|++||-
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence            999999999976532 56888999999999999997432   124677899998873

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=1.3e-14  Score=125.54  Aligned_cols=102  Identities=28%  Similarity=0.400  Sum_probs=64.7

Q ss_pred             cEEECCCCcceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccc
Q 041034           65 QYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSN  144 (701)
Q Consensus        65 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  144 (701)
                      |.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|+.|+.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            45677777776 333 3667777777777777776 4455677777777777777777643 2 3666777777777777


Q ss_pred             cCCCCC-cccccCCCCCcEEEceecccC
Q 041034          145 KLSGVL-PQEIGNLKSLIWLSVMYNTVG  171 (701)
Q Consensus       145 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~  171 (701)
                      +++... ...+..+++|+.|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            766442 234555555556666555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=3.7e-14  Score=122.71  Aligned_cols=101  Identities=31%  Similarity=0.419  Sum_probs=47.2

Q ss_pred             EEEeccCCCCCCCCcccCCCCcccEEEcCCCCCccccCcccCCCCCCcEEEccCccCCCCCcccccCccceeeecCCCCc
Q 041034          234 YLDLSFNQLHSFIPLEIGNFSALAELDLSDNKIRGIIPDELSKLSNLQYLNLSSNLLSGQIPFAIGKLFNLVSLDLSKNK  313 (701)
Q Consensus       234 ~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  313 (701)
                      +|+|++|+|+.. + .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|.|++ +| .++.+++|+.|++++|+
T Consensus         2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            444555555432 2 2444445555555555554 234444455555555555555542 22 24445555555555555


Q ss_pred             CCCCC-CCcccCCCCCCeeeccCCccC
Q 041034          314 LSGSF-PTGIGNCTELQHLALNHNSLD  339 (701)
Q Consensus       314 l~~~~-p~~~~~l~~L~~L~L~~N~l~  339 (701)
                      ++... ...+..+++|+.|++++|+++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            54221 123444555555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=5.6e-15  Score=139.43  Aligned_cols=110  Identities=23%  Similarity=0.294  Sum_probs=45.2

Q ss_pred             ccCCCCCCCEEECCCCCCCCCCccccCCccccceeecccccCCCCCcccccCCCCCcEEEceecccCCCcCccccccccc
Q 041034          105 EIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNL  184 (701)
Q Consensus       105 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  184 (701)
                      .+..+++|++|+|++|+|+.. + .+..+++|++|+|++|+++. +|..+..+++|+.|++++|.++..  ..+..+++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred             HHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccccc
Confidence            344444444444444444422 1 24444444444444444432 122222233344444444444322  124444455


Q ss_pred             ceeEeeecccCCCCC-CCCCCccccCcccccccccc
Q 041034          185 ERLFLGCNQFNGTIP-REIGNLKNLTHLSIITNKLT  219 (701)
Q Consensus       185 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  219 (701)
                      +.|+|++|+++.... ..+..+++|++|+|++|.+.
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccc
Confidence            555555555442211 22344444444444444443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=1e-12  Score=118.48  Aligned_cols=87  Identities=26%  Similarity=0.237  Sum_probs=40.2

Q ss_pred             CCCCCCcEEECCCC-cceeeCCcccCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccc
Q 041034           59 SCFPNLQYLNLWNN-NLSGSIPPQIGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLE  137 (701)
Q Consensus        59 ~~~~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  137 (701)
                      ..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+|+...+..|..+ +|+
T Consensus        28 ~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~  106 (156)
T d2ifga3          28 PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQ  106 (156)
T ss_dssp             CSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCC
T ss_pred             cCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccc-ccc
Confidence            33445555555433 2444444445555555555555555554444445555555555555555543333333222 344


Q ss_pred             eeecccccC
Q 041034          138 ELYLRSNKL  146 (701)
Q Consensus       138 ~L~L~~n~l  146 (701)
                      .|+|++|.+
T Consensus       107 ~L~L~~Np~  115 (156)
T d2ifga3         107 ELVLSGNPL  115 (156)
T ss_dssp             EEECCSSCC
T ss_pred             ccccCCCcc
Confidence            444444444

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=1e-14  Score=137.57  Aligned_cols=113  Identities=23%  Similarity=0.240  Sum_probs=57.5

Q ss_pred             cccCCCCCcEEEceecccCCCcCcccccccccceeEeeecccCCCCCCCCCCccccCccccccccccCCccccccCCCcc
Q 041034          153 EIGNLKSLIWLSVMYNTVGGPIPSTLFRLTNLERLFLGCNQFNGTIPREIGNLKNLTHLSIITNKLTGAIPSTLGHLTSL  232 (701)
Q Consensus       153 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L  232 (701)
                      .+..+++|++|+|++|+++.. + .+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|+..  +.+..+++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred             HHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccc
Confidence            344444444444444444432 1 3455555555555555554 2333333344555555555555532  235555666


Q ss_pred             cEEEeccCCCCCCCC-cccCCCCcccEEEcCCCCCcccc
Q 041034          233 LYLDLSFNQLHSFIP-LEIGNFSALAELDLSDNKIRGII  270 (701)
Q Consensus       233 ~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~  270 (701)
                      ++|++++|+|+.... ..+..+++|+.|+|++|.+....
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccccCc
Confidence            666666666655321 24556666666666666655443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=7.3e-13  Score=119.45  Aligned_cols=105  Identities=19%  Similarity=0.123  Sum_probs=66.2

Q ss_pred             CcEEECCCCcceeeCCcccCCCCCCCEEECcCC-cCcccCCcccCCCCCCCEEECCCCCCCCCCccccCCccccceeecc
Q 041034           64 LQYLNLWNNNLSGSIPPQIGSLSNLKYLNLRWN-NLTGTIPKEIGSLRNLEVLYLSNNSLHGTTPIEIGSLRNLEELYLR  142 (701)
Q Consensus        64 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  142 (701)
                      ...++.+++++. ..|..+..+++|++|+|++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            345666666665 34556666677777777654 3665555667777777777777777776666666777777777777


Q ss_pred             cccCCCCCcccccCCCCCcEEEceeccc
Q 041034          143 SNKLSGVLPQEIGNLKSLIWLSVMYNTV  170 (701)
Q Consensus       143 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l  170 (701)
                      +|+|+...+..|..+ +|+.|+|++|.+
T Consensus        89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          89 FNALESLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             SSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred             CCCCcccChhhhccc-cccccccCCCcc
Confidence            777665544444433 455555555555

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=6.4e-08  Score=94.52  Aligned_cols=150  Identities=14%  Similarity=0.107  Sum_probs=103.9

Q ss_pred             HHHHhhhcCCccceEEeeccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeC
Q 041034          443 EDLINATEDFHIRYCIGTGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHK  521 (701)
Q Consensus       443 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  521 (701)
                      .++....+.|+.++..+.++.+.||+... +++.+++|+........   ...+.+|...+..+. +--+++++.+..++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            35566677887777655555678999875 56677888876543322   234567888877664 44467888888888


Q ss_pred             cEEEEEEEccCCCCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 041034          522 RCMFFIYEYMERGSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHHDC-----------------------------  572 (701)
Q Consensus       522 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----------------------------  572 (701)
                      +..++||++++|.++.+.....        .....++.++++.++.||+..                             
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            9999999999998876544221        112234566666666666431                             


Q ss_pred             ---------------------------CCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          573 ---------------------------TPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       573 ---------------------------~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                                                 ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                       12379999999999998776667999998753

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=2.1e-09  Score=96.97  Aligned_cols=89  Identities=22%  Similarity=0.055  Sum_probs=44.4

Q ss_pred             cCCCCCCCEEECcCCcCcccCCcccCCCCCCCEEECCCCCCCCCC--ccccCCccccceeecccccCCCCCcccccCCCC
Q 041034           82 IGSLSNLKYLNLRWNNLTGTIPKEIGSLRNLEVLYLSNNSLHGTT--PIEIGSLRNLEELYLRSNKLSGVLPQEIGNLKS  159 (701)
Q Consensus        82 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  159 (701)
                      +..+..+..|+...+... .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+++...+-.+....+
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            333444444444443332 33334455666777777777666443  233455666666666666666443322222333


Q ss_pred             CcEEEceecccC
Q 041034          160 LIWLSVMYNTVG  171 (701)
Q Consensus       160 L~~L~L~~N~l~  171 (701)
                      |+.|++++|.+.
T Consensus       117 L~~L~L~~Npl~  128 (162)
T d1koha1         117 LEELWLDGNSLS  128 (162)
T ss_dssp             CSSCCCTTSTTS
T ss_pred             cceeecCCCCcC
Confidence            444444444443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=4.3e-09  Score=94.85  Aligned_cols=65  Identities=20%  Similarity=0.158  Sum_probs=30.1

Q ss_pred             CCCccccCccccccccccCCccccccCCCcccEEEeccCCCCCCCC--cccCCCCcccEEEcCCCCCc
Q 041034          202 IGNLKNLTHLSIITNKLTGAIPSTLGHLTSLLYLDLSFNQLHSFIP--LEIGNFSALAELDLSDNKIR  267 (701)
Q Consensus       202 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~~~~L~~L~L~~N~l~  267 (701)
                      +..+..+..+...+|... .++..+..+++|++|+|++|+|+...+  ..+..+++|+.|+|++|+|+
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~  104 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  104 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence            333444444555444433 333333455666666666666655321  22233444444444444444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.22  E-value=7.1e-07  Score=86.37  Aligned_cols=131  Identities=17%  Similarity=0.133  Sum_probs=86.4

Q ss_pred             EEeeccc-eEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCcEEEEEEEccCC
Q 041034          457 CIGTGGY-GSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVR--HRNIVKLYGFCLHKRCMFFIYEYMER  533 (701)
Q Consensus       457 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~  533 (701)
                      .+..|.. +.||+....++..+++|.......      ..+.+|+..++.+.  .-.+++++.+..+++..++||+|++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            4455553 689999887888899998765543      23566777776663  33467788888888889999999988


Q ss_pred             CCHHHHHhcCCCccCCCHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 041034          534 GSLFYVLRDDDEAIELNWTRRVNIVKSVAHALSYLHH-------------------------------------------  570 (701)
Q Consensus       534 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------------  570 (701)
                      .++.+..        ...   ...+.++++.|+-||+                                           
T Consensus        91 ~~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          91 QDLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             EETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             ccccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence            6543210        110   1112233333333332                                           


Q ss_pred             --------CC----CCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          571 --------DC----TPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       571 --------~~----~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                              ..    .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                    11    22479999999999998876677999998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.77  E-value=4.1e-06  Score=75.13  Aligned_cols=87  Identities=15%  Similarity=0.106  Sum_probs=44.2

Q ss_pred             CCCCcEEECCCC-cceee----CCcccCCCCCCCEEECcCCcCcccC----CcccCCCCCCCEEECCCCCCCCCC----c
Q 041034           61 FPNLQYLNLWNN-NLSGS----IPPQIGSLSNLKYLNLRWNNLTGTI----PKEIGSLRNLEVLYLSNNSLHGTT----P  127 (701)
Q Consensus        61 ~~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~----~  127 (701)
                      .+.|++|+|+++ .++..    +-..+...+.|++|+|++|.+....    .+.+...+.|++|+|++|.++...    .
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            466677777653 34321    2234555566666666666665221    123334456666666666655321    1


Q ss_pred             cccCCccccceeecccccCC
Q 041034          128 IEIGSLRNLEELYLRSNKLS  147 (701)
Q Consensus       128 ~~~~~l~~L~~L~L~~n~l~  147 (701)
                      ..+...++|++|+|++|.+.
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHhCCcCCEEECCCCcCC
Confidence            22334455555555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.75  E-value=4e-06  Score=75.19  Aligned_cols=112  Identities=14%  Similarity=0.103  Sum_probs=78.8

Q ss_pred             CCCCCCCEEECcCC-cCccc----CCcccCCCCCCCEEECCCCCCCCCCc----cccCCccccceeecccccCCCC----
Q 041034           83 GSLSNLKYLNLRWN-NLTGT----IPKEIGSLRNLEVLYLSNNSLHGTTP----IEIGSLRNLEELYLRSNKLSGV----  149 (701)
Q Consensus        83 ~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~----  149 (701)
                      .+.++|++|+|+++ .++..    +-..+...++|++|+|++|.+.....    ..+...+.|++|+|++|.++..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999874 56532    23456677889999999998864322    3345568899999999988753    


Q ss_pred             CcccccCCCCCcEEEceecccCCC-------cCcccccccccceeEeeeccc
Q 041034          150 LPQEIGNLKSLIWLSVMYNTVGGP-------IPSTLFRLTNLERLFLGCNQF  194 (701)
Q Consensus       150 ~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~l  194 (701)
                      +..++...++|++|++++|.+...       +...+...++|+.|+++.+..
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            334566778899999998876532       334455678888888876543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.67  E-value=3e-05  Score=79.63  Aligned_cols=79  Identities=11%  Similarity=0.101  Sum_probs=49.5

Q ss_pred             ceEEeeccceEEEEEEcCC-CcEEEEEEecCCCcc----ChHHHHHHHHHHHHHhcCC-C--CceeeeeeeeeeCcEEEE
Q 041034          455 RYCIGTGGYGSVYKAELPD-GKVVALKKLHQSETE----DSAFVESFQNEARVLSTVR-H--RNIVKLYGFCLHKRCMFF  526 (701)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  526 (701)
                      .+.||.|....||++...+ ++.|+||...+....    -....++...|.++++.+. +  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999997654 678999975432100    0111244566887777663 2  456667665  3445578


Q ss_pred             EEEccCCCC
Q 041034          527 IYEYMERGS  535 (701)
Q Consensus       527 v~e~~~~gs  535 (701)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.50  E-value=0.0002  Score=71.26  Aligned_cols=135  Identities=15%  Similarity=0.174  Sum_probs=77.9

Q ss_pred             eEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCCce--eeee-----eeeeeCcEEEEEEEccCCCCH
Q 041034          464 GSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHRNI--VKLY-----GFCLHKRCMFFIYEYMERGSL  536 (701)
Q Consensus       464 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL  536 (701)
                      -.||++..++|+.|++|+..+....    .+++..|...+..+....+  +..+     ..+...+..+.++++++|..+
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            5899999889999999998775433    2556778888777642221  2111     122346678999999987422


Q ss_pred             H-----HH------H-------hcCC--CccCCCHH----------------------HHHHHHHHHHHHHHHHh-cCCC
Q 041034          537 F-----YV------L-------RDDD--EAIELNWT----------------------RRVNIVKSVAHALSYLH-HDCT  573 (701)
Q Consensus       537 ~-----~~------l-------~~~~--~~~~l~~~----------------------~~~~i~~qi~~~L~~LH-~~~~  573 (701)
                      .     .+      +       ....  .....++.                      .....+.++...+.-.- ....
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            1     10      0       1000  00111111                      11222233333332221 2224


Q ss_pred             CCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          574 PSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       574 ~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                      .++||+|+.|.|||++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            578999999999999743  46899998864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.09  E-value=1.5e-05  Score=71.14  Aligned_cols=64  Identities=16%  Similarity=0.180  Sum_probs=30.9

Q ss_pred             CCCCCcEEECCC-Cccee----eCCcccCCCCCCCEEECcCCcCcccC----CcccCCCCCCCEEECCCCCCC
Q 041034           60 CFPNLQYLNLWN-NNLSG----SIPPQIGSLSNLKYLNLRWNNLTGTI----PKEIGSLRNLEVLYLSNNSLH  123 (701)
Q Consensus        60 ~~~~L~~L~L~~-n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~Ls~N~l~  123 (701)
                      +.+.|++|+|++ +.++.    .+-..+...++|++|+|++|.++...    -+.+...++|+.|++++|.+.
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            345566666655 33432    12233445555666666666554221    122334455555555555554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.08  E-value=4.4e-05  Score=68.02  Aligned_cols=116  Identities=18%  Similarity=0.155  Sum_probs=81.8

Q ss_pred             CcccCCCCCCCEEECcC-CcCccc----CCcccCCCCCCCEEECCCCCCCCCCc----cccCCccccceeecccccCCCC
Q 041034           79 PPQIGSLSNLKYLNLRW-NNLTGT----IPKEIGSLRNLEVLYLSNNSLHGTTP----IEIGSLRNLEELYLRSNKLSGV  149 (701)
Q Consensus        79 ~~~~~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~  149 (701)
                      .....+.+.|++|+|++ +.++..    +-.++...++|++|+|++|.++....    ..+...++|+.|++++|.++..
T Consensus        10 ~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~   89 (166)
T d1io0a_          10 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS   89 (166)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence            34445678999999997 567532    33456678999999999998875432    2345668899999999988643


Q ss_pred             ----CcccccCCCCCcEEEc--eecccCCC----cCcccccccccceeEeeeccc
Q 041034          150 ----LPQEIGNLKSLIWLSV--MYNTVGGP----IPSTLFRLTNLERLFLGCNQF  194 (701)
Q Consensus       150 ----~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  194 (701)
                          +...+...++|+.++|  ++|.++..    +...+...++|+.|+++.+..
T Consensus        90 g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          90 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence                3456677788887655  46666542    344566788999999877654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.05  E-value=0.00077  Score=66.47  Aligned_cols=159  Identities=11%  Similarity=0.034  Sum_probs=85.5

Q ss_pred             ccHHHHHhhhcCCccceEEe-----eccceEEEEEEcCCCcEEEEEEecCCCccChHHHHHHHHHHHHHhcCCCC--cee
Q 041034          440 ILYEDLINATEDFHIRYCIG-----TGGYGSVYKAELPDGKVVALKKLHQSETEDSAFVESFQNEARVLSTVRHR--NIV  512 (701)
Q Consensus       440 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv  512 (701)
                      ++-+|++...++|.+.+...     .|---+.|++...+| .+++|+.......     +++..|++++..+...  .++
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence            45678888888898755443     455578899977655 4899988654221     3445566666666321  122


Q ss_pred             eeee------eeeeCcEEEEEEEccCCCCHHH-----------H---Hhc----C--CCccCCC----------------
Q 041034          513 KLYG------FCLHKRCMFFIYEYMERGSLFY-----------V---LRD----D--DEAIELN----------------  550 (701)
Q Consensus       513 ~l~~------~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~----~--~~~~~l~----------------  550 (701)
                      ..+.      +.......+.++.++.+.....           .   ++.    .  .......                
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            2211      1123456677777776642211           0   000    0  0000000                


Q ss_pred             --HHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCcEEEcCCCCeEEEeecCccc
Q 041034          551 --WTRRVNIVKSVAHALSYLHH-DCTPSIVHRDISSNNILLNSNLEAFVADFGTARL  604 (701)
Q Consensus       551 --~~~~~~i~~qi~~~L~~LH~-~~~~givH~Dlkp~NIll~~~~~~kL~DFGla~~  604 (701)
                        .......+......+...+. ....|+||+|+.++||+++.+...-|+||+.|..
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence              01111122222333333332 2345899999999999999887678999998853

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.00  E-value=0.00082  Score=68.65  Aligned_cols=74  Identities=19%  Similarity=0.185  Sum_probs=49.5

Q ss_pred             cceEEeeccceEEEEEEcCC--------CcEEEEEEecCCCccChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCcEE
Q 041034          454 IRYCIGTGGYGSVYKAELPD--------GKVVALKKLHQSETEDSAFVESFQNEARVLSTVR-HRNIVKLYGFCLHKRCM  524 (701)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  524 (701)
                      .++.|+.|-.-.+|++...+        .+.|++++.-. . ..   .....+|..+++.+. +.-.+++++++.+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            35678888889999997643        34577776542 2 11   134567888888874 4445678887653    


Q ss_pred             EEEEEccCCCCH
Q 041034          525 FFIYEYMERGSL  536 (701)
Q Consensus       525 ~lv~e~~~~gsL  536 (701)
                      ++||||++|.++
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            579999987543